diff --git "a/edge/CTD_genes_diseases.tsv" "b/edge/CTD_genes_diseases.tsv" new file mode 100644--- /dev/null +++ "b/edge/CTD_genes_diseases.tsv" @@ -0,0 +1,33938 @@ +# The Comparative Toxicogenomics Database (CTD) - http://ctdbase.org/ +# Copyright 2002-2012 MDI Biological Laboratory. All rights reserved. +# Copyright 2012-2023 NC State University. All rights reserved. +# +# +# Use is subject to the terms set forth at http://ctdbase.org/about/legal.jsp +# These terms include: +# +# 1. All forms of publication (e.g., web sites, research papers, databases, +# software applications, etc.) that use or rely on CTD data must cite CTD. +# Citation guidelines: http://ctdbase.org/about/publications/#citing +# +# 2. All electronic or online applications must include hyperlinks from +# contexts that use CTD data to the applicable CTD data pages. +# Linking instructions: http://ctdbase.org/help/linking.jsp +# +# 3. You must notify CTD, and describe your use of our data: +# http://ctdbase.org/help/contact.go +# +# 4. For quality control purposes, you must provide CTD with periodic +# access to your publication of our data. +# +# More information: http://ctdbase.org/downloads/ +# +# Report created: Fri Oct 27 13:27:36 EDT 2023 +# +# Fields: +# GeneSymbol GeneID DiseaseName DiseaseID DirectEvidence InferenceChemicalName InferenceScore OmimIDs PubMedIDs +# +A 50518 Dermatitis MESH:D003872 marker/mechanism 32937126 +A 50518 Diabetes Mellitus MESH:D003920 marker/mechanism 1473152 +A 50518 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 8146154 +A 50518 Edema MESH:D004487 marker/mechanism 32937126 +A 50518 Failure to Thrive MESH:D005183 marker/mechanism 32937126 +A 50518 Furunculosis MESH:D005667 marker/mechanism 32937126 +A 50518 Hepatic Veno-Occlusive Disease MESH:D006504 marker/mechanism 32937126 +A 50518 Hyperplasia MESH:D006965 marker/mechanism 32937126 +A 50518 Keratosis MESH:D007642 marker/mechanism 32937126 +A 50518 Liver Neoplasms MESH:D008113 marker/mechanism 15175105 +A 50518 Neoplasms MESH:D009369 marker/mechanism 1473152 +A 50518 Obesity MESH:D009765 marker/mechanism 1473152|25447408|25448685|32937126|8146154 +A 50518 Pigmentation Disorders MESH:D010859 marker/mechanism 32937126|8146154 +A 50518 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 32937126 +A1BG 1 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +A1BG 1 Schizophrenia MESH:D012559 marker/mechanism 25821032 +A2M 2 Acute Kidney Injury MESH:D058186 marker/mechanism 23052191 +A2M 2 Adenoma, Liver Cell MESH:D018248 marker/mechanism 15509519 +A2M 2 Alzheimer Disease MESH:D000544 marker/mechanism 15023809|9697696|9811940 +A2M 2 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15509519 +A2M 2 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +A2M 2 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +A2M 2 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +A2M 2 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +A2M 2 Lung Diseases MESH:D008171 marker/mechanism 2475424 +A2M 2 Lung Neoplasms MESH:D008175 marker/mechanism 17902193|19180532 +A2M 2 Nephrotic Syndrome MESH:D009404 marker/mechanism 11304663 +A2ML1 144568 Otitis Media MESH:D010033 marker/mechanism 166760.0 26121085 +A4GALT 53947 Burkitt Lymphoma MESH:D002051 marker/mechanism 11482875 +AAAS 8086 Achalasia Addisonianism Alacrimia syndrome MESH:C536008 marker/mechanism 231550.0 17853339|23315990 +AAAS 8086 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +AADAC 13 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AADAT 51166 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +AADAT 51166 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AAGAB 79719 Keratoderma, Palmoplantar MESH:D007645 marker/mechanism 23064416 +AAGAB 79719 Keratosis palmoplantaris papulosa MESH:C536161 marker/mechanism 148600.0 +AANAT 15 Sleep Disorders, Circadian Rhythm MESH:D020178 marker/mechanism 12736803 +AARS1 16 Charcot-Marie-Tooth Disease, Axonal, Type 2n MESH:C567653 marker/mechanism 613287.0 +AARS1 16 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29 OMIM:616339 marker/mechanism 616339.0 +AARS2 57505 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8 OMIM:614096 marker/mechanism 614096.0 +AARS2 57505 LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE OMIM:615889 marker/mechanism 615889.0 +AASS 10157 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +AASS 10157 Hyperlysinemias MESH:D020167 marker/mechanism 238700.0 +ABAT 18 Autistic Disorder MESH:D001321 marker/mechanism 15830322 +ABAT 18 Gamma aminobutyric acid transaminase deficiency MESH:C535407 marker/mechanism 613163.0 10407778 +ABAT 18 Gastroesophageal Reflux MESH:D005764 marker/mechanism 21552517 +ABAT 18 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 21552517 +ABAT 18 Lethargy MESH:D053609 marker/mechanism 10407778 +ABAT 18 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ABAT 18 Muscle Hypotonia MESH:D009123 marker/mechanism 10407778 +ABAT 18 Psychomotor Disorders MESH:D011596 marker/mechanism 10407778 +ABAT 18 Reflex, Abnormal MESH:D012021 marker/mechanism 10407778 +ABAT 18 Seizures MESH:D012640 marker/mechanism 10407778 +ABCA1 19 Atherosclerosis MESH:D050197 marker/mechanism 22022523 +ABCA1 19 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCA1 19 Hdl Deficiency, Type 2 MESH:C538394 marker/mechanism 10431236|11476965 +ABCA1 19 Hypercholesterolemia MESH:D006937 marker/mechanism 22022523 +ABCA1 19 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 16030523 +ABCA1 19 Hypoalphalipoproteinemias MESH:D052456 marker/mechanism 604091.0 +ABCA1 19 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +ABCA1 19 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +ABCA1 19 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 21245421 +ABCA1 19 Tangier Disease MESH:D013631 marker/mechanism 205400.0 10431236|11476965|17710129 +ABCA10 10349 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCA12 26154 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCA12 26154 Harlequin type ichthyosis MESH:C538424 marker/mechanism 242500.0 +ABCA12 26154 Ichthyosis, Lamellar MESH:D017490 marker/mechanism 16675967 +ABCA12 26154 Lamellar ichthyosis, type 2 MESH:C537264 marker/mechanism 601277.0 +ABCA12 26154 Recurrence MESH:D012008 marker/mechanism 35837087 +ABCA12 26154 Thyroid Neoplasms MESH:D013964 marker/mechanism 35837087 +ABCA13 154664 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCA13 154664 Disease Progression MESH:D018450 marker/mechanism 22294766 +ABCA2 20 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ABCA3 21 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCA3 21 Emphysema MESH:D004646 marker/mechanism 26780485 +ABCA3 21 Hypertension, Pulmonary MESH:D006976 marker/mechanism 26780485 +ABCA3 21 Pulmonary Fibrosis MESH:D011658 marker/mechanism 26780485 +ABCA3 21 Surfactant Metabolism Dysfunction, Pulmonary, 3 MESH:C567046 marker/mechanism 610921.0 +ABCA4 24 Cleft Lip MESH:D002971 marker/mechanism 20436469 +ABCA4 24 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCA4 24 Cone-Rod Dystrophy 3 MESH:C565827 marker/mechanism 604116.0 +ABCA4 24 Familial Exudative Vitreoretinopathies MESH:D000080345 marker/mechanism 29207047 +ABCA4 24 Macular Degeneration MESH:D008268 marker/mechanism 16968212 +ABCA4 24 Macular Degeneration, Age-Related, 2 MESH:C562479 marker/mechanism 153800.0 +ABCA4 24 Retinitis Pigmentosa MESH:D012174 marker/mechanism 16968212 +ABCA4 24 Retinitis Pigmentosa 19 MESH:C566637 marker/mechanism 601718.0 +ABCA4 24 Stargardt Disease MESH:D000080362 marker/mechanism 248200.0 +ABCA5 23461 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCA5 23461 Hypertrichosis Terminalis, Generalized, with or without Gingival Hyperplasia MESH:C565016 marker/mechanism 135400.0 +ABCA6 23460 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCA6 23460 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +ABCA7 10347 Alzheimer Disease MESH:D000544 marker/mechanism 21460840|25807283 +ABCA7 10347 Alzheimer Disease 9 MESH:C563834 marker/mechanism 608907.0 +ABCA7 10347 Disease Progression MESH:D018450 marker/mechanism 22294766 +ABCA8 10351 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ABCA8 10351 Breast Neoplasms MESH:D001943 marker/mechanism 35191604 +ABCA8 10351 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCA8 10351 Recurrence MESH:D012008 marker/mechanism 35837087 +ABCA8 10351 Thyroid Neoplasms MESH:D013964 marker/mechanism 35837087 +ABCA8A 217258 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ABCA9 10350 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCB1 5243 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 12015757 +ABCB1 5243 Arthritis, Experimental MESH:D001169 marker/mechanism 17827786 +ABCB1 5243 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20080907|22104130 +ABCB1 5243 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ABCB1 5243 Breast Neoplasms MESH:D001943 marker/mechanism 22311042 +ABCB1 5243 Carcinoma MESH:D002277 marker/mechanism 21332314 +ABCB1 5243 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17510421 +ABCB1 5243 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 20627363 +ABCB1 5243 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +ABCB1 5243 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766|23977225 +ABCB1 5243 Disease Progression MESH:D018450 marker/mechanism 20627363 +ABCB1 5243 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 18381794|20563569|21064136|25007187 +ABCB1 5243 Epilepsy MESH:D004827 marker/mechanism 19570321|8001500 +ABCB1 5243 Escherichia coli Infections MESH:D004927 marker/mechanism 24498193 +ABCB1 5243 Esophageal Neoplasms MESH:D004938 marker/mechanism 21332314 +ABCB1 5243 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 22311042 +ABCB1 5243 Heart Defects, Congenital MESH:D006330 marker/mechanism 23874772 +ABCB1 5243 Hematologic Neoplasms MESH:D019337 marker/mechanism 22311042 +ABCB1 5243 Hypotension, Orthostatic MESH:D007024 marker/mechanism 12082591 +ABCB1 5243 Inflammatory Bowel Disease 13 MESH:C567384 marker/mechanism 612244.0 +ABCB1 5243 Kidney Neoplasms MESH:D007680 marker/mechanism 22311042 +ABCB1 5243 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +ABCB1 5243 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21325069 +ABCB1 5243 Marijuana Abuse MESH:D002189 marker/mechanism 19625010 +ABCB1 5243 Mental Disorders MESH:D001523 marker/mechanism 17015054 +ABCB1 5243 Nausea MESH:D009325 marker/mechanism 21840870 +ABCB1 5243 Neoplasm Metastasis MESH:D009362 marker/mechanism 12015757 +ABCB1 5243 Neoplasms MESH:D009369 marker/mechanism 22269388 +ABCB1 5243 Nervous System Diseases MESH:D009422 marker/mechanism 17015054|21064136 +ABCB1 5243 Neuroblastoma MESH:D009447 marker/mechanism 8761367 +ABCB1 5243 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 12352921 +ABCB1 5243 Neutropenia MESH:D009503 marker/mechanism 16950614|25007187 +ABCB1 5243 Pain, Postoperative MESH:D010149 therapeutic 20627697 +ABCB1 5243 Parkinson Disease MESH:D010300 marker/mechanism 20558393 +ABCB1 5243 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 26457621 +ABCB1 5243 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 16950614 +ABCB1 5243 Poisoning MESH:D011041 therapeutic 23562926 +ABCB1 5243 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 22674224 +ABCB1 5243 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 25275603 +ABCB1 5243 Translocation, Genetic MESH:D014178 marker/mechanism 21325069 +ABCB1 5243 Vomiting MESH:D014839 marker/mechanism 21840870 +ABCB10 23456 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCB11 8647 Afibrinogenemia MESH:D000347 marker/mechanism 22120137 +ABCB11 8647 Cholestasis MESH:D002779 marker/mechanism 11179459|22461449|24713091 +ABCB11 8647 CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2 OMIM:605479 marker/mechanism 605479.0 +ABCB11 8647 Cholestasis, Intrahepatic MESH:D002780 marker/mechanism 18049162 +ABCB11 8647 Cholestasis, progressive familial intrahepatic 1 MESH:C535933 marker/mechanism 21056966 +ABCB11 8647 Cholestasis, progressive familial intrahepatic 2 MESH:C535934 marker/mechanism 601847.0 36142670 +ABCB11 8647 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCB11 8647 Pruritus MESH:D011537 marker/mechanism 18049162 +ABCB1A 18671 Cardiomyopathies MESH:D009202 marker/mechanism 33171190 +ABCB1A 18671 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26134275 +ABCB1A 18671 Diarrhea MESH:D003967 marker/mechanism 32387182 +ABCB1A 18671 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 24502637|28193520|32387182 +ABCB1A 18671 Heart Diseases MESH:D006331 marker/mechanism 16844662 +ABCB1A 18671 Hyperlipidemias MESH:D006949 marker/mechanism 24502637 +ABCB1A 18671 Kidney Diseases MESH:D007674 marker/mechanism 24502637 +ABCB1A 18671 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16182555 +ABCB1A 18671 Pain MESH:D010146 therapeutic 28193520 +ABCB1A 18671 Reperfusion Injury MESH:D015427 marker/mechanism 22749977 +ABCB1A 18671 Seizures MESH:D012640 marker/mechanism 17437408 +ABCB1A 18671 Status Epilepticus MESH:D013226 marker/mechanism 14706787 +ABCB1B 18669 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +ABCB1B 18669 Breast Neoplasms MESH:D001943 therapeutic 14633655 +ABCB1B 18669 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 27193730 +ABCB1B 18669 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +ABCB1B 18669 Endotoxemia MESH:D019446 marker/mechanism 20300455 +ABCB1B 18669 Liver Neoplasms MESH:D008113 marker/mechanism 27193730 +ABCB1B 18669 Mammary Neoplasms, Experimental MESH:D008325 therapeutic 14633655 +ABCB1B 18669 Status Epilepticus MESH:D013226 marker/mechanism 14706787 +ABCB4 5244 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22022477 +ABCB4 5244 Cholangitis MESH:D002761 marker/mechanism 8698195 +ABCB4 5244 Cholangitis, Sclerosing MESH:D015209 marker/mechanism 16472600|29808285 +ABCB4 5244 Cholestasis, progressive familial intrahepatic 1 MESH:C535933 marker/mechanism 21056966 +ABCB4 5244 Cholestasis, progressive familial intrahepatic 3 MESH:C535935 marker/mechanism 602347.0 22184139|28552422 +ABCB4 5244 Chronic Disease MESH:D002908 marker/mechanism 29808285 +ABCB4 5244 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCB4 5244 Disease Models, Animal MESH:D004195 marker/mechanism 16472600|29808285 +ABCB4 5244 Disease Progression MESH:D018450 marker/mechanism 22294766 +ABCB4 5244 End Stage Liver Disease MESH:D058625 marker/mechanism 22022477 +ABCB4 5244 GALLBLADDER DISEASE 1 OMIM:600803 marker/mechanism 600803.0 +ABCB4 5244 Inflammation MESH:D007249 marker/mechanism 22022477 +ABCB4 5244 Intrahepatic Cholestasis of Pregnancy MESH:C535932 marker/mechanism 614972.0 +ABCB4 5244 Jaundice, Obstructive MESH:D041781 marker/mechanism 22022477 +ABCB4 5244 Liver Cirrhosis MESH:D008103 marker/mechanism 18221819|8698195 +ABCB4 5244 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 20040336|30682444 +ABCB4 5244 Liver Diseases MESH:D008107 marker/mechanism 29808285 +ABCB4 5244 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 20040336 +ABCB5 340273 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCB5 340273 Melanoma MESH:D008545 marker/mechanism 15899824 +ABCB6 10058 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCB6 10058 DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3 OMIM:615402 marker/mechanism 615402.0 +ABCB6 10058 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7 OMIM:614497 marker/mechanism 614497.0 +ABCB6 10058 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ABCB6 10058 Pseudohyperkalemia, Familial, 2, due to Red Cell Leak MESH:C563785 marker/mechanism 609153.0 +ABCB6 10058 Recurrence MESH:D012008 marker/mechanism 35837087 +ABCB6 10058 Thyroid Neoplasms MESH:D013964 marker/mechanism 35837087 +ABCB7 22 Anemia, Sideroblastic MESH:D000756 marker/mechanism 16892088|18637800 +ABCB7 22 Anemia, sideroblastic spinocerebellar ataxia MESH:C536358 marker/mechanism 301310.0 21326867 +ABCB7 22 Ataxia MESH:D001259 marker/mechanism 16892088 +ABCB8 11194 Recurrence MESH:D012008 marker/mechanism 35837087 +ABCB8 11194 Thyroid Neoplasms MESH:D013964 marker/mechanism 35837087 +ABCC1 4363 Breast Neoplasms MESH:D001943 marker/mechanism 25078270 +ABCC1 4363 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 18466103 +ABCC1 4363 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCC1 4363 Disease Progression MESH:D018450 marker/mechanism 25078270 +ABCC1 4363 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 18256692 +ABCC1 4363 Heart Diseases MESH:D006331 marker/mechanism 16330681 +ABCC1 4363 Hypertension MESH:D006973 marker/mechanism 17272743 +ABCC1 4363 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +ABCC1 4363 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 25275603 +ABCC10 89845 Recurrence MESH:D012008 marker/mechanism 35837087 +ABCC10 89845 Thyroid Neoplasms MESH:D013964 marker/mechanism 35837087 +ABCC11 85320 Disease Progression MESH:D018450 marker/mechanism 22294766 +ABCC12 94160 Bone Marrow Diseases MESH:D001855 marker/mechanism 18466103 +ABCC12 94160 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 18466103 +ABCC13 150000 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCC2 1244 Alopecia MESH:D000505 marker/mechanism 18381794 +ABCC2 1244 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23897011 +ABCC2 1244 Cardiomyopathies MESH:D009202 marker/mechanism 33171190 +ABCC2 1244 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 18381794|18466103 +ABCC2 1244 Cholestasis MESH:D002779 marker/mechanism 10869290|17681005|22521610 +ABCC2 1244 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCC2 1244 Diarrhea MESH:D003967 marker/mechanism 32387182 +ABCC2 1244 Drug Hypersensitivity MESH:D004342 marker/mechanism 20216337 +ABCC2 1244 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 20216337|23222202|25007187|32387182 +ABCC2 1244 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21206495 +ABCC2 1244 Gastrointestinal Diseases MESH:D005767 marker/mechanism 18381794 +ABCC2 1244 Heart Diseases MESH:D006331 marker/mechanism 16330681 +ABCC2 1244 Hyperbilirubinemia MESH:D006932 marker/mechanism 16611851 +ABCC2 1244 Jaundice, Chronic Idiopathic MESH:D007566 marker/mechanism 237500.0 16952291 +ABCC2 1244 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 15542527 +ABCC2 1244 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ABCC2 1244 Nervous System Diseases MESH:D009422 marker/mechanism 21064136 +ABCC2 1244 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29341352 +ABCC2 1244 Seizures MESH:D012640 marker/mechanism 16504477 +ABCC2 1244 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 25275603 +ABCC2 1244 Status Epilepticus MESH:D013226 marker/mechanism 16504477 +ABCC3 8714 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23897011 +ABCC3 8714 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ABCC3 8714 Cholestasis MESH:D002779 marker/mechanism 22461449 +ABCC3 8714 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCC3 8714 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +ABCC4 10257 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23897011 +ABCC4 10257 Cognition Disorders MESH:D003072 marker/mechanism 29382564 +ABCC4 10257 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCC4 10257 Diabetes Complications MESH:D048909 marker/mechanism 29382564 +ABCC4 10257 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 23222202 +ABCC4 10257 Endometriosis MESH:D004715 marker/mechanism 25446850 +ABCC4 10257 Neoplasm Metastasis MESH:D009362 marker/mechanism 17003774 +ABCC4 10257 Prostatic Neoplasms MESH:D011471 marker/mechanism 17003774 +ABCC4 10257 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ABCC5 10057 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23897011 +ABCC5 10057 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCC5 10057 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ABCC6 368 Arterial calcification of infancy MESH:C537440 marker/mechanism 614473 25758222 +ABCC6 368 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCC6 368 Disease Models, Animal MESH:D004195 marker/mechanism 23415960 +ABCC6 368 Disease Progression MESH:D018450 marker/mechanism 22294766 +ABCC6 368 Pseudoxanthoma Elasticum MESH:D011561 marker/mechanism 177850|264800 11880368|12069597|14667841|16571645|17045963|18049453|23415960|25758222 +ABCC6A 566555 Arterial calcification of infancy MESH:C537440 marker/mechanism 25758222 +ABCC6A 566555 Disease Models, Animal MESH:D004195 marker/mechanism 25758222 +ABCC6A 566555 Pseudoxanthoma Elasticum MESH:D011561 marker/mechanism 25758222 +ABCC8 6833 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCC8 6833 Congenital Hyperinsulinism MESH:D044903 marker/mechanism 256450 10334322|15579781 +ABCC8 6833 Diabetes Mellitus, Transient Neonatal, 2 MESH:C563672 marker/mechanism 610374 +ABCC8 6833 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 18025464 +ABCC8 6833 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853 22209866|9568693 +ABCC8 6833 Hypoglycemia, leucine-induced MESH:C537150 marker/mechanism 240800 +ABCC9 10060 ATRIAL FIBRILLATION, FAMILIAL, 12 OMIM:614050 marker/mechanism 614050 +ABCC9 10060 Cantu syndrome MESH:C535572 marker/mechanism 239850 22610116|28842488 +ABCC9 10060 Cardiomyopathy, Dilated, 1o MESH:C563906 marker/mechanism 608569 +ABCC9 10060 Endometrial Neoplasms MESH:D016889 marker/mechanism 23104009 +ABCC9 10060 Endometriosis MESH:D004715 marker/mechanism 20864642 +ABCD1 215 Adrenoleukodystrophy MESH:D000326 marker/mechanism 300100.0 16319717|17602313|22057157 +ABCD2 225 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCD3 5825 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5 OMIM:616278 marker/mechanism 616278.0 +ABCD3 5825 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCD3 5825 Zellweger Syndrome MESH:D015211 marker/mechanism 1301993 +ABCD4 5826 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCD4 5826 Disease Progression MESH:D018450 marker/mechanism 22294766 +ABCD4 5826 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 22922874 +ABCD4 5826 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE OMIM:614857 marker/mechanism 614857.0 +ABCD4 5826 Vitamin B 12 Deficiency MESH:D014806 marker/mechanism 22922874 +ABCE1 6059 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCF1 23 Disease Progression MESH:D018450 marker/mechanism 22294766 +ABCF1 23 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +ABCF1 23 Pneumonia MESH:D011014 marker/mechanism 21625544 +ABCF2 10061 Disease Progression MESH:D018450 marker/mechanism 22294766 +ABCG1 9619 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +ABCG1 9619 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +ABCG1 9619 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ABCG1 9619 Weight Gain MESH:D015430 marker/mechanism 17194745 +ABCG2 9429 Adenoma MESH:D000236 marker/mechanism 21544799 +ABCG2 9429 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23897011 +ABCG2 9429 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ABCG2 9429 Breast Neoplasms MESH:D001943 marker/mechanism 10930538 +ABCG2 9429 Cardiomyopathies MESH:D009202 marker/mechanism 33171190 +ABCG2 9429 Colorectal Neoplasms MESH:D015179 marker/mechanism 21544799|22294766 +ABCG2 9429 Diarrhea MESH:D003967 marker/mechanism 32387182 +ABCG2 9429 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 21064136|32387182 +ABCG2 9429 Gout MESH:D006073 marker/mechanism 21821808|31578528 +ABCG2 9429 Heart Failure MESH:D006333 marker/mechanism 36071497 +ABCG2 9429 Hyperuricemia MESH:D033461 marker/mechanism 21821808 +ABCG2 9429 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 15542527 +ABCG2 9429 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21625222 +ABCG2 9429 Mammary Neoplasms, Experimental MESH:D008325 therapeutic 22767648 +ABCG2 9429 Nervous System Diseases MESH:D009422 marker/mechanism 21064136 +ABCG2 9429 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 20019844 +ABCG2 9429 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 25275603 +ABCG2 9429 URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1 OMIM:138900 marker/mechanism 138900.0 +ABCG5 64240 Atherosclerosis MESH:D050197 marker/mechanism 11138003 +ABCG5 64240 Coronary Artery Disease MESH:D003324 marker/mechanism 11099417|11138003 +ABCG5 64240 Coronary Disease MESH:D003327 marker/mechanism 19060911 +ABCG5 64240 Dyslipidemias MESH:D050171 marker/mechanism 19060911 +ABCG5 64240 Lipid Metabolism, Inborn Errors MESH:D008052 marker/mechanism 11138003 +ABCG5 64240 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ABCG5 64240 Prostatic Neoplasms MESH:D011471 marker/mechanism 22919386 +ABCG5 64240 Sitosterolemia MESH:C537345 marker/mechanism 11099417|11138003 +ABCG5 64240 Xanthomatosis MESH:D014973 marker/mechanism 11138003 +ABCG8 64241 Coronary Artery Disease MESH:D003324 marker/mechanism 11099417 +ABCG8 64241 Gallbladder Disease 4 MESH:C566936 marker/mechanism 611465.0 +ABCG8 64241 Gallstones MESH:D042882 marker/mechanism 17632509 +ABCG8 64241 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ABCG8 64241 Sitosterolemia MESH:C537345 marker/mechanism 210250.0 11099417 +ABHD12 26090 Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa, And Cataract MESH:C567203 marker/mechanism 612674.0 +ABHD5 51099 Chanarin-Dorfman Syndrome MESH:C536560 marker/mechanism 275630.0 +ABI1 10006 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ABI3 51225 Alzheimer Disease MESH:D000544 marker/mechanism 28714976 +ABI3BP 25890 Endometriosis MESH:D004715 marker/mechanism 20864642 +ABL1 25 Adenocarcinoma MESH:D000230 marker/mechanism 21472143 +ABL1 25 Bone Diseases, Developmental MESH:D001848 marker/mechanism 28288113 +ABL1 25 Breast Neoplasms MESH:D001943 marker/mechanism 20234815 +ABL1 25 Carcinogenesis MESH:D063646 marker/mechanism 23968727 +ABL1 25 Esophageal Neoplasms MESH:D004938 marker/mechanism 21472143 +ABL1 25 Failure to Thrive MESH:D005183 marker/mechanism 28288113 +ABL1 25 Heart Defects, Congenital MESH:D006330 marker/mechanism 28288113 +ABL1 25 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 608232.0 15604220|18673174|21908430|33070465 +ABL1 25 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +ABL1 25 Musculoskeletal Abnormalities MESH:D009139 marker/mechanism 28288113 +ABL1 25 Neoplasms, Experimental MESH:D009374 marker/mechanism 19878872 +ABL1 25 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +ABL1 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 11984797|21898527 +ABLIM1 3983 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ABLIM3 22885 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ABO 28 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 25581431 +ABO 28 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990 +ABO 28 COVID-19 MESH:D000086382 marker/mechanism 32558485 +ABO 28 Critical Illness MESH:D016638 marker/mechanism 32558485 +ABO 28 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +ABO 28 Duodenal Ulcer MESH:D004381 marker/mechanism 22387998 +ABO 28 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19648918|26098869 +ABO 28 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ABO 28 Respiratory Insufficiency MESH:D012131 marker/mechanism 32558485 +ABO 28 Stroke MESH:D020521 marker/mechanism 29531354 +ABR 29 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +ABRA 137735 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 16243910 +ABT1 29777 Disease Progression MESH:D018450 marker/mechanism 21364753 +ABT1 29777 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +ABTB3 121551 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +ACAA1B 235674 Heart Failure MESH:D006333 marker/mechanism 26670611 +ACAA2 10449 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +ACAA2 10449 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +ACACA 31 Acetyl-Coa Carboxylase Deficiency MESH:C562678 marker/mechanism 613933.0 +ACACA 31 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +ACACA 31 Heart Failure MESH:D006333 marker/mechanism 26670611 +ACACB 32 Breast Neoplasms MESH:D001943 marker/mechanism 35191604 +ACACB 32 Insulin Resistance MESH:D007333 marker/mechanism 22658938 +ACACB 32 Obesity MESH:D009765 marker/mechanism 20882379 +ACAD8 27034 Disease Progression MESH:D018450 marker/mechanism 21364753 +ACAD8 27034 Isobutyryl-CoA dehydrogenase deficiency MESH:C535541 marker/mechanism 611283.0 +ACAD8 27034 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +ACAD9 28976 Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of MESH:C567006 marker/mechanism 611126.0 21057504 +ACADM 34 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +ACADM 34 Liver Failure MESH:D017093 marker/mechanism 9090694 +ACADM 34 Medium chain acyl CoA dehydrogenase deficiency MESH:C536038 marker/mechanism 201450.0 +ACADM 34 Obesity MESH:D009765 marker/mechanism 20882379 +ACADM 34 Weight Gain MESH:D015430 marker/mechanism 19030233 +ACADS 35 Heart Failure MESH:D006333 marker/mechanism 30827304 +ACADS 35 Short chain Acyl CoA dehydrogenase deficiency MESH:C537596 marker/mechanism 201470.0 +ACADSB 36 2-Methylbutyryl-CoA Dehydrogenase Deficiency MESH:C566487 marker/mechanism 610006.0 +ACADSB 36 Autistic Disorder MESH:D001321 marker/mechanism 17883863 +ACADVL 37 Hypoxia MESH:D000860 marker/mechanism 18258771 +ACADVL 37 VLCAD deficiency MESH:C536353 marker/mechanism 201475.0 20060901 +ACAN 176 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 15292528 +ACAN 176 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 12868502 +ACAN 176 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +ACAN 176 SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS OMIM:165800 marker/mechanism 165800.0 +ACAN 176 Spondyloepimetaphyseal Dysplasia, Aggrecan Type MESH:C567558 marker/mechanism 612813.0 +ACAN 176 Spondyloepiphyseal Dysplasia, Kimberley Type MESH:C564252 marker/mechanism 608361.0 +ACAT1 38 Beta ketothiolase deficiency MESH:C535434 marker/mechanism 203750.0 +ACAT1 38 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +ACAT1 38 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ACAT1 38 Seizures MESH:D012640 marker/mechanism 23266720 +ACAT2 39 Cytosolic acetoacetyl-CoA thiolase deficiency MESH:C536005 marker/mechanism 614055.0 +ACBD4 79777 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ACBD6 84320 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ACD 65057 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6 OMIM:616553 marker/mechanism 616553.0 +ACE 1636 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +ACE 1636 Albuminuria MESH:D000419 marker/mechanism 23733546 +ACE 1636 Allanson Pantzar McLeod syndrome MESH:C537048 marker/mechanism 16116425 +ACE 1636 Alzheimer Disease MESH:D000544 marker/mechanism 10643899|14872014|17192785|30820047|9916793 +ACE 1636 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 15331425 +ACE 1636 Atrial Fibrillation MESH:D001281 marker/mechanism 15331425 +ACE 1636 Autistic Disorder MESH:D001321 marker/mechanism 27082637 +ACE 1636 Berylliosis MESH:D001607 marker/mechanism 10194187 +ACE 1636 Brain Ischemia MESH:D002545 marker/mechanism 15534175 +ACE 1636 Carcinoma, Hepatocellular MESH:D006528 therapeutic 16328049 +ACE 1636 Cardiovascular Diseases MESH:D002318 marker/mechanism 11498459|14657821|16544732 +ACE 1636 Celiac Disease MESH:D002446 marker/mechanism 30097691 +ACE 1636 Cerebral Hemorrhage MESH:D002543 marker/mechanism 614519.0 15277638 +ACE 1636 Coronary Artery Disease MESH:D003324 marker/mechanism 14989558 +ACE 1636 Coronary Disease MESH:D003327 marker/mechanism 8170965 +ACE 1636 Coronary Restenosis MESH:D023903 marker/mechanism 9236417 +ACE 1636 Cough MESH:D003371 marker/mechanism 12848919|15498266 +ACE 1636 Death, Sudden MESH:D003645 marker/mechanism 15331425 +ACE 1636 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22191573 +ACE 1636 Diabetic Nephropathies MESH:D003928 marker/mechanism 10099885|10857950|23733546|28468961|7909524 +ACE 1636 Drug Hypersensitivity MESH:D004342 marker/mechanism 18727619 +ACE 1636 Gaucher Disease MESH:D005776 marker/mechanism 12359135 +ACE 1636 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 18727619 +ACE 1636 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 7593601|9259580 +ACE 1636 Glycogen Storage Disease Type V MESH:D006012 marker/mechanism 12666117 +ACE 1636 Heart Failure MESH:D006333 marker/mechanism 18586661 +ACE 1636 Hypertension MESH:D006973 marker/mechanism 15773232|17473847|20237592|27847271 +ACE 1636 Hypertension, Pulmonary MESH:D006976 marker/mechanism 12359135 +ACE 1636 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 8349331 +ACE 1636 Hypotension MESH:D007022 therapeutic 3544871 +ACE 1636 Infant, Premature, Diseases MESH:D007235 marker/mechanism 14657821 +ACE 1636 Infertility, Male MESH:D007248 marker/mechanism 12075344|8642790 +ACE 1636 Kidney Diseases MESH:D007674 marker/mechanism 8642790 +ACE 1636 Kidney Failure, Chronic MESH:D007676 marker/mechanism 10099885|7593601 +ACE 1636 Lung Diseases MESH:D008171 marker/mechanism 18702808 +ACE 1636 Lung Injury MESH:D055370 marker/mechanism|therapeutic 16001071|33007385 +ACE 1636 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +ACE 1636 Meningococcal Infections MESH:D008589 marker/mechanism 11956052 +ACE 1636 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3 OMIM:612624 marker/mechanism 612624.0 +ACE 1636 Myocardial Infarction MESH:D009203 marker/mechanism 1328889|8131300 +ACE 1636 Neoplasm Metastasis MESH:D009362 marker/mechanism 18059164 +ACE 1636 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615 +ACE 1636 Pneumonia, Viral MESH:D011024 marker/mechanism 15381116 +ACE 1636 Pre-Eclampsia MESH:D011225 marker/mechanism 17114810 +ACE 1636 Prostatic Neoplasms MESH:D011471 marker/mechanism 17465223 +ACE 1636 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 17196621 +ACE 1636 Pulmonary Fibrosis MESH:D011658 therapeutic 33007385 +ACE 1636 Renal Insufficiency MESH:D051437 marker/mechanism 9259580 +ACE 1636 RENAL TUBULAR DYSGENESIS OMIM:267430 marker/mechanism 267430.0 20454656 +ACE 1636 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 12204859|22009550 +ACE 1636 Respiratory Tract Diseases MESH:D012140 marker/mechanism 14657821 +ACE 1636 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 15381116 +ACE 1636 Staphylococcal Infections MESH:D013203 marker/mechanism 8186310 +ACE 1636 Stomach Neoplasms MESH:D013274 marker/mechanism 18059164 +ACE 1636 Stroke MESH:D020521 marker/mechanism 15534175 +ACE 1636 Vascular System Injuries MESH:D057772 marker/mechanism 19258495 +ACE 1636 Weight Gain MESH:D015430 marker/mechanism 25322899 +ACE 1636 Weight Loss MESH:D015431 therapeutic 33007385 +ACE2 59272 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +ACE2 59272 Acute Lung Injury MESH:D055371 therapeutic 27302421 +ACE2 59272 Anxiety Disorders MESH:D001008 marker/mechanism 26767952 +ACE2 59272 Aortic Aneurysm, Abdominal MESH:D017544 therapeutic 25301841 +ACE2 59272 Cardiomyopathies MESH:D009202 therapeutic 28445944 +ACE2 59272 Coronavirus Infections MESH:D018352 marker/mechanism 14647384|16007097|19453650|19625462|22496216|23678171|24172901|24227843|25187545 +ACE2 59272 COVID-19 MESH:D000086382 marker/mechanism|therapeutic 31996437|32061198|32081428|32092392|32117569|32129518|32132184|32133153|32142651|32149769|32201080|32203189|32275855|32286790|32404436 +ACE2 59272 Diabetic Nephropathies MESH:D003928 marker/mechanism|therapeutic 12623933|17600118|20844835 +ACE2 59272 Diabetic Retinopathy MESH:D003930 therapeutic 31380462 +ACE2 59272 Endomyocardial Fibrosis MESH:D004719 marker/mechanism 19221212 +ACE2 59272 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 16723697 +ACE2 59272 Heart Failure MESH:D006333 marker/mechanism 25973029 +ACE2 59272 Hypertension MESH:D006973 marker/mechanism|therapeutic 12075344|15833808|17473847|18391097|19221212|20559404|21859683 +ACE2 59272 Hypertension, Pulmonary MESH:D006976 therapeutic 31931441 +ACE2 59272 Inflammation MESH:D007249 marker/mechanism 19453650 +ACE2 59272 Lung Injury MESH:D055370 marker/mechanism|therapeutic 16001071|19864379|20484496|33007385 +ACE2 59272 Pulmonary Fibrosis MESH:D011658 marker/mechanism|therapeutic 27550926|33007385 +ACE2 59272 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 22009550 +ACE2 59272 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 14647384|16007097|16166518|16339146|19453650|19625462|23678171|24172901|24227843|26801988|31996437|32092392|32201080 +ACE2 59272 Weight Loss MESH:D015431 marker/mechanism 33007385 +ACER3 55331 Melanoma MESH:D008545 marker/mechanism 22535842 +ACHE 43 Alzheimer Disease MESH:D000544 marker/mechanism 22944069|23047022 +ACHE 43 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 16470869 +ACHE 43 Amyloidosis MESH:D000686 marker/mechanism 23047022 +ACHE 43 Anemia MESH:D000740 marker/mechanism 31170385 +ACHE 43 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ACHE 43 Breast Neoplasms MESH:D001943 marker/mechanism 23063927 +ACHE 43 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 18482720 +ACHE 43 Colorectal Neoplasms MESH:D015179 marker/mechanism 31004929 +ACHE 43 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 27083141 +ACHE 43 Growth Disorders MESH:D006130 marker/mechanism 22898132 +ACHE 43 Learning Disabilities MESH:D007859 marker/mechanism 18533140 +ACHE 43 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16496349 +ACHE 43 Memory Disorders MESH:D008569 marker/mechanism 18599028 +ACHE 43 Movement Disorders MESH:D009069 marker/mechanism 19628251 +ACHE 43 Muscular Dystrophies MESH:D009136 marker/mechanism 22906800 +ACHE 43 Nervous System Diseases MESH:D009422 marker/mechanism 22240983 +ACHE 43 Obesity MESH:D009765 marker/mechanism 29273807 +ACHE 43 Organophosphate Poisoning MESH:D062025 marker/mechanism|therapeutic 23000449|3669600|8359835 +ACHE 43 Poisoning MESH:D011041 marker/mechanism 17098105 +ACHE 43 Prenatal Injuries MESH:D049188 marker/mechanism 14657522 +ACHE 43 Prostatic Neoplasms MESH:D011471 marker/mechanism 20356562 +ACHE 43 Seizures MESH:D012640 marker/mechanism|therapeutic 19941057|27083141 +ACHE 43 Tremor MESH:D014202 therapeutic 27083141 +ACHE 43 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 29644616 +ACKR1 2532 Malaria MESH:D008288 marker/mechanism 611162.0 +ACKR3 57007 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +ACKR3 57007 Carcinoma MESH:D002277 marker/mechanism 22180778 +ACKR3 57007 Colorectal Neoplasms MESH:D015179 marker/mechanism 22180778 +ACKR3 57007 Kidney Diseases MESH:D007674 marker/mechanism 22880115 +ACKR3 57007 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ACKR3 57007 Multiple Sclerosis, Relapsing-Remitting MESH:D020529 marker/mechanism 34624384 +ACKR3 57007 Neoplasm Metastasis MESH:D009362 marker/mechanism 22180778 +ACKR4 51554 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +ACL-7 174916 Embryo Loss MESH:D020964 marker/mechanism 25204677 +ACLY 47 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +ACLY 47 Heart Failure MESH:D006333 marker/mechanism 26670611 +ACLY 47 Obesity MESH:D009765 marker/mechanism 20882379 +ACO1 48 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20390345 +ACO1 48 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +ACO2 50 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +ACO2 50 INFANTILE CEREBELLAR-RETINAL DEGENERATION OMIM:614559 marker/mechanism 614559.0 +ACO2 50 OPTIC ATROPHY 9 OMIM:616289 marker/mechanism 616289.0 +ACO2 50 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +ACOT1 641371 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14563825 +ACOT1 641371 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +ACOT1 641371 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +ACOT2 10965 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ACOT6 641372 Schizophrenia MESH:D012559 marker/mechanism 21822266 +ACOT9 23597 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ACOX1 51 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12771043|15565109 +ACOX1 51 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14563825 +ACOX1 51 Peroxisomal ACYL-COA oxidase deficiency MESH:C536662 marker/mechanism 264470.0 +ACOX2 8309 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6 OMIM:617308 marker/mechanism 617308.0 +ACOX2 8309 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ACOX3 8310 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ACOXL 55289 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 23770605 +ACP2 53 Acid Phosphatase Deficiency MESH:C562645 marker/mechanism 200950.0 +ACP3 55 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ACP4 93650 AMELOGENESIS IMPERFECTA, TYPE IJ OMIM:617297 marker/mechanism 617297.0 +ACP5 54 Combined Immunodeficiency with Autoimmunity and Spondylometaphyseal Dysplasia MESH:C564307 marker/mechanism 607944.0 +ACP5 54 Hyperparathyroidism, Secondary MESH:D006962 marker/mechanism 21985997|22373954 +ACP5 54 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ACP5 54 Obesity MESH:D009765 marker/mechanism 20882379 +ACP5 54 Spondyloenchondrodysplasia MESH:C535782 marker/mechanism 21217752|21217755 +ACRBP 84519 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ACRBP 84519 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ACSF3 197322 Combined Malonic and Methylmalonic Aciduria MESH:C580002 marker/mechanism 614265.0 +ACSF3 197322 Malonic aciduria MESH:C535702 marker/mechanism 21841779 +ACSF3 197322 Methylmalonic acidemia MESH:C537358 marker/mechanism 21841779 +ACSL1 2180 Arthritis, Experimental MESH:D001169 marker/mechanism 18988084 +ACSL1 2180 Carcinoma MESH:D002277 marker/mechanism 16316942 +ACSL1 2180 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ACSL1 2180 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 9452481 +ACSL1 2180 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ACSL1 2180 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +ACSL1 2180 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +ACSL1 2180 Obesity MESH:D009765 marker/mechanism 20882379 +ACSL4 2182 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +ACSL4 2182 Arthritis, Experimental MESH:D001169 marker/mechanism 18988084 +ACSL4 2182 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +ACSL4 2182 Depressive Disorder MESH:D003866 marker/mechanism 15108178 +ACSL4 2182 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +ACSL4 2182 Erythema MESH:D004890 marker/mechanism 15108178 +ACSL4 2182 Mental Retardation, X-Linked 63 MESH:C564522 marker/mechanism 300387.0 +ACSL4 2182 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ACSL5 51703 Arthritis, Experimental MESH:D001169 marker/mechanism 18988084 +ACSL6 23305 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +ACSM1 116285 Lung Neoplasms MESH:D008175 marker/mechanism 17114358 +ACSM3 6296 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +ACTA1 58 CONGENITAL MYOPATHY 2A, TYPICAL, AUTOSOMAL DOMINANT OMIM:161800 marker/mechanism 161800.0 +ACTA1 58 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 10601118 +ACTA1 58 MYOPATHY, SCAPULOHUMEROPERONEAL OMIM:616852 marker/mechanism 616852.0 +ACTA2 59 Aortic Aneurysm, Familial Thoracic 6 MESH:C567085 marker/mechanism 611788.0 +ACTA2 59 Aortic Aneurysm, Thoracic MESH:D017545 marker/mechanism 17994018 +ACTA2 59 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +ACTA2 59 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951|31932644 +ACTA2 59 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +ACTA2 59 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +ACTA2 59 Endometriosis MESH:D004715 marker/mechanism 20864642 +ACTA2 59 Fetal Growth Retardation MESH:D005317 marker/mechanism 28157488 +ACTA2 59 Fibrosis MESH:D005355 marker/mechanism 31697999 +ACTA2 59 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 20493835 +ACTA2 59 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +ACTA2 59 Ischemia MESH:D007511 marker/mechanism 19458120 +ACTA2 59 Kidney Diseases MESH:D007674 marker/mechanism 19913069|31697999 +ACTA2 59 Liver Cirrhosis MESH:D008103 marker/mechanism 24239723|24321339|30097701|32659284 +ACTA2 59 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 26435214|26739621 +ACTA2 59 Liver Diseases MESH:D008107 marker/mechanism 11738102 +ACTA2 59 MOYAMOYA DISEASE 5 OMIM:614042 marker/mechanism 614042.0 +ACTA2 59 Myocardial Infarction MESH:D009203 marker/mechanism 24358288 +ACTA2 59 Nephrogenic Fibrosing Dermopathy MESH:D054989 marker/mechanism 20570839 +ACTA2 59 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +ACTA2 59 Pulmonary Fibrosis MESH:D011658 marker/mechanism 30639579 +ACTA2 59 Scleroderma, Systemic MESH:D012595 marker/mechanism 24706986 +ACTA2 59 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +ACTB 60 BARAITSER-WINTER SYNDROME 1 OMIM:243310 marker/mechanism 243310.0 +ACTB 60 Carcinoma MESH:D002277 marker/mechanism 16316942 +ACTB 60 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144|21472284 +ACTB 60 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ACTB 60 Coloboma MESH:D003103 marker/mechanism 22366783 +ACTB 60 Craniofacial Abnormalities MESH:D019465 marker/mechanism 22366783 +ACTB 60 Dysostoses MESH:D004413 marker/mechanism 16685646 +ACTB 60 Dystonia MESH:D004421 marker/mechanism 16685646 +ACTB 60 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +ACTB 60 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 16685646 +ACTB 60 Hypoxia MESH:D000860 marker/mechanism 19579223 +ACTB 60 Juvenile-onset dystonia MESH:C537704 marker/mechanism 607371.0 +ACTB 60 Lung Neoplasms MESH:D008175 marker/mechanism 23692979 +ACTB 60 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +ACTB 60 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +ACTB 60 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ACTB 60 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15654357 +ACTB 60 Nervous System Malformations MESH:D009421 marker/mechanism 22366783 +ACTB 60 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +ACTC1 70 Atrial Septal Defect 5 MESH:C567561 marker/mechanism 612794.0 +ACTC1 70 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 613424.0 +ACTC1 70 Cardiomyopathy, Familial Hypertrophic, 11 MESH:C567419 marker/mechanism 612098.0 +ACTC1 70 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +ACTC1 70 Refractive Errors MESH:D012030 marker/mechanism 20835239 +ACTC1 70 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +ACTG1 71 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +ACTG1 71 BARAITSER-WINTER SYNDROME 2 OMIM:614583 marker/mechanism 614583.0 +ACTG1 71 Carcinoma MESH:D002277 marker/mechanism 16316942 +ACTG1 71 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 25401301 +ACTG1 71 Coloboma MESH:D003103 marker/mechanism 22366783 +ACTG1 71 Craniofacial Abnormalities MESH:D019465 marker/mechanism 22366783 +ACTG1 71 Deafness, Autosomal Dominant 20 MESH:C565754 marker/mechanism 604717.0 +ACTG1 71 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +ACTG1 71 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +ACTG1 71 Nervous System Malformations MESH:D009421 marker/mechanism 22366783 +ACTG1 71 Osteoporosis MESH:D010024 marker/mechanism 18924182 +ACTG2 72 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +ACTG2 72 Megacystis microcolon intestinal hypoperistalsis syndrome MESH:C536138 marker/mechanism 24337657|24676022 +ACTG2 72 VISCERAL MYOPATHY 1 OMIM:155310 marker/mechanism 155310.0 +ACTG2 72 Visceral Myopathy, Familial MESH:C562574 marker/mechanism 22960657 +ACTL6B 51412 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 28973294 +ACTL9 284382 Dermatitis, Atopic MESH:D003876 marker/mechanism 23042114 +ACTN1 87 BLEEDING DISORDER, PLATELET-TYPE, 15 OMIM:615193 marker/mechanism 615193.0 +ACTN1 87 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ACTN2 88 Cardiomyopathy, Dilated, 1AA MESH:C567407 marker/mechanism 612158.0 +ACTN4 81 Carcinoma MESH:D002277 marker/mechanism 12376462 +ACTN4 81 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ACTN4 81 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 603278.0 +ACTN4 81 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +ACTN4 81 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +ACTR3 10096 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ACTRT2 140625 Keloid MESH:D007627 marker/mechanism 20128793 +ACVR1 90 Acute Lung Injury MESH:D055371 marker/mechanism 21297076 +ACVR1 90 Astrocytoma MESH:D001254 marker/mechanism 24705250 +ACVR1 90 Breast Neoplasms MESH:D001943 marker/mechanism 23180569 +ACVR1 90 Glioma MESH:D005910 marker/mechanism 24705251|24705252|24705254 +ACVR1 90 Myositis Ossificans MESH:D009221 marker/mechanism 135100.0 +ACVR1B 91 Pancreatic Neoplasms MESH:D010190 marker/mechanism 260350.0 +ACVR2A 92 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +ACVR2B 93 Heterotaxy Syndrome MESH:D059446 marker/mechanism 9916847 +ACVR2B 93 HETEROTAXY, VISCERAL, 4, AUTOSOMAL OMIM:613751 marker/mechanism 613751.0 +ACVR2B 93 Situs Inversus MESH:D012857 marker/mechanism 9916847 +ACVRL1 94 Hypertension, Pulmonary MESH:D006976 marker/mechanism 26540443 +ACVRL1 94 Osler-rendu-weber syndrome 2 MESH:C537139 marker/mechanism 600376.0 +ACVRL1 94 Telangiectasia, Hereditary Hemorrhagic MESH:D013683 marker/mechanism 20135064 +ACVRL1 94 Vascular Remodeling MESH:D066253 marker/mechanism 26540443 +ACY1 95 Aminoacylase 1 deficiency MESH:C538246 marker/mechanism 609924.0 +ACY1 95 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +ACY1 95 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +ACYP2 98 HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO OMIM:613290 marker/mechanism 25665007 +ADA 100 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ADA 100 Autistic Disorder MESH:D001321 marker/mechanism 11354825 +ADA 100 Hyperemia MESH:D006940 therapeutic 2502780|7949234 +ADA 100 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ADA 100 Lung Neoplasms MESH:D008175 marker/mechanism 2305558 +ADA 100 Severe combined immunodeficiency due to adenosine deaminase deficiency MESH:C531816 marker/mechanism 102700.0 +ADA 100 Spinal Cord Diseases MESH:D013118 marker/mechanism 16325979 +ADA2 51816 Sneddon Syndrome MESH:D018860 marker/mechanism 182410.0 +ADAM10 102 Alzheimer Disease MESH:D000544 marker/mechanism 30820047 +ADAM10 102 ALZHEIMER DISEASE 18 OMIM:615590 marker/mechanism 615590.0 +ADAM10 102 Breast Neoplasms MESH:D001943 marker/mechanism 16583263 +ADAM10 102 Dowling-Degos Disease MESH:C562924 marker/mechanism 615537.0 +ADAM10 102 Fibrosis MESH:D005355 marker/mechanism 32715474 +ADAM10 102 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 32715474 +ADAM10 102 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 32715474 +ADAM10 102 Renal Insufficiency MESH:D051437 marker/mechanism 32715474 +ADAM17 6868 Blister MESH:D001768 marker/mechanism 19167455 +ADAM17 6868 Colitis MESH:D003092 marker/mechanism 24548422 +ADAM17 6868 INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1 OMIM:614328 marker/mechanism 614328.0 +ADAM17 6868 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ADAM26A 13525 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ADAM28 10863 Lung Neoplasms MESH:D008175 marker/mechanism 20544843 +ADAM28 10863 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +ADAM33 80332 Breast Neoplasms MESH:D001943 marker/mechanism 30226539 +ADAM33 80332 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 17061022 +ADAM3A 1587 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +ADAM8 101 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 24646716 +ADAM9 8754 CONE-ROD DYSTROPHY 9 OMIM:612775 marker/mechanism 612775.0 +ADAM9 8754 Prostatic Neoplasms MESH:D011471 marker/mechanism 17018608 +ADAMTS1 9510 Alzheimer Disease MESH:D000544 marker/mechanism 30820047 +ADAMTS1 9510 Breast Neoplasms MESH:D001943 marker/mechanism 23289900 +ADAMTS1 9510 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19514085 +ADAMTS1 9510 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 19027488 +ADAMTS1 9510 Neoplasm Invasiveness MESH:D009361 marker/mechanism 23289900 +ADAMTS10 81794 Weill-Marchesani Syndrome MESH:D056846 marker/mechanism 277600.0 +ADAMTS13 11093 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ADAMTS13 11093 Purpura, Thrombocytopenic, Idiopathic MESH:D016553 marker/mechanism 19260037 +ADAMTS13 11093 Purpura, Thrombotic Thrombocytopenic MESH:D011697 marker/mechanism 274150.0 12656756 +ADAMTS13 11093 Thrombotic Microangiopathies MESH:D057049 marker/mechanism 14625834|16388419 +ADAMTS17 170691 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +ADAMTS17 170691 Weill-Marchesani-Like Syndrome MESH:C567710 marker/mechanism 613195.0 +ADAMTS18 170692 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ADAMTS18 170692 MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS OMIM:615458 marker/mechanism 615458.0 +ADAMTS19 171019 Heart Valve Diseases MESH:D006349 marker/mechanism 31844321 +ADAMTS2 9509 Ehlers-Danlos Syndrome, Type VII, Autosomal Recessive MESH:C567527 marker/mechanism 225410.0 +ADAMTS2 9509 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26139392 +ADAMTS20 80070 Melanoma MESH:D008545 marker/mechanism 21559390 +ADAMTS3 9508 Schizophrenia MESH:D012559 marker/mechanism 21822266 +ADAMTS5 11096 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +ADAMTS7 11173 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990 +ADAMTS7 11173 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ADAMTS8 11095 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +ADAMTS9 56999 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 18372903|23967108 +ADAMTSL2 9719 Acromicric dysplasia MESH:C535662 marker/mechanism 231050.0 18677313 +ADAMTSL2 9719 Contracture MESH:D003286 marker/mechanism 18677313 +ADAMTSL2 9719 Facies MESH:D019066 marker/mechanism 18677313 +ADAMTSL2 9719 Growth Disorders MESH:D006130 marker/mechanism 18677313 +ADAMTSL2 9719 Hand Deformities, Congenital MESH:D006228 marker/mechanism 18677313 +ADAMTSL2 9719 Heart Valve Diseases MESH:D006349 marker/mechanism 18677313 +ADAMTSL2 9719 Hepatomegaly MESH:D006529 marker/mechanism 18677313 +ADAMTSL2 9719 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 18677313 +ADAMTSL2 9719 Osteochondrodysplasias MESH:D010009 marker/mechanism 18677313 +ADAMTSL4 54507 ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE OMIM:225100 marker/mechanism 225100.0 +ADAMTSL4 54507 Ectopia Lentis with Ectopia of Pupil MESH:C563268 marker/mechanism 225200.0 +ADAP1 11033 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 37156999 +ADAR 103 Aicardi-Goutieres syndrome MESH:C535607 marker/mechanism 615010.0 23001123 +ADAR 103 Breast Neoplasms MESH:D001943 marker/mechanism 28188287 +ADAR 103 Dyschromatosis symmetrica hereditaria 1 MESH:C535729 marker/mechanism 127400.0 +ADARB1 104 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ADARB2 105 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +ADARB2 105 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ADAT3 113179 NEURODEVELOPMENTAL DISORDER WITH BRAIN ABNORMALITIES, POOR GROWTH, AND DYSMORPHIC FACIES OMIM:615286 marker/mechanism 615286.0 +ADCY1 107 Deafness, Autosomal Recessive 44 MESH:C565716 marker/mechanism 610154.0 +ADCY1 107 Hyperkinesis MESH:D006948 marker/mechanism 16914643 +ADCY1 107 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +ADCY1 107 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 16914643 +ADCY10 55811 Hypercalciuria, Absorptive, 2 MESH:C562790 marker/mechanism 143870.0 +ADCY2 108 Asthma MESH:D001249 marker/mechanism 21912604 +ADCY2 108 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +ADCY3 109 Diabetic Angiopathies MESH:D003925 marker/mechanism 25381014 +ADCY3 109 Obesity MESH:D009765 marker/mechanism 29311635 +ADCY3 109 Obesity, Morbid MESH:D009767 marker/mechanism 29311637 +ADCY5 111 Birth Weight MESH:D001724 marker/mechanism 23202124 +ADCY5 111 Carcinoma MESH:D002277 marker/mechanism 12376462 +ADCY5 111 Cardiomyopathies MESH:D009202 marker/mechanism 18029912|23536361 +ADCY5 111 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 20081858|23202124 +ADCY5 111 Dyskinesia, Familial, with Facial Myokymia MESH:C564676 marker/mechanism 606703.0 +ADCY5 111 Fibrosis MESH:D005355 therapeutic 25193472 +ADCY5 111 Hypertension MESH:D006973 marker/mechanism 12717102 +ADCY5 111 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +ADCY5 111 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +ADCY5 111 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +ADCY5 111 Osteoporosis MESH:D010024 marker/mechanism 18029912 +ADCY5 111 Ventricular Dysfunction, Left MESH:D018487 therapeutic 25193472 +ADCY6 112 LETHAL CONGENITAL CONTRACTURE SYNDROME 8 OMIM:616287 marker/mechanism 616287.0 +ADCY7 113 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ADCY7 113 Colitis, Ulcerative MESH:D003093 marker/mechanism 28067910 +ADCY7 113 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +ADCY7 113 Schizophrenia MESH:D012559 marker/mechanism 21822266 +ADCY8 114 Diabetic Angiopathies MESH:D003925 marker/mechanism 25381014 +ADCY8 114 Hyperkinesis MESH:D006948 marker/mechanism 16914643 +ADCY8 114 Mood Disorders MESH:D019964 marker/mechanism 19691954 +ADCY8 114 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 16914643 +ADCYAP1 116 Cardiomyopathies MESH:D009202 therapeutic 20378996 +ADCYAP1 116 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +ADCYAP1 116 Hyperemia MESH:D006940 marker/mechanism 8637627 +ADCYAP1 116 Miosis MESH:D015877 marker/mechanism 8637627 +ADCYAP1 116 Neurotoxicity Syndromes MESH:D020258 therapeutic 29604313 +ADCYAP1 116 Psychomotor Agitation MESH:D011595 marker/mechanism 17658665 +ADCYAP1 116 Seizures MESH:D012640 marker/mechanism 29673861 +ADCYAP1 116 Urinary Bladder, Overactive MESH:D053201 therapeutic 16322346 +ADCYAP1R1 117 Asthma MESH:D001249 marker/mechanism 21059121 +ADD1 118 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +ADD1 118 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +ADD1 118 Hypertension MESH:D006973 marker/mechanism 15773232|19199261 +ADD3 120 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +ADD3 120 Brain Ischemia MESH:D002545 marker/mechanism 17901229 +ADD3 120 CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3 OMIM:617008 marker/mechanism 617008.0 +ADD3 120 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ADD3 120 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +ADGRD2 347088 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ADGRE1 2015 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ADGRE2 30817 Familial dermographism MESH:C536612 marker/mechanism 125630.0 +ADGRE5 976 Lung Diseases MESH:D008171 marker/mechanism 21602193 +ADGRF4 221393 Schizophrenia MESH:D012559 marker/mechanism 21822266 +ADGRG1 9289 Polymicrogyria, Bilateral Frontoparietal MESH:C564652 marker/mechanism 606854.0 +ADGRG1 9289 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +ADGRG2 10149 Congenital bilateral aplasia of vas deferens MESH:C535984 marker/mechanism 300985.0 +ADGRG2 10149 Osteoarthritis MESH:D010003 marker/mechanism 17568789 +ADGRG6 57211 LETHAL CONGENITAL CONTRACTURE SYNDROME 9 OMIM:616503 marker/mechanism 616503.0 +ADGRG6 57211 SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 1 OMIM:181800 marker/mechanism 23666238 +ADGRG7 84873 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ADGRL3 23284 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 22405201 +ADGRV1 84059 Febrile Convulsions, Familial, 4 MESH:C565788 marker/mechanism 604352.0 +ADGRV1 84059 Usher syndrome, type 2C MESH:C536492 marker/mechanism 605472.0 +ADH1 11522 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ADH1A 124 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ADH1A 124 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +ADH1A 124 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29718361 +ADH1B 125 Alcoholism MESH:D000437 marker/mechanism 103780.0 16404797|17590986|21168396 +ADH1B 125 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ADH1B 125 Cerebral Infarction MESH:D002544 marker/mechanism 15534263 +ADH1B 125 Colorectal Neoplasms MESH:D015179 marker/mechanism 16332725 +ADH1B 125 Esophageal Neoplasms MESH:D004938 marker/mechanism 18500343 +ADH1B 125 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 22960999 +ADH1B 125 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 16404797|17590986 +ADH1B 125 Laryngeal Neoplasms MESH:D007822 marker/mechanism 18500343 +ADH1B 125 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +ADH1B 125 Mouth Neoplasms MESH:D009062 marker/mechanism 18500343 +ADH1B 125 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29718361 +ADH1B 125 Obesity MESH:D009765 marker/mechanism 20882379 +ADH1B 125 Pharyngeal Neoplasms MESH:D010610 marker/mechanism 18500343 +ADH1C 126 Alcoholism MESH:D000437 marker/mechanism 103780.0 16404797 +ADH1C 126 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 16404797 +ADH1C 126 Mouth Neoplasms MESH:D009062 marker/mechanism 15138216 +ADH1C 126 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +ADH4 127 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ADH4 127 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ADH4 127 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +ADH4 127 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29718361 +ADH5 128 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ADH6 130 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ADH7 131 Esophageal Neoplasms MESH:D004938 marker/mechanism 18500343 +ADH7 131 Laryngeal Neoplasms MESH:D007822 marker/mechanism 18500343 +ADH7 131 Mouth Neoplasms MESH:D009062 marker/mechanism 18500343 +ADH7 131 Pharyngeal Neoplasms MESH:D010610 marker/mechanism 18500343 +ADHFE1 137872 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ADI1 55256 Prostatic Neoplasms MESH:D011471 marker/mechanism 17786183 +ADIPOQ 9370 ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2 OMIM:606770 marker/mechanism 11549668 +ADIPOQ 9370 ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3 OMIM:606771 marker/mechanism 11549668 +ADIPOQ 9370 Arthritis, Experimental MESH:D001169 marker/mechanism 23326410 +ADIPOQ 9370 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +ADIPOQ 9370 Atherosclerosis MESH:D050197 therapeutic 18931039 +ADIPOQ 9370 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 29723618 +ADIPOQ 9370 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 20709802 +ADIPOQ 9370 Coronary Restenosis MESH:D023903 therapeutic 12138120 +ADIPOQ 9370 Crohn Disease MESH:D003424 marker/mechanism 21829567 +ADIPOQ 9370 Diabetes, Gestational MESH:D016640 marker/mechanism 15126557 +ADIPOQ 9370 Diabetes Mellitus MESH:D003920 marker/mechanism 12860835 +ADIPOQ 9370 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 12114044|12354786|15734870 +ADIPOQ 9370 Diabetic Nephropathies MESH:D003928 marker/mechanism 17942768 +ADIPOQ 9370 Heart Failure MESH:D006333 marker/mechanism|therapeutic 19367012|26670611 +ADIPOQ 9370 Heroin Dependence MESH:D006556 marker/mechanism 15717844 +ADIPOQ 9370 Hyperemia MESH:D006940 marker/mechanism 12860835 +ADIPOQ 9370 Hyperglycemia MESH:D006943 therapeutic 29991592 +ADIPOQ 9370 Hypertension MESH:D006973 marker/mechanism 12860835 +ADIPOQ 9370 Hypoadiponectinemia MESH:C567258 marker/mechanism 612556.0 +ADIPOQ 9370 Inflammation MESH:D007249 therapeutic 12860835 +ADIPOQ 9370 Insulin Resistance MESH:D007333 therapeutic 18931039|21484566 +ADIPOQ 9370 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19539174 +ADIPOQ 9370 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 14724832 +ADIPOQ 9370 Metabolic Syndrome MESH:D024821 marker/mechanism 16793964|17618945|18162013|20833989 +ADIPOQ 9370 Myocardial Ischemia MESH:D017202 therapeutic 16155579 +ADIPOQ 9370 Myocardial Reperfusion Injury MESH:D015428 therapeutic 16155579 +ADIPOQ 9370 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 20415685 +ADIPOQ 9370 Obesity MESH:D009765 marker/mechanism|therapeutic 10092513|14617771 +ADIPOQ 9370 Pulmonary Edema MESH:D011654 therapeutic 25945502 +ADIPOQ 9370 Pulmonary Fibrosis MESH:D011658 therapeutic 25945502 +ADIPOQ 9370 Weight Gain MESH:D015430 marker/mechanism 12860835 +ADIPOQ 9370 Weight Loss MESH:D015431 marker/mechanism 18230824 +ADIPOR1 51094 Infertility, Female MESH:D007247 marker/mechanism 22265003 +ADIPOR1 51094 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19539174 +ADIPOR2 79602 Infertility, Female MESH:D007247 marker/mechanism 22265003 +ADIPQTL2 171511 ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2 OMIM:606770 marker/mechanism 11549668 +ADIPQTL3 171512 ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3 OMIM:606771 marker/mechanism 11549668 +ADK 132 HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY OMIM:614300 marker/mechanism 614300.0 21963049 +ADK 132 Hypoxia MESH:D000860 marker/mechanism 19579223 +ADK 132 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ADM 133 Autistic Disorder MESH:D001321 marker/mechanism 12579522 +ADM 133 Glomerulonephritis MESH:D005921 marker/mechanism 15063164|15680492 +ADM 133 Hyperalgesia MESH:D006930 marker/mechanism 17043245 +ADM 133 Hyperglycemia MESH:D006943 therapeutic 33491863 +ADM 133 Insulin Resistance MESH:D007333 therapeutic 33491863 +ADM 133 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15370692|16610064 +ADM 133 Pain MESH:D010146 marker/mechanism 17043245 +ADM 133 Polycystic Ovary Syndrome MESH:D011085 therapeutic 33491863 +ADM 133 Sepsis MESH:D018805 marker/mechanism 14766677 +ADM 133 Stomach Ulcer MESH:D013276 therapeutic 9845272 +ADM2 79924 Myocardial Ischemia MESH:D017202 marker/mechanism 16987513 +ADM2 79924 Phlebitis MESH:D010689 therapeutic 34434487 +ADM2 79924 Vascular Diseases MESH:D014652 therapeutic 19910445 +ADNP 23394 Autistic Disorder MESH:D001321 marker/mechanism 24531329|35982159 +ADNP 23394 HELSMOORTEL-VAN DER AA SYNDROME OMIM:615873 marker/mechanism 615873.0 +ADNP 23394 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +ADORA1 134 Bradycardia MESH:D001919 marker/mechanism 18313046 +ADORA1 134 Catalepsy MESH:D002375 therapeutic 9407998 +ADORA1 134 Drug Hypersensitivity MESH:D004342 marker/mechanism 19019667 +ADORA1 134 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15641640 +ADORA1 134 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 19019667 +ADORA1 134 Hypotension MESH:D007022 marker/mechanism 15641640|18313046 +ADORA1 134 Infarction, Middle Cerebral Artery MESH:D020244 therapeutic 23437309 +ADORA1 134 Ischemia MESH:D007511 marker/mechanism 18950269 +ADORA1 134 Ischemic Attack, Transient MESH:D002546 therapeutic 23437309 +ADORA1 134 Myocardial Infarction MESH:D009203 therapeutic 12160945 +ADORA1 134 Nerve Degeneration MESH:D009410 therapeutic 23437309 +ADORA1 134 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 19092996 +ADORA1 134 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 18950269 +ADORA1 134 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 16226742 +ADORA1 134 Ventricular Dysfunction MESH:D018754 marker/mechanism 15641640 +ADORA2A 135 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 20799992 +ADORA2A 135 Anxiety Disorders MESH:D001008 marker/mechanism 12825092|16118787|18305461|20532872 +ADORA2A 135 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +ADORA2A 135 Cardiomyopathies MESH:D009202 therapeutic 20363887 +ADORA2A 135 Depressive Disorder MESH:D003866 marker/mechanism 26860412 +ADORA2A 135 Drug Hypersensitivity MESH:D004342 marker/mechanism 19019667 +ADORA2A 135 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15641640 +ADORA2A 135 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 19019667 +ADORA2A 135 Hyperkinesis MESH:D006948 therapeutic 15187444 +ADORA2A 135 Hypotension MESH:D007022 marker/mechanism 15641640|1592228|18313046 +ADORA2A 135 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16783407 +ADORA2A 135 Movement Disorders MESH:D009069 marker/mechanism 26526685 +ADORA2A 135 Panic Disorder MESH:D016584 marker/mechanism 12825092 +ADORA2A 135 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 20799992 +ADORA2A 135 Reperfusion Injury MESH:D015427 therapeutic 27757725 +ADORA2A 135 Seizures MESH:D012640 marker/mechanism 19488739 +ADORA2A 135 Sepsis MESH:D018805 marker/mechanism 27757725 +ADORA2A 135 Sleep Initiation and Maintenance Disorders MESH:D007319 marker/mechanism 20532872 +ADORA2A 135 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 14756803|16226742|16470403 +ADORA2A 135 Tremor MESH:D014202 marker/mechanism 16780890 +ADORA2A 135 Ventricular Dysfunction MESH:D018754 marker/mechanism 15641640 +ADORA2A 135 Weight Loss MESH:D015431 marker/mechanism 26526685 +ADORA2B 136 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 35292334 +ADORA2B 136 Neoplasm Metastasis MESH:D009362 marker/mechanism 27590504 +ADORA2B 136 Reperfusion Injury MESH:D015427 therapeutic 27757725 +ADORA2B 136 Sepsis MESH:D018805 marker/mechanism 27757725 +ADORA3 140 Ischemia MESH:D007511 marker/mechanism 7774659 +ADORA3 140 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ADORA3 140 Myocardial Infarction MESH:D009203 therapeutic 12160945|20132822 +ADR-1 172542 Infertility MESH:D007246 marker/mechanism 25204677 +ADRA1A 148 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ADRA1A 148 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 19133277 +ADRA1A 148 Liver Cirrhosis MESH:D008103 marker/mechanism 16782692 +ADRA1A 148 Ventricular Remodeling MESH:D020257 marker/mechanism 20668454 +ADRA1B 147 Cardiomegaly MESH:D006332 marker/mechanism 11278430|11940550 +ADRA1B 147 Hypotension MESH:D007022 marker/mechanism 11278430 +ADRA1B 147 Kidney Diseases MESH:D007674 marker/mechanism 18257748 +ADRA1B 147 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ADRA1B 147 Nerve Degeneration MESH:D009410 marker/mechanism 12871582 +ADRA1B 147 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19125850 +ADRA1B 147 Seizures MESH:D012640 marker/mechanism 19125850 +ADRA1D 146 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +ADRA2A 150 Cardiomegaly MESH:D006332 therapeutic 20083574 +ADRA2A 150 Epilepsy MESH:D004827 therapeutic 17341653 +ADRA2A 150 Fibrosis MESH:D005355 therapeutic 20083574 +ADRA2A 150 Heart Diseases MESH:D006331 marker/mechanism 16844662 +ADRA2A 150 Hypertension MESH:D006973 marker/mechanism 10694191 +ADRA2A 150 Hypotension MESH:D007022 marker/mechanism 16595736|18849358 +ADRA2A 150 Panic Disorder MESH:D016584 marker/mechanism 14656453 +ADRA2B 151 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ADRA2B 151 Cyanosis MESH:D003490 marker/mechanism 20729197 +ADRA2B 151 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ADRA2B 151 Lung Diseases MESH:D008171 marker/mechanism 20729197 +ADRA2C 152 Cardiomegaly MESH:D006332 marker/mechanism 20083574 +ADRA2C 152 Fibrosis MESH:D005355 marker/mechanism 20083574 +ADRA2C 152 Heart Failure MESH:D006333 marker/mechanism 12374873 +ADRB1 153 Birth Weight MESH:D001724 marker/mechanism 23202124 +ADRB1 153 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 9554809 +ADRB1 153 Cardiovascular Diseases MESH:D002318 marker/mechanism 11436944 +ADRB1 153 Diabetes Mellitus MESH:D003920 marker/mechanism 18378355 +ADRB1 153 Endomyocardial Fibrosis MESH:D004719 marker/mechanism 14502278 +ADRB1 153 Heart Failure MESH:D006333 marker/mechanism 12374873|14502278|15816327|21516734|7586371 +ADRB1 153 Hyperemia MESH:D006940 marker/mechanism 17345787 +ADRB1 153 Hypertension MESH:D006973 marker/mechanism 10673262|9260993 +ADRB1 153 Myocardial Ischemia MESH:D017202 marker/mechanism 9554809 +ADRB1 153 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 10900253 +ADRB1 153 Obesity MESH:D009765 marker/mechanism 12032746 +ADRB1 153 Stomach Neoplasms MESH:D013274 marker/mechanism 17003101 +ADRB1 153 Ventricular Dysfunction MESH:D018754 marker/mechanism 14502278 +ADRB2 154 AIDS Dementia Complex MESH:D015526 marker/mechanism 27400929 +ADRB2 154 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ADRB2 154 Autistic Disorder MESH:D001321 marker/mechanism 17199132 +ADRB2 154 Cardiomyopathies MESH:D009202 marker/mechanism 25193472 +ADRB2 154 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 11986409 +ADRB2 154 Encephalitis, Viral MESH:D018792 marker/mechanism 27400929 +ADRB2 154 Fibrosis MESH:D005355 marker/mechanism 25193472 +ADRB2 154 HIV Infections MESH:D015658 marker/mechanism 27400929 +ADRB2 154 Hyperlipidemias MESH:D006949 marker/mechanism 16027735 +ADRB2 154 Hypokalemia MESH:D007008 marker/mechanism 17292646|1848636|2826064 +ADRB2 154 Insulin Resistance MESH:D007333 marker/mechanism 19034036 +ADRB2 154 Lung Diseases MESH:D008171 marker/mechanism 11436944 +ADRB2 154 Myocardial Ischemia MESH:D017202 marker/mechanism 9554809 +ADRB2 154 Nervous System Diseases MESH:D009422 marker/mechanism 21245421 +ADRB2 154 Obesity MESH:D009765 marker/mechanism 15687340 +ADRB2 154 Prostatic Neoplasms MESH:D011471 marker/mechanism 18454446 +ADRB2 154 Stomach Neoplasms MESH:D013274 marker/mechanism 17003101 +ADRB2 154 Tremor MESH:D014202 marker/mechanism|therapeutic 190674|7902979|8102213|9151294 +ADRB2 154 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 25193472 +ADRB3 155 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 17622774 +ADRB3 155 Heart Failure MESH:D006333 marker/mechanism 15009959|17440824 +ADRB3 155 Hyperlipidemias MESH:D006949 marker/mechanism 16027735 +ADRB3 155 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 17345787 +ADRB3 155 Obesity MESH:D009765 marker/mechanism 601665.0 +ADSL 158 Adenylosuccinate lyase deficiency MESH:C538235 marker/mechanism 103050.0 10888601|10958654|12833398 +ADSL 158 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ADSL 158 Autistic Disorder MESH:D001321 marker/mechanism 15471876 +ADSS1 122622 MYOPATHY, DISTAL, 5 OMIM:617030 marker/mechanism 617030.0 +ADTRP 84830 Coronary Artery Disease MESH:D003324 marker/mechanism 21378986 +AEN 64782 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AFAP1-AS1 84740 Hirschsprung Disease MESH:D006627 marker/mechanism 28924375 +AFAP1L2 84632 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 29059373 +AFDN 4301 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AFF2 2334 Fragile X Syndrome MESH:D005600 marker/mechanism 309548.0 +AFF3 3899 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +AFF3 3899 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +AFF4 27125 Abnormalities, Multiple MESH:D000015 marker/mechanism 25730767 +AFF4 27125 Bone Diseases, Developmental MESH:D001848 marker/mechanism 25730767 +AFF4 27125 CHOPS SYNDROME OMIM:616368 marker/mechanism 616368.0 +AFF4 27125 Cognition Disorders MESH:D003072 marker/mechanism 25730767 +AFF4 27125 Facies MESH:D019066 marker/mechanism 25730767 +AFF4 27125 Growth Disorders MESH:D006130 marker/mechanism 25730767 +AFF4 27125 Heart Defects, Congenital MESH:D006330 marker/mechanism 25730767 +AFF4 27125 Lung Diseases MESH:D008171 marker/mechanism 25730767 +AFF4 27125 Obesity MESH:D009765 marker/mechanism 25730767 +AFG2A 166378 NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS, SEIZURES, AND BRAIN ABNORMALITIES OMIM:616577 marker/mechanism 616577.0 +AFG2A 166378 Schizophrenia MESH:D012559 marker/mechanism 21822266 +AFG3L2 10939 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 25401298 +AFG3L2 10939 SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE OMIM:614487 marker/mechanism 614487.0 +AFG3L2 10939 Spinocerebellar ataxia 28 MESH:C537205 marker/mechanism 610246.0 +AFG3L2 10939 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 20208537 +AFM 173 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +AFM 173 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +AFM 173 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AFP 174 alpha-Fetoprotein Deficiency MESH:C566300 marker/mechanism 615969.0 +AFP 174 Breast Neoplasms MESH:D001943 therapeutic 18497072 +AFP 174 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15276417|24012840|28284560|32961231|9029167 +AFP 174 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +AFP 174 Liver Diseases MESH:D008107 marker/mechanism 16965562 +AFP 174 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 24012840|32961231 +AFP 174 Mammary Neoplasms, Experimental MESH:D008325 therapeutic 16322315 +AFP 174 Stomach Neoplasms MESH:D013274 marker/mechanism 23382965 +AGA 175 Aspartylglucosaminuria MESH:D054880 marker/mechanism 208400.0 +AGAP1 116987 Autistic Disorder MESH:D001321 marker/mechanism 15892143 +AGBL1 123624 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8 OMIM:615523 marker/mechanism 615523.0 +AGBL4 84871 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +AGBL4 84871 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +AGBL5 60509 RETINITIS PIGMENTOSA 75 OMIM:617023 marker/mechanism 617023.0 +AGER 177 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 16385501 +AGER 177 Asthma MESH:D001249 marker/mechanism 33075463 +AGER 177 Asthma, Occupational MESH:D059366 marker/mechanism 33075463 +AGER 177 Atherosclerosis MESH:D050197 marker/mechanism 19939336|20372816 +AGER 177 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +AGER 177 Diabetic Angiopathies MESH:D003925 marker/mechanism 20372816 +AGER 177 Hyperalgesia MESH:D006930 marker/mechanism 25014009 +AGER 177 Hyperglycemia MESH:D006943 marker/mechanism 24036142 +AGER 177 Hypertension MESH:D006973 marker/mechanism 32147540 +AGER 177 Hypertrophy MESH:D006984 marker/mechanism 19553346 +AGER 177 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 25446913 +AGER 177 Inflammation MESH:D007249 marker/mechanism 22178603|33075463 +AGER 177 Lewy Body Disease MESH:D020961 marker/mechanism 16141792 +AGER 177 Neuralgia MESH:D009437 marker/mechanism 25014009 +AGER 177 Osteoarthritis MESH:D010003 marker/mechanism 16948116 +AGER 177 Pancreatic Diseases MESH:D010182 marker/mechanism 24036142 +AGER 177 Peripheral Nerve Injuries MESH:D059348 marker/mechanism 25014009 +AGER 177 Pulmonary Emphysema MESH:D011656 marker/mechanism 30659203 +AGFG1 3267 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AGK 55750 CATARACT 38 OMIM:614691 marker/mechanism 614691.0 +AGK 55750 Cataract and cardiomyopathy MESH:C538280 marker/mechanism 212350.0 23266196 +AGL 178 Glycogen Storage Disease Type III MESH:D006010 marker/mechanism 232400.0 24700805|8755644|8990006 +AGL 178 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AGO1 26523 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +AGO2 27161 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +AGO2 27161 Leukemia, Myeloid MESH:D007951 marker/mechanism 21535412 +AGO2 27161 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +AGPAT1 10554 Exfoliation Syndrome MESH:D017889 marker/mechanism 28553957 +AGPAT2 10555 Lipodystrophy, Congenital Generalized MESH:D052497 marker/mechanism 608594.0 +AGPAT3 56894 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +AGPS 8540 Rhizomelic chondrodysplasia punctata, type 3 MESH:C537608 marker/mechanism 600121.0 +AGR2 10551 Breast Neoplasms MESH:D001943 marker/mechanism 20531310 +AGR2 10551 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881|25237833 +AGRN 375790 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +AGRN 375790 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 615120.0 +AGRP 181 Obesity MESH:D009765 marker/mechanism 601665.0 +AGT 183 Albuminuria MESH:D000419 marker/mechanism 12414515|18679781|21896938 +AGT 183 Alkalosis MESH:D000471 therapeutic 7182184 +AGT 183 Allanson Pantzar McLeod syndrome MESH:C537048 marker/mechanism 16116425|17036344 +AGT 183 Anemia MESH:D000740 marker/mechanism 3524928 +AGT 183 Anuria MESH:D001002 therapeutic 8527259 +AGT 183 Aortic Aneurysm MESH:D001014 marker/mechanism 21925196 +AGT 183 Aortic Aneurysm, Abdominal MESH:D017544 marker/mechanism 16514081|20937366|22539767|25301841|30354818 +AGT 183 Aortic Dissection MESH:D000784 marker/mechanism 17502491 +AGT 183 Arrhythmias, Cardiac MESH:D001145 marker/mechanism|therapeutic 1654493|2535056 +AGT 183 Atherosclerosis MESH:D050197 marker/mechanism 21925196|22539767 +AGT 183 Bradycardia MESH:D001919 therapeutic 9519251 +AGT 183 Cardiomegaly MESH:D006332 marker/mechanism|therapeutic 11403367|15226216|15851630|15870116|17124262|18400235|19794523|20190099|20409916|20429690|20616315|20811386|22291909|22335191|24342267|25139994|25488910|27099261|29353218|30634441|30703374|31016362|35510648 +AGT 183 Cardiomyopathies MESH:D009202 marker/mechanism 12145768 +AGT 183 Cardiomyopathy, Alcoholic MESH:D002310 marker/mechanism 22497828 +AGT 183 Cardiotoxicity MESH:D066126 marker/mechanism 33676887 +AGT 183 Cardiovascular Abnormalities MESH:D018376 marker/mechanism 25807386 +AGT 183 Cardiovascular Diseases MESH:D002318 marker/mechanism 16544732 +AGT 183 Carotid Artery Diseases MESH:D002340 marker/mechanism 12911327 +AGT 183 Catalepsy MESH:D002375 therapeutic 1034924 +AGT 183 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 29499335 +AGT 183 Cholestasis MESH:D002779 marker/mechanism 27989131 +AGT 183 Cognition Disorders MESH:D003072 marker/mechanism 22982863 +AGT 183 COVID-19 MESH:D000086382 marker/mechanism 32048163 +AGT 183 Death, Sudden MESH:D003645 marker/mechanism 17502491 +AGT 183 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 15831366|17177138|18829990 +AGT 183 Diabetic Cardiomyopathies MESH:D058065 marker/mechanism 29353218 +AGT 183 Diabetic Nephropathies MESH:D003928 therapeutic 17890855|20383342 +AGT 183 Diabetic Retinopathy MESH:D003930 marker/mechanism 15387897 +AGT 183 Drug Overdose MESH:D062787 therapeutic 8527259 +AGT 183 Endomyocardial Fibrosis MESH:D004719 marker/mechanism|therapeutic 20837116|25139994|25488910|27099261|30703374 +AGT 183 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +AGT 183 Fetal Growth Retardation MESH:D005317 marker/mechanism 17537837 +AGT 183 Fibrosis MESH:D005355 marker/mechanism 12414515|18785976|19373235|25398788|25807386|26648693|30634441|33676887 +AGT 183 Glomerulonephritis MESH:D005921 marker/mechanism 11459117 +AGT 183 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 9259580 +AGT 183 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 19858406 +AGT 183 Glucose Intolerance MESH:D018149 therapeutic 26704350 +AGT 183 Heart Diseases MESH:D006331 marker/mechanism 19373235 +AGT 183 Heart Failure MESH:D006333 marker/mechanism 12025466|1330361|20811386 +AGT 183 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 16292651 +AGT 183 Hyperalgesia MESH:D006930 marker/mechanism 9613798 +AGT 183 Hyperemia MESH:D006940 marker/mechanism 15815331 +AGT 183 Hyperhomocysteinemia MESH:D020138 marker/mechanism 24386282 +AGT 183 Hypertension MESH:D006973 marker/mechanism|therapeutic 10400907|10526905|11459117|11501062|12084390|12121858|12414515|12600921|12676074|1394429|1432030|14751847|15243307|15302986|15699457|15833808|15851630|16618834|16788141|16868307|17272743|17537837|17989111|18420994|1849535|1860718|18679781|1875449|18768397|18785976|18847324|19109942|19133994|19373235|19770776|19858406|19934029|20231528|20429690|20713914|20811386|20837116|20937366|21289285|21393355|21420289|21501650|22083158|22214961|22452651|22753205|22982863|24342267|24347665|24386282|24935938|24965170|25139994|25259750|25398788|25874449|26564064|26648693|26781276|27225954|27678262|27798352|27889505|2831029|2835134|29706566|30354818|30634441|31016362|31098697|3158602|31786979|43064|6742791|7323490|8021468|8109997|8505092|9024144|9260993 +AGT 183 Hypertension, Malignant MESH:D006974 marker/mechanism 2493837|27428043 +AGT 183 Hypertension, Renal MESH:D006977 marker/mechanism 8763405 +AGT 183 Hypertrophy MESH:D006984 marker/mechanism 12054679|12237323|18785976|21071431|24039778|26955731 +AGT 183 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism|therapeutic 10805403|14644620|14751847|18679781|20837116|24688123|31016362 +AGT 183 Hypokalemia MESH:D007008 therapeutic 7182184 +AGT 183 Hypotension MESH:D007022 therapeutic 30634441|3078272|8527259|9323291 +AGT 183 Inflammation MESH:D007249 marker/mechanism 15944212|16868307|27436852|29353218 +AGT 183 Kidney Diseases MESH:D007674 marker/mechanism 12414515|15213268|17989111|21896938|31098697 +AGT 183 Liver Cirrhosis MESH:D008103 marker/mechanism 15613622 +AGT 183 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 12667390 +AGT 183 Myocardial Infarction MESH:D009203 marker/mechanism 16413583|1668233 +AGT 183 Myocardial Ischemia MESH:D017202 marker/mechanism 16775501 +AGT 183 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism|therapeutic 19166939|2535056 +AGT 183 Necrosis MESH:D009336 marker/mechanism 12606818|1535655 +AGT 183 Neointima MESH:D058426 marker/mechanism 19258495|29609002 +AGT 183 Nephrosis MESH:D009401 marker/mechanism 2046802 +AGT 183 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 26954031 +AGT 183 Peptic Ulcer Hemorrhage MESH:D010438 marker/mechanism 20824505 +AGT 183 Pneumonia MESH:D011014 therapeutic 28960804 +AGT 183 Pre-Eclampsia MESH:D011225 marker/mechanism 8513325 +AGT 183 Proteinuria MESH:D011507 marker/mechanism|therapeutic 12937228|17890855|2046802|25398788|464098|9259580 +AGT 183 Pulmonary Fibrosis MESH:D011658 therapeutic 28960804|31181250 +AGT 183 Renal Insufficiency MESH:D051437 marker/mechanism 9259580 +AGT 183 RENAL TUBULAR DYSGENESIS OMIM:267430 marker/mechanism 267430.0 +AGT 183 Reperfusion Injury MESH:D015427 marker/mechanism 23875703 +AGT 183 Retinopathy of Prematurity MESH:D012178 marker/mechanism 15387897 +AGT 183 Seizures MESH:D012640 marker/mechanism 16771832 +AGT 183 Thrombosis MESH:D013927 marker/mechanism|therapeutic 11881036|21501650 +AGT 183 Ureteral Obstruction MESH:D014517 marker/mechanism 26207612 +AGT 183 Vascular Diseases MESH:D014652 marker/mechanism 29706566 +AGT 183 Vascular Remodeling MESH:D066253 marker/mechanism 25259750|27678262 +AGT 183 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 24688123|29353218|30703374 +AGT 183 Ventricular Remodeling MESH:D020257 marker/mechanism 29353218 +AGTPBP1 23287 Nerve Degeneration MESH:D009410 marker/mechanism 16952463 +AGTR1 185 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +AGTR1 185 Allanson Pantzar McLeod syndrome MESH:C537048 marker/mechanism 16116425 +AGTR1 185 Aortic Aneurysm, Abdominal MESH:D017544 marker/mechanism 22539767 +AGTR1 185 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 17481528 +AGTR1 185 Diabetic Retinopathy MESH:D003930 marker/mechanism 16601577 +AGTR1 185 Ductus Arteriosus, Patent MESH:D004374 marker/mechanism 12904590|19336370 +AGTR1 185 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +AGTR1 185 Heart Failure MESH:D006333 marker/mechanism 17208988|18214293|18586661 +AGTR1 185 Hypertension MESH:D006973 marker/mechanism 19047579|23603059|27292124|8952600 +AGTR1 185 Kidney Diseases MESH:D007674 marker/mechanism 15213268 +AGTR1 185 Neoplasm Metastasis MESH:D009362 marker/mechanism 18059164 +AGTR1 185 Pituitary Neoplasms MESH:D010911 marker/mechanism 16977796 +AGTR1 185 Proteinuria MESH:D011507 marker/mechanism 17021606 +AGTR1 185 RENAL TUBULAR DYSGENESIS OMIM:267430 marker/mechanism 267430.0 +AGTR1A 11607 Carcinoma, Ductal MESH:D044584 marker/mechanism 8389152 +AGTR1A 11607 Carcinoma, Lobular MESH:D018275 marker/mechanism 8389152 +AGTR1A 11607 Cardiomegaly MESH:D006332 marker/mechanism 17350036 +AGTR1A 11607 Fibrosis MESH:D005355 marker/mechanism 9596920 +AGTR1A 11607 Glucose Intolerance MESH:D018149 marker/mechanism 11564974 +AGTR1A 11607 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 16292651 +AGTR1A 11607 Kidney Diseases MESH:D007674 marker/mechanism 9596920 +AGTR1A 11607 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 12890498|25380136 +AGTR1A 11607 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 8389152 +AGTR1A 11607 Vascular System Injuries MESH:D057772 marker/mechanism 16982965 +AGTR1B 11608 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 16292651 +AGTR1B 11608 Hypertension MESH:D006973 marker/mechanism 22728133|27847271 +AGTR1B 11608 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 22728133 +AGTR2 186 Carcinoma, Lobular MESH:D018275 marker/mechanism 8389152 +AGTR2 186 Diabetic Cardiomyopathies MESH:D058065 marker/mechanism 15587404|16025228 +AGTR2 186 Hypertension MESH:D006973 marker/mechanism 15710752 +AGTR2 186 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 20467270 +AGTR2 186 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 8389152 +AGTR2 186 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 12089445 +AGTR2 186 Neoplasm Metastasis MESH:D009362 marker/mechanism 18059164 +AGTR2 186 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +AGTR2 186 Stomach Neoplasms MESH:D013274 marker/mechanism 18059164 +AGTR2 186 Vascular System Injuries MESH:D057772 marker/mechanism 16982965 +AGXT 189 Primary hyperoxaluria type 1 MESH:C536414 marker/mechanism 259900.0 +AGXT2 64902 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 21572414 +AHCY 191 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +AHCY 191 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 15024124 +AHCY 191 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +AHCY 191 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +AHCY 191 Hypermethioninemia MESH:C564683 marker/mechanism 613752.0 26974671 +AHCY 191 Hypoxia MESH:D000860 marker/mechanism 19579223 +AHCY 191 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29127188 +AHCYL2 23382 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +AHDC1 27245 XIA-GIBBS SYNDROME OMIM:615829 marker/mechanism 615829.0 +AHI1 54806 Autistic Disorder MESH:D001321 marker/mechanism 18782849 +AHI1 54806 Cerebellar Diseases MESH:D002526 marker/mechanism 20371615 +AHI1 54806 IgA Deficiency MESH:D017098 marker/mechanism 27723758 +AHI1 54806 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +AHI1 54806 Joubert syndrome 3 MESH:C536295 marker/mechanism 608629.0 +AHI1 54806 Retinal Degeneration MESH:D012162 marker/mechanism 20081859 +AHI1 54806 Schizophrenia MESH:D012559 marker/mechanism 20371615 +AHNAK 79026 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +AHNAK 79026 Chloracne MESH:D054506 marker/mechanism 17101203 +AHNAK 79026 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AHNAK 79026 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20388789 +AHR 196 Abortion, Spontaneous MESH:D000022 marker/mechanism 26593447 +AHR 196 Acanthosis Nigricans MESH:D000052 marker/mechanism 27869817 +AHR 196 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 12597446 +AHR 196 Arthritis, Experimental MESH:D001169 marker/mechanism 25194622 +AHR 196 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 18617548 +AHR 196 Atherosclerosis MESH:D050197 marker/mechanism 22228805 +AHR 196 Atrophy MESH:D001284 marker/mechanism 20961953|7826670 +AHR 196 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AHR 196 Behcet Syndrome MESH:D001528 marker/mechanism 25045206 +AHR 196 Birth Weight MESH:D001724 marker/mechanism 27592400 +AHR 196 Bone Resorption MESH:D001862 marker/mechanism 19934163 +AHR 196 Breast Neoplasms MESH:D001943 marker/mechanism 21515334|22296396 +AHR 196 Cardiomegaly MESH:D006332 marker/mechanism 24247421 +AHR 196 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism|therapeutic 21890736|34848246 +AHR 196 Chronobiology Disorders MESH:D021081 marker/mechanism 23291558 +AHR 196 Colitis MESH:D003092 therapeutic 27783946 +AHR 196 Dermatitis, Atopic MESH:D003876 marker/mechanism 27869817 +AHR 196 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +AHR 196 Disease Models, Animal MESH:D004195 marker/mechanism 27869817 +AHR 196 Dyslipidemias MESH:D050171 marker/mechanism 21890736 +AHR 196 Glucose Intolerance MESH:D018149 therapeutic 31306034 +AHR 196 Growth Disorders MESH:D006130 marker/mechanism 20961953 +AHR 196 Heart Defects, Congenital MESH:D006330 marker/mechanism 19261855 +AHR 196 Hepatomegaly MESH:D006529 marker/mechanism|therapeutic 26278112|28487374|33607186|34848246 +AHR 196 Hyperoxia MESH:D018496 marker/mechanism 23337360 +AHR 196 Hyperpigmentation MESH:D017495 marker/mechanism 28029781 +AHR 196 Hypertension MESH:D006973 marker/mechanism 21115475 +AHR 196 Hypertrophy MESH:D006984 marker/mechanism 20961953 +AHR 196 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 14644620|31016362 +AHR 196 Hyperventilation MESH:D006985 marker/mechanism 21115475 +AHR 196 Hypoglycemia MESH:D007003 therapeutic 34848246 +AHR 196 Infertility, Female MESH:D007247 marker/mechanism 36029422 +AHR 196 Infertility, Male MESH:D007248 marker/mechanism 21613234 +AHR 196 Inflammation MESH:D007249 marker/mechanism 22273745|25768209 +AHR 196 Insulin Resistance MESH:D007333 marker/mechanism 25734695 +AHR 196 Keratosis MESH:D007642 marker/mechanism 27869817 +AHR 196 Liver Cirrhosis MESH:D008103 marker/mechanism 29416063 +AHR 196 Liver Diseases MESH:D008107 marker/mechanism 20961953|8692887 +AHR 196 Liver Neoplasms MESH:D008113 marker/mechanism 19996281|30346592 +AHR 196 Lung Injury MESH:D055370 therapeutic 25831079 +AHR 196 Metabolic Diseases MESH:D008659 marker/mechanism 25768209 +AHR 196 Necrosis MESH:D009336 marker/mechanism 25831079 +AHR 196 Neoplasm Invasiveness MESH:D009361 therapeutic 25826687|27752740 +AHR 196 Neoplasm Metastasis MESH:D009362 therapeutic 21948867 +AHR 196 Neoplasms MESH:D009369 marker/mechanism 22037238 +AHR 196 Neoplasms, Experimental MESH:D009374 marker/mechanism 9496914 +AHR 196 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29416063 +AHR 196 Nystagmus, Congenital MESH:D020417 marker/mechanism 23301081 +AHR 196 Obesity MESH:D009765 marker/mechanism 27020609|30813227|31306034 +AHR 196 Pancreatic cancer, adult MESH:C535836 marker/mechanism 12203118 +AHR 196 Pancreatic Neoplasms MESH:D010190 therapeutic 12203118|25826687 +AHR 196 Patent Ductus Venosus MESH:C562830 marker/mechanism 36029422 +AHR 196 Peanut Hypersensitivity MESH:D021183 marker/mechanism 21804081 +AHR 196 Pneumonia MESH:D011014 marker/mechanism 23337360 +AHR 196 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 35687267 +AHR 196 Prostatic Neoplasms MESH:D011471 marker/mechanism 20140206 +AHR 196 Pruritus MESH:D011537 marker/mechanism 27869817 +AHR 196 Pulmonary Arterial Hypertension MESH:D000081029 marker/mechanism 33836606 +AHR 196 Silicosis MESH:D012829 marker/mechanism 22273745 +AHR 196 Splenic Diseases MESH:D013158 marker/mechanism 20961953 +AHR 196 Splenomegaly MESH:D013163 marker/mechanism 8692887 +AHR 196 Stomach Neoplasms MESH:D013274 marker/mechanism 12107286 +AHR 196 Tachycardia MESH:D013610 marker/mechanism 21115475 +AHR 196 Tobacco Use Disorder MESH:D014029 marker/mechanism 25482063 +AHR 196 Ureteral Neoplasms MESH:D014516 marker/mechanism 19755661 +AHR 196 Urinary Bladder Calculi MESH:D001744 marker/mechanism 22232670 +AHR 196 Vascular Diseases MESH:D014652 marker/mechanism 25482063 +AHR 196 Weight Gain MESH:D015430 marker/mechanism 27020609|30813227|31306034|36029422 +AHR 196 Weight Loss MESH:D015431 therapeutic 34848246 +AHR2 30517 Abnormalities, Drug-Induced MESH:D000014 marker/mechanism 27576004 +AHR2 30517 Craniofacial Abnormalities MESH:D019465 marker/mechanism 30907958 +AHR2 30517 Edema MESH:D004487 marker/mechanism 12711302 +AHR2 30517 Embryo Loss MESH:D020964 marker/mechanism 27576004 +AHR2 30517 Heart Defects, Congenital MESH:D006330 marker/mechanism 27576004 +AHR2 30517 Heart Diseases MESH:D006331 marker/mechanism 20605646 +AHR2 30517 Hemorrhage MESH:D006470 marker/mechanism 27576004 +AHR2 30517 Musculoskeletal Abnormalities MESH:D009139 marker/mechanism 22242167 +AHR2 30517 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35412187 +AHSG 197 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +AHSG 197 AMR Syndrome MESH:C565965 marker/mechanism 203650.0 +AHSG 197 Calcinosis MESH:D002114 marker/mechanism 16177000 +AHSG 197 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +AICDA 57379 Autoimmune Diseases MESH:D001327 marker/mechanism 21305519 +AICDA 57379 Blast Crisis MESH:D001752 marker/mechanism 21570118 +AICDA 57379 Hyper-IgM Immunodeficiency Syndrome MESH:D053306 marker/mechanism 605258.0 +AICDA 57379 Leukemia, Lymphoid MESH:D007945 marker/mechanism 23589568 +AIDA 64853 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AIF 33390 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34453990 +AIF1 199 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +AIF1 199 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +AIF1 199 Hyperalgesia MESH:D006930 marker/mechanism 27093858 +AIF1 199 Hypertension MESH:D006973 marker/mechanism 32147540 +AIF1 199 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +AIF1 199 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AIF1 199 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +AIF1 199 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 27157545 +AIF1 199 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +AIFM1 9131 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25743375 +AIFM1 9131 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6 OMIM:300816 marker/mechanism 300816.0 +AIFM1 9131 Cowchock syndrome MESH:C536450 marker/mechanism 310490.0 +AIFM1 9131 Deafness, X-Linked 5 MESH:C564472 marker/mechanism 300614.0 +AIFM1 9131 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 23499715 +AIFM1 9131 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 23499715 +AIFM1 9131 Huntington Disease MESH:D006816 marker/mechanism 12930891 +AIFM1 9131 Necrosis MESH:D009336 therapeutic 16532269 +AIFM1 9131 Retinal Detachment MESH:D012163 marker/mechanism 18497877 +AIFM1 9131 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY OMIM:300232 marker/mechanism 300232.0 +AIM2 9447 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +AIMP1 9255 LEUKODYSTROPHY, HYPOMYELINATING, 3 OMIM:260600 marker/mechanism 260600.0 +AIP 9049 ACTH-Secreting Pituitary Adenoma MESH:D049913 marker/mechanism 219090.0 +AIP 9049 Adenoma MESH:D000236 marker/mechanism 22975028 +AIP 9049 PITUITARY ADENOMA 1, MULTIPLE TYPES OMIM:102200 marker/mechanism 102200.0 +AIPL1 23746 Leber Congenital Amaurosis 4 MESH:C565778 marker/mechanism 604393.0 +AIPL1 23746 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 16272259 +AIRE 326 Autoimmune polyendocrinopathy syndrome, type 1 MESH:C538275 marker/mechanism 240300.0 +AIRE 326 Candidiasis MESH:D002177 marker/mechanism 12050215 +AIRE 326 Polyendocrinopathies, Autoimmune MESH:D016884 marker/mechanism 16982213 +AIRE 326 Skin Neoplasms MESH:D012878 marker/mechanism 26168014 +AJUBA 84962 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +AK1 203 Adenylate Kinase Deficiency, Hemolytic Anemia Due To MESH:C567228 marker/mechanism 612631.0 +AK1 203 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 23676220 +AK1 203 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +AK2 204 Deafness MESH:D003638 marker/mechanism 19043416 +AK2 204 Reticular dysgenesis MESH:C538361 marker/mechanism 267500.0 +AK2 204 Severe Combined Immunodeficiency MESH:D016511 marker/mechanism 19043416|19043417 +AK4 205 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +AK5 26289 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +AKAP1 8165 Obesity MESH:D009765 marker/mechanism 20975297 +AKAP11 11215 Bipolar Disorder MESH:D001714 marker/mechanism 35410376 +AKAP11 11215 Schizophrenia MESH:D012559 marker/mechanism 35410376 +AKAP12 9590 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +AKAP13 11214 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +AKAP13 11214 Esophageal Neoplasms MESH:D004938 marker/mechanism 17068819 +AKAP13 11214 Prostatic Neoplasms MESH:D011471 marker/mechanism 28319090 +AKAP5 9495 Cardiomegaly MESH:D006332 therapeutic 11248077 +AKAP5 9495 Memory Disorders MESH:D008569 marker/mechanism 18711127 +AKAP5 9495 Motor Skills Disorders MESH:D019957 marker/mechanism 18711127 +AKAP6 9472 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +AKAP7 9465 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +AKAP9 10142 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +AKAP9 10142 Long Qt Syndrome 11 MESH:C567513 marker/mechanism 611820.0 +AKAP9 10142 Skin Diseases MESH:D012871 marker/mechanism 16835338 +AKIP1 56672 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +AKR1A1 10327 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AKR1A1 10327 Carcinogenesis MESH:D063646 marker/mechanism 32805337 +AKR1A1 10327 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 32805337 +AKR1A1 10327 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 32805337 +AKR1A1 10327 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +AKR1B1 231 Cataract MESH:D002386 marker/mechanism 21329682|21376710|25541468|28137510 +AKR1B1 231 Diabetes Complications MESH:D048909 marker/mechanism 25304492|25541468 +AKR1B1 231 Endometrial Neoplasms MESH:D016889 marker/mechanism 23146748 +AKR1B1 231 Endometriosis MESH:D004715 marker/mechanism 25446850 +AKR1B1 231 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AKR1B1 231 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +AKR1B10 57016 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AKR1B10 57016 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +AKR1B10 57016 Colorectal Neoplasms MESH:D015179 marker/mechanism 17597105 +AKR1B10 57016 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +AKR1B10 57016 Endometrial Neoplasms MESH:D016889 marker/mechanism 23146748 +AKR1B10 57016 Melanoma MESH:D008545 marker/mechanism 21499247 +AKR1B10 57016 Neoplasm Invasiveness MESH:D009361 marker/mechanism 25686905 +AKR1B10 57016 Neoplasms MESH:D009369 therapeutic 17329238 +AKR1C1 1645 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17094902 +AKR1C1 1645 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 19696165 +AKR1C1 1645 Disorders of Sex Development MESH:D012734 marker/mechanism 25304492 +AKR1C1 1645 Endometrial Neoplasms MESH:D016889 marker/mechanism 16338060 +AKR1C1 1645 Endometriosis MESH:D004715 marker/mechanism 21232532 +AKR1C1 1645 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AKR1C1 1645 Neoplasms, Hormone-Dependent MESH:D009376 marker/mechanism 25304492 +AKR1C1 1645 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +AKR1C1 1645 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 22381227 +AKR1C19 432720 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AKR1C2 1646 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AKR1C2 1646 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +AKR1C2 1646 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 19696165 +AKR1C2 1646 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +AKR1C2 1646 Disorders of Sex Development MESH:D012734 marker/mechanism 25304492 +AKR1C2 1646 Endometriosis MESH:D004715 marker/mechanism 21232532 +AKR1C2 1646 Male Pseudohermaphroditism due to Deficiency of Testicular 17,20-Desmolase MESH:C564109 marker/mechanism 614279.0 +AKR1C2 1646 Neoplasms, Hormone-Dependent MESH:D009376 marker/mechanism 25304492 +AKR1C2 1646 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +AKR1C2 1646 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 22381227 +AKR1C2 1646 Weight Gain MESH:D015430 marker/mechanism 25322899 +AKR1C3 8644 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AKR1C3 8644 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 19696165 +AKR1C3 8644 Disorders of Sex Development MESH:D012734 marker/mechanism 25304492 +AKR1C3 8644 Endometrial Neoplasms MESH:D016889 marker/mechanism 16338060 +AKR1C3 8644 Endometriosis MESH:D004715 marker/mechanism 21232532|25446850 +AKR1C3 8644 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AKR1C3 8644 Neoplasms, Hormone-Dependent MESH:D009376 marker/mechanism 25304492 +AKR1C3 8644 Obesity MESH:D009765 marker/mechanism 20882379 +AKR1C3 8644 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 16263811|21262361|22381227 +AKR1C3 8644 Prostatic Neoplasms MESH:D011471 marker/mechanism 17507624|18306354 +AKR1C3 8644 Prostatic Neoplasms, Castration-Resistant MESH:D064129 marker/mechanism 25555457 +AKR1C3 8644 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +AKR1C3L1 498789 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +AKR1C4 1109 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AKR1C4 1109 Bipolar Disorder MESH:D001714 marker/mechanism 21570127 +AKR1C4 1109 Male Pseudohermaphroditism due to Deficiency of Testicular 17,20-Desmolase MESH:C564109 marker/mechanism 614279.0 +AKR1C4 1109 Paranoid Disorders MESH:D010259 marker/mechanism 22356824 +AKR1D1 6718 Bile acid synthesis defect, congenital, 2 MESH:C535443 marker/mechanism 235555.0 21185810|25304492 +AKR1D1 6718 Hemochromatosis MESH:D006432 marker/mechanism 18624455 +AKR7A2 8574 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AKR7A3 22977 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AKR7A3 22977 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +AKT1 207 Adenocarcinoma MESH:D000230 marker/mechanism 33129824 +AKT1 207 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 17942926 +AKT1 207 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 15982448 +AKT1 207 Aortic Valve, Calcification of MESH:C562942 marker/mechanism 23308213 +AKT1 207 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 20228224 +AKT1 207 Carcinogenesis MESH:D063646 marker/mechanism 32045588 +AKT1 207 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 32045588 +AKT1 207 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21351258 +AKT1 207 Cardiomegaly MESH:D006332 marker/mechanism 24448315 +AKT1 207 Cardiomyopathies MESH:D009202 marker/mechanism 24448315 +AKT1 207 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +AKT1 207 COWDEN SYNDROME 6 OMIM:615109 marker/mechanism 615109.0 +AKT1 207 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 31626838 +AKT1 207 Disease Models, Animal MESH:D004195 marker/mechanism 25658812|32045588 +AKT1 207 Epilepsy MESH:D004827 therapeutic 20064661 +AKT1 207 Fatty Liver MESH:D005234 marker/mechanism 32045588 +AKT1 207 Fibrosis MESH:D005355 marker/mechanism 24448315 +AKT1 207 Hepatomegaly MESH:D006529 marker/mechanism 32045588 +AKT1 207 Hyperplasia MESH:D006965 marker/mechanism 20530298 +AKT1 207 Hypertriglyceridemia MESH:D015228 marker/mechanism 32045588 +AKT1 207 Inflammation MESH:D007249 marker/mechanism 24448315|26297436 +AKT1 207 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 12556562 +AKT1 207 Lung Neoplasms MESH:D008175 marker/mechanism|therapeutic 12511591|21911043|22619562 +AKT1 207 Lymphoma, T-Cell MESH:D016399 marker/mechanism 25658812 +AKT1 207 Marijuana Abuse MESH:D002189 marker/mechanism 21041608 +AKT1 207 Meningioma MESH:D008579 marker/mechanism 23334667 +AKT1 207 Muscular Atrophy MESH:D009133 therapeutic 18467435 +AKT1 207 Obesity MESH:D009765 marker/mechanism 23954404 +AKT1 207 Ovarian Neoplasms MESH:D010051 marker/mechanism 167000.0 16211241|21266360 +AKT1 207 Pain MESH:D010146 marker/mechanism 17084039 +AKT1 207 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +AKT1 207 Prostatic Neoplasms MESH:D011471 marker/mechanism 15682402|29610475|33129824 +AKT1 207 Proteus Syndrome MESH:D016715 marker/mechanism 176920.0 +AKT1 207 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 21041608 +AKT1 207 Schizophrenia MESH:D012559 marker/mechanism 14745448|15982448|17915974|21187413 +AKT1 207 Skin Neoplasms MESH:D012878 marker/mechanism 21351258 +AKT1 207 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 23873848 +AKT1 207 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 36115647 +AKT1S1 84335 Reperfusion Injury MESH:D015427 marker/mechanism 16397181 +AKT1S1 84335 Spinal Cord Injuries MESH:D013119 therapeutic 17457363 +AKT2 208 Adenocarcinoma MESH:D000230 marker/mechanism 33129824 +AKT2 208 Breast Neoplasms MESH:D001943 marker/mechanism 19075277 +AKT2 208 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 +AKT2 208 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY OMIM:240900 marker/mechanism 240900.0 +AKT2 208 Lipodystrophy, Familial Partial MESH:D052496 marker/mechanism 19793595 +AKT2 208 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +AKT2 208 Prostatic Neoplasms MESH:D011471 marker/mechanism 33129824 +AKT3 10000 Malformations of Cortical Development MESH:D054220 marker/mechanism 22729223 +AKT3 10000 Megalancephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome MESH:C566381 marker/mechanism 615937.0 22729224 +AKTIP 64400 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ALAD 210 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALAD 210 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 21799727 +ALAD 210 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 20123609 +ALAD 210 Hematologic Diseases MESH:D006402 marker/mechanism 24631795 +ALAD 210 Hypertension MESH:D006973 marker/mechanism 20123609 +ALAD 210 Kidney Diseases MESH:D007674 marker/mechanism 23792432|24631795 +ALAD 210 Lead Poisoning MESH:D007855 marker/mechanism 21396434|23792432|24631795 +ALAD 210 Lead Poisoning, Nervous System MESH:D020263 marker/mechanism 21439310 +ALAD 210 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +ALAD 210 Liver Diseases MESH:D008107 marker/mechanism 24631795 +ALAD 210 Meningioma MESH:D008579 marker/mechanism 16140629 +ALAD 210 Porphyria, Acute Hepatic MESH:C562618 marker/mechanism 612740.0 +ALAD 210 Porphyrias, Hepatic MESH:D017094 marker/mechanism 1905639|3684400 +ALAD 210 Prostatic Neoplasms MESH:D011471 marker/mechanism 24500903 +ALAD 210 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +ALAD 210 Seizures MESH:D012640 marker/mechanism 19798568 +ALAS1 211 Porphyrias MESH:D011164 marker/mechanism 9222176 +ALAS2 212 Anemia, Sideroblastic MESH:D000756 marker/mechanism 16716198|16892088 +ALAS2 212 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +ALAS2 212 PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED OMIM:300752 marker/mechanism 300752.0 +ALAS2 212 X-linked sideroblastic anemia MESH:C536761 marker/mechanism 300751.0 18637800 +ALB 213 Acute Kidney Injury MESH:D058186 marker/mechanism|therapeutic 2048579|21259293|24361871|28885000 +ALB 213 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +ALB 213 Angioedema MESH:D000799 marker/mechanism 8458210 +ALB 213 Anuria MESH:D001002 marker/mechanism 6734075 +ALB 213 Arthritis, Experimental MESH:D001169 marker/mechanism 20472598 +ALB 213 Azoospermia MESH:D053713 therapeutic 27289041 +ALB 213 Brain Diseases MESH:D001927 marker/mechanism 15923801 +ALB 213 Brain Injuries MESH:D001930 marker/mechanism 17188501|7909931 +ALB 213 Brain Ischemia MESH:D002545 therapeutic 16809570 +ALB 213 Cardiovascular Diseases MESH:D002318 marker/mechanism 8431628 +ALB 213 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 18779383|22310181 +ALB 213 Chemically-Induced Disorders MESH:D064419 marker/mechanism 35999755 +ALB 213 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 30026087 +ALB 213 Colitis, Ulcerative MESH:D003093 marker/mechanism 35999755 +ALB 213 Depressive Disorder MESH:D003866 marker/mechanism 9029664 +ALB 213 Diabetic Angiopathies MESH:D003925 marker/mechanism 19733855 +ALB 213 Diabetic Nephropathies MESH:D003928 therapeutic 16380483 +ALB 213 Disease Models, Animal MESH:D004195 marker/mechanism 16642209|17963606 +ALB 213 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 24361871|28885000 +ALB 213 Echinococcosis MESH:D004443 marker/mechanism 24270252 +ALB 213 Epilepsy MESH:D004827 marker/mechanism 15356194|17121744 +ALB 213 Fibrosis MESH:D005355 marker/mechanism 24309158 +ALB 213 Glomerulonephritis MESH:D005921 marker/mechanism 17161813|17464766|18462998|19524415|3160244|6343549|6769622|8501856 +ALB 213 Glomerulonephritis, Membranoproliferative MESH:D015432 marker/mechanism 1556257 +ALB 213 Glomerulonephritis, Membranous MESH:D015433 marker/mechanism 11938814|12776520|1342223|15385633|17622271|9794552 +ALB 213 Heart Diseases MESH:D006331 marker/mechanism 24309158 +ALB 213 Heart Failure MESH:D006333 marker/mechanism 11771600 +ALB 213 Hemolytic-Uremic Syndrome MESH:D006463 marker/mechanism 6734075 +ALB 213 Hepatic Insufficiency MESH:D048550 marker/mechanism 30026087 +ALB 213 Hepatitis MESH:D006505 marker/mechanism 21851314 +ALB 213 Hepatomegaly MESH:D006529 marker/mechanism 30026087 +ALB 213 HIV Infections MESH:D015658 marker/mechanism 16903978 +ALB 213 HIV Seropositivity MESH:D006679 marker/mechanism 17209195 +ALB 213 Hypersensitivity MESH:D006967 marker/mechanism 8431628 +ALB 213 Hypersensitivity, Delayed MESH:D006968 marker/mechanism 19376187 +ALB 213 Hypertension MESH:D006973 therapeutic 2526952 +ALB 213 Hyperthyroxinemia, Familial Dysalbuminemic MESH:D050010 marker/mechanism 615999.0 8048949|8064810|9329347 +ALB 213 Hypoalbuminemia MESH:D034141 marker/mechanism 616000.0 10337936 +ALB 213 Hypotension MESH:D007022 marker/mechanism 11229087|4463119 +ALB 213 Keloid MESH:D007627 marker/mechanism 20128793 +ALB 213 Kidney Diseases MESH:D007674 marker/mechanism 16316336|17303580|20438795|21338618|2386429|24863737|350256|7297036 +ALB 213 Kidney Failure, Chronic MESH:D007676 marker/mechanism 11938814 +ALB 213 Liver Cirrhosis MESH:D008103 marker/mechanism 17977396|21851314 +ALB 213 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 30026087 +ALB 213 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16642209|17963606|21163135 +ALB 213 Liver Failure, Acute MESH:D017114 marker/mechanism|therapeutic 16750869|18609519 +ALB 213 Lung Injury MESH:D055370 marker/mechanism 30953400 +ALB 213 Meningitis, Aseptic MESH:D008582 marker/mechanism 5108595|5109917|5536438 +ALB 213 Muscular Diseases MESH:D009135 therapeutic 4126124 +ALB 213 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 9572063 +ALB 213 Nephritis MESH:D009393 marker/mechanism 161594|16326737|2945356|3656695|4065304|9380243 +ALB 213 Nephritis, Interstitial MESH:D009395 marker/mechanism 10916085|12217854|18176075|23994741 +ALB 213 Nephrosis MESH:D009401 marker/mechanism 3301049 +ALB 213 Nephrotic Syndrome MESH:D009404 marker/mechanism 1556257|17178036 +ALB 213 Occupational Diseases MESH:D009784 marker/mechanism 23791970 +ALB 213 Pain MESH:D010146 therapeutic 4126124 +ALB 213 Pancreatic Diseases MESH:D010182 marker/mechanism 17169978 +ALB 213 Pancreatitis MESH:D010195 marker/mechanism 17169977 +ALB 213 Poisoning MESH:D011041 marker/mechanism 10511253 +ALB 213 Proteinuria MESH:D011507 marker/mechanism 1011057|10916085|12217854|14514721|16326737|18176075|7288527|7297036|839733 +ALB 213 Respiratory Distress Syndrome MESH:D012128 therapeutic 12394941 +ALB 213 Respiratory Tract Diseases MESH:D012140 marker/mechanism 8431628 +ALB 213 Rhinitis, Allergic, Perennial MESH:D012221 marker/mechanism 19389874 +ALB 213 Serum Sickness MESH:D012713 marker/mechanism 350256|9380243 +ALB 213 Stevens-Johnson Syndrome MESH:D013262 therapeutic 12239465 +ALB 213 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +ALB 213 Stroke MESH:D020521 marker/mechanism|therapeutic 14514741|16174931|16809570|17270091 +ALB 213 Thrombocytopenia MESH:D013921 marker/mechanism 6734075 +ALB 213 Urticaria MESH:D014581 marker/mechanism 8458210 +ALB 213 Uveitis MESH:D014605 marker/mechanism 1556257 +ALCAM 214 Carcinoma MESH:D002277 marker/mechanism 16316942 +ALCAM 214 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +ALCAM 214 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +ALDH16A1 126133 Gout MESH:D006073 marker/mechanism 21983786 +ALDH16A1 126133 Gout, HPRT-Related MESH:C562583 marker/mechanism 23348497 +ALDH16A1 126133 Hyperuricemia MESH:D033461 marker/mechanism 23348497 +ALDH18A1 5832 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +ALDH18A1 5832 Cutis Laxa, Autosomal Dominant MESH:C562627 marker/mechanism 616603.0 +ALDH18A1 5832 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA OMIM:219150 marker/mechanism 219150.0 +ALDH18A1 5832 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +ALDH18A1 5832 Spastic paraplegia 9, autosomal dominant MESH:C536868 marker/mechanism 601162.0 +ALDH18A1 5832 SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE OMIM:616586 marker/mechanism 616586.0 +ALDH1A1 216 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH1A1 216 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +ALDH1A1 216 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 26783756|29626521 +ALDH1A1 216 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +ALDH1A1 216 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +ALDH1A1 216 Liver Diseases MESH:D008107 marker/mechanism 31651977 +ALDH1A1 216 Melanoma MESH:D008545 marker/mechanism 31580832 +ALDH1A1 216 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29718361 +ALDH1A1 216 Parkinsonian Disorders MESH:D020734 marker/mechanism 25045800 +ALDH1A2 8854 Meningomyelocele MESH:D008591 marker/mechanism 16237707 +ALDH1A2 8854 Osteoarthritis MESH:D010003 marker/mechanism 24728293 +ALDH1A2 8854 Parkinsonian Disorders MESH:D020734 marker/mechanism 25045800 +ALDH1A2 8854 Prostatic Neoplasms MESH:D011471 marker/mechanism 16166285 +ALDH1A3 220 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH1A3 220 Melanoma MESH:D008545 marker/mechanism 31580832 +ALDH1A3 220 MICROPHTHALMIA, ISOLATED 8 OMIM:615113 marker/mechanism 615113.0 +ALDH1A3 220 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +ALDH1A7 26358 Heart Failure MESH:D006333 marker/mechanism 26670611 +ALDH1A7 26358 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ALDH1B1 219 Cholestasis MESH:D002779 marker/mechanism 27989131 +ALDH1B1 219 Colonic Neoplasms MESH:D003110 marker/mechanism 25641190 +ALDH1B1 219 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +ALDH1B1 219 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15650968|25380136 +ALDH1B1 219 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29718361 +ALDH1L1 10840 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH1L1 10840 Hypoxia MESH:D000860 marker/mechanism 19579223 +ALDH1L1 10840 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15650968 +ALDH1L1 10840 Obesity MESH:D009765 marker/mechanism 20882379 +ALDH1L2 160428 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ALDH1L2 160428 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ALDH2 217 Alcohol-Induced Disorders MESH:D020751 marker/mechanism 26711020 +ALDH2 217 Alcoholism MESH:D000437 marker/mechanism 16404797|17590986 +ALDH2 217 ALCOHOL SENSITIVITY, ACUTE OMIM:610251 marker/mechanism 610251.0 10627091 +ALDH2 217 Asthma MESH:D001249 marker/mechanism 11506308|9600491 +ALDH2 217 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH2 217 Colorectal Neoplasms MESH:D015179 marker/mechanism 16332725 +ALDH2 217 Dermatitis, Occupational MESH:D009783 marker/mechanism 16758956 +ALDH2 217 Diabetes Complications MESH:D048909 therapeutic 23500772 +ALDH2 217 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +ALDH2 217 Esophageal Neoplasms MESH:D004938 marker/mechanism 8850269 +ALDH2 217 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 16639733|22960999 +ALDH2 217 Flushing MESH:D005483 marker/mechanism 8903321 +ALDH2 217 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 16404797|17590986 +ALDH2 217 Heart Injuries MESH:D006335 therapeutic 23500772 +ALDH2 217 Infertility, Male MESH:D007248 marker/mechanism 24448831 +ALDH2 217 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15650968 +ALDH2 217 Melanosis MESH:D008548 marker/mechanism 30721697 +ALDH2 217 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29718361 +ALDH2 217 Parkinson Disease MESH:D010300 marker/mechanism 24491970 +ALDH2 217 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +ALDH2 217 Vascular Diseases MESH:D014652 marker/mechanism 18596060 +ALDH2 217 Ventricular Dysfunction MESH:D018754 therapeutic 23500772 +ALDH3A1 218 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH3A1 218 Cataract MESH:D002386 marker/mechanism 28038895 +ALDH3A1 218 Corneal Injuries MESH:D065306 marker/mechanism 28038895 +ALDH3A2 224 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH3A2 224 Sjogren-Larsson Syndrome MESH:D016111 marker/mechanism 270200.0 16837225|25641190 +ALDH3B1 221 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH3B2 222 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH4A1 8659 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH4A1 8659 Hyperprolinemia type 2 MESH:C538385 marker/mechanism 239510.0 25641190 +ALDH4A1 8659 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29718361 +ALDH4A1 8659 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +ALDH5A1 7915 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH5A1 7915 Brain Diseases, Metabolic MESH:D001928 marker/mechanism 17438226 +ALDH5A1 7915 Disease Models, Animal MESH:D004195 marker/mechanism 29031482 +ALDH5A1 7915 Dystonic Disorders MESH:D020821 marker/mechanism 17438226 +ALDH5A1 7915 Intellectual Disability MESH:D008607 marker/mechanism 23825041 +ALDH5A1 7915 Neurologic Manifestations MESH:D009461 marker/mechanism 29031482 +ALDH5A1 7915 succinic semialdehyde dehydrogenase deficiency MESH:C535803 marker/mechanism 271980.0 20018576|23825041|25641190|29031482 +ALDH6A1 4329 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 10947204 +ALDH6A1 4329 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALDH6A1 4329 Methylmalonate Semialdehyde Dehydrogenase Deficiency MESH:C566402 marker/mechanism 614105.0 +ALDH6A1 4329 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ALDH6A1 4329 Obesity MESH:D009765 marker/mechanism 20882379 +ALDH7A1 501 Bone Diseases MESH:D001847 marker/mechanism 25004007 +ALDH7A1 501 Coloboma MESH:D003103 marker/mechanism 25004007 +ALDH7A1 501 Disease Progression MESH:D018450 marker/mechanism 21364753 +ALDH7A1 501 Pyridoxine-dependent epilepsy MESH:C536254 marker/mechanism 266100.0 28087462 +ALDH7A1 501 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +ALDH8A1 64577 Cholestasis MESH:D002779 marker/mechanism 27989131 +ALDH9A1 223 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ALDOA 226 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +ALDOA 226 Breast Neoplasms MESH:D001943 marker/mechanism 20562527 +ALDOA 226 Glycogen Storage Disease XII MESH:C562718 marker/mechanism 611881.0 +ALDOA 226 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ALDOA 226 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15654357 +ALDOA 226 Neoplasm Metastasis MESH:D009362 marker/mechanism 20562527 +ALDOB 229 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16115720 +ALDOB 229 Fructose Intolerance MESH:D005633 marker/mechanism 229600.0 15733923|18035330|3383242 +ALDOB 229 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 16115720 +ALDOB 229 Hypoxia MESH:D000860 marker/mechanism 19579223 +ALDOB 229 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +ALG1 56052 Congenital disorder of glycosylation type 1K MESH:C535749 marker/mechanism 608540.0 +ALG10B 144245 Long Qt Syndrome 2 MESH:C563614 marker/mechanism 613688.0 +ALG11 440138 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip OMIM:613661 marker/mechanism 613661.0 +ALG11 440138 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +ALG12 79087 Congenital disorder of glycosylation type 1G MESH:C535745 marker/mechanism 607143.0 +ALG13 79868 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36 OMIM:300884 marker/mechanism 300884.0 +ALG13 79868 Epilepsy MESH:D004827 marker/mechanism 29942082 +ALG13 79868 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +ALG14 199857 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 616227.0 +ALG2 85365 Congenital disorder of glycosylation type II MESH:C535747 marker/mechanism 607906.0 +ALG2 85365 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 616228.0 +ALG3 10195 Congenital disorder of glycosylation type 1D MESH:C535742 marker/mechanism 601110.0 +ALG6 29929 Congenital disorder of glycosylation type 1C MESH:C535741 marker/mechanism 603147.0 +ALG8 79053 Congenital disorder of glycosylation type 1H MESH:C535746 marker/mechanism 608104.0 +ALG9 79796 Congenital disorder of glycosylation type 1L MESH:C535750 marker/mechanism 608776.0 +ALG9 79796 Polycystic Kidney Disease, Potter Type I, with Microbrachycephaly, Hypertelorism, and Brachymelia MESH:C564881 marker/mechanism 263210.0 +ALK 238 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 20979469|21823889|22071784|22135231|22153831|22743652|22980554|22999080 +ALK 238 Brain Neoplasms MESH:D001932 marker/mechanism 22986231 +ALK 238 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +ALK 238 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17625570|20979469|20979473|21102269|21336183|21587085|21757253|21767331|21791641|21823889|21904575|21933749|22215748|22277784|22282074|22286583|22508824|22568572|22617245|22713522|22787409|22887466|22920921|22954507|22968692|22986231|23020724|23686600 +ALK 238 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22743654 +ALK 238 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22286764|23104988 +ALK 238 Granuloma, Plasma Cell MESH:D006104 marker/mechanism 20979472|21030459|22920921 +ALK 238 Inflammatory Breast Neoplasms MESH:D058922 marker/mechanism 22215853 +ALK 238 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 22474449 +ALK 238 Lymphoma, Large-Cell, Anaplastic MESH:D017728 marker/mechanism 16151469|19503098|21345110|22155737|22920921|22968692 +ALK 238 Neoplasm Metastasis MESH:D009362 marker/mechanism 22986231|22999080 +ALK 238 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 22277784 +ALK 238 Neuroblastoma MESH:D009447 marker/mechanism 613014.0 20576349|21823617|21859094|22072639|22286764|22588779|22789543|22920921|22932897|22968692|23104988|23334666 +ALK 238 Plasma Cell Granuloma, Pulmonary MESH:D016726 marker/mechanism 21430068 +ALKBH5 54890 Multiple Myeloma MESH:D009101 marker/mechanism 35038059 +ALKBH5 54890 Pre-Eclampsia MESH:D011225 marker/mechanism 34995009 +ALKBH8 91801 Breast Neoplasms MESH:D001943 marker/mechanism 27811057 +ALKBH8 91801 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27811057 +ALMS1 7840 Alstrom Syndrome MESH:D056769 marker/mechanism 203800.0 22447358 +ALMS1 7840 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 22447358 +ALOX12 239 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ALOX12 239 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALOX12 239 Burns, Chemical MESH:D002057 marker/mechanism 22533443 +ALOX12 239 Hyperalgesia MESH:D006930 marker/mechanism 12582831 +ALOX12 239 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +ALOX12 239 Skin Diseases MESH:D012871 marker/mechanism 22533443 +ALOX12B 242 Adenocarcinoma MESH:D000230 marker/mechanism 30258081 +ALOX12B 242 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 30258081 +ALOX12B 242 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALOX12B 242 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 30258081 +ALOX12B 242 Colonic Neoplasms MESH:D003110 marker/mechanism 30258081 +ALOX12B 242 Ichthyosiform erythroderma, Brocq congenital, nonbullous form MESH:C538603 marker/mechanism 242100.0 +ALOX12B 242 Ichthyosis, Lamellar MESH:D017490 marker/mechanism 21739938 +ALOX12B 242 Ovarian Neoplasms MESH:D010051 marker/mechanism 30258081 +ALOX12B 242 Pancreatic Carcinoma MESH:C562463 marker/mechanism 30258081 +ALOX12B 242 Prostatic Neoplasms MESH:D011471 marker/mechanism 30258081 +ALOX12B 242 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 30258081 +ALOX15 246 Atherosclerosis MESH:D050197 therapeutic 16303615 +ALOX15 246 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALOX15 246 Esophageal Neoplasms MESH:D004938 marker/mechanism 11406566 +ALOX15 246 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +ALOX15 246 Hypertension MESH:D006973 marker/mechanism 22467300 +ALOX15 246 Nasal Polyps MESH:D009298 marker/mechanism 30643255 +ALOX15B 247 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALOX5 240 Adenocarcinoma MESH:D000230 marker/mechanism 30258081 +ALOX5 240 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 30258081 +ALOX5 240 Adenoma MESH:D000236 marker/mechanism 18927292 +ALOX5 240 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +ALOX5 240 Asthma MESH:D001249 marker/mechanism 600807.0 +ALOX5 240 Atherosclerosis MESH:D050197 marker/mechanism 16698924 +ALOX5 240 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 30258081 +ALOX5 240 Colitis MESH:D003092 marker/mechanism 15821759 +ALOX5 240 Colonic Neoplasms MESH:D003110 marker/mechanism 14569062|18927292|30258081 +ALOX5 240 Colonic Polyps MESH:D003111 marker/mechanism 18927292 +ALOX5 240 Drug Eruptions MESH:D003875 marker/mechanism 16502481 +ALOX5 240 Endotoxemia MESH:D019446 marker/mechanism 15328337 +ALOX5 240 Fractures, Closed MESH:D005596 marker/mechanism 19544365 +ALOX5 240 Hyperalgesia MESH:D006930 marker/mechanism 12582831 +ALOX5 240 Hypertension, Pulmonary MESH:D006976 marker/mechanism 14726295 +ALOX5 240 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 19309543 +ALOX5 240 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 therapeutic 19503090|19823023 +ALOX5 240 Multiple Organ Failure MESH:D009102 marker/mechanism 15241586 +ALOX5 240 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20061081 +ALOX5 240 Neoplasm Metastasis MESH:D009362 marker/mechanism 20061081 +ALOX5 240 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +ALOX5 240 Ovarian Neoplasms MESH:D010051 marker/mechanism 30258081 +ALOX5 240 Pancreatic Carcinoma MESH:C562463 marker/mechanism 30258081 +ALOX5 240 Prostatic Neoplasms MESH:D011471 marker/mechanism 30258081 +ALOX5 240 Reperfusion Injury MESH:D015427 marker/mechanism 15266012 +ALOX5 240 Stomach Neoplasms MESH:D013274 marker/mechanism 20061081 +ALOX5 240 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 30258081 +ALOX5 240 Urticaria MESH:D014581 marker/mechanism 16502481 +ALOX5AP 241 Atherosclerosis MESH:D050197 marker/mechanism 16698924 +ALOX5AP 241 Ischemic Stroke MESH:D000083242 marker/mechanism 601367.0 +ALOX5AP 241 Liver Diseases MESH:D008107 marker/mechanism 19784758 +ALOX5AP 241 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +ALOX5AP 241 Proteinuria MESH:D011507 marker/mechanism 12649539 +ALOXE3 59344 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALOXE3 59344 Ichthyosiform erythroderma, Brocq congenital, nonbullous form MESH:C538603 marker/mechanism 242100.0 +ALOXE3 59344 Ichthyosis, Lamellar MESH:D017490 marker/mechanism 21739938 +ALOXE3 59344 Ichthyosis, Lamellar, 5 MESH:C564699 marker/mechanism 606545.0 +ALOXE3 59344 Prostatic Neoplasms MESH:D011471 marker/mechanism 22919386 +ALPG 251 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +ALPK1 80216 Diabetes Mellitus MESH:D003920 marker/mechanism 27542954 +ALPK1 80216 Diabetic Nephropathies MESH:D003928 marker/mechanism 27542954 +ALPK1 80216 Gout MESH:D006073 marker/mechanism 27542954 +ALPK1 80216 Nephrosclerosis MESH:D009400 marker/mechanism 27542954 +ALPK1 80216 Weight Loss MESH:D015431 marker/mechanism 27542954 +ALPL 249 Alveolar Bone Loss MESH:D016301 marker/mechanism 20630305 +ALPL 249 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 26773408 +ALPL 249 Calcinosis MESH:D002114 marker/mechanism 21193197 +ALPL 249 Disease Models, Animal MESH:D004195 marker/mechanism 27466191 +ALPL 249 Heat Stroke MESH:D018883 marker/mechanism 16878031 +ALPL 249 Hyperparathyroidism, Secondary MESH:D006962 marker/mechanism 22373954 +ALPL 249 Hypophosphatasia MESH:D007014 marker/mechanism 27466191 +ALPL 249 Hypophosphatasia, Adult MESH:C562647 marker/mechanism 146300.0 +ALPL 249 Hypophosphatasia, Childhood MESH:C562440 marker/mechanism 241510.0 +ALPL 249 Hypophosphatasia, Infantile MESH:C562646 marker/mechanism 241500.0 +ALPL 249 Liver Diseases MESH:D008107 marker/mechanism 19784758 +ALPL 249 Seizures MESH:D012640 marker/mechanism|therapeutic 27466191|7550313 +ALPP 250 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ALS2 57679 Amyotrophic Lateral Sclerosis 2, Juvenile MESH:C565957 marker/mechanism 205100.0 +ALS2 57679 Hereditary spastic paralysis, infantile onset ascending MESH:C537217 marker/mechanism 607225.0 +ALS2 57679 Primary lateral sclerosis juvenile MESH:C536416 marker/mechanism 606353.0 +ALS2CL 259173 Schizophrenia MESH:D012559 marker/mechanism 21743468 +ALX1 8092 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9847249 +ALX1 8092 Frontonasal dysplasia MESH:C538065 marker/mechanism 613456.0 +ALX3 257 Frontonasal dysplasia MESH:C538065 marker/mechanism 136760.0 19409524 +ALX3 257 Neural Tube Defects MESH:D009436 marker/mechanism 20534379 +ALX4 60529 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9847249 +ALX4 60529 Craniosynostoses MESH:D003398 marker/mechanism 615529.0 +ALX4 60529 Frontonasal dysplasia MESH:C538065 marker/mechanism 613451.0 +ALX4 60529 Lung Neoplasms MESH:D008175 marker/mechanism 24037716 +ALX4 60529 Parietal Foramina MESH:C566826 marker/mechanism 11137991 +ALX4 60529 Parietal Foramina 2 MESH:C566510 marker/mechanism 609597.0 +ALX4 60529 Polydactyly MESH:D017689 marker/mechanism 9847249 +ALYREF 10189 HIV Infections MESH:D015658 marker/mechanism 15308739 +AMACR 23600 Adenoma MESH:D000236 marker/mechanism 17684125 +AMACR 23600 Alpha-Methylacyl-CoA Racemase Deficiency MESH:C565768 marker/mechanism 614307.0 +AMACR 23600 Bile acid synthesis defect, congenital, 4 MESH:C535444 marker/mechanism 214950.0 +AMACR 23600 Colorectal Neoplasms MESH:D015179 marker/mechanism 17684125 +AMACR 23600 Hereditary Sensory and Motor Neuropathy MESH:D015417 marker/mechanism 10655068 +AMACR 23600 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +AMACR 23600 Liver Diseases MESH:D008107 marker/mechanism 12512044 +AMACR 23600 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048|22919386|24763052 +AMBN 258 AMELOGENESIS IMPERFECTA, TYPE IF OMIM:616270 marker/mechanism 616270.0 +AMBP 259 Acute Kidney Injury MESH:D058186 marker/mechanism|therapeutic 28885000|8963945 +AMBP 259 Carcinoma, Transitional Cell MESH:D002295 therapeutic 14644129 +AMBP 259 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 18779383 +AMBP 259 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +AMBP 259 Mood Disorders MESH:D019964 marker/mechanism 29987918 +AMBP 259 Neoplasm Invasiveness MESH:D009361 therapeutic 14644129 +AMBRA1 55626 Spinal Cord Injuries MESH:D013119 marker/mechanism 29793971 +AMELX 265 Amelogenesis imperfecta, hypoplastic-hypomaturation, X-linked 1 MESH:C538243 marker/mechanism 301200.0 +AMELY 266 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +AMER1 139285 Osteopathia striata cranial sclerosis MESH:C536053 marker/mechanism 300373.0 19079258 +AMER1 139285 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +AMFR 267 Alzheimer Disease MESH:D000544 marker/mechanism 22313999 +AMFR 267 Disease Progression MESH:D018450 marker/mechanism 9241080 +AMFR 267 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 9241080 +AMH 268 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +AMH 268 Persistent Mullerian duct syndrome MESH:C536665 marker/mechanism 261550.0 +AMHR2 269 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +AMHR2 269 Persistent Mullerian duct syndrome MESH:C536665 marker/mechanism 261550.0 +AMMECR1 9949 MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS OMIM:300990 marker/mechanism 300990.0 +AMN 81693 Acute Kidney Injury MESH:D058186 therapeutic 20514524 +AMN 81693 Edema MESH:D004487 therapeutic 17698245 +AMN 81693 Extravasation of Diagnostic and Therapeutic Materials MESH:D005119 therapeutic 17698245 +AMN 81693 Neurogenic Inflammation MESH:D020078 therapeutic 16938409|17698245 +AMOT 154796 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +AMOTL1 154810 Disease Progression MESH:D018450 marker/mechanism 34480788 +AMOTL1 154810 Glioma MESH:D005910 marker/mechanism 34480788 +AMOTL1 154810 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34480788 +AMPD1 270 Adenosine monophosphate deaminase deficiency MESH:C538234 marker/mechanism 10996775|11102975|1631143 +AMPD1 270 Muscle Weakness MESH:D018908 marker/mechanism 10996775 +AMPD1 270 Muscular Atrophy MESH:D009133 marker/mechanism 10996775 +AMPD1 270 Muscular Diseases MESH:D009135 marker/mechanism 11102975|18380285 +AMPD1 270 MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY OMIM:615511 marker/mechanism 615511.0 +AMPD2 271 PONTOCEREBELLAR HYPOPLASIA, TYPE 9 OMIM:615809 marker/mechanism 615809.0 +AMPD2 271 SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE OMIM:615686 marker/mechanism 615686.0 +AMPD3 272 Erythrocyte Amp Deaminase Deficiency MESH:C567878 marker/mechanism 612874.0 +AMT 275 Hyperglycinemia, Nonketotic MESH:D020158 marker/mechanism 605899.0 16450403 +AMZ2P1 201283 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +ANG 283 Acute-Phase Reaction MESH:D000210 marker/mechanism 9464241 +ANG 283 Amyotrophic Lateral Sclerosis 9 MESH:C567499 marker/mechanism 611895.0 +ANG 283 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +ANGPT1 284 Fibrosis MESH:D005355 marker/mechanism 18480750|18626492 +ANGPT1 284 Gliosis MESH:D005911 therapeutic 30476904 +ANGPT1 284 Hypertrophy MESH:D006984 therapeutic 18502941 +ANGPT1 284 Inflammation MESH:D007249 marker/mechanism 18480750 +ANGPT1 284 Nerve Degeneration MESH:D009410 therapeutic 30476904 +ANGPT1 284 Neuromuscular Manifestations MESH:D020879 therapeutic 30476904 +ANGPT1 284 Sepsis MESH:D018805 therapeutic 16005988 +ANGPT2 285 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +ANGPTL3 27329 Hypobetalipoproteinemia, Familial, 2 MESH:C565732 marker/mechanism 605019.0 +ANGPTL3 27329 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ANGPTL4 51129 Breast Neoplasms MESH:D001943 marker/mechanism 21489049 +ANGPTL4 51129 Carcinoma MESH:D002277 marker/mechanism 21489049 +ANGPTL4 51129 Coronary Artery Disease MESH:D003324 marker/mechanism 27135400 +ANGPTL4 51129 Dyslipidemias MESH:D050171 marker/mechanism 17322881 +ANGPTL4 51129 Fatty Liver MESH:D005234 marker/mechanism 28842503 +ANGPTL4 51129 Hypertriglyceridemia MESH:D015228 marker/mechanism 28842503 +ANGPTL4 51129 Lymphatic Metastasis MESH:D008207 therapeutic 17130448 +ANGPTL4 51129 Neoplasm Invasiveness MESH:D009361 therapeutic 17130448 +ANGPTL4 51129 Neoplasm Metastasis MESH:D009362 therapeutic 17130448 +ANGPTL4 51129 Obesity MESH:D009765 therapeutic 28842503 +ANGPTL6 83854 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ANK1 286 Bone Diseases, Developmental MESH:D001848 marker/mechanism 18728347 +ANK1 286 Spherocytosis, Type 1 MESH:C567159 marker/mechanism 182900.0 +ANK2 287 Cardiac Arrhythmia, Ankyrin-B-Related MESH:C566996 marker/mechanism 600919.0 +ANK2 287 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +ANK2 287 Stroke MESH:D020521 marker/mechanism 29531354 +ANK3 288 Bipolar Disorder MESH:D001714 marker/mechanism 18711365|21926974|31043756 +ANK3 288 Fetal Alcohol Spectrum Disorders MESH:D063647 marker/mechanism 29109170 +ANK3 288 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 37 OMIM:615493 marker/mechanism 615493.0 +ANK3 288 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +ANK3 288 Progeria MESH:D011371 marker/mechanism 27217151 +ANK3 288 Status Epilepticus MESH:D013226 marker/mechanism 19306853 +ANKFY1 51479 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +ANKH 56172 Chondrocalcinosis 2 MESH:C563162 marker/mechanism 118600.0 +ANKH 56172 Craniofacial Abnormalities MESH:D019465 marker/mechanism 18027777 +ANKH 56172 Craniometaphyseal Dysplasia, Autosomal Dominant MESH:C565145 marker/mechanism 123000.0 +ANKH 56172 Endometriosis MESH:D004715 marker/mechanism 20864642 +ANKH 56172 Tooth Abnormalities MESH:D014071 marker/mechanism 18027777 +ANKK1 255239 Language Disorders MESH:D007806 marker/mechanism 23691092 +ANKLE2 23141 MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE OMIM:616681 marker/mechanism 616681.0 +ANKRD1 27063 Endometriosis MESH:D004715 marker/mechanism 20864642 +ANKRD11 29123 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 18252227|35663546 +ANKRD11 29123 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 17986521 +ANKRD11 29123 Epilepsy MESH:D004827 marker/mechanism 29942082 +ANKRD11 29123 KBG syndrome MESH:C537015 marker/mechanism 148050.0 +ANKRD11 29123 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +ANKRD18A 253650 Lung Neoplasms MESH:D008175 marker/mechanism 23131552 +ANKRD20A2P 441430 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29054765 +ANKRD20A2P 441430 Lung Neoplasms MESH:D008175 marker/mechanism 29054765 +ANKRD23 200539 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +ANKRD26 22852 THROMBOCYTOPENIA 2 OMIM:188000 marker/mechanism 188000.0 +ANKRD34A 284615 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +ANKRD55 79722 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +ANKRD55 79722 Chloracne MESH:D054506 marker/mechanism 17101203 +ANKRD9 122416 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ANKS1A 23294 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990 +ANKS1B 56899 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +ANKS6 203286 Cardiovascular Abnormalities MESH:D018376 marker/mechanism 23793029 +ANKS6 203286 Kidney Diseases, Cystic MESH:D052177 marker/mechanism 23793029 +ANKS6 203286 Liver Cirrhosis MESH:D008103 marker/mechanism 23793029 +ANKS6 203286 NEPHRONOPHTHISIS 16 OMIM:615382 marker/mechanism 615382.0 +ANKS6 203286 Polycystic Kidney, Autosomal Dominant MESH:D016891 marker/mechanism 12089381 +ANKS6 203286 Situs Inversus MESH:D012857 marker/mechanism 23793029 +ANLN 54443 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ANLN 54443 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 616032.0 +ANLN 54443 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ANO10 55129 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 613728.0 +ANO3 63982 Dystonia MESH:D004421 marker/mechanism 615034.0 +ANO3 63982 Seizures, Febrile MESH:D003294 marker/mechanism 25344690 +ANO4 121601 Endometriosis MESH:D004715 marker/mechanism 20864642 +ANO4 121601 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ANO5 203859 GNATHODIAPHYSEAL DYSPLASIA OMIM:166260 marker/mechanism 166260.0 +ANO5 203859 Miyoshi Muscular Dystrophy 3 MESH:C567645 marker/mechanism 613319.0 +ANO5 203859 Muscular Dystrophy, Limb-Girdle, Type 2L MESH:C566968 marker/mechanism 611307.0 +ANO6 196527 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ANO6 196527 Scott Syndrome MESH:C563120 marker/mechanism 262890.0 +ANO6 196527 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 22138694 +ANOS1 3730 Kallmann Syndrome MESH:D017436 marker/mechanism 308700.0 +ANP32A 8125 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +ANP32A 8125 Clinical Deterioration MESH:D000075902 marker/mechanism 27602772 +ANP32A 8125 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +ANP32A 8125 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +ANP32A 8125 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +ANPEP 290 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +ANTXR1 84168 Growth retardation, Alopecia, Pseudoanodontia and Optic atrophy MESH:C535642 marker/mechanism 230740.0 +ANTXR1 84168 Hemangioma, capillary infantile MESH:C535860 marker/mechanism 602089.0 +ANTXR2 118429 Contracture MESH:D003286 marker/mechanism 12973667|14508707 +ANTXR2 118429 Fibroma MESH:D005350 marker/mechanism 12973667|14508707 +ANTXR2 118429 Gingival Hypertrophy MESH:D005886 marker/mechanism 12973667|14508707 +ANTXR2 118429 Hyalinosis, Systemic MESH:D057770 marker/mechanism 228600.0 12973667|14508707 +ANTXR2 118429 Osteolysis MESH:D010014 marker/mechanism 12973667 +ANTXR2 118429 Osteoporosis MESH:D010024 marker/mechanism 12973667 +ANTXR2 118429 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +ANTXR2 118429 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 20062062|21743469 +ANXA1 301 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +ANXA1 301 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +ANXA1 301 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +ANXA1 301 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17405164 +ANXA1 301 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +ANXA1 301 Hypertension MESH:D006973 marker/mechanism 22228705 +ANXA1 301 Kidney Diseases MESH:D007674 therapeutic 20484890 +ANXA1 301 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ANXA1 301 Lymphatic Metastasis MESH:D008207 marker/mechanism 19381893 +ANXA1 301 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942|22248470 +ANXA1 301 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +ANXA1 301 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +ANXA1 301 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15654357 +ANXA1 301 Neoplasm Metastasis MESH:D009362 marker/mechanism 20308542 +ANXA1 301 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973 +ANXA1 301 Stomach Diseases MESH:D013272 therapeutic 15472012 +ANXA10 11199 Pancreatic Neoplasms MESH:D010190 marker/mechanism 28369074 +ANXA11 311 Sarcoidosis MESH:D012507 marker/mechanism 19165924 +ANXA2 302 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +ANXA2 302 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +ANXA2 302 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +ANXA2 302 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ANXA2 302 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +ANXA2 302 Lung Neoplasms MESH:D008175 marker/mechanism 20682992 +ANXA2 302 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 22248470 +ANXA2 302 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 20682992 +ANXA2 302 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +ANXA2 302 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15654357 +ANXA2 302 Osteoporosis MESH:D010024 marker/mechanism 18924182 +ANXA2 302 Weight Gain MESH:D015430 marker/mechanism 19030233 +ANXA2R 389289 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +ANXA3 306 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22446963 +ANXA3 306 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ANXA3 306 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 22446963 +ANXA3 306 Ovarian Neoplasms MESH:D010051 marker/mechanism 21435174 +ANXA3 306 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ANXA4 307 Carcinoma MESH:D002277 marker/mechanism 16316942 +ANXA4 307 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +ANXA4 307 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +ANXA4 307 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +ANXA4 307 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ANXA4 307 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +ANXA4 307 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +ANXA4 307 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +ANXA4 307 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +ANXA4 307 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +ANXA4 307 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ANXA5 308 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +ANXA5 308 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +ANXA5 308 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 21751376 +ANXA5 308 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +ANXA5 308 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ANXA5 308 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +ANXA5 308 Pre-Eclampsia MESH:D011225 therapeutic 19837457 +ANXA5 308 PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3 OMIM:614391 marker/mechanism 614391.0 +ANXA5 308 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +ANXA5 308 Weight Gain MESH:D015430 marker/mechanism 19030233 +ANXA6 309 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ANXA6 309 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +ANXA7 310 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +AOAH 313 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +AOC1 26 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AOC1 26 Cardiomegaly MESH:D006332 marker/mechanism 6218830 +AOC1 26 Hypertension MESH:D006973 marker/mechanism 6218830 +AOC2 314 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AOC3 8639 Diabetes Mellitus MESH:D003920 marker/mechanism 23154672 +AOC3 8639 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14977883 +AOC3 8639 Diabetic Nephropathies MESH:D003928 marker/mechanism 14977883 +AOC3 8639 Hypertension MESH:D006973 marker/mechanism 23154672 +AOC3 8639 Paratuberculosis MESH:D010283 marker/mechanism 22633222 +AOC3 8639 Renal Insufficiency, Chronic MESH:D051436 marker/mechanism 23154672 +AOC4P 90586 Lung Neoplasms MESH:D008175 therapeutic 32325081 +AOC4P 90586 Neoplasm Invasiveness MESH:D009361 therapeutic 32325081 +AOC4P 90586 Neoplasms, Experimental MESH:D009374 therapeutic 32325081 +AOPEP 84909 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +AOPEP 84909 Atrial Fibrillation MESH:D001281 marker/mechanism 22544366|29892015|30061737 +AOPEP 84909 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +AOX1 316 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AOX1 316 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +AP1S1 1174 Cholestasis, Intrahepatic MESH:D002780 marker/mechanism 23423674 +AP1S1 1174 Erythrokeratodermia Variabilis 3 MESH:C563739 marker/mechanism 609313.0 23423674 +AP1S1 1174 Lipidoses MESH:D008064 marker/mechanism 17175557 +AP1S2 8905 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AP1S2 8905 Mental retardation, X-linked, syndromic 5 MESH:C535773 marker/mechanism 304340.0 17186471|17617514|23756445 +AP1S3 130340 Psoriasis MESH:D011565 marker/mechanism 616106.0 +AP2S1 1175 Familial benign hypercalcemia, type 3 MESH:C537147 marker/mechanism 600740.0 23222959 +AP3B1 8546 Hermansky Pudlak syndrome 2 MESH:C537709 marker/mechanism 608233.0 +AP3B2 8120 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 48 OMIM:617276 marker/mechanism 617276.0 +AP3D1 8943 Hermanski-Pudlak Syndrome MESH:D022861 marker/mechanism 617050.0 +AP3S1 1176 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AP3S2 10239 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 21874001 +AP4B1 10717 SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE OMIM:614066 marker/mechanism 614066.0 +AP4E1 23431 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +AP4E1 23431 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE OMIM:613744 marker/mechanism 613744.0 +AP4E1 23431 STUTTERING, FAMILIAL PERSISTENT, 1 OMIM:184450 marker/mechanism 184450.0 +AP4M1 9179 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +AP4M1 9179 Spastic Paraplegia-50, Autosomal Recessive MESH:C567858 marker/mechanism 612936.0 +AP4S1 11154 SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE OMIM:614067 marker/mechanism 614067.0 +AP5M1 55745 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +AP5Z1 9907 SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE OMIM:613647 marker/mechanism 613647.0 +APAF1 317 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 17133271 +APAF1 317 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 17133271 +APAF1 317 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9753320|9753321 +APAF1 317 Eye Abnormalities MESH:D005124 marker/mechanism 9753320 +APAF1 317 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +APAF1 317 Retinal Detachment MESH:D012163 marker/mechanism 18497877 +APAF1 317 Skin Abnormalities MESH:D012868 marker/mechanism 9753320 +APBA2 321 Skin Diseases MESH:D012871 marker/mechanism 28720099 +APBB1IP 54518 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +APBB2 323 Weight Gain MESH:D015430 marker/mechanism 19030233 +APC 324 Aberrant Crypt Foci MESH:D058739 marker/mechanism 14507667 +APC 324 Adenocarcinoma MESH:D000230 marker/mechanism 15639718|9111214 +APC 324 Adenoma MESH:D000236 marker/mechanism 10383901|12034317|19092804|30188895|9111214 +APC 324 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 175100.0 11040535|11420398|11588890|11766074|12394442|17942926|18704758|25200834|25280562|28414304|8071957 +APC 324 Adenomatous Polyps MESH:D018256 marker/mechanism 12810952 +APC 324 Anemia, Macrocytic MESH:D000748 marker/mechanism 27725143 +APC 324 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +APC 324 Autistic Disorder MESH:D001321 marker/mechanism 17221838|8071957 +APC 324 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 114550.0 +APC 324 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 18337602 +APC 324 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 19092804|21967605 +APC 324 Colonic Neoplasms MESH:D003110 marker/mechanism 10383901|12034317|17192441|24431404|25200834|26335331|7846077|8608549 +APC 324 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 12907644|17116713|18716850|19309276|21291235|21531761|21967605 +APC 324 Colorectal Neoplasms, Hereditary Nonpolyposis MESH:D003123 marker/mechanism 7661930 +APC 324 Desmoid disease, hereditary MESH:C535944 marker/mechanism 135290.0 +APC 324 Eye Abnormalities MESH:D005124 marker/mechanism 16938888 +APC 324 Fibromatosis, Abdominal MESH:D018221 marker/mechanism 10686957 +APC 324 Fibromatosis, Aggressive MESH:D018222 marker/mechanism 11816139 +APC 324 Gastrointestinal Hemorrhage MESH:D006471 marker/mechanism 24430131 +APC 324 Gastrointestinal Neoplasms MESH:D005770 marker/mechanism 21297660 +APC 324 Glioblastoma MESH:D005909 marker/mechanism 7661930 +APC 324 Hyperlipidemias MESH:D006949 marker/mechanism 17546600 +APC 324 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 18716850 +APC 324 Intellectual Disability MESH:D008607 marker/mechanism 8071957 +APC 324 Intestinal Neoplasms MESH:D007414 marker/mechanism 14706516|16962818|19092804|26335331|27840820|9111214 +APC 324 Intestinal Polyps MESH:D007417 marker/mechanism 12189188|14991580|15063141|24431404|26262998|31715269|8561861 +APC 324 Leukocytosis MESH:D007964 marker/mechanism 27725143 +APC 324 Liver Neoplasms MESH:D008113 marker/mechanism 27064257 +APC 324 Lung Neoplasms MESH:D008175 marker/mechanism 18337602 +APC 324 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 9111214 +APC 324 Medulloblastoma MESH:D008527 marker/mechanism 7661930 +APC 324 Mesothelioma MESH:D008654 marker/mechanism 17659810 +APC 324 Prostatic Neoplasms MESH:D011471 marker/mechanism 17363566|29610475 +APC 324 Rectal Neoplasms MESH:D012004 marker/mechanism 11766074|8071957 +APC 324 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +APC 324 Splenomegaly MESH:D013163 marker/mechanism 27725143 +APC 324 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 +APC 324 Turcot syndrome MESH:C536928 marker/mechanism 7661930 +APC 324 Weight Loss MESH:D015431 marker/mechanism 24431404 +APC2 10297 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +APC2 10297 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|18716850|21278247 +APC2 10297 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 18716850 +APCDD1 147495 Hypotrichosis simplex MESH:C537160 marker/mechanism 605389.0 20393562 +APCDD1 147495 Obesity MESH:D009765 marker/mechanism 28242765 +APCS 325 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +APCS 325 Coronary Artery Disease MESH:D003324 marker/mechanism 12714198 +APCS 325 Heart Failure MESH:D006333 marker/mechanism 16129801 +APCS 325 Liver Neoplasms MESH:D008113 marker/mechanism 20195826 +APCS 325 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +APEX1 328 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +APEX1 328 Brain Injuries MESH:D001930 marker/mechanism 11447995 +APEX1 328 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 25109342 +APEX1 328 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +APEX1 328 Disease Progression MESH:D018450 marker/mechanism 21364753 +APEX1 328 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 24036326 +APEX1 328 Heart Diseases MESH:D006331 marker/mechanism 22262564 +APEX1 328 Melanoma MESH:D008545 marker/mechanism 16373707 +APEX1 328 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 22245109 +APEX1 328 Prostatic Neoplasms MESH:D011471 marker/mechanism 16406883|29541389 +APEX1 328 Seizures MESH:D012640 marker/mechanism 20446108 +APEX1 328 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +APH1B 83464 Alzheimer Disease MESH:D000544 marker/mechanism 33589840 +APL-1 180783 Nerve Degeneration MESH:D009410 therapeutic 11784781 +APLN 8862 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +APLN 8862 Cardiomegaly MESH:D006332 marker/mechanism 30634441 +APLN 8862 Fibrosis MESH:D005355 marker/mechanism 30634441 +APLN 8862 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +APLN 8862 Hyperuricemia MESH:D033461 therapeutic 30710622 +APLN 8862 Hypotension MESH:D007022 marker/mechanism 30634441 +APLP2 334 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +APLP2 334 Nerve Degeneration MESH:D009410 marker/mechanism 11784781 +APMAP 57136 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +APOA1 335 Acute Lung Injury MESH:D055371 therapeutic 20972769 +APOA1 335 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +APOA1 335 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +APOA1 335 Amyloidosis, familial visceral MESH:C538249 marker/mechanism 105200.0 +APOA1 335 Ataxia with vitamin E deficiency MESH:C535393 marker/mechanism 18458655 +APOA1 335 Atherosclerosis MESH:D050197 marker/mechanism 33861588 +APOA1 335 Behcet Syndrome MESH:D001528 marker/mechanism 12074830 +APOA1 335 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +APOA1 335 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +APOA1 335 Coronary Artery Disease MESH:D003324 marker/mechanism 27135400 +APOA1 335 Death MESH:D003643 therapeutic 20972769 +APOA1 335 Diabetic Cardiomyopathies MESH:D058065 therapeutic 18332268 +APOA1 335 Drug Eruptions MESH:D003875 marker/mechanism 21055120 +APOA1 335 Edema MESH:D004487 therapeutic 20972769 +APOA1 335 Glomerulonephritis, Membranous MESH:D015433 marker/mechanism 7900854 +APOA1 335 HIV Infections MESH:D015658 marker/mechanism 12646808 +APOA1 335 Hypertension MESH:D006973 marker/mechanism 18224302 +APOA1 335 Hypoxia MESH:D000860 marker/mechanism 18258771 +APOA1 335 Inflammation MESH:D007249 therapeutic 20972769 +APOA1 335 Lipid Metabolism Disorders MESH:D052439 marker/mechanism 6816881 +APOA1 335 Lung Neoplasms MESH:D008175 marker/mechanism 19180532 +APOA1 335 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +APOA1 335 Pediatric Obesity MESH:D063766 marker/mechanism 25137265 +APOA1 335 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696|19424620 +APOA1 335 Stroke MESH:D020521 marker/mechanism 19433014 +APOA2 336 HYPERCHOLESTEROLEMIA, FAMILIAL, 1 OMIM:143890 marker/mechanism 143890.0 +APOA2 336 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 12522687 +APOA4 337 Atherosclerosis MESH:D050197 therapeutic 15822908 +APOA4 337 Chemically-Induced Disorders MESH:D064419 marker/mechanism 35999755 +APOA4 337 Colitis, Ulcerative MESH:D003093 marker/mechanism 35999755 +APOA4 337 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 16030523 +APOA4 337 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +APOA4 337 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +APOA4 337 Schizophrenia MESH:D012559 marker/mechanism 25821032 +APOA5 116519 Coronary Artery Disease MESH:D003324 marker/mechanism 24097064 +APOA5 116519 Hyperlipoproteinemia Type III MESH:D006952 marker/mechanism 16143024 +APOA5 116519 Hyperlipoproteinemia Type IV MESH:D006953 marker/mechanism 145750.0 +APOA5 116519 Hyperlipoproteinemia Type V MESH:D006954 marker/mechanism 144650.0 +APOA5 116519 Hypertriglyceridemia MESH:D015228 marker/mechanism 20657596 +APOA5 116519 Pediatric Obesity MESH:D063766 marker/mechanism 25137265 +APOB 338 Ataxia with vitamin E deficiency MESH:C535393 marker/mechanism 18458655 +APOB 338 Behcet Syndrome MESH:D001528 marker/mechanism 12074830 +APOB 338 Cardiovascular Diseases MESH:D002318 marker/mechanism 16544732|17002798 +APOB 338 Celiac Disease MESH:D002446 marker/mechanism 30097691 +APOB 338 Coronary Disease MESH:D003327 marker/mechanism 17658632 +APOB 338 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31186542 +APOB 338 Dyslipidemias MESH:D050171 therapeutic 18230960 +APOB 338 Fatty Liver MESH:D005234 marker/mechanism 12048068|17303181 +APOB 338 Hemorrhage MESH:D006470 marker/mechanism 31186542 +APOB 338 Hypercholesterolemia MESH:D006937 marker/mechanism 1600334 +APOB 338 Hyperlipidemias MESH:D006949 marker/mechanism 17658632 +APOB 338 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 144010.0 10952765 +APOB 338 Hypertriglyceridemia MESH:D015228 marker/mechanism 20657596 +APOB 338 Hypobetalipoproteinemia, Familial, 1 MESH:C566267 marker/mechanism 615558.0 +APOB 338 Hypobetalipoproteinemia, Familial, Apolipoprotein B MESH:D052476 marker/mechanism 2567736|2843815|3473077 +APOBEC1 339 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +APOBEC3A 200315 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +APOBEC3A 200315 Breast Neoplasms MESH:D001943 marker/mechanism 24728294 +APOBEC3A 200315 Neoplasms MESH:D009369 marker/mechanism 26258849 +APOBEC3A 200315 Neoplastic Processes MESH:D009385 marker/mechanism 26258849 +APOBEC3B 9582 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 23852168 +APOBEC3B 9582 Breast Neoplasms MESH:D001943 marker/mechanism 23389445|23852168|24728294|27643540 +APOBEC3B 9582 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 23852168 +APOBEC3B 9582 Head and Neck Neoplasms MESH:D006258 marker/mechanism 23852168 +APOBEC3B 9582 Neoplasms MESH:D009369 marker/mechanism 26258849 +APOBEC3B 9582 Neoplastic Processes MESH:D009385 marker/mechanism 26258849 +APOBEC3B 9582 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 23852168|27643540 +APOBEC3B 9582 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 23852168 +APOC1 341 Alzheimer Disease MESH:D000544 marker/mechanism 29107063|30319691 +APOC1 341 Heart Failure MESH:D006333 marker/mechanism 26670611 +APOC2 344 Drug Eruptions MESH:D003875 marker/mechanism 21055120 +APOC2 344 Hyperlipoproteinemia Type I MESH:D008072 marker/mechanism 207750.0 +APOC2 344 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +APOC2 344 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +APOC3 345 Apolipoprotein C-III Deficiency MESH:C566270 marker/mechanism 614028.0 +APOC3 345 Cardiovascular Diseases MESH:D002318 marker/mechanism 16544732 +APOC3 345 Celiac Disease MESH:D002446 marker/mechanism 30097691 +APOC3 345 Coronary Artery Disease MESH:D003324 marker/mechanism 24097064 +APOC3 345 Drug Eruptions MESH:D003875 marker/mechanism 21055120 +APOC3 345 Hyperlipoproteinemias MESH:D006951 marker/mechanism 2022742 +APOC3 345 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 16030523 +APOC3 345 Lung Neoplasms MESH:D008175 marker/mechanism 19180532 +APOD 347 Glioma MESH:D005910 marker/mechanism 16865689 +APOD 347 Hypokinesia MESH:D018476 marker/mechanism 21688324 +APOD 347 Learning Disabilities MESH:D007859 marker/mechanism 18419796 +APOD 347 Neurodegenerative Diseases MESH:D019636 therapeutic 18458334 +APOE 348 Abortion, Spontaneous MESH:D000022 marker/mechanism 22266326 +APOE 348 Adenocarcinoma MESH:D000230 marker/mechanism 20430468 +APOE 348 Alzheimer Disease MESH:D000544 marker/mechanism 19734902|20819998|24162737|24473795|27023435|29107063|30319691|30320580|8346443 +APOE 348 Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia MESH:C564330 marker/mechanism 607822.0 +APOE 348 Alzheimer disease type 2 MESH:C536595 marker/mechanism 104310.0 +APOE 348 Alzheimer disease type 4 MESH:C536596 marker/mechanism 606889.0 +APOE 348 Amyloidosis MESH:D000686 marker/mechanism 15993987 +APOE 348 Anxiety Disorders MESH:D001008 marker/mechanism 32057829 +APOE 348 Arteriosclerosis MESH:D001161 marker/mechanism 17118406|18287887 +APOE 348 Atherosclerosis MESH:D050197 marker/mechanism 11095717|11231916|11947894|12871831|14594625|16020748|16303615|17438151|18093987|18269830|19124646|19682479|20093625|21043830|21512104|21908651|22005275|22022523|22228805|23148895|23639522|24017971|24096154|24330719|25020133|28483571|30376133|33861588|34673409|9169506|9409251|9649566 +APOE 348 Avoidant Restrictive Food Intake Disorder MESH:D000080146 marker/mechanism 32057829 +APOE 348 Cardiovascular Diseases MESH:D002318 marker/mechanism 16544732 +APOE 348 Carotid Artery Diseases MESH:D002340 marker/mechanism 18022660 +APOE 348 Carotid Stenosis MESH:D016893 marker/mechanism 17243563 +APOE 348 Cerebral Amyloid Angiopathy MESH:D016657 marker/mechanism 11061249 +APOE 348 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +APOE 348 Cognition Disorders MESH:D003072 marker/mechanism 18239197 +APOE 348 Coronary Disease MESH:D003327 marker/mechanism 10736278 +APOE 348 Disease Progression MESH:D018450 marker/mechanism 24473795 +APOE 348 Dyslipidemias MESH:D050171 marker/mechanism 25037058|32853627|34862716 +APOE 348 Emphysema MESH:D004646 marker/mechanism 24096154 +APOE 348 Fatty Liver MESH:D005234 marker/mechanism 32853627 +APOE 348 Fibrosis MESH:D005355 marker/mechanism 32081687 +APOE 348 Hearing Loss MESH:D034381 marker/mechanism 19738398 +APOE 348 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 10686180 +APOE 348 Hypercholesterolemia MESH:D006937 marker/mechanism 11397713|21043830|22022523|22228805 +APOE 348 Hyperlipidemias MESH:D006949 marker/mechanism 11947894|12871831|20530721|20937366 +APOE 348 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 16030523 +APOE 348 Hyperlipoproteinemia Type III MESH:D006952 marker/mechanism 617347.0 12506591|16143024|9649566 +APOE 348 Hypertension MESH:D006973 marker/mechanism 20720404|22228705 +APOE 348 Lipoprotein Glomerulopathy MESH:C567089 marker/mechanism 611771.0 10432380|9176854 +APOE 348 Lung Neoplasms MESH:D008175 marker/mechanism 19180532|20430468 +APOE 348 Macular Degeneration MESH:D008268 marker/mechanism 16453339 +APOE 348 Macular Degeneration, Age-Related, 1 MESH:C566411 marker/mechanism 603075.0 +APOE 348 Mercury Poisoning MESH:D008630 marker/mechanism 16891999 +APOE 348 Multiple Sclerosis MESH:D009103 marker/mechanism 15048896 +APOE 348 Multiple Sclerosis, Relapsing-Remitting MESH:D020529 marker/mechanism 15096402|34624384 +APOE 348 Myocardial Infarction MESH:D009203 marker/mechanism 10587578 +APOE 348 Nerve Degeneration MESH:D009410 marker/mechanism 19522546 +APOE 348 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 32057829 +APOE 348 Obesity MESH:D009765 marker/mechanism 20975297 +APOE 348 Plaque, Atherosclerotic MESH:D058226 marker/mechanism 17438151|18093987|19124646|20720404|22770994|22869926|24330719|24933211|29355567|29425287|30376133|30533443|32081687|32853627|34862716|35022635 +APOE 348 Proteinuria MESH:D011507 marker/mechanism 20842518 +APOE 348 Psoriasis MESH:D011565 marker/mechanism 16433808 +APOE 348 Renal Insufficiency MESH:D051437 marker/mechanism 20842518 +APOE 348 Schizophrenia MESH:D012559 marker/mechanism 18583979 +APOE 348 Sea-Blue Histiocyte Syndrome MESH:D012618 marker/mechanism 269600.0 11095479 +APOE 348 Seizures MESH:D012640 marker/mechanism 23266720 +APOE 348 Splenomegaly MESH:D013163 marker/mechanism 11095479 +APOE 348 Translocation, Genetic MESH:D014178 marker/mechanism 34670124 +APOF 319 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +APOH 350 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +APOH 350 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +APOL1 8542 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 612551.0 +APOL2 23780 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17205118 +APOL2 23780 Marijuana Abuse MESH:D002189 marker/mechanism 17205118 +APOL2 23780 Phencyclidine Abuse MESH:D010623 marker/mechanism 17205118 +APOL2 23780 Schizophrenia MESH:D012559 marker/mechanism 181500.0 +APOL4 80832 Schizophrenia MESH:D012559 marker/mechanism 181500.0 +APOL6 80830 Influenza, Human MESH:D007251 marker/mechanism 23326326 +APOL9A 223672 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +APON 28194 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +APP 351 Aging, Premature MESH:D019588 marker/mechanism 23129026 +APP 351 Alzheimer Disease MESH:D000544 marker/mechanism 104300.0 12192006|12572668|12746438|12852432|1497677|15590663|15591071|15993441|16204253|16266835|16325427|16492752|16651627|1671712|1678058|16969627|17239395|17430250|18583042|19286555|19818510|20111991|20157255|20640797|21157020|21209907|21980910|22507317|23827522|25352456|25714973|27117003|27567873|28448946|29420472|30320580 +APP 351 Amnesia MESH:D000647 marker/mechanism 12642396 +APP 351 Amyloid angiopathy MESH:C538248 marker/mechanism 31939705 +APP 351 Amyloid Neuropathies MESH:D017772 marker/mechanism 27567873 +APP 351 Amyloidosis MESH:D000686 marker/mechanism 23541064 +APP 351 Amyloidosis, Cerebroarterial, App-Related MESH:C537944 marker/mechanism 605714.0 10821838|2111584 +APP 351 Anxiety Disorders MESH:D001008 marker/mechanism 19664757 +APP 351 Brain Diseases MESH:D001927 marker/mechanism 11800653 +APP 351 Cardiomyopathies MESH:D009202 marker/mechanism 29068127 +APP 351 Cerebral Amyloid Angiopathy MESH:D016657 marker/mechanism 21520056 +APP 351 Cognition Disorders MESH:D003072 marker/mechanism 17406652|17600377|21350020|24189446|26945731|32522471 +APP 351 Cognitive Dysfunction MESH:D060825 marker/mechanism 25288670 +APP 351 Dementia MESH:D003704 marker/mechanism 22300406 +APP 351 Disease Models, Animal MESH:D004195 marker/mechanism 12746438|16651627|25881725|27567873|31939705 +APP 351 Eye Manifestations MESH:D005132 marker/mechanism 35247505 +APP 351 Fragile X Syndrome MESH:D005600 therapeutic 22046307 +APP 351 Gliosis MESH:D005911 marker/mechanism 27567873 +APP 351 Learning Disabilities MESH:D007859 marker/mechanism 16474004|18533140|20816828|22484447|25213453|26420483|27306655|29729307|35247505 +APP 351 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +APP 351 Memory Disorders MESH:D008569 marker/mechanism 15364477|18191838|18599028|19664757|19770021|20816828|22484447|23827522|24858312|25213453|25881725|26420483|26480858|27306655|27567873|28448946|29729307|35247505 +APP 351 Necrosis MESH:D009336 marker/mechanism 21839817 +APP 351 Nerve Degeneration MESH:D009410 marker/mechanism 11784781|11800653|12396081|12963085|16951259|17600377|19631677|20111991|20359466|23726866|23827522|33971107 +APP 351 Neurodegenerative Diseases MESH:D019636 marker/mechanism 16122394|23541064 +APP 351 Neurogenic Inflammation MESH:D020078 marker/mechanism 20816828|25288670 +APP 351 Paralysis MESH:D010243 marker/mechanism 16122394|18762355|21706413|22952840|28915354|33290254|34902447 +APP 351 Plaque, Amyloid MESH:D058225 marker/mechanism 19818510|29729307|31939705|33096116 +APP 351 Spinal Cord Diseases MESH:D013118 marker/mechanism 11800653 +APP 351 Splenomegaly MESH:D013163 marker/mechanism 27117003 +APP 351 Weight Gain MESH:D015430 marker/mechanism 19030233 +APPA 58083 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +APPL 31002 Neurodegenerative Diseases MESH:D019636 therapeutic 22266106 +APPL1 26060 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +APPL1 26060 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14 OMIM:616511 marker/mechanism 616511.0 +APPL2 55198 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +APPL2 55198 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +APRT 353 Adenine phosphoribosyltransferase deficiency MESH:C538228 marker/mechanism 614723.0 +APRT 353 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +APRT 353 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +APRT 353 Urolithiasis MESH:D052878 marker/mechanism 3876264|7766 +APTX 54840 Early-onset ataxia with oculomotor apraxia and hypoalbuminemia MESH:C538013 marker/mechanism 208920.0 +AQP1 358 Carcinoma MESH:D002277 marker/mechanism 12376462 +AQP1 358 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +AQP1 358 Choledochal Cyst MESH:D015529 marker/mechanism 18988797 +AQP1 358 Edema, Cardiac MESH:D004489 marker/mechanism 22865611 +AQP1 358 Hypertension MESH:D006973 marker/mechanism 22228705 +AQP1 358 Hyperthyroidism MESH:D006980 marker/mechanism 12621104 +AQP1 358 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +AQP1 358 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +AQP1 358 Pain MESH:D010146 marker/mechanism 20018876 +AQP1 358 Polycystic Kidney, Autosomal Recessive MESH:D017044 marker/mechanism 18988797 +AQP1 358 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +AQP1 358 Shock, Septic MESH:D012772 marker/mechanism 24028651 +AQP1 358 Spinal Cord Injuries MESH:D013119 marker/mechanism 21092735 +AQP2 359 Cardiomyopathies MESH:D009202 marker/mechanism 12145768 +AQP2 359 Diabetes Insipidus, Nephrogenic MESH:D018500 marker/mechanism|therapeutic 125800.0 16121255|18653713|18854434|20374732 +AQP3 360 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21401805 +AQP3 360 Esophageal Neoplasms MESH:D004938 marker/mechanism 21401805 +AQP3 360 Lymphatic Metastasis MESH:D008207 marker/mechanism 21401805 +AQP3 360 Ovarian Neoplasms MESH:D010051 marker/mechanism 18214481 +AQP3 360 Skin Neoplasms MESH:D012878 marker/mechanism 21401805 +AQP3 360 Tongue Neoplasms MESH:D014062 marker/mechanism 21401805 +AQP3 360 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 22306368 +AQP4 361 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +AQP4 361 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AQP4 361 Autistic Disorder MESH:D001321 marker/mechanism 18435417 +AQP4 361 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +AQP4 361 Neuromyelitis Optica MESH:D009471 marker/mechanism 18509235|24070676 +AQP4 361 Spinal Cord Injuries MESH:D013119 marker/mechanism 21092735 +AQP4 361 Status Epilepticus MESH:D013226 marker/mechanism 20886625 +AQP5 362 Diffuse palmoplantar keratoderma, Bothnian type MESH:C536173 marker/mechanism 600231.0 +AQP5 362 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 17245593|17270560 +AQP7 364 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +AQP7 364 Obesity MESH:D009765 marker/mechanism 16325777 +AQP9 366 Arsenic Poisoning MESH:D020261 marker/mechanism 19805235 +AQP9 366 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +AQP9 366 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +AQP9 366 Leukemia MESH:D007938 therapeutic 15336539 +AQP9 366 Leukemia, Myeloid, Acute MESH:D015470 therapeutic 16968895 +AQP9 366 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 23563754 +AQP9 366 MPTP Poisoning MESH:D020267 marker/mechanism 29566083 +AR 367 Alopecia MESH:D000505 marker/mechanism 15902657 +AR 367 Androgen-Insensitivity Syndrome MESH:D013734 marker/mechanism 300068|312300 1303262|8281139 +AR 367 Astrocytoma MESH:D001254 marker/mechanism 24680642 +AR 367 Autistic Disorder MESH:D001321 marker/mechanism 19167832 +AR 367 Breast Neoplasms MESH:D001943 marker/mechanism 21633166|22174584 +AR 367 Breast Neoplasms, Male MESH:D018567 marker/mechanism 1303262|8281139 +AR 367 Bulbospinal neuronopathy, X-linked recessive MESH:C537017 marker/mechanism 313200 +AR 367 Carcinoma, Hepatocellular MESH:D006528 therapeutic 18639551 +AR 367 Diabetes, Gestational MESH:D016640 marker/mechanism 20421132 +AR 367 Genital Diseases, Male MESH:D005832 marker/mechanism 25434310 +AR 367 Hypertension MESH:D006973 marker/mechanism 10523385 +AR 367 Hypospadias 1, X-Linked MESH:C567482 marker/mechanism 300633 +AR 367 Infertility, Female MESH:D007247 marker/mechanism 23710174 +AR 367 Infertility, Male MESH:D007248 marker/mechanism 12220434|18554162|20164437 +AR 367 Insulin Resistance MESH:D007333 marker/mechanism 21444647 +AR 367 Leukemia MESH:D007938 marker/mechanism 19235587 +AR 367 Lung Neoplasms MESH:D008175 marker/mechanism 30008631 +AR 367 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 11742035 +AR 367 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 20601956 +AR 367 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 176807 11742035|12237244|15389811|15790600|16266977|16877366|16934689|16998812|17003774|17141945|18829485|19011039|20729295|22610119|22666205|23704919|25062956|25735316|25908785|25970160|29610475 +AR 367 Prostatic Neoplasms, Castration-Resistant MESH:D064129 marker/mechanism 18985049|24740322|28500234|28757136 +ARAF 369 Breast Neoplasms MESH:D001943 therapeutic 12432273 +ARAP3 64411 HIV Infections MESH:D015658 marker/mechanism 15308739 +ARC 23237 Alzheimer Disease MESH:D000544 marker/mechanism 18503570 +ARC 23237 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18311559 +ARC 23237 Movement Disorders MESH:D009069 marker/mechanism 20298714 +ARCN1 372 Ataxia MESH:D001259 marker/mechanism 20502676 +AREG 374 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +AREG 374 Asthma MESH:D001249 marker/mechanism 15696081 +AREG 374 Breast Neoplasms MESH:D001943 therapeutic 11237771 +AREG 374 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427|16230376 +AREG 374 Carcinoma, Squamous Cell MESH:D002294 therapeutic 11237771 +AREG 374 Endometriosis MESH:D004715 marker/mechanism 20864642 +AREG 374 Head and Neck Neoplasms MESH:D006258 marker/mechanism 15342401 +AREG 374 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +AREG 374 Ovarian Neoplasms MESH:D010051 therapeutic 15313392 +AREG 374 Protoporphyria, Erythropoietic MESH:D046351 marker/mechanism 19267999 +AREG 374 Pulmonary Fibrosis MESH:D011658 marker/mechanism 26817844 +AREG 374 Stomach Neoplasms MESH:D013274 marker/mechanism|therapeutic 15723263|15940630|16367923 +ARF1 375 Breast Neoplasms MESH:D001943 marker/mechanism 27517156 +ARF1 375 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27517156 +ARFGAP1 55738 Developmental Disabilities MESH:D002658 marker/mechanism 20805988 +ARFGAP1 55738 Nervous System Diseases MESH:D009422 marker/mechanism 20805988 +ARFGAP2 84364 Disease Progression MESH:D018450 marker/mechanism 21364753 +ARFGAP2 84364 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +ARFGEF2 10564 Heterotopia, Periventricular, Autosomal Recessive MESH:C564292 marker/mechanism 608097.0 +ARG1 383 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +ARG1 383 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 21239484 +ARG1 383 Asbestosis MESH:D001195 marker/mechanism 26699812 +ARG1 383 Asthma MESH:D001249 marker/mechanism 19281908|19800904 +ARG1 383 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22872058 +ARG1 383 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +ARG1 383 Hair Diseases MESH:D006201 marker/mechanism 21239484 +ARG1 383 Hyperargininemia MESH:D020162 marker/mechanism 207800.0 +ARG1 383 Immune System Diseases MESH:D007154 marker/mechanism 21239484 +ARG1 383 Leishmaniasis MESH:D007896 marker/mechanism 21232540 +ARG1 383 Muscular Diseases MESH:D009135 marker/mechanism 21239484 +ARG1 383 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +ARG1 383 Silicosis MESH:D012829 marker/mechanism 15292275 +ARG2 384 Asthma MESH:D001249 marker/mechanism 19281908 +ARG2 384 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 23424623 +ARG2 384 Disease Progression MESH:D018450 marker/mechanism 23424623 +ARG2 384 Heart Failure MESH:D006333 marker/mechanism 36071497 +ARG2 384 Hypertension, Pulmonary MESH:D006976 marker/mechanism 24951775 +ARG2 384 Necrosis MESH:D009336 marker/mechanism 23424623 +ARG2 384 Nerve Degeneration MESH:D009410 marker/mechanism 30618589 +ARG2 384 Optic Nerve Injuries MESH:D020221 marker/mechanism 30618589 +ARG2 384 Prostatic Neoplasms MESH:D011471 marker/mechanism 23424623 +ARG2 384 Retinal Degeneration MESH:D012162 marker/mechanism 30618589 +ARHGAP10 79658 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +ARHGAP11A 9824 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ARHGAP15 55843 Diverticular Diseases MESH:D000076385 marker/mechanism 28585551|30177863 +ARHGAP22 58504 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +ARHGAP23 57636 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ARHGAP26 23092 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 607785.0 +ARHGAP28 79822 Endometriosis MESH:D004715 marker/mechanism 20864642 +ARHGAP29 9411 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 17488656 +ARHGAP30 257106 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ARHGAP30 257106 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ARHGAP31 57514 Adams Oliver syndrome MESH:C538225 marker/mechanism 100300.0 +ARHGAP35 2909 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +ARHGAP4 393 HIV Infections MESH:D015658 marker/mechanism 15308739 +ARHGAP45 23526 Neoplasms MESH:D009369 marker/mechanism 19096014 +ARHGAP45 23526 Pre-Eclampsia MESH:D011225 marker/mechanism 26095815 +ARHGAP5 394 Stomach Neoplasms MESH:D013274 marker/mechanism 36914835 +ARHGAP6 395 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +ARHGAP9 64333 Coronary Vasospasm MESH:D003329 marker/mechanism 19911011 +ARHGAP9 64333 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ARHGDIA 396 Breast Neoplasms MESH:D001943 marker/mechanism 20562527 +ARHGDIA 396 HIV Infections MESH:D015658 marker/mechanism 15308739 +ARHGDIA 396 Keloid MESH:D007627 marker/mechanism 20128793 +ARHGDIA 396 Neoplasm Metastasis MESH:D009362 marker/mechanism 20562527 +ARHGDIA 396 NEPHROTIC SYNDROME, TYPE 8 OMIM:615244 marker/mechanism 615244.0 +ARHGDIB 397 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +ARHGDIB 397 HIV Infections MESH:D015658 marker/mechanism 15308739 +ARHGDIB 397 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ARHGEF10 9639 Slowed Nerve Conduction Velocity, Autosomal Dominant MESH:C564269 marker/mechanism 608236.0 +ARHGEF12 23365 Weight Gain MESH:D015430 marker/mechanism 19030233 +ARHGEF18 23370 RETINITIS PIGMENTOSA 78 OMIM:617433 marker/mechanism 617433.0 +ARHGEF39 84904 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ARHGEF5 7984 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29054765 +ARHGEF5 7984 Lung Neoplasms MESH:D008175 marker/mechanism 29054765 +ARHGEF5 7984 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ARHGEF9 23229 Hyperekplexia and Epilepsy MESH:C564474 marker/mechanism 300607.0 +ARHGEF9 23229 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 21807943 +ARID1A 8289 Adenocarcinoma MESH:D000230 marker/mechanism 22484628 +ARID1A 8289 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 23525077 +ARID1A 8289 Breast Neoplasms MESH:D001943 marker/mechanism 31932695 +ARID1A 8289 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143597 +ARID1A 8289 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +ARID1A 8289 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22561517|22634756|22922871 +ARID1A 8289 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 21822268 +ARID1A 8289 Cholangiocarcinoma MESH:D018281 marker/mechanism 24185509 +ARID1A 8289 Coffin-Siris syndrome MESH:C536436 marker/mechanism 614607.0 22426308 +ARID1A 8289 Colorectal Neoplasms MESH:D015179 marker/mechanism 27941798 +ARID1A 8289 Endometrial Neoplasms MESH:D016889 marker/mechanism 23104009 +ARID1A 8289 Lymphoma, T-Cell MESH:D016399 marker/mechanism 26192917 +ARID1A 8289 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +ARID1A 8289 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +ARID1A 8289 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +ARID1A 8289 Neuroblastoma MESH:D009447 marker/mechanism 23202128 +ARID1A 8289 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475|29662167 +ARID1A 8289 Rhabdomyosarcoma, Embryonal MESH:D018233 marker/mechanism 29376028 +ARID1A 8289 Sezary Syndrome MESH:D012751 marker/mechanism 26551670 +ARID1A 8289 Stomach Neoplasms MESH:D013274 marker/mechanism 22037554|22484628|24816253 +ARID1A 8289 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21822268 +ARID1A 8289 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +ARID1B 57492 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22634756 +ARID1B 57492 Coffin-Siris syndrome MESH:C536436 marker/mechanism 135900.0 22426308|22426309 +ARID1B 57492 Epilepsy MESH:D004827 marker/mechanism 29942082 +ARID1B 57492 Neuroblastoma MESH:D009447 marker/mechanism 23202128 +ARID1B 57492 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +ARID2 196528 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21822264|22634756 +ARID2 196528 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +ARID3A 1820 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 35179300 +ARID4A 5926 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +ARID4B 51742 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +ARID5B 84159 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22446963|23143596 +ARID5B 84159 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +ARID5B 84159 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 24712521 +ARID5B 84159 Graves Disease MESH:D006111 marker/mechanism 22446963 +ARID5B 84159 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 19684603|19684604 +ARL11 115761 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ARL11 115761 Ovarian Neoplasms MESH:D010051 marker/mechanism 17079447 +ARL13B 200894 Joubert Syndrome 8 MESH:C567358 marker/mechanism 612291.0 +ARL14EP 120534 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ARL2 402 Melanoma MESH:D008545 marker/mechanism 22535842 +ARL2BP 23568 RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS OMIM:615434 marker/mechanism 615434.0 +ARL5B 221079 Melanoma MESH:D008545 marker/mechanism 22535842 +ARL6 84100 Bardet-Biedl syndrome 1 MESH:C537909 marker/mechanism 209900.0 +ARL6 84100 Bardet-Biedl syndrome 3 MESH:C537911 marker/mechanism 600151.0 +ARL6 84100 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 +ARL6 84100 RETINITIS PIGMENTOSA 55 OMIM:613575 marker/mechanism 613575.0 +ARL6IP1 23204 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +ARL6IP1 23204 SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE OMIM:615685 marker/mechanism 615685.0 +ARL6IP5 10550 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 29545876 +ARL6IP5 10550 Neoplasms, Experimental MESH:D009374 marker/mechanism 29545876 +ARL6IP5 10550 Stomach Neoplasms MESH:D013274 marker/mechanism 22452940 +ARL6IP5 10550 Substance Withdrawal Syndrome MESH:D013375 therapeutic 21600884 +ARL8A 127829 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ARMC5 79798 Acth-Independent Macronodular Adrenal Hyperplasia MESH:C565662 marker/mechanism 615954.0 +ARMCX1 51309 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ARMH3 79591 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +ARMS2 387715 Macular Degeneration MESH:D008268 marker/mechanism 17884985|18511946|21909106 +ARMS2 387715 MACULAR DEGENERATION, AGE-RELATED, 8 OMIM:613778 marker/mechanism 613778.0 +ARNT 405 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +ARNT 405 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20935161 +ARNT 405 Colorectal Neoplasms MESH:D015179 marker/mechanism 21081473 +ARNT 405 Endometriosis MESH:D004715 marker/mechanism 22138541 +ARNT 405 Liver Cirrhosis MESH:D008103 marker/mechanism 22271822 +ARNT 405 Melanoma MESH:D008545 marker/mechanism 21983785 +ARNT 405 Neoplasms, Experimental MESH:D009374 marker/mechanism 9496914 +ARNT 405 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 22674224 +ARNT2 9915 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +ARNT2 9915 WEBB-DATTANI SYNDROME OMIM:615926 marker/mechanism 615926.0 +ARPC1B 10095 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ARPC2 10109 Colitis, Ulcerative MESH:D003093 marker/mechanism 18836448 +ARRB1 408 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +ARRB2 409 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 17233643 +ARRB2 409 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ARRDC3 57561 Breast Neoplasms MESH:D001943 marker/mechanism 25038754 +ARSA 410 Leukodystrophy, Metachromatic MESH:D007966 marker/mechanism 250100.0 +ARSB 411 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ARSB 411 Mucopolysaccharidosis VI MESH:D009087 marker/mechanism 253200.0 17458871 +ARSE 100627778 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ARSF 416 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ARSG 22901 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ARSH 347527 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ARSI 340075 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ARSK 153642 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ARSL 415 X-Linked Chondrodysplasia Punctata 1 MESH:C580533 marker/mechanism 302950.0 18348268|7720070 +ARTN 9048 Breast Neoplasms MESH:D001943 marker/mechanism 20305694 +ARTN 9048 Dermatitis, Atopic MESH:D003876 marker/mechanism 27869817 +ARTN 9048 Disease Models, Animal MESH:D004195 marker/mechanism 27869817 +ARTN 9048 Pruritus MESH:D011537 marker/mechanism 27869817 +ARV1 64801 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38 OMIM:617020 marker/mechanism 617020.0 +ARX 170302 Infantile Epileptic-Dyskinetic Encephalopathy MESH:C567924 marker/mechanism 308350.0 +ARX 170302 Lissencephaly, X-Linked, 2 MESH:C564563 marker/mechanism 300215.0 +ARX 170302 Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related MESH:C563150 marker/mechanism 300419.0 +ARX 170302 Partington X-linked mental retardation syndrome MESH:C536300 marker/mechanism 309510.0 +ARX 170302 Proud Syndrome MESH:C563110 marker/mechanism 300004.0 +AS3MT 57412 Arsenic Poisoning MESH:D020261 marker/mechanism|therapeutic 21447609|26366667|35226250 +AS3MT 57412 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 25461954 +AS3MT 57412 Birth Weight MESH:D001724 marker/mechanism 26928318 +AS3MT 57412 Developmental Disabilities MESH:D002658 marker/mechanism 28235556 +AS3MT 57412 Insulin Resistance MESH:D007333 marker/mechanism 35226250 +AS3MT 57412 Lung Neoplasms MESH:D008175 marker/mechanism 36399430 +AS3MT 57412 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 24361376 +AS3MT 57412 Neoplasms, Glandular and Epithelial MESH:D009375 marker/mechanism 21447609 +AS3MT 57412 Schizophrenia MESH:D012559 marker/mechanism 27158905 +AS3MT 57412 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 22747749|29669044|29859237|32539094 +ASAH1 427 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +ASAH1 427 Farber Lipogranulomatosis MESH:D055577 marker/mechanism 228000.0 +ASAH1 427 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414 +ASAH1 427 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ASAH1 427 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +ASAH1 427 SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY OMIM:159950 marker/mechanism 159950.0 +ASAH2 56624 Celiac Disease MESH:D002446 marker/mechanism 30097691 +ASAH2 56624 Liver Diseases MESH:D008107 therapeutic 15946935 +ASAP1 50807 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ASAP1 50807 Tuberculosis, Pulmonary MESH:D014397 marker/mechanism 25774636 +ASAP1 50807 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +ASB10 136371 Glaucoma 1, Open Angle, F MESH:C566383 marker/mechanism 603383.0 +ASB15 142685 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +ASCC1 51008 Barrett Esophagus MESH:D001471 marker/mechanism 614266.0 +ASCC1 51008 SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2 OMIM:616867 marker/mechanism 616867.0 +ASCC3 10973 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ASCL1 429 Acute Lung Injury MESH:D055371 therapeutic 20554700 +ASCL1 429 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ASCL1 429 Nervous System Diseases MESH:D009422 marker/mechanism 23203475 +ASCL1 429 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 26253517 +ASCL2 430 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +ASF1A 25842 Melanoma MESH:D008545 marker/mechanism 22535842 +ASF1B 55723 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ASF1B 55723 Prostatic Neoplasms, Castration-Resistant MESH:D064129 marker/mechanism 29581250 +ASH1L 55870 Liver Neoplasms MESH:D008113 marker/mechanism 27064257 +ASH1L 55870 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +ASH1L 55870 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +ASIC1 41 Brain Injuries MESH:D001930 marker/mechanism 21307247 +ASIC1 41 Brain Ischemia MESH:D002545 marker/mechanism 21307247 +ASIC1 41 Inflammation MESH:D007249 marker/mechanism 11588175 +ASIC2 40 Autistic Disorder MESH:D001321 marker/mechanism 17376794 +ASIC2 40 Inflammation MESH:D007249 marker/mechanism 11588175 +ASIC3 9311 Inflammation MESH:D007249 marker/mechanism 11588175 +ASIP 434 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 18488027 +ASIP 434 Melanoma MESH:D008545 marker/mechanism 18488027|18641652|21983785 +ASIP 434 Skin Neoplasms MESH:D012878 marker/mechanism 18488027 +ASL 435 Argininosuccinic Aciduria MESH:D056807 marker/mechanism 207900.0 3106853 +ASMT 438 Autistic Disorder MESH:D001321 marker/mechanism 17505466 +ASMT 438 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +ASMTL 8623 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +ASNS 440 ASPARAGINE SYNTHETASE DEFICIENCY OMIM:615574 marker/mechanism 615574.0 +ASNS 440 Lipidoses MESH:D008064 marker/mechanism 17175557 +ASNS 440 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ASNS 440 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +ASPA 443 Canavan Disease MESH:D017825 marker/mechanism 271900.0 17027983|17194761 +ASPG 374569 Anaphylaxis MESH:D000707 marker/mechanism 65671 +ASPG 374569 Anemia MESH:D000740 marker/mechanism 2187653 +ASPG 374569 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ASPG 374569 Choledocholithiasis MESH:D042883 marker/mechanism 12902918 +ASPG 374569 Cholelithiasis MESH:D002769 marker/mechanism 12902918 +ASPG 374569 Fever MESH:D005334 marker/mechanism 2187653 +ASPG 374569 Hematuria MESH:D006417 marker/mechanism 2187653 +ASPG 374569 Leukopenia MESH:D007970 marker/mechanism 2187653 +ASPG 374569 Thrombocytopenia MESH:D013921 marker/mechanism 2187653 +ASPG 374569 Vomiting MESH:D014839 marker/mechanism 2187653 +ASPH 444 Ectopia Lentis, Spontaneous Filtering Blebs, and Craniofacial Dysmorphism MESH:C563293 marker/mechanism 601552.0 +ASPM 259266 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +ASPM 259266 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ASPM 259266 Microcephaly, Primary Autosomal Recessive, 5 MESH:C563871 marker/mechanism 608716.0 +ASPM 259266 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ASPM 259266 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +ASPN 54829 Intervertebral disc disease MESH:C535531 marker/mechanism 603932.0 +ASPN 54829 Keloid MESH:D007627 marker/mechanism 20128793 +ASPN 54829 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ASPN 54829 Osteoarthritis MESH:D010003 marker/mechanism 607850.0 +ASPSCR1 79058 Sarcoma, Alveolar Soft Part MESH:D018234 marker/mechanism 606243.0 +ASRGL1 80150 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +ASS1 445 Citrullinemia MESH:D020159 marker/mechanism 215700.0 +ASS1 445 Diabetic Angiopathies MESH:D003925 therapeutic 25033204 +ASS1 445 Liver Diseases MESH:D008107 marker/mechanism 31651977 +ASS1 445 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +ASTN1 460 Brain Injuries MESH:D001930 marker/mechanism 14499481 +ASTN2 23245 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +ASTN2 23245 Autistic Disorder MESH:D001321 marker/mechanism 19404257 +ASTN2 23245 Migraine without Aura MESH:D020326 marker/mechanism 22683712 +ASTN2 23245 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +ASXL1 171023 Bohring syndrome MESH:C537419 marker/mechanism 605039.0 21706002 +ASXL1 171023 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +ASXL1 171023 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 26285909 +ASXL1 171023 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 614286.0 27992414 +ASXL1 171023 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 26285909 +ASXL1 171023 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +ASXL2 55252 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 27798625 +ASXL2 55252 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121791 +ASXL3 80816 BAINBRIDGE-ROPERS SYNDROME OMIM:615485 marker/mechanism 615485.0 +ASXL3 80816 Epilepsy MESH:D004827 marker/mechanism 29942082 +ASXL3 80816 Lymphoma, T-Cell MESH:D016399 marker/mechanism 26192917 +ASXL3 80816 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +ASZ1 136991 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ATAD3A 55210 HAREL-YOON SYNDROME OMIM:617183 marker/mechanism 617183.0 +ATAD3A 55210 Prostatic Neoplasms MESH:D011471 marker/mechanism 21584487 +ATAD5 79915 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 25581431 +ATAT1 79969 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +ATCAY 85300 Cerebellar Ataxia, Cayman Type MESH:C563363 marker/mechanism 601238.0 +ATF1 466 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ATF2 1386 Disease Progression MESH:D018450 marker/mechanism 23591579 +ATF2 1386 Neoplasms MESH:D009369 marker/mechanism 23591579 +ATF3 467 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17043644 +ATF3 467 Cardiomyopathies MESH:D009202 therapeutic 25136830 +ATF3 467 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 34364923 +ATF3 467 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +ATF3 467 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +ATF3 467 Hypospadias MESH:D007021 marker/mechanism 18001166 +ATF3 467 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +ATF3 467 Influenza, Human MESH:D007251 marker/mechanism 23326326 +ATF3 467 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ATF3 467 Liver Neoplasms MESH:D008113 marker/mechanism 21159647 +ATF3 467 Nervous System Diseases MESH:D009422 marker/mechanism 18701217|18754875 +ATF3 467 Ovarian Neoplasms MESH:D010051 therapeutic 15674352 +ATF3 467 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 17686523 +ATF3 467 Prostatic Neoplasms MESH:D011471 marker/mechanism 16516039 +ATF4 468 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 14604972 +ATF4 468 Fatty Liver MESH:D005234 marker/mechanism 27664470 +ATF4 468 Hypoxia MESH:D000860 marker/mechanism 14604972 +ATF4 468 Necrosis MESH:D009336 marker/mechanism 14604972 +ATF4 468 Spinal Cord Injuries MESH:D013119 marker/mechanism 29793971 +ATF5 22809 Glioma MESH:D005910 marker/mechanism 28861715 +ATF5 22809 Huntington Disease MESH:D006816 marker/mechanism 28861715 +ATF6 22926 ACHROMATOPSIA 7 OMIM:616517 marker/mechanism 616517.0 +ATF6 22926 Asbestosis MESH:D001195 marker/mechanism 25324550 +ATF6 22926 Color Vision Defects MESH:D003117 marker/mechanism 26029869 +ATF6 22926 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +ATF6 22926 Nystagmus, Congenital MESH:D020417 marker/mechanism 26029869 +ATF6 22926 Photophobia MESH:D020795 marker/mechanism 26029869 +ATF6 22926 Retinitis Pigmentosa MESH:D012174 marker/mechanism 26029869 +ATF6 22926 Scrapie MESH:D012608 marker/mechanism 23349890 +ATF7IP 55729 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 20543847 +ATF7IP 55729 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 24413735 +ATF7IP 55729 Testicular Neoplasms MESH:D013736 marker/mechanism 20543847 +ATG10 83734 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +ATG101 60673 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +ATG16L1 55054 Crohn Disease MESH:D003424 marker/mechanism 17435756|18438406 +ATG16L1 55054 Inflammatory Bowel Disease 10 MESH:C567021 marker/mechanism 611081.0 +ATG16L1 55054 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 26192919 +ATG16L1 55054 Zika Virus Infection MESH:D000071243 therapeutic 28694387 +ATG2B 55102 Leukemia, Myeloid MESH:D007951 marker/mechanism 26280900 +ATG2B 55102 Myeloproliferative Disorders MESH:D009196 marker/mechanism 26280900 +ATG4C 84938 Crohn Disease MESH:D003424 marker/mechanism 36038634 +ATG5 9474 Anemia MESH:D000740 marker/mechanism 26568842 +ATG5 9474 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22491424 +ATG5 9474 Hepatomegaly MESH:D006529 marker/mechanism 22491424 +ATG5 9474 Lethargy MESH:D053609 marker/mechanism 26568842 +ATG5 9474 Liver Cirrhosis MESH:D008103 marker/mechanism 33549628 +ATG5 9474 Lymphopenia MESH:D008231 marker/mechanism 26568842 +ATG5 9474 Necrosis MESH:D009336 marker/mechanism 20578144 +ATG5 9474 Ovarian Neoplasms MESH:D010051 marker/mechanism 28408137 +ATG5 9474 Spinal Cord Injuries MESH:D013119 marker/mechanism 29793971 +ATG5 9474 Teratozoospermia MESH:D000072660 marker/mechanism 37506864 +ATG5 9474 Weight Loss MESH:D015431 marker/mechanism 26568842 +ATG7 10533 Anemia MESH:D000740 marker/mechanism 26568842 +ATG7 10533 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 29191453 +ATG7 10533 Hepatomegaly MESH:D006529 marker/mechanism 26483381 +ATG7 10533 Lethargy MESH:D053609 marker/mechanism 26568842 +ATG7 10533 Liver Failure MESH:D017093 marker/mechanism 26483381 +ATG7 10533 Lymphopenia MESH:D008231 marker/mechanism 26568842 +ATG7 10533 Necrosis MESH:D009336 therapeutic 21081844 +ATG7 10533 Ovarian Neoplasms MESH:D010051 marker/mechanism 28408137 +ATG7 10533 Weight Loss MESH:D015431 marker/mechanism 26568842 +ATIC 471 AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency MESH:C563876 marker/mechanism 608688.0 15114530 +ATIC 471 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19193698 +ATIC 471 Blindness MESH:D001766 marker/mechanism 15114530 +ATIC 471 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 16947783 +ATIC 471 Osteoporosis MESH:D010024 marker/mechanism 18924182 +ATL1 51062 NEUROPATHY, HEREDITARY SENSORY, TYPE ID OMIM:613708 marker/mechanism 613708.0 +ATL1 51062 Spastic paraplegia 3, autosomal dominant MESH:C536864 marker/mechanism 182600.0 +ATL3 25923 NEUROPATHY, HEREDITARY SENSORY, TYPE IF OMIM:615632 marker/mechanism 615632.0 +ATM 472 Ataxia Telangiectasia MESH:D001260 marker/mechanism 208900.0 11507241|11507245|15177039|15498871|8958160 +ATM 472 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +ATM 472 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +ATM 472 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19919837 +ATM 472 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 25125259 +ATM 472 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 24358288 +ATM 472 Cataract MESH:D002386 marker/mechanism 16799786 +ATM 472 Fibrosis MESH:D005355 marker/mechanism 24358288 +ATM 472 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 17968022 +ATM 472 Liver Cirrhosis MESH:D008103 marker/mechanism 36526012 +ATM 472 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +ATM 472 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 24413734 +ATM 472 Melanoma MESH:D008545 marker/mechanism 21983787 +ATM 472 Myocardial Infarction MESH:D009203 marker/mechanism 24358288 +ATM 472 Neoplasms MESH:D009369 marker/mechanism 21177254 +ATM 472 Pancreatic Neoplasms MESH:D010190 marker/mechanism 26098866|26098869 +ATM 472 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 21177254 +ATM 472 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +ATM 472 Prostatic Neoplasms MESH:D011471 marker/mechanism 17502119|25415046|26098866|29610475 +ATM 472 Stomach Neoplasms MESH:D013274 marker/mechanism 26098866 +ATM 472 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121791 +ATM 472 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 24358288 +ATN1 1822 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 125370.0 10814707 +ATOH1 474 Medulloblastoma MESH:D008527 marker/mechanism 18347096 +ATOH7 220202 Retinal Nonattachment, Nonsyndromic Congenital MESH:C565633 marker/mechanism 221900.0 +ATOH8 84913 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +ATOX1 475 Colorectal Neoplasms MESH:D015179 marker/mechanism 31961892 +ATOX1 475 Hepatitis, Chronic MESH:D006521 marker/mechanism 25053573 +ATOX1 475 Hypertension MESH:D006973 therapeutic 22753205 +ATOX1 475 Lung Neoplasms MESH:D008175 marker/mechanism 23624903 +ATP10A 57194 Autistic Disorder MESH:D001321 marker/mechanism 12851639 +ATP10D 57205 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ATP11A 23250 COVID-19 MESH:D000086382 marker/mechanism 35255492 +ATP11A 23250 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 23583980 +ATP13A2 23400 Kufor-Rakeb syndrome MESH:C537177 marker/mechanism 606693.0 22022275|22768177|22847264 +ATP13A2 23400 Manganese Poisoning MESH:D020149 marker/mechanism 22285144 +ATP13A2 23400 Nerve Degeneration MESH:D009410 marker/mechanism 22847264 +ATP13A2 23400 Neuronal Ceroid-Lipofuscinoses MESH:D009472 marker/mechanism 22022275|22847264 +ATP13A2 23400 Parkinson Disease MESH:D010300 marker/mechanism 23628791|25149416 +ATP13A2 23400 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 22285144 +ATP13A2 23400 Parkinsonian Disorders MESH:D020734 marker/mechanism 23046578 +ATP13A2 23400 SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE OMIM:617225 marker/mechanism 617225.0 +ATP1A1 476 Adenoma MESH:D000236 marker/mechanism 23416519|23913004 +ATP1A1 476 Gastroenteritis, Transmissible, of Swine MESH:D005761 marker/mechanism 28438630 +ATP1A1 476 Hyperaldosteronism MESH:D006929 marker/mechanism 23416519 +ATP1A1 476 Hypertension MESH:D006973 marker/mechanism 23416519 +ATP1A1 476 Myocardial Infarction MESH:D009203 therapeutic 29702141 +ATP1A1 476 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ATP1A1 476 Myocardial Reperfusion Injury MESH:D015428 therapeutic 29702141 +ATP1A1 476 Vestibular Diseases MESH:D015837 marker/mechanism 21269433 +ATP1A2 477 Alternating hemiplegia of childhood MESH:C536589 marker/mechanism 104290.0 +ATP1A2 477 Hemiplegic migraine, familial type 2 MESH:C537246 marker/mechanism 602481.0 23954377 +ATP1A2 477 Hypertension MESH:D006973 marker/mechanism 16166162|16243970 +ATP1A3 478 Alternating hemiplegia of childhood MESH:C536589 marker/mechanism 614820.0 22842232|24631656 +ATP1A3 478 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ATP1A3 478 CAPOS syndrome MESH:C535351 marker/mechanism 601338.0 +ATP1A3 478 Dystonia MESH:D004421 marker/mechanism 15260953 +ATP1A3 478 Dystonia 12 MESH:C538001 marker/mechanism 128235.0 15260953|24631656 +ATP1A3 478 Heart Failure MESH:D006333 marker/mechanism 18418421 +ATP1A3 478 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +ATP1A3 478 Parkinsonian Disorders MESH:D020734 marker/mechanism 15260953 +ATP1A3 478 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 18418421 +ATP1A4 480 Anthracosis MESH:D055008 marker/mechanism 29394417 +ATP1A4 480 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ATP1B1 481 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +ATP1B1 481 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +ATP1B1 481 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ATP1B2 482 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ATP1B2 482 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25129146 +ATP1B2 482 Glioma MESH:D005910 marker/mechanism 16865689 +ATP2A1 487 Brody myopathy MESH:C536607 marker/mechanism 601003 +ATP2A1 487 Heart Failure MESH:D006333 marker/mechanism 19776660 +ATP2A2 488 Cardiomegaly MESH:D006332 marker/mechanism 11679415 +ATP2A2 488 Darier Disease MESH:D007644 marker/mechanism 101900|124200 16733453|20338123 +ATP2A2 488 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +ATP2A2 488 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +ATP2A2 488 Diabetic Cardiomyopathies MESH:D058065 marker/mechanism 16685413 +ATP2A2 488 Heart Diseases MESH:D006331 marker/mechanism 19328205 +ATP2A2 488 Heart Failure MESH:D006333 marker/mechanism 19776660 +ATP2A2 488 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 10734148 +ATP2A2 488 Myocardial Stunning MESH:D017682 marker/mechanism 16317512 +ATP2A2 488 Status Epilepticus MESH:D013226 marker/mechanism 15288437 +ATP2A2 488 Ventricular Dysfunction, Left MESH:D018487 therapeutic 21217071 +ATP2A3 489 Adenoma MESH:D000236 marker/mechanism 23913004 +ATP2A3 489 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +ATP2A3 489 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +ATP2B1 490 Cataract MESH:D002386 marker/mechanism 15003327 +ATP2B1 490 Coronary Artery Disease MESH:D003324 marker/mechanism 22751097 +ATP2B1 490 Hypertension MESH:D006973 marker/mechanism 19430479 +ATP2B2 491 Deafness, Autosomal Recessive 12 MESH:C563327 marker/mechanism 601386 +ATP2B3 492 Adenoma MESH:D000236 marker/mechanism 23416519 +ATP2B3 492 Hyperaldosteronism MESH:D006929 marker/mechanism 23416519 +ATP2B3 492 Hypertension MESH:D006973 marker/mechanism 23416519 +ATP2B3 492 Spinocerebellar Ataxia, X-Linked 1 MESH:C563134 marker/mechanism 302500 +ATP2C1 27032 Pemphigus, Benign Familial MESH:D016506 marker/mechanism 169600.0 11450592|16621454|20338123 +ATP5F1A 498 Alzheimer Disease MESH:D000544 marker/mechanism 19374891 +ATP5F1A 498 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22 OMIM:616045 marker/mechanism 616045.0 +ATP5F1A 498 Endotoxemia MESH:D019446 marker/mechanism 16741687 +ATP5F1A 498 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4B OMIM:615228 marker/mechanism 615228.0 +ATP5F1B 506 Acute Kidney Injury MESH:D058186 marker/mechanism 25666834 +ATP5F1B 506 Hypoxia MESH:D000860 marker/mechanism 19579223 +ATP5F1B 506 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 25666834 +ATP5F1B 506 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +ATP5F1B 506 Spinocerebellar Ataxia 17 MESH:C564616 marker/mechanism 24413982 +ATP5F1D 513 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +ATP5F1E 514 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3 OMIM:614053 marker/mechanism 614053.0 +ATP5IF1 93974 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +ATP5IF1 93974 Fatty Liver MESH:D005234 marker/mechanism 25226513 +ATP5IF1 93974 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942 +ATP5IF1 93974 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +ATP5ME 521 Heart Diseases MESH:D006331 marker/mechanism 16844662 +ATP5PD 10476 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +ATP5PD 10476 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +ATP5PF 522 Heart Diseases MESH:D006331 marker/mechanism 16844662 +ATP6 4508 Diabetes Mellitus MESH:D003920 marker/mechanism 18273840 +ATP6 4508 Glucose Intolerance MESH:D018149 marker/mechanism 18273840 +ATP6 4508 Hypertrophy MESH:D006984 marker/mechanism 18273840 +ATP6 4508 Maternally Inherited Leigh Syndrome MESH:C536035 marker/mechanism 27129022 +ATP6 4508 Neuropathy ataxia and retinitis pigmentosa MESH:C537396 marker/mechanism 551500.0 27129022 +ATP6 4508 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 535000.0 +ATP6AP1 537 IMMUNODEFICIENCY 47 OMIM:300972 marker/mechanism 300972.0 +ATP6AP1 537 Lymphoma, Follicular MESH:D008224 marker/mechanism 26691987 +ATP6AP1L 92270 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +ATP6AP2 10159 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +ATP6AP2 10159 Fibrosis MESH:D005355 marker/mechanism 21795644 +ATP6AP2 10159 Mental Retardation, X-Linked, with Epilepsy MESH:C564516 marker/mechanism 300423.0 +ATP6AP2 10159 PARKINSONISM WITH SPASTICITY, X-LINKED OMIM:300911 marker/mechanism 300911.0 +ATP6V0A2 23545 Cutis Laxa, Autosomal Recessive, Type IIA MESH:C562632 marker/mechanism 219200.0 +ATP6V0A2 23545 Wrinkly skin syndrome MESH:C536750 marker/mechanism 278250.0 18157129 +ATP6V0A4 50617 Renal tubular acidosis, distal, autosomal recessive MESH:C537758 marker/mechanism 602722.0 +ATP6V0D2 245972 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +ATP6V0D2 245972 Stomach Neoplasms MESH:D013274 marker/mechanism 25279216 +ATP6V1A 523 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID OMIM:617403 marker/mechanism 617403.0 +ATP6V1B1 525 Renal Tubular Acidosis, Distal, with Progressive Nerve Deafness MESH:C562897 marker/mechanism 267300.0 +ATP6V1B2 526 Deafness, Congenital, and Onychodystrophy, Autosomal Dominant MESH:C567274 marker/mechanism 124480.0 +ATP6V1B2 526 Lymphoma, Follicular MESH:D008224 marker/mechanism 26691987 +ATP6V1B2 526 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +ATP6V1B2 526 Zimmerman Laband syndrome MESH:C536725 marker/mechanism 616455.0 25915598 +ATP6V1D 51382 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +ATP6V1D 51382 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ATP6V1E1 529 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC OMIM:617402 marker/mechanism 617402.0 +ATP7 32142 Alzheimer Disease MESH:D000544 therapeutic 23827522 +ATP7A 538 Anemia MESH:D000740 marker/mechanism 23776592 +ATP7A 538 Aortic Rupture MESH:D001019 marker/mechanism 2346371|25449986 +ATP7A 538 Ataxia MESH:D001259 marker/mechanism 22815746 +ATP7A 538 Colonic Neoplasms MESH:D003110 marker/mechanism 17510416 +ATP7A 538 Disease Models, Animal MESH:D004195 marker/mechanism 17483305 +ATP7A 538 Growth Disorders MESH:D006130 marker/mechanism 23064757 +ATP7A 538 Hemolysis MESH:D006461 marker/mechanism 25247420 +ATP7A 538 Hepatitis, Chronic MESH:D006521 marker/mechanism 25053573 +ATP7A 538 Hypertension, Pulmonary MESH:D006976 marker/mechanism 24614111 +ATP7A 538 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 23792645 +ATP7A 538 Menkes Kinky Hair Syndrome MESH:D007706 marker/mechanism 309400.0 11092760|11157799|11350187|12221109|12228238|14579150|15923132|16435190|16824500|17003121|17009961|17483305|18779302|20831904|21242307|21667063|22130675|22455587|22664332|22695177|22728746|22815746|22981378|23064757|24627433|25003971|25247420|26199316 +ATP7A 538 Neointima MESH:D058426 marker/mechanism 20671235 +ATP7A 538 Neurologic Manifestations MESH:D009461 marker/mechanism 22815746|23064757 +ATP7A 538 Occipital horn syndrome MESH:C537860 marker/mechanism 304150.0 +ATP7A 538 Paralysis MESH:D010243 marker/mechanism 22815746 +ATP7A 538 Prenatal Injuries MESH:D049188 marker/mechanism 25456742 +ATP7A 538 Recurrence MESH:D012008 marker/mechanism 22304828 +ATP7A 538 Seizures MESH:D012640 marker/mechanism 22815746 +ATP7A 538 Spinal Muscular Atrophy, Distal, X-Linked 3 MESH:C564506 marker/mechanism 300489.0 +ATP7A 538 Tremor MESH:D014202 marker/mechanism 22815746 +ATP7A 538 Vascular System Injuries MESH:D057772 marker/mechanism 20671235 +ATP7B 540 Breast Neoplasms MESH:D001943 marker/mechanism 11802810 +ATP7B 540 Carcinoma MESH:D002277 marker/mechanism 11802810|12216079 +ATP7B 540 Colorectal Neoplasms MESH:D015179 marker/mechanism 19296535 +ATP7B 540 Disease Models, Animal MESH:D004195 marker/mechanism 11803042|15911138|21146535|21364284 +ATP7B 540 Disease Progression MESH:D018450 marker/mechanism 12216079|12509969|19296535 +ATP7B 540 Dyslipidemias MESH:D050171 marker/mechanism 17303181 +ATP7B 540 Fatty Liver MESH:D005234 marker/mechanism 17303181 +ATP7B 540 Hepatitis MESH:D006505 marker/mechanism 14574444|15135151 +ATP7B 540 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 277900 10686180|10790207|10830865|10982773|11157799|11405812|11472373|11803042|11854914|11985593|12228238|12544487|12820478|14574444|14579150|14998371|15135151|15147237|15911138|16133174|16607473|16824500|16932613|17182432|17276780|17634212|17919502|18371106|18779302|19888908|20647314|21146535|21242307|21364284|21406592|22130675|22455587|22565294|22677543|22802922|22945834|22981378|23235335|23333878|23789284|23843956|23963605|24094725|24892424|25003971|25134866 +ATP7B 540 Inflammation MESH:D007249 marker/mechanism 22945834 +ATP7B 540 Kidney Neoplasms MESH:D007680 marker/mechanism 11509115 +ATP7B 540 Liver Cirrhosis MESH:D008103 marker/mechanism 25134866 +ATP7B 540 Liver Diseases MESH:D008107 marker/mechanism 21364284 +ATP7B 540 Liver Failure, Acute MESH:D017114 marker/mechanism 25134866 +ATP7B 540 Liver Neoplasms MESH:D008113 marker/mechanism 11509115 +ATP7B 540 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 23792645 +ATP7B 540 Mouth Neoplasms MESH:D009062 marker/mechanism 12509969 +ATP7B 540 Ovarian Neoplasms MESH:D010051 marker/mechanism 12216079 +ATP7B 540 Prostatic Neoplasms MESH:D011471 marker/mechanism 25320179 +ATP7B 540 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 12509969 +ATP8A2 51761 Dysequilibrium syndrome MESH:C535731 marker/mechanism 615268 +ATP8B1 5205 Cholestasis, Intrahepatic MESH:D002780 marker/mechanism 18379143 +ATP8B1 5205 Cholestasis, progressive familial intrahepatic 1 MESH:C535933 marker/mechanism 211600|243300 +ATP8B1 5205 Intrahepatic Cholestasis of Pregnancy MESH:C535932 marker/mechanism 147480 +ATP9B 374868 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +ATPAF1 64756 Obesity MESH:D009765 marker/mechanism 20882379 +ATPAF2 91647 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1 OMIM:604273 marker/mechanism 604273 +ATPSYNBETA 43829 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +ATR 545 CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL OMIM:614564 marker/mechanism 614564.0 +ATR 545 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +ATR 545 Prostatic Neoplasms MESH:D011471 marker/mechanism 25415046 +ATR 545 Seckel syndrome 1 MESH:C537533 marker/mechanism 210600.0 +ATR 545 Urologic Neoplasms MESH:D014571 marker/mechanism 23618899 +ATRN 8455 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ATRN 8455 Nerve Degeneration MESH:D009410 marker/mechanism 16860906 +ATRX 546 Alpha-Thalassemia Myelodysplasia Syndrome MESH:C563023 marker/mechanism 300448.0 +ATRX 546 ATR-X syndrome MESH:C538258 marker/mechanism 301040.0 +ATRX 546 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +ATRX 546 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19291773 +ATRX 546 Cryptorchidism MESH:D003456 marker/mechanism 19291773 +ATRX 546 Glioma MESH:D005910 marker/mechanism 23583981|24705251 +ATRX 546 Growth Disorders MESH:D006130 marker/mechanism 19291773 +ATRX 546 Mental retardation-hypotonic facies syndrome, x-linked, 1 MESH:C537457 marker/mechanism 309580.0 +ATRX 546 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 19291773 +ATRX 546 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 19157545 +ATRX 546 Neuroblastoma MESH:D009447 marker/mechanism 23334666|26523776 +ATRX 546 Neuroendocrine Tumors MESH:D018358 marker/mechanism 21252315 +ATRX 546 Pancreatic Neoplasms MESH:D010190 marker/mechanism 21252315 +ATRX 546 Penile Diseases MESH:D010409 marker/mechanism 19291773 +ATRX 546 Thoracic Diseases MESH:D013896 marker/mechanism 19291773 +ATXN1 6310 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +ATXN1 6310 Neurodegenerative Diseases MESH:D019636 marker/mechanism 28182653 +ATXN1 6310 Retinal Diseases MESH:D012164 marker/mechanism 28182653 +ATXN1 6310 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 164400.0 11719269|16122429|17322884|18337722 +ATXN10 25814 Spinocerebellar Ataxia 10 MESH:C566874 marker/mechanism 603516.0 +ATXN1L 342371 Spinocerebellar Ataxias MESH:D020754 therapeutic 17322884 +ATXN2 6311 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 27377857|28478440 +ATXN2 6311 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 26752265 +ATXN2 6311 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +ATXN2 6311 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 183090.0 19224595|20065139 +ATXN3 4287 Machado-Joseph Disease MESH:D017827 marker/mechanism 109150.0 31378764 +ATXN3 4287 Nerve Degeneration MESH:D009410 marker/mechanism 9635424 +ATXN3 4287 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +ATXN7 6314 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +ATXN7 6314 Gait Ataxia MESH:D020234 marker/mechanism 25664129 +ATXN7 6314 Movement Disorders MESH:D009069 marker/mechanism 25664129 +ATXN7 6314 Reflex, Abnormal MESH:D012021 marker/mechanism 25664129 +ATXN7 6314 Skin Diseases MESH:D012871 marker/mechanism 16835338 +ATXN7 6314 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 164500.0 25664129 +ATXN7 6314 Vision Disorders MESH:D014786 marker/mechanism 25664129 +ATXN8 724066 Spinocerebellar ataxia 8 MESH:C537307 marker/mechanism 608768.0 +ATXN8OS 6315 Nervous System Diseases MESH:D009422 marker/mechanism 12470185 +ATXN8OS 6315 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +ATXN8OS 6315 Spinocerebellar ataxia 8 MESH:C537307 marker/mechanism 608768.0 +AUH 549 3-Methylglutaconic Aciduria, Type I MESH:C562801 marker/mechanism 250950.0 +AURKA 6790 Aneuploidy MESH:D000782 marker/mechanism 24976383 +AURKA 6790 Breast Neoplasms MESH:D001943 marker/mechanism 18497064 +AURKA 6790 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +AURKA 6790 Chromosomal Instability MESH:D043171 marker/mechanism 24976383 +AURKA 6790 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 24976383 +AURKA 6790 Kidney Neoplasms MESH:D007680 marker/mechanism 18497064 +AURKA 6790 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12124350 +AURKA 6790 Melanoma MESH:D008545 marker/mechanism 22535842 +AURKA 6790 Neuroblastoma MESH:D009447 marker/mechanism 22588779 +AURKA 6790 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +AURKA 6790 Prostatic Neoplasms MESH:D011471 marker/mechanism 17898866 +AURKB 9212 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +AURKB 9212 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +AURKB 9212 Stomach Neoplasms MESH:D013274 marker/mechanism 15993841 +AURKC 6795 Infertility, Male MESH:D007248 marker/mechanism 17435757 +AURKC 6795 Male Infertility with Large-Headed, Multiflagellar, Polyploid Spermatozoa MESH:C562903 marker/mechanism 243060.0 +AUTS2 26053 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +AUTS2 26053 Epilepsy MESH:D004827 marker/mechanism 20502679 +AUTS2 26053 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 26 OMIM:615834 marker/mechanism 615834.0 +AVEN 57099 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427 +AVL9 23080 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +AVP 551 Acute Kidney Injury MESH:D058186 marker/mechanism 2139164 +AVP 551 Amnesia MESH:D000647 therapeutic 7562510 +AVP 551 Angina Pectoris MESH:D000787 marker/mechanism 11128043|11791009 +AVP 551 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 6983645 +AVP 551 Autistic Disorder MESH:D001321 marker/mechanism 8570775 +AVP 551 Cardiomyopathies MESH:D009202 marker/mechanism 12145768 +AVP 551 Dehydration MESH:D003681 therapeutic 2554359 +AVP 551 Diabetes Insipidus MESH:D003919 marker/mechanism 15169711|6945054 +AVP 551 Diabetes Insipidus, Neurogenic MESH:D020790 marker/mechanism 125700.0 7057320 +AVP 551 Drug Overdose MESH:D062787 therapeutic 11914425 +AVP 551 Dysmenorrhea MESH:D004412 marker/mechanism 10440088 +AVP 551 Gastrointestinal Hemorrhage MESH:D006471 therapeutic 6983645 +AVP 551 Heart Failure MESH:D006333 marker/mechanism 18179782 +AVP 551 Hyperalgesia MESH:D006930 marker/mechanism 9613798 +AVP 551 Hypertension MESH:D006973 marker/mechanism 1663982|19133994|3346065|4040330|6367368 +AVP 551 Hypertension, Portal MESH:D006975 therapeutic 6696534 +AVP 551 Hyponatremia MESH:D007010 marker/mechanism 6920297 +AVP 551 Hypotension MESH:D007022 therapeutic 11171655|12019395|17357383|2485266|3544871 +AVP 551 Inappropriate ADH Syndrome MESH:D007177 marker/mechanism 112579|6920297 +AVP 551 Ischemia MESH:D007511 marker/mechanism 10440088|2139164 +AVP 551 Memory Disorders MESH:D008569 therapeutic 11553362 +AVP 551 Pain MESH:D010146 therapeutic 2271928|6094376 +AVP 551 Polyuria MESH:D011141 therapeutic 11012637 +AVP 551 Psychotic Disorders MESH:D011618 marker/mechanism 3567260 +AVP 551 Schizophrenia MESH:D012559 marker/mechanism 3567260 +AVP 551 Shock MESH:D012769 therapeutic 10570779 +AVP 551 Shy-Drager Syndrome MESH:D012791 marker/mechanism 6850280 +AVP 551 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 2832203 +AVP 551 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 4040330 +AVPI1 60370 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +AVPR1A 552 Adrenal Hyperplasia, Congenital MESH:D000312 marker/mechanism 17218722 +AVPR1A 552 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20546835 +AVPR1A 552 Autistic Disorder MESH:D001321 marker/mechanism 16520824 +AVPR2 554 Adrenal Hyperplasia, Congenital MESH:D000312 marker/mechanism 17218722 +AVPR2 554 Cardiomyopathies MESH:D009202 marker/mechanism 12145768 +AVPR2 554 Diabetes Insipidus, Nephrogenic MESH:D018500 marker/mechanism 304800.0 12414899|14998935|19703807|19729836|20374732 +AVPR2 554 Genetic Diseases, X-Linked MESH:D040181 marker/mechanism 19703807 +AVPR2 554 Growth Disorders MESH:D006130 marker/mechanism 19703807 +AVPR2 554 Heart Failure MESH:D006333 marker/mechanism 12145768 +AVPR2 554 Nephrogenic Syndrome of Inappropriate Antidiuresis MESH:C564491 marker/mechanism 300539.0 +AVPR2 554 Oliguria MESH:D009846 marker/mechanism 7977526 +AVR-15 179834 Infertility MESH:D007246 marker/mechanism 25204677 +AXIN1 8312 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 114550.0 25822088 +AXIN1 8312 Caudal Duplication Anomaly MESH:C564315 marker/mechanism 607864.0 +AXIN2 8313 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 29394407 +AXIN2 8313 Colonic Neoplasms MESH:D003110 marker/mechanism 21188121 +AXIN2 8313 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +AXIN2 8313 Disease Models, Animal MESH:D004195 marker/mechanism 29394407 +AXIN2 8313 Myocardial Ischemia MESH:D017202 marker/mechanism 29394407 +AXIN2 8313 Oligodontia-Colorectal Cancer Syndrome MESH:C563898 marker/mechanism 608615.0 +AXIN2 8313 Ventricular Remodeling MESH:D020257 marker/mechanism 29394407 +AXL 558 Carcinoma, Non-Small-Cell Lung MESH:D002289 therapeutic 22751098 +AXL 558 Diabetic Nephropathies MESH:D003928 marker/mechanism 12644472 +AXL 558 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 +AXL 558 Kidney Neoplasms MESH:D007680 marker/mechanism 25551830 +AXL 558 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +AXL 558 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26206560 +AXL 558 Neoplasm Metastasis MESH:D009362 marker/mechanism 26206560 +AXL 558 Neoplasms, Experimental MESH:D009374 marker/mechanism 26206560 +AXL 558 Neurilemmoma MESH:D009442 marker/mechanism 25551830 +AXL 558 Neurofibroma, Plexiform MESH:D018318 marker/mechanism 25551830 +AXL 558 Pancreatic Neoplasms MESH:D010190 marker/mechanism 26206560 +AZGP1 563 Adenocarcinoma MESH:D000230 marker/mechanism 18978557 +AZGP1 563 Lung Neoplasms MESH:D008175 marker/mechanism 18978557 +AZGP1 563 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +AZGP1 563 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048 +AZGP1 563 Sinusitis MESH:D012852 marker/mechanism 18391768 +B2M 567 Acute Kidney Injury MESH:D058186 marker/mechanism 22005293|2689182|28885000 +B2M 567 Amyloidosis, familial visceral MESH:C538249 marker/mechanism 105200.0 +B2M 567 Autoimmune Diseases MESH:D001327 therapeutic 21793797 +B2M 567 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +B2M 567 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +B2M 567 Heart Diseases MESH:D006331 marker/mechanism 16844662 +B2M 567 Hypergammaglobulinemia MESH:D006942 therapeutic 21793797 +B2M 567 Hypoproteinemia, Hypercatabolic MESH:C565476 marker/mechanism 241600.0 +B2M 567 Kidney Diseases MESH:D007674 marker/mechanism 17303580|2202081|24863737 +B2M 567 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 7688627 +B2M 567 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 24413734 +B2M 567 Prostatic Neoplasms MESH:D011471 marker/mechanism 17404077 +B2M 567 Proteinuria MESH:D011507 marker/mechanism 33857584 +B3GALNT2 148789 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 615181.0 +B3GALT6 126792 Ehlers-Danlos syndrome, progeroid form MESH:C536201 marker/mechanism 615349.0 +B3GALT6 126792 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES OMIM:271640 marker/mechanism 271640.0 +B3GAT1 27087 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 24211274 +B3GAT1 27087 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +B3GAT2 135152 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +B3GAT3 26229 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +B3GAT3 26229 MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS OMIM:245600 marker/mechanism 245600.0 +B3GLCT 145173 Krause-Kivlin syndrome MESH:C537617 marker/mechanism 261540.0 16909395 +B3GNT2 10678 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22446963 +B3GNT2 10678 Graves Disease MESH:D006111 marker/mechanism 22446963 +B3GNT9 84752 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860 +B4GALNT1 2583 Spastic paraplegia 26, autosomal recessive MESH:C536862 marker/mechanism 609195.0 +B4GALT1 2683 Congenital disorder of glycosylation type 2D MESH:C535753 marker/mechanism 607091.0 +B4GALT4 8702 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +B4GALT5 9334 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +B4GALT5 9334 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +B4GALT7 11285 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +B4GALT7 11285 Ehlers-Danlos syndrome, progeroid form MESH:C536201 marker/mechanism 130070.0 +B4GAT1 11041 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +B4GAT1 11041 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 615287.0 +B9D1 27077 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +B9D1 27077 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BAALC 79870 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 19822134 +BABAM1 29086 Ovarian Neoplasms MESH:D010051 marker/mechanism 20852633 +BACE1 23621 Alzheimer Disease MESH:D000544 marker/mechanism 16407166 +BACH2 60468 Celiac Disease MESH:D002446 marker/mechanism 20190752 +BACH2 60468 Crohn Disease MESH:D003424 marker/mechanism 21102463 +BACH2 60468 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 18978792 +BACH2 60468 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 21441929 +BACH2 60468 Vitiligo MESH:D014820 marker/mechanism 22561518 +BAD 572 Ischemic Attack, Transient MESH:D002546 marker/mechanism 12629175 +BAD 572 Leukemia MESH:D007938 marker/mechanism 12970779 +BAD 572 Prostatic Neoplasms MESH:D011471 marker/mechanism 17542986|19593445 +BAG1 573 Breast Neoplasms MESH:D001943 marker/mechanism 19066611 +BAG1 573 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 19066611 +BAG3 9531 CARDIOMYOPATHY, DILATED, 1HH OMIM:613881 marker/mechanism 613881.0 +BAG3 9531 HIV Infections MESH:D015658 marker/mechanism 17187345 +BAG3 9531 Myofibrillar Myopathy MESH:C580316 marker/mechanism 612954.0 +BAG5 9529 Parkinson Disease MESH:D010300 marker/mechanism 28348719 +BAIAP2L1 55971 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +BAK1 578 Colonic Neoplasms MESH:D003110 marker/mechanism 18349538 +BAK1 578 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 28100771 +BAK1 578 Myocardial Infarction MESH:D009203 marker/mechanism 29122578 +BAK1 578 Nerve Degeneration MESH:D009410 marker/mechanism 19740541 +BAMBI 25805 Cardiomegaly MESH:D006332 marker/mechanism 29394407 +BAMBI 25805 Heart Failure MESH:D006333 marker/mechanism 29394407 +BAMBI 25805 Liver Cirrhosis MESH:D008103 marker/mechanism 30097701 +BANF1 8815 NESTOR-GUILLERMO PROGERIA SYNDROME OMIM:614008 marker/mechanism 614008.0 +BANK1 55024 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 18204447 +BAP1 8314 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 25231345 +BAP1 8314 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 25231345 +BAP1 8314 Bone Neoplasms MESH:D001859 marker/mechanism 25231345 +BAP1 8314 Breast Neoplasms MESH:D001943 marker/mechanism 25231345|26719535 +BAP1 8314 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26719535 +BAP1 8314 Carcinoma, Mucoepidermoid MESH:D018277 marker/mechanism 25231345 +BAP1 8314 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691|22683710|23797736|25231345 +BAP1 8314 Central Nervous System Neoplasms MESH:D016543 marker/mechanism 25231345 +BAP1 8314 Cholangiocarcinoma MESH:D018281 marker/mechanism 24185509|25231345 +BAP1 8314 Colonic Neoplasms MESH:D003110 marker/mechanism 25231345 +BAP1 8314 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 24928783 +BAP1 8314 Head and Neck Neoplasms MESH:D006258 marker/mechanism 25231345 +BAP1 8314 Kidney Neoplasms MESH:D007680 marker/mechanism 26719535 +BAP1 8314 Leukemia MESH:D007938 marker/mechanism 25231345 +BAP1 8314 Lipoma MESH:D008067 marker/mechanism 25231345 +BAP1 8314 Liver Neoplasms MESH:D008113 marker/mechanism 25231345 +BAP1 8314 Lung Neoplasms MESH:D008175 marker/mechanism 26719535 +BAP1 8314 Melanoma, Cutaneous Malignant MESH:C562393 marker/mechanism 25231345|26719535 +BAP1 8314 Meningioma MESH:D008579 marker/mechanism 25231345 +BAP1 8314 Mesothelioma MESH:D008654 marker/mechanism 21642991|21874000|26119930|26719535 +BAP1 8314 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 24928783|25231345|26463840|26928227|29112861 +BAP1 8314 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +BAP1 8314 Neuroendocrine Tumors MESH:D018358 marker/mechanism 25231345 +BAP1 8314 Nevi and Melanomas MESH:D018326 marker/mechanism 21874003 +BAP1 8314 Nevus, Epithelioid and Spindle Cell MESH:D018332 marker/mechanism 25231345 +BAP1 8314 Ovarian Neoplasms MESH:D010051 marker/mechanism 25231345 +BAP1 8314 Pancreatic Neoplasms MESH:D010190 marker/mechanism 25231345 +BAP1 8314 Paraganglioma MESH:D010235 marker/mechanism 25231345 +BAP1 8314 Prostatic Neoplasms MESH:D011471 marker/mechanism 25231345 +BAP1 8314 Stomach Neoplasms MESH:D013274 marker/mechanism 25231345|26719535 +BAP1 8314 Testicular Neoplasms MESH:D013736 marker/mechanism 25231345 +BAP1 8314 Thymoma MESH:D013945 marker/mechanism 24974848 +BAP1 8314 TUMOR PREDISPOSITION SYNDROME 1 OMIM:614327 marker/mechanism 614327.0 +BAP1 8314 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 25231345 +BAP1 8314 Uterine Neoplasms MESH:D014594 marker/mechanism 25231345 +BAP1 8314 Uveal melanoma MESH:C536494 marker/mechanism 606661.0 21874000|25231345|26719535 +BARD1 580 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +BARD1 580 Neuroblastoma MESH:D009447 marker/mechanism 19412175|23334666 +BARX1 56033 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 24121790 +BASP1 10409 Carcinoma MESH:D002277 marker/mechanism 12376462 +BASP1 10409 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +BASP1 10409 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +BATF2 116071 Melanoma MESH:D008545 marker/mechanism 22535842 +BATF3 55509 Leprosy MESH:D007918 marker/mechanism 25642632 +BAX 581 Acute Kidney Injury MESH:D058186 marker/mechanism 20623750 +BAX 581 Alzheimer Disease MESH:D000544 marker/mechanism 18077176 +BAX 581 Breast Neoplasms MESH:D001943 therapeutic 22572619 +BAX 581 Cerebral Hemorrhage MESH:D002543 marker/mechanism 12721362 +BAX 581 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 17906064 +BAX 581 Colonic Neoplasms MESH:D003110 marker/mechanism 17404573 +BAX 581 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +BAX 581 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 23090186 +BAX 581 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 31626838 +BAX 581 Esophageal Neoplasms MESH:D004938 marker/mechanism 17634542 +BAX 581 HIV Infections MESH:D015658 marker/mechanism 12878215 +BAX 581 Infertility, Male MESH:D007248 marker/mechanism 24723216 +BAX 581 Intestinal Neoplasms MESH:D007414 marker/mechanism 12663524 +BAX 581 Ischemia MESH:D007511 marker/mechanism 15172883 +BAX 581 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 12754746 +BAX 581 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +BAX 581 Myocardial Infarction MESH:D009203 marker/mechanism 20079142|25450231 +BAX 581 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 20026869 +BAX 581 Nerve Degeneration MESH:D009410 therapeutic 20385067 +BAX 581 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21062263 +BAX 581 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 613065.0 +BAX 581 Prostatic Neoplasms MESH:D011471 marker/mechanism 17542986 +BAZ1B 9031 Williams Syndrome MESH:D018980 marker/mechanism 16448863 +BAZ2A 11176 Prostatic Neoplasms MESH:D011471 marker/mechanism 25485837 +BBC3 27113 Brain Ischemia MESH:D002545 marker/mechanism 19095966 +BBC3 27113 Burkitt Lymphoma MESH:D002051 marker/mechanism 18573879 +BBC3 27113 Esophageal Neoplasms MESH:D004938 therapeutic 16481741 +BBC3 27113 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 28100771 +BBIP1 92482 BARDET-BIEDL SYNDROME 18 OMIM:615995 marker/mechanism 615995.0 +BBOF1 80127 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +BBOX1 8424 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BBS1 582 Bardet-Biedl syndrome 1 MESH:C537909 marker/mechanism 209900.0 +BBS10 79738 Bardet-Biedl Syndrome 10 MESH:C565919 marker/mechanism 615987.0 +BBS12 166379 Bardet-Biedl Syndrome 12 MESH:C565921 marker/mechanism 615989.0 +BBS2 583 Bardet-Biedl syndrome 2 MESH:C537910 marker/mechanism 615981.0 +BBS2 583 RETINITIS PIGMENTOSA 74 OMIM:616562 marker/mechanism 616562.0 +BBS4 585 Bardet-Biedl syndrome 4 MESH:C537912 marker/mechanism 615982.0 +BBS5 129880 BARDET-BIEDL SYNDROME 5 OMIM:615983 marker/mechanism 615983.0 +BBS7 55212 Bardet-Biedl Syndrome 7 MESH:C565916 marker/mechanism 615984.0 +BBS7 55212 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +BBS9 27241 Bardet-Biedl Syndrome 9 MESH:C565918 marker/mechanism 615986.0 +BBS9 27241 Craniosynostoses MESH:D003398 marker/mechanism 23160099 +BCAP31 10134 Contiguous Abcd1-Dxs1375e Deletion Syndrome MESH:C564508 marker/mechanism 300475.0 +BCAR1 9564 Carcinoma, Ductal MESH:D044584 marker/mechanism 29295717 +BCAR1 9564 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21291860 +BCAR1 9564 Pancreatic Neoplasms MESH:D010190 marker/mechanism 26098869 +BCAR1 9564 Prostatic Neoplasms MESH:D011471 marker/mechanism 29295717 +BCAR3 8412 Breast Neoplasms MESH:D001943 marker/mechanism 19075277 +BCAR3 8412 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +BCAR4 400500 Breast Neoplasms MESH:D001943 marker/mechanism 20859285|21506106 +BCAS1 8537 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +BCAS1 8537 Prostatic Neoplasms MESH:D011471 marker/mechanism 15583422 +BCAS2 10286 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 27356265 +BCAT1 586 Cholestasis MESH:D002779 marker/mechanism 27989131 +BCAT1 586 Weight Gain MESH:D015430 marker/mechanism 19030233 +BCAT2 587 Maple Syrup Urine Disease MESH:D008375 marker/mechanism 14755340 +BCAT2 587 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +BCHE 590 Alzheimer Disease MESH:D000544 marker/mechanism 23022600 +BCHE 590 Apnea MESH:D001049 marker/mechanism|therapeutic 1058931|12392308|12881446|15826794|1734774|21029050|25054547|38703|4319258|4347326|4698763|4728581|4746059|4850696|4959505|4998912|5365519|5412891|5488351|5667302|6039104|6465587|6859614|6928942|7069741|726855|7378868|7788839|7793179|900467|987736 +BCHE 590 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +BCHE 590 Bamforth syndrome MESH:C537901 marker/mechanism 16884476 +BCHE 590 Breast Neoplasms MESH:D001943 marker/mechanism 23063927 +BCHE 590 Butyrylcholinesterase deficiency MESH:C537417 marker/mechanism 12881446|16788378|18075469|25054547|9110359 +BCHE 590 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 18482720 +BCHE 590 Cardiotoxicity MESH:D066126 therapeutic 26145887 +BCHE 590 Cocaine-Related Disorders MESH:D019970 therapeutic 18292872|18514640|20060817|20971807|22935511|22960160|23000451|25814464 +BCHE 590 Cognition Disorders MESH:D003072 marker/mechanism|therapeutic 12003252|20513442 +BCHE 590 Death MESH:D003643 therapeutic 18597747 +BCHE 590 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 3111302 +BCHE 590 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 15121994 +BCHE 590 Fasciculation MESH:D005207 marker/mechanism 6465587 +BCHE 590 Glioblastoma MESH:D005909 marker/mechanism 2317787 +BCHE 590 Hyperkinesis MESH:D006948 therapeutic 12019200 +BCHE 590 Hypertriglyceridemia MESH:D015228 marker/mechanism 23000450 +BCHE 590 Multiple Sclerosis MESH:D009103 marker/mechanism 20122907 +BCHE 590 Muscular Dystrophies MESH:D009136 marker/mechanism 22906800 +BCHE 590 Neuroblastoma MESH:D009447 marker/mechanism 2317787 +BCHE 590 Neurotoxicity Syndromes MESH:D020258 therapeutic 21620937 +BCHE 590 Obesity MESH:D009765 marker/mechanism|therapeutic 18452903|23000450|23073171|27163854 +BCHE 590 Organophosphate Poisoning MESH:D062025 marker/mechanism|therapeutic 22981459|22982776|23044488|23123253|23178380|23220586|26239905|31201777 +BCHE 590 Paralysis MESH:D010243 marker/mechanism 1218179|122883|1734774|21228368|4319258|4347326|4362560|4728581|5021954|910611 +BCHE 590 Paresis MESH:D010291 marker/mechanism 2249680 +BCHE 590 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 30410011 +BCHE 590 Poisoning MESH:D011041 therapeutic 20176007|20513442|21620937|21683774|29183815 +BCHE 590 Postoperative Complications MESH:D011183 marker/mechanism 6039104 +BCHE 590 Seizures MESH:D012640 therapeutic 18597747|20971807|8667461 +BCHE 590 Sleep Apnea Syndromes MESH:D012891 marker/mechanism 18555211 +BCHE 590 Tachycardia MESH:D013610 therapeutic 18597747 +BCHE 590 Trismus MESH:D014313 marker/mechanism 7378868 +BCKDHA 593 Maple Syrup Urine Disease MESH:D008375 marker/mechanism 248600.0 +BCKDHB 594 Maple Syrup Urine Disease MESH:D008375 marker/mechanism 248600.0 +BCKDK 10295 BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY OMIM:614923 marker/mechanism 614923.0 +BCL10 8915 IMMUNODEFICIENCY 37 OMIM:616098 marker/mechanism 616098.0 +BCL10 8915 Lymphoma, B-Cell, Marginal Zone MESH:D018442 marker/mechanism 137245.0 +BCL10 8915 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 605027.0 +BCL10 8915 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 156240.0 +BCL10 8915 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 273300.0 +BCL11A 53335 Apraxias MESH:D001072 marker/mechanism 27120335 +BCL11A 53335 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +BCL11A 53335 COVID-19 MESH:D000086382 marker/mechanism 35255492 +BCL11A 53335 INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN OMIM:617101 marker/mechanism 617101.0 +BCL11A 53335 Language Development Disorders MESH:D007805 marker/mechanism 27120335 +BCL11A 53335 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +BCL11A 53335 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +BCL11B 64919 IMMUNODEFICIENCY 49 OMIM:617237 marker/mechanism 617237.0 +BCL11B 64919 Lymphoma MESH:D008223 marker/mechanism 17941976 +BCL11B 64919 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 20972433 +BCL2 596 Adenocarcinoma MESH:D000230 marker/mechanism 21472143 +BCL2 596 Adenocarcinoma, Clear Cell MESH:D018262 marker/mechanism 9754764 +BCL2 596 Adenoma MESH:D000236 marker/mechanism 10223192|10426811 +BCL2 596 AIDS-related Kaposi sarcoma MESH:C554498 marker/mechanism 10861090 +BCL2 596 Alzheimer Disease MESH:D000544 marker/mechanism 18077176 +BCL2 596 Asthma MESH:D001249 marker/mechanism 18357729 +BCL2 596 Autistic Disorder MESH:D001321 marker/mechanism 11814262|20375269 +BCL2 596 Azoospermia MESH:D053713 marker/mechanism 20610805 +BCL2 596 Breast Neoplasms MESH:D001943 marker/mechanism 12517783|16954440|23621182 +BCL2 596 Carcinoma MESH:D002277 marker/mechanism 10426811 +BCL2 596 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22666341|2543982|2848196 +BCL2 596 Cerebral Hemorrhage MESH:D002543 marker/mechanism 12721362 +BCL2 596 Chondrosarcoma, Mesenchymal MESH:D018211 marker/mechanism 12817616 +BCL2 596 Colonic Neoplasms MESH:D003110 marker/mechanism 10223192|17404573|19147571 +BCL2 596 Colorectal Neoplasms MESH:D015179 marker/mechanism 18949393 +BCL2 596 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +BCL2 596 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +BCL2 596 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16959961|23090186 +BCL2 596 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16959961|31626838 +BCL2 596 Disease Progression MESH:D018450 marker/mechanism 16081686|21750559 +BCL2 596 Erectile Dysfunction MESH:D007172 marker/mechanism 12394778 +BCL2 596 Esophageal Neoplasms MESH:D004938 marker/mechanism 21472143 +BCL2 596 Gallbladder Neoplasms MESH:D005706 therapeutic 16904648 +BCL2 596 Head and Neck Neoplasms MESH:D006258 marker/mechanism 18566236 +BCL2 596 Hypertension MESH:D006973 marker/mechanism 10075388 +BCL2 596 Infertility, Male MESH:D007248 marker/mechanism 24723216 +BCL2 596 Intestinal Neoplasms MESH:D007414 marker/mechanism 10223192 +BCL2 596 Learning Disabilities MESH:D007859 marker/mechanism 17967740 +BCL2 596 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 21750559|23770605 +BCL2 596 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 23906301 +BCL2 596 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +BCL2 596 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 10426811|28100771 +BCL2 596 Lymphoma, Follicular MESH:D008224 marker/mechanism 12855623|3287162 +BCL2 596 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 16081686 +BCL2 596 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 26239085|3287162 +BCL2 596 Memory Disorders MESH:D008569 marker/mechanism 17967740 +BCL2 596 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 16850164 +BCL2 596 Metaplasia MESH:D008679 marker/mechanism 12704018 +BCL2 596 Multiple Myeloma MESH:D009101 marker/mechanism 12429644 +BCL2 596 Myocardial Infarction MESH:D009203 marker/mechanism 19027736 +BCL2 596 Necrosis MESH:D009336 therapeutic 11781163|16532269 +BCL2 596 Nerve Degeneration MESH:D009410 marker/mechanism|therapeutic 11146106|17967740 +BCL2 596 Osteochondrodysplasias MESH:D010009 marker/mechanism 17954590 +BCL2 596 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21062263 +BCL2 596 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 23471820 +BCL2 596 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +BCL2 596 Prostatic Neoplasms MESH:D011471 marker/mechanism 16733517 +BCL2 596 Reperfusion Injury MESH:D015427 therapeutic 15449323 +BCL2 596 Retinal Degeneration MESH:D012162 therapeutic 8692941 +BCL2 596 Sarcoma, Synovial MESH:D013584 therapeutic 16450387 +BCL2 596 Soft Tissue Neoplasms MESH:D012983 therapeutic 16450387 +BCL2 596 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 36115647 +BCL2A1 597 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +BCL2A1 597 Breast Neoplasms MESH:D001943 marker/mechanism 16298037|17659439 +BCL2A1 597 Esophageal Neoplasms MESH:D004938 marker/mechanism 17634542 +BCL2A1D 12047 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BCL2L1 598 Adenoma MESH:D000236 marker/mechanism 10426811 +BCL2L1 598 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +BCL2L1 598 Carcinoma MESH:D002277 marker/mechanism 10426811 +BCL2L1 598 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism|therapeutic 10629087|11509945 +BCL2L1 598 Cerebral Hemorrhage MESH:D002543 marker/mechanism 12721362 +BCL2L1 598 Cryptorchidism MESH:D003456 marker/mechanism 26050606 +BCL2L1 598 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16959961 +BCL2L1 598 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16959961 +BCL2L1 598 Erectile Dysfunction MESH:D007172 marker/mechanism 12394778 +BCL2L1 598 Head and Neck Neoplasms MESH:D006258 marker/mechanism 18566236 +BCL2L1 598 Hearing Loss MESH:D034381 therapeutic 17697574 +BCL2L1 598 Liver Diseases MESH:D008107 marker/mechanism 19784758 +BCL2L1 598 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 10426811|28100771 +BCL2L1 598 Lung Neoplasms MESH:D008175 marker/mechanism 16007126 +BCL2L1 598 Multiple Myeloma MESH:D009101 marker/mechanism 12429644 +BCL2L1 598 Myocardial Infarction MESH:D009203 marker/mechanism 20079142 +BCL2L1 598 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +BCL2L1 598 Pancreatic Neoplasms MESH:D010190 marker/mechanism 16904634 +BCL2L1 598 Stomach Neoplasms MESH:D013274 therapeutic 26401016 +BCL2L11 10018 Cholangitis, Sclerosing MESH:D015209 marker/mechanism 21151127 +BCL2L11 10018 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +BCL2L11 10018 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +BCL3 602 Atherosclerosis MESH:D050197 marker/mechanism 25374339 +BCL3 602 Dyslipidemias MESH:D050171 marker/mechanism 29670124 +BCL6 604 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 25543051 +BCL6 604 Lymphoma, T-Cell MESH:D016399 marker/mechanism 15375218 +BCL7C 9274 Ependymoma MESH:D004806 marker/mechanism 26075792 +BCL9 607 Ovarian Neoplasms MESH:D010051 marker/mechanism 22024689 +BCLAF1 9774 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +BCO1 53630 Hypercarotenemia And Vitamin A Deficiency, Autosomal Dominant MESH:C567296 marker/mechanism 115300.0 +BCO2 83875 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +BCOR 54880 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +BCOR 54880 Kidney Neoplasms MESH:D007680 marker/mechanism 26098867 +BCOR 54880 Microphthalmia, syndromic 1 MESH:C537464 marker/mechanism 309800.0 +BCOR 54880 Microphthalmia, syndromic 2 MESH:C537465 marker/mechanism 300166.0 17517692 +BCOR 54880 Osteosarcoma MESH:D012516 marker/mechanism 22387997 +BCOR 54880 Rhabdomyosarcoma, Embryonal MESH:D018233 marker/mechanism 29376028 +BCOR 54880 Sarcoma, Clear Cell MESH:D018227 marker/mechanism 26098867 +BCOR 54880 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +BCORL1 63035 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +BCORL1 63035 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +BCR 613 Blast Crisis MESH:D001752 marker/mechanism 21570118 +BCR 613 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 608232.0 15604220|18673174|21908430|33070465 +BCR 613 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BCR 613 Myeloproliferative Disorders MESH:D009196 marker/mechanism 22875613 +BCR 613 Necrosis MESH:D009336 marker/mechanism 23211037 +BCR 613 Neoplasms, Experimental MESH:D009374 marker/mechanism 19878872 +BCR 613 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 613065.0 +BCRP3 644165 Thrombosis MESH:D013927 marker/mechanism 16932337 +BCS1L 617 Bjornstad syndrome MESH:C537633 marker/mechanism 262000.0 +BCS1L 617 Finnish lethal neonatal metabolic syndrome MESH:C537934 marker/mechanism 603358.0 +BCS1L 617 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1 OMIM:124000 marker/mechanism 124000.0 +BDH1 622 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +BDH1 622 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +BDKRB1 623 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 21430409 +BDKRB1 623 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 15196965 +BDKRB1 623 Hyperalgesia MESH:D006930 marker/mechanism 17989505|19300402|19815945 +BDKRB1 623 Inflammation MESH:D007249 marker/mechanism 20152050 +BDKRB1 623 Pain MESH:D010146 marker/mechanism 20152050 +BDKRB1 623 Splenomegaly MESH:D013163 marker/mechanism 20096676 +BDKRB1 623 Vascular System Injuries MESH:D057772 marker/mechanism 16982965 +BDKRB2 624 Acute Kidney Injury MESH:D058186 marker/mechanism 24975837 +BDKRB2 624 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +BDKRB2 624 Cardiomyopathies MESH:D009202 marker/mechanism 10614985 +BDKRB2 624 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 30685357 +BDKRB2 624 Dermatitis, Occupational MESH:D009783 marker/mechanism 30685357 +BDKRB2 624 Disease Models, Animal MESH:D004195 marker/mechanism 30685357 +BDKRB2 624 Epilepsy, Temporal Lobe MESH:D004833 therapeutic 15196965 +BDKRB2 624 Extravasation of Diagnostic and Therapeutic Materials MESH:D005119 marker/mechanism 9622145 +BDKRB2 624 Hemorrhage MESH:D006470 marker/mechanism 16514058 +BDKRB2 624 Hyperalgesia MESH:D006930 marker/mechanism 17989505|19300402|19815945 +BDKRB2 624 Hyperemia MESH:D006940 marker/mechanism 11837250 +BDKRB2 624 Hypertension MESH:D006973 marker/mechanism 10614985 +BDKRB2 624 Hypotension MESH:D007022 marker/mechanism 1334354|16321614 +BDKRB2 624 Inflammation MESH:D007249 marker/mechanism 20152050 +BDKRB2 624 Pain MESH:D010146 marker/mechanism 20152050 +BDKRB2 624 Thrombosis MESH:D013927 marker/mechanism 16514058 +BDKRB2 624 Vascular System Injuries MESH:D057772 marker/mechanism 16982965 +BDNF 627 Alzheimer Disease MESH:D000544 marker/mechanism 17344400 +BDNF 627 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 20736000 +BDNF 627 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24781735 +BDNF 627 Autistic Disorder MESH:D001321 marker/mechanism 17349978|20662941 +BDNF 627 Bipolar Disorder MESH:D001714 marker/mechanism 14708030|19018715 +BDNF 627 Body Weight MESH:D001835 marker/mechanism 22344219|22344221 +BDNF 627 Brain Injuries MESH:D001930 marker/mechanism|therapeutic 15500971|21269288 +BDNF 627 Brain Ischemia MESH:D002545 marker/mechanism 19922383 +BDNF 627 Cocaine-Related Disorders MESH:D019970 marker/mechanism|therapeutic 14973246|17618281|17651427|18311559|19321768|20711185|20810894 +BDNF 627 Deafness MESH:D003638 therapeutic 18607918|19365690 +BDNF 627 Depressive Disorder MESH:D003866 marker/mechanism|therapeutic 16330021|21945287 +BDNF 627 Epilepsy MESH:D004827 marker/mechanism 15282290 +BDNF 627 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 16023256 +BDNF 627 Gliosis MESH:D005911 therapeutic 21087489 +BDNF 627 Heroin Dependence MESH:D006556 marker/mechanism 17715210 +BDNF 627 Hypoxia MESH:D000860 marker/mechanism 16553631 +BDNF 627 Inflammation MESH:D007249 therapeutic 21087489 +BDNF 627 Intellectual Disability MESH:D008607 marker/mechanism 11357950 +BDNF 627 Nerve Degeneration MESH:D009410 marker/mechanism|therapeutic 15372491|19457078|19686240|8921280|8978711 +BDNF 627 Nervous System Diseases MESH:D009422 therapeutic 22240983 +BDNF 627 Obesity, Morbid MESH:D009767 marker/mechanism 21708048 +BDNF 627 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +BDNF 627 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +BDNF 627 Schizophrenia MESH:D012559 marker/mechanism 12951204|14708030|17442489|18408624 +BDNF 627 Seizures MESH:D012640 marker/mechanism|therapeutic 15781040|21269288|9073163 +BDNF 627 Status Epilepticus MESH:D013226 marker/mechanism 8635431|8821376 +BDNF 627 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +BDNF 627 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 12574402 +BDNF 627 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 20418890 +BDNF 627 Tobacco Use Disorder MESH:D014029 marker/mechanism 17186223 +BEAN1 146227 Spinocerebellar Ataxia 31 MESH:C566146 marker/mechanism 117210.0 +BECN1 8678 Brain Injuries MESH:D001930 therapeutic 34929507 +BECN1 8678 Colonic Neoplasms MESH:D003110 marker/mechanism 20876807 +BECN1 8678 Lewy Body Disease MESH:D020961 marker/mechanism 19628769 +BECN1 8678 Lung Neoplasms MESH:D008175 therapeutic 22481206|23790316 +BECN1 8678 Myocardial Infarction MESH:D009203 marker/mechanism 20079142 +BECN1 8678 Spinal Cord Injuries MESH:D013119 marker/mechanism 29793971 +BECN1 8678 Status Epilepticus MESH:D013226 marker/mechanism 19138675 +BEGAIN 57596 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +BEND2 139105 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +BEND4 389206 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 28722770 +BEST1 7439 BESTROPHINOPATHY, AUTOSOMAL RECESSIVE OMIM:611809 marker/mechanism 611809.0 +BEST1 7439 RETINITIS PIGMENTOSA 50 OMIM:613194 marker/mechanism 613194.0 +BEST1 7439 Vitelliform Macular Dystrophy MESH:D057826 marker/mechanism 153700.0 +BEST1 7439 Vitreoretinochoroidopathy MESH:C536352 marker/mechanism 193220.0 +BEST3 144453 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +BEX4 56271 Cholestasis MESH:D002779 marker/mechanism 27989131 +BFSP1 631 Cataract, Cortical, Juvenile-Onset MESH:C566955 marker/mechanism 611391.0 +BFSP2 8419 Cataract, Autosomal Dominant, Multiple Types 1 MESH:C566909 marker/mechanism 611597.0 +BGLAP 632 Asthma MESH:D001249 marker/mechanism 8429434 +BGLAP 632 Calcinosis MESH:D002114 marker/mechanism 21335463 +BGLAP 632 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +BGLAP 632 Prostatic Neoplasms MESH:D011471 marker/mechanism 14666681 +BGN 633 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 15292528 +BGN 633 Breast Neoplasms MESH:D001943 marker/mechanism 35234341 +BGN 633 Disease Progression MESH:D018450 marker/mechanism 35234341 +BGN 633 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BGN 633 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 35234341 +BGN 633 MEESTER-LOEYS SYNDROME OMIM:300989 marker/mechanism 300989.0 +BGN 633 Spondyloepimetaphyseal Dysplasia, X-Linked MESH:C564714 marker/mechanism 300106.0 +BHLHA9 727857 Camptosynpolydactyly, Complex MESH:C564383 marker/mechanism 607539.0 +BHLHA9 727857 Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction MESH:C563721 marker/mechanism 609432.0 +BHLHE40 8553 Bipolar Disorder MESH:D001714 marker/mechanism 25395965 +BHLHE40 8553 Glioblastoma MESH:D005909 marker/mechanism 23582323 +BHLHE40 8553 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +BHLHE40 8553 Sleep Disorders, Circadian Rhythm MESH:D020178 marker/mechanism 25395965 +BHLHE41 79365 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +BHLHE41 79365 Sleep Wake Disorders MESH:D012893 marker/mechanism 612975.0 +BHMT 635 Abruptio Placentae MESH:D000037 marker/mechanism 17376725 +BHMT 635 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23665415 +BHMT 635 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +BHMT 635 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 17119116 +BHMT 635 Neural Tube Defects MESH:D009436 marker/mechanism 17035141 +BHMT2 23743 Cleft Lip MESH:D002971 marker/mechanism 21254359 +BHMT2 23743 Cleft Palate MESH:D002972 marker/mechanism 21254359 +BICD2 23299 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BID 637 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15289866 +BID 637 Stomach Neoplasms MESH:D013274 marker/mechanism 15095271 +BIN1 274 Alzheimer Disease MESH:D000544 marker/mechanism 21460841|33589840 +BIN1 274 Cognitive Dysfunction MESH:D060825 marker/mechanism 30503753 +BIN1 274 Myopathies, Structural, Congenital MESH:D020914 marker/mechanism 17676042 +BIN1 274 Myopathy, Centronuclear, Autosomal Recessive MESH:C562934 marker/mechanism 255200.0 +BIRC2 329 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +BIRC2 329 Disease Progression MESH:D018450 marker/mechanism 34626302 +BIRC2 329 HIV Infections MESH:D015658 marker/mechanism 12878215 +BIRC2 329 Leukemia MESH:D007938 marker/mechanism 12970779 +BIRC2 329 Neuroblastoma MESH:D009447 marker/mechanism 34626302 +BIRC2 329 Stomach Neoplasms MESH:D013274 marker/mechanism 14647439 +BIRC3 330 Disease Progression MESH:D018450 marker/mechanism 34626302 +BIRC3 330 Fatty Liver MESH:D005234 marker/mechanism 21664615 +BIRC3 330 HIV Infections MESH:D015658 marker/mechanism 12878215 +BIRC3 330 Leukemia MESH:D007938 marker/mechanism 12970779 +BIRC3 330 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BIRC3 330 Neuroblastoma MESH:D009447 marker/mechanism 34626302 +BIRC3 330 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 12926068 +BIRC5 332 Adenocarcinoma MESH:D000230 marker/mechanism 26432044 +BIRC5 332 Breast Neoplasms MESH:D001943 marker/mechanism 16322251|16818634 +BIRC5 332 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism|therapeutic 16086872|20514400 +BIRC5 332 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 16382892 +BIRC5 332 Carcinoma, Renal Cell MESH:D002292 therapeutic 16188142 +BIRC5 332 Carcinoma, Small Cell MESH:D018288 marker/mechanism 15981204 +BIRC5 332 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 26432044 +BIRC5 332 Colonic Neoplasms MESH:D003110 marker/mechanism|therapeutic 16224667|19147571 +BIRC5 332 Colorectal Neoplasms MESH:D015179 marker/mechanism 16364925 +BIRC5 332 Endometrial Neoplasms MESH:D016889 marker/mechanism 19363521 +BIRC5 332 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 16497974 +BIRC5 332 Leukemia, Megakaryoblastic, Acute MESH:D007947 therapeutic 16166298 +BIRC5 332 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 therapeutic 16254145 +BIRC5 332 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 27770503 +BIRC5 332 Lung Neoplasms MESH:D008175 marker/mechanism|therapeutic 15981204|16108013 +BIRC5 332 Ovarian Neoplasms MESH:D010051 marker/mechanism|therapeutic 15970709|16202317|16211241|18567002 +BIRC5 332 Prostatic Neoplasms MESH:D011471 marker/mechanism 29541389 +BIRC5 332 Stomach Neoplasms MESH:D013274 marker/mechanism 15993841 +BIRC5 332 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 26432044 +BIRC6 57448 Neoplasms MESH:D009369 marker/mechanism 18239605 +BIRC7 79444 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 17437058|25401301 +BLA-DQB 539241 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +BLI-3 171608 Manganese Poisoning MESH:D020149 marker/mechanism 20865164 +BLI-3 171608 Nerve Degeneration MESH:D009410 marker/mechanism 20865164 +BLK 640 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +BLK 640 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838193 +BLK 640 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11 OMIM:613375 marker/mechanism 613375.0 +BLK 640 Mucocutaneous Lymph Node Syndrome MESH:D009080 marker/mechanism 22446961 +BLM 641 Bloom Syndrome MESH:D001816 marker/mechanism 210900.0 21440839 +BLNK 29760 Agammaglobulinemia MESH:D000361 marker/mechanism 613502.0 +BLOC1S2 282991 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BLOC1S3 388552 Hermanski-Pudlak Syndrome MESH:D022861 marker/mechanism 614077.0 +BLOC1S3 388552 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +BLOC1S6 26258 Hermanski-Pudlak Syndrome MESH:D022861 marker/mechanism 614171.0 +BLTP3A 54887 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838195 +BLTP3A 54887 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +BLTP3B 23074 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +BLVRA 644 Cholestasis MESH:D002779 marker/mechanism 18706437 +BLVRA 644 HYPERBILIVERDINEMIA OMIM:614156 marker/mechanism 614156.0 +BLVRA 644 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BLVRB 645 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +BLVRB 645 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +BLVRB 645 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +BMAL1 406 Abnormalities, Multiple MESH:D000015 marker/mechanism 24652800 +BMAL1 406 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 36602574 +BMAL1 406 Hyperargininemia MESH:D020162 marker/mechanism 27056296 +BMAL1 406 Infertility, Female MESH:D007247 marker/mechanism 20200203 +BMAL1 406 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 16999817 +BMAL1 406 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +BMF 90427 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 23770605 +BMF 90427 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +BMI1 648 Disease Progression MESH:D018450 marker/mechanism 24571310 +BMI1 648 Glioblastoma MESH:D005909 marker/mechanism 19823589 +BMI1 648 Glioma MESH:D005910 marker/mechanism 23383216 +BMI1 648 Hirschsprung Disease MESH:D006627 marker/mechanism 29429387 +BMI1 648 Leukemia, Myeloid, Accelerated Phase MESH:D015465 marker/mechanism 24571310 +BMI1 648 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 24571310 +BMI1 648 Neovascularization, Pathologic MESH:D009389 marker/mechanism 23383216 +BMI1 648 Osteosarcoma MESH:D012516 marker/mechanism 21311599 +BMP1 649 OSTEOGENESIS IMPERFECTA, TYPE XIII OMIM:614856 marker/mechanism 614856.0 +BMP10 27302 Fibrosis MESH:D005355 therapeutic 31712309 +BMP10 27302 Heart Failure, Systolic MESH:D054143 therapeutic 31712309 +BMP15 9210 Ovarian Dysgenesis 2 MESH:C564499 marker/mechanism 300510.0 +BMP15 9210 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 22825968 +BMP2 650 Bone Diseases MESH:D001847 therapeutic 22023753 +BMP2 650 Brachydactyly type A2 MESH:C537089 marker/mechanism 112600.0 +BMP2 650 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +BMP2 650 Calcinosis MESH:D002114 marker/mechanism 30963258|31843813 +BMP2 650 Cardiotoxicity MESH:D066126 therapeutic 29800642 +BMP2 650 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +BMP2 650 Craniosynostoses MESH:D003398 marker/mechanism 23160099 +BMP2 650 Fractures, Bone MESH:D050723 therapeutic 27394662 +BMP2 650 Hemochromatosis MESH:D006432 marker/mechanism 235200.0 +BMP2 650 Myopia MESH:D009216 marker/mechanism 23396134 +BMP2 650 Peripheral Arterial Disease MESH:D058729 marker/mechanism 27082954 +BMP2 650 Prenatal Exposure Delayed Effects MESH:D011297 therapeutic 29800642 +BMP2 650 Right ventricle hypoplasia MESH:C535682 therapeutic 29800642 +BMP2 650 Stomach Neoplasms MESH:D013274 marker/mechanism 16314833 +BMP2 650 Uremia MESH:D014511 marker/mechanism 19092814 +BMP4 652 ACTH-Secreting Pituitary Adenoma MESH:D049913 marker/mechanism 16195406 +BMP4 652 Arthritis, Psoriatic MESH:D015535 marker/mechanism 20008919 +BMP4 652 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20008919 +BMP4 652 Breast Neoplasms MESH:D001943 marker/mechanism 23180569 +BMP4 652 Colorectal Neoplasms MESH:D015179 marker/mechanism 19011631 +BMP4 652 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 18280291 +BMP4 652 Microphthalmia, Syndromic 6 MESH:C566440 marker/mechanism 607932.0 +BMP4 652 Orofacial Cleft 11 MESH:C567410 marker/mechanism 600625.0 +BMP4 652 Osteoarthritis MESH:D010003 marker/mechanism 20008919 +BMP4 652 Osteoporosis MESH:D010024 marker/mechanism 36453845 +BMP4 652 Prolactinoma MESH:D015175 marker/mechanism 16809920 +BMP4 652 Vitamin A Deficiency MESH:D014802 marker/mechanism 16120438 +BMP6 654 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20008919 +BMP6 654 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +BMP6 654 Hemochromatosis MESH:D006432 marker/mechanism 19252486|19252488 +BMP6 654 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 18688853 +BMP6 654 Osteoarthritis MESH:D010003 marker/mechanism 20008919 +BMP7 655 Bone Resorption MESH:D001862 therapeutic 17513972 +BMP7 655 Endometriosis MESH:D004715 marker/mechanism 21063030 +BMP7 655 Femoral Fractures MESH:D005264 therapeutic 16234978 +BMP7 655 Fractures, Bone MESH:D050723 therapeutic 27394662 +BMP7 655 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 17127702 +BMP7 655 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881|19283074 +BMP7 655 Pulmonary Fibrosis MESH:D011658 therapeutic 17975199 +BMP7 655 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +BMP8A 353500 Peripheral Arterial Disease MESH:D058729 marker/mechanism 27082954 +BMPER 168667 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +BMPER 168667 Diaphanospondylodysostosis MESH:C564305 marker/mechanism 608022.0 +BMPER 168667 Opioid-Related Disorders MESH:D009293 marker/mechanism 18438686 +BMPR1A 657 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15804571 +BMPR1A 657 Eye Abnormalities MESH:D005124 marker/mechanism 15804571 +BMPR1A 657 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +BMPR1A 657 Juvenile polyposis syndrome MESH:C537702 marker/mechanism 174900.0 +BMPR1A 657 Polyposis Syndrome, Hereditary Mixed, 2 MESH:C566451 marker/mechanism 610069.0 +BMPR1B 658 ACROMESOMELIC DYSPLASIA 2C OMIM:201250 marker/mechanism 29322508 +BMPR1B 658 Bone Diseases, Developmental MESH:D001848 marker/mechanism 15805157 +BMPR1B 658 BRACHYDACTYLY, TYPE A1, D OMIM:616849 marker/mechanism 616849.0 +BMPR1B 658 Brachydactyly type A2 MESH:C537089 marker/mechanism 112600.0 +BMPR1B 658 Chondrodysplasia, acromesomelic, with genital anomalies MESH:C537913 marker/mechanism 609441.0 15805157 +BMPR1B 658 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15804571 +BMPR1B 658 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +BMPR1B 658 Eye Abnormalities MESH:D005124 marker/mechanism 15804571 +BMPR1B 658 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +BMPR2 659 Breast Neoplasms MESH:D001943 marker/mechanism 23180569 +BMPR2 659 Familial Primary Pulmonary Hypertension MESH:D065627 marker/mechanism 25460361 +BMPR2 659 Hyperandrogenism MESH:D017588 marker/mechanism 22825968 +BMPR2 659 Hypertension, Pulmonary MESH:D006976 marker/mechanism 178600.0 11590841|11893684|12358323|16297860|20496075|20522807|23383100|23502781|24224048 +BMPR2 659 Pulmonary Arterial Hypertension MESH:D000081029 marker/mechanism 28415675 +BMPR2 659 Pulmonary Veno-Occlusive Disease MESH:D011668 marker/mechanism 265450.0 +BMS1 9790 Ectodermal Dysplasia MESH:D004476 marker/mechanism 107600.0 +BNC2 54796 Cleft Palate MESH:D002972 marker/mechanism 19706529 +BNC2 54796 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19706529 +BNC2 54796 Ovarian Neoplasms MESH:D010051 marker/mechanism 20852632 +BNIP3 664 Manganese Poisoning MESH:D020149 marker/mechanism 19442826 +BNIP3 664 Multiple Myeloma MESH:D009101 marker/mechanism 18172295 +BNIP3 664 Prostatic Neoplasms MESH:D011471 marker/mechanism 18163427 +BNIP3 664 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +BNIP3P1 319138 Pre-Eclampsia MESH:D011225 marker/mechanism 35187800 +BOC 91653 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +BOC 91653 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +BOLA3 388962 MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA OMIM:614299 marker/mechanism 614299.0 +BOLA-DRA 506214 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +BOLA-DRB3 282530 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +BOLL 66037 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +BOP1 23246 Disease Progression MESH:D018450 marker/mechanism 21364753 +BOP1 23246 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +BORCS7 119032 Schizophrenia MESH:D012559 marker/mechanism 27158905 +BPGM 669 ERYTHROCYTOSIS, FAMILIAL, 8 OMIM:222800 marker/mechanism 222800.0 +BPIFA1 51297 Fetal Alcohol Spectrum Disorders MESH:D063647 marker/mechanism 15513904 +BPIFA2 140683 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +BPNT1 10380 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +BPNT2 54928 CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE OMIM:614078 marker/mechanism 614078.0 +BPTF 2186 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121791 +BPY2 9083 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +BRAF 673 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 22135231|26463840 +BRAF 673 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 23585556 +BRAF 673 Ameloblastoma MESH:D000564 marker/mechanism 24859340 +BRAF 673 Astrocytoma MESH:D001254 marker/mechanism 23817572 +BRAF 673 Carcinogenesis MESH:D063646 marker/mechanism 24717435 +BRAF 673 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 27222248 +BRAF 673 Cardiofaciocutaneous syndrome MESH:C535579 marker/mechanism 115150.0 16439621|17703371 +BRAF 673 Clinical Deterioration MESH:D000075902 marker/mechanism 29438700 +BRAF 673 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 18718023|25280562|25701956|27222248 +BRAF 673 Costello Syndrome MESH:D056685 marker/mechanism 17703371 +BRAF 673 Craniopharyngioma MESH:D003397 marker/mechanism 24413733 +BRAF 673 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +BRAF 673 Glioma MESH:D005910 marker/mechanism 23583981 +BRAF 673 Kidney Neoplasms MESH:D007680 marker/mechanism 21813464 +BRAF 673 LEOPARD SYNDROME 3 OMIM:613707 marker/mechanism 613707.0 +BRAF 673 Liver Neoplasms MESH:D008113 marker/mechanism 17514646 +BRAF 673 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 +BRAF 673 Lymphatic Metastasis MESH:D008207 marker/mechanism 29426936 +BRAF 673 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +BRAF 673 Mandibular Neoplasms MESH:D008339 marker/mechanism 24859340 +BRAF 673 Melanoma MESH:D008545 marker/mechanism 18421705|19282848|20973932|21499247|21606968|21639808|21656352|21770473|21802280|22535842|22842228|23237741|23432625|23584600|23587417|24154489|25043973|26192916|26214590|27222248|27689874|29426936|29574239|31580832 +BRAF 673 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1 OMIM:155600 marker/mechanism 155600.0 +BRAF 673 Melanoma, Experimental MESH:D008546 marker/mechanism 29179997|29438700 +BRAF 673 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +BRAF 673 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +BRAF 673 Neuroendocrine Tumors MESH:D018358 marker/mechanism 17341847 +BRAF 673 Noonan Syndrome MESH:D009634 marker/mechanism 163950.0 17703371 +BRAF 673 NOONAN SYNDROME 7 OMIM:613706 marker/mechanism 613706.0 +BRAF 673 Prostatic Neoplasms MESH:D011471 marker/mechanism 25735316|29610475 +BRAF 673 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +BRAF 673 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 27222248|28030816 +BRAF 673 Thyroid Neoplasms MESH:D013964 marker/mechanism 16940797|19878585|21185263|26751190|30621213|30935902 +BRAP 8315 Myocardial Infarction MESH:D009203 marker/mechanism 19198608 +BRCA1 672 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 10788334|15750629|15894690|18066063|20135344|20941507|21781528|22614657|26379698|26629949|28825726|7894491 +BRCA1 672 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 OMIM:604370 marker/mechanism 604370.0 +BRCA1 672 Carcinoma MESH:D002277 marker/mechanism 12203372 +BRCA1 672 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +BRCA1 672 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +BRCA1 672 Chromosome Breakage MESH:D019457 marker/mechanism 15894690 +BRCA1 672 Hereditary Breast and Ovarian Cancer Syndrome MESH:D061325 marker/mechanism 21597964|8644702 +BRCA1 672 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12203372 +BRCA1 672 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12203372|22767648 +BRCA1 672 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +BRCA1 672 Neoplasms MESH:D009369 therapeutic 15520196 +BRCA1 672 Ovarian Neoplasms MESH:D010051 marker/mechanism 10788334|15894690|17688236|7795652|7894491 +BRCA1 672 Pancreatic Neoplasms MESH:D010190 marker/mechanism 614320.0 26098869 +BRCA1 672 Prostatic Neoplasms MESH:D011471 marker/mechanism 17585057 +BRCA2 675 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 20135344|22614657|28825726 +BRCA2 675 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2 OMIM:612555 marker/mechanism 612555.0 +BRCA2 675 Fanconi Anemia, Complementation Group D1 MESH:C563980 marker/mechanism 605724.0 +BRCA2 675 Glioma MESH:D005910 marker/mechanism 613029.0 +BRCA2 675 Hereditary Breast and Ovarian Cancer Syndrome MESH:D061325 marker/mechanism 21597964 +BRCA2 675 Lung Neoplasms MESH:D008175 marker/mechanism 24880342 +BRCA2 675 Medulloblastoma MESH:D008527 marker/mechanism 155255.0 +BRCA2 675 Neoplasms, Squamous Cell MESH:D018307 marker/mechanism 24880342 +BRCA2 675 Ovarian Neoplasms MESH:D010051 marker/mechanism 17688236 +BRCA2 675 Pancreatic Neoplasms MESH:D010190 marker/mechanism 613347.0 21613821|26098869 +BRCA2 675 Prostatic Neoplasms MESH:D011471 marker/mechanism 176807.0 29610475 +BRCA2 675 Wilms Tumor MESH:D009396 marker/mechanism 194070.0 +BRD1 23774 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +BRD2 6046 Glioblastoma MESH:D005909 marker/mechanism 27388964 +BRD2 6046 Medulloblastoma MESH:D008527 marker/mechanism 24231268 +BRD3 8019 Medulloblastoma MESH:D008527 marker/mechanism 24231268 +BRD4 23476 Alopecia MESH:D000505 marker/mechanism 25242322 +BRD4 23476 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +BRD4 23476 Colonic Neoplasms MESH:D003110 marker/mechanism 26752646 +BRD4 23476 De Lange Syndrome MESH:D003635 marker/mechanism 29379197 +BRD4 23476 Glioblastoma MESH:D005909 marker/mechanism 26455392|27388964 +BRD4 23476 Hyperplasia MESH:D006965 marker/mechanism 25242322 +BRD4 23476 Hypertension, Pulmonary MESH:D006976 therapeutic 26224795 +BRD4 23476 Medulloblastoma MESH:D008527 marker/mechanism 24231268|31594641 +BRD4 23476 Osteosarcoma MESH:D012516 marker/mechanism 24646477 +BRD4 23476 Polycystic Kidney, Autosomal Dominant MESH:D016891 marker/mechanism 25877301 +BRD4 23476 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +BRD4 23476 Thyroid Neoplasms MESH:D013964 marker/mechanism 26707881 +BRD8 10902 Endometriosis MESH:D004715 marker/mechanism 22138541 +BRD9 65980 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +BRF1 2972 Breast Neoplasms MESH:D001943 marker/mechanism 32198086 +BRF1 2972 CEREBELLOFACIODENTAL SYNDROME OMIM:616202 marker/mechanism 616202.0 +BRIP1 83990 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +BRIP1 83990 Fanconi Anemia MESH:D005199 marker/mechanism 20639400 +BRIP1 83990 Fanconi Anemia, Complementation Group J MESH:C563801 marker/mechanism 609054.0 +BRIP1 83990 Ovarian Neoplasms MESH:D010051 marker/mechanism 21964575 +BRMS1 25855 Neoplasm Invasiveness MESH:D009361 therapeutic 27501413 +BRMS1 25855 Neoplasm Metastasis MESH:D009362 therapeutic 27501413 +BRPF1 7862 INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS OMIM:617333 marker/mechanism 617333.0 +BRPF1 7862 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +BRWD1 54014 Oligospermia MESH:D009845 marker/mechanism 18353305 +BRWD3 254065 Mental Retardation, X-Linked 93 MESH:C567066 marker/mechanism 300659.0 +BSCL2 26580 Asthenozoospermia MESH:D053627 marker/mechanism 26181198 +BSCL2 26580 Disease Models, Animal MESH:D004195 marker/mechanism 25462787 +BSCL2 26580 ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY OMIM:615924 marker/mechanism 615924.0 +BSCL2 26580 Lipodystrophy MESH:D008060 marker/mechanism 25462787 +BSCL2 26580 Lipodystrophy, Congenital Generalized MESH:D052497 marker/mechanism 269700.0 +BSCL2 26580 Oligospermia MESH:D009845 marker/mechanism 26181198 +BSCL2 26580 Puberty, Delayed MESH:D011628 marker/mechanism 25462787 +BSCL2 26580 Spastic paraplegia 17 MESH:C536644 marker/mechanism 270685.0 +BSG 682 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 36574092 +BSG 682 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +BSG 682 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 36574092 +BSG 682 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 36574092 +BSG 682 COVID-19 MESH:D000086382 therapeutic 32307653 +BSG 682 Esophageal Neoplasms MESH:D004938 marker/mechanism 36574092 +BSG 682 Malaria, Falciparum MESH:D016778 therapeutic 22080952|26195724 +BSG 682 Melanoma MESH:D008545 marker/mechanism 36574092 +BSG 682 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21165561 +BSG 682 Neoplasm Metastasis MESH:D009362 marker/mechanism 21956400 +BSG 682 Neoplasms, Experimental MESH:D009374 marker/mechanism 21165561 +BSG 682 Pancreatic Neoplasms MESH:D010190 marker/mechanism 36574092 +BSG 682 Plaque, Atherosclerotic MESH:D058226 marker/mechanism 18647594 +BSG 682 Thymoma MESH:D013945 marker/mechanism 36574092 +BSN 8927 Heart Diseases MESH:D006331 marker/mechanism 16844662 +BSND 7809 Bartter Syndrome, Type 4A MESH:C566530 marker/mechanism 602522.0 +BST1 683 Lung Diseases MESH:D008171 marker/mechanism 21602193 +BST1 683 Parkinson Disease MESH:D010300 marker/mechanism 19915576 +BTBD1 53339 Delayed Emergence from Anesthesia MESH:D055191 marker/mechanism 16115977 +BTBD9 114781 Restless Legs Syndrome MESH:D012148 marker/mechanism 17637780 +BTC 685 Protoporphyria, Erythropoietic MESH:D046351 marker/mechanism 19267999 +BTD 686 Autistic Disorder MESH:D001321 marker/mechanism 13680408 +BTD 686 Biotinidase Deficiency MESH:D028921 marker/mechanism 253260.0 +BTD 686 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 15469856 +BTG1 694 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +BTG1 694 Multiple Myeloma MESH:D009101 marker/mechanism 16918137 +BTG1 694 Schizophrenia MESH:D012559 marker/mechanism 16223876 +BTG2 7832 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18393292 +BTG2 7832 Chloracne MESH:D054506 marker/mechanism 17101203 +BTG3 10950 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +BTG3 10950 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 19221000 +BTG3 10950 Cholestasis MESH:D002779 marker/mechanism 27989131 +BTK 695 Agammaglobulinemia MESH:D000361 therapeutic 15142874 +BTK 695 Bruton type agammaglobulinemia MESH:C537409 marker/mechanism 300755.0 +BTK 695 COVID-19 MESH:D000086382 marker/mechanism 32503877 +BTK 695 Hypogammaglobulinemia and Isolated growth hormone deficiency, X-linked MESH:C537149 marker/mechanism 307200.0 +BTN3A2 11118 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +BTNL2 56244 Berylliosis MESH:D001607 marker/mechanism 17927685 +BTNL2 56244 Sarcoidosis MESH:D012507 marker/mechanism 612387.0 +BUB1 699 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +BUB1 699 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +BUB1B 701 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +BUB1B 701 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +BUB1B 701 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 18691855 +BUB1B 701 Growth Disorders MESH:D006130 marker/mechanism 15475955 +BUB1B 701 Microcephaly MESH:D008831 marker/mechanism 15475955 +BUB1B 701 Mosaic variegated aneuploidy syndrome MESH:C536987 marker/mechanism 257300.0 15475955 +BUB1B 701 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 28553959 +BUB1B 701 PREMATURE CHROMATID SEPARATION TRAIT OMIM:176430 marker/mechanism 176430.0 +BUB1B 701 Rhabdomyosarcoma, Embryonal MESH:D018233 marker/mechanism 15475955 +BVES 11149 MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25 OMIM:616812 marker/mechanism 616812.0 +BZW1 9689 Melanoma MESH:D008545 marker/mechanism 22535842 +BZW2 28969 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +BZW2 28969 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +C02B4.3 182100 Infertility MESH:D007246 marker/mechanism 25204677 +C05D11.13 182261 Embryo Loss MESH:D020964 marker/mechanism 25204677 +C11H3ORF70 498107 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C11ORF21 29125 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 23770605 +C11ORF68 83638 Melanoma MESH:D008545 marker/mechanism 22535842 +C12ORF57 113246 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +C12ORF57 113246 Temtamy syndrome MESH:C536959 marker/mechanism 218340.0 +C13H1ORF21 289084 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C14ORF180 400258 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +C17G10.7 173949 Infertility MESH:D007246 marker/mechanism 25204677 +C19ORF12 83636 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4 OMIM:614298 marker/mechanism 614298.0 +C19ORF12 83636 Ovarian Neoplasms MESH:D010051 marker/mechanism 21397856 +C19ORF12 83636 SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE OMIM:615043 marker/mechanism 615043.0 +C19ORF18 147685 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +C19ORF33 64073 Disease Progression MESH:D018450 marker/mechanism 35142956 +C19ORF33 64073 Pancreatic Carcinoma MESH:C562463 marker/mechanism 35142956 +C1GALT1C1 29071 Tn Syndrome MESH:C562719 marker/mechanism 300622.0 +C1ORF185 284546 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +C1QA 712 C1q DEFICIENCY 1 OMIM:613652 marker/mechanism 613652.0 +C1QA 712 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +C1QA 712 Exanthema MESH:D005076 marker/mechanism 8840296 +C1QA 712 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636|8840296 +C1QA 712 Glomerulonephritis, Membranoproliferative MESH:D015432 marker/mechanism 8840296 +C1QA 712 Immune Complex Diseases MESH:D007105 marker/mechanism 8840296 +C1QA 712 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C1QA 712 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 8840296 +C1QA 712 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +C1QB 713 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +C1QB 713 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +C1QB 713 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 2894352 +C1QB 713 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +C1QB 713 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C1QB 713 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +C1QB 713 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +C1QBP 708 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +C1QC 714 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +C1QC 714 Fatty Liver, Alcoholic MESH:D005235 marker/mechanism 35789393 +C1QC 714 Hepatitis C MESH:D006526 marker/mechanism 35789393 +C1QC 714 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C1QC 714 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35789393 +C1QC 714 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +C1QTNF5 114902 Late-Onset Retinal Degeneration MESH:C565309 marker/mechanism 605670.0 +C1QTNF5 114902 Lens Diseases MESH:D007905 marker/mechanism 16123441 +C1QTNF5 114902 Macular Degeneration MESH:D008268 marker/mechanism 16123441 +C1QTNF6 114904 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 18978792 +C1R 715 Ehlers-Danlos Syndrome, Type VIII MESH:C562626 marker/mechanism 130080.0 +C1R 715 Endometriosis MESH:D004715 marker/mechanism 20864642 +C1R 715 Paratuberculosis MESH:D010283 marker/mechanism 22633222 +C1S 716 Autoimmune Diseases MESH:D001327 marker/mechanism 11390518 +C1S 716 Complement Component C1s Deficiency MESH:C565170 marker/mechanism 613783.0 +C1S 716 EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2 OMIM:617174 marker/mechanism 617174.0 +C1S 716 Hashimoto Disease MESH:D050031 marker/mechanism 11390518 +C1S 716 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 11390518 +C1S 716 Hereditary Angioedema Types I and II MESH:D056829 marker/mechanism 3184114 +C2 717 COMPLEMENT COMPONENT 2 DEFICIENCY OMIM:217000 marker/mechanism 217000.0 +C2 717 Dermatitis, Irritant MESH:D017453 marker/mechanism 27258892 +C2 717 Dermatomyositis MESH:D003882 marker/mechanism 3501473 +C2 717 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +C2 717 Macular Degeneration MESH:D008268 marker/mechanism 16518403 +C2 717 MACULAR DEGENERATION, AGE-RELATED, 14 OMIM:615489 marker/mechanism 615489.0 +C2CD3 26005 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +C2CD3 26005 Orofaciodigital Syndromes MESH:D009958 marker/mechanism 24997988 +C2CD3 26005 OROFACIODIGITAL SYNDROME XIV OMIM:615948 marker/mechanism 615948.0 +C2CD4A 145741 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 20818381 +C2CD4B 388125 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 20818381 +C2ORF88 84281 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +C3 718 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +C3 718 Atypical Hemolytic Uremic Syndrome MESH:D065766 marker/mechanism 612925.0 +C3 718 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +C3 718 Chemically-Induced Disorders MESH:D064419 marker/mechanism 35999755 +C3 718 Colitis, Ulcerative MESH:D003093 marker/mechanism 35999755 +C3 718 Complement Component 3 Deficiency, Autosomal Recessive MESH:C565169 marker/mechanism 613779.0 +C3 718 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 20504758 +C3 718 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +C3 718 Glomerulonephritis, Membranous MESH:D015433 marker/mechanism 25954969 +C3 718 IgA Vasculitis MESH:D011695 marker/mechanism 1353212 +C3 718 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 1350678 +C3 718 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 23199288 +C3 718 Insulin Resistance MESH:D007333 marker/mechanism 18615583 +C3 718 Ischemic Attack, Transient MESH:D002546 marker/mechanism 23199288 +C3 718 Lupus Nephritis MESH:D008181 marker/mechanism 31182691 +C3 718 Macular Degeneration MESH:D008268 marker/mechanism 17767156|24036949|24036950|24036952 +C3 718 Macular Degeneration, Age-Related, 9 MESH:C566958 marker/mechanism 611378.0 +C3 718 Paratuberculosis MESH:D010283 marker/mechanism 22633222 +C3 718 Pemphigus MESH:D010392 marker/mechanism 74171 +C35E7.9 172987 Infertility MESH:D007246 marker/mechanism 25204677 +C47E8.3 183552 Death MESH:D003643 marker/mechanism 25204677 +C4A 720 Complement Component 4a Deficiency MESH:C565167 marker/mechanism 614380.0 +C4A 720 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 8473511 +C4B 721 Autistic Disorder MESH:D001321 marker/mechanism 15694999|20452682 +C4B 721 Autoimmune Diseases MESH:D001327 marker/mechanism 20452682 +C4B 721 COMPLEMENT COMPONENT 4B DEFICIENCY OMIM:614379 marker/mechanism 614379.0 +C4B 721 Drug Eruptions MESH:D003875 marker/mechanism 21055120 +C4ORF19 55286 Cholestasis MESH:D002779 marker/mechanism 27989131 +C5 727 Complement component 5 deficiency MESH:C537005 marker/mechanism 609536.0 +C5 727 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 7730648 +C5 727 Peritonitis MESH:D010538 marker/mechanism 19284563|19346296 +C5AR1 728 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C5AR1 728 Shock, Septic MESH:D012772 marker/mechanism 18063050 +C5H1ORF210 362576 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C5ORF63 401207 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +C6 729 Calcinosis MESH:D002114 marker/mechanism 21335463 +C6 729 Complement Component 6 Deficiency MESH:C567307 marker/mechanism 612446.0 +C6 729 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +C7 730 Complement Component 7 Deficiency MESH:C566443 marker/mechanism 610102.0 +C7 730 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C8A 731 COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I OMIM:613790 marker/mechanism 613790.0 +C8A 731 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 9759902 +C8A 731 Meningitis MESH:D008581 marker/mechanism 9759902 +C8A 731 Neisseriaceae Infections MESH:D016870 marker/mechanism 9759902 +C8B 732 Arthritis, Juvenile MESH:D001171 marker/mechanism 7980680 +C8B 732 COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II OMIM:613789 marker/mechanism 613789.0 +C8B 732 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 8098723 +C8B 732 Meningitis MESH:D008581 marker/mechanism 8098723 +C8B 732 Neisseriaceae Infections MESH:D016870 marker/mechanism 8098723 +C8G 733 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C8H11ORF54 363016 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +C9 735 C9 Deficiency MESH:C565165 marker/mechanism 613825.0 +C9 735 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144|28284560 +C9 735 Dermatomyositis MESH:D003882 marker/mechanism 11359403 +C9 735 Erythema MESH:D004890 marker/mechanism 11359403 +C9 735 Facial Dermatoses MESH:D005148 marker/mechanism 11359403 +C9 735 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 11359403|9570574 +C9 735 Macular Degeneration MESH:D008268 marker/mechanism 24036952 +C9 735 MACULAR DEGENERATION, AGE-RELATED, 15 OMIM:615591 marker/mechanism 615591.0 +C9 735 Meningitis, Meningococcal MESH:D008585 marker/mechanism 9570574 +C9 735 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +C9 735 Opioid-Related Disorders MESH:D009293 marker/mechanism 18438686 +C9ORF72 203228 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 25442110|27713094|28122516|28478440|28973294 +C9ORF72 203228 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +C9ORF72 203228 Eye Diseases MESH:D005128 marker/mechanism 33661518 +C9ORF72 203228 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 1 OMIM:105550 marker/mechanism 105550.0 +C9ORF72 203228 Frontotemporal Dementia With Motor Neuron Disease MESH:C566288 marker/mechanism 26769963 +C9ORF72 203228 Frontotemporal Lobar Degeneration MESH:D057174 marker/mechanism 25442110|27713094 +C9ORF72 203228 Nerve Degeneration MESH:D009410 marker/mechanism 33661518 +CA1 759 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +CA1 759 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +CA1 759 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +CA1 759 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696|19424620 +CA12 771 HYPERCHLORHIDROSIS, ISOLATED OMIM:143860 marker/mechanism 143860.0 +CA12 771 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +CA2 760 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +CA2 760 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 31209396 +CA2 760 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +CA2 760 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +CA2 760 Osteopetrosis with renal tubular acidosis MESH:C536058 marker/mechanism 259730.0 +CA2 760 Osteoporosis MESH:D010024 marker/mechanism 18924182 +CA2 760 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +CA3 761 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CA3 761 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CA3 761 Obesity MESH:D009765 marker/mechanism 20882379 +CA3 761 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +CA5A 763 CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO OMIM:615751 marker/mechanism 615751.0 +CA8 767 Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 3 MESH:C567690 marker/mechanism 613227.0 +CA8 767 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +CA9 768 Anaplasia MESH:D000708 marker/mechanism 19808899 +CA9 768 Carcinoma, Ductal MESH:D044584 marker/mechanism 20526721 +CA9 768 Carcinoma, Intraductal, Noninfiltrating MESH:D002285 marker/mechanism 20526721 +CA9 768 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30381462 +CA9 768 Hypertension, Pulmonary MESH:D006976 marker/mechanism 20110409 +CA9 768 Hypoxia MESH:D000860 marker/mechanism 16954440 +CA9 768 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 17157168 +CABCOCO1 219621 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +CABIN1 23523 Cardiomegaly MESH:D006332 therapeutic 11248077 +CABLES1 91768 Colorectal Neoplasms MESH:D015179 marker/mechanism 17982127 +CABP2 51475 DEAFNESS, AUTOSOMAL RECESSIVE 93 OMIM:614899 marker/mechanism 614899.0 +CABP4 57010 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE OMIM:610427 marker/mechanism 610427.0 +CABYR 26256 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +CACNA1A 773 Ataxia MESH:D001259 marker/mechanism 17376154 +CACNA1A 773 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42 OMIM:617106 marker/mechanism 617106.0 +CACNA1A 773 Epilepsy, Absence MESH:D004832 marker/mechanism 17196942 +CACNA1A 773 Episodic Ataxia, Type 2 MESH:C535506 marker/mechanism 108500.0 11985388 +CACNA1A 773 Exfoliation Syndrome MESH:D017889 marker/mechanism 25706626 +CACNA1A 773 Hemiplegic migraine, familial type 1 MESH:C536890 marker/mechanism 141500.0 11985388|24849341 +CACNA1A 773 Migraine with Aura MESH:D020325 marker/mechanism 35115687 +CACNA1A 773 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 183086.0 11985388|16899342 +CACNA1B 774 Peripheral Nervous System Diseases MESH:D010523 therapeutic 22891239 +CACNA1C 775 Anxiety Disorders MESH:D001008 marker/mechanism 28696432 +CACNA1C 775 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 15454078 +CACNA1C 775 Autistic Disorder MESH:D001321 marker/mechanism 15454078 +CACNA1C 775 Bipolar Disorder MESH:D001714 marker/mechanism 18711365|21926972|21926974|31043756 +CACNA1C 775 Brugada Syndrome 3 MESH:C567509 marker/mechanism 611875.0 +CACNA1C 775 Cognitive Dysfunction MESH:D060825 marker/mechanism 28696432 +CACNA1C 775 Depressive Disorder, Major MESH:D003865 marker/mechanism 28696432 +CACNA1C 775 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 28696432 +CACNA1C 775 Hypertension MESH:D006973 marker/mechanism 22949532 +CACNA1C 775 Hypoglycemia MESH:D007003 marker/mechanism 15454078 +CACNA1C 775 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 15454078 +CACNA1C 775 Limb Deformities, Congenital MESH:D017880 marker/mechanism 15454078 +CACNA1C 775 Psychomotor Agitation MESH:D011595 marker/mechanism 28696432 +CACNA1C 775 Stress Disorders, Traumatic MESH:D040921 marker/mechanism 28696432 +CACNA1C 775 Timothy syndrome MESH:C536962 marker/mechanism 601005.0 15454078 +CACNA1D 776 Adenoma MESH:D000236 marker/mechanism 23913001|23913004 +CACNA1D 776 Bipolar Disorder MESH:D001714 marker/mechanism 28194001 +CACNA1D 776 Bradycardia MESH:D001919 marker/mechanism 26831068 +CACNA1D 776 Deafness MESH:D003638 marker/mechanism 15357422 +CACNA1D 776 Disease Models, Animal MESH:D004195 marker/mechanism 26831068 +CACNA1D 776 Heart Block MESH:D006327 marker/mechanism 26831068 +CACNA1D 776 Hyperaldosteronism MESH:D006929 marker/mechanism 23913001 +CACNA1D 776 Sick Sinus Syndrome MESH:D012804 marker/mechanism 26831068 +CACNA1D 776 Tachycardia, Supraventricular MESH:D013617 marker/mechanism 26831068 +CACNA1F 778 Aland Island Eye Disease MESH:C562664 marker/mechanism 300600.0 +CACNA1F 778 Cone-Rod Dystrophy, X-Linked, 3 MESH:C564507 marker/mechanism 300476.0 +CACNA1F 778 Night blindness, congenital stationary MESH:C536122 marker/mechanism 300071.0 +CACNA1G 8913 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +CACNA1G 8913 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 616795.0 +CACNA1H 8912 Autistic Disorder MESH:D001321 marker/mechanism 16754686 +CACNA1H 8912 beta-Thalassemia MESH:D017086 marker/mechanism 31542421 +CACNA1H 8912 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 30552955 +CACNA1H 8912 Epilepsy, Absence MESH:D004832 marker/mechanism 611942.0 +CACNA1H 8912 HYPERALDOSTERONISM, FAMILIAL, TYPE IV OMIM:617027 marker/mechanism 617027.0 +CACNA1H 8912 Hyperalgesia MESH:D006930 marker/mechanism 19577366|30552955|34286406 +CACNA1H 8912 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 30552955 +CACNA1S 779 Hypokalemic Periodic Paralysis MESH:D020514 marker/mechanism 11912116|19822448 +CACNA1S 779 HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 OMIM:170400 marker/mechanism 170400.0 +CACNA1S 779 Malignant hyperthermia susceptibility type 5 MESH:C535698 marker/mechanism 601887.0 +CACNA1S 779 Respiratory Insufficiency MESH:D012131 marker/mechanism 19822448 +CACNA1S 779 THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1 OMIM:188580 marker/mechanism 188580.0 +CACNA2D1 781 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +CACNA2D1 781 Hyperalgesia MESH:D006930 marker/mechanism 11245671|17881535|24133248 +CACNA2D1 781 Hypertension MESH:D006973 marker/mechanism 22949532 +CACNA2D1 781 Neuralgia MESH:D009437 marker/mechanism 17442347|18400411|19339603|24133248 +CACNA2D1 781 Pain MESH:D010146 marker/mechanism 17088553 +CACNA2D2 9254 Ataxia MESH:D001259 marker/mechanism 14660671 +CACNA2D2 9254 Chorea MESH:D002819 marker/mechanism 14660671 +CACNA2D2 9254 Epilepsy, Absence MESH:D004832 marker/mechanism 14660671 +CACNA2D2 9254 Hearing Loss MESH:D034381 marker/mechanism 27798183 +CACNA2D2 9254 Infertility, Female MESH:D007247 marker/mechanism 14660671 +CACNA2D3 55799 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +CACNA2D4 93589 Retinal Cone Dystrophy 4 MESH:C566470 marker/mechanism 610478.0 +CACNB2 783 Brugada Syndrome 4 MESH:C567508 marker/mechanism 611876.0 +CACNB3 784 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +CACNB4 785 Ataxia MESH:D001259 marker/mechanism 10762541 +CACNB4 785 Epilepsy, Generalized MESH:D004829 marker/mechanism 10762541 +CACNB4 785 Epilepsy, Idiopathic Generalized MESH:C562694 marker/mechanism 607682.0 +CACNB4 785 Episodic Ataxia, Type 5 MESH:C566601 marker/mechanism 613855.0 +CACNB4 785 Myoclonic Epilepsy, Juvenile MESH:D020190 marker/mechanism 10762541 +CACNG2 10369 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 10 OMIM:614256 marker/mechanism 614256.0 +CACUL1 143384 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +CAD 790 Anemia, Hypoplastic, Congenital MESH:D029502 marker/mechanism 38827 +CAD 790 Anemia, Sickle Cell MESH:D000755 marker/mechanism 38827 +CAD 790 beta-Thalassemia MESH:D017086 marker/mechanism 38827 +CAD 790 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50 OMIM:616457 marker/mechanism 616457.0 +CAD 790 Leukemia, Erythroblastic, Acute MESH:D004915 marker/mechanism 38827 +CAD 790 Spherocytosis, Hereditary MESH:D013103 marker/mechanism 38827 +CADM1 23705 Autistic Disorder MESH:D001321 marker/mechanism 18957284 +CADM1 23705 Breast Neoplasms MESH:D001943 marker/mechanism 17260099 +CADM1 23705 Depressive Disorder MESH:D003866 marker/mechanism 22113448 +CADM1 23705 Mitochondrial Diseases MESH:D028361 marker/mechanism 30673822 +CADPS2 93664 Autistic Disorder MESH:D001321 marker/mechanism 17380209 +CADPS2 93664 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +CADPS2 93664 Cholestasis MESH:D002779 marker/mechanism 26881866 +CADPS2 93664 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CALB1 793 Kidney Diseases MESH:D007674 marker/mechanism 21258088|21865292 +CALB2 794 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +CALB2 794 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 22784439 +CALB2 794 Peritoneal Neoplasms MESH:D010534 marker/mechanism 22784439 +CALB2 794 Uveitis MESH:D014605 marker/mechanism 19578012 +CALCA 796 Arthritis, Experimental MESH:D001169 marker/mechanism 16690336 +CALCA 796 Autistic Disorder MESH:D001321 marker/mechanism 11357950 +CALCA 796 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 15127121|16777450 +CALCA 796 Catalepsy MESH:D002375 marker/mechanism 6293644|6303368|6686863 +CALCA 796 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +CALCA 796 Down Syndrome MESH:D004314 marker/mechanism 16289943 +CALCA 796 Edema MESH:D004487 marker/mechanism 7508328 +CALCA 796 Hyperalgesia MESH:D006930 marker/mechanism|therapeutic 12787826|12855330|15265675|27093858 +CALCA 796 Hypercalcemia MESH:D006934 therapeutic 1115441|12637657 +CALCA 796 Hyperkinesis MESH:D006948 therapeutic 6293644|6686863 +CALCA 796 Hypertension MESH:D006973 therapeutic 1849535|9887042 +CALCA 796 Hypertension, Pulmonary MESH:D006976 therapeutic 1357980 +CALCA 796 Inflammation MESH:D007249 marker/mechanism 11588175 +CALCA 796 Intellectual Disability MESH:D008607 marker/mechanism 11357950 +CALCA 796 Migraine Disorders MESH:D008881 marker/mechanism 12574409|17635592|35115687 +CALCA 796 Migraine without Aura MESH:D020326 marker/mechanism 11304026|14659530 +CALCA 796 Neurogenic Inflammation MESH:D020078 marker/mechanism 17961222 +CALCA 796 Osteoarthritis MESH:D010003 marker/mechanism 16690336 +CALCA 796 Prostatic Neoplasms MESH:D011471 marker/mechanism 16222118 +CALCA 796 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17365031 +CALCA 796 Sciatic Neuropathy MESH:D020426 therapeutic 19852068 +CALCA 796 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +CALCA 796 Wounds and Injuries MESH:D014947 therapeutic 18430544 +CALCB 797 Migraine Disorders MESH:D008881 marker/mechanism 35115687 +CALCOCO2 10241 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +CALCR 799 Hypercalcemia MESH:D006934 therapeutic 18627265 +CALCR 799 Osteoporosis MESH:D010024 marker/mechanism 166710.0 +CALCRL 10203 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +CALD1 800 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CALD1 800 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 15292528 +CALHM1 255022 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +CALM1 801 Alzheimer Disease MESH:D000544 marker/mechanism 11470324 +CALM1 801 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17205118 +CALM1 801 LONG QT SYNDROME 14 OMIM:616247 marker/mechanism 616247.0 +CALM1 801 Marijuana Abuse MESH:D002189 marker/mechanism 17205118 +CALM1 801 Phencyclidine Abuse MESH:D010623 marker/mechanism 17205118 +CALM1 801 Polymorphic catecholergic ventricular tachycardia MESH:C536334 marker/mechanism 614916.0 +CALM1 801 Weight Gain MESH:D015430 marker/mechanism 19030233 +CALM2 805 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17205118 +CALM2 805 LONG QT SYNDROME 15 OMIM:616249 marker/mechanism 616249.0 +CALM2 805 Marijuana Abuse MESH:D002189 marker/mechanism 17205118 +CALM2 805 Phencyclidine Abuse MESH:D010623 marker/mechanism 17205118 +CALML3 810 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +CALR 811 Colorectal Neoplasms MESH:D015179 therapeutic 17187072 +CALR 811 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +CALR 811 Melanoma, Experimental MESH:D008546 therapeutic 16388313 +CALR 811 Myeloproliferative Disorders MESH:D009196 marker/mechanism 29047144 +CALR 811 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CALR 811 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +CALR 811 Primary Myelofibrosis MESH:D055728 marker/mechanism 254450.0 +CALR 811 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973 +CALR 811 Thrombocytosis MESH:D013922 marker/mechanism 187950.0 +CALU 813 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +CALU 813 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +CALY 50632 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 30753204 +CALY 50632 Disease Models, Animal MESH:D004195 marker/mechanism 30753204 +CALY 50632 Essential Hypertension MESH:D000075222 marker/mechanism 30753204 +CALY 50632 Memory Disorders MESH:D008569 marker/mechanism 30753204 +CAMK1G 57172 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 23624525 +CAMK2A 815 Cocaine-Related Disorders MESH:D019970 marker/mechanism 14725635 +CAMK2A 815 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +CAMK2A 815 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +CAMK2A 815 Hyperalgesia MESH:D006930 marker/mechanism 20053885 +CAMK2A 815 Mitochondrial Diseases MESH:D028361 marker/mechanism 30673822 +CAMK2B 816 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17205118 +CAMK2B 816 Marijuana Abuse MESH:D002189 marker/mechanism 17205118 +CAMK2B 816 Phencyclidine Abuse MESH:D010623 marker/mechanism 17205118 +CAMK2B 816 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 17603807 +CAMK2B 816 Schizophrenia MESH:D012559 marker/mechanism 11042361|20336626 +CAMK2D 817 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +CAMK2D 817 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CAMK2D 817 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CAMK2D 817 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CAMK4 814 Cocaine-Related Disorders MESH:D019970 marker/mechanism 19001277 +CAMKK1 84254 Nervous System Diseases MESH:D009422 marker/mechanism 21245421 +CAMKK2 10645 Ovarian Neoplasms MESH:D010051 marker/mechanism 28634229 +CAMKK2 10645 Prostatic Neoplasms MESH:D011471 marker/mechanism 28634229 +CAMKMT 79823 Developmental Disabilities MESH:D002658 marker/mechanism 26247364 +CAMKMT 79823 Hypotonia-Cystinuria Syndrome MESH:C564710 marker/mechanism 26247364 +CAMKMT 79823 Learning Disabilities MESH:D007859 marker/mechanism 26247364 +CAMKMT 79823 Mitochondrial Myopathies MESH:D017240 marker/mechanism 26247364 +CAMKMT 79823 Motor Skills Disorders MESH:D019957 marker/mechanism 26247364 +CAMKMT 79823 Muscle Weakness MESH:D018908 marker/mechanism 26247364 +CAMP 820 Erythema MESH:D004890 marker/mechanism 35926563 +CAMP 820 Rosacea MESH:D012393 marker/mechanism 35926563 +CAMSAP1 157922 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CAMTA1 23261 CEREBELLAR DYSFUNCTION WITH VARIABLE COGNITIVE AND BEHAVIORAL ABNORMALITIES OMIM:614756 marker/mechanism 614756.0 +CAND2 23066 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +CANT1 124583 Desbuquois syndrome MESH:C535943 marker/mechanism 251450.0 +CANX 821 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CANX 821 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CAP1 10487 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CAP1 10487 Osteoporosis MESH:D010024 marker/mechanism 18924182 +CAP2 10486 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CAPG 822 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +CAPG 822 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +CAPG 822 Keloid MESH:D007627 marker/mechanism 20128793 +CAPG 822 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +CAPG 822 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CAPN1 823 Melanoma MESH:D008545 marker/mechanism 22535842 +CAPN1 823 Neoplasms MESH:D009369 therapeutic 19266085 +CAPN1 823 Optic Neuritis MESH:D009902 marker/mechanism 23860028 +CAPN1 823 SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE OMIM:616907 marker/mechanism 616907.0 +CAPN10 11132 Diabetes Mellitus, Noninsulin-Dependent, 1 MESH:C563359 marker/mechanism 601283.0 +CAPN10 11132 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23349674 +CAPN10 11132 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +CAPN14 440854 Eosinophilic Esophagitis MESH:D057765 marker/mechanism 25017104 +CAPN2 824 Cognition Disorders MESH:D003072 therapeutic 31672664 +CAPN2 824 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +CAPN3 825 Limb-girdle muscular dystrophy type 2A MESH:C535895 marker/mechanism 253600.0 +CAPN5 726 VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY OMIM:193235 marker/mechanism 193235.0 +CAPN8 388743 Celiac Disease MESH:D002446 marker/mechanism 30097691 +CAPNS1 826 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CAPZA1 829 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +CAPZB 832 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +CAPZB 832 Carcinoma MESH:D002277 marker/mechanism 16316942 +CAPZB 832 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +CAPZB 832 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +CAR2 12349 Cholangitis MESH:D002761 marker/mechanism 15816485 +CAR2 12349 Disease Models, Animal MESH:D004195 marker/mechanism 15816485 +CAR3 12350 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +CAR3 12350 Fatty Liver MESH:D005234 marker/mechanism 25226513 +CAR3 12350 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CAR3 12350 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +CAR4 12351 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +CAR5A 12352 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CARD11 84433 B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY OMIM:616452 marker/mechanism 616452.0 +CARD11 84433 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +CARD11 84433 Dermatitis, Atopic MESH:D003876 marker/mechanism 23042114|28628108 +CARD11 84433 IMMUNODEFICIENCY 11A OMIM:615206 marker/mechanism 615206.0 +CARD11 84433 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +CARD11 84433 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 25049379|26192916 +CARD11 84433 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +CARD11 84433 Sezary Syndrome MESH:D012751 marker/mechanism 26551667|26551670 +CARD14 79092 Pityriasis Rubra Pilaris MESH:D010916 marker/mechanism 173200.0 +CARD14 79092 Psoriasis MESH:D011565 marker/mechanism 602723.0 23143594|24212883 +CARD18 59082 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22514692 +CARD18 59082 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 22514692 +CARD8 22900 Gout MESH:D006073 marker/mechanism 26462562 +CARD8 22900 Occupational Diseases MESH:D009784 marker/mechanism 24142982 +CARD8 22900 Pleural Diseases MESH:D010995 marker/mechanism 24142982 +CARD9 64170 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799 +CARD9 64170 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25305756 +CARD9 64170 IMMUNODEFICIENCY 103, SUSCEPTIBILITY TO FUNGAL INFECTIONS OMIM:212050 marker/mechanism 212050.0 +CARD9 64170 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 21983784 +CARD9 64170 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 21743469 +CARF 79800 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +CARM1 10498 Psoriasis MESH:D011565 marker/mechanism 23143594 +CARMIL3 90668 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CARS2 79587 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27 OMIM:616672 marker/mechanism 616672.0 +CARTPT 9607 Alcohol-Related Disorders MESH:D019973 marker/mechanism 22823101 +CARTPT 9607 Anxiety Disorders MESH:D001008 marker/mechanism 12600694 +CARTPT 9607 Cocaine-Related Disorders MESH:D019970 therapeutic 20886038 +CARTPT 9607 Hyperalgesia MESH:D006930 therapeutic 21167239 +CARTPT 9607 Hyperthyroidism MESH:D006980 marker/mechanism 12395121 +CARTPT 9607 Obesity MESH:D009765 marker/mechanism 601665.0 +CASK 8573 ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY OMIM:300908 marker/mechanism 300908.0 +CASK 8573 Carcinoma MESH:D002277 marker/mechanism 12376462 +CASK 8573 Cerebellar Diseases MESH:D002526 marker/mechanism 19165920 +CASK 8573 Cleft Palate MESH:D002972 marker/mechanism 9787075 +CASK 8573 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +CASK 8573 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +CASK 8573 Mental Retardation And Microcephaly With Pontine And Cerebellar Hypoplasia MESH:C567466 marker/mechanism 300749.0 +CASK 8573 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 19165920|19377476 +CASK 8573 Microcephaly MESH:D008831 marker/mechanism 19165920 +CASK 8573 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +CASK 8573 Opitz-Kaveggia syndrome MESH:C537923 marker/mechanism 300422.0 +CASP1 834 Albuminuria MESH:D000419 marker/mechanism 22647887 +CASP1 834 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +CASP1 834 Hyperhomocysteinemia MESH:D020138 marker/mechanism 22647887 +CASP1 834 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CASP1 834 Inflammation MESH:D007249 marker/mechanism 22325453 +CASP1 834 Insulin Resistance MESH:D007333 marker/mechanism 22325453 +CASP1 834 Kidney Diseases MESH:D007674 marker/mechanism 22647887 +CASP1 834 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CASP1 834 Multiple Sclerosis MESH:D009103 marker/mechanism 25458313 +CASP1 834 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 14998631 +CASP1 834 Obesity MESH:D009765 marker/mechanism 22325453 +CASP1 834 Pneumonia MESH:D011014 marker/mechanism 21625544 +CASP1 834 Status Epilepticus MESH:D013226 marker/mechanism 18571097 +CASP10 843 Autoimmune Lymphoproliferative Syndrome, Type IIA MESH:C565833 marker/mechanism 603909.0 +CASP10 843 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 605027.0 +CASP10 843 Melanoma MESH:D008545 marker/mechanism 18563783 +CASP10 843 Skin Neoplasms MESH:D012878 marker/mechanism 18563783 +CASP10 843 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 +CASP12 100506742 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 23499715 +CASP12 100506742 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CASP12 100506742 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 14998631 +CASP14 23581 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12 OMIM:617320 marker/mechanism 617320.0 +CASP2 835 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 20208132 +CASP2 835 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +CASP3 836 Acute Lung Injury MESH:D055371 marker/mechanism 32062619 +CASP3 836 Alzheimer Disease MESH:D000544 marker/mechanism 18077176 +CASP3 836 Brain Ischemia MESH:D002545 marker/mechanism 11756504|17901229 +CASP3 836 Calcinosis MESH:D002114 marker/mechanism 21335463 +CASP3 836 Cerebral Hemorrhage MESH:D002543 marker/mechanism 17971790 +CASP3 836 Colitis, Ulcerative MESH:D003093 marker/mechanism 24055189 +CASP3 836 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +CASP3 836 Cryptorchidism MESH:D003456 marker/mechanism 26050606 +CASP3 836 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 20654064 +CASP3 836 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 15531508 +CASP3 836 Diabetic Angiopathies MESH:D003925 marker/mechanism 25381014 +CASP3 836 Diabetic Neuropathies MESH:D003929 marker/mechanism 12502508 +CASP3 836 Diabetic Retinopathy MESH:D003930 marker/mechanism 20654064 +CASP3 836 Edema MESH:D004487 marker/mechanism 19874808 +CASP3 836 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +CASP3 836 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +CASP3 836 Mycoplasma Infections MESH:D009175 marker/mechanism 20179380 +CASP3 836 Myocardial Infarction MESH:D009203 marker/mechanism 25450231 +CASP3 836 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 14998631 +CASP3 836 Nerve Degeneration MESH:D009410 marker/mechanism 14999069 +CASP3 836 Nervous System Diseases MESH:D009422 marker/mechanism 12196588 +CASP3 836 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 21972528 +CASP3 836 Reperfusion Injury MESH:D015427 marker/mechanism 23875703 +CASP3 836 Retinal Detachment MESH:D012163 marker/mechanism 18497877 +CASP3 836 Sepsis MESH:D018805 marker/mechanism 16003065|32062619 +CASP3 836 Spinal Cord Injuries MESH:D013119 marker/mechanism 14588118 +CASP3 836 Status Epilepticus MESH:D013226 marker/mechanism 16679645|18571097 +CASP3 836 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 24602480 +CASP4 837 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CASP4 837 Schizophrenia MESH:D012559 marker/mechanism 21743468 +CASP7 840 Breast Neoplasms MESH:D001943 marker/mechanism 16583263 +CASP7 840 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +CASP7 840 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CASP7 840 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 14998631 +CASP7 840 Vitiligo MESH:D014820 marker/mechanism 22561518 +CASP8 841 Adenocarcinoma MESH:D000230 marker/mechanism 21472143 +CASP8 841 Autoimmune Lymphoproliferative Syndrome MESH:D056735 marker/mechanism 607271.0 +CASP8 841 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 15601643|17293864|17450141|29915430 +CASP8 841 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 114550.0 +CASP8 841 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 20471133 +CASP8 841 Cerebral Hemorrhage MESH:D002543 marker/mechanism 17971790 +CASP8 841 Colorectal Neoplasms MESH:D015179 marker/mechanism 17450141 +CASP8 841 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +CASP8 841 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CASP8 841 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 15531508 +CASP8 841 Edema MESH:D004487 marker/mechanism 19874808 +CASP8 841 Esophageal Neoplasms MESH:D004938 marker/mechanism 17450141|21472143 +CASP8 841 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 17450141 +CASP8 841 Melanoma MESH:D008545 marker/mechanism 18563783|21983787 +CASP8 841 Mitochondrial Diseases MESH:D028361 marker/mechanism 30673822 +CASP8 841 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 14998631 +CASP8 841 Papillomavirus Infections MESH:D030361 marker/mechanism 23358896 +CASP8 841 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 therapeutic 22010212 +CASP8 841 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +CASP8 841 Reperfusion Injury MESH:D015427 marker/mechanism 23875703 +CASP8 841 Skin Neoplasms MESH:D012878 marker/mechanism 18563783 +CASP8 841 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 23358896 +CASP8 841 Status Epilepticus MESH:D013226 marker/mechanism 18571097 +CASP8 841 Stomach Neoplasms MESH:D013274 marker/mechanism 17450141 +CASP8 841 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 17450141 +CASP9 842 Brain Ischemia MESH:D002545 marker/mechanism 11756504 +CASP9 842 Edema MESH:D004487 marker/mechanism 19874808 +CASP9 842 Ischemic Attack, Transient MESH:D002546 marker/mechanism 11333366 +CASP9 842 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 14998631 +CASP9 842 Nervous System Diseases MESH:D009422 marker/mechanism 11150333 +CASP9 842 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +CASP9 842 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +CASP9 842 Retinal Detachment MESH:D012163 marker/mechanism 18497877 +CASQ1 844 MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES OMIM:616231 marker/mechanism 616231.0 +CASQ2 845 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +CASQ2 845 Polymorphic catecholergic ventricular tachycardia MESH:C536334 marker/mechanism 611938.0 20513597 +CASQ2 845 Tachycardia, Ventricular MESH:D017180 marker/mechanism 18052993 +CASQ2 845 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY OMIM:604772 marker/mechanism 604772.0 +CASR 846 Epilepsy, Idiopathic Generalized MESH:C562694 marker/mechanism 612899.0 +CASR 846 Hypercalcemia MESH:D006934 marker/mechanism 9011580 +CASR 846 Hyperparathyroidism MESH:D006961 marker/mechanism 11589681|9011580 +CASR 846 Hyperparathyroidism, Neonatal Severe Primary MESH:C563375 marker/mechanism 239200.0 7916660 +CASR 846 Hypocalcemia MESH:D006996 marker/mechanism 11701698|7874174 +CASR 846 Hypocalcemia, Autosomal Dominant, with Bartter Syndrome MESH:C563374 marker/mechanism 601198.0 +CASR 846 Hypocalciuric hypercalcemia, familial, type 1 MESH:C537145 marker/mechanism 145980.0 7916660 +CASR 846 Hypoparathyroidism MESH:D007011 marker/mechanism 11701698 +CASR 846 Hypoparathyroidism familial isolated MESH:C537156 marker/mechanism 20119591 +CASS4 57091 Alzheimer Disease MESH:D000544 marker/mechanism 30320580|33589840 +CAST 831 Coxsackievirus Infections MESH:D003384 therapeutic 34365571 +CAST 831 Liver Failure, Acute MESH:D017114 therapeutic 16871587 +CAST 831 Myocarditis MESH:D009205 therapeutic 34365571 +CAST 831 Necrosis MESH:D009336 therapeutic 17323976 +CAST 831 PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS OMIM:616295 marker/mechanism 616295.0 +CAST 831 Ventricular Dysfunction, Left MESH:D018487 therapeutic 34365571 +CASZ1 54897 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +CASZ1 54897 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +CASZ1 54897 Stroke MESH:D020521 marker/mechanism 29531354 +CAT 847 Abnormalities, Drug-Induced MESH:D000014 therapeutic 21252394|26074427 +CAT 847 Acatalasia MESH:D020642 marker/mechanism|therapeutic 614097.0 11001624|11117918|1551654|2308162|26074427|34390818 +CAT 847 Acute Lung Injury MESH:D055371 therapeutic 15612528 +CAT 847 Aortic Diseases MESH:D001018 marker/mechanism 25101153 +CAT 847 Arthritis, Experimental MESH:D001169 marker/mechanism 22450443 +CAT 847 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22450443 +CAT 847 Asphyxia Neonatorum MESH:D001238 marker/mechanism 17963755 +CAT 847 Asthma MESH:D001249 marker/mechanism 18048809 +CAT 847 Autistic Disorder MESH:D001321 marker/mechanism 15205966 +CAT 847 Behcet Syndrome MESH:D001528 marker/mechanism 12074830 +CAT 847 Brain Ischemia MESH:D002545 marker/mechanism 17564305 +CAT 847 Breast Neoplasms MESH:D001943 marker/mechanism 25322848 +CAT 847 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 33010264 +CAT 847 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 11731445 +CAT 847 Cardiomyopathies MESH:D009202 therapeutic 11800590 +CAT 847 Cardiotoxicity MESH:D066126 therapeutic 35792220 +CAT 847 Cell Transformation, Neoplastic MESH:D002471 therapeutic 20516118|21742780|23518002|25448439|27323401|28881718 +CAT 847 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750|25231249 +CAT 847 Cholestasis MESH:D002779 marker/mechanism 27989131 +CAT 847 Chromosome Breakage MESH:D019457 therapeutic 25172298 +CAT 847 Depressive Disorder, Major MESH:D003865 marker/mechanism 20471444 +CAT 847 Diabetes Mellitus MESH:D003920 marker/mechanism 11117918 +CAT 847 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism|therapeutic 12123627|15855331|20709041 +CAT 847 Diabetes Mellitus, Type 1 MESH:D003922 therapeutic 15111504 +CAT 847 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism|therapeutic 15111504|15531508 +CAT 847 Diabetic Neuropathies MESH:D003929 marker/mechanism 10780678 +CAT 847 Disease Progression MESH:D018450 marker/mechanism|therapeutic 10673208|11283936|16081686 +CAT 847 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism 19109989 +CAT 847 Edema MESH:D004487 marker/mechanism 19874808 +CAT 847 Fatty Liver MESH:D005234 marker/mechanism 10860543 +CAT 847 Fetal Alcohol Spectrum Disorders MESH:D063647 therapeutic 26074427 +CAT 847 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 35764155 +CAT 847 Glioma MESH:D005910 marker/mechanism 21138464 +CAT 847 Heart Failure MESH:D006333 marker/mechanism 16105639 +CAT 847 Hepatitis MESH:D006505 marker/mechanism 1937386 +CAT 847 Hepatitis, Chronic MESH:D006521 marker/mechanism 25053573 +CAT 847 Hyperemia MESH:D006940 therapeutic 10792963 +CAT 847 Hypertension MESH:D006973 marker/mechanism 11479740|20667508|21593737|22228705 +CAT 847 Hyperthyroidism MESH:D006980 marker/mechanism 23391542 +CAT 847 Hypotension MESH:D007022 therapeutic 15612528 +CAT 847 Keratosis MESH:D007642 marker/mechanism 14580687 +CAT 847 Kidney Calculi MESH:D007669 marker/mechanism 24360074 +CAT 847 Kidney Failure, Chronic MESH:D007676 marker/mechanism 16518626|19420110 +CAT 847 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +CAT 847 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 27497885 +CAT 847 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 16081686 +CAT 847 Marfan Syndrome MESH:D008382 marker/mechanism 25101153 +CAT 847 Mesothelioma MESH:D008654 marker/mechanism 11283936 +CAT 847 Myocardial Infarction MESH:D009203 therapeutic 21600015 +CAT 847 Myocardial Reperfusion Injury MESH:D015428 therapeutic 21600015 +CAT 847 Necrosis MESH:D009336 therapeutic 17309078|9548797 +CAT 847 Neoplasm Invasiveness MESH:D009361 therapeutic 21749277|22580338 +CAT 847 Neoplasm Metastasis MESH:D009362 therapeutic 12538496|22580338|23518002 +CAT 847 Neoplasms MESH:D009369 therapeutic 21854796 +CAT 847 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29718361 +CAT 847 Osteoporosis, Postmenopausal MESH:D015663 marker/mechanism 17227729 +CAT 847 Phobic Disorders MESH:D010698 marker/mechanism 15309392 +CAT 847 Precancerous Conditions MESH:D011230 marker/mechanism 14580687 +CAT 847 Premature Birth MESH:D047928 marker/mechanism 26055944 +CAT 847 Protein Deficiency MESH:D011488 marker/mechanism 15865262 +CAT 847 Psoriasis MESH:D011565 marker/mechanism 12559600 +CAT 847 Pulmonary Edema MESH:D011654 therapeutic 15612528 +CAT 847 Pulmonary Embolism MESH:D011655 therapeutic 2510358 +CAT 847 Pulmonary Fibrosis MESH:D011658 therapeutic 19684199 +CAT 847 Reperfusion Injury MESH:D015427 marker/mechanism|therapeutic 16682413|23743330|23875703|8215636 +CAT 847 Rhinitis, Allergic MESH:D065631 marker/mechanism 29028686 +CAT 847 Seizures MESH:D012640 marker/mechanism|therapeutic 18096215|19616071|20592767 +CAT 847 Status Epilepticus MESH:D013226 marker/mechanism|therapeutic 15245787|15752349|17383094|18096215 +CAT 847 Stomach Ulcer MESH:D013276 therapeutic 1887894 +CAT 847 Turner Syndrome MESH:D014424 marker/mechanism 25101153 +CAT 847 Ureteral Calculi MESH:D014514 marker/mechanism 24360074 +CAT 847 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 35764155 +CAT-2 173411 Neurodegenerative Diseases MESH:D019636 marker/mechanism 18514411 +CAT-2 173411 Parkinsonian Disorders MESH:D020734 marker/mechanism 22483307 +CATSPER1 117144 Spermatogenic Failure 7 MESH:C567832 marker/mechanism 612997.0 +CATSPER2 117155 Deafness, Sensorineural, And Male Infertility MESH:C567010 marker/mechanism 611102.0 +CATSPER2 117155 Spermatogenic Failure 7 MESH:C567832 marker/mechanism 612997.0 +CAV1 857 Atrial Fibrillation MESH:D001281 marker/mechanism 20062060|22544366|29892015 +CAV1 857 Breast Neoplasms MESH:D001943 marker/mechanism 19234134|19288272|20562527|21501481 +CAV1 857 Carcinogenesis MESH:D063646 marker/mechanism 29247004 +CAV1 857 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 35622184 +CAV1 857 Cardiomegaly MESH:D006332 marker/mechanism 17487232 +CAV1 857 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 18266981 +CAV1 857 Familial Primary Pulmonary Hypertension MESH:D065627 marker/mechanism 615343.0 +CAV1 857 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 20835238 +CAV1 857 Hypertension MESH:D006973 marker/mechanism 1798635 +CAV1 857 Lipodystrophy, Congenital Generalized, Type 3 MESH:C567282 marker/mechanism 612526.0 +CAV1 857 Lipodystrophy, Familial Partial MESH:D052496 marker/mechanism 19793595 +CAV1 857 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7 OMIM:606721 marker/mechanism 606721.0 +CAV1 857 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CAV1 857 Lung Neoplasms MESH:D008175 marker/mechanism 29247004 +CAV1 857 Neoplasm Metastasis MESH:D009362 marker/mechanism 20562527 +CAV1 857 Ovarian Neoplasms MESH:D010051 therapeutic 15674352 +CAV1 857 Prostatic Neoplasms MESH:D011471 marker/mechanism 15948133|22159333 +CAV1 857 Pulmonary Fibrosis MESH:D011658 marker/mechanism 36053221 +CAV1 857 Silicosis MESH:D012829 marker/mechanism 36053221 +CAV1 857 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +CAV1 857 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +CAV1 857 Weight Gain MESH:D015430 marker/mechanism 19030233 +CAV2 858 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860 +CAV2 858 Atrial Fibrillation MESH:D001281 marker/mechanism 20062060 +CAV2 858 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 20835238 +CAV2 858 Prostatic Neoplasms MESH:D011471 marker/mechanism 15583422 +CAV3 859 Cardiomegaly MESH:D006332 marker/mechanism 19299911 +CAV3 859 Cardiomyopathy, Familial Hypertrophic, 1 MESH:C566005 marker/mechanism 192600.0 +CAV3 859 Chromosome 3, monosomy 3p25 MESH:C536807 marker/mechanism 21082655 +CAV3 859 CREATINE PHOSPHOKINASE, ELEVATED SERUM OMIM:123320 marker/mechanism 123320.0 +CAV3 859 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 18266981 +CAV3 859 Heart Defects, Congenital MESH:D006330 marker/mechanism 21082655 +CAV3 859 Long Qt Syndrome 9 MESH:C567515 marker/mechanism 611818.0 +CAV3 859 Muscular Dystrophies, Limb-Girdle MESH:D049288 marker/mechanism 12847114 +CAV3 859 Muscular Dystrophy, Limb-Girdle, Type 1C MESH:C563362 marker/mechanism 30055862 +CAV3 859 MYOPATHY, DISTAL, TATEYAMA TYPE OMIM:614321 marker/mechanism 614321.0 +CAV3 859 Rippling muscle disease, 1 MESH:C535686 marker/mechanism 606072.0 11431690|15668980|16247063|21294223|30055862 +CAVIN1 284119 Lipodystrophy, Congenital Generalized, Type 4 MESH:C567642 marker/mechanism 613327.0 +CAVIN1 284119 Methylmalonic acidemia MESH:C537358 marker/mechanism 16823967 +CAVIN1 284119 Weight Gain MESH:D015430 marker/mechanism 19030233 +CAVIN2 8436 Hirschsprung Disease MESH:D006627 marker/mechanism 25792468 +CBFB 865 Bone Diseases, Developmental MESH:D001848 marker/mechanism 17022082 +CBFB 865 Cleft Palate MESH:D002972 marker/mechanism 17022082 +CBFB 865 Heart Defects, Congenital MESH:D006330 marker/mechanism 17022082 +CBFB 865 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229|27798625 +CBFB 865 Leukemia, Myelomonocytic, Acute MESH:D015479 marker/mechanism 10958941 +CBFB 865 Ossification, Heterotopic MESH:D009999 marker/mechanism 17022082 +CBL 867 Cryptorchidism MESH:D003456 marker/mechanism 20694012 +CBL 867 Developmental Disabilities MESH:D002658 marker/mechanism 20694012 +CBL 867 Growth Disorders MESH:D006130 marker/mechanism 20694012 +CBL 867 Infertility, Male MESH:D007248 marker/mechanism 16301331 +CBL 867 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 607785.0 20694012|22315502|26457647 +CBL 867 NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA OMIM:613563 marker/mechanism 613563.0 +CBL 867 Vasculitis MESH:D014657 marker/mechanism 20694012 +CBLB 868 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 20453840 +CBLB 868 Multiple Sclerosis MESH:D009103 marker/mechanism 20453840 +CBLIF 2694 Intrinsic Factor Deficiency MESH:C563242 marker/mechanism 261000.0 +CBLIF 2694 Schizophrenia MESH:D012559 marker/mechanism 21822266 +CBLN2 147381 Hypertension, Pulmonary MESH:D006976 marker/mechanism 23502781 +CBR1 873 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CBR1 873 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21056497 +CBR1 873 Cardiomyopathies MESH:D009202 marker/mechanism 11016643 +CBR1 873 Colonic Neoplasms MESH:D003110 marker/mechanism 21056497 +CBR1 873 Dermatitis, Irritant MESH:D017453 therapeutic 25818598 +CBR1 873 Kidney Failure, Chronic MESH:D007676 marker/mechanism 26282591 +CBR1 873 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CBR2 12409 Lung Neoplasms MESH:D008175 marker/mechanism 18597497 +CBR3 874 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CBS 875 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CBS 875 Cardiovascular Diseases MESH:D002318 marker/mechanism 16791140 +CBS 875 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23665415 +CBS 875 Homocystinuria MESH:D006712 marker/mechanism 236200.0 +CBS 875 Hyperhomocysteinemia MESH:D020138 marker/mechanism 17292331|19028542|19204075 +CBS 875 Hypertension MESH:D006973 marker/mechanism 18224302 +CBS 875 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 17119116 +CBS 875 Malnutrition MESH:D044342 marker/mechanism 16709328 +CBS 875 Melanoma MESH:D008545 marker/mechanism 25205294 +CBX1 10951 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +CBX2 84733 46, XY Sex Reversal 5 MESH:C567766 marker/mechanism 613080.0 +CBX5 23468 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +CBX7 23492 Multiple Myeloma MESH:D009101 marker/mechanism 23955597 +CC2D1A 54862 Mental Retardation, Autosomal Recessive 3 MESH:C563929 marker/mechanism 608443.0 +CC2D2A 57545 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +CC2D2A 57545 Joubert Syndrome 9 MESH:C567364 marker/mechanism 612285.0 +CC2D2A 57545 Meckel Syndrome, Type 6 MESH:C567365 marker/mechanism 612284.0 +CCAR2 57805 Wallerian Degeneration MESH:D014855 marker/mechanism 24252177 +CCAT1 100507056 Colonic Neoplasms MESH:D003110 marker/mechanism 26752646 +CCAT1 100507056 Gallbladder Neoplasms MESH:D005706 marker/mechanism 26752646 +CCAT1 100507056 Lung Neoplasms MESH:D008175 marker/mechanism 26752646 +CCAT1 100507056 Pancreatic Neoplasms MESH:D010190 marker/mechanism 26752646 +CCAT1 100507056 Stomach Neoplasms MESH:D013274 marker/mechanism 26752646|31945315 +CCBE1 147372 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CCBE1 147372 Facies MESH:D019066 marker/mechanism 19935664 +CCBE1 147372 Hennekam lymphangiectasia lymphedema syndrome MESH:C537255 marker/mechanism 235510.0 19911200|19935664 +CCBE1 147372 Hydrops Fetalis MESH:D015160 marker/mechanism 19911200 +CCBE1 147372 Intellectual Disability MESH:D008607 marker/mechanism 19935664 +CCDC103 388389 CILIARY DYSKINESIA, PRIMARY, 17 OMIM:614679 marker/mechanism 614679.0 +CCDC103 388389 Kartagener Syndrome MESH:D007619 marker/mechanism 22581229 +CCDC115 84317 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo OMIM:616828 marker/mechanism 616828.0 +CCDC126 90693 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CCDC134 79879 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +CCDC134 79879 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +CCDC137 339230 Schizophrenia MESH:D012559 marker/mechanism 21743468 +CCDC141 285025 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 +CCDC174 51244 HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION OMIM:616816 marker/mechanism 616816.0 +CCDC180 100499483 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +CCDC22 28952 3C syndrome MESH:C535313 marker/mechanism 300963.0 +CCDC26 137196 Glioma MESH:D005910 marker/mechanism 19578367 +CCDC28B 79140 Bardet-Biedl syndrome 1 MESH:C537909 marker/mechanism 209900.0 +CCDC39 339829 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CCDC39 339829 CILIARY DYSKINESIA, PRIMARY, 14 OMIM:613807 marker/mechanism 613807.0 +CCDC40 55036 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CCDC40 55036 CILIARY DYSKINESIA, PRIMARY, 15 OMIM:613808 marker/mechanism 613808.0 +CCDC40 55036 Kartagener Syndrome MESH:D007619 marker/mechanism 21131974 +CCDC50 152137 Deafness, Autosomal Dominant 44 MESH:C564399 marker/mechanism 607453.0 +CCDC6 8030 Alzheimer Disease MESH:D000544 marker/mechanism 33589840 +CCDC6 8030 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +CCDC63 160762 Melanoma MESH:D008545 marker/mechanism 21499247 +CCDC65 85478 CILIARY DYSKINESIA, PRIMARY, 27 OMIM:615504 marker/mechanism 615504.0 +CCDC78 124093 Myopathies, Structural, Congenital MESH:D020914 marker/mechanism 614807.0 +CCDC80 151887 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +CCDC80 151887 Dermatitis, Atopic MESH:D003876 marker/mechanism 23042114 +CCDC86 79080 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 23828858 +CCDC88B 283234 Leprosy MESH:D007918 marker/mechanism 25642632 +CCDC88C 440193 Hydrocephalus MESH:D006849 marker/mechanism 236600.0 +CCDC88C 440193 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 616053.0 +CCDC91 55297 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CCDC92 80212 Coronary Disease MESH:D003327 marker/mechanism 28869590 +CCDC92 80212 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +CCHCR1 54535 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +CCHCR1 54535 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 29379198 +CCHCR1 54535 Prostatic Neoplasms MESH:D011471 marker/mechanism 21743467 +CCK 885 Anorexia MESH:D000855 marker/mechanism 22903826|24385417 +CCK 885 Catalepsy MESH:D002375 therapeutic 2862602|4040614 +CCK 885 Dyskinesia, Drug-Induced MESH:D004409 therapeutic 2320253 +CCK 885 Fever MESH:D005334 therapeutic 27565679 +CCK 885 Gallstones MESH:D042882 marker/mechanism 1631261 +CCK 885 Gastrointestinal Diseases MESH:D005767 therapeutic 7481522 +CCK 885 Hyperkinesis MESH:D006948 therapeutic 3561887|3735805 +CCK 885 Inflammation MESH:D007249 therapeutic 14599722 +CCK 885 Liver Diseases MESH:D008107 marker/mechanism 19784758 +CCK 885 Neurobehavioral Manifestations MESH:D019954 therapeutic 27565679 +CCK 885 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +CCK 885 Pancreatitis MESH:D010195 marker/mechanism 16187300|16499907 +CCK 885 Seizures MESH:D012640 therapeutic 6265841 +CCK 885 Stomach Ulcer MESH:D013276 marker/mechanism|therapeutic 10422768|10458643|11025360|11787760|15024038|9872509 +CCK 885 Unconsciousness MESH:D014474 marker/mechanism 6281507 +CCKAR 886 Alcoholism MESH:D000437 marker/mechanism 9922984 +CCKAR 886 Gallbladder Neoplasms MESH:D005706 marker/mechanism 25025063 +CCKBR 887 Cocaine-Related Disorders MESH:D019970 marker/mechanism 9922984 +CCKBR 887 Hyperalgesia MESH:D006930 marker/mechanism 11880531 +CCKBR 887 Obsessive-Compulsive Disorder MESH:D009771 marker/mechanism 8878350 +CCKBR 887 Panic Disorder MESH:D016584 marker/mechanism 8878350 +CCKBR 887 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 11880531|9496717 +CCL1 6346 Endometriosis MESH:D004715 marker/mechanism 30579999 +CCL1 6346 Glomerulonephritis MESH:D005921 marker/mechanism 10385480 +CCL1 6346 Hypertension, Pulmonary MESH:D006976 marker/mechanism 22507635 +CCL1 6346 Nephritis, Interstitial MESH:D009395 marker/mechanism 10385480 +CCL11 6356 Asthma MESH:D001249 marker/mechanism 600807.0 +CCL11 6356 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +CCL11 6356 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +CCL11 6356 Drug Hypersensitivity MESH:D004342 marker/mechanism 14616128 +CCL11 6356 Endometriosis MESH:D004715 marker/mechanism 30579999 +CCL11 6356 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CCL11 6356 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCL11 6356 Inflammation MESH:D007249 marker/mechanism 23707484 +CCL11 6356 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL11 6356 Polyomavirus Infections MESH:D027601 marker/mechanism 25162674 +CCL11 6356 Pulmonary Fibrosis MESH:D011658 marker/mechanism 16314464|17620002 +CCL11 6356 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +CCL12 20293 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +CCL12 20293 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 12388339 +CCL12 20293 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCL12 20293 Idiopathic Pulmonary Fibrosis MESH:D054990 therapeutic 28434932 +CCL12 20293 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL14 6358 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CCL17 6361 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +CCL17 6361 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCL17 6361 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL18 6362 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23349697 +CCL18 6362 Lung Neoplasms MESH:D008175 marker/mechanism 23349697 +CCL19 6363 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17597826 +CCL19 6363 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCL19 6363 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL2 6347 Asthma MESH:D001249 marker/mechanism 19373627 +CCL2 6347 Atherosclerosis MESH:D050197 marker/mechanism 12677255|12928151|20720404 +CCL2 6347 Brain Injuries MESH:D001930 marker/mechanism 21549006 +CCL2 6347 Brain Ischemia MESH:D002545 marker/mechanism 15829914|17394460 +CCL2 6347 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 12388339 +CCL2 6347 Calcinosis MESH:D002114 marker/mechanism 21193197|21335463 +CCL2 6347 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 25199511 +CCL2 6347 Cardiotoxicity MESH:D066126 marker/mechanism 29959987 +CCL2 6347 Cardiovascular Diseases MESH:D002318 marker/mechanism 16332659 +CCL2 6347 Carotid Artery Diseases MESH:D002340 marker/mechanism 18022660 +CCL2 6347 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +CCL2 6347 Coronary Artery Disease MESH:D003324 marker/mechanism 11500196|16934270 +CCL2 6347 Coronavirus Infections MESH:D018352 marker/mechanism 20484496 +CCL2 6347 COVID-19 MESH:D000086382 marker/mechanism 31986264 +CCL2 6347 Crohn Disease MESH:D003424 marker/mechanism 21829567 +CCL2 6347 Diabetic Nephropathies MESH:D003928 marker/mechanism 16374426 +CCL2 6347 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +CCL2 6347 Endometrial Neoplasms MESH:D016889 marker/mechanism 17380299 +CCL2 6347 Fatty Liver MESH:D005234 marker/mechanism 29684222 +CCL2 6347 Glomerulonephritis MESH:D005921 marker/mechanism 10385480 +CCL2 6347 Heart Failure MESH:D006333 marker/mechanism 29959987 +CCL2 6347 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +CCL2 6347 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +CCL2 6347 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 30418988 +CCL2 6347 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CCL2 6347 Hyperalgesia MESH:D006930 marker/mechanism 17881535 +CCL2 6347 Hyperglycemia MESH:D006943 marker/mechanism 29035695 +CCL2 6347 Hyperinsulinism MESH:D006946 marker/mechanism 29035695 +CCL2 6347 Hyperoxaluria MESH:D006959 marker/mechanism 16284884 +CCL2 6347 Hypersensitivity MESH:D006967 marker/mechanism 15585374|21625544 +CCL2 6347 Hypertension MESH:D006973 marker/mechanism 20667508|27292124 +CCL2 6347 Hypertension, Pulmonary MESH:D006976 marker/mechanism 15302794|30418988 +CCL2 6347 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism|therapeutic 12374626|23043544|25257527 +CCL2 6347 Inflammation MESH:D007249 marker/mechanism 14570645|19762220|20816778 +CCL2 6347 Inflammatory Breast Neoplasms MESH:D058922 marker/mechanism 32512068 +CCL2 6347 Influenza, Human MESH:D007251 marker/mechanism 23326326 +CCL2 6347 Insulin Resistance MESH:D007333 marker/mechanism 29035695 +CCL2 6347 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110|19539174 +CCL2 6347 Leishmaniasis, Cutaneous MESH:D016773 marker/mechanism 20102417 +CCL2 6347 Liver Cirrhosis MESH:D008103 marker/mechanism 20697377 +CCL2 6347 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15492853 +CCL2 6347 Liver Diseases MESH:D008107 marker/mechanism 17125873 +CCL2 6347 Lung Injury MESH:D055370 marker/mechanism 19762220 +CCL2 6347 Metabolic Syndrome MESH:D024821 marker/mechanism 16188961|18486454 +CCL2 6347 Mouth Neoplasms MESH:D009062 marker/mechanism 25199511 +CCL2 6347 Multiple Myeloma MESH:D009101 marker/mechanism 16918137 +CCL2 6347 Muscular Dystrophy, Duchenne MESH:D020388 marker/mechanism 21641384 +CCL2 6347 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948.0 +CCL2 6347 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CCL2 6347 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 12087064 +CCL2 6347 Neoplasm Invasiveness MESH:D009361 marker/mechanism 25199511|32512068 +CCL2 6347 Nephritis, Interstitial MESH:D009395 marker/mechanism 10385480 +CCL2 6347 Neural Tube Defects MESH:D009436 marker/mechanism 182940.0 +CCL2 6347 Obesity MESH:D009765 marker/mechanism 29035695 +CCL2 6347 Obstetric Labor, Premature MESH:D007752 marker/mechanism 18606702 +CCL2 6347 Pleural Diseases MESH:D010995 marker/mechanism 10923243 +CCL2 6347 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL2 6347 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 34652871 +CCL2 6347 Pulmonary Fibrosis MESH:D011658 marker/mechanism 16324872|17720292|26163174 +CCL2 6347 Reperfusion Injury MESH:D015427 marker/mechanism 12468449|15829914 +CCL2 6347 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +CCL2 6347 Retinal Degeneration MESH:D012162 marker/mechanism 20361964 +CCL2 6347 Schizophrenia MESH:D012559 marker/mechanism 18486454 +CCL2 6347 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 20484496 +CCL2 6347 Silicosis MESH:D012829 marker/mechanism 26163174 +CCL2 6347 Spinal Cord Compression MESH:D013117 marker/mechanism 15135227 +CCL2 6347 Spinal Dysraphism MESH:D016135 marker/mechanism 16596675 +CCL2 6347 Status Epilepticus MESH:D013226 marker/mechanism 19490431|20034406 +CCL2 6347 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +CCL2 6347 Thyroid Neoplasms MESH:D013964 marker/mechanism 26037280 +CCL2 6347 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 32512068 +CCL2 6347 Tuberculosis, Pulmonary MESH:D014397 marker/mechanism 16352737|18940815 +CCL2 6347 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +CCL20 6364 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +CCL20 6364 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +CCL20 6364 Colitis, Ulcerative MESH:D003093 marker/mechanism 16306769 +CCL20 6364 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +CCL20 6364 Diabetes Mellitus, Experimental MESH:D003921 therapeutic 21340626 +CCL20 6364 Diabetes Mellitus, Type 1 MESH:D003922 therapeutic 21340626 +CCL20 6364 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCL20 6364 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 30603057 +CCL20 6364 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +CCL20 6364 Neoplasm Metastasis MESH:D009362 marker/mechanism 30603057 +CCL20 6364 Pancreatic Neoplasms MESH:D010190 marker/mechanism 30603057 +CCL20 6364 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL20 6364 Skin Diseases MESH:D012871 marker/mechanism 16835338 +CCL20 6364 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +CCL21 6366 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 18794853|20453842|23143596 +CCL22 6367 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437|22125604 +CCL22 6367 Endometriosis MESH:D004715 marker/mechanism 30579999 +CCL22 6367 Lymphoproliferative Disorders MESH:D008232 marker/mechanism 35534561 +CCL23 6368 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +CCL24 6369 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +CCL24 6369 Drug Hypersensitivity MESH:D004342 marker/mechanism 14616128 +CCL24 6369 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCL24 6369 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL27 10850 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CCL27 10850 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +CCL3 6348 Atherosclerosis MESH:D050197 marker/mechanism 24370436 +CCL3 6348 Brain Ischemia MESH:D002545 marker/mechanism 15829914|17394460 +CCL3 6348 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16284949 +CCL3 6348 Colonic Neoplasms MESH:D003110 marker/mechanism 36346222 +CCL3 6348 COVID-19 MESH:D000086382 marker/mechanism 31986264 +CCL3 6348 Glomerulonephritis MESH:D005921 marker/mechanism 10385480 +CCL3 6348 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CCL3 6348 Hypersensitivity MESH:D006967 marker/mechanism 15585374|23624239 +CCL3 6348 Inflammation MESH:D007249 marker/mechanism 19762220 +CCL3 6348 Lung Injury MESH:D055370 marker/mechanism 19762220 +CCL3 6348 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +CCL3 6348 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CCL3 6348 Neoplasm Invasiveness MESH:D009361 marker/mechanism 36346222 +CCL3 6348 Pulmonary Fibrosis MESH:D011658 marker/mechanism 16324872|17720292 +CCL3 6348 Reperfusion Injury MESH:D015427 marker/mechanism 15829914 +CCL3 6348 Status Epilepticus MESH:D013226 marker/mechanism 19490431 +CCL3L1 6349 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CCL3L3 414062 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +CCL3L3 414062 Skin Diseases MESH:D012871 marker/mechanism 16835338 +CCL4 6351 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +CCL4 6351 Atherosclerosis MESH:D050197 marker/mechanism 24370436 +CCL4 6351 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +CCL4 6351 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +CCL4 6351 Glomerulonephritis MESH:D005921 marker/mechanism 10385480 +CCL4 6351 Hypersensitivity MESH:D006967 marker/mechanism 15585374|21625544 +CCL4 6351 Inflammation MESH:D007249 marker/mechanism 19762220 +CCL4 6351 Lung Injury MESH:D055370 marker/mechanism 19762220 +CCL4 6351 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CCL4 6351 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL4 6351 Polyomavirus Infections MESH:D027601 marker/mechanism 25162674 +CCL4 6351 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17720292 +CCL4 6351 Skin Diseases MESH:D012871 marker/mechanism 16835338 +CCL5 6352 Asthma MESH:D001249 marker/mechanism 8534483 +CCL5 6352 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +CCL5 6352 Glomerulonephritis MESH:D005921 marker/mechanism 10385480 +CCL5 6352 Hepatitis, Alcoholic MESH:D006519 marker/mechanism 12586603 +CCL5 6352 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +CCL5 6352 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CCL5 6352 Hyperoxaluria MESH:D006959 marker/mechanism 16284884 +CCL5 6352 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 12126966 +CCL5 6352 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CCL5 6352 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +CCL5 6352 Neoplasm Invasiveness MESH:D009361 marker/mechanism 18985009 +CCL5 6352 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17620002 +CCL6 20305 Calcinosis MESH:D002114 marker/mechanism 21335463 +CCL6 20305 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +CCL6 20305 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CCL6 20305 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +CCL7 6354 Cholestasis MESH:D002779 marker/mechanism 21224055 +CCL7 6354 Glomerulonephritis MESH:D005921 marker/mechanism 10385480 +CCL7 6354 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCL7 6354 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +CCL7 6354 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +CCL7 6354 Nephritis, Interstitial MESH:D009395 marker/mechanism 10385480 +CCL7 6354 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL8 6355 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +CCL8 6355 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCL8 6355 Influenza, Human MESH:D007251 marker/mechanism 23326326 +CCL8 6355 Nephrogenic Fibrosing Dermopathy MESH:D054989 marker/mechanism 20959327 +CCL8 6355 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL8 6355 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +CCL9 20308 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +CCL9 20308 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCL9 20308 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCL9 20308 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +CCM2 83605 Cerebral Cavernous Malformations 2 MESH:C566394 marker/mechanism 603284.0 +CCM2 83605 Hemangioma, Cavernous, Central Nervous System MESH:D020786 marker/mechanism 18154020 +CCN1 3491 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +CCN1 3491 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17699798 +CCN1 3491 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +CCN1 3491 Scleroderma, Systemic MESH:D012595 marker/mechanism 27482699 +CCN2 1490 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +CCN2 1490 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +CCN2 1490 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +CCN2 1490 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 30365097 +CCN2 1490 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +CCN2 1490 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CCN2 1490 Diabetes, Gestational MESH:D016640 marker/mechanism 34175429 +CCN2 1490 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 17121042 +CCN2 1490 Heart Failure MESH:D006333 marker/mechanism 17229371 +CCN2 1490 Hepatitis B, Chronic MESH:D019694 marker/mechanism 17657819 +CCN2 1490 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 20939759|21258935 +CCN2 1490 Hypertension MESH:D006973 marker/mechanism 16685210 +CCN2 1490 Infertility, Female MESH:D007247 marker/mechanism 21868453 +CCN2 1490 Liver Cirrhosis MESH:D008103 marker/mechanism 16652398|17657819|26396155 +CCN2 1490 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CCN2 1490 Lung Diseases MESH:D008171 marker/mechanism 20939759|21258935 +CCN2 1490 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +CCN2 1490 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 24154679 +CCN2 1490 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 21258935 +CCN2 1490 Pulmonary Fibrosis MESH:D011658 marker/mechanism 15298857|15677772|25815693|26817844 +CCN2 1490 Scleroderma, Systemic MESH:D012595 marker/mechanism 24706986 +CCN2A 321449 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +CCN4 8840 Neoplasm Metastasis MESH:D009362 marker/mechanism 30723155 +CCN4 8840 Paraquat lung MESH:C537171 marker/mechanism 35387687 +CCN6 8838 Arthropathy, progressive pseudorheumatoid, of childhood MESH:C535387 marker/mechanism 208230.0 +CCNA1 8900 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12029619 +CCNA1 8900 Papillomavirus Infections MESH:D030361 marker/mechanism 23358896 +CCNA1 8900 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 23358896|29464035 +CCNA2 890 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +CCNA2 890 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CCNA2 890 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 29464035 +CCNB1 891 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CCNB1 891 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 34837450 +CCNB1 891 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CCNB1 891 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 29464035 +CCNB2 9133 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CCNB2 9133 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CCNB3 85417 Osteosarcoma MESH:D012516 marker/mechanism 22387997 +CCND1 595 Adenocarcinoma MESH:D000230 marker/mechanism 26432044 +CCND1 595 Bowen's Disease MESH:D001913 marker/mechanism 29103775 +CCND1 595 Brain Neoplasms MESH:D001932 marker/mechanism 20932960|27935819 +CCND1 595 Breast Neoplasms MESH:D001943 marker/mechanism 12839951|17255770|19636701|20948315|23839043|25267515 +CCND1 595 Carcinoma MESH:D002277 marker/mechanism 12376462|14522882|16316942|17173897 +CCND1 595 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +CCND1 595 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12029619|19919837|22649188|25822088|26189965 +CCND1 595 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 26432044 +CCND1 595 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 12151359 +CCND1 595 Cecal Neoplasms MESH:D002430 marker/mechanism 14688030 +CCND1 595 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism|therapeutic 21726611|24362009 +CCND1 595 Clinical Deterioration MESH:D000075902 marker/mechanism 29464035 +CCND1 595 Colonic Neoplasms MESH:D003110 marker/mechanism 18283038|19147571|21081470|21188121 +CCND1 595 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +CCND1 595 Disease Progression MESH:D018450 marker/mechanism 29103775 +CCND1 595 Endometrial Neoplasms MESH:D016889 marker/mechanism 29232554 +CCND1 595 Esophageal Neoplasms MESH:D004938 marker/mechanism 12235107 +CCND1 595 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +CCND1 595 Genomic Instability MESH:D042822 marker/mechanism 8548770 +CCND1 595 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +CCND1 595 Hyperparathyroidism MESH:D006961 marker/mechanism 21541686 +CCND1 595 Hyperplasia MESH:D006965 marker/mechanism 12151359|21541686 +CCND1 595 Intestinal Polyps MESH:D007417 marker/mechanism 12584176 +CCND1 595 Kidney Neoplasms MESH:D007680 marker/mechanism 21693435 +CCND1 595 Leukemia MESH:D007938 marker/mechanism 10602166 +CCND1 595 Liver Neoplasms MESH:D008113 marker/mechanism 27064257 +CCND1 595 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 28100771 +CCND1 595 Lung Neoplasms MESH:D008175 marker/mechanism 11307925|16289808 +CCND1 595 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 22383795|26174628 +CCND1 595 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|14522882|16316942|17173897 +CCND1 595 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|14522882|16316942 +CCND1 595 Multiple Myeloma MESH:D009101 marker/mechanism 254500.0 23502783 +CCND1 595 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CCND1 595 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +CCND1 595 Neoplasms, Experimental MESH:D009374 marker/mechanism 20932960 +CCND1 595 Papilloma MESH:D010212 marker/mechanism 12151359 +CCND1 595 Precancerous Conditions MESH:D011230 marker/mechanism 12151359 +CCND1 595 Prostatic Neoplasms MESH:D011471 marker/mechanism 17606477 +CCND1 595 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +CCND1 595 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 26909611|29464035 +CCND1 595 Stomach Neoplasms MESH:D013274 marker/mechanism 21628965 +CCND1 595 Thyroid Neoplasms MESH:D013964 marker/mechanism 23811263 +CCND1 595 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 36115647 +CCND1 595 Urologic Neoplasms MESH:D014571 marker/mechanism 21040761 +CCND1 595 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 26432044 +CCND1 595 von Hippel-Lindau Disease MESH:D006623 marker/mechanism 193300.0 +CCND2 894 Cardiomegaly MESH:D006332 therapeutic 15576649 +CCND2 894 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +CCND2 894 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +CCND2 894 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24464100 +CCND2 894 Fibrosis MESH:D005355 therapeutic 16306446 +CCND2 894 Hydrocephalus MESH:D006849 marker/mechanism 29642246 +CCND2 894 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 27798625 +CCND2 894 Megalancephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome MESH:C566381 marker/mechanism 615938.0 24705253|29642246 +CCND2 894 Megalencephaly MESH:D058627 marker/mechanism 29642246 +CCND2 894 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CCND2 894 Ovarian Neoplasms MESH:D010051 marker/mechanism 17270028 +CCND2 894 Perisylvian syndrome MESH:C536658 marker/mechanism 29642246 +CCND2 894 Polydactyly, Postaxial MESH:C562429 marker/mechanism 29642246 +CCND2 894 Prostatic Neoplasms MESH:D011471 marker/mechanism 17016690 +CCND3 896 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 28671688 +CCNDBP1 23582 Liver Neoplasms, Experimental MESH:D008114 therapeutic 16501603 +CCNE1 898 Breast Neoplasms MESH:D001943 marker/mechanism 19385967|23624423 +CCNE1 898 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12029619|22634754 +CCNE1 898 Disease Progression MESH:D018450 marker/mechanism 19385967 +CCNE1 898 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +CCNE1 898 Ovarian Neoplasms MESH:D010051 marker/mechanism 21397856 +CCNE1 898 Recurrence MESH:D012008 marker/mechanism 19385967 +CCNE1 898 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 29464035 +CCNE1 898 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 20972438|27514407 +CCNE2 9134 Endometriosis MESH:D004715 marker/mechanism 20864642 +CCNE2 9134 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +CCNE2 9134 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CCNE2 9134 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 29464035 +CCNF 899 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CCNG1 900 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CCNG1 900 Lung Neoplasms MESH:D008175 marker/mechanism 16289808 +CCNH 902 Breast Neoplasms MESH:D001943 marker/mechanism 30705370 +CCNH 902 Carcinoma MESH:D002277 marker/mechanism 12606953 +CCNH 902 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +CCNH 902 Colonic Neoplasms MESH:D003110 marker/mechanism 30705370 +CCNH 902 Esophageal Neoplasms MESH:D004938 marker/mechanism 30705370 +CCNH 902 Glioblastoma MESH:D005909 marker/mechanism 30705370 +CCNH 902 Liver Neoplasms MESH:D008113 marker/mechanism 30705370 +CCNH 902 Lymphatic Metastasis MESH:D008207 marker/mechanism 30705370 +CCNH 902 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12606953 +CCNH 902 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12606953 +CCNH 902 Ovarian Neoplasms MESH:D010051 marker/mechanism 30705370 +CCNH 902 Prostatic Neoplasms MESH:D011471 marker/mechanism 30705370 +CCNO 10309 CILIARY DYSKINESIA, PRIMARY, 29 OMIM:615872 marker/mechanism 615872.0 +CCNO 10309 Lung Diseases, Obstructive MESH:D008173 marker/mechanism 24747639 +CCNQ 92002 Toe Syndactyly, Telecanthus, and Anogenital and Renal Malformations MESH:C567475 marker/mechanism 300707.0 18297069 +CCNY 219771 Colitis, Ulcerative MESH:D003093 marker/mechanism 18438405 +CCNY 219771 Crohn Disease MESH:D003424 marker/mechanism 18438405 +CCR1 1230 Behcet Syndrome MESH:D001528 marker/mechanism 23291587 +CCR1 1230 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16284949 +CCR1 1230 Colonic Neoplasms MESH:D003110 marker/mechanism 36346222 +CCR1 1230 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CCR1 1230 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCR1 1230 Liver Diseases MESH:D008107 marker/mechanism 19784758 +CCR1 1230 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCR10 2826 Status Epilepticus MESH:D013226 marker/mechanism 17181556 +CCR2 729230 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +CCR2 729230 COVID-19 MESH:D000086382 marker/mechanism 33307546 +CCR2 729230 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +CCR2 729230 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CCR2 729230 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCR2 729230 Liver Diseases MESH:D008107 marker/mechanism 12845637 +CCR2 729230 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCR2 729230 Pulmonary Fibrosis MESH:D011658 marker/mechanism 14609568 +CCR2 729230 Status Epilepticus MESH:D013226 marker/mechanism 19490431|20034406 +CCR3 1232 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 20485159 +CCR3 1232 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +CCR3 1232 HIV Infections MESH:D015658 marker/mechanism 10202824 +CCR3 1232 Pulmonary Fibrosis MESH:D011658 marker/mechanism 16314464 +CCR3 1232 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 20022477 +CCR3 1232 Status Epilepticus MESH:D013226 marker/mechanism 19490431 +CCR4 1233 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +CCR4 1233 Celiac Disease MESH:D002446 marker/mechanism 20190752 +CCR4 1233 Glioma MESH:D005910 marker/mechanism 17522861 +CCR4 1233 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +CCR4 1233 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +CCR4 1233 Sezary Syndrome MESH:D012751 marker/mechanism 26551670 +CCR5 1234 Acute Kidney Injury MESH:D058186 marker/mechanism 26055553 +CCR5 1234 Colonic Neoplasms MESH:D003110 marker/mechanism 36346222 +CCR5 1234 Colorectal Neoplasms MESH:D015179 marker/mechanism 35072892 +CCR5 1234 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +CCR5 1234 Diabetes Mellitus, Insulin-Dependent, 22 MESH:C567284 marker/mechanism 612522.0 +CCR5 1234 Disease Progression MESH:D018450 marker/mechanism 35072892 +CCR5 1234 Hepatitis C MESH:D006526 marker/mechanism 609532.0 +CCR5 1234 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CCR5 1234 Neoplasm Metastasis MESH:D009362 marker/mechanism 35072892 +CCR5 1234 Neoplasms, Experimental MESH:D009374 marker/mechanism 35072892 +CCR5 1234 Nephritis MESH:D009393 marker/mechanism 26055553 +CCR5 1234 West Nile Fever MESH:D014901 marker/mechanism 610379.0 +CCR6 1235 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453841|20453842|23143596 +CCR6 1235 Colitis, Ulcerative MESH:D003093 marker/mechanism 16306769 +CCR6 1235 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCR6 1235 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCR6 1235 Vitiligo MESH:D014820 marker/mechanism 20526340 +CCR7 1236 Crohn Disease MESH:D003424 marker/mechanism 36038634 +CCR7 1236 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +CCR7 1236 Status Epilepticus MESH:D013226 marker/mechanism 17181556 +CCR8 1237 Status Epilepticus MESH:D013226 marker/mechanism 17181556 +CCR9 10803 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CCR9 10803 Pneumonia MESH:D011014 marker/mechanism 21625544 +CCR9 10803 Status Epilepticus MESH:D013226 marker/mechanism 17181556 +CCRL2 9034 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +CCRL2 9034 Skin Diseases MESH:D012871 marker/mechanism 16835338 +CCS 9973 Deficiency Diseases MESH:D003677 marker/mechanism 12514262 +CCS 9973 Hepatitis, Chronic MESH:D006521 marker/mechanism 25053573 +CCSER1 401145 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +CCT2 10576 Osteoporosis MESH:D010024 marker/mechanism 18924182 +CCT3 7203 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CCT3 7203 HIV Infections MESH:D015658 marker/mechanism 15308739 +CCT5 22948 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +CCT5 22948 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +CCT5 22948 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CCT5 22948 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +CCT5 22948 HIV Infections MESH:D015658 marker/mechanism 15308739 +CCT5 22948 Neuropathy, Hereditary Sensory, with Spastic Paraplegia, Autosomal Recessive MESH:C564948 marker/mechanism 256840.0 +CCT6B 10693 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143597 +CCT7 10574 Acute Kidney Injury MESH:D058186 marker/mechanism 31825490 +CCT7 10574 Disease Progression MESH:D018450 marker/mechanism 21364753 +CCT7 10574 HIV Infections MESH:D015658 marker/mechanism 15308739 +CCT7 10574 Kidney Tubular Necrosis, Acute MESH:D007683 marker/mechanism 31825490 +CCT7 10574 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +CD109 135228 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +CD109 135228 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +CD14 929 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CD14 929 Asthma MESH:D001249 marker/mechanism 17607003 +CD14 929 Brain Injuries MESH:D001930 marker/mechanism 21549006 +CD14 929 Diarrhea MESH:D003967 marker/mechanism 21596674 +CD14 929 Eczema MESH:D004485 marker/mechanism 19759553 +CD14 929 Gout MESH:D006073 marker/mechanism 26462562 +CD14 929 Liver Cirrhosis MESH:D008103 marker/mechanism 20353583 +CD14 929 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 20353583 +CD14 929 Weight Loss MESH:D015431 marker/mechanism 28411859 +CD151 977 Nephropathy with Pretibial Epidermolysis Bullosa and Deafness MESH:C563798 marker/mechanism 609057.0 +CD163 9332 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CD163 9332 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CD163 9332 Carotid Artery Diseases MESH:D002340 marker/mechanism 17095719 +CD163 9332 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +CD163 9332 Hyperglycemia MESH:D006943 marker/mechanism 29035695 +CD163 9332 Hyperinsulinism MESH:D006946 marker/mechanism 29035695 +CD163 9332 Insulin Resistance MESH:D007333 marker/mechanism 29035695 +CD163 9332 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD163 9332 Obesity MESH:D009765 marker/mechanism 29035695 +CD163L1 283316 Melanoma MESH:D008545 marker/mechanism 22842228 +CD164 8763 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CD164 8763 DEAFNESS, AUTOSOMAL DOMINANT 66 OMIM:616969 marker/mechanism 616969.0 +CD19 930 Agammaglobulinemia MESH:D000361 marker/mechanism 16672701 +CD19 930 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 240500|613493 16672701 +CD2 914 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +CD2 914 Nephrotic Syndrome MESH:D009404 marker/mechanism 2465858 +CD2 914 Thrombosis MESH:D013927 marker/mechanism 16932337 +CD200R1 131450 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD200R2 271375 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD209 30835 COVID-19 MESH:D000086382 marker/mechanism 35255492 +CD209 30835 Dengue MESH:D003715 marker/mechanism 614371 15838506 +CD209 30835 Hepatitis C MESH:D006526 marker/mechanism 27385120 +CD209 30835 HIV Infections MESH:D015658 marker/mechanism 609423 15564514 +CD209 30835 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948 +CD209 30835 Tuberculosis, Pulmonary MESH:D014397 marker/mechanism 16379498 +CD226 10666 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CD226 10666 Colorectal Neoplasms MESH:D015179 marker/mechanism 16015041 +CD226 10666 Endometriosis MESH:D004715 marker/mechanism 20864642 +CD226 10666 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 26808113 +CD24 100133941 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD24 100133941 Pancreatic Neoplasms MESH:D010190 marker/mechanism 28369074 +CD244 51744 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 180300.0 18794858 +CD247 919 Immunodeficiency due to Defect in CD3-Zeta MESH:C565712 marker/mechanism 610163.0 +CD247 919 Scleroderma, Systemic MESH:D012595 marker/mechanism 20383147 +CD27 939 Cachexia MESH:D002100 marker/mechanism 17878525 +CD27 939 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 12031769 +CD27 939 LYMPHOPROLIFERATIVE SYNDROME 2 OMIM:615122 marker/mechanism 615122.0 +CD27 939 Myocarditis MESH:D009205 marker/mechanism 12031769 +CD27 939 Virus Diseases MESH:D014777 marker/mechanism 12031769 +CD274 29126 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 16611412 +CD274 29126 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22396772 +CD274 29126 Disease Progression MESH:D018450 marker/mechanism 27692344 +CD274 29126 Hypersensitivity MESH:D006967 marker/mechanism 20488241|23624239 +CD274 29126 Lung Neoplasms MESH:D008175 marker/mechanism 27692344|34166680 +CD274 29126 Lymphatic Metastasis MESH:D008207 marker/mechanism 16530813 +CD274 29126 Lymphoma MESH:D008223 marker/mechanism 28736328 +CD274 29126 Melanoma MESH:D008545 marker/mechanism 20143437 +CD274 29126 Neoplasms, Radiation-Induced MESH:D009381 marker/mechanism 28736328 +CD274 29126 Ovarian Neoplasms MESH:D010051 marker/mechanism 17360651 +CD274 29126 Recurrence MESH:D012008 marker/mechanism 22396772 +CD274 29126 Stomach Neoplasms MESH:D013274 marker/mechanism 16530813 +CD274 29126 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CD274 29126 Thymus Neoplasms MESH:D013953 marker/mechanism 28736328 +CD276 80381 Carcinoma, Hepatocellular MESH:D006528 therapeutic 16217749 +CD276 80381 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD276 80381 Prostatic Neoplasms MESH:D011471 marker/mechanism 30614027 +CD28 940 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19898481|20453842|23143596 +CD28 940 Autoimmune Diseases MESH:D001327 marker/mechanism 15494542|19077085 +CD28 940 Berylliosis MESH:D001607 marker/mechanism 12952926 +CD28 940 Chloracne MESH:D054506 marker/mechanism 17101203 +CD28 940 HIV Infections MESH:D015658 marker/mechanism 7492435 +CD28 940 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +CD28 940 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916|26258847 +CD28 940 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 26192916 +CD2AP 23607 Alzheimer Disease MESH:D000544 marker/mechanism 21460840|21460841|30320580 +CD2AP 23607 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 607832.0 +CD320 51293 METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT OMIM:613646 marker/mechanism 613646.0 +CD33 945 Alzheimer Disease MESH:D000544 marker/mechanism 21460840|21460841 +CD33 945 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 12921496 +CD34 947 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CD34 947 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22011395 +CD36 948 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 10981864 +CD36 948 Celiac Disease MESH:D002446 marker/mechanism 30097691 +CD36 948 Coronary Disease MESH:D003327 marker/mechanism 610938.0 +CD36 948 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +CD36 948 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 31626838 +CD36 948 Glucose Intolerance MESH:D018149 marker/mechanism 14640889 +CD36 948 Hypertension MESH:D006973 marker/mechanism 18587397 +CD36 948 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 15690042 +CD36 948 Insulin Resistance MESH:D007333 marker/mechanism 14640889 +CD36 948 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD36 948 Malaria MESH:D008288 marker/mechanism 611162.0 +CD36 948 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CD36 948 Platelet Glycoprotein IV Deficiency MESH:C564245 marker/mechanism 608404.0 +CD36 948 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +CD36 948 Staphylococcal Infections MESH:D013203 marker/mechanism 15690042 +CD36 948 Weight Gain MESH:D015430 marker/mechanism 19030233 +CD38 952 Albuminuria MESH:D000419 marker/mechanism 21992601 +CD38 952 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD38 952 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CD3D 915 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17597826 +CD3D 915 IMMUNODEFICIENCY 19 OMIM:615617 marker/mechanism 615617.0 +CD3D 915 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 18422935 +CD3D 915 Liver Diseases MESH:D008107 marker/mechanism 19784758 +CD3D 915 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +CD3D 915 Severe Combined Immunodeficiency MESH:D016511 marker/mechanism 15546002 +CD3E 916 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +CD3E 916 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +CD3E 916 IMMUNODEFICIENCY 18 OMIM:615615 marker/mechanism 615615.0 +CD3E 916 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 8490660 +CD3E 916 Inflammation MESH:D007249 marker/mechanism 22325453 +CD3E 916 Severe Combined Immunodeficiency MESH:D016511 marker/mechanism 15546002 +CD3G 917 IMMUNODEFICIENCY 17 OMIM:615607 marker/mechanism 615607.0 +CD4 920 AIDS-Related Opportunistic Infections MESH:D017088 marker/mechanism 9546790 +CD4 920 Graves Disease MESH:D006111 marker/mechanism 33132244 +CD4 920 Muscular Dystrophy, Duchenne MESH:D020388 marker/mechanism 21641384 +CD4 920 Nerve Degeneration MESH:D009410 marker/mechanism 9546790 +CD40 958 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 18794853|20453842|23143596 +CD40 958 Breast Neoplasms MESH:D001943 marker/mechanism 17043144 +CD40 958 Hodgkin Disease MESH:D006689 marker/mechanism 7621881 +CD40 958 Hyperglycemia MESH:D006943 marker/mechanism 29035695 +CD40 958 Hyper-IgM Immunodeficiency Syndrome MESH:D053306 marker/mechanism 606843.0 +CD40 958 Hyperinsulinism MESH:D006946 marker/mechanism 29035695 +CD40 958 Insulin Resistance MESH:D007333 marker/mechanism 29035695 +CD40 958 Mucocutaneous Lymph Node Syndrome MESH:D009080 marker/mechanism 22446961|22446962 +CD40 958 Multiple Sclerosis MESH:D009103 marker/mechanism 19525955 +CD40 958 Obesity MESH:D009765 marker/mechanism 29035695 +CD40 958 Status Epilepticus MESH:D013226 marker/mechanism 18455351 +CD40LG 959 Amyotrophic Lateral Sclerosis MESH:D000690 therapeutic 20348957 +CD40LG 959 Autoimmune Diseases MESH:D001327 marker/mechanism 15494542 +CD40LG 959 Chromosome Breakage MESH:D019457 marker/mechanism 27634759 +CD40LG 959 Coronary Artery Disease MESH:D003324 marker/mechanism 16368305 +CD40LG 959 Hodgkin Disease MESH:D006689 marker/mechanism 7621881|8656679 +CD40LG 959 Hyper-IgM Immunodeficiency Syndrome, Type 1 MESH:D053307 marker/mechanism 308230.0 15611226 +CD40LG 959 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CD40LG 959 Hypertension, Pulmonary MESH:D006976 marker/mechanism 15302794 +CD40LG 959 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 28793932 +CD40LG 959 Necrosis MESH:D009336 marker/mechanism 22295117 +CD40LG 959 Pneumonia MESH:D011014 marker/mechanism 21625544 +CD44 960 Acute Kidney Injury MESH:D058186 marker/mechanism 23052191 +CD44 960 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 28255344 +CD44 960 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +CD44 960 Colorectal Neoplasms, Hereditary Nonpolyposis MESH:D003123 marker/mechanism 28255344 +CD44 960 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CD44 960 Disease Progression MESH:D018450 marker/mechanism 34626302 +CD44 960 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +CD44 960 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 23098472 +CD44 960 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism|therapeutic 16208414|17349212 +CD44 960 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 21283680 +CD44 960 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +CD44 960 Neoplasm Metastasis MESH:D009362 marker/mechanism 23098472 +CD44 960 Nerve Degeneration MESH:D009410 marker/mechanism 15191797 +CD44 960 Neuroblastoma MESH:D009447 marker/mechanism 34626302 +CD44 960 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17446842 +CD44 960 Skin Diseases MESH:D012871 marker/mechanism 16835338 +CD44 960 Stomach Neoplasms MESH:D013274 marker/mechanism 21471434 +CD44 960 Vitiligo MESH:D014820 marker/mechanism 22561518 +CD46 4179 Atypical Hemolytic Uremic Syndrome MESH:D065766 marker/mechanism 612922.0 14615110 +CD46 4179 Measles MESH:D008457 marker/mechanism 8402913 +CD46 4179 Prostatic Neoplasms, Castration-Resistant MESH:D064129 marker/mechanism 30185663 +CD47 961 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +CD48 962 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD5 921 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +CD5 921 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18006695 +CD53 963 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +CD53 963 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD55 1604 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +CD55 1604 Endometriosis MESH:D004715 marker/mechanism 21063030 +CD55 1604 Protein-Losing Enteropathies MESH:D011504 marker/mechanism 226300.0 +CD58 965 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 24413734 +CD58 965 Multiple Sclerosis MESH:D009103 marker/mechanism 19525955|24076602 +CD59 966 CD59 Deficiency MESH:C567355 marker/mechanism 612300.0 +CD59 966 Kidney Diseases MESH:D007674 therapeutic 31618666 +CD59 966 Skin Manifestations MESH:D012877 marker/mechanism 31618666 +CD5L 922 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CD5L 922 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD6 923 Multiple Sclerosis MESH:D009103 marker/mechanism 19525953|24076602 +CD63 967 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD63 967 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +CD68 968 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CD68 968 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +CD68 968 Arthritis, Psoriatic MESH:D015535 marker/mechanism 19732956 +CD68 968 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +CD68 968 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 20388520 +CD68 968 Hyperinsulinism MESH:D006946 marker/mechanism 29035695 +CD68 968 Insulin Resistance MESH:D007333 marker/mechanism 29035695 +CD68 968 Ischemia MESH:D007511 marker/mechanism 19458120 +CD68 968 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19539174 +CD68 968 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD68 968 Obesity MESH:D009765 marker/mechanism 29035695 +CD69 969 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CD69 969 Arthritis MESH:D001168 therapeutic 12882836 +CD69 969 Arthritis, Experimental MESH:D001169 marker/mechanism 12882836 +CD69 969 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 19430480 +CD7 924 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CD7 924 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +CD7 924 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD70 970 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 12031769 +CD70 970 Myocarditis MESH:D009205 marker/mechanism 12031769 +CD70 970 Virus Diseases MESH:D014777 marker/mechanism 12031769 +CD74 972 Breast Neoplasms MESH:D001943 marker/mechanism 19602265 +CD74 972 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22919003 +CD74 972 Disease Progression MESH:D018450 marker/mechanism 34797429 +CD74 972 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD74 972 Liver Failure, Acute MESH:D017114 marker/mechanism 16799971 +CD79A 973 Agammaglobulinemia MESH:D000361 marker/mechanism 613501.0 +CD79A 973 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 25049379 +CD79B 974 Agammaglobulinemia MESH:D000361 marker/mechanism 612692.0 +CD79B 974 Liver Diseases MESH:D008107 marker/mechanism 19784758 +CD79B 974 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21173233 +CD80 941 Celiac Disease MESH:D002446 marker/mechanism 20190752 +CD80 941 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 21399635 +CD80 941 Vitiligo MESH:D014820 marker/mechanism 22561518 +CD81 975 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 613496.0 +CD81 975 Hepatitis C MESH:D006526 marker/mechanism 17517063 +CD82 3732 Abortion, Spontaneous MESH:D000022 marker/mechanism 20075392 +CD82 3732 Neoplasm Invasiveness MESH:D009361 therapeutic 20075392 +CD82 3732 Neoplasm Metastasis MESH:D009362 therapeutic 20075392 +CD83 9308 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +CD83 9308 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CD83 9308 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22446963 +CD83 9308 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD83 9308 Skin Diseases MESH:D012871 marker/mechanism 16835338 +CD84 8832 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CD86 942 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CD86 942 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +CD86 942 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CD86 942 Liver Diseases MESH:D008107 marker/mechanism 19784758 +CD86 942 Multiple Myeloma MESH:D009101 marker/mechanism 16611307 +CD8A 925 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CD8A 925 CD8 Deficiency, Familial MESH:C563824 marker/mechanism 608957.0 +CD8A 925 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 17950725 +CD8B 926 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CD9 928 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17043644 +CD9 928 Colorectal Neoplasms MESH:D015179 marker/mechanism 24836286 +CD9 928 Glioblastoma MESH:D005909 marker/mechanism 26573230 +CD9 928 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +CD9 928 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +CD9 928 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 16168501 +CD9 928 Nerve Degeneration MESH:D009410 marker/mechanism 19522546 +CD9 928 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CD96 10225 C SYNDROME OMIM:211750 marker/mechanism 211750.0 17847009 +CD96 10225 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +CD99 4267 Chondrosarcoma, Mesenchymal MESH:D018211 marker/mechanism 12817616 +CDA 978 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 10811482|25330770 +CDAN1 146059 Anemia, Dyserythropoietic, Congenital MESH:D000742 marker/mechanism 224120.0 +CDC14A 8556 Deafness MESH:D003638 marker/mechanism 29293958 +CDC14A 8556 Deafness, Autosomal Recessive 32 MESH:C563884 marker/mechanism 608653.0 27259055|29293958 +CDC14A 8556 Infertility, Male MESH:D007248 marker/mechanism 29293958 +CDC14A 8556 Oligospermia MESH:D009845 marker/mechanism 29293958 +CDC20 991 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDC25B 994 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +CDC25B 994 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +CDC25C 995 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDC27 996 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +CDC42 998 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 24747643 +CDC42 998 Carcinoma MESH:D002277 marker/mechanism 16316942 +CDC42 998 HIV Infections MESH:D015658 marker/mechanism 15308739 +CDC42 998 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +CDC42 998 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +CDC42 998 Necrosis MESH:D009336 marker/mechanism 19430526 +CDC42 998 TAKENOUCHI-KOSAKI SYNDROME OMIM:616737 marker/mechanism 616737.0 +CDC42BPB 9578 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +CDC42SE1 56882 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CDC45 8318 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDC45 8318 Meier-Gorlin syndrome MESH:C538012 marker/mechanism 617063.0 +CDC6 990 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDC6 990 Meier-Gorlin syndrome MESH:C538012 marker/mechanism 613805.0 21358632 +CDC6 990 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CDC73 79577 Hyperparathyroidism 1 MESH:C564166 marker/mechanism 145000.0 +CDC73 79577 Hyperparathyroidism 2 MESH:C563273 marker/mechanism 145001.0 +CDC73 79577 Parathyroid Neoplasms MESH:D010282 marker/mechanism 608266.0 +CDCA2 157313 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDCA3 83461 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDCA5 113130 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDCA7 83879 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3 OMIM:616910 marker/mechanism 616910.0 +CDCA7 83879 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +CDCA8 55143 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDCP1 64866 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CDH1 999 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 114480.0 17520682|19839049|23921149|24014025 +CDH1 999 Carcinoma MESH:D002277 marker/mechanism 16316942|17520682|8075649 +CDH1 999 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 17520682 +CDH1 999 Carcinoma, Ductal MESH:D044584 marker/mechanism 29295717 +CDH1 999 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 17660459|8557030 +CDH1 999 Carcinoma, Lobular MESH:D018275 marker/mechanism 17660459|8557030 +CDH1 999 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17520682 +CDH1 999 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24014025 +CDH1 999 Colitis, Ulcerative MESH:D003093 marker/mechanism 19915572 +CDH1 999 Colorectal Neoplasms MESH:D015179 marker/mechanism 10072428|19011631 +CDH1 999 Disease Progression MESH:D018450 marker/mechanism 19839049 +CDH1 999 Endometrial Neoplasms MESH:D016889 marker/mechanism 608089.0 8075649 +CDH1 999 Fibrosis MESH:D005355 marker/mechanism 31697999 +CDH1 999 Helicobacter Infections MESH:D016481 marker/mechanism 19184424 +CDH1 999 Kidney Diseases MESH:D007674 marker/mechanism 31697999 +CDH1 999 Liver Cirrhosis MESH:D008103 marker/mechanism 32659284 +CDH1 999 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 20118494|25319454 +CDH1 999 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +CDH1 999 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +CDH1 999 Mesothelioma MESH:D008654 marker/mechanism 15639718 +CDH1 999 Mycoplasma Infections MESH:D009175 marker/mechanism 20179380 +CDH1 999 Neoplasm Invasiveness MESH:D009361 marker/mechanism|therapeutic 19839049|22580338 +CDH1 999 Neoplasm Metastasis MESH:D009362 marker/mechanism 17520682|22580338 +CDH1 999 Neoplasm Seeding MESH:D009366 marker/mechanism 27224422 +CDH1 999 Neoplasms, Experimental MESH:D009374 marker/mechanism 27224422 +CDH1 999 Nerve Degeneration MESH:D009410 marker/mechanism 12387456 +CDH1 999 Ovarian Neoplasms MESH:D010051 marker/mechanism 167000.0 8075649 +CDH1 999 Pancreatic Neoplasms MESH:D010190 marker/mechanism 18223216 +CDH1 999 Precancerous Conditions MESH:D011230 marker/mechanism 19184424 +CDH1 999 Prostate cancer, familial MESH:C537243 marker/mechanism 14961571|16189707 +CDH1 999 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 22581815 +CDH1 999 Prostatic Neoplasms MESH:D011471 marker/mechanism 176807.0 16813949|22581815|29295717|29610475 +CDH1 999 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 17520682 +CDH1 999 Stomach Neoplasms MESH:D013274 marker/mechanism 137215.0 10072428|12588804|19168852|19184424|24816253|36914835|9537325 +CDH1 999 Ureteral Obstruction MESH:D014517 marker/mechanism 31697999 +CDH1 999 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 17520682|26901067 +CDH10 1008 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 28191889 +CDH10 1008 Autistic Disorder MESH:D001321 marker/mechanism 19404256 +CDH12 1010 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +CDH13 1012 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +CDH13 1012 Barrett Esophagus MESH:D001471 marker/mechanism 18729198 +CDH13 1012 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18425332|18553387|28284560 +CDH13 1012 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 18337602 +CDH13 1012 Esophageal Neoplasms MESH:D004938 marker/mechanism 18729198 +CDH13 1012 Lung Neoplasms MESH:D008175 marker/mechanism 18337602 +CDH13 1012 Prostatic Neoplasms MESH:D011471 marker/mechanism 17288544|18264096 +CDH13 1012 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CDH15 1013 Mental Retardation, Autosomal Dominant 3 MESH:C567241 marker/mechanism 612580.0 +CDH15 1013 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CDH17 1015 Asthma, Occupational MESH:D059366 marker/mechanism 25918132 +CDH2 1000 Breast Neoplasms MESH:D001943 marker/mechanism 27811057 +CDH2 1000 Disease Models, Animal MESH:D004195 marker/mechanism 27811057 +CDH2 1000 Disease Progression MESH:D018450 marker/mechanism 23876460 +CDH2 1000 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CDH2 1000 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27811057 +CDH2 1000 Neoplasm Metastasis MESH:D009362 marker/mechanism 23876460 +CDH2 1000 Nerve Degeneration MESH:D009410 marker/mechanism 12387456 +CDH2 1000 Status Epilepticus MESH:D013226 marker/mechanism 12125071 +CDH2 1000 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +CDH22 64405 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +CDH23 64072 Deafness, Autosomal Recessive 12 MESH:C563327 marker/mechanism 601386.0 +CDH23 64072 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +CDH23 64072 Usher syndrome, type 1D MESH:C536487 marker/mechanism 601067.0 +CDH3 1001 Colitis, Ulcerative MESH:D003093 marker/mechanism 19915572 +CDH3 1001 Ectodermal dysplasia, ectrodactyly, and macular dystrophy MESH:C536190 marker/mechanism 225280.0 +CDH3 1001 Juvenile macular degeneration and hypotrichosis MESH:C537698 marker/mechanism 601553.0 +CDH3 1001 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +CDH5 1003 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +CDH5 1003 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500 +CDH5 1003 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 18422935 +CDH5 1003 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CDH5 1003 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 28377727 +CDH5 1003 No-Reflow Phenomenon MESH:D054318 therapeutic 16824628 +CDH6 1004 Cachexia MESH:D002100 marker/mechanism 17878525 +CDH7 1005 Colorectal Neoplasms MESH:D015179 marker/mechanism 16015041 +CDH9 1007 Autistic Disorder MESH:D001321 marker/mechanism 19404256 +CDHR1 92211 CONE-ROD DYSTROPHY 15 OMIM:613660 marker/mechanism 613660.0 +CDHR3 222256 Asthma MESH:D001249 marker/mechanism 24241537 +CDIN1 84529 Anemia, Dyserythropoietic, Congenital MESH:D000742 marker/mechanism 615631.0 +CDK1 983 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDK1 983 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CDK1 983 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 19223503 +CDK12 51755 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +CDK13 8621 CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER OMIM:617360 marker/mechanism 617360.0 +CDK14 5218 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22922871 +CDK17 5128 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +CDK2 1017 Abortion, Habitual MESH:D000026 marker/mechanism 35038060 +CDK2 1017 Embryo Loss MESH:D020964 marker/mechanism 35038060 +CDK2 1017 Melanoma MESH:D008545 marker/mechanism 21559390 +CDK2 1017 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 29464035 +CDK2 1017 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 33727089 +CDK20 23552 Alcoholism MESH:D000437 marker/mechanism 18438686 +CDK2AP2 10263 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CDK4 1019 Brain Neoplasms MESH:D001932 marker/mechanism 20932960 +CDK4 1019 Brain Stem Neoplasms MESH:D020295 marker/mechanism 24098593 +CDK4 1019 Carcinoma MESH:D002277 marker/mechanism 12376462|14522882 +CDK4 1019 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 26189965 +CDK4 1019 Liposarcoma MESH:D008080 marker/mechanism|therapeutic 20601955|23569312 +CDK4 1019 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|14522882 +CDK4 1019 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|14522882|25221644 +CDK4 1019 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3 OMIM:609048 marker/mechanism 609048.0 +CDK4 1019 Neoplasms, Experimental MESH:D009374 marker/mechanism 20932960 +CDK4 1019 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 29464035 +CDK4 1019 Stomach Neoplasms MESH:D013274 marker/mechanism 21628965 +CDK4 1019 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 33727089 +CDK5 1020 LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA OMIM:616342 marker/mechanism 616342.0 +CDK5 1020 Tauopathies MESH:D024801 marker/mechanism 26945731 +CDK5R1 8851 Brain Diseases MESH:D001927 marker/mechanism 15665076 +CDK5R1 8851 Cognition Disorders MESH:D003072 marker/mechanism 17581637 +CDK5R1 8851 Nerve Degeneration MESH:D009410 marker/mechanism 17581637 +CDK5RAP2 55755 Microcephaly, Primary Autosomal Recessive, 3 MESH:C565746 marker/mechanism 604804.0 +CDK6 1021 Anemia MESH:D000740 marker/mechanism 28255017 +CDK6 1021 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 18794853 +CDK6 1021 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +CDK6 1021 Brain Stem Neoplasms MESH:D020295 marker/mechanism 24098593 +CDK6 1021 Chloracne MESH:D054506 marker/mechanism 17101203 +CDK6 1021 Chromosome Aberrations MESH:D002869 marker/mechanism 24736461 +CDK6 1021 Clinical Deterioration MESH:D000075902 marker/mechanism 29464035 +CDK6 1021 Glioblastoma MESH:D005909 marker/mechanism 20534551 +CDK6 1021 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +CDK6 1021 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 25221644 +CDK6 1021 Medulloblastoma MESH:D008527 marker/mechanism 19270706|23138228 +CDK6 1021 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +CDK6 1021 MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE OMIM:616080 marker/mechanism 616080.0 +CDK6 1021 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 24736461 +CDK6 1021 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 29464035 +CDK6 1021 Stroke MESH:D020521 marker/mechanism 29531354 +CDK6 1021 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 33727089 +CDK9 1025 Medulloblastoma MESH:D008527 marker/mechanism 31594641 +CDKAL1 54901 Acquired Hyperostosis Syndrome MESH:D020083 marker/mechanism 27936930 +CDKAL1 54901 Birth Weight MESH:D001724 marker/mechanism 23202124 +CDKAL1 54901 Body Weight MESH:D001835 marker/mechanism 22344219|22344221 +CDKAL1 54901 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 17460697|23104008|23202124 +CDKL2 8999 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 25333262 +CDKL2 8999 Disease Progression MESH:D018450 marker/mechanism 25333262 +CDKL2 8999 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 25333262 +CDKL2 8999 Neoplasm Metastasis MESH:D009362 marker/mechanism 25333262 +CDKL5 6792 Angelman Syndrome MESH:D017204 marker/mechanism 19241098 +CDKL5 6792 CDKL5 deficiency disorder MESH:C564064 marker/mechanism 300672.0 +CDKL5 6792 Epilepsy MESH:D004827 marker/mechanism 29942082 +CDKL5 6792 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +CDKL5 6792 Rett Syndrome MESH:D015518 marker/mechanism 19241098 +CDKL5 6792 Seizures MESH:D012640 marker/mechanism 22264704 +CDKN1A 1026 Abortion, Habitual MESH:D000026 marker/mechanism 35038060 +CDKN1A 1026 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +CDKN1A 1026 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 12151359|18640142 +CDKN1A 1026 Colonic Neoplasms MESH:D003110 marker/mechanism 20876807 +CDKN1A 1026 Diabetic Nephropathies MESH:D003928 marker/mechanism 27652271 +CDKN1A 1026 Embryo Loss MESH:D020964 marker/mechanism 35038060 +CDKN1A 1026 Esophageal Squamous Cell Carcinoma MESH:D000077277 therapeutic 15375580 +CDKN1A 1026 HIV Infections MESH:D015658 marker/mechanism 12878215 +CDKN1A 1026 Hypertrophy MESH:D006984 marker/mechanism 27652271 +CDKN1A 1026 Intestinal Neoplasms MESH:D007414 marker/mechanism|therapeutic 11535846|12468628 +CDKN1A 1026 Kidney Diseases MESH:D007674 marker/mechanism 16968891 +CDKN1A 1026 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CDKN1A 1026 Liver Neoplasms MESH:D008113 marker/mechanism 33010264 +CDKN1A 1026 Lung Neoplasms MESH:D008175 marker/mechanism 12466968|18508827 +CDKN1A 1026 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 11453316 +CDKN1A 1026 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 12868502 +CDKN1A 1026 Papilloma MESH:D010212 marker/mechanism 12151359 +CDKN1A 1026 Prostatic Neoplasms MESH:D011471 marker/mechanism 12727815|15598783 +CDKN1A 1026 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 35303175 +CDKN1A 1026 Reperfusion Injury MESH:D015427 marker/mechanism 16968891 +CDKN1A 1026 Stomach Neoplasms MESH:D013274 marker/mechanism 14647439 +CDKN1A 1026 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 18640142 +CDKN1B 1027 Adenoma, Liver Cell MESH:D018248 marker/mechanism 17620307 +CDKN1B 1027 Breast Neoplasms MESH:D001943 marker/mechanism 17092400 +CDKN1B 1027 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20698225 +CDKN1B 1027 Chloracne MESH:D054506 marker/mechanism 17101203 +CDKN1B 1027 Helicobacter Infections MESH:D016481 marker/mechanism 15138205 +CDKN1B 1027 Intestinal Neoplasms MESH:D007414 marker/mechanism 24185511 +CDKN1B 1027 Kidney Neoplasms MESH:D007680 marker/mechanism 21693435 +CDKN1B 1027 Liver Neoplasms MESH:D008113 marker/mechanism 16391232 +CDKN1B 1027 Lung Neoplasms MESH:D008175 marker/mechanism 12466968|16391232|20512841 +CDKN1B 1027 Mesothelioma MESH:D008654 marker/mechanism 18301454 +CDKN1B 1027 Multiple Endocrine Neoplasia, Type IV MESH:C567059 marker/mechanism 610755.0 +CDKN1B 1027 Neuroendocrine Tumors MESH:D018358 marker/mechanism 24185511 +CDKN1B 1027 Ovarian Neoplasms MESH:D010051 marker/mechanism 16391232 +CDKN1B 1027 Pituitary Neoplasms MESH:D010911 marker/mechanism 16391232 +CDKN1B 1027 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +CDKN1B 1027 Prostatic Intraepithelial Neoplasia MESH:D019048 therapeutic 20932324 +CDKN1B 1027 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 12727815|20932324|29610475 +CDKN1B 1027 Rectal Neoplasms MESH:D012004 marker/mechanism 15525823 +CDKN1B 1027 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +CDKN1B 1027 Stomach Neoplasms MESH:D013274 marker/mechanism 15138205 +CDKN1B 1027 Uterine Neoplasms MESH:D014594 marker/mechanism 16391232 +CDKN1C 1028 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +CDKN1C 1028 Beckwith-Wiedemann Syndrome MESH:D001506 marker/mechanism 130650.0 22634751 +CDKN1C 1028 Endometrial Hyperplasia MESH:D004714 marker/mechanism 22064387 +CDKN1C 1028 Endometrial Neoplasms MESH:D016889 marker/mechanism 22064387 +CDKN1C 1028 Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies MESH:C564543 marker/mechanism 614732.0 22634751 +CDKN1C 1028 Lung Neoplasms MESH:D008175 marker/mechanism 20512841|21552421 +CDKN1C 1028 Melanoma MESH:D008545 marker/mechanism 17145863 +CDKN2A 1029 Adenocarcinoma MESH:D000230 marker/mechanism 20135361 +CDKN2A 1029 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 23525077 +CDKN2A 1029 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 24747643 +CDKN2A 1029 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 24747642 +CDKN2A 1029 Bone Diseases MESH:D001847 marker/mechanism 30259626 +CDKN2A 1029 Brain Neoplasms MESH:D001932 marker/mechanism 15144691|16860786 +CDKN2A 1029 Brain Stem Neoplasms MESH:D020295 marker/mechanism 24098593 +CDKN2A 1029 Breast Neoplasms MESH:D001943 marker/mechanism 20948315 +CDKN2A 1029 Carcinogenesis MESH:D063646 marker/mechanism 21526190 +CDKN2A 1029 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 25822088|28284560|33010264 +CDKN2A 1029 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 18337602|19375815 +CDKN2A 1029 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 24986516 +CDKN2A 1029 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 25125259 +CDKN2A 1029 Chromosome Deletion MESH:D002872 marker/mechanism 21526190 +CDKN2A 1029 Colorectal Neoplasms MESH:D015179 marker/mechanism 31004929 +CDKN2A 1029 Esophageal Neoplasms MESH:D004938 marker/mechanism 18410530 +CDKN2A 1029 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +CDKN2A 1029 Fluoride Poisoning MESH:D005458 marker/mechanism 30259626 +CDKN2A 1029 Glaucoma MESH:D005901 marker/mechanism 21532571 +CDKN2A 1029 Glioma MESH:D005910 marker/mechanism 15814359|19578367 +CDKN2A 1029 Liver Neoplasms MESH:D008113 marker/mechanism 12378512|16317707|27064257|33010264 +CDKN2A 1029 Lung Neoplasms MESH:D008175 marker/mechanism 11872642|12115568|18337602|20135361 +CDKN2A 1029 Lymphatic Metastasis MESH:D008207 marker/mechanism 29426936 +CDKN2A 1029 Lymphoma MESH:D008223 marker/mechanism 9488045 +CDKN2A 1029 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21325069 +CDKN2A 1029 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +CDKN2A 1029 Melanoma MESH:D008545 marker/mechanism 24495407|29426936 +CDKN2A 1029 Melanoma astrocytoma syndrome MESH:C536149 marker/mechanism 155755.0 +CDKN2A 1029 Melanoma, Cutaneous Malignant MESH:C562393 marker/mechanism 22080950 +CDKN2A 1029 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2 OMIM:155601 marker/mechanism 155601.0 +CDKN2A 1029 Melanoma-Pancreatic Cancer Syndrome MESH:C563985 marker/mechanism 606719.0 +CDKN2A 1029 Mesothelioma MESH:D008654 marker/mechanism 18379362 +CDKN2A 1029 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 19223589|21526190|29112861 +CDKN2A 1029 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 26410583 +CDKN2A 1029 Mouth Neoplasms MESH:D009062 marker/mechanism 24991542 +CDKN2A 1029 Multiple Myeloma MESH:D009101 marker/mechanism 16008847 +CDKN2A 1029 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +CDKN2A 1029 Neoplasm Invasiveness MESH:D009361 marker/mechanism 24495407 +CDKN2A 1029 Neoplasms MESH:D009369 marker/mechanism 11544531|19223589 +CDKN2A 1029 Nerve Sheath Neoplasms MESH:D018317 marker/mechanism 25240281 +CDKN2A 1029 Neuroblastoma MESH:D009447 marker/mechanism 15814359 +CDKN2A 1029 Pancreatic Neoplasms MESH:D010190 marker/mechanism 10627132|26098869 +CDKN2A 1029 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 23872714 +CDKN2A 1029 Poisoning MESH:D011041 marker/mechanism 20044985 +CDKN2A 1029 Precancerous Conditions MESH:D011230 marker/mechanism 24991542 +CDKN2A 1029 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 20453839 +CDKN2A 1029 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 35303175 +CDKN2A 1029 Sezary Syndrome MESH:D012751 marker/mechanism 26551670 +CDKN2A 1029 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 24991542|26192916|26909611 +CDKN2A 1029 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +CDKN2A 1029 Thymoma MESH:D013945 marker/mechanism 24974848 +CDKN2A 1029 Translocation, Genetic MESH:D014178 marker/mechanism 21325069|21526190 +CDKN2A 1029 Trisomy MESH:D014314 marker/mechanism 21526190 +CDKN2A 1029 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism|therapeutic 12973940|15987713 +CDKN2A 1029 Urogenital Neoplasms MESH:D014565 marker/mechanism 17300232 +CDKN2A 1029 Vulvar Lichen Sclerosus MESH:D007724 marker/mechanism 17300232 +CDKN2AIPNL 91368 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CDKN2B 1030 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 33010264 +CDKN2B 1030 Coronary Artery Disease MESH:D003324 marker/mechanism 23104008|34961328 +CDKN2B 1030 Glaucoma MESH:D005901 marker/mechanism 21532571 +CDKN2B 1030 Glioma MESH:D005910 marker/mechanism 19578366|19578367 +CDKN2B 1030 Liver Neoplasms MESH:D008113 marker/mechanism 33010264 +CDKN2B 1030 Lymphoma MESH:D008223 marker/mechanism 9488045 +CDKN2B 1030 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 17294728 +CDKN2B 1030 Poisoning MESH:D011041 marker/mechanism 20044985 +CDKN2B-AS1 100048912 Chromosome Breakage MESH:D019457 therapeutic 28117929 +CDKN2B-AS1 100048912 Endometriosis MESH:D004715 marker/mechanism 20601957 +CDKN2B-AS1 100048912 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 21532571 +CDKN2B-AS1 100048912 Heart Failure MESH:D006333 marker/mechanism 36071497 +CDKN2B-AS1 100048912 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 23770605 +CDKN2B-AS1 100048912 Mouth Neoplasms MESH:D009062 marker/mechanism 27749845 +CDKN2B-AS1 100048912 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 28117929 +CDKN2C 1031 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDKN2D 1032 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +CDKN3 1033 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDKN3 1033 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CDO1 1036 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23665415 +CDO1 1036 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CDON 50937 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +CDON 50937 HOLOPROSENCEPHALY 11 OMIM:614226 marker/mechanism 614226.0 +CDR3 8163 CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3 OMIM:602197 marker/mechanism 602197.0 +CDS1 1040 Carcinoma MESH:D002277 marker/mechanism 16316942 +CDS1 1040 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +CDS1 1040 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +CDS1 1040 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +CDSN 1041 HYPOTRICHOSIS 2 OMIM:146520 marker/mechanism 146520.0 +CDSN 1041 Peeling Skin Syndrome MESH:C564818 marker/mechanism 270300.0 +CDT1 81620 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CDT1 81620 Meier-Gorlin syndrome MESH:C538012 marker/mechanism 613804.0 21358632 +CDT1 81620 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 35048507 +CDX2 1045 Colonic Neoplasms MESH:D003110 marker/mechanism 29439001 +CDX2 1045 Precancerous Conditions MESH:D011230 marker/mechanism 29439001 +CDX2 1045 Stomach Neoplasms MESH:D013274 marker/mechanism 35674868 +CDY1 9085 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +CDY2A 9426 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +CDYL 9425 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +CEACAM1 634 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CEACAM1 634 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +CEACAM1 634 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +CEACAM16 388551 DEAFNESS, AUTOSOMAL DOMINANT 4B OMIM:614614 marker/mechanism 614614.0 +CEACAM20 125931 Carcinoma, Ehrlich Tumor MESH:D002286 marker/mechanism 34605108 +CEACAM5 1048 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CEACAM6 4680 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CEACAM6 4680 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +CEBPA 1050 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16288022|21785164 +CEBPA 1050 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17510391|21346772 +CEBPA 1050 Emphysema MESH:D004646 therapeutic 29078374 +CEBPA 1050 Head and Neck Neoplasms MESH:D006258 marker/mechanism 17510391 +CEBPA 1050 Infertility, Female MESH:D007247 marker/mechanism 21177758 +CEBPA 1050 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 18987666|19822134|30420649 +CEBPA 1050 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism|therapeutic 16788101|26285909 +CEBPA 1050 Neoplasms, Radiation-Induced MESH:D009381 marker/mechanism 21346772 +CEBPA 1050 Obesity MESH:D009765 marker/mechanism 28242765 +CEBPA 1050 Precancerous Conditions MESH:D011230 marker/mechanism 21785164 +CEBPA 1050 Pre-Eclampsia MESH:D011225 marker/mechanism 34398343 +CEBPA 1050 Pulmonary Fibrosis MESH:D011658 therapeutic 29078374 +CEBPA 1050 Skin Neoplasms MESH:D012878 marker/mechanism 21346772 +CEBPA-DT 80054 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +CEBPB 1051 Adenocarcinoma MESH:D000230 marker/mechanism 34973135 +CEBPB 1051 Brain Injuries MESH:D001930 marker/mechanism 21549006 +CEBPB 1051 Brain Ischemia MESH:D002545 marker/mechanism 17394460 +CEBPB 1051 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 14563831 +CEBPB 1051 Cardiomegaly MESH:D006332 therapeutic 29266779 +CEBPB 1051 Disease Progression MESH:D018450 marker/mechanism 34973135 +CEBPB 1051 Fatty Liver MESH:D005234 marker/mechanism 24469900 +CEBPB 1051 Fibrosis MESH:D005355 therapeutic 29266779 +CEBPB 1051 Infertility, Female MESH:D007247 marker/mechanism 21177758 +CEBPB 1051 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17177178 +CEBPB 1051 Stomach Neoplasms MESH:D013274 marker/mechanism 34973135 +CEBPD 1052 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 14563831 +CEBPD 1052 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17234736 +CEBPD 1052 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CEBPD 1052 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CEBPD 1052 Prolactinoma MESH:D015175 marker/mechanism 21980073 +CEBPE 1053 Leukemia, Promyelocytic, Acute MESH:D015473 therapeutic 16788101 +CEBPE 1053 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 19684604 +CEBPE 1053 Specific Granule Deficiency MESH:C562873 marker/mechanism 245480.0 28369034 +CECR 1055 Abnormalities, Multiple MESH:D000015 marker/mechanism 11693792 +CECR 1055 Craniofacial Abnormalities MESH:D019465 marker/mechanism 11693792 +CECR 1055 Eye Abnormalities MESH:D005124 marker/mechanism 11693792 +CECR 1055 Schmid-Fraccaro syndrome MESH:C535918 marker/mechanism 115470.0 11693792 +CECR2 27443 Neural Tube Defects MESH:D009436 marker/mechanism 15640247 +CED-4 175643 Nerve Degeneration MESH:D009410 marker/mechanism 23106139 +CEL 1056 Maturity-Onset Diabetes of the Young, Type 8, with Exocrine Dysfunction MESH:C565225 marker/mechanism 609812.0 +CEL 1056 Pancreatitis, Chronic MESH:D050500 marker/mechanism 25774637 +CELA1 1990 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +CELA1 1990 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +CELA2A 63036 Atherosclerosis MESH:D050197 marker/mechanism 31358993 +CELA2A 63036 Hypertension MESH:D006973 marker/mechanism 21602471 +CELA2A 63036 Metabolic Syndrome MESH:D024821 marker/mechanism 31358993 +CELA3B 23436 Exocrine Pancreatic Insufficiency MESH:D010188 marker/mechanism 14687815 +CELF2 10659 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CELF2 10659 Prostatic Neoplasms MESH:D011471 marker/mechanism 28319090 +CELF2 10659 Schizophrenia MESH:D012559 marker/mechanism 21822266 +CELF2 10659 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +CELP 1057 Pancreatitis, Chronic MESH:D050500 marker/mechanism 25774637 +CELSR2 1952 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +CELSR2 1952 Endometrial Hyperplasia MESH:D004714 marker/mechanism 22248470 +CELSR3 1951 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CEMIP2 23670 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CENPA 1058 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CENPCP1 1061 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +CENPE 1062 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CENPE 1062 MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE OMIM:616051 marker/mechanism 616051.0 +CENPF 1063 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +CENPF 1063 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CENPF 1063 Jejunal Atresia with Microcephaly and Ocular Anomalies MESH:C565460 marker/mechanism 243605.0 +CENPF 1063 Prostatic Neoplasms MESH:D011471 marker/mechanism 29581250 +CENPJ 55835 Microcephaly, Primary Autosomal Recessive, 6 MESH:C564247 marker/mechanism 608393.0 +CENPJ 55835 SECKEL SYNDROME 4 OMIM:613676 marker/mechanism 613676.0 +CENPK 64105 Prostatic Neoplasms, Castration-Resistant MESH:D064129 marker/mechanism 29581250 +CENPM 79019 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CENPU 79682 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CENPW 387103 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CEP120 153241 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 616300.0 +CEP131 22994 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CEP135 9662 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE OMIM:614673 marker/mechanism 614673.0 +CEP152 22995 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE OMIM:614852 marker/mechanism 614852.0 +CEP152 22995 Seckel syndrome 1 MESH:C537533 marker/mechanism 21131973 +CEP164 22897 NEPHRONOPHTHISIS 15 OMIM:614845 marker/mechanism 614845.0 +CEP19 84984 MORBID OBESITY AND SPERMATOGENIC FAILURE OMIM:615703 marker/mechanism 615703.0 +CEP290 80184 Bardet-Biedl Syndrome MESH:D020788 marker/mechanism 18327255 +CEP290 80184 Bardet-Biedl Syndrome 14 MESH:C567141 marker/mechanism 615991.0 +CEP290 80184 Joubert syndrome 5 MESH:C537688 marker/mechanism 610188.0 +CEP290 80184 Leber Congenital Amaurosis 10 MESH:C565720 marker/mechanism 611755.0 +CEP290 80184 Meckel Syndrome, Type 4 MESH:C567003 marker/mechanism 611134.0 +CEP290 80184 Senior-Loken Syndrome 6 MESH:C565708 marker/mechanism 610189.0 +CEP41 95681 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21438139 +CEP55 55165 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CEP55 55165 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CEP57 9702 Mosaic variegated aneuploidy syndrome MESH:C536987 marker/mechanism 614114.0 21552266|28553959 +CEP63 80254 Microcephaly MESH:D008831 marker/mechanism 21983783 +CEP68 23177 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +CEP78 84131 CONE-ROD DYSTROPHY AND HEARING LOSS 1 OMIM:617236 marker/mechanism 617236.0 +CEP83 51134 NEPHRONOPHTHISIS 18 OMIM:615862 marker/mechanism 615862.0 +CERK 64781 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CERKL 375298 Retinitis Pigmentosa 26 MESH:C564249 marker/mechanism 608380.0 +CERS1 10715 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 616230.0 +CERS3 204219 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9 OMIM:615023 marker/mechanism 615023.0 +CERS6 253782 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CERT1 10087 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427 +CERT1 10087 Epilepsy MESH:D004827 marker/mechanism 29942082 +CERT1 10087 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 34 OMIM:616351 marker/mechanism 616351.0 +CERT1 10087 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +CES1 1066 Brain Injuries MESH:D001930 marker/mechanism 23159883 +CES1 1066 Cocaine-Related Disorders MESH:D019970 therapeutic 12679808|12773168 +CES1 1066 Hypercholesterolemia MESH:D006937 therapeutic 12773168 +CES1 1066 Lung Neoplasms MESH:D008175 marker/mechanism 17114358|17311802 +CES1 1066 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 18485328 +CES1 1066 Obesity MESH:D009765 marker/mechanism 20975297 +CES1 1066 Opioid-Related Disorders MESH:D009293 therapeutic 12679808 +CES1C 13884 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +CES1C 13884 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +CES1F 234564 Lung Neoplasms MESH:D008175 marker/mechanism 17311802 +CES1G 12623 Fatty Liver MESH:D005234 marker/mechanism 24597639 +CES1G 12623 Hyperlipidemias MESH:D006949 marker/mechanism 24597639 +CES1G 12623 Obesity MESH:D009765 marker/mechanism 24597639 +CES2 8824 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CES2 8824 Cocaine-Related Disorders MESH:D019970 therapeutic 19710369 +CES2 8824 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 19931604 +CES2 8824 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CES3 23491 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CES3 23491 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CES3 23491 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CES3 23491 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +CETP 1071 Atherosclerosis MESH:D050197 therapeutic 28096968 +CETP 1071 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CETP 1071 Cardiovascular Diseases MESH:D002318 marker/mechanism 16544732 +CETP 1071 Disease Models, Animal MESH:D004195 therapeutic 28096968 +CETP 1071 Dyslipidemias MESH:D050171 marker/mechanism 17952847 +CETP 1071 HYPERALPHALIPOPROTEINEMIA 1 OMIM:143470 marker/mechanism 143470.0 +CETP 1071 Hyperlipidemias MESH:D006949 marker/mechanism 10519734 +CETP 1071 Hyperlipoproteinemias MESH:D006951 marker/mechanism 2215607|8408659 +CETP 1071 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 16030523 +CETP 1071 Hypertension MESH:D006973 marker/mechanism 20511482 +CETP 1071 Hypertriglyceridemia MESH:D015228 marker/mechanism 12754275 +CETP 1071 Pediatric Obesity MESH:D063766 marker/mechanism 25137265 +CFAP20 29105 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CFAP298 56683 CILIARY DYSKINESIA, PRIMARY, 26 OMIM:615500 marker/mechanism 615500.0 +CFAP410 755 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 27455348 +CFAP418 157657 BARDET-BIEDL SYNDROME 21 OMIM:617406 marker/mechanism 617406.0 +CFAP418 157657 CONE-ROD DYSTROPHY 16 OMIM:614500 marker/mechanism 614500.0 +CFAP418 157657 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 +CFAP43 80217 Hydrocephalus, Normal Pressure MESH:D006850 marker/mechanism 236690.0 +CFAP45 25790 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +CFAP53 220136 HETEROTAXY, VISCERAL, 6, AUTOSOMAL OMIM:614779 marker/mechanism 614779.0 +CFAP65 255101 Schizophrenia MESH:D012559 marker/mechanism 21822266 +CFB 629 Atypical Hemolytic Uremic Syndrome MESH:D065766 marker/mechanism 612924.0 17182750 +CFB 629 Brain Injuries MESH:D001930 marker/mechanism 17474994 +CFB 629 Chemically-Induced Disorders MESH:D064419 marker/mechanism 35999755 +CFB 629 Colitis, Ulcerative MESH:D003093 marker/mechanism 35999755 +CFB 629 COMPLEMENT FACTOR B DEFICIENCY OMIM:615561 marker/mechanism 615561.0 +CFB 629 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838195 +CFB 629 Macular Degeneration MESH:D008268 marker/mechanism 16518403 +CFB 629 MACULAR DEGENERATION, AGE-RELATED, 14 OMIM:615489 marker/mechanism 615489.0 +CFB 629 Myasthenia Gravis MESH:D009157 marker/mechanism 6605118 +CFC1 55997 Double Outlet Right Ventricle MESH:D004310 marker/mechanism 11799476 +CFC1 55997 HETEROTAXY, VISCERAL, 2, AUTOSOMAL OMIM:605376 marker/mechanism 605376.0 +CFC1 55997 Transposition of Great Vessels MESH:D014188 marker/mechanism 11799476 +CFD 1675 Asbestosis MESH:D001195 marker/mechanism 22832039 +CFD 1675 Complement Factor D Deficiency MESH:C565027 marker/mechanism 613912.0 +CFD 1675 Endometriosis MESH:D004715 marker/mechanism 21063030 +CFD 1675 Glomerulonephritis MESH:D005921 marker/mechanism 14675043 +CFD 1675 Heart Failure MESH:D006333 marker/mechanism 26670611 +CFD 1675 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 11457876|16527897 +CFD 1675 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CFD 1675 Meningococcal Infections MESH:D008589 marker/mechanism 16527897 +CFD 1675 Neisseriaceae Infections MESH:D016870 marker/mechanism 11457876 +CFD 1675 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +CFD 1675 Pulmonary Fibrosis MESH:D011658 marker/mechanism 22832039 +CFH 3075 Atypical Hemolytic Uremic Syndrome MESH:D065766 marker/mechanism 235400.0 14978182|22019782 +CFH 3075 Basal Laminar Drusen MESH:C563034 marker/mechanism 126700.0 +CFH 3075 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CFH 3075 Complement Factor H Deficiency MESH:C562875 marker/mechanism 609814.0 +CFH 3075 Glomerulonephritis, Membranoproliferative MESH:D015432 marker/mechanism 14978182 +CFH 3075 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 14978182 +CFH 3075 Macular Degeneration MESH:D008268 marker/mechanism 16518403|16754848|17554167|21909106|22019782|26691988 +CFH 3075 Macular Degeneration, Age-Related, 4 MESH:C565196 marker/mechanism 610698.0 +CFH 3075 Meningococcal Infections MESH:D008589 marker/mechanism 20694013 +CFHR1 3078 Atypical Hemolytic Uremic Syndrome MESH:D065766 marker/mechanism 235400.0 +CFHR1 3078 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +CFHR1 3078 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 21399633 +CFHR1 3078 Macular Degeneration, Age-Related, 1 MESH:C566411 marker/mechanism 603075.0 +CFHR1 3078 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +CFHR3 10878 Atypical Hemolytic Uremic Syndrome MESH:D065766 marker/mechanism 235400.0 +CFHR3 10878 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 21399633 +CFHR3 10878 Macular Degeneration, Age-Related, 1 MESH:C566411 marker/mechanism 603075.0 +CFHR3 10878 Meningococcal Infections MESH:D008589 marker/mechanism 20694013 +CFHR5 81494 C3 GLOMERULOPATHY 3 OMIM:614809 marker/mechanism 614809.0 +CFHR5 81494 Cholestasis MESH:D002779 marker/mechanism 27989131 +CFI 3426 Atypical Hemolytic Uremic Syndrome MESH:D065766 marker/mechanism 612923.0 +CFI 3426 Complement Factor I Deficiency MESH:C572568 marker/mechanism 610984.0 +CFI 3426 Macular Degeneration MESH:D008268 marker/mechanism 23685748|24036952|26691988 +CFI 3426 MACULAR DEGENERATION, AGE-RELATED, 13 OMIM:615439 marker/mechanism 615439.0 +CFL1 1072 Breast Neoplasms MESH:D001943 marker/mechanism 20562527 +CFL1 1072 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +CFL1 1072 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +CFL1 1072 Neoplasm Metastasis MESH:D009362 marker/mechanism 20562527 +CFL1 1072 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +CFL1 1072 Spinal Dysraphism MESH:D016135 marker/mechanism 17352815 +CFL2 1073 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +CFL2 1073 Nemaline Myopathy 7 MESH:C565198 marker/mechanism 610687.0 +CFLAR 8837 Hodgkin Disease MESH:D006689 marker/mechanism 17659339 +CFLAR 8837 Leukemia MESH:D007938 marker/mechanism 12970779 +CFLAR 8837 Lymphoma, Extranodal NK-T-Cell MESH:D054391 marker/mechanism 15924153 +CFLAR 8837 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 16105982 +CFLAR 8837 Pancreatic Neoplasms MESH:D010190 marker/mechanism 20876774 +CFM1 10167 CYSTIC FIBROSIS, MODIFIER OF, 1 OMIM:603855 marker/mechanism 603855.0 +CFP 5199 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CFP 5199 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CFP 5199 Meningitis, Meningococcal MESH:D008585 marker/mechanism 10909851|8530058 +CFP 5199 Properdin deficiency, X-linked MESH:C537241 marker/mechanism 312060.0 10909851|8530058 +CFP 5199 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +CFTR 1080 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CFTR 1080 Azoospermia MESH:D053713 marker/mechanism 10856487 +CFTR 1080 Bronchiectasis With Or Without Elevated Sweat Chloride 1 MESH:C567618 marker/mechanism 211400.0 +CFTR 1080 Choledochal Cyst MESH:D015529 marker/mechanism 18988797 +CFTR 1080 Colorectal Neoplasms MESH:D015179 marker/mechanism 22294766 +CFTR 1080 Congenital bilateral aplasia of vas deferens MESH:C535984 marker/mechanism 277180.0 10875853|11119745 +CFTR 1080 Cystic Fibrosis MESH:D003550 marker/mechanism 219700.0 11401894|11786964|16463024|16763370|1718974|17290305|17347447|17541014|18230692|19309154|19846789|21083385|21303308|21602569|31251792|7560099 +CFTR 1080 Hereditary pancreatitis MESH:C537262 marker/mechanism 167800.0 +CFTR 1080 Hereditary renal agenesis MESH:C536482 marker/mechanism 11119745 +CFTR 1080 Hernia, Diaphragmatic MESH:D006548 therapeutic 16473863 +CFTR 1080 Infertility, Male MESH:D007248 marker/mechanism 17823699|18554162 +CFTR 1080 Pancreatitis MESH:D010195 marker/mechanism 18360295|23143602 +CFTR 1080 Pancreatitis, Chronic MESH:D050500 marker/mechanism 18206817 +CFTR 1080 Polycystic Kidney, Autosomal Recessive MESH:D017044 marker/mechanism 18988797 +CFTR 1080 Rhinitis MESH:D012220 marker/mechanism 16083808 +CFTR 1080 Sinusitis MESH:D012852 marker/mechanism 16083808 +CFTR 1080 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CGA 1081 Adrenal Gland Diseases MESH:D000307 therapeutic 20146381 +CGA 1081 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +CGA 1081 Disease Progression MESH:D018450 marker/mechanism 10566621 +CGA 1081 Hemiplegia MESH:D006429 marker/mechanism 10566621 +CGA 1081 Oligospermia MESH:D009845 therapeutic 16483355 +CGA 1081 Ovarian Diseases MESH:D010049 therapeutic 20146381 +CGA 1081 Thyroid cancer, follicular MESH:C572845 marker/mechanism 10566621 +CGA 1081 Uterine Diseases MESH:D014591 therapeutic 20146381 +CGB1 114335 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CGB3 1082 Fetal Resorption MESH:D005327 therapeutic 3816235 +CGB3 1082 Hypogonadism MESH:D007006 therapeutic 8263139|9334596 +CGB5 93659 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CGN 57530 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CGNL1 84952 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CGREF1 10669 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +CHADL 150356 Osteoarthritis, Hip MESH:D015207 marker/mechanism 28319091|30374069 +CHAF1A 10036 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +CHAF1B 8208 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CHAF1B 8208 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +CHAMP1 283489 NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED LANGUAGE, AND DYSMORPHIC FEATURES OMIM:616579 marker/mechanism 616579.0 +CHAT 1103 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHAT 1103 Congenital myasthenic syndrome with episodic apnea MESH:C535759 marker/mechanism 254210.0 +CHAT 1103 Glaucoma, Angle-Closure MESH:D015812 marker/mechanism 27064256 +CHAT 1103 Reperfusion Injury MESH:D015427 marker/mechanism 23075401 +CHAT 1103 Retinal Diseases MESH:D012164 marker/mechanism 23075401 +CHAT 1103 Seizures MESH:D012640 marker/mechanism 19941057 +CHC-1 176434 Infertility MESH:D007246 marker/mechanism 31369748 +CHCHD10 400916 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2 OMIM:615911 marker/mechanism 615911.0 +CHCHD10 400916 MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT OMIM:616209 marker/mechanism 616209.0 +CHCHD10 400916 SPINAL MUSCULAR ATROPHY, JOKELA TYPE OMIM:615048 marker/mechanism 615048.0 +CHCHD2 51142 PARKINSON DISEASE 22, AUTOSOMAL DOMINANT OMIM:616710 marker/mechanism 616710.0 +CHCHD3 54927 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CHD1 1105 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +CHD1 1105 Memory Disorders MESH:D008569 marker/mechanism 30728766 +CHD1 1105 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +CHD1L 9557 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CHD2 1106 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 28191889 +CHD2 1106 Epilepsy MESH:D004827 marker/mechanism 23708187|29942082 +CHD2 1106 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 615369.0 +CHD2 1106 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +CHD3 1107 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +CHD3 1107 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +CHD3 1107 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +CHD4 1108 Autistic Disorder MESH:D001321 marker/mechanism 30559488 +CHD4 1108 Developmental Disabilities MESH:D002658 marker/mechanism 30559488 +CHD4 1108 Endometrial Neoplasms MESH:D016889 marker/mechanism 23104009 +CHD4 1108 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 35362730 +CHD4 1108 Lung Neoplasms MESH:D008175 marker/mechanism 30008631 +CHD4 1108 Schizophrenia MESH:D012559 marker/mechanism 21743468 +CHD4 1108 Stomach Neoplasms MESH:D013274 marker/mechanism 35362730 +CHD5 26038 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +CHD5 26038 Neuroblastoma MESH:D009447 marker/mechanism 26121086 +CHD5 26038 Recurrence MESH:D012008 marker/mechanism 26121086 +CHD6 84181 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 21822268 +CHD6 84181 Neuroblastoma MESH:D009447 marker/mechanism 18577749 +CHD6 84181 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +CHD6 84181 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21822268 +CHD7 55636 CHARGE Syndrome MESH:D058747 marker/mechanism 214800.0 16615981|21532573 +CHD7 55636 Kallmann Syndrome MESH:D017436 marker/mechanism 612370.0 +CHD7 55636 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +CHD8 57680 Anxiety Disorders MESH:D001008 marker/mechanism 35365720 +CHD8 57680 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24998929|28191889|30670789 +CHD8 57680 Autistic Disorder MESH:D001321 marker/mechanism 615032.0 25961944|35982159 +CHD8 57680 Facies MESH:D019066 marker/mechanism 30670789 +CHD8 57680 Gastrointestinal Diseases MESH:D005767 marker/mechanism 24998929 +CHD8 57680 Intellectual Disability MESH:D008607 marker/mechanism 30670789 +CHD8 57680 Megalencephaly MESH:D058627 marker/mechanism 24998929|30670789 +CHDH 55349 Heart Failure MESH:D006333 marker/mechanism 36071497 +CHEK1 1111 Breast Neoplasms MESH:D001943 marker/mechanism 25688741 +CHEK1 1111 Polyploidy MESH:D011123 marker/mechanism 25123929 +CHEK2 11200 Breast Neoplasms MESH:D001943 marker/mechanism 11967536|12690581|15122511|18297428 +CHEK2 11200 Breast Neoplasms, Male MESH:D018567 marker/mechanism 11967536 +CHEK2 11200 Colorectal Neoplasms MESH:D015179 marker/mechanism 12690581 +CHEK2 11200 Disease Progression MESH:D018450 marker/mechanism 21364753 +CHEK2 11200 Li-Fraumeni Syndrome MESH:D016864 marker/mechanism 10617473|11719428 +CHEK2 11200 Li-Fraumeni Syndrome 2 MESH:C563755 marker/mechanism 609265.0 +CHEK2 11200 Lung Neoplasms MESH:D008175 marker/mechanism 24880342 +CHEK2 11200 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 26506619 +CHEK2 11200 Neoplasms, Squamous Cell MESH:D018307 marker/mechanism 24880342 +CHEK2 11200 Neuroblastoma MESH:D009447 marker/mechanism 23334666 +CHEK2 11200 Osteosarcoma MESH:D012516 marker/mechanism 259500.0 11746983 +CHEK2 11200 Prostate cancer, familial MESH:C537243 marker/mechanism 12533788 +CHEK2 11200 Prostatic Neoplasms MESH:D011471 marker/mechanism 176807.0 12533788 +CHEK2 11200 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +CHES1 555843 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CHFR 55743 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 20705357 +CHFR 55743 Endometrial Neoplasms MESH:D016889 marker/mechanism 17143476 +CHFR 55743 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +CHGA 1113 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21595568 +CHGA 1113 Pheochromocytoma MESH:D010673 marker/mechanism 11116123 +CHI3L1 1116 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7 OMIM:611960 marker/mechanism 611960.0 +CHI3L1 1116 Glioblastoma MESH:D005909 marker/mechanism 21029458 +CHI3L1 1116 Glioma MESH:D005910 marker/mechanism 20506295 +CHI3L1 1116 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21029458 +CHI3L1 1116 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +CHI3L1 1116 Schizophrenia MESH:D012559 marker/mechanism 181500.0 +CHIA 27159 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CHIC2 26511 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +CHIT1 1118 Gaucher Disease MESH:D005776 marker/mechanism 17464953 +CHKA 1119 Spinal Dysraphism MESH:D016135 marker/mechanism 17184542 +CHKB 1120 Muscular Dystrophy, Congenital, Megaconial Type MESH:C566527 marker/mechanism 602541.0 +CHKB 1120 Narcolepsy MESH:D009290 marker/mechanism 18820697 +CHL1 10752 Intellectual Disability MESH:D008607 marker/mechanism 12812975 +CHL1 10752 Schizophrenia MESH:D012559 marker/mechanism 11986985|15653271 +CHM 1121 Choroideremia MESH:D015794 marker/mechanism 303100.0 +CHMP1A 5119 PONTOCEREBELLAR HYPOPLASIA, TYPE 8 OMIM:614961 marker/mechanism 614961.0 +CHMP2B 25978 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 16807408 +CHMP2B 25978 Frontotemporal Dementia MESH:D057180 marker/mechanism 16041373 +CHMP2B 25978 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 7 OMIM:600795 marker/mechanism 600795.0 +CHMP2B 25978 Frontotemporal Lobar Degeneration MESH:D057174 marker/mechanism 17956895 +CHMP4B 128866 Cataract, posterior polar, 3 MESH:C535343 marker/mechanism 605387.0 +CHMP4C 92421 Ovarian Neoplasms MESH:D010051 marker/mechanism 23535730|31043753 +CHMP5 51510 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17708794 +CHN1 1123 Duane Retraction Syndrome MESH:D004370 marker/mechanism 604356.0 +CHN2 1124 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +CHN2 1124 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +CHP 43690 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +CHPT1 56994 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 16292752 +CHRDL1 91851 Megalocornea MESH:C562829 marker/mechanism 309300.0 +CHRM1 1128 Brain Ischemia MESH:D002545 marker/mechanism 18501976 +CHRM1 1128 Epilepsy MESH:D004827 marker/mechanism 18333967 +CHRM1 1128 Memory Disorders MESH:D008569 marker/mechanism 21682298 +CHRM1 1128 Seizures MESH:D012640 marker/mechanism 10069499|11392617|12091480|12713643|8028781 +CHRM2 1129 Bradycardia MESH:D001919 marker/mechanism 11181912 +CHRM2 1129 Brain Injuries MESH:D001930 marker/mechanism 23159883 +CHRM2 1129 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 18603373 +CHRM2 1129 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 18603373 +CHRM2 1129 Diabetic Neuropathies MESH:D003929 therapeutic 20624991 +CHRM2 1129 Epilepsy MESH:D004827 marker/mechanism 18333967 +CHRM2 1129 Substance-Related Disorders MESH:D019966 marker/mechanism 20393457 +CHRM2 1129 Urinary Bladder, Neurogenic MESH:D001750 therapeutic 20624991 +CHRM2A 352938 Bradycardia MESH:D001919 marker/mechanism 12411408 +CHRM3 1131 Ascites MESH:D001201 marker/mechanism 20197374 +CHRM3 1131 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20197374 +CHRM3 1131 Cryptorchidism MESH:D003456 marker/mechanism 22077972 +CHRM3 1131 Liver Cirrhosis MESH:D008103 marker/mechanism 20197374 +CHRM3 1131 Prune Belly Syndrome MESH:D011535 marker/mechanism 100100.0 22077972 +CHRM3 1131 Urinary Bladder Diseases MESH:D001745 marker/mechanism 22077972 +CHRM4 1132 Catatonia MESH:D002389 therapeutic 15273762 +CHRM4 1132 Tremor MESH:D014202 marker/mechanism 9920179 +CHRM5 1133 Cocaine-Related Disorders MESH:D019970 marker/mechanism 13130510 +CHRM5 1133 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 12154229 +CHRNA1 1134 Fibrosis MESH:D005355 marker/mechanism 19690163 +CHRNA1 1134 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE OMIM:253290 marker/mechanism 253290.0 +CHRNA1 1134 Myasthenic Syndrome, Congenital, Fast-Channel MESH:C563832 marker/mechanism 608930.0 +CHRNA1 1134 Myasthenic syndrome, congenital, postsynaptic slow-channel MESH:C536091 marker/mechanism 601462.0 +CHRNA2 1135 Epilepsy, Nocturnal Frontal Lobe, Type 4 MESH:C563679 marker/mechanism 610353.0 19383498 +CHRNA2 1135 Lung Neoplasms MESH:D008175 marker/mechanism 28604730 +CHRNA3 1136 Alcoholism MESH:D000437 marker/mechanism 18414406 +CHRNA3 1136 Lung Neoplasms MESH:D008175 marker/mechanism 612052.0 18385738 +CHRNA3 1136 Seizures MESH:D012640 marker/mechanism 15275829 +CHRNA3 1136 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 20372150|20418890 +CHRNA3 1136 Tobacco Use Disorder MESH:D014029 marker/mechanism 18414406|29666375 +CHRNA4 1137 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 21748252 +CHRNA4 1137 Autistic Disorder MESH:D001321 marker/mechanism 15046869 +CHRNA4 1137 Developmental Disabilities MESH:D002658 marker/mechanism 20805988 +CHRNA4 1137 Dystonia MESH:D004421 marker/mechanism 19404753 +CHRNA4 1137 Epilepsy, Frontal Lobe MESH:D017034 marker/mechanism 12823585|14996991|17881519 +CHRNA4 1137 Epilepsy, Nocturnal Frontal Lobe, Type 1 MESH:C563930 marker/mechanism 600513.0 +CHRNA4 1137 Inflammation MESH:D007249 therapeutic 20943775 +CHRNA4 1137 Nervous System Diseases MESH:D009422 marker/mechanism 20805988 +CHRNA4 1137 Seizures MESH:D012640 marker/mechanism 10942032|16339034 +CHRNA4 1137 Sleep Wake Disorders MESH:D012893 marker/mechanism 16339034 +CHRNA4 1137 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 188890.0 +CHRNA5 1138 Alcoholism MESH:D000437 marker/mechanism 18414406 +CHRNA5 1138 Anxiety Disorders MESH:D001008 marker/mechanism 19220484|29944862 +CHRNA5 1138 Lung Neoplasms MESH:D008175 marker/mechanism 612052.0 18385738 +CHRNA5 1138 Seizures MESH:D012640 marker/mechanism 14996991|9495872 +CHRNA5 1138 Substance-Related Disorders MESH:D019966 marker/mechanism 20438829 +CHRNA5 1138 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 18184829 +CHRNA5 1138 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 20372150 +CHRNA5 1138 Tobacco Use Disorder MESH:D014029 marker/mechanism 18414406|18519132|28472521 +CHRNA6 8973 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 19644040 +CHRNA6 8973 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 20418888 +CHRNA6 8973 Tobacco Use Disorder MESH:D014029 marker/mechanism 28851948 +CHRNA7 1139 Alzheimer Disease MESH:D000544 marker/mechanism 18071042 +CHRNA7 1139 Auditory Perceptual Disorders MESH:D001308 therapeutic 10578459 +CHRNA7 1139 Autistic Disorder MESH:D001321 marker/mechanism 15046869 +CHRNA7 1139 Brain Injuries MESH:D001930 marker/mechanism 23159883 +CHRNA7 1139 Chromosome 15q13.3 Microdeletion Syndrome MESH:C567439 marker/mechanism 612001.0 +CHRNA7 1139 Epilepsy, Generalized MESH:D004829 marker/mechanism 19136953 +CHRNA7 1139 Hernia, Umbilical MESH:D006554 marker/mechanism 22473653 +CHRNA7 1139 Lung Neoplasms MESH:D008175 marker/mechanism 24089524 +CHRNA7 1139 Memory Disorders MESH:D008569 therapeutic 18848931 +CHRNA7 1139 Neoplasm Invasiveness MESH:D009361 marker/mechanism 18844224 +CHRNA7 1139 Nerve Degeneration MESH:D009410 therapeutic 21715663 +CHRNA7 1139 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 19898479 +CHRNA7 1139 Seizures MESH:D012640 marker/mechanism 10565853|10942032|11893908|14996991|9495872 +CHRNA7 1139 Spina Bifida Cystica MESH:D016137 marker/mechanism 22473653 +CHRNA7 1139 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 18184829 +CHRNA7 1139 Sudden Infant Death MESH:D013398 marker/mechanism 22000980 +CHRNA7 1139 Tobacco Use Disorder MESH:D014029 marker/mechanism 24289814 +CHRNA9 55584 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 30259641 +CHRNB1 1140 Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency MESH:C563829 marker/mechanism 616314.0 +CHRNB1 1140 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 616313.0 +CHRNB2 1141 Alzheimer Disease MESH:D000544 marker/mechanism 17192785 +CHRNB2 1141 Anxiety Disorders MESH:D001008 marker/mechanism 23419392 +CHRNB2 1141 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 21748252 +CHRNB2 1141 Autistic Disorder MESH:D001321 marker/mechanism 15046869 +CHRNB2 1141 Epilepsy, Frontal Lobe MESH:D017034 marker/mechanism 14996991 +CHRNB2 1141 Epilepsy, Nocturnal Frontal Lobe, Type 3 MESH:C565334 marker/mechanism 605375.0 +CHRNB2 1141 Hypothermia MESH:D007035 marker/mechanism 14982698 +CHRNB2 1141 Inflammation MESH:D007249 therapeutic 20943775 +CHRNB2 1141 Nerve Degeneration MESH:D009410 therapeutic 21715663 +CHRNB2 1141 Reflex, Abnormal MESH:D012021 therapeutic 23419392 +CHRNB2 1141 Sleep Wake Disorders MESH:D012893 marker/mechanism 12228730 +CHRNB2 1141 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 18184829 +CHRNB2 1141 Sudden Infant Death MESH:D013398 marker/mechanism 22000980 +CHRNB3 1142 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 20418888 +CHRNB3 1142 Tobacco Use Disorder MESH:D014029 marker/mechanism 28851948 +CHRNB4 1143 Lung Neoplasms MESH:D008175 marker/mechanism 18385738 +CHRNB4 1143 Seizures MESH:D012640 marker/mechanism 14996991|15275829 +CHRNB4 1143 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 15537871 +CHRNB4 1143 Tobacco Use Disorder MESH:D014029 marker/mechanism 29666375 +CHRND 1144 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE OMIM:253290 marker/mechanism 253290.0 +CHRND 1144 Myasthenic Syndrome, Congenital, Fast-Channel MESH:C563832 marker/mechanism 616322.0 +CHRND 1144 Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency MESH:C563829 marker/mechanism 616323.0 +CHRND 1144 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 616321.0 +CHRND 1144 Paralysis MESH:D010243 marker/mechanism 18694773 +CHRNE 1145 Myasthenia, Familial Infantile, 1 MESH:C565289 marker/mechanism 605809.0 +CHRNE 1145 Myasthenic Syndrome, Congenital, Fast-Channel MESH:C563832 marker/mechanism 616324.0 +CHRNE 1145 Myasthenic syndrome, congenital, type Id MESH:C536090 marker/mechanism 608931.0 +CHRNG 1146 Arthrogryposis MESH:D001176 marker/mechanism 16826520|16826531 +CHRNG 1146 Bone Diseases, Developmental MESH:D001848 marker/mechanism 16826531 +CHRNG 1146 Multiple pterygium syndrome MESH:C537377 marker/mechanism 265000.0 16826520|16826531 +CHRNG 1146 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE OMIM:253290 marker/mechanism 253290.0 +CHRNG 1146 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 16826520 +CHST10 9486 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST11 50515 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST12 55501 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST13 166012 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST14 113189 Adducted Thumbs Syndrome MESH:C562949 marker/mechanism 20004762 +CHST14 113189 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST14 113189 Clubfoot MESH:D003025 marker/mechanism 20004762 +CHST14 113189 Craniofacial Abnormalities MESH:D019465 marker/mechanism 20842734 +CHST14 113189 Ehlers-Danlos Syndrome, musculocontractural type 1 MESH:C000600608 marker/mechanism 601776.0 20004762|20842734 +CHST14 113189 Joint Instability MESH:D007593 marker/mechanism 20842734 +CHST14 113189 Muscle Hypotonia MESH:D009123 marker/mechanism 20842734 +CHST14 113189 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 27415467 +CHST14 113189 Prostatic Neoplasms MESH:D011471 marker/mechanism 27415467 +CHST15 51363 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +CHST3 9469 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST3 9469 MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS OMIM:245600 marker/mechanism 245600.0 +CHST3 9469 Osteochondrodysplasias MESH:D010009 marker/mechanism 30200136 +CHST3 9469 SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS OMIM:143095 marker/mechanism 143095.0 +CHST4 10164 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST5 23563 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST6 4166 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST6 4166 Macular dystrophy, corneal type 1 MESH:C537834 marker/mechanism 217800.0 +CHST8 64377 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CHST8 64377 Peeling Skin Syndrome MESH:C564818 marker/mechanism 616265.0 +CHSY1 22856 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CHSY1 22856 Temtamy preaxial brachydactyly syndrome MESH:C536958 marker/mechanism 605282.0 +CHUK 1147 Abnormalities, Multiple MESH:D000015 marker/mechanism 20961246 +CHUK 1147 Autistic Disorder MESH:D001321 marker/mechanism 20957522 +CHUK 1147 Bone Diseases, Developmental MESH:D001848 marker/mechanism 10346820 +CHUK 1147 Cleft Palate MESH:D002972 marker/mechanism 10346820 +CHUK 1147 Fetal Diseases MESH:D005315 marker/mechanism 10195895|10195896|10346820|20961246 +CHUK 1147 FETAL ENCASEMENT SYNDROME OMIM:613630 marker/mechanism 613630.0 +CHUK 1147 Limb Deformities, Congenital MESH:D017880 marker/mechanism 10195895|10195896|10346820|20961246 +CHUK 1147 Skin Abnormalities MESH:D012868 marker/mechanism 10195895|10195896|10346820 +CIB2 10518 Deafness, Autosomal Recessive 48 MESH:C563720 marker/mechanism 609439.0 23023331 +CIB2 10518 USHER SYNDROME, TYPE IJ OMIM:614869 marker/mechanism 614869.0 23023331 +CIBAR1 137392 Ciliopathies MESH:D000072661 marker/mechanism 30395363 +CIBAR1 137392 Polydactyly, Postaxial MESH:C562429 marker/mechanism 30395363 +CIBAR1 137392 Syndactyly MESH:D013576 marker/mechanism 30395363 +CIBAR2 339145 Crohn Disease MESH:D003424 marker/mechanism 17435756 +CIC 23152 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 28288114 +CIC 23152 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 28288114 +CIC 23152 Intellectual Disability MESH:D008607 marker/mechanism 21076407|28288114 +CIC 23152 Neoplasm Metastasis MESH:D009362 marker/mechanism 27869830 +CIC 23152 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 18337722 +CIDEA 1149 Heart Failure MESH:D006333 marker/mechanism 26670611 +CIDEA 1149 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CIDEA 1149 Liver Neoplasms MESH:D008113 marker/mechanism 25058030|28108177 +CIDEA 1149 Obesity MESH:D009765 marker/mechanism 20975297 +CIDEC 63924 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +CIDEC 63924 Lipodystrophy, Familial Partial MESH:D052496 marker/mechanism 615238.0 +CIDS-2 172691 Infertility MESH:D007246 marker/mechanism 25204677 +CIITA 4261 Addison Disease MESH:D000224 marker/mechanism 18593762 +CIITA 4261 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 180300.0 +CIITA 4261 Bare lymphocyte syndrome 2 MESH:C537079 marker/mechanism 209920.0 +CIITA 4261 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +CILK1 22858 Endocrine-Cerebroosteodysplasia MESH:C567210 marker/mechanism 612651.0 +CILP 8483 Intervertebral disc disease MESH:C535531 marker/mechanism 603932.0 +CIMAP1B 440836 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CIRBP 1153 Alcohol-Induced Disorders, Nervous System MESH:D020268 marker/mechanism 24223948 +CIRBP 1153 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24781735 +CIRBP 1153 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CIRBP 1153 Neurogenic Inflammation MESH:D020078 marker/mechanism 24223948 +CISD2 493856 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +CISD2 493856 Wolfram Syndrome 2 MESH:C565733 marker/mechanism 604928.0 24705017 +CISH 1154 Bacteremia MESH:D016470 marker/mechanism 614383.0 +CISH 1154 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +CISH 1154 Malaria MESH:D008288 marker/mechanism 611162.0 +CISH 1154 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948.0 +CISH 1154 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +CIT 11113 MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE OMIM:617090 marker/mechanism 617090.0 +CITED2 10370 ATRIAL SEPTAL DEFECT 8 OMIM:614433 marker/mechanism 614433.0 +CITED2 10370 Heart Septal Defects MESH:D006343 marker/mechanism 16287139 +CITED2 10370 Heart Septal Defects, Ventricular MESH:D006345 marker/mechanism 614431.0 +CITED2 10370 Muscular Atrophy MESH:D009133 therapeutic 19032942 +CITED2 10370 Neoplasms MESH:D009369 marker/mechanism 21660965 +CIZ1 25792 Cervical Dystonia, Primary MESH:C566572 marker/mechanism 22447717 +CIZ1 25792 Dystonia MESH:D004421 marker/mechanism 23222958 +CIZ1 25792 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +CIZ1 25792 Sarcoma, Ewing MESH:D012512 marker/mechanism 17508423 +CKAP2L 150468 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CKAP2L 150468 Filippi syndrome MESH:C538152 marker/mechanism 272440.0 +CKAP5 9793 Aneuploidy MESH:D000782 marker/mechanism 24976383 +CKAP5 9793 Chromosomal Instability MESH:D043171 marker/mechanism 24976383 +CKB 1152 Acute Coronary Syndrome MESH:D054058 marker/mechanism 15966572 +CKB 1152 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +CKB 1152 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CKB 1152 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 11406506 +CKB 1152 Myocardial Infarction MESH:D009203 marker/mechanism 12359538 +CKB 1152 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 2828370 +CKB 1152 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +CKLF 51192 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CKM 1158 Acute Coronary Syndrome MESH:D054058 marker/mechanism 15966572 +CKM 1158 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +CKM 1158 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 11406506 +CKM 1158 Ischemia MESH:D007511 marker/mechanism 21912612 +CKM 1158 Myocardial Infarction MESH:D009203 marker/mechanism 12359538|3279722 +CKS2 1164 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CLCA2 9635 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +CLCC1 23155 Retinitis Pigmentosa 32 MESH:C563689 marker/mechanism 609913.0 +CLCF1 23529 Crisponi syndrome MESH:C536214 marker/mechanism 610313.0 +CLCN1 1180 Myotonia Congenita MESH:D009224 marker/mechanism 255700.0 20399394 +CLCN1 1180 MYOTONIA CONGENITA, AUTOSOMAL DOMINANT OMIM:160800 marker/mechanism 160800.0 +CLCN2 1181 Epilepsy, Idiopathic Generalized MESH:C562694 marker/mechanism 607628.0 +CLCN2 1181 Glioma MESH:D005910 marker/mechanism 12843258 +CLCN2 1181 Hyperaldosteronism MESH:D006929 marker/mechanism 29403012 +CLCN2 1181 Hyperaldosteronism, Familial, Type II MESH:C565312 marker/mechanism 605635.0 29403011 +CLCN2 1181 LEUKOENCEPHALOPATHY WITH ATAXIA OMIM:615651 marker/mechanism 615651.0 +CLCN3 1182 Disease Progression MESH:D018450 marker/mechanism 21364753 +CLCN3 1182 Glioma MESH:D005910 marker/mechanism 12843258 +CLCN3 1182 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 22108225 +CLCN3 1182 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +CLCN4 1183 RAYNAUD-CLAES SYNDROME OMIM:300114 marker/mechanism 300114.0 +CLCN5 1184 Dent Disease MESH:D057973 marker/mechanism 10561751|15719255|20804101 +CLCN5 1184 Dent disease 1 MESH:C538212 marker/mechanism 300009.0 +CLCN5 1184 Familial Hypophosphatemic Rickets MESH:D053098 marker/mechanism 300554.0 +CLCN5 1184 Glioma MESH:D005910 marker/mechanism 12843258 +CLCN5 1184 Goiter MESH:D006042 marker/mechanism 16306076 +CLCN5 1184 Low Molecular Weight Proteinuria with Hypercalciuria and Nephrocalcinosis MESH:C545036 marker/mechanism 308990.0 +CLCN5 1184 Nephrolithiasis, X-Linked Recessive, with Renal Failure MESH:C562901 marker/mechanism 310468.0 +CLCN5 1184 Proteinuria MESH:D011507 marker/mechanism 15719255 +CLCN7 1186 Osteopetrosis MESH:D010022 marker/mechanism 166600.0 +CLCN7 1186 Osteopetrosis, Autosomal Recessive 4 MESH:C566933 marker/mechanism 611490.0 +CLCNKA 1187 Bartter Syndrome, Type 4b MESH:C567762 marker/mechanism 613090.0 +CLCNKA 1187 Hypertension MESH:D006973 marker/mechanism 18480177 +CLCNKB 1188 Bartter Syndrome MESH:D001477 marker/mechanism 10561751 +CLCNKB 1188 Bartter syndrome, type 3 MESH:C537653 marker/mechanism 607364.0 +CLCNKB 1188 Bartter Syndrome, Type 4b MESH:C567762 marker/mechanism 613090.0 +CLDN1 9076 Breast Neoplasms MESH:D001943 marker/mechanism 19579870|24014025 +CLDN1 9076 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 33665778 +CLDN1 9076 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24014025 +CLDN1 9076 Dermatitis, Contact MESH:D003877 marker/mechanism 23136956 +CLDN1 9076 Endometriosis MESH:D004715 marker/mechanism 20864642 +CLDN1 9076 Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis MESH:C564365 marker/mechanism 607626.0 +CLDN1 9076 Lymphatic Metastasis MESH:D008207 marker/mechanism 33665778 +CLDN1 9076 Mouth Neoplasms MESH:D009062 marker/mechanism 33665778 +CLDN1 9076 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 33665778 +CLDN10 9071 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 28377727 +CLDN11 5010 Disease Models, Animal MESH:D004195 marker/mechanism 25911099 +CLDN11 5010 Multiple Sclerosis MESH:D009103 marker/mechanism 25911099 +CLDN14 23562 Deafness MESH:D003638 marker/mechanism 11163249 +CLDN14 23562 DEAFNESS, AUTOSOMAL RECESSIVE 29 OMIM:614035 marker/mechanism 614035.0 +CLDN14 23562 Kidney Calculi MESH:D007669 marker/mechanism 19561606 +CLDN15 24146 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 28377727 +CLDN16 10686 Hypomagnesemia primary MESH:C537153 marker/mechanism 248250.0 +CLDN18 51208 Asthma MESH:D001249 marker/mechanism 27215490 +CLDN19 149461 Hypomagnesemia 5, Renal, with Ocular Involvement MESH:C565423 marker/mechanism 248190.0 +CLDN2 9075 Pancreatitis MESH:D010195 marker/mechanism 23143602 +CLDN3 1365 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CLDN3 1365 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CLDN3 1365 Rhinitis, Allergic MESH:D065631 marker/mechanism 33441633 +CLDN3 1365 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +CLDN4 1364 Breast Neoplasms MESH:D001943 marker/mechanism 19142967 +CLDN4 1364 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 19142967 +CLDN4 1364 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 28377727 +CLDN4 1364 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 19142967 +CLDN4 1364 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CLDN4 1364 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 30608172 +CLDN5 7122 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 28377727 +CLDN5 7122 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 30608172 +CLDN7 1366 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 21134740 +CLDN7 1366 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CLDN7 1366 Rhinitis, Allergic MESH:D065631 marker/mechanism 33441633 +CLDN8 9073 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 28377727 +CLDN9 9080 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CLEC10A 10462 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CLEC11A 6320 Anemia MESH:D000740 marker/mechanism 19884328 +CLEC11A 6320 Carotid Stenosis MESH:D016893 marker/mechanism 26564003 +CLEC11A 6320 Malaria, Falciparum MESH:D016778 marker/mechanism 19884328 +CLEC11A 6320 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +CLEC11A 6320 Osteoporosis MESH:D010024 marker/mechanism 27976999 +CLEC12A 160364 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +CLEC-137 185281 Infertility MESH:D007246 marker/mechanism 25204677 +CLEC16A 23274 Addison Disease MESH:D000224 marker/mechanism 18593762 +CLEC16A 23274 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 17632545|18946483 +CLEC16A 23274 IgA Deficiency MESH:D017098 marker/mechanism 20694011|27723758 +CLEC16A 23274 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 21399635 +CLEC16A 23274 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838195 +CLEC16A 23274 Multiple Sclerosis MESH:D009103 marker/mechanism 18946483|19525955 +CLEC1A 51267 Aspergillosis MESH:D001228 marker/mechanism 614079.0 +CLEC1B 51266 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CLEC4A 50856 Hypersensitivity MESH:D006967 marker/mechanism 23624239 +CLEC4A 50856 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CLEC4A1 269799 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CLEC4A3 73149 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CLEC4B2 381809 Liver Diseases MESH:D008107 marker/mechanism 19784758 +CLEC4D 338339 Lung Diseases MESH:D008171 marker/mechanism 21602193 +CLEC4E 26253 Brain Injuries MESH:D001930 marker/mechanism 21549006 +CLEC4E 26253 Lung Diseases MESH:D008171 marker/mechanism 21602193 +CLEC4F 165530 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CLEC4G 339390 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CLEC4M 10332 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CLEC5A 23601 Severe Dengue MESH:D019595 therapeutic 18496526 +CLEC7A 64581 Aspergillosis MESH:D001228 marker/mechanism 614079.0 +CLEC7A 64581 Candidiasis familial chronic mucocutaneous, autosomal recessive MESH:C537979 marker/mechanism 613108.0 +CLIC1 1192 Breast Neoplasms MESH:D001943 marker/mechanism 20562527 +CLIC1 1192 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +CLIC1 1192 HIV Infections MESH:D015658 marker/mechanism 15308739 +CLIC1 1192 Keloid MESH:D007627 marker/mechanism 20128793 +CLIC1 1192 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CLIC1 1192 Neoplasm Metastasis MESH:D009362 marker/mechanism 20562527 +CLIC1 1192 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +CLIC2 1193 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 32 OMIM:300886 marker/mechanism 300886.0 +CLIC2 1193 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CLIC4 25932 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +CLIC4 25932 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +CLIC4 25932 Weight Gain MESH:D015430 marker/mechanism 19030233 +CLIC5 53405 DEAFNESS, AUTOSOMAL RECESSIVE 103 OMIM:616042 marker/mechanism 616042.0 +CLMP 79827 Intestinal Pseudo-Obstruction MESH:D007418 marker/mechanism 615237 +CLN3 1201 Disease Progression MESH:D018450 marker/mechanism 21364753 +CLN3 1201 Neuronal Ceroid-Lipofuscinoses MESH:D009472 marker/mechanism 204200 +CLN3 1201 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +CLN5 1203 Ceroid lipofuscinosis, neuronal 5 MESH:C575534 marker/mechanism 256731 +CLN6 54982 Atrophy MESH:D001284 marker/mechanism 23789114 +CLN6 54982 Ceroid Lipofuscinosis, Neuronal, 6 MESH:C566627 marker/mechanism 601780 23516525 +CLN6 54982 Disease Models, Animal MESH:D004195 marker/mechanism 23789114 +CLN6 54982 Inflammation MESH:D007249 marker/mechanism 23789114 +CLN6 54982 Motor Skills Disorders MESH:D019957 marker/mechanism 23789114 +CLN6 54982 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 25401298 +CLN6 54982 Neuronal Ceroid-Lipofuscinoses MESH:D009472 marker/mechanism 204300 23789114 +CLN6 54982 Vision Disorders MESH:D014786 marker/mechanism 23789114 +CLN6 54982 Weight Loss MESH:D015431 marker/mechanism 23789114 +CLN8 2055 Ceroid lipofuscinosis, neuronal 8 MESH:C537952 marker/mechanism 600143|610003 +CLN8 2055 Disease Models, Animal MESH:D004195 marker/mechanism 22302580 +CLN8 2055 Neuronal Ceroid-Lipofuscinoses MESH:D009472 marker/mechanism 22302580 +CLNK 116449 Vitiligo MESH:D014820 marker/mechanism 22561518 +CLNS1A 1207 Melanoma MESH:D008545 marker/mechanism 22535842 +CLP1 10978 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CLP1 10978 PONTOCEREBELLAR HYPOPLASIA, TYPE 10 OMIM:615803 marker/mechanism 615803 +CLPB 81570 3-METHYLGLUTACONIC ACIDURIA, TYPE VIIB OMIM:616271 marker/mechanism 616271 +CLPP 8192 PERRAULT SYNDROME 3 OMIM:614129 marker/mechanism 614129.0 +CLPTM1 1209 Pancreatic Neoplasms MESH:D010190 marker/mechanism 26098869 +CLPTM1L 81037 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 22675468 +CLPTM1L 81037 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 19151717 +CLPTM1L 81037 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22675468 +CLPTM1L 81037 Leukemia, Lymphoid MESH:D007945 marker/mechanism 24292274 +CLPTM1L 81037 Lung Neoplasms MESH:D008175 marker/mechanism 18978787|19151717|23433592|24366883 +CLPTM1L 81037 Mouth Neoplasms MESH:D009062 marker/mechanism 27749845 +CLPTM1L 81037 Prostatic Neoplasms MESH:D011471 marker/mechanism 19151717 +CLPTM1L 81037 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 19151717 +CLPTM1L 81037 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 19151717 +CLRN1 7401 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 +CLRN1 7401 RETINITIS PIGMENTOSA 61 OMIM:614180 marker/mechanism 614180.0 +CLRN1 7401 USHER SYNDROME, TYPE IIIA OMIM:276902 marker/mechanism 276902.0 +CLSTN2 64084 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +CLTB 1212 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +CLTC 1213 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 22474449 +CLTRN 57393 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CLTRN 57393 Ureteral Obstruction MESH:D014517 marker/mechanism 12887829 +CLU 1191 Acute Kidney Injury MESH:D058186 marker/mechanism 20118187|20623750|22005293|23052191|24361871|28885000 +CLU 1191 Alzheimer Disease MESH:D000544 marker/mechanism 19734902|19734903|21460841 +CLU 1191 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +CLU 1191 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CLU 1191 Atrophy MESH:D001284 marker/mechanism 21536718 +CLU 1191 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +CLU 1191 Cognitive Dysfunction MESH:D060825 marker/mechanism 30503753 +CLU 1191 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 24361871|28885000 +CLU 1191 Kidney Diseases MESH:D007674 marker/mechanism 21258088|21593213|24863737 +CLU 1191 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 15304052 +CLU 1191 Melanoma MESH:D008545 therapeutic 15955107 +CLU 1191 Neovascularization, Pathologic MESH:D009389 therapeutic 16308731 +CLU 1191 Osteoarthritis MESH:D010003 marker/mechanism 17568789|18784066 +CLU 1191 Prostatic Neoplasms MESH:D011471 marker/mechanism 17148459 +CLU 1191 Seizures MESH:D012640 marker/mechanism 23266720 +CLUL1 27098 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +CMA1 1215 Hypertension MESH:D006973 marker/mechanism 14620933 +CMA1 1215 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 14620933 +CMA1 1215 Pulmonary Fibrosis MESH:D011658 marker/mechanism 15297733 +CMAHP 8418 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +CMC2 56942 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +CMIP 80790 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +CMKLR1 1240 Granulosa Cell Tumor MESH:D006106 marker/mechanism 29653259 +CMKLR1 1240 Pre-Eclampsia MESH:D011225 marker/mechanism 34398343 +CMTM2 146225 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CMTM3 123920 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CMTR2 55783 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +CMTR2 55783 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +CMTR2 55783 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CNBP 7555 Myotonic Dystrophy MESH:D009223 marker/mechanism 602668.0 +CNC-8 181239 Infertility MESH:D007246 marker/mechanism 25204677 +CNDP1 84735 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CNDP1 84735 Diabetic Nephropathies MESH:D003928 marker/mechanism 17942768|21393041|21573905 +CNDP1 84735 Homocarnosinosis MESH:C535328 marker/mechanism 4172777 +CNDP1 84735 Intellectual Disability MESH:D008607 marker/mechanism 4673339|4718759 +CNDP1 84735 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CNDP1 84735 Neurologic Manifestations MESH:D009461 marker/mechanism 4673339 +CNDP2 55748 Diabetic Nephropathies MESH:D003928 marker/mechanism 21573905 +CNDP2 55748 Fatty Liver MESH:D005234 marker/mechanism 25226513 +CNGA1 1259 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 7479749 +CNGA1 1259 RETINITIS PIGMENTOSA 49 OMIM:613756 marker/mechanism 613756.0 +CNGA3 1261 Achromatopsia 2 MESH:C536128 marker/mechanism 216900.0 +CNGA3 1261 Color Vision Defects MESH:D003117 marker/mechanism 30418171 +CNGB1 1258 Retinitis Pigmentosa MESH:D012174 marker/mechanism 11379879 +CNGB1 1258 RETINITIS PIGMENTOSA 45 OMIM:613767 marker/mechanism 613767.0 +CNGB3 54714 Achromatopsia 3 MESH:C536129 marker/mechanism 262300.0 +CNGB3 54714 Color Vision Defects MESH:D003117 marker/mechanism 30418171 +CNIH3 149111 Endometriosis MESH:D004715 marker/mechanism 20864642 +CNKSR1 10256 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +CNKSR2 22866 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +CNN2 1265 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +CNN3 1266 Carcinoma MESH:D002277 marker/mechanism 12376462 +CNN3 1266 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +CNN3 1266 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +CNN3 1266 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CNNM1 26507 Melanoma MESH:D008545 marker/mechanism 16778180 +CNNM2 54805 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 23027747 +CNNM2 54805 HYPOMAGNESEMIA 6, RENAL OMIM:613882 marker/mechanism 613882.0 +CNNM2 54805 HYPOMAGNESEMIA, SEIZURES, AND IMPAIRED INTELLECTUAL DEVELOPMENT 1 OMIM:616418 marker/mechanism 616418.0 +CNNM2 54805 Kidney Diseases MESH:D007674 marker/mechanism 23027747 +CNNM2 54805 Seizures MESH:D012640 marker/mechanism 23027747 +CNNM2 54805 Tetany MESH:D013746 marker/mechanism 23027747 +CNNM4 26504 Amaurosis hypertrichosis MESH:C536604 marker/mechanism 217080.0 +CNOT3 4849 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 23263491 +CNOT3 4849 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475|29662167 +CNP 1267 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CNPPD1 27013 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +CNPY2 10330 Disease Progression MESH:D018450 marker/mechanism 21364753 +CNPY2 10330 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +CNPY4 245812 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CNR1 1268 Anxiety Disorders MESH:D001008 marker/mechanism 15081793|18690112 +CNR1 1268 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 22034972 +CNR1 1268 Binge-Eating Disorder MESH:D056912 marker/mechanism 23072421 +CNR1 1268 Catalepsy MESH:D002375 marker/mechanism|therapeutic 10318961|27149200|27535976|31877572 +CNR1 1268 Cholestasis MESH:D002779 marker/mechanism 26884397 +CNR1 1268 Cocaine-Related Disorders MESH:D019970 marker/mechanism 16314880|17596442|19052543 +CNR1 1268 Cognition Disorders MESH:D003072 marker/mechanism 29294249 +CNR1 1268 Disease Models, Animal MESH:D004195 marker/mechanism 23072421 +CNR1 1268 Endometrial Neoplasms MESH:D016889 marker/mechanism 29805589|32751388 +CNR1 1268 Endometriosis MESH:D004715 marker/mechanism 20864642 +CNR1 1268 Epilepsy, Temporal Lobe MESH:D004833 therapeutic 20498848 +CNR1 1268 Glucose Intolerance MESH:D018149 therapeutic 26563389 +CNR1 1268 Huntington Disease MESH:D006816 marker/mechanism 20929960 +CNR1 1268 Hyperalgesia MESH:D006930 therapeutic 17572696 +CNR1 1268 Hypotension MESH:D007022 marker/mechanism 9888857 +CNR1 1268 Hypothermia MESH:D007035 marker/mechanism|therapeutic 27149200|27535976|31877572|9888857 +CNR1 1268 Liver Cirrhosis MESH:D008103 marker/mechanism 11433348|21863215 +CNR1 1268 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17043671 +CNR1 1268 Marijuana Abuse MESH:D002189 marker/mechanism 19016476 +CNR1 1268 Marijuana Use MESH:D000074609 marker/mechanism 29294249 +CNR1 1268 Melanoma, Cutaneous Malignant MESH:C562393 marker/mechanism 28131817 +CNR1 1268 Memory Disorders MESH:D008569 marker/mechanism 29294249 +CNR1 1268 Motor Skills Disorders MESH:D019957 therapeutic 26460022 +CNR1 1268 Movement Disorders MESH:D009069 therapeutic 10802025 +CNR1 1268 Multiple Sclerosis MESH:D009103 therapeutic 12876144 +CNR1 1268 Muscle Spasticity MESH:D009128 marker/mechanism 17220914 +CNR1 1268 Nerve Degeneration MESH:D009410 marker/mechanism|therapeutic 11517236|24211273 +CNR1 1268 Obesity MESH:D009765 marker/mechanism 18722357 +CNR1 1268 Pain MESH:D010146 therapeutic 19193902 +CNR1 1268 Pancreatic Neoplasms MESH:D010190 marker/mechanism 16818650 +CNR1 1268 Pancreatitis MESH:D010195 marker/mechanism 17484889 +CNR1 1268 Rhabdomyosarcoma MESH:D012208 marker/mechanism 19509271 +CNR1 1268 Schizophrenia MESH:D012559 marker/mechanism 21513772 +CNR1 1268 Scleroderma, Systemic MESH:D012595 marker/mechanism 27228633 +CNR1 1268 Seizures MESH:D012640 marker/mechanism|therapeutic 12954810|26460022 +CNR1 1268 Status Epilepticus MESH:D013226 marker/mechanism 19368833 +CNR1 1268 Stress Disorders, Post-Traumatic MESH:D013313 marker/mechanism 34262461 +CNR1 1268 Substance-Related Disorders MESH:D019966 marker/mechanism 18690112|21513772|9888857 +CNR1 1268 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 18705688 +CNR1 1268 Weight Gain MESH:D015430 marker/mechanism 20107430 +CNR1 1268 Weight Loss MESH:D015431 marker/mechanism 31570772|32365865 +CNR2 1269 Anterior Cruciate Ligament Injuries MESH:D000070598 marker/mechanism 34537380 +CNR2 1269 Atherosclerosis MESH:D050197 therapeutic 15815632 +CNR2 1269 Breast Neoplasms MESH:D001943 marker/mechanism 16818634 +CNR2 1269 Catalepsy MESH:D002375 therapeutic 31877572 +CNR2 1269 Cholestasis MESH:D002779 marker/mechanism 26884397 +CNR2 1269 Depressive Disorder MESH:D003866 marker/mechanism 18286196 +CNR2 1269 Diarrhea MESH:D003967 marker/mechanism 27611972 +CNR2 1269 Disease Models, Animal MESH:D004195 marker/mechanism 27317300 +CNR2 1269 Endometrial Neoplasms MESH:D016889 marker/mechanism 29805589 +CNR2 1269 Hyperalgesia MESH:D006930 marker/mechanism|therapeutic 17572696|18664590 +CNR2 1269 Hyperemia MESH:D006940 marker/mechanism 27611972 +CNR2 1269 Hyperglycemia MESH:D006943 marker/mechanism 32365865 +CNR2 1269 Immune System Diseases MESH:D007154 marker/mechanism 16924491 +CNR2 1269 Inflammatory Bowel Diseases MESH:D015212 therapeutic 30102254 +CNR2 1269 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 15039279 +CNR2 1269 Liver Cirrhosis MESH:D008103 marker/mechanism 15765409 +CNR2 1269 Pancreatic Neoplasms MESH:D010190 marker/mechanism 16818650 +CNR2 1269 Pancreatitis MESH:D010195 marker/mechanism 17484889 +CNR2 1269 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 27317300 +CNR2 1269 Scleroderma, Systemic MESH:D012595 marker/mechanism 27228633 +CNR2 1269 Stress Disorders, Post-Traumatic MESH:D013313 marker/mechanism 34262461 +CNR2 1269 Weight Loss MESH:D015431 marker/mechanism|therapeutic 27611972|30102254 +CNST 163882 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +CNTF 1270 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11951178 +CNTF 1270 Cerebral Hemorrhage MESH:D002543 therapeutic 11701153 +CNTF 1270 Nerve Degeneration MESH:D009410 therapeutic 15372491 +CNTN1 1272 Myopathy, Congenital, Compton-North MESH:C567261 marker/mechanism 612540.0 +CNTN2 6900 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5 OMIM:615400 marker/mechanism 615400.0 +CNTN3 5067 Autistic Disorder MESH:D001321 marker/mechanism 18621663 +CNTN3 5067 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17597826 +CNTN4 152330 Autistic Disorder MESH:D001321 marker/mechanism 18349135 +CNTN4 152330 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15106122 +CNTN4 152330 Developmental Disabilities MESH:D002658 marker/mechanism 15106122 +CNTN4 152330 Growth Disorders MESH:D006130 marker/mechanism 15106122 +CNTN6 27255 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +CNTNAP1 8506 LETHAL CONGENITAL CONTRACTURE SYNDROME 7 OMIM:616286 marker/mechanism 616286.0 +CNTNAP2 26047 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20176116|21082657|21572417|21962519 +CNTNAP2 26047 Autistic Disorder MESH:D001321 marker/mechanism 612100.0 18179894|18621663|20157312|21310003 +CNTNAP2 26047 Cortical Dysplasia-Focal Epilepsy Syndrome MESH:C567657 marker/mechanism 610042.0 +CNTNAP2 26047 Epilepsy MESH:D004827 marker/mechanism 20502679|21962519 +CNTNAP2 26047 Hyperkinesis MESH:D006948 marker/mechanism 21962519 +CNTNAP2 26047 Language Development Disorders MESH:D007805 marker/mechanism 20157312|21082657|21310003 +CNTNAP2 26047 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +CNTNAP2 26047 Pitt-Hopkins syndrome MESH:C537403 marker/mechanism 19896112 +CNTNAP2 26047 Schizophrenia MESH:D012559 marker/mechanism 20157312 +CNTNAP2 26047 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +CNTNAP2 26047 Stuttering MESH:D013342 marker/mechanism 21108403 +CNTNAP4 85445 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CNTROB 116840 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +CNX99A 44643 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +COA5 493753 Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency MESH:C565784 marker/mechanism 616500.0 +COA6 388753 Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency MESH:C565784 marker/mechanism 616501.0 +COASY 80347 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6 OMIM:615643 marker/mechanism 615643.0 +COBLL1 22837 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 34355838 +COBLL1 22837 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +COCH 1690 Deafness, Autosomal Dominant 9 MESH:C563335 marker/mechanism 601369.0 +COG1 9382 Congenital disorder of glycosylation, type 2G MESH:C535756 marker/mechanism 611209.0 +COG1 9382 Enterovirus Infections MESH:D004769 marker/mechanism 28446605 +COG2 22796 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq OMIM:617395 marker/mechanism 617395.0 +COG4 25839 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj OMIM:613489 marker/mechanism 613489.0 +COG4 25839 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +COG5 10466 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +COG5 10466 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi OMIM:613612 marker/mechanism 613612.0 +COG5 10466 Enterovirus Infections MESH:D004769 marker/mechanism 28446605 +COG6 57511 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl OMIM:614576 marker/mechanism 614576.0 +COG7 91949 Congenital disorder of glycosylation type 2E MESH:C535754 marker/mechanism 608779.0 +COG8 84342 Congenital Disorder Of Glycosylation, Type IIH MESH:C566987 marker/mechanism 611182.0 +COL10A1 1300 Metaphyseal chondrodysplasia Schmid type MESH:C537352 marker/mechanism 156500.0 19035365 +COL11A1 1301 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19638309 +COL11A1 1301 Fibrochondrogenesis MESH:C562524 marker/mechanism 228520.0 +COL11A1 1301 Glaucoma, Angle-Closure MESH:D015812 marker/mechanism 22922875|27064256 +COL11A1 1301 Intervertebral disc disease MESH:C535531 marker/mechanism 603932.0 +COL11A1 1301 Intervertebral Disc Displacement MESH:D007405 marker/mechanism 17999364 +COL11A1 1301 Marshall syndrome MESH:C536025 marker/mechanism 154780.0 9529347 +COL11A1 1301 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +COL11A1 1301 Osteochondrodysplasias MESH:D010009 marker/mechanism 19638309 +COL11A1 1301 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +COL11A1 1301 Stickler syndrome, type 2 MESH:C537493 marker/mechanism 604841.0 +COL11A2 1302 Cartilage Diseases MESH:D002357 marker/mechanism 11668593 +COL11A2 1302 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16637051 +COL11A2 1302 Deafness, Autosomal Dominant 13 MESH:C566612 marker/mechanism 601868.0 +COL11A2 1302 Deafness, Autosomal Recessive 53 MESH:C566453 marker/mechanism 609706.0 +COL11A2 1302 Fibrochondrogenesis MESH:C562524 marker/mechanism 614524.0 +COL11A2 1302 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 16637051 +COL11A2 1302 Limb Deformities, Congenital MESH:D017880 marker/mechanism 16637051 +COL11A2 1302 Megaepiphyseal dwarfism MESH:C536140 marker/mechanism 16637051 +COL11A2 1302 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE OMIM:215150 marker/mechanism 215150.0 +COL11A2 1302 Pierre Robin syndrome with fetal chondrodysplasia MESH:C535776 marker/mechanism 184840.0 +COL12A1 1303 Bethlem myopathy MESH:C535436 marker/mechanism 616471.0 +COL12A1 1303 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COL12A1 1303 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +COL12A1 1303 Scleroatonic muscular dystrophy MESH:C537521 marker/mechanism 616470.0 +COL13A1 1305 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +COL13A1 1305 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 616720.0 +COL14A1 7373 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +COL15A1 1306 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +COL15A1 1306 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +COL17A1 1308 Epidermolysis Bullosa, Junctional, Non-Herlitz Type MESH:C562639 marker/mechanism 24550734 +COL17A1 1308 Epithelial Recurrent Erosion Dystrophy MESH:C565155 marker/mechanism 122400.0 +COL18A1 80781 Calcinosis MESH:D002114 marker/mechanism 21335463 +COL18A1 80781 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +COL18A1 80781 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +COL18A1 80781 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +COL18A1 80781 Knobloch syndrome MESH:C537209 marker/mechanism 267750.0 +COL19A1 1310 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +COL1A1 1277 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +COL1A1 1277 Aortic Dissection MESH:D000784 marker/mechanism 8757037 +COL1A1 1277 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +COL1A1 1277 Autoimmune Diseases MESH:D001327 marker/mechanism 25055964 +COL1A1 1277 Calcinosis MESH:D002114 marker/mechanism 21335463 +COL1A1 1277 Cholangitis MESH:D002761 marker/mechanism 25055964 +COL1A1 1277 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951|31932644 +COL1A1 1277 Ehlers-Danlos Syndrome, Type VII, Autosomal Dominant MESH:C562625 marker/mechanism 130060.0 +COL1A1 1277 Fibrosis MESH:D005355 marker/mechanism 20388698 +COL1A1 1277 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +COL1A1 1277 Hyperostosis, Cortical, Congenital MESH:D006958 marker/mechanism 114000.0 +COL1A1 1277 Hypertension MESH:D006973 marker/mechanism 11682445 +COL1A1 1277 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 11181017 +COL1A1 1277 Keloid MESH:D007627 marker/mechanism 20128793 +COL1A1 1277 Liver Cirrhosis MESH:D008103 marker/mechanism 21863215|24239723|24321339|26396155|32659284 +COL1A1 1277 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136|26435214|26739621 +COL1A1 1277 Nephrogenic Fibrosing Dermopathy MESH:D054989 marker/mechanism 20570839 +COL1A1 1277 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +COL1A1 1277 Nephrotic Syndrome MESH:D009404 marker/mechanism 1281619 +COL1A1 1277 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +COL1A1 1277 Osteogenesis Imperfecta MESH:D010013 marker/mechanism 166200.0 8757037 +COL1A1 1277 Osteogenesis imperfecta, type 2A MESH:C536042 marker/mechanism 166210.0 +COL1A1 1277 Osteogenesis imperfecta, type 3 MESH:C536044 marker/mechanism 259420.0 +COL1A1 1277 Osteogenesis Imperfecta, Type IV MESH:C000631847 marker/mechanism 166220.0 +COL1A1 1277 Osteoporosis MESH:D010024 marker/mechanism 166710.0 +COL1A2 1278 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +COL1A2 1278 Ehlers-Danlos syndrome, cardiac valvular form MESH:C536200 marker/mechanism 225320.0 15077201 +COL1A2 1278 Fibrosis MESH:D005355 marker/mechanism 20388698 +COL1A2 1278 Heart Valve Diseases MESH:D006349 marker/mechanism 15077201 +COL1A2 1278 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +COL1A2 1278 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COL1A2 1278 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +COL1A2 1278 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +COL1A2 1278 Osteogenesis imperfecta, type 2A MESH:C536042 marker/mechanism 166210.0 +COL1A2 1278 Osteogenesis imperfecta, type 3 MESH:C536044 marker/mechanism 259420.0 +COL1A2 1278 Osteogenesis Imperfecta, Type IV MESH:C000631847 marker/mechanism 166220.0 +COL1A2 1278 Osteoporosis MESH:D010024 marker/mechanism 166710.0 +COL1A2 1278 Scleroderma, Systemic MESH:D012595 marker/mechanism 24706986 +COL21A1 81578 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +COL22A1 169044 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +COL23A1 91522 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +COL23A1 91522 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +COL25A1 84570 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5 OMIM:616219 marker/mechanism 616219.0 +COL28A1 340267 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +COL2A1 1280 Achondrogenesis type 2 MESH:C536017 marker/mechanism 200610.0 7741714 +COL2A1 1280 Arthritis MESH:D001168 marker/mechanism 17299831|24144632|26640276|36121554 +COL2A1 1280 Arthritis, Experimental MESH:D001169 marker/mechanism 16200597|21188452|23326410|24709313|25194622|25481498|26070417|29908986|29935983|36181686 +COL2A1 1280 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 27028940|29935983 +COL2A1 1280 Bone Resorption MESH:D001862 marker/mechanism 27028940 +COL2A1 1280 Cartilage Diseases MESH:D002357 marker/mechanism 27028940 +COL2A1 1280 Cataract MESH:D002386 marker/mechanism 8317498 +COL2A1 1280 Chondrosarcoma MESH:D002813 marker/mechanism 23770606 +COL2A1 1280 Cleft Palate MESH:D002972 marker/mechanism 15562585 +COL2A1 1280 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15562585|9061443 +COL2A1 1280 Czech dysplasia, metatarsal type MESH:C535766 marker/mechanism 609162.0 +COL2A1 1280 Disease Models, Animal MESH:D004195 marker/mechanism 17299831 +COL2A1 1280 Edema MESH:D004487 marker/mechanism 25194622|27028940|29908986|29935983 +COL2A1 1280 Epiphyseal Dysplasia, Multiple, with Myopia and Conductive Deafness MESH:C565046 marker/mechanism 132450.0 +COL2A1 1280 Erythema MESH:D004890 marker/mechanism 25194622|27028940 +COL2A1 1280 Femur Head Necrosis MESH:D005271 marker/mechanism 608805.0 +COL2A1 1280 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 16189708 +COL2A1 1280 Hyaloideoretinal degeneration of Wagner MESH:C536075 marker/mechanism 11812423 +COL2A1 1280 Hyperplasia MESH:D006965 marker/mechanism 25481498 +COL2A1 1280 Inflammation MESH:D007249 marker/mechanism 24144632|27028940 +COL2A1 1280 Kniest dysplasia MESH:C537207 marker/mechanism 156550.0 11297324 +COL2A1 1280 Legg-Calve-Perthes Disease MESH:D007873 marker/mechanism 150600.0 +COL2A1 1280 Megaepiphyseal dwarfism MESH:C536140 marker/mechanism 16189708 +COL2A1 1280 Melanoma MESH:D008545 marker/mechanism 16778180 +COL2A1 1280 Myopia MESH:D009216 marker/mechanism 17653045 +COL2A1 1280 Osteoarthritis MESH:D010003 marker/mechanism 16189708|9061443 +COL2A1 1280 Osteoarthritis with Mild Chondrodysplasia MESH:C565740 marker/mechanism 604864.0 +COL2A1 1280 Osteochondrodysplasias MESH:D010009 marker/mechanism 8486375 +COL2A1 1280 Platyspondylic Lethal Skeletal Dysplasia, Torrance Type MESH:C563627 marker/mechanism 151210.0 +COL2A1 1280 Retinal Detachment MESH:D012163 marker/mechanism 8317498 +COL2A1 1280 Spondyloepiphyseal dysplasia, congenita MESH:C535788 marker/mechanism 183900.0 +COL2A1 1280 SPONDYLOPERIPHERAL DYSPLASIA OMIM:271700 marker/mechanism 271700.0 +COL2A1 1280 Stickler syndrome, type 1 MESH:C537492 marker/mechanism 108300.0 +COL2A1 1280 Stickler Syndrome, Type I, Nonsyndromic Ocular MESH:C563709 marker/mechanism 609508.0 +COL2A1 1280 Strudwick syndrome MESH:C537501 marker/mechanism 184250.0 +COL2A1 1280 Synovitis MESH:D013585 marker/mechanism 25194622 +COL2A1 1280 Weight Loss MESH:D015431 marker/mechanism 26070417|29908986 +COL3A1 1281 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +COL3A1 1281 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16679477 +COL3A1 1281 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +COL3A1 1281 Ehlers-Danlos Syndrome MESH:D004535 marker/mechanism 130050.0 +COL3A1 1281 Endomyocardial Fibrosis MESH:D004719 marker/mechanism 11300427 +COL3A1 1281 Fatty Liver MESH:D005234 marker/mechanism 15787813 +COL3A1 1281 Fibrosis MESH:D005355 marker/mechanism 20388698 +COL3A1 1281 Hypercholesterolemia MESH:D006937 marker/mechanism 21852083 +COL3A1 1281 Hyperglycemia MESH:D006943 marker/mechanism 20836762 +COL3A1 1281 Hyperinsulinism MESH:D006946 marker/mechanism 20836762 +COL3A1 1281 Hypertension MESH:D006973 marker/mechanism 11682445 +COL3A1 1281 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 11181017 +COL3A1 1281 Keloid MESH:D007627 marker/mechanism 20128793 +COL3A1 1281 Liver Cirrhosis MESH:D008103 marker/mechanism 11167689|15787813|16679477|1880254|2566230 +COL3A1 1281 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +COL3A1 1281 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 11788567|25380136 +COL3A1 1281 Liver Diseases MESH:D008107 marker/mechanism 11738102 +COL3A1 1281 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 12868502 +COL3A1 1281 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +COL3A1 1281 Pulmonary Fibrosis MESH:D011658 marker/mechanism 26817844 +COL3A1 1281 Schizophrenia MESH:D012559 marker/mechanism 21822266 +COL3A1 1281 Ureteral Obstruction MESH:D014517 marker/mechanism 17164399 +COL4A1 1282 Anemia, Hemolytic MESH:D000743 marker/mechanism 23225343 +COL4A1 1282 Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps MESH:C567088 marker/mechanism 611773.0 +COL4A1 1282 Axenfeld-Rieger syndrome MESH:C535679 marker/mechanism 17696175|20385946 +COL4A1 1282 BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES OMIM:175780 marker/mechanism 175780.0 +COL4A1 1282 Cerebral Hemorrhage MESH:D002543 marker/mechanism 614519.0 16598045 +COL4A1 1282 Cerebral Small Vessel Diseases MESH:D059345 marker/mechanism 16598045|17696175 +COL4A1 1282 Diabetic Nephropathies MESH:D003928 marker/mechanism 18682491|27997345 +COL4A1 1282 Eye Abnormalities MESH:D005124 marker/mechanism 20385946 +COL4A1 1282 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 16191423|18682491 +COL4A1 1282 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +COL4A1 1282 Leukoencephalopathies MESH:D056784 marker/mechanism 20385946 +COL4A1 1282 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COL4A1 1282 Nephrotic Syndrome MESH:D009404 marker/mechanism 1281619 +COL4A1 1282 Porencephaly MESH:D065708 marker/mechanism 23225343|607595 +COL4A1 1282 RETINAL ARTERIES, TORTUOSITY OF OMIM:180000 marker/mechanism 180000.0 +COL4A1 1282 Schizencephaly MESH:D065707 marker/mechanism 23225343 +COL4A2 1284 Cerebral Hemorrhage MESH:D002543 marker/mechanism 614519.0 +COL4A2 1284 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COL4A2 1284 Nephrotic Syndrome MESH:D009404 marker/mechanism 1281619 +COL4A2 1284 Porencephaly MESH:D065708 marker/mechanism 614483.0 +COL4A2 1284 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +COL4A3 1285 Alport syndrome, dominant type MESH:C536586 marker/mechanism 104200.0 +COL4A3 1285 Nephritis, Hereditary MESH:D009394 marker/mechanism 12631109 +COL4A4 1286 Alport syndrome, recessive type MESH:C536587 marker/mechanism 203780.0 +COL4A4 1286 Hematuria, Benign Familial MESH:C562476 marker/mechanism 141200.0 +COL4A5 1287 ALPORT SYNDROME 1, X-LINKED OMIM:301050 marker/mechanism 301050.0 +COL4A5 1287 Leiomyoma, Epithelioid MESH:D018230 marker/mechanism 17069596 +COL4A6 1288 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +COL4A6 1288 DEAFNESS, X-LINKED 6 OMIM:300914 marker/mechanism 300914.0 +COL4A6 1288 Leiomyoma, Epithelioid MESH:D018230 marker/mechanism 17069596 +COL5A1 1289 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +COL5A1 1289 Carcinoma MESH:D002277 marker/mechanism 12376462 +COL5A1 1289 Ehlers-Danlos syndrome type 1 MESH:C536194 marker/mechanism 130000.0 20635400|8752669|9042913 +COL5A1 1289 Ehlers-Danlos syndrome type 2 MESH:C536195 marker/mechanism 8752669|9042913 +COL5A1 1289 Keloid MESH:D007627 marker/mechanism 20128793 +COL5A1 1289 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COL5A1 1289 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +COL5A1 1289 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +COL5A1 1289 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +COL5A1 1289 Rupture, Spontaneous MESH:D012422 marker/mechanism 20635400 +COL5A2 1290 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +COL5A2 1290 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +COL5A2 1290 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COL5A3 50509 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +COL6A1 1291 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +COL6A1 1291 Bethlem myopathy MESH:C535436 marker/mechanism 158810.0 +COL6A1 1291 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +COL6A1 1291 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COL6A1 1291 Lung Neoplasms MESH:D008175 marker/mechanism 23692979 +COL6A1 1291 Muscular Dystrophies MESH:D009136 marker/mechanism 20716577 +COL6A1 1291 Scleroatonic muscular dystrophy MESH:C537521 marker/mechanism 254090.0 +COL6A2 1292 Bethlem myopathy MESH:C535436 marker/mechanism 158810.0 +COL6A2 1292 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COL6A2 1292 Myosclerosis, Autosomal Recessive MESH:C564968 marker/mechanism 255600.0 +COL6A2 1292 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +COL6A2 1292 Scleroatonic muscular dystrophy MESH:C537521 marker/mechanism 254090.0 +COL6A3 1293 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +COL6A3 1293 Bethlem myopathy MESH:C535436 marker/mechanism 158810.0 +COL6A3 1293 Dystonia MESH:D004421 marker/mechanism 616411.0 +COL6A3 1293 Scleroatonic muscular dystrophy MESH:C537521 marker/mechanism 254090.0 +COL6A3 1293 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +COL7A1 1294 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +COL7A1 1294 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30381462 +COL7A1 1294 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500 +COL7A1 1294 Disease Progression MESH:D018450 marker/mechanism 30381462 +COL7A1 1294 Epidermolysis Bullosa Dystrophica MESH:D016108 marker/mechanism 226600.0 32947957 +COL7A1 1294 Epidermolysis bullosa dystrophica, Pasini type MESH:C535956 marker/mechanism 131750.0 +COL7A1 1294 Epidermolysis bullosa, pretibial MESH:C535494 marker/mechanism 131850.0 +COL7A1 1294 Epidermolysis Bullosa Pruriginosa MESH:C563192 marker/mechanism 604129.0 +COL7A1 1294 Epidermolysis Bullosa With Congenital Localized Absence Of Skin And Deformity Of Nails MESH:C562638 marker/mechanism 132000.0 +COL7A1 1294 Toenail Dystrophy, Isolated MESH:C564384 marker/mechanism 607523.0 +COL7A1 1294 Transient bullous dermolysis of the newborn MESH:C536979 marker/mechanism 131705.0 +COL8A1 1295 Congenital Abnormalities MESH:D000013 marker/mechanism 19035365 +COL8A1 1295 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +COL8A2 1296 Corneal dystrophy, Fuchs' endothelial, 1 MESH:C535478 marker/mechanism 136800.0 +COL8A2 1296 Corneal Dystrophy, Posterior Polymorphous, 2 MESH:C565176 marker/mechanism 609140.0 +COL9A1 1297 EPIPHYSEAL DYSPLASIA, MULTIPLE, 6 OMIM:614135 marker/mechanism 614135.0 +COL9A1 1297 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 16909383 +COL9A1 1297 Myopia MESH:D009216 marker/mechanism 16909383 +COL9A1 1297 Osteochondrodysplasias MESH:D010009 marker/mechanism 11565064|16909383 +COL9A1 1297 Retinal Diseases MESH:D012164 marker/mechanism 16909383 +COL9A1 1297 STICKLER SYNDROME, TYPE IV OMIM:614134 marker/mechanism 614134.0 +COL9A2 1298 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +COL9A2 1298 Epiphyseal dysplasia, multiple, 2 MESH:C535502 marker/mechanism 600204.0 +COL9A2 1298 STICKLER SYNDROME, TYPE V OMIM:614284 marker/mechanism 614284.0 +COL9A3 1299 Epiphyseal dysplasia, multiple, 3 MESH:C535503 marker/mechanism 600969.0 +COL9A3 1299 Intervertebral disc disease MESH:C535531 marker/mechanism 603932.0 +COLEC10 10584 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +COLEC10 10584 Malpuech facial clefting syndrome MESH:C535704 marker/mechanism 248340.0 +COLEC11 78989 Carnevale syndrome MESH:C535586 marker/mechanism 265050.0 21258343 +COLEC11 78989 Craniofacial Abnormalities MESH:D019465 marker/mechanism 21258343 +COLEC11 78989 Malpuech facial clefting syndrome MESH:C535704 marker/mechanism 21258343 +COLEC11 78989 Oculopalatoskeletal syndrome MESH:C537738 marker/mechanism 21258343 +COLEC11 78989 Pigmentation Disorders MESH:D010859 marker/mechanism 21258343 +COLEC12 81035 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COLEC12 81035 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +COLQ 8292 Diverticular Diseases MESH:D000076385 marker/mechanism 28585551 +COLQ 8292 Endplate Acetylcholinesterase Deficiency MESH:C566415 marker/mechanism|therapeutic 603034.0 22981737 +COMMD1 150684 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +COMMD1 150684 Dog Diseases MESH:D004283 marker/mechanism 17919502 +COMMD1 150684 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 23583003 +COMMD1 150684 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914|25053573 +COMMD1 150684 Hypersensitivity MESH:D006967 marker/mechanism 22216203 +COMMD1 150684 Liver Cirrhosis MESH:D008103 marker/mechanism 17919502 +COMP 1311 Epiphyseal dysplasia, multiple, 1 MESH:C535501 marker/mechanism 132400.0 7670472|9887340 +COMP 1311 Joint Instability MESH:D007593 marker/mechanism 9887340 +COMP 1311 Osteoarthritis MESH:D010003 marker/mechanism 7670472 +COMP 1311 Osteoarthritis, Hip MESH:D015207 marker/mechanism 28319091 +COMP 1311 Pseudoachondroplasia MESH:C535819 marker/mechanism 177170.0 7670471|7670472|9887340 +COMT 1312 Alcoholism MESH:D000437 marker/mechanism 10395222 +COMT 1312 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 15274053 +COMT 1312 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 10490706 +COMT 1312 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +COMT 1312 Autistic Disorder MESH:D001321 marker/mechanism 16917939 +COMT 1312 Bipolar Disorder MESH:D001714 marker/mechanism 11772685 +COMT 1312 Breast Neoplasms MESH:D001943 marker/mechanism 15455371|16077979|9407957 +COMT 1312 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15341023 +COMT 1312 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18704099 +COMT 1312 Cognition Disorders MESH:D003072 marker/mechanism 17123785 +COMT 1312 DiGeorge Syndrome MESH:D004062 marker/mechanism 8886163 +COMT 1312 Fetal Growth Retardation MESH:D005317 marker/mechanism 23667712 +COMT 1312 HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO OMIM:613290 marker/mechanism 19898482 +COMT 1312 Hyperalgesia MESH:D006930 marker/mechanism 28195063 +COMT 1312 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 18424824 +COMT 1312 Memory Disorders MESH:D008569 marker/mechanism 28195063 +COMT 1312 Mental Disorders MESH:D001523 marker/mechanism 16780746 +COMT 1312 Musculoskeletal Pain MESH:D059352 marker/mechanism 25218601 +COMT 1312 Pain MESH:D010146 marker/mechanism 20561508 +COMT 1312 Panic Disorder MESH:D016584 marker/mechanism 167870.0 +COMT 1312 Pheochromocytoma MESH:D010673 marker/mechanism 22569243 +COMT 1312 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +COMT 1312 Schizophrenia MESH:D012559 marker/mechanism 181500.0 16234811|17123785|18583979|20561508 +COMT 1312 Schizophrenia Spectrum and Other Psychotic Disorders MESH:D019967 marker/mechanism 28195063 +COMT 1312 Temporomandibular Joint Disorders MESH:D013705 marker/mechanism 25218601 +COP1 64326 Autistic Disorder MESH:D001321 marker/mechanism 19404257 +COPA 1314 Arthritis MESH:D001168 marker/mechanism 25894502 +COPA 1314 Autoimmune Diseases MESH:D001327 marker/mechanism 25894502 +COPA 1314 AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE OMIM:616414 marker/mechanism 616414.0 +COPA 1314 Lung Diseases, Interstitial MESH:D017563 marker/mechanism 25894502 +COPG1 22820 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26463840 +COPG2 26958 Weight Gain MESH:D015430 marker/mechanism 19030233 +COPS2 9318 Endometriosis MESH:D004715 marker/mechanism 22138541 +COPS3 8533 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +COPS5 10987 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20698225 +COPS5 10987 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +COPS6 10980 HIV Infections MESH:D015658 marker/mechanism 15308739 +COPS7A 50813 Disease Progression MESH:D018450 marker/mechanism 21364753 +COPS7A 50813 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +COQ10A 93058 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COQ2 27235 COENZYME Q10 DEFICIENCY, PRIMARY, 1 OMIM:607426 marker/mechanism 607426.0 +COQ2 27235 Multiple System Atrophy MESH:D019578 marker/mechanism 146500.0 +COQ4 51117 COENZYME Q10 DEFICIENCY, PRIMARY, 7 OMIM:616276 marker/mechanism 616276.0 +COQ5 84274 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +COQ6 51004 COENZYME Q10 DEFICIENCY, PRIMARY, 6 OMIM:614650 marker/mechanism 614650.0 +COQ7 10229 COENZYME Q10 DEFICIENCY, PRIMARY, 8 OMIM:616733 marker/mechanism 616733.0 +COQ8A 56997 COENZYME Q10 DEFICIENCY, PRIMARY, 1 OMIM:607426 marker/mechanism 18319072 +COQ8A 56997 COENZYME Q10 DEFICIENCY, PRIMARY, 4 OMIM:612016 marker/mechanism 612016.0 +COQ8B 79934 NEPHROTIC SYNDROME, TYPE 9 OMIM:615573 marker/mechanism 615573.0 +COQ9 57017 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +COQ9 57017 COENZYME Q10 DEFICIENCY, PRIMARY, 5 OMIM:614654 marker/mechanism 614654.0 +CORIN 10699 Pre-Eclampsia MESH:D011225 marker/mechanism 614595.0 +CORO1A 11151 Carcinoma MESH:D002277 marker/mechanism 21489049 +CORO1A 11151 IMMUNODEFICIENCY 8 WITH LYMPHOPROLIFERATION OMIM:615401 marker/mechanism 615401.0 +CORO1A 11151 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 21489049 +CORO1A 11151 Tuberculosis MESH:D014376 marker/mechanism 16040207 +CORO1C 23603 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427 +CORO1C 23603 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +COTL1 23406 Breast Neoplasms MESH:D001943 marker/mechanism 20562527 +COTL1 23406 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +COX1 4512 Carcinoma MESH:D002277 marker/mechanism 12376462 +COX1 4512 Cardiomyopathies MESH:D009202 marker/mechanism 14568902 +COX1 4512 Deafness, Sensorineural, Autosomal-Mitochondrial Type MESH:C565637 marker/mechanism 500008.0 +COX1 4512 Hypertrophy MESH:D006984 therapeutic 20582486 +COX1 4512 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +COX1 4512 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +COX1 4512 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +COX15 1355 Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency MESH:C565784 marker/mechanism 615119.0 +COX17 10063 Hepatitis, Chronic MESH:D006521 marker/mechanism 25053573 +COX17 10063 Lung Neoplasms MESH:D008175 marker/mechanism 23624903 +COX2 4513 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14563825 +COX2 4513 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +COX2 4513 Neuroblastoma MESH:D009447 marker/mechanism 15492235 +COX3 4514 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 17092649 +COX3 4514 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +COX3 4514 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 535000.0 +COX4I2 84701 Exocrine Pancreatic Insufficiency, Dyserythropoietic Anemia, and Calvarial Hyperostosis MESH:C567195 marker/mechanism 612714.0 +COX5B 1329 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +COX6A1 1337 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D OMIM:616039 marker/mechanism 616039.0 +COX7B 1349 LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2 OMIM:300887 marker/mechanism 300887.0 +COX7B 1349 Microphthalmia, syndromic 7 MESH:C537466 marker/mechanism 309801.0 +COX7B2 170712 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +COX7C 1350 Obesity MESH:D009765 marker/mechanism 20882379 +CP 1356 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +CP 1356 Albuminuria MESH:D000419 marker/mechanism 21752484 +CP 1356 Arthritis, Experimental MESH:D001169 marker/mechanism 19330884 +CP 1356 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 26001728 +CP 1356 Ataxia MESH:D001259 marker/mechanism 12572680 +CP 1356 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CP 1356 Autistic Disorder MESH:D001321 marker/mechanism 15363659 +CP 1356 Brain Diseases MESH:D001927 marker/mechanism 19005224 +CP 1356 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19229483 +CP 1356 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +CP 1356 Colonic Neoplasms MESH:D003110 marker/mechanism 23792645 +CP 1356 Deficiency Diseases MESH:D003677 marker/mechanism 12514262 +CP 1356 Dementia MESH:D003704 marker/mechanism 12572680 +CP 1356 Diabetes Mellitus MESH:D003920 marker/mechanism 12572680 +CP 1356 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 20012460 +CP 1356 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +CP 1356 Dyskinesias MESH:D020820 marker/mechanism 12572680 +CP 1356 Familial apoceruloplasmin deficiency MESH:C536004 marker/mechanism 604290.0 12572680|20801540|22243965 +CP 1356 Hemochromatosis MESH:D006432 marker/mechanism 17258727 +CP 1356 Hepatitis, Chronic MESH:D006521 marker/mechanism 25053573 +CP 1356 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 22243965|23519153|7849148 +CP 1356 Iron Metabolism Disorders MESH:D019189 marker/mechanism 16988052 +CP 1356 Iron Overload MESH:D019190 marker/mechanism 20801540 +CP 1356 Ischemia MESH:D007511 marker/mechanism 15668637|18091701 +CP 1356 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513|26396155 +CP 1356 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 23792645 +CP 1356 Melanoma MESH:D008545 marker/mechanism 23792645 +CP 1356 Menkes Kinky Hair Syndrome MESH:D007706 marker/mechanism 22243965 +CP 1356 Nerve Degeneration MESH:D009410 therapeutic 18804145 +CP 1356 Parkinson Disease MESH:D010300 marker/mechanism 19159062|25758665 +CP 1356 Pasteurellaceae Infections MESH:D016871 marker/mechanism 16755360 +CP 1356 Pre-Eclampsia MESH:D011225 marker/mechanism 18679377 +CP 1356 Psoriasis MESH:D011565 marker/mechanism 12559600 +CP 1356 Retinal Degeneration MESH:D012162 marker/mechanism 12572680 +CP 1356 Schizophrenia MESH:D012559 marker/mechanism 16842975 +CPA1 1357 Pancreatitis, Chronic MESH:D050500 marker/mechanism 23955596 +CPA2 1358 Hypoxia MESH:D000860 marker/mechanism 19579223 +CPA6 57094 EPILEPSY, FAMILIAL TEMPORAL LOBE, 5 OMIM:614417 marker/mechanism 614417.0 +CPA6 57094 FEBRILE SEIZURES, FAMILIAL, 11 OMIM:614418 marker/mechanism 614418.0 +CPAMD8 27151 Anterior segment mesenchymal dysgenesis MESH:C537775 marker/mechanism 617319.0 +CPAMD8 27151 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +CPB2 1361 Amenorrhea MESH:D000568 marker/mechanism 16167916 +CPB2 1361 Obesity MESH:D009765 marker/mechanism 16959692 +CPE 1363 Endocrine System Diseases MESH:D004700 marker/mechanism 15358678 +CPE 1363 Insulin Resistance MESH:D007333 marker/mechanism 15358678 +CPE 1363 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +CPE 1363 Obesity MESH:D009765 marker/mechanism 15358678|23434795 +CPEB1 64506 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 20062064 +CPEB3 22849 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CPED1 79974 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +CPLANE1 65250 Orofaciodigital syndrome 6 MESH:C536531 marker/mechanism 277170.0 +CPLX1 10815 Bipolar Disorder MESH:D001714 marker/mechanism 14708030 +CPLX1 10815 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +CPLX1 10815 Schizophrenia MESH:D012559 marker/mechanism 14708030 +CPLX1 10815 Wolf-Hirschhorn Syndrome MESH:D054877 marker/mechanism 194190.0 +CPLX2 10814 Bipolar Disorder MESH:D001714 marker/mechanism 14708030 +CPLX2 10814 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +CPLX2 10814 Schizophrenia MESH:D012559 marker/mechanism 11483314|14708030 +CPM 1368 Endometriosis MESH:D004715 marker/mechanism 20864642 +CPM 1368 Silicosis MESH:D012829 marker/mechanism 24986923 +CPN1 1369 Carboxypeptidase N Deficiency MESH:C562876 marker/mechanism 212070.0 +CPNE3 8895 Prostatic Neoplasms MESH:D011471 marker/mechanism 18264096 +CPOX 1371 Coproporphyria, Hereditary MESH:D046349 marker/mechanism 121300.0 11831056 +CPOX 1371 Porphyria Cutanea Tarda MESH:D017119 marker/mechanism 11831056 +CPQ 10404 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25401301 +CPQ 10404 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CPR 33883 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +CPR64AA 38508 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +CPR66D 38990 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +CPS1 1373 Carbamoyl-Phosphate Synthase I Deficiency Disease MESH:D020165 marker/mechanism 237300.0 17310273|8486760 +CPS1 1373 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CPS1 1373 Coma MESH:D003128 marker/mechanism 8438805 +CPS1 1373 Endotoxemia MESH:D019446 marker/mechanism 16741687 +CPS1 1373 Hyperammonemia MESH:D022124 marker/mechanism 17310273|8486760 +CPS1 1373 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15650968 +CPS1 1373 Persistent Fetal Circulation Syndrome MESH:D010547 marker/mechanism 11407344 +CPS1 1373 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +CPS1 1373 PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO OMIM:615371 marker/mechanism 615371.0 +CPSF1 29894 Disease Progression MESH:D018450 marker/mechanism 21364753 +CPSF1 29894 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +CPT1A 1374 Breast Neoplasms MESH:D001943 marker/mechanism 25151356 +CPT1A 1374 Carnitine palmitoyl transferase 1A deficiency MESH:C535588 marker/mechanism 255120.0 +CPT1A 1374 Diabetes Mellitus MESH:D003920 marker/mechanism 19233164 +CPT1A 1374 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +CPT1A 1374 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +CPT1A 1374 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +CPT1A 1374 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29289645 +CPT1B 1375 Cardiomegaly MESH:D006332 marker/mechanism 24330405 +CPT1B 1375 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14563825 +CPT1B 1375 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +CPT1B 1375 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CPT1B 1375 Narcolepsy MESH:D009290 marker/mechanism 18820697 +CPT1C 126129 Melanoma MESH:D008545 marker/mechanism 16778180 +CPT1C 126129 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +CPT1C 126129 SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT OMIM:616282 marker/mechanism 616282.0 +CPT2 1376 Brain Diseases, Metabolic MESH:D001928 marker/mechanism 21816645 +CPT2 1376 Carnitine Palmitoyltransferase II Deficiency, Infantile MESH:C563462 marker/mechanism 600649.0 +CPT2 1376 Carnitine Palmitoyltransferase II Deficiency, Late-Onset MESH:C563461 marker/mechanism 255110.0 +CPT2 1376 Carnitine Palmitoyltransferase II Deficiency, Lethal Neonatal MESH:C563463 marker/mechanism 608836.0 +CPT2 1376 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4 OMIM:614212 marker/mechanism 614212.0 +CPT2 1376 Muscular Diseases MESH:D009135 marker/mechanism 18380285 +CR1 1378 Alzheimer Disease MESH:D000544 marker/mechanism 19734903|21460841 +CR1 1378 Cognitive Dysfunction MESH:D060825 marker/mechanism 30503753 +CR1 1378 Malaria MESH:D008288 marker/mechanism 611162 +CR1 1378 Malaria, Falciparum MESH:D016778 marker/mechanism 11724985|9230440 +CR2 1380 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 240500|614699 +CR2 1380 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 610927 +CRABP1 1381 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 16254461 +CRABP1 1381 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 17438526 +CRABP1 1381 Keloid MESH:D007627 marker/mechanism 20128793 +CRABP1 1381 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +CRABP2 1382 Methylmalonic acidemia MESH:C537358 marker/mechanism 16823967 +CRABP2 1382 Ovarian Neoplasms MESH:D010051 marker/mechanism 35442568 +CRABP2 1382 Recurrence MESH:D012008 marker/mechanism 8400267 +CRADD 8738 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 20208132 +CRADD 8738 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY OMIM:614499 marker/mechanism 614499 +CRB1 23418 Leber Congenital Amaurosis MESH:D057130 marker/mechanism 11389483 +CRB1 23418 LEBER CONGENITAL AMAUROSIS 8 OMIM:613835 marker/mechanism 613835.0 +CRB1 23418 Pigmented Paravenous Chorioretinal Atrophy MESH:C566801 marker/mechanism 172870.0 +CRB1 23418 Retinal Detachment MESH:D012163 marker/mechanism 11389483 +CRB1 23418 Retinal Telangiectasis MESH:D058456 marker/mechanism 11389483 +CRB1 23418 Retinitis Pigmentosa MESH:D012174 marker/mechanism 10508521|11389483|16272259 +CRB1 23418 Retinitis Pigmentosa 12 MESH:C563999 marker/mechanism 600105.0 +CRB2 286204 Cystic Kidney Disease with Ventriculomegaly MESH:C565657 marker/mechanism 219730.0 +CRB2 286204 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 616220.0 +CRBN 51185 Abnormalities, Drug-Induced MESH:D000014 marker/mechanism 27751757 +CRBN 51185 Mental Retardation, Autosomal Recessive 2 MESH:C564404 marker/mechanism 607417.0 +CRBN 51185 Multiple Myeloma MESH:D009101 marker/mechanism 26186254 +CRBN 51185 Nervous System Malformations MESH:D009421 marker/mechanism 27751757 +CREB1 1385 Cocaine-Related Disorders MESH:D019970 marker/mechanism 11717377|16359811|18596687 +CREB1 1385 Histiocytoma, Angiomatoid Fibrous MESH:C563181 marker/mechanism 612160.0 +CREB1 1385 Melanoma, Cutaneous Malignant MESH:C562393 marker/mechanism 29179997 +CREB1 1385 Morphine Dependence MESH:D009021 marker/mechanism 11717377 +CREB1 1385 Myocardial Infarction MESH:D009203 marker/mechanism 19027736 +CREB1 1385 Neoplasm Metastasis MESH:D009362 marker/mechanism 29179997 +CREB1 1385 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 18596687 +CREB1.S 379764 Hyperpigmentation MESH:D017495 marker/mechanism 26443706 +CREB3L4 148327 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 27415467 +CREB3L4 148327 Prostatic Neoplasms MESH:D011471 marker/mechanism 27415467 +CREB5 9586 Abortion, Habitual MESH:D000026 marker/mechanism 30100398 +CREB5 9586 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +CREBBP 1387 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +CREBBP 1387 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +CREBBP 1387 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +CREBBP 1387 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27158780 +CREBBP 1387 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 21822268 +CREBBP 1387 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +CREBBP 1387 Lymphoma, Follicular MESH:D008224 marker/mechanism 24362818 +CREBBP 1387 Prostatic Neoplasms MESH:D011471 marker/mechanism 15378487|25735316 +CREBBP 1387 Rubinstein-Taybi Syndrome MESH:D012415 marker/mechanism 180849.0 +CREBBP 1387 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +CREBBP 1387 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941188 +CREBBP 1387 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21822268 +CREG1 8804 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +CREG1 8804 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CRELD1 78987 Atrioventricular Septal Defect, Partial, with Heterotaxy Syndrome MESH:C565249 marker/mechanism 606217.0 +CREM 1390 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CREM 1390 Chloracne MESH:D054506 marker/mechanism 17101203 +CREM 1390 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +CREM 1390 Diabetic Angiopathies MESH:D003925 marker/mechanism 25381014 +CREM 1390 Hypertrophy MESH:D006984 therapeutic 12791704 +CREM 1390 Myocardial Infarction MESH:D009203 marker/mechanism 19027736 +CRH 1392 Alopecia MESH:D000505 marker/mechanism 21359208 +CRH 1392 Alzheimer Disease MESH:D000544 therapeutic 7477348 +CRH 1392 Anorexia MESH:D000855 marker/mechanism 16420149 +CRH 1392 Anxiety Disorders MESH:D001008 marker/mechanism 11440811|11875628|12424556|12438692|14575894|16495007|17293045|21268831|22231481|7816204|8736133 +CRH 1392 Bradycardia MESH:D001919 marker/mechanism 6093200 +CRH 1392 Chest Pain MESH:D002637 marker/mechanism 2563132 +CRH 1392 Cocaine-Related Disorders MESH:D019970 marker/mechanism 10516337|11797056|18596687|19349312|7796157 +CRH 1392 Cognition Disorders MESH:D003072 marker/mechanism 16039799 +CRH 1392 Cushing Syndrome MESH:D003480 marker/mechanism 21359208 +CRH 1392 Depressive Disorder MESH:D003866 marker/mechanism 12438692|18698320 +CRH 1392 Fever MESH:D005334 marker/mechanism 11852909 +CRH 1392 Hypotension MESH:D007022 marker/mechanism 1320258|6093200 +CRH 1392 Movement Disorders MESH:D009069 marker/mechanism 21618986 +CRH 1392 Pain MESH:D010146 therapeutic 16495007 +CRH 1392 Pituitary Apoplexy MESH:D010899 marker/mechanism 12699433|12699434 +CRH 1392 Psychomotor Disorders MESH:D011596 therapeutic 1335535 +CRH 1392 Puberty, Delayed MESH:D011628 marker/mechanism 20002962 +CRH 1392 Retinitis MESH:D012173 marker/mechanism 11384150 +CRH 1392 Seizures MESH:D012640 marker/mechanism 11074187|1596084|1700951|1914160|7821275|8923670 +CRH 1392 Spasms, Infantile MESH:D013036 marker/mechanism 11341487 +CRH 1392 Status Epilepticus MESH:D013226 marker/mechanism 7756609 +CRH 1392 Stereotypic Movement Disorder MESH:D019956 marker/mechanism 1914160 +CRH 1392 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 12968131|18596687 +CRH 1392 Weight Loss MESH:D015431 marker/mechanism 8986836 +CRHBP 1393 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CRHBP 1393 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17437087 +CRHR1 1394 Anorexia MESH:D000855 marker/mechanism 16420149 +CRHR1 1394 Anxiety Disorders MESH:D001008 marker/mechanism 22231481|9299637 +CRHR1 1394 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +CRHR1 1394 Cocaine-Related Disorders MESH:D019970 marker/mechanism 19339610 +CRHR1 1394 Depressive Disorder, Major MESH:D003865 marker/mechanism 23529111 +CRHR1 1394 Dermatitis, Contact MESH:D003877 marker/mechanism 12631246 +CRHR1 1394 Hyperalgesia MESH:D006930 marker/mechanism 28434951 +CRHR1 1394 Hyperkinesis MESH:D006948 marker/mechanism 19339610 +CRHR1 1394 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30664745 +CRHR1 1394 Pain, Postoperative MESH:D010149 marker/mechanism 28434951 +CRHR2 1395 Anorexia MESH:D000855 marker/mechanism 17627984 +CRHR2 1395 Anxiety Disorders MESH:D001008 marker/mechanism 10742108 +CRHR2 1395 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17437087 +CRHR2 1395 Hypertension MESH:D006973 marker/mechanism 10742107 +CRHR2 1395 Inflammation MESH:D007249 therapeutic 16855006 +CRHR2 1395 Lung Diseases MESH:D008171 therapeutic 16855006 +CRIP 44892 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CRIPTO 6997 Heterotaxy Syndrome MESH:D059446 marker/mechanism 11062482 +CRIPTO 6997 Holoprosencephaly MESH:D016142 marker/mechanism 12073012 +CRISP3 10321 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CRISP3 10321 Pregnancy, Ectopic MESH:D011271 marker/mechanism 19282327 +CRISPLD2 83716 Liver Diseases MESH:D008107 marker/mechanism 19784758 +CRISPLD2 83716 Lung Diseases MESH:D008171 marker/mechanism 21069352 +CRISPLD2 83716 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +CRK 1398 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CRKL 1399 DiGeorge Syndrome MESH:D004062 marker/mechanism 16399080 +CRLF1 9244 Crisponi syndrome MESH:C536214 marker/mechanism 272430.0 +CRLF2 64109 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 24141364 +CRLF2 64109 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 19838194 +CRLF2 64109 Recurrence MESH:D012008 marker/mechanism 22904298 +CRMP 40675 Purine-Pyrimidine Metabolism, Inborn Errors MESH:D011686 marker/mechanism 16361227 +CRN 12935 Neural Tube Defects MESH:D009436 marker/mechanism 3902948 +CROT 54677 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CRP 1401 Acute Coronary Syndrome MESH:D054058 marker/mechanism 15966572|23305094 +CRP 1401 Anxiety Disorders MESH:D001008 marker/mechanism 20194079 +CRP 1401 Arsenic Poisoning MESH:D020261 marker/mechanism 22521605 +CRP 1401 Arthritis, Experimental MESH:D001169 marker/mechanism 19330884 +CRP 1401 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 1568518 +CRP 1401 Atherosclerosis MESH:D050197 marker/mechanism 16931792 +CRP 1401 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +CRP 1401 Cardiovascular Diseases MESH:D002318 marker/mechanism 12876635|16332659|29114965 +CRP 1401 Cerebrovascular Disorders MESH:D002561 marker/mechanism 29114965 +CRP 1401 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CRP 1401 Coronary Artery Disease MESH:D003324 marker/mechanism 24868163 +CRP 1401 COVID-19 MESH:D000086382 marker/mechanism 32534021 +CRP 1401 Crohn Disease MESH:D003424 marker/mechanism 11339241 +CRP 1401 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 20012460 +CRP 1401 Diabetic Retinopathy MESH:D003930 marker/mechanism 20012460 +CRP 1401 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +CRP 1401 Heart Diseases MESH:D006331 marker/mechanism 17388968 +CRP 1401 Heart Failure MESH:D006333 marker/mechanism 16360360 +CRP 1401 Hyperparathyroidism, Secondary MESH:D006962 marker/mechanism 21350317 +CRP 1401 Hypertension MESH:D006973 marker/mechanism 14620923|16680063|19770776|20667508 +CRP 1401 Hypertriglyceridemia MESH:D015228 therapeutic 11893366 +CRP 1401 Infections MESH:D007239 marker/mechanism 3285537 +CRP 1401 Inflammation MESH:D007249 marker/mechanism 14970111|16125490|21437516 +CRP 1401 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19539174 +CRP 1401 Leishmaniasis MESH:D007896 marker/mechanism 17218153 +CRP 1401 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 10467834 +CRP 1401 Lung Neoplasms MESH:D008175 marker/mechanism 17114654 +CRP 1401 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 17718048 +CRP 1401 Malaria MESH:D008288 marker/mechanism 8730300 +CRP 1401 Meningitis MESH:D008581 marker/mechanism 14513990 +CRP 1401 Metabolic Diseases MESH:D008659 marker/mechanism 19131468 +CRP 1401 Metabolic Syndrome MESH:D024821 marker/mechanism 16644639 +CRP 1401 Myocardial Ischemia MESH:D017202 marker/mechanism 11840375 +CRP 1401 Myocarditis MESH:D009205 marker/mechanism 20361910 +CRP 1401 Nephritis, Interstitial MESH:D009395 marker/mechanism 17014549 +CRP 1401 Obesity MESH:D009765 marker/mechanism 24042701 +CRP 1401 Pasteurellaceae Infections MESH:D016871 marker/mechanism 16755360 +CRP 1401 Periodontitis MESH:D010518 marker/mechanism 20011938 +CRP 1401 Psoriasis MESH:D011565 marker/mechanism 12559600 +CRP 1401 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 29329563 +CRP 1401 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +CRP 1401 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 12858318 +CRP 1401 Thrombosis MESH:D013927 marker/mechanism 16931792 +CRPPA 729920 Eye Abnormalities MESH:D005124 marker/mechanism 22522421 +CRPPA 729920 Hydrocephalus MESH:D006849 marker/mechanism 22522421 +CRPPA 729920 Muscular Diseases MESH:D009135 marker/mechanism 22522421 +CRPPA 729920 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7 OMIM:616052 marker/mechanism 616052.0 +CRPPA 729920 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 614643.0 22522420|22522421 +CRTAP 10491 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CRTAP 10491 Osteogenesis Imperfecta MESH:D010013 marker/mechanism 18566967 +CRTAP 10491 Osteogenesis Imperfecta Type VII MESH:C565200 marker/mechanism 610682.0 +CRTC1 23373 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 24121790 +CRX 1406 CONE-ROD DYSTROPHY 2 OMIM:120970 marker/mechanism 120970.0 +CRX 1406 Leber Congenital Amaurosis MESH:D057130 marker/mechanism 9537410|9931337 +CRX 1406 LEBER CONGENITAL AMAUROSIS 7 OMIM:613829 marker/mechanism 613829.0 +CRX 1406 Retinal Degeneration MESH:D012162 marker/mechanism 9792858 +CRX 1406 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 +CRY1 1407 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 16999817 +CRY1 1407 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CRY1 1407 Sleep Disorders, Circadian Rhythm MESH:D020178 marker/mechanism 614163.0 +CRY2 1408 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 16999817 +CRYAA 1409 Autoimmune Diseases MESH:D001327 marker/mechanism 21850155 +CRYAA 1409 Cataract MESH:D002386 marker/mechanism 9467006 +CRYAA 1409 Cataract, Autosomal Dominant MESH:C565815 marker/mechanism 604219.0 +CRYAA 1409 Uveitis MESH:D014605 marker/mechanism 19578012|21850155 +CRYAB 1410 Alpha-B Crystallinopathy MESH:C563848 marker/mechanism 608810.0 +CRYAB 1410 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +CRYAB 1410 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +CRYAB 1410 CARDIOMYOPATHY, DILATED, 1II OMIM:615184 marker/mechanism 615184.0 +CRYAB 1410 Cataract MESH:D002386 marker/mechanism 11577372 +CRYAB 1410 CATARACT 16, MULTIPLE TYPES OMIM:613763 marker/mechanism 613763.0 +CRYAB 1410 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +CRYAB 1410 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +CRYAB 1410 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CRYAB 1410 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +CRYAB 1410 MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED OMIM:613869 marker/mechanism 613869.0 +CRYAB 1410 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +CRYAB 1410 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +CRYAB 1410 Tongue Neoplasms MESH:D014062 marker/mechanism 19840781 +CRYBA1 1411 Cataract, Congenital Zonular, with Sutural Opacities MESH:C563435 marker/mechanism 600881.0 +CRYBA2 1412 CATARACT 42 OMIM:115900 marker/mechanism 115900.0 +CRYBA4 1413 CATARACT 23, MULTIPLE TYPES OMIM:610425 marker/mechanism 610425.0 +CRYBB1 1414 Cataract MESH:D002386 marker/mechanism 12360425 +CRYBB1 1414 Cataract, Congenital Nuclear, Autosomal Recessive 3 MESH:C566923 marker/mechanism 611544.0 +CRYBB2 1415 Autoimmune Diseases MESH:D001327 marker/mechanism 21850155 +CRYBB2 1415 CATARACT 3, MULTIPLE TYPES OMIM:601547 marker/mechanism 601547.0 +CRYBB2 1415 Cerulean cataract MESH:C537955 marker/mechanism 9158139 +CRYBB2 1415 Uveitis MESH:D014605 marker/mechanism 19578012|21850155 +CRYBB3 1417 Cataract, Congenital Nuclear, Autosomal Recessive 2 MESH:C565725 marker/mechanism 609741.0 +CRYBG1 202 Disease Progression MESH:D018450 marker/mechanism 22402438 +CRYBG1 202 Melanoma MESH:D008545 marker/mechanism 22402438 +CRYGB 1419 CATARACT 39, MULTIPLE TYPES OMIM:615188 marker/mechanism 615188.0 +CRYGC 1420 Cataract MESH:D002386 marker/mechanism 10914683|11773036 +CRYGC 1420 Cataract, Coppock-Like MESH:C565133 marker/mechanism 604307.0 +CRYGD 1421 Cataract MESH:D002386 marker/mechanism 30242128|9927684 +CRYGD 1421 CATARACT 4, MULTIPLE TYPES OMIM:115700 marker/mechanism 115700.0 +CRYGD 1421 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +CRYGF 12969 Cataract MESH:D002386 marker/mechanism 12202521 +CRYGS 1427 Cataract MESH:D002386 marker/mechanism 16141006 +CRYGS 1427 CATARACT 20, MULTIPLE TYPES OMIM:116100 marker/mechanism 116100.0 +CRYL1 51084 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +CRYL1 51084 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CRYM 1428 DEAFNESS, AUTOSOMAL DOMINANT 40 OMIM:616357 marker/mechanism 616357.0 +CRYM 1428 Heart Failure MESH:D006333 marker/mechanism 36071497 +CRYZ 1429 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CS 1431 Cardiomyopathies MESH:D009202 marker/mechanism 14568902 +CS 1431 Heart Failure MESH:D006333 marker/mechanism 8922916 +CS 1431 Hypoxia MESH:D000860 marker/mechanism 19579223 +CS 1431 Obesity MESH:D009765 marker/mechanism 20882379 +CSAD 51380 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CSE1L 1434 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34022224 +CSF1 1435 Breast Neoplasms MESH:D001943 marker/mechanism 16618760 +CSF1 1435 Cardiotoxicity MESH:D066126 marker/mechanism 32068018 +CSF1 1435 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +CSF1 1435 Osteitis Deformans MESH:D010001 marker/mechanism 20436471 +CSF1R 1436 Breast Neoplasms MESH:D001943 marker/mechanism 16618760 +CSF1R 1436 Hereditary Diffuse Leukoencephalopathy with Spheroids MESH:C580150 marker/mechanism 221820.0 +CSF1R 1436 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 1390197 +CSF1R 1436 Leukoencephalopathies MESH:D056784 marker/mechanism 22197934 +CSF1R 1436 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CSF1R 1436 Neoplasm Metastasis MESH:D009362 marker/mechanism 1390197 +CSF1R 1436 Neoplasms MESH:D009369 marker/mechanism 1390197 +CSF2 1437 Agranulocytosis MESH:D000380 marker/mechanism 11732872|8120554 +CSF2 1437 Amnesia MESH:D000647 therapeutic 8877002 +CSF2 1437 Anemia MESH:D000740 marker/mechanism 11732872|8297739 +CSF2 1437 Anemia, Aplastic MESH:D000741 therapeutic 12221670|9885444 +CSF2 1437 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22446963 +CSF2 1437 Breast Neoplasms MESH:D001943 therapeutic 11325840 +CSF2 1437 Carcinoma MESH:D002277 therapeutic 11605069 +CSF2 1437 Colorectal Neoplasms MESH:D015179 therapeutic 15289873 +CSF2 1437 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 7960606 +CSF2 1437 Eyelid Diseases MESH:D005141 therapeutic 17075842 +CSF2 1437 Gastrointestinal Hemorrhage MESH:D006471 marker/mechanism 11732872 +CSF2 1437 Heart Failure MESH:D006333 marker/mechanism 11732872 +CSF2 1437 Inflammation MESH:D007249 marker/mechanism 23159501 +CSF2 1437 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 17404324 +CSF2 1437 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 21441929 +CSF2 1437 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 22315502 +CSF2 1437 Liver Neoplasms MESH:D008113 therapeutic 17326190 +CSF2 1437 Lymphoma, AIDS-Related MESH:D016483 therapeutic 7680712|9817281 +CSF2 1437 Lymphoma, Non-Hodgkin MESH:D008228 therapeutic 11486401|11732872|7680712 +CSF2 1437 Melanoma MESH:D008545 therapeutic 11061616 +CSF2 1437 Mucositis MESH:D052016 marker/mechanism 8120554 +CSF2 1437 Multiple Myeloma MESH:D009101 therapeutic 7540856|8104070|8555506 +CSF2 1437 Muscle Weakness MESH:D018908 marker/mechanism 8622042 +CSF2 1437 Neoplasm, Residual MESH:D018365 therapeutic 14654953 +CSF2 1437 Neural Tube Defects MESH:D009436 therapeutic 17075842 +CSF2 1437 Neutropenia MESH:D009503 therapeutic 11264156|7875148 +CSF2 1437 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615 +CSF2 1437 Pain MESH:D010146 marker/mechanism 8622042 +CSF2 1437 Pneumonia MESH:D011014 marker/mechanism 11732872 +CSF2 1437 Psoriasis MESH:D011565 marker/mechanism 7744320 +CSF2 1437 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17894541 +CSF2 1437 Sarcoma MESH:D012509 therapeutic 11605069 +CSF2 1437 Thrombocytopenia MESH:D013921 marker/mechanism 8297739 +CSF2 1437 Thyroid Neoplasms MESH:D013964 marker/mechanism 26037280 +CSF2 1437 Venous Thrombosis MESH:D020246 marker/mechanism 8120554 +CSF2RA 1438 Pulmonary Alveolar Proteinosis MESH:D011649 marker/mechanism 29484482 +CSF2RA 1438 Surfactant Metabolism Dysfunction, Pulmonary, 4 MESH:C567461 marker/mechanism 300770.0 +CSF2RB 1439 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5 OMIM:614370 marker/mechanism 614370.0 +CSF3 1440 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CSF3 1440 Agranulocytosis MESH:D000380 therapeutic 15999287 +CSF3 1440 Anemia MESH:D000740 marker/mechanism 12085204|16076697|17047649 +CSF3 1440 Anemia, Aplastic MESH:D000741 marker/mechanism|therapeutic 10544668|10629575|15863969|1642096|16553037|9777751 +CSF3 1440 Arthralgia MESH:D018771 marker/mechanism 7543699 +CSF3 1440 Bone Marrow Neoplasms MESH:D019046 marker/mechanism 20026017 +CSF3 1440 Brain Injuries MESH:D001930 marker/mechanism 21549006 +CSF3 1440 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 12926135|16076697|16298037|17047649|7541186|7543699|7692001|9018096 +CSF3 1440 Carcinoma MESH:D002277 therapeutic 9018096 +CSF3 1440 Carcinoma, Non-Small-Cell Lung MESH:D002289 therapeutic 7692001 +CSF3 1440 Carcinoma, Transitional Cell MESH:D002295 therapeutic 7525883|7543010 +CSF3 1440 Cardiomyopathy, Dilated MESH:D002311 therapeutic 17334414 +CSF3 1440 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 20005281 +CSF3 1440 COVID-19 MESH:D000086382 marker/mechanism 31986264 +CSF3 1440 Depressive Disorder MESH:D003866 marker/mechanism 9018096 +CSF3 1440 Diarrhea MESH:D003967 marker/mechanism 7543699 +CSF3 1440 Disease Models, Animal MESH:D004195 therapeutic 27737899 +CSF3 1440 Disease Susceptibility MESH:D004198 marker/mechanism 20026017 +CSF3 1440 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism|therapeutic 27737899|31557154|7692001 +CSF3 1440 Esophageal Neoplasms MESH:D004938 therapeutic 7692001 +CSF3 1440 Fever MESH:D005334 marker/mechanism 9740541 +CSF3 1440 Fibrosis MESH:D005355 therapeutic 18785976|20005281 +CSF3 1440 Gastrointestinal Diseases MESH:D005767 marker/mechanism 17047649 +CSF3 1440 Headache MESH:D006261 marker/mechanism 10864982 +CSF3 1440 Head and Neck Neoplasms MESH:D006258 therapeutic 7692001 +CSF3 1440 Heart Diseases MESH:D006331 therapeutic 19429242 +CSF3 1440 Heart Failure MESH:D006333 marker/mechanism 15585077 +CSF3 1440 Hemangiosarcoma MESH:D006394 therapeutic 9774950 +CSF3 1440 Hepatic Veno-Occlusive Disease MESH:D006504 marker/mechanism 8602625 +CSF3 1440 Hodgkin Disease MESH:D006689 therapeutic 17562247 +CSF3 1440 Hyperbilirubinemia MESH:D006932 marker/mechanism 8602625 +CSF3 1440 Hypertrophy MESH:D006984 therapeutic 18785976 +CSF3 1440 Infarction MESH:D007238 therapeutic 15135374 +CSF3 1440 Kidney Diseases MESH:D007674 therapeutic 19429242 +CSF3 1440 Leiomyosarcoma MESH:D007890 therapeutic 9774950 +CSF3 1440 Leukemia, Myeloid, Acute MESH:D015470 therapeutic 7528855 +CSF3 1440 Leukopenia MESH:D007970 marker/mechanism|therapeutic 16076697|16120623|16937080|7543699 +CSF3 1440 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 15661404 +CSF3 1440 Liver Diseases MESH:D008107 therapeutic 19429242 +CSF3 1440 Liver Failure, Acute MESH:D017114 marker/mechanism 21550386 +CSF3 1440 Liver Neoplasms MESH:D008113 therapeutic 9018096 +CSF3 1440 Lymphoma, AIDS-Related MESH:D016483 therapeutic 12176798 +CSF3 1440 Lymphoma, B-Cell MESH:D016393 therapeutic 11042651 +CSF3 1440 Lymphoma, Non-Hodgkin MESH:D008228 therapeutic 11911406 +CSF3 1440 Melanoma MESH:D008545 therapeutic 16120623|16260693 +CSF3 1440 Mucositis MESH:D052016 marker/mechanism 17047649|7543699 +CSF3 1440 Multiple Myeloma MESH:D009101 therapeutic 7534716|7540856 +CSF3 1440 Muscle Weakness MESH:D018908 marker/mechanism 8622042 +CSF3 1440 Muscular Diseases MESH:D009135 marker/mechanism 7543699 +CSF3 1440 Neoplasm Metastasis MESH:D009362 therapeutic 7543699|9018096 +CSF3 1440 Neoplasms, Second Primary MESH:D016609 marker/mechanism 20026017 +CSF3 1440 Nervous System Diseases MESH:D009422 marker/mechanism 17047649 +CSF3 1440 Neutropenia MESH:D009503 marker/mechanism|therapeutic 11712802|12085204|12884814|12926135|15585077|16761898|27737899|7524159|7529132|7543699|7688884|9740541|9774950 +CSF3 1440 Pain MESH:D010146 marker/mechanism 10864982|7541186|8622042 +CSF3 1440 Pancytopenia MESH:D010198 therapeutic 17505274|9051142 +CSF3 1440 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 9740541 +CSF3 1440 Poisoning MESH:D011041 therapeutic 15727166 +CSF3 1440 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17894541 +CSF3 1440 Scleroderma, Localized MESH:D012594 therapeutic 15863969 +CSF3 1440 Sepsis MESH:D018805 therapeutic 17505274 +CSF3 1440 Skin Neoplasms MESH:D012878 therapeutic 9774950 +CSF3 1440 Small Cell Lung Carcinoma MESH:D055752 therapeutic 9093707 +CSF3 1440 Soft Tissue Neoplasms MESH:D012983 therapeutic 7543699 +CSF3 1440 Somatosensory Disorders MESH:D020886 marker/mechanism 7543699 +CSF3 1440 Staphylococcal Infections MESH:D013203 therapeutic 27737899 +CSF3 1440 Stevens-Johnson Syndrome MESH:D013262 therapeutic 11321886 +CSF3 1440 Stomatitis MESH:D013280 marker/mechanism 12085204 +CSF3 1440 Thrombocytopenia MESH:D013921 marker/mechanism 12085204|7543699 +CSF3 1440 Urinary Bladder Neoplasms MESH:D001749 therapeutic 17515069|7525883 +CSF3 1440 Uterine Neoplasms MESH:D014594 therapeutic 9774950 +CSF3 1440 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism|therapeutic 12926135|17334414 +CSF3R 1441 Leukocytosis MESH:D007964 marker/mechanism 19620628 +CSF3R 1441 NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE OMIM:617014 marker/mechanism 617014.0 +CSF3R 1441 Neutrophilia, Hereditary MESH:C563010 marker/mechanism 162830.0 +CSGALNACT1 55790 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CSH1 1442 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CSH1 1442 Silver-Russell Syndrome MESH:D056730 marker/mechanism 14642004 +CSK 1445 Hyperalgesia MESH:D006930 marker/mechanism 16769263 +CSK 1445 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 23042117 +CSMD1 64478 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +CSMD1 64478 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CSMD1 64478 Psoriasis MESH:D011565 marker/mechanism 20953187 +CSMD1 64478 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CSMD3 114788 Autistic Disorder MESH:D001321 marker/mechanism 18270536 +CSMD3 114788 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691|23797736 +CSMD3 114788 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CSN2 1447 Carcinoma MESH:D002277 marker/mechanism 16316942|9879772 +CSN2 1447 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942|9879772 +CSN2 1447 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942|9879772 +CSN3 1448 Carcinoma MESH:D002277 marker/mechanism 16316942 +CSN3 1448 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +CSN3 1448 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +CSNK1A1 1452 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +CSNK1A1 1452 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +CSNK1D 1453 Advanced Sleep-Phase Syndrome, Familial MESH:C565789 marker/mechanism 615224.0 +CSNK2A1 1457 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18572023 +CSNK2A1 1457 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +CSNK2A1 1457 OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME OMIM:617062 marker/mechanism 617062.0 +CSNK2A1 1457 Skin Neoplasms MESH:D012878 marker/mechanism 18572023 +CSNK2A2 1459 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18572023 +CSNK2A2 1459 Skin Neoplasms MESH:D012878 marker/mechanism 18572023 +CSNK2B 1460 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18572023 +CSNK2B 1460 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +CSNK2B 1460 Skin Neoplasms MESH:D012878 marker/mechanism 18572023 +CSPG4 1464 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CSRNP1 64651 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CSRNP1 64651 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 16243910 +CSRNP3 80034 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CSRNP3 80034 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CSRP1 1465 Endometrial Hyperplasia MESH:D004714 marker/mechanism 22248470 +CSRP1 1465 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +CSRP3 8048 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +CSRP3 8048 Cardiomyopathy, Dilated, 1M MESH:C564390 marker/mechanism 607482.0 +CSRP3 8048 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12 OMIM:612124 marker/mechanism 612124.0 +CSRP3 8048 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +CSRP3 8048 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CST1 1469 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +CST1 1469 Rhinitis, Allergic, Seasonal MESH:D006255 marker/mechanism 23950865 +CST1 1469 Stomach Neoplasms MESH:D013274 marker/mechanism 19463800 +CST3 1471 Acute Kidney Injury MESH:D058186 marker/mechanism 22005293|28885000 +CST3 1471 Alzheimer Disease MESH:D000544 marker/mechanism|therapeutic 17192785|18026100 +CST3 1471 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +CST3 1471 Cardiovascular Diseases MESH:D002318 marker/mechanism 21356263 +CST3 1471 Cerebral Amyloid Angiopathy, Familial MESH:D028243 marker/mechanism 105150.0 18566660 +CST3 1471 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +CST3 1471 Kidney Diseases MESH:D007674 marker/mechanism 22525860|24863737 +CST3 1471 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +CST3 1471 Macular Degeneration, Age-Related, 11 MESH:C567450 marker/mechanism 611953.0 +CST3 1471 Meningioma MESH:D008579 marker/mechanism 19747051 +CST3 1471 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +CST3 1471 Poisoning MESH:D011041 marker/mechanism 22525860 +CST3 1471 Recurrence MESH:D012008 marker/mechanism 19747051 +CST6 1474 Breast Neoplasms MESH:D001943 marker/mechanism 17043665 +CST6 1474 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17043644 +CST6 1474 Melanoma MESH:D008545 marker/mechanism 22535842 +CST6 1474 Prostatic Neoplasms MESH:D011471 marker/mechanism 19503093 +CST7 8530 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +CST8 10047 Infertility, Male MESH:D007248 marker/mechanism 20811015 +CSTA 1475 Disease Progression MESH:D018450 marker/mechanism 20461718|22287159 +CSTA 1475 Exfoliative Ichthyosis, Autosomal Recessive, Ichthyosis Bullosa of Siemens-like MESH:C564309 marker/mechanism 607936.0 +CSTA 1475 Glioblastoma MESH:D005909 marker/mechanism 22287159 +CSTA 1475 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 20461718 +CSTA 1475 Neoplasm Metastasis MESH:D009362 marker/mechanism 20461718 +CSTB 1476 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +CSTB 1476 Glioblastoma MESH:D005909 marker/mechanism 22287159 +CSTB 1476 Meningioma MESH:D008579 marker/mechanism 19747051 +CSTB 1476 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19747051|22287159 +CSTB 1476 Recurrence MESH:D012008 marker/mechanism 19747051 +CSTB 1476 Unverricht-Lundborg Syndrome MESH:D020194 marker/mechanism 254800.0 11814737|25288807 +CTBP1 1487 Colorectal Neoplasms MESH:D015179 marker/mechanism 17028196 +CTBP1 1487 Wolf-Hirschhorn Syndrome MESH:D054877 marker/mechanism 194190.0 +CTBP2 1488 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 28414304 +CTBP2 1488 Neoplasm Invasiveness MESH:D009361 marker/mechanism 28414304 +CTBP2 1488 Prostatic Neoplasms MESH:D011471 marker/mechanism 18264096 +CTC1 80169 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 22267198 +CTC1 80169 Brain Diseases MESH:D001927 marker/mechanism 22267198 +CTC1 80169 Calcinosis MESH:D002114 marker/mechanism 22267198 +CTC1 80169 Cerebroretinal Microangiopathy with Calcifications and Cysts MESH:C567401 marker/mechanism 612199.0 +CTC1 80169 Gastric Antral Vascular Ectasia MESH:D020252 marker/mechanism 22267198 +CTC1 80169 Retinal Telangiectasis MESH:D058456 marker/mechanism 22267198 +CTCF 10664 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21 OMIM:615502 marker/mechanism 615502.0 +CTCF 10664 Leukemia, Megakaryoblastic, of Down Syndrome MESH:C566025 marker/mechanism 24056718 +CTCF 10664 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +CTCF 10664 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 28671688 +CTDP1 9150 Congenital Cataracts, Facial Dysmorphism, And Neuropathy MESH:C565822 marker/mechanism 604168.0 16194727 +CTF1 1489 Cardiomegaly MESH:D006332 marker/mechanism 18400235|19100119 +CTF1 1489 Hypercholesterolemia MESH:D006937 marker/mechanism 21803294 +CTF1 1489 Hypotension MESH:D007022 marker/mechanism 11304496 +CTF1 1489 Insulin Resistance MESH:D007333 marker/mechanism 21803294 +CTF1 1489 Kidney Diseases MESH:D007674 therapeutic 23335628 +CTF1 1489 Necrosis MESH:D009336 therapeutic 23335628 +CTF1 1489 Obesity MESH:D009765 marker/mechanism 21803294 +CTH 1491 Fetal Growth Retardation MESH:D005317 marker/mechanism 28157488 +CTH 1491 Gamma-cystathionase deficiency MESH:C535408 marker/mechanism 219500.0 +CTH 1491 Melanoma MESH:D008545 marker/mechanism 25205294 +CTH 1491 Retinal Neovascularization MESH:D015861 marker/mechanism 27273718 +CTHRC1 115908 Barrett Esophagus MESH:D001471 marker/mechanism 614266.0 +CTL-1 259738 Death MESH:D003643 marker/mechanism 25204677 +CTL-1 259738 Infertility MESH:D007246 marker/mechanism 25204677 +CTL-2 175085 Death MESH:D003643 marker/mechanism 25204677 +CTL-2 175085 Infertility MESH:D007246 marker/mechanism 25204677 +CTLA2A 13024 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CTLA4 1493 Alopecia Areata MESH:D000506 marker/mechanism 20596022 +CTLA4 1493 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CTLA4 1493 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +CTLA4 1493 Asthma MESH:D001249 marker/mechanism 28807506 +CTLA4 1493 Celiac Disease MESH:D002446 marker/mechanism 609755.0 +CTLA4 1493 Diabetes Mellitus, Insulin-Dependent, 12 MESH:C563326 marker/mechanism 601388.0 +CTLA4 1493 Graft vs Host Disease MESH:D006086 therapeutic 14642129 +CTLA4 1493 Graves Disease MESH:D006111 marker/mechanism 19731979|21841780|23104008 +CTLA4 1493 Hashimoto Disease MESH:D050031 marker/mechanism 140300.0 +CTLA4 1493 IMMUNE DYSREGULATION WITH AUTOIMMUNITY, IMMUNODEFICIENCY, AND LYMPHOPROLIFERATION OMIM:616100 marker/mechanism 616100.0 +CTLA4 1493 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +CTLA4 1493 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 152700.0 +CTLA4 1493 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26258847 +CTLA4 1493 Melanoma MESH:D008545 therapeutic 21802280 +CTLA4 1493 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +CTLA4 1493 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 21228734 +CTNNA1 1495 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +CTNNA1 1495 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +CTNNA1 1495 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 17330099 +CTNNA1 1495 Patterned dystrophy of retinal pigment epithelium MESH:C536309 marker/mechanism 608970.0 26691986 +CTNNA2 1496 Lissencephaly MESH:D054082 marker/mechanism 30013181 +CTNNA2 1496 Stomach Neoplasms MESH:D013274 marker/mechanism 24816253 +CTNNA3 29119 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13 OMIM:615616 marker/mechanism 615616.0 +CTNNA3 29119 Asthma MESH:D001249 marker/mechanism 19187332 +CTNNA3 29119 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CTNNB1 1499 Aberrant Crypt Foci MESH:D058739 marker/mechanism 10965019|12351151|14507667 +CTNNB1 1499 Abnormalities, Multiple MESH:D000015 marker/mechanism 22975441 +CTNNB1 1499 Adenocarcinoma MESH:D000230 marker/mechanism 10965019|14507667|15459021 +CTNNB1 1499 Adenoma MESH:D000236 marker/mechanism 10223192|10965019 +CTNNB1 1499 Adenoma, Liver Cell MESH:D018248 marker/mechanism 21147764 +CTNNB1 1499 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 24747643 +CTNNB1 1499 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 24747642 +CTNNB1 1499 Breast Neoplasms MESH:D001943 marker/mechanism 12165863|25330770 +CTNNB1 1499 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 114550.0 20118494|21147764|25822088|27738331|28284560 +CTNNB1 1499 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 29394407 +CTNNB1 1499 Cecal Neoplasms MESH:D002430 marker/mechanism 14688030 +CTNNB1 1499 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 29626521 +CTNNB1 1499 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 19679878 +CTNNB1 1499 Colonic Neoplasms MESH:D003110 marker/mechanism 12628520|12800193|14507667|15459021|17404573|18283038|21081470|22323126|9515794 +CTNNB1 1499 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 10965019|12907644|21291235|25280562 +CTNNB1 1499 Craniofacial Abnormalities MESH:D019465 marker/mechanism 11262227 +CTNNB1 1499 Craniopharyngioma MESH:D003397 marker/mechanism 24413733 +CTNNB1 1499 Disease Models, Animal MESH:D004195 marker/mechanism 29394407 +CTNNB1 1499 Disease Progression MESH:D018450 marker/mechanism 27738331|29106415|34019859 +CTNNB1 1499 Fibrosis MESH:D005355 marker/mechanism 29394407 +CTNNB1 1499 Hemangiosarcoma MESH:D006394 marker/mechanism 13678655 +CTNNB1 1499 Hepatoblastoma MESH:D018197 marker/mechanism 21237236 +CTNNB1 1499 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 29394407 +CTNNB1 1499 Intestinal Neoplasms MESH:D007414 marker/mechanism 10223192 +CTNNB1 1499 Liver Cirrhosis MESH:D008103 marker/mechanism 21047994 +CTNNB1 1499 Liver Neoplasms MESH:D008113 marker/mechanism 10467420|21047994 +CTNNB1 1499 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11280770|20118494|21147764 +CTNNB1 1499 Lung Neoplasms MESH:D008175 marker/mechanism 18372914 +CTNNB1 1499 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 18787224 +CTNNB1 1499 Medulloblastoma MESH:D008527 marker/mechanism 155255.0 +CTNNB1 1499 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 22784439 +CTNNB1 1499 Muscular Atrophy MESH:D009133 therapeutic 18467435 +CTNNB1 1499 Myocardial Ischemia MESH:D017202 marker/mechanism 29394407 +CTNNB1 1499 Neoplasm Invasiveness MESH:D009361 marker/mechanism 23707762|26990689 +CTNNB1 1499 Neoplasm Metastasis MESH:D009362 marker/mechanism 29106415 +CTNNB1 1499 Neoplasms, Experimental MESH:D009374 marker/mechanism 35066776 +CTNNB1 1499 Nerve Degeneration MESH:D009410 marker/mechanism 12387456 +CTNNB1 1499 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +CTNNB1 1499 NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS OMIM:615075 marker/mechanism 615075.0 +CTNNB1 1499 No-Reflow Phenomenon MESH:D054318 therapeutic 16824628 +CTNNB1 1499 Ovarian Neoplasms MESH:D010051 marker/mechanism 167000.0 22000491 +CTNNB1 1499 Pancreatic Neoplasms MESH:D010190 marker/mechanism 18223216 +CTNNB1 1499 Peritoneal Neoplasms MESH:D010534 marker/mechanism 22784439 +CTNNB1 1499 Pilomatrixoma MESH:D018296 marker/mechanism 132600.0 +CTNNB1 1499 Prostatic Neoplasms MESH:D011471 marker/mechanism 17363566|29610475 +CTNNB1 1499 Recurrence MESH:D012008 marker/mechanism 34019859 +CTNNB1 1499 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 34019859 +CTNNB1 1499 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +CTNNB1 1499 Thyroid Neoplasms MESH:D013964 marker/mechanism 35066776 +CTNNB1 1499 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 25061499 +CTNNB1 1499 Vascular Calcification MESH:D061205 therapeutic 23223575 +CTNNB1 1499 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 29394407 +CTNNB1 1499 Ventricular Remodeling MESH:D020257 marker/mechanism 29394407 +CTNNB1 1499 Wilms Tumor MESH:D009396 marker/mechanism 21237236|28825729 +CTNND2 1501 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23917401 +CTNND2 1501 Glioblastoma MESH:D005909 marker/mechanism 23917401 +CTNS 1497 Cystinosis MESH:D003554 marker/mechanism 219800.0 15879904 +CTNS 1497 Cystinosis, Late-Onset Juvenile or Adolescent Nephropathic Type MESH:C562683 marker/mechanism 219900.0 +CTNS 1497 Cystinosis, ocular nonnephropathic MESH:C535765 marker/mechanism 219750.0 +CTPS1 1503 IMMUNODEFICIENCY 24 OMIM:615897 marker/mechanism 615897.0 +CTR1B 40989 Alzheimer Disease MESH:D000544 therapeutic 23827522 +CTR1C 43668 Alzheimer Disease MESH:D000544 therapeutic 23827522 +CTR1C 43668 Nerve Degeneration MESH:D009410 therapeutic 23827522 +CTRB1 1504 Hypoxia MESH:D000860 marker/mechanism 19579223 +CTRC 11330 Hereditary pancreatitis MESH:C537262 marker/mechanism 167800.0 +CTRC 11330 Pancreatitis, Chronic MESH:D050500 marker/mechanism 18059268 +CTSA 5476 Neuraminidase deficiency with beta-galactosidase deficiency MESH:C536411 marker/mechanism 256540.0 +CTSB 1508 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +CTSB 1508 Disease Progression MESH:D018450 marker/mechanism 22287159 +CTSB 1508 Glioblastoma MESH:D005909 marker/mechanism 22287159 +CTSB 1508 Inflammatory Breast Neoplasms MESH:D058922 marker/mechanism 32512068 +CTSB 1508 Keratolytic winter erythema MESH:C536155 marker/mechanism 148370.0 +CTSB 1508 Muscular Diseases MESH:D009135 marker/mechanism 7099197 +CTSB 1508 Necrosis MESH:D009336 marker/mechanism 22287159 +CTSB 1508 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19700239|19747051 +CTSB 1508 Prostatic Neoplasms MESH:D011471 marker/mechanism 19503093 +CTSB 1508 Proteinuria MESH:D011507 marker/mechanism 3669494 +CTSC 1075 Aggressive Periodontitis MESH:D010520 marker/mechanism 170650.0 +CTSC 1075 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +CTSC 1075 Disease Progression MESH:D018450 marker/mechanism 21364753 +CTSC 1075 Keratosis palmoplantaris with periodontopathia and onychogryposis MESH:C537627 marker/mechanism 245010.0 10662807 +CTSC 1075 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CTSC 1075 Papillon-Lefevre Disease MESH:D010214 marker/mechanism 245000.0 10662807|16008657 +CTSC 1075 Periodontal Diseases MESH:D010510 marker/mechanism 10662807 +CTSC 1075 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +CTSD 1509 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +CTSD 1509 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +CTSD 1509 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +CTSD 1509 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +CTSD 1509 Ceroid Lipofuscinosis, Neuronal, 10 MESH:C566438 marker/mechanism 610127.0 +CTSD 1509 Diabetic Nephropathies MESH:D003928 marker/mechanism 28468961 +CTSD 1509 Kidney Diseases MESH:D007674 marker/mechanism 15213268 +CTSD 1509 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +CTSD 1509 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +CTSD 1509 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CTSD 1509 Weight Gain MESH:D015430 marker/mechanism 19030233 +CTSE 1510 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +CTSE 1510 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CTSF 8722 CEROID LIPOFUSCINOSIS, NEURONAL, 13 (KUFS TYPE) OMIM:615362 marker/mechanism 615362.0 +CTSH 1512 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 18978792 +CTSH 1512 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +CTSK 1513 Glioblastoma MESH:D005909 marker/mechanism 25356585 +CTSK 1513 Osteoarthritis MESH:D010003 marker/mechanism 30664745 +CTSK 1513 Pycnodysostosis MESH:D058631 marker/mechanism 265800.0 15163881 +CTSL 1514 Coronavirus Infections MESH:D018352 marker/mechanism 16081529|23678171|27733646 +CTSL 1514 Meningioma MESH:D008579 marker/mechanism 19747051 +CTSL 1514 Proteinuria MESH:D011507 marker/mechanism 3669494 +CTSL 1514 Recurrence MESH:D012008 marker/mechanism 19747051 +CTSL 1514 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 16081529|16339146|22496216|23678171 +CTSL 1514 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +CTSLP8 1518 Disease Progression MESH:D018450 marker/mechanism 34510316 +CTSLP8 1518 Ovarian Neoplasms MESH:D010051 marker/mechanism 34510316 +CTSS 1520 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CTSS 1520 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CTSS 1520 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19700239 +CTSS 1520 Obesity MESH:D009765 marker/mechanism 21156398 +CTSZ 1522 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +CTSZ 1522 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CTTN 2017 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CTTN 2017 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27148699 +CTTN 2017 Leukoplakia MESH:D007971 marker/mechanism 27148699 +CTTNBP2 83992 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 28191889 +CTTNBP2 83992 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CTTNBP2NL 55917 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CTU1 90353 Breast Neoplasms MESH:D001943 marker/mechanism 27811057 +CTU1 90353 Disease Models, Animal MESH:D004195 marker/mechanism 27811057 +CTU1 90353 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27811057 +CTU1 90353 Neoplasm Metastasis MESH:D009362 marker/mechanism 27811057 +CTU2 348180 Breast Neoplasms MESH:D001943 marker/mechanism 27811057 +CTU2 348180 Disease Models, Animal MESH:D004195 marker/mechanism 27811057 +CTU2 348180 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27811057 +CTU2 348180 Neoplasm Metastasis MESH:D009362 marker/mechanism 27811057 +CUBN 8029 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +CUBN 8029 Imerslund-Grasbeck syndrome MESH:C538556 marker/mechanism 261100.0 +CUBN 8029 Melanoma MESH:D008545 marker/mechanism 22535842 +CUL1 8454 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +CUL2 8453 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 21983784 +CUL3 8452 Melanoma MESH:D008545 marker/mechanism 22535842 +CUL3 8452 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +CUL3 8452 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +CUL3 8452 PSEUDOHYPOALDOSTERONISM, TYPE IIE OMIM:614496 marker/mechanism 614496.0 +CUL4A 8451 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +CUL4A 8451 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +CUL4B 8450 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE OMIM:300354 marker/mechanism 300354.0 +CUL5 8065 Breast Neoplasms MESH:D001943 therapeutic 20949323 +CUL7 9820 Autistic Disorder MESH:D001321 marker/mechanism 25961944 +CUL7 9820 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +CUL7 9820 Miller-McKusick-Malvaux-Syndrome (3M Syndrome) MESH:C535314 marker/mechanism 273750.0 +CUX1 1523 Carcinogenesis MESH:D063646 marker/mechanism 24316979 +CWC27 10283 Metaphyseal Chondrodysplasia with Retinitis Pigmentosa MESH:C565398 marker/mechanism 250410.0 +CWF19L1 55280 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 616127.0 +CWH43 80157 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +CX3CL1 6376 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 20388520 +CX3CL1 6376 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CX3CL1 6376 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CX3CL1 6376 Pneumonia MESH:D011014 marker/mechanism 21625544 +CX3CL1 6376 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +CX3CR1 1524 Chloracne MESH:D054506 marker/mechanism 17101203 +CX3CR1 1524 Coronary Disease MESH:D003327 marker/mechanism 607339.0 +CX3CR1 1524 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CX3CR1 1524 MACULAR DEGENERATION, AGE-RELATED, 12 OMIM:613784 marker/mechanism 613784.0 +CX3CR1 1524 Retinal Degeneration MESH:D012162 marker/mechanism 20361964 +CXADR 1525 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CXCL1 2919 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CXCL1 2919 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 12388339 +CXCL1 2919 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16118408 +CXCL1 2919 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +CXCL1 2919 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CXCL1 2919 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CXCL1 2919 Liver Neoplasms MESH:D008113 marker/mechanism 33010264 +CXCL1 2919 Pneumonia MESH:D011014 marker/mechanism 21625544 +CXCL1 2919 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 23099361 +CXCL1 2919 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +CXCL1 2919 Respiratory Hypersensitivity MESH:D012130 therapeutic 23056391 +CXCL1 2919 Shock, Hemorrhagic MESH:D012771 marker/mechanism 21192278 +CXCL1 2919 Wounds and Injuries MESH:D014947 marker/mechanism 21192278 +CXCL10 3627 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CXCL10 3627 Alopecia Areata MESH:D000506 marker/mechanism 22358057 +CXCL10 3627 Brain Injuries MESH:D001930 marker/mechanism 21549006 +CXCL10 3627 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +CXCL10 3627 Cardiovascular Diseases MESH:D002318 marker/mechanism 29114965 +CXCL10 3627 Celiac Disease MESH:D002446 marker/mechanism 30097691 +CXCL10 3627 Cerebrovascular Disorders MESH:D002561 marker/mechanism 29114965 +CXCL10 3627 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 11739529 +CXCL10 3627 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +CXCL10 3627 COVID-19 MESH:D000086382 marker/mechanism 31986264 +CXCL10 3627 Cystitis, Interstitial MESH:D018856 marker/mechanism 18957084 +CXCL10 3627 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +CXCL10 3627 Influenza, Human MESH:D007251 marker/mechanism 23326326 +CXCL10 3627 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 18422935 +CXCL10 3627 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CXCL10 3627 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CXCL10 3627 Thyroid Neoplasms MESH:D013964 marker/mechanism 26037280 +CXCL11 6373 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 24979617 +CXCL11 6373 Celiac Disease MESH:D002446 marker/mechanism 30097691 +CXCL11 6373 Cystitis, Interstitial MESH:D018856 marker/mechanism 18957084 +CXCL12 6387 Breast Neoplasms MESH:D001943 marker/mechanism 18521742 +CXCL12 6387 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144|28284560 +CXCL12 6387 Chronic Periodontitis MESH:D055113 marker/mechanism 20731768 +CXCL12 6387 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990 +CXCL12 6387 Dermatitis MESH:D003872 marker/mechanism 27206134 +CXCL12 6387 Endomyocardial Fibrosis MESH:D004719 therapeutic 34310909 +CXCL12 6387 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CXCL12 6387 Ischemia MESH:D007511 marker/mechanism 18227068 +CXCL12 6387 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CXCL12 6387 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +CXCL12 6387 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19700239|25231984|25753200 +CXCL12 6387 Neoplasm Metastasis MESH:D009362 marker/mechanism 21312072|23743303 +CXCL12 6387 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +CXCL12 6387 Prostatic Neoplasms MESH:D011471 marker/mechanism 17785557 +CXCL12 6387 Recurrence MESH:D012008 therapeutic 22607768 +CXCL12 6387 Ventricular Dysfunction, Left MESH:D018487 therapeutic 34310909 +CXCL13 10563 Endometriosis MESH:D004715 marker/mechanism 30579999 +CXCL13 10563 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CXCL13 10563 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +CXCL13 10563 Recurrence MESH:D012008 therapeutic 22607768 +CXCL14 9547 Asthma MESH:D001249 marker/mechanism 21150878 +CXCL14 9547 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CXCL14 9547 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CXCL14 9547 Endometriosis MESH:D004715 marker/mechanism 21063030 +CXCL14 9547 Liver Cirrhosis MESH:D008103 marker/mechanism 33069761 +CXCL14 9547 Lung Neoplasms MESH:D008175 therapeutic 20562917 +CXCL14 9547 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +CXCL15 20309 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CXCL15 20309 Liver Cirrhosis MESH:D008103 therapeutic 15763341 +CXCL15 20309 Pemphigoid, Bullous MESH:D010391 marker/mechanism 11359455 +CXCL15 20309 Pneumonia MESH:D011014 marker/mechanism 21625544 +CXCL16 58191 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CXCL2 2920 Acute Lung Injury MESH:D055371 marker/mechanism 27525872 +CXCL2 2920 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +CXCL2 2920 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 15292528 +CXCL2 2920 Bone Resorption MESH:D001862 therapeutic 21507677 +CXCL2 2920 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +CXCL2 2920 Cholestasis MESH:D002779 marker/mechanism 21224055 +CXCL2 2920 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 23178550 +CXCL2 2920 Esophageal Neoplasms MESH:D004938 marker/mechanism 21509778 +CXCL2 2920 Heart Failure MESH:D006333 marker/mechanism 22352330 +CXCL2 2920 Hypertension MESH:D006973 marker/mechanism 22352330 +CXCL2 2920 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +CXCL2 2920 Inflammation MESH:D007249 marker/mechanism 23451061 +CXCL2 2920 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +CXCL2 2920 Osteoarthritis MESH:D010003 marker/mechanism 15292528 +CXCL2 2920 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 23099361 +CXCL2 2920 Pulmonary Fibrosis MESH:D011658 marker/mechanism 16324872 +CXCL2 2920 Reperfusion Injury MESH:D015427 marker/mechanism 12468449 +CXCL2 2920 Shock, Hemorrhagic MESH:D012771 marker/mechanism 21192278 +CXCL2 2920 Skin Diseases MESH:D012871 marker/mechanism 16835338 +CXCL2 2920 Wounds and Injuries MESH:D014947 marker/mechanism 21192278 +CXCL3 2921 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +CXCL3 2921 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +CXCL3 2921 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +CXCL3 2921 Skin Diseases MESH:D012871 marker/mechanism 16835338 +CXCL5 6374 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CXCL5 6374 Pneumonia MESH:D011014 marker/mechanism 21625544 +CXCL5 6374 Recurrence MESH:D012008 therapeutic 22607768 +CXCL6 6372 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 15292528 +CXCL6 6372 Osteoarthritis MESH:D010003 marker/mechanism 15292528 +CXCL8 3576 Adenocarcinoma MESH:D000230 marker/mechanism 18307536 +CXCL8 3576 Angina, Unstable MESH:D000789 marker/mechanism 10660968 +CXCL8 3576 Arthritis, Psoriatic MESH:D015535 marker/mechanism 19732956 +CXCL8 3576 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860|19192274 +CXCL8 3576 Barrett Esophagus MESH:D001471 marker/mechanism 15387324 +CXCL8 3576 Behcet Syndrome MESH:D001528 marker/mechanism 8712863 +CXCL8 3576 Breast Neoplasms MESH:D001943 marker/mechanism 16298037|17516992 +CXCL8 3576 Cachexia MESH:D002100 marker/mechanism 17878525 +CXCL8 3576 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism|therapeutic 12432545|35776891 +CXCL8 3576 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15956251 +CXCL8 3576 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15956251 +CXCL8 3576 Cardiotoxicity MESH:D066126 marker/mechanism 29959987 +CXCL8 3576 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22015448 +CXCL8 3576 Cholestasis MESH:D002779 marker/mechanism 21224055 +CXCL8 3576 Colitis, Ulcerative MESH:D003093 marker/mechanism 12133438|15955209 +CXCL8 3576 Colorectal Neoplasms MESH:D015179 marker/mechanism 20065508 +CXCL8 3576 COVID-19 MESH:D000086382 marker/mechanism 32161940 +CXCL8 3576 Down Syndrome MESH:D004314 marker/mechanism 16289943 +CXCL8 3576 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +CXCL8 3576 Edema MESH:D004487 marker/mechanism 19874808 +CXCL8 3576 Endometrial Neoplasms MESH:D016889 marker/mechanism 17380299 +CXCL8 3576 Esophagitis, Peptic MESH:D004942 marker/mechanism 18193101 +CXCL8 3576 Eye Infections, Bacterial MESH:D015818 marker/mechanism 23661603 +CXCL8 3576 Fatty Liver MESH:D005234 marker/mechanism 23348005 +CXCL8 3576 Fever MESH:D005334 marker/mechanism 11852909 +CXCL8 3576 Gastroesophageal Reflux MESH:D005764 marker/mechanism 18193101|20616304 +CXCL8 3576 Glioblastoma MESH:D005909 marker/mechanism 16356833 +CXCL8 3576 Glomerulonephritis MESH:D005921 marker/mechanism 10910440|9403216 +CXCL8 3576 Heart Failure MESH:D006333 marker/mechanism 29959987 +CXCL8 3576 Hepatitis, Alcoholic MESH:D006519 marker/mechanism 26220752 +CXCL8 3576 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 25002079 +CXCL8 3576 Hyperalgesia MESH:D006930 marker/mechanism 10401557|7881729 +CXCL8 3576 Hypertension, Pulmonary MESH:D006976 marker/mechanism 15302794 +CXCL8 3576 Inflammation MESH:D007249 marker/mechanism 20578705|24795235 +CXCL8 3576 Inflammatory Breast Neoplasms MESH:D058922 marker/mechanism 32512068 +CXCL8 3576 Keratitis MESH:D007634 marker/mechanism 23661603 +CXCL8 3576 Leishmaniasis, Cutaneous MESH:D016773 marker/mechanism 20102417 +CXCL8 3576 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 22461696 +CXCL8 3576 Lichenoid Eruptions MESH:D017512 marker/mechanism 18393961 +CXCL8 3576 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674|28377727 +CXCL8 3576 Neoplasm Invasiveness MESH:D009361 marker/mechanism 32512068 +CXCL8 3576 Neuralgia, Postherpetic MESH:D051474 marker/mechanism 11280320 +CXCL8 3576 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 28984080 +CXCL8 3576 Osteoarthritis, Spine MESH:D055013 marker/mechanism 34697729 +CXCL8 3576 Ovarian Neoplasms MESH:D010051 marker/mechanism 19401270|21742513 +CXCL8 3576 Pain, Intractable MESH:D010148 marker/mechanism 11280320 +CXCL8 3576 Pancreatic Neoplasms MESH:D010190 marker/mechanism 18307536 +CXCL8 3576 Pemphigoid, Bullous MESH:D010391 marker/mechanism 11359455 +CXCL8 3576 Pneumonia, Pneumococcal MESH:D011018 marker/mechanism 24894820 +CXCL8 3576 Prostatic Neoplasms MESH:D011471 marker/mechanism 16606632|17606477 +CXCL8 3576 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 15337792|23099361|28864214 +CXCL8 3576 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17266442|17894541 +CXCL8 3576 Reperfusion Injury MESH:D015427 marker/mechanism 12865660 +CXCL8 3576 Salmonella Infections, Animal MESH:D012481 marker/mechanism 29421334 +CXCL8 3576 Staphylococcal Infections MESH:D013203 marker/mechanism 23661603 +CXCL8 3576 Stomach Neoplasms MESH:D013274 marker/mechanism|therapeutic 15492468|15723263 +CXCL8 3576 Thyroid Neoplasms MESH:D013964 marker/mechanism 26037280 +CXCL8 3576 Tobacco Use Disorder MESH:D014029 marker/mechanism 28864214 +CXCL8 3576 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 32512068 +CXCL8 3576 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 22015448 +CXCL9 4283 Alopecia Areata MESH:D000506 marker/mechanism 22358057 +CXCL9 4283 Breast Neoplasms MESH:D001943 marker/mechanism 18925433 +CXCL9 4283 Carotid Stenosis MESH:D016893 marker/mechanism 26564003 +CXCL9 4283 Celiac Disease MESH:D002446 marker/mechanism 30097691 +CXCL9 4283 Cystitis, Interstitial MESH:D018856 marker/mechanism 18957084 +CXCL9 4283 Endometriosis MESH:D004715 marker/mechanism 30579999 +CXCL9 4283 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CXCL9 4283 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 18422935 +CXCL9 4283 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CXCL9 4283 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +CXCL9 4283 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +CXCL9 4283 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 18925433 +CXCL9 4283 Pneumonia MESH:D011014 marker/mechanism 21625544 +CXCR1 3577 Colitis, Ulcerative MESH:D003093 marker/mechanism 21297633 +CXCR1 3577 HIV Infections MESH:D015658 marker/mechanism 609423.0 +CXCR2 3579 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +CXCR2 3579 Brain Diseases MESH:D001927 marker/mechanism 35961375 +CXCR2 3579 Colitis, Ulcerative MESH:D003093 marker/mechanism 21297633 +CXCR2 3579 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CXCR2 3579 Hypertension MESH:D006973 marker/mechanism 27678262 +CXCR2 3579 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 25257527 +CXCR2 3579 Liver Diseases MESH:D008107 marker/mechanism 35961375 +CXCR2 3579 Mastitis MESH:D008413 marker/mechanism 16041010 +CXCR2 3579 Neuralgia MESH:D009437 marker/mechanism 31432094 +CXCR2 3579 Pneumonia MESH:D011014 marker/mechanism 21625544 +CXCR2 3579 Sepsis MESH:D018805 marker/mechanism 17138957 +CXCR2 3579 Vascular Remodeling MESH:D066253 marker/mechanism 27678262 +CXCR3 2833 Alopecia Areata MESH:D000506 marker/mechanism 22358057 +CXCR3 2833 Autoimmune Diseases MESH:D001327 marker/mechanism 12517959 +CXCR3 2833 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +CXCR3 2833 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CXCR3 2833 Glomerulonephritis MESH:D005921 marker/mechanism 12517959 +CXCR3 2833 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +CXCR3 2833 Inflammation MESH:D007249 marker/mechanism 12517959 +CXCR3 2833 Ischemia MESH:D007511 marker/mechanism 12517959 +CXCR3 2833 Pleural Diseases MESH:D010995 marker/mechanism 21357438 +CXCR3 2833 Pneumonia MESH:D011014 marker/mechanism 21625544 +CXCR3 2833 Stroke MESH:D020521 marker/mechanism 12374626 +CXCR4 7852 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504|26387944 +CXCR4 7852 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +CXCR4 7852 Breast Neoplasms MESH:D001943 marker/mechanism 25753200 +CXCR4 7852 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23743303 +CXCR4 7852 Neoplasm Invasiveness MESH:D009361 marker/mechanism 25753200 +CXCR4 7852 Neoplasm Metastasis MESH:D009362 marker/mechanism 21312072|23743303 +CXCR4 7852 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +CXCR4 7852 Neuralgia MESH:D009437 marker/mechanism 17292584 +CXCR4 7852 WHIM syndrome MESH:C536697 marker/mechanism 193670.0 23734232 +CXCR5 643 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 21399635 +CYB5A 1528 Endometriosis MESH:D004715 marker/mechanism 20864642 +CYB5A 1528 Methemoglobinemia Type IV MESH:C567102 marker/mechanism 250790.0 +CYB5A 1528 Obesity MESH:D009765 marker/mechanism 20882379 +CYB5A 1528 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +CYB5R3 1727 Cyanosis MESH:D003490 marker/mechanism 16469290 +CYB5R3 1727 Methemoglobinemia MESH:D008708 marker/mechanism 16469290 +CYB5R3 1727 NADH cytochrome B5 reductase deficiency MESH:C537841 marker/mechanism 250800.0 +CYBA 1535 Atherosclerosis MESH:D050197 marker/mechanism 20720404 +CYBA 1535 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 11812764|12967931 +CYBA 1535 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 15531508 +CYBA 1535 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +CYBA 1535 Granulomatous Disease, Chronic MESH:D006105 marker/mechanism 2243141 +CYBA 1535 Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative MESH:C565533 marker/mechanism 233690.0 +CYBA 1535 Heart Diseases MESH:D006331 marker/mechanism 16330681 +CYBA 1535 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +CYBA 1535 Hypertension MESH:D006973 marker/mechanism 16685210|17324946|20505675|32147540 +CYBA 1535 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +CYBA 1535 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +CYBA 1535 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYBA 1535 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34453990 +CYBA 1535 Renal Insufficiency MESH:D051437 marker/mechanism 23325087 +CYBB 1536 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 24313545 +CYBB 1536 Atypical Mycobacteriosis, Familial, X-Linked 2 MESH:C567068 marker/mechanism 300645.0 +CYBB 1536 Brain Infarction MESH:D020520 marker/mechanism 19417757 +CYBB 1536 Diabetes Mellitus MESH:D003920 marker/mechanism 23723366 +CYBB 1536 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 19478208 +CYBB 1536 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +CYBB 1536 Granulomatous Disease, Chronic MESH:D006105 marker/mechanism|therapeutic 306400.0 11045425|11122248|11498749 +CYBB 1536 Heart Failure MESH:D006333 marker/mechanism 20304815 +CYBB 1536 Hypertension MESH:D006973 marker/mechanism 16685210|21593737|27659729|27847271|32147540|32165127 +CYBB 1536 Kidney Diseases MESH:D007674 marker/mechanism 20116427 +CYBB 1536 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +CYBB 1536 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYBB 1536 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 19207477 +CYBB 1536 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34453990 +CYBB 1536 Proteinuria MESH:D011507 marker/mechanism 20116427 +CYBB 1536 Reperfusion Injury MESH:D015427 marker/mechanism 19193722 +CYC1 1537 Mitochondrial Complex III Deficiency MESH:C565128 marker/mechanism 615453.0 +CYCE 34924 Eye Abnormalities MESH:D005124 therapeutic 17517339 +CYCS 54205 Brain Ischemia MESH:D002545 marker/mechanism 11756504 +CYCS 54205 Chloracne MESH:D054506 marker/mechanism 17101203 +CYCS 54205 Fatty Liver MESH:D005234 marker/mechanism 10860543 +CYCS 54205 Ischemia MESH:D007511 marker/mechanism 15172883 +CYCS 54205 Ischemic Attack, Transient MESH:D002546 marker/mechanism 11333366 +CYCS 54205 Methylmalonic acidemia MESH:C537358 marker/mechanism 16823967 +CYCS 54205 Obesity MESH:D009765 marker/mechanism 16317704 +CYCS 54205 Thrombocytopenia MESH:D013921 marker/mechanism 18345000 +CYCS 54205 Thrombocytopenia 4 MESH:C567438 marker/mechanism 612004 +CYGB 114757 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 30026087 +CYGB 114757 Hepatic Insufficiency MESH:D048550 marker/mechanism 30026087 +CYGB 114757 Hepatomegaly MESH:D006529 marker/mechanism 30026087 +CYGB 114757 Heredodegenerative Disorders, Nervous System MESH:D020271 marker/mechanism 16825958 +CYGB 114757 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 30026087 +CYGB 114757 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 16581302 +CYLD 1540 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21109933 +CYLD 1540 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17043644 +CYLD 1540 Familial cylindromatosis MESH:C536611 marker/mechanism 132700|601606|605041 18234730 +CYLD 1540 Listeriosis MESH:D008088 marker/mechanism 23825949 +CYLD 1540 Thymoma MESH:D013945 marker/mechanism 24974848 +CYLD 1540 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 29477382 +CYN-8 181136 Infertility MESH:D007246 marker/mechanism 25204677 +CYP11A1 1583 Adrenal Insufficiency MESH:D000309 marker/mechanism 11502818 +CYP11A1 1583 Adrenal Insufficiency, Congenital, With 46,Xy Sex Reversal MESH:C566131 marker/mechanism 613743 +CYP11A1 1583 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP11A1 1583 Disorder of Sex Development, 46,XY MESH:D058490 marker/mechanism 11502818 +CYP11A1 1583 Endometrial Neoplasms MESH:D016889 marker/mechanism 23200943 +CYP11A1 1583 Lipoid congenital adrenal hyperplasia MESH:C537027 marker/mechanism 11502818 +CYP11A1 1583 Seizures MESH:D012640 therapeutic 19125849 +CYP11B1 1584 Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency MESH:C535978 marker/mechanism 202010 +CYP11B1 1584 Glucocorticoid-Remediable Aldosteronism MESH:C563177 marker/mechanism 103900 1472060|1731223 +CYP11B1 1584 Hyperaldosteronism MESH:D006929 marker/mechanism 11085685 +CYP11B2 1585 18-Hydroxylase deficiency MESH:C537806 marker/mechanism 203400|610600 +CYP11B2 1585 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP11B2 1585 Glucocorticoid-Remediable Aldosteronism MESH:C563177 marker/mechanism 1472060|1731223 +CYP11B2 1585 Hyperaldosteronism MESH:D006929 marker/mechanism 11085685 +CYP11B2 1585 Hypoaldosteronism MESH:D006994 marker/mechanism 11238478 +CYP11B2 1585 Prostatic Neoplasms MESH:D011471 marker/mechanism 25735316 +CYP17A1 1586 Adrenal Hyperplasia, Congenital MESH:D000312 marker/mechanism 18645707 +CYP17A1 1586 Adrenal hyperplasia, congenital, type 5 MESH:C538237 marker/mechanism 202110 +CYP17A1 1586 Amenorrhea MESH:D000568 marker/mechanism 18645707 +CYP17A1 1586 Breast Neoplasms MESH:D001943 marker/mechanism 19913079|34426286 +CYP17A1 1586 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15341023 +CYP17A1 1586 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 35764155 +CYP17A1 1586 Hyperkalemia MESH:D006947 marker/mechanism 18645707 +CYP17A1 1586 Hypertension, Malignant MESH:D006974 marker/mechanism 3142437 +CYP17A1 1586 Hypogonadism MESH:D007006 marker/mechanism 18645707 +CYP17A1 1586 Hypopituitarism MESH:D007018 marker/mechanism 12970278 +CYP17A1 1586 Infertility, Female MESH:D007247 marker/mechanism 18645707 +CYP17A1 1586 Infertility, Male MESH:D007248 marker/mechanism 15890676 +CYP17A1 1586 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CYP17A1 1586 Neuralgia MESH:D009437 marker/mechanism 17720801 +CYP17A1 1586 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 15706422 +CYP17A1 1586 Oligomenorrhea MESH:D009839 marker/mechanism 18645707 +CYP17A1 1586 Ovarian Cysts MESH:D010048 marker/mechanism 18645707 +CYP17A1 1586 Prostatic Neoplasms MESH:D011471 marker/mechanism 15538743|16424004|16859836|16998812|17592021 +CYP17A1 1586 Sexual Dysfunctions, Psychological MESH:D020018 marker/mechanism 15890676 +CYP17A1 1586 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 35764155 +CYP19A1 1588 Adenocarcinoma MESH:D000230 marker/mechanism 21472143 +CYP19A1 1588 Amenorrhea MESH:D000568 marker/mechanism 8265607 +CYP19A1 1588 Aromatase deficiency MESH:C537436 marker/mechanism 139300|613546 10566648|8265607|9177373 +CYP19A1 1588 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP19A1 1588 Autistic Disorder MESH:D001321 marker/mechanism 21359227 +CYP19A1 1588 Bone Resorption MESH:D001862 marker/mechanism 11985600 +CYP19A1 1588 Breast Neoplasms MESH:D001943 marker/mechanism 11850205|19639193|23342035|28112739|29701941|34426286 +CYP19A1 1588 Critical Illness MESH:D016638 marker/mechanism 16670151 +CYP19A1 1588 Diabetes, Gestational MESH:D016640 marker/mechanism 20421132 +CYP19A1 1588 Endometriosis MESH:D004715 marker/mechanism 18815356|21958689 +CYP19A1 1588 Esophageal Neoplasms MESH:D004938 marker/mechanism 21472143 +CYP19A1 1588 Fatty Liver MESH:D005234 marker/mechanism 11929713 +CYP19A1 1588 Fibrosis MESH:D005355 marker/mechanism 22028442 +CYP19A1 1588 Hypogonadism MESH:D007006 marker/mechanism 9177373 +CYP19A1 1588 Hypopituitarism MESH:D007018 marker/mechanism 12970278 +CYP19A1 1588 Infertility, Female MESH:D007247 marker/mechanism 14684609 +CYP19A1 1588 Neoplasm Metastasis MESH:D009362 marker/mechanism 28112739 +CYP19A1 1588 Osteoporosis MESH:D010024 marker/mechanism 20723554 +CYP19A1 1588 Ovarian Diseases MESH:D010049 marker/mechanism 11985600 +CYP19A1 1588 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21262361|22381227|8265607|9177373 +CYP19A1 1588 Prostatic Neoplasms MESH:D011471 marker/mechanism 16424004|17704407 +CYP19A1 1588 Recurrence MESH:D012008 marker/mechanism 28112739 +CYP19A1 1588 Sexual Infantilism MESH:D050035 marker/mechanism 8265607 +CYP1A 140634 Edema MESH:D004487 marker/mechanism 12711302 +CYP1A1 1543 Abortion, Spontaneous MESH:D000022 marker/mechanism 19022366|26593447 +CYP1A1 1543 Arteritis MESH:D001167 marker/mechanism 19022366 +CYP1A1 1543 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP1A1 1543 Birth Weight MESH:D001724 marker/mechanism 27592400 +CYP1A1 1543 Bradycardia MESH:D001919 marker/mechanism 26988683 +CYP1A1 1543 Breast Neoplasms MESH:D001943 marker/mechanism 16792888 +CYP1A1 1543 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15341023 +CYP1A1 1543 Cardiomegaly MESH:D006332 marker/mechanism 18725507 +CYP1A1 1543 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 33814510 +CYP1A1 1543 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 11312644|19022366 +CYP1A1 1543 Dermatitis, Atopic MESH:D003876 marker/mechanism 27869817 +CYP1A1 1543 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CYP1A1 1543 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22342832 +CYP1A1 1543 Drug Eruptions MESH:D003875 marker/mechanism 19351467 +CYP1A1 1543 Hamartoma MESH:D006222 marker/mechanism 21998131 +CYP1A1 1543 Hematuria MESH:D006417 marker/mechanism 29027484 +CYP1A1 1543 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +CYP1A1 1543 Hyperoxia MESH:D018496 marker/mechanism 24893714 +CYP1A1 1543 Hypersensitivity MESH:D006967 marker/mechanism 19022366 +CYP1A1 1543 Hypertension MESH:D006973 marker/mechanism 20634294|22995157 +CYP1A1 1543 Infertility, Male MESH:D007248 marker/mechanism 19303595 +CYP1A1 1543 Kidney Neoplasms MESH:D007680 marker/mechanism 15003126 +CYP1A1 1543 Long QT Syndrome MESH:D008133 marker/mechanism 26988683 +CYP1A1 1543 Lung Injury MESH:D055370 marker/mechanism 24893714|25703676 +CYP1A1 1543 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 23138419 +CYP1A1 1543 Occupational Diseases MESH:D009784 marker/mechanism 16737584 +CYP1A1 1543 Peripheral Vascular Diseases MESH:D016491 marker/mechanism 19022366 +CYP1A1 1543 Prostatic Neoplasms MESH:D011471 marker/mechanism 11275366|17919073 +CYP1A1 1543 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 19022366 +CYP1A1 1543 Tachycardia, Sinus MESH:D013616 marker/mechanism 26988683 +CYP1A2 1544 Atrophy MESH:D001284 marker/mechanism 20961953 +CYP1A2 1544 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP1A2 1544 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CYP1A2 1544 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 22072123 +CYP1A2 1544 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28762043 +CYP1A2 1544 Cholestasis MESH:D002779 marker/mechanism 27565560 +CYP1A2 1544 Colorectal Neoplasms MESH:D015179 marker/mechanism 21081473 +CYP1A2 1544 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22244987 +CYP1A2 1544 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 10445756 +CYP1A2 1544 Growth Disorders MESH:D006130 marker/mechanism 20961953 +CYP1A2 1544 Hepatomegaly MESH:D006529 marker/mechanism 10445756 +CYP1A2 1544 Liver Cirrhosis MESH:D008103 marker/mechanism 27565560 +CYP1A2 1544 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CYP1A2 1544 Liver Diseases MESH:D008107 marker/mechanism 12969438 +CYP1A2 1544 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11376689|21147764 +CYP1A2 1544 Lung Injury MESH:D055370 marker/mechanism 25703676 +CYP1A2 1544 Lung Neoplasms MESH:D008175 marker/mechanism 22072123 +CYP1A2 1544 Methemoglobinemia MESH:D008708 marker/mechanism 12030840 +CYP1A2 1544 Neural Tube Defects MESH:D009436 marker/mechanism 20641098 +CYP1A2 1544 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 27565560 +CYP1A2 1544 Porphyria Cutanea Tarda MESH:D017119 marker/mechanism 11153915 +CYP1A2 1544 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 22674224 +CYP1A2 1544 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 20797314 +CYP1A2 1544 Splenic Diseases MESH:D013158 marker/mechanism 20961953 +CYP1A2 1544 Splenomegaly MESH:D013163 marker/mechanism 10445756 +CYP1B1 1545 Adenoma MESH:D000236 marker/mechanism 11376689 +CYP1B1 1545 Anterior segment mesenchymal dysgenesis MESH:C537775 marker/mechanism 617315.0 +CYP1B1 1545 Breast Neoplasms MESH:D001943 marker/mechanism 16298037|17297925 +CYP1B1 1545 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 22114726 +CYP1B1 1545 Cardiomegaly MESH:D006332 marker/mechanism 18725507 +CYP1B1 1545 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 33814510 +CYP1B1 1545 Colorectal Neoplasms MESH:D015179 marker/mechanism 20878130 +CYP1B1 1545 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +CYP1B1 1545 Fatty Liver MESH:D005234 therapeutic 27036855 +CYP1B1 1545 Glaucoma 3, Primary Congenital, A MESH:C565547 marker/mechanism 231300.0 +CYP1B1 1545 Glaucoma 3, primary infantile, B MESH:C536824 marker/mechanism 600975.0 +CYP1B1 1545 Glucose Intolerance MESH:D018149 therapeutic 27036855 +CYP1B1 1545 Hepatomegaly MESH:D006529 therapeutic 27036855 +CYP1B1 1545 Lung Neoplasms MESH:D008175 marker/mechanism 11376689 +CYP1B1 1545 Melanoma MESH:D008545 marker/mechanism 17145863 +CYP1B1 1545 Mouth Neoplasms MESH:D009062 marker/mechanism 22114726 +CYP1B1 1545 Obesity MESH:D009765 therapeutic 27036855 +CYP1B1 1545 Ovarian Neoplasms MESH:D010051 marker/mechanism 17372243 +CYP1B1 1545 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 22674224 +CYP1B1 1545 Prostatic Neoplasms MESH:D011471 marker/mechanism 17704407 +CYP21A2 1589 Adrenal Hyperplasia, Congenital MESH:D000312 marker/mechanism 16705555|18445671 +CYP21A2 1589 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP21A2 1589 Congenital adrenal hyperplasia due to 21 hydroxylase deficiency MESH:C535979 marker/mechanism 201910.0 +CYP24A1 1591 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +CYP24A1 1591 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP24A1 1591 Breast Neoplasms MESH:D001943 marker/mechanism 16280049 +CYP24A1 1591 Hypercalcemia MESH:D006934 marker/mechanism 22337913 +CYP24A1 1591 Hypercalcemia, Infantile MESH:C562999 marker/mechanism 143880.0 +CYP24A1 1591 Hypercalciuria MESH:D053565 marker/mechanism 22337913 +CYP24A1 1591 Lung Neoplasms MESH:D008175 marker/mechanism 22797725 +CYP24A1 1591 Nephrolithiasis MESH:D053040 marker/mechanism 22337913 +CYP24A1 1591 Osteoporosis MESH:D010024 marker/mechanism 22337913 +CYP24A1 1591 Renal Insufficiency MESH:D051437 marker/mechanism 8164439 +CYP26A1 1592 Adenocarcinoma MESH:D000230 marker/mechanism 18059332 +CYP26A1 1592 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 16885356 +CYP26A1 1592 Barrett Esophagus MESH:D001471 marker/mechanism 18059332 +CYP26A1 1592 Colonic Neoplasms MESH:D003110 marker/mechanism 16885356 +CYP26A1 1592 Endometriosis MESH:D004715 marker/mechanism 21063030 +CYP26A1 1592 Esophageal Neoplasms MESH:D004938 marker/mechanism 18059332 +CYP26A1 1592 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYP26B1 56603 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP26B1 56603 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 29379198 +CYP26B1 56603 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +CYP26B1 56603 Obesity MESH:D009765 marker/mechanism 20882379 +CYP26C1 340665 Focal Facial Dermal Dysplasias MESH:D000090303 marker/mechanism 614974.0 +CYP27A1 1593 Atherosclerosis MESH:D050197 marker/mechanism 11166758|19801147 +CYP27A1 1593 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP27A1 1593 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 24381012 +CYP27A1 1593 Cholestasis MESH:D002779 marker/mechanism 15795599 +CYP27A1 1593 Liver Cirrhosis MESH:D008103 marker/mechanism 24381012 +CYP27A1 1593 Xanthomatosis, Cerebrotendinous MESH:D019294 marker/mechanism 213700.0 12117727|15795599|17444890|19801147 +CYP27B1 1594 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP27B1 1594 Hypercalcemia MESH:D006934 marker/mechanism 20427501 +CYP27B1 1594 Polymyositis MESH:D017285 marker/mechanism 20427501 +CYP27B1 1594 Rickets MESH:D012279 marker/mechanism 16494812 +CYP27B1 1594 Vitamin D Hydroxylation-Deficient Rickets, Type 1A MESH:C562688 marker/mechanism 264700.0 +CYP27C1 339761 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2A13 1553 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 18669584 +CYP2A13 1553 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2A13 1553 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 26084420 +CYP2A2 24895 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYP2A4 13086 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +CYP2A5 13087 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 23628428 +CYP2A6 1548 Adenocarcinoma MESH:D000230 marker/mechanism 12115524 +CYP2A6 1548 Brain Diseases MESH:D001927 marker/mechanism 22498344 +CYP2A6 1548 Carcinoma, Large Cell MESH:D018287 marker/mechanism 17549345 +CYP2A6 1548 Carcinoma, Small Cell MESH:D018288 marker/mechanism 17549345 +CYP2A6 1548 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 21741958 +CYP2A6 1548 Colorectal Neoplasms MESH:D015179 marker/mechanism 17683511 +CYP2A6 1548 Coumarin Resistance MESH:C563039 marker/mechanism 122700.0 +CYP2A6 1548 Disease Progression MESH:D018450 marker/mechanism 21364592 +CYP2A6 1548 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 11241319 +CYP2A6 1548 Hepatitis B MESH:D006509 marker/mechanism 8864187 +CYP2A6 1548 Hepatitis C MESH:D006526 marker/mechanism 8864187 +CYP2A6 1548 Liver Diseases, Parasitic MESH:D008109 marker/mechanism 8896890 +CYP2A6 1548 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 10441482|11241319|12214673|16176798|17549345|26132489 +CYP2A6 1548 Nasopharyngeal Neoplasms MESH:D009303 marker/mechanism 16377082 +CYP2A6 1548 Opisthorchiasis MESH:D009889 marker/mechanism 8896890 +CYP2A6 1548 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +CYP2A6 1548 Pulmonary Emphysema MESH:D011656 marker/mechanism 12832682 +CYP2A6 1548 Stomach Neoplasms MESH:D013274 marker/mechanism 12115524|21364592 +CYP2A6 1548 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism|therapeutic 188890.0 11259349|20418888 +CYP2A6 1548 Tobacco Use Disorder MESH:D014029 marker/mechanism 15564629|16720336|22569203|26644138|28472521 +CYP2A7 1549 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2B1 24300 Breast Neoplasms MESH:D001943 therapeutic 10811482|8640822 +CYP2B1 24300 Glioma MESH:D005910 therapeutic 7834628 +CYP2B1 24300 Hepatitis C MESH:D006526 marker/mechanism 8864187 +CYP2B1 24300 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +CYP2B1 24300 Inflammation MESH:D007249 marker/mechanism 21467745 +CYP2B1 24300 Necrosis MESH:D009336 marker/mechanism 11332993 +CYP2B1 24300 Pancreatic Neoplasms MESH:D010190 therapeutic 10026857|10326030|10415878|11332152|11377651|12042985|12649565|12698877 +CYP2B10 13088 Cholestasis MESH:D002779 marker/mechanism 22461449 +CYP2B10 13088 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22342832 +CYP2B2 361523 Inflammation MESH:D007249 marker/mechanism 21467745 +CYP2B6 1555 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2B6 1555 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CYP2B6 1555 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28762043|33814510 +CYP2B6 1555 EFAVIRENZ, POOR METABOLISM OF OMIM:614546 marker/mechanism 614546.0 +CYP2B6 1555 Gliosarcoma MESH:D018316 therapeutic 11389073|9766669 +CYP2B6 1555 Kidney Failure, Chronic MESH:D007676 marker/mechanism 15248218 +CYP2B6 1555 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 20418888 +CYP2B9 13094 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22342832 +CYP2C 100328933 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CYP2C11 29277 Cardiomegaly MESH:D006332 marker/mechanism 18725507 +CYP2C11 29277 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +CYP2C11 29277 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYP2C18 1562 Gliosarcoma MESH:D018316 therapeutic 9766669 +CYP2C18 1562 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +CYP2C19 1557 Acute Kidney Injury MESH:D058186 marker/mechanism 19814645 +CYP2C19 1557 Atrial Fibrillation MESH:D001281 marker/mechanism 27356304 +CYP2C19 1557 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2C19 1557 Cardiovascular Diseases MESH:D002318 marker/mechanism 20978260 +CYP2C19 1557 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 12963435|28762043 +CYP2C19 1557 Drug Metabolism, Poor, CYP2C19-Related MESH:C563703 marker/mechanism 609535.0 20435227 +CYP2C19 1557 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 27356304 +CYP2C19 1557 Kidney Failure, Chronic MESH:D007676 marker/mechanism 15248218 +CYP2C19 1557 Primary Ovarian Insufficiency MESH:D016649 marker/mechanism 15248218 +CYP2C19 1557 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +CYP2C19 1557 Thrombosis MESH:D013927 marker/mechanism 20978260 +CYP2C29 13095 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +CYP2C8 1558 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2C8 1558 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CYP2C8 1558 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 27736846 +CYP2C8 1558 Kidney Diseases MESH:D007674 marker/mechanism 18769365 +CYP2C8 1558 Nervous System Diseases MESH:D009422 marker/mechanism 21245421 +CYP2C8 1558 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 27736846 +CYP2C8 1558 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 22674224 +CYP2C8 1558 Rhabdomyolysis MESH:D012206 marker/mechanism 15365880 +CYP2C9 1559 Acute Kidney Injury MESH:D058186 marker/mechanism 19814645 +CYP2C9 1559 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2C9 1559 Brain Neoplasms MESH:D001932 marker/mechanism 16475710 +CYP2C9 1559 Cardiomyopathies MESH:D009202 marker/mechanism 16580879 +CYP2C9 1559 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 14971821|21741958|28762043|33814510 +CYP2C9 1559 Coumarin Resistance MESH:C563039 marker/mechanism 122700.0 19899329|20210733|20386359 +CYP2C9 1559 Drug Hypersensitivity MESH:D004342 marker/mechanism 20485159 +CYP2C9 1559 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 11740344|19925388|23104259 +CYP2C9 1559 Hemorrhage MESH:D006470 marker/mechanism 18429757|18756910|20597268|25521356|27581200 +CYP2C9 1559 Nephritis, Interstitial MESH:D009395 marker/mechanism 19814645 +CYP2C9 1559 Nervous System Diseases MESH:D009422 marker/mechanism 21245421 +CYP2C9 1559 Peptic Ulcer Hemorrhage MESH:D010438 marker/mechanism 17681167 +CYP2C9 1559 Warfarin Sensitivity MESH:C567080 marker/mechanism 27581200 +CYP2D22 56448 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +CYP2D4 171522 Cognition Disorders MESH:D003072 marker/mechanism 20727252 +CYP2D4 171522 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYP2D6 1565 Acute Kidney Injury MESH:D058186 marker/mechanism 19814645 +CYP2D6 1565 Alzheimer Disease MESH:D000544 marker/mechanism 7574463 +CYP2D6 1565 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18280655 +CYP2D6 1565 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2D6 1565 Basal Ganglia Diseases MESH:D001480 marker/mechanism 16000684 +CYP2D6 1565 Bradycardia MESH:D001919 marker/mechanism 19284319 +CYP2D6 1565 Breast Neoplasms MESH:D001943 marker/mechanism 19597703 +CYP2D6 1565 Coma MESH:D003128 marker/mechanism 18359183 +CYP2D6 1565 Drug Metabolism, Poor, CYP2D6-Related MESH:C563835 marker/mechanism 608902.0 +CYP2D6 1565 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 23609392 +CYP2D6 1565 Dystonia MESH:D004421 marker/mechanism 16702617 +CYP2D6 1565 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 16835697 +CYP2D6 1565 Manganese Poisoning MESH:D020149 marker/mechanism 12171760 +CYP2D6 1565 Muscle Rigidity MESH:D009127 marker/mechanism 15570195 +CYP2D6 1565 Nephritis, Interstitial MESH:D009395 marker/mechanism 19814645 +CYP2D6 1565 Occupational Diseases MESH:D009784 marker/mechanism 16737584 +CYP2D6 1565 Parkinson Disease MESH:D010300 marker/mechanism 14991823|15174030 +CYP2D6 1565 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 15570195 +CYP2D6 1565 Sexual Dysfunctions, Psychological MESH:D020018 marker/mechanism 12378847|17541852 +CYP2D6 1565 Substance-Related Disorders MESH:D019966 marker/mechanism 17089107 +CYP2D6 1565 Tremor MESH:D014202 marker/mechanism 15570195 +CYP2D6 1565 Weight Gain MESH:D015430 marker/mechanism 19997080 +CYP2E1 1571 Adenocarcinoma MESH:D000230 marker/mechanism 16142352 +CYP2E1 1571 Alcoholism MESH:D000437 marker/mechanism 20843640 +CYP2E1 1571 Asthma MESH:D001249 marker/mechanism 28807506 +CYP2E1 1571 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15162526 +CYP2E1 1571 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 16142352 +CYP2E1 1571 Cardiomegaly MESH:D006332 marker/mechanism 18725507 +CYP2E1 1571 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 12668988|16770646|21741958|28762043 +CYP2E1 1571 Drug Eruptions MESH:D003875 marker/mechanism 19351467 +CYP2E1 1571 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 18990727 +CYP2E1 1571 Fatty Liver MESH:D005234 marker/mechanism 18952117 +CYP2E1 1571 Fatty Liver, Alcoholic MESH:D005235 marker/mechanism 26428356 +CYP2E1 1571 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 20843640 +CYP2E1 1571 Liver Neoplasms MESH:D008113 marker/mechanism 17093202 +CYP2E1 1571 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 18056438 +CYP2E1 1571 Lung Neoplasms MESH:D008175 marker/mechanism 1673675|17093202 +CYP2E1 1571 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 11406608 +CYP2E1 1571 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 22156006 +CYP2E1 1571 Necrosis MESH:D009336 marker/mechanism 12086689|12566070 +CYP2E1 1571 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +CYP2E1 1571 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 26428356 +CYP2E1 1571 Obesity MESH:D009765 marker/mechanism 23954404 +CYP2E1 1571 Parkinson Disease MESH:D010300 marker/mechanism 16510128 +CYP2E1 1571 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 11774269 +CYP2E1 1571 Prostatic Neoplasms MESH:D011471 marker/mechanism 12771559 +CYP2F1 1572 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2F2 13107 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +CYP2J2 1573 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2K18 393484 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28069987 +CYP2R1 120227 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2R1 120227 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 24381012 +CYP2R1 120227 Liver Cirrhosis MESH:D008103 marker/mechanism 24381012 +CYP2R1 120227 Vitamin D Hydroxylation-Deficient Rickets, Type 1B MESH:C564005 marker/mechanism 600081.0 +CYP2S1 29785 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2S1 29785 Psoriasis MESH:D011565 marker/mechanism 12711469 +CYP2T1 171380 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYP2U1 113612 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP2U1 113612 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE, WITH OR WITHOUT PSEUDOXANTHOMA ELASTICUM OMIM:615030 marker/mechanism 615030.0 +CYP39A1 51302 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP39A1 51302 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CYP3A11 13112 Cholestasis MESH:D002779 marker/mechanism 22461449 +CYP3A11 13112 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22342832 +CYP3A11 13112 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CYP3A13 13113 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +CYP3A16 13114 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +CYP3A18 252931 Nephrosis MESH:D009401 marker/mechanism 18725544 +CYP3A2 266682 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22244987 +CYP3A2 266682 Inflammation MESH:D007249 marker/mechanism 21467745 +CYP3A23-3A1 25642 Acute Kidney Injury MESH:D058186 marker/mechanism 20623750 +CYP3A23-3A1 25642 Adenoma, Liver Cell MESH:D018248 marker/mechanism 10959800 +CYP3A23-3A1 25642 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +CYP3A23-3A1 25642 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22244987 +CYP3A23-3A1 25642 Inflammation MESH:D007249 marker/mechanism 21467745 +CYP3A37 678669 Escherichia coli Infections MESH:D004927 marker/mechanism 24498193 +CYP3A4 1576 Breast Neoplasms MESH:D001943 marker/mechanism 15496535 +CYP3A4 1576 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 35622184 +CYP3A4 1576 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28762043 +CYP3A4 1576 Hepatitis C MESH:D006526 marker/mechanism 8864187 +CYP3A4 1576 Osteosarcoma MESH:D012516 marker/mechanism 17279585 +CYP3A4 1576 Prostatic Neoplasms MESH:D011471 marker/mechanism 15496535 +CYP3A4 1576 Torsades de Pointes MESH:D016171 marker/mechanism 15875343 +CYP3A43 64816 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP3A43 64816 Prostatic Neoplasms MESH:D011471 marker/mechanism 15894682 +CYP3A5 1577 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP3A5 1577 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +CYP3A5 1577 Kidney Diseases MESH:D007674 marker/mechanism 18408564|20526235 +CYP3A5 1577 Neurotoxicity Syndromes MESH:D020258 therapeutic 21225912 +CYP3A5 1577 Prostatic Neoplasms MESH:D011471 marker/mechanism 18306354 +CYP3A5 1577 Thrombosis MESH:D013927 marker/mechanism 16754899 +CYP3A62 170509 Reperfusion Injury MESH:D015427 marker/mechanism 22749977 +CYP3A7 1551 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP3A9 171352 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYP3A9 171352 Nephrosis MESH:D009401 marker/mechanism 18725544 +CYP3A9 171352 Reperfusion Injury MESH:D015427 marker/mechanism 22749977 +CYP46A1 10858 Alzheimer Disease MESH:D000544 marker/mechanism 19286353 +CYP4A10 13117 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22342832 +CYP4A10 13117 Hypertension MESH:D006973 marker/mechanism 16691295 +CYP4A11 1579 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP4A11 1579 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +CYP4A11 1579 Liver Cirrhosis MESH:D008103 marker/mechanism 36368619 +CYP4A14 13119 Cholestasis MESH:D002779 marker/mechanism 22461449 +CYP4A14 13119 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22342832 +CYP4A14 13119 Hepatitis, Animal MESH:D006520 marker/mechanism 18559427 +CYP4A22 284541 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP4A3 298423 Cardiomegaly MESH:D006332 marker/mechanism 18725507 +CYP4A3 298423 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +CYP4B1 1580 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP4B1 1580 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 18713828 +CYP4F12 66002 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP4F2 8529 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP4F2 8529 Hypertension MESH:D006973 marker/mechanism 30932691 +CYP4F22 126410 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP4F22 126410 Lamellar ichthyosis, type 3 MESH:C537265 marker/mechanism 604777.0 +CYP4F3 4051 Poisoning MESH:D011041 marker/mechanism 20036648 +CYP4F8 11283 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP4V2 285440 Bietti Crystalline Dystrophy MESH:C535440 marker/mechanism 210370.0 +CYP4X1 260293 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP7A1 1581 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +CYP7A1 1581 Cholestasis MESH:D002779 marker/mechanism 22461449|9797378 +CYP7A1 1581 Hypercholesterolemia MESH:D006937 therapeutic 8245718 +CYP7B1 9420 Adenocarcinoma MESH:D000230 marker/mechanism 17639508 +CYP7B1 9420 Bile Acid Synthesis Defect, Congenital, 3 MESH:C566340 marker/mechanism 613812.0 +CYP7B1 9420 Cholestasis MESH:D002779 marker/mechanism 9802883 +CYP7B1 9420 Fatty Liver MESH:D005234 marker/mechanism 23391614 +CYP7B1 9420 Lipid Metabolism, Inborn Errors MESH:D008052 marker/mechanism 18252231 +CYP7B1 9420 Liver Diseases MESH:D008107 marker/mechanism 9802883 +CYP7B1 9420 Prostatic Neoplasms MESH:D011471 marker/mechanism 17639508 +CYP7B1 9420 Spastic Paraplegia, Hereditary MESH:D015419 marker/mechanism 18252231 +CYP7B1 9420 Spastic paraplegia type 5A, recessive MESH:C536871 marker/mechanism 270800.0 19812052 +CYP8B1 1582 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25448281 +CYP8B1 1582 Cholestasis MESH:D002779 marker/mechanism 22461449 +CYRIA 81553 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYRIB 51571 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +CYRIB 51571 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYSLTR1 10800 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 16502481|17641958|20485159 +CYSLTR1 10800 Drug Hypersensitivity MESH:D004342 marker/mechanism 16630147 +CYSLTR1 10800 Fractures, Closed MESH:D005596 marker/mechanism 19544365 +CYSLTR2 57105 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 16502481|20485159 +CYSLTR2 57105 Drug Hypersensitivity MESH:D004342 marker/mechanism 15970796 +CYSLTR2 57105 Pulmonary Fibrosis MESH:D011658 marker/mechanism 15328359 +CYSLTR2 57105 Uveal melanoma MESH:C536494 marker/mechanism 27089179|33288675 +CYSTM1 84418 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +CYTB 4519 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +CYTB 4519 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 535000.0 +CYTH1 9267 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +D2HGDH 728294 2-Hydroxyglutaricaciduria MESH:C535306 marker/mechanism 600721.0 +D2HGDH 728294 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 15609246 +DAAM2 23500 Osteoporosis MESH:D010024 marker/mechanism 30598549 +DAB1 1600 Autistic Disorder MESH:D001321 marker/mechanism 15820235 +DAB2IP 153090 Aortic Aneurysm, Abdominal MESH:D017544 marker/mechanism 20622881 +DAB2IP 153090 Lung Neoplasms MESH:D008175 marker/mechanism 22046421 +DAB2IP 153090 Myocardial Infarction MESH:D009203 marker/mechanism 20622881 +DAB2IP 153090 Peripheral Vascular Diseases MESH:D016491 marker/mechanism 20622881 +DAB2IP 153090 Prostatic Neoplasms MESH:D011471 marker/mechanism 18073375 +DAB2IP 153090 Pulmonary Embolism MESH:D011655 marker/mechanism 20622881 +DACT1 51339 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +DACT1 51339 Townes-Brocks syndrome MESH:C536974 marker/mechanism 617466.0 +DACT2 168002 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +DACT3 147906 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +DAF-16 172981 Death MESH:D003643 marker/mechanism 26796881 +DAF-2 175410 Hypoxia MESH:D000860 therapeutic 19936206 +DAG1 1605 Lassa Fever MESH:D007835 marker/mechanism 17287727 +DAG1 1605 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9 OMIM:613818 marker/mechanism 613818.0 +DAG1 1605 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +DAG1 1605 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 616538.0 +DAO 1610 Autistic Disorder MESH:D001321 marker/mechanism 17629951 +DAO 1610 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DAO 1610 Schizophrenia MESH:D012559 marker/mechanism 18583979 +DAOA 267012 Schizophrenia MESH:D012559 marker/mechanism 181500.0 +DAP 1611 Colitis, Ulcerative MESH:D003093 marker/mechanism 21297633 +DAP3 7818 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +DAPK1 1612 Adenocarcinoma MESH:D000230 marker/mechanism 15172992 +DAPK1 1612 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +DAPK1 1612 Brain Neoplasms MESH:D001932 marker/mechanism 17319784 +DAPK1 1612 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +DAPK1 1612 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 11313923 +DAPK1 1612 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 17133271 +DAPK1 1612 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 17133271 +DAPK1 1612 Conjunctival Diseases MESH:D003229 marker/mechanism 23872714 +DAPK1 1612 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 19874806 +DAPK1 1612 Lung Neoplasms MESH:D008175 marker/mechanism 15172992 +DAPK1 1612 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 19874806 +DAPK1 1612 Neoplasm Metastasis MESH:D009362 marker/mechanism 17319784 +DAPK1 1612 Neoplasms, Second Primary MESH:D016609 marker/mechanism 19874806 +DAPK1 1612 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 23872714 +DAPK1 1612 Respiratory Tract Diseases MESH:D012140 marker/mechanism 23872714 +DAPK1 1612 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +DAPK2 23604 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +DAPK2 23604 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 28978663 +DAPP1 27071 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +DARS1 1615 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY OMIM:615281 marker/mechanism 615281.0 +DARS2 55157 Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation MESH:C567009 marker/mechanism 611105.0 +DAT-1 176304 Manganese Poisoning MESH:D020149 marker/mechanism 20865164 +DAT-1 176304 Nerve Degeneration MESH:D009410 marker/mechanism 20865164 +DAXX 1616 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 24747642 +DAXX 1616 Neuroendocrine Tumors MESH:D018358 marker/mechanism 21252315 +DAXX 1616 Pancreatic Neoplasms MESH:D010190 marker/mechanism 21252315 +DAZ1 1617 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +DAZ2 57055 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +DAZ3 57054 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +DAZL 1618 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 23666240 +DBH 1621 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DBH 1621 dopamine beta hydroxylase deficiency MESH:C535600 marker/mechanism 223360.0 +DBH 1621 Neuroblastoma MESH:D009447 marker/mechanism 25174395 +DBH 1621 Paranoid Disorders MESH:D010259 marker/mechanism 10673769|12555232|17157269 +DBH 1621 Pheochromocytoma MESH:D010673 marker/mechanism 22569243 +DBI 1622 Carcinoma MESH:D002277 marker/mechanism 12376462 +DBI 1622 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +DBI 1622 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +DBNDD2 55861 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DBR1 51163 Amyotrophic Lateral Sclerosis MESH:D000690 therapeutic 23104007 +DBT 1629 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +DBT 1629 Maple Syrup Urine Disease MESH:D008375 marker/mechanism 248600.0 +DBX1 120237 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +DCAF17 80067 Woodhouse Sakati syndrome MESH:C536742 marker/mechanism 241080.0 +DCAF4L2 138009 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DCAF6 55827 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +DCAF7 10238 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +DCAF7 10238 Leukemia, Megakaryoblastic, of Down Syndrome MESH:C566025 marker/mechanism 24056718 +DCAF8 50717 Giant Axonal Neuropathy, Autosomal Dominant MESH:C566444 marker/mechanism 610100.0 +DCBLD1 285761 Melanoma MESH:D008545 marker/mechanism 22535842 +DCBLD2 131566 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +DCBLD2 131566 Stomach Neoplasms MESH:D013274 marker/mechanism 18314483 +DCC 1630 Agenesis of Corpus Callosum MESH:D061085 marker/mechanism 28250454 +DCC 1630 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 15365072 +DCC 1630 Esophageal Neoplasms MESH:D004938 marker/mechanism 133239.0 +DCC 1630 gaze palsy, familial horizontal, with progressive scoliosis MESH:C564593 marker/mechanism 28250456 +DCC 1630 Intellectual Disability MESH:D008607 marker/mechanism 28250456 +DCC 1630 Melanoma MESH:D008545 marker/mechanism 22842228 +DCC 1630 MIRROR MOVEMENTS 1 OMIM:157600 marker/mechanism 157600.0 +DCD 117159 Liver Neoplasms MESH:D008113 marker/mechanism 20195826 +DCDC2 51473 Deafness, Autosomal Recessive 66 MESH:C565701 marker/mechanism 610212.0 +DCDC2 51473 NEPHRONOPHTHISIS 19 OMIM:616217 marker/mechanism 616217.0 +DCDC2 51473 SCLEROSING CHOLANGITIS, NEONATAL OMIM:617394 marker/mechanism 617394.0 +DCHS1 8642 Heterotopia, Periventricular, Autosomal Recessive MESH:C564292 marker/mechanism 24056717 +DCHS1 8642 Mitral Valve Prolapse, Myxomatous 2 MESH:C564326 marker/mechanism 607829.0 +DCHS1 8642 Van Maldergem Wetzburger Verloes syndrome MESH:C536530 marker/mechanism 601390.0 24056717 +DCLK1 9201 Colorectal Neoplasms MESH:D015179 therapeutic 23202126 +DCLRE1C 64421 Reticuloendotheliosis, familial, with eosinophilia MESH:C538564 marker/mechanism 603554.0 +DCLRE1C 64421 Severe combined immunodeficiency with sensitivity to ionizing radiation MESH:C537589 marker/mechanism 602450.0 +DCN 1634 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DCN 1634 Corneal Dystrophy, Congenital Stromal MESH:C566452 marker/mechanism 610048.0 +DCN 1634 Endometrial Neoplasms MESH:D016889 marker/mechanism 16804899 +DCN 1634 Fibrosis MESH:D005355 marker/mechanism 16005714 +DCN 1634 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 12868502 +DCN 1634 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +DCN 1634 Nephritis, Interstitial MESH:D009395 marker/mechanism 16005714 +DCPS 28960 AL-RAQAD SYNDROME OMIM:616459 marker/mechanism 616459.0 +DCR 1637 Down Syndrome MESH:D004314 marker/mechanism 190685.0 +DCSTAMP 81501 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +DCSTAMP 81501 Endometriosis MESH:D004715 marker/mechanism 20864642 +DCSTAMP 81501 Osteitis Deformans MESH:D010001 marker/mechanism 21623375 +DCTN1 1639 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 105400.0 +DCTN1 1639 Hypoventilation MESH:D007040 marker/mechanism 19136952 +DCTN1 1639 Mood Disorders MESH:D019964 marker/mechanism 19136952 +DCTN1 1639 Neuronopathy, Distal Hereditary Motor, Type Viib MESH:C564362 marker/mechanism 607641.0 +DCTN1 1639 Parkinsonian Disorders MESH:D020734 marker/mechanism 19136952 +DCTN1 1639 Perry Syndrome MESH:C566822 marker/mechanism 168605.0 +DCTN4 51164 Cystic Fibrosis MESH:D003550 marker/mechanism 22772370 +DCTN4 51164 Pseudomonas Infections MESH:D011552 marker/mechanism 22772370 +DCX 1641 Classical Lissencephalies and Subcortical Band Heterotopias MESH:D054221 marker/mechanism 300067.0 +DCXR 51181 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DCXR 51181 Obesity MESH:D009765 marker/mechanism 20882379 +DCXR 51181 Pentosuria MESH:C536652 marker/mechanism 260800.0 25526675|28595002 +DCXR 51181 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +DDAH1 23576 Liver Diseases MESH:D008107 marker/mechanism 19784758 +DDAH2 23564 Coronary Artery Disease MESH:D003324 marker/mechanism 17267746 +DDAH2 23564 Pre-Eclampsia MESH:D011225 marker/mechanism 22285683 +DDB1 1642 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +DDB1 1642 Disease Progression MESH:D018450 marker/mechanism 21364753 +DDB1 1642 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +DDB2 1643 Xeroderma Pigmentosum, Complementation Group E MESH:C564732 marker/mechanism 278740.0 24753253 +DDC 1644 Aromatic amino acid decarboxylase deficiency MESH:C537437 marker/mechanism 608643.0 +DDC 1644 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DDC 1644 Mental Disorders MESH:D001523 marker/mechanism 2969953 +DDC 1644 Nerve Degeneration MESH:D009410 marker/mechanism 19522546 +DDC 1644 Parkinson Disease MESH:D010300 therapeutic 11445284|2969953 +DDC 1644 Parkinsonian Disorders MESH:D020734 therapeutic 16269145 +DDC 1644 Pheochromocytoma MESH:D010673 marker/mechanism 22569243 +DDHD1 80821 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 31209396 +DDHD1 80821 Spastic Paraplegia 28, Autosomal Recessive MESH:C563732 marker/mechanism 609340.0 +DDHD2 23259 Schizophrenia MESH:D012559 marker/mechanism 33462483 +DDHD2 23259 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE OMIM:615033 marker/mechanism 615033.0 +DDIT3 1649 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +DDIT3 1649 Asbestosis MESH:D001195 marker/mechanism 25324550 +DDIT3 1649 Breast Neoplasms MESH:D001943 marker/mechanism 14604972 +DDIT3 1649 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +DDIT3 1649 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 23499715 +DDIT3 1649 Fatty Liver MESH:D005234 marker/mechanism 27664470 +DDIT3 1649 Intestinal Diseases MESH:D007410 marker/mechanism 20668000 +DDIT3 1649 Liposarcoma, Myxoid MESH:D018208 marker/mechanism 1283316|7503811|8510758 +DDIT3 1649 Myocardial Infarction MESH:D009203 marker/mechanism 25450231 +DDIT3 1649 Nephrosis MESH:D009401 marker/mechanism 16400006 +DDIT3 1649 Obesity MESH:D009765 marker/mechanism 26655953 +DDIT3 1649 Ocular Hypertension MESH:D009798 therapeutic 24691439 +DDIT3 1649 Spinal Cord Injuries MESH:D013119 marker/mechanism 29793971 +DDIT3 1649 Ulcer MESH:D014456 marker/mechanism 20668000 +DDIT4 54541 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860 +DDIT4 54541 Leukemia MESH:D007938 therapeutic 17379067 +DDIT4 54541 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +DDIT4 54541 Nerve Degeneration MESH:D009410 therapeutic 17005863 +DDIT4 54541 Parkinson Disease MESH:D010300 therapeutic 17005863 +DDIT4L 115265 Melanoma MESH:D008545 marker/mechanism 16778180 +DDO 8528 Ataxia MESH:D001259 therapeutic 25979765 +DDO 8528 Sexual Dysfunction, Physiological MESH:D012735 marker/mechanism 16525061 +DDO 8528 Weight Gain MESH:D015430 marker/mechanism 16525061 +DDOST 1650 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir OMIM:614507 marker/mechanism 614507.0 +DDR1 780 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +DDR1 780 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +DDR1 780 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 21283680 +DDR1 780 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +DDR2 4921 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 26206333 +DDR2 4921 Spondylometaepiphyseal Dysplasia, Short Limb-Hand Type MESH:C564794 marker/mechanism 271665.0 +DDR2 4921 Tobacco Use Disorder MESH:D014029 marker/mechanism 29216386 +DDX1 1653 Endometrial Hyperplasia MESH:D004714 marker/mechanism 22248470 +DDX1 1653 HIV Infections MESH:D015658 marker/mechanism 24183723 +DDX1 1653 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +DDX11 1663 Chromosome Breakage MESH:D019457 marker/mechanism 25561740 +DDX11 1663 WARSAW BREAKAGE SYNDROME OMIM:613398 marker/mechanism 613398.0 +DDX3X 1654 Epilepsy MESH:D004827 marker/mechanism 29942082 +DDX3X 1654 HIV Infections MESH:D015658 marker/mechanism 24183723 +DDX3X 1654 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE OMIM:300958 marker/mechanism 300958.0 +DDX3X 1654 Lymphoma, T-Cell MESH:D016399 marker/mechanism 26192917 +DDX3X 1654 Medulloblastoma MESH:D008527 marker/mechanism 27058758 +DDX3X 1654 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +DDX3X 1654 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +DDX3X 1654 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +DDX3Y 8653 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +DDX41 51428 Acute erythroleukemia MESH:C535673 marker/mechanism 30926971 +DDX41 51428 MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO OMIM:616871 marker/mechanism 616871.0 +DDX5 1655 Endometriosis MESH:D004715 marker/mechanism 22138541 +DDX51 317781 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +DDX54 79039 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +DDX54 79039 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +DDX54 79039 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +DDX59 83479 Orofaciodigital syndrome 5 MESH:C557819 marker/mechanism 174300.0 +DDX6 1656 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +DDX60 55601 Influenza, Human MESH:D007251 marker/mechanism 23326326 +DEAF1 10522 Intellectual Disability MESH:D008607 marker/mechanism 21076407 +DEAF1 10522 NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES OMIM:617171 marker/mechanism 617171.0 +DEAF1 10522 VULTO-VAN SILFHOUT-DE VRIES SYNDROME OMIM:615828 marker/mechanism 615828.0 +DECR1 1666 2,4-Dienoyl-CoA Reductase Deficiency MESH:C565624 marker/mechanism 25526675 +DECR1 1666 Lipid Metabolism, Inborn Errors MESH:D008052 marker/mechanism 2332510 +DEF4 3289964 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +DEF6 50619 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 26808113 +DEFA24 503491 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +DEFA3 1668 Leukemia, Promyelocytic, Acute MESH:D015473 therapeutic 16019513 +DEFA5 1670 Adenomatous Polyps MESH:D018256 marker/mechanism 15844706 +DEFA5 1670 Colitis, Ulcerative MESH:D003093 marker/mechanism 20452301 +DEFA5 1670 Colonic Neoplasms MESH:D003110 marker/mechanism 15844706 +DEFA5 1670 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 22197929|25305756 +DEFA5 1670 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 18394979 +DEFA5 1670 Peutz-Jeghers Syndrome MESH:D010580 marker/mechanism 17934846 +DEFA6 1671 Colitis, Ulcerative MESH:D003093 marker/mechanism 20452301 +DEFAL1 613220 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +DEFB1 1672 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +DEFB1 1672 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +DEFB4A 1673 Pneumonia, Pneumococcal MESH:D011018 marker/mechanism 24894820 +DEGS1 8560 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +DEK 7913 Breast Neoplasms MESH:D001943 marker/mechanism 27811057 +DEK 7913 Disease Models, Animal MESH:D004195 marker/mechanism 27811057 +DEK 7913 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21291860|27811057 +DEK 7913 Neoplasm Metastasis MESH:D009362 marker/mechanism 27811057 +DENND1B 163486 Crohn Disease MESH:D003424 marker/mechanism 21102463 +DENND1B 163486 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 21399635 +DENND4B 9909 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +DENND5A 23258 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 49 OMIM:617281 marker/mechanism 617281.0 +DEPDC1 55635 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DEPDC1B 55789 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DEPDC5 9681 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21725309 +DEPDC5 9681 Epilepsy, Partial, with Variable Foci MESH:C565785 marker/mechanism 604364.0 23542697|23542701 +DEPDC7 91614 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DEPP1 11067 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +DEPP1 11067 Endometriosis MESH:D004715 marker/mechanism 20864642 +DEPP1 11067 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414|17175557 +DERL1 79139 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +DES 1674 Atrial Fibrillation MESH:D001281 marker/mechanism 20137276 +DES 1674 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +DES 1674 Carcinoma MESH:D002277 marker/mechanism 12376462 +DES 1674 Cardiomyopathy, Dilated, 1i MESH:C565752 marker/mechanism 604765.0 +DES 1674 Fetal Growth Retardation MESH:D005317 marker/mechanism 28157488 +DES 1674 Glomerulonephritis MESH:D005921 marker/mechanism 20962747 +DES 1674 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 27651373 +DES 1674 Hyperhomocysteinemia MESH:D020138 marker/mechanism 20116427 +DES 1674 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +DES 1674 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +DES 1674 Muscular Dystrophies, Limb-Girdle MESH:D049288 marker/mechanism 23687351|30055862 +DES 1674 Myofibrillar Myopathy MESH:C580316 marker/mechanism 601419.0 20718792|30055862 +DES 1674 Myopathy, Myofibrillar, Desmin-Related MESH:C563319 marker/mechanism 20718792|30055862 +DES 1674 Nephrosis MESH:D009401 marker/mechanism 16418842 +DES 1674 Scapuloperoneal Syndrome, Neurogenic, Kaeser Type MESH:C566695 marker/mechanism 181400.0 +DES 1674 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +DESI2 51029 Ovarian Neoplasms MESH:D010051 therapeutic 21667029 +DEUP1 159989 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +DEUP1 159989 Glioblastoma MESH:D005909 marker/mechanism 30705370 +DFFB 1677 Chromosome Breakage MESH:D019457 marker/mechanism 31401084 +DGAT1 8694 Diarrhea MESH:D003967 marker/mechanism 615863.0 +DGAT2 84649 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 17984051 +DGAT2 84649 Cholestasis MESH:D002779 marker/mechanism 27989131 +DGCR 1714 DiGeorge Syndrome MESH:D004062 marker/mechanism 188400.0 +DGCR2 9993 DiGeorge Syndrome MESH:D004062 marker/mechanism 192430.0 +DGCR2 9993 Schizophrenia MESH:D012559 marker/mechanism 21822266 +DGCR6 8214 DiGeorge Syndrome MESH:D004062 marker/mechanism 192430.0 +DGCR8 54487 DiGeorge Syndrome MESH:D004062 marker/mechanism 192430.0 +DGCR8 54487 Mental Disorders MESH:D001523 marker/mechanism 18469815 +DGCR8 54487 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +DGKB 1607 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +DGKD 8527 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +DGKE 8526 Atypical Hemolytic Uremic Syndrome MESH:D065766 marker/mechanism 23542698 +DGKE 8526 NEPHROTIC SYNDROME, TYPE 7 OMIM:615008 marker/mechanism 615008.0 +DGKH 160851 Diabetic Nephropathies MESH:D003928 marker/mechanism 20665664 +DGKK 139189 Hypospadias MESH:D007021 marker/mechanism 21113153|27098078 +DGKQ 1609 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097067 +DGKZ 8525 Myocardial Infarction MESH:D009203 therapeutic 17071729 +DGUOK 1716 Deoxyguanosine Kinase Deficiency MESH:C580039 marker/mechanism 26342080 +DGUOK 1716 Hypertension, Portal MESH:D006975 marker/mechanism 617068.0 +DGUOK 1716 MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE) OMIM:251880 marker/mechanism 251880.0 +DGUOK 1716 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4 OMIM:617070 marker/mechanism 617070.0 +DHCR24 1718 Alzheimer Disease MESH:D000544 marker/mechanism 23042211 +DHCR24 1718 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24781735 +DHCR24 1718 Desmosterolosis MESH:C566555 marker/mechanism 602398.0 16410790 +DHCR24 1718 Q Fever MESH:D011778 marker/mechanism 16469060 +DHCR7 1717 Autistic Disorder MESH:D001321 marker/mechanism 14659996 +DHCR7 1717 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 24381012 +DHCR7 1717 Disease Models, Animal MESH:D004195 marker/mechanism 29698737 +DHCR7 1717 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +DHCR7 1717 Liver Cirrhosis MESH:D008103 marker/mechanism 24381012 +DHCR7 1717 Smith-Lemli-Opitz Syndrome MESH:D019082 marker/mechanism 270400.0 11254748|12818773|12906934|14659996|15896653|16446309|16814115|17994283|19365639|27097157|29698737 +DHDDS 79947 RETINITIS PIGMENTOSA 59 OMIM:613861 marker/mechanism 613861.0 +DHDH 27294 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +DHFR 1719 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +DHFR 1719 Anemia, Megaloblastic MESH:D000749 marker/mechanism 21310276|21310277 +DHFR 1719 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23897011 +DHFR 1719 Autistic Disorder MESH:D001321 marker/mechanism 17597297 +DHFR 1719 Breast Neoplasms MESH:D001943 marker/mechanism 21501481|28188287 +DHFR 1719 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 19648163 +DHFR 1719 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641 +DHFR 1719 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 21064136 +DHFR 1719 Folic Acid Deficiency MESH:D005494 marker/mechanism 21310277 +DHFR 1719 Infertility, Female MESH:D007247 therapeutic 17519396 +DHFR 1719 Megaloblastic Anemia due to Dihydrofolate Reductase Deficiency MESH:C565095 marker/mechanism 613839.0 +DHFR 1719 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 21310276|21310277 +DHFR 1719 Neoplasm Metastasis MESH:D009362 marker/mechanism 19159907 +DHFR 1719 Nervous System Diseases MESH:D009422 marker/mechanism 21064136|21310277 +DHFR 1719 Osteosarcoma MESH:D012516 marker/mechanism 19159907 +DHFR 1719 Pancytopenia MESH:D010198 marker/mechanism 21310276 +DHH 50846 46,XY Gonadal Dysgenesis, Complete or Partial, DHH-Related MESH:C565537 marker/mechanism 233420.0 +DHH 50846 46,Xy Gonadal Dysgenesis, Partial, With Minifascicular Neuropathy MESH:C567773 marker/mechanism 607080.0 +DHODH 1723 Anemia, Sickle Cell MESH:D000755 marker/mechanism 38827 +DHODH 1723 beta-Thalassemia MESH:D017086 marker/mechanism 38827 +DHODH 1723 Genee-Wiedemann syndrome MESH:C537680 marker/mechanism 263750.0 +DHODH 1723 Leukemia, Erythroblastic, Acute MESH:D004915 marker/mechanism 38827 +DHODH 1723 Spherocytosis, Hereditary MESH:D013103 marker/mechanism 38827 +DHRS1 115817 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DHRS2 10202 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DHRS3 9249 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DHRS7 51635 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +DHRS7 51635 Fatty Liver MESH:D005234 marker/mechanism 25226513 +DHRS7 51635 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DHRS7 51635 Tobacco Use Disorder MESH:D014029 marker/mechanism 29216386 +DHRS9 10170 Birth Weight MESH:D001724 marker/mechanism 34200176 +DHTKD1 55526 ALPHA-AMINOADIPIC AND ALPHA-KETOADIPIC ACIDURIA OMIM:204750 marker/mechanism 204750.0 +DHTKD1 55526 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q OMIM:615025 marker/mechanism 615025.0 +DHTKD1 55526 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DHX15 1665 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 27798625|29163777 +DHX30 22907 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +DHX38 9785 Retinitis Pigmentosa MESH:D012174 marker/mechanism 30208423 +DIABLO 56616 Brain Ischemia MESH:D002545 marker/mechanism 11756504 +DIABLO 56616 DEAFNESS, AUTOSOMAL DOMINANT 64 OMIM:614152 marker/mechanism 614152.0 +DIABLO 56616 Huntington Disease MESH:D006816 marker/mechanism 12930891 +DIABLO 56616 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 14998631 +DIABLO 56616 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30664745 +DIABLO 56616 Prostatic Neoplasms MESH:D011471 therapeutic 17718901 +DIAPH1 1729 Deafness, Autosomal Dominant 1 MESH:C565121 marker/mechanism 124900.0 +DIAPH1 1729 SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME OMIM:616632 marker/mechanism 616632.0 +DIAPH2 1730 Premature Ovarian Failure 2a MESH:C564498 marker/mechanism 300511.0 +DIAPH2-AS1 10824 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +DIAPH3 81624 Auditory Neuropathy, Autosomal Dominant, 1 MESH:C563790 marker/mechanism 609129.0 +DICER1 23405 Endometriosis MESH:D004715 marker/mechanism 21063030 +DICER1 23405 GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS OMIM:138800 marker/mechanism 138800.0 +DICER1 23405 Liver Neoplasms MESH:D008113 marker/mechanism 24478143 +DICER1 23405 Oligospermia MESH:D009845 marker/mechanism 22381205 +DICER1 23405 Pleuropulmonary blastoma MESH:C537516 marker/mechanism 601200.0 +DICER1 23405 Rhabdomyosarcoma, Embryonal, 2 MESH:C566709 marker/mechanism 180295.0 +DICER1 23405 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +DIDO1 11083 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 30431698 +DIO1 1733 Hyperthyroxinemia MESH:D006981 marker/mechanism 3346351 +DIO1 1733 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +DIO1 1733 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 17105838 +DIO1 1733 Thyroid Diseases MESH:D013959 marker/mechanism 17105838 +DIO2 1734 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24781735 +DIO2 1734 Endometriosis MESH:D004715 marker/mechanism 21063030 +DIO2 1734 Mesothelioma MESH:D008654 marker/mechanism 11425850 +DIO2 1734 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +DIO3 1735 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24781735 +DIO3 1735 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +DIO3 1735 Neoplasm Metastasis MESH:D009362 marker/mechanism 26825960 +DIO3 1735 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +DIO3OS 64150 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +DIP2A 23181 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 28191889 +DIP2B 57609 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +DIP2B 57609 Mental Retardation, Fra12a Type MESH:C566980 marker/mechanism 136630.0 +DIP2C 22982 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +DIPK2A 205428 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21283809 +DIPK2A 205428 Autistic Disorder MESH:D001321 marker/mechanism 18621663 +DIPK2A 205428 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DIPK2B 79742 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21264219|21283809 +DIPK2B 79742 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DIPK2B 79742 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 21264219 +DIRAS3 9077 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DIS3L2 129563 Nephroblastomatosis, fetal ascites, macrosomia and Wilms tumor MESH:C536399 marker/mechanism 267000.0 22306653 +DISC1 27185 Anxiety Disorders MESH:D001008 marker/mechanism 29643356 +DISC1 27185 Asperger Syndrome MESH:D020817 marker/mechanism 17579608 +DISC1 27185 Autistic Disorder MESH:D001321 marker/mechanism 17579608|20002455 +DISC1 27185 Depressive Disorder MESH:D003866 marker/mechanism 29643356 +DISC1 27185 Hyperkinesis MESH:D006948 marker/mechanism 26754951 +DISC1 27185 Intellectual Disability MESH:D008607 marker/mechanism 20002455 +DISC1 27185 Motor Skills Disorders MESH:D019957 marker/mechanism 26754951 +DISC1 27185 Pain MESH:D010146 marker/mechanism 20561508 +DISC1 27185 Schizophrenia MESH:D012559 marker/mechanism 604906.0 20531374|20561508 +DISC2 27184 Schizophrenia MESH:D012559 marker/mechanism 181500.0 +DISP1 84976 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +DIXDC1 85458 Anxiety Disorders MESH:D001008 marker/mechanism 27752079 +DIXDC1 85458 Autistic Disorder MESH:D001321 marker/mechanism 27752079 +DIXDC1 85458 Bipolar Disorder MESH:D001714 marker/mechanism 27752079 +DIXDC1 85458 Depressive Disorder MESH:D003866 marker/mechanism 27752079 +DIXDC1 85458 Schizophrenia MESH:D012559 marker/mechanism 27752079 +DJ-1BETA 43652 Parkinsonian Disorders MESH:D020734 marker/mechanism 20423725 +DKC1 1736 Dyskeratosis Congenita MESH:D019871 marker/mechanism 305000.0 17785587|22299032 +DKK1 22943 Breast Neoplasms MESH:D001943 marker/mechanism 18283316 +DKK1 22943 Endometriosis MESH:D004715 marker/mechanism 21063030 +DKK1 22943 Fractures, Bone MESH:D050723 marker/mechanism 22504420 +DLAT 1737 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +DLAT 1737 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +DLAT 1737 Pyruvate Dehydrogenase E2 Deficiency MESH:C565448 marker/mechanism 245348.0 +DLC1 10395 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +DLC1 10395 Neoplasms MESH:D009369 marker/mechanism 21455586 +DLC1 10395 Ovarian Neoplasms MESH:D010051 therapeutic 15674352 +DLC1 10395 Stomach Neoplasms MESH:D013274 therapeutic 26401016 +DLD 1738 Lactic Acidosis, Congenital Infantile, Due To LAD Deficiency MESH:C573012 marker/mechanism 246900.0 +DLEU2 8847 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 21441929 +DLG1 1739 Cleft Palate MESH:D002972 marker/mechanism 11238884 +DLG1 1739 Schizophrenia MESH:D012559 marker/mechanism 12421351|18665322|20691406 +DLG2 1740 Melanoma MESH:D008545 marker/mechanism 22535842 +DLG3 1741 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 90 OMIM:300850 marker/mechanism 300850.0 +DLG3 1741 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 15185169 +DLG4 1742 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20952458 +DLG4 1742 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +DLG4 1742 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +DLG4 1742 Williams Syndrome MESH:D018980 marker/mechanism 20952458 +DLGAP1 9229 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +DLGAP2 9228 Autistic Disorder MESH:D001321 marker/mechanism 20531469 +DLGAP5 9787 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DLK1 8788 Fetal Growth Retardation MESH:D005317 marker/mechanism 27776119 +DLK1 8788 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 18575777 +DLL1 28514 Brain Neoplasms MESH:D001932 marker/mechanism 21127729 +DLL1 28514 Breast Neoplasms MESH:D001943 marker/mechanism 21036696 +DLL3 10683 Astrocytoma MESH:D001254 marker/mechanism 21127729 +DLL3 10683 Congenital Abnormalities MESH:D000013 marker/mechanism 17849441 +DLL3 10683 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17849441 +DLL3 10683 Osteochondrodysplasias MESH:D010009 marker/mechanism 11146471 +DLL3 10683 Scoliosis MESH:D012600 marker/mechanism 17849441 +DLL3 10683 Spondylocostal dysostosis, autosomal recessive MESH:C535781 marker/mechanism 277300.0 +DLL4 54567 Adams Oliver syndrome MESH:C538225 marker/mechanism 616589.0 +DLL4 54567 Breast Neoplasms MESH:D001943 marker/mechanism 21036696 +DLX1 1745 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21302352 +DLX1 1745 Autistic Disorder MESH:D001321 marker/mechanism 18728693 +DLX1 1745 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9187081 +DLX2 1746 Autistic Disorder MESH:D001321 marker/mechanism 18728693 +DLX2 1746 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9187081 +DLX3 1747 Amelogenesis Imperfecta, Type IV MESH:C566293 marker/mechanism 104510.0 +DLX3 1747 TRICHODENTOOSSEOUS SYNDROME OMIM:190320 marker/mechanism 190320.0 +DLX4 1748 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +DLX4 1748 OROFACIAL CLEFT 15 OMIM:616788 marker/mechanism 616788.0 +DLX5 1749 Birth Weight MESH:D001724 marker/mechanism 31082282 +DLX5 1749 Bone Diseases, Developmental MESH:D001848 marker/mechanism 10433909 +DLX5 1749 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10433909|10433912|14666512 +DLX5 1749 Ectrodactyly MESH:C574275 marker/mechanism 183600.0 +DLX5 1749 Split-Hand-Foot Malformation With Sensorineural Hearing Loss MESH:C565647 marker/mechanism 220600.0 +DLX6 1750 Craniofacial Abnormalities MESH:D019465 marker/mechanism 14666512 +DMBT1 1755 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +DMD 1756 Ataxia MESH:D001259 marker/mechanism 30074247 +DMD 1756 Calcinosis MESH:D002114 marker/mechanism 18340010 +DMD 1756 Cardiomegaly MESH:D006332 marker/mechanism 23297412 +DMD 1756 Cardiomyopathies MESH:D009202 marker/mechanism|therapeutic 17440445|18340010|20675662 +DMD 1756 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 11496434 +DMD 1756 CARDIOMYOPATHY, DILATED, 3B OMIM:302045 marker/mechanism 302045 +DMD 1756 Disease Models, Animal MESH:D004195 marker/mechanism 22795790|26930420|30074247 +DMD 1756 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 24793134 +DMD 1756 Leiomyosarcoma MESH:D007890 marker/mechanism 24793134 +DMD 1756 Muscle Weakness MESH:D018908 marker/mechanism 26930420|30074247 +DMD 1756 Muscular Dystrophies MESH:D009136 marker/mechanism|therapeutic 10797403|17440445|20805873|22906800 +DMD 1756 Muscular Dystrophy, Animal MESH:D009137 marker/mechanism 22795790 +DMD 1756 Muscular Dystrophy, Duchenne MESH:D020388 marker/mechanism 300376|310200 10939566|11409421|12966700|14751810|16122626|19309154|21273767|23297412|24349043|26930420|29404407|30074247|32955503|33025945|33285037 +DMD 1756 Necrosis MESH:D009336 marker/mechanism 22795790 +DMD 1756 Neoplasm Invasiveness MESH:D009361 marker/mechanism 24793134 +DMD 1756 Neoplasm Metastasis MESH:D009362 marker/mechanism 24793134 +DMD 1756 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +DMD 1756 Rhabdomyosarcoma, Embryonal MESH:D018233 marker/mechanism 24793134 +DMD 1756 Status Epilepticus MESH:D013226 marker/mechanism 20886625 +DMD 1756 Ventricular Dysfunction MESH:D018754 marker/mechanism 21273767 +DMGDH 29958 Dimethylglycine Dehydrogenase Deficiency MESH:C565278 marker/mechanism 605850 +DMP1 1758 Hypophosphatemic Rickets, Autosomal Recessive, 1 MESH:C562792 marker/mechanism 241520 +DMPK 1760 Myotonia MESH:D009222 marker/mechanism 24039817 +DMPK 1760 Myotonic Dystrophy MESH:D009223 marker/mechanism 160900 24039817|27030674 +DMRT1 1761 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 20543847 +DMRT1 1761 Testicular Neoplasms MESH:D013736 marker/mechanism 20543847 +DMXL1 1657 Glioma MESH:D005910 marker/mechanism 16865689 +DNA2 1763 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6 OMIM:615156 marker/mechanism 615156.0 +DNAAF1 123872 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DNAAF1 123872 Ciliary Dyskinesia, Primary, 13 MESH:C567713 marker/mechanism 613193.0 +DNAAF11 23639 CILIARY DYSKINESIA, PRIMARY, 19 OMIM:614935 marker/mechanism 614935.0 +DNAAF2 55172 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DNAAF2 55172 Ciliary Dyskinesia, Primary, 10 MESH:C567287 marker/mechanism 612518.0 +DNAAF3 352909 Kartagener Syndrome MESH:D007619 marker/mechanism 22387996 +DNAAF3 352909 Primary ciliary dyskinesia, 2 MESH:C535277 marker/mechanism 606763.0 +DNAAF4 161582 CILIARY DYSKINESIA, PRIMARY, 25 OMIM:615482 marker/mechanism 615482.0 +DNAAF4 161582 Dyslexia MESH:D004410 marker/mechanism 127700.0 +DNAAF4 161582 Infertility, Male MESH:D007248 marker/mechanism 23872636 +DNAAF4 161582 Kartagener Syndrome MESH:D007619 marker/mechanism 23872636 +DNAAF5 54919 CILIARY DYSKINESIA, PRIMARY, 18 OMIM:614874 marker/mechanism 614874.0 +DNAAF6 139212 CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED OMIM:300991 marker/mechanism 300991.0 +DNAH10 196385 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +DNAH11 8701 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DNAH11 8701 Ciliary Dyskinesia, Primary, 7 MESH:C567504 marker/mechanism 611884.0 +DNAH11 8701 Coronary Disease MESH:D003327 marker/mechanism 19060911 +DNAH11 8701 Dyslipidemias MESH:D050171 marker/mechanism 19060911 +DNAH11 8701 Weight Gain MESH:D015430 marker/mechanism 19030233 +DNAH5 1767 Asthma MESH:D001249 marker/mechanism 21912604 +DNAH5 1767 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DNAH5 1767 Primary ciliary dyskinesia, 3 MESH:C535278 marker/mechanism 608644.0 +DNAH7 56171 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DNAH8 1769 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +DNAH8 1769 Paranoid Disorders MESH:D010259 marker/mechanism 18438686 +DNAH8 1769 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +DNAI1 27019 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DNAI1 27019 Kartagener Syndrome MESH:D007619 marker/mechanism 244400.0 19675306 +DNAI2 64446 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DNAI2 64446 Ciliary Dyskinesia, Primary, 9 MESH:C567310 marker/mechanism 612444.0 +DNAI7 55259 Lung Neoplasms MESH:D008175 marker/mechanism 15064703 +DNAJA1 3301 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +DNAJB13 374407 CILIARY DYSKINESIA, PRIMARY, 34 OMIM:617091 marker/mechanism 617091.0 +DNAJB2 3300 NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL RECESSIVE 5 OMIM:614881 marker/mechanism 614881.0 +DNAJB6 10049 Muscular Dystrophies, Limb-Girdle MESH:D049288 marker/mechanism 22366786 +DNAJB6 10049 Muscular Dystrophy, Limb-Girdle, Type 1E MESH:C566589 marker/mechanism 603511.0 +DNAJB9 4189 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +DNAJB9 4189 Cholestasis MESH:D002779 marker/mechanism 26881866 +DNAJC1 64215 Melanoma MESH:D008545 marker/mechanism 22535842 +DNAJC10 54431 Neoplasms MESH:D009369 therapeutic 17353921 +DNAJC10 54431 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +DNAJC12 56521 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +DNAJC12 56521 Cholestasis MESH:D002779 marker/mechanism 26881866 +DNAJC12 56521 HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT OMIM:617384 marker/mechanism 617384.0 +DNAJC15 29103 Melanoma MESH:D008545 marker/mechanism 17145863 +DNAJC19 131118 3-Methylglutaconic Aciduria, Type V MESH:C565706 marker/mechanism 610198.0 +DNAJC21 134218 Congenital Bone Marrow Failure Syndromes MESH:D000080984 marker/mechanism 617052.0 +DNAJC21 134218 Shwachman-Diamond Syndrome MESH:D000081003 marker/mechanism 260400.0 +DNAJC3 5611 ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS OMIM:616192 marker/mechanism 616192.0 +DNAJC3 5611 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +DNAJC6 9829 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DNAJC6 9829 PARKINSON DISEASE 19A, JUVENILE-ONSET OMIM:615528 marker/mechanism 615528.0 +DNAJC7 7266 HIV Infections MESH:D015658 marker/mechanism 15308739 +DNAL1 83544 CILIARY DYSKINESIA, PRIMARY, 16 OMIM:614017 marker/mechanism 614017.0 +DNAL4 10126 MIRROR MOVEMENTS 3 OMIM:616059 marker/mechanism 616059.0 +DNASE1 1773 Airway Obstruction MESH:D000402 therapeutic 28780505 +DNASE1 1773 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 152700.0 +DNASE1 1773 Proteinuria MESH:D011507 marker/mechanism 22479529 +DNASE1 1773 Respiratory Syncytial Virus Infections MESH:D018357 therapeutic 28780505 +DNASE1L2 1775 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +DNASE1L3 1776 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596|30224649 +DNASE1L3 1776 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DNASE1L3 1776 Lung Neoplasms MESH:D008175 therapeutic 21720004 +DNASE1L3 1776 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 614420.0 22019780 +DNASE2A 13423 Arthritis, Experimental MESH:D001169 marker/mechanism 20974942 +DNASE2A 13423 Splenomegaly MESH:D013163 marker/mechanism 20974942 +DNHD1 144132 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +DNM1 1759 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31A OMIM:616346 marker/mechanism 616346.0 +DNM1 1759 Dog Diseases MESH:D004283 marker/mechanism 18806795 +DNM1 1759 Epilepsy MESH:D004827 marker/mechanism 29942082 +DNM1 1759 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +DNM1L 10059 Acidosis, Lactic MESH:D000140 marker/mechanism 17460227 +DNM1L 10059 Coxsackievirus Infections MESH:D003384 marker/mechanism 34365571 +DNM1L 10059 ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1 OMIM:614388 marker/mechanism 614388.0 +DNM1L 10059 Microcephaly MESH:D008831 marker/mechanism 17460227 +DNM1L 10059 Mitochondrial Encephalomyopathies MESH:D017237 marker/mechanism 17460227 +DNM1L 10059 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +DNM1L 10059 Myocarditis MESH:D009205 marker/mechanism 34365571 +DNM1L 10059 Optic Atrophy MESH:D009896 marker/mechanism 17460227 +DNM1L 10059 Optic atrophy 5 MESH:C537126 marker/mechanism 610708.0 +DNM1L 10059 Parkinson Disease MESH:D010300 marker/mechanism 28215578 +DNM2 1785 Charcot-Marie-Tooth Disease, Dominant Intermediate B MESH:C564703 marker/mechanism 606482.0 +DNM2 1785 LETHAL CONGENITAL CONTRACTURE SYNDROME 5 OMIM:615368 marker/mechanism 615368.0 +DNM2 1785 Myopathies, Structural, Congenital MESH:D020914 marker/mechanism 160150.0 17376685 +DNM3 26052 Kidney Neoplasms MESH:D007680 marker/mechanism 28321044 +DNMT1 1786 Adenocarcinoma MESH:D000230 marker/mechanism 17571247 +DNMT1 1786 Anxiety Disorders MESH:D001008 marker/mechanism 23791455 +DNMT1 1786 Arthritis, Experimental MESH:D001169 marker/mechanism 25194984 +DNMT1 1786 Asthma MESH:D001249 marker/mechanism 23423710 +DNMT1 1786 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DNMT1 1786 Breast Neoplasms MESH:D001943 marker/mechanism 22520950|28544374 +DNMT1 1786 Carcinoma MESH:D002277 marker/mechanism 21458988 +DNMT1 1786 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 29844410 +DNMT1 1786 Cerebellar Ataxia, Deafness, and Narcolepsy MESH:C565825 marker/mechanism 604121.0 +DNMT1 1786 Clear-cell metastatic renal cell carcinoma MESH:C538445 marker/mechanism 27292127 +DNMT1 1786 Colonic Neoplasms MESH:D003110 marker/mechanism 19723570 +DNMT1 1786 Dementia MESH:D003704 marker/mechanism 21532572 +DNMT1 1786 Hearing Loss MESH:D034381 marker/mechanism 21532572 +DNMT1 1786 Hereditary Sensory and Autonomic Neuropathies MESH:D009477 marker/mechanism 21532572 +DNMT1 1786 Medulloblastoma MESH:D008527 marker/mechanism 19155313 +DNMT1 1786 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 32431489 +DNMT1 1786 Neoplasm Invasiveness MESH:D009361 marker/mechanism 28544374 +DNMT1 1786 NEUROPATHY, HEREDITARY SENSORY, TYPE IE OMIM:614116 marker/mechanism 614116.0 +DNMT1 1786 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 22581815 +DNMT1 1786 Prostatic Neoplasms MESH:D011471 marker/mechanism 22581815 +DNMT1 1786 Stomach Neoplasms MESH:D013274 marker/mechanism 17571247|21458988 +DNMT3A 1788 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 25290267 +DNMT3A 1788 Breast Neoplasms MESH:D001943 marker/mechanism 22520950 +DNMT3A 1788 Clear-cell metastatic renal cell carcinoma MESH:C538445 marker/mechanism 27292127 +DNMT3A 1788 Craniofacial Abnormalities MESH:D019465 marker/mechanism 24614070 +DNMT3A 1788 Crohn Disease MESH:D003424 marker/mechanism 21102463 +DNMT3A 1788 Dwarfism MESH:D004392 marker/mechanism 30478443 +DNMT3A 1788 Facies MESH:D019066 marker/mechanism 24614070 +DNMT3A 1788 Growth Disorders MESH:D006130 marker/mechanism 24614070|30478443 +DNMT3A 1788 Immunoblastic Lymphadenopathy MESH:D007119 marker/mechanism 24413737 +DNMT3A 1788 Intellectual Disability MESH:D008607 marker/mechanism 24614070 +DNMT3A 1788 Leukemia, Monocytic, Acute MESH:D007948 marker/mechanism 21399634 +DNMT3A 1788 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 27335278 +DNMT3A 1788 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +DNMT3A 1788 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 26285909 +DNMT3A 1788 Lung Neoplasms MESH:D008175 marker/mechanism 26192916 +DNMT3A 1788 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +DNMT3A 1788 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 24413734|24413737 +DNMT3A 1788 Microcephaly MESH:D008831 marker/mechanism 30478443 +DNMT3A 1788 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 32431489 +DNMT3A 1788 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 26285909 +DNMT3A 1788 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +DNMT3A 1788 TATTON-BROWN-RAHMAN SYNDROME OMIM:615879 marker/mechanism 615879.0 +DNMT3B 1789 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 25290267|35663546 +DNMT3B 1789 Breast Neoplasms MESH:D001943 marker/mechanism 18221536|22520950 +DNMT3B 1789 Carcinoma MESH:D002277 marker/mechanism 21458988 +DNMT3B 1789 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17908720 +DNMT3B 1789 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1 OMIM:242860 marker/mechanism 242860.0 15580563|15952214|17893117|18029387|18762900 +DNMT3B 1789 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 17908720 +DNMT3B 1789 Infertility, Female MESH:D007247 marker/mechanism 34773530 +DNMT3B 1789 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 32431489 +DNMT3B 1789 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +DNMT3B 1789 Prostatic Neoplasms MESH:D011471 marker/mechanism 16012746 +DNMT3B 1789 Stomach Neoplasms MESH:D013274 marker/mechanism 21458988 +DOCK1 1793 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +DOCK10 55619 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DOCK2 1794 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 23525077 +DOCK2 1794 IMMUNODEFICIENCY 40 OMIM:616433 marker/mechanism 616433.0 +DOCK2 1794 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +DOCK4 9732 Autistic Disorder MESH:D001321 marker/mechanism 19401682 +DOCK6 57572 Adams Oliver syndrome MESH:C538225 marker/mechanism 614219.0 +DOCK7 85440 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23 OMIM:615859 marker/mechanism 615859.0 +DOCK7 85440 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DOCK8 81704 Developmental Disabilities MESH:D002658 marker/mechanism 18060736 +DOCK8 81704 Intellectual Disability MESH:D008607 marker/mechanism 18060736 +DOCK8 81704 Job Syndrome MESH:D007589 marker/mechanism 243700.0 +DOCK8 81704 Neuroblastoma MESH:D009447 marker/mechanism 26121086 +DOCK8 81704 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +DOCK8 81704 Recurrence MESH:D012008 marker/mechanism 26121086 +DOK1 1796 Lung Neoplasms MESH:D008175 marker/mechanism 20139980 +DOK1 1796 Ovarian Neoplasms MESH:D010051 therapeutic 21856257 +DOK2 9046 Crohn Disease MESH:D003424 marker/mechanism 36038634 +DOK2 9046 Lung Neoplasms MESH:D008175 marker/mechanism 20139980 +DOK3 79930 Lung Neoplasms MESH:D008175 marker/mechanism 20139980 +DOK7 285489 Congenital myasthenic syndrome ib MESH:C536089 marker/mechanism 254300.0 +DOLK 22845 Congenital Disorder Of Glycosylation, Type Im MESH:C563666 marker/mechanism 610768.0 +DONSON 29980 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +DONSON 29980 Dwarfism MESH:D004392 marker/mechanism 28191891 +DONSON 29980 Microcephaly MESH:D008831 marker/mechanism 28191891 +DOP1R2 43484 Parkinsonian Disorders MESH:D020734 marker/mechanism 25158689 +DOT1L 84444 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +DOT1L 84444 Colorectal Neoplasms MESH:D015179 marker/mechanism 31888761 +DOT1L 84444 Prostatic Neoplasms MESH:D011471 marker/mechanism 32814769 +DPAGT1 1798 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +DPAGT1 1798 Congenital disorder of glycosylation type 1J MESH:C535748 marker/mechanism 608093.0 +DPAGT1 1798 Disease Progression MESH:D018450 marker/mechanism 21364753 +DPAGT1 1798 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 614750.0 +DPAGT1 1798 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +DPEP1 1800 Chemically-Induced Disorders MESH:D064419 marker/mechanism 35999755 +DPEP1 1800 Colitis, Ulcerative MESH:D003093 marker/mechanism 35999755 +DPEP1 1800 Osteoarthritis MESH:D010003 marker/mechanism 30664745 +DPF3 8110 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +DPH1 1801 DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR 1 OMIM:616901 marker/mechanism 616901.0 +DPM1 8813 Congenital disorder of glycosylation type 1E MESH:C535743 marker/mechanism 608799.0 +DPM2 8818 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu OMIM:615042 marker/mechanism 615042.0 +DPM3 54344 Congenital Disorder of Glycosylation, Type Io MESH:C567857 marker/mechanism 612937.0 +DPP 33432 Juvenile polyposis syndrome MESH:C537702 marker/mechanism 23733344 +DPP10 57628 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 18252227 +DPP10 57628 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +DPP10 57628 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +DPP4 1803 Coronavirus Infections MESH:D018352 marker/mechanism 30626688 +DPP4 1803 Proteinuria MESH:D011507 marker/mechanism 2880436 +DPP6 1804 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 18084291 +DPP6 1804 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 18252227|20844286 +DPP6 1804 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 33 OMIM:616311 marker/mechanism 616311.0 +DPP6 1804 Paroxysmal ventricular fibrillation MESH:C537182 marker/mechanism 612956.0 +DPP7 29952 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DPP7 29952 Necrosis MESH:D009336 marker/mechanism 16725115 +DPP9 91039 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 23583980 +DPPA3 359787 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 16168501 +DPT 1805 Varicose Veins MESH:D014648 marker/mechanism 17643059 +DPY19L2 283417 SPERMATOGENIC FAILURE 9 OMIM:613958 marker/mechanism 613958.0 +DPYD 1806 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 18252227|20844286 +DPYD 1806 Autistic Disorder MESH:D001321 marker/mechanism 21114665 +DPYD 1806 Breast Neoplasms MESH:D001943 marker/mechanism 19020767 +DPYD 1806 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18019677 +DPYD 1806 Colonic Neoplasms MESH:D003110 marker/mechanism 18652704 +DPYD 1806 Colorectal Neoplasms MESH:D015179 marker/mechanism 15222106|15814641|17047489|17611699|19020767 +DPYD 1806 Dihydropyrimidine Dehydrogenase Deficiency MESH:D054067 marker/mechanism 274270.0 16151913|9816193 +DPYD 1806 Head and Neck Neoplasms MESH:D006258 marker/mechanism 19020767 +DPYD 1806 Language Development Disorders MESH:D007805 marker/mechanism 21114665 +DPYD 1806 Leukoencephalopathies MESH:D056784 marker/mechanism 11148247 +DPYD 1806 Lung Neoplasms MESH:D008175 marker/mechanism 19020767 +DPYD 1806 Neoplasm Metastasis MESH:D009362 marker/mechanism 17611699 +DPYD 1806 Nervous System Diseases MESH:D009422 marker/mechanism 16435204 +DPYD 1806 Neutropenia MESH:D009503 marker/mechanism 12562666 +DPYD 1806 Obesity MESH:D009765 marker/mechanism 20882379 +DPYD 1806 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17443278|19020767 +DPYD 1806 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +DPYD 1806 Purine-Pyrimidine Metabolism, Inborn Errors MESH:D011686 marker/mechanism 15571261|3335642 +DPYD 1806 Schizophrenia MESH:D012559 marker/mechanism 21822266|23042115 +DPYD 1806 Stomach Neoplasms MESH:D013274 marker/mechanism 15837757|17089033|18652704 +DPYS 1807 Dihydropyrimidinase Deficiency MESH:C562815 marker/mechanism 222748.0 +DPYS 1807 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DPYSL2 1808 Alzheimer Disease MESH:D000544 marker/mechanism 19374891 +DPYSL2 1808 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +DPYSL2 1808 Schizophrenia, Paranoid MESH:D012563 marker/mechanism 17105906 +DRAM1 55332 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DRAM2 128338 CONE-ROD DYSTROPHY 21 OMIM:616502 marker/mechanism 616502.0 +DRAP1 10589 Melanoma MESH:D008545 marker/mechanism 22535842 +DRAXIN 374946 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +DRC1 92749 CILIARY DYSKINESIA, PRIMARY, 21 OMIM:615294 marker/mechanism 615294.0 +DRC1 92749 Kartagener Syndrome MESH:D007619 marker/mechanism 23354437 +DRD1 1812 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18363855|19444617 +DRD1 1812 Autistic Disorder MESH:D001321 marker/mechanism 18205172 +DRD1 1812 Bipolar Disorder MESH:D001714 marker/mechanism 19153942 +DRD1 1812 Catalepsy MESH:D002375 marker/mechanism 1365866|3283778|7845605 +DRD1 1812 Cocaine-Related Disorders MESH:D019970 marker/mechanism 15295029|16014726|16541082|20456009 +DRD1 1812 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism 10858612|16982285|19520364|7845605 +DRD1 1812 Hyperkinesis MESH:D006948 marker/mechanism 24418703 +DRD1 1812 Hypotension MESH:D007022 marker/mechanism 12946566|1724532 +DRD1 1812 Movement Disorders MESH:D009069 marker/mechanism 6858777 +DRD1 1812 Parkinson Disease MESH:D010300 therapeutic 8558425 +DRD1 1812 Schizophrenia MESH:D012559 marker/mechanism 18583979 +DRD1 1812 Seizures MESH:D012640 marker/mechanism 1451735|1829682 +DRD2 1813 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18363855|18555060|19940168 +DRD2 1813 Anxiety Disorders MESH:D001008 marker/mechanism 18305461|20532872 +DRD2 1813 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 17671965 +DRD2 1813 Basal Ganglia Diseases MESH:D001480 marker/mechanism 11198054|12211096|18480698|19225277|19506579 +DRD2 1813 Bradycardia MESH:D001919 marker/mechanism 10626749|1724532 +DRD2 1813 Catalepsy MESH:D002375 marker/mechanism 1365866|3283778|7845605|9618422 +DRD2 1813 Cocaine-Related Disorders MESH:D019970 marker/mechanism|therapeutic 10900248|11751029|11923462|15010698|15042275|16541082|16971900|17332411|18418874|20494958 +DRD2 1813 Cognition Disorders MESH:D003072 marker/mechanism 19910723 +DRD2 1813 Developmental Disabilities MESH:D002658 marker/mechanism 21592505 +DRD2 1813 Disruptive, Impulse Control, and Conduct Disorders MESH:D007174 marker/mechanism 17332411|19940168|20671181 +DRD2 1813 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism 10534246|14629710|7845605 +DRD2 1813 Dyskinesias MESH:D020820 marker/mechanism 16435402 +DRD2 1813 Heroin Dependence MESH:D006556 marker/mechanism 11751029 +DRD2 1813 Hyperkinesis MESH:D006948 marker/mechanism 1975278|24418703 +DRD2 1813 Hyperprolactinemia MESH:D006966 marker/mechanism 15286066|19339912 +DRD2 1813 Hypertension MESH:D006973 marker/mechanism 11566895 +DRD2 1813 Hypotension MESH:D007022 marker/mechanism 10626749|12946566|1724532|9917201 +DRD2 1813 Language Disorders MESH:D007806 marker/mechanism 23691092 +DRD2 1813 Memory Disorders MESH:D008569 marker/mechanism 21592505 +DRD2 1813 Movement Disorders MESH:D009069 marker/mechanism 6858777 +DRD2 1813 Pain MESH:D010146 marker/mechanism 15996639 +DRD2 1813 Parkinson Disease MESH:D010300 therapeutic 8558425 +DRD2 1813 Parkinsonian Disorders MESH:D020734 marker/mechanism|therapeutic 12476322|15469457|9171869 +DRD2 1813 Pituitary Neoplasms MESH:D010911 marker/mechanism 12727942 +DRD2 1813 Schizophrenia MESH:D012559 marker/mechanism 10831489|11245917|18583979|21187413 +DRD2 1813 Seizures MESH:D012640 marker/mechanism|therapeutic 11860278|1829682|7936204 +DRD2 1813 Substance-Related Disorders MESH:D019966 marker/mechanism 16901644 +DRD2 1813 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 17189962 +DRD2 1813 Tachycardia MESH:D013610 marker/mechanism 10721819|9777039 +DRD2 1813 Tobacco Use Disorder MESH:D014029 marker/mechanism 18579413 +DRD2 1813 Weight Gain MESH:D015430 marker/mechanism 20375926 +DRD3 1814 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 19940168 +DRD3 1814 Autistic Disorder MESH:D001321 marker/mechanism 19058789 +DRD3 1814 Basal Ganglia Diseases MESH:D001480 marker/mechanism 19506579 +DRD3 1814 Cocaine-Related Disorders MESH:D019970 marker/mechanism|therapeutic 10523822|15100700|17332411|18566292|20494958 +DRD3 1814 Cognition Disorders MESH:D003072 marker/mechanism 15619116 +DRD3 1814 Disruptive, Impulse Control, and Conduct Disorders MESH:D007174 marker/mechanism 17332411|19940168|20671181 +DRD3 1814 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism 20945430 +DRD3 1814 Gambling MESH:D005715 marker/mechanism 10523822 +DRD3 1814 Hyperalgesia MESH:D006930 marker/mechanism 20433900 +DRD3 1814 Hyperkinesis MESH:D006948 therapeutic 16026479 +DRD3 1814 Movement Disorders MESH:D009069 therapeutic 12535962 +DRD3 1814 Schizophrenia MESH:D012559 marker/mechanism 181500.0 10523822 +DRD3 1814 Seizures MESH:D012640 therapeutic 18566292 +DRD3 1814 Tourette Syndrome MESH:D005879 marker/mechanism 10523822 +DRD3 1814 Tremor hereditary essential, 1 MESH:C536545 marker/mechanism 190300.0 +DRD4 1815 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 15274053 +DRD4 1815 Anxiety, Separation MESH:D001010 marker/mechanism 20731709 +DRD4 1815 Attention Deficit and Disruptive Behavior Disorders MESH:D019958 marker/mechanism 20731709 +DRD4 1815 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 143465.0 14699430|14699433|17671965|29054088 +DRD4 1815 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +DRD4 1815 Child Development Disorders, Pervasive MESH:D002659 marker/mechanism 20731709 +DRD4 1815 Schizophrenia MESH:D012559 marker/mechanism 18583979 +DRD4 1815 Tic Disorders MESH:D013981 marker/mechanism 20731709 +DRD5 1816 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 143465.0 14699430|14732906 +DRD5 1816 Benign essential blepharospasm MESH:C535428 marker/mechanism 606798.0 +DRD5 1816 Bipolar Disorder MESH:D001714 marker/mechanism 14708030 +DRD5 1816 Blepharospasm MESH:D001764 marker/mechanism 11781417 +DRD5 1816 Depressive Disorder MESH:D003866 marker/mechanism 14708030 +DRD5 1816 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +DRD5 1816 Torticollis MESH:D014103 marker/mechanism 11459908 +DROSHA 29102 Infertility, Male MESH:D007248 marker/mechanism 22381205 +DROSHA 29102 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +DSC1 1823 Melanoma MESH:D008545 marker/mechanism 22197931 +DSC2 1824 Arrhythmogenic Right Ventricular Dysplasia, Familial, 11 MESH:C566471 marker/mechanism 610476.0 +DSC2 1824 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +DSC3 1825 Breast Neoplasms MESH:D001943 marker/mechanism 16799634 +DSC3 1825 Hypotrichosis And Recurrent Skin Vesicles MESH:C567751 marker/mechanism 613102.0 +DSCAM 1826 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +DSCAM 1826 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +DSCAM 1826 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +DSE 29940 EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2 OMIM:615539 marker/mechanism 615539.0 +DSG1 1828 Dermatitis MESH:D003872 marker/mechanism 23974871 +DSG1 1828 ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE OMIM:615508 marker/mechanism 615508.0 +DSG1 1828 Hypersensitivity MESH:D006967 marker/mechanism 23974871 +DSG1 1828 Keratosis palmoplantaris striata 1 MESH:C536162 marker/mechanism 148700.0 +DSG1 1828 Metabolic Diseases MESH:D008659 marker/mechanism 23974871 +DSG2 1829 Arrhythmogenic Right Ventricular Dysplasia, Familial, 10 MESH:C565707 marker/mechanism 610193.0 +DSG2 1829 Cardiomyopathy, Dilated, 1BB MESH:C567877 marker/mechanism 612877.0 +DSG4 147409 Hypotrichosis, Localized, Autosomal Recessive 1 MESH:C564312 marker/mechanism 607903.0 +DSP 1832 Arrhythmogenic Right Ventricular Dysplasia, Familial, 8 MESH:C564400 marker/mechanism 607450.0 +DSP 1832 Cardiomyopathy dilated with woolly hair and keratoderma MESH:C535581 marker/mechanism 605676.0 21193976 +DSP 1832 CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS OMIM:615821 marker/mechanism 615821.0 +DSP 1832 Death, Sudden, Cardiac MESH:D016757 marker/mechanism 20435227 +DSP 1832 Epidermolysis bullosa, lethal acantholytic MESH:C535493 marker/mechanism 609638.0 +DSP 1832 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 23583980 +DSP 1832 Keratosis Palmoplantaris Striata II MESH:C565102 marker/mechanism 612908.0 +DSP 1832 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 28166215 +DSP 1832 Pulmonary Fibrosis MESH:D011658 marker/mechanism 28166215 +DSPP 1834 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21103065 +DSPP 1834 Deafness, Autosomal Dominant 39, with Dentinogenesis Imperfecta 1 MESH:C565316 marker/mechanism 605594.0 +DSPP 1834 DENTIN DYSPLASIA, TYPE II OMIM:125420 marker/mechanism 125420.0 +DSPP 1834 Dentinogenesis Imperfecta MESH:D003811 marker/mechanism 125490.0 +DSPP 1834 Dentinogenesis imperfecta, shields type 3 MESH:C538216 marker/mechanism 125500.0 +DSPP 1834 Mouth Neoplasms MESH:D009062 marker/mechanism 21103065 +DST 667 Epidermolysis Bullosa Simplex, Autosomal Recessive MESH:C563408 marker/mechanism 615425.0 +DST 667 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI OMIM:614653 marker/mechanism 614653.0 +DSTN 11034 Disease Models, Animal MESH:D004195 marker/mechanism 29394407 +DSTN 11034 Heart Failure MESH:D006333 marker/mechanism 29394407 +DSTN 11034 Ventricular Remodeling MESH:D020257 marker/mechanism 29394407 +DSTYK 25778 Renal Hypodysplasia, Nonsyndromic, 1 MESH:C563661 marker/mechanism 610805.0 +DSTYK 25778 Spastic paraplegia 23 MESH:C536859 marker/mechanism 270750.0 +DTL 51514 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +DTL 51514 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +DTL 51514 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +DTNA 1837 LEFT VENTRICULAR NONCOMPACTION 1 OMIM:604169 marker/mechanism 604169.0 +DTNBP1 84062 Hermanski-Pudlak Syndrome MESH:D022861 marker/mechanism 614076.0 +DTNBP1 84062 Mental Disorders MESH:D001523 marker/mechanism 25298178 +DTNBP1 84062 Schizophrenia MESH:D012559 marker/mechanism 18583979 +DTX1 1840 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +DTX1 1840 Oligodendroglioma MESH:D009837 marker/mechanism 21127729 +DTX2 113878 Brain Neoplasms MESH:D001932 marker/mechanism 21127729 +DTX3 196403 Breast Neoplasms MESH:D001943 marker/mechanism 25151356 +DTX4 23220 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +DTX4 23220 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +DUBR 344595 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +DUOX2 50506 Congenital Hypothyroidism MESH:D003409 marker/mechanism 16134168|16322276 +DUOX2 50506 Thyroid Dyshormonogenesis 6 MESH:C564608 marker/mechanism 607200.0 +DUOXA2 405753 Thyroid Dyshormonogenesis 5 MESH:C562771 marker/mechanism 274900.0 +DUS1L 64118 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DUSP1 1843 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +DUSP1 1843 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +DUSP1 1843 Endometriosis MESH:D004715 marker/mechanism 21063030 +DUSP1 1843 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +DUSP1 1843 Osteoarthritis, Spine MESH:D055013 marker/mechanism 34697729 +DUSP10 11221 Inflammation MESH:D007249 therapeutic 17151092 +DUSP16 80824 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DUSP2 1844 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +DUSP28 285193 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +DUSP3 1845 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427 +DUSP4 1846 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +DUSP5 1847 Hypertension MESH:D006973 marker/mechanism 25397684 +DUSP6 1848 Carcinoma MESH:D002277 marker/mechanism 16316942 +DUSP6 1848 Glioblastoma MESH:D005909 marker/mechanism 21499306 +DUSP6 1848 HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA OMIM:615269 marker/mechanism 615269 +DUSP6 1848 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110 +DUSP6 1848 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DUSP6 1848 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +DUSP6 1848 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +DUSP6 1848 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +DUX4 100288687 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 22796148 +DUX4 100288687 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 27019113 +DUX4 100288687 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 27776115 +DUX4L5 653545 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +DUXAP10 503639 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 34373904 +DUXAP9 503638 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 34086387 +DVL1 1855 Robinow Syndrome MESH:C562492 marker/mechanism 180700|616331 +DVL3 1857 Robinow Syndrome MESH:C562492 marker/mechanism 616894 +DYM 54808 Dyggve-Melchior-Clausen syndrome MESH:C535726 marker/mechanism 223800.0 +DYM 54808 Smith-McCort Dysplasia MESH:C564589 marker/mechanism 607326.0 +DYNC1H1 1778 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O OMIM:614228 marker/mechanism 614228.0 +DYNC1H1 1778 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 13 OMIM:614563 marker/mechanism 614563.0 +DYNC1H1 1778 Intellectual Disability MESH:D008607 marker/mechanism 21076407 +DYNC1H1 1778 Malformations of Cortical Development MESH:D054220 marker/mechanism 23603762 +DYNC1H1 1778 Microcephaly MESH:D008831 marker/mechanism 23603762 +DYNC1H1 1778 Spinal Muscular Atrophies of Childhood MESH:D014897 marker/mechanism 158600.0 +DYNC1H1 1778 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +DYNC1I1 1780 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 21228734 +DYNC1LI2 1783 Weight Gain MESH:D015430 marker/mechanism 19030233 +DYNC2H1 79659 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +DYNC2H1 79659 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 22499340 +DYNC2H1 79659 Short rib-polydactyly syndrome, Verma-Naumoff type MESH:C537602 marker/mechanism 613091.0 +DYNC2I1 55112 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 615503.0 +DYNC2I2 89891 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 615633.0 +DYNC2LI1 51626 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 617088.0 +DYNLL1 8655 Brain Ischemia MESH:D002545 marker/mechanism 9522364 +DYNLT2B 255758 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 617405.0 +DYRK1A 1859 Epilepsy MESH:D004827 marker/mechanism 29942082 +DYRK1A 1859 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 7 OMIM:614104 marker/mechanism 614104.0 +DYRK1A 1859 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +DYRK1A 1859 Pancreatic Neoplasms MESH:D010190 marker/mechanism 31838052 +DYRK1B 9149 ABDOMINAL OBESITY-METABOLIC SYNDROME 3 OMIM:615812 marker/mechanism 615812.0 +DYRK1B 9149 Ovarian Neoplasms MESH:D010051 marker/mechanism 20857490 +DYRK2 8445 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +DYSF 8291 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +DYSF 8291 Limb-girdle muscular dystrophy, type 2B MESH:C535899 marker/mechanism 253601.0 15535137 +DYSF 8291 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +DYSF 8291 Miyoshi myopathy MESH:C537480 marker/mechanism 254130.0 15535137|17868276 +DYSF 8291 Myopathy, Distal, with Anterior Tibial Onset MESH:C564664 marker/mechanism 606768.0 15535137 +DZIP1 22873 Mitral Valve Prolapse, Myxomatous 3 MESH:C563655 marker/mechanism 610840.0 +DZIP1L 199221 Polycystic Kidney, Autosomal Recessive MESH:D017044 marker/mechanism 28530676 +E2F1 1869 Breast Neoplasms MESH:D001943 marker/mechanism 14672398 +E2F1 1869 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12029619|15565109|28284560 +E2F1 1869 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 29754146 +E2F1 1869 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 30515189 +E2F1 1869 Clinical Deterioration MESH:D000075902 marker/mechanism 29464002 +E2F1 1869 Melanoma MESH:D008545 marker/mechanism|therapeutic 15574415|16827129 +E2F1 1869 Neoplasms MESH:D009369 marker/mechanism 29464002 +E2F2 1870 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 29754146 +E2F2 1870 Disease Progression MESH:D018450 marker/mechanism 29754146 +E2F3 1871 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 29754146 +E2F4 1874 Disease Progression MESH:D018450 marker/mechanism 29754146 +E2F5 1875 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 29754146 +E2F5 1875 Disease Progression MESH:D018450 marker/mechanism 29754146 +E2F6 1876 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 29754146 +E2F6 1876 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 35225430 +E2F7 144455 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 29754146 +E2F7 144455 Disease Progression MESH:D018450 marker/mechanism 29754146 +E2F8 79733 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +E2F8 79733 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 29754146 +E2F8 79733 Disease Progression MESH:D018450 marker/mechanism 29754146 +E2F8 79733 Neoplasm Metastasis MESH:D009362 marker/mechanism 27683099 +E4F1 1877 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 30506647 +EAF2 55840 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20564326 +EAF2 55840 Lung Neoplasms MESH:D008175 marker/mechanism 20564326 +EAF2 55840 Lymphoma, B-Cell MESH:D016393 marker/mechanism 20564326 +EAF2 55840 Prostatic Neoplasms MESH:D011471 marker/mechanism 20564326 +EARS2 124454 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12 OMIM:614924 marker/mechanism 614924.0 +EAS 32585 Paralysis MESH:D010243 marker/mechanism 14978727 +EAS 32585 Seizures MESH:D012640 marker/mechanism 14978727 +EBF1 1879 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24362818 +EBF1 1879 Lymphoma, Follicular MESH:D008224 marker/mechanism 24362818 +EBF1 1879 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +EBF3 253738 HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME OMIM:617330 marker/mechanism 617330.0 +EBI3 10148 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +EBI3 10148 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +EBP 10682 Chondrodysplasia Punctata MESH:D002806 marker/mechanism 302960.0 18176751 +EBP 10682 MEND SYNDROME OMIM:300960 marker/mechanism 300960.0 +EBVS1 1888 EPSTEIN-BARR VIRUS INSERTION SITE 1 OMIM:132850 marker/mechanism 132850.0 +ECE1 1889 Autonomic Nervous System Diseases MESH:D001342 marker/mechanism 9915973 +ECE1 1889 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9449665 +ECE1 1889 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16387788 +ECE1 1889 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +ECE1 1889 Heart Defects, Congenital MESH:D006330 marker/mechanism 9449665|9915973 +ECE1 1889 Hirschsprung Disease MESH:D006627 marker/mechanism 9915973 +ECE1 1889 Hirschsprung Disease, Cardiac Defects, and Autonomic Dysfunction MESH:C563939 marker/mechanism 613870.0 +ECE1 1889 Hypertension MESH:D006973 marker/mechanism 12566389 +ECEL1 9427 ARTHROGRYPOSIS, DISTAL, TYPE 5D OMIM:615065 marker/mechanism 615065.0 +ECHDC1 55862 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +ECHDC1 55862 Melanoma MESH:D008545 marker/mechanism 22535842 +ECHS1 1892 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ECHS1 1892 Leigh Disease MESH:D007888 marker/mechanism 25125611|26099313 +ECHS1 1892 MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY OMIM:616277 marker/mechanism 616277.0 +ECHS1 1892 Obesity MESH:D009765 marker/mechanism 20882379 +ECHS1 1892 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +ECM1 1893 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +ECM1 1893 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ECM1 1893 Colitis, Ulcerative MESH:D003093 marker/mechanism 18438406 +ECM1 1893 Lipoid Proteinosis of Urbach and Wiethe MESH:D008065 marker/mechanism 247100 +ECM1 1893 Stomach Neoplasms MESH:D013274 marker/mechanism 31472228 +ECM2 1842 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +ECT2 1894 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ECT2 1894 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EDA 1896 Craniofrontonasal dysplasia MESH:C536456 marker/mechanism 17941886 +EDA 1896 Ectodermal Dysplasia 1, Anhidrotic MESH:D053358 marker/mechanism 305100 +EDA 1896 Melanoma MESH:D008545 marker/mechanism 22535842 +EDA 1896 Tooth Agenesis, Selective, X-Linked, 1 MESH:C567060 marker/mechanism 313500 +EDAR 10913 Ectodermal Dysplasia 3, Anhidrotic MESH:D053359 marker/mechanism 129490 +EDAR 10913 Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive MESH:D053360 marker/mechanism 224900 +EDARADD 128178 ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT OMIM:614940 marker/mechanism 614940 +EDARADD 128178 Ectodermal Dysplasia 3, Anhidrotic MESH:D053359 marker/mechanism 129490 +EDARADD 128178 Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive MESH:D053360 marker/mechanism 224900|614941 +EDC3 80153 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 50 OMIM:616460 marker/mechanism 616460 +EDEM1 9695 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +EDEM2 55741 Schizophrenia MESH:D012559 marker/mechanism 21822266 +EDIL3 10085 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +EDN1 1906 Acute Kidney Injury MESH:D058186 marker/mechanism 9788586 +EDN1 1906 Acute Lung Injury MESH:D055371 marker/mechanism 16625121 +EDN1 1906 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 12011762|15838369 +EDN1 1906 Asthma MESH:D001249 marker/mechanism 16981460 +EDN1 1906 Atrial Fibrillation MESH:D001281 marker/mechanism 16762801 +EDN1 1906 Auriculo-condylar syndrome MESH:C538270 marker/mechanism 612798|615706 +EDN1 1906 Bradycardia MESH:D001919 therapeutic 1309933|8440307 +EDN1 1906 Cardiomegaly MESH:D006332 marker/mechanism 22198280 +EDN1 1906 Cardiomyopathies MESH:D009202 marker/mechanism 11589785 +EDN1 1906 Cardiovascular Abnormalities MESH:D018376 marker/mechanism 20707411 +EDN1 1906 Cardiovascular Diseases MESH:D002318 marker/mechanism 16332659 +EDN1 1906 Cartilage Diseases MESH:D002357 marker/mechanism 20707411 +EDN1 1906 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 25194819 +EDN1 1906 Cerebrovascular Disorders MESH:D002561 marker/mechanism 17578707 +EDN1 1906 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10100047|20707411|8152482|9671575 +EDN1 1906 Depressive Disorder, Major MESH:D003865 marker/mechanism 29175309 +EDN1 1906 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 12458661|12967931 +EDN1 1906 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16387788 +EDN1 1906 Erectile Dysfunction MESH:D007172 marker/mechanism 12002441 +EDN1 1906 Gastrointestinal Diseases MESH:D005767 marker/mechanism 16324314 +EDN1 1906 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 16191423 +EDN1 1906 Heart Defects, Congenital MESH:D006330 marker/mechanism 9671575 +EDN1 1906 Heart Failure MESH:D006333 marker/mechanism 11136700|11707688|16360360|16762801|7967349|7969316|9861300 +EDN1 1906 Hepatorenal Syndrome MESH:D006530 marker/mechanism 7967349 +EDN1 1906 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10693666|9473106 +EDN1 1906 Hyperalgesia MESH:D006930 marker/mechanism 19429182 +EDN1 1906 Hypercholesterolemia MESH:D006937 marker/mechanism 15486036 +EDN1 1906 Hypertension MESH:D006973 marker/mechanism 10474778|10669576|11847185|12149661|12425201|12600921|15188945|15302986|15314687|15834289|17130675|7721406|8152482|8440307 +EDN1 1906 Hypertension, Pulmonary MESH:D006976 marker/mechanism 12391278|20929026|20967148|7549228|9918753 +EDN1 1906 Hypertrophy MESH:D006984 marker/mechanism 12791704|20177073 +EDN1 1906 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 10601118|15486036 +EDN1 1906 Hypotension MESH:D007022 therapeutic 10399635|1309933 +EDN1 1906 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 17197033 +EDN1 1906 Inflammation MESH:D007249 marker/mechanism 23451061 +EDN1 1906 Kidney Diseases MESH:D007674 marker/mechanism 10399635|15106802|8604712 +EDN1 1906 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +EDN1 1906 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 12609069 +EDN1 1906 Myocardial Ischemia MESH:D017202 marker/mechanism 10462014|11707688|16306806 +EDN1 1906 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 15642760|16700825 +EDN1 1906 Nephrosis MESH:D009401 marker/mechanism 7756592 +EDN1 1906 Nephrotic Syndrome MESH:D009404 marker/mechanism 34783119 +EDN1 1906 Oral Ulcer MESH:D019226 therapeutic 16391412 +EDN1 1906 Pain MESH:D010146 marker/mechanism 19429182|20042899 +EDN1 1906 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +EDN1 1906 Peptic Ulcer MESH:D010437 therapeutic 16384872 +EDN1 1906 Pre-Eclampsia MESH:D011225 marker/mechanism 25230003 +EDN1 1906 Premature Birth MESH:D047928 marker/mechanism 25230003 +EDN1 1906 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17235729 +EDN1 1906 Renal Insufficiency MESH:D051437 marker/mechanism 7967349 +EDN1 1906 Reperfusion Injury MESH:D015427 marker/mechanism 17470888 +EDN1 1906 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 16625121 +EDN1 1906 Stroke MESH:D020521 marker/mechanism 20083630 +EDN1 1906 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 8587695 +EDN1 1906 Ureteral Obstruction MESH:D014517 marker/mechanism 26207612 +EDN1 1906 Urinary Bladder, Overactive MESH:D053201 marker/mechanism 15371886 +EDN1 1906 Urinary Retention MESH:D016055 marker/mechanism 15371886 +EDN2 1907 Bradycardia MESH:D001919 therapeutic 1309933 +EDN2 1907 Hypotension MESH:D007022 therapeutic 1309933 +EDN3 1908 Bradycardia MESH:D001919 therapeutic 1309933 +EDN3 1908 Congenital central hypoventilation syndrome MESH:C536209 marker/mechanism 8696331 +EDN3 1908 Hirschsprung Disease MESH:D006627 marker/mechanism 613712 8630502|8630503|8896568|9359047 +EDN3 1908 Hypertension MESH:D006973 marker/mechanism 2059916 +EDN3 1908 Hypotension MESH:D007022 marker/mechanism|therapeutic 1309933|7982458 +EDN3 1908 Waardenburg syndrome, type 4 MESH:C536467 marker/mechanism 17516928|8630502|8630503 +EDN3 1908 Waardenburg Syndrome, Type 4b MESH:C567680 marker/mechanism 613265 +EDNRA 1909 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17294360|9811577 +EDNRA 1909 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16387788 +EDNRA 1909 Disease Progression MESH:D018450 marker/mechanism 25194819 +EDNRA 1909 Erectile Dysfunction MESH:D007172 marker/mechanism 18823320 +EDNRA 1909 Heart Defects, Congenital MESH:D006330 marker/mechanism 9811577 +EDNRA 1909 Heart Failure MESH:D006333 marker/mechanism 28095452 +EDNRA 1909 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10693666|9473106 +EDNRA 1909 Hypertension MESH:D006973 marker/mechanism 12600921 +EDNRA 1909 MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA OMIM:616367 marker/mechanism 616367.0 +EDNRA 1909 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1 OMIM:157300 marker/mechanism 157300.0 +EDNRA 1909 Nasopharyngeal Neoplasms MESH:D009303 marker/mechanism 17032313 +EDNRA 1909 Ovarian Neoplasms MESH:D010051 marker/mechanism 25194819 +EDNRA 1909 Sleep Apnea, Obstructive MESH:D020181 marker/mechanism 20083432 +EDNRA 1909 Stroke MESH:D020521 marker/mechanism 29531354 +EDNRB 1910 ABCD syndrome MESH:C535334 marker/mechanism 600501.0 +EDNRB 1910 Breast Neoplasms MESH:D001943 therapeutic 16244791 +EDNRB 1910 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16387788 +EDNRB 1910 Heart Failure MESH:D006333 marker/mechanism 28095452 +EDNRB 1910 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10693666 +EDNRB 1910 Hirschsprung Disease MESH:D006627 marker/mechanism 600155.0 8896568 +EDNRB 1910 Hypertension, Pulmonary MESH:D006976 marker/mechanism 15927975 +EDNRB 1910 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +EDNRB 1910 Nephrosis MESH:D009401 marker/mechanism 7756592 +EDNRB 1910 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 8587695 +EDNRB 1910 WAARDENBURG SYNDROME, TYPE 4A OMIM:277580 marker/mechanism 277580.0 +EED 8726 Nerve Sheath Neoplasms MESH:D018317 marker/mechanism 25240281 +EED 8726 Neurilemmoma MESH:D009442 marker/mechanism 25119042 +EEF1A1 1915 Carcinoma MESH:D002277 marker/mechanism 12376462 +EEF1A1 1915 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +EEF1A1 1915 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +EEF1A1 1915 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +EEF1A2 1917 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 33 OMIM:616409 marker/mechanism 616409.0 +EEF1A2 1917 Epilepsy MESH:D004827 marker/mechanism 29942082 +EEF1A2 1917 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 38 OMIM:616393 marker/mechanism 616393.0 +EEF1A2 1917 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +EEF1A2 1917 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +EEF1B2 1933 Breast Neoplasms MESH:D001943 marker/mechanism 20562527 +EEF1B2 1933 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +EEF1B2 1933 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005|20562527 +EEF2 1938 Adenocarcinoma MESH:D000230 marker/mechanism 21554491 +EEF2 1938 Breast Neoplasms MESH:D001943 marker/mechanism 20562527 +EEF2 1938 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +EEF2 1938 Lung Neoplasms MESH:D008175 marker/mechanism 21554491 +EEF2 1938 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21554491 +EEF2 1938 Neoplasm Metastasis MESH:D009362 marker/mechanism 20562527 +EEF2 1938 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +EEF2 1938 Recurrence MESH:D012008 marker/mechanism 21554491 +EEF2 1938 Spinocerebellar ataxia 26 MESH:C537203 marker/mechanism 609306.0 +EEFSEC 60678 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 28166215 +EEIG2 284611 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EFEMP1 2202 Adenocarcinoma MESH:D000230 marker/mechanism 17671114 +EFEMP1 2202 Breast Neoplasms MESH:D001943 marker/mechanism 19115204 +EFEMP1 2202 Carcinoma MESH:D002277 marker/mechanism 12376462 +EFEMP1 2202 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +EFEMP1 2202 Doyne honeycomb retinal dystrophy MESH:C535602 marker/mechanism 126600.0 +EFEMP1 2202 Lung Neoplasms MESH:D008175 marker/mechanism 17671114 +EFEMP1 2202 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +EFEMP1 2202 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +EFEMP1 2202 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 27032653 +EFEMP1 2202 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19208748 +EFEMP2 30008 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB OMIM:614437 marker/mechanism 614437.0 +EFEMP2 30008 Prostatic Neoplasms MESH:D011471 marker/mechanism 17929269 +EFHC1 114327 Epilepsy, Absence MESH:D004832 marker/mechanism 607631.0 +EFHC1 114327 Myoclonic Epilepsy, Juvenile MESH:D020190 marker/mechanism 254770.0 +EFHD1 80303 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +EFHD1 80303 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +EFHD2 79180 Binge Drinking MESH:D063425 marker/mechanism 28397836 +EFL1 79631 Glioma MESH:D005910 marker/mechanism 25015090 +EFNA1 1942 Breast Neoplasms MESH:D001943 marker/mechanism 20154726 +EFNA5 1946 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +EFNB1 1947 Craniofrontonasal dysplasia MESH:C536456 marker/mechanism 304110.0 15124102|15166289|16639408|16685650|17941886|18043713 +EFNB1 1947 Craniosynostoses MESH:D003398 marker/mechanism 15166289 +EFNB1 1947 Frontonasal dysplasia MESH:C538065 marker/mechanism 15166289 +EFNB1 1947 Hypertelorism MESH:D006972 marker/mechanism 15166289 +EFNB1 1947 Inflammation MESH:D007249 marker/mechanism 24098442 +EFNB1 1947 Obesity MESH:D009765 marker/mechanism 24098442 +EFNB2 1948 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +EFNB2 1948 Lung agenesis MESH:C562992 therapeutic 30106123 +EFNB2 1948 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +EFNB2 1948 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +EFNB2 1948 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +EFTUD2 9343 MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE OMIM:610536 marker/mechanism 610536.0 +EGF 1950 Adenocarcinoma MESH:D000230 marker/mechanism 23064031 +EGF 1950 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +EGF 1950 Autistic Disorder MESH:D001321 marker/mechanism 17626784 +EGF 1950 Breast Neoplasms MESH:D001943 marker/mechanism 16175315|21942447|23064031 +EGF 1950 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 9029167 +EGF 1950 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 12687016|18245498|18995957 +EGF 1950 Cleft Palate MESH:D002972 marker/mechanism 11399798 +EGF 1950 Dermatitis MESH:D003872 marker/mechanism 27206134 +EGF 1950 Disease Progression MESH:D018450 marker/mechanism 21794976 +EGF 1950 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 14514962 +EGF 1950 Glioblastoma MESH:D005909 marker/mechanism 16598420 +EGF 1950 Hypomagnesemia 4, Renal MESH:C567127 marker/mechanism 611718.0 +EGF 1950 Kidney Diseases MESH:D007674 marker/mechanism 21865292 +EGF 1950 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EGF 1950 Metaplasia MESH:D008679 marker/mechanism 26390243 +EGF 1950 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15802018|22869556|23064031|24587105|27634460 +EGF 1950 Neoplasm Metastasis MESH:D009362 marker/mechanism 21942447|23064031 +EGF 1950 Precancerous Conditions MESH:D011230 marker/mechanism 26390243 +EGF 1950 Prostatic Neoplasms MESH:D011471 marker/mechanism 16340751 +EGF 1950 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17266442 +EGF 1950 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +EGF 1950 Stomach Ulcer MESH:D013276 therapeutic 9324159|9479624 +EGF 1950 Wounds and Injuries MESH:D014947 therapeutic 21967610 +EGFR 1956 Acute Kidney Injury MESH:D058186 therapeutic 14638913 +EGFR 1956 Adenocarcinoma MESH:D000230 marker/mechanism 20934974|21541241|22042947|2523869|27720938 +EGFR 1956 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 22071784|22135231|28144970 +EGFR 1956 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 25200834 +EGFR 1956 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 23585556 +EGFR 1956 Arthritis, Experimental MESH:D001169 therapeutic 7589090 +EGFR 1956 Bile Duct Neoplasms MESH:D001650 therapeutic 17341899 +EGFR 1956 Breast Neoplasms MESH:D001943 marker/mechanism 16950593|18768436|19075277|20135347|20941507|23867902 +EGFR 1956 Carcinoma MESH:D002277 marker/mechanism 15302576 +EGFR 1956 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 9029167 +EGFR 1956 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21336183|21440325|21478906|21777763|21782507|21791641|21904575|21933749|22286583|22617245|22751098|22787409|22787412|22948846|23435014|24467950 +EGFR 1956 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 12942316|22042947|22948846 +EGFR 1956 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 18599591 +EGFR 1956 Chloracne MESH:D054506 marker/mechanism 21237254 +EGFR 1956 Cholangiocarcinoma MESH:D018281 therapeutic 17341899 +EGFR 1956 Colonic Neoplasms MESH:D003110 marker/mechanism 14569062|25200834 +EGFR 1956 Colorectal Neoplasms MESH:D015179 marker/mechanism 17575224|18998757 +EGFR 1956 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10319864 +EGFR 1956 Dermatitis MESH:D003872 marker/mechanism 27206134 +EGFR 1956 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22238402 +EGFR 1956 Disease Progression MESH:D018450 marker/mechanism 20859196 +EGFR 1956 Endometriosis MESH:D004715 marker/mechanism 21063030 +EGFR 1956 Esophageal Neoplasms MESH:D004938 marker/mechanism 21298351|21468131|22042947 +EGFR 1956 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21947696 +EGFR 1956 Gallbladder Neoplasms MESH:D005706 marker/mechanism 24997986 +EGFR 1956 Glioblastoma MESH:D005909 marker/mechanism 19204207|23917401|26455392 +EGFR 1956 Head and Neck Neoplasms MESH:D006258 marker/mechanism 12942316|15342401|23917044 +EGFR 1956 INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2 OMIM:616069 marker/mechanism 616069.0 +EGFR 1956 Insulin Resistance MESH:D007333 marker/mechanism 22238402 +EGFR 1956 Leiomyoma MESH:D007889 marker/mechanism 31468104 +EGFR 1956 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 18927287|19336973|20934974|21541241|23523951|27935865|29106415 +EGFR 1956 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 8603490 +EGFR 1956 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 2523869|8603490 +EGFR 1956 Mesothelioma MESH:D008654 marker/mechanism 21787763 +EGFR 1956 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 27032653 +EGFR 1956 Nasopharyngeal Neoplasms MESH:D009303 marker/mechanism 21786012 +EGFR 1956 Neoplasm Invasiveness MESH:D009361 marker/mechanism 18844224|23867902 +EGFR 1956 Neoplasm Metastasis MESH:D009362 marker/mechanism 17369752|17575224|23867902 +EGFR 1956 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 21786012|22277784 +EGFR 1956 Osteosarcoma MESH:D012516 marker/mechanism 22235915 +EGFR 1956 Ovarian Neoplasms MESH:D010051 marker/mechanism 16211241|21909139 +EGFR 1956 Pancreatic Neoplasms MESH:D010190 marker/mechanism 27720938 +EGFR 1956 Papilloma MESH:D010212 marker/mechanism 8603490 +EGFR 1956 Polycystic Kidney, Autosomal Recessive MESH:D017044 marker/mechanism 9486961 +EGFR 1956 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 15302576|17136230|17914592 +EGFR 1956 Rectal Neoplasms MESH:D012004 marker/mechanism 16839708 +EGFR 1956 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 20837450 +EGFR 1956 Stomach Neoplasms MESH:D013274 marker/mechanism|therapeutic 15723263|21173787|22042947 +EGFR 1956 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 11723127|23523951 +EGFR 1956 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 18703609|20859196|21329967 +EGLN1 54583 Erythrocytosis, Familial, 3 MESH:C565221 marker/mechanism 609820.0 +EGLN1 54583 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 29471019 +EGLN2 112398 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 20418890 +EGLN3 112399 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +EGR1 1958 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +EGR1 1958 Autoimmune Diseases MESH:D001327 marker/mechanism 25055964 +EGR1 1958 Brain Ischemia MESH:D002545 marker/mechanism 17394460 +EGR1 1958 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +EGR1 1958 Cholangitis MESH:D002761 marker/mechanism 25055964 +EGR1 1958 Cholestasis MESH:D002779 marker/mechanism 21224055 +EGR1 1958 Cholestasis, Intrahepatic MESH:D002780 marker/mechanism 18364083|22094456 +EGR1 1958 Cocaine-Related Disorders MESH:D019970 marker/mechanism|therapeutic 16157275|16738229|18311559 +EGR1 1958 Hydronephrosis MESH:D006869 marker/mechanism 25015655 +EGR1 1958 Hypoxia MESH:D000860 marker/mechanism 12468449 +EGR1 1958 Inflammation MESH:D007249 marker/mechanism 22094456 +EGR1 1958 Ischemia MESH:D007511 marker/mechanism 12468449 +EGR1 1958 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +EGR1 1958 Mesothelioma MESH:D008654 marker/mechanism 15878867 +EGR1 1958 Pneumonia MESH:D011014 therapeutic 29787794 +EGR1 1958 Prostatic Neoplasms MESH:D011471 marker/mechanism 16552752 +EGR1 1958 Reperfusion Injury MESH:D015427 marker/mechanism 12468449 +EGR2 1959 Autistic Disorder MESH:D001321 marker/mechanism 19000991 +EGR2 1959 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +EGR2 1959 Charcot-Marie-Tooth disease, Type 1D MESH:C537985 marker/mechanism 607678.0 +EGR2 1959 Charcot-Marie-Tooth disease, Type 4E MESH:C535301 marker/mechanism 605253.0 +EGR2 1959 Hereditary Sensory and Motor Neuropathy MESH:D015417 marker/mechanism 145900.0 +EGR2 1959 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +EGR2 1959 Rett Syndrome MESH:D015518 marker/mechanism 19000991 +EGR2 1959 Sarcoma, Ewing MESH:D012512 marker/mechanism 26214589 +EGR3 1960 Ataxia MESH:D001259 marker/mechanism 16091474 +EHBP1 23301 Prostate Cancer, Hereditary, 12 MESH:C567510 marker/mechanism 611868.0 +EHBP1 23301 Prostatic Neoplasms MESH:D011471 marker/mechanism 23593118 +EHD1 10938 Disease Progression MESH:D018450 marker/mechanism 35616188 +EHD1 10938 Glioma MESH:D005910 marker/mechanism 35616188 +EHD1 10938 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 35616188 +EHD3 30845 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +EHD3 30845 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +EHF 26298 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +EHHADH 1962 Fanconi Syndrome MESH:D005198 marker/mechanism 615605.0 +EHHADH 1962 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +EHHADH 1962 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +EHMT1 79813 Kleefstra Syndrome MESH:C563043 marker/mechanism 610253.0 +EHMT1 79813 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +EHMT1 79813 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 32889036 +EHMT2 10919 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 25115793 +EHMT2 10919 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 29391238 +EHMT2 10919 Chromosome Breakage MESH:D019457 marker/mechanism 29391238 +EHMT2 10919 Cocaine-Related Disorders MESH:D019970 therapeutic 20056891 +EHMT2 10919 Infertility MESH:D007246 marker/mechanism 25975992 +EHMT2 10919 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 24532712 +EHMT2 10919 Lung Neoplasms MESH:D008175 marker/mechanism 20940408 +EHMT2 10919 Neoplasm Metastasis MESH:D009362 marker/mechanism 20940408|25115793 +EHMT2 10919 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 32889036 +EHMT2 10919 Vesicular Stomatitis MESH:D054243 therapeutic 26418342 +EI24 9538 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +EID1 23741 Mesothelioma MESH:D008654 marker/mechanism 15920167 +EIF1AD 84285 Melanoma MESH:D008545 marker/mechanism 22535842 +EIF1AX 1964 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +EIF1AX 1964 Uveal melanoma MESH:C536494 marker/mechanism 23793026 +EIF2A 83939 Myocardial Ischemia MESH:D017202 marker/mechanism 19041636 +EIF2A 83939 Reperfusion Injury MESH:D015427 marker/mechanism 19041636 +EIF2AK1 27102 Anemia, Hemolytic MESH:D000743 marker/mechanism 25411909 +EIF2AK1 27102 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25411909 +EIF2AK1 27102 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29289645 +EIF2AK1 27102 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +EIF2AK1 27102 Splenomegaly MESH:D013163 marker/mechanism 25411909 +EIF2AK2 5610 Influenza, Human MESH:D007251 marker/mechanism 23326326 +EIF2AK2 5610 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +EIF2AK2 5610 Status Epilepticus MESH:D013226 marker/mechanism 16492139 +EIF2AK3 9451 Myocardial Ischemia MESH:D017202 marker/mechanism 19041636 +EIF2AK3 9451 Status Epilepticus MESH:D013226 marker/mechanism 16492139 +EIF2AK3 9451 Supranuclear Palsy, Progressive MESH:D013494 marker/mechanism 21685912 +EIF2AK3 9451 Wolcott-Rallison syndrome MESH:C536739 marker/mechanism 226980.0 +EIF2AK4 440275 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 21239484 +EIF2AK4 440275 Hair Diseases MESH:D006201 marker/mechanism 21239484 +EIF2AK4 440275 Hypertension, Pulmonary MESH:D006976 marker/mechanism 24292273 +EIF2AK4 440275 Immune System Diseases MESH:D007154 marker/mechanism 21239484 +EIF2AK4 440275 Muscular Diseases MESH:D009135 marker/mechanism 21239484 +EIF2AK4 440275 Pulmonary Veno-Occlusive Disease MESH:D011668 marker/mechanism 234810.0 24292273 +EIF2B1 1967 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +EIF2B1 1967 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +EIF2B1 1967 Vanishing White Matter Leukodystrophy with Ovarian Failure MESH:C565836 marker/mechanism 603896.0 +EIF2B2 8892 Vanishing White Matter Leukodystrophy with Ovarian Failure MESH:C565836 marker/mechanism 12707859 +EIF2B4 8890 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 24366584 +EIF2B4 8890 Vanishing White Matter Leukodystrophy with Ovarian Failure MESH:C565836 marker/mechanism 12707859 +EIF2B5 8893 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 24366584 +EIF2B5 8893 Vanishing White Matter Leukodystrophy with Ovarian Failure MESH:C565836 marker/mechanism 12707859 +EIF2S1 1965 Alzheimer Disease MESH:D000544 marker/mechanism 17406652 +EIF2S1 1965 Cognition Disorders MESH:D003072 marker/mechanism 17406652 +EIF2S1 1965 Nerve Degeneration MESH:D009410 marker/mechanism 16492139 +EIF2S1 1965 Osteosarcoma MESH:D012516 marker/mechanism 14767549 +EIF2S1 1965 Status Epilepticus MESH:D013226 marker/mechanism 15003282 +EIF2S2 8894 Breast Neoplasms MESH:D001943 marker/mechanism 25151356 +EIF2S3 1968 MEHMO syndrome MESH:C537451 marker/mechanism 300148.0 +EIF3A 8661 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +EIF3B 8662 HIV Infections MESH:D015658 marker/mechanism 15308739 +EIF3D 8664 Pre-Eclampsia MESH:D011225 marker/mechanism 34520790 +EIF3E 3646 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +EIF3E 3646 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +EIF3EA 325102 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17895999 +EIF3H 8667 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 14578863 +EIF3H 8667 Colorectal Neoplasms MESH:D015179 marker/mechanism 18372905 +EIF3H 8667 Prostatic Neoplasms MESH:D011471 marker/mechanism 14997205 +EIF3I 8668 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 11830523|24056964 +EIF3I 8668 Colonic Neoplasms MESH:D003110 marker/mechanism 24056964 +EIF4A1 1973 HIV Infections MESH:D015658 marker/mechanism 15308739 +EIF4A2 1974 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +EIF4A3 9775 Richieri Costa Pereira syndrome MESH:C535677 marker/mechanism 268305.0 +EIF4E 1977 Autistic Disorder MESH:D001321 marker/mechanism 615091.0 +EIF4E 1977 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 17148679 +EIF4E 1977 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20388789 +EIF4E3 317649 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EIF4EBP1 1978 HIV Infections MESH:D015658 marker/mechanism 15308739 +EIF4EBP1 1978 Inflammation MESH:D007249 marker/mechanism 26297436 +EIF4EBP1 1978 Kidney Neoplasms MESH:D007680 marker/mechanism 21813464 +EIF4EBP1 1978 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 19458359 +EIF4EBP1 1978 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 17148679 +EIF4EBP1 1978 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +EIF4EBP2 1979 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +EIF4G1 1981 Autistic Disorder MESH:D001321 marker/mechanism 20957522 +EIF4G1 1981 PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO OMIM:614251 marker/mechanism 614251.0 +EIF5 1983 Schizophrenia MESH:D012559 marker/mechanism 21743468 +EIF5A 1984 Carcinoma MESH:D002277 marker/mechanism 16316942 +EIF5A 1984 Keloid MESH:D007627 marker/mechanism 20128793 +EIF5A 1984 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +EIF5A 1984 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +EIF6 3692 Breast Neoplasms MESH:D001943 marker/mechanism 25151356 +EIF6 3692 HIV Infections MESH:D015658 marker/mechanism 15308739 +EIPR1 7260 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ELAC2 60528 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17 OMIM:615440 marker/mechanism 615440.0 +ELAC2 60528 Prostatic Neoplasms MESH:D011471 marker/mechanism 16114055 +ELANE 1991 Cyclic neutropenia MESH:C536227 marker/mechanism 162800.0 +ELANE 1991 Neutropenia MESH:D009503 marker/mechanism 17436313 +ELANE 1991 Neutropenia, Severe Congenital, Autosomal Dominant 1 MESH:C565969 marker/mechanism 202700.0 +ELAVL1 1994 Endometriosis MESH:D004715 marker/mechanism 20889954 +ELAVL2 1993 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +ELAVL3 1995 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ELF2 1998 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ELF3 1999 Biliary Tract Neoplasms MESH:D001661 marker/mechanism 26258846 +ELF3 1999 Lung Injury MESH:D055370 therapeutic 21709667 +ELK3 2004 Breast Neoplasms MESH:D001943 marker/mechanism 16583263 +ELK3 2004 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +ELMO1 9844 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 23525077 +ELMO1 9844 Diabetic Nephropathies MESH:D003928 marker/mechanism 17942768 +ELMO1 9844 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +ELMO2 63916 Vascular Malformation, Primary Intraosseous MESH:C564648 marker/mechanism 606893.0 +ELMOD3 84173 DEAFNESS, AUTOSOMAL RECESSIVE 88 OMIM:615429 marker/mechanism 615429.0 +ELN 2006 Aortic Stenosis, Supravalvular MESH:D021921 marker/mechanism 185500.0 20007321|8096434 +ELN 2006 Cutis Laxa MESH:D003483 marker/mechanism 12189163 +ELN 2006 Cutis Laxa, Autosomal Dominant MESH:C562627 marker/mechanism 123700.0 +ELN 2006 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +ELN 2006 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10359170 +ELN 2006 Hypertension MESH:D006973 marker/mechanism 17039479 +ELN 2006 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 12868502 +ELN 2006 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ELN 2006 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 25106431 +ELN 2006 Pulmonary Emphysema MESH:D011656 marker/mechanism 25106431 +ELN 2006 Pulmonary Fibrosis MESH:D011658 marker/mechanism 10761639|26817844 +ELN 2006 Williams Syndrome MESH:D018980 marker/mechanism 194050.0 +ELOC 6921 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +ELOVL2 54898 Infertility, Male MESH:D007248 marker/mechanism 21106902 +ELOVL4 6785 Stargardt disease 3 MESH:C535805 marker/mechanism 600110.0 +ELOVL5 60481 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ELOVL5 60481 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 615957.0 +ELOVL6 79071 Heart Failure MESH:D006333 marker/mechanism 26670611 +ELP1 8518 Breast Neoplasms MESH:D001943 marker/mechanism 27811057 +ELP1 8518 Dysautonomia, Familial MESH:D004402 marker/mechanism 223900.0 +ELP1 8518 Medulloblastoma MESH:D008527 marker/mechanism 155255.0 +ELP1 8518 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27811057 +ELP2 55250 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 58 OMIM:617270 marker/mechanism 617270.0 +ELP2 55250 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ELP3 55140 Breast Neoplasms MESH:D001943 marker/mechanism 27811057 +ELP3 55140 Disease Models, Animal MESH:D004195 marker/mechanism 27811057 +ELP3 55140 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27811057 +ELP3 55140 Neoplasm Metastasis MESH:D009362 marker/mechanism 27811057 +ELP4 26610 Aniridia MESH:D015783 marker/mechanism 617141.0 +ELP4 26610 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +EMB 133418 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +EMB 133418 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EMC1 23065 CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION OMIM:616875 marker/mechanism 616875.0 +EMD 2010 Muscular Dystrophy, Emery-Dreifuss MESH:D020389 marker/mechanism 310300.0 +EMG1 10436 Bowen-Conradi syndrome MESH:C537081 marker/mechanism 211180.0 +EMG1 10436 HIV Infections MESH:D015658 marker/mechanism 15308739 +EML1 2009 Band Heterotopia of Brain MESH:C563950 marker/mechanism 600348.0 +EML4 27436 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 22980554|22999080 +EML4 27436 Brain Neoplasms MESH:D001932 marker/mechanism 22986231 +EML4 27436 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17625570|21757253|21767331|22568572|22617245|22986231 +EML4 27436 Neoplasm Metastasis MESH:D009362 marker/mechanism 22986231|22999080 +EMP1 2012 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +EMP1 2012 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EMP1 2012 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +EMP2 2013 NEPHROTIC SYNDROME, TYPE 10 OMIM:615861 marker/mechanism 615861.0 +EMP3 2014 Prostatic Neoplasms MESH:D011471 marker/mechanism 15583422 +EMSY 56946 Breast Neoplasms MESH:D001943 marker/mechanism 19636701 +EMSY 56946 Dermatitis, Atopic MESH:D003876 marker/mechanism 23042114 +EMSY 56946 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +EMSY 56946 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +EMX2 2018 Familial schizencephaly MESH:C538514 marker/mechanism 269160.0 +EMX2 2018 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +EMX2 2018 Lung Neoplasms MESH:D008175 marker/mechanism 20697358 +EN1 2019 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +EN1 2019 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +EN1 2019 Nervous System Diseases MESH:D009422 marker/mechanism 21892157 +EN1 2019 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +EN2 2020 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 25290267 +EN2 2020 Autistic Disorder MESH:D001321 marker/mechanism 15024396|16935268|19186208|20523082 +EN2 2020 Taste Disorders MESH:D013651 marker/mechanism 29953887 +ENAH 55740 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 26237430 +ENAM 10117 Amelogenesis Imperfecta MESH:D000567 marker/mechanism 15649948|17652207 +ENAM 10117 Amelogenesis Imperfecta, Type IB MESH:C562879 marker/mechanism 104500.0 +ENAM 10117 Amelogenesis Imperfecta, Type Ic MESH:C567147 marker/mechanism 204650.0 +ENC1 8507 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ENG 2022 Cystic Fibrosis MESH:D003550 marker/mechanism 30806029 +ENG 2022 Telangiectasia, Hereditary Hemorrhagic MESH:D013683 marker/mechanism 187300.0 15115879|20135064 +ENO1 2023 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +ENO1 2023 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +ENO1 2023 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893|27602772 +ENO1 2023 Alzheimer Disease MESH:D000544 marker/mechanism 19374891 +ENO1 2023 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19898480 +ENO1 2023 Breast Neoplasms MESH:D001943 marker/mechanism 19655245 +ENO1 2023 Carcinoma MESH:D002277 marker/mechanism 12376462 +ENO1 2023 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +ENO1 2023 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17094902 +ENO1 2023 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +ENO1 2023 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942|25231249 +ENO1 2023 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +ENO1 2023 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +ENO1 2023 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +ENO1 2023 Infertility, Male MESH:D007248 marker/mechanism 27460355 +ENO1 2023 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +ENO1 2023 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +ENO1 2023 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +ENO1 2023 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15654357 +ENO1 2023 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +ENO1 2023 Osteoporosis MESH:D010024 marker/mechanism 18924182 +ENO1 2023 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +ENO2 2026 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21595568 +ENO2 2026 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22613180 +ENO2 2026 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +ENO2 2026 Lewy Body Disease MESH:D020961 marker/mechanism 30236862 +ENO2 2026 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 2910524 +ENO2 2026 Neoplasms, Experimental MESH:D009374 marker/mechanism 22613180 +ENO2 2026 Parkinson Disease MESH:D010300 marker/mechanism 30236862 +ENO2 2026 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 22613180 +ENO3 2027 Glycogen Storage Disease XIII MESH:C567861 marker/mechanism 612932.0 +ENO3 2027 Liver Diseases MESH:D008107 marker/mechanism 19784758 +ENO4 387712 Infertility, Male MESH:D007248 marker/mechanism 23446454 +ENOPH1 58478 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +ENOX2 10495 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26807072 +ENOX2 10495 Neoplasms MESH:D009369 marker/mechanism 20518072 +ENPEP 2028 Diabetic Nephropathies MESH:D003928 marker/mechanism 28468961 +ENPEP 2028 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ENPP1 5167 Arterial calcification of infancy MESH:C537440 marker/mechanism 208000.0 +ENPP1 5167 COLE DISEASE OMIM:615522 marker/mechanism 615522.0 +ENPP1 5167 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 +ENPP1 5167 Endometriosis MESH:D004715 marker/mechanism 20864642 +ENPP1 5167 Hypophosphatemic Rickets, Autosomal Recessive, 2 MESH:C567647 marker/mechanism 613312.0 +ENPP1 5167 Obesity MESH:D009765 marker/mechanism 601665.0 +ENPP2 5168 Birth Weight MESH:D001724 marker/mechanism 23866971 +ENPP2 5168 Hepatitis MESH:D006505 marker/mechanism 17850827 +ENPP2 5168 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +ENPP2 5168 Neoplasm Metastasis MESH:D009362 marker/mechanism 26037280 +ENPP2 5168 Thyroid Neoplasms MESH:D013964 marker/mechanism 26037280 +ENPP5 59084 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ENSA 2029 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ENTPD1 953 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ENTPD1 953 SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE OMIM:615683 marker/mechanism 615683.0 +ENTPD2 954 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 15651265 +ENTPD6 955 Obesity MESH:D009765 marker/mechanism 29273807 +ENTPD6 955 Seminoma MESH:D018239 marker/mechanism 21519793 +EOGT 285203 Adams Oliver syndrome MESH:C538225 marker/mechanism 615297.0 +EOMES 8320 Anxiety Disorders MESH:D001008 marker/mechanism 26415720 +EOMES 8320 Autoimmune Diseases of the Nervous System MESH:D020274 marker/mechanism 27742544 +EOMES 8320 Colonic Neoplasms MESH:D003110 marker/mechanism 27539959 +EOMES 8320 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +EOMES 8320 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +EP300 2033 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +EP300 2033 Breast Neoplasms MESH:D001943 marker/mechanism 26229107 +EP300 2033 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +EP300 2033 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27158780 +EP300 2033 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 21822268 +EP300 2033 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500 +EP300 2033 Craniofacial Abnormalities MESH:D019465 marker/mechanism 26921506 +EP300 2033 Endometrial Neoplasms MESH:D016889 marker/mechanism 23104009 +EP300 2033 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 17965222|25151357 +EP300 2033 Lymphoma, T-Cell MESH:D016399 marker/mechanism 26192917 +EP300 2033 Melanoma MESH:D008545 marker/mechanism 23698071 +EP300 2033 Obesity MESH:D009765 marker/mechanism 26441656 +EP300 2033 Rubinstein-Taybi Syndrome MESH:D012415 marker/mechanism 180849|613684 +EP300 2033 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941188 +EP300 2033 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +EP300 2033 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21822268 +EPAS1 2034 Carcinogenesis MESH:D063646 marker/mechanism 26735578 +EPAS1 2034 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 26735578 +EPAS1 2034 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 21131975 +EPAS1 2034 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23333640|26735578|30090327 +EPAS1 2034 Chromosome Aberrations MESH:D002869 marker/mechanism 23333640 +EPAS1 2034 Disease Progression MESH:D018450 marker/mechanism 26735578 +EPAS1 2034 Erythrocytosis, Familial, 4 MESH:C567086 marker/mechanism 611783 +EPAS1 2034 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26735578|30090327 +EPB41 2035 Elliptocytosis 1 MESH:C567520 marker/mechanism 611804 +EPB41 2035 Melanoma MESH:D008545 marker/mechanism 17145863 +EPB41L1 2036 CHROMOSOME 20q11-q12 DELETION SYNDROME OMIM:614257 marker/mechanism 614257 +EPB41L2 2037 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EPB41L3 23136 Breast Neoplasms MESH:D001943 marker/mechanism 17260099 +EPB42 2038 Spherocytosis, Type 5 MESH:C567202 marker/mechanism 612690.0 +EPC2 26122 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +EPCAM 4072 Carcinoma MESH:D002277 marker/mechanism 16316942 +EPCAM 4072 Colorectal Cancer, Hereditary Nonpolyposis, Type 8 MESH:C567685 marker/mechanism 613244.0 +EPCAM 4072 Colorectal Neoplasms, Hereditary Nonpolyposis MESH:D003123 marker/mechanism 25701956 +EPCAM 4072 Diarrhea 5, With Tufting Enteropathy, Congenital MESH:C567703 marker/mechanism 613217.0 +EPCAM 4072 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EPCAM 4072 Lynch syndrome I (site-specific colonic cancer) MESH:C537261 marker/mechanism 19098912 +EPCAM 4072 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +EPCAM 4072 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +EPCAM 4072 Ovarian Neoplasms MESH:D010051 marker/mechanism 20870202 +EPCAM 4072 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17446842 +EPCAM 4072 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +EPDR1 54749 Glaucoma, Angle-Closure MESH:D015812 marker/mechanism 27064256 +EPG5 57724 Absent corpus callosum cataract immunodeficiency MESH:C535566 marker/mechanism 242840.0 23222957 +EPG5 57724 Cardiomyopathies MESH:D009202 marker/mechanism 23222957 +EPG5 57724 Hypopigmentation MESH:D017496 marker/mechanism 23222957 +EPG5 57724 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 23222957 +EPHA1 2041 Alzheimer Disease MESH:D000544 marker/mechanism 21460840|21460841 +EPHA1 2041 Colorectal Neoplasms MESH:D015179 marker/mechanism 19277044 +EPHA2 1969 CATARACT 6, MULTIPLE TYPES OMIM:116600 marker/mechanism 116600.0 +EPHA2 1969 Disease Progression MESH:D018450 marker/mechanism 21479221 +EPHA2 1969 LEOPARD Syndrome MESH:D044542 marker/mechanism 22845314 +EPHA2 1969 Neoplasms MESH:D009369 marker/mechanism 21479221 +EPHA2 1969 Noonan Syndrome MESH:D009634 marker/mechanism 22845314 +EPHA3 2042 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +EPHA7 2045 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 30357299 +EPHA7 2045 Hemorrhage MESH:D006470 marker/mechanism 30357299 +EPHA7 2045 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941188 +EPHB2 2048 Ependymoma MESH:D004806 marker/mechanism 26075792 +EPHB2 2048 PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY OMIM:603688 marker/mechanism 603688.0 +EPHB4 2050 Breast Neoplasms MESH:D001943 marker/mechanism 23063927 +EPHB4 2050 LYMPHATIC MALFORMATION 7 OMIM:617300 marker/mechanism 617300.0 +EPHB4 2050 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +EPHX1 2052 Abnormalities, Drug-Induced MESH:D000014 marker/mechanism 2336087 +EPHX1 2052 Acute Lung Injury MESH:D055371 marker/mechanism 26840748 +EPHX1 2052 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 19598248 +EPHX1 2052 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +EPHX1 2052 Carcinoma MESH:D002277 marker/mechanism 12376462 +EPHX1 2052 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 7892276 +EPHX1 2052 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +EPHX1 2052 Fever MESH:D005334 therapeutic 31422080 +EPHX1 2052 Hypercholanemia, Familial MESH:C564336 marker/mechanism 12878321 +EPHX1 2052 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 29605894 +EPHX1 2052 Lung Neoplasms MESH:D008175 marker/mechanism 17114358|17311802 +EPHX1 2052 Lymphoma MESH:D008223 marker/mechanism 11406608 +EPHX1 2052 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 11406608 +EPHX1 2052 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +EPHX1 2052 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +EPHX1 2052 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 16697254 +EPHX1 2052 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 22156006 +EPHX1 2052 Multiple Myeloma MESH:D009101 marker/mechanism 16949155 +EPHX1 2052 Myocardial Ischemia MESH:D017202 marker/mechanism 29298899 +EPHX1 2052 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 21983886 +EPHX1 2052 Pre-Eclampsia MESH:D011225 marker/mechanism 11283205|12173035 +EPHX1 2052 Prostatic Neoplasms MESH:D011471 marker/mechanism 17919073|21716162|24763052 +EPHX1 2052 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 9288046 +EPHX1 2052 Pulmonary Emphysema MESH:D011656 marker/mechanism 9288046 +EPHX1 2052 Skin Neoplasms MESH:D012878 marker/mechanism 26295053 +EPHX2 2053 Acute Kidney Injury MESH:D058186 therapeutic 26165641 +EPHX2 2053 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 30890645|35663546 +EPHX2 2053 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 26165641 +EPHX2 2053 Heart Failure MESH:D006333 marker/mechanism 18443590 +EPHX2 2053 HYPERCHOLESTEROLEMIA, FAMILIAL, 1 OMIM:143890 marker/mechanism 143890.0 +EPHX2 2053 Myocardial Ischemia MESH:D017202 marker/mechanism 29298899 +EPHX2 2053 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 19834332 +EPHX2 2053 Schizophrenia MESH:D012559 marker/mechanism 30890645 +EPHX2 2053 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 19834332 +EPHX3 79852 Melanoma MESH:D008545 marker/mechanism 16778180 +EPHX3 79852 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +EPM2A 7957 Lafora Disease MESH:D020192 marker/mechanism 254780.0 +EPM2A 7957 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 25401298 +EPN3 55040 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +EPO 2056 Acute Kidney Injury MESH:D058186 therapeutic 21847101|24561306 +EPO 2056 Anemia MESH:D000740 marker/mechanism|therapeutic 10506726|10713657|11245434|11273875|11454181|11569724|11828949|11981781|12670280|12713065|12820454|12897097|12899718|14568602|14706663|15160343|1516988|15232364|15660393|1574960|16434484|16511603|16637862|16707910|16798232|16949463|16970215|16970600|17058596|17168855|17180133|17288690|17397412|17409018|17559739|18265628|18403296|18611800|18695134|1893952|19015056|19212639|19787831|1982298|20189893|20303990|21860424|2186273|2206997|22174104|23077460|7529132|7602351|7631396|7732690|8202718|8250662|8260696|8418619|8504984|9118049|9616293|9617462|9743294 +EPO 2056 Anemia, Hemolytic MESH:D000743 therapeutic 10733367|16629641|20446436 +EPO 2056 beta-Thalassemia MESH:D017086 therapeutic 16225658 +EPO 2056 Brain Injuries MESH:D001930 therapeutic 20833152 +EPO 2056 Calcinosis MESH:D002114 marker/mechanism 12148126 +EPO 2056 Cardiomyopathies MESH:D009202 therapeutic 16449733|16731534|17924179|17928571 +EPO 2056 Central Nervous System Diseases MESH:D002493 therapeutic 15816862 +EPO 2056 Cognition Disorders MESH:D003072 therapeutic 20833152 +EPO 2056 Coronary Artery Disease MESH:D003324 therapeutic 25245553 +EPO 2056 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 therapeutic 18382691 +EPO 2056 Fatigue MESH:D005221 therapeutic 18695134 +EPO 2056 Heart Diseases MESH:D006331 therapeutic 16707910 +EPO 2056 Heart Septal Defects, Ventricular MESH:D006345 marker/mechanism 19337937 +EPO 2056 Hemolytic-Uremic Syndrome MESH:D006463 therapeutic 12053072 +EPO 2056 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 27880037 +EPO 2056 Hypertension MESH:D006973 marker/mechanism 10694834|1516988 +EPO 2056 Inflammation MESH:D007249 therapeutic 21497595 +EPO 2056 Kidney Diseases MESH:D007674 therapeutic 20606417 +EPO 2056 Kidney Failure, Chronic MESH:D007676 therapeutic 16707910 +EPO 2056 Melanoma MESH:D008545 marker/mechanism 15743794 +EPO 2056 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 30944280 +EPO 2056 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2 OMIM:612623 marker/mechanism 612623.0 +EPO 2056 Myelodysplastic Syndromes MESH:D009190 therapeutic 12670338|16076383 +EPO 2056 Myocardial Infarction MESH:D009203 marker/mechanism 19337937 +EPO 2056 Neoplasm Invasiveness MESH:D009361 marker/mechanism 16699298 +EPO 2056 Neoplasm Metastasis MESH:D009362 marker/mechanism 16699298 +EPO 2056 Nerve Degeneration MESH:D009410 therapeutic 17010629|17166730|19497871|30837834 +EPO 2056 Neurodegenerative Diseases MESH:D019636 therapeutic 15816862 +EPO 2056 Pancytopenia MESH:D010198 therapeutic 9051142 +EPO 2056 Paraneoplastic Syndromes MESH:D010257 marker/mechanism 10713657 +EPO 2056 Poisoning MESH:D011041 therapeutic 15727166 +EPO 2056 Polyneuropathies MESH:D011115 therapeutic 17010629 +EPO 2056 Pulmonary Embolism MESH:D011655 marker/mechanism 12670338 +EPO 2056 Renal Insufficiency MESH:D051437 therapeutic 22013135 +EPO 2056 Sarcoma, Experimental MESH:D012513 therapeutic 9743294 +EPO 2056 Shock, Cardiogenic MESH:D012770 marker/mechanism 19337937 +EPO 2056 Status Epilepticus MESH:D013226 therapeutic 16679645|17166730 +EPO 2056 Stomach Ulcer MESH:D013276 therapeutic 20723003 +EPO 2056 Tachycardia, Ventricular MESH:D017180 therapeutic 18156309 +EPO 2056 Thrombocytopenia MESH:D013921 therapeutic 8260696 +EPO 2056 Thrombosis MESH:D013927 marker/mechanism 14979412|25013951 +EPO 2056 Thyroid Neoplasms MESH:D013964 marker/mechanism 16699298 +EPO 2056 Uremia MESH:D014511 therapeutic 12675867 +EPO 2056 Vascular Diseases MESH:D014652 therapeutic 25013951 +EPO 2056 Venous Thrombosis MESH:D020246 marker/mechanism 12670338|17547733 +EPO 2056 Ventricular Fibrillation MESH:D014693 therapeutic 18156309 +EPO 2056 Weight Loss MESH:D015431 therapeutic 8260696 +EPOR 2057 Breast Neoplasms MESH:D001943 marker/mechanism 19706814 +EPOR 2057 Melanoma MESH:D008545 marker/mechanism 21860424 +EPOR 2057 Neoplasm Invasiveness MESH:D009361 marker/mechanism 16699298 +EPOR 2057 Neoplasm Metastasis MESH:D009362 marker/mechanism 16699298 +EPOR 2057 Nerve Degeneration MESH:D009410 therapeutic 19497871 +EPOR 2057 Polycythemia MESH:D011086 marker/mechanism 16484586 +EPOR 2057 Polycythemia, primary familial and congenital MESH:C536842 marker/mechanism 133100.0 +EPOR 2057 Thyroid Neoplasms MESH:D013964 marker/mechanism 16699298 +EPPK1 83481 Chloracne MESH:D054506 marker/mechanism 17101203 +EPS8 2059 DEAFNESS, AUTOSOMAL RECESSIVE 102 OMIM:615974 marker/mechanism 615974.0 +EPS8 2059 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19799886 +EPS8L3 79574 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +EPS8L3 79574 Hypotrichosis 5 MESH:C567554 marker/mechanism 612841.0 +EPS8L3 79574 Prostatic Neoplasms MESH:D011471 marker/mechanism 19223546 +EPX 8288 Presentey Anomaly MESH:C564893 marker/mechanism 261500.0 +ERAP1 51752 Behcet Syndrome MESH:D001528 marker/mechanism 23291587 +ERAP1 51752 Hypertension MESH:D006973 marker/mechanism 13678427 +ERAP1 51752 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ERAP1 51752 Psoriasis MESH:D011565 marker/mechanism 20953187|20953190|23291587|24212883 +ERAP1 51752 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 17952073|20062062|21743469|23291587 +ERAP2 64167 Birdshot Chorioretinopathy MESH:D000080365 marker/mechanism 36013011 +ERAP2 64167 Crohn Disease MESH:D003424 marker/mechanism 21102463 +ERAP2 64167 Plague MESH:D010930 therapeutic 36261521 +ERAP2 64167 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 33550689 +ERBB2 2064 Adenocarcinoma MESH:D000230 marker/mechanism 21673877|22042947 +ERBB2 2064 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 10897039|11222871|11248153|11583189|11970740|12006526|12655533|12839951|15581045|15970926|15994142|16091755|16137437|16234514|16446318|16495393|16596621|16682728|16865596|16950593|16978400|17614302|18086299|18768436|18819904|18840765|19075277|19436038|19617202|19801490|19896266|20197467|20332317|20941507|21501481|21638049|22302033|25221644|25358515|26124351|35234341 +ERBB2 2064 Carcinogenesis MESH:D063646 marker/mechanism 25221644 +ERBB2 2064 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +ERBB2 2064 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 28235801 +ERBB2 2064 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +ERBB2 2064 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 10897039 +ERBB2 2064 Cholangiocarcinoma MESH:D018281 marker/mechanism 16818635 +ERBB2 2064 Clinical Deterioration MESH:D000075902 marker/mechanism 29044505 +ERBB2 2064 Colonic Neoplasms MESH:D003110 marker/mechanism 11222871 +ERBB2 2064 Disease Models, Animal MESH:D004195 marker/mechanism 22302033 +ERBB2 2064 Disease Progression MESH:D018450 marker/mechanism 10897039|21638049|21750559 +ERBB2 2064 Esophageal Neoplasms MESH:D004938 marker/mechanism 22042947 +ERBB2 2064 Gallbladder Neoplasms MESH:D005706 marker/mechanism 24997986 +ERBB2 2064 Gastrointestinal Neoplasms MESH:D005770 marker/mechanism 21673877 +ERBB2 2064 Glioma MESH:D005910 marker/mechanism 137800.0 +ERBB2 2064 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 12483526 +ERBB2 2064 Lymphatic Metastasis MESH:D008207 marker/mechanism 21532492 +ERBB2 2064 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 8603490 +ERBB2 2064 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 25221644|8603490 +ERBB2 2064 Medulloblastoma MESH:D008527 marker/mechanism 20168248 +ERBB2 2064 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +ERBB2 2064 Neoplasm Metastasis MESH:D009362 marker/mechanism 16984552 +ERBB2 2064 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 16984552 +ERBB2 2064 Neoplasms, Experimental MESH:D009374 marker/mechanism 14612517 +ERBB2 2064 Neoplastic Cells, Circulating MESH:D009360 marker/mechanism 29044505 +ERBB2 2064 Ovarian Neoplasms MESH:D010051 marker/mechanism 167000.0 10897039|19896266 +ERBB2 2064 Papilloma MESH:D010212 marker/mechanism 8603490 +ERBB2 2064 Prostatic Neoplasms MESH:D011471 marker/mechanism 11222871|16984552|17363613 +ERBB2 2064 Recurrence MESH:D012008 marker/mechanism 20079691|21638049|26124351 +ERBB2 2064 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 15640503|21532492|22042947 +ERBB2 2064 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 34291863 +ERBB3 2065 Breast Neoplasms MESH:D001943 marker/mechanism 21638049|28114269 +ERBB3 2065 Disease Progression MESH:D018450 marker/mechanism 21638049 +ERBB3 2065 Gallbladder Neoplasms MESH:D005706 marker/mechanism 24997986 +ERBB3 2065 Lethal Congenital Contracture Syndrome 2 MESH:C564369 marker/mechanism 607598.0 +ERBB3 2065 Lung Neoplasms MESH:D008175 marker/mechanism 12483526 +ERBB3 2065 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +ERBB3 2065 Neoplasm Metastasis MESH:D009362 marker/mechanism 28114269 +ERBB3 2065 Neuronal intestinal pseudoobstruction MESH:C537394 marker/mechanism 243180.0 +ERBB3 2065 Prostatic Neoplasms MESH:D011471 marker/mechanism 17634423 +ERBB3 2065 Recurrence MESH:D012008 marker/mechanism 21638049 +ERBB4 2066 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 32065797 +ERBB4 2066 AMYOTROPHIC LATERAL SCLEROSIS 19 OMIM:615515 marker/mechanism 615515.0 +ERBB4 2066 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +ERBB4 2066 Gallbladder Neoplasms MESH:D005706 marker/mechanism 24997986 +ERBB4 2066 Melanoma MESH:D008545 marker/mechanism 19718025 +ERBB4 2066 Skin Neoplasms MESH:D012878 marker/mechanism 19718025 +ERBIN 55914 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +ERCC1 2067 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 21327329 +ERCC1 2067 Arsenic Poisoning MESH:D020261 marker/mechanism 12569548 +ERCC1 2067 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21553054|23912706 +ERCC1 2067 Cerebrooculofacioskeletal Syndrome 4 MESH:C565184 marker/mechanism 610758.0 +ERCC1 2067 Chromosome Aberrations MESH:D002869 marker/mechanism 24036326 +ERCC1 2067 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 24036326 +ERCC1 2067 Lung Neoplasms MESH:D008175 marker/mechanism 30453383 +ERCC1 2067 Melanoma MESH:D008545 marker/mechanism 21722328 +ERCC1 2067 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 20605357 +ERCC1 2067 Neoplasm Metastasis MESH:D009362 marker/mechanism 20801905 +ERCC1 2067 Neoplasms MESH:D009369 marker/mechanism 23203453 +ERCC1 2067 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 19956886 +ERCC1 2067 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20979931 +ERCC1 2067 Stomach Neoplasms MESH:D013274 marker/mechanism 21133646 +ERCC1 2067 Testicular Neoplasms MESH:D013736 marker/mechanism 19956886 +ERCC1 2067 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 20934765 +ERCC2 2068 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17687452 +ERCC2 2068 Cerebrooculofacioskeletal Syndrome 2 MESH:C565185 marker/mechanism 610756.0 +ERCC2 2068 Colorectal Neoplasms MESH:D015179 marker/mechanism 18267032 +ERCC2 2068 Hyperkeratosis, Epidermolytic MESH:D017488 marker/mechanism 17050553 +ERCC2 2068 Occupational Diseases MESH:D009784 marker/mechanism 16889696 +ERCC2 2068 Prostatic Neoplasms MESH:D011471 marker/mechanism 17695467 +ERCC2 2068 Skin Abnormalities MESH:D012868 marker/mechanism 17470448 +ERCC2 2068 Skin Diseases MESH:D012871 marker/mechanism 17050553 +ERCC2 2068 Skin Neoplasms MESH:D012878 marker/mechanism 17050553 +ERCC2 2068 Stomach Neoplasms MESH:D013274 marker/mechanism 17009404 +ERCC2 2068 Sunburn MESH:D013471 marker/mechanism 17470448 +ERCC2 2068 TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE OMIM:601675 marker/mechanism 601675.0 +ERCC2 2068 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121791|27111033 +ERCC2 2068 Xeroderma Pigmentosum, Complementation Group D MESH:C562591 marker/mechanism 278730.0 +ERCC3 2071 Arsenic Poisoning MESH:D020261 marker/mechanism 12569548 +ERCC3 2071 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +ERCC3 2071 TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE OMIM:616390 marker/mechanism 616390.0 +ERCC3 2071 Xeroderma Pigmentosum, Complementation Group B MESH:C562590 marker/mechanism 610651.0 +ERCC4 2072 Arsenic Poisoning MESH:D020261 marker/mechanism 12569548 +ERCC4 2072 FANCONI ANEMIA, COMPLEMENTATION GROUP Q OMIM:615272 marker/mechanism 615272.0 +ERCC4 2072 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 24036326 +ERCC4 2072 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 21216194|24036326 +ERCC4 2072 Neoplasm Metastasis MESH:D009362 marker/mechanism 20372803 +ERCC4 2072 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 19956886 +ERCC4 2072 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +ERCC4 2072 Recurrence MESH:D012008 marker/mechanism 20062074 +ERCC4 2072 Testicular Neoplasms MESH:D013736 marker/mechanism 19956886 +ERCC4 2072 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 20062074 +ERCC4 2072 Xeroderma Pigmentosum, Complementation Group F MESH:C562592 marker/mechanism 278760.0 +ERCC4 2072 XFE Progeroid Syndrome MESH:C567043 marker/mechanism 610965.0 +ERCC5 2073 Cerebrooculofacioskeletal Syndrome 3 MESH:C565035 marker/mechanism 616570.0 +ERCC5 2073 Colorectal Neoplasms MESH:D015179 marker/mechanism 34182385 +ERCC5 2073 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 34182385 +ERCC5 2073 Xeroderma Pigmentosum, Complementation Group G MESH:C562593 marker/mechanism 278780.0 +ERCC6 2074 Aging, Premature MESH:D019588 marker/mechanism 25440059 +ERCC6 2074 Arthrogryposis MESH:D001176 marker/mechanism 18628313 +ERCC6 2074 Cataract MESH:D002386 marker/mechanism 18628313 +ERCC6 2074 Cerebrooculofacioskeletal Syndrome 1 MESH:C562434 marker/mechanism 214150.0 10739753 +ERCC6 2074 Cockayne Syndrome MESH:D003057 marker/mechanism 133540.0 10739753|10767341|22466610|22466612|25440059|26972010|9443879 +ERCC6 2074 Craniofacial Abnormalities MESH:D019465 marker/mechanism 18628313 +ERCC6 2074 De Sanctis-Cacchione syndrome MESH:C535992 marker/mechanism 278800.0 10767341 +ERCC6 2074 Growth Disorders MESH:D006130 marker/mechanism 18628313 +ERCC6 2074 Hearing Loss MESH:D034381 marker/mechanism 25440059 +ERCC6 2074 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 17854076 +ERCC6 2074 Macular Degeneration MESH:D008268 marker/mechanism 16754848 +ERCC6 2074 MACULAR DEGENERATION, AGE-RELATED, 5 OMIM:613761 marker/mechanism 613761.0 +ERCC6 2074 Microcephaly MESH:D008831 marker/mechanism 10739753|18628313 +ERCC6 2074 Microphthalmos MESH:D008850 marker/mechanism 10739753 +ERCC6 2074 PREMATURE OVARIAN FAILURE 11 OMIM:616946 marker/mechanism 616946.0 +ERCC6 2074 Psychomotor Disorders MESH:D011596 marker/mechanism 18628313 +ERCC6 2074 UV-Sensitive Syndrome MESH:C563466 marker/mechanism 600630.0 26972010 +ERCC6L2 375748 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 30879219 +ERCC6L2 375748 Congenital Bone Marrow Failure Syndromes MESH:D000080984 marker/mechanism 615715.0 +ERCC8 1161 Cockayne Syndrome MESH:D003057 marker/mechanism 216400.0 22466610|22466612 +ERCC8 1161 UV-Sensitive Syndrome MESH:C563466 marker/mechanism 614621.0 +EREG 2069 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 35776891 +EREG 2069 Ovarian Neoplasms MESH:D010051 therapeutic 15313392 +EREG 2069 Protoporphyria, Erythropoietic MESH:D046351 marker/mechanism 19267999 +ERF 2077 Arnold-Chiari Malformation MESH:D001139 marker/mechanism 23354439 +ERF 2077 CHITAYAT SYNDROME OMIM:617180 marker/mechanism 617180.0 +ERF 2077 Craniofacial Abnormalities MESH:D019465 marker/mechanism 23354439 +ERF 2077 Craniosynostoses MESH:D003398 marker/mechanism 600775.0 23354439 +ERF 2077 Language Development Disorders MESH:D007805 marker/mechanism 23354439 +ERF 2077 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +ERG 2078 Leukemia MESH:D007938 marker/mechanism 19108891 +ERG 2078 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 19822134 +ERG 2078 Neoplastic Processes MESH:D009385 marker/mechanism 27783944 +ERG 2078 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 27776115 +ERG 2078 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048|18798265|19396168|25735316|27223260|27783944|28783165 +ERGIC1 57222 Arthrogryposis multiplex congenita neurogenic type MESH:C536614 marker/mechanism 208100.0 +ERGIC3 51614 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 27588471 +ERGIC3 51614 Lung Neoplasms MESH:D008175 marker/mechanism 27588471 +ERGIC3 51614 Neoplasms, Experimental MESH:D009374 marker/mechanism 27588471 +ERGIC3 51614 Precancerous Conditions MESH:D011230 marker/mechanism 27588471 +ERLEC1 27248 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +ERLEC1 27248 Cholestasis MESH:D002779 marker/mechanism 26881866 +ERLIN1 10613 SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE OMIM:615681 marker/mechanism 615681.0 +ERLIN2 11160 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ERLIN2 11160 Spastic Paraplegia 18, Autosomal Recessive MESH:C567628 marker/mechanism 611225.0 +ERMARD 55780 Periventricular Nodular Heterotopia MESH:D054091 marker/mechanism 615544.0 +ERN1 2081 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 30538632 +ERN1 2081 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 30661753 +ERN1 2081 Epilepsy MESH:D004827 marker/mechanism 19558813 +ERN1 2081 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 30538632 +ERN1 2081 Multiple Sclerosis MESH:D009103 marker/mechanism 30661753 +ERP29 10961 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +ERP29 10961 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +ERP29 10961 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +ERP29 10961 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ERP44 23071 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ERRFI1 54206 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 28688920 +ERRFI1 54206 Endometriosis MESH:D004715 marker/mechanism 20864642 +ERRFI1 54206 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ES2 109579 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +ESAM 90952 Schizophrenia MESH:D012559 marker/mechanism 21822266 +ESCO2 157570 Kidney Neoplasms MESH:D007680 marker/mechanism 28321044 +ESCO2 157570 Roberts Syndrome MESH:C535687 marker/mechanism 268300.0 16380922|18186147|20101700 +ESD 2098 Hypoxia MESH:D000860 marker/mechanism 19579223 +ESD 2098 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +ESM1 11082 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ESM1 11082 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +ESPL1 9700 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +ESPL1 9700 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 24121792 +ESPL1 9700 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +ESPL1 9700 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121792 +ESPN 83715 Deafness MESH:D003638 marker/mechanism 15286153|15930085 +ESPN 83715 DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;DFNB36 DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT, OMIM:609006 marker/mechanism 609006.0 +ESPN 83715 Vestibular Diseases MESH:D015837 marker/mechanism 15286153 +ESR1 2099 Adenocarcinoma MESH:D000230 marker/mechanism 15639718|20458558 +ESR1 2099 Alzheimer Disease MESH:D000544 marker/mechanism 17192785 +ESR1 2099 Astrocytoma MESH:D001254 marker/mechanism 24680642 +ESR1 2099 Atherosclerosis MESH:D050197 marker/mechanism 11894143 +ESR1 2099 Bone Diseases MESH:D001847 marker/mechanism 28505433 +ESR1 2099 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 18505767 +ESR1 2099 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 17417639|20104649|20458558|20966540|21501481|21541733|22038807|22174584|23001124|24014025|24185510|24185512|25330770|27580430 +ESR1 2099 Carcinoma MESH:D002277 marker/mechanism 15637090|17173897 +ESR1 2099 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144|28284560 +ESR1 2099 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24014025|27366082 +ESR1 2099 Coronary Artery Disease MESH:D003324 marker/mechanism 20559769|9396482 +ESR1 2099 Disease Models, Animal MESH:D004195 marker/mechanism 20962747 +ESR1 2099 Disease Progression MESH:D018450 marker/mechanism 20104649 +ESR1 2099 Endometrial Neoplasms MESH:D016889 marker/mechanism 24185510 +ESR1 2099 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +ESR1 2099 Feminization MESH:D005262 marker/mechanism 22275727 +ESR1 2099 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 35764155 +ESR1 2099 Glomerulonephritis MESH:D005921 marker/mechanism 20962747 +ESR1 2099 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 30165855 +ESR1 2099 Infertility, Female MESH:D007247 marker/mechanism 23710174 +ESR1 2099 Infertility, Male MESH:D007248 marker/mechanism 20833731|23213263 +ESR1 2099 Leiomyoma MESH:D007889 marker/mechanism 18701604|31468104 +ESR1 2099 Leukemia MESH:D007938 marker/mechanism 18808365 +ESR1 2099 Liver Neoplasms MESH:D008113 marker/mechanism 16712894 +ESR1 2099 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 35044086 +ESR1 2099 Lung Neoplasms MESH:D008175 marker/mechanism 11872642|17077188 +ESR1 2099 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 15637090|17173897|34606849 +ESR1 2099 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 15637090 +ESR1 2099 Mesothelioma MESH:D008654 marker/mechanism 15639718|17659810 +ESR1 2099 Migraine Disorders MESH:D008881 marker/mechanism 15133719 +ESR1 2099 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1 OMIM:157300 marker/mechanism 157300.0 +ESR1 2099 Mitochondrial Diseases MESH:D028361 marker/mechanism 30673822 +ESR1 2099 Musculoskeletal Pain MESH:D059352 marker/mechanism 25218601 +ESR1 2099 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 14600184 +ESR1 2099 Neoplasm Invasiveness MESH:D009361 marker/mechanism|therapeutic 26990689|27366082|35044086 +ESR1 2099 Neoplasm Metastasis MESH:D009362 marker/mechanism 20104649|35044086 +ESR1 2099 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 20556506 +ESR1 2099 Neuroblastoma MESH:D009447 marker/mechanism 27366082 +ESR1 2099 Obesity MESH:D009765 marker/mechanism 20667977 +ESR1 2099 Oligospermia MESH:D009845 marker/mechanism 20833731 +ESR1 2099 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 16220300 +ESR1 2099 Prostatic Neoplasms MESH:D011471 marker/mechanism 16220300|17176215 +ESR1 2099 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 19386276 +ESR1 2099 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 16712894|35764155 +ESR2 2100 Adenocarcinoma MESH:D000230 marker/mechanism 17639508 +ESR2 2100 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 22166976 +ESR2 2100 Astrocytoma MESH:D001254 marker/mechanism 24680642 +ESR2 2100 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +ESR2 2100 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 17132221|19434490|19548127 +ESR2 2100 Carcinoma MESH:D002277 marker/mechanism 15637090 +ESR2 2100 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 16700038 +ESR2 2100 Cell Transformation, Neoplastic MESH:D002471 therapeutic 22398780 +ESR2 2100 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17133264 +ESR2 2100 Colorectal Neoplasms MESH:D015179 marker/mechanism 15954165 +ESR2 2100 Coronary Artery Disease MESH:D003324 marker/mechanism 20559769 +ESR2 2100 Coronary Disease MESH:D003327 marker/mechanism 17367797 +ESR2 2100 Endometrial Neoplasms MESH:D016889 marker/mechanism 25437045 +ESR2 2100 Endometriosis MESH:D004715 marker/mechanism 17625110 +ESR2 2100 Infertility, Female MESH:D007247 marker/mechanism 23710174 +ESR2 2100 Lithiasis MESH:D020347 marker/mechanism 21670126 +ESR2 2100 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 15637090 +ESR2 2100 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 15637090 +ESR2 2100 Medulloblastoma MESH:D008527 therapeutic 21351254 +ESR2 2100 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 16220300 +ESR2 2100 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 15046698|16220300|16921512|17132221|17639508|26443449 +ESR2 2100 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 16700038 +ESRRA 2101 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22975021 +ESRRA 2101 Breast Neoplasms MESH:D001943 marker/mechanism 20961995 +ESRRA 2101 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 23090186 +ESRRA 2101 Disease Progression MESH:D018450 marker/mechanism 34524571 +ESRRA 2101 Metabolic Diseases MESH:D008659 therapeutic 16515477 +ESRRA 2101 Neoplasms, Experimental MESH:D009374 marker/mechanism 34524571 +ESRRA 2101 Osteosarcoma MESH:D012516 marker/mechanism 24967384|34524571 +ESRRB 2103 Deafness, Autosomal Recessive 35 MESH:C563908 marker/mechanism 608565.0 +ESRRG 2104 Fetal Growth Retardation MESH:D005317 marker/mechanism 35220427 +ESS2 8220 DiGeorge Syndrome MESH:D004062 marker/mechanism 192430.0 +ETAA1 54465 Pancreatic Neoplasms MESH:D010190 marker/mechanism 26098869 +ETFA 2108 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +ETFA 2108 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +ETFA 2108 Multiple Acyl Coenzyme A Dehydrogenase Deficiency MESH:D054069 marker/mechanism 231680.0 +ETFA 2108 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +ETFB 2109 Multiple Acyl Coenzyme A Dehydrogenase Deficiency MESH:D054069 marker/mechanism 231680.0 +ETFDH 2110 Metabolic Diseases MESH:D008659 marker/mechanism 17050691 +ETFDH 2110 Multiple Acyl Coenzyme A Dehydrogenase Deficiency MESH:D054069 marker/mechanism 231680.0 +ETFDH 2110 Obesity MESH:D009765 marker/mechanism 20882379 +ETHE1 23474 Ethylmalonic encephalopathy MESH:C535737 marker/mechanism 602473.0 +ETNK1 55500 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ETS1 2113 Celiac Disease MESH:D002446 marker/mechanism 20190752 +ETS1 2113 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +ETS1 2113 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838193 +ETS1 2113 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +ETS2 2114 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +ETS2 2114 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19764029 +ETS2 2114 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +ETS2 2114 Nerve Degeneration MESH:D009410 marker/mechanism 19522546 +ETV1 2115 Colorectal Neoplasms MESH:D015179 marker/mechanism 30224643 +ETV1 2115 Neoplastic Processes MESH:D009385 marker/mechanism 27783944 +ETV1 2115 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048|17671502|27783944 +ETV3 2117 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +ETV4 2118 Breast Neoplasms MESH:D001943 marker/mechanism 21679465 +ETV4 2118 Neoplasm Metastasis MESH:D009362 marker/mechanism 27869830 +ETV4 2118 Neoplastic Processes MESH:D009385 marker/mechanism 27783944 +ETV4 2118 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048|27783944 +ETV5 2119 Neoplastic Processes MESH:D009385 marker/mechanism 27783944 +ETV5 2119 Prostatic Neoplasms MESH:D011471 marker/mechanism 27783944 +ETV6 2120 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ETV6 2120 Hematologic Neoplasms MESH:D019337 marker/mechanism 25581430 +ETV6 2120 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +ETV6 2120 Macrocytosis, Familial MESH:C564004 marker/mechanism 25807284 +ETV6 2120 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 15217836|24413735|25807284 +ETV6 2120 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 17255265 +ETV6 2120 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ETV6 2120 Thrombocytopenia MESH:D013921 marker/mechanism 25581430|25807284 +ETV6 2120 THROMBOCYTOPENIA 5 OMIM:616216 marker/mechanism 616216.0 +EVC 2121 Ellis-Van Creveld Syndrome MESH:D004613 marker/mechanism 225500.0 +EVC 2121 Weyers acrofacial dysostosis MESH:C536695 marker/mechanism 193530.0 +EVC2 132884 Ellis-Van Creveld Syndrome MESH:D004613 marker/mechanism 225500.0 +EVC2 132884 Weyers acrofacial dysostosis MESH:C536695 marker/mechanism 193530.0 +EVL 51466 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +EVL 51466 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +EWSR1 2130 Neoplastic Processes MESH:D009385 marker/mechanism 27783944 +EWSR1 2130 Neuroectodermal Tumors, Primitive MESH:D018242 marker/mechanism 12162413 +EWSR1 2130 Prostatic Neoplasms MESH:D011471 marker/mechanism 27783944 +EWSR1 2130 Sarcoma, Ewing MESH:D012512 marker/mechanism 612219.0 16646077|26214589|27006472 +EXO1 9156 Breast Neoplasms MESH:D001943 marker/mechanism 25751625 +EXO1 9156 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +EXO1 9156 Colorectal Neoplasms MESH:D015179 marker/mechanism 17656264 +EXOSC2 23404 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +EXOSC2 23404 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +EXOSC3 51010 Pontocerebellar Hypoplasia Type 1 MESH:C548069 marker/mechanism 22544365 +EXOSC3 51010 PONTOCEREBELLAR HYPOPLASIA, TYPE 1B OMIM:614678 marker/mechanism 614678.0 +EXOSC5 56915 Disease Progression MESH:D018450 marker/mechanism 21364753 +EXOSC5 56915 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +EXOSC8 11340 PONTOCEREBELLAR HYPOPLASIA, TYPE 1C OMIM:616081 marker/mechanism 616081.0 +EXPH5 23086 Epidermolysis Bullosa MESH:D004820 marker/mechanism 615028.0 +EXT1 2131 Autistic Disorder MESH:D001321 marker/mechanism 12032595 +EXT1 2131 Chondrosarcoma MESH:D002813 marker/mechanism 215300.0 +EXT1 2131 Exostoses, Multiple Hereditary MESH:D005097 marker/mechanism 20080592|23439489 +EXT1 2131 EXOSTOSES, MULTIPLE, TYPE I OMIM:133700 marker/mechanism 133700.0 +EXT2 2132 Exostoses, Multiple Hereditary MESH:D005097 marker/mechanism 23439489 +EXT2 2132 EXOSTOSES, MULTIPLE, TYPE II OMIM:133701 marker/mechanism 133701.0 +EXTL1 2134 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EXTL3 2137 IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES OMIM:617425 marker/mechanism 617425.0 +EY 43812 Eye Abnormalities MESH:D005124 marker/mechanism 29045453 +EYA1 2138 Branchiootic syndrome MESH:C537104 marker/mechanism 602588.0 +EYA1 2138 Branchio-Oto-Renal Syndrome MESH:D019280 marker/mechanism 113650.0 12834866 +EYA1 2138 Cayler cardiofacial syndrome MESH:C535349 marker/mechanism 15493068 +EYA1 2138 Congenital Abnormalities MESH:D000013 marker/mechanism 10471511 +EYA1 2138 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10471511 +EYA1 2138 Hearing Loss, Conductive MESH:D006314 marker/mechanism 10471511 +EYA1 2138 Heart Defects, Congenital MESH:D006330 marker/mechanism 15493068 +EYA1 2138 Otofaciocervical Syndrome MESH:C563481 marker/mechanism 166780.0 +EYA4 2070 Cardiomyopathy, Dilated, 1J MESH:C565337 marker/mechanism 605362.0 +EYA4 2070 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +EYA4 2070 Deafness, Autosomal Dominant 10 MESH:C563354 marker/mechanism 601316.0 +EYS 346007 Retinitis Pigmentosa MESH:D012174 marker/mechanism 18836446 +EYS 346007 Retinitis Pigmentosa 25 MESH:C566425 marker/mechanism 602772.0 +EZH2 2146 Breast Neoplasms MESH:D001943 marker/mechanism 21903722 +EZH2 2146 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560|34545456 +EZH2 2146 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 29391238 +EZH2 2146 Chromosome Breakage MESH:D019457 marker/mechanism 29391238 +EZH2 2146 Craniosynostoses MESH:D003398 marker/mechanism 26424790 +EZH2 2146 Endometrial Neoplasms MESH:D016889 marker/mechanism 21903722 +EZH2 2146 Leukemia, Megakaryoblastic, of Down Syndrome MESH:C566025 marker/mechanism 24056718 +EZH2 2146 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +EZH2 2146 Lymphoma, Follicular MESH:D008224 marker/mechanism 24362818 +EZH2 2146 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 20081860 +EZH2 2146 Myelodysplastic-Myeloproliferative Diseases MESH:D054437 marker/mechanism 20601953 +EZH2 2146 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 20601954 +EZH2 2146 Osteosarcoma MESH:D012516 marker/mechanism 14767549 +EZH2 2146 Ovarian Neoplasms MESH:D010051 marker/mechanism 35442568 +EZH2 2146 Primary Myelofibrosis MESH:D055728 marker/mechanism 20601953 +EZH2 2146 Prostatic Neoplasms MESH:D011471 marker/mechanism 17003774|17173048|21903722 +EZH2 2146 Upper Extremity Deformities, Congenital MESH:D038062 marker/mechanism 26424790 +EZH2 2146 Weaver syndrome MESH:C536687 marker/mechanism 277590.0 +EZH2 2146 Weight Gain MESH:D015430 marker/mechanism 30971429 +EZR 7430 Carcinoma MESH:D002277 marker/mechanism 12376462 +EZR 7430 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +EZR 7430 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +EZR 7430 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +EZR 7430 Neoplasm Metastasis MESH:D009362 marker/mechanism 27137931 +EZR 7430 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +EZR 7430 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881|17566973|24763052 +F02C9.2 184074 Infertility MESH:D007246 marker/mechanism 25204677 +F08F1.4 181095 Infertility MESH:D007246 marker/mechanism 25204677 +F08G2.7 175036 Embryo Loss MESH:D020964 marker/mechanism 25204677 +F10 2159 Blood Coagulation Disorders MESH:D001778 marker/mechanism 62897 +F10 2159 Factor X Deficiency MESH:D005171 marker/mechanism 227600.0 +F10 2159 Thrombosis MESH:D013927 marker/mechanism 1279834 +F11 2160 Factor XI Deficiency MESH:D005173 marker/mechanism 612416.0 +F11 2160 Hypertension MESH:D006973 marker/mechanism 6383834 +F12 2161 Angioedemas, Hereditary MESH:D054179 marker/mechanism 19477491 +F12 2161 Factor XII Deficiency MESH:D005175 marker/mechanism 234000.0 +F12 2161 Hereditary Angioedema Type III MESH:D056828 marker/mechanism 610618.0 +F12 2161 Hypertension MESH:D006973 marker/mechanism 6383834 +F12 2161 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +F12 2161 Thromboembolism MESH:D013923 marker/mechanism 16009717 +F13A1 2162 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +F13A1 2162 Factor Xiii, A Subunit, Deficiency Of MESH:C567691 marker/mechanism 613225.0 +F13A1 2162 Factor XIII Deficiency MESH:D005177 marker/mechanism 1644910 +F13A1 2162 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 17393027 +F13A1 2162 Thrombophilia MESH:D019851 marker/mechanism 188050.0 +F13A1 2162 Venous Thrombosis MESH:D020246 marker/mechanism 10365735 +F13B 2165 Factor XIII, B Subunit, Deficiency Of MESH:C567688 marker/mechanism 613235.0 +F13B 2165 Factor XIII Deficiency MESH:D005177 marker/mechanism 2334637 +F13B 2165 Venous Thrombosis MESH:D020246 marker/mechanism 16241947 +F13H8.2 174038 Infertility MESH:D007246 marker/mechanism 25204677 +F18G5.1 184654 Embryo Loss MESH:D020964 marker/mechanism 25204677 +F2 2147 Alzheimer Disease MESH:D000544 marker/mechanism 8333868 +F2 2147 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 26001728 +F2 2147 Blood Coagulation Disorders MESH:D001778 marker/mechanism 17721328 +F2 2147 Brain Ischemia MESH:D002545 marker/mechanism 14753426|15534175 +F2 2147 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 2821104 +F2 2147 Disseminated Intravascular Coagulation MESH:D004211 marker/mechanism 1894189 +F2 2147 Fatty Liver MESH:D005234 marker/mechanism 20008134 +F2 2147 Hemorrhage MESH:D006470 marker/mechanism 7740448 +F2 2147 Hypertrophy MESH:D006984 marker/mechanism 26385185 +F2 2147 Hypoprothrombinemias MESH:D007020 marker/mechanism 3567158|7740448 +F2 2147 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 29651748 +F2 2147 Ischemic Stroke MESH:D000083242 marker/mechanism 601367.0 +F2 2147 Liver Cirrhosis MESH:D008103 marker/mechanism 10216089 +F2 2147 Liver Failure MESH:D017093 marker/mechanism 18618250 +F2 2147 Mesenteric Ischemia MESH:D065666 marker/mechanism 24282370 +F2 2147 Myocardial Infarction MESH:D009203 marker/mechanism 10027711|9292507|9531249 +F2 2147 Nephrosis MESH:D009401 marker/mechanism 18541230 +F2 2147 Nerve Degeneration MESH:D009410 marker/mechanism 19969022 +F2 2147 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 22841818 +F2 2147 Obesity MESH:D009765 marker/mechanism 22841818 +F2 2147 Paratuberculosis MESH:D010283 marker/mechanism 22633222 +F2 2147 PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2 OMIM:614390 marker/mechanism 614390.0 +F2 2147 PROTHROMBIN DEFICIENCY, CONGENITAL OMIM:613679 marker/mechanism 613679.0 +F2 2147 Schizophrenia MESH:D012559 marker/mechanism 25821032 +F2 2147 Sinus Thrombosis, Intracranial MESH:D012851 marker/mechanism 12269725 +F2 2147 Skin Diseases, Vascular MESH:D017445 marker/mechanism 17535202 +F2 2147 Stroke MESH:D020521 marker/mechanism 15534175 +F2 2147 Thromboembolism MESH:D013923 marker/mechanism 14693181 +F2 2147 Thrombophilia MESH:D019851 marker/mechanism 188050.0 16628723 +F2 2147 Thrombosis MESH:D013927 marker/mechanism 10064001|11132655|1279834|17245631 +F2 2147 Venous Thromboembolism MESH:D054556 marker/mechanism 12411922 +F2 2147 Venous Thrombosis MESH:D020246 marker/mechanism 12296757|19920886|9869612 +F2R 2149 Fatty Liver MESH:D005234 marker/mechanism 20008134|21907177|22841818 +F2R 2149 Hepatitis MESH:D006505 marker/mechanism 21907177 +F2R 2149 Inflammation MESH:D007249 marker/mechanism 20008134 +F2R 2149 Liver Cirrhosis MESH:D008103 marker/mechanism 21037076 +F2R 2149 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +F2R 2149 Neoplasms, Experimental MESH:D009374 marker/mechanism 17374729 +F2R 2149 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +F2RL1 2150 Gastroenteritis MESH:D005759 marker/mechanism 12682265 +F2RL1 2150 Inflammation MESH:D007249 marker/mechanism 12682265|24795235 +F2RL1 2150 Melanoma MESH:D008545 marker/mechanism 17145863 +F2RL1 2150 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +F2RL1 2150 Pruritus MESH:D011537 marker/mechanism 19712758 +F2RL3 9002 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20974703 +F2RL3 9002 Cholestasis MESH:D002779 marker/mechanism 20974703 +F2RL3 9002 Peliosis Hepatis MESH:D010382 marker/mechanism 20974703 +F3 2152 Breast Neoplasms MESH:D001943 marker/mechanism 15562024 +F3 2152 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22407844 +F3 2152 Coronary Artery Dissection, Spontaneous MESH:C565153 marker/mechanism 37248441 +F3 2152 Disseminated Intravascular Coagulation MESH:D004211 marker/mechanism 20642682|7740478|9134660 +F3 2152 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 16206674 +F3 2152 Liver Cirrhosis MESH:D008103 marker/mechanism 10216089 +F3 2152 Myocardial Ischemia MESH:D017202 marker/mechanism 16286589 +F3 2152 Nephrotic Syndrome MESH:D009404 marker/mechanism 17513194 +F3 2152 Purpura, Thrombotic Thrombocytopenic MESH:D011697 marker/mechanism 7740478 +F3 2152 Thrombosis MESH:D013927 marker/mechanism 11858183|25339356 +F3 2152 Venous Thrombosis MESH:D020246 marker/mechanism 14967414 +F32D8.8 185206 Infertility MESH:D007246 marker/mechanism 25204677 +F38H4.3 185479 Infertility MESH:D007246 marker/mechanism 25204677 +F44D12.6 260110 Death MESH:D003643 marker/mechanism 25204677 +F44D12.6 260110 Infertility MESH:D007246 marker/mechanism 25204677 +F46G10.1 185875 Embryo Loss MESH:D020964 marker/mechanism 25204677 +F47B10.4 185903 Infertility MESH:D007246 marker/mechanism 25204677 +F49C5.7 186018 Infertility MESH:D007246 marker/mechanism 25204677 +F5 2153 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 25200834 +F5 2153 Blood Coagulation Disorders MESH:D001778 marker/mechanism 17721328 +F5 2153 Brain Ischemia MESH:D002545 marker/mechanism 15534175 +F5 2153 Budd-Chiari Syndrome MESH:D006502 marker/mechanism 600880.0 +F5 2153 Colonic Neoplasms MESH:D003110 marker/mechanism 25200834 +F5 2153 Factor V Deficiency MESH:D005166 marker/mechanism 227400.0 +F5 2153 Ischemic Stroke MESH:D000083242 marker/mechanism 601367.0 +F5 2153 Liver Cirrhosis MESH:D008103 marker/mechanism 18485088 +F5 2153 Mesenteric Ischemia MESH:D065666 marker/mechanism 24282370 +F5 2153 Myocardial Infarction MESH:D009203 marker/mechanism 9531249 +F5 2153 PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1 OMIM:614389 marker/mechanism 614389.0 +F5 2153 Retinal Vein Occlusion MESH:D012170 marker/mechanism 12022286 +F5 2153 Sagittal Sinus Thrombosis MESH:D020225 marker/mechanism 18382986 +F5 2153 Stroke MESH:D020521 marker/mechanism 15534175 +F5 2153 Thromboembolism MESH:D013923 marker/mechanism 14693181|20554945 +F5 2153 Thrombophilia due to Activated Protein C Resistance MESH:C566056 marker/mechanism 188055.0 +F5 2153 Thrombophilia, hereditary MESH:C540694 marker/mechanism 9136971 +F5 2153 Thrombosis MESH:D013927 marker/mechanism 11132655|9164807 +F5 2153 Venous Thromboembolism MESH:D054556 marker/mechanism 7500743|9149031 +F5 2153 Venous Thrombosis MESH:D020246 marker/mechanism 12296757|12827938|12865888|15033664|16875063 +F53E10.1 178729 Infertility MESH:D007246 marker/mechanism 25204677 +F54D10.7 173728 Infertility MESH:D007246 marker/mechanism 25204677 +F54D11.3 186237 Hypoxia MESH:D000860 therapeutic 19936206 +F54G2.1 180562 Hypoxia MESH:D000860 therapeutic 19936206 +F56C9.10 176040 Infertility MESH:D007246 marker/mechanism 25204677 +F7 2155 Cerebral Hemorrhage MESH:D002543 therapeutic 16671457|21127298 +F7 2155 Disease Models, Animal MESH:D004195 therapeutic 21127298 +F7 2155 Disseminated Intravascular Coagulation MESH:D004211 marker/mechanism 16159073 +F7 2155 Factor VII Deficiency MESH:D005168 marker/mechanism 227500.0 20885134 +F7 2155 Hematoma, Subdural, Acute MESH:D020199 therapeutic 12503044 +F7 2155 Hematuria MESH:D006417 therapeutic 17133240 +F7 2155 Hemorrhage MESH:D006470 therapeutic 12707733|12851533|16553518 +F7 2155 Hemorrhagic Disorders MESH:D006474 marker/mechanism 16706976 +F7 2155 Intracranial Hemorrhages MESH:D020300 therapeutic 15595332|16159073|18617125|20172985|20522813 +F7 2155 Intracranial Hemorrhage, Traumatic MESH:D020198 therapeutic 20370756 +F7 2155 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +F7 2155 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 +F7 2155 Postoperative Complications MESH:D011183 therapeutic 12707733 +F7 2155 Thromboembolism MESH:D013923 marker/mechanism 20172985 +F7 2155 Venous Thrombosis MESH:D020246 marker/mechanism 14967414 +F8 2157 Autoimmune Diseases MESH:D001327 marker/mechanism 11886462 +F8 2157 COVID-19 MESH:D000086382 marker/mechanism 35255492 +F8 2157 Factor 8 deficiency, acquired MESH:C536392 therapeutic 11886462 +F8 2157 Hemophilia A MESH:D006467 marker/mechanism 306700.0 11918545|16051741 +F8 2157 Thrombophilia MESH:D019851 marker/mechanism 16628723 +F8 2157 Venous Thrombosis MESH:D020246 marker/mechanism 16875063 +F9 2158 Hemophilia A MESH:D006467 marker/mechanism 16051741 +F9 2158 Hemophilia B MESH:D002836 marker/mechanism 306900.0 2388855|7062952 +F9 2158 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +F9 2158 Thrombophilia, X-Linked, Due To Factor Ix Defect MESH:C567581 marker/mechanism 300807.0 +F9 2158 Thrombosis MESH:D013927 marker/mechanism 1279834 +FA2H 79152 SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION OMIM:612319 marker/mechanism 612319.0 +FAAH 2166 Huntington Disease MESH:D006816 marker/mechanism 20929960 +FAAH 2166 Obesity MESH:D009765 marker/mechanism 19103437|20716455 +FAAH 2166 Pregnancy Complications MESH:D011248 marker/mechanism 16886060 +FAAH 2166 Seizures MESH:D012640 therapeutic 25933444 +FAAH 2166 Substance-Related Disorders MESH:D019966 marker/mechanism 606581.0 12060782|19103437 +FAAH 2166 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 18705688|19002671 +FAAH2 158584 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25401301 +FABP1 2168 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +FABP1 2168 Kidney Tubular Necrosis, Acute MESH:D007683 therapeutic 18368030 +FABP1 2168 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414 +FABP1 2168 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +FABP2 2169 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FABP3 2170 Muscular Diseases MESH:D009135 marker/mechanism 18308699 +FABP3 2170 Necrosis MESH:D009336 marker/mechanism 18308699 +FABP4 2167 Carcinoma MESH:D002277 marker/mechanism 16316942 +FABP4 2167 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +FABP4 2167 Kidney Diseases MESH:D007674 marker/mechanism 30215792 +FABP4 2167 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +FABP4 2167 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +FABP5 2171 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +FABP5 2171 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +FABP7 2173 Breast Neoplasms MESH:D001943 marker/mechanism 22322885 +FABP7 2173 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +FADD 8772 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17656375 +FADD 8772 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +FADD 8772 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 17656375 +FADD 8772 IMMUNODEFICIENCY 90 WITH ENCEPHALOPATHY, FUNCTIONAL HYPOSPLENIA, AND HEPATIC DYSFUNCTION OMIM:613759 marker/mechanism 613759.0 +FADD 8772 Neoplasm Metastasis MESH:D009362 marker/mechanism 16450001 +FADD 8772 Oculoauricular Syndrome MESH:C567416 marker/mechanism 17656375 +FADD 8772 Stomatognathic Diseases MESH:D009057 marker/mechanism 17656375 +FADS1 3992 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +FADS1 3992 Colorectal Neoplasms MESH:D015179 marker/mechanism 24836286 +FADS1 3992 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +FADS2 9415 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +FADS2 9415 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +FADS2 9415 Colorectal Neoplasms MESH:D015179 marker/mechanism 24836286 +FADS2 9415 Lipidoses MESH:D008064 marker/mechanism 21123845 +FAF2 23197 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +FAH 2184 Tyrosinemias MESH:D020176 marker/mechanism 276700.0 12899938|23895425 +FAHD1 81889 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FAM107A 11170 Glioma MESH:D005910 marker/mechanism 16865689 +FAM111A 63901 Gracile bone dysplasia MESH:C537291 marker/mechanism 602361.0 +FAM111A 63901 Kenny-Caffey syndrome, type 2 MESH:C537020 marker/mechanism 127000.0 +FAM111B 374393 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FAM111B 374393 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +FAM134B 100859798 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FAM13A 10144 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 23583980 +FAM13A 10144 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 20173748|28166215 +FAM13A 10144 Pulmonary Fibrosis MESH:D011658 marker/mechanism 28166215 +FAM161A 84140 RETINITIS PIGMENTOSA 28 OMIM:606068 marker/mechanism 606068.0 +FAM167B 84734 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FAM168A 23201 Disease Progression MESH:D018450 marker/mechanism 21364753 +FAM168A 23201 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +FAM180A 389558 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FAM180A 389558 Endometriosis MESH:D004715 marker/mechanism 20864642 +FAM184A 79632 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +FAM184B 27146 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +FAM20A 54757 AMELOGENESIS IMPERFECTA, TYPE IG OMIM:204690 marker/mechanism 204690.0 +FAM20A 54757 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FAM20C 56975 Raine syndrome MESH:C535282 marker/mechanism 259775.0 +FAM210A 125228 Fractures, Bone MESH:D050723 marker/mechanism 22504420 +FAM234A 83986 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +FAM3D 131177 Schizophrenia MESH:D012559 marker/mechanism 21822266 +FAM43A 131583 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FAM50A 9130 Armfield X-Linked Mental Retardation Syndrome MESH:C564551 marker/mechanism 300261.0 +FAM65C 428169 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FAM66C 440078 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 34418280 +FAM66C 440078 Cholangiocarcinoma MESH:D018281 marker/mechanism 34418280 +FAM66C 440078 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34418280 +FAM72B 653820 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FAM83A 84985 Disease Progression MESH:D018450 marker/mechanism 34931434 +FAM83A 84985 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34931434 +FAM83A 84985 Ovarian Neoplasms MESH:D010051 marker/mechanism 34931434 +FAM83D 81610 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FAM83D 81610 Glioblastoma MESH:D005909 marker/mechanism 35150198 +FAM83H 286077 Amelogenesis Imperfecta MESH:D000567 marker/mechanism 18484629|19407157 +FAM83H 286077 Amelogenesis Imperfecta, Type III MESH:C562880 marker/mechanism 130900.0 +FAM83H 286077 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19407157 +FAM89A 375061 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FAN1 22909 INTERSTITIAL NEPHRITIS, KARYOMEGALIC OMIM:614817 marker/mechanism 614817.0 +FAN1 22909 Megalocytic interstitial nephritis MESH:C536144 marker/mechanism 22772369 +FANCA 2175 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +FANCA 2175 Fanconi Anemia MESH:D005199 marker/mechanism 227650.0 22482891 +FANCA 2175 Hyperinsulinism MESH:D006946 marker/mechanism 22482891 +FANCA 2175 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +FANCA 2175 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121791 +FANCB 2187 Fanconi Anemia, Complementation Group B MESH:C564497 marker/mechanism 300514.0 +FANCB 2187 VACTERL Association With Hydrocephalus MESH:C564751 marker/mechanism 314390.0 +FANCC 2176 Fanconi Anemia MESH:D005199 marker/mechanism 22482891 +FANCC 2176 FANCONI ANEMIA, COMPLEMENTATION GROUP C OMIM:227645 marker/mechanism 227645.0 +FANCC 2176 Hyperinsulinism MESH:D006946 marker/mechanism 22482891 +FANCD2 2177 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FANCD2 2177 Fanconi Anemia MESH:D005199 marker/mechanism 14667412 +FANCD2 2177 FANCONI ANEMIA, COMPLEMENTATION GROUP D2 OMIM:227646 marker/mechanism 227646.0 +FANCE 2178 FANCONI ANEMIA, COMPLEMENTATION GROUP E OMIM:600901 marker/mechanism 600901.0 +FANCF 2188 FANCONI ANEMIA, COMPLEMENTATION GROUP F OMIM:603467 marker/mechanism 603467.0 +FANCG 2189 Fanconi Anemia MESH:D005199 marker/mechanism 10807541|11093276 +FANCG 2189 FANCONI ANEMIA, COMPLEMENTATION GROUP G OMIM:614082 marker/mechanism 614082.0 +FANCG 2189 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +FANCI 55215 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FANCI 55215 Fanconi Anemia, Complementation Group I MESH:C563802 marker/mechanism 609053.0 +FANCL 55120 Fanconi Anemia MESH:D005199 marker/mechanism 12973351|19405097 +FANCL 55120 FANCONI ANEMIA, COMPLEMENTATION GROUP L OMIM:614083 marker/mechanism 614083.0 +FANCM 57697 Fanconi Anemia MESH:D005199 marker/mechanism 16116422 +FARP1 10160 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +FARP2 9855 Autistic Disorder MESH:D001321 marker/mechanism 19365831 +FARP2 9855 Chromosome 2q37 deletion syndrome MESH:C538317 marker/mechanism 19365831 +FARP2 9855 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 20062064 +FARS2 10667 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14 OMIM:614946 marker/mechanism 614946.0 +FARS2 10667 SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE OMIM:617046 marker/mechanism 617046.0 +FARSB 10056 RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1 OMIM:613658 marker/mechanism 613658.0 +FAS 355 Acute Lung Injury MESH:D055371 marker/mechanism 11778176 +FAS 355 Autoimmune Diseases MESH:D001327 marker/mechanism 22536412|2545777|26590112 +FAS 355 Autoimmune Lymphoproliferative Syndrome MESH:D056735 marker/mechanism 601859.0 15877736|17674358 +FAS 355 Cardiomyopathies MESH:D009202 marker/mechanism 10716473|10920071|17943461 +FAS 355 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 17943461 +FAS 355 Cardiotoxicity MESH:D066126 marker/mechanism 34713381 +FAS 355 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +FAS 355 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +FAS 355 Disease Models, Animal MESH:D004195 marker/mechanism 22536412|26590112 +FAS 355 Disease Progression MESH:D018450 marker/mechanism 11594583 +FAS 355 Glomerulonephritis MESH:D005921 marker/mechanism 21880982 +FAS 355 Hematologic Diseases MESH:D006402 marker/mechanism 15877736 +FAS 355 Hypersplenism MESH:D006971 marker/mechanism 15877736 +FAS 355 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 7579353 +FAS 355 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 30737368 +FAS 355 Liver Failure, Acute MESH:D017114 marker/mechanism 12828076 +FAS 355 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 30737368 +FAS 355 Lung Neoplasms MESH:D008175 marker/mechanism 26192916 +FAS 355 Lupus Nephritis MESH:D008181 marker/mechanism 33632240 +FAS 355 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 26192916 +FAS 355 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +FAS 355 Lymphomatoid Papulosis MESH:D017731 marker/mechanism 11594583 +FAS 355 Malaria, Falciparum MESH:D016778 marker/mechanism 21625619 +FAS 355 Myasthenia Gravis MESH:D009157 marker/mechanism 15169653 +FAS 355 Necrosis MESH:D009336 marker/mechanism 15664267 +FAS 355 Nephritis MESH:D009393 marker/mechanism 26590112 +FAS 355 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 23127599 +FAS 355 Pregnancy Complications, Cardiovascular MESH:D011249 marker/mechanism 10716473 +FAS 355 Proteinuria MESH:D011507 marker/mechanism 26590112|33632240 +FAS 355 Splenomegaly MESH:D013163 marker/mechanism 21880982 +FAS 355 Taste Disorders MESH:D013651 marker/mechanism 22536412 +FAS 355 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 9070496 +FAS 355 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 11809923 +FASL 14103 Cardiotoxicity MESH:D066126 marker/mechanism 34713381 +FASL 14103 Necrosis MESH:D009336 marker/mechanism 15664267 +FASLG 356 Acute Lung Injury MESH:D055371 marker/mechanism 11778176 +FASLG 356 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20008919 +FASLG 356 Atherosclerosis MESH:D050197 marker/mechanism 15063428 +FASLG 356 Autoimmune Lymphoproliferative Syndrome MESH:D056735 marker/mechanism 601859.0 +FASLG 356 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21807637 +FASLG 356 Cardiomyopathies MESH:D009202 marker/mechanism 16324756|17943461 +FASLG 356 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 17943461 +FASLG 356 Cardiotoxicity MESH:D066126 marker/mechanism 34713381 +FASLG 356 Carotid Artery Diseases MESH:D002340 marker/mechanism 15063428 +FASLG 356 Diabetic Angiopathies MESH:D003925 marker/mechanism 25381014 +FASLG 356 Drug Hypersensitivity MESH:D004342 marker/mechanism 19706026 +FASLG 356 Hepatitis MESH:D006505 marker/mechanism 19706026 +FASLG 356 Hyperlipidemia, Familial Combined MESH:D006950 marker/mechanism 15063428 +FASLG 356 Liver Failure, Acute MESH:D017114 marker/mechanism 19505222 +FASLG 356 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 +FASLG 356 Melanoma MESH:D008545 therapeutic 16487513 +FASLG 356 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +FASLG 356 Prostatic Neoplasms MESH:D011471 therapeutic 17875776 +FASLG 356 Testicular Diseases MESH:D013733 marker/mechanism 19429229 +FASN 2194 Acute Coronary Syndrome MESH:D054058 marker/mechanism 23305094 +FASN 2194 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +FASN 2194 Breast Neoplasms MESH:D001943 marker/mechanism 17089011|18281512 +FASN 2194 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 14563831|15543204|21147110 +FASN 2194 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 26670611 +FASN 2194 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 26670611 +FASN 2194 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +FASN 2194 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +FASN 2194 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 29379198 +FASN 2194 Heart Failure MESH:D006333 marker/mechanism 26670611 +FASN 2194 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +FASN 2194 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +FASN 2194 Liposarcoma MESH:D008080 therapeutic 20372807 +FASN 2194 Melanoma MESH:D008545 marker/mechanism 18770866|20805790|21213365 +FASN 2194 Neoplasms MESH:D009369 marker/mechanism 20373869 +FASN 2194 Obesity MESH:D009765 marker/mechanism 20882379 +FASN 2194 Ovarian Neoplasms MESH:D010051 marker/mechanism 21442130 +FASTKD5 60493 Schizophrenia MESH:D012559 marker/mechanism 21822266 +FAT1 2195 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +FAT1 2195 Carcinoma, Non-Small-Cell Lung MESH:D002289 therapeutic 34390292 +FAT1 2195 Colorectal Neoplasms MESH:D015179 marker/mechanism 23354438 +FAT1 2195 Disease Progression MESH:D018450 therapeutic 34390292 +FAT1 2195 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +FAT1 2195 Glioblastoma MESH:D005909 marker/mechanism 23354438 +FAT1 2195 Head and Neck Neoplasms MESH:D006258 marker/mechanism 23354438 +FAT1 2195 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FAT1 2195 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +FAT2 2196 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +FAT3 120114 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +FAT4 79633 Adenocarcinoma MESH:D000230 marker/mechanism 22484628 +FAT4 79633 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +FAT4 79633 Hennekam lymphangiectasia lymphedema syndrome MESH:C537255 marker/mechanism 616006.0 +FAT4 79633 Heterotopia, Periventricular, Autosomal Recessive MESH:C564292 marker/mechanism 24056717 +FAT4 79633 Kidney Diseases, Cystic MESH:D052177 marker/mechanism 18604206 +FAT4 79633 Melanoma MESH:D008545 marker/mechanism 22197931 +FAT4 79633 Stomach Neoplasms MESH:D013274 marker/mechanism 22484628 +FAT4 79633 Van Maldergem Wetzburger Verloes syndrome MESH:C536530 marker/mechanism 615546.0 24056717 +FATE1 89885 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15580283 +FAX 39826 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +FAXDC2 10826 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FBL 2091 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +FBL 2091 Autoimmune Diseases MESH:D001327 marker/mechanism 19077085|8738957|9693280 +FBL 2091 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +FBL 2091 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +FBLN1 2192 Endometriosis MESH:D004715 marker/mechanism 20864642 +FBLN1 2192 Prostatic Neoplasms MESH:D011471 marker/mechanism 17929269 +FBLN1 2192 Synpolydactyly 2 MESH:C564278 marker/mechanism 608180.0 +FBLN2 2199 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +FBLN2 2199 Weight Gain MESH:D015430 marker/mechanism 19030233 +FBLN5 10516 Cutis Laxa, Autosomal Dominant MESH:C562627 marker/mechanism 614434 +FBLN5 10516 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA OMIM:219100 marker/mechanism 219100 +FBLN5 10516 Cutis laxa, recessive MESH:C536225 marker/mechanism 12189163 +FBLN5 10516 Emphysema MESH:D004646 marker/mechanism 12189163 +FBLN5 10516 Heart Failure MESH:D006333 marker/mechanism 12189163 +FBLN5 10516 Hypertension, Pulmonary MESH:D006976 marker/mechanism 12189163 +FBLN5 10516 Macular Degeneration, Age-Related, 3 MESH:C563838 marker/mechanism 608895 +FBLN5 10516 Prostatic Neoplasms MESH:D011471 marker/mechanism 17929269 +FBLN5 10516 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +FBLN5 10516 Respiratory Insufficiency MESH:D012131 marker/mechanism 12189163 +FBLN5 10516 Respiratory Tract Infections MESH:D012141 marker/mechanism 12189163 +FBLN5 10516 Vascular Diseases MESH:D014652 marker/mechanism 12189163 +FBN1 2200 Acromicric dysplasia MESH:C535662 marker/mechanism 102370|614185 +FBN1 2200 Aortic Aneurysm, Thoracic MESH:D017545 marker/mechanism 21909107 +FBN1 2200 Aortic Rupture MESH:D001019 marker/mechanism 18178469 +FBN1 2200 Arachnodactyly MESH:D054119 marker/mechanism 22772368 +FBN1 2200 Ectopia Lentis MESH:D004479 marker/mechanism 22772368 +FBN1 2200 ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT OMIM:129600 marker/mechanism 129600 +FBN1 2200 Endometriosis MESH:D004715 marker/mechanism 21063030 +FBN1 2200 Hyperglycemia MESH:D006943 marker/mechanism 20836762 +FBN1 2200 Hyperinsulinism MESH:D006946 marker/mechanism 20836762 +FBN1 2200 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +FBN1 2200 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FBN1 2200 MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME OMIM:616914 marker/mechanism 616914 +FBN1 2200 Marfan Syndrome MESH:D008382 marker/mechanism 154700 15235604|17657824|18178469|18212506|19430350|21909107|22772368 +FBN1 2200 MASS syndrome MESH:C536030 marker/mechanism 604308 +FBN1 2200 Stiff Skin Syndrome MESH:C566112 marker/mechanism 184900 +FBN1 2200 Weill-Marchesani Syndrome MESH:D056846 marker/mechanism 608328 +FBN2 2201 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +FBN2 2201 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +FBN2 2201 Congenital contractural arachnodactyly MESH:C536211 marker/mechanism 121050 +FBN2 2201 MACULAR DEGENERATION, EARLY-ONSET OMIM:616118 marker/mechanism 616118 +FBP1 2203 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22039417 +FBP1 2203 Colonic Neoplasms MESH:D003110 marker/mechanism 22039417 +FBP1 2203 Fructose-1,6-Diphosphatase Deficiency MESH:D015319 marker/mechanism 229700 9382095 +FBP1 2203 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +FBP1 2203 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +FBP1 2203 Stomach Neoplasms MESH:D013274 marker/mechanism 22039417 +FBP2 8789 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +FBRSL1 57666 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +FBRSL1 57666 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +FBXA-202 189038 Disease MESH:D004194 marker/mechanism 25204677 +FBXA-206 180130 Infertility MESH:D007246 marker/mechanism 25204677 +FBXA-78 191046 Death MESH:D003643 marker/mechanism 25204677 +FBXA-78 191046 Infertility MESH:D007246 marker/mechanism 25204677 +FBXL18 80028 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FBXL19 54620 Arthritis, Psoriatic MESH:D015535 marker/mechanism 20953189 +FBXL19 54620 Psoriasis MESH:D011565 marker/mechanism 20953189 +FBXL4 26235 MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE) OMIM:615471 marker/mechanism 615471.0 +FBXL9P 26231 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +FBXO21 23014 Weight Gain MESH:D015430 marker/mechanism 19030233 +FBXO31 79791 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 45 OMIM:615979 marker/mechanism 615979.0 +FBXO32 114907 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +FBXO32 114907 Muscular Atrophy MESH:D009133 marker/mechanism 21139329 +FBXO38 81545 NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 6 OMIM:615575 marker/mechanism 615575.0 +FBXO40 51725 Autistic Disorder MESH:D001321 marker/mechanism 19404257 +FBXO44 93611 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +FBXO44 93611 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +FBXO6 26270 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +FBXO7 25793 Pallidopyramidal syndrome MESH:C538104 marker/mechanism 260300.0 25029497 +FBXO9 26268 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FBXW12 285231 Diabetic Nephropathies MESH:D003928 marker/mechanism 36073553 +FBXW7 55294 Breast Neoplasms MESH:D001943 marker/mechanism 17588203 +FBXW7 55294 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +FBXW7 55294 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +FBXW7 55294 Endometrial Neoplasms MESH:D016889 marker/mechanism 23104009 +FBXW7 55294 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +FBXW7 55294 Genomic Instability MESH:D042822 marker/mechanism 17588203 +FBXW7 55294 Glioma MESH:D005910 marker/mechanism 18931460 +FBXW7 55294 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 19246562|24394663 +FBXW8 26259 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +FCER1A 2205 Drug Eruptions MESH:D003875 marker/mechanism 16502481 +FCER1A 2205 Drug Hypersensitivity MESH:D004342 marker/mechanism 17125826|20485159 +FCER1A 2205 Urticaria MESH:D014581 marker/mechanism 16502481|20485159 +FCER1G 2207 Drug Hypersensitivity MESH:D004342 marker/mechanism 18534082|18595682 +FCER1G 2207 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 18595682 +FCER1G 2207 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FCER2 2208 Encephalitis MESH:D004660 marker/mechanism 11500085 +FCER2 2208 HIV Infections MESH:D015658 marker/mechanism 11500085 +FCER2 2208 Hypersensitivity, Immediate MESH:D006969 marker/mechanism 22967010 +FCER2 2208 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +FCGBP 8857 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +FCGR1 14129 Arthritis, Experimental MESH:D001169 marker/mechanism 12875993 +FCGR1A 2209 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FCGR1A 2209 Calcinosis MESH:D002114 marker/mechanism 21335463 +FCGR1A 2209 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +FCGR1A 2209 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FCGR2A 2212 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +FCGR2A 2212 Colitis, Ulcerative MESH:D003093 marker/mechanism 19915573|20228799 +FCGR2A 2212 Cystic Fibrosis MESH:D003550 marker/mechanism 219700.0 +FCGR2A 2212 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 152700.0 18204446 +FCGR2A 2212 Malaria MESH:D008288 marker/mechanism 611162.0 +FCGR2A 2212 Mucocutaneous Lymph Node Syndrome MESH:D009080 marker/mechanism 22081228|22446962 +FCGR2A 2212 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097067 +FCGR2A 2212 Thrombocytopenia MESH:D013921 marker/mechanism 11588041 +FCGR2A 2212 Thrombosis MESH:D013927 marker/mechanism 11588041 +FCGR2B 2213 Autoimmune Diseases MESH:D001327 marker/mechanism 10848805 +FCGR2B 2213 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 152700.0 +FCGR2B 2213 Malaria MESH:D008288 marker/mechanism 611162.0 +FCGR2B 2213 Neutropenia MESH:D009503 marker/mechanism 10848805 +FCGR3A 2214 Celiac Disease MESH:D002446 marker/mechanism 30097691 +FCGR3A 2214 IMMUNODEFICIENCY 20 OMIM:615707 marker/mechanism 615707.0 +FCGR3A 2214 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FCGR3A 2214 Lupus Vasculitis, Central Nervous System MESH:D020945 marker/mechanism 26773105 +FCGR3B 2215 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +FCGR3B 2215 Granulomatosis with Polyangiitis MESH:D014890 marker/mechanism 16482158 +FCGR3B 2215 Hyperglycemia MESH:D006943 marker/mechanism 29035695 +FCGR3B 2215 Hyperinsulinism MESH:D006946 marker/mechanism 29035695 +FCGR3B 2215 Lupus Nephritis MESH:D008181 marker/mechanism 16482158 +FCGR3B 2215 Lupus Vasculitis, Central Nervous System MESH:D020945 marker/mechanism 26773105 +FCGR3B 2215 Obesity MESH:D009765 marker/mechanism 29035695 +FCHO1 23149 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +FCHSD2 9873 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FCMR 9214 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +FCN1 2219 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FCN2 2220 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FCN2 2220 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +FCN3 8547 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FCN3 8547 FICOLIN 3 DEFICIENCY OMIM:613860 marker/mechanism 613860.0 +FCN3 8547 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 19535802 +FCRL3 115352 Graves Disease MESH:D006111 marker/mechanism 21841780 +FCRL3 115352 Thyroiditis, Autoimmune MESH:D013967 marker/mechanism 17952073 +FDFT1 2222 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +FDFT1 2222 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17205118 +FDFT1 2222 Marijuana Abuse MESH:D002189 marker/mechanism 17205118 +FDFT1 2222 Phencyclidine Abuse MESH:D010623 marker/mechanism 17205118 +FDPS 2224 Osteoporosis, Postmenopausal MESH:D015663 marker/mechanism 31774873 +FDPS 2224 POROKERATOSIS 9, MULTIPLE TYPES OMIM:616631 marker/mechanism 616631.0 +FDX2 112812 Mitochondrial Myopathies MESH:D017240 marker/mechanism 251900.0 +FECH 2235 Bile Duct Diseases MESH:D001649 marker/mechanism 10464147 +FECH 2235 Fibrosis MESH:D005355 marker/mechanism 10464147 +FECH 2235 Protoporphyria, Erythropoietic MESH:D046351 marker/mechanism|therapeutic 177000.0 10464147|12950064|15284838|15793285|17600043|29906468 +FEN1 2237 Colorectal Neoplasms MESH:D015179 marker/mechanism 24836286 +FEN1 2237 Lung Neoplasms MESH:D008175 marker/mechanism 28371273 +FERMT1 55612 Poikiloderma of Kindler MESH:C536321 marker/mechanism 173650.0 +FERMT2 10979 Glaucoma, Angle-Closure MESH:D015812 marker/mechanism 27064256 +FERMT2 10979 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21624607 +FERMT3 83706 Blood Platelet Disorders MESH:D001791 marker/mechanism 18278053 +FERMT3 83706 Hemorrhage MESH:D006470 marker/mechanism 18278053 +FERMT3 83706 Leukocyte Adhesion Deficiency, Type III MESH:C567555 marker/mechanism 612840.0 +FERMT3 83706 Osteopetrosis MESH:D010022 marker/mechanism 18278053 +FES 2242 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +FETUB 26998 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +FEV 54738 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 31209396 +FEV 54738 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +FEZ2 9637 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +FEZ2 9637 Weight Gain MESH:D015430 marker/mechanism 19030233 +FEZF1 389549 HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA OMIM:616030 marker/mechanism 616030.0 +FEZF1 389549 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 +FFAR2 2867 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +FFAR2 2867 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34453990 +FFAR3 2865 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +FFAR3 2865 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34453990 +FFAR4 338557 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10 OMIM:607514 marker/mechanism 607514.0 +FGA 2243 Afibrinogenemia MESH:D000347 marker/mechanism 202400.0 10602365|10891444|12358944|1391954 +FGA 2243 Amyloidosis, Familial MESH:D028226 marker/mechanism 8097946|8639778 +FGA 2243 Amyloidosis, familial visceral MESH:C538249 marker/mechanism 105200.0 +FGA 2243 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20974703 +FGA 2243 Cholestasis MESH:D002779 marker/mechanism 20974703 +FGA 2243 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15805072 +FGA 2243 Dysfibrinogenemia, Congenital MESH:C562727 marker/mechanism 616004.0 +FGA 2243 Kidney Diseases MESH:D007674 marker/mechanism 8097946|8639778 +FGA 2243 Mouth Neoplasms MESH:D009062 marker/mechanism 16239339 +FGA 2243 Osteoporosis MESH:D010024 marker/mechanism 18924182 +FGA 2243 Pulmonary Embolism MESH:D011655 marker/mechanism 10910940 +FGA 2243 Stroke MESH:D020521 marker/mechanism 29531354 +FGA 2243 Thrombophilia MESH:D019851 marker/mechanism 8473507 +FGA 2243 Thrombosis MESH:D013927 marker/mechanism 8473507 +FGA 2243 Venous Thromboembolism MESH:D054556 marker/mechanism 16362348 +FGB 2244 Afibrinogenemia MESH:D000347 marker/mechanism 202400.0 +FGB 2244 Dysfibrinogenemia, Congenital MESH:C562727 marker/mechanism 616004.0 +FGB 2244 Osteoporosis MESH:D010024 marker/mechanism 18924182 +FGB 2244 Parkinson Disease MESH:D010300 marker/mechanism 23233872 +FGD1 2245 Aarskog Syndrome MESH:C535331 marker/mechanism 305400.0 10930571|11093277|14560308|15327482|17152066|7954831 +FGD1 2245 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 15809997 +FGD1 2245 Craniofacial Abnormalities MESH:D019465 marker/mechanism 7954831 +FGD1 2245 Foot Deformities, Congenital MESH:D005532 marker/mechanism 11940089 +FGD1 2245 Growth Disorders MESH:D006130 marker/mechanism 10930571|11093277|11940089|7954831 +FGD1 2245 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 11940089 +FGD1 2245 Nervous System Malformations MESH:D009421 marker/mechanism 11093277 +FGD1 2245 Urogenital Abnormalities MESH:D014564 marker/mechanism 10930571|11093277|7954831 +FGD2 221472 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +FGD4 121512 Charcot-Marie-Tooth Disease, Type 4H MESH:C563740 marker/mechanism 609311.0 +FGD5 152273 Breast Neoplasms MESH:D001943 marker/mechanism 25151356 +FGD5 152273 Disease Progression MESH:D018450 marker/mechanism 34427968 +FGD5 152273 Stomach Neoplasms MESH:D013274 marker/mechanism 34427968 +FGD6 55785 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +FGD6 55785 Wet Macular Degeneration MESH:D057135 marker/mechanism 27089177 +FGF1 2246 Hypotension MESH:D007022 marker/mechanism 9233905 +FGF1 2246 Leukemia MESH:D007938 marker/mechanism 17219402 +FGF1 2246 Mesothelioma MESH:D008654 marker/mechanism 15878867 +FGF1 2246 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +FGF1 2246 Ovarian Neoplasms MESH:D010051 marker/mechanism 25174399 +FGF1 2246 Pulmonary Fibrosis MESH:D011658 marker/mechanism 16324872 +FGF1 2246 Weight Gain MESH:D015430 marker/mechanism 19030233 +FGF10 2255 Aplasia of Lacrimal and Salivary Glands MESH:C562407 marker/mechanism 180920.0 +FGF10 2255 Breast Neoplasms MESH:D001943 marker/mechanism 18438407 +FGF10 2255 Cleft Lip MESH:D002971 marker/mechanism 17963255 +FGF10 2255 Cleft Palate MESH:D002972 marker/mechanism 17963255 +FGF10 2255 Prostatic Neoplasms MESH:D011471 marker/mechanism 21743467 +FGF12 2257 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47 OMIM:617166 marker/mechanism 617166.0 +FGF12 2257 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +FGF13 2258 Neoplasm Metastasis MESH:D009362 marker/mechanism 19917848 +FGF13 2258 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19917848 +FGF14 2259 Cartilage Diseases MESH:D002357 marker/mechanism 11241832 +FGF14 2259 Cognition Disorders MESH:D003072 marker/mechanism 26089778 +FGF14 2259 Spinocerebellar ataxia 27 MESH:C537204 marker/mechanism 26089778 +FGF14 2259 SPINOCEREBELLAR ATAXIA 27A OMIM:193003 marker/mechanism 193003.0 +FGF15 14170 Colitis MESH:D003092 marker/mechanism 27580383 +FGF15 14170 Hepatic Insufficiency MESH:D048550 marker/mechanism 28673684 +FGF15 14170 Insulin Resistance MESH:D007333 marker/mechanism 28673684 +FGF15 14170 Liver Cirrhosis MESH:D008103 marker/mechanism 28673684 +FGF15 14170 Metabolic Syndrome MESH:D024821 marker/mechanism 28673684 +FGF15 14170 Necrosis MESH:D009336 marker/mechanism 24699334 +FGF16 8823 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +FGF16 8823 Metacarpal 4 5 Fusion MESH:C564100 marker/mechanism 309630.0 +FGF17 8822 HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA OMIM:615270 marker/mechanism 615270.0 +FGF17 8822 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 +FGF18 8817 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 17303798 +FGF18 8817 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +FGF18 8817 Osteoarthritis MESH:D010003 marker/mechanism 30664745 +FGF18 8817 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +FGF19 9965 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 25822088 +FGF2 2247 Brain Infarction MESH:D020520 therapeutic 17524524 +FGF2 2247 Brain Injuries MESH:D001930 therapeutic 21269288 +FGF2 2247 Cardiomegaly MESH:D006332 marker/mechanism 10491406 +FGF2 2247 Cleft Lip MESH:D002971 marker/mechanism 17963255 +FGF2 2247 Cleft Palate MESH:D002972 marker/mechanism 17963255 +FGF2 2247 Cocaine-Related Disorders MESH:D019970 marker/mechanism 19014962 +FGF2 2247 Corneal Neovascularization MESH:D016510 marker/mechanism 9301478 +FGF2 2247 Depressive Disorder MESH:D003866 marker/mechanism 16861106 +FGF2 2247 Diabetes, Gestational MESH:D016640 marker/mechanism 20421132 +FGF2 2247 Disease Progression MESH:D018450 marker/mechanism 12644816 +FGF2 2247 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 16023256 +FGF2 2247 Glioma MESH:D005910 therapeutic 10673511 +FGF2 2247 Gliosis MESH:D005911 therapeutic 21087489 +FGF2 2247 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10646786 +FGF2 2247 Inflammation MESH:D007249 therapeutic 21087489 +FGF2 2247 Kidney Diseases MESH:D007674 marker/mechanism 8995747 +FGF2 2247 Liver Cirrhosis MESH:D008103 therapeutic 17093919 +FGF2 2247 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16116963 +FGF2 2247 Mesothelioma MESH:D008654 marker/mechanism 15878867 +FGF2 2247 Myocardial Ischemia MESH:D017202 therapeutic 12173832|14583313 +FGF2 2247 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +FGF2 2247 Nephrotic Syndrome MESH:D009404 marker/mechanism 21441931 +FGF2 2247 Nerve Degeneration MESH:D009410 therapeutic 10203697 +FGF2 2247 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +FGF2 2247 Periapical Periodontitis MESH:D010485 marker/mechanism 16631837 +FGF2 2247 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 19014962 +FGF2 2247 Prostatic Neoplasms MESH:D011471 marker/mechanism 12644816 +FGF2 2247 Pulmonary Fibrosis MESH:D011658 marker/mechanism 8952537 +FGF2 2247 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +FGF2 2247 Seizures MESH:D012640 therapeutic 21269288 +FGF2 2247 Thrombocythemia, Essential MESH:D013920 marker/mechanism 15682418 +FGF2 2247 Wounds and Injuries MESH:D014947 therapeutic 11842932 +FGF21 26291 Diabetes Mellitus, Experimental MESH:D003921 therapeutic 23499715 +FGF21 26291 Diabetes Mellitus, Type 1 MESH:D003922 therapeutic 23499715 +FGF21 26291 Diabetes Mellitus, Type 2 MESH:D003924 therapeutic 26797127 +FGF21 26291 Fatty Liver MESH:D005234 therapeutic 24184811 +FGF21 26291 Hypertension MESH:D006973 therapeutic 29706566 +FGF21 26291 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 25257527 +FGF21 26291 Non-alcoholic Fatty Liver Disease MESH:D065626 therapeutic 26797127|29289645 +FGF21 26291 Obesity MESH:D009765 therapeutic 24184811|26797127 +FGF21 26291 Vascular Diseases MESH:D014652 therapeutic 29706566 +FGF23 8074 Calcinosis MESH:D002114 marker/mechanism 17710231 +FGF23 8074 Hyperphosphatemia MESH:D054559 marker/mechanism 17710231 +FGF23 8074 Hypophosphatemic Rickets, Autosomal Dominant MESH:C562791 marker/mechanism 193100.0 +FGF3 2248 Breast Neoplasms MESH:D001943 marker/mechanism 21936542 +FGF3 2248 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 25822088 +FGF3 2248 Cleft Lip MESH:D002971 marker/mechanism 17963255 +FGF3 2248 Cleft Palate MESH:D002972 marker/mechanism 17963255 +FGF3 2248 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17656375 +FGF3 2248 Deafness, Congenital, with Inner Ear Agenesis, Microtia, and Microdontia MESH:C565195 marker/mechanism 610706.0 +FGF3 2248 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 17656375 +FGF3 2248 Stomatognathic Diseases MESH:D009057 marker/mechanism 17656375 +FGF4 2249 Breast Neoplasms MESH:D001943 marker/mechanism 21936542 +FGF4 2249 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 25822088 +FGF5 2250 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +FGF6 2251 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +FGF7 2252 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +FGF7 2252 Cleft Lip MESH:D002971 marker/mechanism 17963255 +FGF7 2252 Cleft Palate MESH:D002972 marker/mechanism 17963255 +FGF7 2252 Gingival Hyperplasia MESH:D005885 marker/mechanism 11023675 +FGF7 2252 Liver Cirrhosis MESH:D008103 marker/mechanism 17692400 +FGF7 2252 Lung Injury MESH:D055370 therapeutic 18385170 +FGF7 2252 Prostatic Hyperplasia MESH:D011470 marker/mechanism 14999240 +FGF7 2252 Pulmonary Fibrosis MESH:D011658 marker/mechanism 15677771 +FGF7 2252 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +FGF8 2253 22q11 Deletion Syndrome MESH:D058165 marker/mechanism 12223415 +FGF8 2253 Cardiovascular Abnormalities MESH:D018376 marker/mechanism 16720880 +FGF8 2253 Cleft Lip MESH:D002971 marker/mechanism 17963255 +FGF8 2253 Cleft Palate MESH:D002972 marker/mechanism 17963255 +FGF8 2253 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16720880 +FGF8 2253 DiGeorge Syndrome MESH:D004062 marker/mechanism 16399080 +FGF8 2253 Kallmann Syndrome MESH:D017436 marker/mechanism 612702.0 +FGF8 2253 Microphthalmos MESH:D008850 therapeutic 32472575 +FGF9 2254 Adenocarcinoma MESH:D000230 marker/mechanism 20464547 +FGF9 2254 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 19358281 +FGF9 2254 Cleft Lip MESH:D002971 marker/mechanism 17963255 +FGF9 2254 Cleft Palate MESH:D002972 marker/mechanism 17963255 +FGF9 2254 Lung Neoplasms MESH:D008175 marker/mechanism 20464547 +FGF9 2254 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +FGF9 2254 Multiple Synostoses Syndrome 3 MESH:C567839 marker/mechanism 612961.0 +FGF9 2254 Testicular Neoplasms MESH:D013736 marker/mechanism 33172093 +FGFR1 2260 Astrocytoma MESH:D001254 marker/mechanism 23817572 +FGFR1 2260 Breast Neoplasms MESH:D001943 marker/mechanism 20179196|21936542 +FGFR1 2260 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 36029209 +FGFR1 2260 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22286583|27794399 +FGFR1 2260 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 22286583|27794399 +FGFR1 2260 Cleft Lip MESH:D002971 marker/mechanism 17963255 +FGFR1 2260 Cleft Palate MESH:D002972 marker/mechanism 17963255 +FGFR1 2260 Craniofacial Abnormalities MESH:D019465 marker/mechanism 12514106 +FGFR1 2260 Craniosynostoses MESH:D003398 marker/mechanism 190440 +FGFR1 2260 Depressive Disorder MESH:D003866 marker/mechanism 16861106 +FGFR1 2260 Encephalocraniocutaneous lipomatosis MESH:C535736 marker/mechanism 613001 +FGFR1 2260 Glioma MESH:D005910 marker/mechanism 23583981 +FGFR1 2260 Heart Valve Diseases MESH:D006349 marker/mechanism 30008375 +FGFR1 2260 Jackson-Weiss syndrome MESH:C537559 marker/mechanism 123150 +FGFR1 2260 Kallmann Syndrome MESH:D017436 marker/mechanism 147950 +FGFR1 2260 Lung Neoplasms MESH:D008175 marker/mechanism 21936542 +FGFR1 2260 Myeloproliferative Disorders MESH:D009196 marker/mechanism 21936542|22875613 +FGFR1 2260 Osteoglophonic dwarfism MESH:C536050 marker/mechanism 166250 +FGFR1 2260 Pfeiffer type acrocephalosyndactyly MESH:C538582 marker/mechanism 101600 +FGFR1 2260 Schizophrenia MESH:D012559 marker/mechanism 16861106 +FGFR1 2260 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941188 +FGFR1OP2 26127 Myeloproliferative Disorders MESH:D009196 marker/mechanism 22875613 +FGFR2 2263 Abnormalities, Multiple MESH:D000015 marker/mechanism 10631169 +FGFR2 2263 Acrocephalosyndactylia MESH:D000168 marker/mechanism 101200|101400 17694057|19186770|9002682|9502772 +FGFR2 2263 Ankylosis MESH:D000844 marker/mechanism 9605588 +FGFR2 2263 Antley-Bixler Syndrome Phenotype MESH:D054882 marker/mechanism 9605588 +FGFR2 2263 ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS OMIM:207410 marker/mechanism 207410 +FGFR2 2263 BENT BONE DYSPLASIA SYNDROME 1 OMIM:614592 marker/mechanism 614592 +FGFR2 2263 Breast Neoplasms MESH:D001943 marker/mechanism 17529967|17529973|18438407 +FGFR2 2263 Burns, Chemical MESH:D002057 marker/mechanism 22533443 +FGFR2 2263 Cholangiocarcinoma MESH:D018281 marker/mechanism 26258846 +FGFR2 2263 Cleft Lip MESH:D002971 marker/mechanism 17963255 +FGFR2 2263 Cleft Palate MESH:D002972 marker/mechanism 17963255|29526646 +FGFR2 2263 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10631169|16465081|18082115 +FGFR2 2263 Craniofacial Dysostosis MESH:D003394 marker/mechanism 123500 9152842 +FGFR2 2263 Craniosynostoses MESH:D003398 marker/mechanism 16465081|8957519|9605588 +FGFR2 2263 Cutis Gyrata Syndrome of Beare And Stevenson MESH:C565129 marker/mechanism 123790 17449949 +FGFR2 2263 Endometrial Neoplasms MESH:D016889 marker/mechanism 21936542 +FGFR2 2263 Hamartoma Syndrome, Multiple MESH:D006223 marker/mechanism 9002682 +FGFR2 2263 Intellectual Disability MESH:D008607 marker/mechanism 16465081 +FGFR2 2263 Jackson-Weiss syndrome MESH:C537559 marker/mechanism 123150 +FGFR2 2263 Lacrimoauriculodentodigital syndrome MESH:C538132 marker/mechanism 149730 +FGFR2 2263 Limb Deformities, Congenital MESH:D017880 marker/mechanism 10631169 +FGFR2 2263 Liver Cirrhosis MESH:D008103 marker/mechanism 17692400 +FGFR2 2263 Lung Neoplasms MESH:D008175 marker/mechanism 17311802 +FGFR2 2263 Motor Skills Disorders MESH:D019957 marker/mechanism 16465081 +FGFR2 2263 Pfeiffer type acrocephalosyndactyly MESH:C538582 marker/mechanism 101600 +FGFR2 2263 Plagiocephaly, Nonsynostotic MESH:D049068 marker/mechanism 9152842 +FGFR2 2263 Scaphocephaly, Maxillary Retrusion, And Mental Retardation MESH:C566511 marker/mechanism 609579 +FGFR2 2263 Skin Abnormalities MESH:D012868 marker/mechanism 10631169 +FGFR2 2263 Skin Diseases MESH:D012871 marker/mechanism 22533443 +FGFR2 2263 Spinal Dysraphism MESH:D016135 marker/mechanism 9605588 +FGFR2 2263 Stomach Neoplasms MESH:D013274 marker/mechanism 613659 21173787|21936542 +FGFR2 2263 Tooth Abnormalities MESH:D014071 marker/mechanism 10631169 +FGFR3 2261 Achondroplasia MESH:D000130 marker/mechanism 100800|616482 +FGFR3 2261 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 24121792 +FGFR3 2261 CATSHL syndrome MESH:C537975 marker/mechanism 610474 +FGFR3 2261 Cleft Lip MESH:D002971 marker/mechanism 17963255 +FGFR3 2261 Cleft Palate MESH:D002972 marker/mechanism 17963255 +FGFR3 2261 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500 +FGFR3 2261 Crouzon Syndrome With Acanthosis Nigricans MESH:C567382 marker/mechanism 612247 23437153 +FGFR3 2261 Epidermal Nevus MESH:C580062 marker/mechanism 162900 +FGFR3 2261 Hypochondroplasia MESH:C562937 marker/mechanism 146000 +FGFR3 2261 Muenke Syndrome MESH:C537369 marker/mechanism 602849 +FGFR3 2261 Multiple Myeloma MESH:D009101 marker/mechanism 21936542 +FGFR3 2261 Seminoma MESH:D018239 marker/mechanism 19855393 +FGFR3 2261 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 273300 +FGFR3 2261 Thanatophoric Dysplasia MESH:D013796 marker/mechanism 19855393 +FGFR3 2261 Thanatophoric dysplasia, type 2 MESH:C536508 marker/mechanism 187601 +FGFR3 2261 Thanatophoric Dysplasia, Type I MESH:C566844 marker/mechanism 187600 +FGFR3 2261 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 109800 19855393|20348956|21936542|24121792|26853465 +FGFR3 2261 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 603956 +FGFR4 2264 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +FGFR4 2264 Prostatic Neoplasms MESH:D011471 marker/mechanism 15448004 +FGFR4 2264 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +FGFRL1 53834 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 20938900 +FGFRL1 53834 Wolf-Hirschhorn Syndrome MESH:D054877 marker/mechanism 194190 +FGG 2266 Afibrinogenemia MESH:D000347 marker/mechanism 202400 +FGG 2266 Dysfibrinogenemia, Congenital MESH:C562727 marker/mechanism 616004 +FGG 2266 Keloid MESH:D007627 marker/mechanism 20128793 +FGG 2266 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +FGGY 55277 Obesity MESH:D009765 marker/mechanism 29220483 +FGGY 55277 Weight Gain MESH:D015430 marker/mechanism 29220483 +FGL2 10875 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +FGL2 10875 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FGR 2268 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FH 2271 Fumaric aciduria MESH:C538191 marker/mechanism 606812.0 +FH 2271 Hereditary leiomyomatosis and renal cell cancer MESH:C535516 marker/mechanism 150800.0 16403393|28289076|30013182 +FHIP2A 57700 Melanoma MESH:D008545 marker/mechanism 22535842 +FHIT 2272 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +FHIT 2272 Carcinoma MESH:D002277 marker/mechanism 16061637 +FHIT 2272 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 11788890 +FHIT 2272 Liver Neoplasms MESH:D008113 marker/mechanism 12112319 +FHIT 2272 Lung Neoplasms MESH:D008175 marker/mechanism 10959838|16061637 +FHIT 2272 Mesothelioma MESH:D008654 marker/mechanism 14569398|18038314 +FHIT 2272 Prostatic Neoplasms MESH:D011471 marker/mechanism 17548701 +FHIT 2272 Stomach Neoplasms MESH:D013274 marker/mechanism 12958204 +FHIT 2272 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +FHIT 2272 Urologic Neoplasms MESH:D014571 marker/mechanism 23618899 +FHL1 2273 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +FHL1 2273 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FHL1 2273 Myopathy, Reducing Body, X-Linked, Childhood-Onset MESH:C567468 marker/mechanism 300718.0 +FHL1 2273 Myopathy, Reducing Body, X-Linked, Early-Onset, Severe MESH:C567469 marker/mechanism 300717.0 +FHL1 2273 Scapuloperoneal Myopathy, X-Linked Dominant MESH:C567481 marker/mechanism 300695.0 +FHL1 2273 X-Linked Emery-Dreifuss Muscular Dystrophy MESH:D000083143 marker/mechanism 300696.0 +FHL2 2274 Breast Neoplasms MESH:D001943 marker/mechanism 17682292 +FHL2 2274 Cardiomegaly MESH:D006332 marker/mechanism 25358972 +FHL2 2274 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +FHL2 2274 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FHL3 2275 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +FHL5 9457 Migraine Disorders MESH:D008881 marker/mechanism 23793025 +FHOD3 80206 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +FIBIN 387758 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +FIBP 9158 THAUVIN-ROBINET-FAIVRE SYNDROME OMIM:617107 marker/mechanism 617107.0 +FIG4 9896 Amyotrophic Lateral Sclerosis 11 MESH:C567244 marker/mechanism 612577.0 +FIG4 9896 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 17572665 +FIG4 9896 Charcot-Marie-Tooth Disease, Type 4j MESH:C566984 marker/mechanism 611228.0 +FIG4 9896 Polymicrogyria, Bilateral Occipital MESH:C567201 marker/mechanism 612691.0 +FIG4 9896 Yunis Varon syndrome MESH:C536719 marker/mechanism 216340.0 +FIGLA 344018 Premature Ovarian Failure 6 MESH:C567351 marker/mechanism 612310.0 +FIGNL1 63979 Kidney Neoplasms MESH:D007680 marker/mechanism 28321044 +FILIP1 27145 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +FILIP1 27145 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +FIP1L1 81608 Heart Failure MESH:D006333 marker/mechanism 28347583 +FIP1L1 81608 Hypereosinophilic Syndrome MESH:D017681 marker/mechanism 16778211|28347583|31036733 +FIS1 51024 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254 +FIS1 51024 Ventricular Remodeling MESH:D020257 marker/mechanism 20886221 +FJX1 24147 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +FKBP10 60681 Bruck syndrome 1 MESH:C537406 marker/mechanism 259450.0 +FKBP10 60681 OSTEOGENESIS IMPERFECTA, TYPE XI OMIM:610968 marker/mechanism 610968.0 +FKBP11 51303 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +FKBP11 51303 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +FKBP14 55033 EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2 OMIM:614557 marker/mechanism 614557.0 +FKBP15 23307 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +FKBP15 23307 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +FKBP1A 2280 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +FKBP1A 2280 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FKBP2 2286 Disease Progression MESH:D018450 marker/mechanism 21364753 +FKBP2 2286 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +FKBP5 2289 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +FKBP5 2289 Depressive Disorder, Major MESH:D003865 marker/mechanism 608516 +FKBP5 2289 Endometriosis MESH:D004715 marker/mechanism 20864642 +FKBP5 2289 Infant, Newborn, Diseases MESH:D007232 marker/mechanism 25115650 +FKBP5 2289 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 25115650 +FKBPL 63943 Breast Neoplasms MESH:D001943 therapeutic 20103631 +FKH-3 181465 Infertility MESH:D007246 marker/mechanism 25204677 +FKRP 79147 Dyspnea MESH:D004417 marker/mechanism 29571322 +FKRP 79147 MUSCLE HYPERTROPHY OMIM:614160 marker/mechanism 29571322 +FKRP 79147 Muscle Weakness MESH:D018908 marker/mechanism 29571322 +FKRP 79147 Muscular Dystrophies MESH:D009136 marker/mechanism 29571322 +FKRP 79147 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5 OMIM:606612 marker/mechanism 606612 +FKRP 79147 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5 OMIM:607155 marker/mechanism 607155 +FKRP 79147 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 236670|613153 +FKTN 2218 Cardiomyopathy, Dilated, 1x MESH:C566907 marker/mechanism 611615 +FKTN 2218 Muscular Dystrophies MESH:D009136 marker/mechanism 16531417 +FKTN 2218 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 4 OMIM:613152 marker/mechanism 613152 +FKTN 2218 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4 OMIM:611588 marker/mechanism 611588 +FKTN 2218 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 236670|253800 +FLACC1 130540 Anthracosis MESH:D055008 marker/mechanism 29394417 +FLACC1 130540 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +FLAD1 80308 Myopathy with Abnormal Lipid Metabolism MESH:C562935 marker/mechanism 255100 +FLCN 201163 Birt-Hogg-Dube Syndrome MESH:D058249 marker/mechanism 135150 12204536|24726356|27072130 +FLCN 201163 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 144700 12204536 +FLCN 201163 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +FLCN 201163 Cysts MESH:D003560 marker/mechanism 27072130 +FLCN 201163 Hamartoma MESH:D006222 marker/mechanism 12204536|27072130 +FLCN 201163 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +FLCN 201163 Oncocytoma, renal MESH:C537750 marker/mechanism 12204536 +FLCN 201163 Pneumothorax MESH:D011030 marker/mechanism 173600.0 12204536 +FLCN 201163 Potocki-Lupski syndrome MESH:C538355 marker/mechanism 610883.0 +FLG 2312 Dermatitis MESH:D003872 marker/mechanism 31330126 +FLG 2312 Dermatitis, Atopic MESH:D003876 marker/mechanism 19349982|23042114|23348739|24061166 +FLG 2312 Dermatitis, Atopic, 2 MESH:C565293 marker/mechanism 605803.0 +FLG 2312 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +FLG 2312 Eczema MESH:D004485 marker/mechanism 17417636 +FLG 2312 Ichthyosis Vulgaris MESH:D016112 marker/mechanism 146700.0 17417636|24061166 +FLI1 2313 BLEEDING DISORDER, PLATELET-TYPE, 21 OMIM:617443 marker/mechanism 617443.0 +FLI1 2313 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FLI1 2313 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +FLI1 2313 Sarcoma, Ewing MESH:D012512 marker/mechanism 11772151|16646077|26214589 +FLNA 2316 Breast Neoplasms MESH:D001943 marker/mechanism 26437033 +FLNA 2316 Cardiac valvular dysplasia, X-linked MESH:C535576 marker/mechanism 314400.0 +FLNA 2316 Congenital idiopathic intestinal pseudoobstruction MESH:C535532 marker/mechanism 300048.0 +FLNA 2316 Epilepsy MESH:D004827 marker/mechanism 11914408 +FLNA 2316 Frontometaphyseal dysplasia MESH:C538064 marker/mechanism 305620.0 12612583|16596676 +FLNA 2316 Heterotopia, Periventricular, Ehlers-Danlos Variant MESH:C564492 marker/mechanism 15668422 +FLNA 2316 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FLNA 2316 Opitz-Kaveggia syndrome MESH:C537923 marker/mechanism 300321.0 17632775 +FLNA 2316 Osteochondrodysplasias MESH:D010009 marker/mechanism 309350.0 12612583 +FLNA 2316 Oto-Palato-digital syndrome type 1 MESH:C536065 marker/mechanism 311300.0 12612583|15940695|16596676 +FLNA 2316 Oto-palato-digital syndrome, type 2 MESH:C538089 marker/mechanism 304120.0 12612583|15378534 +FLNA 2316 Periventricular Nodular Heterotopia MESH:D054091 marker/mechanism 300049.0 11914408|9883725 +FLNA 2316 Phyllodes Tumor MESH:D003557 marker/mechanism 26437033 +FLNA 2316 TERMINAL OSSEOUS DYSPLASIA OMIM:300244 marker/mechanism 300244.0 +FLNB 2317 Atelosteogenesis, type 1 MESH:C535396 marker/mechanism 108720.0 14991055 +FLNB 2317 ATELOSTEOGENESIS, TYPE III OMIM:108721 marker/mechanism 108721.0 14991055 +FLNB 2317 Boomerang dysplasia MESH:C536573 marker/mechanism 112310.0 +FLNB 2317 Larsen syndrome, dominant type MESH:C537873 marker/mechanism 150250.0 14991055 +FLNB 2317 Spondylocarpotarsal synostosis MESH:C535780 marker/mechanism 272460.0 14991055 +FLNC 2318 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26 OMIM:617047 marker/mechanism 617047.0 +FLNC 2318 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +FLNC 2318 Filaminopathy, autosomal dominant MESH:C537932 marker/mechanism 609524.0 +FLNC 2318 MYOPATHY, DISTAL, 4 OMIM:614065 marker/mechanism 614065.0 +FLOT1 10211 Q Fever MESH:D011778 marker/mechanism 16469060 +FLRT3 23767 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +FLRT3 23767 HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA OMIM:615271 marker/mechanism 615271.0 +FLT1 2321 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +FLT1 2321 Breast Neoplasms MESH:D001943 marker/mechanism 23146280|26124351 +FLT1 2321 Carcinoma, Renal Cell MESH:D002292 therapeutic 16596207 +FLT1 2321 Cerebral Hemorrhage MESH:D002543 marker/mechanism 17888890 +FLT1 2321 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 21135413 +FLT1 2321 Disease Progression MESH:D018450 marker/mechanism 23146280 +FLT1 2321 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +FLT1 2321 Liver Cirrhosis MESH:D008103 marker/mechanism 11981751 +FLT1 2321 Melanoma MESH:D008545 marker/mechanism 19718025 +FLT1 2321 Neoplasm Metastasis MESH:D009362 marker/mechanism 21975929 +FLT1 2321 Osteochondrodysplasias MESH:D010009 marker/mechanism 17954590 +FLT1 2321 Pre-Eclampsia MESH:D011225 marker/mechanism 18679377|28628106 +FLT1 2321 Recurrence MESH:D012008 marker/mechanism 23146280|26124351 +FLT1 2321 Skin Neoplasms MESH:D012878 marker/mechanism 19718025 +FLT1 2321 Uremia MESH:D014511 marker/mechanism 19092814 +FLT3 2322 Acute erythroleukemia MESH:C535673 marker/mechanism 30926971 +FLT3 2322 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 17050201|17184839|19822134|21441929|21482694|21928377|22409268|23036488|23906301|24526162|25053825|27099147|27992414 +FLT3 2322 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 17454189|24160850|26285909 +FLT3 2322 Leukocytosis MESH:D007964 marker/mechanism 27099147|27725143 +FLT3 2322 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 613065.0 +FLT3 2322 Splenomegaly MESH:D013163 marker/mechanism 27725143 +FLT3 2322 Thrombosis MESH:D013927 marker/mechanism 16932337 +FLT4 2324 Clear-cell metastatic renal cell carcinoma MESH:C538445 marker/mechanism 25239121 +FLT4 2324 Hemangioma, capillary infantile MESH:C535860 marker/mechanism 602089.0 +FLT4 2324 Lymphedema MESH:D008209 marker/mechanism 153100.0 +FLT4 2324 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +FLT4 2324 Tetralogy of Fallot MESH:D013771 marker/mechanism 28991257 +FLVCR1 28982 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FLVCR1 28982 Posterior column ataxia with retinitis pigmentosa MESH:C536343 marker/mechanism 609033.0 +FLVCR2 55640 Encephaloclastic Proliferative Vasculopathy MESH:C565593 marker/mechanism 225790.0 +FMC1 154791 Parkinson Disease, Mitochondrial MESH:C564015 marker/mechanism 29371327 +FMC1 154791 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 29371327 +FMN2 56776 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +FMN2 56776 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 47 OMIM:616193 marker/mechanism 616193.0 +FMNL1 752 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FMNL2 114793 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FMO1 2326 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 17127561 +FMO1 2326 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +FMO1 2326 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +FMO2 2327 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +FMO2 2327 Endometriosis MESH:D004715 marker/mechanism 20864642 +FMO3 2328 Adenomatous Polyposis Coli MESH:D011125 therapeutic 17559352 +FMO3 2328 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +FMO3 2328 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 24973094 +FMO3 2328 Trimethylaminuria MESH:C536561 marker/mechanism 602079.0 12214664|16601883 +FMO4 2329 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +FMR1 2332 Anxiety Disorders MESH:D001008 marker/mechanism 28616095 +FMR1 2332 Autistic Disorder MESH:D001321 marker/mechanism 14755444|15000256|18621663|20425835|9806479 +FMR1 2332 Cognition Disorders MESH:D003072 marker/mechanism 22043169 +FMR1 2332 Congenital Abnormalities MESH:D000013 marker/mechanism 20425835 +FMR1 2332 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17065172|22043169 +FMR1 2332 Facies MESH:D019066 marker/mechanism 22043169 +FMR1 2332 Fragile X Syndrome MESH:D005600 marker/mechanism 300624.0 15028757|16043816|16510718|17065172|18835858|20300527|22043169|28616095 +FMR1 2332 Fragile X Tremor Ataxia Syndrome MESH:C564105 marker/mechanism 300623.0 27385396 +FMR1 2332 Gonadal Dysgenesis MESH:D006059 marker/mechanism 22043169 +FMR1 2332 Intellectual Disability MESH:D008607 marker/mechanism 15000256|20425835 +FMR1 2332 Primary Ovarian Insufficiency MESH:D016649 marker/mechanism 311360.0 12548733 +FN1 2335 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +FN1 2335 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +FN1 2335 Breast Neoplasms MESH:D001943 marker/mechanism 24014025 +FN1 2335 Carcinoma MESH:D002277 marker/mechanism 12376462 +FN1 2335 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24014025 +FN1 2335 Crohn Disease MESH:D003424 marker/mechanism 19751734 +FN1 2335 Diabetes Mellitus MESH:D003920 marker/mechanism 20551625 +FN1 2335 Diabetic Nephropathies MESH:D003928 marker/mechanism 24413998 +FN1 2335 Glioblastoma MESH:D005909 marker/mechanism 17099729 +FN1 2335 Glomerulopathy with fibronectin deposits MESH:C536826 marker/mechanism 601894.0 +FN1 2335 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 16191423 +FN1 2335 Hypertension MESH:D006973 marker/mechanism 11682445|17324946 +FN1 2335 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 11181017 +FN1 2335 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +FN1 2335 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +FN1 2335 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +FN1 2335 Neoplasm Invasiveness MESH:D009361 marker/mechanism 24014025 +FN1 2335 Pulmonary Fibrosis MESH:D011658 marker/mechanism 26817844 +FN1 2335 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +FNBP1P1 100533642 Anthracosis MESH:D055008 marker/mechanism 29394417 +FNDC3B 64778 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +FNDC3B 64778 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 23291589 +FNDC3B 64778 Keratoconus MESH:D007640 marker/mechanism 23291589 +FNDC3B 64778 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 28314734 +FNDC4 64838 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414|17175557 +FNDC5 252995 Cardiomegaly MESH:D006332 therapeutic 30703374 +FNDC5 252995 Endomyocardial Fibrosis MESH:D004719 therapeutic 30703374 +FNDC5 252995 Hypertension MESH:D006973 therapeutic 32165127 +FNDC5 252995 Inflammation MESH:D007249 therapeutic 32165127 +FNDC5 252995 Ventricular Dysfunction, Left MESH:D018487 therapeutic 30703374 +FOCAD 54914 Liver Cirrhosis MESH:D008103 marker/mechanism 35864190 +FOLH1 2346 Prostatic Neoplasms MESH:D011471 marker/mechanism 18247401|21923190 +FOLR1 2348 Brain Diseases, Metabolic, Inborn MESH:D020739 marker/mechanism 19732866 +FOLR1 2348 Colonic Neoplasms MESH:D003110 marker/mechanism 15705887|18926688 +FOLR1 2348 Congenital Abnormalities MESH:D000013 marker/mechanism 20235221 +FOLR1 2348 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15800851 +FOLR1 2348 Epilepsy MESH:D004827 marker/mechanism 19732866 +FOLR1 2348 Heart Defects, Congenital MESH:D006330 marker/mechanism 17286298 +FOLR1 2348 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +FOLR1 2348 Movement Disorders MESH:D009069 marker/mechanism 19732866 +FOLR1 2348 Neural Tube Defects MESH:D009436 marker/mechanism 15800851 +FOLR1 2348 Neurodegeneration Due To Cerebral Folate Transport Deficiency MESH:C567791 marker/mechanism 613068.0 +FOLR1 2348 Osteosarcoma MESH:D012516 marker/mechanism 17473184 +FOLR1 2348 Ovarian Neoplasms MESH:D010051 therapeutic 17466904 +FOLR1 2348 Psychomotor Disorders MESH:D011596 marker/mechanism 19732866 +FOLR2 2350 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +FOLR2 2350 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FOLR2 2350 Neural Tube Defects MESH:D009436 marker/mechanism 11749123 +FOLR2 2350 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 30794826 +FOS 2353 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 19689456 +FOS 2353 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +FOS 2353 Anxiety Disorders MESH:D001008 marker/mechanism 16488545 +FOS 2353 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FOS 2353 Brain Injuries MESH:D001930 marker/mechanism 9630518 +FOS 2353 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +FOS 2353 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560|9029167 +FOS 2353 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +FOS 2353 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 8777434 +FOS 2353 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +FOS 2353 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17276011|18311559|19533625 +FOS 2353 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +FOS 2353 Endometriosis MESH:D004715 marker/mechanism 23284138 +FOS 2353 Epilepsy MESH:D004827 marker/mechanism 15973680 +FOS 2353 Fibrous Dysplasia of Bone MESH:D005357 marker/mechanism 7739708 +FOS 2353 Heat Stroke MESH:D018883 marker/mechanism 24039931 +FOS 2353 Hemorrhage MESH:D006470 marker/mechanism 7844257 +FOS 2353 Hyperalgesia MESH:D006930 marker/mechanism 27093858 +FOS 2353 Hyperkinesis MESH:D006948 marker/mechanism 18355967 +FOS 2353 Hypertension MESH:D006973 marker/mechanism 12044476|24039778 +FOS 2353 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +FOS 2353 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FOS 2353 Lung Neoplasms MESH:D008175 marker/mechanism 16289808 +FOS 2353 Nervous System Diseases MESH:D009422 marker/mechanism 12890883 +FOS 2353 Neurotoxicity Syndromes MESH:D020258 therapeutic 19220411 +FOS 2353 Obesity MESH:D009765 marker/mechanism 27071101 +FOS 2353 Reperfusion Injury MESH:D015427 marker/mechanism 7922267 +FOS 2353 Seizures MESH:D012640 marker/mechanism 11955713|12946577|8923670|9630518 +FOS 2353 Status Epilepticus MESH:D013226 marker/mechanism 16696126|18587450|18988310|7984056 +FOS 2353 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 15196791|15196794|18485423 +FOS 2353 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +FOSB 2354 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FOSB 2354 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +FOSB 2354 Cocaine-Related Disorders MESH:D019970 marker/mechanism|therapeutic 12657709|17898221|18539927|19331462 +FOSB 2354 Cognition Disorders MESH:D003072 marker/mechanism 24067299 +FOSB 2354 Disruptive, Impulse Control, and Conduct Disorders MESH:D007174 marker/mechanism 18539927 +FOSB 2354 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism 17219962 +FOSB 2354 Epilepsy MESH:D004827 marker/mechanism 16391389 +FOSB 2354 Liver Neoplasms MESH:D008113 marker/mechanism 26411935 +FOSB 2354 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +FOSB 2354 Movement Disorders MESH:D009069 marker/mechanism 10600402 +FOSB 2354 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 26411935 +FOSL2 2355 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FOSL2 2355 Glioblastoma MESH:D005909 marker/mechanism 23582323 +FOSL2 2355 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +FOXA1 3169 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 34254728 +FOXA1 3169 Breast Neoplasms MESH:D001943 marker/mechanism 23001124 +FOXA1 3169 Carcinoma, Ductal MESH:D044584 marker/mechanism 29295717 +FOXA1 3169 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 32717239 +FOXA1 3169 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 32717239 +FOXA1 3169 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 32717239 +FOXA1 3169 Fatty Liver MESH:D005234 marker/mechanism 24469900 +FOXA1 3169 Prostatic Neoplasms MESH:D011471 marker/mechanism 22610119|26457646|29295717|29610475|32690948 +FOXA2 3170 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 16863852 +FOXA2 3170 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FOXA2 3170 Lung Diseases MESH:D008171 marker/mechanism 16863852 +FOXA3 3171 Prostatic Neoplasms MESH:D011471 marker/mechanism 22919386 +FOXC1 2296 AXENFELD-RIEGER SYNDROME, TYPE 1 OMIM:180500 marker/mechanism 14630904 +FOXC1 2296 AXENFELD-RIEGER SYNDROME, TYPE 3 OMIM:602482 marker/mechanism 602482.0 +FOXC1 2296 Dandy-Walker Syndrome MESH:D003616 marker/mechanism 19668217 +FOXC1 2296 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 26752265 +FOXC1 2296 Iridogoniodysgenesis type1 MESH:C535535 marker/mechanism 601631.0 +FOXC1 2296 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +FOXC1 2296 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 19668217 +FOXC1 2296 Tetralogy of Fallot MESH:D013771 marker/mechanism 25093829 +FOXC2 2303 Cardiovascular Abnormalities MESH:D018376 marker/mechanism 9409679 +FOXC2 2303 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9106663|9409679 +FOXC2 2303 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 27663689 +FOXC2 2303 Lymphedema distichiasis syndrome MESH:C537710 marker/mechanism 153400.0 11078474 +FOXC2 2303 Musculoskeletal Abnormalities MESH:D009139 marker/mechanism 9106663 +FOXC2 2303 Tetralogy of Fallot MESH:D013771 marker/mechanism 25093829 +FOXD3 27022 AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1 OMIM:607836 marker/mechanism 607836.0 +FOXD4L3 286380 Lung Neoplasms MESH:D008175 marker/mechanism 29054765 +FOXD4L5 653427 Lung Neoplasms MESH:D008175 marker/mechanism 29054765 +FOXE1 2304 Bamforth syndrome MESH:C537901 marker/mechanism 241850.0 16884476 +FOXE1 2304 THYROID CANCER, NONMEDULLARY, 4 OMIM:616534 marker/mechanism 616534.0 +FOXE3 2301 AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO OMIM:617349 marker/mechanism 617349.0 +FOXE3 2301 Aphakia, congenital primary MESH:C537786 marker/mechanism 610256.0 +FOXE3 2301 Cataract, Autosomal Recessive Congenital 3 MESH:C567835 marker/mechanism 612968.0 +FOXF1 2294 Alveolar capillary dysplasia MESH:C536590 marker/mechanism 265380.0 +FOXF1 2294 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +FOXF1 2294 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 27663689 +FOXF1 2294 Lung Diseases, Obstructive MESH:D008173 marker/mechanism 18421012 +FOXF1 2294 Mastocytosis MESH:D008415 marker/mechanism 18421012 +FOXF2 2295 Stroke MESH:D020521 marker/mechanism 29531354 +FOXF2A 407681 Craniofacial Abnormalities MESH:D019465 marker/mechanism 20055451 +FOXG1 2290 Acrocallosal Syndrome MESH:D055673 marker/mechanism 18627055 +FOXG1 2290 Epilepsy MESH:D004827 marker/mechanism 29942082 +FOXG1 2290 Intellectual Disability MESH:D008607 marker/mechanism 18627055 +FOXG1 2290 Microcephaly MESH:D008831 marker/mechanism 18627055 +FOXG1 2290 Nervous System Diseases MESH:D009422 marker/mechanism 23203475 +FOXG1 2290 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +FOXG1 2290 RETT SYNDROME, CONGENITAL VARIANT OMIM:613454 marker/mechanism 613454.0 +FOXG1 2290 Seizures MESH:D012640 marker/mechanism 18627055 +FOXH1 8928 Tetralogy of Fallot MESH:D013771 marker/mechanism 25093829 +FOXI1 2299 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +FOXI1 2299 DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT OMIM:600791 marker/mechanism 600791.0 +FOXI1 2299 Pendred syndrome MESH:C536648 marker/mechanism 274600.0 +FOXK2 3607 Infertility, Male MESH:D007248 marker/mechanism 32522586 +FOXL2 668 Blepharophimosis, Ptosis, and Epicanthus Inversus MESH:C562419 marker/mechanism 110100.0 +FOXL2 668 Blepharophimosis syndrome type 1 MESH:C536233 marker/mechanism 16219626|20429427|21889601 +FOXL2 668 Bpes With Duane Retraction Syndrome MESH:C566222 marker/mechanism 16283882 +FOXL2 668 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +FOXL2 668 Keloid MESH:D007627 marker/mechanism 20711176 +FOXL2 668 Premature Ovarian Failure 3 MESH:C563816 marker/mechanism 608996.0 +FOXM1 2305 Breast Neoplasms MESH:D001943 marker/mechanism 20208560 +FOXM1 2305 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15082532|17173139|28284560 +FOXM1 2305 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 18345025|19672312 +FOXM1 2305 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +FOXM1 2305 Leukemia MESH:D007938 marker/mechanism 19436953 +FOXM1 2305 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 15082532 +FOXM1 2305 Lung Neoplasms MESH:D008175 marker/mechanism 16489016|23255470 +FOXM1 2305 Precancerous Conditions MESH:D011230 marker/mechanism 13679865 +FOXN1 8456 T-cell immunodeficiency, congenital alopecia and nail dystrophy MESH:C536781 marker/mechanism 601705.0 +FOXO1 2308 Hypertension, Pulmonary MESH:D006976 marker/mechanism 27663689 +FOXO1 2308 Keratoconus MESH:D007640 marker/mechanism 23291589 +FOXO1 2308 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +FOXO1 2308 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +FOXO1 2308 Rhabdomyosarcoma, Alveolar MESH:D018232 marker/mechanism 268220.0 +FOXO1A 768121 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FOXO1A 768121 Endometriosis MESH:D004715 marker/mechanism 21063030 +FOXO3 2309 Abortion, Habitual MESH:D000026 marker/mechanism 35038060 +FOXO3 2309 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19380174 +FOXO3 2309 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +FOXO3 2309 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 19380174 +FOXO3 2309 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 23090186|23792339 +FOXO3 2309 Embryo Loss MESH:D020964 marker/mechanism 35038060 +FOXO3 2309 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 27742544 +FOXO3 2309 Liver Cirrhosis MESH:D008103 marker/mechanism 33372984 +FOXO3 2309 Obesity MESH:D009765 marker/mechanism 23954404 +FOXO3 2309 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 23099361 +FOXO3A 494532 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FOXP1 27086 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 24121790 +FOXP1 27086 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +FOXP1 27086 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21572417 +FOXP1 27086 Autistic Disorder MESH:D001321 marker/mechanism 35982159 +FOXP1 27086 INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES OMIM:613670 marker/mechanism 613670.0 +FOXP1 27086 Lymphatic Metastasis MESH:D008207 marker/mechanism 25485836 +FOXP1 27086 Neoplasm Invasiveness MESH:D009361 marker/mechanism 25485836 +FOXP1 27086 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +FOXP1 27086 Pancreatic Neoplasms MESH:D010190 marker/mechanism 25485836 +FOXP1 27086 Vitiligo MESH:D014820 marker/mechanism 20526340 +FOXP2 93986 Apraxias MESH:D001072 marker/mechanism 602081.0 17033973|27120335 +FOXP2 93986 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +FOXP2 93986 Autistic Disorder MESH:D001321 marker/mechanism 15108192|17033973 +FOXP2 93986 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +FOXP2 93986 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17033973 +FOXP2 93986 Language Development Disorders MESH:D007805 marker/mechanism 27120335 +FOXP2 93986 Silver-Russell Syndrome MESH:D056730 marker/mechanism 17033973 +FOXP3 50943 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20476861 +FOXP3 50943 Asthma MESH:D001249 marker/mechanism 27965764|29317916 +FOXP3 50943 Breast Neoplasms MESH:D001943 marker/mechanism 17570480 +FOXP3 50943 Dermatitis, Occupational MESH:D009783 marker/mechanism 29477354 +FOXP3 50943 Hypersensitivity MESH:D006967 marker/mechanism 27965764 +FOXP3 50943 Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome MESH:C580192 marker/mechanism 304790.0 27783946 +FOXP3 50943 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 23962110 +FOXP3 50943 Lung Injury MESH:D055370 marker/mechanism 28630656 +FOXP3 50943 Lung Neoplasms MESH:D008175 marker/mechanism 34166680 +FOXP3 50943 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +FOXP4 116113 Prostatic Neoplasms MESH:D011471 marker/mechanism 20676098 +FOXP4-AS1 101060264 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 34545456 +FOXP4-AS1 101060264 Disease Progression MESH:D018450 marker/mechanism 34545456 +FOXP4-AS1 101060264 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 34545456 +FOXQ1 94234 Breast Neoplasms MESH:D001943 marker/mechanism 27129776 +FOXR2 139628 Nerve Sheath Neoplasms MESH:D018317 marker/mechanism 23685747 +FOXRED1 55572 Mitochondrial Diseases MESH:D028361 marker/mechanism 20818383 +FOXRED1 55572 Mitochondrial Encephalomyopathies MESH:D017237 marker/mechanism 20858599 +FPGS 2356 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23897011 +FPGS 2356 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641 +FPGS 2356 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 17119116 +FPGS 2356 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 25013492 +FPGT 8790 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +FPR2 2358 Crohn Disease MESH:D003424 marker/mechanism 21659618 +FRA16E 2464 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB OMIM:136570 marker/mechanism 136570.0 +FRAS1 80144 Fraser Syndrome MESH:D058497 marker/mechanism 219000.0 17163535 +FRAS1 80144 Macrostomia MESH:D008265 marker/mechanism 17163535 +FREM1 158326 Bifid nose MESH:C535441 marker/mechanism 23221805 +FREM1 158326 Bifid Nose With Or Without Anorectal And Renal Anomalies MESH:C567672 marker/mechanism 608980.0 23221805 +FREM1 158326 Craniosynostoses MESH:D003398 marker/mechanism 614485.0 +FREM1 158326 Eye Abnormalities MESH:D005124 marker/mechanism 23221805 +FREM1 158326 Hereditary renal agenesis MESH:C536482 marker/mechanism 23221805 +FREM1 158326 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 23221805|26382659 +FREM1 158326 Marles Greenberg Persaud syndrome MESH:C536022 marker/mechanism 248450.0 23221805 +FREM2 341640 Fraser Syndrome MESH:D058497 marker/mechanism 17163535 +FREM3 166752 Depressive Disorder, Major MESH:D003865 marker/mechanism 26441752 +FRG1 2483 Facioscapulohumeral muscular dystrophy 1a MESH:C536391 marker/mechanism 158900.0 +FRK 2444 Glucose Intolerance MESH:D018149 marker/mechanism 17179392 +FRMD3 257019 Chloracne MESH:D054506 marker/mechanism 17101203 +FRMD4A 55691 CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA OMIM:616819 marker/mechanism 616819.0 +FRMD4A 55691 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +FRMD4B 23150 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +FRMD7 90167 Nystagmus 1, congenital, X- linked MESH:C537853 marker/mechanism 310700.0 19892780 +FRMPD4 9758 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 104 OMIM:300983 marker/mechanism 300983.0 +FRRS1L 23732 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37 OMIM:616981 marker/mechanism 616981.0 +FRY 10129 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +FRY 10129 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FRZB 2487 Osteoarthritis MESH:D010003 marker/mechanism 165720.0 +FSCN2 25794 Retinitis Pigmentosa 30 MESH:C564310 marker/mechanism 607921.0 +FSD1 79187 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +FSHB 2488 Alcoholism MESH:D000437 marker/mechanism 8590623 +FSHB 2488 Amenorrhea MESH:D000568 marker/mechanism 8220432 +FSHB 2488 Fever MESH:D005334 marker/mechanism 6350720 +FSHB 2488 Follicle-stimulating hormone deficiency, isolated MESH:C537070 marker/mechanism 229070.0 +FSHB 2488 Hypogonadism MESH:D007006 marker/mechanism|therapeutic 18449926|24739304|8263139 +FSHB 2488 Infertility, Female MESH:D007247 marker/mechanism 8220432 +FSHB 2488 Infertility, Male MESH:D007248 marker/mechanism 387166 +FSHB 2488 Lateral Medullary Syndrome MESH:D014854 marker/mechanism 17344003 +FSHB 2488 Oligospermia MESH:D009845 marker/mechanism 4607150 +FSHR 2492 OVARIAN DYSGENESIS 1 OMIM:233300 marker/mechanism 233300.0 +FSHR 2492 Ovarian Hyperstimulation Syndrome MESH:D016471 marker/mechanism 608115.0 +FSHR 2492 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 22885925 +FST 10468 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +FST 10468 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +FST 10468 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12203361|19363144 +FST 10468 Liver Failure, Acute MESH:D017114 marker/mechanism 12560755 +FST 10468 Liver Neoplasms MESH:D008113 marker/mechanism 12203361 +FST 10468 Muscular Atrophy MESH:D009133 therapeutic 33034787 +FST 10468 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +FST 10468 Weight Loss MESH:D015431 therapeutic 33034787 +FSTL1 11167 Acute Kidney Injury MESH:D058186 marker/mechanism 20861081 +FSTL1 11167 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +FSTL1 11167 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FSTL1 11167 Scleroderma, Systemic MESH:D012595 marker/mechanism 27482699 +FSTL1 11167 Weight Gain MESH:D015430 marker/mechanism 19030233 +FSTL5 56884 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +FTCD 10841 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143597 +FTCD 10841 Glutamate formiminotransferase deficiency MESH:C537425 marker/mechanism 229100.0 +FTCD 10841 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FTH1 2495 Depressive Disorder MESH:D003866 marker/mechanism 17063146 +FTH1 2495 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +FTH1 2495 Glioma MESH:D005910 marker/mechanism 21385903 +FTH1 2495 HEMOCHROMATOSIS, TYPE 5 OMIM:615517 marker/mechanism 615517.0 +FTH1 2495 Iron Overload MESH:D019190 marker/mechanism 11389486 +FTH1 2495 Keloid MESH:D007627 marker/mechanism 20128793 +FTH1 2495 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26818092 +FTH1 2495 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20390345 +FTH1 2495 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +FTH1 2495 Precancerous Conditions MESH:D011230 marker/mechanism 21785164 +FTL 2512 Depressive Disorder MESH:D003866 marker/mechanism 17063146 +FTL 2512 Heredodegenerative Disorders, Nervous System MESH:D020271 marker/mechanism 16825958 +FTL 2512 Hyperferritinemia, hereditary, with congenital cataracts MESH:C538137 marker/mechanism 600886.0 +FTL 2512 Iron Metabolism Disorders MESH:D019189 marker/mechanism 16822677 +FTL 2512 Keloid MESH:D007627 marker/mechanism 20128793 +FTL 2512 L-FERRITIN DEFICIENCY OMIM:615604 marker/mechanism 615604.0 +FTL 2512 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20390345 +FTL 2512 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +FTL 2512 Neuroferritinopathy MESH:C548080 marker/mechanism 606159.0 +FTL 2512 Obesity MESH:D009765 marker/mechanism 20882379 +FTL 2512 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +FTL1 14325 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +FTL1 14325 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +FTO 79068 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14 OMIM:612460 marker/mechanism 612460.0 +FTO 79068 Body Weight MESH:D001835 marker/mechanism 22344219|22344221 +FTO 79068 Breast Neoplasms MESH:D001943 marker/mechanism 23535733 +FTO 79068 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23104008 +FTO 79068 Growth Retardation, Developmental Delay, Coarse Facies, And Early Death MESH:C567856 marker/mechanism 612938.0 +FTO 79068 Melanoma MESH:D008545 marker/mechanism 23455637 +FTO 79068 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +FTO 79068 Obesity MESH:D009765 marker/mechanism 17496892|19079260|19079261|19151714|19918250|21076408 +FTO 79068 Pediatric Obesity MESH:D063766 marker/mechanism 25137265 +FTO 79068 Weight Gain MESH:D015430 marker/mechanism 25322899 +FTSJ1 24140 Mental Retardation, X-Linked 9 MESH:C563137 marker/mechanism 309549.0 +FUBP1 8880 Lung Neoplasms MESH:D008175 marker/mechanism 35915169 +FUCA1 2517 Fucosidosis MESH:D005645 marker/mechanism 230000.0 +FURIN 5045 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +FURIN 5045 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +FURIN 5045 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942 +FURIN 5045 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +FUS 2521 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 28478440|29419416|29434138|30455313 +FUS 2521 Amyotrophic Lateral Sclerosis 6, Autosomal Recessive MESH:C567699 marker/mechanism 608030.0 +FUS 2521 Liposarcoma, Myxoid MESH:D018208 marker/mechanism 7503811|8510758 +FUS 2521 TREMOR, HEREDITARY ESSENTIAL, 4 OMIM:614782 marker/mechanism 614782.0 +FUT2 2524 Caliciviridae Infections MESH:D017250 marker/mechanism 12692541 +FUT2 2524 COVID-19 MESH:D000086382 marker/mechanism 35255492 +FUT2 2524 Crohn Disease MESH:D003424 marker/mechanism 21102463 +FUT2 2524 VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1 OMIM:612542 marker/mechanism 612542.0 +FUT4 2526 Thrombosis MESH:D013927 marker/mechanism 16932337 +FUT7 2529 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +FUZ 80199 Neural Tube Defects MESH:D009436 marker/mechanism 182940.0 +FXN 2395 Friedreich Ataxia MESH:D005621 marker/mechanism 12923074|16120311|16239244|16911956|17101455|20098685|22016819|23418481|26954031|29272104|30451920 +FXN 2395 Friedreich Ataxia 1 MESH:C565561 marker/mechanism 229300.0 +FXN 2395 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 26954031 +FXYD2 486 Hypertension MESH:D006973 marker/mechanism 22228705 +FXYD2 486 Hypomagnesemia 2, renal MESH:C537152 marker/mechanism 154020.0 +FXYD2 486 Hypomagnesemia primary MESH:C537153 marker/mechanism 11062458 +FXYD2 486 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FXYD2 486 Magnesium Deficiency MESH:D008275 marker/mechanism 11062458 +FXYD3 5349 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +FXYD3 5349 Pancreatic Neoplasms MESH:D010190 marker/mechanism 16003754 +FXYD5 53827 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FXYD6 53826 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +FXYD6 53826 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FYB1 2533 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +FYB1 2533 Thrombocytopenia 3 MESH:C567487 marker/mechanism 273900.0 +FYCO1 79443 Cataract, autosomal recessive congenital 2 MESH:C535337 marker/mechanism 610019.0 +FYN 2534 Catalepsy MESH:D002375 marker/mechanism 16407246 +FYN 2534 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +FYN 2534 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FYN 2534 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 24413734 +FYN 2534 Pulmonary Fibrosis MESH:D011658 marker/mechanism 30658076 +FYN 2534 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +FZD2 2535 Colonic Neoplasms MESH:D003110 marker/mechanism 21188121 +FZD4 8322 Arachnodactyly MESH:D054119 marker/mechanism 17103440 +FZD4 8322 Cleft Palate MESH:D002972 marker/mechanism 17103440 +FZD4 8322 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17103440 +FZD4 8322 Exudative vitreoretinopathy 1 MESH:C536382 marker/mechanism 133780.0 +FZD4 8322 Retinal Diseases MESH:D012164 marker/mechanism 17103440 +FZD4 8322 Syndactyly MESH:D013576 marker/mechanism 17103440 +FZD6 8323 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1 OMIM:161050 marker/mechanism 161050.0 +FZD8 8325 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +FZR1 51343 Polyploidy MESH:D011123 marker/mechanism 25123929 +G0S2 50486 Carcinoma MESH:D002277 marker/mechanism 16316942 +G0S2 50486 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +G0S2 50486 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +G0S2 50486 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +G3BP1 10146 Astrocytoma MESH:D001254 marker/mechanism 27106762 +G3BP1 10146 Disease Progression MESH:D018450 marker/mechanism 27106762 +G6PC1 2538 Glycogen Storage Disease Type I MESH:D005953 marker/mechanism 7573034|8211187 +G6PC1 2538 Hepatorenal form of glycogen storage disease MESH:C538655 marker/mechanism 232200.0 +G6PC1 2538 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +G6PC3 92579 Neutropenia, Severe Congenital, Autosomal Recessive 4 MESH:C567260 marker/mechanism 612541.0 +G6PD 2539 Acute Kidney Injury MESH:D058186 marker/mechanism 4794122|602954|734759 +G6PD 2539 Anemia, Hemolytic MESH:D000743 marker/mechanism 2502894|4794122|8562390 +G6PD 2539 Anemia, Hemolytic, Congenital Nonspherocytic MESH:D000746 marker/mechanism 10666231|4125296 +G6PD 2539 ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY OMIM:300908 marker/mechanism 300908.0 +G6PD 2539 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +G6PD 2539 Favism MESH:D005236 marker/mechanism 12028056|16143877 +G6PD 2539 Glucosephosphate Dehydrogenase Deficiency MESH:D005955 marker/mechanism 10666231|4125296|4728291 +G6PD 2539 Granulomatous Disease, Chronic MESH:D006105 marker/mechanism 4125296 +G6PD 2539 Hemolysis MESH:D006461 marker/mechanism 5432368|734759 +G6PD 2539 Malaria MESH:D008288 marker/mechanism 611162.0 +G6PD 2539 Phagocyte Bactericidal Dysfunction MESH:D010585 marker/mechanism 4125296 +G8 54253 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +GAA 2548 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 11328962 +GAA 2548 Glomerulonephritis, Membranous MESH:D015433 marker/mechanism 15466083 +GAA 2548 Glycogen Storage Disease Type II MESH:D006009 marker/mechanism|therapeutic 232300.0 11328962|15466083|18176891|21644219|21963784 +GAA 2548 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 11328962 +GAA 2548 Ventricular Dysfunction MESH:D018754 marker/mechanism 11328962 +GAB1 2549 Deafness, Autosomal Recessive 26 MESH:C565329 marker/mechanism 605428.0 +GAB1 2549 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +GAB2 9846 Melanoma MESH:D008545 marker/mechanism 22535842 +GAB2 9846 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21996746 +GAB2 9846 Neoplasm Metastasis MESH:D009362 marker/mechanism 21996746 +GABBR1 2550 Alcoholism MESH:D000437 marker/mechanism 22253714 +GABBR1 2550 Autistic Disorder MESH:D001321 marker/mechanism 16770606|19002745 +GABBR1 2550 Cocaine-Related Disorders MESH:D019970 marker/mechanism 22253714 +GABBR1 2550 Hyperkinesis MESH:D006948 marker/mechanism 16990508 +GABBR2 9568 Autistic Disorder MESH:D001321 marker/mechanism 19002745 +GABBR2 9568 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 188890.0 +GABRA1 2554 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +GABRA1 2554 Ataxia MESH:D001259 marker/mechanism 12404077 +GABRA1 2554 Autistic Disorder MESH:D001321 marker/mechanism 18821008 +GABRA1 2554 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19 OMIM:615744 marker/mechanism 615744.0 +GABRA1 2554 Essential Tremor MESH:D020329 marker/mechanism 15765150 +GABRA1 2554 Hepatic Encephalopathy MESH:D006501 marker/mechanism 15929193 +GABRA1 2554 Myoclonic Epilepsy, Juvenile MESH:D020190 marker/mechanism 611136.0 +GABRA1 2554 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +GABRA1 2554 Seizures MESH:D012640 marker/mechanism 30949046 +GABRA2 2555 Alcoholism MESH:D000437 marker/mechanism 103780.0 22253714 +GABRA2 2555 Anxiety Disorders MESH:D001008 marker/mechanism 18313124 +GABRA2 2555 Autistic Disorder MESH:D001321 marker/mechanism 18821008 +GABRA2 2555 Cocaine-Related Disorders MESH:D019970 marker/mechanism 19833324|20133874 +GABRA2 2555 Heroin Dependence MESH:D006556 marker/mechanism 19833324 +GABRA3 2556 Autistic Disorder MESH:D001321 marker/mechanism 18821008 +GABRA4 2557 Ataxia MESH:D001259 marker/mechanism 16091474 +GABRA4 2557 Autistic Disorder MESH:D001321 marker/mechanism 16080114|16770606 +GABRA5 2558 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 27231709 +GABRA5 2558 Autistic Disorder MESH:D001321 marker/mechanism 17353214 +GABRA5 2558 Isodicentric Chromosome 15 Syndrome MESH:C580205 marker/mechanism 23663378 +GABRA5 2558 Memory Disorders MESH:D008569 marker/mechanism 20180861 +GABRA5 2558 Seizures MESH:D012640 marker/mechanism 8985701 +GABRA5 2558 Social Communication Disorder MESH:D000067404 marker/mechanism 27231709 +GABRA6 2559 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 25257527 +GABRA6 2559 Schizophrenia MESH:D012559 marker/mechanism 18923069 +GABRB1 2560 Autistic Disorder MESH:D001321 marker/mechanism 16080114|16770606 +GABRB1 2560 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 45 OMIM:617153 marker/mechanism 617153.0 +GABRB1 2560 Hepatic Encephalopathy MESH:D006501 marker/mechanism 15929193 +GABRB1 2560 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +GABRB2 2561 Epilepsy MESH:D004827 marker/mechanism 29942082 +GABRB2 2561 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +GABRB2 2561 Schizophrenia MESH:D012559 marker/mechanism 18583979 +GABRB3 2562 Angelman Syndrome MESH:D017204 marker/mechanism 15878204 +GABRB3 2562 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 22037176 +GABRB3 2562 Autistic Disorder MESH:D001321 marker/mechanism 11920158|9545402 +GABRB3 2562 Brain Injuries MESH:D001930 marker/mechanism 23159883 +GABRB3 2562 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15878204 +GABRB3 2562 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43 OMIM:617113 marker/mechanism 617113.0 +GABRB3 2562 Epilepsy MESH:D004827 marker/mechanism 15878204|29942082 +GABRB3 2562 Epilepsy, Absence MESH:D004832 marker/mechanism 612269.0 18514161 +GABRB3 2562 Isodicentric Chromosome 15 Syndrome MESH:C580205 marker/mechanism 23663378 +GABRB3 2562 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +GABRB3 2562 Sleep Initiation and Maintenance Disorders MESH:D007319 marker/mechanism 12189488 +GABRD 2563 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GABRD 2563 Epilepsy, Idiopathic Generalized MESH:C562694 marker/mechanism 613060.0 +GABRD 2563 Schizophrenia MESH:D012559 marker/mechanism 18923069 +GABRG2 2566 Alcoholism MESH:D000437 marker/mechanism 22253714 +GABRG2 2566 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 15772696 +GABRG2 2566 Cocaine-Related Disorders MESH:D019970 marker/mechanism 22253714 +GABRG2 2566 FEBRILE SEIZURES, FAMILIAL, 8 OMIM:607681 marker/mechanism 607681.0 +GABRG2 2566 Hepatic Encephalopathy MESH:D006501 marker/mechanism 15929193 +GABRG2 2566 Seizures, Febrile MESH:D003294 marker/mechanism 25362483 +GABRG3 2567 Brain Injuries MESH:D001930 marker/mechanism 23159883 +GABRG3 2567 Isodicentric Chromosome 15 Syndrome MESH:C580205 marker/mechanism 23663378 +GABRR2 2570 Liver Diseases MESH:D008107 marker/mechanism 19784758 +GABRR2 2570 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +GAD1 2571 Autistic Disorder MESH:D001321 marker/mechanism 17918742 +GAD1 2571 Bipolar Disorder MESH:D001714 marker/mechanism 15560956 +GAD1 2571 Cocaine-Related Disorders MESH:D019970 marker/mechanism 22253714 +GAD1 2571 Depressive Disorder, Major MESH:D003865 marker/mechanism 15560956 +GAD1 2571 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism 9767399 +GAD1 2571 Hyperprolactinemia MESH:D006966 marker/mechanism 7138674 +GAD1 2571 Hypertension MESH:D006973 marker/mechanism 32165127 +GAD1 2571 Schizophrenia MESH:D012559 marker/mechanism 15560956|17942719|18923069|19110320 +GAD2 2572 Bipolar Disorder MESH:D001714 marker/mechanism 15560956 +GAD2 2572 Cocaine-Related Disorders MESH:D019970 marker/mechanism 22253714 +GAD2 2572 Depressive Disorder, Major MESH:D003865 marker/mechanism 15560956 +GAD2 2572 Diabetic Retinopathy MESH:D003930 marker/mechanism 21412422 +GAD2 2572 Schizophrenia MESH:D012559 marker/mechanism 15560956|18923069 +GAD2 2572 Seizures MESH:D012640 marker/mechanism 8954991|8985701 +GADD45A 1647 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +GADD45A 1647 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +GADD45A 1647 Chloracne MESH:D054506 marker/mechanism 17101203 +GADD45A 1647 HIV Infections MESH:D015658 marker/mechanism 12878215 +GADD45A 1647 Ovarian Neoplasms MESH:D010051 therapeutic 17474084 +GADD45A 1647 Pancreatic Neoplasms MESH:D010190 therapeutic 19003803 +GADD45A 1647 Prostatic Neoplasms MESH:D011471 marker/mechanism 19190346 +GADD45A 1647 Stomach Neoplasms MESH:D013274 marker/mechanism 15837757 +GADD45B 4616 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +GADD45B 4616 Skin Diseases MESH:D012871 marker/mechanism 16835338 +GADL1 339896 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +GADR-1 186498 Hypoxia MESH:D000860 therapeutic 19936206 +GAGE1 2543 Adenocarcinoma MESH:D000230 marker/mechanism 14991579 +GAGE1 2543 Pancreatic Neoplasms MESH:D010190 marker/mechanism 14991579 +GAK 2580 Parkinson Disease MESH:D010300 marker/mechanism 20711177 +GAL 51083 Depressive Disorder, Major MESH:D003865 marker/mechanism 27940914 +GAL 51083 EPILEPSY, FAMILIAL TEMPORAL LOBE, 8 OMIM:616461 marker/mechanism 616461.0 +GAL 51083 Hyperalgesia MESH:D006930 marker/mechanism 12787826 +GAL 51083 Hypertension MESH:D006973 marker/mechanism 10818254 +GAL 51083 Inflammation MESH:D007249 marker/mechanism 17999197 +GAL 51083 Neuralgia MESH:D009437 marker/mechanism 18400411 +GAL 51083 Tachycardia MESH:D013610 marker/mechanism 10818254 +GAL3ST1 9514 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GAL3ST3 89792 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GALC 2581 Leukodystrophy, Globoid Cell MESH:D007965 marker/mechanism 245200.0 +GALC 2581 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GALE 2582 Galactosemias MESH:D005693 marker/mechanism 230350.0 25526675 +GALK1 2584 Cataract MESH:D002386 marker/mechanism 7670469 +GALK1 2584 Galactosemias MESH:D005693 marker/mechanism 230200.0 7670469 +GALNS 2588 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GALNS 2588 Inflammation MESH:D007249 therapeutic 7849337 +GALNS 2588 Mucopolysaccharidosis IV MESH:D009085 marker/mechanism 253000.0 +GALNT12 79695 Colorectal Neoplasms MESH:D015179 marker/mechanism 608812.0 +GALNT13 114805 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +GALNT16 57452 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +GALNT3 2591 Calcinosis MESH:D002114 marker/mechanism 17710231 +GALNT3 2591 Hyperphosphatemia MESH:D054559 marker/mechanism 17710231 +GALNT3 2591 Ovarian Neoplasms MESH:D010051 marker/mechanism 34520102 +GALNT3 2591 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +GALNT3 2591 Tumoral Calcinosis, Hyperphosphatemic, Familial MESH:C566870 marker/mechanism 211900.0 +GALNTL5 168391 Skin Diseases MESH:D012871 marker/mechanism 28720099 +GALR1 2587 Depressive Disorder, Major MESH:D003865 marker/mechanism 27940914 +GALR2 8811 Depressive Disorder, Major MESH:D003865 marker/mechanism 27940914 +GALR3 8484 Depressive Disorder, Major MESH:D003865 marker/mechanism 27940914 +GALT 2592 Galactosemias MESH:D005693 marker/mechanism 230400.0 22773758 +GAMT 2593 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 15651030 +GAMT 2593 Guanidinoacetate methyltransferase deficiency MESH:C537622 marker/mechanism 612736.0 15651030 +GAMT 2593 Intellectual Disability MESH:D008607 marker/mechanism 15651030 +GAMT 2593 Seizures MESH:D012640 marker/mechanism 15651030 +GAN 8139 Giant Axonal Neuropathy MESH:D056768 marker/mechanism 256850.0 +GAN 8139 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 19398414 +GANAB 23193 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +GANAB 23193 Polycystic Kidney, Autosomal Dominant MESH:D016891 marker/mechanism 600666.0 +GAP43 2596 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +GAP43 2596 Status Epilepticus MESH:D013226 marker/mechanism 10366005 +GAPDH 2597 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +GAPDH 2597 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +GAPDH 2597 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16767786|21472284 +GAPDH 2597 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +GAPDH 2597 Clinical Deterioration MESH:D000075902 marker/mechanism 27602772 +GAPDH 2597 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +GAPDH 2597 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +GAPDH 2597 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +GAPDH 2597 Hypoxia MESH:D000860 marker/mechanism 19579223 +GAPDH 2597 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +GAPDH 2597 Necrosis MESH:D009336 therapeutic 25725130 +GAPDH 2597 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +GAPDH 2597 Osteoporosis MESH:D010024 marker/mechanism 18924182 +GAPDH 2597 Parkinsonian Disorders MESH:D020734 marker/mechanism 29886133 +GAPDHS 26330 Alzheimer Disease MESH:D000544 marker/mechanism 17192785 +GAR1 54433 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +GAR1 54433 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +GAR1 54433 Dyskeratosis Congenita MESH:D019871 marker/mechanism 22299032 +GAR1 54433 Hematologic Diseases MESH:D006402 marker/mechanism 22299032 +GARS1 2617 Charcot-Marie-Tooth disease, Type 2D MESH:C537993 marker/mechanism 601472.0 +GARS1 2617 Neuronopathy, Distal Hereditary Motor, Type V MESH:C563443 marker/mechanism 600794.0 +GART 2618 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +GART 2618 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23897011 +GART 2618 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +GAS1 2619 Holoprosencephaly MESH:D016142 marker/mechanism 17525797 +GAS2 2620 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +GAS2 2620 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +GAS2L1 10634 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +GAS5 60674 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GAS6 2621 Acute Kidney Injury MESH:D058186 marker/mechanism 19564549 +GAS6 2621 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +GAS6 2621 Cardiomegaly MESH:D006332 marker/mechanism 19564549 +GAS6 2621 Diabetic Nephropathies MESH:D003928 marker/mechanism 12644472 +GAS6 2621 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +GAS6 2621 Thromboembolism MESH:D013923 marker/mechanism 16564713 +GAS6 2621 Thrombosis MESH:D013927 marker/mechanism 11175853|15130911|15733062|16564713 +GAS7 8522 Obesity MESH:D009765 marker/mechanism 19270708 +GAS8 2622 CILIARY DYSKINESIA, PRIMARY, 33 OMIM:616726 marker/mechanism 616726.0 +GASK1B 51313 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GAST 2520 Adenocarcinoma MESH:D000230 marker/mechanism 3952654 +GAST 2520 Barrett Esophagus MESH:D001471 marker/mechanism 15387324 +GAST 2520 Colonic Neoplasms MESH:D003110 marker/mechanism 3952654 +GAST 2520 Gastrointestinal Diseases MESH:D005767 marker/mechanism 12729842 +GAST 2520 Lung Neoplasms MESH:D008175 marker/mechanism 11208460 +GAST 2520 Peptic Ulcer MESH:D010437 marker/mechanism 10700044 +GAST 2520 Reperfusion Injury MESH:D015427 marker/mechanism 10594344 +GAST 2520 Stomach Neoplasms MESH:D013274 marker/mechanism 15492468 +GATA1 2623 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES OMIM:300835 marker/mechanism 300835.0 +GATA1 2623 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 28963909 +GATA1 2623 Myeloproliferative Syndrome, Transient MESH:C563551 marker/mechanism 159595.0 +GATA1 2623 Thrombocytopenia MESH:D013921 marker/mechanism 16966598 +GATA1 2623 Thrombocytopenia, Platelet Dysfunction, Hemolysis, and Imbalanced Globin Synthesis MESH:C564050 marker/mechanism 314050.0 +GATA1 2623 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA OMIM:300367 marker/mechanism 300367.0 +GATA1 2623 Transient Myeloproliferative Disorder of Down Syndrome MESH:C566024 marker/mechanism 24056718 +GATA2 2624 Arteriosclerosis MESH:D001161 marker/mechanism 28569748 +GATA2 2624 Cardiovascular Abnormalities MESH:D018376 marker/mechanism 20707411 +GATA2 2624 Cartilage Diseases MESH:D002357 marker/mechanism 20707411 +GATA2 2624 Craniofacial Abnormalities MESH:D019465 marker/mechanism 20707411 +GATA2 2624 IMMUNODEFICIENCY 21 OMIM:614172 marker/mechanism 614172.0 +GATA2 2624 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 21892158|21892162 +GATA2 2624 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +GATA2 2624 Lymphedema MESH:D008209 marker/mechanism 21892158 +GATA2 2624 LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA OMIM:614038 marker/mechanism 614038.0 +GATA2 2624 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 614286.0 21892158|21892162|27992414 +GATA2 2624 Neointima MESH:D058426 marker/mechanism 28569748 +GATA2 2624 Primary Graft Dysfunction MESH:D055031 marker/mechanism 28569748 +GATA2 2624 Vascular Remodeling MESH:D066253 marker/mechanism 28569748 +GATA2 2624 Vasculitis MESH:D014657 marker/mechanism 28569748 +GATA3 2625 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +GATA3 2625 Barakat syndrome MESH:C537907 marker/mechanism 146255.0 20006695 +GATA3 2625 Carcinogenesis MESH:D063646 marker/mechanism 35115686 +GATA3 2625 Carcinoma MESH:D002277 marker/mechanism 16316942 +GATA3 2625 Eosinophilia MESH:D004802 therapeutic 27315767 +GATA3 2625 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +GATA3 2625 Hodgkin Disease MESH:D006689 marker/mechanism 21037568 +GATA3 2625 Inflammation MESH:D007249 marker/mechanism 22325453 +GATA3 2625 Kidney Failure, Chronic MESH:D007676 marker/mechanism 26970513 +GATA3 2625 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +GATA3 2625 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +GATA3 2625 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +GATA3 2625 Metaplasia MESH:D008679 therapeutic 27315767 +GATA3 2625 Neuroblastoma MESH:D009447 marker/mechanism 30127528 +GATA3 2625 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 24141364 +GATA3 2625 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 35115686 +GATA4 2626 Alcoholism MESH:D000437 marker/mechanism 20585342 +GATA4 2626 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +GATA4 2626 Atrial septal defect 2 MESH:C538263 marker/mechanism 607941.0 +GATA4 2626 Atrioventricular Septal Defect MESH:C562831 marker/mechanism 614430.0 +GATA4 2626 Cardiomegaly MESH:D006332 marker/mechanism 16259952|18252717 +GATA4 2626 Colorectal Neoplasms MESH:D015179 marker/mechanism 19509152 +GATA4 2626 Disease Models, Animal MESH:D004195 marker/mechanism 29394407 +GATA4 2626 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31190750 +GATA4 2626 Heart Septal Defects, Ventricular MESH:D006345 marker/mechanism 614429.0 +GATA4 2626 Hemorrhage MESH:D006470 marker/mechanism 31190750 +GATA4 2626 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 18280291 +GATA4 2626 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 23426975 +GATA4 2626 Myocardial Infarction MESH:D009203 therapeutic 20200331 +GATA4 2626 TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE OMIM:615542 marker/mechanism 615542.0 +GATA4 2626 Tetralogy of Fallot MESH:D013771 marker/mechanism 187500.0 +GATA4 2626 Ventricular Remodeling MESH:D020257 marker/mechanism 29394407 +GATA5 140628 Colorectal Neoplasms MESH:D015179 marker/mechanism 19509152 +GATA6 2627 ATRIAL SEPTAL DEFECT 9 OMIM:614475 marker/mechanism 614475.0 +GATA6 2627 Atrioventricular Septal Defect MESH:C562831 marker/mechanism 614474.0 +GATA6 2627 CONOTRUNCAL HEART MALFORMATIONS OMIM:217095 marker/mechanism 217095.0 +GATA6 2627 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31190750 +GATA6 2627 HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES OMIM:600001 marker/mechanism 600001.0 +GATA6 2627 Hemorrhage MESH:D006470 marker/mechanism 31190750 +GATA6 2627 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 18280291 +GATA6 2627 Lung Neoplasms MESH:D008175 marker/mechanism 16271038 +GATA6 2627 Pancreatic Agenesis, Congenital MESH:C564908 marker/mechanism 22158542 +GATA6 2627 Tetralogy of Fallot MESH:D013771 marker/mechanism 187500.0 +GATAD1 57798 CARDIOMYOPATHY, DILATED, 2B OMIM:614672 marker/mechanism 614672.0 +GATAD2A 54815 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 35362730 +GATAD2A 54815 Stomach Neoplasms MESH:D013274 marker/mechanism 35362730 +GATAD2B 57459 GAND SYNDROME OMIM:615074 marker/mechanism 615074.0 +GATM 2628 Arginine-Glycine Amidinotransferase Deficiency MESH:C567192 marker/mechanism 612718.0 +GATM 2628 Carcinoma MESH:D002277 marker/mechanism 16316942 +GATM 2628 Fanconi Syndrome MESH:D005198 marker/mechanism 134600.0 +GATM 2628 Heart Failure MESH:D006333 marker/mechanism 16820567|36071497 +GATM 2628 Kidney Diseases MESH:D007674 marker/mechanism 22061828 +GATM 2628 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +GATM 2628 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +GATM 2628 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GATM 2628 Necrosis MESH:D009336 marker/mechanism 22061828 +GBA1 2629 Gaucher Disease MESH:D005776 marker/mechanism 230800|230900|231000 10757640|12359135|21250698|21370884|26027833|9101438 +GBA1 2629 Gaucher Disease, Perinatal Lethal MESH:C564306 marker/mechanism 608013 +GBA1 2629 Gaucher Disease, Type Iiic MESH:C565553 marker/mechanism 231005 +GBA1 2629 Hypertension, Pulmonary MESH:D006976 marker/mechanism 12359135 +GBA1 2629 Lewy Body Disease MESH:D020961 marker/mechanism 127750 22803570|33589841 +GBA1 2629 Parkinson Disease MESH:D010300 marker/mechanism 20947659|25064009 +GBA1 2629 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600 +GBA1 2629 Parkinsonian Disorders MESH:D020734 marker/mechanism 25881142 +GBA2 57704 SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE OMIM:614409 marker/mechanism 614409 +GBA3 57733 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GBA3 57733 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +GBE1 2632 Glycogen Storage Disease Type IV MESH:D006011 marker/mechanism 232500 +GBE1 2632 Polyglucosan Body Disease, Adult Form MESH:C564878 marker/mechanism 263570 +GBF1 8729 Charcot-Marie-Tooth Disease, Dominant Intermediate A MESH:C564702 marker/mechanism 606483 +GBP1 2633 Influenza, Human MESH:D007251 marker/mechanism 23326326 +GBP2 2634 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GBP2 2634 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GBP4 115361 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GBP5 115362 Celiac Disease MESH:D002446 marker/mechanism 30097691 +GBX2 2637 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +GC 2638 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +GC 2638 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 3874814 +GC 2638 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 24381012 +GC 2638 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +GC 2638 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +GC 2638 Graves Disease MESH:D006111 marker/mechanism 12050214 +GC 2638 Hepatic Encephalopathy MESH:D006501 marker/mechanism 11510020 +GC 2638 Liver Cirrhosis MESH:D008103 marker/mechanism 24381012 +GC 2638 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GC 2638 Liver Failure, Acute MESH:D017114 marker/mechanism 17852808|8666322 +GC 2638 Lung Neoplasms MESH:D008175 marker/mechanism 17902193 +GC 2638 Multiple Sclerosis MESH:D009103 marker/mechanism 25590278 +GC 2638 Schizophrenia MESH:D012559 marker/mechanism 25821032 +GC 2638 Shock, Septic MESH:D012772 marker/mechanism 17852808 +GC 2638 Wounds and Injuries MESH:D014947 marker/mechanism 17852808 +GCAT 23464 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GCC1 79571 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17205118 +GCC1 79571 Marijuana Abuse MESH:D002189 marker/mechanism 17205118 +GCC1 79571 Phencyclidine Abuse MESH:D010623 marker/mechanism 17205118 +GCDH 2639 Glutaric Acidemia I MESH:C536833 marker/mechanism 231670.0 10759157|25204480 +GCG 2641 Aberrant Crypt Foci MESH:D058739 marker/mechanism 22323126 +GCG 2641 Anorexia MESH:D000855 marker/mechanism 21824258|28633506 +GCG 2641 Bradycardia MESH:D001919 therapeutic 3277781|3736332|6542785|7787496|9674488 +GCG 2641 Catalepsy MESH:D002375 marker/mechanism 9798264 +GCG 2641 Colitis MESH:D003092 therapeutic 22323126 +GCG 2641 Colonic Neoplasms MESH:D003110 marker/mechanism 22323126 +GCG 2641 Coma MESH:D003128 therapeutic 10464538 +GCG 2641 Constipation MESH:D003248 marker/mechanism 12107204 +GCG 2641 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23466488 +GCG 2641 Heart Diseases MESH:D006331 therapeutic 3277781 +GCG 2641 Heart Failure MESH:D006333 therapeutic 7608802 +GCG 2641 Hyperglycemia MESH:D006943 marker/mechanism|therapeutic 18669601|3019152 +GCG 2641 Hyperinsulinism MESH:D006946 marker/mechanism 3019152 +GCG 2641 Hyperkinesis MESH:D006948 therapeutic 9798264 +GCG 2641 Hyperlipidemias MESH:D006949 therapeutic 69995 +GCG 2641 Hypertension MESH:D006973 marker/mechanism 22228705 +GCG 2641 Hypotension MESH:D007022 therapeutic 3277781|8517581 +GCG 2641 Hypothermia MESH:D007035 therapeutic 10464538 +GCG 2641 Obesity MESH:D009765 therapeutic 20065960 +GCG 2641 Poisoning MESH:D011041 therapeutic 7629900 +GCG 2641 Spasm MESH:D013035 marker/mechanism 7192515 +GCG 2641 Stomach Diseases MESH:D013272 therapeutic 17891687 +GCG 2641 Tachycardia MESH:D013610 marker/mechanism 7629900 +GCG 2641 Tachycardia, Sinus MESH:D013616 marker/mechanism 7359351 +GCG 2641 Taste Disorders MESH:D013651 marker/mechanism 21824258 +GCG 2641 Vascular Diseases MESH:D014652 therapeutic 10464538 +GCGR 2642 Acth-Independent Macronodular Adrenal Hyperplasia MESH:C565662 marker/mechanism 20529775 +GCH1 2643 Dyskinesia, Drug-Induced MESH:D004409 therapeutic 15659429 +GCH1 2643 Dystonia MESH:D004421 marker/mechanism 15389992 +GCH1 2643 Dystonia, Dopa-responsive MESH:C538007 marker/mechanism 128230.0 10825351 +GCH1 2643 Hyperphenylalaninemia, BH4-Deficient, B MESH:C562656 marker/mechanism 233910.0 +GCH1 2643 Hypertension MESH:D006973 marker/mechanism 12855421 +GCH1 2643 Hypokinesia MESH:D018476 marker/mechanism 17368676 +GCH1 2643 Muscle Rigidity MESH:D009127 marker/mechanism 17368676 +GCH1 2643 Musculoskeletal Pain MESH:D059352 marker/mechanism 25218601 +GCH1 2643 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GCH1 2643 Pain MESH:D010146 marker/mechanism 19081190 +GCHFR 2644 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GCK 2645 Congenital Hyperinsulinism MESH:D044903 marker/mechanism 15277402 +GCK 2645 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +GCK 2645 Diabetes Mellitus, Permanent Neonatal MESH:C563425 marker/mechanism 606176.0 +GCK 2645 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 15102714|15161764|16123366|20081858 +GCK 2645 Hyperglycemia MESH:D006943 marker/mechanism 18056790 +GCK 2645 Hyperinsulinemic hypoglycemia, familial, 3 MESH:C538374 marker/mechanism 602485.0 +GCK 2645 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +GCK 2645 Maturity-Onset Diabetes of the Young, Type 2 MESH:C564219 marker/mechanism 125851.0 21115832 +GCKR 2646 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 20081858 +GCKR 2646 Hypertriglyceridemia MESH:D015228 marker/mechanism 20657596 +GCLC 2729 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 10515893 +GCLC 2729 Anemia, Hemolytic MESH:D000743 marker/mechanism 10515893 +GCLC 2729 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427 +GCLC 2729 Cell Transformation, Neoplastic MESH:D002471 therapeutic 30940545 +GCLC 2729 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 19481141 +GCLC 2729 Coronary Vessel Anomalies MESH:D003330 marker/mechanism 12598062 +GCLC 2729 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +GCLC 2729 Diabetes Mellitus, Type 2 MESH:D003924 therapeutic 32715377 +GCLC 2729 Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to MESH:C565557 marker/mechanism 230450.0 +GCLC 2729 Hypertension MESH:D006973 marker/mechanism 22228705 +GCLC 2729 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +GCLC 2729 Microphthalmos MESH:D008850 marker/mechanism 35123994 +GCLC 2729 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 12598062 +GCLC 2729 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GCLM 2730 Berylliosis MESH:D001607 marker/mechanism 16766924 +GCLM 2730 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +GCLM 2730 Diabetes Mellitus, Type 2 MESH:D003924 therapeutic 32715377 +GCLM 2730 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 12081989|12975258 +GCM2 9247 HYPERPARATHYROIDISM 4 OMIM:617343 marker/mechanism 617343.0 +GCNT1 2650 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GCNT1 2650 Prostatic Neoplasms MESH:D011471 marker/mechanism 15882971 +GCNT2 2651 CATARACT 13 WITH ADULT i PHENOTYPE OMIM:116700 marker/mechanism 116700.0 +GCOM1 145781 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +GDA 9615 Carcinoma MESH:D002277 marker/mechanism 12376462 +GDA 9615 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +GDA 9615 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +GDA 9615 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +GDAP1 54332 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE OMIM:607706 marker/mechanism 607706.0 +GDAP1 54332 Charcot-Marie-Tooth Disease, Recessive Intermediate A MESH:C564256 marker/mechanism 608340.0 +GDAP1 54332 Charcot-Marie-Tooth disease, Type 2K MESH:C535418 marker/mechanism 607831.0 +GDAP1 54332 Charcot-Marie-Tooth disease, Type 4A MESH:C535419 marker/mechanism 214400.0 +GDF1 2657 CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6 OMIM:613854 marker/mechanism 613854.0 +GDF1 2657 Double Outlet Right Ventricle MESH:D004310 marker/mechanism 17924340 +GDF1 2657 Heart Defects, Congenital MESH:D006330 marker/mechanism 28991257 +GDF1 2657 Heterotaxy Syndrome MESH:D059446 marker/mechanism 208530.0 +GDF1 2657 Tetralogy of Fallot MESH:D013771 marker/mechanism 17924340 +GDF1 2657 Transposition of Great Vessels MESH:D014188 marker/mechanism 17924340 +GDF10 2662 Breast Neoplasms MESH:D001943 marker/mechanism 23180569 +GDF10 2662 Mesothelioma MESH:D008654 marker/mechanism 18949431 +GDF15 9518 Anemia, Sideroblastic MESH:D000756 marker/mechanism 19036111 +GDF15 9518 Cachexia MESH:D002100 marker/mechanism 30782979 +GDF15 9518 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20512989 +GDF15 9518 Coronary Artery Disease MESH:D003324 marker/mechanism 20855664 +GDF15 9518 Gastrointestinal Neoplasms MESH:D005770 therapeutic 24440808 +GDF15 9518 Heart Failure MESH:D006333 marker/mechanism 20855664 +GDF15 9518 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 19505289 +GDF15 9518 Melanoma MESH:D008545 marker/mechanism 17145863 +GDF15 9518 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +GDF15 9518 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GDF15 9518 Neoplasm Metastasis MESH:D009362 marker/mechanism 23996089 +GDF15 9518 Prostatic Neoplasms MESH:D011471 marker/mechanism 16775185|23996089 +GDF15 9518 Weight Gain MESH:D015430 marker/mechanism 19030233 +GDF2 2658 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 23936038|28284560 +GDF2 2658 Fractures, Bone MESH:D050723 therapeutic 27394662 +GDF2 2658 Hypertension, Pulmonary MESH:D006976 marker/mechanism 26801773 +GDF2 2658 Telangiectasia, Hereditary Hemorrhagic MESH:D013683 marker/mechanism 26801773 +GDF2 2658 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5 OMIM:615506 marker/mechanism 615506.0 +GDF3 9573 Camptocormia MESH:C537968 marker/mechanism 22613031 +GDF3 9573 Edema MESH:D004487 marker/mechanism 22613031 +GDF3 9573 Heart Defects, Congenital MESH:D006330 marker/mechanism 22613031 +GDF3 9573 KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT OMIM:613702 marker/mechanism 613702.0 +GDF3 9573 MICROPHTHALMIA, ISOLATED 7 OMIM:613704 marker/mechanism 613704.0 +GDF3 9573 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6 OMIM:613703 marker/mechanism 613703.0 +GDF3 9573 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 16168501 +GDF5 8200 ACROMESOMELIC DYSPLASIA 2C OMIM:201250 marker/mechanism 201250.0 +GDF5 8200 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 18830904 +GDF5 8200 BRACHYDACTYLY, TYPE A1, C OMIM:615072 marker/mechanism 615072.0 +GDF5 8200 Brachydactyly type A2 MESH:C537089 marker/mechanism 112600.0 +GDF5 8200 Brachydactyly type C MESH:C537093 marker/mechanism 113100.0 +GDF5 8200 Chondrodysplasia, Grebe type MESH:C537915 marker/mechanism 200700.0 +GDF5 8200 DEVELOPMENTAL DYSPLASIA OF THE HIP 1 OMIM:142700 marker/mechanism 18947434 +GDF5 8200 Fibular hypoplasia and complex brachydactyly MESH:C537931 marker/mechanism 228900.0 +GDF5 8200 Multiple synostoses syndrome 2 MESH:C537380 marker/mechanism 610017.0 +GDF5 8200 Osteoarthritis MESH:D010003 marker/mechanism 612400.0 18830904|30664745 +GDF5 8200 Osteoarthritis, Knee MESH:D020370 marker/mechanism 30374069 +GDF5 8200 SYMPHALANGISM, PROXIMAL, 1B OMIM:615298 marker/mechanism 615298.0 +GDF6 392255 Klippel-Feil Syndrome MESH:D007714 marker/mechanism 18425797 +GDF6 392255 Klippel Feil syndrome dominant type MESH:C536887 marker/mechanism 118100.0 +GDF6 392255 LEBER CONGENITAL AMAUROSIS 17 OMIM:615360 marker/mechanism 615360.0 +GDF6 392255 Microphthalmia, Isolated 4 MESH:C567757 marker/mechanism 613094.0 +GDF6 392255 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6 OMIM:613703 marker/mechanism 613703.0 +GDF9 2661 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 22825968 +GDI1 2664 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +GDI1 2664 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +GDI1 2664 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 41 OMIM:300849 marker/mechanism 300849.0 +GDI1 2664 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 8826463|9668174 +GDI2 2665 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +GDNF 2668 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 17356005 +GDNF 2668 Cocaine-Related Disorders MESH:D019970 therapeutic 14622243|15899247 +GDNF 2668 Congenital central hypoventilation syndrome MESH:C536209 marker/mechanism 9497256 +GDNF 2668 Dyskinesia, Drug-Induced MESH:D004409 therapeutic 11168568 +GDNF 2668 Ependymoma MESH:D004806 marker/mechanism 19138852 +GDNF 2668 Glioblastoma MESH:D005909 marker/mechanism 19138852 +GDNF 2668 Glioma MESH:D005910 marker/mechanism 19138852 +GDNF 2668 Hirschsprung Disease MESH:D006627 marker/mechanism 613711.0 8896568|8968758 +GDNF 2668 Huntington Disease MESH:D006816 therapeutic 16943855 +GDNF 2668 Hyperalgesia MESH:D006930 marker/mechanism 20457222 +GDNF 2668 Neurodegenerative Diseases MESH:D019636 therapeutic 11592846 +GDNF 2668 Neurologic Manifestations MESH:D009461 therapeutic 19894114 +GDNF 2668 Oligodendroglioma MESH:D009837 marker/mechanism 19138852 +GDNF 2668 Parkinson Disease MESH:D010300 therapeutic 11031079|16324109 +GDNF 2668 Parkinson Disease, Secondary MESH:D010302 therapeutic 19909981 +GDNF 2668 Parkinsonian Disorders MESH:D020734 therapeutic 12213621|9266731 +GDNF 2668 Pheochromocytoma MESH:D010673 marker/mechanism 9215674 +GDNF 2668 Retinal Degeneration MESH:D012162 therapeutic 17935603 +GDNF 2668 Status Epilepticus MESH:D013226 marker/mechanism 12914250|7854063 +GDPD3 79153 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414|17175557 +GET1 7485 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GFAP 2670 Alexander Disease MESH:D038261 marker/mechanism 203450.0 31484723 +GFAP 2670 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 11723166 +GFAP 2670 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +GFAP 2670 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GFAP 2670 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254 +GFAP 2670 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +GFAP 2670 Epilepsy MESH:D004827 marker/mechanism 21177194 +GFAP 2670 Gliosis MESH:D005911 marker/mechanism 12183020 +GFAP 2670 Hyperalgesia MESH:D006930 marker/mechanism 27093858 +GFAP 2670 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +GFAP 2670 Nervous System Diseases MESH:D009422 marker/mechanism 10773198|9427479|9634552 +GFAP 2670 Neuromyelitis Optica MESH:D009471 marker/mechanism 18509235 +GFAP 2670 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +GFAP 2670 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 10447555 +GFAP 2670 Spina Bifida Cystica MESH:D016137 marker/mechanism 8422324 +GFAP 2670 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +GFER 2671 Acute Kidney Injury MESH:D058186 therapeutic 20030531 +GFER 2671 Carbon Tetrachloride Poisoning MESH:D002252 therapeutic 15968720 +GFER 2671 Liver Failure, Acute MESH:D017114 therapeutic 15968720 +GFER 2671 Myopathy, Mitochondrial Progressive, With Congenital Cataract, Hearing Loss, And Developmental Delay MESH:C567769 marker/mechanism 613076.0 +GFI1 2672 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +GFI1 2672 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +GFI1 2672 Neutropenia, Nonimmune Chronic Idiopathic, Adult MESH:C564320 marker/mechanism 607847.0 +GFI1 2672 Neutropenia, Severe Congenital, Autosomal Dominant 2 MESH:C567748 marker/mechanism 613107.0 +GFI1 2672 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 16122429 +GFI1B 8328 Thrombasthenia-Thrombocytopenia, Hereditary MESH:C566060 marker/mechanism 187900.0 +GFM1 85476 Combined Oxidative Phosphorylation Deficiency 1 MESH:C563797 marker/mechanism 609060.0 +GFOD1 54438 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +GFOD3P 57212 Oligodendroglioma MESH:D009837 marker/mechanism 20477830 +GFPT1 2673 Muscular Diseases MESH:D009135 marker/mechanism 29905857 +GFPT1 2673 Myasthenic syndrome, congenital, type Id MESH:C536090 marker/mechanism 608931.0 +GFPT1 2673 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 610542.0 29905857 +GFPT1 2673 Obesity MESH:D009765 marker/mechanism 20882379 +GFRA1 2674 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GFRA1 2674 Neuralgia MESH:D009437 marker/mechanism 18400411 +GGCX 2677 Blood Coagulation Disorders MESH:D001778 marker/mechanism 19141161 +GGCX 2677 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +GGCX 2677 Pseudoxanthoma Elasticum-Like Disorder with Multiple Coagulation Factor Deficiency MESH:C563654 marker/mechanism 610842.0 +GGCX 2677 Urolithiasis MESH:D052878 marker/mechanism 9471053 +GGCX 2677 Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, 1 MESH:C564741 marker/mechanism 277450.0 +GGH 8836 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23897011 +GGH 8836 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 19815704 +GGH 8836 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 21219404 +GGH 8836 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641 +GGH 8836 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GGH 8836 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 19815704 +GGT1 2678 Alcoholism MESH:D000437 marker/mechanism 12747453 +GGT1 2678 Carcinoma MESH:D002277 marker/mechanism 12376462 +GGT1 2678 Glutathionuria MESH:C536836 marker/mechanism 231950.0 +GGT1 2678 Liver Diseases MESH:D008107 marker/mechanism 19784758 +GGT1 2678 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +GGT1 2678 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +GGT1 2678 Myocardial Infarction MESH:D009203 marker/mechanism 19419996 +GGT1 2678 Periodontitis MESH:D010518 marker/mechanism 12747453 +GGT1 2678 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +GGTA1 2681 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GH 14599 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 15528971 +GH 14599 Weight Gain MESH:D015430 marker/mechanism 17372281 +GH1 2688 Acromegaly MESH:D000172 marker/mechanism 1682667|18381583|18388193|3059976|6237480|7440347|9186818 +GH1 2688 Azotemia MESH:D053099 marker/mechanism 14728886 +GH1 2688 Cardiovascular Diseases MESH:D002318 therapeutic 17324600 +GH1 2688 Growth Disorders MESH:D006130 therapeutic 15151564 +GH1 2688 Growth Hormone-Secreting Pituitary Adenoma MESH:D049912 marker/mechanism 1611713|2042694 +GH1 2688 Insulin Resistance MESH:D007333 marker/mechanism 21559284 +GH1 2688 Isolated Growth Hormone Deficiency, Type IB MESH:C567564 marker/mechanism 612781.0 +GH1 2688 Isolated Growth Hormone Deficiency, Type II MESH:C562704 marker/mechanism 173100.0 +GH1 2688 Kowarski syndrome MESH:C537505 marker/mechanism 262650.0 +GH1 2688 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 15334695 +GH1 2688 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12082019|17584969 +GH1 2688 Muscular Atrophy MESH:D009133 therapeutic 8937196 +GH1 2688 Obesity MESH:D009765 marker/mechanism 8923850 +GH1 2688 Pituitary dwarfism 1 MESH:C537404 marker/mechanism 262400.0 +GH1 2688 Pituitary Neoplasms MESH:D010911 marker/mechanism 19420816 +GH1 2688 Polycythemia MESH:D011086 marker/mechanism 15161484 +GH1 2688 Turner Syndrome MESH:D014424 therapeutic 15151564 +GH1 2688 Weight Gain MESH:D015430 marker/mechanism 17372281 +GH1 2688 Weight Loss MESH:D015431 therapeutic 7711889 +GH2 2689 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GH2 2689 Silver-Russell Syndrome MESH:D056730 marker/mechanism 14642004 +GHR 2690 Autistic Disorder MESH:D001321 marker/mechanism 17547689 +GHR 2690 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GHR 2690 HYPERCHOLESTEROLEMIA, FAMILIAL, 1 OMIM:143890 marker/mechanism 143890.0 +GHR 2690 Laron Syndrome MESH:D046150 marker/mechanism 262500.0 +GHR 2690 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +GHR 2690 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GHR 2690 Prostatic Neoplasms MESH:D011471 marker/mechanism 17220348 +GHR 2690 Short Stature, Idiopathic, Autosomal MESH:C565805 marker/mechanism 604271.0 +GHRH 2691 Pulmonary Edema MESH:D011654 therapeutic 22308467 +GHRL 51738 Adenocarcinoma MESH:D000230 marker/mechanism 21472143 +GHRL 51738 Bone Resorption MESH:D001862 therapeutic 29477364 +GHRL 51738 Cachexia MESH:D002100 therapeutic 17347304 +GHRL 51738 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17407494 +GHRL 51738 Colitis MESH:D003092 therapeutic 19617644 +GHRL 51738 Colitis, Ulcerative MESH:D003093 marker/mechanism 19617644 +GHRL 51738 Depressive Disorder MESH:D003866 marker/mechanism 19272368 +GHRL 51738 Esophageal Neoplasms MESH:D004938 marker/mechanism 21472143 +GHRL 51738 Heart Failure MESH:D006333 therapeutic 20572026 +GHRL 51738 Nerve Degeneration MESH:D009410 therapeutic 19429016 +GHRL 51738 Neural Tube Defects MESH:D009436 therapeutic 17400914 +GHRL 51738 Obesity MESH:D009765 marker/mechanism 601665.0 +GHRL 51738 Reperfusion Injury MESH:D015427 therapeutic 16581065 +GHRL 51738 Seizures MESH:D012640 therapeutic 19429016 +GHRL 51738 Stomach Ulcer MESH:D013276 therapeutic 15177919|16259727 +GHRL 51738 Weight Gain MESH:D015430 marker/mechanism 16493877|33301842 +GHSR 2693 Alcoholism MESH:D000437 therapeutic 23977009 +GHSR 2693 Digestive System Neoplasms MESH:D004067 marker/mechanism 18064392 +GIGYF2 26058 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +GIGYF2 26058 Parkinson Disease 11 MESH:C564345 marker/mechanism 607688.0 +GIN1 54826 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +GINS1 9837 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GINS2 51659 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +GINS2 51659 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +GIP 2695 Anorexia MESH:D000855 marker/mechanism 28633506|28666375|29689362 +GIPC3 126326 Deafness, Autosomal Recessive 15 MESH:C566611 marker/mechanism 601869.0 21326233 +GIPR 2696 Body Weight MESH:D001835 marker/mechanism 22344221 +GIPR 2696 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17094902 +GIT1 28964 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 21499268 +GIT1 28964 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 28100775 +GIT1 28964 Hyperkinesis MESH:D006948 marker/mechanism 21499268 +GIT1 28964 Memory Disorders MESH:D008569 marker/mechanism 21499268 +GIT2 9815 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 37156999 +GJA1 2697 Adenoma MESH:D000236 marker/mechanism 16926031 +GJA1 2697 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 18003637|18077386 +GJA1 2697 Autistic Disorder MESH:D001321 marker/mechanism 18435417 +GJA1 2697 Basaran Yilmaz syndrome MESH:C537660 marker/mechanism 104100.0 +GJA1 2697 Breast Neoplasms MESH:D001943 marker/mechanism 29180066 +GJA1 2697 Coronary Aneurysm MESH:D003323 marker/mechanism 15548583 +GJA1 2697 Craniometaphyseal dysplasia, autosomal recessive type MESH:C536570 marker/mechanism 218400.0 +GJA1 2697 Disease Progression MESH:D018450 marker/mechanism 29180066 +GJA1 2697 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 16292552|16720372 +GJA1 2697 Hyperalgesia MESH:D006930 marker/mechanism 34286406 +GJA1 2697 Hypertension MESH:D006973 marker/mechanism 16448880 +GJA1 2697 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GJA1 2697 Lung Neoplasms MESH:D008175 marker/mechanism 15166089|16926031 +GJA1 2697 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 17445419 +GJA1 2697 Oculodentodigital Dysplasia MESH:C563160 marker/mechanism 164200.0 12457340|15879313|16155213|16211004|16378922|17420259|17509830|17687502|18003637|18077386|18660473|18946008|19725242 +GJA1 2697 Oculodentodigital Dysplasia, Autosomal Recessive MESH:C567605 marker/mechanism 257850.0 +GJA1 2697 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +GJA1 2697 Renal Insufficiency, Chronic MESH:D051436 marker/mechanism 32045570 +GJA1 2697 Skin Neoplasms MESH:D012878 marker/mechanism 7586191 +GJA1 2697 Syndactyly, type 3 MESH:C538154 marker/mechanism 186100.0 +GJA3 2700 Cataract, Zonular Pulverulent 3 MESH:C566608 marker/mechanism 601885.0 +GJA4 2701 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +GJA4 2701 Hypertension MESH:D006973 marker/mechanism 16448880 +GJA4 2701 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GJA5 2702 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +GJA5 2702 ATRIAL FIBRILLATION, FAMILIAL, 11 OMIM:614049 marker/mechanism 614049.0 +GJA5 2702 Atrial Standstill MESH:C563984 marker/mechanism 108770.0 +GJA5 2702 Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb MESH:C567291 marker/mechanism 612474.0 +GJA5 2702 Hypertension MESH:D006973 marker/mechanism 19109587 +GJA8 2703 Cataract MESH:D002386 marker/mechanism 9497259 +GJA8 2703 Cataract microcornea syndrome MESH:C538287 marker/mechanism 16604058 +GJA8 2703 Cataract, Nuclear Progressive MESH:C564596 marker/mechanism 14627691 +GJA8 2703 Cataract, Zonular Pulverulent 1 MESH:C566158 marker/mechanism 116200.0 +GJA8 2703 Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb MESH:C567291 marker/mechanism 612474.0 +GJB1 2705 Adenoma MESH:D000236 marker/mechanism 16926031 +GJB1 2705 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17978847 +GJB1 2705 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 18264126 +GJB1 2705 Charcot-Marie-Tooth disease, X-linked, 1 MESH:C535919 marker/mechanism 302800.0 +GJB1 2705 Liver Neoplasms MESH:D008113 marker/mechanism 2559087 +GJB1 2705 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 18308698 +GJB1 2705 Lung Neoplasms MESH:D008175 marker/mechanism 15492231|16926031 +GJB1 2705 Neoplasm Metastasis MESH:D009362 marker/mechanism 17978847 +GJB1 2705 Precancerous Conditions MESH:D011230 marker/mechanism 2559087 +GJB1 2705 Reperfusion Injury MESH:D015427 marker/mechanism 25530438 +GJB2 2706 Cellulitis MESH:D002481 marker/mechanism 16172043 +GJB2 2706 Deafness MESH:D003638 marker/mechanism 16172043 +GJB2 2706 Deafness, Autosomal Dominant 3A MESH:C567277 marker/mechanism 601544.0 +GJB2 2706 Deafness, Autosomal Recessive 1A MESH:C567134 marker/mechanism 220290.0 +GJB2 2706 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 15091236 +GJB2 2706 Hidradenitis Suppurativa MESH:D017497 marker/mechanism 16172043 +GJB2 2706 HID Syndrome MESH:C566528 marker/mechanism 602540.0 +GJB2 2706 Ichthyosis MESH:D007057 marker/mechanism 16172043 +GJB2 2706 Keratitis MESH:D007634 marker/mechanism 16172043 +GJB2 2706 Keratitis, Ichthyosis, and Deafness (KID) Syndrome MESH:C536168 marker/mechanism 148210.0 +GJB2 2706 Keratoderma, Palmoplantar MESH:D007645 marker/mechanism 16172043 +GJB2 2706 Knuckle pads, leuconychia and sensorineural deafness MESH:C537210 marker/mechanism 149200.0 +GJB2 2706 Palmoplantar Keratoderma with Deafness MESH:C536152 marker/mechanism 148350.0 +GJB2 2706 Progressive hearing loss stapes fixation MESH:C536424 marker/mechanism 304400.0 +GJB2 2706 Psoriasis MESH:D011565 marker/mechanism 20953187|24212883 +GJB2 2706 Skin Neoplasms MESH:D012878 marker/mechanism 7586191 +GJB2 2706 Vohwinkel syndrome MESH:C536457 marker/mechanism 124500.0 +GJB3 2707 Deafness MESH:D003638 marker/mechanism 9843210 +GJB3 2707 Deafness, Autosomal Dominant 2B MESH:C567214 marker/mechanism 612644.0 +GJB3 2707 Deafness, Autosomal Recessive 1A MESH:C567134 marker/mechanism 220290.0 +GJB3 2707 Erythrokeratodermia Variabilis MESH:D056266 marker/mechanism 133200.0 9843209 +GJB3 2707 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 11309368 +GJB3 2707 Hyperkeratosis, Epidermolytic MESH:D017488 marker/mechanism 16297190 +GJB3 2707 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 11309368 +GJB3 2707 Skin Diseases MESH:D012871 marker/mechanism 16372802 +GJB4 127534 Hyperkeratosis, Epidermolytic MESH:D017488 marker/mechanism 16297190 +GJB5 2709 Skin Neoplasms MESH:D012878 marker/mechanism 7586191 +GJB6 10804 Deafness, Autosomal Dominant 3B MESH:C567215 marker/mechanism 612643.0 +GJB6 10804 Deafness, Autosomal Recessive 1A MESH:C567134 marker/mechanism 220290.0 +GJB6 10804 Deafness, Autosomal Recessive 1b MESH:C567213 marker/mechanism 612645.0 +GJB6 10804 Ectodermal Dysplasia MESH:D004476 marker/mechanism 129500.0 +GJB6 10804 Progressive hearing loss stapes fixation MESH:C536424 marker/mechanism 304400.0 +GJC1 10052 Hypertension MESH:D006973 therapeutic 19109587 +GJC2 57165 Leukodystrophy, Hypomyelinating, 2 MESH:C563855 marker/mechanism 608804.0 18571143 +GJC2 57165 LYMPHATIC MALFORMATION 3 OMIM:613480 marker/mechanism 613480.0 +GJC2 57165 Spastic Paraplegia 44, Autosomal Recessive MESH:C567707 marker/mechanism 613206.0 +GJD2 57369 Myopia MESH:D009216 marker/mechanism 23396134 +GJD2 57369 Refractive Errors MESH:D012030 marker/mechanism 20835239 +GJE1 100126572 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 21228734 +GK 2710 GLYCEROL KINASE DEFICIENCY OMIM:307030 marker/mechanism 307030.0 +GK 2710 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GK 2710 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GKN1 56287 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +GKN1 56287 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +GKN1 56287 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +GLA 2717 Angiokeratoma MESH:D000794 therapeutic 19925601 +GLA 2717 Fabry Disease MESH:D000795 marker/mechanism 301500.0 18565198|19925601|22773828 +GLAZ 36447 Neurodegenerative Diseases MESH:D019636 marker/mechanism 28182653 +GLAZ 36447 Retinal Diseases MESH:D012164 marker/mechanism 28182653 +GLB1 2720 Bone Diseases, Developmental MESH:D001848 marker/mechanism 7586649 +GLB1 2720 Corneal Opacity MESH:D003318 marker/mechanism 817853 +GLB1 2720 Dermatitis, Atopic MESH:D003876 marker/mechanism 23042114 +GLB1 2720 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +GLB1 2720 Gangliosidosis, GM1 MESH:D016537 marker/mechanism 230500|230600|230650 +GLB1 2720 Mucopolysaccharidosis IV MESH:D009085 marker/mechanism 253010 1928092|7586649 +GLB1 2720 Osteochondrodysplasias MESH:D010009 marker/mechanism 817853 +GLDC 2731 Hyperglycinemia, Nonketotic MESH:D020158 marker/mechanism 605899 16404748|16450403|17361008 +GLDN 342035 LETHAL CONGENITAL CONTRACTURE SYNDROME 11 OMIM:617194 marker/mechanism 617194 +GLE1 2733 Lethal Arthrogryposis With Anterior Horn Cell Disease MESH:C567502 marker/mechanism 611890 +GLE1 2733 Lethal congenital contracture syndrome 1 MESH:C537194 marker/mechanism 253310 18204449 +GLI1 2735 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 26189965 +GLI1 2735 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +GLI1 2735 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 23867347 +GLI1 2735 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21625222 +GLI1 2735 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +GLI1 2735 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 20179202 +GLI2 2736 Basal Cell Nevus Syndrome MESH:D001478 marker/mechanism 16936257 +GLI2 2736 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 10700170 +GLI2 2736 CULLER-JONES SYNDROME OMIM:615849 marker/mechanism 615849.0 +GLI2 2736 Disease Models, Animal MESH:D004195 marker/mechanism 27585885 +GLI2 2736 Facial Dysmorphism with Multiple Malformations MESH:C565579 marker/mechanism 27585885 +GLI2 2736 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +GLI2 2736 Holoprosencephaly MESH:D016142 marker/mechanism 27585885 +GLI2 2736 Holoprosencephaly 9 MESH:C563659 marker/mechanism 610829.0 +GLI2 2736 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 23867347 +GLI2 2736 Skin Neoplasms MESH:D012878 marker/mechanism 10700170 +GLI3 2737 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +GLI3 2737 Greig cephalopolysyndactyly syndrome MESH:C537300 marker/mechanism 175700.0 10441342|14608643|15739154|18154020|18241058|9302279 +GLI3 2737 Hypopigmentation MESH:D017496 marker/mechanism 18397875 +GLI3 2737 Neural Tube Defects MESH:D009436 marker/mechanism 16359493 +GLI3 2737 Pallister-Hall Syndrome MESH:D054975 marker/mechanism 146510.0 15739154|21532573 +GLI3 2737 Polydactyly MESH:D017689 marker/mechanism 17688467 +GLI3 2737 Polydactyly, Postaxial MESH:C562429 marker/mechanism 174200.0 +GLI3 2737 Polydactyly, preaxial 4 MESH:C536333 marker/mechanism 174700.0 +GLI3 2737 Stomach Neoplasms MESH:D013274 marker/mechanism 24816253 +GLIPR1 11010 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GLIPR1 11010 Wilms Tumor MESH:D009396 marker/mechanism 18030365 +GLIS2 84662 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +GLIS2 84662 Kidney Diseases MESH:D007674 marker/mechanism 17618285 +GLIS2 84662 Nephronophthisis 7 MESH:C566930 marker/mechanism 611498.0 +GLIS3 169792 Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism MESH:C565705 marker/mechanism 610199.0 +GLIS3 169792 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 19430480 +GLIS3 169792 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22158537 +GLIS3 169792 Glaucoma, Angle-Closure MESH:D015812 marker/mechanism 27064256 +GLMN 11146 Glomus vagale tumors MESH:C536827 marker/mechanism 138000.0 +GLO1 2739 Anxiety Disorders MESH:D001008 marker/mechanism 22113448 +GLO1 2739 Autistic Disorder MESH:D001321 marker/mechanism 15386471 +GLO1 2739 Depressive Disorder MESH:D003866 marker/mechanism 22113448 +GLO1 2739 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +GLO1 2739 Melanoma MESH:D008545 marker/mechanism 20093988 +GLP1R 2740 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +GLP1R 2740 Hyperplasia MESH:D006965 marker/mechanism 23471186 +GLP1R 2740 Hypertension MESH:D006973 marker/mechanism 22228705 +GLP1R 2740 Neoplasms MESH:D009369 marker/mechanism 23471186 +GLRA1 2741 Dystonic Disorders MESH:D020821 marker/mechanism 17114051 +GLRA1 2741 Hyperexplexia hereditary MESH:C538136 marker/mechanism 149400.0 18175347|9927632 +GLRA3 8001 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +GLRB 2743 Hyperexplexia hereditary MESH:C538136 marker/mechanism 614619.0 +GLRX3 10539 Cardiomegaly MESH:D006332 therapeutic 16809552 +GLRX5 51218 Anemia, Sideroblastic MESH:D000756 marker/mechanism 18637800 +GLRX5 51218 Anemia, Sideroblastic, Pyridoxine-Refractory, Autosomal Recessive MESH:C567145 marker/mechanism 616860.0 +GLS 2744 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +GLS 2744 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GLS 2744 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +GLS2 27165 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GLT8D1 55830 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GLUD1 2746 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 33483742 +GLUD1 2746 Fetal Growth Retardation MESH:D005317 marker/mechanism 19500843 +GLUD1 2746 Hyperammonemia MESH:D022124 marker/mechanism 9571255 +GLUD1 2746 Hyperinsulinemic hypoglycemia, familial, 6 MESH:C538375 marker/mechanism 606762.0 +GLUD1 2746 Hyperinsulinism MESH:D006946 marker/mechanism 9571255 +GLUD2 2747 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +GLUL 2752 Brain Diseases, Metabolic, Inborn MESH:D020739 marker/mechanism 16267323 +GLUL 2752 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +GLUL 2752 Glutamine deficiency, congenital MESH:C536832 marker/mechanism 610015.0 16267323 +GLUL 2752 Hepatic Encephalopathy MESH:D006501 marker/mechanism 10564534 +GLUL 2752 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 20118494|21147764 +GLUL 2752 Obesity MESH:D009765 marker/mechanism 20882379 +GLY-1 174679 Infertility MESH:D007246 marker/mechanism 25204677 +GLYCAM1 644076 Carcinoma MESH:D002277 marker/mechanism 16316942 +GLYCAM1 644076 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +GLYCAM1 644076 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +GLYCAM1 644076 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +GLYCTK 132158 D-glycericacidemia MESH:C535767 marker/mechanism 220120.0 +GM2A 2760 Tay-Sachs Disease, AB Variant MESH:D049290 marker/mechanism 272750.0 +GMFG 9535 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GMNN 51053 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GMNN 51053 Meier-Gorlin syndrome MESH:C538012 marker/mechanism 616835.0 +GMPPA 29926 ALACRIMA, ACHALASIA, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME OMIM:615510 marker/mechanism 615510.0 +GMPPB 29925 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14 OMIM:615351 marker/mechanism 615351.0 +GMPPB 29925 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14 OMIM:615352 marker/mechanism 615352.0 +GMPPB 29925 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 615350.0 +GMPR 2766 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +GMPR2 51292 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +GMPR2 51292 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +GNA11 2767 Heart Defects, Congenital MESH:D006330 marker/mechanism 9687499 +GNA11 2767 Hypocalciuric hypercalcemia, familial, type 2 MESH:C537146 marker/mechanism 145981.0 +GNA11 2767 Melanoma MESH:D008545 marker/mechanism 23432625 +GNA11 2767 Uveal melanoma MESH:C536494 marker/mechanism 22733540|26397223|27089179 +GNA12 2768 Colitis, Ulcerative MESH:D003093 marker/mechanism 21297633 +GNA12 2768 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GNA13 10672 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143597 +GNA14 9630 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GNAI1 2770 Amnesia MESH:D000647 marker/mechanism 11350863 +GNAI1 2770 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 12199159 +GNAI2 2771 Atrioventricular Block MESH:D054537 marker/mechanism 17277016 +GNAI2 2771 Bradycardia MESH:D001919 marker/mechanism 17277016 +GNAI2 2771 Breast Neoplasms MESH:D001943 marker/mechanism 18925433 +GNAI2 2771 Carcinoma MESH:D002277 marker/mechanism 16316942 +GNAI2 2771 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GNAI2 2771 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +GNAI2 2771 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +GNAI2 2771 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 18925433 +GNAI2 2771 VENTRICULAR TACHYCARDIA, FAMILIAL OMIM:192605 marker/mechanism 192605.0 +GNAI3 2773 Amnesia MESH:D000647 marker/mechanism 11350863 +GNAI3 2773 Auriculo-condylar syndrome MESH:C538270 marker/mechanism 602483.0 +GNAL 2774 Dystonia MESH:D004421 marker/mechanism 615073.0 23222958 +GNAL 2774 Dystonic Disorders MESH:D020821 marker/mechanism 23222958 +GNAO1 2775 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GNAO1 2775 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 OMIM:615473 marker/mechanism 615473 +GNAO1 2775 Epilepsy MESH:D004827 marker/mechanism 29942082 +GNAO1 2775 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +GNAO1 2775 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 12199159 +GNAQ 2776 Albuminuria MESH:D000419 marker/mechanism 16267159 +GNAQ 2776 Blood Coagulation Disorders MESH:D001778 marker/mechanism 9296496 +GNAQ 2776 CAPILLARY MALFORMATIONS, CONGENITAL OMIM:163000 marker/mechanism 163000 +GNAQ 2776 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9687499 +GNAQ 2776 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 16267159 +GNAQ 2776 Heart Defects, Congenital MESH:D006330 marker/mechanism 9687499 +GNAQ 2776 Melanoma MESH:D008545 marker/mechanism 23432625 +GNAQ 2776 Port-Wine Stain MESH:D019339 marker/mechanism 23656586 +GNAQ 2776 Sturge-Weber Syndrome MESH:D013341 marker/mechanism 185300 23656586 +GNAQ 2776 Uveal melanoma MESH:C536494 marker/mechanism 22733540|26397223|27089179 +GNAS 2778 Acromegaly MESH:D000172 marker/mechanism 11254676 +GNAS 2778 Acth-Independent Macronodular Adrenal Hyperplasia MESH:C565662 marker/mechanism 219080 +GNAS 2778 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 24747643 +GNAS 2778 Brachydactyly MESH:D059327 marker/mechanism 12719376 +GNAS 2778 Cafe-au-Lait Spots MESH:D019080 marker/mechanism 1594625|1944469 +GNAS 2778 Cholangiocarcinoma MESH:D018281 marker/mechanism 22561520 +GNAS 2778 Endocrine System Diseases MESH:D004700 marker/mechanism 1594625|1944469 +GNAS 2778 Fibrous Dysplasia, Polyostotic MESH:D005359 marker/mechanism 174800 1594625|18345393|1944469 +GNAS 2778 Gallstones MESH:D042882 marker/mechanism 21823526 +GNAS 2778 Growth Hormone-Secreting Pituitary Adenoma MESH:D049912 marker/mechanism 11254676 +GNAS 2778 Hemorrhagic Disorders MESH:D006474 marker/mechanism 11583302 +GNAS 2778 Hypertension MESH:D006973 marker/mechanism 9506701 +GNAS 2778 Hypoxia MESH:D000860 marker/mechanism 20862257 +GNAS 2778 Insulin Resistance MESH:D007333 marker/mechanism 17062894 +GNAS 2778 Intellectual Disability MESH:D008607 marker/mechanism 11583302 +GNAS 2778 Liver Diseases, Parasitic MESH:D008109 marker/mechanism 22561520 +GNAS 2778 Neuroblastoma MESH:D009447 marker/mechanism 20862257 +GNAS 2778 Obesity MESH:D009765 marker/mechanism 17062894 +GNAS 2778 Osseous Heteroplasia, Progressive MESH:C562735 marker/mechanism 166350 +GNAS 2778 Ossification, Heterotopic MESH:D009999 marker/mechanism 18553568 +GNAS 2778 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +GNAS 2778 Pseudohypoaldosteronism MESH:D011546 marker/mechanism 603233|612462 +GNAS 2778 Pseudohypoparathyroidism MESH:D011547 marker/mechanism 103580 17299070|2109828|2122458|21823526|9506752 +GNAS 2778 Pseudohypoparathyroidism Type 1B MESH:C548075 marker/mechanism 21836370 +GNAS 2778 Pseudopseudohypoparathyroidism MESH:D011556 marker/mechanism 612463 9506752 +GNAS 2778 Puberty, Precocious MESH:D011629 marker/mechanism 1594625|1944469 +GNAS 2778 Respiration Disorders MESH:D012120 marker/mechanism 9506701 +GNAS 2778 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 12199159 +GNAS 2778 Tachycardia MESH:D013610 marker/mechanism 9506701 +GNAS-AS1 149775 Pseudohypoaldosteronism MESH:D011546 marker/mechanism 603233 +GNAT1 2779 Night blindness, congenital stationary MESH:C536122 marker/mechanism 616389 +GNAT1 2779 Night Blindness, Congenital Stationary, Autosomal Dominant 3 MESH:C566475 marker/mechanism 610444 +GNAT2 2780 Achromatopsia 4 MESH:C564206 marker/mechanism 613856 +GNAT2 2780 Color Vision Defects MESH:D003117 marker/mechanism 12077706 +GNAT3 346562 Infertility, Male MESH:D007248 marker/mechanism 23818598 +GNAZ 2781 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GNB1 2782 Anxiety Disorders MESH:D001008 marker/mechanism 22113448 +GNB1 2782 Depressive Disorder MESH:D003866 marker/mechanism 22113448 +GNB1 2782 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 42 OMIM:616973 marker/mechanism 616973 +GNB1 2782 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 614286 +GNB1 2782 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 613065 +GNB3 2784 Coronary Artery Disease MESH:D003324 marker/mechanism 16141801 +GNB3 2784 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 12511541 +GNB3 2784 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +GNB3 2784 Hypertension MESH:D006973 marker/mechanism 15961981|16141801 +GNB3 2784 Night blindness, congenital stationary MESH:C536122 marker/mechanism 617024.0 +GNB3 2784 Obesity MESH:D009765 marker/mechanism 15961981|16141801 +GNB3 2784 Seizures MESH:D012640 marker/mechanism 18855531 +GNB3 2784 Weight Gain MESH:D015430 marker/mechanism 16141801 +GNB4 59345 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +GNB4 59345 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F OMIM:615185 marker/mechanism 615185.0 +GNB4 59345 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +GNB5 10681 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +GNB5 10681 LODDER-MERLA SYNDROME, TYPE 1, WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CARDIAC ARRHYTHMIA OMIM:617173 marker/mechanism 617173.0 +GNB5 10681 LODDER-MERLA SYNDROME, TYPE 2, WITH DEVELOPMENTAL DELAY AND WITH OR WITHOUT CARDIAC ARRHYTHMIA OMIM:617182 marker/mechanism 617182.0 +GNE 10020 Distal myopathy, Nonaka type MESH:C536816 marker/mechanism 605820.0 11916006 +GNE 10020 Inclusion body myopathy autosomal recessive MESH:C538329 marker/mechanism 12473780 +GNE 10020 Myositis, Inclusion Body MESH:D018979 marker/mechanism 17261181 +GNE 10020 Sialic Acid Storage Disease MESH:D029461 marker/mechanism 269921.0 +GNG11 2791 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 24366584 +GNG11 2791 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +GNG5 2787 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +GNG7 2788 Esophageal Neoplasms MESH:D004938 marker/mechanism 18219292 +GNG8 94235 Liver Diseases MESH:D008107 marker/mechanism 19784758 +GNGT1 2792 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GNGT2 2793 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GNMT 27232 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19146867|31086990 +GNMT 27232 Hepatitis MESH:D006505 marker/mechanism 21137059 +GNMT 27232 Hepatitis, Chronic MESH:D006521 marker/mechanism 19146867 +GNMT 27232 Hyperhomocysteinemia MESH:D020138 marker/mechanism 16317120 +GNMT 27232 Hypermethioninemia MESH:C564683 marker/mechanism 606664.0 11596649|11810299 +GNMT 27232 Liver Neoplasms MESH:D008113 marker/mechanism 21137059 +GNMT 27232 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 31086990 +GNMT 27232 Prostatic Neoplasms MESH:D011471 marker/mechanism 17332283 +GNPAT 8443 Rhizomelic chondrodysplasia punctata, type 2 MESH:C537607 marker/mechanism 222765.0 +GNPDA1 10007 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GNPDA2 132789 Body Weight MESH:D001835 marker/mechanism 22344219 +GNPDA2 132789 Obesity MESH:D009765 marker/mechanism 19079261 +GNPNAT1 64841 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +GNPNAT1 64841 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +GNPTAB 79158 MUCOLIPIDOSIS II ALPHA/BETA OMIM:252500 marker/mechanism 252500.0 +GNPTAB 79158 MUCOLIPIDOSIS III ALPHA/BETA OMIM:252600 marker/mechanism 252600.0 +GNPTG 84572 Mucolipidosis III Gamma MESH:C565367 marker/mechanism 252605.0 +GNRH1 2796 Adrenal Gland Neoplasms MESH:D000310 therapeutic 19261682 +GNRH1 2796 Bradycardia MESH:D001919 therapeutic 6350720 +GNRH1 2796 Eunuchoidism, familial hypogonadotropic MESH:C535764 marker/mechanism 614841.0 +GNRH1 2796 Headache MESH:D006261 marker/mechanism 12910066 +GNRH1 2796 Hyperprolactinemia MESH:D006966 marker/mechanism 2204052 +GNRH1 2796 Hypertension MESH:D006973 marker/mechanism 6350720 +GNRH1 2796 Hypogonadism MESH:D007006 therapeutic 20063086 +GNRH1 2796 Hypothermia MESH:D007035 marker/mechanism 6350720 +GNRH1 2796 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 19535795 +GNRH1 2796 Infertility, Male MESH:D007248 therapeutic 20063086 +GNRH1 2796 Intestinal Polyps MESH:D007417 therapeutic 24431404 +GNRH1 2796 Puberty, Precocious MESH:D011629 marker/mechanism 18345393 +GNRH1 2796 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +GNRH1 2796 Tachycardia MESH:D013610 marker/mechanism 6350720 +GNRH1 2796 Vomiting MESH:D014839 marker/mechanism 12910066 +GNRH1 2796 Weight Loss MESH:D015431 therapeutic 24431404 +GNRHR 2798 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 19131502 +GNRHR 2798 Hypogonadism MESH:D007006 marker/mechanism 15625238 +GNRHR 2798 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 +GNS 2799 Mucopolysaccharidosis III MESH:D009084 marker/mechanism 252940.0 3391615 +GOLGA4 2803 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +GOLGA4 2803 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +GOLGA4 2803 Skin Diseases MESH:D012871 marker/mechanism 16835338 +GOLGA6L7 728310 Skin Diseases MESH:D012871 marker/mechanism 28720099 +GOLM1 51280 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +GOLM1 51280 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +GON4L 54856 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +GOPC 57120 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +GOPC 57120 Melanoma MESH:D008545 marker/mechanism 22535842 +GORAB 92344 Gerodermia osteodysplastica MESH:C537799 marker/mechanism 231070.0 18997784 +GORAB 92344 Osteoporosis MESH:D010024 marker/mechanism 18997784 +GORAB 92344 Skin Abnormalities MESH:D012868 marker/mechanism 18997784 +GOSR2 9570 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +GOSR2 9570 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 614018.0 +GOT1 2805 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +GOT1 2805 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +GP1BA 2811 Bernard-Soulier Syndrome MESH:D001606 marker/mechanism 231200.0 +GP1BA 2811 BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT OMIM:153670 marker/mechanism 153670.0 +GP1BA 2811 Hypertension MESH:D006973 marker/mechanism 22352330 +GP1BA 2811 NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO OMIM:258660 marker/mechanism 258660.0 +GP1BA 2811 Thrombosis MESH:D013927 marker/mechanism 17334511 +GP1BA 2811 Von Willebrand disease, platelet type MESH:C536458 marker/mechanism 177820.0 +GP1BB 2812 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +GP1BB 2812 Bernard-Soulier Syndrome MESH:D001606 marker/mechanism 231200.0 +GP1BB 2812 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15213848 +GP1BB 2812 Heart Defects, Congenital MESH:D006330 marker/mechanism 15213848 +GP1BB 2812 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +GP1BB 2812 Thrombocytopenia MESH:D013921 marker/mechanism 15213848 +GP2 2813 Body Weight MESH:D001835 marker/mechanism 22344219 +GP2 2813 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +GP6 51206 BLEEDING DISORDER, PLATELET-TYPE, 11 OMIM:614201 marker/mechanism 614201.0 +GP9 2815 Bernard-Soulier Syndrome MESH:D001606 marker/mechanism 231200.0 +GP9 2815 Thrombocytopenia MESH:D013921 marker/mechanism 15225244 +GPAM 57678 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 9452481 +GPAM 57678 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GPAM 57678 Melanoma MESH:D008545 marker/mechanism 22535842 +GPBAR1 151306 Constipation MESH:D003248 marker/mechanism 23041323 +GPBAR1 151306 Crohn Disease MESH:D003424 marker/mechanism 23566200 +GPC3 2719 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16698587|28284560 +GPC3 2719 Mesothelioma MESH:D008654 marker/mechanism 10656689 +GPC3 2719 Simpson-Golabi-Behmel syndrome MESH:C537340 marker/mechanism 312870.0 +GPC3 2719 Wilms Tumor MESH:D009396 marker/mechanism 194070.0 +GPC4 2239 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +GPC4 2239 Simpson-Golabi-Behmel syndrome MESH:C537340 marker/mechanism 312870.0 +GPC4 2239 Wilms Tumor MESH:D009396 marker/mechanism 194070.0 +GPC5 2262 Albuminuria MESH:D000419 therapeutic 21441931 +GPC5 2262 Nephrotic Syndrome MESH:D009404 therapeutic 21441931 +GPC6 10082 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19481194 +GPC6 10082 Limb Deformities, Congenital MESH:D017880 marker/mechanism 19481194 +GPC6 10082 Omodysplasia type 1 MESH:C537746 marker/mechanism 258315.0 19481194 +GPC6 10082 Osteoporosis MESH:D010024 marker/mechanism 28869591 +GPCPD1 56261 Neoplasm Metastasis MESH:D009362 marker/mechanism 25482527 +GPD1 2819 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +GPD1 2819 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE OMIM:614480 marker/mechanism 614480.0 +GPD1L 23171 Brugada Syndrome 2 MESH:C567087 marker/mechanism 611777.0 +GPD1L 23171 Fatty Liver MESH:D005234 marker/mechanism 25226513 +GPD2 2820 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +GPD2 2820 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 16123366 +GPD2 2820 Methylmalonic acidemia MESH:C537358 marker/mechanism 16823967 +GPD2 2820 Osteoporosis MESH:D010024 marker/mechanism 18924182 +GPDH1 33824 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +GPER1 2852 Abnormalities, Multiple MESH:D000015 marker/mechanism 21984484 +GPER1 2852 Breast Neoplasms MESH:D001943 marker/mechanism 24440569 +GPER1 2852 Hepatomegaly MESH:D006529 marker/mechanism 30641053 +GPER1 2852 Hyperalgesia MESH:D006930 therapeutic 25280432 +GPER1 2852 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 30165855 +GPER1 2852 Leiomyoma MESH:D007889 marker/mechanism 31468104 +GPER1 2852 Liver Neoplasms MESH:D008113 therapeutic 30641053 +GPHA2 170589 Melanoma MESH:D008545 marker/mechanism 22535842 +GPHN 10243 Alcoholism MESH:D000437 marker/mechanism 22253714 +GPHN 10243 Cocaine-Related Disorders MESH:D019970 marker/mechanism 22253714 +GPHN 10243 Hyperexplexia hereditary MESH:C538136 marker/mechanism 149400.0 +GPHN 10243 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +GPHN 10243 Molybdenum Cofactor Deficiency, Complementation Group C MESH:C565374 marker/mechanism 615501.0 +GPI 2821 Anemia, Hemolytic MESH:D000743 marker/mechanism 8822954 +GPI 2821 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +GPI 2821 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY OMIM:613470 marker/mechanism 613470.0 +GPI1 14751 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +GPI1 14751 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +GPIHBP1 338328 HYPERLIPOPROTEINEMIA, TYPE ID OMIM:615947 marker/mechanism 615947.0 +GPM6A 2823 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GPN1 11321 Mouth Neoplasms MESH:D009062 marker/mechanism 27749845 +GPNMB 10457 Acute Kidney Injury MESH:D058186 marker/mechanism 23052191 +GPNMB 10457 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +GPNMB 10457 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 24979617 +GPNMB 10457 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +GPNMB 10457 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GPNMB 10457 Liver Failure, Acute MESH:D017114 marker/mechanism 15763343 +GPR101 83550 Growth Hormone-Secreting Pituitary Adenoma MESH:D049912 marker/mechanism 300943.0 +GPR135 64582 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 28722770 +GPR137B-PS 664862 Liver Cirrhosis MESH:D008103 marker/mechanism 33069761 +GPR143 4935 NYSTAGMUS 6, CONGENITAL, X-LINKED OMIM:300814 marker/mechanism 300814.0 +GPR143 4935 Ocular Albinism type 1 MESH:C537863 marker/mechanism 300500.0 +GPR150 285601 Ovarian Neoplasms MESH:D010051 marker/mechanism 17303177 +GPR153 387509 Schizophrenia MESH:D012559 marker/mechanism 21822266 +GPR155 151556 Autistic Disorder MESH:D001321 marker/mechanism 17519220 +GPR155 151556 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +GPR158 57512 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GPR158 57512 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +GPR161 23432 Medulloblastoma MESH:D008527 marker/mechanism 155255.0 +GPR17 2840 Brain Infarction MESH:D020520 therapeutic 18974869 +GPR17 2840 Hypercholesterolemia MESH:D006937 marker/mechanism 34144038 +GPR17 2840 Insulin Resistance MESH:D007333 marker/mechanism 34144038 +GPR17 2840 Metabolic Syndrome MESH:D024821 marker/mechanism 34144038 +GPR17 2840 Obesity MESH:D009765 marker/mechanism 34144038 +GPR17 2840 Pediatric Obesity MESH:D063766 marker/mechanism 34144038 +GPR179 440435 Night blindness, congenital stationary MESH:C536122 marker/mechanism 614565.0 +GPR179 440435 Polyomavirus Infections MESH:D027601 marker/mechanism 25463609 +GPR182 11318 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GPR183 1880 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +GPR183 1880 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +GPR27 2850 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +GPR32 2854 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GPR34 2857 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +GPR37 2861 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +GPR50 9248 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20657642 +GPR55 9290 Hyperglycemia MESH:D006943 marker/mechanism 30148676 +GPR55 9290 Hypertriglyceridemia MESH:D015228 marker/mechanism 30148676 +GPR55 9290 Neoplasms MESH:D009369 marker/mechanism 27423937 +GPR55 9290 Weight Gain MESH:D015430 marker/mechanism 30148676 +GPR65 8477 Colitis, Ulcerative MESH:D003093 marker/mechanism 30616622 +GPR68 8111 AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6 OMIM:617217 marker/mechanism 617217.0 +GPR68 8111 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GPR88 54112 CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION OMIM:616939 marker/mechanism 616939.0 +GPRC5A 9052 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860 +GPSM1 26086 Cocaine-Related Disorders MESH:D019970 marker/mechanism 15091342 +GPSM2 29899 Chudley-Mccullough syndrome MESH:C535459 marker/mechanism 604213.0 22578326 +GPT 2875 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 145039|19481104 +GPT 2875 Fatty Liver MESH:D005234 marker/mechanism 19481104 +GPT 2875 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +GPT 2875 Liver Diseases MESH:D008107 marker/mechanism 25455894 +GPT 2875 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +GPT 2875 Reperfusion Injury MESH:D015427 marker/mechanism 8215636 +GPT2 84706 NEURODEVELOPMENTAL DISORDER WITH SPASTIC PARAPLEGIA AND MICROCEPHALY OMIM:616281 marker/mechanism 616281.0 +GPX1 2876 Autistic Disorder MESH:D001321 marker/mechanism 19195803 +GPX1 2876 Brain Ischemia MESH:D002545 therapeutic 12531513 +GPX1 2876 Breast Neoplasms MESH:D001943 marker/mechanism 12810669 +GPX1 2876 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15557674 +GPX1 2876 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 15247771 +GPX1 2876 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 18940188 +GPX1 2876 Cardiovascular Diseases MESH:D002318 marker/mechanism 14573732 +GPX1 2876 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +GPX1 2876 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366|23795780 +GPX1 2876 Epilepsy MESH:D004827 marker/mechanism 19499324 +GPX1 2876 Fatty Liver MESH:D005234 marker/mechanism 10860543 +GPX1 2876 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 35764155 +GPX1 2876 Glutathione Peroxidase Deficiency, Hemolytic Anemia possibly due to MESH:C564217 marker/mechanism 614164.0 +GPX1 2876 Head and Neck Neoplasms MESH:D006258 marker/mechanism 15557674 +GPX1 2876 Hepatitis, Chronic MESH:D006521 marker/mechanism 25053573 +GPX1 2876 Hyperglycemia MESH:D006943 marker/mechanism 15184668 +GPX1 2876 Hyperinsulinism MESH:D006946 marker/mechanism 15184668|18560803 +GPX1 2876 Hypertension MESH:D006973 marker/mechanism 21593737 +GPX1 2876 Hyperthermia MESH:D000084462 therapeutic 34082047 +GPX1 2876 Hyperthyroidism MESH:D006980 marker/mechanism 19914224 +GPX1 2876 Lung Neoplasms MESH:D008175 marker/mechanism 11103801 +GPX1 2876 Obesity MESH:D009765 marker/mechanism 15184668 +GPX1 2876 Osteoporosis MESH:D010024 marker/mechanism 18924182 +GPX1 2876 Parkinson Disease MESH:D010300 therapeutic 15824117 +GPX1 2876 Reperfusion Injury MESH:D015427 marker/mechanism 23743330 +GPX1 2876 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 15247771|35764155 +GPX2 2877 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GPX2 2877 Breast Neoplasms MESH:D001943 marker/mechanism 18056462 +GPX2 2877 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +GPX2 2877 Neoplasm Metastasis MESH:D009362 marker/mechanism 23867582 +GPX3 2878 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +GPX3 2878 Endometriosis MESH:D004715 marker/mechanism 20864642|21063030 +GPX3 2878 Fanconi Syndrome MESH:D005198 marker/mechanism 9851889 +GPX3 2878 Insulin Resistance MESH:D007333 marker/mechanism 19270708 +GPX3 2878 Liver Neoplasms MESH:D008113 marker/mechanism 20195826 +GPX3 2878 Lung Neoplasms MESH:D008175 marker/mechanism 19180532|21552421 +GPX3 2878 Neoplasms MESH:D009369 marker/mechanism 21684681 +GPX3 2878 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +GPX3 2878 Obesity MESH:D009765 marker/mechanism 11328671|19270708 +GPX3 2878 Prostatic Neoplasms MESH:D011471 marker/mechanism 17804715 +GPX4 2879 Breast Neoplasms MESH:D001943 marker/mechanism 17634480 +GPX4 2879 Cadmium Poisoning MESH:D002105 marker/mechanism 20643113 +GPX4 2879 Colorectal Neoplasms MESH:D015179 marker/mechanism 18850177 +GPX4 2879 Cryptorchidism MESH:D003456 marker/mechanism 26050606 +GPX4 2879 Embryo Loss MESH:D020964 marker/mechanism 12566075 +GPX4 2879 Fatty Liver MESH:D005234 marker/mechanism 26042203 +GPX4 2879 Fibrosis MESH:D005355 marker/mechanism 26042203 +GPX4 2879 Glucose Intolerance MESH:D018149 marker/mechanism 26042203 +GPX4 2879 Heart Failure MESH:D006333 marker/mechanism 20304815 +GPX4 2879 Infertility, Male MESH:D007248 marker/mechanism 19417079|19744930 +GPX4 2879 Spondylometaphyseal dysplasia, Sedaghatian type MESH:C535798 marker/mechanism 250220.0 +GPX5 2880 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GPX6 257202 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GPX6 257202 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 25581431 +GPX-7 187542 Infertility MESH:D007246 marker/mechanism 25204677 +GPX8 493869 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GRB14 2888 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 21874001 +GRB14 2888 Weight Gain MESH:D015430 marker/mechanism 19030233 +GRB7 2886 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +GRB7 2886 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 17426702|19075277 +GRB7 2886 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +GRB7 2886 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +GRB7 2886 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +GREB1 9687 Endometriosis MESH:D004715 marker/mechanism 23104006 +GREB1 9687 Prostatic Neoplasms MESH:D011471 marker/mechanism 16496412 +GREM1 26585 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 22561515 +GREM1 26585 Colorectal Neoplasms MESH:D015179 marker/mechanism 18084292|30510241 +GREM1 26585 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17975199 +GREM1 26585 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +GREM2 64388 TOOTH AGENESIS, SELECTIVE, 9 OMIM:617275 marker/mechanism 617275.0 +GREP1 283875 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 34652879 +GREP1 283875 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34652879 +GREP1 283875 Neoplasms, Experimental MESH:D009374 marker/mechanism 34652879 +GREP1 283875 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 34652879 +GRHL2 79977 Deafness, Autosomal Dominant 28 MESH:C563890 marker/mechanism 608641.0 +GRHL2 79977 ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME OMIM:616029 marker/mechanism 616029.0 +GRHL2-DT 107986962 Disease Progression MESH:D018450 therapeutic 33607219 +GRHL2-DT 107986962 Stomach Neoplasms MESH:D013274 therapeutic 33607219 +GRHL3 57822 Fetal Death MESH:D005313 marker/mechanism 6635991 +GRHL3 57822 Neural Tube Defects MESH:D009436 marker/mechanism 6635991 +GRHL3 57822 Van der Woude syndrome 2 MESH:C536529 marker/mechanism 606713.0 +GRHPR 9380 Primary hyperoxaluria type 2 MESH:C536415 marker/mechanism 260000.0 +GRHPR 9380 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +GRIA1 2890 Autistic Disorder MESH:D001321 marker/mechanism 11706102 +GRIA1 2890 Cocaine-Related Disorders MESH:D019970 marker/mechanism|therapeutic 14684464|15764012|16495937|18430032|18486119 +GRIA1 2890 Hyperkinesis MESH:D006948 marker/mechanism 18171924|19036973 +GRIA1 2890 Hypotension MESH:D007022 marker/mechanism 18639534 +GRIA1 2890 Learning Disabilities MESH:D007859 marker/mechanism 16495937 +GRIA1 2890 Morphine Dependence MESH:D009021 marker/mechanism 11404432 +GRIA1 2890 Olfaction Disorders MESH:D000857 marker/mechanism 34624383 +GRIA1 2890 Rhinitis, Allergic MESH:D065631 marker/mechanism 34624383 +GRIA1 2890 Sexual Dysfunctions, Psychological MESH:D020018 marker/mechanism 19295509 +GRIA1 2890 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 11404432|12511956 +GRIA2 2891 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18945913 +GRIA2 2891 Hyperkinesis MESH:D006948 marker/mechanism 18171924 +GRIA2 2891 Olfaction Disorders MESH:D000857 marker/mechanism 34624383 +GRIA2 2891 Rhinitis, Allergic MESH:D065631 marker/mechanism 34624383 +GRIA2 2891 Status Epilepticus MESH:D013226 marker/mechanism 19222700 +GRIA2 2891 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 12511956 +GRIA3 2892 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 15264227 +GRIA3 2892 Mental Retardation, X-Linked 94 MESH:C567479 marker/mechanism 300699.0 +GRIA3 2892 Sexual Dysfunctions, Psychological MESH:D020018 marker/mechanism 19295509 +GRIA4 2893 Myopia MESH:D009216 marker/mechanism 23396134 +GRIA4 2893 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +GRID1 2894 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +GRID2 2895 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 616204.0 +GRIK1 2897 Seizures MESH:D012640 marker/mechanism 12080343 +GRIK2 2898 Autistic Disorder MESH:D001321 marker/mechanism 11920157|20442744 +GRIK2 2898 Bipolar Disorder MESH:D001714 marker/mechanism 18332879 +GRIK2 2898 Breast Neoplasms MESH:D001943 marker/mechanism 30705370 +GRIK2 2898 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +GRIK2 2898 Colonic Neoplasms MESH:D003110 marker/mechanism 30705370 +GRIK2 2898 Esophageal Neoplasms MESH:D004938 marker/mechanism 30705370 +GRIK2 2898 Glioblastoma MESH:D005909 marker/mechanism 30705370 +GRIK2 2898 Liver Neoplasms MESH:D008113 marker/mechanism 30705370 +GRIK2 2898 Lymphatic Metastasis MESH:D008207 marker/mechanism 30705370 +GRIK2 2898 Mental Retardation, Autosomal Recessive 6 MESH:C567017 marker/mechanism 611092.0 +GRIK2 2898 Ovarian Neoplasms MESH:D010051 marker/mechanism 30705370 +GRIK2 2898 Schizophrenia MESH:D012559 marker/mechanism 18923069 +GRIK2 2898 Sexual Dysfunctions, Psychological MESH:D020018 marker/mechanism 19295509 +GRIK2 2898 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +GRIK3 2899 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +GRIK5 2901 Schizophrenia MESH:D012559 marker/mechanism 18923069 +GRIN1 2902 Cocaine-Related Disorders MESH:D019970 marker/mechanism 16014726|20149346 +GRIN1 2902 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +GRIN1 2902 Hyperalgesia MESH:D006930 marker/mechanism 27093858 +GRIN1 2902 NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT OMIM:614254 marker/mechanism 614254.0 +GRIN1 2902 Pain MESH:D010146 therapeutic 18155693 +GRIN1 2902 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +GRIN1 2902 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +GRIN2A 2903 Autistic Disorder MESH:D001321 marker/mechanism 15830322 +GRIN2A 2903 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +GRIN2A 2903 Colorectal Neoplasms MESH:D015179 marker/mechanism 17922030 +GRIN2A 2903 Epilepsy MESH:D004827 marker/mechanism 20890276|23933818 +GRIN2A 2903 EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT OMIM:245570 marker/mechanism 245570.0 +GRIN2A 2903 Epilepsy, Rolandic MESH:D019305 marker/mechanism 23933819 +GRIN2A 2903 Landau-Kleffner Syndrome MESH:D018887 marker/mechanism 23933820 +GRIN2A 2903 Language Development Disorders MESH:D007805 marker/mechanism 23933820 +GRIN2A 2903 Melanoma MESH:D008545 marker/mechanism 21499247 +GRIN2A 2903 Morphine Dependence MESH:D009021 marker/mechanism 12878694 +GRIN2A 2903 Speech Disorders MESH:D013064 marker/mechanism 23933820 +GRIN2A 2903 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 12878694 +GRIN2B 2904 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21572417 +GRIN2B 2904 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27 OMIM:616139 marker/mechanism 616139.0 +GRIN2B 2904 Epilepsy MESH:D004827 marker/mechanism 16407536|29942082 +GRIN2B 2904 Hyperalgesia MESH:D006930 marker/mechanism 20042082 +GRIN2B 2904 Hypotension MESH:D007022 marker/mechanism 18639534 +GRIN2B 2904 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES OMIM:613970 marker/mechanism 613970.0 +GRIN2B 2904 Intellectual Disability MESH:D008607 marker/mechanism 20890276 +GRIN2B 2904 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +GRIN2B 2904 Schizophrenia MESH:D012559 marker/mechanism 18583979 +GRIN2D 2906 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46 OMIM:617162 marker/mechanism 617162.0 +GRIN2D 2906 Nerve Degeneration MESH:D009410 marker/mechanism 19911010 +GRIN2D 2906 Schizophrenia MESH:D012559 marker/mechanism 19856012 +GRIN3A 116443 Erectile Dysfunction MESH:D007172 marker/mechanism 19295509 +GRK1 6011 Neuralgia MESH:D009437 marker/mechanism 31432094 +GRK1 6011 Oguchi disease MESH:C537743 marker/mechanism 613411.0 +GRK2 156 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 10094932 +GRK2 156 Cardiomegaly MESH:D006332 marker/mechanism 11901213 +GRK2 156 Cardiomyopathies MESH:D009202 therapeutic 17008600 +GRK2 156 Cardiovascular Diseases MESH:D002318 marker/mechanism 26032411 +GRK2 156 Congenital Abnormalities MESH:D000013 marker/mechanism 17008600 +GRK2 156 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +GRK2 156 Embryo Loss MESH:D020964 marker/mechanism 17008600 +GRK2 156 Heart Failure MESH:D006333 marker/mechanism 26670611 +GRK2 156 Hypertension MESH:D006973 marker/mechanism 11901213 +GRK3 157 Bipolar Disorder MESH:D001714 marker/mechanism 12808434 +GRK4 2868 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +GRK5 2869 Cardiovascular Diseases MESH:D002318 marker/mechanism 26032411 +GRK5 2869 Liver Diseases MESH:D008107 marker/mechanism 19784758 +GRK6 2870 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 10094932 +GRM1 2911 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 22138692 +GRM1 2911 Epilepsy MESH:D004827 marker/mechanism 19853022 +GRM1 2911 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 15694259 +GRM1 2911 Fibroma MESH:D005350 marker/mechanism 24658000 +GRM1 2911 Neoplasms, Bone Tissue MESH:D018213 marker/mechanism 24658000 +GRM1 2911 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 614831.0 +GRM1 2911 Status Epilepticus MESH:D013226 marker/mechanism 15058486|17446080 +GRM2 2912 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 20211215 +GRM2 2912 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 18804094 +GRM2 2912 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 20211215 +GRM2 2912 Schizophrenia MESH:D012559 marker/mechanism 18923069 +GRM3 2913 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 18804094 +GRM3 2913 Melanoma MESH:D008545 marker/mechanism 21946352|22842228 +GRM3 2913 Schizophrenia MESH:D012559 marker/mechanism 18256595 +GRM4 2914 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 15694259 +GRM4 2914 Nerve Degeneration MESH:D009410 therapeutic 17446080 +GRM4 2914 Osteosarcoma MESH:D012516 marker/mechanism 23727862 +GRM5 2915 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 19546859|22138692 +GRM5 2915 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20826661 +GRM5 2915 Diabetic Neuropathies MESH:D003929 marker/mechanism 19840219 +GRM5 2915 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 15694259 +GRM5 2915 Neuralgia MESH:D009437 marker/mechanism 19840219 +GRM5 2915 Status Epilepticus MESH:D013226 marker/mechanism 17634364|18774262 +GRM5 2915 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +GRM6 2916 Night blindness, congenital stationary MESH:C536122 marker/mechanism 257270.0 +GRM7 2917 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 22138692 +GRM7 2917 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +GRM8 2918 Anxiety Disorders MESH:D001008 marker/mechanism 17434465 +GRM8 2918 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 22138692 +GRM8 2918 Autistic Disorder MESH:D001321 marker/mechanism 12676915 +GRM8 2918 Brain Injuries MESH:D001930 marker/mechanism 23159883 +GRM8 2918 Gliosis MESH:D005911 marker/mechanism 11226630 +GRM8 2918 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +GRN 2896 CEROID LIPOFUSCINOSIS, NEURONAL, 11 OMIM:614706 marker/mechanism 614706.0 +GRN 2896 Dementia MESH:D003704 marker/mechanism 17436289|18543312 +GRN 2896 Frontotemporal Dementia MESH:D057180 marker/mechanism 21454553|22028881|24569924 +GRN 2896 Frontotemporal Lobar Degeneration MESH:D057174 marker/mechanism 20154673 +GRN 2896 FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED OMIM:607485 marker/mechanism 607485.0 +GRN 2896 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GRN 2896 Nerve Degeneration MESH:D009410 therapeutic 21820214 +GRP 2922 Amnesia MESH:D000647 therapeutic 11564462 +GRP 2922 Head and Neck Neoplasms MESH:D006258 marker/mechanism 15342401 +GRP 2922 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 2910524 +GRP 2922 Pruritus MESH:D011537 marker/mechanism 29669290 +GRPEL1 80273 HIV Infections MESH:D015658 marker/mechanism 15308739 +GRPR 2925 Memory Disorders MESH:D008569 marker/mechanism 17097693 +GRPR 2925 Prostatic Neoplasms MESH:D011471 marker/mechanism 17204703 +GRWD1 83743 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +GRWD1 83743 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +GRXCR1 389207 DEAFNESS, AUTOSOMAL RECESSIVE 25 OMIM:613285 marker/mechanism 613285.0 +GRXCR2 643226 DEAFNESS, AUTOSOMAL RECESSIVE 101 OMIM:615837 marker/mechanism 615837.0 +GSC 145258 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10433910 +GSDMB 55876 Asthma MESH:D001249 marker/mechanism 24241537 +GSDME 1687 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860 +GSDME 1687 Deafness, Autosomal Dominant 5 MESH:C563410 marker/mechanism 600994.0 +GSDME 1687 Hearing Loss MESH:D034381 marker/mechanism 21782914 +GSK3A 2931 Bipolar Disorder MESH:D001714 marker/mechanism 20357757 +GSK3A 2931 Depressive Disorder MESH:D003866 marker/mechanism 20357757 +GSK3A 2931 Schizophrenia MESH:D012559 marker/mechanism 16223876 +GSK3B 2932 Abnormalities, Multiple MESH:D000015 marker/mechanism 22975441 +GSK3B 2932 Acute Kidney Injury MESH:D058186 marker/mechanism 22785175 +GSK3B 2932 Alzheimer Disease MESH:D000544 marker/mechanism 17409235|22944069 +GSK3B 2932 Arthritis, Experimental MESH:D001169 marker/mechanism 16713974 +GSK3B 2932 Bipolar Disorder MESH:D001714 marker/mechanism 20357757 +GSK3B 2932 Brain Injuries MESH:D001930 marker/mechanism 24675465 +GSK3B 2932 Breast Neoplasms MESH:D001943 marker/mechanism 35639300 +GSK3B 2932 Cardiomegaly MESH:D006332 marker/mechanism 17901358 +GSK3B 2932 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 29626521 +GSK3B 2932 Ceroid Lipofuscinosis, Neuronal, 6 MESH:C566627 marker/mechanism 23516525 +GSK3B 2932 Cognition Disorders MESH:D003072 marker/mechanism 24634145 +GSK3B 2932 Depressive Disorder MESH:D003866 marker/mechanism 20357757|20534517 +GSK3B 2932 Heart Failure MESH:D006333 marker/mechanism 17901358 +GSK3B 2932 Hypertension MESH:D006973 marker/mechanism 22982863 +GSK3B 2932 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 18787224 +GSK3B 2932 Muscular Atrophy MESH:D009133 therapeutic 18467435 +GSK3B 2932 Myocardial Infarction MESH:D009203 marker/mechanism 16716347 +GSK3B 2932 Peritonitis MESH:D010538 marker/mechanism 16713974 +GSK3B 2932 Poisoning MESH:D011041 marker/mechanism 22975441 +GSK3B 2932 Prostatic Neoplasms MESH:D011471 marker/mechanism 16421604|25246272 +GSK3B 2932 Schizophrenia MESH:D012559 marker/mechanism 14745448|31563592 +GSK3B 2932 Tauopathies MESH:D024801 marker/mechanism 26945731 +GSK3B 2932 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 36115647 +GSKIP 51527 Leukemia, Myeloid MESH:D007951 marker/mechanism 26280900 +GSKIP 51527 Myeloproliferative Disorders MESH:D009196 marker/mechanism 26280900 +GSN 2934 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +GSN 2934 Cardiomegaly MESH:D006332 marker/mechanism 30240538 +GSN 2934 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +GSN 2934 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GSN 2934 Meretoja syndrome MESH:C537459 marker/mechanism 105120.0 +GSN 2934 Mesothelioma MESH:D008654 marker/mechanism 15920167 +GSN 2934 Osteoporosis MESH:D010024 marker/mechanism 18924182 +GSN 2934 Paratuberculosis MESH:D010283 marker/mechanism 22633222 +GSN 2934 Weight Gain MESH:D015430 marker/mechanism 19030233 +GSR 2936 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 16681429 +GSR 2936 Anemia MESH:D000740 marker/mechanism 5984971 +GSR 2936 Anemia, Hemolytic MESH:D000743 marker/mechanism 13931269 +GSR 2936 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513|28069987 +GSR 2936 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +GSR 2936 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 20620209 +GSR 2936 Edema MESH:D004487 marker/mechanism 19874808 +GSR 2936 Hyperthyroidism MESH:D006980 marker/mechanism 19914224 +GSR 2936 Hypoglycemia MESH:D007003 marker/mechanism 20620209 +GSR 2936 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +GSR 2936 Parkinsonian Disorders MESH:D020734 therapeutic 22721943 +GSR 2936 Protein Deficiency MESH:D011488 marker/mechanism 15865262 +GSR 2936 Ureteral Calculi MESH:D014514 marker/mechanism 24360074 +GSS 2937 Carcinoma MESH:D002277 marker/mechanism 12376462 +GSS 2937 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +GSS 2937 Glutathione synthetase deficiency MESH:C536835 marker/mechanism 266130.0 +GSS 2937 GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO OMIM:231900 marker/mechanism 231900.0 +GSS 2937 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +GSS 2937 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +GSS 2937 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +GST-1 176281 Nerve Degeneration MESH:D009410 therapeutic 23721876 +GST-18 185412 Infertility MESH:D007246 marker/mechanism 25204677 +GSTA1 2938 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +GSTA1 2938 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28412881 +GSTA1 2938 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +GSTA1 2938 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GSTA1 2938 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 23643483 +GSTA1 2938 Prostatic Neoplasms MESH:D011471 marker/mechanism 15616829 +GSTA2 2939 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GSTA2 2939 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +GSTA3 2940 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GSTA3 2940 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GSTA4 2941 Arteriosclerosis MESH:D001161 marker/mechanism|therapeutic 15064094|20177342 +GSTA4 2941 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +GSTA4 2941 Parkinson Disease MESH:D010300 marker/mechanism 16510128 +GSTA4 2941 Precancerous Conditions MESH:D011230 marker/mechanism 20180811 +GSTA5 221357 Hypertension MESH:D006973 marker/mechanism 22228705 +GSTCD 79807 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +GSTK1 373156 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +GSTK1 373156 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +GSTM1 2944 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 19254865 +GSTM1 2944 Asthma MESH:D001249 marker/mechanism 16870661|18988661 +GSTM1 2944 Atherosclerosis MESH:D050197 marker/mechanism 19822795 +GSTM1 2944 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GSTM1 2944 Autistic Disorder MESH:D001321 marker/mechanism 16472391 +GSTM1 2944 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 7892276 +GSTM1 2944 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 31569996 +GSTM1 2944 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 18566013|26656529 +GSTM1 2944 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 22072123 +GSTM1 2944 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 17465707|18666253 +GSTM1 2944 Chloracne MESH:D054506 marker/mechanism 17101203 +GSTM1 2944 Chromosome Aberrations MESH:D002869 marker/mechanism 23159492|24036326 +GSTM1 2944 Chromosome Breakage MESH:D019457 marker/mechanism 27406225 +GSTM1 2944 Colorectal Neoplasms MESH:D015179 marker/mechanism 20878130 +GSTM1 2944 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22652274 +GSTM1 2944 Disease Susceptibility MESH:D004198 marker/mechanism 16537716|31569996 +GSTM1 2944 Drug Hypersensitivity MESH:D004342 marker/mechanism 20485159 +GSTM1 2944 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 24036326 +GSTM1 2944 Leukemia MESH:D007938 marker/mechanism 14694614|18505952 +GSTM1 2944 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15650968 +GSTM1 2944 Liver Neoplasms MESH:D008113 marker/mechanism 21214675 +GSTM1 2944 Lung Neoplasms MESH:D008175 marker/mechanism 17114358|17311802|22072123|24852519 +GSTM1 2944 Mesothelioma MESH:D008654 marker/mechanism 17290392 +GSTM1 2944 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 16697254 +GSTM1 2944 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 20951227 +GSTM1 2944 Neoplasms, Second Primary MESH:D016609 marker/mechanism 16703596 +GSTM1 2944 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +GSTM1 2944 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 23643483 +GSTM1 2944 Parkinson Disease MESH:D010300 marker/mechanism 17449559 +GSTM1 2944 Prostatic Neoplasms MESH:D011471 marker/mechanism 11275366|18304461|22564066 +GSTM1 2944 Raynaud Disease MESH:D011928 marker/mechanism 16977343 +GSTM1 2944 Skin Diseases MESH:D012871 marker/mechanism 16353154 +GSTM1 2944 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 18505952|20972438 +GSTM1 2944 Urticaria MESH:D014581 marker/mechanism 16433794 +GSTM2 2946 Acute Kidney Injury MESH:D058186 marker/mechanism 20623750 +GSTM2 2946 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 19900515 +GSTM2 2946 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +GSTM2 2946 Down Syndrome MESH:D004314 marker/mechanism 11771762 +GSTM2 2946 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GSTM2 2946 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +GSTM3 2947 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 25743375 +GSTM3 2947 Chloracne MESH:D054506 marker/mechanism 17101203 +GSTM3 2947 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +GSTM3 2947 Prostatic Neoplasms MESH:D011471 marker/mechanism 14968442 +GSTM4 2948 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +GSTM4 2948 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +GSTM5 2949 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GSTM5 2949 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +GSTM5 2949 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +GSTM6 14867 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +GSTO1 9446 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GSTO1 9446 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +GSTO1 9446 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +GSTO1 9446 Leukemia MESH:D007938 marker/mechanism 22293942 +GSTO1 9446 Lung Diseases MESH:D008171 marker/mechanism 22293942 +GSTO1 9446 Neoplasms MESH:D009369 marker/mechanism 21899313 +GSTO1 9446 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +GSTO1 9446 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +GSTO1 9446 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +GSTO1 9446 Skin Diseases MESH:D012871 marker/mechanism 17548696 +GSTO2 119391 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 22306368 +GSTP1 2950 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +GSTP1 2950 Acute Kidney Injury MESH:D058186 marker/mechanism 20623750 +GSTP1 2950 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 15729709 +GSTP1 2950 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 16109392 +GSTP1 2950 Asthma MESH:D001249 marker/mechanism 11994713|16870661|18988661|24117884|29411558 +GSTP1 2950 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GSTP1 2950 Autistic Disorder MESH:D001321 marker/mechanism 17404132 +GSTP1 2950 Breast Neoplasms MESH:D001943 marker/mechanism 25322848 +GSTP1 2950 Carcinoma MESH:D002277 marker/mechanism 11196146 +GSTP1 2950 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 9029167 +GSTP1 2950 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17094902 +GSTP1 2950 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +GSTP1 2950 Carotid Artery Diseases MESH:D002340 marker/mechanism 16973168 +GSTP1 2950 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750|25226513 +GSTP1 2950 Chromosome Aberrations MESH:D002869 marker/mechanism 16537716 +GSTP1 2950 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +GSTP1 2950 Disease Progression MESH:D018450 marker/mechanism 21364753 +GSTP1 2950 Drug Hypersensitivity MESH:D004342 marker/mechanism 20485159 +GSTP1 2950 Essential Tremor MESH:D020329 marker/mechanism 18215156 +GSTP1 2950 Glioma MESH:D005910 marker/mechanism 16899598 +GSTP1 2950 Hodgkin Disease MESH:D006689 marker/mechanism 11406608 +GSTP1 2950 Hypertension MESH:D006973 marker/mechanism 24915237 +GSTP1 2950 Kidney Calculi MESH:D007669 marker/mechanism 24360074 +GSTP1 2950 Kidney Diseases MESH:D007674 marker/mechanism 12868187 +GSTP1 2950 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 20843134 +GSTP1 2950 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 20188851|2563599|3124819|7585603 +GSTP1 2950 Lung Neoplasms MESH:D008175 marker/mechanism 17909032 +GSTP1 2950 Mitochondrial Diseases MESH:D028361 marker/mechanism 30673822 +GSTP1 2950 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GSTP1 2950 Necrosis MESH:D009336 marker/mechanism 14710442 +GSTP1 2950 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 23643483 +GSTP1 2950 Osteosarcoma MESH:D012516 marker/mechanism 17152492 +GSTP1 2950 Parkinson Disease MESH:D010300 marker/mechanism 17190945|23721876 +GSTP1 2950 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20979931 +GSTP1 2950 Precancerous Conditions MESH:D011230 marker/mechanism 15526359|16332721|20188851|21785164|2563599|7585603 +GSTP1 2950 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 22581815 +GSTP1 2950 Prostatic Neoplasms MESH:D011471 marker/mechanism 11196146|15538743|17173048|19223546|22581815 +GSTP1 2950 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 15729709 +GSTP1 2950 Respiratory Sounds MESH:D012135 marker/mechanism 18950799 +GSTP1 2950 Sarcoma MESH:D012509 marker/mechanism 17152492 +GSTP1 2950 Stomach Neoplasms MESH:D013274 marker/mechanism 21133646|21364753 +GSTP1 2950 Ureteral Calculi MESH:D014514 marker/mechanism 24360074 +GSTP1 2950 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 12500666|22306368|7729958 +GSTP1 2950 Vestibular Diseases MESH:D015837 marker/mechanism 18776599 +GSTP2 14869 Lung Neoplasms MESH:D008175 marker/mechanism 17909032 +GSTP3 225884 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GSTT1 2952 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18186040|19254865 +GSTT1 2952 Asbestosis MESH:D001195 marker/mechanism 17563610 +GSTT1 2952 Asthenozoospermia MESH:D053627 marker/mechanism 19303595 +GSTT1 2952 Carcinoma MESH:D002277 marker/mechanism 20663906 +GSTT1 2952 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 31569996 +GSTT1 2952 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 18566013|26656529 +GSTT1 2952 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 18397238|18666253|25226513 +GSTT1 2952 Chromosome Aberrations MESH:D002869 marker/mechanism 16537716|16980312|23159492 +GSTT1 2952 Disease Susceptibility MESH:D004198 marker/mechanism 31569996 +GSTT1 2952 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 17173682 +GSTT1 2952 Glioblastoma MESH:D005909 marker/mechanism 16874663 +GSTT1 2952 Hypertension MESH:D006973 marker/mechanism 22228705 +GSTT1 2952 Kidney Neoplasms MESH:D007680 marker/mechanism 20663906 +GSTT1 2952 Lung Neoplasms MESH:D008175 marker/mechanism 17000715|24852519 +GSTT1 2952 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 16702390 +GSTT1 2952 Multiple Myeloma MESH:D009101 marker/mechanism 16949155 +GSTT1 2952 Neoplasms MESH:D009369 marker/mechanism 25325283 +GSTT1 2952 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 23643483 +GSTT1 2952 Prostatic Neoplasms MESH:D011471 marker/mechanism 11275366|16998812|17507624|22564066 +GSTT1 2952 Raynaud Disease MESH:D011928 marker/mechanism 16977343 +GSTT1 2952 Skin Neoplasms MESH:D012878 marker/mechanism 26295053 +GSTT1B 393556 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28069987 +GSTT2 2953 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GSTT2 2953 Hypertension MESH:D006973 marker/mechanism 22228705 +GSTT2 2953 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 12868502 +GSTT3 103140 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +GSTZ1 2954 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 22306368 +GSTZ1 2954 Vestibular Diseases MESH:D015837 marker/mechanism 18776599 +GSX2 170825 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +GTF2E2 2961 TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE OMIM:616943 marker/mechanism 616943.0 +GTF2H5 404672 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE OMIM:616395 marker/mechanism 616395.0 +GTF2I 2969 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +GTF2I 2969 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 22048961 +GTF2I 2969 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +GTF2I 2969 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097066 +GTF2I 2969 Thymic epithelial tumor MESH:C536905 marker/mechanism 24974848 +GTF2I 2969 Williams Syndrome MESH:D018980 marker/mechanism 20007321|21328569 +GTF2IRD1 9569 Craniofacial Abnormalities MESH:D019465 marker/mechanism 20007321 +GTF2IRD1 9569 Williams Syndrome MESH:D018980 marker/mechanism 20007321 +GTF3A 2971 HIV Infections MESH:D015658 marker/mechanism 15308739 +GTPBP1 9567 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +GTPBP2 54676 Cholestasis MESH:D002779 marker/mechanism 27989131 +GTPBP3 84705 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23 OMIM:616198 marker/mechanism 616198.0 +GTSE1 51512 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GUCA1A 2978 Cone Dystrophy 3 MESH:C566579 marker/mechanism 602093.0 +GUCA1B 2979 Retinitis Pigmentosa MESH:D012174 marker/mechanism 15452722 +GUCA1B 2979 RETINITIS PIGMENTOSA 48 OMIM:613827 marker/mechanism 613827.0 +GUCA2B 2981 Kidney Failure, Chronic MESH:D007676 marker/mechanism 15780094 +GUCA2B 2981 Nephrotic Syndrome MESH:D009404 marker/mechanism 15780094 +GUCD1 83606 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +GUCY1A1 2982 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +GUCY1A1 2982 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +GUCY1A1 2982 Coronary Artery Disease MESH:D003324 marker/mechanism 22751097 +GUCY1A1 2982 Hypertension MESH:D006973 marker/mechanism 18339647 +GUCY1A1 2982 MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA OMIM:615750 marker/mechanism 615750.0 +GUCY1A1 2982 Pulmonary edema of mountaineers MESH:C535833 marker/mechanism 25373139 +GUCY1A1 2982 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +GUCY1A1 2982 Thrombosis MESH:D013927 marker/mechanism 24213632 +GUCY1A2 2977 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +GUCY1A2 2977 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +GUCY2C 2984 Colorectal Neoplasms MESH:D015179 marker/mechanism 17155897 +GUCY2C 2984 Diarrhea MESH:D003967 marker/mechanism 614616.0 22436048 +GUCY2C 2984 Meconium Ileus MESH:D000074270 marker/mechanism 614665.0 +GUCY2D 3000 Amaurosis congenita of Leber, type 1 MESH:C536600 marker/mechanism 204000.0 +GUCY2D 3000 Choroidal sclerosis MESH:C535358 marker/mechanism 215500.0 +GUCY2D 3000 Retinal cone dystrophy 2 MESH:C538363 marker/mechanism 601777.0 +GUCY2D 3000 Retinitis Pigmentosa MESH:D012174 marker/mechanism 16272259 +GUF1 60558 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40 OMIM:617065 marker/mechanism 617065.0 +GULO 268756 Ascorbic Acid Deficiency MESH:D001206 marker/mechanism 30606963 +GULO 268756 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +GULO 268756 Fatty Liver MESH:D005234 marker/mechanism 25226513 +GULO 268756 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +GULP1 51454 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GULP1 51454 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +GUSB 2990 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +GUSB 2990 Mucopolysaccharidosis VII MESH:D016538 marker/mechanism 253220.0 +GUSB 2990 Nervous System Diseases MESH:D009422 marker/mechanism 7073948|7107415 +GUSB 2990 Proteinuria MESH:D011507 marker/mechanism 2880436 +GYG1 2992 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 20357282 +GYG1 2992 Glycogen Storage Disease MESH:D006008 marker/mechanism 20357282 +GYG1 2992 GLYCOGEN STORAGE DISEASE XV OMIM:613507 marker/mechanism 613507.0 +GYG1 2992 Muscle Weakness MESH:D018908 marker/mechanism 20357282 +GYG1 2992 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +GYPA 2993 Malaria MESH:D008288 marker/mechanism 611162.0 +GYPA 2993 Skin Neoplasms MESH:D012878 marker/mechanism 17029826 +GYPB 2994 Malaria MESH:D008288 marker/mechanism 611162.0 +GYPC 2995 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +GYPC 2995 Malaria MESH:D008288 marker/mechanism 611162.0 +GYS1 2997 Glycogen Storage Disease 0, Muscle MESH:C566917 marker/mechanism 611556.0 +GYS2 2998 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +GYS2 2998 Glycogen Storage Disease 0, Liver MESH:C565485 marker/mechanism 240600.0 +GZMA 3001 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +GZMB 3002 Autistic Disorder MESH:D001321 marker/mechanism 18762240 +GZMB 3002 Breast Neoplasms MESH:D001943 marker/mechanism 19446661 +GZMB 3002 Drug Hypersensitivity MESH:D004342 marker/mechanism 19706026 +GZMB 3002 Hepatitis MESH:D006505 marker/mechanism 19706026 +H1-0 3005 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +H1-2 3006 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +H1-2 3006 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +H1-4 3008 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +H19 283120 Birth Weight MESH:D001724 marker/mechanism 31082282 +H19 283120 Breast Neoplasms MESH:D001943 marker/mechanism 28544374 +H19 283120 Carcinogenesis MESH:D063646 marker/mechanism 32739445 +H19 283120 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 32739445 +H19 283120 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 30515189 +H19 283120 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 32739445 +H19 283120 Heart Failure MESH:D006333 marker/mechanism 36071497 +H19 283120 Hepatitis, Animal MESH:D006520 marker/mechanism 18559427 +H19 283120 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +H19 283120 Neoplasm Invasiveness MESH:D009361 marker/mechanism 28544374 +H19 283120 Silver-Russell Syndrome MESH:D056730 marker/mechanism 19066168 +H19 283120 Tobacco Use Disorder MESH:D014029 marker/mechanism 32739445 +H19 283120 Wilms Tumor MESH:D009396 marker/mechanism 194070.0 +H19-ICR 105259599 Beckwith-Wiedemann Syndrome MESH:D001506 marker/mechanism 130650.0 +H19-ICR 105259599 Familial Wilms tumor 2 MESH:C536853 marker/mechanism 194071.0 +H19-ICR 105259599 Silver-Russell Syndrome MESH:D056730 marker/mechanism 180860.0 +H1F10 243529 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +H1F10 243529 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +H2AC16 8332 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +H2AC8 3012 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +H2AX 3014 Breast Neoplasms MESH:D001943 marker/mechanism 18925433|21463514 +H2AX 3014 Chromosome Breakage MESH:D019457 marker/mechanism 26231820 +H2AX 3014 Glioblastoma MESH:D005909 marker/mechanism 26651356 +H2AX 3014 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 26651356 +H2AX 3014 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 18925433 +H2AX 3014 Polyploidy MESH:D011123 marker/mechanism 25123929 +H2BC12 85236 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +H2BC14 8342 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +H2BC4 8347 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +H2BC4 8347 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +H2BC4 8347 Clinical Deterioration MESH:D000075902 marker/mechanism 27602772 +H2BC4 8347 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +H2BC8 8339 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +H2BC8 8339 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +H2-T23 15040 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +H3-3A 3020 Giant Cell Tumor of Bone MESH:D018212 marker/mechanism 24162739 +H3-3A 3020 Glioblastoma MESH:D005909 marker/mechanism 22286216|23817572 +H3-3A 3020 Glioma MESH:D005910 marker/mechanism 22286216|23583981 +H3-3B 3021 Chondroblastoma MESH:D002804 marker/mechanism 24162739 +H3-4 8290 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +H3-4 8290 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +H3C2 8358 Glioblastoma MESH:D005909 marker/mechanism 22286216 +H3C2 8358 Glioma MESH:D005910 marker/mechanism 22286216 +H3F3B 15081 Carcinoma MESH:D002277 marker/mechanism 16316942 +H3F3B 15081 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +H3F3B 15081 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +H4C1 8359 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +H4C2 8366 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +H4C3 8364 Craniofacial Abnormalities MESH:D019465 marker/mechanism 28920961 +H4C3 8364 Growth Disorders MESH:D006130 marker/mechanism 28920961 +H4C3 8364 Intellectual Disability MESH:D008607 marker/mechanism 28920961 +H4C3 8364 Microcephaly MESH:D008831 marker/mechanism 28920961 +H4C4 8360 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +H4C8 8365 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +H6PD 9563 Breast Neoplasms MESH:D001943 marker/mechanism 29295867 +H6PD 9563 Cortisone reductase deficiency MESH:C536447 marker/mechanism 604931.0 +HABP2 3026 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +HABP2 3026 Thrombophilia MESH:D019851 marker/mechanism 188050.0 +HABP2 3026 THYROID CANCER, NONMEDULLARY, 5 OMIM:616535 marker/mechanism 616535.0 +HACD1 9200 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +HACE1 57531 Neuroblastoma MESH:D009447 marker/mechanism 22941191 +HACL1 26061 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +HACL1 26061 Cholestasis MESH:D002779 marker/mechanism 26881866 +HADH 3033 3-Hydroxyacyl-CoA Dehydrogenase Deficiency MESH:C535310 marker/mechanism 231530.0 +HADH 3033 Hyperinsulinemic Hypoglycemia, Familial, 4 MESH:C566493 marker/mechanism 609975.0 +HADH 3033 Obesity MESH:D009765 marker/mechanism 20882379 +HADH 3033 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +HADHA 3030 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +HADHA 3030 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY OMIM:609016 marker/mechanism 609016.0 +HADHA 3030 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HADHA 3030 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +HADHA 3030 Trifunctional Protein Deficiency With Myopathy And Neuropathy MESH:C566945 marker/mechanism 609015.0 +HADHB 3032 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +HADHB 3032 Fatty Liver MESH:D005234 marker/mechanism 17116638 +HADHB 3032 Heart Diseases MESH:D006331 marker/mechanism 17116638 +HADHB 3032 Lipid Metabolism Disorders MESH:D052439 marker/mechanism 17116638 +HAGH 3029 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HAL 3034 Histidinemia MESH:C538320 marker/mechanism 235800.0 +HAL 3034 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HAMP 57817 Anemia MESH:D000740 marker/mechanism 16434484|16627556|24086573 +HAMP 57817 beta-Thalassemia MESH:D017086 marker/mechanism 16755567 +HAMP 57817 Biliary Atresia MESH:D001656 marker/mechanism 16627878 +HAMP 57817 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +HAMP 57817 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +HAMP 57817 Hemochromatosis MESH:D006432 marker/mechanism 16574947|16627556|17255318|19252486|21411349|22383097 +HAMP 57817 Hemochromatosis, Type 2B MESH:C566557 marker/mechanism 613313.0 +HAMP 57817 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +HAMP 57817 Iron Overload MESH:D019190 marker/mechanism 20801540|22659129 +HAMP 57817 Kidney Failure, Chronic MESH:D007676 marker/mechanism 16929540 +HAMP 57817 Kidney Neoplasms MESH:D007680 marker/mechanism 28321044 +HAMP2 66438 Iron Overload MESH:D019190 marker/mechanism 19524651 +HAND1 9421 Poisoning MESH:D011041 marker/mechanism 21964422 +HAND2 9464 Atrial Fibrillation MESH:D001281 marker/mechanism 28416822|29892015|30061737 +HAND2 9464 Cardiomegaly MESH:D006332 marker/mechanism 29394407 +HAND2 9464 Disease Models, Animal MESH:D004195 marker/mechanism 29394407 +HAND2 9464 Heart Defects, Congenital MESH:D006330 marker/mechanism 9671575 +HAND2 9464 Heart Failure MESH:D006333 marker/mechanism 29394407 +HAND2 9464 Neuroblastoma MESH:D009447 marker/mechanism 30127528 +HAND2 9464 Tetralogy of Fallot MESH:D013771 marker/mechanism 25093829 +HAND2 9464 Ventricular Remodeling MESH:D020257 marker/mechanism 29394407 +HAO1 54363 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HAO1 54363 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +HAO2 51179 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +HAO2 51179 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +HAO2 51179 Cholestasis MESH:D002779 marker/mechanism 27989131 +HAO2 51179 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +HAPLN1 1404 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +HAPLN1 1404 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +HAPLN1 1404 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9988279 +HAPLN1 1404 Dwarfism MESH:D004392 marker/mechanism 9988279 +HAPLN1 1404 Limb Deformities, Congenital MESH:D017880 marker/mechanism 9988279 +HAPLN4 404037 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +HARS1 3035 Autoimmune Diseases MESH:D001327 marker/mechanism 23256773 +HARS1 3035 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +HARS1 3035 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W OMIM:616625 marker/mechanism 616625.0 +HARS1 3035 Lung Diseases MESH:D008171 marker/mechanism 23256773 +HARS1 3035 USHER SYNDROME, TYPE IIIB OMIM:614504 marker/mechanism 614504.0 +HAS3 3038 Fatty Liver MESH:D005234 marker/mechanism 27042213 +HAUS6 54801 Ovarian Neoplasms MESH:D010051 marker/mechanism 31043753 +HAUS6 54801 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +HAVCR1 26762 Acute Kidney Injury MESH:D058186 marker/mechanism 20118187|21259293|21835770|22005293|23052191|23845967|24189134|24361871|24958931|28885000 +HAVCR1 26762 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +HAVCR1 26762 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15805072|24361871|28885000 +HAVCR1 26762 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 19225054 +HAVCR1 26762 Kidney Diseases MESH:D007674 marker/mechanism 19349640|20181666|20438795|21888673|23019274|24863737|24880025 +HAVCR1 26762 Necrosis MESH:D009336 marker/mechanism 24880025 +HAVCR1 26762 Proteinuria MESH:D011507 marker/mechanism 19225054 +HAVCR2 84868 Lymphohistiocytosis, Hemophagocytic MESH:D051359 marker/mechanism 30374066 +HAVCR2 84868 Subcutaneous panniculitis-like T-cell lymphoma MESH:C537503 marker/mechanism 30374066 +HAX1 10456 Neutropenia, Severe Congenital, Autosomal Recessive 3 MESH:C537592 marker/mechanism 610738 +HBA1 3039 alpha-Thalassemia MESH:D017085 marker/mechanism 604131|613978 16798638 +HBA1 3039 Carcinoma MESH:D002277 marker/mechanism 12376462 +HBA1 3039 Cerebral Infarction MESH:D002544 marker/mechanism 1634355 +HBA1 3039 Chloracne MESH:D054506 marker/mechanism 17101203 +HBA1 3039 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16632892 +HBA1 3039 Heinz Body Anemias MESH:C563030 marker/mechanism 140700 2833478 +HBA1 3039 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +HBA1 3039 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +HBA1 3039 Methemoglobinemia MESH:D008708 marker/mechanism 3026948 +HBA1 3039 Polycythemia MESH:D011086 marker/mechanism 1634355 +HBA1 3039 Polycythemia Vera MESH:D011087 marker/mechanism 1634355 +HBA2 3040 alpha-Thalassemia MESH:D017085 marker/mechanism 604131|613978 15182556|16798638 +HBA2 3040 beta-Thalassemia MESH:D017086 marker/mechanism 17292142 +HBA2 3040 Chloracne MESH:D054506 marker/mechanism 17101203 +HBA2 3040 Heinz Body Anemias MESH:C563030 marker/mechanism 140700 +HBA-A1 15122 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +HBB 3043 alpha-Thalassemia MESH:D017085 marker/mechanism 604131.0 +HBB 3043 Anemia, Sickle Cell MESH:D000755 marker/mechanism 603903.0 29255069|32142671|81926 +HBB 3043 beta-Thalassemia MESH:D017086 marker/mechanism 613985.0 16755567|23975182|3021607|6270663|6280057|88735 +HBB 3043 Beta Thalassemia, Dominant Inclusion Body Type MESH:C565834 marker/mechanism 603902.0 +HBB 3043 Chloracne MESH:D054506 marker/mechanism 17101203 +HBB 3043 Cyanosis MESH:D003490 marker/mechanism 15929117 +HBB 3043 Disease Models, Animal MESH:D004195 marker/mechanism 23975182|29255069 +HBB 3043 Echinococcosis MESH:D004443 marker/mechanism 24270252 +HBB 3043 Heinz Body Anemias MESH:C563030 marker/mechanism 140700.0 5420592|8704193 +HBB 3043 Hemoglobinopathies MESH:D006453 marker/mechanism 5773089 +HBB 3043 Malaria MESH:D008288 marker/mechanism 611162.0 +HBB 3043 Malaria, Falciparum MESH:D016778 marker/mechanism 20305663 +HBB 3043 Methemoglobinemia MESH:D008708 marker/mechanism 15929117 +HBB 3043 Polycythemia MESH:D011086 marker/mechanism 1117598|7161106 +HBB 3043 Polycythemia Vera MESH:D011087 marker/mechanism 5773089 +HBB 3043 Splenomegaly MESH:D013163 marker/mechanism 29255069 +HBB-B1 15129 beta-Thalassemia MESH:D017086 marker/mechanism 17018382 +HBB-B2 15130 beta-Thalassemia MESH:D017086 marker/mechanism 17018382 +HBB-LCR 109580095 beta-Thalassemia MESH:D017086 marker/mechanism 613985.0 +HBD 3045 Chloracne MESH:D054506 marker/mechanism 17101203 +HBD 3045 Keloid MESH:D007627 marker/mechanism 20128793 +HBEGF 1839 Acute Kidney Injury MESH:D058186 marker/mechanism 7635938 +HBEGF 1839 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +HBEGF 1839 Cardiotoxicity MESH:D066126 therapeutic 29305325 +HBEGF 1839 Disease Models, Animal MESH:D004195 marker/mechanism 21937979 +HBEGF 1839 Endometriosis MESH:D004715 marker/mechanism 20864642 +HBEGF 1839 Enterocolitis, Necrotizing MESH:D020345 therapeutic 16567187 +HBEGF 1839 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 16023256 +HBEGF 1839 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 9709397 +HBEGF 1839 Kidney Failure, Chronic MESH:D007676 marker/mechanism 21937979 +HBEGF 1839 Reperfusion Injury MESH:D015427 marker/mechanism 7635938 +HBEGF 1839 Stomach Neoplasms MESH:D013274 therapeutic 15723263 +HBEGFA 797938 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +HBEGFB 407664 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +HBG1 3047 Chloracne MESH:D054506 marker/mechanism 17101203 +HBG1 3047 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +HBG1 3047 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +HBG2 3048 Acute Kidney Injury MESH:D058186 marker/mechanism 562503|851170 +HBG2 3048 CYANOSIS, TRANSIENT NEONATAL OMIM:613977 marker/mechanism 613977.0 +HBG2 3048 Oliguria MESH:D009846 marker/mechanism 851170 +HBG2 3048 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +HCAR2 338442 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21655214 +HCAR2 338442 Flushing MESH:D005483 marker/mechanism 16322797 +HCAR2 338442 Psoriasis MESH:D011565 marker/mechanism 18722346 +HCAR2 338442 Schizophrenia MESH:D012559 marker/mechanism 18639743 +HCAR2 338442 Skin Neoplasms MESH:D012878 marker/mechanism 21655214 +HCAR3 8843 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21655214 +HCAR3 8843 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +HCAR3 8843 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34453990 +HCAR3 8843 Skin Neoplasms MESH:D012878 marker/mechanism 21655214 +HCCS 3052 Microphthalmia, syndromic 7 MESH:C537466 marker/mechanism 309801.0 +HCFC1 3054 Liver Neoplasms MESH:D008113 marker/mechanism 19255062 +HCFC1 3054 Mental Retardation, X-Linked 3 MESH:C563136 marker/mechanism 309541.0 +HCK 3055 Autoimmune Diseases MESH:D001327 marker/mechanism 33617879 +HCK 3055 COVID-19 MESH:D000086382 marker/mechanism 33617879 +HCK 3055 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HCK 3055 Neoplasms MESH:D009369 marker/mechanism 33617879 +HCK 3055 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 17344919 +HCLS1 3059 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +HCN1 348980 Ataxia MESH:D001259 marker/mechanism 19747469 +HCN1 348980 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24 OMIM:615871 marker/mechanism 615871.0 +HCN1 348980 Disease Models, Animal MESH:D004195 marker/mechanism 19747469 +HCN1 348980 Epilepsy MESH:D004827 marker/mechanism 12890777 +HCN1 348980 Infantile Epileptic-Dyskinetic Encephalopathy MESH:C567924 marker/mechanism 24747641 +HCN1 348980 Seizures MESH:D012640 marker/mechanism 20384728 +HCN2 610 Febrile Convulsions, Familial, 2 MESH:C566541 marker/mechanism 602477.0 +HCN4 10021 Atrial Fibrillation MESH:D001281 marker/mechanism 22544366|30061737 +HCN4 10021 Brugada Syndrome 8 MESH:C567732 marker/mechanism 613123.0 +HCN4 10021 Sick Sinus Syndrome 2, Autosomal Dominant MESH:C563513 marker/mechanism 163800.0 +HCP5 10866 Disease Progression MESH:D018450 marker/mechanism 34331612 +HCP5 10866 Multiple Myeloma MESH:D009101 marker/mechanism 34331612 +HCRT 3060 Cocaine-Related Disorders MESH:D019970 marker/mechanism 16357203 +HCRT 3060 Hyperphagia MESH:D006963 marker/mechanism 27071101 +HCRT 3060 Hypothermia MESH:D007035 marker/mechanism 26799708 +HCRT 3060 Narcolepsy 1 MESH:C563534 marker/mechanism 161400.0 +HCRT 3060 Neurodegenerative Diseases MESH:D019636 marker/mechanism 23246865 +HCRT 3060 Obesity MESH:D009765 marker/mechanism 27071101 +HCRT 3060 Pain MESH:D010146 therapeutic 16202530 +HCRT 3060 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 20738730 +HCRT 3060 Weight Gain MESH:D015430 marker/mechanism 27071101 +HCRTR1 3061 Cocaine-Related Disorders MESH:D019970 marker/mechanism 16357203|19591850|19741128 +HCRTR1 3061 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 20667500 +HCRTR2 3062 Narcolepsy MESH:D009290 marker/mechanism 17521418 +HDA-6 177316 Infertility MESH:D007246 marker/mechanism 25204677 +HDAC1 3065 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 32289289 +HDAC1 3065 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21527555 +HDAC1 3065 Endometriosis MESH:D004715 marker/mechanism 22138541 +HDAC1 3065 Familial Primary Pulmonary Hypertension MESH:D065627 marker/mechanism 22711276 +HDAC1 3065 Heart Diseases MESH:D006331 marker/mechanism 18625706 +HDAC1 3065 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 28963909 +HDAC2 3066 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21527555 +HDAC2 3066 Cardiomegaly MESH:D006332 marker/mechanism 18625706 +HDAC2 3066 Emphysema MESH:D004646 marker/mechanism 24040961 +HDAC2 3066 Endometriosis MESH:D004715 marker/mechanism 22138541 +HDAC2 3066 Leukemia, Myeloid MESH:D007951 marker/mechanism 21535412 +HDAC2 3066 Liver Cirrhosis MESH:D008103 marker/mechanism 27396813 +HDAC2 3066 Melanoma MESH:D008545 marker/mechanism 22535842 +HDAC2 3066 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +HDAC2 3066 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 15337792|18421014 +HDAC3 8841 Adenocarcinoma MESH:D000230 marker/mechanism 34973135 +HDAC3 8841 Disease Progression MESH:D018450 marker/mechanism 34973135 +HDAC3 8841 Heart Diseases MESH:D006331 marker/mechanism 18625706 +HDAC3 8841 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34973135 +HDAC3 8841 Neoplasm Metastasis MESH:D009362 marker/mechanism 34973135 +HDAC3 8841 Stomach Neoplasms MESH:D013274 marker/mechanism 34973135 +HDAC3 8841 Weight Loss MESH:D015431 marker/mechanism 34973135 +HDAC4 9759 Brachydactyly MESH:D059327 marker/mechanism 20691407 +HDAC4 9759 Brachydactyly, Type E MESH:C566194 marker/mechanism 24715439 +HDAC4 9759 Chromosome 2q37 deletion syndrome MESH:C538317 marker/mechanism 600430.0 20691407 +HDAC4 9759 Cocaine-Related Disorders MESH:D019970 therapeutic 17988634 +HDAC4 9759 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +HDAC4 9759 Diabetes Complications MESH:D048909 marker/mechanism 35554780 +HDAC4 9759 Familial Primary Pulmonary Hypertension MESH:D065627 marker/mechanism 22711276 +HDAC4 9759 Intellectual Disability MESH:D008607 marker/mechanism 20691407 +HDAC4 9759 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +HDAC4 9759 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21507255 +HDAC5 10014 Adjustment Disorders MESH:D000275 marker/mechanism 17988634 +HDAC5 10014 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +HDAC5 10014 Cocaine-Related Disorders MESH:D019970 therapeutic 17988634 +HDAC5 10014 Familial Primary Pulmonary Hypertension MESH:D065627 marker/mechanism 22711276 +HDAC5 10014 Scleroderma, Systemic MESH:D012595 marker/mechanism 27482699 +HDAC6 10013 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 35764897 +HDAC6 10013 CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA OMIM:300863 marker/mechanism 300863.0 +HDAC6 10013 Disease Progression MESH:D018450 marker/mechanism 34524571 +HDAC6 10013 Melanoma MESH:D008545 marker/mechanism 22535842 +HDAC6 10013 Neoplasms, Experimental MESH:D009374 marker/mechanism 34524571 +HDAC6 10013 Osteosarcoma MESH:D012516 marker/mechanism 34524571 +HDAC6 10013 Ovarian Neoplasms MESH:D010051 marker/mechanism 19010849 +HDAC6 10013 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +HDAC9 9734 Atherosclerosis MESH:D050197 marker/mechanism 36322813 +HDAC9 9734 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +HDAC9 9734 Stroke MESH:D020521 marker/mechanism 22306652 +HDC 3067 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +HDC 3067 Tourette Syndrome MESH:D005879 marker/mechanism 137580.0 +HDGF 3068 HIV Infections MESH:D015658 marker/mechanism 15308739 +HDHD2 84064 Weight Gain MESH:D015430 marker/mechanism 19030233 +HDLBP 3069 Autistic Disorder MESH:D001321 marker/mechanism 19365831 +HDLBP 3069 Chromosome 2q37 deletion syndrome MESH:C538317 marker/mechanism 19365831 +HDLBP 3069 Neoplastic Processes MESH:D009385 marker/mechanism 25129143 +HEBP2 23593 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +HECTD4 283450 Alcohol-Induced Disorders MESH:D020751 marker/mechanism 35713687 +HECTD4 283450 Coronary Artery Disease MESH:D003324 marker/mechanism 22751097 +HECTD4 283450 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 35713687 +HECW2 57520 NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE OMIM:617268 marker/mechanism 617268.0 +HELLS 3070 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +HELLS 3070 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +HELLS 3070 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4 OMIM:616911 marker/mechanism 616911.0 +HELLS 3070 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HELLS 3070 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +HEN-1 191666 Infertility MESH:D007246 marker/mechanism 25204677 +HEPACAM 220296 Megalencephalic leukoencephalopathy with subcortical cysts MESH:C536141 marker/mechanism 604004|613925 +HEPACAM 220296 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT OMIM:613926 marker/mechanism 613926 +HEPH 9843 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26818092 +HERC1 8925 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +HERC1 8925 MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION OMIM:617011 marker/mechanism 617011 +HERC2 8924 Asthma, Occupational MESH:D059366 marker/mechanism 25918132 +HERC2 8924 Colitis, Ulcerative MESH:D003093 marker/mechanism 18438405 +HERC2 8924 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 38 OMIM:615516 marker/mechanism 615516 +HERC2 8924 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270 +HERC3 8916 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +HERC5 51191 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28919514 +HERC5 51191 Endometriosis MESH:D004715 marker/mechanism 20864642 +HERC5 51191 Influenza, Human MESH:D007251 marker/mechanism 23326326 +HERC6 55008 Influenza, Human MESH:D007251 marker/mechanism 23326326 +HERPUD1 9709 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +HERPUD2 64224 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +HES1 3280 Breast Neoplasms MESH:D001943 marker/mechanism 20197467|21036696 +HES1 3280 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21994468 +HES1 3280 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +HES1 3280 Colonic Neoplasms MESH:D003110 marker/mechanism 19147571 +HES1 3280 Glioblastoma MESH:D005909 marker/mechanism 21127729 +HES1 3280 Lung Neoplasms MESH:D008175 marker/mechanism 17804716 +HES1 3280 Lymphangioleiomyomatosis MESH:D018192 marker/mechanism 20038814 +HES1 3280 Meningioma MESH:D008579 marker/mechanism 21127729 +HES1 3280 Neuroectodermal Tumors, Primitive MESH:D018242 marker/mechanism 21127729 +HES1 3280 Oligodendroglioma MESH:D009837 marker/mechanism 21127729 +HES1 3280 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +HES1 3280 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 25061499 +HES5 388585 Brain Neoplasms MESH:D001932 marker/mechanism 21127729 +HES5 388585 Nervous System Diseases MESH:D009422 marker/mechanism 23203475 +HES7 84667 Spondylocostal dysostosis, autosomal recessive MESH:C535781 marker/mechanism 613686.0 +HESX1 8820 Hypopituitarism and septooptic 'dysplasia' MESH:C531815 marker/mechanism 182230.0 +HEXA 3073 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +HEXA 3073 Tay-Sachs Disease MESH:D013661 marker/mechanism 272800.0 11392526 +HEXB 3074 Acute Kidney Injury MESH:D058186 marker/mechanism 22005293 +HEXB 3074 Sandhoff Disease MESH:D012497 marker/mechanism 268800.0 +HEXIM1 10614 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HEY1 23462 Astrocytoma MESH:D001254 marker/mechanism 21127729 +HEY1 23462 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20868653 +HEY1 23462 Breast Neoplasms MESH:D001943 marker/mechanism 21036696 +HEY1 23462 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +HEY1 23462 Glioblastoma MESH:D005909 marker/mechanism 21127729 +HEY1 23462 Lung Neoplasms MESH:D008175 marker/mechanism 17804716 +HEY1 23462 Neuroectodermal Tumors, Primitive MESH:D018242 marker/mechanism 21127729 +HEY1 23462 Oligodendroglioma MESH:D009837 marker/mechanism 21127729 +HEY1 23462 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +HEY2 23493 Astrocytoma MESH:D001254 marker/mechanism 21127729 +HEY2 23493 Breast Neoplasms MESH:D001943 marker/mechanism 21036696 +HEY2 23493 Brugada Syndrome MESH:D053840 marker/mechanism 23872634 +HEY2 23493 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +HEY2 23493 Cardiomyopathy, Hypertrophic MESH:D002312 therapeutic 20001863 +HEY2 23493 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +HEYL 26508 Breast Neoplasms MESH:D001943 marker/mechanism 21036696 +HFE 3077 Alzheimer Disease MESH:D000544 marker/mechanism 15060098|17047092 +HFE 3077 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20808228 +HFE 3077 Birth Weight MESH:D001724 marker/mechanism 20659343 +HFE 3077 Hemochromatosis MESH:D006432 marker/mechanism 235200.0 11050162|16793930|17119292|17236123|17255318|17258727|17376729|18317567|20160468|20843714|21411349|22383097|23705020|25874029 +HFE 3077 Hepatitis C MESH:D006526 marker/mechanism 15865084 +HFE 3077 Lead Poisoning MESH:D007855 marker/mechanism 20659343 +HFE 3077 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 17001480 +HFE 3077 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +HFE 3077 Parkinson Disease MESH:D010300 marker/mechanism 16824219 +HFE 3077 Porphyria Cutanea Tarda MESH:D017119 marker/mechanism 12622622 +HFM1 164045 PREMATURE OVARIAN FAILURE 9 OMIM:615724 marker/mechanism 615724.0 +HGD 3081 Alkaptonuria MESH:D000474 marker/mechanism 203500.0 +HGF 3082 Astrocytoma MESH:D001254 marker/mechanism 11223164 +HGF 3082 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +HGF 3082 Barrett Esophagus MESH:D001471 marker/mechanism 15387324 +HGF 3082 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 11896611|9932610 +HGF 3082 Carcinoma, Squamous Cell MESH:D002294 therapeutic 21273587 +HGF 3082 Cardiomyopathies MESH:D009202 therapeutic 16109756|18083897 +HGF 3082 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +HGF 3082 Deafness, Autosomal Recessive 39 MESH:C564265 marker/mechanism 608265.0 +HGF 3082 Diabetic Neuropathies MESH:D003929 therapeutic 26000320 +HGF 3082 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +HGF 3082 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 22683780 +HGF 3082 Liver Cirrhosis MESH:D008103 therapeutic 17097021 +HGF 3082 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 10677585|12918455|15793283|16465399|16627068|17714472|18637143 +HGF 3082 Liver Failure, Acute MESH:D017114 therapeutic 12479984 +HGF 3082 Liver Neoplasms MESH:D008113 therapeutic 8807143 +HGF 3082 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11896611 +HGF 3082 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +HGF 3082 Myocardial Ischemia MESH:D017202 therapeutic 12447174 +HGF 3082 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15654357|9932610 +HGF 3082 Neoplasm Metastasis MESH:D009362 marker/mechanism 25971889 +HGF 3082 Neoplasms, Experimental MESH:D009374 therapeutic 21273587 +HGF 3082 Neuroblastoma MESH:D009447 marker/mechanism 16051641 +HGF 3082 Pain MESH:D010146 therapeutic 26000320 +HGF 3082 Pancreatitis MESH:D010195 therapeutic 14751415 +HGF 3082 Parkinson Disease MESH:D010300 therapeutic 16791285 +HGF 3082 Polyomavirus Infections MESH:D027601 marker/mechanism 25162674 +HGF 3082 Pulmonary Fibrosis MESH:D011658 marker/mechanism 16324872 +HGF 3082 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +HGF 3082 Thrombosis MESH:D013927 marker/mechanism 15367830 +HGF 3082 Vascular Diseases MESH:D014652 therapeutic 15071489 +HGF 3082 Wounds, Penetrating MESH:D014950 therapeutic 12890377 +HGFAC 3083 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +HGFAC 3083 Crohn Disease MESH:D003424 marker/mechanism 36038634 +HGSNAT 138050 Mucopolysaccharidosis III MESH:D009084 marker/mechanism 252930.0 +HGSNAT 138050 RETINITIS PIGMENTOSA 73 OMIM:616544 marker/mechanism 616544.0 +HHAT 55733 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +HHEX 3087 Breast Neoplasms MESH:D001943 marker/mechanism 16854221 +HHEX 3087 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23104008 +HHEX 3087 Fatty Liver MESH:D005234 marker/mechanism 24469900 +HHIP 64399 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18559595 +HHIP 64399 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +HHIP 64399 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +HHIP 64399 Hypospadias MESH:D007021 marker/mechanism 31568847 +HHIPL1 84439 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990 +HIBCH 26275 Beta-Hydroxyisobutyryl CoA Deacylase Deficiency MESH:C562803 marker/mechanism 250620.0 +HIBCH 26275 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +HIC1 3090 Breast Neoplasms MESH:D001943 marker/mechanism 20154726 +HIC1 3090 Gastrointestinal Neoplasms MESH:D005770 marker/mechanism 21297660 +HIC1 3090 Macular Degeneration MESH:D008268 marker/mechanism 30742112 +HIC1 3090 Medulloblastoma MESH:D008527 marker/mechanism 18347096 +HIC1 3090 Polyps MESH:D011127 marker/mechanism 21297660 +HIF-1A 100337573 Reperfusion Injury MESH:D015427 marker/mechanism 35312153 +HIF1A 3091 Anaplasia MESH:D000708 marker/mechanism 19808899 +HIF1A 3091 Astrocytoma MESH:D001254 marker/mechanism 15341671 +HIF1A 3091 Brain Ischemia MESH:D002545 marker/mechanism 19429140 +HIF1A 3091 Breast Neoplasms MESH:D001943 marker/mechanism 24349381 +HIF1A 3091 Carcinoma MESH:D002277 marker/mechanism 19808899 +HIF1A 3091 Carcinoma, Ductal MESH:D044584 marker/mechanism 20526721 +HIF1A 3091 Carcinoma, Intraductal, Noninfiltrating MESH:D002285 marker/mechanism 20526721 +HIF1A 3091 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30381462 +HIF1A 3091 Cardiomegaly MESH:D006332 marker/mechanism 15942707 +HIF1A 3091 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 29501572 +HIF1A 3091 Cholangitis, Sclerosing MESH:D015209 marker/mechanism 22271822 +HIF1A 3091 Diabetes Complications MESH:D048909 marker/mechanism 26073000 +HIF1A 3091 Disease Progression MESH:D018450 marker/mechanism 30381462 +HIF1A 3091 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 17201171 +HIF1A 3091 Glioblastoma MESH:D005909 marker/mechanism 12811834 +HIF1A 3091 Heart Defects, Congenital MESH:D006330 marker/mechanism 26073000 +HIF1A 3091 Heart Failure MESH:D006333 marker/mechanism 15732037 +HIF1A 3091 Hemangioblastoma MESH:D018325 marker/mechanism 15341671 +HIF1A 3091 Hyperplasia MESH:D006965 marker/mechanism 20526721 +HIF1A 3091 Hypertension MESH:D006973 therapeutic 22349312 +HIF1A 3091 Hypertension, Pulmonary MESH:D006976 marker/mechanism 20110409 +HIF1A 3091 Hypoxia-Ischemia, Brain MESH:D020925 marker/mechanism 23694759 +HIF1A 3091 Idiopathic Pulmonary Fibrosis MESH:D054990 therapeutic 28434932 +HIF1A 3091 Liver Cirrhosis MESH:D008103 marker/mechanism 36126797 +HIF1A 3091 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 22271822 +HIF1A 3091 Lung Diseases MESH:D008171 marker/mechanism 20152896 +HIF1A 3091 Micronuclei, Chromosome-Defective MESH:D048629 therapeutic 23065176 +HIF1A 3091 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 18549825|22050707 +HIF1A 3091 Neoplasm Invasiveness MESH:D009361 marker/mechanism 12811834|29501572 +HIF1A 3091 Neoplasms, Experimental MESH:D009374 marker/mechanism 28574600 +HIF1A 3091 Pancreatic Neoplasms MESH:D010190 marker/mechanism 16628086 +HIF1A 3091 Prostatic Neoplasms MESH:D011471 marker/mechanism 16205110 +HIF1A 3091 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 26752192 +HIF1A 3091 Radiation Injuries, Experimental MESH:D011833 therapeutic 23065176 +HIF1A 3091 Skin Neoplasms MESH:D012878 marker/mechanism 19276359 +HIF1A 3091 Spinal Cord Injuries MESH:D013119 marker/mechanism 21092735 +HIF1A 3091 Thyroid Neoplasms MESH:D013964 marker/mechanism 19808899 +HIF1A 3091 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 36115647 +HIF1A 3091 Venous Thrombosis MESH:D020246 marker/mechanism 36162953 +HIGD2A 192286 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +HIGD2A 192286 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +HIKESHI 51501 Disease Progression MESH:D018450 marker/mechanism 21364753 +HIKESHI 51501 LEUKODYSTROPHY, HYPOMYELINATING, 13 OMIM:616881 marker/mechanism 616881.0 +HIKESHI 51501 Melanoma MESH:D008545 marker/mechanism 22535842 +HIKESHI 51501 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +HILPDA 29923 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +HIM-6 178201 Hypoxia MESH:D000860 therapeutic 19936206 +HINT1 3094 Inherited Peripheral Neuropathy MESH:C548028 marker/mechanism 22961002 +HINT1 3094 Isaacs Syndrome MESH:D020386 marker/mechanism 137200.0 +HINT1 3094 Muscular Diseases MESH:D009135 marker/mechanism 22961002 +HINT1 3094 Schizophrenia MESH:D012559 marker/mechanism 17203012|20514075 +HINT1 3094 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 20514075 +HIP1 3092 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HIP1R 9026 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +HIPK1 204851 Acute Kidney Injury MESH:D058186 marker/mechanism 36052886 +HIPK1 204851 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +HIPK2 28996 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +HIPK2 28996 Nephrosclerosis MESH:D009400 marker/mechanism 28318631 +HIPK2 28996 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +HIVEP2 3097 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 43 OMIM:616977 marker/mechanism 616977.0 +HIVEP2 3097 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HIVEP3 59269 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +HJURP 55355 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +HJV 148738 Cholestasis MESH:D002779 marker/mechanism 27989131 +HJV 148738 Hemochromatosis MESH:D006432 marker/mechanism 16868025|17255318|19252486|21411349 +HJV 148738 Hemochromatosis, type 2 MESH:C537247 marker/mechanism 602390.0 +HJV 148738 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HK1 3098 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +HK1 3098 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +HK1 3098 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +HK1 3098 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +HK1 3098 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY OMIM:235700 marker/mechanism 235700.0 +HK1 3098 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HK1 3098 Neuropathy, hereditary motor and sensory, Russe type MESH:C535813 marker/mechanism 605285.0 +HK1 3098 RETINITIS PIGMENTOSA 79 OMIM:617460 marker/mechanism 617460.0 +HK2 3099 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +HK2 3099 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +HK2 3099 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HK2 3099 Obesity MESH:D009765 marker/mechanism 20882379 +HK3 3101 Liver Diseases MESH:D008107 marker/mechanism 19784758 +HLA-A 3105 Autistic Disorder MESH:D001321 marker/mechanism 16720216 +HLA-A 3105 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 21570397|28043905 +HLA-A 3105 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 3459889 +HLA-A 3105 Glioma MESH:D005910 marker/mechanism 14511464 +HLA-A 3105 Multiple Myeloma MESH:D009101 marker/mechanism 17283154 +HLA-A 3105 Parapsoriasis MESH:D010267 marker/mechanism 16538176 +HLA-A 3105 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 608579.0 +HLA-A 3105 Thrombocytopenia MESH:D013921 marker/mechanism 3459889 +HLA-B 3106 Behcet Syndrome MESH:D001528 marker/mechanism 20622878|23396137 +HLA-B 3106 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 19483685 +HLA-B 3106 Dermatitis MESH:D003872 marker/mechanism 18007983|3084782 +HLA-B 3106 Dermatomyositis MESH:D003882 marker/mechanism 3501473 +HLA-B 3106 Drug Eruptions MESH:D003875 marker/mechanism 19712599|29370880 +HLA-B 3106 Drug Hypersensitivity MESH:D004342 marker/mechanism 11943262|15024131|17392574|18007983 +HLA-B 3106 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 29370880|3084782|3133153|3157529|3437418|6770269 +HLA-B 3106 Exanthema MESH:D005076 marker/mechanism 20485159 +HLA-B 3106 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 3459889 +HLA-B 3106 Glioma MESH:D005910 marker/mechanism 14511464 +HLA-B 3106 HIV Infections MESH:D015658 marker/mechanism 17496894 +HLA-B 3106 Hypersensitivity MESH:D006967 marker/mechanism 23541086 +HLA-B 3106 Myasthenia Gravis MESH:D009157 marker/mechanism 6402089|6605118 +HLA-B 3106 Nephritis MESH:D009393 marker/mechanism 3084782 +HLA-B 3106 Proteinuria MESH:D011507 marker/mechanism 3459889|3487119|6376799|6770269 +HLA-B 3106 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 106300.0 21743469|22138694|8053961 +HLA-B 3106 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 608579.0 15057820|15743917|16538176|18855540|19694795|19915237|20235791|20485159|21428768|25099164 +HLA-B 3106 Synovitis MESH:D013585 marker/mechanism 12648975 +HLA-C 3107 Arthritis, Psoriatic MESH:D015535 marker/mechanism 20953186 +HLA-C 3107 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 19629158 +HLA-C 3107 Glioma MESH:D005910 marker/mechanism 14511464 +HLA-C 3107 Hepatitis B, Chronic MESH:D019694 marker/mechanism 24162738 +HLA-C 3107 HIV Infections MESH:D015658 marker/mechanism 609423.0 +HLA-C 3107 Psoriasis MESH:D011565 marker/mechanism 177900.0 19169254|20953190 +HLA-C 3107 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 19629158 +HLA-DMA 3108 Dermatitis, Contact MESH:D003877 marker/mechanism 18348411 +HLA-DMA 3108 Dermatitis, Occupational MESH:D009783 marker/mechanism 16737583 +HLA-DOA 3111 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +HLA-DPA1 3113 Dermatitis, Irritant MESH:D017453 marker/mechanism 27258892 +HLA-DPA1 3113 Hepatitis B, Chronic MESH:D019694 marker/mechanism 19349983 +HLA-DPB1 3115 Angioedema MESH:D000799 marker/mechanism 15784113 +HLA-DPB1 3115 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17956852|22286218 +HLA-DPB1 3115 Asthma MESH:D001249 marker/mechanism 16792590|17956852 +HLA-DPB1 3115 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 16502481 +HLA-DPB1 3115 Berylliosis MESH:D001607 marker/mechanism 11551429|14662898|15273960|17927685|17956852|8105536 +HLA-DPB1 3115 Celiac Disease MESH:D002446 marker/mechanism 17956852 +HLA-DPB1 3115 Dermatitis, Irritant MESH:D017453 marker/mechanism 27258892 +HLA-DPB1 3115 Drug Eruptions MESH:D003875 marker/mechanism 16502481 +HLA-DPB1 3115 Endometriosis MESH:D004715 marker/mechanism 17956852 +HLA-DPB1 3115 Hepatitis B, Chronic MESH:D019694 marker/mechanism 19349983 +HLA-DPB1 3115 Memory Disorders MESH:D008569 marker/mechanism 14975599 +HLA-DPB1 3115 Multiple Sclerosis MESH:D009103 marker/mechanism 17956852 +HLA-DPB1 3115 Myasthenia Gravis MESH:D009157 marker/mechanism 17956852 +HLA-DPB1 3115 Sarcoidosis MESH:D012507 marker/mechanism 14508706|17956852|8909942 +HLA-DPB1 3115 Urticaria MESH:D014581 marker/mechanism 16502481 +HLA-DPB1 3115 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 23817570 +HLA-DPB2 3116 Berylliosis MESH:D001607 marker/mechanism 16272364 +HLA-DPB2 3116 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 23817570 +HLA-DQA1 3117 Asthma MESH:D001249 marker/mechanism 10792356 +HLA-DQA1 3117 Celiac Disease MESH:D002446 marker/mechanism 212750.0 +HLA-DQA1 3117 Dermatitis MESH:D003872 marker/mechanism 16836882 +HLA-DQA1 3117 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 26168013 +HLA-DQA1 3117 Eosinophilia-Myalgia Syndrome MESH:D016603 marker/mechanism 19790128 +HLA-DQA1 3117 Esophageal Achalasia MESH:D004931 marker/mechanism 24997987 +HLA-DQA1 3117 Glomerulonephritis, Membranous MESH:D015433 marker/mechanism 11436868 +HLA-DQA1 3117 Hypersensitivity MESH:D006967 marker/mechanism 8725357 +HLA-DQA1 3117 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 23291585 +HLA-DQA1 3117 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 11436868 +HLA-DQA1 3117 Mycobacterium tuberculosis, susceptibility to infection by MESH:C536092 marker/mechanism 26829749 +HLA-DQA1 3117 Oropharyngeal Neoplasms MESH:D009959 marker/mechanism 27749845 +HLA-DQA1 3117 Pancreatitis MESH:D010195 marker/mechanism 25217962 +HLA-DQA1 3117 Proteinuria MESH:D011507 marker/mechanism 11436868 +HLA-DQA2 3118 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +HLA-DQB1 3119 Angioedema MESH:D000799 marker/mechanism 15784113 +HLA-DQB1 3119 Asthma MESH:D001249 marker/mechanism 10792356 +HLA-DQB1 3119 Celiac Disease MESH:D002446 marker/mechanism 212750.0 +HLA-DQB1 3119 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 21570397 +HLA-DQB1 3119 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 123400.0 +HLA-DQB1 3119 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 26168013 +HLA-DQB1 3119 Drug Eruptions MESH:D003875 marker/mechanism 16502481 +HLA-DQB1 3119 Esophageal Achalasia MESH:D004931 marker/mechanism 24997987 +HLA-DQB1 3119 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25305756 +HLA-DQB1 3119 Hypersensitivity MESH:D006967 marker/mechanism 8725357 +HLA-DQB1 3119 Multiple Sclerosis MESH:D009103 marker/mechanism 126200.0 +HLA-DQB1 3119 Narcolepsy MESH:D009290 marker/mechanism 20711174 +HLA-DQB1 3119 Oropharyngeal Neoplasms MESH:D009959 marker/mechanism 27749845 +HLA-DQB1 3119 Scleroderma, Systemic MESH:D012595 marker/mechanism 20383147 +HLA-DQB1 3119 Urticaria MESH:D014581 marker/mechanism 16502481 +HLA-DRA 3122 Multiple Sclerosis MESH:D009103 marker/mechanism 17660530 +HLA-DRA 3122 Parkinson Disease MESH:D010300 marker/mechanism 20711177 +HLA-DRA 3122 Shock, Septic MESH:D012772 marker/mechanism 28771573 +HLA-DRB1 3123 Angioedema MESH:D000799 marker/mechanism 15784113 +HLA-DRB1 3123 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19898480|20453842|22286218 +HLA-DRB1 3123 Asthma MESH:D001249 marker/mechanism 16792590 +HLA-DRB1 3123 Autistic Disorder MESH:D001321 marker/mechanism 8765331 +HLA-DRB1 3123 Berylliosis MESH:D001607 marker/mechanism 16272364|17927685 +HLA-DRB1 3123 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 21570397 +HLA-DRB1 3123 Colitis, Ulcerative MESH:D003093 marker/mechanism 25559196 +HLA-DRB1 3123 Crohn Disease MESH:D003424 marker/mechanism 25559196 +HLA-DRB1 3123 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 26168013 +HLA-DRB1 3123 Drug Hypersensitivity MESH:D004342 marker/mechanism 20485159 +HLA-DRB1 3123 Eosinophilia-Myalgia Syndrome MESH:D016603 marker/mechanism 19790128 +HLA-DRB1 3123 Glomerulonephritis, Membranous MESH:D015433 marker/mechanism 11436868 +HLA-DRB1 3123 Hypersensitivity MESH:D006967 marker/mechanism 8725357 +HLA-DRB1 3123 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 23291585 +HLA-DRB1 3123 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 11436868 +HLA-DRB1 3123 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 22096508 +HLA-DRB1 3123 Multiple Sclerosis MESH:D009103 marker/mechanism 126200.0 25911099 +HLA-DRB1 3123 Narcolepsy MESH:D009290 marker/mechanism 20711174 +HLA-DRB1 3123 Nephrotic Syndrome MESH:D009404 marker/mechanism 11095018|6420562 +HLA-DRB1 3123 Oropharyngeal Neoplasms MESH:D009959 marker/mechanism 27749845 +HLA-DRB1 3123 Pancreatitis MESH:D010195 marker/mechanism 25217962 +HLA-DRB1 3123 Proteinuria MESH:D011507 marker/mechanism 11436868|6420562 +HLA-DRB1 3123 Sarcoidosis MESH:D012507 marker/mechanism 181000.0 14508706 +HLA-DRB1 3123 Schizophrenia MESH:D012559 marker/mechanism 16223876 +HLA-DRB1 3123 Typhoid Fever MESH:D014435 marker/mechanism 25383971 +HLA-DRB1 3123 Urticaria MESH:D014581 marker/mechanism 20485159 +HLA-DRB4 3126 Hypersensitivity MESH:D006967 marker/mechanism 8725357 +HLA-DRB5 3127 Alzheimer Disease MESH:D000544 marker/mechanism 27713094 +HLA-DRB5 3127 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +HLA-DRB5 3127 Hypersensitivity MESH:D006967 marker/mechanism 8725357 +HLA-DRB5 3127 Parkinson Disease MESH:D010300 marker/mechanism 27713094 +HLA-E 3133 Parapsoriasis MESH:D010267 marker/mechanism 16538176 +HLA-G 3135 Asthma MESH:D001249 marker/mechanism 600807.0 +HLCS 3141 Holocarboxylase Synthetase Deficiency MESH:D028922 marker/mechanism 253270.0 +HLF 3131 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 26214592 +HLTF 6596 Kidney Neoplasms MESH:D007680 marker/mechanism 16762066 +HMBS 3145 Porphyria, Acute Intermittent MESH:D017118 marker/mechanism 176000.0 6132132|8772850 +HMCN1 83872 Macular Degeneration, Age-Related, 1 MESH:C566411 marker/mechanism 603075.0 +HMG20A 10363 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 21874001 +HMGA1 3159 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 23512162 +HMGA1 3159 Hyperglycemia MESH:D006943 marker/mechanism 23512162 +HMGA1 3159 Insulin Resistance MESH:D007333 marker/mechanism 23512162 +HMGA1 3159 Leiomyosarcoma MESH:D007890 marker/mechanism 18645019 +HMGA1 3159 Metabolic Syndrome MESH:D024821 marker/mechanism 23512162 +HMGA1 3159 Uterine Neoplasms MESH:D014594 marker/mechanism 18645019 +HMGA2 8091 Birth Weight MESH:D001724 marker/mechanism 23202124 +HMGA2 8091 Neoplasm Invasiveness MESH:D009361 marker/mechanism 28830677 +HMGA2 8091 Neoplasms MESH:D009369 marker/mechanism 18413806 +HMGB1 3146 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 19783637 +HMGB1 3146 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +HMGB1 3146 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 27474498 +HMGB1 3146 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +HMGB1 3146 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +HMGB1 3146 Fever MESH:D005334 marker/mechanism 19265175 +HMGB1 3146 Hyperalgesia MESH:D006930 marker/mechanism 27474498 +HMGB1 3146 Hypertension MESH:D006973 marker/mechanism 32147540 +HMGB1 3146 Inflammation MESH:D007249 marker/mechanism 21617575|22178603|22386814|22429818|23146691 +HMGB1 3146 Leukostasis MESH:D018921 marker/mechanism 28294475 +HMGB1 3146 Multiple Organ Failure MESH:D009102 marker/mechanism 19265175 +HMGB1 3146 Myocardial Infarction MESH:D009203 marker/mechanism 21113057 +HMGB1 3146 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HMGB1 3146 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 21113057 +HMGB1 3146 Necrosis MESH:D009336 marker/mechanism 19783637|22178603 +HMGB1 3146 Neuralgia MESH:D009437 marker/mechanism 25014009 +HMGB1 3146 Neuropathy, Painful MESH:C564945 marker/mechanism 27474498 +HMGB1 3146 Pulmonary Fibrosis MESH:D011658 marker/mechanism 27616297 +HMGB1 3146 Sepsis MESH:D018805 marker/mechanism 19265175|23146691 +HMGB1 3146 Systemic Vasculitis MESH:D056647 marker/mechanism 23146691 +HMGB2 3148 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 24366584|27602772 +HMGB2 3148 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20851854 +HMGB2 3148 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +HMGB2 3148 Obesity MESH:D009765 marker/mechanism 20882379 +HMGB2 3148 Prostatic Neoplasms MESH:D011471 marker/mechanism 29877212 +HMGB3 3149 MICROPHTHALMIA, SYNDROMIC 13 OMIM:300915 marker/mechanism 300915.0 +HMGB3 3149 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30639441 +HMGCL 3155 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency MESH:C538324 marker/mechanism 246450.0 +HMGCR 3156 Autoimmune Diseases MESH:D001327 marker/mechanism 23953224 +HMGCR 3156 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110|9207284 +HMGCR 3156 Gallstones MESH:D042882 marker/mechanism 7461467 +HMGCR 3156 Hypercholesterolemia MESH:D006937 marker/mechanism 8593127 +HMGCR 3156 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 12477733 +HMGCR 3156 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +HMGCR 3156 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HMGCR 3156 Mevalonate Kinase Deficiency MESH:D054078 marker/mechanism 12477733 +HMGCR 3156 Muscular Diseases MESH:D009135 marker/mechanism 23953224 +HMGCR 3156 Q Fever MESH:D011778 marker/mechanism 16469060 +HMGCS2 3158 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency MESH:C567784 marker/mechanism 605911.0 +HMGCS2 3158 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925|27816970 +HMGCS2 3158 Heart Failure MESH:D006333 marker/mechanism 36071497 +HMGCS2 3158 Mouth Neoplasms MESH:D009062 marker/mechanism 27816970 +HMGCS2 3158 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HMGCS2 3158 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27816970 +HMGCS2 3158 Recurrence MESH:D012008 marker/mechanism 27816970 +HMGN1 3150 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24747640 +HMGN5 79366 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 28914995 +HMGN5 79366 Glioma MESH:D005910 marker/mechanism 22109888 +HMGN5 79366 Prostatic Neoplasms MESH:D011471 marker/mechanism 22109888 +HMGN5 79366 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 22109888 +HMGN5B 120097335 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HMMR 3161 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 17922014 +HMMR 3161 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +HMMR 3161 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 17157168 +HMMR 3161 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +HMMR-AS1 101927813 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 35179300 +HMOX 100528875 Anterior Compartment Syndrome MESH:D000868 marker/mechanism 36193742 +HMOX1 3162 Acute Kidney Injury MESH:D058186 therapeutic 21048024 +HMOX1 3162 Adrenoleukodystrophy MESH:D000326 marker/mechanism 16319717 +HMOX1 3162 Alzheimer Disease MESH:D000544 marker/mechanism 11144356 +HMOX1 3162 Anemia, Hemolytic MESH:D000743 marker/mechanism 9884342 +HMOX1 3162 Asthma MESH:D001249 marker/mechanism 18048809 +HMOX1 3162 Blood Coagulation Disorders MESH:D001778 marker/mechanism 9884342 +HMOX1 3162 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +HMOX1 3162 Cardiomegaly MESH:D006332 therapeutic 15226216 +HMOX1 3162 Carotid Artery Diseases MESH:D002340 marker/mechanism 17095719 +HMOX1 3162 Cerebral Hemorrhage MESH:D002543 marker/mechanism 12401953 +HMOX1 3162 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism|therapeutic 18227147|22688006 +HMOX1 3162 Colitis MESH:D003092 therapeutic 16365149|21444764 +HMOX1 3162 Coronary Artery Disease MESH:D003324 marker/mechanism 12136229 +HMOX1 3162 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +HMOX1 3162 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism|therapeutic 16123366|16959961|18375438|19804535 +HMOX1 3162 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism|therapeutic 12136229|16123366|16959961 +HMOX1 3162 Diabetic Angiopathies MESH:D003925 therapeutic 16959961 +HMOX1 3162 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 18227147 +HMOX1 3162 Fibrosis MESH:D005355 therapeutic 18784349 +HMOX1 3162 Gastroparesis MESH:D018589 therapeutic 20378827 +HMOX1 3162 Growth Disorders MESH:D006130 marker/mechanism 9884342 +HMOX1 3162 Heart Failure MESH:D006333 marker/mechanism 22352330 +HMOX1 3162 Heme Oxygenase 1 Deficiency MESH:C564200 marker/mechanism 614034.0 +HMOX1 3162 Hemolysis MESH:D006461 marker/mechanism 25247420 +HMOX1 3162 Hepatitis MESH:D006505 therapeutic 14512878 +HMOX1 3162 Hepatorenal Syndrome MESH:D006530 marker/mechanism 21253390 +HMOX1 3162 Hyperinsulinism MESH:D006946 therapeutic 19171794 +HMOX1 3162 Hyperplasia MESH:D006965 therapeutic 19234301 +HMOX1 3162 Hypertension MESH:D006973 marker/mechanism|therapeutic 16959961|22349312|22352330 +HMOX1 3162 Inflammation MESH:D007249 marker/mechanism 12649161|16982915|23451061|29086419 +HMOX1 3162 Insulin Resistance MESH:D007333 marker/mechanism|therapeutic 18375438|19171794 +HMOX1 3162 Iron Metabolism Disorders MESH:D019189 marker/mechanism 9884342 +HMOX1 3162 Ischemia MESH:D007511 therapeutic 15036356|19667931 +HMOX1 3162 Kidney Failure, Chronic MESH:D007676 therapeutic 22622455 +HMOX1 3162 Learning Disabilities MESH:D007859 marker/mechanism 11718997 +HMOX1 3162 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 22461696 +HMOX1 3162 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism|therapeutic 16025519|16610050|21163135|25380136 +HMOX1 3162 Liver Diseases MESH:D008107 marker/mechanism|therapeutic 16964402|17002867|17275847 +HMOX1 3162 Liver Neoplasms MESH:D008113 therapeutic 17002867 +HMOX1 3162 Lung Injury MESH:D055370 marker/mechanism 17365036 +HMOX1 3162 Lung Neoplasms MESH:D008175 marker/mechanism 15688187|18508827|31227482 +HMOX1 3162 Mammary Neoplasms, Experimental MESH:D008325 therapeutic 16319139 +HMOX1 3162 Mastocytosis, Systemic MESH:D034721 marker/mechanism 17420286 +HMOX1 3162 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HMOX1 3162 Neoplasm Invasiveness MESH:D009361 therapeutic 24211270 +HMOX1 3162 Neurodegenerative Diseases MESH:D019636 marker/mechanism 10942521|12709579|15964507 +HMOX1 3162 Obesity MESH:D009765 marker/mechanism 18334666|18375438|19171794 +HMOX1 3162 Pancreatic Diseases MESH:D010182 therapeutic 18784349 +HMOX1 3162 Parkinson Disease MESH:D010300 marker/mechanism 21318773 +HMOX1 3162 Pneumonia MESH:D011014 marker/mechanism 16582079 +HMOX1 3162 Pre-Eclampsia MESH:D011225 marker/mechanism 22197494 +HMOX1 3162 Prostatic Neoplasms MESH:D011471 marker/mechanism 25246272 +HMOX1 3162 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 606963.0 +HMOX1 3162 Pulmonary Emphysema MESH:D011656 marker/mechanism 10631150 +HMOX1 3162 Pulmonary Fibrosis MESH:D011658 marker/mechanism 15814490 +HMOX1 3162 Reperfusion Injury MESH:D015427 marker/mechanism|therapeutic 12352873|16982915|17660127|17906103|23075401|25780291 +HMOX1 3162 Retinal Diseases MESH:D012164 marker/mechanism 23075401 +HMOX1 3162 Spinocerebellar Ataxia 17 MESH:C564616 marker/mechanism 24413982 +HMOX1 3162 Status Epilepticus MESH:D013226 marker/mechanism 20971094 +HMOX1 3162 Stomach Neoplasms MESH:D013274 marker/mechanism 14647439|22490514 +HMOX1 3162 Thrombosis MESH:D013927 therapeutic 19168058 +HMOX1 3162 Vascular System Injuries MESH:D057772 therapeutic 19234301 +HMOX1 3162 Wounds and Injuries MESH:D014947 marker/mechanism 12649161 +HMOX2 3163 Cerebral Hemorrhage MESH:D002543 therapeutic 16459095 +HMOX2 3163 Migraine with Aura MESH:D020325 marker/mechanism 35115687 +HMX1 3166 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19379485 +HMX1 3166 Microphthalmos MESH:D008850 marker/mechanism 19379485 +HMX1 3166 Oculoauricular Syndrome MESH:C567416 marker/mechanism 612109.0 19379485 +HNF1A 6927 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 144700.0 +HNF1A 6927 Coronary Disease MESH:D003327 marker/mechanism 28869590 +HNF1A 6927 Diabetes Mellitus, Insulin-Dependent, 20 MESH:C567286 marker/mechanism 612520.0 +HNF1A 6927 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 222100.0 +HNF1A 6927 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 28869590 +HNF1A 6927 Hepatic Adenomas, Familial MESH:C564190 marker/mechanism 142330.0 +HNF1A 6927 Hyperglycemia MESH:D006943 marker/mechanism 29753610 +HNF1A 6927 Hypoglycemia MESH:D007003 marker/mechanism 15787664 +HNF1A 6927 Maturity-Onset Diabetes of the Young, Type 3 MESH:C563933 marker/mechanism 600496.0 29753610 +HNF1B 6928 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 144700.0 +HNF1B 6928 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism|therapeutic 125853.0 17603485 +HNF1B 6928 Prostatic Neoplasms MESH:D011471 marker/mechanism 18264096|18758462 +HNF1B 6928 Renal cysts and diabetes syndrome MESH:C535520 marker/mechanism 137920.0 +HNF4A 3172 Colitis, Ulcerative MESH:D003093 marker/mechanism 19915572 +HNF4A 3172 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 17317762|21874001|22158537 +HNF4A 3172 FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG OMIM:616026 marker/mechanism 616026.0 +HNF4A 3172 Maturity-Onset Diabetes of the Young, Type 1 MESH:C565101 marker/mechanism 125850.0 21115832 +HNMT 3176 Asthma MESH:D001249 marker/mechanism 600807.0 17651147 +HNMT 3176 Drug Hypersensitivity MESH:D004342 marker/mechanism 20485159 +HNMT 3176 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 51 OMIM:616739 marker/mechanism 616739.0 +HNMT 3176 Rhinitis MESH:D012220 marker/mechanism 17651147 +HNMT 3176 Urticaria MESH:D014581 marker/mechanism 20485159 +HNRNPA1 3178 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +HNRNPA1 3178 AMYOTROPHIC LATERAL SCLEROSIS 20 OMIM:615426 marker/mechanism 615426.0 +HNRNPA1 3178 Carcinoma MESH:D002277 marker/mechanism 16316942 +HNRNPA1 3178 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +HNRNPA1 3178 Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia MESH:C563476 marker/mechanism 615424.0 +HNRNPA1 3178 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +HNRNPA1 3178 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +HNRNPA1 3178 Myopathy, Distal 3 MESH:C566445 marker/mechanism 610099.0 +HNRNPA2B1 3181 Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia MESH:C563476 marker/mechanism 615422.0 +HNRNPA2B1 3181 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +HNRNPA3 220988 Schizophrenia MESH:D012559 marker/mechanism 16223876 +HNRNPAB 3182 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 15538050 +HNRNPDL 9987 Limb-Girdle Muscular Dystrophy, Type 1G MESH:C563794 marker/mechanism 609115.0 +HNRNPH1 3187 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973 +HNRNPH2 3188 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BAIN TYPE OMIM:300986 marker/mechanism 300986.0 +HNRNPK 3190 AU-KLINE SYNDROME OMIM:616580 marker/mechanism 616580.0 +HNRNPK 3190 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +HNRNPL 3191 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +HNRNPL 3191 Disease Progression MESH:D018450 marker/mechanism 21364753 +HNRNPL 3191 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +HNRNPR 10236 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +HNRNPU 3192 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 54 OMIM:617391 marker/mechanism 617391.0 +HNRNPU 3192 Epilepsy MESH:D004827 marker/mechanism 29942082 +HNRNPU 3192 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +HNRNPUL2 221092 Autistic Disorder MESH:D001321 marker/mechanism 35982159 +HOGA1 112817 Cholestasis MESH:D002779 marker/mechanism 27989131 +HOGA1 112817 HYPEROXALURIA, PRIMARY, TYPE III OMIM:613616 marker/mechanism 613616.0 +HOMER1 9456 Cocaine-Related Disorders MESH:D019970 marker/mechanism|therapeutic 16160706|16314758 +HOMER1 9456 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 24126708 +HOMER1 9456 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism 24126708 +HOMER1 9456 Hallucinations MESH:D006212 marker/mechanism 24126708 +HOMER2 9455 Cocaine-Related Disorders MESH:D019970 marker/mechanism 15545022 +HOMER2 9455 DEAFNESS, AUTOSOMAL DOMINANT 68 OMIM:616707 marker/mechanism 616707.0 +HOMER3 9454 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +HOMER3 9454 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +HOOK3 84376 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +HOPX 84525 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HOTAIR 100124700 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21327457 +HOTAIR 100124700 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 21327457 +HOTAIR 100124700 Stomach Neoplasms MESH:D013274 marker/mechanism 26384301 +HOTAIR 100124700 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 29572071 +HOTTIP 100316868 Heart Failure MESH:D006333 marker/mechanism 36071497 +HOXA1 3198 Athabaskan brainstem dysgenesis MESH:C535397 marker/mechanism 601536.0 24239177 +HOXA1 3198 Autistic Disorder MESH:D001321 marker/mechanism 11091361 +HOXA1 3198 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10529420 +HOXA1 3198 Heart Defects, Congenital MESH:D006330 marker/mechanism 21940751 +HOXA1 3198 Nervous System Malformations MESH:D009421 marker/mechanism 10529420 +HOXA10 3206 Adenocarcinoma MESH:D000230 marker/mechanism 21670700 +HOXA10 3206 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +HOXA10 3206 Endometrial Neoplasms MESH:D016889 marker/mechanism 21670700 +HOXA10 3206 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +HOXA11 3207 Endometrial Neoplasms MESH:D016889 marker/mechanism 16804899 +HOXA11 3207 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +HOXA11 3207 Kidney Diseases MESH:D007674 marker/mechanism 7596412 +HOXA11 3207 Limb Deformities, Congenital MESH:D017880 marker/mechanism 7596412 +HOXA11 3207 Osteochondrodysplasias MESH:D010009 marker/mechanism 35253374 +HOXA11 3207 Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia MESH:C565328 marker/mechanism 605432.0 24239177 +HOXA11 3207 Urogenital Abnormalities MESH:D014564 marker/mechanism 35253374 +HOXA11-AS 221883 Heart Failure MESH:D006333 marker/mechanism 36071497 +HOXA13 3209 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +HOXA13 3209 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +HOXA13 3209 Hand foot uterus syndrome MESH:C535627 marker/mechanism 140000.0 24239177|9020844 +HOXA13 3209 Preaxial deficiency, postaxial polydactyly and hypospadias MESH:C538278 marker/mechanism 176305.0 24239177 +HOXA2 3199 Microtia, Hearing Impairment, And Cleft Palate MESH:C567359 marker/mechanism 612290.0 24239177 +HOXA2 3199 Stomach Neoplasms MESH:D013274 marker/mechanism 17786296 +HOXA3 3200 Craniofacial Abnormalities MESH:D019465 marker/mechanism 1673020 +HOXA3 3200 Heart Defects, Congenital MESH:D006330 marker/mechanism 1673020 +HOXA3 3200 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HOXA3 3200 Lymphatic Abnormalities MESH:D044148 marker/mechanism 1673020 +HOXA5 3202 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 18351244 +HOXA5 3202 Mouth Neoplasms MESH:D009062 marker/mechanism 22227861 +HOXA5 3202 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 22227861 +HOXA9 3205 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 22541086 +HOXA9 3205 Melanoma MESH:D008545 marker/mechanism 16778180 +HOXA9 3205 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 26332997 +HOXA9 3205 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26332997 +HOXB1 3211 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10529420 +HOXB1 3211 Facial paresis, hereditary, congenital MESH:C536386 marker/mechanism 614744.0 24239177 +HOXB1 3211 Nervous System Malformations MESH:D009421 marker/mechanism 10529420 +HOXB13 10481 Breast Neoplasms MESH:D001943 marker/mechanism 24239177 +HOXB13 10481 Melanoma MESH:D008545 marker/mechanism 17145863 +HOXB13 10481 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +HOXB13 10481 Prostate cancer, familial MESH:C537243 marker/mechanism 22236224 +HOXB13 10481 Prostate Cancer, Hereditary, 9 MESH:C567031 marker/mechanism 610997.0 +HOXB13 10481 Prostatic Neoplasms MESH:D011471 marker/mechanism 23104005|24239177|24390282|26457646|32690948|35468964 +HOXB3 3213 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 18351244 +HOXB3 3213 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34652879 +HOXB5 3215 Obesity MESH:D009765 marker/mechanism 22484627 +HOXB8 3218 Obsessive-Compulsive Disorder MESH:D009771 marker/mechanism 11779477 +HOXB8 3218 Trichotillomania MESH:D014256 marker/mechanism 11779477 +HOXB9 3219 Acute erythroleukemia MESH:C535673 marker/mechanism 30926971 +HOXB9 3219 Breast Neoplasms MESH:D001943 marker/mechanism 27182052 +HOXB9 3219 Ovarian Neoplasms MESH:D010051 marker/mechanism 27182052 +HOXB9 3219 Prostatic Neoplasms MESH:D011471 marker/mechanism 27182052 +HOXB9 3219 Uterine Neoplasms MESH:D014594 marker/mechanism 27182052 +HOXC13 3229 ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE OMIM:602032 marker/mechanism 24239177 +HOXC13 3229 ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE OMIM:614931 marker/mechanism 614931.0 +HOXD1 3231 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +HOXD1 3231 Hyperalgesia MESH:D006930 marker/mechanism 21151121 +HOXD1 3231 Ovarian Neoplasms MESH:D010051 marker/mechanism 20852632 +HOXD1 3231 Pain MESH:D010146 marker/mechanism 21151121 +HOXD10 3236 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +HOXD10 3236 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 15146389 +HOXD10 3236 Disease Progression MESH:D018450 marker/mechanism 34737577 +HOXD10 3236 Flatfoot MESH:D005413 marker/mechanism 15146389|16450407|24239177 +HOXD10 3236 Glioblastoma MESH:D005909 marker/mechanism 34737577 +HOXD10 3236 Lower Extremity Deformities, Congenital MESH:D038061 marker/mechanism 9409668 +HOXD10 3236 Mouth Neoplasms MESH:D009062 marker/mechanism 22227861 +HOXD10 3236 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 22227861 +HOXD10 3236 VERTICAL TALUS, CONGENITAL OMIM:192950 marker/mechanism 192950.0 +HOXD11 3237 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +HOXD11 3237 Autistic Disorder MESH:D001321 marker/mechanism 19540081 +HOXD11 3237 Bone Diseases, Developmental MESH:D001848 marker/mechanism 7925020 +HOXD11 3237 Breast Neoplasms MESH:D001943 marker/mechanism 15818620 +HOXD11 3237 Disease Progression MESH:D018450 marker/mechanism 33614284 +HOXD11 3237 Glioma MESH:D005910 marker/mechanism 33614284 +HOXD11 3237 Infertility, Male MESH:D007248 marker/mechanism 7925020 +HOXD11 3237 Kidney Diseases MESH:D007674 marker/mechanism 7596412 +HOXD11 3237 Limb Deformities, Congenital MESH:D017880 marker/mechanism 7596412|7925020|8620844 +HOXD11 3237 Mouth Neoplasms MESH:D009062 marker/mechanism 22227861 +HOXD11 3237 Ovarian Neoplasms MESH:D010051 marker/mechanism 17303177 +HOXD11 3237 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 22227861 +HOXD12 3238 Limb Deformities, Congenital MESH:D017880 marker/mechanism 19108020|8620844 +HOXD12 3238 Melanoma MESH:D008545 marker/mechanism 16778180 +HOXD13 3239 Anemia MESH:D000740 marker/mechanism 27725143 +HOXD13 3239 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +HOXD13 3239 Brachydactyly-Syndactyly Syndrome MESH:C565193 marker/mechanism 610713.0 24239177 +HOXD13 3239 Brachydactyly, Type D MESH:C562420 marker/mechanism 113200.0 24239177 +HOXD13 3239 BRACHYDACTYLY, TYPE E1 OMIM:113300 marker/mechanism 113300.0 24239177 +HOXD13 3239 Limb Deformities, Congenital MESH:D017880 marker/mechanism 8620844 +HOXD13 3239 Lymphopenia MESH:D008231 marker/mechanism 27725143 +HOXD13 3239 Neutropenia MESH:D009503 marker/mechanism 27725143 +HOXD13 3239 Syndactyly MESH:D013576 marker/mechanism 186000.0 +HOXD13 3239 Syndactyly, type 2 MESH:C538153 marker/mechanism 24239177 +HOXD13 3239 Syndactyly, type v MESH:C538155 marker/mechanism 186300.0 24239177 +HOXD13 3239 VATER association MESH:C536534 marker/mechanism 19006232 +HOXD3 3232 Prostatic Neoplasms MESH:D011471 marker/mechanism 19283074 +HOXD4 3233 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 15776434 +HOXD9 3235 Adenocarcinoma, Mucinous MESH:D002288 marker/mechanism 26075790 +HOXD9 3235 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +HOXD9 3235 Colorectal Neoplasms MESH:D015179 marker/mechanism 26075790 +HOXD9 3235 Neoplastic Processes MESH:D009385 marker/mechanism 26075790 +HOXD9 3235 Ovarian Neoplasms MESH:D010051 marker/mechanism 26075790 +HP 3240 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +HP 3240 Anemia MESH:D000740 marker/mechanism 16637741 +HP 3240 Anemia, Sickle Cell MESH:D000755 marker/mechanism 16597321 +HP 3240 Arthritis MESH:D001168 marker/mechanism 16597321 +HP 3240 Atherosclerosis MESH:D050197 marker/mechanism 16597321 +HP 3240 Autoimmune Diseases MESH:D001327 marker/mechanism 16597321 +HP 3240 Breast Neoplasms MESH:D001943 marker/mechanism 16597321 +HP 3240 Cardiovascular Diseases MESH:D002318 marker/mechanism 19769483 +HP 3240 Chemically-Induced Disorders MESH:D064419 marker/mechanism 35999755 +HP 3240 Colitis, Ulcerative MESH:D003093 marker/mechanism 35999755 +HP 3240 Diabetes Complications MESH:D048909 marker/mechanism 19769483 +HP 3240 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 16506275 +HP 3240 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16506275 +HP 3240 Diabetic Angiopathies MESH:D003925 marker/mechanism 16597321 +HP 3240 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +HP 3240 Dyslipidemias MESH:D050171 marker/mechanism 16597321 +HP 3240 Foodborne Diseases MESH:D005517 marker/mechanism 21075095 +HP 3240 Genital Neoplasms, Female MESH:D005833 marker/mechanism 16597321 +HP 3240 Hemochromatosis MESH:D006432 marker/mechanism 16597321 +HP 3240 Hemolysis MESH:D006461 marker/mechanism 25247420 +HP 3240 Hepatitis B MESH:D006509 marker/mechanism 16597321 +HP 3240 Hepatitis B, Chronic MESH:D019694 marker/mechanism 16597321 +HP 3240 Hepatitis C, Chronic MESH:D019698 marker/mechanism 16597321 +HP 3240 HIV Infections MESH:D015658 marker/mechanism 16597321 +HP 3240 Hypersensitivity MESH:D006967 marker/mechanism 16597321 +HP 3240 Hypertension MESH:D006973 marker/mechanism 16597321 +HP 3240 Hypertension, Pregnancy-Induced MESH:D046110 marker/mechanism 16597321 +HP 3240 Leukemia MESH:D007938 marker/mechanism 16597321 +HP 3240 Malaria MESH:D008288 marker/mechanism 16597321|8730300 +HP 3240 Myocardial Infarction MESH:D009203 marker/mechanism 16597321|17068284|17207726 +HP 3240 Pasteurellaceae Infections MESH:D016871 marker/mechanism 16755360 +HP 3240 Retinal Detachment MESH:D012163 marker/mechanism 16597321 +HP 3240 Schizophrenia MESH:D012559 marker/mechanism 18583979 +HP 3240 Tuberculosis MESH:D014376 marker/mechanism 16597321 +HPCA 3208 Dystonia musculorum deformans type 2 MESH:C538006 marker/mechanism 224500 +HPCAL1 3241 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HPD 3242 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942|22872058 +HPD 3242 Hawkinsinuria MESH:C535845 marker/mechanism 140350 +HPD 3242 Tyrosinemias MESH:D020176 marker/mechanism 276710 +HPDL 84842 NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES OMIM:619026 marker/mechanism 619026 +HPGD 3248 Carcinoma, Medullary MESH:D018276 therapeutic 11352223 +HPGD 3248 Osteoarthropathy, Primary Hypertrophic MESH:D010004 marker/mechanism 119900|259100 18500342|25526675 +HPGD 3248 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +HPGD 3248 Thyroid Neoplasms MESH:D013964 therapeutic 11352223 +HPGDS 27306 Kidney Neoplasms MESH:D007680 marker/mechanism 28321044 +HPGDS 27306 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HPGDS 27306 Liver Diseases MESH:D008107 marker/mechanism 19784758 +HPGDS 27306 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 23666239 +HPH1 15447 Disease Models, Animal MESH:D004195 marker/mechanism 22784235 +HPH1 15447 Phenylketonurias MESH:D010661 marker/mechanism 22784235 +HPN 3249 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414 +HPN 3249 Prostatic Neoplasms MESH:D011471 marker/mechanism 15583422|16783571 +HPRT1 3251 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +HPRT1 3251 Gout, HPRT-Related MESH:C562583 marker/mechanism 300323.0 23348497 +HPRT1 3251 Hyperuricemia MESH:D033461 marker/mechanism 23348497 +HPRT1 3251 Lesch-Nyhan Syndrome MESH:D007926 marker/mechanism 300322.0 +HPS1 3257 Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells MESH:C538539 marker/mechanism 203300.0 +HPS3 84343 Hermanski-Pudlak Syndrome MESH:D022861 marker/mechanism 614072.0 +HPS4 89781 Hermanski-Pudlak Syndrome MESH:D022861 marker/mechanism 614073.0 +HPS5 11234 Hermanski-Pudlak Syndrome MESH:D022861 marker/mechanism 614074.0 +HPS6 79803 Hermanski-Pudlak Syndrome MESH:D022861 marker/mechanism 614075.0 +HPSE 10855 Breast Neoplasms MESH:D001943 marker/mechanism 16391819 +HPSE 10855 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +HPSE 10855 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15095483|18458672 +HPSE 10855 Melanoma MESH:D008545 marker/mechanism 22240343 +HPSE 10855 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22240343 +HPSE 10855 Neoplasm Metastasis MESH:D009362 marker/mechanism 22240343 +HPSE 10855 Nephrosis MESH:D009401 marker/mechanism 16899518 +HPSE2 60495 Urofacial syndrome MESH:C536480 marker/mechanism 236730.0 20560209 +HPV18I1 3260 HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1 OMIM:167959 marker/mechanism 167959.0 +HPV18I2 3261 HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2 OMIM:167960 marker/mechanism 167960.0 +HPX 3263 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +HPX 3263 Autoimmune Diseases MESH:D001327 marker/mechanism 18641331 +HPX 3263 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +HPX 3263 Compartment Syndromes MESH:D003161 therapeutic 14500188 +HPX 3263 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16506275 +HPX 3263 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +HR 55806 Alopecia MESH:D000505 marker/mechanism 16455232 +HR 55806 Alopecia universalis MESH:C537055 marker/mechanism 203655.0 +HR 55806 Atrichia with Papular Lesions MESH:C565924 marker/mechanism 209500.0 +HR 55806 Marie Unna congenital hypotrichosis MESH:C535912 marker/mechanism 19122663 +HRAS 3265 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 26558449 +HRAS 3265 Adenoma, Liver Cell MESH:D018248 marker/mechanism 8200073 +HRAS 3265 Autistic Disorder MESH:D001321 marker/mechanism 8098541 +HRAS 3265 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +HRAS 3265 Breast Neoplasms MESH:D001943 marker/mechanism 12165863|15958052|17474063|19652463|32621833 +HRAS 3265 Carcinoma MESH:D002277 marker/mechanism 8185828 +HRAS 3265 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +HRAS 3265 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20118494|27517622|28284560|8200073|9311599 +HRAS 3265 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 24224046|25125259 +HRAS 3265 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 3433577 +HRAS 3265 Cardiofaciocutaneous syndrome MESH:C535579 marker/mechanism 17703371 +HRAS 3265 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 12115494|18245498|18829283|22048643|23877152 +HRAS 3265 Costello Syndrome MESH:D056685 marker/mechanism 218040.0 17468812|17703371|19132118 +HRAS 3265 Disease Progression MESH:D018450 marker/mechanism 12082015|32621833 +HRAS 3265 Epidermal Nevus MESH:C580062 marker/mechanism 162900.0 +HRAS 3265 Glioma MESH:D005910 marker/mechanism 30619488 +HRAS 3265 Hemangiosarcoma MESH:D006394 marker/mechanism 10930038 +HRAS 3265 Liver Neoplasms MESH:D008113 marker/mechanism 10874023|12082015|12127263|16410370|17514646 +HRAS 3265 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 20118494|21147764|27517622|7955063 +HRAS 3265 Lung Neoplasms MESH:D008175 marker/mechanism 10779650|11307925|11552296|12765245|15902970 +HRAS 3265 Lymphoma, T-Cell MESH:D016399 marker/mechanism 29438700 +HRAS 3265 Malformations of Cortical Development MESH:D054220 marker/mechanism 27935819 +HRAS 3265 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 8185828 +HRAS 3265 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 11376698|8185828 +HRAS 3265 Melanocytic nevus syndrome, congenital MESH:C536819 marker/mechanism 137550.0 +HRAS 3265 Melanoma MESH:D008545 marker/mechanism 30619488 +HRAS 3265 Mouth Neoplasms MESH:D009062 marker/mechanism 24224046 +HRAS 3265 Neoplasm Invasiveness MESH:D009361 marker/mechanism 23877152 +HRAS 3265 Neoplasms, Experimental MESH:D009374 marker/mechanism 11552296|26558449|3433577 +HRAS 3265 Neoplastic Processes MESH:D009385 marker/mechanism 12082015 +HRAS 3265 Neuroblastoma MESH:D009447 marker/mechanism 15814359|26121086 +HRAS 3265 Nevus, Sebaceous of Jadassohn MESH:D054000 marker/mechanism 163200.0 22683711 +HRAS 3265 Noonan Syndrome MESH:D009634 marker/mechanism 17703371 +HRAS 3265 Papilloma MESH:D010212 marker/mechanism 8330346 +HRAS 3265 Penile Neoplasms MESH:D010412 marker/mechanism 18355852 +HRAS 3265 Precancerous Conditions MESH:D011230 marker/mechanism 2675901 +HRAS 3265 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +HRAS 3265 Recurrence MESH:D012008 marker/mechanism 26121086 +HRAS 3265 Seminoma MESH:D018239 marker/mechanism 19855393 +HRAS 3265 Skin Neoplasms MESH:D012878 marker/mechanism 15958052|18758463|24898257|26558449|8330346|8508502|9766437 +HRAS 3265 Splenic Neoplasms MESH:D013160 marker/mechanism 26558449 +HRAS 3265 Stomach Neoplasms MESH:D013274 marker/mechanism 11397402|26558449 +HRAS 3265 Thyroid cancer, follicular MESH:C572845 marker/mechanism 188470.0 +HRAS 3265 Thyroid Neoplasms MESH:D013964 marker/mechanism 3078959 +HRAS 3265 Tongue Neoplasms MESH:D014062 marker/mechanism 20043093 +HRAS 3265 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 109800.0 15958052|2228319|2278634 +HRC 3270 Body Weight MESH:D001835 marker/mechanism 17030629 +HRC 3270 Cardiomegaly MESH:D006332 marker/mechanism 17030629 +HRG 3273 Breast Neoplasms MESH:D001943 marker/mechanism 19552798 +HRG 3273 Thrombophilia Due To Elevated Histidine-Rich Glycoprotein MESH:C567737 marker/mechanism 613116.0 +HRH1 3269 Atherosclerosis MESH:D050197 marker/mechanism 25020133 +HRH1 3269 Extravasation of Diagnostic and Therapeutic Materials MESH:D005119 therapeutic 32061592 +HRH1 3269 Hypotension MESH:D007022 marker/mechanism 2105067 +HRH1 3269 Pain MESH:D010146 marker/mechanism 12128009|14569158 +HRH1 3269 Pruritus MESH:D011537 marker/mechanism 19652466 +HRH1 3269 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 12095164 +HRH1 3269 Rhinitis MESH:D012220 marker/mechanism 12167471 +HRH1 3269 Rhinitis, Allergic MESH:D065631 marker/mechanism 23333628 +HRH1 3269 Schizophrenia MESH:D012559 marker/mechanism 1912125 +HRH1 3269 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 8870037 +HRH1 3269 Telangiectasis MESH:D013684 therapeutic 32061592 +HRH2 3274 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 6224980 +HRH2 3274 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22926047 +HRH2 3274 Coronary Stenosis MESH:D023921 marker/mechanism 12721106 +HRH2 3274 Hypertension MESH:D006973 marker/mechanism 30310171 +HRH2 3274 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 30310171 +HRH2 3274 Neoplasm Metastasis MESH:D009362 marker/mechanism 6224980 +HRH2 3274 Neoplasms, Experimental MESH:D009374 marker/mechanism 6224980 +HRH2 3274 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 8870037 +HRH3 11255 Amnesia MESH:D000647 marker/mechanism 11125734 +HRH3 11255 Hypertension MESH:D006973 marker/mechanism 9050021 +HRH3 11255 Memory Disorders MESH:D008569 marker/mechanism 16488453 +HRH4 59340 Adenocarcinoma MESH:D000230 marker/mechanism 22363581 +HRH4 59340 Pruritus MESH:D011537 marker/mechanism 19652466 +HRH4 59340 Stomach Neoplasms MESH:D013274 marker/mechanism 22363581 +HRURF 120766137 Marie Unna congenital hypotrichosis MESH:C535912 marker/mechanism 146550.0 +HS3ST3B1 9953 Endometriosis MESH:D004715 marker/mechanism 20864642 +HS3ST4 9951 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +HS3ST5 222537 Melanoma MESH:D008545 marker/mechanism 22535842 +HS3ST6 64711 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +HS6ST1 9394 HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA OMIM:614880 marker/mechanism 614880.0 +HSC70-3 32133 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +HSD11B1 3290 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +HSD11B1 3290 Cortisone reductase deficiency MESH:C536447 marker/mechanism 614662.0 25526675 +HSD11B1 3290 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +HSD11B1 3290 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14697232 +HSD11B1 3290 Hyperglycemia MESH:D006943 marker/mechanism 14697232 +HSD11B1 3290 Hypertension MESH:D006973 marker/mechanism 15199296|21786805|9683905 +HSD11B1 3290 Insulin Resistance MESH:D007333 marker/mechanism 21786805 +HSD11B1 3290 Obesity MESH:D009765 marker/mechanism 17628001|21786805 +HSD11B1 3290 Obesity, Abdominal MESH:D056128 marker/mechanism 15199296 +HSD11B2 3291 Apparent mineralocorticoid excess MESH:C537422 marker/mechanism 218030.0 11085685|19075542|7608290|7670488|9683905|9707624 +HSD11B2 3291 Asthma MESH:D001249 marker/mechanism 11932298 +HSD11B2 3291 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 16616286 +HSD11B2 3291 Hypertension MESH:D006973 marker/mechanism 11082157|7670488|9683905|9707624 +HSD11B2 3291 Liver Cirrhosis MESH:D008103 marker/mechanism 15199296 +HSD11B2 3291 Mineralocorticoid Excess Syndrome, Apparent MESH:D043204 marker/mechanism 25526675 +HSD11B2 3291 Myocardial Infarction MESH:D009203 marker/mechanism 17587755 +HSD11B2 3291 Nephrotic Syndrome MESH:D009404 marker/mechanism 15199296 +HSD11B2 3291 Pregnancy Complications MESH:D011248 marker/mechanism 11932298 +HSD17B1 3292 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +HSD17B1 3292 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +HSD17B1 3292 Endometriosis MESH:D004715 marker/mechanism 18815356 +HSD17B1 3292 Prostatic Neoplasms MESH:D011471 marker/mechanism 17507624 +HSD17B10 3028 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +HSD17B10 3028 Mental Retardation, X-Linked, Syndromic 10 MESH:C564560 marker/mechanism 300438.0 25526675 +HSD17B2 3294 Endometrial Neoplasms MESH:D016889 marker/mechanism 23200943 +HSD17B2 3294 Endometriosis MESH:D004715 marker/mechanism 18815356|21232532 +HSD17B2 3294 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +HSD17B3 3293 17-Hydroxysteroid Dehydrogenase Deficiency MESH:C537805 marker/mechanism 264300.0 25526675 +HSD17B3 3293 Disorders of Sex Development MESH:D012734 marker/mechanism 17071532 +HSD17B3 3293 Prostatic Neoplasms MESH:D011471 marker/mechanism 12210481 +HSD17B4 3295 D-BIFUNCTIONAL PROTEIN DEFICIENCY OMIM:261515 marker/mechanism 261515.0 +HSD17B4 3295 Gonadal dysgenesis XX type deafness MESH:C537286 marker/mechanism 233400.0 25526675 +HSD17B4 3295 Peroxisomal Disorders MESH:D018901 marker/mechanism 16385454|9345094 +HSD17B4 3295 Spasms, Infantile MESH:D013036 marker/mechanism 16919904 +HSD17B4 3295 Zellweger Syndrome MESH:D015211 marker/mechanism 10343282 +HSD17B6 8630 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +HSD3B1 3283 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +HSD3B1 3283 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 22381227 +HSD3B1 3283 Prostatic Neoplasms MESH:D011471 marker/mechanism 17826523 +HSD3B2 3284 Adrenal hyperplasia 2 MESH:C538236 marker/mechanism 201810.0 25526675 +HSD3B2 3284 Adrenal Hyperplasia, Congenital MESH:D000312 marker/mechanism 18252794 +HSD3B2 3284 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +HSD3B2 3284 Cryptorchidism MESH:D003456 marker/mechanism 26050606 +HSD3B2 3284 Hypospadias MESH:D007021 marker/mechanism 14764821 +HSD3B2 3284 Paranoid Disorders MESH:D010259 marker/mechanism 22356824 +HSD3B2 3284 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 22381227 +HSD3B2 3284 Prostatic Neoplasms MESH:D011471 marker/mechanism 17823934 +HSD3B7 80270 Bile acid synthesis defect, congenital, 1 MESH:C535442 marker/mechanism 607765.0 +HSD3B7 80270 Cholestasis MESH:D002779 marker/mechanism 25526675 +HSDL2 84263 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +HSF1 3297 Amyotrophic lateral sclerosis 1 MESH:C531617 therapeutic 24256636 +HSF1 3297 Neoplasms MESH:D009369 marker/mechanism 22885793 +HSF2 3298 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +HSF4 3299 Cataract, zonular MESH:C535342 marker/mechanism 116800.0 +HSFY1 86614 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +HSP27 39078 Myocardial Infarction MESH:D009203 therapeutic 12160945 +HSP70 403612 Hypoxia MESH:D000860 marker/mechanism 18258771 +HSP90AA1 3320 Breast Neoplasms MESH:D001943 marker/mechanism 20562527 +HSP90AA1 3320 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +HSP90AA1 3320 HIV Infections MESH:D015658 marker/mechanism 12878215 +HSP90AA1 3320 Lymphoma, Large-Cell, Anaplastic MESH:D017728 marker/mechanism 17157164 +HSP90AA1 3320 Neoplasm Metastasis MESH:D009362 marker/mechanism 20562527 +HSP90AB1 3326 HIV Infections MESH:D015658 marker/mechanism 15308739 +HSP90AB1 3326 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973 +HSP90B1 7184 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973 +HSPA12A 259217 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +HSPA14 51182 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +HSPA1A 3303 Acute Kidney Injury MESH:D058186 marker/mechanism 12690470|19546256 +HSPA1A 3303 Brain Injuries MESH:D001930 marker/mechanism 21549006 +HSPA1A 3303 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 17234771 +HSPA1A 3303 Drug Hypersensitivity MESH:D004342 marker/mechanism 16538175 +HSPA1A 3303 Heat Stress Disorders MESH:D018882 therapeutic 16627676 +HSPA1A 3303 Liver Diseases MESH:D008107 marker/mechanism 19784758 +HSPA1A 3303 Melanoma MESH:D008545 marker/mechanism 26984758 +HSPA1A 3303 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HSPA1A 3303 Neoplasm Metastasis MESH:D009362 marker/mechanism 26984758 +HSPA1A 3303 Parkinson Disease MESH:D010300 therapeutic 15585408 +HSPA1A 3303 Prostatic Neoplasms MESH:D011471 marker/mechanism 15764345 +HSPA1A 3303 Pulmonary Fibrosis MESH:D011658 therapeutic 37307957 +HSPA1A 3303 Reperfusion Injury MESH:D015427 marker/mechanism 7922267 +HSPA1B 3304 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +HSPA1B 3304 Atherosclerosis MESH:D050197 marker/mechanism 16513158 +HSPA1B 3304 Breast Neoplasms MESH:D001943 therapeutic 15665820 +HSPA1B 3304 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 17234771 +HSPA1B 3304 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 12868502 +HSPA1B 3304 Pulmonary Fibrosis MESH:D011658 therapeutic 37307957 +HSPA1B 3304 Skin Diseases MESH:D012871 marker/mechanism 16835338 +HSPA1L 3305 Drug Hypersensitivity MESH:D004342 marker/mechanism 16538175 +HSPA2 3306 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +HSPA2 3306 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HSPA4 3308 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 12868502 +HSPA5 3309 Asbestosis MESH:D001195 marker/mechanism 25324550 +HSPA5 3309 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284|29698666 +HSPA5 3309 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +HSPA5 3309 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +HSPA5 3309 Hematologic Neoplasms MESH:D019337 marker/mechanism 23777986 +HSPA5 3309 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 23777986 +HSPA5 3309 Myocardial Infarction MESH:D009203 marker/mechanism 25450231 +HSPA5 3309 Obesity MESH:D009765 marker/mechanism 26655953 +HSPA5 3309 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 24211530 +HSPA5 3309 Spinocerebellar Ataxia 17 MESH:C564616 marker/mechanism 24413982 +HSPA6 3310 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +HSPA8 3312 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +HSPA8 3312 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +HSPA8 3312 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +HSPA8 3312 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +HSPA8 3312 Reperfusion Injury MESH:D015427 therapeutic 10216529 +HSPA8 3312 Spinocerebellar Ataxia 17 MESH:C564616 marker/mechanism 24413982 +HSPA8 3312 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +HSPA9 3313 Anemia, Sideroblastic MESH:D000756 marker/mechanism 182170.0 +HSPA9 3313 Autoimmune Diseases MESH:D001327 marker/mechanism 21850155 +HSPA9 3313 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +HSPA9 3313 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +HSPA9 3313 Endotoxemia MESH:D019446 marker/mechanism 16741687 +HSPA9 3313 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +HSPA9 3313 EVEN-PLUS SYNDROME OMIM:616854 marker/mechanism 616854.0 +HSPA9 3313 HIV Infections MESH:D015658 marker/mechanism 15308739 +HSPA9 3313 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +HSPA9 3313 Parkinson Disease MESH:D010300 marker/mechanism 16565515 +HSPA9 3313 Uveitis MESH:D014605 marker/mechanism 21850155 +HSPB1 3315 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +HSPB1 3315 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +HSPB1 3315 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +HSPB1 3315 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +HSPB1 3315 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 9527842 +HSPB1 3315 Charcot-Marie-Tooth disease, Type 2F MESH:C535413 marker/mechanism 606595.0 +HSPB1 3315 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +HSPB1 3315 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +HSPB1 3315 Heart Failure MESH:D006333 therapeutic 17481944 +HSPB1 3315 HIV Infections MESH:D015658 marker/mechanism 12878215 +HSPB1 3315 Hyperplasia MESH:D006965 marker/mechanism 20864298 +HSPB1 3315 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +HSPB1 3315 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +HSPB1 3315 Multiple Myeloma MESH:D009101 marker/mechanism 12855565 +HSPB1 3315 Neuronopathy, Distal Hereditary Motor, Type IIB MESH:C567084 marker/mechanism 608634.0 +HSPB1 3315 Reperfusion Injury MESH:D015427 therapeutic 19193722 +HSPB1 3315 Status Epilepticus MESH:D013226 marker/mechanism 20971094 +HSPB1 3315 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +HSPB1 3315 Tongue Neoplasms MESH:D014062 marker/mechanism 19840781 +HSPB11 790918 Developmental Disabilities MESH:D002658 marker/mechanism 31546644 +HSPB3 8988 NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 4 OMIM:613376 marker/mechanism 613376.0 +HSPB6 126393 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 18948619 +HSPB6 126393 Heart Diseases MESH:D006331 therapeutic 18948619 +HSPB8 26353 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L OMIM:608673 marker/mechanism 608673.0 +HSPB8 26353 Neuropathy, Distal Hereditary Motor, Type IIA MESH:C563561 marker/mechanism 158590.0 +HSPB9 94086 Developmental Disabilities MESH:D002658 marker/mechanism 31546644 +HSPD1 3329 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +HSPD1 3329 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +HSPD1 3329 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +HSPD1 3329 Cardiomyopathies MESH:D009202 therapeutic 12967636 +HSPD1 3329 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 9527842 +HSPD1 3329 Endotoxemia MESH:D019446 marker/mechanism 16741687 +HSPD1 3329 HIV Infections MESH:D015658 marker/mechanism 15308739 +HSPD1 3329 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +HSPD1 3329 Leukodystrophy, Hypomyelinating, 4 MESH:C567390 marker/mechanism 612233.0 18571143 +HSPD1 3329 Spastic paraplegia 13, autosomal dominant MESH:C537485 marker/mechanism 605280.0 18571143 +HSPD1 3329 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696|19424620 +HSPE1 3336 Cardiomyopathies MESH:D009202 therapeutic 12967636 +HSPG2 3339 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +HSPG2 3339 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10545953 +HSPG2 3339 Dyssegmental dysplasia MESH:C537998 marker/mechanism 224410.0 11279527 +HSPG2 3339 Osteochondrodysplasias MESH:D010009 marker/mechanism 255800.0 10545953|11279527 +HSPH1 10808 HIV Infections MESH:D015658 marker/mechanism 15308739 +HTATIP2 10553 Carcinoma, Hepatocellular MESH:D006528 therapeutic 16799960 +HTN1 3346 Autistic Disorder MESH:D001321 marker/mechanism 19367726 +HTOR 3349 5-HYDROXYTRYPTAMINE OXYGENASE REGULATOR OMIM:143460 marker/mechanism 143460.0 +HTR1A 3350 Apnea MESH:D001049 therapeutic 10640309 +HTR1A 3350 Bradycardia MESH:D001919 marker/mechanism 2207497 +HTR1A 3350 Cocaine-Related Disorders MESH:D019970 marker/mechanism 11853856 +HTR1A 3350 Fever MESH:D005334 marker/mechanism 21990073 +HTR1A 3350 Learning Disabilities MESH:D007859 marker/mechanism 12591222 +HTR1A 3350 Memory Disorders MESH:D008569 marker/mechanism 12591222 +HTR1A 3350 Pain MESH:D010146 therapeutic 12595749 +HTR1A 3350 PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT OMIM:614674 marker/mechanism 614674.0 +HTR1A 3350 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 19747927 +HTR1A 3350 Seizures MESH:D012640 marker/mechanism|therapeutic 12646302|16313900|2533336 +HTR1A 3350 Stomach Neoplasms MESH:D013274 therapeutic 21447133 +HTR1A 3350 Tremor MESH:D014202 marker/mechanism 11070179 +HTR1B 3351 Amphetamine-Related Disorders MESH:D019969 therapeutic 10780831 +HTR1B 3351 Autistic Disorder MESH:D001321 marker/mechanism 19038234 +HTR1B 3351 Cocaine-Related Disorders MESH:D019970 marker/mechanism|therapeutic 17509084|9603521 +HTR1B 3351 Hypotension MESH:D007022 marker/mechanism 9109356 +HTR1B 3351 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +HTR1B 3351 Seizures MESH:D012640 marker/mechanism 2533336 +HTR1D 3352 Autistic Disorder MESH:D001321 marker/mechanism 19038234 +HTR1D 3352 Hypotension MESH:D007022 marker/mechanism 9109356 +HTR1D 3352 Obsessive-Compulsive Disorder MESH:D009771 marker/mechanism 10621951 +HTR1F 3355 Migraine Disorders MESH:D008881 marker/mechanism 35115687 +HTR2A 3356 Alcoholism MESH:D000437 marker/mechanism 103780.0 +HTR2A 3356 Anorexia Nervosa MESH:D000856 marker/mechanism 606788.0 +HTR2A 3356 Asthma MESH:D001249 marker/mechanism 25322896 +HTR2A 3356 Autistic Disorder MESH:D001321 marker/mechanism 17280648 +HTR2A 3356 Basal Ganglia Diseases MESH:D001480 marker/mechanism 18480698 +HTR2A 3356 Bipolar Disorder MESH:D001714 marker/mechanism 14708030 +HTR2A 3356 Cocaine-Related Disorders MESH:D019970 marker/mechanism 11259563|16300424|19212317 +HTR2A 3356 Cognition Disorders MESH:D003072 marker/mechanism 29294249 +HTR2A 3356 Depressive Disorder, Major MESH:D003865 marker/mechanism 608516.0 +HTR2A 3356 Dyskinesias MESH:D020820 marker/mechanism 11526996 +HTR2A 3356 Fever MESH:D005334 marker/mechanism 19879056 +HTR2A 3356 Hallucinations MESH:D006212 marker/mechanism 29748632 +HTR2A 3356 Hyperalgesia MESH:D006930 marker/mechanism 17888573|18930597 +HTR2A 3356 Hyperkinesis MESH:D006948 marker/mechanism 16300424|19347958 +HTR2A 3356 Marijuana Use MESH:D000074609 marker/mechanism 29294249 +HTR2A 3356 Memory Disorders MESH:D008569 marker/mechanism 29294249 +HTR2A 3356 Metabolic Diseases MESH:D008659 marker/mechanism 19142110 +HTR2A 3356 Migraine Disorders MESH:D008881 marker/mechanism 12482207 +HTR2A 3356 Obesity MESH:D009765 marker/mechanism 17097612 +HTR2A 3356 Obsessive-Compulsive Disorder MESH:D009771 marker/mechanism 164230.0 19644229 +HTR2A 3356 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +HTR2A 3356 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 22048642 +HTR2A 3356 Schizophrenia MESH:D012559 marker/mechanism 181500.0 14708030|18513383 +HTR2B 3357 Cardiomegaly MESH:D006332 marker/mechanism 15302781|19023134|20374255 +HTR2B 3357 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 16863450 +HTR2B 3357 Heart Failure MESH:D006333 marker/mechanism 19023134 +HTR2B 3357 Heart Valve Diseases MESH:D006349 marker/mechanism 10617681|11104741|16141947|19505264 +HTR2B 3357 Hypertension MESH:D006973 marker/mechanism 8627522 +HTR2B 3357 Hypertension, Pulmonary MESH:D006976 marker/mechanism 14659797 +HTR2C 3358 Hyperkinesis MESH:D006948 therapeutic 19347958 +HTR2C 3358 Metabolic Syndrome MESH:D024821 marker/mechanism 17632216|18515891|19142101 +HTR2C 3358 Neuralgia MESH:D009437 marker/mechanism 28011743 +HTR2C 3358 Obesity MESH:D009765 marker/mechanism 17702092|19142110 +HTR2C 3358 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 17105947 +HTR2C 3358 Weight Gain MESH:D015430 marker/mechanism 19434072|19997080 +HTR3A 3359 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 19689456 +HTR3A 3359 Autistic Disorder MESH:D001321 marker/mechanism 19184136 +HTR3B 9177 Muscular Diseases MESH:D009135 marker/mechanism 17600820 +HTR3B 9177 Pain MESH:D010146 marker/mechanism 17600820 +HTR3C 170572 Autistic Disorder MESH:D001321 marker/mechanism 19035560 +HTR4 3360 Adrenal Hyperplasia, Congenital MESH:D000312 marker/mechanism 17218722 +HTR4 3360 Anorexia MESH:D000855 marker/mechanism 15146954 +HTR4 3360 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 9806222 +HTR4 3360 Atrial Fibrillation MESH:D001281 therapeutic 7886817 +HTR4 3360 Stroke MESH:D020521 therapeutic 7886817 +HTR4 3360 Tachycardia MESH:D013610 marker/mechanism 7886817 +HTR5A 3361 Autistic Disorder MESH:D001321 marker/mechanism 17203304 +HTR6 3362 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 20705401 +HTR6 3362 Memory Disorders MESH:D008569 marker/mechanism 19733250 +HTR6 3362 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 20705401 +HTR6 3362 Schizophrenia MESH:D012559 marker/mechanism 12165372 +HTR7 3363 Anxiety Disorders MESH:D001008 marker/mechanism 21859099 +HTR7 3363 Depressive Disorder MESH:D003866 marker/mechanism 21859099 +HTR7 3363 Learning Disabilities MESH:D007859 marker/mechanism 21859099 +HTR7 3363 Memory Disorders MESH:D008569 marker/mechanism 21859099 +HTR7 3363 Muscular Diseases MESH:D009135 marker/mechanism 17600820 +HTR7 3363 Pain MESH:D010146 marker/mechanism 17600820 +HTR7 3363 Schizophrenia MESH:D012559 marker/mechanism 12165372 +HTR7 3363 Sleep Wake Disorders MESH:D012893 marker/mechanism 21859099 +HTRA1 5654 CADASIL MESH:D046589 marker/mechanism 616779.0 +HTRA1 5654 CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY OMIM:600142 marker/mechanism 600142.0 +HTRA1 5654 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +HTRA1 5654 Macular Degeneration, Age-Related, 7 MESH:C565718 marker/mechanism 610149.0 +HTRA2 27429 3-METHYLGLUTACONIC ACIDURIA, TYPE VIII OMIM:617248 marker/mechanism 617248.0 +HTRA2 27429 Ischemic Attack, Transient MESH:D002546 marker/mechanism 15306124 +HTRA2 27429 Parkinson Disease 13 MESH:C565204 marker/mechanism 610297.0 +HTRA2 27429 Parkinsonian Disorders MESH:D020734 marker/mechanism 26558463 +HTRA4 203100 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +HTT 3064 Cadmium Poisoning MESH:D002105 marker/mechanism 19845833 +HTT 3064 Huntington Disease MESH:D006816 marker/mechanism 143100.0 15218539|15312898|16137562|17018277|17925440|18831068|19094060|19476553|20929960|21867705|28111121 +HTT 3064 Manganese Poisoning MESH:D020149 therapeutic 19845833 +HTT 3064 Movement Disorders MESH:D009069 marker/mechanism 20929960 +HULC 728655 Liver Neoplasms MESH:D008113 marker/mechanism 28765279 +HULC 728655 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26317792 +HUWE1 10075 Mental Retardation, X-Linked, Syndromic, Turner Type MESH:C567476 marker/mechanism 309590.0 +HXK-1 172751 Infertility MESH:D007246 marker/mechanism 25204677 +HYAL1 3373 Hyaluronidase Deficiency MESH:C563209 marker/mechanism 601492.0 +HYCC1 84668 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +HYCC1 84668 Leukodystrophy, Hypomyelinating, 5 MESH:C567166 marker/mechanism 610532.0 +HYCC1 84668 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +HYCC2 285172 Weight Gain MESH:D015430 marker/mechanism 19030233 +HYDIN 54768 Ciliary Dyskinesia, Primary, 5 MESH:C563886 marker/mechanism 608647.0 +HYDIN 54768 Hydrocephalus MESH:D006849 marker/mechanism 12719380|19029900 +HYDIN2 100288805 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19029900 +HYKK 123688 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +HYLS1 219844 Hydrolethalus Syndrome 1 MESH:C565504 marker/mechanism 236680.0 +HYMAI 57061 Diabetes Mellitus, Transient Neonatal, 1 MESH:C563322 marker/mechanism 601410.0 +HYOU1 10525 Spinocerebellar Ataxia 17 MESH:C564616 marker/mechanism 24413982 +IAPP 3375 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +IAPP 3375 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366|23793354 +IAPP 3375 Stomach Ulcer MESH:D013276 therapeutic 9286623 +IARS1 3376 GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY OMIM:617093 marker/mechanism 617093.0 +IARS2 55699 CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA OMIM:616007 marker/mechanism 616007.0 +IARS2 55699 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +IBA57 200205 Multiple Mitochondrial Dysfunctions Syndrome MESH:C565304 marker/mechanism 615330.0 +IBA57 200205 SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE OMIM:616451 marker/mechanism 616451.0 +IBSP 3381 Breast Neoplasms MESH:D001943 marker/mechanism 24980816 +IBSP 3381 Neoplasm Metastasis MESH:D009362 marker/mechanism 22407340|24980816 +IBSP 3381 Osteolysis MESH:D010014 marker/mechanism 22407340 +ICA1L 130026 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +ICAM1 3383 Acute Lung Injury MESH:D055371 marker/mechanism 17973899|27525872 +ICAM1 3383 Arteriosclerosis MESH:D001161 marker/mechanism 28569748 +ICAM1 3383 Asthma MESH:D001249 marker/mechanism 17014439|25003170 +ICAM1 3383 Atherosclerosis MESH:D050197 marker/mechanism 12677255 +ICAM1 3383 Behcet Syndrome MESH:D001528 marker/mechanism 12074830|8712863 +ICAM1 3383 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 28642177 +ICAM1 3383 Brain Ischemia MESH:D002545 marker/mechanism 17394460|19417757 +ICAM1 3383 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 17014439 +ICAM1 3383 Bronchiectasis MESH:D001987 marker/mechanism 17931847 +ICAM1 3383 Cardiovascular Diseases MESH:D002318 marker/mechanism 16332659|25575156 +ICAM1 3383 Cholestasis MESH:D002779 marker/mechanism 21224055 +ICAM1 3383 Colitis, Ulcerative MESH:D003093 marker/mechanism 15553846 +ICAM1 3383 Colonic Neoplasms MESH:D003110 marker/mechanism 16497620|7902311 +ICAM1 3383 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14871415|20388520|24513509 +ICAM1 3383 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24513509 +ICAM1 3383 Diabetic Retinopathy MESH:D003930 therapeutic 10485912 +ICAM1 3383 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 12759764|17245593 +ICAM1 3383 Hodgkin Disease MESH:D006689 marker/mechanism 7621881|8656679 +ICAM1 3383 Hypercholesterolemia MESH:D006937 marker/mechanism 14602771 +ICAM1 3383 Hypertension MESH:D006973 marker/mechanism 12149661|12425201 +ICAM1 3383 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +ICAM1 3383 Inflammation MESH:D007249 marker/mechanism 19324842|23371441 +ICAM1 3383 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 28067908 +ICAM1 3383 Leukostasis MESH:D018921 marker/mechanism 10485912 +ICAM1 3383 Malaria MESH:D008288 marker/mechanism 611162.0 +ICAM1 3383 Mouth Neoplasms MESH:D009062 marker/mechanism 24069166 +ICAM1 3383 Multiple Sclerosis MESH:D009103 marker/mechanism 20175758 +ICAM1 3383 Myocardial Infarction MESH:D009203 marker/mechanism 10070497 +ICAM1 3383 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ICAM1 3383 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 12087064 +ICAM1 3383 Nephrosis MESH:D009401 marker/mechanism 12845231 +ICAM1 3383 Obesity MESH:D009765 marker/mechanism 11782876 +ICAM1 3383 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 21245421 +ICAM1 3383 Pleurisy MESH:D010998 marker/mechanism 11181422 +ICAM1 3383 Prostatic Neoplasms MESH:D011471 marker/mechanism 16606632 +ICAM1 3383 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 29329563 +ICAM1 3383 Reperfusion Injury MESH:D015427 marker/mechanism 11557319|23743330 +ICAM1 3383 Respiratory Syncytial Virus Infections MESH:D018357 marker/mechanism 17425601 +ICAM1 3383 Retinal Diseases MESH:D012164 marker/mechanism 19324842 +ICAM1 3383 Shock, Hemorrhagic MESH:D012771 marker/mechanism 21192278 +ICAM1 3383 Stroke MESH:D020521 marker/mechanism 20083630 +ICAM1 3383 Uremia MESH:D014511 marker/mechanism 17347482 +ICAM1 3383 Urticaria MESH:D014581 marker/mechanism 12121561 +ICAM1 3383 Wounds and Injuries MESH:D014947 marker/mechanism 21192278 +ICAM2 3384 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ICAM2 3384 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +ICAM2 3384 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +ICAM3 3385 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 18422935 +ICAM5 7087 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +ICAM5 7087 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +ICAM5 7087 COVID-19 MESH:D000086382 marker/mechanism 35255492 +ICE2 79664 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +ICE2 79664 Paranoid Disorders MESH:D010259 marker/mechanism 18438686 +ICOS 29851 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 240500|607594 +ICOS 29851 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +ICOSLG 23308 Celiac Disease MESH:D002446 marker/mechanism 20190752 +ICOSLG 23308 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799 +ID1 3397 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +ID1 3397 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +ID1 3397 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 21283680 +ID1 3397 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ID1 3397 Neoplasm Metastasis MESH:D009362 therapeutic 24910342 +ID1 3397 Neoplasms MESH:D009369 marker/mechanism 16966095 +ID2 3398 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +ID2 3398 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +ID2 3398 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 17127702 +ID2 3398 Skin Diseases MESH:D012871 marker/mechanism 16835338 +ID2 3398 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 23582323 +ID2 3398 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +ID3 3399 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +ID3 3399 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143595|23143597 +ID3 3399 Carcinoma MESH:D002277 marker/mechanism 12376462 +ID3 3399 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +ID3 3399 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +ID3 3399 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +ID3 3399 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +ID3 3399 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ID3 3399 Nervous System Diseases MESH:D009422 marker/mechanism 21245421 +ID3 3399 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +ID3 3399 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +ID3 3399 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +ID4 3400 Carcinoma MESH:D002277 marker/mechanism 14633621 +ID4 3400 Cholestasis MESH:D002779 marker/mechanism 27989131 +ID4 3400 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ID4 3400 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 14633621 +ID4 3400 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 14633621 +ID4 3400 Neoplasm Invasiveness MESH:D009361 marker/mechanism 14633621 +ID4 3400 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +IDE 3416 Alzheimer Disease MESH:D000544 marker/mechanism 17192785 +IDH1 3417 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +IDH1 3417 Cholangiocarcinoma MESH:D018281 marker/mechanism 24185509 +IDH1 3417 Chondroma MESH:D002812 marker/mechanism 22057234|25895133 +IDH1 3417 Enchondromatosis MESH:D004687 marker/mechanism 22057234|22057236 +IDH1 3417 Glioma MESH:D005910 marker/mechanism 137800.0 19901110|25391653|25848751|26618343|28122345 +IDH1 3417 Hemangioma MESH:D006391 marker/mechanism 22057234 +IDH1 3417 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 25324972|27992414 +IDH1 3417 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 26285909 +IDH1 3417 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +IDH1 3417 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 26285909 +IDH1 3417 Oligodendroglioma MESH:D009837 marker/mechanism 20160062 +IDH1 3417 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 22674224 +IDH1 3417 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +IDH2 3418 2-Hydroxyglutaricaciduria MESH:C535306 marker/mechanism 613657.0 27469509 +IDH2 3418 Cardiomegaly MESH:D006332 marker/mechanism 27469509 +IDH2 3418 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 27469509 +IDH2 3418 Central Nervous System Diseases MESH:D002493 marker/mechanism 27469509 +IDH2 3418 Cholangiocarcinoma MESH:D018281 marker/mechanism 24185509 +IDH2 3418 Chondroma MESH:D002812 marker/mechanism 22057234|25895133 +IDH2 3418 Craniofacial Abnormalities MESH:D019465 marker/mechanism 27469509 +IDH2 3418 Disease Models, Animal MESH:D004195 marker/mechanism 27469509 +IDH2 3418 Enchondromatosis MESH:D004687 marker/mechanism 22057234|22057236 +IDH2 3418 Growth Disorders MESH:D006130 marker/mechanism 27469509 +IDH2 3418 Hemangioma MESH:D006391 marker/mechanism 22057234 +IDH2 3418 Hydronephrosis MESH:D006869 marker/mechanism 27469509 +IDH2 3418 Immunoblastic Lymphadenopathy MESH:D007119 marker/mechanism 24413737 +IDH2 3418 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 25324972|27992414 +IDH2 3418 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 26285909 +IDH2 3418 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 24413734|24413737 +IDH2 3418 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 26285909 +IDH2 3418 Oligodendroglioma MESH:D009837 marker/mechanism 20160062 +IDH2 3418 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +IDH2 3418 Osteoporosis MESH:D010024 marker/mechanism 18924182 +IDH2 3418 Renal Insufficiency MESH:D051437 marker/mechanism 27469509 +IDH2 3418 Seizures MESH:D012640 marker/mechanism 27469509 +IDH2 3418 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 27469509 +IDH3A 3419 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +IDH3B 3420 Disease Progression MESH:D018450 marker/mechanism 21364753 +IDH3B 3420 Retinitis Pigmentosa MESH:D012174 marker/mechanism 18806796 +IDH3B 3420 Retinitis Pigmentosa 46 MESH:C567249 marker/mechanism 612572.0 +IDH3B 3420 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +IDO1 3620 Breast Neoplasms MESH:D001943 marker/mechanism 18925433 +IDO1 3620 Endometriosis MESH:D004715 marker/mechanism 21063030 +IDO1 3620 Inflammation MESH:D007249 marker/mechanism 16365156 +IDO1 3620 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 18925433 +IDO1 3620 Neurodegenerative Diseases MESH:D019636 marker/mechanism 16365156 +IDO1 3620 Obesity MESH:D009765 marker/mechanism 27020609 +IDO1 3620 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 35687267 +IDO1 3620 Weight Gain MESH:D015430 marker/mechanism 27020609 +IDO2 169355 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 32289347 +IDO2 169355 Liver Cirrhosis MESH:D008103 marker/mechanism 32289347 +IDS 3423 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +IDS 3423 Mucopolysaccharidosis II MESH:D016532 marker/mechanism 309900.0 +IDUA 3425 Mucopolysaccharidosis I MESH:D008059 marker/mechanism|therapeutic 607014|607015|607016 11159948|15081804|15194053|19309154|22822036 +IER2 9592 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +IER3 8870 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +IER3 8870 Dermatitis, Irritant MESH:D017453 marker/mechanism 27258892 +IER3 8870 Hypertension MESH:D006973 marker/mechanism 20713914 +IER3 8870 Skin Diseases MESH:D012871 marker/mechanism 16835338 +IER3IP1 51124 MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1 OMIM:614231 marker/mechanism 614231 +IFI204 15951 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IFI27 3429 Celiac Disease MESH:D002446 marker/mechanism 30097691 +IFI27 3429 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFI27L2B 217845 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IFI30 10437 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17597826 +IFI30 10437 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +IFI30 10437 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +IFI35 3430 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IFI35 3430 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFI35 3430 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IFI44 10561 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IFI44 10561 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFI44L 10964 Depressive Disorder, Major MESH:D003865 marker/mechanism 29175309 +IFI44L 10964 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFI6 2537 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IFI6 2537 Depressive Disorder, Major MESH:D003865 marker/mechanism 29175309 +IFI6 2537 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFIH1 64135 Aicardi-Goutieres syndrome MESH:C535607 marker/mechanism 615846.0 24686847 +IFIH1 64135 Graves Disease MESH:D006111 marker/mechanism 17535987 +IFIH1 64135 IgA Deficiency MESH:D017098 marker/mechanism 20694011|27723758 +IFIH1 64135 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFIH1 64135 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838195|24686847 +IFIH1 64135 Psoriasis MESH:D011565 marker/mechanism 20953190 +IFIH1 64135 Singleton Merten syndrome MESH:C537343 marker/mechanism 182250.0 +IFIH1 64135 Vitiligo MESH:D014820 marker/mechanism 22561518 +IFIT1 3434 Endometriosis MESH:D004715 marker/mechanism 20864642 +IFIT1 3434 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFIT2 3433 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFIT3 3437 Disease Models, Animal MESH:D004195 marker/mechanism 36071497 +IFIT3 3437 Heart Failure MESH:D006333 marker/mechanism 36071497 +IFIT3 3437 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFIT5 24138 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IFITM1 8519 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IFITM3 10410 Influenza, Human MESH:D007251 marker/mechanism 614680.0 23326326 +IFITM5 387733 Osteogenesis Imperfecta, Type V MESH:C567042 marker/mechanism 610967.0 +IFNA 111654 Carcinoma, Transitional Cell MESH:D002295 therapeutic 2297754 +IFNA 111654 Hepatitis C, Chronic MESH:D019698 therapeutic 9058296 +IFNA 111654 Hypertriglyceridemia MESH:D015228 marker/mechanism 15304625 +IFNA 111654 Melanoma MESH:D008545 therapeutic 15304625 +IFNA 111654 Neoplasms, Experimental MESH:D009374 therapeutic 1674182|2297754 +IFNA 111654 Urinary Bladder Neoplasms MESH:D001749 therapeutic 1674182|2297754 +IFNA1 3439 Acquired Immunodeficiency Syndrome MESH:D000163 marker/mechanism 9612607 +IFNA1 3439 Adenocarcinoma MESH:D000230 therapeutic 17198089 +IFNA1 3439 Carcinoma, Hepatocellular MESH:D006528 therapeutic 17088986|17971768|18665156 +IFNA1 3439 Colorectal Neoplasms MESH:D015179 therapeutic 15289873 +IFNA1 3439 Hepatitis B MESH:D006509 therapeutic 15504288 +IFNA1 3439 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 therapeutic 20370541 +IFNA1 3439 Liver Cirrhosis MESH:D008103 therapeutic 18665156 +IFNA1 3439 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 12898905|14512876|16027843 +IFNA1 3439 Liver Neoplasms MESH:D008113 therapeutic 14633663 +IFNA1 3439 Melanoma MESH:D008545 therapeutic 15176220|15577320|15577323|16034308|16260693|16260697|16432458 +IFNA1 3439 Pancreatic Neoplasms MESH:D010190 therapeutic 17198089|17961653 +IFNA1 3439 Severe Acute Respiratory Syndrome MESH:D045169 therapeutic 15200845 +IFNA1 3439 Vaginal Neoplasms MESH:D014625 therapeutic 15577323 +IFNA1 3439 Vipoma MESH:D003969 therapeutic 17961653 +IFNA10 3446 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IFNA2 3440 Abdominal Pain MESH:D015746 marker/mechanism 9234591 +IFNA2 3440 Acute Kidney Injury MESH:D058186 marker/mechanism 12810204 +IFNA2 3440 Anemia MESH:D000740 marker/mechanism 11981781|12620292|16557544|1670585|8886046 +IFNA2 3440 Anemia, Hemolytic MESH:D000743 marker/mechanism 11010742|15293138|16633111 +IFNA2 3440 Anorexia MESH:D000855 marker/mechanism 8759893 +IFNA2 3440 Anxiety Disorders MESH:D001008 marker/mechanism 12297606 +IFNA2 3440 Carcinoma, Renal Cell MESH:D002292 therapeutic 8886046 +IFNA2 3440 Carcinoma, Squamous Cell MESH:D002294 therapeutic 17172406 +IFNA2 3440 Carcinoma, Transitional Cell MESH:D002295 therapeutic 17172406 +IFNA2 3440 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 1670585 +IFNA2 3440 Chills MESH:D023341 marker/mechanism 8759893 +IFNA2 3440 Colorectal Neoplasms MESH:D015179 therapeutic 8026229 +IFNA2 3440 Depressive Disorder MESH:D003866 marker/mechanism 12297606|17292481|17451562|19691667 +IFNA2 3440 Diarrhea MESH:D003967 marker/mechanism 12620292 +IFNA2 3440 Fatigue MESH:D005221 marker/mechanism 8759893 +IFNA2 3440 Fatty Liver MESH:D005234 marker/mechanism|therapeutic 31299271|7736406 +IFNA2 3440 Fever MESH:D005334 marker/mechanism 8026229|8759893 +IFNA2 3440 Flavivirus Infections MESH:D018177 therapeutic 16902856 +IFNA2 3440 Glioblastoma MESH:D005909 therapeutic 18679580 +IFNA2 3440 Headache MESH:D006261 marker/mechanism 15951019 +IFNA2 3440 Hemangioendothelioma, Epithelioid MESH:D018323 therapeutic 15982392 +IFNA2 3440 Hepatitis B MESH:D006509 therapeutic 10836394|11112032|9339942 +IFNA2 3440 Hepatitis B, Chronic MESH:D019694 therapeutic 12802750|15340535|15751770|16246192|16476009|16557544|16944240 +IFNA2 3440 Hepatitis C MESH:D006526 therapeutic 11010742|11132533|11981781|15980766|19302339|19691667|9722937 +IFNA2 3440 Hepatitis C, Chronic MESH:D019698 therapeutic 11454181|15293138|15751770|15951019|15996025|16476009|16633111|18294165|9563925|9860407 +IFNA2 3440 Hepatitis, Chronic MESH:D006521 therapeutic 15516819 +IFNA2 3440 Hepatomegaly MESH:D006529 therapeutic 31299271 +IFNA2 3440 Hodgkin Disease MESH:D006689 therapeutic 16170182 +IFNA2 3440 Hypertriglyceridemia MESH:D015228 marker/mechanism 12643008 +IFNA2 3440 Intestinal Perforation MESH:D007416 marker/mechanism 12810204 +IFNA2 3440 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 therapeutic 12560223|17077332 +IFNA2 3440 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 therapeutic 10520005|10715301|12620292 +IFNA2 3440 Leukopenia MESH:D007970 marker/mechanism 10520005|12620292|3298131|3597002|8886046 +IFNA2 3440 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 12649538 +IFNA2 3440 Lymphoma, Follicular MESH:D008224 therapeutic 12855623 +IFNA2 3440 Lymphoma, Non-Hodgkin MESH:D008228 therapeutic 7515650 +IFNA2 3440 Melanoma MESH:D008545 therapeutic 11135225|12374674|12393984|12439608|12829675|12883367|15917704|16034308|16248763|16939954|17023156|17576461|17709802|17761969|17973783|18176117|18281266|18332650 +IFNA2 3440 Meningism MESH:D008580 marker/mechanism 15951019 +IFNA2 3440 Mental Disorders MESH:D001523 marker/mechanism 10715301 +IFNA2 3440 Multiple Myeloma MESH:D009101 therapeutic 3597002|8833401|9234591 +IFNA2 3440 Myocardial Infarction MESH:D009203 marker/mechanism 3597002 +IFNA2 3440 Nausea MESH:D009325 marker/mechanism 8759893|8886046|9234591 +IFNA2 3440 Neutropenia MESH:D009503 marker/mechanism 1670585 +IFNA2 3440 Optic Neuropathy, Ischemic MESH:D018917 marker/mechanism 15980766 +IFNA2 3440 Pain MESH:D010146 marker/mechanism 8759893 +IFNA2 3440 Pancreatic Neoplasms MESH:D010190 therapeutic 12738744 +IFNA2 3440 Polycythemia Vera MESH:D011087 therapeutic 20160369 +IFNA2 3440 Polyomavirus Infections MESH:D027601 marker/mechanism 25162674 +IFNA2 3440 Pterygium MESH:D011625 therapeutic 16723453 +IFNA2 3440 Raynaud Disease MESH:D011928 marker/mechanism 12620292 +IFNA2 3440 Renal Insufficiency MESH:D051437 marker/mechanism 3597002 +IFNA2 3440 Retinal Detachment MESH:D012163 marker/mechanism 15951019|20177954 +IFNA2 3440 Retinal Diseases MESH:D012164 marker/mechanism 12578794 +IFNA2 3440 Sepsis MESH:D018805 marker/mechanism 3597002 +IFNA2 3440 Skin Diseases MESH:D012871 marker/mechanism 12620292 +IFNA2 3440 Somatoform Disorders MESH:D013001 marker/mechanism 12297606 +IFNA2 3440 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +IFNA2 3440 Stomatitis MESH:D013280 marker/mechanism 9234591 +IFNA2 3440 Substance Withdrawal Syndrome MESH:D013375 therapeutic 2449543 +IFNA2 3440 Thrombocythemia, Essential MESH:D013920 therapeutic 12924084 +IFNA2 3440 Thrombocytopenia MESH:D013921 marker/mechanism 10520005|12620292|15274073|8886046 +IFNA2 3440 Thyroid Neoplasms MESH:D013964 therapeutic 17909728 +IFNA2 3440 Tinnitus MESH:D014012 marker/mechanism 15951019 +IFNA2 3440 Urinary Bladder Neoplasms MESH:D001749 therapeutic 17172406 +IFNA2 3440 Uveomeningoencephalitic Syndrome MESH:D014607 marker/mechanism 14633182|15951019|20172621|20177954 +IFNA2 3440 Viremia MESH:D014766 therapeutic 11132533 +IFNA2 3440 Vomiting MESH:D014839 marker/mechanism 8759893|8886046 +IFNA2 3440 Weight Gain MESH:D015430 therapeutic 31299271 +IFNA2 3440 Weight Loss MESH:D015431 marker/mechanism 1670585 +IFNA5 3442 Melanoma MESH:D008545 therapeutic 16809738 +IFNA5 3442 Pancreatic Neoplasms MESH:D010190 therapeutic 15320962 +IFNAR1 3454 Virus Diseases MESH:D014777 marker/mechanism 18722370 +IFNAR2 3455 COVID-19 MESH:D000086382 marker/mechanism 33307546 +IFNAR2 3455 Hepatitis B MESH:D006509 marker/mechanism 610424.0 +IFNAR2 3455 IMMUNODEFICIENCY 45 OMIM:616669 marker/mechanism 616669.0 +IFNB1 3456 Anus Neoplasms MESH:D001005 therapeutic 12170190|12397731 +IFNB1 3456 Brain Diseases MESH:D001927 marker/mechanism 8615598 +IFNB1 3456 Breast Neoplasms MESH:D001943 therapeutic 18608205 +IFNB1 3456 Carcinoma, Transitional Cell MESH:D002295 therapeutic 2297754 +IFNB1 3456 Coronavirus Infections MESH:D018352 therapeutic 24323636 +IFNB1 3456 Hepatitis B MESH:D006509 therapeutic 15994231 +IFNB1 3456 Melanoma MESH:D008545 therapeutic 16928243|21846298 +IFNB1 3456 Melanoma, Amelanotic MESH:D018328 therapeutic 15990972 +IFNB1 3456 Melanoma, Experimental MESH:D008546 therapeutic 16417267 +IFNB1 3456 Multiple Sclerosis MESH:D009103 therapeutic 10520943|12424511|12432978|23517930|27806875 +IFNB1 3456 Neoplasms, Experimental MESH:D009374 therapeutic 2297754 +IFNB1 3456 Neuroblastoma MESH:D009447 therapeutic 16115947 +IFNB1 3456 Seizures MESH:D012640 marker/mechanism 12432978 +IFNB1 3456 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism|therapeutic 15200845|26861016 +IFNB1 3456 Urinary Bladder Neoplasms MESH:D001749 therapeutic 2297754 +IFNG 3458 Acquired Immunodeficiency Syndrome MESH:D000163 marker/mechanism 9612607 +IFNG 3458 Adrenoleukodystrophy MESH:D000326 marker/mechanism 16319717 +IFNG 3458 Anemia, Aplastic MESH:D000741 marker/mechanism 609135.0 +IFNG 3458 Appendicitis MESH:D001064 marker/mechanism 16367942 +IFNG 3458 Arthritis, Experimental MESH:D001169 marker/mechanism 19203382|22450443 +IFNG 3458 Arthritis, Infectious MESH:D001170 marker/mechanism 19203382 +IFNG 3458 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22450443 +IFNG 3458 Atherosclerosis MESH:D050197 marker/mechanism 9169506 +IFNG 3458 Autistic Disorder MESH:D001321 marker/mechanism 16360218 +IFNG 3458 Autoimmune Diseases MESH:D001327 marker/mechanism 19077085|9647229 +IFNG 3458 Brain Diseases MESH:D001927 therapeutic 18282668 +IFNG 3458 Breast Neoplasms MESH:D001943 marker/mechanism 19446661 +IFNG 3458 Bronchiolitis Obliterans MESH:D001989 therapeutic 16137903 +IFNG 3458 Celiac Disease MESH:D002446 marker/mechanism 30097691 +IFNG 3458 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 12153990|21245496 +IFNG 3458 Chills MESH:D023341 marker/mechanism 3091246 +IFNG 3458 Chlamydia Infections MESH:D002690 marker/mechanism 19203382 +IFNG 3458 Colitis MESH:D003092 marker/mechanism 24548422 +IFNG 3458 Colonic Neoplasms MESH:D003110 therapeutic 10866311 +IFNG 3458 Crohn Disease MESH:D003424 marker/mechanism 21829567 +IFNG 3458 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 11312644|12484431|15347381 +IFNG 3458 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437|33274957 +IFNG 3458 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 21340626 +IFNG 3458 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 21340626 +IFNG 3458 Disease Models, Animal MESH:D004195 therapeutic 16845661 +IFNG 3458 Drug Eruptions MESH:D003875 marker/mechanism 31150805 +IFNG 3458 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +IFNG 3458 Entamoebiasis MESH:D004749 marker/mechanism 16374615 +IFNG 3458 Eyelid Diseases MESH:D005141 therapeutic 17075842 +IFNG 3458 Fever MESH:D005334 marker/mechanism|therapeutic 18282668|3091246 +IFNG 3458 Glomerulonephritis MESH:D005921 marker/mechanism 1825860 +IFNG 3458 Graft vs Host Disease MESH:D006086 marker/mechanism 22077062 +IFNG 3458 Graves Disease MESH:D006111 marker/mechanism 33132244 +IFNG 3458 Heart Arrest MESH:D006323 marker/mechanism 9806674 +IFNG 3458 Heart Failure MESH:D006333 marker/mechanism 20938210|3091246 +IFNG 3458 Hepatitis MESH:D006505 marker/mechanism 3091246 +IFNG 3458 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IFNG 3458 Hepatitis B MESH:D006509 therapeutic 15994231|20610715 +IFNG 3458 Hepatitis C MESH:D006526 marker/mechanism 609532.0 +IFNG 3458 HIV Infections MESH:D015658 marker/mechanism 609423.0 10202824 +IFNG 3458 Hypersensitivity MESH:D006967 marker/mechanism|therapeutic 10886234|21625544 +IFNG 3458 Hyponatremia MESH:D007010 marker/mechanism 3091246 +IFNG 3458 Hypotension MESH:D007022 marker/mechanism 3091246 +IFNG 3458 Immune Complex Diseases MESH:D007105 marker/mechanism 1825860 +IFNG 3458 Inflammation MESH:D007249 marker/mechanism|therapeutic 21937650|22617429|23164921 +IFNG 3458 Job Syndrome MESH:D007589 marker/mechanism 16112032 +IFNG 3458 Legionnaires' Disease MESH:D007877 therapeutic 11349020 +IFNG 3458 Leishmaniasis MESH:D007896 marker/mechanism 16540374|17218153 +IFNG 3458 Leishmaniasis, Cutaneous MESH:D016773 marker/mechanism|therapeutic 20102417|8154019|9234779 +IFNG 3458 Leishmaniasis, Mucocutaneous MESH:D007897 therapeutic 7854095 +IFNG 3458 Leishmaniasis, Visceral MESH:D007898 therapeutic 1901333|7854095 +IFNG 3458 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 23962110 +IFNG 3458 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 22617429 +IFNG 3458 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 12389079|15996030|16953842|17347453 +IFNG 3458 Lung Neoplasms MESH:D008175 therapeutic 7614408 +IFNG 3458 Lupus Nephritis MESH:D008181 marker/mechanism 31182691 +IFNG 3458 Lymphoproliferative Disorders MESH:D008232 marker/mechanism 22617429 +IFNG 3458 Manganese Poisoning MESH:D020149 marker/mechanism 18041089 +IFNG 3458 Melanoma MESH:D008545 therapeutic 9794839 +IFNG 3458 Mesothelioma MESH:D008654 therapeutic 12768194 +IFNG 3458 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +IFNG 3458 Multiple Sclerosis MESH:D009103 marker/mechanism 23517930 +IFNG 3458 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948.0 +IFNG 3458 Nausea MESH:D009325 marker/mechanism 3091246 +IFNG 3458 Necrosis MESH:D009336 marker/mechanism 10903806|10909967 +IFNG 3458 Neoplasms, Experimental MESH:D009374 therapeutic 15711825 +IFNG 3458 Nerve Degeneration MESH:D009410 marker/mechanism 15153526|16307444|19457078 +IFNG 3458 Neural Tube Defects MESH:D009436 therapeutic 17075842 +IFNG 3458 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +IFNG 3458 Peritonitis MESH:D010538 marker/mechanism 19804847 +IFNG 3458 Pleural Diseases MESH:D010995 marker/mechanism 21357438 +IFNG 3458 Pneumonia MESH:D011014 marker/mechanism 21625544 +IFNG 3458 Proteinuria MESH:D011507 marker/mechanism 3091246|8289579 +IFNG 3458 Radiation Injuries, Experimental MESH:D011833 marker/mechanism 11121210 +IFNG 3458 Renal Insufficiency MESH:D051437 marker/mechanism 3091246|8289579 +IFNG 3458 Respiratory Syncytial Virus Infections MESH:D018357 marker/mechanism 21937650 +IFNG 3458 Respiratory Tract Diseases MESH:D012140 marker/mechanism 21937650 +IFNG 3458 Rhinitis, Allergic MESH:D065631 marker/mechanism 29871060 +IFNG 3458 Salmonella Infections, Animal MESH:D012481 marker/mechanism 16002714 +IFNG 3458 Sarcoma MESH:D012509 therapeutic 9794839 +IFNG 3458 Sepsis MESH:D018805 marker/mechanism 9806674 +IFNG 3458 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +IFNG 3458 Trichuriasis MESH:D014257 marker/mechanism 20864659 +IFNG 3458 Tuberous Sclerosis MESH:D014402 therapeutic 16845661 +IFNG 3458 Tuberous Sclerosis 2 MESH:C566021 marker/mechanism 613254.0 +IFNG 3458 Vomiting MESH:D014839 marker/mechanism 3091246 +IFNGR1 3459 Endometriosis MESH:D004715 marker/mechanism 21063030 +IFNGR1 3459 Helicobacter Infections MESH:D016481 marker/mechanism 600263.0 +IFNGR1 3459 Hepatitis B MESH:D006509 marker/mechanism 610424.0 +IFNGR1 3459 IMMUNODEFICIENCY 27B OMIM:615978 marker/mechanism 615978.0 +IFNGR1 3459 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IFNGR1 3459 Mycobacterium Infections, Nontuberculous MESH:D009165 marker/mechanism 209950.0 +IFNGR1 3459 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948.0 +IFNGR1 3459 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +IFNGR2 3460 IMMUNODEFICIENCY 28 OMIM:614889 marker/mechanism 614889.0 +IFNL3 282617 Asthma MESH:D001249 marker/mechanism 22295096 +IFNL3 282617 Brain Injuries MESH:D001930 marker/mechanism 23159883 +IFNL3 282617 Dermatitis, Atopic MESH:D003876 marker/mechanism 22295096 +IFNL3 282617 Food Hypersensitivity MESH:D005512 marker/mechanism 22295096 +IFNL3 282617 Hepatic Fibrosis, Congenital MESH:C562378 marker/mechanism 28394349 +IFNL3 282617 Hepatitis C MESH:D006526 marker/mechanism 609532.0 +IFNL3 282617 Inflammation MESH:D007249 marker/mechanism 28394349 +IFNL3 282617 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 therapeutic 21304406 +IFNLR1 163702 Psoriasis MESH:D011565 marker/mechanism 20953190 +IFRD1 3475 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IFRD1 3475 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +IFT122 55764 Ciliary Motility Disorders MESH:D002925 marker/mechanism 20493458 +IFT122 55764 Cranioectodermal Dysplasia MESH:C562966 marker/mechanism 218330.0 +IFT122 55764 Craniosynostoses MESH:D003398 marker/mechanism 20493458 +IFT122 55764 Edema, Cardiac MESH:D004489 marker/mechanism 20493458 +IFT122 55764 Eye Abnormalities MESH:D005124 marker/mechanism 20493458 +IFT122 55764 Hydrocephalus MESH:D006849 marker/mechanism 20493458 +IFT122 55764 Kidney Diseases MESH:D007674 marker/mechanism 20493458 +IFT122 55764 Spinal Curvatures MESH:D013121 marker/mechanism 20493458 +IFT140 9742 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 266920.0 +IFT172 26160 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +IFT172 26160 RETINITIS PIGMENTOSA 71 OMIM:616394 marker/mechanism 616394.0 +IFT172 26160 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 615630.0 +IFT27 11020 BARDET-BIEDL SYNDROME 19 OMIM:615996 marker/mechanism 615996.0 +IFT43 112752 Cranioectodermal Dysplasia MESH:C562966 marker/mechanism 614099.0 +IFT52 51098 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +IFT52 51098 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 617102.0 +IFT74 80173 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +IFT74 80173 BARDET-BIEDL SYNDROME 22 OMIM:617119 marker/mechanism 617119.0 +IFT80 57560 Asphyxia MESH:D001237 marker/mechanism 17468754 +IFT80 57560 Asphyxiating Thoracic Dystrophy 2 MESH:C566982 marker/mechanism 611263.0 +IFT80 57560 Bone Diseases, Developmental MESH:D001848 marker/mechanism 17468754 +IFT80 57560 Kidney Diseases, Cystic MESH:D052177 marker/mechanism 17468754 +IFT80 57560 Polydactyly MESH:D017689 marker/mechanism 17468754 +IFT80 57560 Respiratory Insufficiency MESH:D012131 marker/mechanism 17468754 +IFT80 57560 Retinal Degeneration MESH:D012162 marker/mechanism 17468754 +IFT80 57560 Thoracic Diseases MESH:D013896 marker/mechanism 17468754 +IFT88 8100 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +IFT88 8100 Liver Neoplasms MESH:D008113 marker/mechanism 9362446 +IFT88 8100 Polycystic Kidney, Autosomal Recessive MESH:D017044 marker/mechanism 8191288|8608416 +IFT88 8100 Polydactyly MESH:D017689 marker/mechanism 12701101 +IFT88 8100 Precancerous Conditions MESH:D011230 marker/mechanism 9362446 +IGBP1 3476 Breast Neoplasms MESH:D001943 marker/mechanism 21339737 +IGBP1 3476 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21339737 +IGBP1 3476 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21339737 +IGBP1 3476 Corpus Callosum, Agenesis of, with Mental Retardation, Ocular Coloboma, and Micrognathia MESH:C564509 marker/mechanism 300472.0 +IGBP1 3476 Lung Neoplasms MESH:D008175 marker/mechanism 21339737 +IGF1 3479 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IGF1 3479 Acromegaly MESH:D000172 marker/mechanism 1682667|18381583|18388193|9186818 +IGF1 3479 Acute Kidney Injury MESH:D058186 therapeutic 7540432 +IGF1 3479 Adenoma MESH:D000236 marker/mechanism 1611713 +IGF1 3479 Alzheimer Disease MESH:D000544 marker/mechanism 15750215 +IGF1 3479 Autistic Disorder MESH:D001321 marker/mechanism 17547689 +IGF1 3479 Bone Diseases, Metabolic MESH:D001851 therapeutic 11014614 +IGF1 3479 Breast Neoplasms MESH:D001943 marker/mechanism 17520698|18398872 +IGF1 3479 Cachexia MESH:D002100 marker/mechanism 30782979 +IGF1 3479 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +IGF1 3479 Cardiomegaly MESH:D006332 marker/mechanism 10547078 +IGF1 3479 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 23639586|25226513 +IGF1 3479 Cholestasis MESH:D002779 therapeutic 12826230 +IGF1 3479 Colitis MESH:D003092 marker/mechanism 24782617 +IGF1 3479 Corneal Diseases MESH:D003316 therapeutic 12824234 +IGF1 3479 Crohn Disease MESH:D003424 marker/mechanism 19751734 +IGF1 3479 Demyelinating Diseases MESH:D003711 therapeutic 9452187 +IGF1 3479 Diabetes Mellitus, Experimental MESH:D003921 therapeutic 24632065 +IGF1 3479 Diabetes Mellitus, Type 1 MESH:D003922 therapeutic 24632065 +IGF1 3479 Diabetic Cardiomyopathies MESH:D058065 therapeutic 11375343 +IGF1 3479 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 20064577 +IGF1 3479 Endometriosis MESH:D004715 marker/mechanism 21063030 +IGF1 3479 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +IGF1 3479 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10370016 +IGF1 3479 Hyperalgesia MESH:D006930 therapeutic 9452187 +IGF1 3479 Hypertension MESH:D006973 marker/mechanism|therapeutic 19502719|22228705 +IGF1 3479 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 25257527 +IGF1 3479 Insulin-Like Growth Factor I Deficiency MESH:C563867 marker/mechanism 608747 +IGF1 3479 Kidney Diseases MESH:D007674 therapeutic 8825380 +IGF1 3479 Kidney Failure, Chronic MESH:D007676 therapeutic 10198369 +IGF1 3479 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 15591519|15745444 +IGF1 3479 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 15217511|15528971|17584969 +IGF1 3479 Muscular Atrophy MESH:D009133 therapeutic 18467435 +IGF1 3479 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +IGF1 3479 Neoplasm Invasiveness MESH:D009361 marker/mechanism 18398872 +IGF1 3479 Neoplasm Metastasis MESH:D009362 marker/mechanism 18398872 +IGF1 3479 Nerve Degeneration MESH:D009410 therapeutic 10203697|9452187 +IGF1 3479 Peripheral Nervous System Diseases MESH:D010523 therapeutic 8866126|9452187 +IGF1 3479 Pituitary Neoplasms MESH:D010911 marker/mechanism 1611713 +IGF1 3479 Prostatic Neoplasms MESH:D011471 marker/mechanism 16465378|19208208|24586243 +IGF1 3479 Puberty, Precocious MESH:D011629 marker/mechanism 21402727 +IGF1 3479 Pulmonary Fibrosis MESH:D011658 marker/mechanism 15286697 +IGF1 3479 Skin Neoplasms MESH:D012878 marker/mechanism 24353828 +IGF1 3479 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 30594912 +IGF1 3479 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 19415693 +IGF1R 3480 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 22407999 +IGF1R 3480 Alzheimer Disease MESH:D000544 marker/mechanism 15750215 +IGF1R 3480 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +IGF1R 3480 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +IGF1R 3480 Breast Neoplasms MESH:D001943 marker/mechanism 21057462 +IGF1R 3480 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17441810|23958494 +IGF1R 3480 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23748240 +IGF1R 3480 Endometrial Neoplasms MESH:D016889 marker/mechanism 21442237 +IGF1R 3480 Fetal Growth Retardation MESH:D005317 marker/mechanism 14657428 +IGF1R 3480 Growth Disorders MESH:D006130 marker/mechanism 14657428 +IGF1R 3480 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 20620343|21433279 +IGF1R 3480 Insulin-Like Growth Factor I, Resistance To MESH:C564816 marker/mechanism 270450 +IGF1R 3480 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +IGF1R 3480 Lung Diseases MESH:D008171 marker/mechanism 20620343|21433279 +IGF1R 3480 Myeloproliferative Disorders MESH:D009196 marker/mechanism 35568132 +IGF1R 3480 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +IGF1R 3480 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +IGF1R 3480 Respiratory Insufficiency MESH:D012131 marker/mechanism 20620343 +IGF1R 3480 Skin Neoplasms MESH:D012878 marker/mechanism 10365914 +IGF2 3481 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IGF2 3481 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 21521927|23417626 +IGF2 3481 Alzheimer Disease MESH:D000544 marker/mechanism 15750215 +IGF2 3481 Anemia MESH:D000740 therapeutic 12090760 +IGF2 3481 Atherosclerosis MESH:D050197 marker/mechanism 11726660 +IGF2 3481 Autistic Disorder MESH:D001321 marker/mechanism 17547689 +IGF2 3481 Beckwith-Wiedemann Syndrome MESH:D001506 marker/mechanism 130650 8252039|9349812 +IGF2 3481 Bone Diseases, Developmental MESH:D001848 marker/mechanism 9349812 +IGF2 3481 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12532445|16092956 +IGF2 3481 Cognition Disorders MESH:D003072 therapeutic 21270887 +IGF2 3481 Colonic Neoplasms MESH:D003110 marker/mechanism 15057734 +IGF2 3481 Colorectal Neoplasms MESH:D015179 marker/mechanism 12637750 +IGF2 3481 Fetal Growth Retardation MESH:D005317 marker/mechanism 12087403|16040806 +IGF2 3481 Growth Disorders MESH:D006130 marker/mechanism 9349812 +IGF2 3481 Hepatoblastoma MESH:D018197 marker/mechanism 23958494 +IGF2 3481 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10370016 +IGF2 3481 Hypoglycemia MESH:D007003 marker/mechanism 3185662 +IGF2 3481 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +IGF2 3481 Liver Neoplasms MESH:D008113 marker/mechanism 12127304 +IGF2 3481 Memory Disorders MESH:D008569 therapeutic 21270887 +IGF2 3481 Nerve Degeneration MESH:D009410 therapeutic 24667322 +IGF2 3481 Obesity MESH:D009765 marker/mechanism 11528401 +IGF2 3481 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +IGF2 3481 Placenta Diseases MESH:D010922 marker/mechanism 12087403 +IGF2 3481 Polyhydramnios MESH:D006831 marker/mechanism 9349812 +IGF2 3481 Precancerous Conditions MESH:D011230 marker/mechanism 16092956 +IGF2 3481 Rhabdomyosarcoma MESH:D012208 marker/mechanism 7981680 +IGF2 3481 Silver-Russell Syndrome MESH:D056730 marker/mechanism 180860|616489 19066168 +IGF2 3481 Wilms Tumor MESH:D009396 marker/mechanism 194070 8252039 +IGF2BP1 10642 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +IGF2BP1 10642 Cell Transformation, Neoplastic MESH:D002471 therapeutic 34974052 +IGF2BP2 10644 Arsenic Poisoning MESH:D020261 marker/mechanism 35226250 +IGF2BP2 10644 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 +IGF2BP2 10644 Insulin Resistance MESH:D007333 marker/mechanism 35226250 +IGF2BP3 10643 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +IGF2BP3 10643 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IGF2BP3 10643 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23621518 +IGF2BP3 10643 Peritoneal Neoplasms MESH:D010534 marker/mechanism 23621518 +IGF2R 3482 Alzheimer Disease MESH:D000544 marker/mechanism 15750215 +IGF2R 3482 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 114550.0 15057872 +IGF2R 3482 Diabetic Cardiomyopathies MESH:D058065 marker/mechanism 36462176 +IGF2R 3482 Endomyocardial Fibrosis MESH:D004719 marker/mechanism 30450786|36462176 +IGF2R 3482 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 20620343|21433279 +IGF2R 3482 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +IGF2R 3482 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IGF2R 3482 Lung Diseases MESH:D008171 marker/mechanism 20620343|21433279 +IGF2R 3482 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +IGF2R 3482 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +IGF2R 3482 Ventricular Dysfunction MESH:D018754 marker/mechanism 30450786 +IGF2R 3482 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 36462176 +IGFALS 3483 ACID-LABILE SUBUNIT DEFICIENCY OMIM:615961 marker/mechanism 615961.0 +IGFALS 3483 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +IGFALS 3483 Growth Disorders MESH:D006130 marker/mechanism 14762184|17726072 +IGFALS 3483 Insulin Resistance MESH:D007333 marker/mechanism 17726072 +IGFALS 3483 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IGFALS 3483 Puberty, Delayed MESH:D011628 marker/mechanism 14762184|17726072 +IGFBP1 3484 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IGFBP1 3484 Acute Kidney Injury MESH:D058186 therapeutic 7540432 +IGFBP1 3484 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +IGFBP1 3484 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15805072 +IGFBP1 3484 Endometriosis MESH:D004715 marker/mechanism 20864642 +IGFBP1 3484 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +IGFBP1 3484 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 18422935 +IGFBP1 3484 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +IGFBP1 3484 Precancerous Conditions MESH:D011230 therapeutic 12619036 +IGFBP2 3485 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +IGFBP2 3485 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +IGFBP2 3485 Insulin Resistance MESH:D007333 marker/mechanism 22537059 +IGFBP2 3485 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +IGFBP2 3485 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +IGFBP2 3485 Obesity MESH:D009765 marker/mechanism 22537059 +IGFBP2 3485 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +IGFBP3 3486 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IGFBP3 3486 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860 +IGFBP3 3486 Autistic Disorder MESH:D001321 marker/mechanism 17547689 +IGFBP3 3486 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 21347663 +IGFBP3 3486 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +IGFBP3 3486 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IGFBP3 3486 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +IGFBP3 3486 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 15318950|16000583|24586243 +IGFBP3 3486 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +IGFBP3 3486 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21347663 +IGFBP5 3488 Breast Neoplasms MESH:D001943 marker/mechanism 20354179 +IGFBP5 3488 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +IGFBP5 3488 Weight Gain MESH:D015430 marker/mechanism 19030233 +IGFBP6 3489 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IGFBP6 3489 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +IGFBP6 3489 Endometriosis MESH:D004715 marker/mechanism 21063030 +IGFBP6 3489 Prostatic Neoplasms MESH:D011471 therapeutic 15846301 +IGFBP6 3489 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +IGFBP7 3490 Breast Neoplasms MESH:D001943 therapeutic 12592389 +IGFBP7 3490 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IGFBP7 3490 Prostatic Neoplasms MESH:D011471 therapeutic 12592389 +IGFBP7 3490 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +IGG1C 404060 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +IGG-2A 367586 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +IGG-2A 367586 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +IGG-2A 367586 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +IGH-6 299357 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +IGHG1 3500 Myositis MESH:D009220 marker/mechanism 18821675 +IGHG1 3500 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +IGHG2 3501 Myositis MESH:D009220 marker/mechanism 18821675 +IGHM 3507 Agammaglobulinemia MESH:D000361 marker/mechanism 601495.0 +IGHMBP2 3508 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S OMIM:616155 marker/mechanism 616155.0 +IGHMBP2 3508 Spinal muscular atrophy with respiratory distress 1 MESH:C536880 marker/mechanism 604320.0 +IGHV3-21 28444 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 15817677 +IGKC 3514 Dysgammaglobulinemia MESH:D004406 marker/mechanism 3931219 +IGKC 3514 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +IGKC 3514 IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY OMIM:614102 marker/mechanism 614102.0 +IGKC 3514 Myositis MESH:D009220 marker/mechanism 18821675 +IGLL1 3543 Agammaglobulinemia MESH:D000361 marker/mechanism 613500.0 +IGSF1 3547 Congenital Hypothyroidism MESH:D003409 marker/mechanism 23143598 +IGSF1 3547 HYPOTHYROIDISM, CENTRAL, WITH TESTICULAR ENLARGEMENT OMIM:300888 marker/mechanism 300888.0 +IGSF1 3547 Testicular Diseases MESH:D013733 marker/mechanism 23143598 +IGSF21 84966 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +IGSF3 3321 Lacrimal Duct Obstruction MESH:D007767 marker/mechanism 149700.0 +IGSF5 150084 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +IGSF6 10261 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +IGSF6 10261 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IHH 3549 Acrocapitofemoral Dysplasia MESH:C564334 marker/mechanism 607778.0 +IHH 3549 Brachydactyly type A1 MESH:C537088 marker/mechanism 112500.0 +IHH 3549 Endometriosis MESH:D004715 marker/mechanism 21063030 +IHH 3549 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +IHH 3549 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +IKBKB 3551 Glucose Intolerance MESH:D018149 therapeutic 31095431 +IKBKB 3551 Hyperbilirubinemia, Neonatal MESH:D051556 marker/mechanism 28167773 +IKBKB 3551 Hypertension MESH:D006973 marker/mechanism 27659729|32147540 +IKBKB 3551 IMMUNODEFICIENCY 15B OMIM:615592 marker/mechanism 615592.0 +IKBKB 3551 Inflammation MESH:D007249 marker/mechanism 29036520 +IKBKB 3551 Insulin Resistance MESH:D007333 marker/mechanism 29036520 +IKBKB 3551 Pneumonia MESH:D011014 marker/mechanism 31095431 +IKBKB 3551 Vascular Diseases MESH:D014652 marker/mechanism 29036520 +IKBKG 8517 Ectodermal dysplasia, hypohidrotic, with immune deficiency MESH:C536181 marker/mechanism 300291.0 +IKBKG 8517 Incontinentia Pigmenti MESH:D007184 marker/mechanism 308300.0 +IKBKG 8517 Invasive Pneumococcal Disease, Recurrent Isolated, 2 MESH:C564468 marker/mechanism 300636.0 +IKBKG 8517 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 30737368 +IKBKG 8517 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 30737368 +IKBKG 8517 Lung Neoplasms MESH:D008175 marker/mechanism 17114358 +IKBKG 8517 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21115542 +IKZF1 10320 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799 +IKZF1 10320 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 616873.0 +IKZF1 10320 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +IKZF1 10320 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838193 +IKZF1 10320 Lymphoma MESH:D008223 marker/mechanism 11980663 +IKZF1 10320 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 24141364 +IKZF1 10320 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 19684604 +IKZF2 22807 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +IKZF2 22807 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 23334668 +IKZF3 22806 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +IKZF3 22806 Asthma MESH:D001249 marker/mechanism 25256354 +IKZF3 22806 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +IKZF3 22806 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 23334668 +IKZF4 64375 Alopecia Areata MESH:D000506 marker/mechanism 20596022 +IKZF4 64375 Vitiligo MESH:D014820 marker/mechanism 22561518 +IL10 3586 Acute Kidney Injury MESH:D058186 marker/mechanism 18460982 +IL10 3586 Appendicitis MESH:D001064 marker/mechanism 16367942 +IL10 3586 Arthritis, Experimental MESH:D001169 marker/mechanism|therapeutic 20974942|22450443 +IL10 3586 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 180300.0 22450443 +IL10 3586 Asthma MESH:D001249 marker/mechanism 29317916 +IL10 3586 Autistic Disorder MESH:D001321 marker/mechanism 16360218 +IL10 3586 Behcet Syndrome MESH:D001528 marker/mechanism 20622878|20622879 +IL10 3586 Brain Injuries MESH:D001930 marker/mechanism 21549006 +IL10 3586 Breast Neoplasms MESH:D001943 marker/mechanism 29582634 +IL10 3586 Burns MESH:D002056 marker/mechanism 18277951 +IL10 3586 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 20471133 +IL10 3586 Chemically-Induced Disorders MESH:D064419 marker/mechanism 36108500 +IL10 3586 Colitis MESH:D003092 marker/mechanism|therapeutic 19238344|21807089|22119709|24314293 +IL10 3586 Colitis, Ulcerative MESH:D003093 marker/mechanism 18836448|20228799 +IL10 3586 COVID-19 MESH:D000086382 marker/mechanism 31986264|32161940 +IL10 3586 Crohn Disease MESH:D003424 marker/mechanism 21102463 +IL10 3586 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 15347381 +IL10 3586 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +IL10 3586 Dermatitis, Occupational MESH:D009783 marker/mechanism 29477354 +IL10 3586 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 19430480 +IL10 3586 Disease Models, Animal MESH:D004195 marker/mechanism 27580383|28411859 +IL10 3586 Drug Hypersensitivity MESH:D004342 marker/mechanism 19222424|20485159 +IL10 3586 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +IL10 3586 Endometriosis MESH:D004715 marker/mechanism 30579999 +IL10 3586 Entamoebiasis MESH:D004749 marker/mechanism 16374615 +IL10 3586 Enterocolitis MESH:D004760 marker/mechanism 17574631 +IL10 3586 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +IL10 3586 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 19222424 +IL10 3586 Glomerulonephritis MESH:D005921 marker/mechanism 10910440 +IL10 3586 Graft vs Host Disease MESH:D006086 marker/mechanism 614395.0 +IL10 3586 Heat Stroke MESH:D018883 marker/mechanism 24039931 +IL10 3586 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IL10 3586 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 25002079 +IL10 3586 HIV Infections MESH:D015658 marker/mechanism 609423.0 10202824 +IL10 3586 Hyperalgesia MESH:D006930 marker/mechanism|therapeutic 17174526|7582491 +IL10 3586 Hypersensitivity, Immediate MESH:D006969 marker/mechanism 20485159 +IL10 3586 Ileitis MESH:D007079 marker/mechanism 27580383 +IL10 3586 Inflammation MESH:D007249 marker/mechanism 11181422 +IL10 3586 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 23291587|27783946|28411859 +IL10 3586 Irritable Bowel Syndrome MESH:D043183 marker/mechanism 12404228 +IL10 3586 Leishmaniasis MESH:D007896 marker/mechanism 16540374|20404924 +IL10 3586 Leishmaniasis, Cutaneous MESH:D016773 marker/mechanism 20102417 +IL10 3586 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 15716043|17404324|22461696 +IL10 3586 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 23962110 +IL10 3586 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 12632514|15362042|16097045|16126171|16539848|16552806|16609999|16688825|18251166 +IL10 3586 Lung Neoplasms MESH:D008175 marker/mechanism 14587096 +IL10 3586 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838195|20728533 +IL10 3586 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 14999141 +IL10 3586 Mucositis MESH:D052016 marker/mechanism 20881642 +IL10 3586 Multiple Organ Failure MESH:D009102 therapeutic 10479408 +IL10 3586 Multiple Sclerosis MESH:D009103 marker/mechanism 23517930 +IL10 3586 Myocardial Infarction MESH:D009203 marker/mechanism 15883752|16310260 +IL10 3586 Pleurisy MESH:D010998 marker/mechanism 11181422 +IL10 3586 Prostatic Neoplasms MESH:D011471 marker/mechanism 16284379|17999153|18174250 +IL10 3586 Prostatitis MESH:D011472 marker/mechanism 12050565 +IL10 3586 Reperfusion Injury MESH:D015427 marker/mechanism 18460982 +IL10 3586 Sepsis MESH:D018805 therapeutic 11441115 +IL10 3586 Weight Loss MESH:D015431 marker/mechanism|therapeutic 24314293|27580383 +IL10RA 3587 Crohn Disease MESH:D003424 marker/mechanism 36038634 +IL10RA 3587 Inflammatory Bowel Disease 28, Autosomal Recessive MESH:C567728 marker/mechanism 613148.0 +IL10RA 3587 Leishmaniasis, Visceral MESH:D007898 therapeutic 15716043 +IL10RB 3588 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +IL10RB 3588 COVID-19 MESH:D000086382 marker/mechanism 35255492 +IL10RB 3588 Hepatitis B MESH:D006509 marker/mechanism 610424.0 +IL10RB 3588 Inflammatory Bowel Disease 25, Autosomal Recessive MESH:C567251 marker/mechanism 612567.0 +IL11 3589 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IL11 3589 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 11421492 +IL11 3589 Cystitis MESH:D003556 therapeutic 17980069 +IL11 3589 Edema MESH:D004487 therapeutic 17980069 +IL11 3589 Hemorrhage MESH:D006470 therapeutic 17980069 +IL11 3589 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 25257527 +IL11 3589 Liver Diseases MESH:D008107 therapeutic 16964402 +IL11 3589 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069|30664745 +IL11RA 3590 CRANIOSYNOSTOSIS AND DENTAL ANOMALIES OMIM:614188 marker/mechanism 614188.0 +IL11RA 3590 Ovarian Neoplasms MESH:D010051 marker/mechanism 11161848 +IL11RA1 16157 Heat Stroke MESH:D018883 marker/mechanism 24039931 +IL12A 3592 Glioma MESH:D005910 therapeutic 18176109 +IL12A 3592 Hypothermia MESH:D007035 marker/mechanism 16369138 +IL12A 3592 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 20639880 +IL12A 3592 Liver Neoplasms MESH:D008113 therapeutic 17326190 +IL12A 3592 Multiple Sclerosis MESH:D009103 marker/mechanism 24076602 +IL12A 3592 Neoplasms, Experimental MESH:D009374 therapeutic 17332360 +IL12A 3592 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +IL12A 3592 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097067 +IL12A-AS1 101928376 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 29059373 +IL12B 3593 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IL12B 3593 Arthritis, Psoriatic MESH:D015535 marker/mechanism 20953186 +IL12B 3593 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 36520315 +IL12B 3593 Colitis, Ulcerative MESH:D003093 marker/mechanism 18438406|20228799|21297633 +IL12B 3593 Crohn Disease MESH:D003424 marker/mechanism 18438406 +IL12B 3593 Glioma MESH:D005910 therapeutic 18176109 +IL12B 3593 Hypothermia MESH:D007035 marker/mechanism 16369138 +IL12B 3593 IMMUNODEFICIENCY 29 OMIM:614890 marker/mechanism 614890.0 +IL12B 3593 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 20639880 +IL12B 3593 Liver Neoplasms MESH:D008113 therapeutic 17326190 +IL12B 3593 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838195|26808113 +IL12B 3593 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +IL12B 3593 Neoplasms, Experimental MESH:D009374 therapeutic 17332360 +IL12B 3593 Neuralgia MESH:D009437 marker/mechanism 31432094 +IL12B 3593 Psoriasis MESH:D011565 marker/mechanism 19169254|19169255|20953190 +IL12B 3593 Pulmonary Fibrosis MESH:D011658 marker/mechanism 12193738 +IL12B 3593 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 21743469 +IL12RB1 3594 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +IL12RB1 3594 IMMUNODEFICIENCY 30 OMIM:614891 marker/mechanism 614891.0 +IL12RB2 3595 Brain Injuries MESH:D001930 marker/mechanism 23159883 +IL13 3596 Arthritis, Experimental MESH:D001169 therapeutic 10444273 +IL13 3596 Asthma MESH:D001249 marker/mechanism 600807.0 22867017 +IL13 3596 Autistic Disorder MESH:D001321 marker/mechanism 16360218 +IL13 3596 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 12654629|23434795 +IL13 3596 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22317767 +IL13 3596 Dermatitis MESH:D003872 marker/mechanism 31330126 +IL13 3596 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437|22355542 +IL13 3596 Drug Hypersensitivity MESH:D004342 marker/mechanism 20485159 +IL13 3596 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IL13 3596 Hyperplasia MESH:D006965 marker/mechanism 19342650 +IL13 3596 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL13 3596 Hypersensitivity, Immediate MESH:D006969 marker/mechanism 20485159|22967010 +IL13 3596 Inflammation MESH:D007249 marker/mechanism 22867017 +IL13 3596 Lung Diseases MESH:D008171 marker/mechanism 22355542 +IL13 3596 Metaplasia MESH:D008679 marker/mechanism 21203431 +IL13 3596 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL13 3596 Psoriasis MESH:D011565 marker/mechanism 19169254|20953190 +IL13 3596 Pulmonary Fibrosis MESH:D011658 marker/mechanism 15322207 +IL13 3596 Rhinitis, Allergic MESH:D065631 marker/mechanism 607154.0 +IL13 3596 Sinusitis MESH:D012852 marker/mechanism 20358028 +IL13RA1 3597 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +IL13RA2 3598 Brain Injuries MESH:D001930 marker/mechanism 23159883 +IL15 3600 Autistic Disorder MESH:D001321 marker/mechanism 18929414 +IL15 3600 Celiac Disease MESH:D002446 marker/mechanism 23269601 +IL15 3600 Endometriosis MESH:D004715 marker/mechanism 21063030 +IL15 3600 Polyomavirus Infections MESH:D027601 marker/mechanism 25162674 +IL15 3600 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 18394133 +IL16 3603 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IL16 3603 Hypersensitivity MESH:D006967 marker/mechanism 23624239 +IL16 3603 Prostatic Neoplasms MESH:D011471 marker/mechanism 18264096 +IL17A 3605 Acute Lung Injury MESH:D055371 marker/mechanism 28600744 +IL17A 3605 Arthritis, Experimental MESH:D001169 marker/mechanism 20974942 +IL17A 3605 Autoimmune Diseases MESH:D001327 marker/mechanism 21227906 +IL17A 3605 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +IL17A 3605 Cardiovascular Diseases MESH:D002318 marker/mechanism 29114965 +IL17A 3605 Central Nervous System Diseases MESH:D002493 marker/mechanism 19940258 +IL17A 3605 Cerebrovascular Disorders MESH:D002561 marker/mechanism 29114965 +IL17A 3605 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 19633216|24949944 +IL17A 3605 Chemically-Induced Disorders MESH:D064419 marker/mechanism 36108500 +IL17A 3605 Colitis MESH:D003092 marker/mechanism 24548422 +IL17A 3605 Drug Eruptions MESH:D003875 marker/mechanism 31150805 +IL17A 3605 Emphysema MESH:D004646 marker/mechanism 27380433 +IL17A 3605 Graft vs Host Disease MESH:D006086 marker/mechanism 22077062 +IL17A 3605 Graves Disease MESH:D006111 marker/mechanism 33132244 +IL17A 3605 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL17A 3605 Inflammation MESH:D007249 marker/mechanism 22617429 +IL17A 3605 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 22617429 +IL17A 3605 Lymphoproliferative Disorders MESH:D008232 marker/mechanism 22617429 +IL17A 3605 MPTP Poisoning MESH:D020267 marker/mechanism 31351185 +IL17A 3605 Multiple Sclerosis MESH:D009103 marker/mechanism 23517930 +IL17A 3605 Necrosis MESH:D009336 marker/mechanism 24949944 +IL17A 3605 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL17A 3605 Pulmonary Edema MESH:D011654 marker/mechanism 28600744 +IL17F 112744 CANDIDIASIS, FAMILIAL, 6 OMIM:613956 marker/mechanism 613956.0 +IL17RA 23765 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +IL17RA 23765 IMMUNODEFICIENCY 51 OMIM:613953 marker/mechanism 613953.0 +IL17RA 23765 Inflammation MESH:D007249 marker/mechanism 29724254 +IL17RC 84818 CANDIDIASIS, FAMILIAL, 9 OMIM:616445 marker/mechanism 616445.0 +IL17RC 84818 Prostatic Neoplasms MESH:D011471 marker/mechanism 17603628 +IL17RD 54756 Brain Injuries MESH:D001930 marker/mechanism 23159883 +IL17RD 54756 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +IL17RD 54756 HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA OMIM:615267 marker/mechanism 615267.0 +IL17RD 54756 Prostatic Neoplasms MESH:D011471 marker/mechanism 16474841 +IL17REL 400935 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228798 +IL18 3606 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 16368150 +IL18 3606 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +IL18 3606 Calcinosis MESH:D002114 marker/mechanism 21335463 +IL18 3606 Cardiomegaly MESH:D006332 marker/mechanism 18660453 +IL18 3606 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 19164858 +IL18 3606 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 27585668 +IL18 3606 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +IL18 3606 Drug Eruptions MESH:D003875 marker/mechanism 18204966 +IL18 3606 Glomerulonephritis MESH:D005921 therapeutic 18462998 +IL18 3606 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +IL18 3606 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IL18 3606 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL18 3606 Hypersensitivity, Immediate MESH:D006969 marker/mechanism 22967010 +IL18 3606 Leishmaniasis MESH:D007896 marker/mechanism 16879623 +IL18 3606 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IL18 3606 Metabolic Syndrome MESH:D024821 marker/mechanism 16644639 +IL18 3606 Mouth Neoplasms MESH:D009062 marker/mechanism 24349532 +IL18 3606 Neoplasm Metastasis MESH:D009362 marker/mechanism 12748951 +IL18 3606 Neoplasms MESH:D009369 therapeutic 21273262 +IL18 3606 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL18 3606 Polyomavirus Infections MESH:D027601 marker/mechanism 25162674 +IL18 3606 Prostatic Neoplasms MESH:D011471 marker/mechanism 17688413 +IL18 3606 Radiation Injuries, Experimental MESH:D011833 marker/mechanism 11121210 +IL18 3606 Sarcoidosis MESH:D012507 marker/mechanism 16100009 +IL18 3606 Urticaria MESH:D014581 marker/mechanism 18204966 +IL18BP 10068 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IL18R1 8809 Brain Injuries MESH:D001930 marker/mechanism 23159883 +IL18RAP 8807 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799 +IL18RAP 8807 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 21983784 +IL19 29949 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 19430480 +IL19 29949 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18006695 +IL19 29949 Renal Insufficiency, Chronic MESH:D051436 marker/mechanism 24714768 +IL1A 3552 Amnesia MESH:D000647 therapeutic 8003924 +IL1A 3552 Anthracosis MESH:D055008 marker/mechanism 20005085 +IL1A 3552 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +IL1A 3552 Brain Injuries MESH:D001930 marker/mechanism 21549006 +IL1A 3552 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +IL1A 3552 Burns MESH:D002056 marker/mechanism 10431976 +IL1A 3552 Burns, Chemical MESH:D002057 marker/mechanism 22533443 +IL1A 3552 Cardiomyopathies MESH:D009202 marker/mechanism 7979221 +IL1A 3552 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 8218930 +IL1A 3552 Chondrosarcoma, Mesenchymal MESH:D018211 marker/mechanism 12817616 +IL1A 3552 Chorioamnionitis MESH:D002821 marker/mechanism 21493953 +IL1A 3552 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 23178550 +IL1A 3552 Dermatomyositis MESH:D003882 marker/mechanism 19035492 +IL1A 3552 Diarrhea MESH:D003967 marker/mechanism 9278552 +IL1A 3552 Disease Progression MESH:D018450 marker/mechanism 27738319 +IL1A 3552 Fever MESH:D005334 marker/mechanism 15384034 +IL1A 3552 Heat Stroke MESH:D018883 marker/mechanism 24039931 +IL1A 3552 Hemolytic-Uremic Syndrome MESH:D006463 marker/mechanism 15384034 +IL1A 3552 HIV Wasting Syndrome MESH:D019247 marker/mechanism 7979221 +IL1A 3552 Hyperalgesia MESH:D006930 marker/mechanism 12727271 +IL1A 3552 Hypotension MESH:D007022 marker/mechanism 15384034 +IL1A 3552 Inflammation MESH:D007249 marker/mechanism 21467745|22163019 +IL1A 3552 Kearns-Sayre Syndrome MESH:D007625 marker/mechanism 7979221 +IL1A 3552 MELAS Syndrome MESH:D017241 marker/mechanism 7979221 +IL1A 3552 MERRF Syndrome MESH:D017243 marker/mechanism 7979221 +IL1A 3552 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +IL1A 3552 Mitochondrial Myopathies MESH:D017240 marker/mechanism 7979221 +IL1A 3552 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +IL1A 3552 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615 +IL1A 3552 Ophthalmoplegia, Chronic Progressive External MESH:D017246 marker/mechanism 7979221 +IL1A 3552 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 7979221 +IL1A 3552 Polymyositis MESH:D017285 marker/mechanism 7979221 +IL1A 3552 Reperfusion Injury MESH:D015427 marker/mechanism 23875703 +IL1A 3552 Skin Diseases MESH:D012871 marker/mechanism 16835338|22533443 +IL1A 3552 Skin Neoplasms MESH:D012878 marker/mechanism 8435107 +IL1A 3552 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 27738319 +IL1A 3552 Vitiligo MESH:D014820 marker/mechanism 28836394 +IL1B 3553 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IL1B 3553 Acute Lung Injury MESH:D055371 marker/mechanism 32062619 +IL1B 3553 Adenocarcinoma MESH:D000230 marker/mechanism 19028472 +IL1B 3553 Alzheimer Disease MESH:D000544 marker/mechanism 18675847 +IL1B 3553 Anorexia MESH:D000855 marker/mechanism 12077204|25392278 +IL1B 3553 Anthracosis MESH:D055008 marker/mechanism 20005085 +IL1B 3553 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +IL1B 3553 Arthritis, Experimental MESH:D001169 marker/mechanism 19330884|20131233|20974942|22450443 +IL1B 3553 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12566094|17379860|22450443 +IL1B 3553 Asbestosis MESH:D001195 marker/mechanism 8473757 +IL1B 3553 Asthma MESH:D001249 marker/mechanism 9176529 +IL1B 3553 Brain Injuries MESH:D001930 marker/mechanism 19800810|21549006 +IL1B 3553 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 28642177 +IL1B 3553 Brain Ischemia MESH:D002545 marker/mechanism 15737438|15756928|17394460|9236716 +IL1B 3553 Breast Neoplasms MESH:D001943 marker/mechanism 16298037|17516992|28212736 +IL1B 3553 Bronchopulmonary Dysplasia MESH:D001997 marker/mechanism 16813970 +IL1B 3553 Burns MESH:D002056 marker/mechanism 18277951 +IL1B 3553 Burns, Chemical MESH:D002057 marker/mechanism 22533443 +IL1B 3553 Calcinosis MESH:D002114 marker/mechanism 21335463 +IL1B 3553 Cardiomegaly MESH:D006332 marker/mechanism 15302781 +IL1B 3553 Cardiomyopathies MESH:D009202 marker/mechanism 7979221 +IL1B 3553 Cardiotoxicity MESH:D066126 marker/mechanism 32068018 +IL1B 3553 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism|therapeutic 19164858|28138970 +IL1B 3553 Chemically-Induced Disorders MESH:D064419 marker/mechanism 36108500 +IL1B 3553 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +IL1B 3553 Colitis MESH:D003092 marker/mechanism 23810507|24548422 +IL1B 3553 Colitis, Ulcerative MESH:D003093 marker/mechanism 12133438|15955209|20452301|22119283 +IL1B 3553 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925|18987561|19028472 +IL1B 3553 COVID-19 MESH:D000086382 marker/mechanism 32171193 +IL1B 3553 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +IL1B 3553 Dermatomyositis MESH:D003882 marker/mechanism 19035492 +IL1B 3553 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 12123627 +IL1B 3553 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +IL1B 3553 Disease Progression MESH:D018450 marker/mechanism 34626302 +IL1B 3553 Entamoebiasis MESH:D004749 marker/mechanism 16374615 +IL1B 3553 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +IL1B 3553 Fever MESH:D005334 marker/mechanism 11852909|15384034|22143887|25164664|9952427 +IL1B 3553 Fibrosis MESH:D005355 therapeutic 25388157 +IL1B 3553 Gastritis, Atrophic MESH:D005757 marker/mechanism 19448967 +IL1B 3553 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 22467534 +IL1B 3553 Glioblastoma MESH:D005909 marker/mechanism 16356833 +IL1B 3553 Glomerulonephritis MESH:D005921 marker/mechanism 10910440|9403216 +IL1B 3553 Gout MESH:D006073 marker/mechanism 26462562 +IL1B 3553 Heart Failure MESH:D006333 marker/mechanism 15135663 +IL1B 3553 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +IL1B 3553 Heat Stroke MESH:D018883 marker/mechanism 24039931 +IL1B 3553 Hemolytic-Uremic Syndrome MESH:D006463 marker/mechanism 15384034 +IL1B 3553 HIV Wasting Syndrome MESH:D019247 marker/mechanism 7979221 +IL1B 3553 Hyperalgesia MESH:D006930 marker/mechanism 10401557|12727271|17320857|20937348|27093858|7582491 +IL1B 3553 Hyperemia MESH:D006940 marker/mechanism 8846404 +IL1B 3553 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL1B 3553 Hypertension MESH:D006973 marker/mechanism 27292124|27659729|27847271|32147540|32165127 +IL1B 3553 Hypoglycemia MESH:D007003 marker/mechanism 1884014 +IL1B 3553 Hypotension MESH:D007022 marker/mechanism 15384034|1884014 +IL1B 3553 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 25257527 +IL1B 3553 Inflammation MESH:D007249 marker/mechanism 11181422|16227999|21437948|21467745|22001142|23640035|24609059|28212736|9952427 +IL1B 3553 Kearns-Sayre Syndrome MESH:D007625 marker/mechanism 7979221 +IL1B 3553 Learning Disabilities MESH:D007859 marker/mechanism 21290410 +IL1B 3553 Leishmaniasis, Cutaneous MESH:D016773 marker/mechanism 20102417 +IL1B 3553 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 17404324 +IL1B 3553 Lethargy MESH:D053609 marker/mechanism 22143887 +IL1B 3553 Leukocytosis MESH:D007964 marker/mechanism 1884014 +IL1B 3553 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16085334 +IL1B 3553 Lung Neoplasms MESH:D008175 marker/mechanism 22369883|28212736 +IL1B 3553 Lymphopenia MESH:D008231 marker/mechanism 1884014 +IL1B 3553 Manganese Poisoning MESH:D020149 marker/mechanism 18041089 +IL1B 3553 MELAS Syndrome MESH:D017241 marker/mechanism 7979221 +IL1B 3553 Memory Disorders MESH:D008569 marker/mechanism 21290410 +IL1B 3553 MERRF Syndrome MESH:D017243 marker/mechanism 7979221 +IL1B 3553 Mitochondrial Myopathies MESH:D017240 marker/mechanism 7979221 +IL1B 3553 Mucositis MESH:D052016 marker/mechanism 20844880 +IL1B 3553 Multiple Sclerosis MESH:D009103 marker/mechanism|therapeutic 15210533|25458313 +IL1B 3553 Muscular Diseases MESH:D009135 marker/mechanism 9184656 +IL1B 3553 Myocardial Infarction MESH:D009203 marker/mechanism 11743230|15883752|16310260 +IL1B 3553 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +IL1B 3553 Necrosis MESH:D009336 marker/mechanism 10631206|10903806|10909967 +IL1B 3553 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27567548 +IL1B 3553 Neoplasms MESH:D009369 marker/mechanism 22467534 +IL1B 3553 Neuroblastoma MESH:D009447 marker/mechanism 34626302 +IL1B 3553 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34453990 +IL1B 3553 Neutropenia MESH:D009503 marker/mechanism 1884014 +IL1B 3553 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 32613381 +IL1B 3553 Ophthalmoplegia, Chronic Progressive External MESH:D017246 marker/mechanism 7979221 +IL1B 3553 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 7979221 +IL1B 3553 Osteoarthritis MESH:D010003 marker/mechanism 21954917 +IL1B 3553 Osteoporosis, Postmenopausal MESH:D015663 marker/mechanism 9032749 +IL1B 3553 Peptic Ulcer MESH:D010437 marker/mechanism 19448967 +IL1B 3553 Pleurisy MESH:D010998 marker/mechanism 11181422 +IL1B 3553 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL1B 3553 Polymyositis MESH:D017285 marker/mechanism 7979221 +IL1B 3553 Psoriasis MESH:D011565 marker/mechanism 7744320 +IL1B 3553 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17266442|23640035 +IL1B 3553 Pyogenic arthritis, pyoderma gangrenosum, and acne MESH:C536253 marker/mechanism 27106250 +IL1B 3553 Radiation Injuries, Experimental MESH:D011833 marker/mechanism 11121210 +IL1B 3553 Reperfusion Injury MESH:D015427 marker/mechanism 10594344|12468449|15829914|19058328|19673871 +IL1B 3553 Schizophrenia MESH:D012559 marker/mechanism 18583979 +IL1B 3553 Seizures MESH:D012640 marker/mechanism 16824509 +IL1B 3553 Sepsis MESH:D018805 marker/mechanism 32062619 +IL1B 3553 Silicosis MESH:D012829 marker/mechanism 23640035 +IL1B 3553 Skin Diseases MESH:D012871 marker/mechanism 16835338|22533443 +IL1B 3553 Sleep Wake Disorders MESH:D012893 marker/mechanism 17520785 +IL1B 3553 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 15492468|19584167|22414649 +IL1B 3553 Stomach Ulcer MESH:D013276 marker/mechanism 11376495 +IL1B 3553 Stroke MESH:D020521 marker/mechanism 10950380 +IL1B 3553 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 27157545 +IL1B 3553 Thyroid Neoplasms MESH:D013964 marker/mechanism 26037280 +IL1B 3553 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +IL1B 3553 Urticaria MESH:D014581 marker/mechanism 12121561 +IL1R1 3554 Brain Injuries MESH:D001930 marker/mechanism 21549006 +IL1R1 3554 Burns, Chemical MESH:D002057 marker/mechanism 22533443 +IL1R1 3554 Chronic recurrent multifocal osteomyelitis MESH:C535456 marker/mechanism 259680.0 +IL1R1 3554 Endometriosis MESH:D004715 marker/mechanism 20864642|21063030 +IL1R1 3554 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL1R1 3554 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL1R1 3554 Skin Diseases MESH:D012871 marker/mechanism 22533443 +IL1R2 7850 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 17984051 +IL1R2 7850 Colitis, Ulcerative MESH:D003093 marker/mechanism 21297633 +IL1R2 7850 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL1R2 7850 Liver Diseases MESH:D008107 marker/mechanism 19784758 +IL1R2 7850 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +IL1R2 7850 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL1R2 7850 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 20062062 +IL1RAP 3556 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +IL1RAP 3556 Disease Progression MESH:D018450 marker/mechanism 27738319 +IL1RAP 3556 Liver Diseases MESH:D008107 marker/mechanism 19784758 +IL1RAP 3556 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 27738319 +IL1RAPL1 11141 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20479760 +IL1RAPL1 11141 Autistic Disorder MESH:D001321 marker/mechanism 18801879|20437600 +IL1RAPL1 11141 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 21 OMIM:300143 marker/mechanism 300143.0 +IL1RAPL1 11141 Melanoma MESH:D008545 marker/mechanism 22535842 +IL1RAPL1 11141 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 18801879 +IL1RL1 9173 Acute Lung Injury MESH:D055371 therapeutic 21352201 +IL1RL1 9173 Arthritis, Experimental MESH:D001169 marker/mechanism 20472598 +IL1RL1 9173 Asthma MESH:D001249 marker/mechanism 19198610|21150878|21804549|24241537|27472835 +IL1RL1 9173 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +IL1RL1 9173 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 32777237 +IL1RN 3557 Anorexia MESH:D000855 therapeutic 25392278 +IL1RN 3557 Anthracosis MESH:D055008 marker/mechanism 20005085 +IL1RN 3557 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +IL1RN 3557 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +IL1RN 3557 Arthritis, Rheumatoid MESH:D001172 marker/mechanism|therapeutic 19192274|7706905 +IL1RN 3557 Asthma MESH:D001249 marker/mechanism 9176529 +IL1RN 3557 Atrophy MESH:D001284 therapeutic 7637259 +IL1RN 3557 Autistic Disorder MESH:D001321 marker/mechanism 11803234 +IL1RN 3557 Brain Injuries MESH:D001930 therapeutic 25665855 +IL1RN 3557 Brain Ischemia MESH:D002545 therapeutic 9236716 +IL1RN 3557 Bronchial Hyperreactivity MESH:D016535 therapeutic 14754758 +IL1RN 3557 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +IL1RN 3557 Cardiovascular Diseases MESH:D002318 marker/mechanism 29114965 +IL1RN 3557 Cerebrovascular Disorders MESH:D002561 marker/mechanism 29114965 +IL1RN 3557 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 2, WITH PERIOSTITIS AND PUSTULOSIS OMIM:612852 marker/mechanism 612852.0 +IL1RN 3557 Colonic Neoplasms MESH:D003110 marker/mechanism 18987561 +IL1RN 3557 Diarrhea MESH:D003967 therapeutic 20844880 +IL1RN 3557 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +IL1RN 3557 Exanthema MESH:D005076 therapeutic 16096327 +IL1RN 3557 Extravasation of Diagnostic and Therapeutic Materials MESH:D005119 marker/mechanism 7706905 +IL1RN 3557 Fever MESH:D005334 therapeutic 16096327 +IL1RN 3557 Fibrosis MESH:D005355 therapeutic 7637259 +IL1RN 3557 Gout MESH:D006073 therapeutic 18403674 +IL1RN 3557 Hyperalgesia MESH:D006930 marker/mechanism|therapeutic 15317861|17174526|20937348|8864563 +IL1RN 3557 Inflammation MESH:D007249 therapeutic 25665855 +IL1RN 3557 Kidney Diseases MESH:D007674 therapeutic 9370186 +IL1RN 3557 Learning Disabilities MESH:D007859 therapeutic 25665855 +IL1RN 3557 Liver Failure, Acute MESH:D017114 therapeutic 20644519 +IL1RN 3557 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4 OMIM:612628 marker/mechanism 612628.0 +IL1RN 3557 Mucositis MESH:D052016 therapeutic 20844880 +IL1RN 3557 Multiple Sclerosis MESH:D009103 marker/mechanism 25458313 +IL1RN 3557 Myocardial Infarction MESH:D009203 therapeutic 18474815|19005744 +IL1RN 3557 Myositis MESH:D009220 marker/mechanism 10886238 +IL1RN 3557 Necrosis MESH:D009336 therapeutic 1838896|20644519 +IL1RN 3557 Neoplasm Invasiveness MESH:D009361 therapeutic 27567548 +IL1RN 3557 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +IL1RN 3557 Pain MESH:D010146 therapeutic 15317861 +IL1RN 3557 Prostatic Neoplasms MESH:D011471 marker/mechanism 16106254|16284379 +IL1RN 3557 Proteinuria MESH:D011507 therapeutic 9370186 +IL1RN 3557 Pulmonary Fibrosis MESH:D011658 therapeutic 18403674 +IL1RN 3557 Schnitzler Syndrome MESH:D019873 therapeutic 16096327 +IL1RN 3557 Sclerosis MESH:D012598 therapeutic 7637259 +IL1RN 3557 Skin Diseases MESH:D012871 marker/mechanism 16835338|7706905 +IL1RN 3557 Status Epilepticus MESH:D013226 therapeutic 19010416 +IL1RN 3557 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 +IL1RN 3557 Stroke MESH:D020521 marker/mechanism 12374626 +IL2 3558 Acquired Immunodeficiency Syndrome MESH:D000163 therapeutic 9861562 +IL2 3558 Amnesia MESH:D000647 marker/mechanism 8241462 +IL2 3558 Anemia MESH:D000740 therapeutic 7678812 +IL2 3558 Anorexia MESH:D000855 marker/mechanism 8635092 +IL2 3558 Asthenia MESH:D001247 marker/mechanism 8635092 +IL2 3558 Autistic Disorder MESH:D001321 marker/mechanism 16360218|18929414 +IL2 3558 Brain Injuries MESH:D001930 marker/mechanism 23159883 +IL2 3558 Brain Neoplasms MESH:D001932 marker/mechanism 6319491 +IL2 3558 COVID-19 MESH:D000086382 marker/mechanism 31986264 +IL2 3558 Depressive Disorder, Major MESH:D003865 marker/mechanism 12635532 +IL2 3558 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 11312644|22245253 +IL2 3558 Drug Eruptions MESH:D003875 marker/mechanism 31150805 +IL2 3558 Entamoebiasis MESH:D004749 marker/mechanism 16374615 +IL2 3558 Fever MESH:D005334 marker/mechanism 8635092 +IL2 3558 Glioblastoma MESH:D005909 therapeutic 7719933 +IL2 3558 Glomerulonephritis MESH:D005921 marker/mechanism 10910440|9403216 +IL2 3558 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IL2 3558 HIV Infections MESH:D015658 marker/mechanism 12878215 +IL2 3558 Hyperkinesis MESH:D006948 marker/mechanism 8241462 +IL2 3558 Hypotension MESH:D007022 marker/mechanism 8635092 +IL2 3558 Kidney Neoplasms MESH:D007680 therapeutic 17105418|18298334|18625569|19409039 +IL2 3558 Leukemia MESH:D007938 therapeutic 17500047 +IL2 3558 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 23962110 +IL2 3558 Leukopenia MESH:D007970 therapeutic 7678812 +IL2 3558 Liver Neoplasms MESH:D008113 therapeutic 18298334 +IL2 3558 Lung Neoplasms MESH:D008175 therapeutic 18298334|18625569|7614408 +IL2 3558 Melanoma MESH:D008545 therapeutic 12374674|12439608|15577323|15917704|16131448|16248763|16260693|16432458|16809738|16939954|17023156|17105418|17576460|17709802|17761969|18176117|18281670|18298334|18332650|18999936|19243244|20423231 +IL2 3558 Neoplasm Metastasis MESH:D009362 therapeutic 17105418 +IL2 3558 Neoplasm, Residual MESH:D018365 therapeutic 14654953 +IL2 3558 Neoplasms MESH:D009369 therapeutic 12579325 +IL2 3558 Neoplasms, Experimental MESH:D009374 therapeutic 1949363|22306178|3495671 +IL2 3558 Nephrotic Syndrome MESH:D009404 marker/mechanism 19242727 +IL2 3558 Pain MESH:D010146 therapeutic 12421473 +IL2 3558 Prostatic Neoplasms MESH:D011471 marker/mechanism 17115417 +IL2 3558 Urinary Bladder Neoplasms MESH:D001749 therapeutic 1949363|3495671 +IL2 3558 Vaginal Neoplasms MESH:D014625 therapeutic 15577323 +IL20 50604 Acute Kidney Injury MESH:D058186 marker/mechanism 18496552 +IL20 50604 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 19430480 +IL20RA 53832 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IL21 59067 Celiac Disease MESH:D002446 marker/mechanism 17558408 +IL21 59067 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 615767.0 +IL21 59067 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 17911475 +IL21R 50615 IMMUNODEFICIENCY 56 OMIM:615207 marker/mechanism 615207.0 +IL21R 50615 Lupus Erythematosus, Systemic MESH:D008180 therapeutic 17911475 +IL22 50616 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 15122762|16212920|23375450 +IL22 50616 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IL22 50616 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 25257527 +IL23A 51561 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +IL23A 51561 Dermatitis, Atopic MESH:D003876 marker/mechanism 33274957 +IL23A 51561 Psoriasis MESH:D011565 marker/mechanism 19169254|20953190|21348542 +IL23R 149233 Colitis, Ulcerative MESH:D003093 marker/mechanism 18438406|19122664|20228799 +IL23R 149233 Crohn Disease MESH:D003424 marker/mechanism 17435756|18438406 +IL23R 149233 Inflammatory Bowel Disease 17 MESH:C567378 marker/mechanism 612261.0 +IL23R 149233 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 21983784|23291587|26192919 +IL23R 149233 Leprosy MESH:D007918 marker/mechanism 22019778 +IL23R 149233 Psoriasis MESH:D011565 marker/mechanism 605606.0 19169254|20953190|24212883 +IL23R 149233 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 17952073|20062062 +IL24 11009 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IL24 11009 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 16298037|21671747 +IL24 11009 Lung Neoplasms MESH:D008175 therapeutic 12830052|15713900 +IL24 11009 Pancreatic Neoplasms MESH:D010190 therapeutic 15580305 +IL24 11009 Prostatic Neoplasms MESH:D011471 therapeutic 14678967|21671747 +IL27 246778 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 19430480 +IL27 246778 Prostatic Neoplasms MESH:D011471 therapeutic 21801027|24028178 +IL27RA 9466 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +IL2RA 3559 Alopecia Areata MESH:D000506 marker/mechanism 20596022 +IL2RA 3559 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|20476861|23143596 +IL2RA 3559 Berylliosis MESH:D001607 marker/mechanism 8977230 +IL2RA 3559 COVID-19 MESH:D000086382 marker/mechanism 32026671|32161940 +IL2RA 3559 Crohn Disease MESH:D003424 marker/mechanism 21102463 +IL2RA 3559 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +IL2RA 3559 Diabetes Mellitus, Insulin-Dependent, 10 MESH:C566602 marker/mechanism 601942.0 +IL2RA 3559 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 17676041|19119414|19701192|30224649 +IL2RA 3559 Glomerulonephritis MESH:D005921 marker/mechanism 10910440 +IL2RA 3559 HIV Infections MESH:D015658 marker/mechanism 12878215 +IL2RA 3559 Interleukin 2 Receptor, Alpha, Deficiency of MESH:C565232 marker/mechanism 606367.0 +IL2RA 3559 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +IL2RA 3559 Multiple Sclerosis MESH:D009103 marker/mechanism 17660530|19119414|19525955|24076602 +IL2RA 3559 Schizophrenia MESH:D012559 marker/mechanism 8067274 +IL2RB 3560 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +IL2RB 3560 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +IL2RB 3560 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL2RB 3560 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IL2RB 3560 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL2RG 3561 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IL2RG 3561 Sezary Syndrome MESH:D012751 marker/mechanism 26551670 +IL2RG 3561 X-Linked Combined Immunodeficiency Diseases MESH:D053632 marker/mechanism 300400|312863 +IL3 3562 Anemia MESH:D000740 therapeutic 12090760|8202718 +IL3 3562 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 8202718 +IL3 3562 Leukopenia MESH:D007970 therapeutic 8202718 +IL3 3562 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +IL3 3562 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615 +IL3 3562 Thrombocytopenia MESH:D013921 therapeutic 8202718 +IL31 386653 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +IL31RA 133396 Amyloidosis, Primary Cutaneous MESH:C562642 marker/mechanism 613955 +IL31RA 133396 Brain Injuries MESH:D001930 marker/mechanism 23159883 +IL32 9235 Colonic Neoplasms MESH:D003110 marker/mechanism 25279216 +IL32 9235 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17597826 +IL32 9235 Kidney Neoplasms MESH:D007680 marker/mechanism 25279216 +IL32 9235 Sezary Syndrome MESH:D012751 marker/mechanism 26551670 +IL32 9235 Stomach Neoplasms MESH:D013274 marker/mechanism 25279216 +IL33 90865 Arthritis, Experimental MESH:D001169 marker/mechanism 20472598 +IL33 90865 Asthma MESH:D001249 marker/mechanism 19198610|21804549|24241537|27472835|29067999 +IL33 90865 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +IL33 90865 Hypersensitivity, Immediate MESH:D006969 marker/mechanism 22967010 +IL33 90865 Kidney Diseases MESH:D007674 marker/mechanism 21949094 +IL33 90865 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IL33 90865 Pneumonia MESH:D011014 marker/mechanism 24453940 +IL34 146433 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +IL36RN 26525 Psoriasis MESH:D011565 marker/mechanism 614204 +IL4 3565 Arthritis, Experimental MESH:D001169 therapeutic 10444273 +IL4 3565 Asthma MESH:D001249 marker/mechanism 18357729 +IL4 3565 Autistic Disorder MESH:D001321 marker/mechanism 16360218 +IL4 3565 Autoimmune Diseases MESH:D001327 marker/mechanism 19077085|7871386|8898950 +IL4 3565 Cardiomyopathies MESH:D009202 marker/mechanism 7578376 +IL4 3565 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism|therapeutic 21094227|21735453|22107450 +IL4 3565 Chromosome Breakage MESH:D019457 marker/mechanism 27634759 +IL4 3565 Colitis MESH:D003092 therapeutic 24314293 +IL4 3565 Dermatitis MESH:D003872 marker/mechanism 31330126 +IL4 3565 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 12484431|21804303 +IL4 3565 Dermatitis, Atopic MESH:D003876 marker/mechanism 11886533|12230500|18249437 +IL4 3565 Drug Eruptions MESH:D003875 marker/mechanism 19351467 +IL4 3565 Drug Hypersensitivity MESH:D004342 marker/mechanism 15867870|20485159 +IL4 3565 Fibrosis MESH:D005355 marker/mechanism 24286936 +IL4 3565 Graves Disease MESH:D006111 marker/mechanism 33132244 +IL4 3565 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IL4 3565 Hypersensitivity MESH:D006967 marker/mechanism 16095146|21625544 +IL4 3565 Hypersensitivity, Immediate MESH:D006969 marker/mechanism 12755381|20485159|22967010 +IL4 3565 Leishmaniasis, Cutaneous MESH:D016773 marker/mechanism 20102417 +IL4 3565 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 23962110 +IL4 3565 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 18158872 +IL4 3565 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +IL4 3565 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615 +IL4 3565 Pleural Diseases MESH:D010995 marker/mechanism 21357438 +IL4 3565 Pneumoconiosis MESH:D011009 marker/mechanism 21857939 +IL4 3565 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL4 3565 Premature Birth MESH:D047928 marker/mechanism 26055944 +IL4 3565 Psoriasis MESH:D011565 marker/mechanism 19169254 +IL4 3565 Pulmonary Fibrosis MESH:D011658 marker/mechanism 12574379|15322207 +IL4 3565 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 18394133 +IL4 3565 Respiratory Sounds MESH:D012135 marker/mechanism 18410779 +IL4 3565 Rhinitis MESH:D012220 marker/mechanism 19672097 +IL4 3565 Tuberculosis, Bovine MESH:D014380 therapeutic 17387165 +IL4 3565 Weight Loss MESH:D015431 therapeutic 24314293 +IL4I1 259307 Acute Lung Injury MESH:D055371 marker/mechanism 36537648 +IL4I1 259307 Inflammation MESH:D007249 marker/mechanism 36537648 +IL4R 3566 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22317767|30472377 +IL4R 3566 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 30472377 +IL4R 3566 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 11918534 +IL4RA 16190 Drug Hypersensitivity MESH:D004342 marker/mechanism 20485159 +IL4RA 16190 Eczema MESH:D004485 marker/mechanism 19759553 +IL4RA 16190 Hypersensitivity, Immediate MESH:D006969 marker/mechanism 20485159 +IL5 3567 Asthma MESH:D001249 marker/mechanism 23266719|7540862 +IL5 3567 Autistic Disorder MESH:D001321 marker/mechanism 16360218 +IL5 3567 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 15347381 +IL5 3567 Dermatitis, Atopic MESH:D003876 marker/mechanism 11886533|18249437|33274957 +IL5 3567 Entamoebiasis MESH:D004749 marker/mechanism 16374615 +IL5 3567 Eosinophilia MESH:D004802 marker/mechanism 11006010|1988543 +IL5 3567 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IL5 3567 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17620002 +IL5RA 3568 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IL5RA 3568 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL5RA 3568 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL6 3569 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IL6 3569 Acute Coronary Syndrome MESH:D054058 marker/mechanism 23305094 +IL6 3569 Acute Kidney Injury MESH:D058186 therapeutic 21570986 +IL6 3569 Acute Lung Injury MESH:D055371 marker/mechanism 32062619 +IL6 3569 Albuminuria MESH:D000419 marker/mechanism 17167242 +IL6 3569 Amnesia MESH:D000647 therapeutic 9189931 +IL6 3569 Arthritis, Experimental MESH:D001169 marker/mechanism 20131233|20974942|22450443 +IL6 3569 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274|22450443 +IL6 3569 Asthma MESH:D001249 marker/mechanism 29902480 +IL6 3569 Atherosclerosis MESH:D050197 marker/mechanism 19330073 +IL6 3569 Autistic Disorder MESH:D001321 marker/mechanism 8964908 +IL6 3569 Autoimmune Diseases MESH:D001327 marker/mechanism 19077085 +IL6 3569 Berylliosis MESH:D001607 marker/mechanism 8428540 +IL6 3569 Brain Injuries MESH:D001930 marker/mechanism 19800810|21549006|23159883 +IL6 3569 Brain Ischemia MESH:D002545 marker/mechanism 15829914|17394460 +IL6 3569 Breast Neoplasms MESH:D001943 marker/mechanism 16298037|17516992|19435922|19446661 +IL6 3569 Burns MESH:D002056 marker/mechanism 10431976|18277951 +IL6 3569 Burns, Chemical MESH:D002057 marker/mechanism 22533443 +IL6 3569 Cachexia MESH:D002100 marker/mechanism 17878525 +IL6 3569 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 22108589 +IL6 3569 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17615358|20818158|26297436|27022031 +IL6 3569 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 7834629 +IL6 3569 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 26372664 +IL6 3569 Cardiomyopathies MESH:D009202 marker/mechanism 10716473 +IL6 3569 Castleman Disease MESH:D005871 marker/mechanism 15182131 +IL6 3569 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23593346|26101800 +IL6 3569 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 15763341|7532385 +IL6 3569 Chemically-Induced Disorders MESH:D064419 marker/mechanism 36108500 +IL6 3569 Cholangiocarcinoma MESH:D018281 marker/mechanism 17621267 +IL6 3569 Cholestasis MESH:D002779 marker/mechanism 22461449 +IL6 3569 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +IL6 3569 Colitis MESH:D003092 marker/mechanism 22410118|24548422 +IL6 3569 COVID-19 MESH:D000086382 marker/mechanism 32026671|32161940|32171193|32534021 +IL6 3569 Coxsackievirus Infections MESH:D003384 marker/mechanism 25396421 +IL6 3569 Crohn Disease MESH:D003424 marker/mechanism 10700533|21829567 +IL6 3569 Depressive Disorder MESH:D003866 marker/mechanism 18458677 +IL6 3569 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +IL6 3569 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22138235 +IL6 3569 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 222100.0 +IL6 3569 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 +IL6 3569 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +IL6 3569 Edema MESH:D004487 marker/mechanism 19874808 +IL6 3569 Entamoebiasis MESH:D004749 marker/mechanism 16374615 +IL6 3569 Fever MESH:D005334 marker/mechanism 11852909|15384034|7537110 +IL6 3569 Glomerulonephritis MESH:D005921 marker/mechanism 9403216 +IL6 3569 Goiter, Nodular MESH:D006044 marker/mechanism 16372246 +IL6 3569 Graves Disease MESH:D006111 marker/mechanism 16372246 +IL6 3569 Hashimoto Disease MESH:D050031 marker/mechanism 16372246 +IL6 3569 Headache MESH:D006261 marker/mechanism 7537110 +IL6 3569 Heart Failure MESH:D006333 marker/mechanism 15135663|16360360 +IL6 3569 Heat Stroke MESH:D018883 marker/mechanism 24039931 +IL6 3569 Hemolytic-Uremic Syndrome MESH:D006463 marker/mechanism 15384034 +IL6 3569 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IL6 3569 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 25002079 +IL6 3569 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 18500730 +IL6 3569 HIV Wasting Syndrome MESH:D019247 marker/mechanism 7979221 +IL6 3569 Hyperalgesia MESH:D006930 marker/mechanism 10401557|18652822|7582491 +IL6 3569 Hypercalcemia MESH:D006934 marker/mechanism 10638776 +IL6 3569 Hyperglycemia MESH:D006943 marker/mechanism 29035695 +IL6 3569 Hyperoxaluria MESH:D006959 marker/mechanism 16284884 +IL6 3569 Hyperparathyroidism, Secondary MESH:D006962 marker/mechanism 21350317 +IL6 3569 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL6 3569 Hypertension MESH:D006973 marker/mechanism 27292124|27659729|27847271|32147540|32165127 +IL6 3569 Hypoalbuminemia MESH:D034141 marker/mechanism 15044820 +IL6 3569 Hypotension MESH:D007022 marker/mechanism 15217654|15384034 +IL6 3569 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626|21940958|25257527 +IL6 3569 Inflammation MESH:D007249 marker/mechanism 11181422|16227999|19762220|19803787|20056584|20578705|20816778|21467745|23159501|23371441|26297436 +IL6 3569 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 266600.0 +IL6 3569 Intracranial Arteriovenous Malformations MESH:D002538 marker/mechanism 108010.0 +IL6 3569 Ischemia MESH:D007511 marker/mechanism 18091701 +IL6 3569 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19539174 +IL6 3569 Leishmaniasis MESH:D007896 marker/mechanism 16540374 +IL6 3569 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 17404324|22461696|7554475 +IL6 3569 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18006695 +IL6 3569 Lichenoid Eruptions MESH:D017512 marker/mechanism 18393961 +IL6 3569 Liver Cirrhosis MESH:D008103 marker/mechanism 12830005 +IL6 3569 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +IL6 3569 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 26297436 +IL6 3569 Lung Injury MESH:D055370 marker/mechanism 19762220 +IL6 3569 Lung Neoplasms MESH:D008175 marker/mechanism 26372664 +IL6 3569 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 18158872 +IL6 3569 Meningitis, Aseptic MESH:D008582 marker/mechanism 10888991 +IL6 3569 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +IL6 3569 Metabolic Syndrome MESH:D024821 marker/mechanism 16644639 +IL6 3569 Mitochondrial Myopathies MESH:D017240 marker/mechanism 7979221 +IL6 3569 Multiple Myeloma MESH:D009101 marker/mechanism 12855565|19330649|8520508 +IL6 3569 Myocardial Infarction MESH:D009203 marker/mechanism 15883752|16310260 +IL6 3569 Myocardial Ischemia MESH:D017202 marker/mechanism 16286589 +IL6 3569 Myocarditis MESH:D009205 marker/mechanism 25396421 +IL6 3569 Necrosis MESH:D009336 marker/mechanism 7608651 +IL6 3569 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26101800|26284488 +IL6 3569 Neoplasm Metastasis MESH:D009362 marker/mechanism 21937440|26101800 +IL6 3569 Neurodegenerative Diseases MESH:D019636 marker/mechanism 12836160 +IL6 3569 Obesity MESH:D009765 marker/mechanism 20141834|24042701 +IL6 3569 Obstetric Labor, Premature MESH:D007752 marker/mechanism 20610570|22122352 +IL6 3569 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 28984080 +IL6 3569 Osteoarthritis, Spine MESH:D055013 marker/mechanism 34697729 +IL6 3569 Osteoporosis MESH:D010024 marker/mechanism 15995586 +IL6 3569 Osteoporosis, Postmenopausal MESH:D015663 marker/mechanism 9032749 +IL6 3569 Ovarian Neoplasms MESH:D010051 marker/mechanism 19401270 +IL6 3569 Parkinson Disease MESH:D010300 marker/mechanism 21318773 +IL6 3569 Peripheral Nervous System Diseases MESH:D010523 therapeutic 18270703 +IL6 3569 Pleural Diseases MESH:D010995 marker/mechanism 21357438 +IL6 3569 Pleurisy MESH:D010998 marker/mechanism 11181422 +IL6 3569 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL6 3569 Polymyositis MESH:D017285 marker/mechanism 7979221 +IL6 3569 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +IL6 3569 Pregnancy Complications, Cardiovascular MESH:D011249 marker/mechanism 10716473 +IL6 3569 Premature Birth MESH:D047928 marker/mechanism 26055944 +IL6 3569 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 15672864|17196171|19011039|19240160|25970160 +IL6 3569 Psoriasis MESH:D011565 marker/mechanism 16844318 +IL6 3569 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 28864214|29329563|31349846 +IL6 3569 Pulmonary Fibrosis MESH:D011658 marker/mechanism 17266442|25216247 +IL6 3569 Reperfusion Injury MESH:D015427 marker/mechanism 15829914|17032661|18258783|19673871|21940958 +IL6 3569 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 18394133 +IL6 3569 Rheumatoid Arthritis, Systemic Juvenile MESH:C565798 marker/mechanism 604302.0 +IL6 3569 Sarcoma, Kaposi MESH:D012514 marker/mechanism 148000.0 +IL6 3569 Schizophrenia MESH:D012559 marker/mechanism 8067274 +IL6 3569 Seizures MESH:D012640 marker/mechanism 12836160 +IL6 3569 Sepsis MESH:D018805 marker/mechanism 32062619 +IL6 3569 Shock, Hemorrhagic MESH:D012771 marker/mechanism 21192278 +IL6 3569 Skin Diseases MESH:D012871 marker/mechanism 22533443 +IL6 3569 Stomach Neoplasms MESH:D013274 marker/mechanism 23593346 +IL6 3569 Stroke MESH:D020521 marker/mechanism 18319729 +IL6 3569 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 27157545 +IL6 3569 Thyroid Neoplasms MESH:D013964 marker/mechanism 26037280 +IL6 3569 Tobacco Use Disorder MESH:D014029 marker/mechanism 28864214 +IL6 3569 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 16286589 +IL6 3569 Wounds and Injuries MESH:D014947 marker/mechanism 21192278 +IL6R 3570 Arthritis, Rheumatoid MESH:D001172 marker/mechanism|therapeutic 16729287|23143596 +IL6R 3570 Asthma MESH:D001249 marker/mechanism 29902480 +IL6R 3570 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22552503 +IL6R 3570 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 7834629 +IL6R 3570 Graves Disease MESH:D006111 marker/mechanism 16372246 +IL6R 3570 Hashimoto Disease MESH:D050031 marker/mechanism 16372246 +IL6R 3570 Osteoporosis MESH:D010024 marker/mechanism 15995586 +IL6R 3570 Schizophrenia MESH:D012559 marker/mechanism 8067274 +IL6R 3570 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +IL6RA 16194 Fever MESH:D005334 marker/mechanism 25429137 +IL6RA 16194 Heat Stroke MESH:D018883 marker/mechanism 24039931 +IL6RA 16194 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 21940958 +IL6RA 16194 Reperfusion Injury MESH:D015427 marker/mechanism 21940958 +IL6ST 3572 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842 +IL6ST 3572 Carcinoma MESH:D002277 marker/mechanism 12606953 +IL6ST 3572 Colorectal Neoplasms MESH:D015179 marker/mechanism 19223499 +IL6ST 3572 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +IL6ST 3572 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 21940958 +IL6ST 3572 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12606953 +IL6ST 3572 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12606953 +IL6ST 3572 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +IL6ST 3572 Ovarian Neoplasms MESH:D010051 marker/mechanism 11161848 +IL6ST 3572 Pneumonia MESH:D011014 marker/mechanism 21625544 +IL6ST 3572 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475|29662167 +IL6ST 3572 Reperfusion Injury MESH:D015427 marker/mechanism 21940958 +IL7 3574 Brain Injuries MESH:D001930 marker/mechanism 23159883 +IL7 3574 COVID-19 MESH:D000086382 marker/mechanism 31986264 +IL7 3574 Glucose Intolerance MESH:D018149 therapeutic 20376352 +IL7 3574 Hyperglycemia MESH:D006943 therapeutic 20376352 +IL7 3574 Insulin Resistance MESH:D007333 therapeutic 20376352 +IL7 3574 Lymphopenia MESH:D008231 marker/mechanism 17151827 +IL7 3574 Multiple Sclerosis MESH:D009103 marker/mechanism 17660816 +IL7 3574 Obesity MESH:D009765 therapeutic 20376352 +IL7 3574 Weight Gain MESH:D015430 therapeutic 20376352 +IL7R 3575 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21892159 +IL7R 3575 Colitis, Ulcerative MESH:D003093 marker/mechanism 21297633 +IL7R 3575 Endometriosis MESH:D004715 marker/mechanism 20864642 +IL7R 3575 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 21399635 +IL7R 3575 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IL7R 3575 Multiple Sclerosis MESH:D009103 marker/mechanism 17660530|17660816|17660817|19525955 +IL7R 3575 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 21892159 +IL7R 3575 Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive MESH:C563822 marker/mechanism 608971.0 +IL9 3578 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +IL9 3578 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +IL9 3578 Hyperplasia MESH:D006965 marker/mechanism 19342650 +IL9R 3581 Brain Injuries MESH:D001930 marker/mechanism 23159883 +IL9R 3581 Liver Diseases MESH:D008107 marker/mechanism 19784758 +ILDR1 286676 Deafness, Autosomal Recessive 42 MESH:C566460 marker/mechanism 609646.0 +ILF2 3608 HIV Infections MESH:D015658 marker/mechanism 15308739 +ILF2 3608 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +ILK 3611 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18702665|19629758 +ILK 3611 Colonic Polyps MESH:D003111 marker/mechanism 11593435 +ILK 3611 Epilepsy MESH:D004827 therapeutic 20064661 +ILK 3611 Ischemic Attack, Transient MESH:D002546 marker/mechanism 15472100 +ILK 3611 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16941698 +ILK 3611 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23045294 +ILK 3611 Thoracic Diseases MESH:D013896 marker/mechanism 23045294 +IMMP2L 83943 Autistic Disorder MESH:D001321 marker/mechanism 19401682 +IMMP2L 83943 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 27356265 +IMMT 10989 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +IMMT 10989 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +IMPA1 3612 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59 OMIM:617323 marker/mechanism 617323.0 +IMPA1 3612 Seizures MESH:D012640 marker/mechanism 17460611 +IMPA2 3613 Endometriosis MESH:D004715 marker/mechanism 20864642 +IMPA2 3613 Seizures, Febrile MESH:D003294 marker/mechanism 15557493 +IMPDH1 3614 Leber Congenital Amaurosis MESH:D057130 marker/mechanism 16384941 +IMPDH1 3614 Leber Congenital Amaurosis 11 MESH:C564140 marker/mechanism 613837.0 +IMPDH1 3614 Retinitis Pigmentosa MESH:D012174 marker/mechanism 11875050|16384941 +IMPDH1 3614 Retinitis Pigmentosa 10 MESH:C566715 marker/mechanism 180105.0 +IMPDH2 3615 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +IMPDH2 3615 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +IMPG1 3617 Macular dystrophy, concentric annular MESH:C537833 marker/mechanism 153870.0 +IMPG1 3617 Vitelliform Macular Dystrophy MESH:D057826 marker/mechanism 616151.0 +IMPG2 50939 RETINITIS PIGMENTOSA 56 OMIM:613581 marker/mechanism 613581.0 +IMPG2 50939 Vitelliform Macular Dystrophy MESH:D057826 marker/mechanism 616152.0 +INA 9118 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +INAVA 55765 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 21983784 +INCENP 3619 Melanoma MESH:D008545 marker/mechanism 22535842 +INCENP 3619 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +INF2 64423 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E OMIM:614455 marker/mechanism 614455.0 +INF2 64423 Focal Segmental Glomerulosclerosis 5 MESH:C567687 marker/mechanism 613237.0 +INF2 64423 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 20023659 +ING1 3621 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +ING1 3621 Disease Progression MESH:D018450 marker/mechanism 21364753 +ING1 3621 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 275355.0 +ING1 3621 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +ING4 51147 Colorectal Neoplasms MESH:D015179 therapeutic 27806345 +ING4 51147 Lymphatic Metastasis MESH:D008207 therapeutic 27806345 +INHA 3623 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +INHA 3623 Familial Testotoxicosis MESH:C536961 marker/mechanism 16684832 +INHBA 3624 Leiomyoma MESH:D007889 marker/mechanism 22228119 +INHBA 3624 Liver Failure, Acute MESH:D017114 marker/mechanism 12560755 +INHBA 3624 Pre-Eclampsia MESH:D011225 marker/mechanism 17332518 +INHBA 3624 Uterine Neoplasms MESH:D014594 marker/mechanism 22228119 +INHBB 3625 Familial Testotoxicosis MESH:C536961 marker/mechanism 16684832 +INHBC 3626 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +INHBE 83729 Lipidoses MESH:D008064 marker/mechanism 17175557 +INHBE 83729 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +INMT 11185 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +INMT 11185 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +INPP1 3628 Autistic Disorder MESH:D001321 marker/mechanism 14627686 +INPP4A 3631 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +INPP4B 8821 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 29415082 +INPP4B 8821 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 29415082 +INPP4B 8821 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 29415082 +INPP4B 8821 Pancreatic Carcinoma MESH:C562463 marker/mechanism 29415082 +INPP4B 8821 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 29415082 +INPP5A 3632 Arsenic Poisoning MESH:D020261 marker/mechanism 25759212 +INPP5A 3632 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 25759212 +INPP5A 3632 Schizophrenia MESH:D012559 marker/mechanism 21822266 +INPP5A 3632 Skin Diseases MESH:D012871 marker/mechanism 25759212 +INPP5D 3635 Alzheimer Disease MESH:D000544 marker/mechanism 30320580 +INPP5D 3635 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +INPP5D 3635 Reperfusion Injury MESH:D015427 therapeutic 25780291 +INPP5E 56623 Agenesis of Cerebellar Vermis MESH:C536293 marker/mechanism 213300.0 19668216 +INPP5E 56623 Ciliary Motility Disorders MESH:D002925 marker/mechanism 19668215|19668216 +INPP5E 56623 Eye Diseases, Hereditary MESH:D015785 marker/mechanism 19668215 +INPP5E 56623 Intellectual Disability MESH:D008607 marker/mechanism 19668215 +INPP5E 56623 MORM syndrome MESH:C536984 marker/mechanism 610156.0 +INPP5E 56623 Obesity MESH:D009765 marker/mechanism 19668215 +INPP5E 56623 Penile Diseases MESH:D010409 marker/mechanism 19668215 +INPP5K 51763 MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY OMIM:617404 marker/mechanism 617404.0 +INPPL1 3636 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 12086927|25635986 +INPPL1 3636 Hypertension MESH:D006973 marker/mechanism 15220217 +INPPL1 3636 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +INPPL1 3636 Metabolic Syndrome MESH:D024821 marker/mechanism 15220217 +INPPL1 3636 Opsismodysplasia MESH:C537122 marker/mechanism 258480.0 +INS 3630 Acute Kidney Injury MESH:D058186 marker/mechanism 12243603 +INS 3630 Albuminuria MESH:D000419 marker/mechanism 9861226 +INS 3630 Alzheimer Disease MESH:D000544 marker/mechanism 15750215|9443474 +INS 3630 Bipolar Disorder MESH:D001714 marker/mechanism 5506046 +INS 3630 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 8660453 +INS 3630 Diabetes Mellitus MESH:D003920 marker/mechanism|therapeutic 11446671|15628829|17855560|18162506|2055425|7294224|7624867|8400068 +INS 3630 Diabetes Mellitus, Insulin-Dependent, 2 MESH:C565100 marker/mechanism 125852.0 +INS 3630 Diabetes Mellitus, Type 1 MESH:D003922 therapeutic 20620209 +INS 3630 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism|therapeutic 11522680|11978674|15531508|16259526|16519038|21680998|21779873|23349674|3511099|7573102 +INS 3630 Diabetic Cardiomyopathies MESH:D058065 therapeutic 20828608 +INS 3630 Diabetic Ketoacidosis MESH:D016883 therapeutic 11430560 +INS 3630 Diabetic Nephropathies MESH:D003928 marker/mechanism|therapeutic 2143390|7713310|7987072 +INS 3630 Edema MESH:D004487 marker/mechanism 15628829 +INS 3630 Fatty Liver MESH:D005234 marker/mechanism 9048448 +INS 3630 Glucose Intolerance MESH:D018149 marker/mechanism 21779873 +INS 3630 Heart Arrest MESH:D006323 therapeutic 17449947 +INS 3630 Heart Failure MESH:D006333 marker/mechanism 15628829 +INS 3630 Hepatitis MESH:D006505 marker/mechanism 12243603 +INS 3630 Hyperglycemia MESH:D006943 marker/mechanism|therapeutic 8660453|9861226 +INS 3630 Hyperinsulinism MESH:D006946 marker/mechanism 2991050|3511099|36764371|4019786|6382002 +INS 3630 Hyperkalemia MESH:D006947 marker/mechanism|therapeutic 20466255|8606734 +INS 3630 Hyperproinsulinemia MESH:C562776 marker/mechanism 616214.0 +INS 3630 Hypertension MESH:D006973 marker/mechanism|therapeutic 18360027|9719048 +INS 3630 Hypertriglyceridemia MESH:D015228 marker/mechanism 12754275 +INS 3630 Hypoglycemia MESH:D007003 marker/mechanism 1324617|1646414|1890151|20620209|22940631|2554359|48835 +INS 3630 Hypokalemia MESH:D007008 marker/mechanism 496411 +INS 3630 Hypotension MESH:D007022 marker/mechanism|therapeutic 1324617|48835|7418494 +INS 3630 Insulin Resistance MESH:D007333 marker/mechanism 11522680|24648896|25796170|33651899 +INS 3630 Kidney Diseases, Cystic MESH:D052177 therapeutic 9879822 +INS 3630 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +INS 3630 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 26806094 +INS 3630 Liver Diseases MESH:D008107 marker/mechanism 29684222 +INS 3630 Liver Failure, Acute MESH:D017114 marker/mechanism 12639207 +INS 3630 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10 OMIM:613370 marker/mechanism 613370.0 +INS 3630 Memory Disorders MESH:D008569 therapeutic 9264093 +INS 3630 Metabolic Diseases MESH:D008659 marker/mechanism 19131468 +INS 3630 Metabolic Syndrome MESH:D024821 marker/mechanism 11274935|16259526 +INS 3630 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 27884723|30266311 +INS 3630 MPTP Poisoning MESH:D020267 therapeutic 26364587 +INS 3630 Muscular Diseases MESH:D009135 marker/mechanism 496411 +INS 3630 Neoplasm Invasiveness MESH:D009361 marker/mechanism 24587105 +INS 3630 Neural Tube Defects MESH:D009436 therapeutic 19446573 +INS 3630 Neurocognitive Disorders MESH:D019965 therapeutic 21911655 +INS 3630 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 32613381 +INS 3630 Obesity MESH:D009765 marker/mechanism 11528401|2777199|29035695|8923850 +INS 3630 Pancreatitis MESH:D010195 marker/mechanism 17163263 +INS 3630 Panic Disorder MESH:D016584 marker/mechanism 12073167 +INS 3630 Paralysis MESH:D010243 therapeutic 7433326 +INS 3630 Paresthesia MESH:D010292 marker/mechanism 9861226 +INS 3630 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +INS 3630 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 11889176|16123091|2777199 +INS 3630 Prostatic Neoplasms MESH:D011471 marker/mechanism 12610512 +INS 3630 Renal Insufficiency MESH:D051437 marker/mechanism 8606734|9861226 +INS 3630 Rhabdomyolysis MESH:D012206 marker/mechanism 12243603 +INS 3630 Seizures MESH:D012640 marker/mechanism 14714756|4115818 +INS 3630 Tachycardia MESH:D013610 marker/mechanism 1324617 +INS 3630 Telomeric 22q13 Monosomy Syndrome MESH:C536801 therapeutic 18948358 +INS 3630 Urinary Bladder Diseases MESH:D001745 therapeutic 2055425 +INS 3630 Ventricular Dysfunction, Left MESH:D018487 therapeutic 11872684 +INS 3630 Ventricular Fibrillation MESH:D014693 therapeutic 5348156 +INS 3630 Ventricular Outflow Obstruction MESH:D014694 marker/mechanism 8660453 +INS 3630 Weight Loss MESH:D015431 marker/mechanism 22940631 +INS1 16333 Bradycardia MESH:D001919 therapeutic 3525850 +INS1 16333 Depressive Disorder MESH:D003866 therapeutic 34352274 +INS1 16333 Diabetes Mellitus, Experimental MESH:D003921 therapeutic 2975197|3044883 +INS1 16333 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 19586609 +INS1 16333 Diabetic Cardiomyopathies MESH:D058065 therapeutic 6225876 +INS1 16333 Hyperglycemia MESH:D006943 therapeutic 26887929|28422052|29682576|32554039 +INS1 16333 Hypoglycemia MESH:D007003 marker/mechanism 18545258|222008|3084764|6797439 +INS1 16333 Insulin Resistance MESH:D007333 marker/mechanism 19586609 +INS1 16333 Ketosis MESH:D007662 therapeutic 29420703 +INS1 16333 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 21558470 +INS1 16333 Necrosis MESH:D009336 therapeutic 9826672 +INS1 16333 Reflex, Abnormal MESH:D012021 therapeutic 3525850 +INS1 16333 Seizures MESH:D012640 marker/mechanism 3084764|3928877|6797439 +INS1 16333 Ventricular Dysfunction, Left MESH:D018487 therapeutic 29682576 +INS1 16333 Weight Loss MESH:D015431 therapeutic 29682576|34352274 +INS2 16334 Albuminuria MESH:D000419 marker/mechanism 29420703 +INS2 16334 Diabetes Mellitus MESH:D003920 marker/mechanism 19775285 +INS2 16334 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 17151334|29420703 +INS2 16334 Diabetic Retinopathy MESH:D003930 marker/mechanism 30463601 +INS2 16334 Hyperglycemia MESH:D006943 marker/mechanism 18056790|29211853 +INS2 16334 Hypertension MESH:D006973 marker/mechanism 29211853 +INS2 16334 Kidney Diseases MESH:D007674 marker/mechanism 29211853 +INS2 16334 Weight Loss MESH:D015431 marker/mechanism 29211853 +INSIG1 3638 Carcinoma MESH:D002277 marker/mechanism 12376462 +INSIG1 3638 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +INSIG1 3638 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +INSIG2 51141 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +INSIG2 51141 Weight Gain MESH:D015430 marker/mechanism 18195716|20373477 +INS-IGF2 723961 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +INSL3 3640 Cryptorchidism MESH:D003456 marker/mechanism 219050 14687758|16102138 +INSM1 3642 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 23582323 +INSR 3643 Alzheimer Disease MESH:D000544 marker/mechanism 24055495 +INSR 3643 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +INSR 3643 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22138235|9243097 +INSR 3643 Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans MESH:C562710 marker/mechanism 610549 +INSR 3643 Diabetic Neuropathies MESH:D003929 marker/mechanism 18331706 +INSR 3643 Donohue Syndrome MESH:D056731 marker/mechanism 246200|262190 18411068 +INSR 3643 Glucose Intolerance MESH:D018149 marker/mechanism 10949030 +INSR 3643 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 21433279 +INSR 3643 Hyperalgesia MESH:D006930 marker/mechanism 18331706 +INSR 3643 Hyperglycemia MESH:D006943 marker/mechanism 18056790 +INSR 3643 Hyperinsulinemic Hypoglycemia, Familial, 5 MESH:C566494 marker/mechanism 609968 +INSR 3643 Hyperinsulinism MESH:D006946 marker/mechanism 10949030|18411068 +INSR 3643 Insulin Resistance MESH:D007333 marker/mechanism 10949030|11887975 +INSR 3643 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +INSR 3643 Lung Diseases MESH:D008171 marker/mechanism 20438933|21433279 +INSR 3643 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +INSR 3643 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +INSRR 3645 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +INTS13 55726 Chloracne MESH:D054506 marker/mechanism 17101203 +INTS4 92105 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +INVS 27130 Nephronophthisis 2 MESH:C566582 marker/mechanism 602088.0 +IP6K2 51447 Huntington Disease MESH:D006816 marker/mechanism 21652713 +IPCEF1 26034 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +IPCEF1 26034 Leukemia, Lymphoid MESH:D007945 marker/mechanism 24292274 +IPO11 51194 Weight Gain MESH:D015430 marker/mechanism 19030233 +IPO4 79711 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +IPO4 79711 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +IPO5 3843 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +IPO5 3843 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +IPO7 10527 HIV Infections MESH:D015658 marker/mechanism 15308739 +IPP 3652 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +IPW 3653 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270.0 +IQCB1 9657 Senior-Loken Syndrome 5 MESH:C563763 marker/mechanism 609254.0 +IQCC 55721 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +IQCH 64799 Melanoma MESH:D008545 marker/mechanism 22535842 +IQCK 124152 Alzheimer Disease MESH:D000544 marker/mechanism 30820047 +IQGAP1 8826 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +IQGAP1 8826 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20977743 +IQGAP1 8826 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IQGAP1 8826 Weight Gain MESH:D015430 marker/mechanism 19030233 +IQGAP2 10788 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +IQGAP2 10788 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20977743 +IQGAP3 128239 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 28191889 +IQGAP3 128239 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +IQSEC1 9922 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +IQSEC2 23096 Epilepsy MESH:D004827 marker/mechanism 29942082 +IQSEC2 23096 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 20473311 +IQSEC2 23096 Mental Retardation, X-Linked 1 MESH:C567906 marker/mechanism 309530.0 26793055 +IQSEC2 23096 Mental Retardation, X-Linked 78 MESH:C564489 marker/mechanism 26793055 +IQSEC2 23096 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +IRAK1 3654 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +IRAK1 3654 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +IRAK1 3654 Coronary Artery Disease MESH:D003324 marker/mechanism 20524934 +IRAK1 3654 Hypoxia-Ischemia, Brain MESH:D020925 marker/mechanism 21925238 +IRAK1 3654 Lentivirus Infections MESH:D016180 marker/mechanism 26937033 +IRAK1BP1 134728 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097067 +IRAK3 11213 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5 OMIM:611064 marker/mechanism 611064.0 +IRAK3 11213 Reperfusion Injury MESH:D015427 therapeutic 25780291 +IRAK4 51135 Disease Models, Animal MESH:D004195 marker/mechanism 28003376 +IRAK4 51135 Hypoxia-Ischemia, Brain MESH:D020925 marker/mechanism 21925238 +IRAK4 51135 IRAK4 Deficiency MESH:C564352 marker/mechanism 607676.0 +IRAK4 51135 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 28003376 +IRAK4 51135 Prostatic Neoplasms MESH:D011471 marker/mechanism 16537705 +IREB2 3658 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20390345 +IRF1 3659 Brain Injuries MESH:D001930 marker/mechanism 21549006 +IRF1 3659 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 +IRF1 3659 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +IRF1 3659 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 +IRF1 3659 Stroke MESH:D020521 marker/mechanism 12374626 +IRF2 3660 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22561517 +IRF2BP2 359948 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 25583766 +IRF2BPL 64207 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +IRF3 3661 Encephalitis, Herpes Simplex MESH:D020803 marker/mechanism 616532.0 +IRF3 3661 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 26861016 +IRF4 3662 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18758461 +IRF4 3662 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +IRF4 3662 Lung Neoplasms MESH:D008175 marker/mechanism 35915169 +IRF4 3662 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +IRF4 3662 Multiple Myeloma MESH:D009101 marker/mechanism 18568025 +IRF5 3663 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +IRF5 3663 Colitis, Ulcerative MESH:D003093 marker/mechanism 21297633 +IRF5 3663 Inflammatory Bowel Disease 14 MESH:C567383 marker/mechanism 612245.0 +IRF5 3663 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 612251.0 18204446|19838193 +IRF5 3663 Scleroderma, Systemic MESH:D012595 marker/mechanism 20383147 +IRF6 3664 Cleft Lip MESH:D002971 marker/mechanism 17041601|18836445|20436469 +IRF6 3664 Cleft Palate MESH:D002972 marker/mechanism 17041601 +IRF6 3664 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17041601 +IRF6 3664 Limb Deformities, Congenital MESH:D017880 marker/mechanism 17041601 +IRF6 3664 OROFACIAL CLEFT 6, SUSCEPTIBILITY TO OMIM:608864 marker/mechanism 608864.0 +IRF6 3664 Popliteal Pterygium Syndrome MESH:C562509 marker/mechanism 119500.0 +IRF6 3664 Skin Abnormalities MESH:D012868 marker/mechanism 17041601 +IRF6 3664 Van der Woude syndrome MESH:C536528 marker/mechanism 119300.0 16211254|16998136|18813858 +IRF7 3665 IMMUNODEFICIENCY 39 OMIM:616345 marker/mechanism 616345.0 +IRF7 3665 Inflammation MESH:D007249 marker/mechanism 20513754 +IRF7 3665 Influenza, Human MESH:D007251 marker/mechanism 23326326 +IRF8 3394 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +IRF8 3394 IMMUNODEFICIENCY 32A OMIM:614893 marker/mechanism 614893.0 +IRF8 3394 IMMUNODEFICIENCY 32B OMIM:226990 marker/mechanism 226990.0 21524210|27893462 +IRF8 3394 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IRF8 3394 Multiple Sclerosis MESH:D009103 marker/mechanism 19525953 +IRGM 345611 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799 +IRGM 345611 Crohn Disease MESH:D003424 marker/mechanism 17554261|18438406|19165925|21278745 +IRGM 345611 Inflammatory Bowel Disease 19 MESH:C567372 marker/mechanism 612278.0 +IRGM 345611 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 26192919 +IRGM 345611 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948.0 +IRS1 3667 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 1311924|23958494 +IRS1 3667 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23748240 +IRS1 3667 Coronary Artery Disease MESH:D003324 marker/mechanism 10591678 +IRS1 3667 Coronary Disease MESH:D003327 marker/mechanism 28869590 +IRS1 3667 Diabetes Mellitus MESH:D003920 marker/mechanism 10591678 +IRS1 3667 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22138235 +IRS1 3667 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 10430617|12679424|15688983|19734900|28869590|8104271|8723689 +IRS1 3667 Hyperinsulinism MESH:D006946 marker/mechanism 19734900 +IRS1 3667 Hyperlipidemias MESH:D006949 marker/mechanism 10591678 +IRS1 3667 Insulin Resistance MESH:D007333 marker/mechanism 19734900 +IRS1 3667 Obesity MESH:D009765 marker/mechanism 23954404 +IRS1 3667 Precancerous Conditions MESH:D011230 marker/mechanism 9466558 +IRS1 3667 Prostatic Neoplasms MESH:D011471 marker/mechanism 15678496 +IRS1 3667 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 30594912 +IRS2 8660 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16127164 +IRS2 8660 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 25808216 +IRS2 8660 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 +IRS2 8660 Hyperglycemia MESH:D006943 marker/mechanism 20028942|25808216 +IRS2 8660 Insulin Resistance MESH:D007333 marker/mechanism 25808216 +IRS2 8660 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +IRS2 8660 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +IRX1 79192 Lung Diseases MESH:D008171 marker/mechanism 21238641 +IRX2 153572 Lung Diseases MESH:D008171 marker/mechanism 21238641 +IRX3 79191 Lung Diseases MESH:D008171 marker/mechanism 21238641 +IRX4 50805 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +IRX4 50805 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +IRX5 10265 Anemia, hypochromic microcytic MESH:C536357 marker/mechanism 22581230 +IRX5 10265 Anodontia MESH:D000848 marker/mechanism 22581230 +IRX5 10265 Craniofacial Abnormalities MESH:D019465 marker/mechanism 22581230 +IRX5 10265 Fractures, Bone MESH:D050723 marker/mechanism 22581230 +IRX5 10265 Frontonasal dysplasia MESH:C538065 marker/mechanism 22581230 +IRX5 10265 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 22581230 +IRX5 10265 Heart Defects, Congenital MESH:D006330 marker/mechanism 22581230 +IRX5 10265 Hypertelorism, Severe, With Midface Prominence, Myopia, Mental Retardation, And Bone Fragility MESH:C566988 marker/mechanism 611174.0 +IRX5 10265 Lacrimal Apparatus Diseases MESH:D007766 marker/mechanism 22581230 +IRX5 10265 Lung Diseases MESH:D008171 marker/mechanism 21238641 +IRX5 10265 Myopia MESH:D009216 marker/mechanism 22581230 +ISCA2 122961 Multiple Mitochondrial Dysfunctions Syndrome MESH:C565304 marker/mechanism 616370.0 +ISCU 23479 Myopathy with Lactic Acidosis, Hereditary MESH:C564972 marker/mechanism 255125.0 +ISG15 9636 Carcinogenesis MESH:D063646 marker/mechanism 35506701 +ISG15 9636 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28919514 +ISG15 9636 Depressive Disorder, Major MESH:D003865 marker/mechanism 29175309 +ISG15 9636 Glioma MESH:D005910 marker/mechanism 35506701 +ISG15 9636 IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION OMIM:616126 marker/mechanism 616126.0 +ISG15 9636 Influenza, Human MESH:D007251 marker/mechanism 23326326 +ISG15 9636 Neoplasms, Experimental MESH:D009374 marker/mechanism 35506701 +ISG20 3669 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ISL1 3670 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 26332997 +ISL1 3670 Neuroblastoma MESH:D009447 marker/mechanism 30127528 +ISL1 3670 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26332997 +ISL2 64843 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +ISOC2 79763 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +ISX 91464 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 35687267 +ISYNA1 51477 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +ISYNA1 51477 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ISYNA1 51477 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ISYNA1 51477 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +ITCH 83737 AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM OMIM:613385 marker/mechanism 613385.0 +ITGA1 3672 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +ITGA1 3672 Gliosis MESH:D005911 marker/mechanism 12851778 +ITGA2 3673 Endometriosis MESH:D004715 marker/mechanism 20864642 +ITGA2 3673 Gliosis MESH:D005911 marker/mechanism 12851778 +ITGA2 3673 Hyperalgesia MESH:D006930 marker/mechanism 18234883 +ITGA2 3673 Retinal Vein Occlusion MESH:D012170 marker/mechanism 12928694 +ITGA2B 3674 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ITGA2B 3674 Carotid Artery Thrombosis MESH:D002341 marker/mechanism 1605806 +ITGA2B 3674 Cerebral Hemorrhage MESH:D002543 marker/mechanism 9445356 +ITGA2B 3674 Glanzmann Thrombasthenia, Autosomal Dominant MESH:C566061 marker/mechanism 187800.0 +ITGA2B 3674 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ITGA2B 3674 Stroke MESH:D020521 marker/mechanism 9445356 +ITGA2B 3674 Thrombasthenia MESH:D013915 marker/mechanism 273800.0 +ITGA2B 3674 Thrombocytopenia MESH:D013921 marker/mechanism 15225244 +ITGA3 3675 EPIDERMOLYSIS BULLOSA, JUNCTIONAL 7, WITH INTERSTITIAL LUNG DISEASE AND NEPHROTIC SYNDROME OMIM:614748 marker/mechanism 614748.0 +ITGA4 3676 Autistic Disorder MESH:D001321 marker/mechanism 18348195 +ITGA4 3676 Gliosis MESH:D005911 marker/mechanism 12851778 +ITGA4 3676 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 28067908 +ITGA4 3676 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 21093051 +ITGA5 3678 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21401805 +ITGA5 3678 Gliosis MESH:D005911 marker/mechanism 12851778 +ITGA5 3678 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21224397 +ITGA5 3678 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +ITGA5 3678 Stomach Neoplasms MESH:D013274 marker/mechanism 17786296 +ITGA6 3655 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860 +ITGA7 3679 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +ITGA7 3679 Muscular Dystrophy, Congenital, Due To Integrin Alpha-7 Deficiency MESH:C567709 marker/mechanism 613204.0 +ITGA8 8516 Hereditary renal agenesis MESH:C536482 marker/mechanism 191830.0 +ITGA8 8516 Ovarian Neoplasms MESH:D010051 marker/mechanism 17303177 +ITGA8 8516 Stomach Neoplasms MESH:D013274 marker/mechanism 17786296 +ITGAL 3683 Behcet Syndrome MESH:D001528 marker/mechanism 8712863 +ITGAL 3683 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 28067908 +ITGAL 3683 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 16764927 +ITGAL 3683 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ITGAM 3684 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +ITGAM 3684 Hyperglycemia MESH:D006943 marker/mechanism 29035695 +ITGAM 3684 Hyperinsulinism MESH:D006946 marker/mechanism 29035695 +ITGAM 3684 Ileitis MESH:D007079 marker/mechanism 10647630 +ITGAM 3684 Insulin Resistance MESH:D007333 marker/mechanism 29035695 +ITGAM 3684 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 16764927 +ITGAM 3684 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 18204446|18204448 +ITGAM 3684 Lupus Vasculitis, Central Nervous System MESH:D020945 marker/mechanism 26773105 +ITGAM 3684 Nerve Degeneration MESH:D009410 therapeutic 32375810 +ITGAM 3684 Obesity MESH:D009765 marker/mechanism 29035695 +ITGAV 3685 Cerebral Hemorrhage MESH:D002543 marker/mechanism 9445356 +ITGAV 3685 Stroke MESH:D020521 marker/mechanism 9445356 +ITGAX 3687 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 16764927 +ITGB1 3688 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 25668593 +ITGB1 3688 Calcinosis MESH:D002114 marker/mechanism 18340010 +ITGB1 3688 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21478906 +ITGB1 3688 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21401805 +ITGB1 3688 Cardiomyopathies MESH:D009202 marker/mechanism 18340010 +ITGB1 3688 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 11884376 +ITGB1 3688 Endometriosis MESH:D004715 marker/mechanism 21063030 +ITGB1 3688 Gliosis MESH:D005911 marker/mechanism 12851778 +ITGB1 3688 Heart Failure MESH:D006333 marker/mechanism 11884376 +ITGB1 3688 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ITGB1 3688 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21224397 +ITGB1 3688 Neoplasm Metastasis MESH:D009362 marker/mechanism 23562787 +ITGB1BP1 9270 Bone Diseases, Developmental MESH:D001848 marker/mechanism 17567669 +ITGB1BP1 9270 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17567669 +ITGB2 3689 Behcet Syndrome MESH:D001528 marker/mechanism 8712863 +ITGB2 3689 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +ITGB2 3689 Calcinosis MESH:D002114 marker/mechanism 21335463 +ITGB2 3689 Chloracne MESH:D054506 marker/mechanism 17101203 +ITGB2 3689 Dermatitis MESH:D003872 marker/mechanism 9653089 +ITGB2 3689 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +ITGB2 3689 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +ITGB2 3689 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 16764927 +ITGB2 3689 Leukocyte-Adhesion Deficiency Syndrome MESH:D018370 marker/mechanism 9653089 +ITGB2 3689 Leukocyte adhesion deficiency type 1 MESH:C535887 marker/mechanism 116920.0 +ITGB2 3689 Leukocyte Disorders MESH:D007960 marker/mechanism 2880869|9653089 +ITGB2 3689 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ITGB2 3689 Nephrosis MESH:D009401 marker/mechanism 12845231 +ITGB2 3689 Pneumonia MESH:D011014 marker/mechanism 21625544 +ITGB2 3689 Skin Ulcer MESH:D012883 marker/mechanism 9653089 +ITGB3 3690 Acute Coronary Syndrome MESH:D054058 marker/mechanism 15840736 +ITGB3 3690 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21254450 +ITGB3 3690 Autistic Disorder MESH:D001321 marker/mechanism 16721604|16724005|17203304 +ITGB3 3690 Carotid Artery Thrombosis MESH:D002341 marker/mechanism 1605806 +ITGB3 3690 Cerebral Hemorrhage MESH:D002543 marker/mechanism 9445356 +ITGB3 3690 Coronary Thrombosis MESH:D003328 marker/mechanism 8598867 +ITGB3 3690 Gliosis MESH:D005911 marker/mechanism 12851778 +ITGB3 3690 Hemorrhage MESH:D006470 marker/mechanism 16153930 +ITGB3 3690 Hip Fractures MESH:D006620 marker/mechanism 17264806 +ITGB3 3690 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ITGB3 3690 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 8598867 +ITGB3 3690 Prostatic Neoplasms MESH:D011471 marker/mechanism 16158739 +ITGB3 3690 Stroke MESH:D020521 marker/mechanism 9445356 +ITGB3 3690 Thrombasthenia MESH:D013915 marker/mechanism 1371279|1602006 +ITGB3 3690 Thrombocytopenia MESH:D013921 marker/mechanism 15225244 +ITGB3 3690 Thrombocytopenia, Neonatal Alloimmune MESH:D054098 marker/mechanism 2257303|7694683 +ITGB3BP 23421 Endometriosis MESH:D004715 marker/mechanism 22138541 +ITGB4 3691 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +ITGB4 3691 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +ITGB4 3691 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 27107458 +ITGB4 3691 Ectodermal Dysplasia MESH:D004476 marker/mechanism 18348258 +ITGB4 3691 Epidermolysis Bullosa MESH:D004820 marker/mechanism 18348258 +ITGB4 3691 Epidermolysis Bullosa, Junctional MESH:D016109 marker/mechanism 7545057 +ITGB4 3691 Epidermolysis bullosa with pyloric atresia MESH:C535377 marker/mechanism 226730.0 18348258|7545057 +ITGB4 3691 Gliosis MESH:D005911 marker/mechanism 12851778 +ITGB4 3691 Pyloric Atresia MESH:C562561 marker/mechanism 18348258|7545057 +ITGB4 3691 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +ITGB5 3693 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ITGB5 3693 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +ITGB6 3694 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +ITGB6 3694 AMELOGENESIS IMPERFECTA, TYPE IH OMIM:616221 marker/mechanism 616221.0 +ITGB6 3694 Autoimmune Diseases MESH:D001327 marker/mechanism 25055964 +ITGB6 3694 Cholangitis MESH:D002761 marker/mechanism 25055964 +ITGB6 3694 Hepatitis C, Chronic MESH:D019698 marker/mechanism 18221819 +ITGB6 3694 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 18221819 +ITGB6 3694 Liver Diseases MESH:D008107 marker/mechanism 18221819 +ITGB6 3694 Pulmonary Emphysema MESH:D011656 marker/mechanism 12634787 +ITGB8 3696 Endometriosis MESH:D004715 marker/mechanism 20864642 +ITGB8 3696 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 28067908 +ITGB8 3696 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +ITIH1 3697 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +ITIH1 3697 Liver Neoplasms MESH:D008113 marker/mechanism 17114358 +ITIH1 3697 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +ITIH3 3699 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +ITIH4 3700 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 25200834 +ITIH4 3700 Colonic Neoplasms MESH:D003110 marker/mechanism 25200834 +ITK 3702 Lymphoproliferative Syndrome, Ebv-Associated, Autosomal, 1 MESH:C567815 marker/mechanism 613011.0 +ITLN1 55600 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23555749 +ITLN1 55600 Mesothelioma MESH:D008654 marker/mechanism 15777968 +ITLN1 55600 Ventricular Dysfunction, Left MESH:D018487 therapeutic 23555749 +ITM2B 9445 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1 OMIM:176500 marker/mechanism 176500.0 +ITM2B 9445 Dementia, familial Danish MESH:C538209 marker/mechanism 117300.0 +ITM2B 9445 Hypertension MESH:D006973 marker/mechanism 22228705 +ITM2B 9445 RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES OMIM:616079 marker/mechanism 616079.0 +ITPA 3704 Anemia, Hemolytic MESH:D000743 therapeutic 20547162 +ITPA 3704 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35 OMIM:616647 marker/mechanism 616647.0 +ITPA 3704 Inosine Triphosphatase Deficiency MESH:C564127 marker/mechanism 613850.0 +ITPA 3704 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 12384777|20547162 +ITPA 3704 Recurrence MESH:D012008 marker/mechanism 23029095 +ITPA 3704 Thrombocytopenia MESH:D013921 marker/mechanism 18662289 +ITPK1 3705 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +ITPKC 80271 Coronary Aneurysm MESH:D003323 marker/mechanism 18084290 +ITPKC 80271 Mucocutaneous Lymph Node Syndrome MESH:D009080 marker/mechanism 18084290 +ITPR1 3708 Aniridia cerebellar ataxia mental deficiency MESH:C536370 marker/mechanism 206700.0 +ITPR1 3708 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +ITPR1 3708 Hypoxia, Brain MESH:D002534 marker/mechanism 17285299 +ITPR1 3708 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +ITPR1 3708 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +ITPR1 3708 Spinocerebellar Ataxia 15 MESH:C564685 marker/mechanism 606658.0 22986007 +ITPR1 3708 Spinocerebellar Ataxia 29 MESH:C537206 marker/mechanism 117360.0 22986007 +ITPR2 3709 ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS OMIM:106190 marker/mechanism 106190.0 +ITPR2 3709 Cardiomegaly MESH:D006332 marker/mechanism 20616315 +ITPR2 3709 Hypoxia, Brain MESH:D002534 marker/mechanism 17285299 +ITPR3 3710 Acrodermatitis MESH:D000169 marker/mechanism 27258892 +ITPR3 3710 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 37047547 +ITPR3 3710 Autistic Disorder MESH:D001321 marker/mechanism 33166615 +ITPR3 3710 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 222100.0 +ITPR3 3710 Disease Models, Animal MESH:D004195 marker/mechanism 37047547 +ITSN1 6453 Autistic Disorder MESH:D001321 marker/mechanism 35982159 +ITSN1 6453 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +ITSN2 50618 Breast Neoplasms MESH:D001943 marker/mechanism 18925433 +ITSN2 50618 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 18925433 +ITSN2 50618 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +ITSN2 50618 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097067 +IVD 3712 Acidemia, isovaleric MESH:C538167 marker/mechanism 243500.0 +IVD 3712 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IVL 3713 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18572023 +IVL 3713 Skin Neoplasms MESH:D012878 marker/mechanism 18572023 +IVNS1ABP 10625 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +IYD 389434 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +IYD 389434 Thyroid Dyshormonogenesis 4 MESH:C562770 marker/mechanism 274800.0 +JADE2 23338 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +JADE2 23338 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +JAG1 182 Alagille Syndrome MESH:D016738 marker/mechanism 118450.0 21532573|9207787|9207788 +JAG1 182 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +JAG1 182 Bone Diseases MESH:D001847 marker/mechanism 9207788 +JAG1 182 Breast Neoplasms MESH:D001943 marker/mechanism 21036696 +JAG1 182 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +JAG1 182 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +JAG1 182 Corneal Opacity MESH:D003318 marker/mechanism 12022040 +JAG1 182 Deafness MESH:D003638 marker/mechanism 12022040 +JAG1 182 Eye Abnormalities MESH:D005124 marker/mechanism 12022040|9207787|9207788 +JAG1 182 Facies MESH:D019066 marker/mechanism 9207787|9207788 +JAG1 182 Glioblastoma MESH:D005909 marker/mechanism 21127729 +JAG1 182 Heart Defects, Congenital MESH:D006330 marker/mechanism 12022040 +JAG1 182 Lung Neoplasms MESH:D008175 marker/mechanism 17804716 +JAG1 182 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +JAG1 182 Tetralogy of Fallot MESH:D013771 marker/mechanism 187500.0 11152664 +JAG2 3714 Breast Neoplasms MESH:D001943 marker/mechanism 21036696 +JAG2 3714 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +JAG2 3714 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9531541 +JAG2 3714 Glioblastoma MESH:D005909 marker/mechanism 21127729 +JAG2 3714 Lymphangioleiomyomatosis MESH:D018192 marker/mechanism 20038814 +JAG2 3714 Syndactyly MESH:D013576 marker/mechanism 9531541 +JAGN1 84522 Neutropenia MESH:D009503 marker/mechanism 25129144|25129145 +JAGN1 84522 NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE OMIM:616022 marker/mechanism 616022.0 +JAK1 3716 Lupus Nephritis MESH:D008181 marker/mechanism 31182691 +JAK1 3716 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +JAK2 3717 Abortion, Spontaneous MESH:D000022 marker/mechanism 17989398 +JAK2 3717 Budd-Chiari Syndrome MESH:D006502 marker/mechanism 600880.0 16762626|19293426 +JAK2 3717 Calcinosis MESH:D002114 marker/mechanism 21335463 +JAK2 3717 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 35568132 +JAK2 3717 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799|21297633 +JAK2 3717 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29047144 +JAK2 3717 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +JAK2 3717 Inflammation MESH:D007249 therapeutic 20943775 +JAK2 3717 Leukemia MESH:D007938 marker/mechanism 19636672 +JAK2 3717 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 16247455 +JAK2 3717 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +JAK2 3717 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 28100771 +JAK2 3717 Mesenteric Vascular Occlusion MESH:D008641 marker/mechanism 20434300 +JAK2 3717 Myeloproliferative Disorders MESH:D009196 marker/mechanism 22087750|29047144|35568132 +JAK2 3717 Myocardial Ischemia MESH:D017202 marker/mechanism 15746188|16214533 +JAK2 3717 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 28100771 +JAK2 3717 Polycythemia MESH:D011086 marker/mechanism 17267906 +JAK2 3717 Polycythemia, primary familial and congenital MESH:C536842 marker/mechanism 133100.0 +JAK2 3717 Polycythemia Vera MESH:D011087 marker/mechanism 263300.0 15781101|15793561|15858187|16484586|17267906|18717827|19154659|19287382|19287384|20160369|21942426 +JAK2 3717 Pregnancy Complications MESH:D011248 marker/mechanism 19636672 +JAK2 3717 Primary Myelofibrosis MESH:D055728 marker/mechanism 254450.0 15781101|15858187|16951397|19154659|19287382|19287384|19287385|19636672|21942426 +JAK2 3717 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +JAK2 3717 Thrombocythemia, Essential MESH:D013920 marker/mechanism 15781101|15858187|16484586|16896569|19154659|19636672|20434300|21942426 +JAK2 3717 Thrombocytosis MESH:D013922 marker/mechanism 614521.0 19287382|19287384 +JAK2 3717 Thromboembolism MESH:D013923 marker/mechanism 19636672 +JAK2 3717 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 36115647 +JAK2 3717 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 27470402 +JAK2 3717 Venous Thrombosis MESH:D020246 marker/mechanism 20434300 +JAK3 3718 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +JAK3 3718 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 23832011 +JAK3 3718 Lymphoma, B-Cell MESH:D016393 marker/mechanism 24837469 +JAK3 3718 Lymphoma, Extranodal NK-T-Cell MESH:D054391 marker/mechanism 22705984|23689514 +JAK3 3718 Mediastinal Neoplasms MESH:D008479 marker/mechanism 24837469 +JAK3 3718 Severe Combined Immunodeficiency MESH:D016511 marker/mechanism 15220007|15661026 +JAK3 3718 Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative MESH:C563440 marker/mechanism 600802.0 +JAKMIP1 152789 Autistic Disorder MESH:D001321 marker/mechanism 17519220 +JAKMIP2 9832 Melanoma MESH:D008545 marker/mechanism 22842228 +JAM2 58494 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +JAM3 83700 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +JAM3 83700 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS OMIM:613730 marker/mechanism 613730.0 +JARID2 3720 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21308764 +JARID2 3720 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +JAZF1 221895 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 18372903 +JAZF1 221895 Endometrial Neoplasms MESH:D016889 marker/mechanism 18264096 +JAZF1 221895 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838195 +JAZF1 221895 Prostatic Neoplasms MESH:D011471 marker/mechanism 18264096 +JCAD 57608 Coronary Artery Disease MESH:D003324 marker/mechanism 21378988 +JDP2 122953 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20214788 +JDP2 122953 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +JMJD1C 221037 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +JMJD1C 221037 Autistic Disorder MESH:D001321 marker/mechanism 17290275 +JMJD1C 221037 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +JMJD2C 100329036 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +JMJD6 23210 Breast Neoplasms MESH:D001943 marker/mechanism 30619488 +JMJD6 23210 Melanoma MESH:D008545 marker/mechanism 30619488 +JMJD6 23210 Melanoma, Cutaneous Malignant MESH:C562393 marker/mechanism 30619488 +JMJD6 23210 Mesothelioma MESH:D008654 marker/mechanism 30619488 +JMJD6 23210 Ovarian Neoplasms MESH:D010051 marker/mechanism 30619488 +JMJD6 23210 Prostatic Neoplasms MESH:D011471 marker/mechanism 30619488 +JMJD6 23210 Uveal melanoma MESH:C536494 marker/mechanism 30619488 +JPH1 56704 Charcot-Marie-Tooth disease, Type 2K MESH:C535418 marker/mechanism 607831.0 +JPH2 57158 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17 OMIM:613873 marker/mechanism 613873.0 +JPH3 57338 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +JPH3 57338 Huntington Disease-Like 2 MESH:C564708 marker/mechanism 606438.0 +JRK 8629 Epilepsy, Absence MESH:D004832 marker/mechanism 11463517 +JRK 8629 Epilepsy, Generalized MESH:D004829 marker/mechanism 11463517 +JRK 8629 Myoclonic Epilepsy, Juvenile MESH:D020190 marker/mechanism 11463517 +JSRP1 126306 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +JUN 3725 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +JUN 3725 Brain Injuries MESH:D001930 marker/mechanism 21549006 +JUN 3725 Brain Ischemia MESH:D002545 marker/mechanism 17901229 +JUN 3725 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +JUN 3725 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20214788 +JUN 3725 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21726611|8777434 +JUN 3725 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +JUN 3725 Colonic Neoplasms MESH:D003110 marker/mechanism 12628520|18283038 +JUN 3725 Heat Stroke MESH:D018883 marker/mechanism 24039931 +JUN 3725 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +JUN 3725 Hypertension MESH:D006973 marker/mechanism 24039778 +JUN 3725 Intestinal Polyps MESH:D007417 marker/mechanism 12584176 +JUN 3725 Liver Neoplasms MESH:D008113 marker/mechanism 12127263|24183702 +JUN 3725 Lung Neoplasms MESH:D008175 marker/mechanism 20716630 +JUN 3725 Mercury Poisoning, Nervous System MESH:D020262 marker/mechanism 15515958 +JUN 3725 Osteosarcoma MESH:D012516 marker/mechanism 18645001 +JUN 3725 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 17686523 +JUN 3725 Reperfusion Injury MESH:D015427 marker/mechanism 7922267 +JUN 3725 Silicosis MESH:D012829 marker/mechanism 27621875 +JUN 3725 Status Epilepticus MESH:D013226 marker/mechanism 7984056 +JUN 3725 Stomach Neoplasms MESH:D013274 marker/mechanism 17355264 +JUNB 3726 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 24366584 +JUNB 3726 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +JUNB 3726 Lung Neoplasms MESH:D008175 marker/mechanism 16289808|27935865 +JUNB 3726 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +JUNB 3726 Status Epilepticus MESH:D013226 marker/mechanism 7984056 +JUND 3727 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +JUND 3727 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 30515189 +JUND 3727 Cocaine-Related Disorders MESH:D019970 therapeutic 17898221 +JUND 3727 Glomerulonephritis MESH:D005921 marker/mechanism 18443593 +JUND 3727 Liver Cirrhosis MESH:D008103 marker/mechanism 17133482 +JUND 3727 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +JUND 3727 Status Epilepticus MESH:D013226 marker/mechanism 7984056 +JUP 3728 Arrhythmogenic Right Ventricular Dysplasia, Familial, 12 MESH:C566925 marker/mechanism 611528.0 +JUP 3728 Liver Diseases MESH:D008107 marker/mechanism 19784758 +JUP 3728 Naxos disease MESH:C538346 marker/mechanism 601214.0 +JUP 3728 No-Reflow Phenomenon MESH:D054318 therapeutic 16824628 +JUP 3728 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +JUS 43453 Paralysis MESH:D010243 marker/mechanism 14978727 +JUS 43453 Seizures MESH:D012640 marker/mechanism 14978727 +KANK1 23189 Cerebral Palsy, Spastic Quadriplegic, 2 MESH:C567867 marker/mechanism 612900.0 +KANK1 23189 Cholestasis MESH:D002779 marker/mechanism 27989131 +KANK1 23189 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +KANK2 25959 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +KANK2 25959 PALMOPLANTAR KERATODERMA AND WOOLLY HAIR OMIM:616099 marker/mechanism 616099.0 +KANSL1 284058 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +KANSL1 284058 Chromosome 17 deletion MESH:C538045 marker/mechanism 22544363|22544367 +KANSL1 284058 Chromosome 17q21.31 Deletion Syndrome MESH:C566476 marker/mechanism 610443.0 +KANSL1 284058 Craniofacial Abnormalities MESH:D019465 marker/mechanism 22544363|22544367 +KANSL1 284058 Intellectual Disability MESH:D008607 marker/mechanism 22544363|22544367 +KANSL1 284058 Leukemia, Megakaryoblastic, of Down Syndrome MESH:C566025 marker/mechanism 24056718 +KANSL1 284058 Muscle Hypotonia MESH:D009123 marker/mechanism 22544363|22544367 +KANSL1 284058 Ovarian Neoplasms MESH:D010051 marker/mechanism 31043753 +KANSL1-AS1 644246 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +KARS1 3735 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B OMIM:613641 marker/mechanism 613641.0 +KARS1 3735 DEAFNESS, AUTOSOMAL RECESSIVE 89 OMIM:613916 marker/mechanism 613916.0 +KAT5 10524 Mesothelioma, Malignant MESH:D000086002 therapeutic 26780987 +KAT6A 7994 ARBOLEDA-THAM SYNDROME OMIM:616268 marker/mechanism 616268.0 +KAT6A 7994 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +KAT6A 7994 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +KAT6A 7994 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +KAT6B 23522 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +KAT6B 23522 Genitopatellar Syndrome MESH:C565255 marker/mechanism 606170.0 +KAT6B 23522 Young Simpson syndrome MESH:C536717 marker/mechanism 603736.0 +KAT8 84148 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 27768893 +KAT8 84148 Heart Failure MESH:D006333 marker/mechanism 27768893 +KATNAL2 83473 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +KATNB1 10300 LISSENCEPHALY 6 WITH MICROCEPHALY OMIM:616212 marker/mechanism 616212.0 +KBTBD11 9920 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KBTBD13 390594 Nemaline myopathy 6 MESH:C538398 marker/mechanism 609273.0 +KCNA1 3736 Episodic Ataxia, Type 1 MESH:C563278 marker/mechanism 160120.0 +KCNA2 3737 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32 OMIM:616366 marker/mechanism 616366.0 +KCNA2 3737 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 15088113 +KCNA2 3737 Intellectual Disability MESH:D008607 marker/mechanism 25751627 +KCNA2 3737 Language Development Disorders MESH:D007805 marker/mechanism 25751627 +KCNA2 3737 Seizures MESH:D012640 marker/mechanism 25751627 +KCNA5 3741 Atrial Fibrillation MESH:D001281 marker/mechanism 19698954 +KCNA5 3741 Atrial Fibrillation, Familial, 7 MESH:C567389 marker/mechanism 612240.0 +KCNA5 3741 Hypertension, Pulmonary MESH:D006976 marker/mechanism 27522126 +KCNAB2 8514 Epilepsy MESH:D004827 marker/mechanism 11580756 +KCNB1 3745 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26 OMIM:616056 marker/mechanism 616056.0 +KCNB1 3745 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 15088113 +KCNB1 3745 Schizophrenia MESH:D012559 marker/mechanism 26240432 +KCNC1 3746 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 616187.0 25401298 +KCNC3 3748 Spinocerebellar ataxia 13 MESH:C537195 marker/mechanism 605259.0 +KCNC4 3749 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 20971086 +KCND2 3751 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 34418280 +KCND2 3751 Cholangiocarcinoma MESH:D018281 marker/mechanism 34418280 +KCND2 3751 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34418280 +KCND3 3752 Atrial Fibrillation MESH:D001281 marker/mechanism 28416822|29892015|30061737 +KCND3 3752 BRUGADA SYNDROME 9 OMIM:616399 marker/mechanism 616399.0 +KCND3 3752 Spinocerebellar ataxia 19 MESH:C537198 marker/mechanism 607346.0 +KCNE1 3753 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 16823764 +KCNE1 3753 Jervell And Lange-Nielsen Syndrome 2 MESH:C567343 marker/mechanism 612347.0 +KCNE1 3753 Jervell-Lange Nielsen Syndrome MESH:D029593 marker/mechanism 9354783 +KCNE1 3753 Long QT Syndrome MESH:D008133 marker/mechanism 14510655|18329740|9354802 +KCNE1 3753 Long Qt Syndrome 5 MESH:C566766 marker/mechanism 613695.0 +KCNE2 9992 Atrial Fibrillation MESH:D001281 marker/mechanism 15368194 +KCNE2 9992 Atrial Fibrillation, Familial, 4 MESH:C566244 marker/mechanism 611493.0 +KCNE2 9992 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +KCNE2 9992 Long QT Syndrome MESH:D008133 marker/mechanism 10219239|10984545|14510655 +KCNE2 9992 Long Qt Syndrome 6 MESH:C566333 marker/mechanism 613693.0 +KCNE2 9992 Ventricular Fibrillation MESH:D014693 marker/mechanism 10219239 +KCNE3 10008 Brugada Syndrome 6 MESH:C567735 marker/mechanism 613119.0 +KCNH1 3756 Breast Neoplasms MESH:D001943 marker/mechanism 17520698 +KCNH1 3756 Epilepsy MESH:D004827 marker/mechanism 25420144|29942082 +KCNH1 3756 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +KCNH1 3756 Osteosarcoma MESH:D012516 marker/mechanism 22248279 +KCNH1 3756 Temple-Baraitser Syndrome MESH:C567516 marker/mechanism 611816.0 25420144 +KCNH1 3756 Zimmerman Laband syndrome MESH:C536725 marker/mechanism 135500.0 25915598 +KCNH2 3757 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 14678746|15673388|18250272 +KCNH2 3757 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +KCNH2 3757 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24830940 +KCNH2 3757 Colonic Neoplasms MESH:D003110 marker/mechanism 16086867 +KCNH2 3757 Long QT Syndrome MESH:D008133 marker/mechanism 11741928|12070109|14510655|15043509|15213294|17467628|18329740|18848812|19057127|19583963|20211602|20513597|21650221|22396785|23103450|25107562|28768059|7889573|8635257 +KCNH2 3757 Long Qt Syndrome 2 MESH:C563614 marker/mechanism 613688.0 +KCNH2 3757 Muscular Atrophy MESH:D009133 marker/mechanism 16723379 +KCNH2 3757 Neoplasms MESH:D009369 marker/mechanism 24830940 +KCNH2 3757 Short QT Syndrome 1 MESH:C566506 marker/mechanism 609620.0 18724381|29574456 +KCNH2 3757 Torsades de Pointes MESH:D016171 marker/mechanism 15043509|15213294|20034863 +KCNJ1 3758 Bartter Syndrome MESH:D001477 marker/mechanism 10561751|12911542|22275899 +KCNJ1 3758 Bartter syndrome, antenatal , type 2 MESH:C537651 marker/mechanism 241200.0 +KCNJ1 3758 Hypertension MESH:D006973 marker/mechanism 22228705 +KCNJ10 3766 DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT OMIM:600791 marker/mechanism 600791.0 +KCNJ10 3766 Multiple Sclerosis MESH:D009103 marker/mechanism 24070676 +KCNJ10 3766 Pendred syndrome MESH:C536648 marker/mechanism 274600.0 +KCNJ10 3766 SeSAME syndrome MESH:C557674 marker/mechanism 612780.0 +KCNJ11 3767 Congenital Hyperinsulinism MESH:D044903 marker/mechanism 601820.0 15579781 +KCNJ11 3767 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +KCNJ11 3767 Diabetes Mellitus, Transient Neonatal, 3 MESH:C566432 marker/mechanism 610582.0 +KCNJ11 3767 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 18025464 +KCNJ11 3767 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 16123366|22209866 +KCNJ11 3767 Insulin Resistance MESH:D007333 marker/mechanism 9032110 +KCNJ11 3767 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13 OMIM:616329 marker/mechanism 616329.0 +KCNJ11 3767 Seizures MESH:D012640 marker/mechanism 18021373 +KCNJ12 3768 Disease Progression MESH:D018450 marker/mechanism 34755307 +KCNJ12 3768 Lymphatic Metastasis MESH:D008207 marker/mechanism 34755307 +KCNJ12 3768 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 34755307 +KCNJ13 3769 LEBER CONGENITAL AMAUROSIS 16 OMIM:614186 marker/mechanism 614186.0 +KCNJ13 3769 Snowflake vitreoretinal degeneration MESH:C536677 marker/mechanism 193230.0 +KCNJ15 3772 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +KCNJ18 100134444 THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2 OMIM:613239 marker/mechanism 613239.0 +KCNJ2 3759 Andersen Syndrome MESH:D050030 marker/mechanism 170390.0 17399643|19931173 +KCNJ2 3759 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 17399643|17546530 +KCNJ2 3759 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +KCNJ2 3759 ATRIAL FIBRILLATION, FAMILIAL, 9 OMIM:613980 marker/mechanism 613980.0 +KCNJ2 3759 Short QT Syndrome 3 MESH:C566504 marker/mechanism 609622.0 +KCNJ2 3759 Skin Diseases MESH:D012871 marker/mechanism 16835338 +KCNJ2 3759 Tachycardia, Ventricular MESH:D017180 marker/mechanism 17546530 +KCNJ4 3761 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 30512237 +KCNJ4 3761 Nerve Degeneration MESH:D009410 therapeutic 18619942 +KCNJ4 3761 Parkinson Disease MESH:D010300 therapeutic 18619942 +KCNJ5 3762 Adenoma MESH:D000236 marker/mechanism 23913001|23913004 +KCNJ5 3762 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +KCNJ5 3762 Heart Block MESH:D006327 therapeutic 26831068 +KCNJ5 3762 HYPERALDOSTERONISM, FAMILIAL, TYPE III OMIM:613677 marker/mechanism 613677.0 +KCNJ5 3762 LONG QT SYNDROME 13 OMIM:613485 marker/mechanism 613485.0 +KCNJ5 3762 Sick Sinus Syndrome MESH:D012804 therapeutic 26831068 +KCNJ6 3763 KEPPEN-LUBINSKY SYNDROME OMIM:614098 marker/mechanism 614098.0 +KCNJ6 3763 Nerve Degeneration MESH:D009410 marker/mechanism 15256069 +KCNJ8 3764 Cantu syndrome MESH:C535572 marker/mechanism 28842488 +KCNJ8 3764 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 19120683 +KCNJ8 3764 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +KCNJ8 3764 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +KCNJ8 3764 Ventricular Fibrillation MESH:D014693 marker/mechanism 19120683 +KCNK1 3775 Hyperplasia MESH:D006965 therapeutic 23291559 +KCNK16 83795 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22158537 +KCNK18 338567 MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 13 OMIM:613656 marker/mechanism 613656.0 +KCNK2 3776 Depressive Disorder MESH:D003866 marker/mechanism 21871532 +KCNK3 3777 Familial Primary Pulmonary Hypertension MESH:D065627 marker/mechanism 615344.0 +KCNK3 3777 Gliosis MESH:D005911 marker/mechanism 18671295 +KCNK3 3777 Hypertension, Pulmonary MESH:D006976 marker/mechanism 30365877 +KCNK3 3777 Stroke MESH:D020521 marker/mechanism 29531354 +KCNK5 8645 Status Epilepticus MESH:D013226 marker/mechanism 19220408 +KCNK9 51305 Birk-Barel Mental Retardation Dysmorphism Syndrome MESH:C567357 marker/mechanism 612292.0 +KCNK9 51305 Epilepsy, Absence MESH:D004832 marker/mechanism 15781965 +KCNMA1 3778 Autistic Disorder MESH:D001321 marker/mechanism 16946189 +KCNMA1 3778 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 21695131 +KCNMA1 3778 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +KCNMA1 3778 Generalized Epilepsy and Paroxysmal Dyskinesia MESH:C563719 marker/mechanism 609446.0 +KCNMA1 3778 Growth Disorders MESH:D006130 marker/mechanism 28242822 +KCNMA1 3778 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 15088113 +KCNMA1 3778 Hypertension, Pulmonary MESH:D006976 marker/mechanism 28090300 +KCNMA1 3778 Obesity MESH:D009765 marker/mechanism 27605626 +KCNMA1 3778 Obesity, Morbid MESH:D009767 marker/mechanism 21708048 +KCNMA1 3778 Perinatal Death MESH:D066087 marker/mechanism 28242822 +KCNMA1 3778 Status Epilepticus MESH:D013226 marker/mechanism 18695509 +KCNMA1 3778 Weight Gain MESH:D015430 marker/mechanism 27605626 +KCNMB1 3779 Hypertension MESH:D006973 marker/mechanism 17700361 +KCNMB1 3779 Hypertension, Diastolic, Resistance to MESH:C563897 marker/mechanism 608622.0 +KCNMB1 3779 Weight Gain MESH:D015430 marker/mechanism 27288421 +KCNN2 3781 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +KCNN2 3781 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KCNN3 3782 Atrial Fibrillation MESH:D001281 marker/mechanism 20173747|30061737 +KCNN4 3783 Xerocytosis, hereditary MESH:C536764 marker/mechanism 616689.0 +KCNQ1 3784 Adenocarcinoma MESH:D000230 marker/mechanism 23975432 +KCNQ1 3784 Atrial Fibrillation, Familial, 3 MESH:C563817 marker/mechanism 607554.0 +KCNQ1 3784 Beckwith-Wiedemann Syndrome MESH:D001506 marker/mechanism 130650.0 +KCNQ1 3784 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 18711366|18711367|26551672 +KCNQ1 3784 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 16823764 +KCNQ1 3784 Intestinal Neoplasms MESH:D007414 marker/mechanism 23975432 +KCNQ1 3784 Jervell-Lange Nielsen Syndrome MESH:D029593 marker/mechanism 220400.0 +KCNQ1 3784 Long QT Syndrome MESH:D008133 marker/mechanism 10868744|14510655|15028050|17467628|18329740|20513597|22910039 +KCNQ1 3784 Romano-Ward Syndrome MESH:D029597 marker/mechanism 192500.0 15004216 +KCNQ1 3784 Short QT Syndrome 2 MESH:C566505 marker/mechanism 609621.0 +KCNQ1OT1 10984 Beckwith-Wiedemann Syndrome MESH:D001506 marker/mechanism 130650.0 +KCNQ2 3785 Brain Diseases MESH:D001927 marker/mechanism 27602407 +KCNQ2 3785 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7 OMIM:613720 marker/mechanism 613720.0 +KCNQ2 3785 Developmental Disabilities MESH:D002658 marker/mechanism 20805988|27602407 +KCNQ2 3785 Epilepsy MESH:D004827 marker/mechanism 16464983|29942082 +KCNQ2 3785 Epilepsy, Benign Neonatal MESH:D020936 marker/mechanism 19380078|26910900 +KCNQ2 3785 Nervous System Diseases MESH:D009422 marker/mechanism 20805988 +KCNQ2 3785 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +KCNQ2 3785 Seizures MESH:D012640 marker/mechanism 27602407 +KCNQ2 3785 SEIZURES, BENIGN FAMILIAL NEONATAL, 1 OMIM:121200 marker/mechanism 121200.0 +KCNQ3 3786 SEIZURES, BENIGN FAMILIAL NEONATAL, 2 OMIM:121201 marker/mechanism 121201.0 +KCNQ4 9132 Deafness, Autosomal Dominant 2A MESH:C567441 marker/mechanism 600101.0 +KCNQ4 9132 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 16823764 +KCNQ5 56479 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 28189443 +KCNQ5 56479 Myopia MESH:D009216 marker/mechanism 23396134 +KCNT1 57582 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14 OMIM:614959 marker/mechanism 614959.0 +KCNT1 57582 Developmental Disabilities MESH:D002658 marker/mechanism 23086397 +KCNT1 57582 Epilepsies, Partial MESH:D004828 marker/mechanism 23086397 +KCNT1 57582 Epilepsy, Frontal Lobe MESH:D017034 marker/mechanism 23086396 +KCNT1 57582 EPILEPSY, NOCTURNAL FRONTAL LOBE, 5 OMIM:615005 marker/mechanism 615005.0 +KCNU1 157855 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +KCNV2 169522 Retinal Cone Dystrophy 3B MESH:C563678 marker/mechanism 610356.0 +KCTD1 284252 Scalp ear nipple syndrome MESH:C536623 marker/mechanism 181270.0 +KCTD15 79047 Obesity MESH:D009765 marker/mechanism 19079261 +KCTD17 79734 Myoclonic dystonia MESH:C536096 marker/mechanism 616398.0 +KCTD7 154881 EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS OMIM:611726 marker/mechanism 611726.0 +KDELR1 10945 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +KDF1 126695 ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE OMIM:617337 marker/mechanism 617337.0 +KDM1A 23028 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22493729 +KDM1A 23028 CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES OMIM:616728 marker/mechanism 616728.0 +KDM1A 23028 Clinical Deterioration MESH:D000075902 marker/mechanism 29438700 +KDM1A 23028 Colonic Neoplasms MESH:D003110 marker/mechanism 25043185 +KDM1A 23028 Critical Illness MESH:D016638 marker/mechanism 22493729 +KDM1A 23028 Disease Progression MESH:D018450 marker/mechanism 22493729 +KDM1A 23028 Hyperplasia MESH:D006965 marker/mechanism 22493729 +KDM1A 23028 Lymphoma, T-Cell MESH:D016399 marker/mechanism 29438700 +KDM1A 23028 Melanoma MESH:D008545 marker/mechanism 29438700 +KDM1A 23028 Melanoma, Experimental MESH:D008546 marker/mechanism 29438700 +KDM1A 23028 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22493729 +KDM1A 23028 Prostatic Neoplasms, Castration-Resistant MESH:D064129 marker/mechanism 29581250 +KDM1B 221656 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +KDM2A 22992 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +KDM2A 22992 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +KDM2B 84678 Schizophrenia MESH:D012559 marker/mechanism 21743468 +KDM3B 51780 Heavy Metal Poisoning MESH:D000075322 therapeutic 21262293 +KDM4A 9682 Melanoma MESH:D008545 marker/mechanism 29438700 +KDM4B 23030 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +KDM4B 23030 Melanoma MESH:D008545 marker/mechanism 29438700 +KDM4C 23081 Lymphoma, T-Cell MESH:D016399 marker/mechanism 29438700 +KDM4C 23081 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +KDM4C 23081 Melanoma MESH:D008545 marker/mechanism 29438700 +KDM4C 23081 Melanoma, Experimental MESH:D008546 marker/mechanism 29438700 +KDM5A 5927 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +KDM5B 10765 Colonic Neoplasms MESH:D003110 marker/mechanism 25043185 +KDM5C 8242 Autistic Disorder MESH:D001321 marker/mechanism 18203167 +KDM5C 8242 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +KDM5C 8242 Intellectual Disability MESH:D008607 marker/mechanism 21076407 +KDM5C 8242 Mental Retardation, X-Linked, Syndromic, Jarid1c-Related MESH:C564494 marker/mechanism 300534 +KDM5D 8284 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000 +KDM6A 7403 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +KDM6A 7403 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 21822268 +KDM6A 7403 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +KDM6A 7403 Kabuki syndrome MESH:C537705 marker/mechanism 147920|300867 +KDM6A 7403 Neoplasms MESH:D009369 marker/mechanism 19330029 +KDM6A 7403 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +KDM6A 7403 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21822268 +KDM6B 23135 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +KDM6B 23135 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +KDM8 79831 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KDR 3791 Adenocarcinoma MESH:D000230 marker/mechanism 21472143 +KDR 3791 Breast Neoplasms MESH:D001943 marker/mechanism 20135347|35917945 +KDR 3791 Cerebral Hemorrhage MESH:D002543 marker/mechanism 17888890 +KDR 3791 Colorectal Neoplasms MESH:D015179 marker/mechanism|therapeutic 20346928|35917945 +KDR 3791 Diabetic Nephropathies MESH:D003928 marker/mechanism 18630688 +KDR 3791 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 17533168 +KDR 3791 Esophageal Neoplasms MESH:D004938 marker/mechanism 21472143|35917945 +KDR 3791 Eye Neoplasms MESH:D005134 marker/mechanism 35917945 +KDR 3791 Hemangioma, capillary infantile MESH:C535860 marker/mechanism 602089.0 +KDR 3791 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +KDR 3791 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11956651 +KDR 3791 Lung Neoplasms MESH:D008175 marker/mechanism 35917945 +KDR 3791 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +KDR 3791 Neovascularization, Pathologic MESH:D009389 marker/mechanism 17533168 +KDR 3791 Osteochondrodysplasias MESH:D010009 marker/mechanism 17954590 +KDR 3791 Ovarian Neoplasms MESH:D010051 marker/mechanism 35917945 +KDR 3791 Pancreatic Neoplasms MESH:D010190 therapeutic 12385004 +KDR 3791 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +KDR 3791 Schizophrenia MESH:D012559 marker/mechanism 21647420 +KDR 3791 Uremia MESH:D014511 marker/mechanism 19092814 +KDR 3791 Venous Thrombosis MESH:D020246 marker/mechanism 26600200 +KDSR 2531 Lymphoma, Follicular MESH:D008224 marker/mechanism 25526675 +KEAP1 9817 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22684020 +KEAP1 9817 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +KEAP1 9817 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 30026087 +KEAP1 9817 Disease Progression MESH:D018450 marker/mechanism 20124447 +KEAP1 9817 Gallbladder Neoplasms MESH:D005706 marker/mechanism 18692501 +KEAP1 9817 Gastrointestinal Diseases MESH:D005767 marker/mechanism 20404090 +KEAP1 9817 Hepatic Insufficiency MESH:D048550 marker/mechanism 30026087 +KEAP1 9817 Hepatitis MESH:D006505 marker/mechanism 20404090 +KEAP1 9817 Hepatomegaly MESH:D006529 marker/mechanism 30026087 +KEAP1 9817 Keratosis MESH:D007642 marker/mechanism 20404090 +KEAP1 9817 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 30026087 +KEAP1 9817 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052|29610475 +KERA 11081 Cornea Plana 2 MESH:C565677 marker/mechanism 217300.0 +KHDC3L 154288 Hydatidiform Mole MESH:D006828 marker/mechanism 614293.0 +KHDRBS2 202559 Melanoma MESH:D008545 marker/mechanism 21499247 +KHK 3795 Fructosuria MESH:C538068 marker/mechanism 229800.0 18035330|7833921 +KHSRP 8570 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +KIAA0586 9786 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15554946 +KIAA0586 9786 Polydactyly MESH:D017689 marker/mechanism 15554946 +KIAA0586 9786 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 616546.0 +KIAA0753 9851 OROFACIODIGITAL SYNDROME XV OMIM:617127 marker/mechanism 617127.0 +KIAA1462 420476 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +KIAA1549 57670 Astrocytoma MESH:D001254 marker/mechanism 23817572 +KICS2 144577 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +KIF11 3832 Aneuploidy MESH:D000782 marker/mechanism 17974955 +KIF11 3832 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIF11 3832 Chromosomal Instability MESH:D043171 marker/mechanism 17974955 +KIF11 3832 MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR IMPAIRED INTELLECTUAL DEVELOPMENT OMIM:152950 marker/mechanism 152950.0 +KIF11 3832 Neoplasms, Experimental MESH:D009374 marker/mechanism 17974955 +KIF14 9928 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIF15 56992 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIF15 56992 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +KIF17 57576 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +KIF18A 81930 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIF18B 146909 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIF18B 146909 Melanoma MESH:D008545 marker/mechanism 31617652 +KIF1A 547 Autistic Disorder MESH:D001321 marker/mechanism 30559488 +KIF1A 547 Developmental Disabilities MESH:D002658 marker/mechanism 30559488 +KIF1A 547 Diabetes Mellitus MESH:D003920 marker/mechanism 23776493 +KIF1A 547 NESCAV SYNDROME OMIM:614255 marker/mechanism 614255.0 +KIF1A 547 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA OMIM:201300 marker/mechanism 201300.0 +KIF1A 547 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC OMIM:614213 marker/mechanism 614213.0 +KIF1A 547 Spastic Paraplegia 30, Autosomal Recessive MESH:C563677 marker/mechanism 610357.0 +KIF1B 23095 Charcot-Marie-Tooth Disease, Axonal, Type 2a1 MESH:C566138 marker/mechanism 118210.0 +KIF1B 23095 Multiple Sclerosis MESH:D009103 marker/mechanism 18997785 +KIF1B 23095 Neuroblastoma MESH:D009447 marker/mechanism 256700.0 +KIF1C 10749 Ataxia, Spastic, 2, Autosomal Recessive MESH:C566969 marker/mechanism 611302.0 +KIF20A 10112 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIF21A 55605 Fibrosis of Extraocular Muscles, Congenital, 3B MESH:C567739 marker/mechanism 135700.0 +KIF21A 55605 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +KIF21B 23046 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799 +KIF23 9493 Anemia, Dyserythropoietic, Congenital MESH:D000742 marker/mechanism 105600.0 +KIF23 9493 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIF2A 3796 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3 OMIM:615411 marker/mechanism 615411.0 +KIF2A 3796 Malformations of Cortical Development MESH:D054220 marker/mechanism 23603762 +KIF2A 3796 Microcephaly MESH:D008831 marker/mechanism 23603762 +KIF2C 11004 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIF2C 11004 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +KIF3A 11127 Asthma MESH:D001249 marker/mechanism 21912604 +KIF3A 11127 Bone Diseases, Developmental MESH:D001848 marker/mechanism 17698054 +KIF3A 11127 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17698054 +KIF3A 11127 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +KIF3A 11127 Polydactyly MESH:D017689 marker/mechanism 17698054 +KIF3C 3797 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +KIF3C 3797 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +KIF4A 24137 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIF4A 24137 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 100 OMIM:300923 marker/mechanism 300923.0 +KIF5A 3798 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +KIF5A 3798 MYOCLONUS, INTRACTABLE, NEONATAL OMIM:617235 marker/mechanism 617235.0 +KIF5A 3798 Spastic paraplegia 10, autosomal dominant MESH:C537482 marker/mechanism 604187.0 +KIF5B 3799 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21757253 +KIF5B 3799 Diabetes Mellitus MESH:D003920 marker/mechanism 23776493 +KIF5C 3800 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2 OMIM:615282 marker/mechanism 615282.0 +KIF5C 3800 Malformations of Cortical Development MESH:D054220 marker/mechanism 23603762 +KIF5C 3800 Microcephaly MESH:D008831 marker/mechanism 23603762 +KIF6 221458 Myocardial Infarction MESH:D009203 marker/mechanism 21943003 +KIF7 374654 Acrocallosal Syndrome MESH:D055673 marker/mechanism 200990.0 21552264 +KIF7 374654 Cleft Palate MESH:D002972 marker/mechanism 21552264 +KIF7 374654 Hydrolethalus syndrome MESH:C536079 marker/mechanism 21552264 +KIF7 374654 Hydrolethalus Syndrome 1 MESH:C565504 marker/mechanism 614120.0 +KIF7 374654 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +KIF7 374654 Macrocephaly with Multiple Epiphyseal Dysplasia and Distinctive Facies MESH:C564621 marker/mechanism 607131.0 +KIFBP 26128 Goldberg-Shprintzen megacolon syndrome MESH:C537279 marker/mechanism 609460.0 15883926 +KIFBP 26128 Intellectual Disability MESH:D008607 marker/mechanism 15883926 +KIFBP 26128 Malformations of Cortical Development MESH:D054220 marker/mechanism 15883926 +KIFBP 26128 Microcephaly MESH:D008831 marker/mechanism 15883926 +KIFC1 3833 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +KIFC1 3833 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +KIFC1 3833 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 26177331 +KIR3DL1 3811 HIV Infections MESH:D015658 marker/mechanism 609423.0 17496894 +KISS1 3814 HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA OMIM:614842 marker/mechanism 614842.0 +KISS1 3814 Lymphatic Metastasis MESH:D008207 therapeutic 21383688 +KISS1 3814 Puberty, Delayed MESH:D011628 marker/mechanism 21527035 +KISS1 3814 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 therapeutic 21383688 +KISS1 3814 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +KISS1R 84634 HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA OMIM:614837 marker/mechanism 614837.0 +KISS1R 84634 Puberty, Delayed MESH:D011628 marker/mechanism 21527035 +KISS1R 84634 Puberty, Precocious MESH:D011629 marker/mechanism 176400.0 +KISS1R 84634 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +KIT 3815 Breast Neoplasms MESH:D001943 marker/mechanism 20941507 +KIT 3815 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 24688052 +KIT 3815 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 606764.0 16740725|20028860|27793025 +KIT 3815 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +KIT 3815 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 26285909 +KIT 3815 Lung Diseases MESH:D008171 marker/mechanism 21471107 +KIT 3815 Mastocytosis MESH:D008415 marker/mechanism 154800.0 +KIT 3815 Mastocytosis, Systemic MESH:D034721 marker/mechanism 16597595 +KIT 3815 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +KIT 3815 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 22277784 +KIT 3815 Neuroectodermal Tumors, Primitive, Peripheral MESH:D018241 marker/mechanism 15618851 +KIT 3815 Piebaldism MESH:D016116 marker/mechanism 172800.0 +KIT 3815 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 15499612 +KIT 3815 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 273300.0 +KITL 17311 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 12594235 +KITL 17311 Mastocytosis, Cutaneous MESH:D034701 marker/mechanism 20559008 +KITL 17311 Obesity MESH:D009765 marker/mechanism 23954404 +KITLG 4254 Carcinoma MESH:D002277 marker/mechanism 16316942 +KITLG 4254 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 24979617 +KITLG 4254 DEAFNESS, AUTOSOMAL DOMINANT 69 OMIM:616697 marker/mechanism 616697.0 +KITLG 4254 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 1720698 +KITLG 4254 HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE OMIM:145250 marker/mechanism 145250.0 +KITLG 4254 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +KITLG 4254 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +KITLG 4254 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +KITLG 4254 Nasal Polyps MESH:D009298 marker/mechanism 15813808 +KITLG 4254 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 19483681|19483682 +KITLG 4254 Testicular Neoplasms MESH:D013736 marker/mechanism 19483681|19483682 +KIZ 55857 RETINITIS PIGMENTOSA 69 OMIM:615780 marker/mechanism 615780.0 +KL 9365 Aging, Premature MESH:D019588 marker/mechanism 25550330|9363890 +KL 9365 Arteriosclerosis MESH:D001161 marker/mechanism 9363890 +KL 9365 Calcinosis MESH:D002114 marker/mechanism 17710231 +KL 9365 Coronary Artery Disease MESH:D003324 marker/mechanism 12669274 +KL 9365 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +KL 9365 Disease Models, Animal MESH:D004195 marker/mechanism 25550330 +KL 9365 Emphysema MESH:D004646 marker/mechanism 9363890 +KL 9365 Hypercalcemia MESH:D006934 marker/mechanism 17710231 +KL 9365 Hypercalcemia, Idiopathic, of Infancy MESH:C562581 marker/mechanism 20394945 +KL 9365 Hypercalciuria, childhood idiopathic MESH:C536082 marker/mechanism 20394945 +KL 9365 Hyperphosphatemia MESH:D054559 marker/mechanism 17710231 +KL 9365 Infertility MESH:D007246 marker/mechanism 9363890 +KL 9365 Kidney Diseases MESH:D007674 marker/mechanism 23665422 +KL 9365 Learning Disabilities MESH:D007859 marker/mechanism 25309793 +KL 9365 Memory Disorders MESH:D008569 marker/mechanism 25309793|25550330 +KL 9365 Osteoporosis MESH:D010024 marker/mechanism 9363890 +KL 9365 Skin Diseases MESH:D012871 marker/mechanism 9363890 +KLB 152831 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29289645 +KLC2 64837 Spastic Paraplegia, Optic Atrophy, and Neuropathy MESH:C563702 marker/mechanism 609541.0 +KLF1 10661 Anemia, Dyserythropoietic, Congenital MESH:D000742 marker/mechanism 613673.0 +KLF1 10661 Hematologic Diseases MESH:D006402 marker/mechanism 20676099 +KLF11 8462 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +KLF11 8462 Maturity-Onset Diabetes of the Young, Type 7 MESH:C566466 marker/mechanism 610508.0 +KLF12 11278 Schizophrenia MESH:D012559 marker/mechanism 21822266 +KLF12 11278 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +KLF13 51621 Chromosome 15q13.3 Microdeletion Syndrome MESH:C567439 marker/mechanism 612001.0 +KLF13 51621 Endometriosis MESH:D004715 marker/mechanism 21063030 +KLF13 51621 Myocardial Infarction MESH:D009203 marker/mechanism 29122578 +KLF14 136259 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 29632379 +KLF14 136259 Dyslipidemias MESH:D050171 marker/mechanism 29632379 +KLF14 136259 Insulin Resistance MESH:D007333 marker/mechanism 29632379 +KLF15 28999 Endomyocardial Fibrosis MESH:D004719 marker/mechanism 34310909 +KLF15 28999 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +KLF2 10365 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +KLF2 10365 Lung Diseases MESH:D008171 marker/mechanism 21053160 +KLF4 9314 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +KLF4 9314 Congenital Abnormalities MESH:D000013 marker/mechanism 20439457 +KLF4 9314 Heart Defects, Congenital MESH:D006330 marker/mechanism 20439457 +KLF4 9314 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +KLF4 9314 Thrombosis MESH:D013927 therapeutic 25339356 +KLF5 688 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +KLF5 688 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27158780 +KLF5 688 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +KLF5 688 Liver Cirrhosis MESH:D008103 marker/mechanism 33549628 +KLF5 688 Neointima MESH:D058426 marker/mechanism 16224062 +KLF5 688 Pancreatic Neoplasms MESH:D010190 marker/mechanism 26098869 +KLF5 688 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 30639269 +KLF5 688 Thyroid Neoplasms MESH:D013964 therapeutic 32173973 +KLF5 688 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 27514407 +KLF6 1316 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +KLF6 1316 Prostatic Neoplasms MESH:D011471 marker/mechanism 176807.0 +KLF6 1316 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 +KLF9 687 Body Weight MESH:D001835 marker/mechanism 22344221 +KLF9 687 Endometriosis MESH:D004715 marker/mechanism 21063030 +KLF9 687 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +KLF9 687 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +KLHDC10 23008 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +KLHDC7A 127707 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +KLHDC8B 200942 Hodgkin Disease MESH:D006689 marker/mechanism 236000.0 +KLHL10 317719 SPERMATOGENIC FAILURE 11 OMIM:615081 marker/mechanism 615081.0 +KLHL15 80311 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 103 OMIM:300982 marker/mechanism 300982.0 +KLHL24 54800 EPIDERMOLYSIS BULLOSA SIMPLEX 6, GENERALIZED INTERMEDIATE, WITH OR WITHOUT CARDIOMYOPATHY OMIM:617294 marker/mechanism 617294.0 +KLHL3 26249 Pseudohypoaldosteronism MESH:D011546 marker/mechanism 22406640 +KLHL3 26249 PSEUDOHYPOALDOSTERONISM, TYPE IID OMIM:614495 marker/mechanism 614495.0 +KLHL40 131377 NEMALINE MYOPATHY 8 OMIM:615348 marker/mechanism 615348.0 +KLHL41 10324 NEMALINE MYOPATHY 9 OMIM:615731 marker/mechanism 615731.0 +KLHL5 51088 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +KLHL6 89857 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +KLHL7 55975 Crisponi syndrome MESH:C536214 marker/mechanism 617055.0 +KLHL7 55975 Retinitis Pigmentosa 42 MESH:C567854 marker/mechanism 612943.0 +KLK1 3816 Acute Kidney Injury MESH:D058186 therapeutic 18227104 +KLK1 3816 Diabetic Cardiomyopathies MESH:D058065 therapeutic 16129698 +KLK1 3816 Diabetic Nephropathies MESH:D003928 therapeutic 19516248 +KLK1 3816 Fibrosis MESH:D005355 therapeutic 18227104 +KLK1 3816 Hypertension MESH:D006973 therapeutic 14568997 +KLK1 3816 Kallikrein, Decreased Urinary Activity of MESH:C563653 marker/mechanism 615953.0 +KLK1 3816 Myocardial Infarction MESH:D009203 therapeutic 12411458 +KLK10 5655 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +KLK10 5655 Breast Neoplasms MESH:D001943 marker/mechanism 16800735 +KLK10 5655 Ovarian Neoplasms MESH:D010051 marker/mechanism 20686372 +KLK10 5655 Stomach Neoplasms MESH:D013274 marker/mechanism 17182177 +KLK2 3817 Prostatic Neoplasms MESH:D011471 marker/mechanism 15643194|17085659 +KLK3 354 Disease Progression MESH:D018450 marker/mechanism 12644816 +KLK3 354 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 16984552 +KLK3 354 Phyllodes Tumor of the Prostate MESH:C549759 marker/mechanism 22360509 +KLK3 354 Prostatic Hyperplasia MESH:D011470 marker/mechanism 21128595 +KLK3 354 Prostatic Neoplasms MESH:D011471 marker/mechanism 12644816|15790600|16424004|16442593|16984552|17003774|17148459|18264097|18500220|18676866|27318894 +KLK4 9622 Amelogenesis imperfecta pigmented hypomaturation type MESH:C538242 marker/mechanism 204700.0 +KLK5 25818 Prostatic Neoplasms MESH:D011471 marker/mechanism 16517595 +KLKB1 3818 Carotid Artery Thrombosis MESH:D002341 marker/mechanism 25339356 +KLKB1 3818 Prekallikrein Deficiency MESH:C562725 marker/mechanism 612423.0 +KLKB1 3818 Pulmonary Embolism MESH:D011655 marker/mechanism 25339356 +KLKB1 3818 Thrombosis MESH:D013927 marker/mechanism 25339356 +KLKP1 606293 Prostatic Neoplasms MESH:D011471 marker/mechanism 16541416 +KLLN 100144748 COWDEN SYNDROME 4 OMIM:615107 marker/mechanism 615107.0 +KLRB1 3820 Melanoma MESH:D008545 marker/mechanism 17295095 +KLRC2 3822 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +KLRC4 8302 Behcet Syndrome MESH:D001528 marker/mechanism 23291587 +KLRC4 8302 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18006695 +KLRK1 22914 Melanoma MESH:D008545 marker/mechanism 17295095 +KMO 8564 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +KMO 8564 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +KMT2A 4297 Acute erythroleukemia MESH:C535673 marker/mechanism 30926971 +KMT2A 4297 Adenocarcinoma MESH:D000230 marker/mechanism 22484628 +KMT2A 4297 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22634756 +KMT2A 4297 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 21822268 +KMT2A 4297 Chromosome Aberrations MESH:D002869 marker/mechanism 24736461 +KMT2A 4297 Leukemia MESH:D007938 marker/mechanism 11731795|12937054 +KMT2A 4297 Leukemia, Lymphoid MESH:D007945 marker/mechanism 17463288 +KMT2A 4297 Leukemia, Monocytic, Acute MESH:D007948 marker/mechanism 8282816 +KMT2A 4297 Leukemia, Myeloid MESH:D007951 marker/mechanism 17463288|8282816 +KMT2A 4297 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 10339604|26237430 +KMT2A 4297 Leukemia, Myelomonocytic, Acute MESH:D015479 marker/mechanism 8282816 +KMT2A 4297 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +KMT2A 4297 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 24736461|25730765 +KMT2A 4297 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +KMT2A 4297 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941188 +KMT2A 4297 Stomach Neoplasms MESH:D013274 marker/mechanism 22484628 +KMT2A 4297 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21822268 +KMT2A 4297 WIEDEMANN-STEINER SYNDROME OMIM:605130 marker/mechanism 605130.0 +KMT2B 9757 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22634754 +KMT2B 9757 Dystonia MESH:D004421 marker/mechanism 27992417 +KMT2B 9757 Dystonic Disorders MESH:D020821 marker/mechanism 617284.0 +KMT2C 58508 Adenocarcinoma MESH:D000230 marker/mechanism 22484628 +KMT2C 58508 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +KMT2C 58508 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22634756 +KMT2C 58508 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 21822268 +KMT2C 58508 Cholangiocarcinoma MESH:D018281 marker/mechanism 22561520 +KMT2C 58508 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +KMT2C 58508 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 24794707 +KMT2C 58508 Liver Diseases, Parasitic MESH:D008109 marker/mechanism 22561520 +KMT2C 58508 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +KMT2C 58508 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +KMT2C 58508 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +KMT2C 58508 Stomach Neoplasms MESH:D013274 marker/mechanism 22484628 +KMT2C 58508 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21822268 +KMT2D 8085 Breast Neoplasms MESH:D001943 marker/mechanism 26437033 +KMT2D 8085 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +KMT2D 8085 Infertility, Male MESH:D007248 marker/mechanism 19348672 +KMT2D 8085 Kabuki syndrome MESH:C537705 marker/mechanism 147920.0 20711175 +KMT2D 8085 Lymphoma, Follicular MESH:D008224 marker/mechanism 24362818 +KMT2D 8085 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21804550 +KMT2D 8085 Lymphoma, T-Cell MESH:D016399 marker/mechanism 26192917 +KMT2D 8085 Phyllodes Tumor MESH:D003557 marker/mechanism 26437033 +KMT2D 8085 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +KMT2D 8085 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +KMT2D 8085 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121791 +KMT2E 55904 Leukemia MESH:D007938 marker/mechanism 18818388 +KMT2E 55904 Leukemia, Myeloid MESH:D007951 marker/mechanism 18854576 +KMT2E 55904 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +KMT5B 51111 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +KNG1 3827 Acquired angioedema MESH:C538173 marker/mechanism 9734886 +KNG1 3827 Acute Kidney Injury MESH:D058186 therapeutic 3015452|513486 +KNG1 3827 Anaphylaxis MESH:D000707 marker/mechanism 7623993 +KNG1 3827 Angioedemas, Hereditary MESH:D054179 marker/mechanism 9734886 +KNG1 3827 Arrhythmias, Cardiac MESH:D001145 therapeutic 2535056 +KNG1 3827 Bradycardia MESH:D001919 marker/mechanism 1281941 +KNG1 3827 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20362651|30685357 +KNG1 3827 Cough MESH:D003371 marker/mechanism 22693178 +KNG1 3827 Dermatitis, Occupational MESH:D009783 marker/mechanism 30685357 +KNG1 3827 Disease Models, Animal MESH:D004195 marker/mechanism 30685357 +KNG1 3827 Drug Eruptions MESH:D003875 marker/mechanism|therapeutic 1371395|3034372 +KNG1 3827 Edema MESH:D004487 marker/mechanism 9719496 +KNG1 3827 Extravasation of Diagnostic and Therapeutic Materials MESH:D005119 marker/mechanism 9622145 +KNG1 3827 Flaujeac factor deficiency MESH:C537060 marker/mechanism 228960.0 +KNG1 3827 Hyperalgesia MESH:D006930 marker/mechanism 10401557|10499367|10543429|15626726|16259764|16793879|18234883|2010815|2128375|21521205|3061568|7493622|7582491|7881729|9714424|9720808 +KNG1 3827 Hyperemia MESH:D006940 marker/mechanism 11837250 +KNG1 3827 Hyperesthesia MESH:D006941 marker/mechanism 8190269 +KNG1 3827 Hypersensitivity MESH:D006967 marker/mechanism 11160071 +KNG1 3827 Hypertension MESH:D006973 marker/mechanism 7027322 +KNG1 3827 Hypotension MESH:D007022 marker/mechanism 10805402|1334354|14744816|16321614|18084312|21420289|2404862|6675575|9249246 +KNG1 3827 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 18054572 +KNG1 3827 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 22248470 +KNG1 3827 Myocardial Reperfusion Injury MESH:D015428 therapeutic 2535056|7856280 +KNG1 3827 Pain MESH:D010146 marker/mechanism 10445233|10543429|1281941|16076651|20018876|29655911|3951883 +KNG1 3827 Tachycardia MESH:D013610 marker/mechanism 7027322 +KNL1 57082 Microcephaly, Primary Autosomal Recessive, 4 MESH:C565792 marker/mechanism 604321.0 +KNL1 57082 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +KNSTRN 90417 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 25194279 +KNSTRN 90417 Roifman-Chitayat Syndrome MESH:C567641 marker/mechanism 613328.0 +KPNA1 3836 Schizophrenia MESH:D012559 marker/mechanism 21743468 +KPNA2 3838 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +KPNA2 3838 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +KPNB1 3837 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +KPNB1 3837 HIV Infections MESH:D015658 marker/mechanism 15308739 +KPTN 11133 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 41 OMIM:615637 marker/mechanism 615637.0 +KRAS 3845 Adenocarcinoma MESH:D000230 marker/mechanism 11745231|16247444|20101149 +KRAS 3845 Adenocarcinoma, Follicular MESH:D018263 marker/mechanism 27440272 +KRAS 3845 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 22071784|22135231|24045185|25184679|26463840|8143615|8425762 +KRAS 3845 Adenoma MESH:D000236 marker/mechanism 10545420|10813127|25851810|8761429 +KRAS 3845 Anemia MESH:D000740 marker/mechanism 27725143 +KRAS 3845 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +KRAS 3845 Astrocytoma MESH:D001254 marker/mechanism 23817572 +KRAS 3845 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +KRAS 3845 Carcinogenesis MESH:D063646 marker/mechanism 26595770|29247004 +KRAS 3845 Carcinoma MESH:D002277 marker/mechanism 10545420|20565773 +KRAS 3845 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 11286481|11563603 +KRAS 3845 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21336183|22617245|22787409|22887466|23435014|24688052|27588471 +KRAS 3845 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 25347530|30654191 +KRAS 3845 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 19435901|25125259 +KRAS 3845 Cardiofaciocutaneous syndrome MESH:C535579 marker/mechanism 615278.0 17703371 +KRAS 3845 Cecal Neoplasms MESH:D002430 marker/mechanism 14688030 +KRAS 3845 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 27510461 +KRAS 3845 Cholangiocarcinoma MESH:D018281 marker/mechanism 22561520|8968066 +KRAS 3845 Colonic Neoplasms MESH:D003110 marker/mechanism 10813127|12800193|12839936|17192441|18372904|19424582 +KRAS 3845 Colorectal Neoplasms MESH:D015179 marker/mechanism 20565773|21369707|25280562 +KRAS 3845 Costello Syndrome MESH:D056685 marker/mechanism 17468812|17703371 +KRAS 3845 Disease Models, Animal MESH:D004195 marker/mechanism 26390243|27588471|33380422 +KRAS 3845 Disease Progression MESH:D018450 marker/mechanism 30654191 +KRAS 3845 Endometriosis MESH:D004715 marker/mechanism 23284138 +KRAS 3845 Gallbladder Neoplasms MESH:D005706 marker/mechanism 24997986 +KRAS 3845 Hemangiosarcoma MESH:D006394 marker/mechanism 10930038|12211074|13678655|20737008 +KRAS 3845 Intracranial Arteriovenous Malformations MESH:D002538 marker/mechanism 108010.0 +KRAS 3845 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +KRAS 3845 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +KRAS 3845 Leukocytosis MESH:D007964 marker/mechanism 27725143 +KRAS 3845 Liver Diseases, Parasitic MESH:D008109 marker/mechanism 22561520 +KRAS 3845 Liver Neoplasms MESH:D008113 marker/mechanism 10629081|12211074 +KRAS 3845 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 8603461 +KRAS 3845 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 10223196|10545420|10874023|11641043|11745231|11884234|12376484|12725029|16247444|16271038|16289808|16410370|16823377|17233834|17290066|17325976|18062963|18758463|18927287|19336973|19424582|19555203|20101149|21519798|22028818|25851810|26390243|29247004|33380422|7614698|7750092|8508514|8597069|8761429 +KRAS 3845 Lymphoma MESH:D008223 marker/mechanism 9205081 +KRAS 3845 Mouth Neoplasms MESH:D009062 marker/mechanism 19435901 +KRAS 3845 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 27992414 +KRAS 3845 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +KRAS 3845 Neoplasm Metastasis MESH:D009362 marker/mechanism 8635384 +KRAS 3845 Neoplasms MESH:D009369 marker/mechanism 10673434|26595770 +KRAS 3845 Neoplasms, Experimental MESH:D009374 marker/mechanism 10813127|21311774|25851810|26390243|9205081 +KRAS 3845 Neuroblastoma MESH:D009447 marker/mechanism 26121086 +KRAS 3845 Nevus, Sebaceous of Jadassohn MESH:D054000 marker/mechanism 163200.0 22683711 +KRAS 3845 Noonan Syndrome MESH:D009634 marker/mechanism 17468812|17603482|17603483|17703371 +KRAS 3845 Noonan syndrome 3 MESH:C537847 marker/mechanism 609942.0 +KRAS 3845 Ovarian Neoplasms MESH:D010051 marker/mechanism 21372221 +KRAS 3845 Pancreatic Neoplasms MESH:D010190 marker/mechanism 260350.0 14520703|19424582|21699781|24694877|25961927|26390243 +KRAS 3845 Penile Neoplasms MESH:D010412 marker/mechanism 18355852 +KRAS 3845 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +KRAS 3845 Recurrence MESH:D012008 marker/mechanism 26121086 +KRAS 3845 Splenomegaly MESH:D013163 marker/mechanism 27725143 +KRAS 3845 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 10874023|11397402 +KRAS 3845 Thyroid Neoplasms MESH:D013964 marker/mechanism 3078959 +KRAS 3845 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 30654191 +KRAS 3845 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 109800.0 29644616 +KRAS 3845 Uterine Neoplasms MESH:D014594 marker/mechanism 17325976 +KRASP1 3844 Heart Failure MESH:D006333 marker/mechanism 36071497 +KREMEN1 83999 ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE OMIM:617392 marker/mechanism 617392.0 +KRIT1 889 Hemangioma, Cavernous, Central Nervous System MESH:D020786 marker/mechanism 116860.0 +KRT1 3848 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18572023 +KRT1 3848 Hyperkeratosis, Epidermolytic MESH:D017488 marker/mechanism 113800.0 +KRT1 3848 Ichthyosis hystrix, Curth Macklin type MESH:C536088 marker/mechanism 146590.0 +KRT1 3848 Keratosis MESH:D007642 marker/mechanism 35363433 +KRT1 3848 Keratosis palmoplantaris striata 3 MESH:C536163 marker/mechanism 607654.0 +KRT1 3848 Palmoplantar Keratoderma, Nonepidermolytic MESH:C563422 marker/mechanism 600962.0 +KRT1 3848 Skin Neoplasms MESH:D012878 marker/mechanism 18572023 +KRT10 3858 Arsenic Poisoning MESH:D020261 marker/mechanism 19953893 +KRT10 3858 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18572023 +KRT10 3858 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +KRT10 3858 Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis MESH:C564367 marker/mechanism 607602.0 +KRT10 3858 ICHTHYOSIS WITH CONFETTI OMIM:609165 marker/mechanism 609165.0 +KRT10 3858 Keratosis MESH:D007642 marker/mechanism 35363433 +KRT10 3858 Skin Neoplasms MESH:D012878 marker/mechanism 18572023 +KRT12 3859 Corneal Dystrophy, Juvenile Epithelial of Meesmann MESH:D053559 marker/mechanism 122100 +KRT13 3860 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +KRT13 3860 Leukokeratosis, Hereditary Mucosal MESH:D053529 marker/mechanism 615785 +KRT14 3861 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +KRT14 3861 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 16543248 +KRT14 3861 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22011395 +KRT14 3861 Dermatopathia pigmentosa reticularis MESH:C535374 marker/mechanism 125595 +KRT14 3861 Epidermolysis Bullosa Simplex MESH:D016110 marker/mechanism 131760|131800|131900 +KRT14 3861 Epidermolysis Bullosa Simplex, Autosomal Recessive MESH:C563408 marker/mechanism 601001 +KRT14 3861 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 16543248 +KRT14 3861 Naegeli syndrome MESH:C538331 marker/mechanism 161000 16960809 +KRT14 3861 Pigmentation Disorders MESH:D010859 marker/mechanism 16960809 +KRT14 3861 Tongue Neoplasms MESH:D014062 marker/mechanism 16543248 +KRT15 3866 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +KRT15 3866 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22011395 +KRT15 3866 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +KRT16 3868 Pachyonychia Congenita MESH:D053549 marker/mechanism 167200 +KRT16 3868 PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1 OMIM:613000 marker/mechanism 613000 +KRT16 3868 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 20186695 +KRT17 3872 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 20871598 +KRT17 3872 Chloracne MESH:D054506 marker/mechanism 21237254 +KRT17 3872 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +KRT17 3872 Pachyonychia Congenita MESH:D053549 marker/mechanism 167210 +KRT17 3872 Skin Neoplasms MESH:D012878 marker/mechanism 26168014 +KRT17 3872 Steatocystoma Multiplex MESH:D062685 marker/mechanism 184500 +KRT18 3875 Breast Neoplasms MESH:D001943 marker/mechanism 20061804|25330770 +KRT18 3875 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 19783637|33483742 +KRT18 3875 Cirrhosis, Familial MESH:C566123 marker/mechanism 215600 +KRT18 3875 Liver Cirrhosis MESH:D008103 therapeutic 20538000 +KRT18 3875 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15999547|17072980|18395095|25380136 +KRT18 3875 Liver Failure, Acute MESH:D017114 marker/mechanism 20538000 +KRT18 3875 Liver Neoplasms MESH:D008113 marker/mechanism 19409407|19796649 +KRT18 3875 Necrosis MESH:D009336 marker/mechanism 19783637 +KRT19 3880 Asthma MESH:D001249 marker/mechanism 15478392 +KRT19 3880 Autoimmune Diseases MESH:D001327 marker/mechanism 25055964 +KRT19 3880 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22011395 +KRT19 3880 Cholangitis MESH:D002761 marker/mechanism 25055964 +KRT19 3880 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +KRT19 3880 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +KRT19 3880 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +KRT19 3880 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +KRT19 3880 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +KRT2 3849 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +KRT2 3849 Ichthyosis Bullosa of Siemens MESH:D053560 marker/mechanism 146800.0 +KRT20 54474 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +KRT20 54474 Cecal Neoplasms MESH:D002430 marker/mechanism 14688030 +KRT20 54474 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +KRT25 147183 Woolly Hair, Autosomal Recessive MESH:C564735 marker/mechanism 616760.0 +KRT3 3850 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +KRT32 3882 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +KRT4 3851 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +KRT4 3851 Leukokeratosis, Hereditary Mucosal MESH:D053529 marker/mechanism 193900.0 +KRT5 3852 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +KRT5 3852 Carcinoma MESH:D002277 marker/mechanism 12376462 +KRT5 3852 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +KRT5 3852 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 19578363|20871598 +KRT5 3852 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22011395 +KRT5 3852 Dowling-Degos Disease MESH:C562924 marker/mechanism 179850.0 +KRT5 3852 Epidermolysis Bullosa Simplex MESH:D016110 marker/mechanism 131760.0 +KRT5 3852 Epidermolysis Bullosa Simplex with Migratory Circinate Erythema MESH:C563730 marker/mechanism 609352.0 +KRT5 3852 Epidermolysis bullosa simplex with mottled pigmentation MESH:C535959 marker/mechanism 131960.0 +KRT5 3852 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +KRT5 3852 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +KRT5 3852 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +KRT6 110309 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +KRT6 110309 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 20186695 +KRT6A 3853 Pachyonychia Congenita MESH:D053549 marker/mechanism 615726.0 +KRT6B 3854 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +KRT6B 3854 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +KRT6B 3854 Pachyonychia Congenita MESH:D053549 marker/mechanism 615728.0 +KRT6C 286887 PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE OMIM:615735 marker/mechanism 615735.0 +KRT7 3855 Adenoma, Oxyphilic MESH:D018249 marker/mechanism 16927643 +KRT7 3855 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329|16927643 +KRT7 3855 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +KRT7 3855 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +KRT7 3855 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 21681009 +KRT7 3855 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19921857 +KRT71 112802 Carcinoma MESH:D002277 marker/mechanism 16316942 +KRT71 112802 Hypotrichosis MESH:D007039 marker/mechanism 615896.0 +KRT71 112802 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +KRT71 112802 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +KRT73 319101 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +KRT74 121391 ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE OMIM:614929 marker/mechanism 614929.0 +KRT74 121391 Hypotrichosis MESH:D007039 marker/mechanism 613981.0 +KRT74 121391 WOOLLY HAIR, AUTOSOMAL DOMINANT OMIM:194300 marker/mechanism 194300.0 +KRT75 9119 pseudofolliculitis barbae MESH:C563016 marker/mechanism 612318.0 +KRT8 3856 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +KRT8 3856 Breast Neoplasms MESH:D001943 marker/mechanism 20061804 +KRT8 3856 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +KRT8 3856 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +KRT8 3856 Liver Cirrhosis MESH:D008103 therapeutic 20538000 +KRT8 3856 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +KRT8 3856 Liver Failure, Acute MESH:D017114 marker/mechanism 20538000 +KRT8 3856 Liver Neoplasms MESH:D008113 marker/mechanism 19409407|19796649 +KRT8 3856 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +KRT8 3856 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +KRT81 3887 Monilethrix MESH:D056734 marker/mechanism 158000.0 +KRT83 3889 Monilethrix MESH:D056734 marker/mechanism 158000.0 +KRT85 3891 ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE OMIM:602032 marker/mechanism 602032.0 +KRT86 3892 Monilethrix MESH:D056734 marker/mechanism 158000.0 +KRT9 3857 Keratoderma, Palmoplantar, Epidermolytic MESH:D053546 marker/mechanism 144200.0 +KRT90 239673 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +KSR2 283455 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +KSR2 283455 Obesity, Morbid MESH:D009767 marker/mechanism 29273807 +KST 38418 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +KTN1 3895 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +KY 339855 Myofibrillar Myopathy MESH:C580316 marker/mechanism 617114.0 +KYAT1 883 Carcinoma MESH:D002277 marker/mechanism 20663906 +KYAT1 883 Kidney Neoplasms MESH:D007680 marker/mechanism 20663906 +KYNU 8942 Hydroxykynureninuria MESH:C536081 marker/mechanism 236800.0 17334708 +KYNU 8942 Inflammation MESH:D007249 marker/mechanism 16365156 +KYNU 8942 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +KYNU 8942 Neurodegenerative Diseases MESH:D019636 marker/mechanism 16365156 +L1CAM 3897 Aphasia MESH:D001037 marker/mechanism 7920660 +L1CAM 3897 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 21097529 +L1CAM 3897 Corpus Callosum, Partial Agenesis of, X-Linked MESH:C564115 marker/mechanism 304100.0 +L1CAM 3897 Gait Disorders, Neurologic MESH:D020233 marker/mechanism 7920660 +L1CAM 3897 Hand Deformities, Congenital MESH:D006228 marker/mechanism 7920660 +L1CAM 3897 Hydrocephalus, X-linked MESH:C536078 marker/mechanism 307000.0 7920659|7920660 +L1CAM 3897 MASA (Mental Retardation, Aphasia, Shuffling Gait, Adducted Thumbs) Syndrome MESH:C536029 marker/mechanism 303350.0 7920659|7920660 +L2HGDH 79944 2-Hydroxyglutaricaciduria MESH:C535306 marker/mechanism 236792.0 15385440|15548604|21937992 +L2HGDH 79944 Epilepsy MESH:D004827 marker/mechanism 15385440 +L2HGDH 79944 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +L2HGDH 79944 Nervous System Malformations MESH:D009421 marker/mechanism 15385440 +L3HYPDH 112849 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +L3MBTL2 83746 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +L3MBTL3 84456 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +L3MBTL3 84456 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +LACTB 114294 Obesity MESH:D009765 marker/mechanism 18344982 +LAGE3 8270 Galloway Mowat syndrome MESH:C537548 marker/mechanism 28805828 +LAIR1 3903 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +LAMA1 284217 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 25668593 +LAMA1 284217 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +LAMA1 284217 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +LAMA1 284217 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615 +LAMA1 284217 Schizophrenia MESH:D012559 marker/mechanism 21743468 +LAMA2 3908 Muscular Dystrophies MESH:D009136 marker/mechanism 18074402|22906800 +LAMA2 3908 Muscular dystrophy congenital, merosin negative MESH:C537384 marker/mechanism 607855.0 +LAMA2 3908 Myopia MESH:D009216 marker/mechanism 23396134 +LAMA2 3908 Schizophrenia MESH:D012559 marker/mechanism 21822266|23042115 +LAMA2 3908 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +LAMA3 3909 Epidermolysis Bullosa, Junctional MESH:D016109 marker/mechanism 226700.0 12915477 +LAMA3 3909 Laryngo onycho cutaneous syndrome MESH:C537032 marker/mechanism 245660.0 12915477 +LAMA3 3909 Nail Diseases MESH:D009260 marker/mechanism 12915477 +LAMA3 3909 Skin Ulcer MESH:D012883 marker/mechanism 12915477 +LAMA3 3909 Wounds and Injuries MESH:D014947 therapeutic 15541073 +LAMA4 3910 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +LAMA4 3910 CARDIOMYOPATHY, DILATED, 1JJ OMIM:615235 marker/mechanism 615235.0 +LAMB1 3912 Autistic Disorder MESH:D001321 marker/mechanism 15523497 +LAMB1 3912 Colitis, Ulcerative MESH:D003093 marker/mechanism 19915572 +LAMB1 3912 Coloboma MESH:D003103 marker/mechanism 18809619 +LAMB1 3912 Endometriosis MESH:D004715 marker/mechanism 21063030 +LAMB1 3912 Lissencephaly MESH:D054082 marker/mechanism 615191.0 +LAMB1 3912 Pulmonary Fibrosis MESH:D011658 marker/mechanism 28444932 +LAMB2 3913 Cognition Disorders MESH:D003072 marker/mechanism 30226399 +LAMB2 3913 Mesangial sclerosis, diffuse MESH:C537346 marker/mechanism 15367484 +LAMB2 3913 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES OMIM:614199 marker/mechanism 614199.0 +LAMB2 3913 Pierson syndrome MESH:C537185 marker/mechanism 609049.0 15367484 +LAMB2 3913 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +LAMB3 3914 Amelogenesis imperfecta local hypoplastic form MESH:C538240 marker/mechanism 104530.0 +LAMB3 3914 Epidermolysis Bullosa, Junctional MESH:D016109 marker/mechanism 226700.0 +LAMB3 3914 Epidermolysis Bullosa, Junctional, Non-Herlitz Type MESH:C562639 marker/mechanism 226650.0 +LAMB3 3914 Wounds and Injuries MESH:D014947 therapeutic 15541073 +LAMC1 3915 Aortic Diseases MESH:D001018 marker/mechanism 25101153 +LAMC1 3915 Gliosis MESH:D005911 therapeutic 30476904 +LAMC1 3915 Marfan Syndrome MESH:D008382 marker/mechanism 25101153 +LAMC1 3915 Nerve Degeneration MESH:D009410 therapeutic 30476904 +LAMC1 3915 Neuromuscular Manifestations MESH:D020879 therapeutic 30476904 +LAMC1 3915 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +LAMC2 3918 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30381462 +LAMC2 3918 Disease Progression MESH:D018450 marker/mechanism 30381462 +LAMC2 3918 Epidermolysis Bullosa, Junctional MESH:D016109 marker/mechanism 226700.0 +LAMC2 3918 Epidermolysis Bullosa, Junctional, Non-Herlitz Type MESH:C562639 marker/mechanism 24550734 +LAMC2 3918 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +LAMC2 3918 Wounds and Injuries MESH:D014947 therapeutic 15541073 +LAMC3 10319 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21572417|28191889 +LAMC3 10319 Brain Diseases MESH:D001927 marker/mechanism 21572413 +LAMC3 10319 CORTICAL MALFORMATIONS, OCCIPITAL OMIM:614115 marker/mechanism 614115.0 +LAMC3 10319 Mouth Neoplasms MESH:D009062 marker/mechanism 27749845 +LAMP2 3920 Glycogen Storage Disease Type IIb MESH:D052120 marker/mechanism 300257.0 +LAMP2 3920 Status Epilepticus MESH:D013226 marker/mechanism 19272430 +LAMP3 27074 Influenza, Human MESH:D007251 marker/mechanism 23326326 +LAMTOR2 28956 Immunodeficiency due to Defect in MAPBP-Interacting Protein MESH:C563663 marker/mechanism 610798.0 +LAMTOR5 10542 Breast Neoplasms MESH:D001943 marker/mechanism 26229107 +LAMTOR5 10542 Glucose Intolerance MESH:D018149 therapeutic 29259128 +LAP3 51056 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +LAPTM5 7805 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +LAPTM5 7805 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LARGE1 9215 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +LARGE1 9215 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +LARGE1 9215 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6 OMIM:608840 marker/mechanism 608840 +LARGE1 9215 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 236670|613154 +LARGE1 9215 Weight Gain MESH:D015430 marker/mechanism 19030233 +LARP4 113251 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +LARP4B 23185 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +LARP7 51574 ALAZAMI SYNDROME OMIM:615071 marker/mechanism 615071.0 +LARP7 51574 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +LARS1 51520 INFANTILE LIVER FAILURE SYNDROME 1 OMIM:615438 marker/mechanism 615438.0 +LARS2 23395 HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA OMIM:617021 marker/mechanism 617021.0 +LAS1L 81887 Wilson-Turner X-linked mental retardation syndrome MESH:C536708 marker/mechanism 309585.0 +LASP1 3927 Autistic Disorder MESH:D001321 marker/mechanism 17376794 +LASP1 3927 Endometrial Neoplasms MESH:D016889 marker/mechanism 28232485 +LAT 27040 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +LAT 27040 Liver Diseases MESH:D008107 marker/mechanism 19784758 +LAT 27040 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +LAT2 7462 Disease Progression MESH:D018450 marker/mechanism 32587277 +LAT2 7462 Leukemia, Experimental MESH:D007942 marker/mechanism 32587277 +LAT2 7462 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32587277 +LATS1 9113 Astrocytoma MESH:D001254 marker/mechanism 17049657 +LATS1 9113 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +LATS1 9113 Neoplasms, Glandular and Epithelial MESH:D009375 marker/mechanism 21447609 +LATS2 26524 Astrocytoma MESH:D001254 marker/mechanism 17049657 +LBH 81606 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LBP 3929 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +LBP 3929 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +LBP 3929 Exanthema MESH:D005076 marker/mechanism 34142820 +LBP 3929 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +LBP 3929 Metabolic Syndrome MESH:D024821 marker/mechanism 23349936 +LBP 3929 Multiple Organ Failure MESH:D009102 marker/mechanism 22167001 +LBP 3929 Obesity MESH:D009765 marker/mechanism 23349936 +LBP 3929 Sepsis MESH:D018805 marker/mechanism 22167001 +LBP 3929 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +LBP 3929 Weight Gain MESH:D015430 marker/mechanism 19030233 +LBR 3930 GREENBERG DYSPLASIA OMIM:215140 marker/mechanism 215140 +LBR 3930 Pelger-Huet Anomaly MESH:D010381 marker/mechanism 169400 +LBR 3930 REYNOLDS SYNDROME OMIM:613471 marker/mechanism 613471 +LBX1 10660 Breast Neoplasms MESH:D001943 marker/mechanism 19651985 +LCA5 167691 Amaurosis congenita of Leber, type 5 MESH:C536602 marker/mechanism 604537 +LCA5 167691 Blindness MESH:D001766 marker/mechanism 17546029 +LCAT 3931 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +LCAT 3931 Lecithin Cholesterol Acyltransferase Deficiency MESH:D007863 marker/mechanism 136120|245900 +LCE2B 26239 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +LCE3B 353143 Psoriasis MESH:D011565 marker/mechanism 19169253 +LCE3C 353144 Psoriasis MESH:D011565 marker/mechanism 19169253 +LCE3D 84648 Psoriasis MESH:D011565 marker/mechanism 20953190|24212883 +LCK 3932 IMMUNODEFICIENCY 22 OMIM:615758 marker/mechanism 615758.0 +LCMT1 51451 Embryo Loss MESH:D020964 marker/mechanism 17724024 +LCN1 3933 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 28381600 +LCN2 3934 Acute Kidney Injury MESH:D058186 marker/mechanism 20623750|22005293|23052191|27888128|28885000 +LCN2 3934 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 7554268 +LCN2 3934 beta-Thalassemia MESH:D017086 marker/mechanism 16755567 +LCN2 3934 Calcinosis MESH:D002114 marker/mechanism 21335463 +LCN2 3934 Celiac Disease MESH:D002446 marker/mechanism 30097691 +LCN2 3934 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20362651|20623750 +LCN2 3934 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +LCN2 3934 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +LCN2 3934 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +LCN2 3934 Hepatitis, Animal MESH:D006520 marker/mechanism 18559427 +LCN2 3934 Inflammation MESH:D007249 marker/mechanism 20118187 +LCN2 3934 Kidney Diseases MESH:D007674 marker/mechanism 19349640|20181666|20438795|27026710 +LCN2 3934 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +LCN2 3934 Neoplasm Metastasis MESH:D009362 marker/mechanism 24570342 +LCN2 3934 Neoplasms MESH:D009369 therapeutic 17114340 +LCN2 3934 Renal Insufficiency, Chronic MESH:D051436 marker/mechanism 24714768 +LCN2 3934 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +LCORL 254251 Birth Weight MESH:D001724 marker/mechanism 23202124 +LCP1 3936 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LCP1 3936 Tobacco Use Disorder MESH:D014029 marker/mechanism 18438686 +LCP2 3937 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LCT 3938 Lactase Deficiency, Congenital MESH:C562600 marker/mechanism 223000.0 +LCT 3938 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +LCT-AS1 100507600 Hirschsprung Disease MESH:D006627 marker/mechanism 29429387 +LDAH 60526 Prostatic Neoplasms MESH:D011471 marker/mechanism 20676098 +LDB3 11155 Cardiomyopathy, Dilated, 1C MESH:C563307 marker/mechanism 601493.0 +LDB3 11155 Myofibrillar Myopathy MESH:C580316 marker/mechanism 609452.0 +LDHA 3939 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +LDHA 3939 Cardiomyopathies MESH:D009202 marker/mechanism 15231041 +LDHA 3939 Clinical Deterioration MESH:D000075902 marker/mechanism 29384525 +LDHA 3939 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +LDHA 3939 Lactate dehydrogenase deficiency type A MESH:C538133 marker/mechanism 612933.0 +LDHA 3939 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +LDHA 3939 Myocardial Infarction MESH:D009203 marker/mechanism 3279722 +LDHA 3939 Myoglobinuria MESH:D009212 marker/mechanism 21332213 +LDHA 3939 Pancreatic Neoplasms MESH:D010190 marker/mechanism 29384525 +LDHAL6B 92483 Breast Neoplasms MESH:D001943 marker/mechanism 20562527 +LDHB 3945 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +LDHB 3945 Breast Neoplasms MESH:D001943 marker/mechanism 23437403 +LDHB 3945 Carcinoma, Intraductal, Noninfiltrating MESH:D002285 marker/mechanism 23437403 +LDHB 3945 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +LDHB 3945 Lactate Dehydrogenase B Deficiency MESH:C563641 marker/mechanism 614128.0 +LDHB 3945 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LDHB 3945 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 2334429 +LDHB 3945 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +LDHB 3945 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973 +LDHC 3948 Infertility, Male MESH:D007248 marker/mechanism 21565994|23486916 +LDHC 3948 Lung Diseases MESH:D008171 marker/mechanism 21602193 +LDLR 3949 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +LDLR 3949 Atherosclerosis MESH:D050197 marker/mechanism|therapeutic 11947894|18450471|22153697|25619500|28899902|34717031|36108984 +LDLR 3949 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 36108984 +LDLR 3949 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990|27135400 +LDLR 3949 Coronary Disease MESH:D003327 marker/mechanism 9430375 +LDLR 3949 Dyslipidemias MESH:D050171 marker/mechanism 20530721|36108984 +LDLR 3949 Fatty Liver MESH:D005234 marker/mechanism 25554529|36108984 +LDLR 3949 Hypercholesterolemia MESH:D006937 marker/mechanism 18450471|20530721|22884763|26875785 +LDLR 3949 HYPERCHOLESTEROLEMIA, FAMILIAL, 1 OMIM:143890 marker/mechanism 143890.0 +LDLR 3949 Hyperlipidemias MESH:D006949 marker/mechanism 11947894|25619500 +LDLR 3949 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 10952765|11600564|12009418|12477733|12522687|12673584|9430375 +LDLR 3949 Hyperplasia MESH:D006965 marker/mechanism 9207284 +LDLR 3949 Liver Cirrhosis MESH:D008103 marker/mechanism 36108984 +LDLR 3949 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 20938947|23127599|23285030 +LDLR 3949 Obesity MESH:D009765 marker/mechanism 25554529 +LDLR 3949 Q Fever MESH:D011778 marker/mechanism 16469060 +LDLRAD3 143458 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +LDLRAP1 26119 Hypercholesterolemia, Autosomal Recessive MESH:C566331 marker/mechanism 603813.0 +LEC-10 179034 Death MESH:D003643 marker/mechanism 25204677 +LEC-10 179034 Infertility MESH:D007246 marker/mechanism 25204677 +LECT2 3950 Carcinoma, Lewis Lung MESH:D018827 therapeutic 30453282 +LECT2 3950 Lung Neoplasms MESH:D008175 therapeutic 30453282 +LECT2 3950 Neoplasm Metastasis MESH:D009362 therapeutic 30453282 +LECT2 3950 Neoplasms, Experimental MESH:D009374 therapeutic 30453282 +LEF1 51176 Breast Neoplasms MESH:D001943 marker/mechanism 27811057 +LEF1 51176 Colonic Neoplasms MESH:D003110 marker/mechanism 21188121 +LEF1 51176 Disease Models, Animal MESH:D004195 marker/mechanism 27811057 +LEF1 51176 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 23770605 +LEF1 51176 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27811057 +LEF1 51176 Neoplasm Metastasis MESH:D009362 marker/mechanism 27811057 +LEF1 51176 Sebaceous Gland Neoplasms MESH:D012626 marker/mechanism 16565724 +LEFTY2 7044 Abnormalities, Multiple MESH:D000015 marker/mechanism 10053005 +LEFTY2 7044 Heterotaxy Syndrome MESH:D059446 marker/mechanism 10053005 +LEMD2 221496 CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY OMIM:212500 marker/mechanism 212500.0 +LEMD3 23592 Buschke-Ollendorff syndrome MESH:C537415 marker/mechanism 166700.0 +LEP 3952 Alzheimer Disease MESH:D000544 therapeutic 20157255 +LEP 3952 Arthritis, Experimental MESH:D001169 marker/mechanism 15142272 +LEP 3952 Autistic Disorder MESH:D001321 marker/mechanism 17347881 +LEP 3952 Breast Neoplasms MESH:D001943 marker/mechanism 21353530|35191604 +LEP 3952 Colonic Neoplasms MESH:D003110 marker/mechanism 17354198 +LEP 3952 Crohn Disease MESH:D003424 marker/mechanism 21829567 +LEP 3952 Diabetes, Gestational MESH:D016640 marker/mechanism 20421132 +LEP 3952 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 28242381|31313498|31483951 +LEP 3952 Diabetes Mellitus, Type 2 MESH:D003924 therapeutic 15070752 +LEP 3952 Fatty Liver MESH:D005234 marker/mechanism 12661780|19716478|24525044|25554529|27071101|27712037 +LEP 3952 Glucose Intolerance MESH:D018149 marker/mechanism 21315688|24150608|29650965 +LEP 3952 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +LEP 3952 Hepatomegaly MESH:D006529 marker/mechanism 19716478|27071101 +LEP 3952 Heroin Dependence MESH:D006556 marker/mechanism 15717844 +LEP 3952 Hypercholesterolemia MESH:D006937 marker/mechanism 25086370 +LEP 3952 Hyperglycemia MESH:D006943 marker/mechanism 19716478|21561152|29650965|31313498|31483951 +LEP 3952 Hyperinsulinism MESH:D006946 marker/mechanism 9826672 +LEP 3952 Hyperphagia MESH:D006963 marker/mechanism|therapeutic 12177191|25086370|26186301|27071101 +LEP 3952 Hyperplasia MESH:D006965 marker/mechanism 27712037 +LEP 3952 Hypertension MESH:D006973 marker/mechanism 12050272|16827954|25205467|27226618 +LEP 3952 Hypogonadism MESH:D007006 marker/mechanism|therapeutic 15070752|9500540 +LEP 3952 Infertility, Female MESH:D007247 marker/mechanism 22265003 +LEP 3952 Inflammation MESH:D007249 marker/mechanism|therapeutic 14599722|27712037 +LEP 3952 Insulin Resistance MESH:D007333 marker/mechanism|therapeutic 10753628|11342529|24150608|29650965 +LEP 3952 LEPTIN DEFICIENCY OR DYSFUNCTION OMIM:614962 marker/mechanism 614962.0 +LEP 3952 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +LEP 3952 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 12586293|16097051|29248466 +LEP 3952 Metabolic Syndrome MESH:D024821 marker/mechanism 16793964|18515891 +LEP 3952 Nerve Degeneration MESH:D009410 therapeutic 17993459 +LEP 3952 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 24211274 +LEP 3952 Obesity MESH:D009765 marker/mechanism|therapeutic 17517446|18515891|19913045|20122948|24042701|25086370|25551525|25554529|26186301|27071101|28698385|31313498|9202122|9502777|9826672 +LEP 3952 Obesity, Morbid MESH:D009767 marker/mechanism|therapeutic 15070752|9500540 +LEP 3952 Oral Ulcer MESH:D019226 therapeutic 16391412 +LEP 3952 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 22381227 +LEP 3952 Polydipsia MESH:D059606 marker/mechanism 25086370 +LEP 3952 Polyuria MESH:D011141 marker/mechanism 25086370 +LEP 3952 Prostatic Neoplasms MESH:D011471 marker/mechanism 15042602 +LEP 3952 Proteinuria MESH:D011507 marker/mechanism 25205467 +LEP 3952 Seizures MESH:D012640 therapeutic 17993459 +LEP 3952 Stomach Ulcer MESH:D013276 therapeutic 10422768|11025360|11787760|15024038|16015682|18181030 +LEP 3952 Tachycardia MESH:D013610 marker/mechanism 16827954 +LEP 3952 Weight Gain MESH:D015430 marker/mechanism|therapeutic 15070752|15809509|17502770|19716478|21561152|25086370|27472835|29967158 +LEP 3952 Weight Loss MESH:D015431 marker/mechanism 27417254 +LEPR 3953 Albuminuria MESH:D000419 marker/mechanism 17065336|20175764|23159718|28130181|29988851 +LEPR 3953 Bone Diseases MESH:D001847 marker/mechanism 28130181 +LEPR 3953 Breast Neoplasms MESH:D001943 marker/mechanism 21353530 +LEPR 3953 Cardiomyopathies MESH:D009202 marker/mechanism 33345901 +LEPR 3953 Cognition Disorders MESH:D003072 marker/mechanism 35192202 +LEPR 3953 Diabetes, Gestational MESH:D016640 marker/mechanism 20421132 +LEPR 3953 Diabetes Mellitus MESH:D003920 marker/mechanism 15028607 +LEPR 3953 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 15093691|16427799|17065336|19452630|19478208|20567778|22933112|24263156|26939912|27151219|30635400|35472412|36066211 +LEPR 3953 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 20175764|22933112|24263156|26939912 +LEPR 3953 Diabetic Cardiomyopathies MESH:D058065 marker/mechanism 35235096 +LEPR 3953 Diabetic Nephropathies MESH:D003928 marker/mechanism 28130181|29988851|36066211 +LEPR 3953 Diabetic Neuropathies MESH:D003929 marker/mechanism 24263156 +LEPR 3953 Disease Models, Animal MESH:D004195 marker/mechanism 35235096 +LEPR 3953 Dyslipidemias MESH:D050171 marker/mechanism 20567778|29988851 +LEPR 3953 Fatty Liver MESH:D005234 marker/mechanism 25367288|29743445 +LEPR 3953 Fibrosis MESH:D005355 marker/mechanism 20567778|29988851|36066211 +LEPR 3953 Gliosis MESH:D005911 marker/mechanism 29191728 +LEPR 3953 Glucose Intolerance MESH:D018149 marker/mechanism 19452630|25367288|28611668|29988851 +LEPR 3953 Granulosa Cell Tumor MESH:D006106 marker/mechanism 28861689 +LEPR 3953 Hepatomegaly MESH:D006529 marker/mechanism 23038009|29743445|36880193 +LEPR 3953 Hyperalgesia MESH:D006930 marker/mechanism 29143802 +LEPR 3953 Hyperglycemia MESH:D006943 marker/mechanism 15093691|17065336|19682441|20567778|24384915|28130181|29143802|29743445|29988851|29991592|30635400|33345901|3519326|35235096|36066211|36880193 +LEPR 3953 Hyperinsulinism MESH:D006946 marker/mechanism 15093691|22949526|24384915|25222487|29988851|30689673|33345901|3519326 +LEPR 3953 Hyperlipidemias MESH:D006949 marker/mechanism 25222487|33345901 +LEPR 3953 Hyperphagia MESH:D006963 marker/mechanism 15093691|17229951|3519326 +LEPR 3953 Hypertension MESH:D006973 marker/mechanism 22949526 +LEPR 3953 Hypertension, Pulmonary MESH:D006976 marker/mechanism 30689673 +LEPR 3953 Hypertrophy, Right Ventricular MESH:D017380 marker/mechanism 30689673 +LEPR 3953 Hypogonadism MESH:D007006 marker/mechanism 17229951 +LEPR 3953 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 17229951 +LEPR 3953 Infertility MESH:D007246 marker/mechanism 15093691 +LEPR 3953 Infertility, Female MESH:D007247 marker/mechanism 22265003 +LEPR 3953 Insulin Resistance MESH:D007333 marker/mechanism 19452630|20567778|25367288|28611668|29988851|30689673 +LEPR 3953 Kidney Diseases MESH:D007674 marker/mechanism 20567778|33345901 +LEPR 3953 LEPTIN RECEPTOR DEFICIENCY OMIM:614963 marker/mechanism 614963.0 +LEPR 3953 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 17229951 +LEPR 3953 Nephritis MESH:D009393 marker/mechanism 29988851 +LEPR 3953 Obesity MESH:D009765 marker/mechanism 17065336|17229951|19913045|20567778|22276206|23563609|24263156|25222487|29743445|30689673|30993381|3519326|35235096|35472412 +LEPR 3953 Obesity, Morbid MESH:D009767 marker/mechanism 9537324 +LEPR 3953 Overweight MESH:D050177 marker/mechanism 23038009 +LEPR 3953 Pancreatic Diseases MESH:D010182 marker/mechanism 3519326 +LEPR 3953 Pituitary Diseases MESH:D010900 marker/mechanism 9537324 +LEPR 3953 Proteinuria MESH:D011507 marker/mechanism 36066211 +LEPR 3953 Puberty, Delayed MESH:D011628 marker/mechanism 17229951 +LEPR 3953 Renal Insufficiency MESH:D051437 marker/mechanism 29988851 +LEPR 3953 Respiratory Tract Infections MESH:D012141 marker/mechanism 17229951 +LEPR 3953 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 35235096 +LEPR 3953 Weight Gain MESH:D015430 marker/mechanism 15809509|29143802|29988851|36066211|36880193 +LETM1 3954 Carcinoma, Hepatocellular MESH:D006528 therapeutic 23392203 +LETM1 3954 Craniofacial Abnormalities MESH:D019465 marker/mechanism 14706454 +LETM1 3954 Intellectual Disability MESH:D008607 marker/mechanism 14706454 +LETM1 3954 Muscle Hypotonia MESH:D009123 marker/mechanism 14706454 +LETM1 3954 Seizures MESH:D012640 marker/mechanism 14706454 +LETM1 3954 Wolf-Hirschhorn Syndrome MESH:D054877 marker/mechanism 194190.0 14706454 +LFNG 3955 Spondylocostal dysostosis, autosomal recessive MESH:C535781 marker/mechanism 609813.0 +LGALS1 3956 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17094902 +LGALS1 3956 Keloid MESH:D007627 marker/mechanism 20128793 +LGALS1 3956 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +LGALS1 3956 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LGALS1 3956 Nephritis MESH:D009393 therapeutic 11044214 +LGALS13 29124 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +LGALS14 56891 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +LGALS14 56891 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +LGALS16 148003 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +LGALS2 3957 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +LGALS2 3957 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LGALS2 3957 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 15129282 +LGALS3 3958 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +LGALS3 3958 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 16322222 +LGALS3 3958 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22461450 +LGALS3 3958 Esophageal Neoplasms MESH:D004938 marker/mechanism 17634542 +LGALS3 3958 Fibrosis MESH:D005355 marker/mechanism 27870162 +LGALS3 3958 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16549783|25380136 +LGALS3 3958 Melanoma MESH:D008545 marker/mechanism 23994248 +LGALS3 3958 Myocardial Infarction MESH:D009203 marker/mechanism 29769800 +LGALS3 3958 Necrosis MESH:D009336 marker/mechanism 22461450 +LGALS3 3958 Neoplasm Metastasis MESH:D009362 marker/mechanism 25882088 +LGALS3 3958 Nephritis MESH:D009393 therapeutic 11044214 +LGALS3 3958 Osteoarthritis MESH:D010003 marker/mechanism 34894372 +LGALS3 3958 ST Elevation Myocardial Infarction MESH:D000072657 marker/mechanism 29769800 +LGALS3 3958 Stomach Neoplasms MESH:D013274 marker/mechanism 21750908 +LGALS3 3958 Vascular Diseases MESH:D014652 marker/mechanism 27870162 +LGALS3BP 3959 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +LGALS7 3963 Carcinoma MESH:D002277 marker/mechanism 16316942 +LGALS7 3963 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +LGALS7 3963 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +LGALS7 3963 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +LGALS7 3963 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +LGALS9 3965 Nephritis MESH:D009393 therapeutic 11044214 +LGALSL 29094 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LGI1 9211 EPILEPSY, FAMILIAL TEMPORAL LOBE, 1 OMIM:600512 marker/mechanism 600512.0 +LGI4 163175 ARTHROGRYPOSIS MULTIPLEX CONGENITA 1, NEUROGENIC, WITH MYELIN DEFECT OMIM:617468 marker/mechanism 617468.0 +LGMN 5641 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LGMN 5641 Orthomyxoviridae Infections MESH:D009976 marker/mechanism 22916010 +LGR4 55366 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17 OMIM:615311 marker/mechanism 615311.0 +LGR5 8549 Colonic Neoplasms MESH:D003110 marker/mechanism 21188121 +LGR5 8549 Colorectal Neoplasms MESH:D015179 marker/mechanism 25280562 +LGR6 59352 Breast Neoplasms MESH:D001943 marker/mechanism 18507500|23535733 +LGR6 59352 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 28945253 +LGR6 59352 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +LGR6 59352 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 32215045 +LHB 3972 Alcoholism MESH:D000437 marker/mechanism 8590623 +LHB 3972 Bradycardia MESH:D001919 therapeutic 6350720 +LHB 3972 Cocaine-Related Disorders MESH:D019970 marker/mechanism 12893845 +LHB 3972 Fertile eunuch syndrome MESH:C537919 marker/mechanism 228300.0 +LHB 3972 Hyperprolactinemia MESH:D006966 marker/mechanism 6770916 +LHB 3972 Hypertension MESH:D006973 marker/mechanism 6350720 +LHB 3972 Hypogonadism MESH:D007006 marker/mechanism|therapeutic 15602022|1727547|18449926|8263139 +LHB 3972 Hypothermia MESH:D007035 marker/mechanism 6350720 +LHB 3972 Infertility, Female MESH:D007247 marker/mechanism 9457942 +LHB 3972 Infertility, Male MESH:D007248 marker/mechanism 10739843|15602022|387166 +LHB 3972 Leydig Cell Tumor MESH:D007984 marker/mechanism 25289773 +LHB 3972 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 11889176|20378617 +LHB 3972 Puberty, Delayed MESH:D011628 marker/mechanism 15602022 +LHB 3972 Puberty, Precocious MESH:D011629 marker/mechanism 18345393 +LHB 3972 Tachycardia MESH:D013610 marker/mechanism 6350720 +LHB 3972 Tobacco Use Disorder MESH:D014029 marker/mechanism 12893845 +LHCGR 3973 Disorder of Sex Development, 46,XY MESH:D058490 marker/mechanism 19887492|7719343 +LHCGR 3973 Disorders of Sex Development MESH:D012734 marker/mechanism 22615892 +LHCGR 3973 Familial Testotoxicosis MESH:C536961 marker/mechanism 176410.0 16684832|18345393|19209621|26831561|7692306 +LHCGR 3973 Infertility, Male MESH:D007248 marker/mechanism 20164437 +LHCGR 3973 Leydig Cell Hypoplasia MESH:C562567 marker/mechanism 238320.0 7719343 +LHCGR 3973 Leydig Cell Tumor MESH:D007984 marker/mechanism 10580072|11857565 +LHFPL2 10184 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +LHFPL5 222662 Deafness, Autosomal Recessive 67 MESH:C565207 marker/mechanism 610265.0 30177809 +LHFPL6 10186 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LHX1 3975 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +LHX2 9355 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +LHX3 8022 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +LHX3 8022 Winkelman Bethge Pfeiffer syndrome MESH:C536710 marker/mechanism 221750.0 +LHX4 89884 Pituitary Hormone Deficiency, Combined, 4 MESH:C567492 marker/mechanism 262700.0 +LIAS 11019 HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES OMIM:614462 marker/mechanism 614462.0 +LIAS 11019 Pneumonia MESH:D011014 therapeutic 32017981 +LIAS 11019 Pulmonary Fibrosis MESH:D011658 therapeutic 32017981 +LIF 3976 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +LIF 3976 Cardiomegaly MESH:D006332 marker/mechanism 15226216 +LIF 3976 Embryo Loss MESH:D020964 marker/mechanism 23409146 +LIF 3976 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +LIF 3976 Infertility, Female MESH:D007247 marker/mechanism 23407384 +LIF 3976 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615 +LIF 3976 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +LIF 3976 Weight Loss MESH:D015431 marker/mechanism 23291613 +LIFR 3977 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +LIFR 3977 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +LIFR 3977 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +LIFR 3977 Stuve-Wiedemann syndrome MESH:C537502 marker/mechanism 601559.0 19603067 +LIG1 3978 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 8631603 +LIG4 3981 LIG4 Syndrome MESH:C564694 marker/mechanism 606593.0 +LIG4 3981 Multiple Myeloma MESH:D009101 marker/mechanism 254500.0 +LILRA4 23547 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18006695 +LILRA5 353514 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +LILRB5 10990 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +LIM2 3982 Cataract MESH:D002386 marker/mechanism 11917274 +LIM2 3982 CATARACT 19, MULTIPLE TYPES OMIM:615277 marker/mechanism 615277.0 +LIM2 3982 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +LIMCH1 22998 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +LIMCH1 22998 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +LIMD2 80774 Breast Neoplasms MESH:D001943 marker/mechanism 18925433 +LIMD2 80774 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 18925433 +LIMK2 3985 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LIMS2 55679 MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE OMIM:616827 marker/mechanism 616827.0 +LIN28A 79727 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 19483683 +LIN28A 79727 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26910839 +LIN28A 79727 Neoplasms MESH:D009369 marker/mechanism 19483683 +LIN28B 389421 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 19483683 +LIN28B 389421 Neoplasms MESH:D009369 marker/mechanism 19483683 +LIN28B 389421 Neuroblastoma MESH:D009447 marker/mechanism 22941191|23042116 +LIN7A 8825 Carcinoma MESH:D002277 marker/mechanism 12376462 +LIN7A 8825 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LIN7A 8825 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +LIN7A 8825 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +LINC00115 79854 Disease Progression MESH:D018450 marker/mechanism 34643030 +LINC00115 79854 Lung Neoplasms MESH:D008175 marker/mechanism 34643030 +LINC00115 79854 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34643030 +LINC00115 79854 Neoplasms, Experimental MESH:D009374 marker/mechanism 34643030 +LINC00221 338005 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +LINC00324 284029 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 34322788 +LINC00475 158314 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +LINC00477 144360 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +LINC00671 388387 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +LINC00673 100499467 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +LINC00673 100499467 Pancreatic Neoplasms MESH:D010190 marker/mechanism 27213290 +LINC00852 84657 Disease Progression MESH:D018450 marker/mechanism 35088190 +LINC00852 84657 Neoplasms, Experimental MESH:D009374 marker/mechanism 35088190 +LINC00852 84657 Stomach Neoplasms MESH:D013274 marker/mechanism 35088190 +LINC00880 339894 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 27322209 +LINC00908 284276 Birth Weight MESH:D001724 marker/mechanism 25982381 +LINC00908 284276 Fetal Growth Retardation MESH:D005317 marker/mechanism 25982381 +LINC00977 728724 Leukemia MESH:D007938 marker/mechanism 26752646 +LINC01089 338799 Disease Progression MESH:D018450 marker/mechanism 34561789 +LINC01089 338799 Lung Neoplasms MESH:D008175 marker/mechanism 34561789 +LINC01089 338799 Neoplasms, Experimental MESH:D009374 marker/mechanism 34561789 +LINC01091 285419 Stomach Neoplasms MESH:D013274 marker/mechanism 35674868 +LINC01142 284688 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +LINC01287 103724390 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 34254728 +LINC01426 100506385 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +LINC01588 283551 Myocardial Infarction MESH:D009203 therapeutic 35258167 +LINC01588 283551 Myocardial Reperfusion Injury MESH:D015428 therapeutic 35258167 +LINC01588 283551 Ventricular Dysfunction, Left MESH:D018487 therapeutic 35258167 +LINC03103 100507527 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +LINC-ROR 100885779 Liver Neoplasms MESH:D008113 therapeutic 36576707 +LINGO1 84894 Essential Tremor MESH:D020329 marker/mechanism 19182806 +LINGO2 158038 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +LINGO2 158038 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +LINS1 55180 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 27 OMIM:614340 marker/mechanism 614340.0 +LINS1 55180 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +LIPA 3988 Cholesterol Ester Storage Disease MESH:D015217 marker/mechanism 24295952 +LIPA 3988 Coronary Artery Disease MESH:D003324 marker/mechanism 21378988|34961328|35590109 +LIPA 3988 Fibrosis MESH:D005355 marker/mechanism 35679793 +LIPA 3988 Lysosomal acid lipase deficiency MESH:C531854 marker/mechanism 278000.0 +LIPA 3988 Niemann-Pick Disease, Type C MESH:D052556 therapeutic 20557099 +LIPC 3990 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 15126514|15656877 +LIPC 3990 HEPATIC LIPASE DEFICIENCY OMIM:614025 marker/mechanism 614025.0 +LIPC 3990 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12 OMIM:612797 marker/mechanism 612797.0 +LIPC 3990 Hyperemia MESH:D006940 marker/mechanism 16330034 +LIPC 3990 Hyperlipidemias MESH:D006949 marker/mechanism 1883393 +LIPC 3990 Hyperlipoproteinemias MESH:D006951 marker/mechanism 18160998 +LIPC 3990 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 16030523 +LIPC 3990 Insulin Resistance MESH:D007333 marker/mechanism 15504970 +LIPC 3990 Lipid Metabolism, Inborn Errors MESH:D008052 marker/mechanism 15292318|1671786|1883393 +LIPE 3991 Lipodystrophy, Familial Partial MESH:D052496 marker/mechanism 615980.0 +LIPH 200879 Hypotrichosis MESH:D007039 marker/mechanism 604379.0 23066499 +LIPH 200879 Woolly hair, congenital MESH:C536745 marker/mechanism 23066499 +LIPN 643418 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8 OMIM:613943 marker/mechanism 613943.0 +LIPT1 51601 LIPOYLTRANSFERASE 1 DEFICIENCY OMIM:616299 marker/mechanism 616299.0 +LITAF 9516 Charcot-Marie-Tooth disease, Type 1C MESH:C537984 marker/mechanism 601098.0 +LITAF 9516 Prostatic Neoplasms MESH:D011471 marker/mechanism 29845714 +LKB1 41673 Huntington Disease MESH:D006816 therapeutic 21909362 +LLGL1 3996 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +LLGL2 3993 Breast Neoplasms MESH:D001943 marker/mechanism 28114269 +LLGL2 3993 Neoplasm Metastasis MESH:D009362 marker/mechanism 28114269 +LMAN1 3998 FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1 OMIM:227300 marker/mechanism 227300.0 +LMAN2L 81562 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +LMAN2L 81562 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +LMAN2L 81562 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 52 OMIM:616887 marker/mechanism 616887.0 +LMBR1 64327 Absence of tibia with polydactyly MESH:C535564 marker/mechanism 188740.0 +LMBR1 64327 Acheiropodia MESH:C536014 marker/mechanism 200500.0 +LMBR1 64327 Laurin-Sandrow syndrome MESH:C535689 marker/mechanism 135750.0 +LMBR1 64327 POLYDACTYLY, PREAXIAL II OMIM:174500 marker/mechanism 174500.0 +LMBR1 64327 Syndactyly, Type IV MESH:C566092 marker/mechanism 186200.0 +LMBRD1 55788 Methylmalonic Aciduria and Homocystinuria, CblF Type MESH:C564747 marker/mechanism 277380.0 22922874 +LMCD1 29995 Mitral Valve Insufficiency MESH:D008944 marker/mechanism 26301497 +LMCD1 29995 Mitral Valve Prolapse MESH:D008945 marker/mechanism 26301497 +LMF1 64788 Hypertriglyceridemia MESH:D015228 marker/mechanism 17994020 +LMF1 64788 Lipase deficiency combined MESH:C535904 marker/mechanism 246650.0 +LMNA 4000 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +LMNA 4000 Atrioventricular Block MESH:D054537 marker/mechanism 10580070 +LMNA 4000 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 115200 10580070|15996213|20019332|21689390 +LMNA 4000 CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM OMIM:212112 marker/mechanism 212112 +LMNA 4000 Charcot-Marie-Tooth disease, Type 2B1 MESH:C537990 marker/mechanism 605588 +LMNA 4000 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15726408 +LMNA 4000 Death, Sudden, Cardiac MESH:D016757 marker/mechanism 15996213 +LMNA 4000 Foot Deformities, Congenital MESH:D005532 marker/mechanism 15996213 +LMNA 4000 Hand Deformities, Congenital MESH:D006228 marker/mechanism 15996213 +LMNA 4000 Heart Block MESH:D006327 marker/mechanism 15996213 +LMNA 4000 Heart-hand syndrome, Slovenian type MESH:C535852 marker/mechanism 610140 +LMNA 4000 HIV-Associated Lipodystrophy Syndrome MESH:D039682 marker/mechanism 18230615 +LMNA 4000 Lipodystrophy, Familial Partial MESH:D052496 marker/mechanism 151660 12844477|14510863|16241930|19793595 +LMNA 4000 Mandibuloacral dysplasia with type A lipodystrophy MESH:C535705 marker/mechanism 248370 12788894|17848409|19764019 +LMNA 4000 Muscular Dystrophies, Limb-Girdle MESH:D049288 marker/mechanism 10814726|12032588|30055862 +LMNA 4000 Muscular Dystrophy, Congenital, Lmna-Related MESH:C567708 marker/mechanism 613205 +LMNA 4000 Muscular Dystrophy, Emery-Dreifuss MESH:D020389 marker/mechanism 181350|616516 10814726|12032588|30055862 +LMNA 4000 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +LMNA 4000 Progeria MESH:D011371 marker/mechanism 176670 15726408|17469202|23217256|28229933|29703891 +LMNA 4000 Scleroderma, Localized MESH:D012594 marker/mechanism 15726408 +LMNA 4000 Sinoatrial Block MESH:D012848 marker/mechanism 15996213 +LMNA 4000 Tachycardia, Ventricular MESH:D017180 marker/mechanism 15996213 +LMNB1 4001 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +LMNB1 4001 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +LMNB1 4001 Pelizaeus-Merzbacher Disease MESH:D020371 marker/mechanism 169500 +LMNB2 84823 Lipodystrophy, Partial, Acquired MESH:C562448 marker/mechanism 608709 +LMNB2 84823 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 616540 +LMNTD1 160492 Lung Neoplasms MESH:D008175 marker/mechanism 15064703 +LMO1 4004 Leukemia, T-Cell MESH:D015458 marker/mechanism 2034676|3259177 +LMO1 4004 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 19246562 +LMO2 4005 Leukemia, T-Cell MESH:D015458 marker/mechanism 2034676 +LMO2 4005 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LMO2 4005 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 19246562|24394663 +LMOD1 25802 Coronary Artery Disease MESH:D003324 marker/mechanism 28530674 +LMOD1 25802 Endometriosis MESH:D004715 marker/mechanism 20864642 +LMOD3 56203 NEMALINE MYOPATHY 10 OMIM:616165 marker/mechanism 616165.0 +LMTK2 22853 Prostatic Neoplasms MESH:D011471 marker/mechanism 18264097 +LMX1A 4009 Deafness, Autosomal Dominant 7 MESH:C563321 marker/mechanism 601412.0 +LMX1A 4009 Hearing Loss MESH:D034381 marker/mechanism 29971487 +LMX1B 4010 Clubfoot MESH:D003025 marker/mechanism 19147669 +LMX1B 4010 Hematuria MESH:D006417 marker/mechanism 19147669 +LMX1B 4010 Hyperlipidemias MESH:D006949 marker/mechanism 20199424 +LMX1B 4010 Mental Disorders MESH:D001523 marker/mechanism 20199424 +LMX1B 4010 Nail-Patella Syndrome MESH:D009261 marker/mechanism 161200.0 19147669|20199424 +LMX1B 4010 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 20199424 +LMX1B 4010 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +LMX1B 4010 Proteinuria MESH:D011507 marker/mechanism 19147669|20199424 +LMX1B 4010 Sleep Initiation and Maintenance Disorders MESH:D007319 marker/mechanism 20199424 +LNCRI 401296 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 29216366 +LNPEP 4012 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16619500 +LNPEP 4012 Memory Disorders MESH:D008569 marker/mechanism 11730987 +LONP1 9361 CODAS syndrome MESH:C536434 marker/mechanism 600373.0 +LOQS 34751 Central Nervous System Diseases MESH:D002493 marker/mechanism 25554729 +LORICRIN 4014 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18572023 +LORICRIN 4014 Skin Neoplasms MESH:D012878 marker/mechanism 18572023 +LORICRIN 4014 Vohwinkel Syndrome, Variant Form MESH:C565826 marker/mechanism 604117.0 +LOX 4015 AORTIC ANEURYSM, FAMILIAL THORACIC 10 OMIM:617168 marker/mechanism 617168.0 +LOX 4015 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +LOX 4015 Hepatitis B MESH:D006509 marker/mechanism 16023247 +LOX 4015 Hepatitis C MESH:D006526 marker/mechanism 16023247 +LOX 4015 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 16023247 +LOX 4015 Hypertension, Pulmonary MESH:D006976 marker/mechanism 24614111 +LOX 4015 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +LOX 4015 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 16023247 +LOX 4015 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LOX 4015 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +LOX 4015 Osteosarcoma MESH:D012516 marker/mechanism 23886186 +LOX 4015 Prenatal Injuries MESH:D049188 marker/mechanism 20045017 +LOXHD1 125336 Deafness, Autosomal Recessive 77 MESH:C567543 marker/mechanism 613079.0 +LOXL1 4016 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +LOXL1 4016 Exfoliation Syndrome MESH:D017889 marker/mechanism 177650.0 25706626|28553957 +LOXL1 4016 Liver Cirrhosis MESH:D008103 marker/mechanism 30097701 +LOXL1 4016 Prenatal Injuries MESH:D049188 marker/mechanism 20045017 +LOXL1 4016 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 17456585 +LOXL2 4017 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +LOXL2 4017 Breast Neoplasms MESH:D001943 marker/mechanism 19330836|24014025 +LOXL2 4017 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24014025 +LOXL2 4017 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 24716982 +LOXL2 4017 Hepatitis B MESH:D006509 marker/mechanism 16023247 +LOXL2 4017 Hepatitis C MESH:D006526 marker/mechanism 16023247 +LOXL2 4017 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 16023247 +LOXL2 4017 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 16023247 +LOXL2 4017 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LOXL2 4017 Neoplasm Invasiveness MESH:D009361 marker/mechanism 24014025 +LOXL3 84695 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 35841383 +LOXL3 84695 Disease Progression MESH:D018450 marker/mechanism 35841383 +LOXL4 84171 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +LOXL4 84171 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 17456585 +LOXL5B 100124531 Prenatal Injuries MESH:D049188 marker/mechanism 20045017 +LPA 4018 Atherosclerosis MESH:D050197 marker/mechanism 1465128|17845920|9770530 +LPA 4018 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +LPA 4018 Cardiovascular Diseases MESH:D002318 marker/mechanism 18775538 +LPA 4018 Coronary Artery Disease MESH:D003324 marker/mechanism 20435227|21378990 +LPA 4018 Coronary Disease MESH:D003327 marker/mechanism 10484779 +LPA 4018 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +LPA 4018 Hypercholesterolemia MESH:D006937 marker/mechanism 12697372 +LPA 4018 Hypolipoproteinemias MESH:D007009 marker/mechanism 10484779 +LPA 4018 Ischemic Stroke MESH:D000083242 marker/mechanism 17845920 +LPA 4018 Stroke MESH:D020521 marker/mechanism 10484779 +LPA 4018 Thromboembolism MESH:D013923 marker/mechanism 9164807 +LPA 4018 Venous Thrombosis MESH:D020246 marker/mechanism 9164807 +LPAR1 1902 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +LPAR1 1902 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +LPAR1 1902 Craniofacial Abnormalities MESH:D019465 marker/mechanism 11087877 +LPAR1 1902 Fetal Death MESH:D005313 marker/mechanism 11087877 +LPAR1 1902 Growth Disorders MESH:D006130 marker/mechanism 11087877 +LPAR1 1902 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +LPAR1 1902 Olfaction Disorders MESH:D000857 marker/mechanism 11087877 +LPAR1 1902 Prostatic Neoplasms MESH:D011471 marker/mechanism 16809448 +LPAR6 10161 Hypotrichosis MESH:D007039 marker/mechanism 278150.0 18297072 +LPAR6 10161 Hypotrichosis simplex MESH:C537160 marker/mechanism 18297070 +LPCAT2 54947 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +LPGAT1 9926 Weight Gain MESH:D015430 marker/mechanism 19030233 +LPIN1 23175 Myoglobinuria, Acute Recurrent, Autosomal Recessive MESH:C564832 marker/mechanism 268200.0 +LPIN2 9663 Majeed syndrome MESH:C537839 marker/mechanism 609628.0 +LPL 4023 Carcinoma MESH:D002277 marker/mechanism 12376462 +LPL 4023 Cardiomyopathies MESH:D009202 marker/mechanism 10533957 +LPL 4023 Cardiovascular Diseases MESH:D002318 marker/mechanism 16544732 +LPL 4023 Celiac Disease MESH:D002446 marker/mechanism 30097691 +LPL 4023 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +LPL 4023 Dyslipidemias MESH:D050171 marker/mechanism 17952847 +LPL 4023 Hepatitis C MESH:D006526 therapeutic 17517063 +LPL 4023 Hypercholesterolemia MESH:D006937 marker/mechanism 21852083 +LPL 4023 Hyperlipidemia, Familial Combined MESH:D006950 marker/mechanism 144250.0 +LPL 4023 Hyperlipidemias MESH:D006949 marker/mechanism 17658632 +LPL 4023 Hyperlipoproteinemia Type I MESH:D008072 marker/mechanism 238600.0 +LPL 4023 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 16030523 +LPL 4023 Hypertension MESH:D006973 marker/mechanism 22228705 +LPL 4023 Hypertriglyceridemia MESH:D015228 marker/mechanism|therapeutic 20657596|8147947 +LPL 4023 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LPL 4023 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +LPL 4023 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +LPL 4023 Necrosis MESH:D009336 marker/mechanism 10533957 +LPL 4023 Obesity MESH:D009765 marker/mechanism 18344982 +LPL 4023 Pancreatitis MESH:D010195 marker/mechanism 18936103 +LPL 4023 Prostatic Neoplasms MESH:D011471 marker/mechanism 15386377 +LPP 4026 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +LPP 4026 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +LPXN 9404 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LRAT 9227 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +LRAT 9227 Celiac Disease MESH:D002446 marker/mechanism 30097691 +LRAT 9227 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +LRAT 9227 Eye Diseases, Hereditary MESH:D015785 marker/mechanism 16968212 +LRAT 9227 Leber Congenital Amaurosis MESH:D057130 marker/mechanism 19339306 +LRAT 9227 Leber Congenital Amaurosis 14 MESH:C567636 marker/mechanism 613341.0 +LRAT 9227 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LRAT 9227 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 16250670|17011878 +LRAT 9227 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 +LRAT 9227 Vitamin A Deficiency MESH:D014802 marker/mechanism 16174770 +LRATD1 151354 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +LRBA 987 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY OMIM:614700 marker/mechanism 614700.0 +LRCH1 23143 Stroke MESH:D020521 marker/mechanism 29531354 +LRG1 116844 Acute Kidney Injury MESH:D058186 marker/mechanism 34677723 +LRG1 116844 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 25200834 +LRG1 116844 Colonic Neoplasms MESH:D003110 marker/mechanism 25200834 +LRG1 116844 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +LRG1 116844 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +LRIG1 26018 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +LRIG2 9860 Urofacial syndrome MESH:C536480 marker/mechanism 615112.0 +LRIT3 345193 Night blindness, congenital stationary MESH:C536122 marker/mechanism 615058.0 +LRMDA 83938 ALBINISM, OCULOCUTANEOUS, TYPE VII OMIM:615179 marker/mechanism 615179.0 +LRMDA 83938 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +LRMDA 83938 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +LRP1 4035 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +LRP1 4035 KERATOSIS PILARIS ATROPHICANS OMIM:604093 marker/mechanism 604093.0 +LRP1 4035 Migraine Disorders MESH:D008881 marker/mechanism 21666692 +LRP1 4035 Migraine without Aura MESH:D020326 marker/mechanism 22683712 +LRP1 4035 Schizophrenia MESH:D012559 marker/mechanism 21743468 +LRP12 29967 Muscular Dystrophy, Oculopharyngeal MESH:D039141 marker/mechanism 31332380 +LRP1B 53353 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +LRP1B 53353 Melanoma MESH:D008545 marker/mechanism 22197931 +LRP1B 53353 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +LRP2 4036 Acute Kidney Injury MESH:D058186 marker/mechanism 29286200 +LRP2 4036 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 10052453 +LRP2 4036 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17632512 +LRP2 4036 Developmental Disabilities MESH:D002658 marker/mechanism 17632512 +LRP2 4036 Donnai-Barrow syndrome MESH:C536390 marker/mechanism 222448.0 +LRP2 4036 Eye Diseases, Hereditary MESH:D015785 marker/mechanism 17632512 +LRP2 4036 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 17632512 +LRP2 4036 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 17632512 +LRP2 4036 Kidney Diseases MESH:D007674 marker/mechanism 17632512 +LRP2 4036 Prostatic Neoplasms MESH:D011471 marker/mechanism 22919386 +LRP2 4036 Vitamin D Deficiency MESH:D014808 marker/mechanism 10052453 +LRP4 4038 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 616304.0 +LRP4 4038 Sclerosteosis MESH:C537525 marker/mechanism 614305.0 +LRP4 4038 Syndactyly MESH:D013576 marker/mechanism 16207730 +LRP4 4038 Syndactyly Cenani Lenz type MESH:C538150 marker/mechanism 212780.0 +LRP4 4038 Tooth Abnormalities MESH:D014071 marker/mechanism 16207730 +LRP5 4041 Exudative vitreoretinopathy 1 MESH:C536382 marker/mechanism 133780.0 +LRP5 4041 Exudative Vitreoretinopathy 4 MESH:C566619 marker/mechanism 601813.0 +LRP5 4041 Familial Exudative Vitreoretinopathies MESH:D000080345 marker/mechanism 29207047 +LRP5 4041 Fractures, Bone MESH:D050723 marker/mechanism 22504420 +LRP5 4041 Osteopetrosis autosomal dominant type 1 MESH:C536056 marker/mechanism 607634.0 +LRP5 4041 Osteoporosis MESH:D010024 marker/mechanism 601884.0 +LRP5 4041 Osteoporosis-pseudoglioma syndrome MESH:C536063 marker/mechanism 259770.0 18825883 +LRP5 4041 Vitreoretinopathy, Proliferative MESH:D018630 marker/mechanism 18263894 +LRP5 4041 Worth syndrome MESH:C536748 marker/mechanism 144750.0 +LRP6 4040 Coronary Artery Disease, Autosomal Dominant 2 MESH:C567045 marker/mechanism 610947.0 +LRP6 4040 TOOTH AGENESIS, SELECTIVE, 7 OMIM:616724 marker/mechanism 616724.0 +LRP6 4040 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 24552774 +LRP8 7804 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 +LRP8 7804 Nerve Degeneration MESH:D009410 marker/mechanism 18172410 +LRPAP1 4043 MYOPIA 23, AUTOSOMAL RECESSIVE OMIM:615431 marker/mechanism 615431.0 +LRPPRC 10128 Leigh syndrome , French Canadian type MESH:C537004 marker/mechanism 220111.0 12529507 +LRRC1 55227 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +LRRC10 376132 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +LRRC10 376132 Heart Failure MESH:D006333 marker/mechanism 36071497 +LRRC28 123355 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LRRC37A 9884 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +LRRC37A2 474170 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +LRRC3B 116135 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +LRRC3B 116135 Colorectal Neoplasms MESH:D015179 marker/mechanism 18815942 +LRRC3B 116135 Stomach Neoplasms MESH:D013274 marker/mechanism 18757430 +LRRC46 90506 Ovarian Neoplasms MESH:D010051 marker/mechanism 31043753 +LRRC51 120356739 Deafness MESH:D003638 marker/mechanism 18953341 +LRRC59 55379 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 30705370 +LRRC59 55379 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +LRRC59 55379 Glioblastoma MESH:D005909 marker/mechanism 30705370 +LRRC59 55379 Lymphatic Metastasis MESH:D008207 marker/mechanism 30705370 +LRRC59 55379 Ovarian Neoplasms MESH:D010051 marker/mechanism 30705370 +LRRC7 57554 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +LRRC8A 56262 Agammaglobulinemia MESH:D000361 marker/mechanism 613506.0 +LRRC8C 84230 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +LRRFIP1 9208 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LRRK2 120892 Blepharoptosis MESH:D001763 marker/mechanism 31174552 +LRRK2 120892 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +LRRK2 120892 Endometriosis MESH:D004715 marker/mechanism 20864642 +LRRK2 120892 Motor Disorders MESH:D000068079 marker/mechanism 31174552 +LRRK2 120892 Nerve Degeneration MESH:D009410 marker/mechanism 19741132 +LRRK2 120892 Parkinson Disease MESH:D010300 marker/mechanism 17388990|19915575|19915576|20205471|22043175|23017109|23472874|23628791|25149416|25475535|25631236 +LRRK2 120892 PARKINSON DISEASE 8, AUTOSOMAL DOMINANT OMIM:607060 marker/mechanism 607060.0 +LRRK2 120892 Parkinsonian Disorders MESH:D020734 marker/mechanism 23046578|25017139|26558463 +LRRK2 120892 Psychomotor Disorders MESH:D011596 marker/mechanism 31174552 +LRRK2 120892 Signs and Symptoms MESH:D012816 marker/mechanism 31174552 +LRRK2 120892 Weight Loss MESH:D015431 marker/mechanism 31174552 +LRRN3 54674 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20678249 +LRRTM3 347731 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20678249 +LRSAM1 90678 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 20865121 +LRSAM1 90678 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P OMIM:614436 marker/mechanism 614436.0 +LRSAM1 90678 Charcot-Marie-Tooth disease, Type 4A, axonal form MESH:C539595 marker/mechanism 22781092|27686364 +LRTOMT 220074 Deafness, Autosomal Recessive 63 MESH:C566951 marker/mechanism 611451.0 +LSG1 55341 Brain Injuries MESH:D001930 marker/mechanism 14499481 +LSM5 23658 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +LSP1 4046 Breast Neoplasms MESH:D001943 marker/mechanism 17529967|20453838 +LSP1 4046 Calcinosis MESH:D002114 marker/mechanism 21335463 +LSP1 4046 Colitis, Ulcerative MESH:D003093 marker/mechanism 21297633 +LSP1 4046 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +LSR 51599 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +LSR 51599 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942 +LSR 51599 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +LSS 4047 CATARACT 44 OMIM:616509 marker/mechanism 616509.0 +LSS 4047 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414 +LSS 4047 Q Fever MESH:D011778 marker/mechanism 16469060 +LTA 4049 Arthritis, Psoriatic MESH:D015535 marker/mechanism 607507.0 12746914 +LTA 4049 Coronary Artery Disease MESH:D003324 marker/mechanism 15266304 +LTA 4049 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 29379198 +LTA 4049 Hepatic Encephalopathy MESH:D006501 marker/mechanism 9696492 +LTA 4049 Leprosy MESH:D007918 marker/mechanism 610988.0 17353895 +LTA 4049 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +LTA 4049 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 12426569|15129282 +LTA 4049 Sepsis MESH:D018805 marker/mechanism 22977509 +LTA4H 4048 Atherosclerosis MESH:D050197 marker/mechanism 16698924 +LTA4H 4048 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LTB 4050 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LTB4R 1241 Anaphylaxis MESH:D000707 marker/mechanism 10934231 +LTB4R 1241 Inflammation MESH:D007249 marker/mechanism 10934231 +LTB4R 1241 Liver Diseases MESH:D008107 marker/mechanism 19784758 +LTB4R1 16995 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28487374 +LTB4R1 16995 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +LTBP1 4052 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LTBP1 4052 Osteoarthritis, Knee MESH:D020370 marker/mechanism 30374069 +LTBP2 4053 Glaucoma MESH:D005901 marker/mechanism 19361779|27149523 +LTBP2 4053 Glaucoma 3, Primary Congenital, D MESH:C567765 marker/mechanism 613086.0 +LTBP2 4053 Glaucoma 3, primary infantile, B MESH:C536824 marker/mechanism 600975.0 +LTBP2 4053 MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA OMIM:251750 marker/mechanism 251750.0 +LTBP2 4053 Weill-Marchesani Syndrome MESH:D056846 marker/mechanism 614819.0 +LTBP3 4054 Amelogenesis Imperfecta MESH:D000567 marker/mechanism 25669657 +LTBP3 4054 Anodontia MESH:D000848 marker/mechanism 19344874|25899461 +LTBP3 4054 Bone Diseases MESH:D001847 marker/mechanism 19344874 +LTBP3 4054 Brachyolmia MESH:C537098 marker/mechanism 25669657 +LTBP3 4054 Craniofacial Abnormalities MESH:D019465 marker/mechanism 11790802|12379497 +LTBP3 4054 Growth Disorders MESH:D006130 marker/mechanism 19344874|25899461 +LTBP3 4054 Kyphosis MESH:D007738 marker/mechanism 11790802 +LTBP3 4054 Mitral Valve Prolapse MESH:D008945 marker/mechanism 25899461 +LTBP3 4054 Osteoarthritis MESH:D010003 marker/mechanism 11790802|12379497 +LTBP3 4054 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +LTBP3 4054 Osteosclerosis MESH:D010026 marker/mechanism 11790802|12379497 +LTBP3 4054 Tooth Agenesis, Selective, 6 MESH:C567755 marker/mechanism 601216.0 +LTBP4 8425 Cutis Laxa With Severe Pulmonary, Gastrointestinal, And Urinary Abnormalities MESH:C567716 marker/mechanism 613177.0 +LTBP4 8425 Glioblastoma MESH:D005909 marker/mechanism 27270107 +LTBP4 8425 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 27270107 +LTBR 4055 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +LTBR 4055 Malaria MESH:D008288 marker/mechanism 15788153 +LTC4S 4056 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 10970818|20485159|9393345|9466979 +LTC4S 4056 Drug Hypersensitivity MESH:D004342 marker/mechanism 16433794 +LTC4S 4056 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +LTC4S 4056 Leukotriene C4 Synthase Deficiency MESH:C565439 marker/mechanism 614037.0 +LTF 4057 Candidiasis, Oral MESH:D002180 therapeutic 16640825 +LTF 4057 Candidiasis, Vulvovaginal MESH:D002181 therapeutic 16640825 +LTF 4057 Carbon Tetrachloride Poisoning MESH:D002252 therapeutic 16141546 +LTF 4057 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 16141546 +LTF 4057 Chemically-Induced Disorders MESH:D064419 marker/mechanism 35999755 +LTF 4057 Colitis, Ulcerative MESH:D003093 marker/mechanism|therapeutic 16640825|35999755 +LTF 4057 Colonic Neoplasms MESH:D003110 therapeutic 12079509 +LTF 4057 Diarrhea MESH:D003967 therapeutic 16640825 +LTF 4057 Endometriosis MESH:D004715 marker/mechanism 21063030 +LTF 4057 Enterocolitis, Necrotizing MESH:D020345 therapeutic 16640825 +LTF 4057 Gastrointestinal Hemorrhage MESH:D006471 therapeutic 15651117 +LTF 4057 Hypertension MESH:D006973 therapeutic 24587916 +LTF 4057 Hypotension MESH:D007022 marker/mechanism 14563657 +LTF 4057 Inflammation MESH:D007249 therapeutic 16141546 +LTF 4057 Joint Diseases MESH:D007592 therapeutic 16640825 +LTF 4057 Liver Neoplasms MESH:D008113 therapeutic 12079509 +LTF 4057 Neoplasms MESH:D009369 therapeutic 16640825 +LTF 4057 Osteoporosis MESH:D010024 therapeutic 16648989|16936800 +LTF 4057 Premature Birth MESH:D047928 therapeutic 16640825 +LTF 4057 Weight Loss MESH:D015431 therapeutic 24587916 +LTF 4057 Wounds and Injuries MESH:D014947 therapeutic 16640825 +LTK 4058 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +LUM 4060 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +LUM 4060 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LUM 4060 Muscular Dystrophy, Facioscapulohumeral MESH:D020391 marker/mechanism 12868502 +LUM 4060 Wounds and Injuries MESH:D014947 therapeutic 24367547 +LURAP1L 286343 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LXN 56925 Chromosomal Instability MESH:D043171 marker/mechanism 25341047 +LXN 56925 Melanoma MESH:D008545 marker/mechanism 17145863 +LY6 17062 Acute Kidney Injury MESH:D058186 marker/mechanism 8305641 +LY6 17062 Nephritis MESH:D009393 marker/mechanism 8305641 +LY6E 4061 Influenza, Human MESH:D007251 marker/mechanism 23326326 +LY6E 4061 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17446842 +LY6G 546644 Kidney Diseases MESH:D007674 marker/mechanism 19913069 +LY86 9450 Brain Injuries MESH:D001930 marker/mechanism 21549006 +LY86 9450 Calcinosis MESH:D002114 marker/mechanism 21335463 +LY86 9450 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +LY86 9450 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LY96 23643 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860 +LY96 23643 Carcinoma MESH:D002277 marker/mechanism 22180778 +LY96 23643 Cholestasis MESH:D002779 marker/mechanism 27989131 +LY96 23643 Colorectal Neoplasms MESH:D015179 marker/mechanism 22180778 +LY96 23643 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +LY96 23643 Neoplasm Metastasis MESH:D009362 marker/mechanism 22180778 +LYL1 4066 Leukemia, Lymphoid MESH:D007945 marker/mechanism 3162254 +LYL1 4066 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 16094422 +LYL1 4066 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 16094422 +LYN 4067 HIV Infections MESH:D015658 marker/mechanism 15308739 +LYRM4 57128 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19 OMIM:615595 marker/mechanism 615595.0 +LYRM7 90624 Mitochondrial Complex III Deficiency MESH:C565128 marker/mechanism 615838.0 +LYRM9 201229 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +LYSMD3 116068 Tobacco Use Disorder MESH:D014029 marker/mechanism 18438686 +LYST 1130 Chediak-Higashi Syndrome MESH:D002609 marker/mechanism 214500.0 +LYST 1130 Influenza, Human MESH:D007251 marker/mechanism 26597256 +LYVE1 10894 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +LYZ 4069 Amyloidosis, familial visceral MESH:C538249 marker/mechanism 105200.0 +LZTFL1 54585 BARDET-BIEDL SYNDROME 17 OMIM:615994 marker/mechanism 615994.0 +LZTFL1 54585 COVID-19 MESH:D000086382 marker/mechanism 32558485|32998156 +LZTFL1 54585 Critical Illness MESH:D016638 marker/mechanism 32558485|32998156 +LZTFL1 54585 Respiratory Insufficiency MESH:D012131 marker/mechanism 32558485 +LZTR1 8216 Autistic Disorder MESH:D001321 marker/mechanism 25961944 +LZTR1 8216 Glioblastoma MESH:D005909 marker/mechanism 23917401 +LZTR1 8216 NOONAN SYNDROME 10 OMIM:616564 marker/mechanism 616564.0 +LZTR1 8216 Noonan Syndrome 2 MESH:C548081 marker/mechanism 605275.0 +LZTR1 8216 Schwannomatosis MESH:C536641 marker/mechanism 615670.0 24362817 +LZTS1 11178 Esophageal Neoplasms MESH:D004938 marker/mechanism 133239.0 +LZTS1 11178 Prostatic Neoplasms MESH:D011471 marker/mechanism 12377406 +M6PR 4074 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +M6PR 4074 Disease Progression MESH:D018450 marker/mechanism 21364753 +M6PR 4074 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +M6PR 4074 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +MAB21L2 10586 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +MAB21L2 10586 MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME OMIM:615877 marker/mechanism 615877.0 +MACC1 346389 Neoplasm Metastasis MESH:D009362 marker/mechanism 36008464 +MACIR 90355 Breast Neoplasms MESH:D001943 marker/mechanism 30705370 +MACIR 90355 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +MACIR 90355 Colonic Neoplasms MESH:D003110 marker/mechanism 30705370 +MACIR 90355 Esophageal Neoplasms MESH:D004938 marker/mechanism 30705370 +MACIR 90355 Glioblastoma MESH:D005909 marker/mechanism 30705370 +MACIR 90355 Liver Neoplasms MESH:D008113 marker/mechanism 30705370 +MACIR 90355 Lymphatic Metastasis MESH:D008207 marker/mechanism 30705370 +MACIR 90355 Ovarian Neoplasms MESH:D010051 marker/mechanism 30705370 +MACIR 90355 Prostatic Neoplasms MESH:D011471 marker/mechanism 30705370 +MACO1 55219 Coronary Disease MESH:D003327 marker/mechanism 19060911 +MACO1 55219 Dyslipidemias MESH:D050171 marker/mechanism 19060911 +MACROD2 140733 Autistic Disorder MESH:D001321 marker/mechanism 20663923 +MACROD2 140733 Liver Neoplasms MESH:D008113 marker/mechanism 27064257 +MACROD2 140733 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +MAD1L1 8379 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MAD1L1 8379 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +MAD1L1 8379 Prostatic Neoplasms MESH:D011471 marker/mechanism 176807.0 +MAD1L1 8379 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 23666239 +MAD2L1 4085 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MAD2L1 4085 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 18691855 +MAD2L1 4085 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +MAD2L2 10459 FANCONI ANEMIA, COMPLEMENTATION GROUP V OMIM:617243 marker/mechanism 617243.0 +MADCAM1 8174 Colitis MESH:D003092 therapeutic 16917232 +MADCAM1 8174 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +MAEA 10296 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22158537 +MAF 4094 Cataract, Pulverulent, Juvenile-Onset MESH:C565703 marker/mechanism 610202.0 +MAF 4094 Cataracts, Congenital, with Sensorineural Deafness, Down Syndrome-Like Facial Appearance, Short Stature, and Mental Retardation MESH:C563390 marker/mechanism 601088.0 +MAF 4094 Cholestasis, Intrahepatic MESH:D002780 marker/mechanism 20146260 +MAF 4094 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +MAFB 9935 Cleft Lip MESH:D002971 marker/mechanism 20436469 +MAFB 9935 Duane Retraction Syndrome MESH:D004370 marker/mechanism 617041.0 +MAFB 9935 MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME OMIM:166300 marker/mechanism 166300.0 +MAFF 23764 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MAFG 4097 Cholestasis, Intrahepatic MESH:D002780 marker/mechanism 20146260 +MAG 4099 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +MAG 4099 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +MAG 4099 SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE OMIM:616680 marker/mechanism 616680.0 +MAGEA1 4100 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MAGEA1 4100 Melanoma MESH:D008545 marker/mechanism 26640592 +MAGEA3 4102 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MAGEA6 4105 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MAGEA6 4105 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 35285568 +MAGEA8 4107 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +MAGEA9 4108 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 17290406 +MAGEC1 9947 Melanoma MESH:D008545 marker/mechanism 22842228 +MAGEC1 9947 Schizophrenia MESH:D012559 marker/mechanism 21822266 +MAGEC2 51438 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MAGED2 10916 BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT OMIM:300971 marker/mechanism 300971.0 +MAGED4 728239 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +MAGEE1 57692 Bile Duct Diseases MESH:D001649 marker/mechanism 30515189 +MAGEE1 57692 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MAGEL2 54551 Autistic Disorder MESH:D001321 marker/mechanism 24076603 +MAGEL2 54551 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270.0 24076603 +MAGI1 9223 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +MAGI2 9863 Anxiety Disorders MESH:D001008 marker/mechanism 25653350 +MAGI2 9863 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +MAGI2 9863 Memory Disorders MESH:D008569 marker/mechanism 25653350 +MAGI2 9863 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 25653350 +MAGI2 9863 Schizophrenia MESH:D012559 marker/mechanism 25653350 +MAGOHB 55110 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +MAGT1 84061 IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA OMIM:300853 marker/mechanism 300853.0 +MAK 4117 RETINITIS PIGMENTOSA 62 OMIM:614181 marker/mechanism 614181.0 +MAL 4118 Breast Neoplasms MESH:D001943 marker/mechanism 19208741 +MAL 4118 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 19445022 +MAL 4118 Head and Neck Neoplasms MESH:D006258 marker/mechanism 19445022 +MALAT1 378938 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 29912916|30349115 +MALAT1 378938 Carcinogenesis MESH:D063646 marker/mechanism 26735578 +MALAT1 378938 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 26735578 +MALAT1 378938 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 26735578 +MALAT1 378938 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 30515189 +MALAT1 378938 Disease Progression MESH:D018450 marker/mechanism 26735578 +MALAT1 378938 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25538231 +MALAT1 378938 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 29119387 +MALAT1 378938 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 26435214 +MALAT1 378938 Liver Neoplasms MESH:D008113 marker/mechanism 27064257 +MALAT1 378938 Neoplasm Invasiveness MESH:D009361 marker/mechanism 25538231|26735578 +MALAT1 378938 Neoplasm Metastasis MESH:D009362 marker/mechanism|therapeutic 24244343|26735578|30349115 +MALAT1 378938 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +MALT1 10892 IMMUNODEFICIENCY 12 OMIM:615468 marker/mechanism 615468.0 +MALT1 10892 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21173233 +MAML2 84441 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MAML3 55534 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +MAML3 55534 Heart Defects, Congenital MESH:D006330 marker/mechanism 23708190 +MAML3 55534 Sarcoma MESH:D012509 marker/mechanism 24859338 +MAML3 55534 Sinonasal undifferentiated carcinoma MESH:C537344 marker/mechanism 24859338 +MAMLD1 10046 Hypospadias MESH:D007021 marker/mechanism 21559465 +MAMLD1 10046 Hypospadias 2, X-Linked MESH:C567462 marker/mechanism 300758.0 +MAN1B1 11253 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +MAN1B1 11253 RAFIQ SYNDROME OMIM:614202 marker/mechanism 614202.0 +MAN2B1 4125 alpha-Mannosidosis MESH:D008363 marker/mechanism 248500.0 +MAN2B1 4125 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +MAN2C1 4123 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +MANBA 4126 beta-Mannosidosis MESH:D044905 marker/mechanism 248510.0 +MANEA 79694 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686|19255376 +MANEA 79694 Paranoid Disorders MESH:D010259 marker/mechanism 18438686 +MANEA 79694 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +MAOA 4128 Antisocial Personality Disorder MESH:D000987 marker/mechanism 12161658|18212819|8503438 +MAOA 4128 Autistic Disorder MESH:D001321 marker/mechanism 12919132|18361446|20573161 +MAOA 4128 Brunner Syndrome MESH:C563156 marker/mechanism 300615.0 8211186 +MAOA 4128 Cognition Disorders MESH:D003072 marker/mechanism 24402517 +MAOA 4128 Endometriosis MESH:D004715 marker/mechanism 21063030 +MAOA 4128 End Stage Liver Disease MESH:D058625 marker/mechanism 15025246 +MAOA 4128 Fetal Nutrition Disorders MESH:D048070 marker/mechanism 22340208 +MAOA 4128 Hepatic Encephalopathy MESH:D006501 marker/mechanism 10206825|10564534|9048767 +MAOA 4128 Huntington Disease MESH:D006816 marker/mechanism 21075085 +MAOA 4128 Hypotension MESH:D007022 marker/mechanism 11834493 +MAOA 4128 Mental Disorders MESH:D001523 marker/mechanism 22340208 +MAOA 4128 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 8503438 +MAOA 4128 Muscular Diseases MESH:D009135 marker/mechanism 15946989 +MAOA 4128 Parkinson Disease MESH:D010300 marker/mechanism 17449559 +MAOA 4128 Pheochromocytoma MESH:D010673 marker/mechanism 22569243 +MAOA 4128 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 22340208 +MAOB 4129 Alzheimer Disease MESH:D000544 marker/mechanism 21075085|7816197 +MAOB 4129 Anemia, Megaloblastic MESH:D000749 marker/mechanism 7430361 +MAOB 4129 Autistic Disorder MESH:D001321 marker/mechanism 19221690 +MAOB 4129 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +MAOB 4129 Endometriosis MESH:D004715 marker/mechanism 21063030 +MAOB 4129 Hepatic Encephalopathy MESH:D006501 marker/mechanism 10564534 +MAOB 4129 Huntington Disease MESH:D006816 marker/mechanism 21075085 +MAOB 4129 Hypotension MESH:D007022 marker/mechanism 11834493 +MAOB 4129 Parkinson Disease MESH:D010300 marker/mechanism 21318773 +MAOB 4129 Pheochromocytoma MESH:D010673 marker/mechanism 22569243 +MAOB 4129 Plaque, Amyloid MESH:D058225 marker/mechanism 7816197 +MAOB 4129 Schizophrenia MESH:D012559 marker/mechanism 20479760 +MAP1 109953 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +MAP1 109953 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +MAP1LC3A 84557 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MAP1LC3B 81631 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +MAP1LC3B 81631 Mitochondrial Diseases MESH:D028361 marker/mechanism 30673822 +MAP1LC3B 81631 Spinal Cord Injuries MESH:D013119 marker/mechanism 29793971 +MAP1LC3B 81631 Starvation MESH:D013217 marker/mechanism 26483381 +MAP2 4133 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MAP2 4133 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MAP2 4133 Lewy Body Disease MESH:D020961 marker/mechanism 30236862 +MAP2 4133 Parkinson Disease MESH:D010300 marker/mechanism 30236862 +MAP2K1 5604 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 22135231 +MAP2K1 5604 Brain Ischemia MESH:D002545 marker/mechanism 17901229 +MAP2K1 5604 Cardiofaciocutaneous syndrome MESH:C535579 marker/mechanism 615279.0 16439621|17703371 +MAP2K1 5604 Costello Syndrome MESH:D056685 marker/mechanism 17703371 +MAP2K1 5604 Heart Failure MESH:D006333 marker/mechanism 36071497 +MAP2K1 5604 Leukemia, Hairy Cell MESH:D007943 marker/mechanism 24241536 +MAP2K1 5604 Melanoma MESH:D008545 marker/mechanism 22197931 +MAP2K1 5604 Melorheostosis MESH:D008557 marker/mechanism 155950.0 +MAP2K1 5604 Noonan Syndrome MESH:D009634 marker/mechanism 163950.0 17703371 +MAP2K1 5604 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +MAP2K1 5604 Prostatic Neoplasms MESH:D011471 marker/mechanism 32512071 +MAP2K2 5605 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +MAP2K2 5605 Cardiofaciocutaneous syndrome MESH:C535579 marker/mechanism 615280.0 16439621|17703371 +MAP2K2 5605 Costello Syndrome MESH:D056685 marker/mechanism 17703371 +MAP2K2 5605 Melanoma MESH:D008545 marker/mechanism 22197931 +MAP2K2 5605 Noonan Syndrome MESH:D009634 marker/mechanism 17703371 +MAP2K2 5605 Prostatic Neoplasms MESH:D011471 marker/mechanism 32512071 +MAP2K3 5606 Prostatic Neoplasms MESH:D011471 marker/mechanism 32512071 +MAP2K5 5607 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +MAP2K5 5607 Body Weight MESH:D001835 marker/mechanism 22344219 +MAP2K5 5607 Prostatic Neoplasms MESH:D011471 marker/mechanism 32512071 +MAP2K6 5608 Colonic Neoplasms MESH:D003110 therapeutic 15037631 +MAP2K6 5608 Edema MESH:D004487 therapeutic 21544193 +MAP2K6 5608 Hypersensitivity MESH:D006967 therapeutic 21544193 +MAP2K6 5608 Prostatic Neoplasms MESH:D011471 marker/mechanism 32512071 +MAP2K7 5609 Breast Neoplasms MESH:D001943 marker/mechanism 21317887 +MAP2K7 5609 Fibrosis MESH:D005355 marker/mechanism 21284947 +MAP2K7 5609 Heart Failure MESH:D006333 marker/mechanism 21284947 +MAP2K7 5609 Lung Neoplasms MESH:D008175 marker/mechanism 21317887 +MAP2K7 5609 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 21317887 +MAP2K7 5609 Precancerous Conditions MESH:D011230 marker/mechanism 21317887 +MAP3K1 4214 46,XY SEX REVERSAL 6 OMIM:613762 marker/mechanism 613762.0 +MAP3K1 4214 Breast Neoplasms MESH:D001943 marker/mechanism 17529967 +MAP3K1 4214 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +MAP3K20 51776 SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY OMIM:616890 marker/mechanism 616890.0 +MAP3K3 4215 Esophageal Neoplasms MESH:D004938 marker/mechanism 17068819 +MAP3K4 4216 Endometrial Neoplasms MESH:D016889 marker/mechanism 23104009 +MAP3K4 4216 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +MAP3K5 4217 Cardiomyopathies MESH:D009202 marker/mechanism 18342293 +MAP3K5 4217 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 18700144 +MAP3K5 4217 Diabetes Mellitus MESH:D003920 marker/mechanism 16731828 +MAP3K5 4217 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 18342293 +MAP3K5 4217 Melanoma MESH:D008545 marker/mechanism 22197930 +MAP3K5 4217 Parkinson Disease MESH:D010300 marker/mechanism 21815648 +MAP3K7 6885 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +MAP3K7 6885 Forney Robinson Pascoe syndrome MESH:C537269 marker/mechanism 157800.0 +MAP3K7 6885 Frontometaphyseal dysplasia MESH:C538064 marker/mechanism 617137.0 +MAP3K7 6885 Pancreatic Carcinoma MESH:C562463 marker/mechanism 34686948 +MAP3K7 6885 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +MAP3K8 1326 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MAP3K8 1326 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 +MAP3K8 1326 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +MAP3K9 4293 Melanoma MESH:D008545 marker/mechanism 22197930 +MAP4 4134 Weight Gain MESH:D015430 marker/mechanism 19030233 +MAP4K4 9448 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +MAP6 4135 Hyperkinesis MESH:D006948 marker/mechanism 16046005 +MAPK1 5594 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MAPK1 5594 Brain Ischemia MESH:D002545 marker/mechanism 17901229 +MAPK1 5594 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21401805 +MAPK1 5594 Cardiomyopathies MESH:D009202 therapeutic 10620750 +MAPK1 5594 Ceroid Lipofuscinosis, Neuronal, 6 MESH:C566627 marker/mechanism 23516525 +MAPK1 5594 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +MAPK1 5594 Cocaine-Related Disorders MESH:D019970 marker/mechanism 16407894|20692647 +MAPK1 5594 Coronavirus Infections MESH:D018352 marker/mechanism 20484496 +MAPK1 5594 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +MAPK1 5594 Gliosis MESH:D005911 marker/mechanism 19402951 +MAPK1 5594 Head and Neck Neoplasms MESH:D006258 marker/mechanism 15342401 +MAPK1 5594 Hodgkin Disease MESH:D006689 marker/mechanism 7545087 +MAPK1 5594 Hyperalgesia MESH:D006930 marker/mechanism 12941468|27093858 +MAPK1 5594 Hypertrophy MESH:D006984 marker/mechanism 12237323 +MAPK1 5594 Infertility, Female MESH:D007247 marker/mechanism 21177758 +MAPK1 5594 Kidney Neoplasms MESH:D007680 marker/mechanism 21813464 +MAPK1 5594 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 28100771 +MAPK1 5594 Lung Neoplasms MESH:D008175 marker/mechanism 11884234|12376484 +MAPK1 5594 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22580338 +MAPK1 5594 Neoplasm Metastasis MESH:D009362 marker/mechanism 22580338 +MAPK1 5594 Nerve Degeneration MESH:D009410 marker/mechanism 19911010 +MAPK1 5594 Ovarian Neoplasms MESH:D010051 marker/mechanism 16211241 +MAPK1 5594 Pneumonia, Pneumococcal MESH:D011018 marker/mechanism 24894820 +MAPK1 5594 Radiation Injuries, Experimental MESH:D011833 therapeutic 22247605 +MAPK1 5594 Sepsis MESH:D018805 marker/mechanism 15489642 +MAPK1 5594 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 20484496 +MAPK1 5594 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +MAPK1 5594 Stomach Neoplasms MESH:D013274 marker/mechanism 17003101 +MAPK1 5594 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 17549049 +MAPK1 5594 Thyroid Neoplasms MESH:D013964 marker/mechanism 34323000 +MAPK1 5594 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +MAPK10 5602 Heart Failure MESH:D006333 marker/mechanism 36071497 +MAPK11 5600 Cardiomyopathies MESH:D009202 therapeutic 10620750 +MAPK13 5603 Cholestasis MESH:D002779 marker/mechanism 20626112 +MAPK14 1432 Cardiomyopathies MESH:D009202 marker/mechanism 10620750 +MAPK14 1432 Cholestasis MESH:D002779 marker/mechanism 20626112 +MAPK14 1432 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 30026087 +MAPK14 1432 Hepatic Insufficiency MESH:D048550 marker/mechanism 30026087 +MAPK14 1432 Hepatomegaly MESH:D006529 marker/mechanism 30026087 +MAPK14 1432 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 therapeutic 16818652 +MAPK14 1432 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 30026087 +MAPK14 1432 Liver Neoplasms MESH:D008113 marker/mechanism 17468757 +MAPK14 1432 Lung Neoplasms MESH:D008175 marker/mechanism 17468755 +MAPK14 1432 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +MAPK15 225689 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +MAPK3 5595 Atrophy MESH:D001284 marker/mechanism 16391472 +MAPK3 5595 Autistic Disorder MESH:D001321 marker/mechanism 30559488 +MAPK3 5595 Brain Ischemia MESH:D002545 marker/mechanism 17901229 +MAPK3 5595 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21401805 +MAPK3 5595 Cardiomyopathies MESH:D009202 therapeutic 10620750 +MAPK3 5595 Ceroid Lipofuscinosis, Neuronal, 6 MESH:C566627 marker/mechanism 23516525 +MAPK3 5595 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +MAPK3 5595 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20692647 +MAPK3 5595 Coronavirus Infections MESH:D018352 marker/mechanism 20484496 +MAPK3 5595 Developmental Disabilities MESH:D002658 marker/mechanism 30559488 +MAPK3 5595 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +MAPK3 5595 Gliosis MESH:D005911 marker/mechanism 19402951 +MAPK3 5595 Head and Neck Neoplasms MESH:D006258 marker/mechanism 15342401 +MAPK3 5595 Hyperalgesia MESH:D006930 marker/mechanism 12941468|27093858 +MAPK3 5595 Hypertrophy MESH:D006984 marker/mechanism 12237323 +MAPK3 5595 Infertility, Female MESH:D007247 marker/mechanism 21177758 +MAPK3 5595 Kidney Neoplasms MESH:D007680 marker/mechanism 21813464 +MAPK3 5595 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 28100771 +MAPK3 5595 Lung Neoplasms MESH:D008175 marker/mechanism 11884234|12083368 +MAPK3 5595 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22580338 +MAPK3 5595 Neoplasm Metastasis MESH:D009362 marker/mechanism 22580338 +MAPK3 5595 Nerve Degeneration MESH:D009410 marker/mechanism 19911010 +MAPK3 5595 Ovarian Neoplasms MESH:D010051 marker/mechanism 16211241 +MAPK3 5595 Pneumonia, Pneumococcal MESH:D011018 marker/mechanism 24894820 +MAPK3 5595 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +MAPK3 5595 Radiation Injuries, Experimental MESH:D011833 therapeutic 22247605 +MAPK3 5595 Sepsis MESH:D018805 marker/mechanism 15489642 +MAPK3 5595 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 20484496 +MAPK3 5595 Stomach Neoplasms MESH:D013274 marker/mechanism 17003101 +MAPK3 5595 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 17549049 +MAPK3 5595 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +MAPK6 5597 Hyperplasia MESH:D006965 marker/mechanism 22561872 +MAPK7 5598 Hyperalgesia MESH:D006930 marker/mechanism 17237256 +MAPK7 5598 Neoplasms, Experimental MESH:D009374 marker/mechanism 29507229 +MAPK8 5599 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21726611 +MAPK8 5599 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +MAPK8 5599 Dermatitis, Atopic MESH:D003876 marker/mechanism 24046278 +MAPK8 5599 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +MAPK8 5599 Hyperalgesia MESH:D006930 marker/mechanism 27093858 +MAPK8 5599 Liver Failure, Acute MESH:D017114 marker/mechanism 17185352 +MAPK8 5599 Precancerous Conditions MESH:D011230 marker/mechanism 21317887 +MAPK8 5599 Reperfusion Injury MESH:D015427 marker/mechanism 20302854 +MAPK8 5599 Stomach Neoplasms MESH:D013274 marker/mechanism 18593901 +MAPK8 5599 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +MAPK8IP1 9479 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 +MAPK8IP3 23162 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +MAPK9 5601 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +MAPK9 5601 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +MAPK9 5601 Hyperalgesia MESH:D006930 marker/mechanism 27093858 +MAPK9 5601 Ischemia MESH:D007511 marker/mechanism 19667931 +MAPK9 5601 Neoplasm Metastasis MESH:D009362 therapeutic 21779479 +MAPK9 5601 Precancerous Conditions MESH:D011230 marker/mechanism 21317887 +MAPK9 5601 Prostatic Neoplasms MESH:D011471 marker/mechanism 32512071 +MAPK9 5601 Reperfusion Injury MESH:D015427 marker/mechanism 19667931|20302854 +MAPK9 5601 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +MAPKAPK3 7867 Patterned dystrophy of retinal pigment epithelium MESH:C536309 marker/mechanism 617111.0 +MAPKBP1 23005 NEPHRONOPHTHISIS 20 OMIM:617271 marker/mechanism 617271.0 +MAPRE1 22919 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +MAPRE1 22919 Weight Gain MESH:D015430 marker/mechanism 19030233 +MAPRE3 22924 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MAPRE3 22924 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +MAPT 4137 Alzheimer Disease MESH:D000544 marker/mechanism 12852432|14517953|15750215|20157255|21715663|25352456|27117003 +MAPT 4137 Anxiety Disorders MESH:D001008 marker/mechanism 29860433 +MAPT 4137 Ataxia MESH:D001259 therapeutic 31783120 +MAPT 4137 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +MAPT 4137 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MAPT 4137 Cardiomyopathies MESH:D009202 marker/mechanism 29068127 +MAPT 4137 Cognition Disorders MESH:D003072 marker/mechanism 24556215|26945731 +MAPT 4137 Dementia MESH:D003704 marker/mechanism 11889249|22300406 +MAPT 4137 Disease Models, Animal MESH:D004195 marker/mechanism 24556215 +MAPT 4137 Frontotemporal Dementia MESH:D057180 marker/mechanism 600274.0 10802785|11117542|11912108|16495328|9641683|9789048 +MAPT 4137 Learning Disabilities MESH:D007859 marker/mechanism 24556215 +MAPT 4137 Memory Disorders MESH:D008569 marker/mechanism 12368474|24556215|29203278|29860433 +MAPT 4137 Neurodegenerative Diseases MESH:D019636 marker/mechanism 9789048 +MAPT 4137 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30664745 +MAPT 4137 Parkinson Disease MESH:D010300 marker/mechanism 19915575|20711177 +MAPT 4137 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +MAPT 4137 Parkinsonian Disorders MESH:D020734 marker/mechanism 10802785|19458322 +MAPT 4137 Pick Disease of the Brain MESH:D020774 marker/mechanism 172700.0 10604746|11117542|11601501|9641683 +MAPT 4137 Progressive supranuclear palsy atypical MESH:C537240 marker/mechanism 260540.0 +MAPT 4137 Psychomotor Agitation MESH:D011595 marker/mechanism 24556215 +MAPT 4137 Respiratory Insufficiency MESH:D012131 marker/mechanism 14595660 +MAPT 4137 Splenomegaly MESH:D013163 marker/mechanism 27117003 +MAPT 4137 Supranuclear Palsy, Progressive MESH:D013494 marker/mechanism 601104.0 12325083|19458322|21685912|25402454 +MAPT 4137 Tauopathies MESH:D024801 marker/mechanism 10604746|11889249|14595660|24556215|27569447 +MAPT 4137 Weight Gain MESH:D015430 marker/mechanism 29203278 +MAPT 4137 Weight Loss MESH:D015431 marker/mechanism 24556215 +MARCHF6 10299 Epilepsy, Familial Adult Myoclonic, 3 MESH:C567098 marker/mechanism 613608.0 +MARCHF8 220972 Esophageal Neoplasms MESH:D004938 marker/mechanism 17068819 +MARCKS 4082 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +MARCKS 4082 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +MARCKS 4082 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +MARCKS 4082 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +MARCO 8685 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MARK1 4139 Autistic Disorder MESH:D001321 marker/mechanism 18492799 +MARK1 4139 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +MARK2 2011 Autistic Disorder MESH:D001321 marker/mechanism 35982159 +MARK2 2011 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +MARK2 2011 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +MARS1 4141 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U OMIM:616280 marker/mechanism 616280.0 +MARS1 4141 INTERSTITIAL LUNG AND LIVER DISEASE OMIM:615486 marker/mechanism 615486.0 +MARS2 92935 Ataxia, Spastic, 3, Autosomal Recessive MESH:C566956 marker/mechanism 611390.0 +MARS2 92935 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25 OMIM:616430 marker/mechanism 616430.0 +MARVELD1 83742 Neoplasms MESH:D009369 marker/mechanism 31205918 +MARVELD2 153562 Deafness, Autosomal Recessive 49 MESH:C565717 marker/mechanism 610153.0 +MAS1 4142 Thrombosis MESH:D013927 therapeutic 25339356 +MASP1 5648 Carnevale syndrome MESH:C535586 marker/mechanism 21258343 +MASP1 5648 Craniofacial Abnormalities MESH:D019465 marker/mechanism 21258343 +MASP1 5648 Malpuech facial clefting syndrome MESH:C535704 marker/mechanism 21258343 +MASP1 5648 Oculopalatoskeletal syndrome MESH:C537738 marker/mechanism 257920.0 21258343 +MASP1 5648 Pigmentation Disorders MESH:D010859 marker/mechanism 21258343 +MASP2 10747 Colitis, Ulcerative MESH:D003093 marker/mechanism 12904520 +MASP2 10747 Erythema Multiforme MESH:D004892 marker/mechanism 12904520 +MASP2 10747 Immune Complex Diseases MESH:D007105 marker/mechanism 12904520 +MASP2 10747 Inflammation MESH:D007249 marker/mechanism 12904520 +MASP2 10747 MASP2 Deficiency MESH:C565360 marker/mechanism 613791.0 +MASP2 10747 Pneumonia, Pneumococcal MESH:D011018 marker/mechanism 12904520 +MAT1A 4143 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 7560086|8770875 +MAT1A 4143 Brain Diseases MESH:D001927 marker/mechanism 8770875 +MAT1A 4143 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12060674 +MAT1A 4143 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +MAT1A 4143 Demyelinating Diseases MESH:D003711 marker/mechanism 8770875 +MAT1A 4143 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23665415 +MAT1A 4143 Fatty Liver MESH:D005234 marker/mechanism 12060674 +MAT1A 4143 Hypermethioninemia MESH:C564683 marker/mechanism 250850.0 +MAT1A 4143 Hyperplasia MESH:D006965 marker/mechanism 12060674 +MAT2A 4144 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +MATN3 4148 Epiphyseal dysplasia, multiple, 5 MESH:C535505 marker/mechanism 607078.0 +MATN3 4148 Osteoarthritis MESH:D010003 marker/mechanism 140600.0 +MATN3 4148 Spondyloepimetaphyseal Dysplasia, Matrilin-3 Related MESH:C563869 marker/mechanism 608728.0 +MATN4 8785 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +MATR3 9782 Myopathy, Distal 2 MESH:C565262 marker/mechanism 606070.0 +MAX 4149 Pheochromocytoma MESH:D010673 marker/mechanism 171300.0 21685915 +MAX 4149 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +MAZ 4150 HIV Infections MESH:D015658 marker/mechanism 15308739 +MBD1 4152 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +MBD2 8932 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +MBD2 8932 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +MBD3 53615 Autistic Disorder MESH:D001321 marker/mechanism 19921286 +MBD3L2 125997 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +MBD4 8930 Autistic Disorder MESH:D001321 marker/mechanism 19921286 +MBD4 8930 Uveal melanoma MESH:C536494 marker/mechanism 606660.0 +MBD5 55777 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +MBD5 55777 Mental Retardation, Autosomal Dominant 1 MESH:C566947 marker/mechanism 156200.0 +MBL2 4153 Birth Weight MESH:D001724 marker/mechanism 20923744 +MBL2 4153 Diabetes, Gestational MESH:D016640 marker/mechanism 15472209 +MBL2 4153 HIV Infections MESH:D015658 marker/mechanism 16960176 +MBL2 4153 Infections MESH:D007239 marker/mechanism 7707811 +MBL2 4153 Mannose-Binding Protein Deficiency MESH:C563602 marker/mechanism 614372.0 +MBL2 4153 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +MBL2 4153 Premature Birth MESH:D047928 marker/mechanism 16912583 +MBNL1 4154 Myotonia MESH:D009222 therapeutic 24039817 +MBNL1 4154 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +MBOAT1 154141 Cholestasis MESH:D002779 marker/mechanism 27989131 +MBOAT2 129642 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +MBOAT7 79143 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 57 OMIM:617188 marker/mechanism 617188.0 +MBOAT7 79143 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 26482880 +MBP 4155 Cerebrovascular Disorders MESH:D002561 marker/mechanism 15159442 +MBP 4155 Demyelinating Diseases MESH:D003711 marker/mechanism 2580064 +MBP 4155 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 11501064|15159442|17884951|24070732 +MBP 4155 Inflammation MESH:D007249 marker/mechanism 15159442 +MBP 4155 Neuromyelitis Optica MESH:D009471 marker/mechanism 18509235 +MBTPS1 8720 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 14563831 +MBTPS1 8720 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +MBTPS1 8720 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +MBTPS2 51360 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 14563831 +MBTPS2 51360 Ichthyosis follicularis atrichia photophobia syndrome MESH:C536085 marker/mechanism 308205.0 +MBTPS2 51360 Keratosis Follicularis Spinulosa Decalvans, X-Linked MESH:C536159 marker/mechanism 308800.0 +MBTPS2 51360 OLMSTED SYNDROME, X-LINKED OMIM:300918 marker/mechanism 300918.0 +MC1R 4157 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 18539553 +MC1R 4157 Hyperalgesia MESH:D006930 marker/mechanism 19996949 +MC1R 4157 Melanoma MESH:D008545 marker/mechanism 19578364|21559390|21983785 +MC1R 4157 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5 OMIM:613099 marker/mechanism 613099.0 +MC1R 4157 Oculocutaneous albinism type 2 MESH:C537730 marker/mechanism 203200.0 +MC1R 4157 Vitiligo MESH:D014820 marker/mechanism 22561518 +MC2R 4158 Familial Glucocorticoid Deficiency 1 MESH:C565974 marker/mechanism 202200.0 +MC2R 4158 Hypertension MESH:D006973 marker/mechanism 11082157 +MC2R 4158 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +MC3R 4159 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9 OMIM:602025 marker/mechanism 602025.0 +MC4R 4160 Body Weight MESH:D001835 marker/mechanism 22344219|22344221 +MC4R 4160 Hyperinsulinism MESH:D006946 marker/mechanism 23251400 +MC4R 4160 Hyperphagia MESH:D006963 marker/mechanism 23251400 +MC4R 4160 Insulin Resistance MESH:D007333 marker/mechanism 18454146 +MC4R 4160 Obesity MESH:D009765 marker/mechanism 17143585|18454148|19079260|19079261|19151714|23251400 +MC4R 4160 Obesity, Morbid MESH:D009767 marker/mechanism 29273807|29311635 +MCAM 4162 Autoimmune Diseases of the Nervous System MESH:D020274 therapeutic 23595028 +MCAM 4162 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 22784439|23621518 +MCAM 4162 Multiple Sclerosis MESH:D009103 therapeutic 23595028 +MCAM 4162 Neurogenic Inflammation MESH:D020078 therapeutic 23595028 +MCAM 4162 Peritoneal Neoplasms MESH:D010534 marker/mechanism 22784439|23621518 +MCC 4163 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 8071957 +MCC 4163 Autistic Disorder MESH:D001321 marker/mechanism 8071957 +MCC 4163 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +MCC 4163 Intellectual Disability MESH:D008607 marker/mechanism 8071957 +MCC 4163 Rectal Neoplasms MESH:D012004 marker/mechanism 8071957 +MCCC1 56922 3-methylcrotonyl CoA carboxylase 1 deficiency MESH:C535308 marker/mechanism 210200.0 +MCCC1 56922 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +MCCC2 64087 3-methylcrotonyl CoA carboxylase 2 deficiency MESH:C535309 marker/mechanism 210210.0 +MCEE 84693 Methylmalonyl-CoA Epimerase Deficiency MESH:C565386 marker/mechanism 251120.0 +MCFD2 90411 FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2 OMIM:613625 marker/mechanism 613625.0 +MCL1 4170 Barrett Esophagus MESH:D001471 marker/mechanism 21127259 +MCL1 4170 Leishmaniasis MESH:D007896 marker/mechanism 26670606 +MCL1 4170 Lung Neoplasms MESH:D008175 marker/mechanism 19903766|27935865 +MCL1 4170 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 12754746 +MCL1 4170 Multiple Myeloma MESH:D009101 marker/mechanism 12429644 +MCL1 4170 Sarcoma MESH:D012509 marker/mechanism 15217956 +MCM10 55388 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MCM2 4171 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MCM2 4171 Colonic Neoplasms MESH:D003110 therapeutic 23770000 +MCM2 4171 DEAFNESS, AUTOSOMAL DOMINANT 70 OMIM:616968 marker/mechanism 616968.0 +MCM4 4173 IMMUNODEFICIENCY 54 OMIM:609981 marker/mechanism 609981.0 +MCM6 4175 Lactose Intolerance, Adult Type MESH:C562601 marker/mechanism 223100.0 +MCM8 84515 PREMATURE OVARIAN FAILURE 10 OMIM:612885 marker/mechanism 612885.0 +MCM9 254394 OVARIAN DYSGENESIS 4 OMIM:616185 marker/mechanism 616185.0 +MCOLN1 57192 Mucolipidoses MESH:D009081 marker/mechanism 252650.0 20864526|21613607 +MCPH1 79648 Microcephaly, Primary Autosomal Recessive, 1 MESH:C565384 marker/mechanism 251200.0 +MCPT1 17224 Depressive Disorder MESH:D003866 marker/mechanism 19058337 +MCPT1 17224 Hypertension MESH:D006973 marker/mechanism 11416217 +MDH1 4190 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +MDH1 4190 Hypertension MESH:D006973 marker/mechanism 22228705 +MDH1 4190 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MDH1 4190 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +MDH1 4190 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MDH2 4191 Carcinoma MESH:D002277 marker/mechanism 12376462 +MDH2 4191 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +MDH2 4191 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51 OMIM:617339 marker/mechanism 617339.0 +MDH2 4191 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +MDH2 4191 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +MDK 4192 Anxiety Disorders MESH:D001008 marker/mechanism 19217924 +MDK 4192 Diabetic Nephropathies MESH:D003928 marker/mechanism 17607302 +MDK 4192 Glioma MESH:D005910 marker/mechanism 21233844 +MDK 4192 Memory Disorders MESH:D008569 marker/mechanism 19217924 +MDK 4192 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +MDM2 4193 Acquired Hyperostosis Syndrome MESH:D020083 marker/mechanism 19779722 +MDM2 4193 Breast Neoplasms MESH:D001943 marker/mechanism 26229107 +MDM2 4193 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 19941079|21268124 +MDM2 4193 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 614401.0 15550242 +MDM2 4193 HIV Infections MESH:D015658 marker/mechanism 12878215 +MDM2 4193 Infertility, Male MESH:D007248 marker/mechanism 22773013 +MDM2 4193 Melanoma MESH:D008545 marker/mechanism 17210701 +MDM2 4193 Precancerous Conditions MESH:D011230 marker/mechanism 14555611 +MDM2 4193 Prostatic Neoplasms MESH:D011471 marker/mechanism 20875869 +MDM2 4193 Stomach Neoplasms MESH:D013274 marker/mechanism 31945315 +MDM4 4194 Breast Neoplasms MESH:D001943 marker/mechanism 23535733 +MDM4 4194 Glioblastoma MESH:D005909 marker/mechanism 20472715 +MDM4 4194 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +ME1 4199 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +ME1 4199 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +ME1 4199 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +ME1 4199 Obesity MESH:D009765 marker/mechanism 19270708 +ME1 4199 Weight Gain MESH:D015430 marker/mechanism 19030233 +MECOM 2122 Breast Neoplasms MESH:D001943 marker/mechanism 23770046 +MECOM 2122 Colonic Neoplasms MESH:D003110 marker/mechanism 23770046 +MECOM 2122 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29047144 +MECOM 2122 Leukemia, Lymphoid MESH:D007945 marker/mechanism 23770046 +MECOM 2122 Leukemia, Myeloid MESH:D007951 marker/mechanism 23770046 +MECOM 2122 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 30472098 +MECOM 2122 Myeloproliferative Disorders MESH:D009196 marker/mechanism 29047144 +MECOM 2122 Nasopharyngeal Neoplasms MESH:D009303 marker/mechanism 20512145 +MECOM 2122 Ovarian Neoplasms MESH:D010051 marker/mechanism 23770046 +MECOM 2122 Pancytopenia MESH:D010198 marker/mechanism 27725143 +MECOM 2122 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +MECOM 2122 Splenomegaly MESH:D013163 marker/mechanism 27725143 +MECP2 4204 Anxiety Disorders MESH:D001008 marker/mechanism 22231481 +MECP2 4204 Autistic Disorder MESH:D001321 marker/mechanism 300496.0 15211631|18621663|19921286 +MECP2 4204 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 26189965 +MECP2 4204 Child Development Disorders, Pervasive MESH:D002659 marker/mechanism 22231481 +MECP2 4204 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20711185 +MECP2 4204 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19559301 +MECP2 4204 Developmental Disabilities MESH:D002658 marker/mechanism 19559301 +MECP2 4204 Disease Models, Animal MESH:D004195 marker/mechanism 28592917|33010341 +MECP2 4204 Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations MESH:C566878 marker/mechanism 300673.0 20098342 +MECP2 4204 Epilepsy MESH:D004827 marker/mechanism 29942082 +MECP2 4204 Hyperalgesia MESH:D006930 marker/mechanism 33010341 +MECP2 4204 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13 OMIM:300055 marker/mechanism 300055.0 +MECP2 4204 Intellectual Disability MESH:D008607 marker/mechanism 19921286|20098342 +MECP2 4204 Learning Disabilities MESH:D007859 marker/mechanism 19921286 +MECP2 4204 Lubs X-linked mental retardation syndrome MESH:C537723 marker/mechanism 300260.0 +MECP2 4204 Muscle Hypotonia MESH:D009123 marker/mechanism 19559301 +MECP2 4204 Myoclonus MESH:D009207 marker/mechanism 19559301 +MECP2 4204 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +MECP2 4204 Psychomotor Disorders MESH:D011596 marker/mechanism 20098342 +MECP2 4204 Pulmonary Fibrosis MESH:D011658 marker/mechanism 21435439 +MECP2 4204 Respiratory Insufficiency MESH:D012131 marker/mechanism 19559301 +MECP2 4204 Rett Syndrome MESH:D015518 marker/mechanism 312750.0 14593183|16670375|17433737|19000991|19190538|19559301|19921286|20098342|21316312|21966470|22343140|22532851|23892605|26214522|28498846|28592917|33010341 +MECP2 4204 Seizures MESH:D012640 marker/mechanism 19921286 +MECR 51102 DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES OMIM:617282 marker/mechanism 617282.0 +MED1 5469 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20007298 +MED1 5469 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16109766 +MED1 5469 Endometriosis MESH:D004715 marker/mechanism 22138541 +MED12 9968 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 24747642 +MED12 9968 Blepharophimosis syndrome Ohdo type MESH:C536232 marker/mechanism 300895.0 +MED12 9968 Breast Neoplasms MESH:D001943 marker/mechanism 25038752|26437033 +MED12 9968 Fibroadenoma MESH:D018226 marker/mechanism 25038752|26437033 +MED12 9968 Lujan Fryns syndrome MESH:C537724 marker/mechanism 309520.0 +MED12 9968 Opitz-Kaveggia syndrome MESH:C537923 marker/mechanism 305450.0 17334363 +MED12 9968 Phyllodes Tumor MESH:D003557 marker/mechanism 26437033 +MED12 9968 Prostatic Neoplasms MESH:D011471 marker/mechanism 22610119|29610475 +MED13L 23389 IMPAIRED INTELLECTUAL DEVELOPMENT AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS OMIM:616789 marker/mechanism 616789.0 +MED13L 23389 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +MED13L 23389 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +MED14 9282 Endometriosis MESH:D004715 marker/mechanism 22138541 +MED16 10025 Endometriosis MESH:D004715 marker/mechanism 22138541 +MED17 9440 Endometriosis MESH:D004715 marker/mechanism 22138541 +MED17 9440 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY OMIM:613668 marker/mechanism 613668.0 +MED23 9439 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 18, WITH OR WITHOUT EPILEPSY OMIM:614249 marker/mechanism 614249.0 +MED25 81857 BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME OMIM:616449 marker/mechanism 616449.0 +MED25 81857 Charcot-Marie-Tooth disease, Type 2B2 MESH:C537991 marker/mechanism 605589.0 +MED28 80306 Breast Neoplasms MESH:D001943 marker/mechanism 21942447 +MED28 80306 Neoplasm Metastasis MESH:D009362 marker/mechanism 21942447 +MED4 29079 Endometriosis MESH:D004715 marker/mechanism 22138541 +MEF2A 4205 Coronary Artery Disease, Autosomal Dominant, 1 MESH:C564258 marker/mechanism 608320 +MEF2C 4208 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20412115 +MEF2C 4208 Autistic Disorder MESH:D001321 marker/mechanism 19131610 +MEF2C 4208 Epilepsy MESH:D004827 marker/mechanism 20412115|29942082 +MEF2C 4208 Intellectual Disability MESH:D008607 marker/mechanism 20412115 +MEF2C 4208 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +MEF2C 4208 NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, STEREOTYPIC HAND MOVEMENTS, AND IMPAIRED LANGUAGE OMIM:613443 marker/mechanism 613443 +MEF2C 4208 Status Epilepticus MESH:D013226 marker/mechanism 18949272 +MEF2C 4208 Stereotypic Movement Disorder MESH:D019956 marker/mechanism 20412115 +MEF2D 4209 Migraine without Aura MESH:D020326 marker/mechanism 22683712 +MEFV 4210 Acne Vulgaris MESH:D000152 marker/mechanism 27106250 +MEFV 4210 Arthritis, Psoriatic MESH:D015535 marker/mechanism 17408446 +MEFV 4210 Familial Mediterranean Fever MESH:D010505 marker/mechanism 134610|249100 15805719|21329287 +MEFV 4210 Hidradenitis Suppurativa MESH:D017497 marker/mechanism 27106250 +MEFV 4210 Pyoderma Gangrenosum MESH:D017511 marker/mechanism 27106250 +MEG3 55384 Cell Transformation, Neoplastic MESH:D002471 therapeutic 34520792 +MEG3 55384 Cleft Palate MESH:D002972 marker/mechanism 33812962 +MEG3 55384 Cognition Disorders MESH:D003072 therapeutic 35164634 +MEGF10 84466 Deglutition Disorders MESH:D003680 marker/mechanism 22101682 +MEGF10 84466 Muscular Diseases MESH:D009135 marker/mechanism 22101682 +MEGF10 84466 Respiratory Distress Syndrome, Newborn MESH:D012127 marker/mechanism 22101682 +MEGF8 1954 Acrocephalopolysyndactyly Type II MESH:C563187 marker/mechanism 614976.0 +MEIS1 4211 Breast Neoplasms MESH:D001943 marker/mechanism 19776672 +MEIS1 4211 Restless Legs Syndrome MESH:D012148 marker/mechanism 17637780|28604731 +MEIS1 4211 Sleep Initiation and Maintenance Disorders MESH:D007319 marker/mechanism 28604731 +MEIS1-AS3 730198 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +MEIS2 4212 Cardiac Malformation, Cleft Lip-Palate, Microcephaly and Digital Anomalies MESH:C563414 marker/mechanism 600987.0 +MELK 9833 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MELTF 4241 Melanoma MESH:D008545 marker/mechanism 16704991 +MEN1 4221 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 24747642 +MEN1 4221 Gastrinoma MESH:D015408 marker/mechanism 17961653 +MEN1 4221 Glucagonoma MESH:D005935 marker/mechanism 17961653 +MEN1 4221 Insulinoma MESH:D007340 marker/mechanism 17961653 +MEN1 4221 Multiple Endocrine Neoplasia Type 1 MESH:D018761 marker/mechanism 131100.0 19847644 +MEN1 4221 Neuroendocrine Tumors MESH:D018358 marker/mechanism 21252315 +MEN1 4221 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17961653|21252315 +MEN1 4221 Vipoma MESH:D003969 marker/mechanism 17961653 +MEOX1 4222 Adenocarcinoma of Lung MESH:D000077192 therapeutic 34837450 +MEOX1 4222 Carcinoma, Non-Small-Cell Lung MESH:D002289 therapeutic 34837450 +MEOX1 4222 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +MEOX1 4222 Klippel Feil syndrome recessive type MESH:C536888 marker/mechanism 214300.0 +MEOX2 4223 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MEOX2 4223 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +MEP1A 4224 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +MEPE 56955 Fractures, Bone MESH:D050723 marker/mechanism 22504420 +MEPE 56955 Osteomalacia MESH:D010018 marker/mechanism 11414762 +MERTK 10461 Carcinoma MESH:D002277 marker/mechanism 19028587 +MERTK 10461 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +MERTK 10461 Pulmonary Embolism MESH:D011655 therapeutic 19028587 +MERTK 10461 Retinitis Pigmentosa MESH:D012174 marker/mechanism 11062461 +MERTK 10461 RETINITIS PIGMENTOSA 38 OMIM:613862 marker/mechanism 613862.0 +MERTK 10461 Thromboembolism MESH:D013923 therapeutic 17047157 +MERTK 10461 Thrombosis MESH:D013927 marker/mechanism 15130911 +MESP2 145873 Spondylocostal dysostosis, autosomal recessive MESH:C535781 marker/mechanism 277300|608681 +MEST 4232 Weight Gain MESH:D015430 marker/mechanism 19030233 +MET 4233 Adenocarcinoma MESH:D000230 marker/mechanism 20934974|22042947 +MET 4233 Astrocytoma MESH:D001254 marker/mechanism 11223164 +MET 4233 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +MET 4233 Autistic Disorder MESH:D001321 marker/mechanism 17053076|21328570 +MET 4233 Carcinogenesis MESH:D063646 marker/mechanism 32045588 +MET 4233 Carcinoma MESH:D002277 marker/mechanism 20661229 +MET 4233 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 114550 32045588 +MET 4233 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21623265|21815704|22787409|24688052 +MET 4233 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 605074 25401301 +MET 4233 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 22948846 +MET 4233 Cognition Disorders MESH:D003072 marker/mechanism 20080979 +MET 4233 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +MET 4233 DEAFNESS, AUTOSOMAL RECESSIVE 97 OMIM:616705 marker/mechanism 616705 +MET 4233 Disease Models, Animal MESH:D004195 marker/mechanism 32045588 +MET 4233 Esophageal Neoplasms MESH:D004938 marker/mechanism 22042947 +MET 4233 Fatty Liver MESH:D005234 marker/mechanism 32045588 +MET 4233 Glioblastoma MESH:D005909 marker/mechanism 22162573 +MET 4233 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +MET 4233 Hepatomegaly MESH:D006529 marker/mechanism 32045588 +MET 4233 Hypertriglyceridemia MESH:D015228 marker/mechanism 32045588 +MET 4233 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 22683780 +MET 4233 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11956651 +MET 4233 Lung Neoplasms MESH:D008175 marker/mechanism 20934974 +MET 4233 Lymphatic Metastasis MESH:D008207 marker/mechanism 29426936 +MET 4233 Melanoma MESH:D008545 marker/mechanism 29426936 +MET 4233 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +MET 4233 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15654357 +MET 4233 Neoplasm Metastasis MESH:D009362 marker/mechanism 20080979|21225626 +MET 4233 Neuroblastoma MESH:D009447 marker/mechanism 16051641 +MET 4233 Osteofibrous Dysplasia MESH:C563276 marker/mechanism 607278 +MET 4233 Osteosarcoma MESH:D012516 marker/mechanism 22235915 +MET 4233 Ovarian Neoplasms MESH:D010051 marker/mechanism 20661229 +MET 4233 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +MET 4233 Schizophrenia MESH:D012559 marker/mechanism 20080979 +MET 4233 Sinusitis MESH:D012852 marker/mechanism 18391768 +MET 4233 Stomach Neoplasms MESH:D013274 marker/mechanism 22042947|22729845 +METRNL 284207 Glucose Intolerance MESH:D018149 therapeutic 30213948 +METRNL 284207 Insulin Resistance MESH:D007333 therapeutic 30213948 +METRNL 284207 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +METRNL 284207 Weight Gain MESH:D015430 therapeutic 30213948 +METTL13 51603 DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF OMIM:605429 marker/mechanism 605429 +METTL14 57721 Arsenic Poisoning MESH:D020261 marker/mechanism 35226250 +METTL14 57721 Cardiomyopathies MESH:D009202 marker/mechanism 34648132 +METTL14 57721 Cardiotoxicity MESH:D066126 marker/mechanism 34648132 +METTL14 57721 Edema MESH:D004487 marker/mechanism 34648132 +METTL14 57721 Insulin Resistance MESH:D007333 marker/mechanism 35226250 +METTL14 57721 Multiple Myeloma MESH:D009101 marker/mechanism 35038059 +METTL14 57721 Necrosis MESH:D009336 marker/mechanism 34648132 +METTL14 57721 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 34648132 +METTL23 124512 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 44 OMIM:615942 marker/mechanism 615942.0 +METTL23 124512 Intellectual Disability MESH:D008607 marker/mechanism 24626631 +METTL3 56339 Emphysema MESH:D004646 therapeutic 33660100 +METTL3 56339 Multiple Myeloma MESH:D009101 marker/mechanism 35038059 +METTL6 131965 Breast Neoplasms MESH:D001943 marker/mechanism 25151356 +MEX3C 51320 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MEX3C 51320 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +MFAP2 4237 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +MFAP4 4239 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MFAP5 8076 AORTIC ANEURYSM, FAMILIAL THORACIC 9 OMIM:616166 marker/mechanism 616166.0 +MFF 56947 ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2 OMIM:617086 marker/mechanism 617086.0 +MFF 56947 Myocardial Infarction MESH:D009203 marker/mechanism 23867156 +MFF 56947 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 23867156 +MFGE8 4240 Breast Neoplasms MESH:D001943 marker/mechanism 21127199 +MFGE8 4240 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 21505870 +MFGE8 4240 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +MFN1 55669 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22975021 +MFN1 55669 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254 +MFN2 9927 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22975021 +MFN2 9927 Cardiomegaly MESH:D006332 marker/mechanism 17499311 +MFN2 9927 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B OMIM:617087 marker/mechanism 617087.0 +MFN2 9927 Charcot-Marie-Tooth Disease, Axonal, Type 2A2 MESH:C563757 marker/mechanism 609260.0 +MFN2 9927 Diabetic Nephropathies MESH:D003928 marker/mechanism 27997345 +MFN2 9927 Hereditary Motor And Sensory Neuropathy VI MESH:C562851 marker/mechanism 601152.0 +MFN2 9927 Hyperalgesia MESH:D006930 marker/mechanism 28587902 +MFN2 9927 Ventricular Remodeling MESH:D020257 marker/mechanism 20886221 +MFRP 83552 MICROPHTHALMIA, ISOLATED 5 OMIM:611040 marker/mechanism 611040.0 +MFRP 83552 Nanophthalmos 2 MESH:C563700 marker/mechanism 609549.0 +MFSD2A 84879 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MFSD2A 84879 Intellectual Disability MESH:D008607 marker/mechanism 26005865 +MFSD2A 84879 Microcephaly MESH:D008831 marker/mechanism 26005865|26005868 +MFSD2A 84879 NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN IMAGING ABNORMALITIES OMIM:616486 marker/mechanism 616486.0 +MFSD2A 84879 Speech Disorders MESH:D013064 marker/mechanism 26005865 +MFSD8 256471 Ceroid Lipofuscinosis, Neuronal, 7 MESH:C563989 marker/mechanism 610951.0 +MFSD8 256471 MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT OMIM:616170 marker/mechanism 616170.0 +MGA 23269 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +MGA 23269 Lymphoma, T-Cell MESH:D016399 marker/mechanism 26192917 +MGA 23269 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 24413735 +MGA 23269 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +MGARP 84709 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +MGAT2 4247 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MGAT2 4247 Congenital disorder of glycosylation type 2A MESH:C535752 marker/mechanism 212066.0 +MGAT5 4249 Enterovirus Infections MESH:D004769 marker/mechanism 28446605 +MGAT5 4249 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 23798564 +MGAT5B 146664 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +MGLL 11343 Liver Cirrhosis MESH:D008103 therapeutic 30301768 +MGLL 11343 Osteoporosis MESH:D010024 marker/mechanism 18924182 +MGME1 92667 Emaciation MESH:D004614 marker/mechanism 23313956 +MGME1 92667 Mitochondrial Diseases MESH:D028361 marker/mechanism 23313956 +MGME1 92667 MITOCHONDRIAL DNA DEPLETION SYNDROME 11 OMIM:615084 marker/mechanism 615084.0 +MGME1 92667 Ophthalmoplegia MESH:D009886 marker/mechanism 23313956 +MGME1 92667 Respiratory Insufficiency MESH:D012131 marker/mechanism 23313956 +MGMT 4255 Brain Neoplasms MESH:D001932 marker/mechanism 20131314 +MGMT 4255 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25520135 +MGMT 4255 Glioblastoma MESH:D005909 marker/mechanism 20131314|22162573 +MGMT 4255 Glioma MESH:D005910 marker/mechanism 16033832|16899598|19901110 +MGMT 4255 Leukemia MESH:D007938 marker/mechanism 16412662 +MGMT 4255 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MGMT 4255 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 26410583 +MGMT 4255 Mouth Neoplasms MESH:D009062 marker/mechanism 24991542 +MGMT 4255 Necrosis MESH:D009336 therapeutic 21619552 +MGMT 4255 Precancerous Conditions MESH:D011230 marker/mechanism 24991542 +MGMT 4255 Recurrence MESH:D012008 marker/mechanism 20131314 +MGMT 4255 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 24991542 +MGP 4256 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MGP 4256 Bicuspid Aortic Valve Disease MESH:D000082882 marker/mechanism 19350115 +MGP 4256 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +MGP 4256 Keutel syndrome MESH:C536167 marker/mechanism 245150.0 21705322 +MGP 4256 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MGP 4256 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942 +MGP 4256 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +MGP 4256 Uremia MESH:D014511 marker/mechanism 19092814 +MGP 4256 Varicose Veins MESH:D014648 marker/mechanism 17643059 +MGP 4256 Vascular Calcification MESH:D061205 marker/mechanism 21705322 +MGST1 4257 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +MIA 8190 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +MIA3 375056 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990|34961328 +MIA3 375056 Myocardial Infarction MESH:D009203 marker/mechanism 19198609 +MIAT 440823 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 17066261 +MIB1 57534 LEFT VENTRICULAR NONCOMPACTION 7 OMIM:615092 marker/mechanism 615092.0 +MIB1 57534 Seizures MESH:D012640 marker/mechanism 20943912 +MICA 100507436 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21499248 +MICA 100507436 Coronary Aneurysm MESH:D003323 marker/mechanism 10899738 +MICA 100507436 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +MICAL1 64780 EPILEPSY, FAMILIAL TEMPORAL LOBE, 1 OMIM:600512 marker/mechanism 600512.0 +MICAL2 9645 Liver Cirrhosis MESH:D008103 marker/mechanism 32659284 +MICB 4277 Severe Dengue MESH:D019595 marker/mechanism 22001756 +MICU1 10367 Basal Ganglia Diseases MESH:D001480 marker/mechanism 24336167 +MICU1 10367 Learning Disabilities MESH:D007859 marker/mechanism 24336167 +MICU1 10367 Movement Disorders MESH:D009069 marker/mechanism 24336167 +MICU1 10367 Muscular Diseases MESH:D009135 marker/mechanism 24336167 +MICU1 10367 MYOPATHY WITH EXTRAPYRAMIDAL SIGNS OMIM:615673 marker/mechanism 615673.0 +MID1 4281 Opitz GBBB Syndrome, X-Linked MESH:C567932 marker/mechanism 300000.0 +MID1IP1 58526 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MID2 11043 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 101 OMIM:300928 marker/mechanism 300928.0 +MIER2 54531 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +MIER2 54531 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +MIF 4282 Anxiety Disorders MESH:D001008 marker/mechanism 20177408 +MIF 4282 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 16872482 +MIF 4282 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 30503813 +MIF 4282 Autistic Disorder MESH:D001321 marker/mechanism 18676531 +MIF 4282 Breast Neoplasms MESH:D001943 marker/mechanism 19602265 +MIF 4282 Carcinoma MESH:D002277 marker/mechanism 12376462 +MIF 4282 Colitis MESH:D003092 therapeutic 12105854 +MIF 4282 Depressive Disorder MESH:D003866 marker/mechanism 20177408 +MIF 4282 Disease Progression MESH:D018450 marker/mechanism 34797429 +MIF 4282 Inflammation MESH:D007249 marker/mechanism 20127836 +MIF 4282 Keloid MESH:D007627 marker/mechanism 20128793 +MIF 4282 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +MIF 4282 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +MIF 4282 Memory Disorders MESH:D008569 marker/mechanism 20177408 +MIF 4282 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +MIF 4282 Prostatic Neoplasms MESH:D011471 marker/mechanism 17728788 +MIF 4282 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 26752192 +MIF 4282 Rheumatoid Arthritis, Systemic Juvenile MESH:C565798 marker/mechanism 604302.0 +MIF 4282 Sepsis MESH:D018805 therapeutic 9892616 +MIF 4282 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 9372356 +MINDY3 80013 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MINPP1 9562 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +MINPP1 9562 Skin Diseases MESH:D012871 marker/mechanism 16835338 +MINPP1 9562 Thyroid cancer, follicular MESH:C572845 marker/mechanism 188470.0 +MIP 4284 Cataract MESH:D002386 marker/mechanism 10802646 +MIP 4284 CATARACT 15, MULTIPLE TYPES OMIM:615274 marker/mechanism 615274.0 +MIPEP 4285 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31 OMIM:617228 marker/mechanism 617228.0 +MIPOL1 145282 Polydactyly MESH:D017689 marker/mechanism 11954550 +MIR100 406892 Alzheimer Disease MESH:D000544 marker/mechanism 25992776 +MIR100 406892 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 30026881 +MIR100 406892 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR100 406892 Disease Progression MESH:D018450 marker/mechanism 30026881 +MIR100 406892 Glomerulonephritis MESH:D005921 marker/mechanism 25758243 +MIR100 406892 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR100 406892 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 24447120 +MIR100 406892 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR100 406892 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR100 406892 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30026881 +MIR100HG 399959 Pulmonary Fibrosis MESH:D011658 therapeutic 35472619 +MIR101-1 406893 Pulmonary Fibrosis MESH:D011658 therapeutic 28726637 +MIR101-2 406894 Breast Neoplasms MESH:D001943 marker/mechanism 24475105 +MIR103-1 723824 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR105 100124463 Embryo Loss MESH:D020964 marker/mechanism 35038060 +MIR106A 406899 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 20889678 +MIR106A 406899 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR106A 406899 Prostatic Neoplasms MESH:D011471 marker/mechanism 29845714 +MIR106B 406900 Autistic Disorder MESH:D001321 marker/mechanism 20374639 +MIR106B 406900 Colorectal Neoplasms MESH:D015179 marker/mechanism 22510560 +MIR106B 406900 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR106B 406900 Osteosarcoma MESH:D012516 marker/mechanism 22510560 +MIR107 406901 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25359176|28545106 +MIR107 406901 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR107 406901 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR10A 406902 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR10A 406902 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR10A 406902 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR10A 406902 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR10A 406902 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR10A 406902 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR10A 406902 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR10A 406902 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 24447120 +MIR10A 406902 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR10A 406902 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR10B 406903 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR10B 406903 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR10B 406903 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR10B 406903 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR10B 406903 Glomerulonephritis MESH:D005921 marker/mechanism 25758243 +MIR10B 406903 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 24447120 +MIR10B 406903 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR1-1 406904 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 30125006 +MIR1179 100302235 Pancreatic Neoplasms MESH:D010190 marker/mechanism 29859832 +MIR1193 100422837 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR1193 100422837 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR1197 100302250 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR1-1HG 128826 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +MIR122 406906 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR122 406906 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16924677 +MIR122 406906 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22045675|22363424|25359176|25527335|26489516|28545106|28844483|33483742 +MIR122 406906 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR122 406906 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR122 406906 Radiation Injuries MESH:D011832 marker/mechanism 32422326 +MIR122 406906 Radiation Injuries, Experimental MESH:D011833 marker/mechanism 32422326 +MIR1226 100302232 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR1228 100302201 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR124 100631041 Eye Injuries MESH:D005131 marker/mechanism 27208084 +MIR124 100631041 Retinal Diseases MESH:D012164 marker/mechanism 27208084 +MIR1246 100302142 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22048643 +MIR1246 100302142 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR1246 100302142 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1246 100302142 Lung Neoplasms MESH:D008175 marker/mechanism 35894553 +MIR1247 100302145 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1247 100302145 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR1249 100302149 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1249 100302149 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR124A-3 723951 Alzheimer Disease MESH:D000544 therapeutic 28867212 +MIR124A-3 723951 Learning Disabilities MESH:D007859 therapeutic 28867212 +MIR125A 406910 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR125A 406910 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR125A 406910 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +MIR125A 406910 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR125A 406910 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR125A 406910 Pulmonary Fibrosis MESH:D011658 therapeutic 30658076 +MIR125B1 406911 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR125B1 406911 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399 +MIR125B2 406912 Cardiomegaly MESH:D006332 therapeutic 29122578 +MIR125B2 406912 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR125B2 406912 Down Syndrome MESH:D004314 marker/mechanism 29403643 +MIR125B2 406912 Endomyocardial Fibrosis MESH:D004719 therapeutic 29122578 +MIR125B2 406912 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR125B2 406912 Myocardial Infarction MESH:D009203 therapeutic 29122578 +MIR125B2 406912 Ventricular Dysfunction, Left MESH:D018487 therapeutic 29122578 +MIR126 406913 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR126 406913 Carcinoma, Non-Small-Cell Lung MESH:D002289 therapeutic 20097187 +MIR126 406913 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399 +MIR126 406913 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR126 406913 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 21483773 +MIR126 406913 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR126 406913 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR1260A 100302236 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1260A 100302236 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR1260B 100422991 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1260B 100422991 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR1268A 100302233 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR127 406914 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR127 406914 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR127 406914 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR127 406914 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR127 406914 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR127 406914 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR1271 100302203 Colorectal Neoplasms MESH:D015179 marker/mechanism 29315995 +MIR1271 100302203 Neoplasm Invasiveness MESH:D009361 marker/mechanism 29315995 +MIR1273C 100422821 Colorectal Neoplasms MESH:D015179 marker/mechanism 25701956 +MIR1273C 100422821 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +MIR1273H 102466247 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1275 100302123 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR1275 100302123 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR128-1 406915 Hirschsprung Disease MESH:D006627 marker/mechanism 29429387 +MIR1281 100302237 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 27716620 +MIR128-2 406916 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR1285-1 100302218 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1290 100302276 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1291 100302221 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR129-2 406918 Neoplasms MESH:D009369 marker/mechanism 29212414 +MIR1296 100302150 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR1301 100302246 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR1303 100302284 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1304 100302240 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1306 100302197 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1306 100302197 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR1307 100302174 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1307 100302174 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR130A 406919 Adenocarcinoma, Bronchiolo-Alveolar MESH:D002282 marker/mechanism 25926378 +MIR130A 406919 Albuminuria MESH:D000419 marker/mechanism 24223694 +MIR130A 406919 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25359176|28545106 +MIR130A 406919 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR130A 406919 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR130A 406919 Obesity MESH:D009765 marker/mechanism 28242765 +MIR130A 406919 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR130B 406920 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR130B 406920 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR130B 406920 Colorectal Neoplasms MESH:D015179 marker/mechanism 22510560 +MIR130B 406920 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399 +MIR130B 406920 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR130B 406920 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR130B 406920 Obesity MESH:D009765 marker/mechanism 28242765 +MIR130B 406920 Osteosarcoma MESH:D012516 marker/mechanism 22510560 +MIR130B 406920 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR132 406921 Brain Injuries MESH:D001930 marker/mechanism 23159883 +MIR132 406921 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR132 406921 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR132 406921 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 34755307 +MIR133A1 406922 Fibrosis MESH:D005355 therapeutic 19893015 +MIR133A-2 723954 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 28751527 +MIR133A2 406923 Heart Failure MESH:D006333 marker/mechanism 28751527 +MIR134 406924 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR134 406924 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR134 406924 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR1343 100616437 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR135A-2 723955 Neuralgia MESH:D009437 marker/mechanism 31432094 +MIR135B 442891 Neuralgia MESH:D009437 marker/mechanism 31432094 +MIR135B 442891 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR136 406927 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR136 406927 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR136 406927 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR136 406927 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR137 406928 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR137 406928 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR137 406928 Schizophrenia MESH:D012559 marker/mechanism 21926974 +MIR138-1 406929 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR139 406931 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR140 406932 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR140 406932 Cognitive Dysfunction MESH:D060825 marker/mechanism 32062618 +MIR140 406932 Diabetes Complications MESH:D048909 marker/mechanism 32062618 +MIR140 406932 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399 +MIR140 406932 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR140 406932 Pulmonary Fibrosis MESH:D011658 marker/mechanism|therapeutic 25926378|32462952 +MIR141 406933 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR141 406933 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424|28545106 +MIR141 406933 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR141 406933 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR141 406933 Neoplasm Invasiveness MESH:D009361 therapeutic 27616325 +MIR141 406933 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR142 406934 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 29844410 +MIR142 406934 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR142 406934 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399 +MIR142 406934 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR143 406935 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR143 406935 Carcinogenesis MESH:D063646 therapeutic 28736328 +MIR143 406935 Cell Transformation, Neoplastic MESH:D002471 therapeutic 26721309 +MIR143 406935 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 30125006 +MIR143 406935 Cholestasis MESH:D002779 marker/mechanism 30125006 +MIR143 406935 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 17892514 +MIR143 406935 Lymphoma MESH:D008223 therapeutic 28736328 +MIR143 406935 Lymphoma, B-Cell MESH:D016393 marker/mechanism 17892514 +MIR143 406935 Neoplasms, Experimental MESH:D009374 therapeutic 28736328|31152816 +MIR144 406936 Adenocarcinoma, Bronchiolo-Alveolar MESH:D002282 marker/mechanism 25926378 +MIR144 406936 Adenoma MESH:D000236 marker/mechanism 25926378 +MIR144 406936 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR144 406936 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR145 406937 Albuminuria MESH:D000419 marker/mechanism 24223694 +MIR145 406937 Arsenic Poisoning MESH:D020261 marker/mechanism 29705342 +MIR145 406937 Breast Neoplasms MESH:D001943 marker/mechanism 21463514 +MIR145 406937 Carcinoma, Non-Small-Cell Lung MESH:D002289 therapeutic 20097187 +MIR145 406937 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 30365097 +MIR145 406937 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 30026881 +MIR145 406937 Diabetic Nephropathies MESH:D003928 marker/mechanism 24223694 +MIR145 406937 Disease Progression MESH:D018450 marker/mechanism 30026881 +MIR145 406937 Esophageal Neoplasms MESH:D004938 marker/mechanism 21248297 +MIR145 406937 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR145 406937 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 17892514 +MIR145 406937 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR145 406937 Lymphoma, B-Cell MESH:D016393 marker/mechanism 17892514 +MIR145 406937 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 24447120 +MIR145 406937 Myocardial Infarction MESH:D009203 marker/mechanism 29956747 +MIR145 406937 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR145 406937 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30026881 +MIR145A 387163 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR1468 100302115 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR1468 100302115 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR1469 100302258 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR146A 406938 Alzheimer Disease MESH:D000544 marker/mechanism 22099153|25992776 +MIR146A 406938 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR146A 406938 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR146A 406938 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR146A 406938 Coronary Artery Disease MESH:D003324 marker/mechanism 20524934 +MIR146A 406938 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR146B 574447 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR146B 574447 Coronary Artery Disease MESH:D003324 marker/mechanism 20524934 +MIR146B 574447 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR146B 574447 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 21789255 +MIR148A 406940 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR148A 406940 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25359176|28545106 +MIR148A 406940 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR148A 406940 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR148A 406940 Liver Neoplasms MESH:D008113 therapeutic 32268151 +MIR148A 406940 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR148B 442892 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR148B 442892 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR148B 442892 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR148B 442892 Reperfusion Injury MESH:D015427 marker/mechanism 30308185 +MIR149 406941 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR150 406942 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR150 406942 Colitis MESH:D003092 marker/mechanism 26937033 +MIR150 406942 Diarrhea MESH:D003967 marker/mechanism 26937033 +MIR150 406942 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR150 406942 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR150 406942 Lentivirus Infections MESH:D016180 marker/mechanism 26937033 +MIR150 406942 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR150 406942 Pneumonia MESH:D011014 therapeutic 29205062 +MIR151 387169 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR151 387169 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR151 387169 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR151A 442893 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR151A 442893 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR151B 100616247 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR152 406943 Acute Kidney Injury MESH:D058186 marker/mechanism 32583487 +MIR152 406943 Arthritis, Experimental MESH:D001169 marker/mechanism 25194984 +MIR152 406943 Breast Neoplasms MESH:D001943 marker/mechanism 28544374 +MIR152 406943 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR153 387171 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR153C 100033678 Bone Diseases, Developmental MESH:D001848 marker/mechanism 22253472 +MIR153C 100033678 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 22253472 +MIR154 406946 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR154 406946 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR154 406946 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR154 406946 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR154 406946 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR155 406947 Albuminuria MESH:D000419 marker/mechanism 24223694 +MIR155 406947 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR155 406947 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 28688901 +MIR155 406947 Down Syndrome MESH:D004314 marker/mechanism 29403643 +MIR155 406947 Lung Neoplasms MESH:D008175 marker/mechanism 25105010|27692344 +MIR155 406947 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +MIR155 406947 Neoplasm Invasiveness MESH:D009361 marker/mechanism 28315615 +MIR155 406947 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542|27692344 +MIR155 406947 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR15A 406948 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR15A 406948 Leukemia, Promyelocytic, Acute MESH:D015473 therapeutic 21056550 +MIR15A 406948 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR15A 406948 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR15B 406949 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR15B 406949 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR16-1 406950 Leukemia, Promyelocytic, Acute MESH:D015473 therapeutic 21056550 +MIR17 406952 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 30365097 +MIR17 406952 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR17 406952 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR17 406952 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR17 406952 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR17HG 407975 Bone Diseases, Developmental MESH:D001848 marker/mechanism 21892160 +MIR17HG 407975 Coronary Disease MESH:D003327 marker/mechanism 28869590 +MIR17HG 407975 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +MIR17HG 407975 Growth Disorders MESH:D006130 marker/mechanism 21892160 +MIR17HG 407975 Limb Deformities, Congenital MESH:D017880 marker/mechanism 21892160 +MIR17HG 407975 Microcephaly MESH:D008831 marker/mechanism 21892160 +MIR181A1 406995 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR181B-1 723890 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20868653 +MIR181C 406957 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR181C 406957 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR181C 406957 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR181C 406957 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR181C 406957 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR181C 406957 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR181C 406957 Parkinson Disease MESH:D010300 marker/mechanism 28770951 +MIR181D 574457 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR181D 574457 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR181D 574457 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR182 406958 Eye Injuries MESH:D005131 marker/mechanism 27208084 +MIR182 406958 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR182 406958 Retinal Diseases MESH:D012164 marker/mechanism 27208084 +MIR183 406959 Brain Injuries MESH:D001930 marker/mechanism 23159883 +MIR183 406959 Eye Injuries MESH:D005131 marker/mechanism 27208084 +MIR183 406959 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR183 406959 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR183 406959 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR183 406959 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR183 406959 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR183 406959 Retinal Diseases MESH:D012164 marker/mechanism 27208084 +MIR184 406960 EDICT SYNDROME OMIM:614303 marker/mechanism 614303.0 +MIR184 406960 Macular Degeneration MESH:D008268 therapeutic 35690295 +MIR184 406960 Obesity MESH:D009765 marker/mechanism 23954404 +MIR185 406961 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR185 406961 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR186 406962 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR186 406962 Disease Progression MESH:D018450 marker/mechanism 34291859 +MIR186 406962 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR186 406962 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR186 406962 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR186 406962 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34291859 +MIR186 406962 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 34291859 +MIR188 406964 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR188 406964 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR18A 406953 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR18A 406953 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR18A 406953 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR18A 406953 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR18A 406953 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +MIR18B 574033 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR18B 574033 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR1908 100302263 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR190A 406965 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21750348 +MIR190A 406965 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR190A 406965 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR190B 100126346 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR190B 100126346 Lentivirus Infections MESH:D016180 marker/mechanism 26937033 +MIR191 406966 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643|29277653 +MIR191 406966 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR191 406966 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR191 406966 Kidney Diseases MESH:D007674 marker/mechanism 31775542 +MIR191 406966 Neoplasm Invasiveness MESH:D009361 marker/mechanism 29277653 +MIR1915 100302129 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR192 406967 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR192 406967 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22045675|25359176|28483554|28545106 +MIR192 406967 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399 +MIR192 406967 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR192 406967 Hepatomegaly MESH:D006529 therapeutic 28483554 +MIR192 406967 Kidney Diseases MESH:D007674 marker/mechanism 24880025 +MIR192 406967 Necrosis MESH:D009336 marker/mechanism 24880025 +MIR192 406967 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR193A 406968 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR193A 406968 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR193A 406968 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR193A 406968 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR193A 406968 Pulmonary Fibrosis MESH:D011658 therapeutic 30744607 +MIR193B 574455 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR193B 574455 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR193B 574455 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR193B 574455 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR193B 574455 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 35764155 +MIR194-1 406969 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28844483 +MIR194-2 406970 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR195 406971 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399 +MIR195 406971 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR195 406971 Hirschsprung Disease MESH:D006627 marker/mechanism 25007945 +MIR195 406971 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR196A 100314048 Disease Progression MESH:D018450 marker/mechanism 27816459 +MIR196A 100314048 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 27816459 +MIR196B 442920 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR196B 442920 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR196B 442920 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR197 406974 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR197 406974 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 27716620 +MIR197 406974 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR197 406974 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR199A2 406977 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 24447120 +MIR19A 406979 Adenocarcinoma, Bronchiolo-Alveolar MESH:D002282 marker/mechanism 25926378 +MIR19A 406979 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR19A 406979 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR19A 406979 Multiple Myeloma MESH:D009101 marker/mechanism 29687521 +MIR19A 406979 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR19A 406979 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR1A-1 387136 Lung Neoplasms MESH:D008175 marker/mechanism 23761296 +MIR200A 406983 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR200A 406983 Lung agenesis MESH:C562992 marker/mechanism 33048239 +MIR200A 406983 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR200B 406984 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 19839049|20099276 +MIR200B 406984 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21292642 +MIR200B 406984 Disease Progression MESH:D018450 marker/mechanism 19839049 +MIR200B 406984 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR200B 406984 Neoplasm Invasiveness MESH:D009361 therapeutic 19839049 +MIR200B 406984 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR200B 406984 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR200C 406985 Breast Neoplasms MESH:D001943 marker/mechanism|therapeutic 19839049|20099276 +MIR200C 406985 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR200C 406985 Disease Progression MESH:D018450 marker/mechanism 19839049 +MIR200C 406985 Endometrial Neoplasms MESH:D016889 marker/mechanism 22569286 +MIR200C 406985 Esophageal Neoplasms MESH:D004938 marker/mechanism 21248297 +MIR200C 406985 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR200C 406985 Lung agenesis MESH:C562992 marker/mechanism 33048239 +MIR200C 406985 Neoplasm Invasiveness MESH:D009361 therapeutic 19839049 +MIR200C 406985 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR200C 406985 Pulmonary Fibrosis MESH:D011658 marker/mechanism|therapeutic 25926378|29113749 +MIR201 387197 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR203 387199 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 32659284 +MIR203 387199 Liver Cirrhosis MESH:D008103 therapeutic 32659284 +MIR203A 406986 Carcinogenesis MESH:D063646 therapeutic 23968727 +MIR203A 406986 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR203A 406986 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR204 406987 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR204 406987 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR204 406987 Hypertension, Pulmonary MESH:D006976 marker/mechanism 26224795 +MIR204 406987 Nerve Degeneration MESH:D009410 therapeutic 36177783 +MIR204 406987 RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CATARACT OMIM:616722 marker/mechanism 616722.0 +MIR205 406988 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR205 406988 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21563230 +MIR205 406988 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21563230 +MIR205 406988 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 25586904 +MIR205 406988 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR205 406988 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR205 406988 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 24447120 +MIR205 406988 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR206 406989 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22975021|27538595 +MIR206 406989 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR206 406989 Disease Progression MESH:D018450 marker/mechanism 27538595 +MIR206 406989 Hirschsprung Disease MESH:D006627 marker/mechanism 25792468 +MIR206 406989 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR206 406989 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR207 387203 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR207 387203 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR207 387203 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR208A 406990 Cardiotoxicity MESH:D066126 marker/mechanism 26454886 +MIR208A 406990 Neuralgia MESH:D009437 marker/mechanism 31432094 +MIR20A 406982 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR20A 406982 Hypertrophy, Right Ventricular MESH:D017380 marker/mechanism 32720422 +MIR20B 574032 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR20B 574032 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR20B 574032 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR20B 574032 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR21 406991 Cardiomegaly MESH:D006332 marker/mechanism 17525252 +MIR21 406991 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism|therapeutic 26101800|27323401|27344173|28881718|29501572 +MIR21 406991 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR21 406991 Disease Progression MESH:D018450 marker/mechanism 27816459 +MIR21 406991 Endometriosis MESH:D004715 marker/mechanism 21063030 +MIR21 406991 Esophageal Neoplasms MESH:D004938 marker/mechanism 21248297 +MIR21 406991 Fibrosis MESH:D005355 marker/mechanism 23469132 +MIR21 406991 Heart Diseases MESH:D006331 marker/mechanism 29355689 +MIR21 406991 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR21 406991 Inflammation MESH:D007249 marker/mechanism 29355689 +MIR21 406991 Kidney Diseases MESH:D007674 marker/mechanism 23469132 +MIR21 406991 Lung Neoplasms MESH:D008175 marker/mechanism 27323401 +MIR21 406991 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +MIR21 406991 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR21 406991 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26101800|29501572 +MIR21 406991 Neoplasm Metastasis MESH:D009362 marker/mechanism 26101800 +MIR21 406991 Obesity MESH:D009765 marker/mechanism 23954404 +MIR21 406991 Prostatic Neoplasms MESH:D011471 marker/mechanism 23272133 +MIR210 406992 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR210 406992 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR210 406992 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR211 406993 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR2116 100313886 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR212 406994 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20613834|20711185 +MIR212 406994 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR212 406994 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR214 406996 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 27538595 +MIR214 406996 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR214 406996 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR214 406996 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR215 406997 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR215 406997 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR215 406997 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR215 406997 Neoplasm Invasiveness MESH:D009361 therapeutic 28887306 +MIR215 406997 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR215 406997 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR216A 406998 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR216B 100126319 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR217 406999 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR217 406999 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25538231 +MIR217 406999 Fibrosis MESH:D005355 marker/mechanism 26891083 +MIR217 406999 Inflammation MESH:D007249 marker/mechanism 26891083 +MIR217 406999 Neoplasm Invasiveness MESH:D009361 marker/mechanism 25538231 +MIR217 406999 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR218-1 407000 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424|30125006 +MIR218-1 407000 Cholestasis MESH:D002779 marker/mechanism 22363424|30125006 +MIR218-1 407000 Hirschsprung Disease MESH:D006627 marker/mechanism 25786906 +MIR218-2 407001 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 28864214 +MIR218-2 407001 Tobacco Use Disorder MESH:D014029 marker/mechanism 28864214 +MIR219A1 407002 Disease Models, Animal MESH:D004195 therapeutic 35962723 +MIR219A1 407002 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR219A1 407002 Osteoarthritis, Knee MESH:D020370 therapeutic 35962723 +MIR21A 387140 Weight Gain MESH:D015430 therapeutic 26996129 +MIR22 407004 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25359176|28545106 +MIR22 407004 Inflammation MESH:D007249 marker/mechanism 28161397 +MIR22 407004 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26244872 +MIR22 407004 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR221 407006 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR221 407006 Cataract MESH:D002386 marker/mechanism 30926320 +MIR221 407006 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR221 407006 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR221 407006 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR221 407006 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR221 407006 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR221 407006 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 35764155 +MIR222 407007 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR222 407007 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR222 407007 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR222 407007 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399|28545106 +MIR222 407007 Dyslipidemias MESH:D050171 marker/mechanism 34862716 +MIR222 407007 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR222 407007 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR222 407007 Plaque, Atherosclerotic MESH:D058226 marker/mechanism 34862716 +MIR222 407007 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 19487542 +MIR222 407007 Tongue Neoplasms MESH:D014062 marker/mechanism 19487542 +MIR223 407008 Colonic Neoplasms MESH:D003110 marker/mechanism 29660302 +MIR224 407009 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR224 407009 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR224 407009 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR22HG 84981 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MIR22HG 84981 Stomach Neoplasms MESH:D013274 marker/mechanism 30670679 +MIR23A 407010 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR23A 407010 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22975021 +MIR23A 407010 Autistic Disorder MESH:D001321 marker/mechanism 20374639 +MIR23A 407010 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR23A 407010 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR23B 407011 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR23B 407011 Cholangiocarcinoma MESH:D018281 marker/mechanism 34418280 +MIR23B 407011 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR23C 100500809 Pulmonary Fibrosis MESH:D011658 therapeutic 29216763 +MIR24-1 407012 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR24-2 407013 Breast Neoplasms MESH:D001943 marker/mechanism 21463514 +MIR2467 100616360 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 35225430 +MIR25 407014 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR25 407014 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR26A 100314290 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR26A 100314290 Arthritis, Experimental MESH:D001169 therapeutic 24423102 +MIR26A 100314290 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR26A 100314290 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR26A1 407015 Diabetes Complications MESH:D048909 marker/mechanism 35554780 +MIR26B 407017 Colorectal Neoplasms MESH:D015179 marker/mechanism 23922874 +MIR26B 407017 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR26B 407017 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR26B 407017 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR26B 407017 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR27A 407018 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR27A 407018 Multiple Myeloma MESH:D009101 marker/mechanism 35038059 +MIR27A 407018 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR27A 407018 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR27A 407018 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 35764155 +MIR27B 407019 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25359176|28545106 +MIR27B 407019 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR27B 407019 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR27B 407019 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR28 407020 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR28 407020 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR2861 100422910 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15 OMIM:613418 marker/mechanism 613418.0 +MIR290 100314249 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR290 100314249 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR291A 100049715 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR292 100049711 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR292 100049711 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR296 407022 Alzheimer Disease MESH:D000544 marker/mechanism 25992776 +MIR296 407022 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR299 407023 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR29A 407021 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR29A 407021 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22048643 +MIR29A 407021 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR29A 407021 Kidney Diseases MESH:D007674 therapeutic 30642005 +MIR29A 407021 Liver Neoplasms MESH:D008113 therapeutic 21175813 +MIR29A 407021 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR29B2 407025 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR29C 407026 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 30026881 +MIR29C 407026 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106|30515189 +MIR29C 407026 Disease Progression MESH:D018450 marker/mechanism 30026881 +MIR29C 407026 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR29C 407026 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR29C 407026 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR29C 407026 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR29C 407026 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30026881 +MIR300 100126297 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR300 100126297 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR300 100126297 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR301A 407027 Breast Neoplasms MESH:D001943 marker/mechanism 29763890 +MIR301A 407027 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 35305058 +MIR301A 407027 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR301A 407027 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR301A 407027 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR301B 100126318 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR301B 100126318 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR301B 100126318 Stomach Neoplasms MESH:D013274 marker/mechanism 35246762 +MIR302B 442894 Osteosarcoma MESH:D012516 therapeutic 23845851 +MIR302C 442895 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR302D 442896 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR302D 442896 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR30A 407029 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR30A 407029 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR30A 407029 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424|25359176|28545106 +MIR30A 407029 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR30A 407029 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR30A 407029 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR30A 407029 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR30A 407029 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR30A 407029 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR30A 407029 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR30A 407029 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR30B 407030 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +MIR30B 407030 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR30B 407030 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR30B 407030 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR30B 407030 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR30B 407030 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR30B 407030 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR30C-1 387227 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR30C-1 387227 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR30C1 407031 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 20889907 +MIR30C1 407031 Inflammation MESH:D007249 therapeutic 34217758 +MIR30C1 407031 Myocardial Infarction MESH:D009203 therapeutic 34217758 +MIR30C1 407031 Myocardial Reperfusion Injury MESH:D015428 therapeutic 34217758 +MIR30C2 407032 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR30D 407033 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR30D 407033 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR30D 407033 Fibrosis MESH:D005355 marker/mechanism 31697999 +MIR30D 407033 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR30D 407033 Kidney Diseases MESH:D007674 marker/mechanism 31697999 +MIR30D 407033 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR30D 407033 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR30E 407034 Fibrosis MESH:D005355 marker/mechanism 31697999 +MIR30E 407034 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR30E 407034 Kidney Diseases MESH:D007674 marker/mechanism 31697999 +MIR30E 407034 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR30E 407034 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR31 407035 Lung Neoplasms MESH:D008175 marker/mechanism 20237410 +MIR31 407035 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR31 407035 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR3135B 100616218 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR3173 100422981 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR31HG 554202 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +MIR32 407036 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 27716620 +MIR320A 407037 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR320A 407037 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106|30125006 +MIR320A 407037 Fatty Liver MESH:D005234 marker/mechanism 30125006 +MIR323 723839 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR323 723839 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR323A 442897 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR323B 574410 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR324 442898 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR324 442898 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR324 442898 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR325 442899 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR326 442900 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR326 442900 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR327 100124437 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR327 100124437 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR328 442901 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR328 442901 Osteosarcoma MESH:D012516 marker/mechanism 25605016 +MIR329-1 574408 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR330 442902 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR331 442903 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR331 442903 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR331 442903 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR331 442903 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR335 442904 Acute Kidney Injury MESH:D058186 marker/mechanism 36052886 +MIR335 442904 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR335 442904 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR335 442904 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR335 442904 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR335 442904 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR336 100314219 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR337 442905 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR337 442905 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR337 442905 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR337 442905 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR337 442905 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR337 442905 Osteoarthritis, Spine MESH:D055013 marker/mechanism 34697729 +MIR337 442905 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR337 442905 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR338 442906 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR338 442906 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR338 442906 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR338 442906 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR339 442907 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR339 442907 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR339 442907 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR33B 693120 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 30026881 +MIR33B 693120 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR33B 693120 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR33B 693120 Disease Progression MESH:D018450 marker/mechanism 30026881 +MIR33B 693120 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30026881 +MIR340 442908 Hyperplasia MESH:D006965 marker/mechanism 25926378 +MIR340 442908 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR340 442908 Melanoma MESH:D008545 marker/mechanism 25043973 +MIR340 442908 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR341 723846 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR342 442909 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR342 442909 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR342 442909 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR342 442909 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR344-1 100313981 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR344F 100526527 Neuralgia MESH:D009437 marker/mechanism 31432094 +MIR345 442910 Adenocarcinoma, Bronchiolo-Alveolar MESH:D002282 marker/mechanism 25926378 +MIR345 442910 Adenoma MESH:D000236 marker/mechanism 25926378 +MIR345 442910 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR345 442910 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR345 442910 Liver Cirrhosis MESH:D008103 therapeutic 36126797 +MIR345 442910 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR346 442911 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 27777383 +MIR346 442911 Colorectal Neoplasms MESH:D015179 marker/mechanism 34773443 +MIR346 442911 Disease Progression MESH:D018450 marker/mechanism 27777383 +MIR346 442911 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR346 442911 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 27501413 +MIR346 442911 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27501413|27777383 +MIR346 442911 Neoplasm Metastasis MESH:D009362 marker/mechanism 27501413|27777383 +MIR346 442911 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR347 100313982 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR347 100313982 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR3473 102466618 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR349 100313983 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR349 100313983 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR349 100313983 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR34A 407040 Anxiety Disorders MESH:D001008 marker/mechanism 27424985 +MIR34A 407040 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR34A 407040 Fatty Liver MESH:D005234 marker/mechanism 23834033 +MIR34A 407040 Glucose Intolerance MESH:D018149 marker/mechanism 23834033 +MIR34A 407040 Heart Diseases MESH:D006331 marker/mechanism 25448438 +MIR34A 407040 Inflammation MESH:D007249 marker/mechanism 23834033 +MIR34A 407040 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR34A 407040 Obesity MESH:D009765 marker/mechanism 23834033 +MIR34B 407041 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR34B 407041 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 30026881 +MIR34B 407041 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21339737 +MIR34B 407041 Disease Progression MESH:D018450 marker/mechanism 30026881 +MIR34B 407041 Lung Neoplasms MESH:D008175 marker/mechanism 21339737|25105010 +MIR34B 407041 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR34B 407041 Neoplasms, Experimental MESH:D009374 therapeutic 22113133 +MIR34B 407041 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30026881 +MIR34C 407042 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR34C 407042 Cell Transformation, Neoplastic MESH:D002471 therapeutic 24362009 +MIR34C 407042 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR34C 407042 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR34C 407042 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR34C 407042 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR350 723921 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR351 723910 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR351 723910 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR351 723910 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR352 100313986 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR3529 100616238 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 34254728 +MIR3591 100616357 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR361 494323 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR361 494323 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR361 494323 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR361 494323 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR361 494323 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR3615 100500847 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR3615 100500847 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR362 574030 Adenocarcinoma, Bronchiolo-Alveolar MESH:D002282 marker/mechanism 25926378 +MIR362 574030 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR362 574030 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR3622B 100500871 Alzheimer Disease MESH:D000544 marker/mechanism 25992776 +MIR365A 100126355 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR365B 100126356 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR3663 100500893 Carcinoma, Hepatocellular MESH:D006528 therapeutic 33838155 +MIR367 442912 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR369 442914 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR369 442914 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR369 442914 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR369 442914 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR369 442914 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR369 442914 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR370 442915 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR370 442915 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR370 442915 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR370 442915 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR370 442915 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR374A 442919 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR374B 100126317 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR375 494324 Alzheimer Disease MESH:D000544 marker/mechanism 25992776 +MIR375 494324 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR375 494324 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR375 494324 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR376A 723855 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR376A 723855 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR376A 723855 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR376A 723855 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR376A1 494325 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR376A2 664615 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR376B 574435 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR376B 574435 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR376B 574435 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR376C 442913 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 21224400 +MIR376C 442913 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR376C 442913 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR376C 442913 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR376C 442913 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR377 494326 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR377 494326 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR377 494326 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR378A 494327 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR378A 494327 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR378A 494327 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR378C 100422867 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR378F 100616492 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR378I 100616259 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR378I 100616259 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR379 494328 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR379 494328 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR379 494328 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR380 494329 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR380 494329 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR380 494329 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR381 494330 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR381 494330 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR381 494330 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR382 494331 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR382 494331 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR383 494332 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR384 494333 Cardiomegaly MESH:D006332 therapeutic 35510648 +MIR384 494333 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR384 494333 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR409 574413 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR409 574413 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR409 574413 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR409 574413 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR409 574413 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR409 574413 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR409 574413 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR410 574434 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR410 574434 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR410 574434 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR410 574434 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR410 574434 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR411 693121 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR411 693121 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR411 693121 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR412 574433 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR421 693122 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR421 693122 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR423 494335 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR423 494335 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399 +MIR423 494335 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 24205249 +MIR423 494335 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR423 494335 Myocardial Infarction MESH:D009203 marker/mechanism 24253456 +MIR424 494336 Albuminuria MESH:D000419 marker/mechanism 24223694 +MIR424 494336 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 27538595 +MIR424 494336 Disease Progression MESH:D018450 marker/mechanism 27538595 +MIR425 494337 Adenoma MESH:D000236 marker/mechanism 25926378 +MIR425 494337 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR429 554210 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR429 554210 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR429 554210 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR429 554210 Lung agenesis MESH:C562992 marker/mechanism 33048239 +MIR429 554210 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR429 554210 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR431 574038 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR431 574038 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR432 574451 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR432 574451 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR432 574451 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR432 574451 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR4324 100422979 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 30026881 +MIR4324 100422979 Disease Progression MESH:D018450 marker/mechanism 30026881 +MIR4324 100422979 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30026881 +MIR433 574034 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR433 574034 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR433 574034 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR4428 100616141 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR4433B 102465833 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR4435-2HG 541471 Lung Neoplasms MESH:D008175 marker/mechanism 25888808 +MIR4448 100616127 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR4467 100616367 Alzheimer Disease MESH:D000544 marker/mechanism 25992776 +MIR4482 100616323 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR4485 100616263 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR4492 100616376 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR4497 100616454 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR449C 100313923 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR4507 100616135 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR4516 100616258 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR4516 100616258 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR451A 574411 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR451A 574411 Pulmonary Fibrosis MESH:D011658 therapeutic 34460027 +MIR452 574412 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR452 574412 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR454 768216 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR455 619556 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22975021 +MIR455 619556 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 35286011 +MIR455 619556 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR455 619556 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR463 723887 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR467B 735257 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR4721 100616256 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR4732 100616385 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR483 619552 Acute Lung Injury MESH:D055371 marker/mechanism 32062619 +MIR483 619552 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR483 619552 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR483 619552 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR483 619552 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR483 619552 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR483 619552 Sepsis MESH:D018805 marker/mechanism 32062619 +MIR484 619553 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR484 619553 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR484 619553 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR484 619553 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +MIR485 574436 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR485 574436 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR485 574436 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR486 723876 Acute Kidney Injury MESH:D058186 marker/mechanism|therapeutic 30682439|35279909 +MIR486-1 619554 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20868653 +MIR487A 619555 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR487B 664616 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR487B 664616 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR487B 664616 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR487B 664616 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR487B 664616 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR488 574441 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR489 574442 Breast Neoplasms MESH:D001943 marker/mechanism 20099276 +MIR490 574443 Pulmonary Fibrosis MESH:D011658 therapeutic 33482250 +MIR493 574450 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR493 574450 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR494 574452 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR494 574452 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR494 574452 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR494 574452 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR495 574453 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR495 574453 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR496 574454 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR497 574456 Adenocarcinoma, Bronchiolo-Alveolar MESH:D002282 marker/mechanism 25926378 +MIR497 574456 Adenoma MESH:D000236 marker/mechanism 25926378 +MIR497 574456 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR497 574456 Diabetic Neuropathies MESH:D003929 therapeutic 35478295 +MIR497 574456 Neoplasm Invasiveness MESH:D009361 marker/mechanism 35066776 +MIR497 574456 Neoplasms, Experimental MESH:D009374 therapeutic 35066776 +MIR497 574456 Thyroid Neoplasms MESH:D013964 marker/mechanism 35066776 +MIR499A 574501 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR500 723974 Adenoma MESH:D000236 marker/mechanism 25926378 +MIR500 723974 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR500 723974 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR501 574503 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 29477382 +MIR503 574506 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR503 574506 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR503 574506 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR503 574506 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR503 574506 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR505 574508 Alzheimer Disease MESH:D000544 marker/mechanism 25992776 +MIR505 574508 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR505 574508 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR506 574511 Azoospermia MESH:D053713 marker/mechanism 27107421 +MIR506 574511 Breast Neoplasms MESH:D001943 marker/mechanism 36156333 +MIR506 574511 Neoplasms, Experimental MESH:D009374 therapeutic 21726609 +MIR5099 100628578 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28844483 +MIR511 574445 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR511 574445 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR5112 100628586 Adenoma MESH:D000236 marker/mechanism 25926378 +MIR5189 100847057 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR5196 100847070 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR519C 574466 Neoplasm Metastasis MESH:D009362 therapeutic 20233879 +MIR520B 574473 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 29191453 +MIR532 693124 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 30639441 +MIR532 693124 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR532 693124 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24478399 +MIR532 693124 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR532 693124 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR532 693124 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR532 693124 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR532 693124 Neoplasm Invasiveness MESH:D009361 marker/mechanism 30639441 +MIR532 693124 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR532 693124 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR532 693124 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30639441 +MIR539 664612 Carcinoma, Hepatocellular MESH:D006528 therapeutic 27717846 +MIR539 664612 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR539 664612 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR542 664617 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR542 664617 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR543 100126335 Neoplasm Invasiveness MESH:D009361 therapeutic 30710498 +MIR543 100126335 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR543 100126335 Uterine Cervical Neoplasms MESH:D002583 therapeutic 30710498 +MIR544 100124450 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR548B 693128 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR5588 100847054 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR564 693149 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR574 693159 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR574 693159 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR5787 102464817 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR582 693167 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR589 693174 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR589 693174 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR590 693175 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR592 693177 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424|28545106 +MIR595 693180 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR598 693183 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR598 693183 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR607 693192 Lung Neoplasms MESH:D008175 therapeutic 34643030 +MIR607 693192 Neoplasm Invasiveness MESH:D009361 therapeutic 34643030 +MIR609 693194 Pancreatitis MESH:D010195 marker/mechanism 27840954 +MIR6125 102465133 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR6132 102466616 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR615 693200 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22819824 +MIR6240 102466620 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR625 693210 Carcinoma, Non-Small-Cell Lung MESH:D002289 therapeutic 34664776 +MIR625 693210 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR627 693212 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR628 693213 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR629 693214 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR629 693214 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR637 693222 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 36029209 +MIR638 693223 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22048643 +MIR638 693223 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR638 693223 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR642A 693227 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR6500 102466656 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +MIR651 723779 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR652 724022 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR652 724022 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR654 724024 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 28030816 +MIR654 724024 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR654 724024 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR655 724025 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR656 724026 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR660 724030 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR660 724030 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR664B 100847052 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR665 100126315 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20643829 +MIR666 751521 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR671 768213 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR672 751535 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR674 732489 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR6741 102466270 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR6741 102466270 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR6769B 102466202 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR6785 102466911 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR6794 102466196 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR6803 102466739 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR6815 102465489 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR6852 102465513 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR6869 102465524 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR687 751541 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR6881 102465530 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR6893 102466271 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR690 751543 Adenoma MESH:D000236 marker/mechanism 25926378 +MIR697 735277 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR702 735283 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +MIR704 735289 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR704 735289 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR706 735290 Fatty Liver MESH:D005234 marker/mechanism 22363424 +MIR708 100126333 Alzheimer Disease MESH:D000544 marker/mechanism 25992776 +MIR708 100126333 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR708 100126333 Neoplasm Invasiveness MESH:D009361 therapeutic 34652879 +MIR741 100049545 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR743A 100314117 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR743B 100124496 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR743B 100124496 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR744 100126313 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424|28545106 +MIR744 100126313 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR744 100126313 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR758 768212 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIR758 768212 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR758 768212 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR760 100126348 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR761 100313892 Myocardial Infarction MESH:D009203 therapeutic 23867156 +MIR761 100313892 Ventricular Dysfunction, Left MESH:D018487 therapeutic 23867156 +MIR764 100313838 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR764 100313838 Liver Cirrhosis MESH:D008103 marker/mechanism 22363424 +MIR766 768218 Alzheimer Disease MESH:D000544 marker/mechanism 25992776 +MIR766 768218 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR766 768218 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR7688 102465791 Neuralgia MESH:D009437 marker/mechanism 31432094 +MIR769 768217 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 36029209 +MIR770 768222 Neoplasms, Experimental MESH:D009374 marker/mechanism 28030816 +MIR770 768222 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR7704 102465802 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR7704 102465802 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR7977 102465858 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR802 768219 Down Syndrome MESH:D004314 marker/mechanism 29403643 +MIR8061 102466251 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR8485 103504737 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR872 100124456 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR872 100124456 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR872 100124456 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR873 100126316 Carcinoma, Pancreatic Ductal MESH:D021441 therapeutic 30654191 +MIR873 100126316 Triple Negative Breast Neoplasms MESH:D064726 therapeutic 30654191 +MIR874 100126343 Neoplasm Invasiveness MESH:D009361 therapeutic 30004169 +MIR875 100126309 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR877 100126314 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR877 100126314 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 27713024 +MIR879 100124492 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22363424 +MIR885 100126334 Carcinoma, Hepatocellular MESH:D006528 therapeutic 27738331 +MIR885 100126334 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR885 100126334 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR885 100126334 Disease Progression MESH:D018450 therapeutic 27738331 +MIR885 100126334 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR885 100126334 Hepatitis B, Chronic MESH:D019694 marker/mechanism 27738331 +MIR885 100126334 Liver Cirrhosis MESH:D008103 marker/mechanism 27738331 +MIR885 100126334 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR885 100126334 Neoplasm Metastasis MESH:D009362 therapeutic 27738331 +MIR889 100126345 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +MIR9-1 407046 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 22253472 +MIR92A1 407048 Multiple Myeloma MESH:D009101 marker/mechanism 29687521 +MIR92B 693235 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR92B 693235 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR92B 693235 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR92B 693235 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR93 407050 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR93 407050 Colorectal Neoplasms MESH:D015179 marker/mechanism 22510560 +MIR93 407050 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR93 407050 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 28545106 +MIR93 407050 Osteosarcoma MESH:D012516 marker/mechanism 22510560 +MIR93 407050 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 35764155 +MIR938 100126327 Carcinoid Tumor MESH:D002276 marker/mechanism 25105010 +MIR938 100126327 Lung Neoplasms MESH:D008175 marker/mechanism 25105010 +MIR939 100126351 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR940 100126328 Neoplasm Invasiveness MESH:D009361 therapeutic 28423620 +MIR942 100126331 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR942 100126331 Liver Cirrhosis MESH:D008103 marker/mechanism 30097701 +MIR96 407053 DEAFNESS, AUTOSOMAL DOMINANT 50 OMIM:613074 marker/mechanism 613074.0 +MIR96 407053 Eye Injuries MESH:D005131 marker/mechanism 27208084 +MIR96 407053 Hearing Loss MESH:D034381 marker/mechanism 19363478|19363479 +MIR96 407053 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR96 407053 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR96 407053 Retinal Diseases MESH:D012164 marker/mechanism 27208084 +MIR98 407054 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 30365097 +MIR98 407054 Colonic Neoplasms MESH:D003110 marker/mechanism 27270317 +MIR98 407054 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIR98 407054 Esophageal Neoplasms MESH:D004938 marker/mechanism 27270317 +MIR98 407054 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR98 407054 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR98 407054 Lung Neoplasms MESH:D008175 marker/mechanism 27270317 +MIR98 407054 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIR99A 407055 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIR99A 407055 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 30026881 +MIR99A 407055 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIR99A 407055 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIR99A 407055 Disease Progression MESH:D018450 marker/mechanism 30026881 +MIR99A 407055 Down Syndrome MESH:D004314 marker/mechanism 29403643 +MIR99A 407055 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIR99A 407055 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR99A 407055 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIR99A 407055 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30026881 +MIR99B 407056 Acute Lung Injury MESH:D055371 therapeutic 33109608 +MIR99B 407056 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22048643 +MIR99B 407056 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +MIR99B 407056 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIR99B 407056 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIR99B 407056 Neoplasm Metastasis MESH:D009362 marker/mechanism 19487542 +MIR99B 407056 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIRLET7B 406884 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106|30125006 +MIRLET7B 406884 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIRLET7B 406884 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIRLET7B 406884 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIRLET7B 406884 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIRLET7BHG 400931 Lung Neoplasms MESH:D008175 marker/mechanism 26199339 +MIRLET7C 406885 Cell Transformation, Neoplastic MESH:D002471 therapeutic 24704393 +MIRLET7C 406885 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIRLET7C 406885 Down Syndrome MESH:D004314 marker/mechanism 29403643 +MIRLET7C 406885 Hepatitis B MESH:D006509 marker/mechanism 28545106 +MIRLET7D 406886 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIRLET7D 406886 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28545106 +MIRLET7D 406886 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIRLET7D 406886 Precancerous Conditions MESH:D011230 marker/mechanism 21035526 +MIRLET7D 406886 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MIRLET7E 406887 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIRLET7F-2 387253 Fibrosis MESH:D005355 marker/mechanism 31570982 +MIRLET7F-2 387253 Heart Injuries MESH:D006335 marker/mechanism 31570982 +MIRLET7G 406890 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIRLET7G 406890 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIRLET7I 406891 Acute Kidney Injury MESH:D058186 marker/mechanism 30682439 +MIRLET7I 406891 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28545106 +MIRLET7I 406891 Cholestasis MESH:D002779 marker/mechanism 22363424 +MIRLET7I 406891 Heart Failure MESH:D006333 marker/mechanism 36071497 +MIRLET7I 406891 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21035526 +MIRLET7I 406891 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +MIS12 79003 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MITF 4286 Albinism, Oculocutaneous MESH:D016115 marker/mechanism 9158138 +MITF 4286 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22012259 +MITF 4286 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 25401301 +MITF 4286 COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS OMIM:617306 marker/mechanism 617306.0 +MITF 4286 Deafness MESH:D003638 marker/mechanism 9158138 +MITF 4286 Melanoma MESH:D008545 marker/mechanism 25043973 +MITF 4286 Melanoma, Cutaneous Malignant MESH:C562393 marker/mechanism 22080950 +MITF 4286 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8 OMIM:614456 marker/mechanism 614456.0 22012259 +MITF 4286 Pigmentation Disorders MESH:D010859 marker/mechanism 9158138 +MITF 4286 Tietz syndrome MESH:C536919 marker/mechanism 103500.0 +MITF 4286 Waardenburg syndrome type 2 MESH:C536463 marker/mechanism 9158138 +MITF 4286 Waardenburg syndrome type 2A MESH:C536464 marker/mechanism 193510.0 +MKI67 4288 Adenocarcinoma MESH:D000230 marker/mechanism 19028472 +MKI67 4288 Adenoma, Liver Cell MESH:D018248 marker/mechanism 31939706 +MKI67 4288 Breast Neoplasms MESH:D001943 marker/mechanism 15706428|18768436|19436038 +MKI67 4288 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MKI67 4288 Chondrosarcoma, Mesenchymal MESH:D018211 marker/mechanism 12817616 +MKI67 4288 Colonic Neoplasms MESH:D003110 marker/mechanism 19028472 +MKI67 4288 Colorectal Neoplasms MESH:D015179 marker/mechanism 12645814 +MKI67 4288 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +MKI67 4288 Disease Progression MESH:D018450 marker/mechanism 29179997 +MKI67 4288 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +MKI67 4288 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MKI67 4288 Ovarian Neoplasms MESH:D010051 marker/mechanism 21442130 +MKI67 4288 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +MKI67 4288 Psoriasis MESH:D011565 marker/mechanism 10384915 +MKI67IP 476111 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +MKI67IP 476111 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +MKKS 8195 Bardet-Biedl Syndrome 6 MESH:C565738 marker/mechanism 605231.0 +MKKS 8195 McKusick Kaufman syndrome MESH:C538159 marker/mechanism 236700.0 +MKNK1 8569 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +MKRN3 7681 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270.0 +MKRN3 7681 Puberty, Precocious MESH:D011629 marker/mechanism 615346.0 23738509 +MKRN3-AS1 10108 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270.0 +MKS1 54903 Bardet-Biedl Syndrome MESH:D020788 marker/mechanism 18327255 +MKS1 54903 Bardet-Biedl Syndrome 13 MESH:C567140 marker/mechanism 615990.0 +MKS1 54903 Meckel syndrome type 1 MESH:C536133 marker/mechanism 249000.0 +MKS-6 187121 Infertility MESH:D007246 marker/mechanism 25204677 +MLANA 2315 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +MLANA 2315 Melanoma MESH:D008545 marker/mechanism 26640592 +MLANA 2315 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 22784439 +MLANA 2315 Peritoneal Neoplasms MESH:D010534 marker/mechanism 22784439 +MLC1 23209 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +MLC1 23209 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +MLC1 23209 Megalencephalic leukoencephalopathy with subcortical cysts MESH:C536141 marker/mechanism 604004.0 11254442 +MLC1 23209 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +MLF1 4291 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +MLH1 4292 Colonic Neoplasms MESH:D003110 marker/mechanism 25043185 +MLH1 4292 Colorectal Neoplasms MESH:D015179 marker/mechanism 18497967|18718023|18949393 +MLH1 4292 Colorectal Neoplasms, Hereditary Nonpolyposis MESH:D003123 marker/mechanism 14756672|20020535|21064154|22102614|25701956 +MLH1 4292 Lymphoma MESH:D008223 marker/mechanism 15700306 +MLH1 4292 Lynch Syndrome II MESH:D055847 marker/mechanism 609310.0 25077178 +MLH1 4292 Muir-Torre Syndrome MESH:D055653 marker/mechanism 158320.0 +MLH1 4292 Neoplasm Metastasis MESH:D009362 marker/mechanism 17717427 +MLH1 4292 Ovarian Neoplasms MESH:D010051 marker/mechanism 19032668 +MLH1 4292 Prostatic Neoplasms MESH:D011471 marker/mechanism 15583422 +MLH1 4292 Turcot syndrome MESH:C536928 marker/mechanism 276300.0 +MLH3 27030 Colorectal Cancer, Hereditary Nonpolyposis, Type 7 MESH:C565777 marker/mechanism 614385.0 +MLH3 27030 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 17656264 +MLH3 27030 Colorectal Neoplasms, Hereditary Nonpolyposis MESH:D003123 marker/mechanism 12702580 +MLH3 27030 Endometrial Neoplasms MESH:D016889 marker/mechanism 608089.0 +MLH3 27030 Esophageal Neoplasms MESH:D004938 marker/mechanism 16981255 +MLLT1 4298 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +MLLT10 8028 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +MLLT10 8028 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +MLLT10 8028 Melanoma MESH:D008545 marker/mechanism 22535842 +MLLT10 8028 Meningioma MESH:D008579 marker/mechanism 21804547 +MLLT11 10962 Burkitt Lymphoma MESH:D002051 marker/mechanism 31587870 +MLN 4295 Drug Hypersensitivity MESH:D004342 marker/mechanism 16538176 +MLP60A 37853 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +MLPH 79083 Griscelli syndrome type 3 MESH:C537303 marker/mechanism 609227.0 +MLXIPL 51085 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +MLXIPL 51085 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +MLXIPL 51085 Williams Syndrome MESH:D018980 marker/mechanism 194050.0 +MLYCD 23417 Malonic aciduria MESH:C535702 marker/mechanism 248360.0 +MMAA 166785 Methylmalonic aciduria cblA type MESH:C537360 marker/mechanism 251100.0 +MMAB 326625 Methylmalonic aciduria cblB type MESH:C537361 marker/mechanism 251110.0 +MMACHC 25974 Methylmalonic acidemia with homocystinuria MESH:C537359 marker/mechanism 277400.0 19700356 +MMADHC 27249 Methylmalonic Aciduria and Homocystinuria, CblD Type MESH:C564743 marker/mechanism 277410.0 +MME 4311 Breast Neoplasms MESH:D001943 marker/mechanism 23063927 +MME 4311 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 35212467 +MME 4311 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T OMIM:617017 marker/mechanism 617017.0 +MME 4311 Cryopyrin-Associated Periodic Syndromes MESH:D056587 marker/mechanism 12928894 +MME 4311 Diabetic Neuropathies MESH:D003929 marker/mechanism 20148083 +MME 4311 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16085334 +MME 4311 Lung Injury MESH:D055370 marker/mechanism 21114838 +MME 4311 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048 +MME 4311 Renal Insufficiency MESH:D051437 marker/mechanism 10485324 +MME 4311 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 617018.0 +MMEL1 79258 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +MMEL1 79258 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 20639879 +MMP1 4312 Aneurysm MESH:D000783 marker/mechanism 21742783 +MMP1 4312 Asthma MESH:D001249 marker/mechanism 24469321 +MMP1 4312 Atherosclerosis MESH:D050197 marker/mechanism 21742783 +MMP1 4312 Breast Neoplasms MESH:D001943 marker/mechanism 23548910 +MMP1 4312 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 20471133 +MMP1 4312 Colorectal Neoplasms MESH:D015179 marker/mechanism 23548910 +MMP1 4312 Epidermolysis Bullosa Dystrophica MESH:D016108 marker/mechanism 226600.0 +MMP1 4312 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 12557150 +MMP1 4312 Lung Neoplasms MESH:D008175 marker/mechanism 23548910 +MMP1 4312 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22580338 +MMP1 4312 Neoplasm Metastasis MESH:D009362 marker/mechanism 12538496|19487542|22580338|23548910 +MMP1 4312 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615 +MMP1 4312 Ocular Hypertension MESH:D009798 therapeutic 20089869 +MMP1 4312 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +MMP1 4312 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 606963.0 +MMP10 4319 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +MMP10 4319 Asthma MESH:D001249 marker/mechanism 16926187 +MMP10 4319 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +MMP10 4319 Lung Neoplasms MESH:D008175 marker/mechanism 22022614 +MMP10 4319 Neoplasm Metastasis MESH:D009362 marker/mechanism 22022614 +MMP10 4319 Stomach Neoplasms MESH:D013274 marker/mechanism 22285823 +MMP11 4320 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MMP11 4320 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 10741738 +MMP12 4321 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MMP12 4321 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +MMP12 4321 Celiac Disease MESH:D002446 marker/mechanism 30097691 +MMP12 4321 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +MMP12 4321 Pulmonary Emphysema MESH:D011656 marker/mechanism 12634787|25106431 +MMP12 4321 Stroke MESH:D020521 marker/mechanism 29531354 +MMP12 4321 Weight Gain MESH:D015430 marker/mechanism 19030233 +MMP13 4322 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17728286 +MMP13 4322 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 17404313 +MMP13 4322 Metaphyseal chondrodysplasia Spahr type MESH:C537353 marker/mechanism 250400.0 +MMP13 4322 Prostatic Neoplasms MESH:D011471 marker/mechanism 15138554 +MMP13 4322 Spondyloepimetaphyseal Dysplasia, Missouri Type MESH:C566574 marker/mechanism 602111.0 +MMP14 4323 Adenocarcinoma MESH:D000230 marker/mechanism 21472143 +MMP14 4323 Aortic Aneurysm, Abdominal MESH:D017544 marker/mechanism 19010778 +MMP14 4323 Breast Neoplasms MESH:D001943 marker/mechanism 24014025 +MMP14 4323 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 33010264 +MMP14 4323 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23804419 +MMP14 4323 Esophageal Neoplasms MESH:D004938 marker/mechanism 21472143 +MMP14 4323 Liver Neoplasms MESH:D008113 marker/mechanism 33010264 +MMP14 4323 Neoplasm Invasiveness MESH:D009361 marker/mechanism 24014025 +MMP14 4323 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +MMP14 4323 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 19661247 +MMP14 4323 Winchester syndrome MESH:C536709 marker/mechanism 277950.0 +MMP15 4324 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MMP15 4324 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MMP19 4327 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MMP19 4327 Cavitary Optic Disc Anomalies MESH:C566924 marker/mechanism 611543.0 +MMP1A 83995 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +MMP1A 83995 Nephrotic Syndrome MESH:D009404 marker/mechanism 1281619 +MMP2 4313 Aortic Aneurysm, Thoracic MESH:D017545 marker/mechanism 16159824 +MMP2 4313 Aortic Diseases MESH:D001018 marker/mechanism 15545515 +MMP2 4313 Aortic Rupture MESH:D001019 marker/mechanism 18178469 +MMP2 4313 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 16872482 +MMP2 4313 Bone Diseases MESH:D001847 marker/mechanism 17440987 +MMP2 4313 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 17440987 +MMP2 4313 Bone Neoplasms MESH:D001859 marker/mechanism 16475674 +MMP2 4313 Breast Neoplasms MESH:D001943 marker/mechanism 18398872|18507500 +MMP2 4313 Calcinosis MESH:D002114 marker/mechanism 15545515|21193197 +MMP2 4313 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20084675 +MMP2 4313 Cerebral Hemorrhage MESH:D002543 marker/mechanism 10698078 +MMP2 4313 Cerebral Infarction MESH:D002544 marker/mechanism 16846501 +MMP2 4313 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 15763341 +MMP2 4313 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +MMP2 4313 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +MMP2 4313 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17400654|17440987 +MMP2 4313 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 21963884 +MMP2 4313 Diabetic Neuropathies MESH:D003929 marker/mechanism 20213226 +MMP2 4313 Disease Progression MESH:D018450 marker/mechanism 22321834 +MMP2 4313 Fetal Growth Retardation MESH:D005317 marker/mechanism 28157488 +MMP2 4313 Glioblastoma MESH:D005909 marker/mechanism 16598420 +MMP2 4313 Hypertension MESH:D006973 marker/mechanism 18836702 +MMP2 4313 Inflammation MESH:D007249 marker/mechanism 24795235 +MMP2 4313 Leishmaniasis, Cutaneous MESH:D016773 marker/mechanism 21091666 +MMP2 4313 Liver Cirrhosis MESH:D008103 marker/mechanism 15763341|26396155 +MMP2 4313 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +MMP2 4313 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15095483|25380136 +MMP2 4313 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 30603057 +MMP2 4313 Lupus Nephritis MESH:D008181 marker/mechanism 22479529 +MMP2 4313 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 28574600 +MMP2 4313 Mandibular Diseases MESH:D008336 marker/mechanism 19070762 +MMP2 4313 Marfan Syndrome MESH:D008382 marker/mechanism 18178469 +MMP2 4313 Maxillary Diseases MESH:D008439 marker/mechanism 19070762 +MMP2 4313 Myocardial Infarction MESH:D009203 marker/mechanism 16310260|24358288 +MMP2 4313 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 20461718 +MMP2 4313 Nasopharyngeal Neoplasms MESH:D009303 marker/mechanism 17607721 +MMP2 4313 Neointima MESH:D058426 marker/mechanism 17964422 +MMP2 4313 Neoplasm Invasiveness MESH:D009361 marker/mechanism 18398872|19770485|22321834|23707804|34278709 +MMP2 4313 Neoplasm Metastasis MESH:D009362 marker/mechanism 16475674|18398872|21209944|22321834|23707804|30603057 +MMP2 4313 Nose Neoplasms MESH:D009669 marker/mechanism 16178123 +MMP2 4313 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +MMP2 4313 Osteolysis hereditary multicentric MESH:C536051 marker/mechanism 259600.0 17400654 +MMP2 4313 Osteonecrosis MESH:D010020 marker/mechanism 19070762 +MMP2 4313 Osteosarcoma MESH:D012516 marker/mechanism 25605016 +MMP2 4313 Pancreatic Neoplasms MESH:D010190 marker/mechanism 30603057 +MMP2 4313 Pulmonary Emphysema MESH:D011656 marker/mechanism 25106431 +MMP2 4313 Pulmonary Fibrosis MESH:D011658 marker/mechanism 21468558 +MMP2 4313 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 22321834 +MMP2 4313 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30548095 +MMP2 4313 Weight Gain MESH:D015430 marker/mechanism 25322899 +MMP20 9313 Amelogenesis Imperfecta, Hypomaturation Type, Iia2 MESH:C567279 marker/mechanism 612529.0 +MMP21 118856 Heterotaxy Syndrome MESH:D059446 marker/mechanism 26437028 +MMP21 118856 HETEROTAXY, VISCERAL, 7, AUTOSOMAL OMIM:616749 marker/mechanism 616749.0 +MMP21 118856 Histiocytoma, Benign Fibrous MESH:D018219 marker/mechanism 16984259 +MMP21 118856 Skin Diseases MESH:D012871 marker/mechanism 16984259 +MMP24 10893 Neoplasm Metastasis MESH:D009362 marker/mechanism 27869830 +MMP26 56547 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MMP26 56547 Skin Diseases MESH:D012871 marker/mechanism 16984259 +MMP3 4314 Arthritis, Experimental MESH:D001169 marker/mechanism 20974942 +MMP3 4314 Astrocytoma MESH:D001254 marker/mechanism 20188714 +MMP3 4314 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +MMP3 4314 Celiac Disease MESH:D002446 marker/mechanism 30097691 +MMP3 4314 Cerebral Hemorrhage MESH:D002543 marker/mechanism 17971790 +MMP3 4314 Coronary Artery Disease MESH:D003324 marker/mechanism 8662692 +MMP3 4314 Coronary Disease MESH:D003327 marker/mechanism 614466.0 +MMP3 4314 Coronary Restenosis MESH:D023903 marker/mechanism 8662692 +MMP3 4314 Hyperalgesia MESH:D006930 marker/mechanism 18754875 +MMP3 4314 Idiopathic Pulmonary Fibrosis MESH:D054990 therapeutic 28434932 +MMP3 4314 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20188714|26284488 +MMP3 4314 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 18754875 +MMP3 4314 Tuberculosis, Pulmonary MESH:D014397 marker/mechanism 24890593 +MMP7 4316 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MMP7 4316 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +MMP7 4316 Recurrence MESH:D012008 marker/mechanism 25596746 +MMP7 4316 Stomach Neoplasms MESH:D013274 marker/mechanism 25847246 +MMP7 4316 Tuberculosis, Pulmonary MESH:D014397 marker/mechanism 24890593 +MMP7 4316 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +MMP8 4317 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +MMP8 4317 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 15057751 +MMP8 4317 Lung Diseases MESH:D008171 marker/mechanism 21602193 +MMP8 4317 Melanoma MESH:D008545 therapeutic 19330028 +MMP8 4317 Tuberculosis, Pulmonary MESH:D014397 marker/mechanism 24890593 +MMP8 4317 Wounds and Injuries MESH:D014947 marker/mechanism 11172683 +MMP9 4318 Acute Coronary Syndrome MESH:D054058 marker/mechanism 20981132 +MMP9 4318 Angina, Stable MESH:D060050 marker/mechanism 20981132 +MMP9 4318 Aortic Aneurysm MESH:D001014 marker/mechanism 10231640 +MMP9 4318 Aortic Aneurysm, Abdominal MESH:D017544 marker/mechanism 17196988 +MMP9 4318 Aortic Aneurysm, Thoracic MESH:D017545 marker/mechanism 16159824 +MMP9 4318 Aortic Diseases MESH:D001018 marker/mechanism 15545515 +MMP9 4318 Aortic Rupture MESH:D001019 marker/mechanism 18178469 +MMP9 4318 Asthma MESH:D001249 marker/mechanism 11742282|15131573 +MMP9 4318 Astrocytoma MESH:D001254 marker/mechanism 20188714 +MMP9 4318 Bone Neoplasms MESH:D001859 marker/mechanism 16475674 +MMP9 4318 Brain Edema MESH:D001929 therapeutic 15529013 +MMP9 4318 Brain Injuries MESH:D001930 marker/mechanism 19631748 +MMP9 4318 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 25668593 +MMP9 4318 Brain Ischemia MESH:D002545 marker/mechanism 15060315 +MMP9 4318 Breast Neoplasms MESH:D001943 marker/mechanism 19617202 +MMP9 4318 Calcinosis MESH:D002114 marker/mechanism 15545515|21193197 +MMP9 4318 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20084675 +MMP9 4318 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21789004 +MMP9 4318 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18572023 +MMP9 4318 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 14700523|19617202|22011395|30090327 +MMP9 4318 Cerebral Hemorrhage MESH:D002543 marker/mechanism|therapeutic 14630814|15488484|15529013|16190367|19095969 +MMP9 4318 Cerebral Infarction MESH:D002544 marker/mechanism 16846501 +MMP9 4318 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22507835 +MMP9 4318 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +MMP9 4318 Colitis, Ulcerative MESH:D003093 marker/mechanism 22119283 +MMP9 4318 Colonic Neoplasms MESH:D003110 marker/mechanism 15725655 +MMP9 4318 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 21963884|22191573 +MMP9 4318 Diabetic Neuropathies MESH:D003929 marker/mechanism 20213226 +MMP9 4318 Disease Models, Animal MESH:D004195 marker/mechanism 21051829 +MMP9 4318 Disease Progression MESH:D018450 marker/mechanism 34626302 +MMP9 4318 Glioblastoma MESH:D005909 marker/mechanism 16598420 +MMP9 4318 Hyperplasia MESH:D006965 marker/mechanism 15728660 +MMP9 4318 Hypertension MESH:D006973 marker/mechanism 21051829 +MMP9 4318 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 19309543 +MMP9 4318 Inflammation MESH:D007249 marker/mechanism 24429678|24795235 +MMP9 4318 Lead Poisoning MESH:D007855 marker/mechanism 16700817 +MMP9 4318 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15095483 +MMP9 4318 Liver Diseases MESH:D008107 marker/mechanism 19784758 +MMP9 4318 Lupus Nephritis MESH:D008181 marker/mechanism 22479529 +MMP9 4318 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 21283680 +MMP9 4318 Mandibuloacral dysplasia with type A lipodystrophy MESH:C535705 marker/mechanism 18554282 +MMP9 4318 Marfan Syndrome MESH:D008382 marker/mechanism 18178469 +MMP9 4318 Metaphyseal Anadysplasia 2 MESH:C567771 marker/mechanism 613073.0 +MMP9 4318 Morphine Dependence MESH:D009021 marker/mechanism 20519536 +MMP9 4318 Multiple Organ Failure MESH:D009102 marker/mechanism 15259001 +MMP9 4318 Myocardial Infarction MESH:D009203 marker/mechanism 16310260|24358288 +MMP9 4318 Neointima MESH:D058426 marker/mechanism 17964422 +MMP9 4318 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19617202|19700239|20188714|21187089|22503731|23867902|24333868 +MMP9 4318 Neoplasm Metastasis MESH:D009362 marker/mechanism 15659795|16475674|18930813|21209944|21942447|34626302 +MMP9 4318 Neuroblastoma MESH:D009447 marker/mechanism 34626302 +MMP9 4318 Obesity MESH:D009765 marker/mechanism 21156398 +MMP9 4318 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +MMP9 4318 Pancreatic Neoplasms MESH:D010190 marker/mechanism 22952646 +MMP9 4318 Periodontitis MESH:D010518 marker/mechanism 22808498|24640096 +MMP9 4318 Premature Birth MESH:D047928 marker/mechanism 24429678 +MMP9 4318 Prostatic Neoplasms MESH:D011471 marker/mechanism 16606632 +MMP9 4318 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 19299917 +MMP9 4318 Pulmonary Emphysema MESH:D011656 marker/mechanism 25106431 +MMP9 4318 Pulmonary Fibrosis MESH:D011658 marker/mechanism 21468558 +MMP9 4318 Reperfusion Injury MESH:D015427 marker/mechanism 23075401 +MMP9 4318 Retinal Diseases MESH:D012164 marker/mechanism 23075401 +MMP9 4318 Sepsis MESH:D018805 marker/mechanism 16003065 +MMP9 4318 Skin Neoplasms MESH:D012878 marker/mechanism 18572023 +MMP9 4318 Stomach Ulcer MESH:D013276 marker/mechanism 17603938 +MMP9 4318 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 27157545 +MMP9 4318 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 20519536 +MMP9 4318 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30548095 +MMUT 4594 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 19427250 +MMUT 4594 Methylmalonic acidemia MESH:C537358 marker/mechanism 16823967 +MMUT 4594 Methylmalonic Aciduria due to Methylmalonyl-CoA Mutase Deficiency MESH:C565390 marker/mechanism 251000.0 +MMUT 4594 Obesity MESH:D009765 marker/mechanism 20882379 +MN1 4330 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 19822134 +MN1 4330 Meningioma, familial MESH:C537443 marker/mechanism 607174.0 +MNT 4335 Classical Lissencephalies and Subcortical Band Heterotopias MESH:D054221 marker/mechanism 15028671 +MNT 4335 Cleft Palate MESH:D002972 marker/mechanism 15028671 +MNT 4335 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15028671 +MNX1 3110 Currarino triad MESH:C536221 marker/mechanism 176450.0 +MNX1-AS1 645249 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 28114269 +MNX1-AS1 645249 Breast Neoplasms MESH:D001943 marker/mechanism 28114269 +MNX1-AS1 645249 Neoplasm Metastasis MESH:D009362 marker/mechanism 28114269 +MOB2 81532 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +MOB3A 126308 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MOBP 4336 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 27455348 +MOBP 4336 Supranuclear Palsy, Progressive MESH:D013494 marker/mechanism 21685912 +MOCOS 55034 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 29935280 +MOCOS 55034 Pancytopenia MESH:D010198 marker/mechanism 29935280 +MOCOS 55034 Vasculitis MESH:D014657 marker/mechanism 29935280 +MOCOS 55034 Xanthinuria, Type II MESH:C566358 marker/mechanism 603592.0 29935280 +MOCS1 4337 Molybdenum cofactor deficiency MESH:C535811 marker/mechanism 252150.0 +MOCS2 4338 Molybdenum Cofactor Deficiency, Complementation Group B MESH:C565373 marker/mechanism 252160.0 +MOG 4340 Demyelinating Diseases MESH:D003711 marker/mechanism 23360710|23547115 +MOG 4340 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 12904460|16931536|17654737|17728465|18566399|18667803|21068375|21317386|21341682|23360710|23547115|23639249|30661753 +MOG 4340 Narcolepsy MESH:D009290 marker/mechanism 614250.0 +MOG 4340 Paralysis MESH:D010243 marker/mechanism 23547115 +MOGAT2 80168 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MOGS 7841 Congenital Disorder Of Glycosylation, Type IIB MESH:C565264 marker/mechanism 606056.0 +MOK 5891 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23500658 +MON1A 84315 Iron Metabolism Disorders MESH:D019189 marker/mechanism 17632513 +MORC2 22880 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 28581500 +MORC2 22880 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z OMIM:616688 marker/mechanism 616688.0 +MORF4L1 10933 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +MORN1 79906 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +MOXD2 194357 Hypertension MESH:D006973 marker/mechanism 3814904 +MPC1 51660 MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY OMIM:614741 marker/mechanism 614741.0 +MPC1 51660 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +MPDU1 9526 Congenital disorder of glycosylation type 1F MESH:C535744 marker/mechanism 609180.0 +MPDZ 8777 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +MPDZ 8777 HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES OMIM:615219 marker/mechanism 615219.0 +MPDZ 8777 Seizures MESH:D012640 marker/mechanism 14960011 +MPEG1 219972 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +MPI 4351 Congenital disorder of glycosylation type 1B MESH:C535740 marker/mechanism 602579.0 +MPIG6B 80739 THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS OMIM:617441 marker/mechanism 617441.0 +MPL 4352 Congenital amegakaryocytic thrombocytopenia MESH:C535982 marker/mechanism 604498.0 +MPL 4352 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +MPL 4352 Myeloproliferative Disorders MESH:D009196 marker/mechanism 29047144 +MPL 4352 Primary Myelofibrosis MESH:D055728 marker/mechanism 254450.0 +MPL 4352 Thrombocytosis MESH:D013922 marker/mechanism 601977.0 15813844|16484586 +MPLKIP 136647 Trichothiodystrophy Syndromes MESH:D054463 marker/mechanism 234050.0 +MPO 4353 Acute Kidney Injury MESH:D058186 marker/mechanism 20623750 +MPO 4353 Alzheimer Disease MESH:D000544 marker/mechanism 104300.0 15023809 +MPO 4353 Arthritis, Experimental MESH:D001169 marker/mechanism 22450443 +MPO 4353 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22450443|26001728 +MPO 4353 Atherosclerosis MESH:D050197 marker/mechanism 33861588 +MPO 4353 Brain Diseases MESH:D001927 marker/mechanism 23593274 +MPO 4353 Brain Injuries MESH:D001930 marker/mechanism 23159883 +MPO 4353 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 25668593 +MPO 4353 Brain Ischemia MESH:D002545 marker/mechanism 19417757 +MPO 4353 Burns MESH:D002056 marker/mechanism 11996850 +MPO 4353 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19731237 +MPO 4353 Cardiovascular Diseases MESH:D002318 marker/mechanism 19326902 +MPO 4353 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +MPO 4353 Colitis MESH:D003092 marker/mechanism 23810507 +MPO 4353 Colitis, Ulcerative MESH:D003093 marker/mechanism 20380826|22119283|24055189 +MPO 4353 Depressive Disorder, Major MESH:D003865 marker/mechanism 20471444 +MPO 4353 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 20388520 +MPO 4353 Drug Eruptions MESH:D003875 marker/mechanism 18204966 +MPO 4353 Hypoxia MESH:D000860 marker/mechanism 8552434 +MPO 4353 Inflammation MESH:D007249 marker/mechanism 10407471|19066340|19326902|23371441|23451061 +MPO 4353 Keratosis MESH:D007642 marker/mechanism 14580687 +MPO 4353 Kidney Diseases MESH:D007674 marker/mechanism 19913069 +MPO 4353 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 19731237|23274713 +MPO 4353 Lung Diseases MESH:D008171 marker/mechanism 23451061 +MPO 4353 Lung Neoplasms MESH:D008175 marker/mechanism 12111688 +MPO 4353 Myeloperoxidase Deficiency MESH:C562864 marker/mechanism 254600.0 +MPO 4353 Occupational Diseases MESH:D009784 marker/mechanism 15576619 +MPO 4353 Pancreatitis MESH:D010195 marker/mechanism 16440434 +MPO 4353 Precancerous Conditions MESH:D011230 marker/mechanism 14580687 +MPO 4353 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +MPO 4353 Reperfusion Injury MESH:D015427 marker/mechanism 10706834|12024109|16971220|19058328|20863214|8869312 +MPO 4353 Shock, Hemorrhagic MESH:D012771 marker/mechanism 21192278 +MPO 4353 Trichuriasis MESH:D014257 marker/mechanism 20864659 +MPO 4353 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 14729580 +MPO 4353 Urticaria MESH:D014581 marker/mechanism 18204966 +MPO 4353 Wounds and Injuries MESH:D014947 marker/mechanism 21192278 +MPP1 4354 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +MPP1 4354 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +MPP7 143098 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +MPPED2 744 Migraine with Aura MESH:D020325 marker/mechanism 35115687 +MPRIP 23164 Weight Gain MESH:D015430 marker/mechanism 19030233 +MPST 4357 Melanoma MESH:D008545 marker/mechanism 25205294 +MPV17 4358 Cochlear Diseases MESH:D015834 marker/mechanism 18818194 +MPV17 4358 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 18818194 +MPV17 4358 Mitochondrial Diseases MESH:D028361 marker/mechanism 18818194 +MPV17 4358 Navajo neurohepatopathy MESH:C538344 marker/mechanism 256810 +MPV17 4358 Pigmentation Disorders MESH:D010859 marker/mechanism 18818194 +MPV17 4358 Proteinuria MESH:D011507 marker/mechanism 18818194 +MPZ 4359 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 118200|180800 +MPZ 4359 Charcot-Marie-Tooth Disease, Dominant Intermediate D MESH:C564333 marker/mechanism 607791 +MPZ 4359 Charcot-Marie-Tooth disease, Type 2I MESH:C535416 marker/mechanism 607677 +MPZ 4359 Charcot-Marie-Tooth disease, Type 2J MESH:C535417 marker/mechanism 607736 +MPZ 4359 Hereditary Sensory and Motor Neuropathy MESH:D015417 marker/mechanism 145900 +MPZ 4359 Hyperalgesia MESH:D006930 marker/mechanism 16676325 +MPZ 4359 Nerve Degeneration MESH:D009410 marker/mechanism 16676325 +MPZL1 9019 Carcinoma MESH:D002277 marker/mechanism 16316942 +MPZL1 9019 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +MPZL1 9019 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +MRAP 56246 Glucocorticoid Deficiency 2 MESH:C564577 marker/mechanism 607398.0 +MRAP2 112609 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18 OMIM:615457 marker/mechanism 615457.0 +MRAS 22808 Carotid Artery Diseases MESH:D002340 marker/mechanism 19198612 +MRAS 22808 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990|35590109 +MRAS 22808 Coronary Disease MESH:D003327 marker/mechanism 28869590 +MRAS 22808 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +MRC1 4360 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +MRC1 4360 Hyperinsulinism MESH:D006946 marker/mechanism 29035695 +MRC1 4360 Insulin Resistance MESH:D007333 marker/mechanism 29035695 +MRC1 4360 Obesity MESH:D009765 marker/mechanism 29035695 +MRC2 9902 Carcinoma MESH:D002277 marker/mechanism 16316942 +MRC2 9902 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +MRC2 9902 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +MRE11 4361 Ataxia Telangiectasia Like Disorder MESH:C565779 marker/mechanism 604391.0 +MRE11A 17535 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +MRE11A 17535 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +MRE11A 17535 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +MRLC2 414399 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +MRO 83876 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MRO 83876 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MRPL12 6182 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +MRPL12 6182 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +MRPL13 28998 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +MRPL13 28998 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +MRPL13 28998 Disease Progression MESH:D018450 marker/mechanism 21364753 +MRPL13 28998 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +MRPL13 28998 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +MRPL19 9801 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +MRPL3 11222 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9 OMIM:614582 marker/mechanism 614582.0 +MRPL44 65080 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16 OMIM:615395 marker/mechanism 615395.0 +MRPL49 740 Melanoma MESH:D008545 marker/mechanism 22535842 +MRPL9 65005 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +MRPS11 64963 Disease Progression MESH:D018450 marker/mechanism 21364753 +MRPS11 64963 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +MRPS16 51021 Combined Oxidative Phosphorylation Deficiency 2 MESH:C566468 marker/mechanism 610498.0 +MRPS18B 28973 Disease Progression MESH:D018450 marker/mechanism 21364753 +MRPS18B 28973 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +MRPS22 56945 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +MRPS22 56945 Combined Oxidative Phosphorylation Deficiency 5 MESH:C567126 marker/mechanism 611719.0 +MRPS23 51649 Breast Neoplasms MESH:D001943 marker/mechanism 25151356 +MRPS28 28957 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +MRPS33 51650 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +MRPS5 64969 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +MRPS5 64969 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +MRPS6 64968 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990|34961328 +MRPS7 51081 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +MRTFB 57496 Child Development Disorders, Pervasive MESH:D002659 marker/mechanism 20442744 +MS4A1 931 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 22514692 +MS4A1 931 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22514692 +MS4A1 931 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 22514692 +MS4A1 931 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 613495.0 +MS4A1 931 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +MS4A2 2206 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 16502481 +MS4A2 2206 Drug Hypersensitivity MESH:D004342 marker/mechanism 16839402|18534082|20485159 +MS4A2 2206 Hypersensitivity, Immediate MESH:D006969 marker/mechanism 20485159 +MS4A4A 51338 Alzheimer Disease MESH:D000544 marker/mechanism 21460841 +MS4A4A 51338 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MS4A6A 64231 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +MS4A6A 64231 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +MSGN1 343930 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +MSH2 4436 Colorectal Neoplasms MESH:D015179 marker/mechanism 18949393 +MSH2 4436 Colorectal Neoplasms, Hereditary Nonpolyposis MESH:D003123 marker/mechanism 12702580|14756672|22102614|25701956 +MSH2 4436 Lynch syndrome I (site-specific colonic cancer) MESH:C537261 marker/mechanism 120435.0 19098912 +MSH2 4436 Muir-Torre Syndrome MESH:D055653 marker/mechanism 158320.0 +MSH2 4436 Ovarian Neoplasms MESH:D010051 marker/mechanism 19032668 +MSH3 4437 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 21327329 +MSH3 4437 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 617100.0 +MSH3 4437 Endometrial Neoplasms MESH:D016889 marker/mechanism 608089.0 +MSH3 4437 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +MSH3 4437 Prostatic Neoplasms MESH:D011471 marker/mechanism 18355840 +MSH4 4438 SPERMATOGENIC FAILURE 2 OMIM:108420 marker/mechanism 108420.0 +MSH5 4439 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MSH5 4439 PREMATURE OVARIAN FAILURE 13 OMIM:617442 marker/mechanism 617442.0 +MSH6 2956 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 21327329 +MSH6 2956 Colorectal Cancer, Hereditary Nonpolyposis, Type 5 MESH:C563456 marker/mechanism 614350.0 +MSH6 2956 Colorectal Neoplasms, Hereditary Nonpolyposis MESH:D003123 marker/mechanism 11586295|18417481|22102614|25701956|9354786 +MSH6 2956 Endometrial Neoplasms MESH:D016889 marker/mechanism 608089.0 10508506 +MSH6 2956 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29616133 +MSH6 2956 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +MSH6 2956 Thyroid Neoplasms MESH:D013964 marker/mechanism 29616133 +MSL3 10943 Craniofacial Abnormalities MESH:D019465 marker/mechanism 30224647 +MSL3 10943 Developmental Disabilities MESH:D002658 marker/mechanism 30224647 +MSL3 10943 Facies MESH:D019066 marker/mechanism 30224647 +MSL3 10943 Gait Disorders, Neurologic MESH:D020233 marker/mechanism 30224647 +MSL3 10943 Genetic Diseases, X-Linked MESH:D040181 marker/mechanism 30224647 +MSL3P1 151507 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +MSLN 10232 Adenocarcinoma MESH:D000230 marker/mechanism 11751476 +MSLN 10232 Carcinoma, Endometrioid MESH:D018269 marker/mechanism 14576474 +MSLN 10232 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 14576474|21775916|25347530 +MSLN 10232 Cholangiocarcinoma MESH:D018281 marker/mechanism 14576474 +MSLN 10232 Disease Progression MESH:D018450 marker/mechanism 35396937 +MSLN 10232 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 35396937 +MSLN 10232 Lymphatic Metastasis MESH:D008207 marker/mechanism 22644300 +MSLN 10232 Mesothelioma MESH:D008654 marker/mechanism 11751476|18394747|20933535 +MSLN 10232 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 19190155|27032653 +MSLN 10232 Neoplasms MESH:D009369 marker/mechanism 23277285 +MSLN 10232 Neoplasms, Mesothelial MESH:D018301 marker/mechanism 20371980|21984916 +MSLN 10232 Ovarian Neoplasms MESH:D010051 marker/mechanism 11751476 +MSLN 10232 Pancreatic Neoplasms MESH:D010190 marker/mechanism 11751476 +MSLN 10232 Pleural Diseases MESH:D010995 marker/mechanism 23277285 +MSLN 10232 Stomach Neoplasms MESH:D013274 marker/mechanism 22644300|35396937 +MSMB 4477 Prostate Cancer, Hereditary, 13 MESH:C567456 marker/mechanism 611928.0 +MSMB 4477 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881|18264096|18264097 +MSMO1 6307 MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS OMIM:616834 marker/mechanism 616834.0 +MSN 4478 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MSN 4478 IMMUNODEFICIENCY 50 OMIM:300988 marker/mechanism 300988.0 +MSN 4478 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MSN 4478 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +MSN 4478 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +MSR1 4481 Barrett Esophagus MESH:D001471 marker/mechanism 614266.0 +MSR1 4481 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +MSR1 4481 Prostatic Neoplasms MESH:D011471 marker/mechanism 16998812 +MSRA 4482 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +MSRB3 253827 DEAFNESS, AUTOSOMAL RECESSIVE 74 OMIM:613718 marker/mechanism 613718.0 +MSRB3 253827 Hearing Loss MESH:D034381 marker/mechanism 21782914 +MST1 4485 Breast Neoplasms MESH:D001943 marker/mechanism 28114269 +MST1 4485 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +MST1 4485 Cholangitis, Sclerosing MESH:D015209 marker/mechanism 21151127 +MST1 4485 Colitis, Ulcerative MESH:D003093 marker/mechanism 18438406|20228799 +MST1 4485 Crohn Disease MESH:D003424 marker/mechanism 18438406 +MST1 4485 Neoplasm Metastasis MESH:D009362 marker/mechanism 28114269 +MST1R 4486 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22575169 +MST1R 4486 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 617075.0 +MST1R 4486 Osteosarcoma MESH:D012516 marker/mechanism 22235915 +MSTN 2660 Heart Failure MESH:D006333 marker/mechanism 16968467 +MSTN 2660 MUSCLE HYPERTROPHY OMIM:614160 marker/mechanism 614160.0 +MSTN 2660 Myostatin-related muscle hypertrophy MESH:C536106 marker/mechanism 15215484|19248183 +MSX1 4487 Anodontia MESH:D000848 marker/mechanism 106600.0 +MSX1 4487 Cleft Palate MESH:D002972 marker/mechanism 12163415|12701100|15301380 +MSX1 4487 Craniofacial Abnormalities MESH:D019465 marker/mechanism 12163415|14630905|14654219|15301380 +MSX1 4487 Nonsyndromic Deafness MESH:C580334 marker/mechanism 27356075 +MSX1 4487 Orofacial Cleft 5 MESH:C563843 marker/mechanism 608874.0 +MSX1 4487 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +MSX1 4487 Tooth Abnormalities MESH:D014071 marker/mechanism 14630905 +MSX1 4487 Witkop syndrome MESH:C536736 marker/mechanism 189500.0 +MSX1 4487 Wolf-Hirschhorn Syndrome MESH:D054877 marker/mechanism 14630905 +MSX2 4488 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9147639 +MSX2 4488 Craniosynostosis, Type 2 MESH:C565753 marker/mechanism 604757.0 +MSX2 4488 Female Urogenital Diseases MESH:D052776 marker/mechanism 16513791 +MSX2 4488 Parietal Foramina MESH:C566826 marker/mechanism 168500.0 11137991 +MSX2 4488 Parietal Foramina With Cleidocranial Dysplasia MESH:C566825 marker/mechanism 168550.0 +MT1 17748 Acute Lung Injury MESH:D055371 marker/mechanism 16166738 +MT1 17748 Amyotrophic lateral sclerosis 1 MESH:C531617 therapeutic 24163136 +MT1 17748 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 16543248 +MT1 17748 Cardiac Output, Low MESH:D002303 marker/mechanism 30096613 +MT1 17748 Cognition Disorders MESH:D003072 marker/mechanism 18226494 +MT1 17748 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 16543248 +MT1 17748 Learning Disabilities MESH:D007859 marker/mechanism 16216453 +MT1 17748 Listeriosis MESH:D008088 marker/mechanism 19576872 +MT1 17748 Movement Disorders MESH:D009069 marker/mechanism 16216453 +MT1 17748 Muscular Atrophy MESH:D009133 therapeutic 24163136 +MT1 17748 Nerve Degeneration MESH:D009410 therapeutic 11835189 +MT1 17748 Prenatal Injuries MESH:D049188 therapeutic 12514265 +MT1 17748 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +MT1 17748 Sepsis MESH:D018805 marker/mechanism 17374846 +MT1 17748 Tongue Neoplasms MESH:D014062 marker/mechanism 16543248 +MT1 17748 Weight Loss MESH:D015431 therapeutic 24163136 +MT1A 4489 Arsenic Poisoning MESH:D020261 marker/mechanism 19953893 +MT1A 4489 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17363595|19363144 +MT1A 4489 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17418620 +MT1A 4489 Hepatitis, Chronic MESH:D006521 marker/mechanism 25053573 +MT1A 4489 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +MT1A 4489 Lymphatic Metastasis MESH:D008207 marker/mechanism 17418620 +MT1A 4489 Mouth Neoplasms MESH:D009062 marker/mechanism 17418620 +MT1A 4489 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 16565513 +MT1E 4493 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MT1F 4494 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MT1G 4495 Esophageal Neoplasms MESH:D004938 marker/mechanism 17068819 +MT2 17750 Acute Lung Injury MESH:D055371 marker/mechanism 16166738 +MT2 17750 Cardiac Output, Low MESH:D002303 marker/mechanism 30096613 +MT2 17750 Cognition Disorders MESH:D003072 marker/mechanism 18226494 +MT2 17750 Learning Disabilities MESH:D007859 marker/mechanism 16216453 +MT2 17750 Listeriosis MESH:D008088 marker/mechanism 19576872 +MT2 17750 Lung Injury MESH:D055370 therapeutic 18528683 +MT2 17750 Movement Disorders MESH:D009069 marker/mechanism 16216453 +MT2 17750 Nerve Degeneration MESH:D009410 therapeutic 11835189 +MT2 17750 Pulmonary Fibrosis MESH:D011658 therapeutic 18528683 +MT2 17750 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +MT2 17750 Sepsis MESH:D018805 marker/mechanism 17374846 +MT2A 4502 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17363595|28284560 +MT2A 4502 Cardiomegaly MESH:D006332 therapeutic 11309296 +MT2A 4502 Diabetes Mellitus MESH:D003920 marker/mechanism 27122239 +MT2A 4502 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 27122239 +MT2A 4502 Heart Diseases MESH:D006331 therapeutic 16144979 +MT2A 4502 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MT2A 4502 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21187089 +MT2A 4502 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 16574721 +MT2A 4502 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 16574721|17914565 +MT2A 4502 Renal Insufficiency, Chronic MESH:D051436 marker/mechanism 27122239 +MT2A 4502 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MT2A 4502 Stomach Neoplasms MESH:D013274 marker/mechanism 14503839 +MT2A 4502 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 16565513|7729958 +MT3 4504 Breast Neoplasms MESH:D001943 marker/mechanism 21170156 +MT3 4504 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17043644 +MT3 4504 Neoplasm Invasiveness MESH:D009361 marker/mechanism 23794209 +MT3 4504 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +MT3 4504 Seizures MESH:D012640 marker/mechanism 23266720 +MT3 4504 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 16854967 +MT4 84560 Kidney Diseases MESH:D007674 marker/mechanism 19921116 +MT4 84560 Lead Poisoning MESH:D007855 marker/mechanism 19921116 +MTA1 9112 Endometriosis MESH:D004715 marker/mechanism 22138541 +MTA1 9112 Parkinson Disease MESH:D010300 marker/mechanism 27044752 +MTA2 9219 Endometriosis MESH:D004715 marker/mechanism 22138541 +MTAP 4507 Diaphyseal medullary stenosis with malignant fibrous histiocytoma MESH:C536169 marker/mechanism 112250.0 +MTAP 4507 Melanoma MESH:D008545 marker/mechanism 19578364 +MTAP 4507 Nevus MESH:D009506 marker/mechanism 19578365 +MTAP 4507 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +MTARC1 64757 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +MTARC2 54996 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +MTARC2 54996 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +MTBP 27085 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 29765550 +MTCH2 23788 Obesity MESH:D009765 marker/mechanism 19079261 +MTCL1 23255 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 28166215 +MTDH 92140 Breast Neoplasms MESH:D001943 marker/mechanism 19111877 +MTDH 92140 Colorectal Neoplasms MESH:D015179 marker/mechanism 29315995 +MTDH 92140 Neoplasm Invasiveness MESH:D009361 marker/mechanism 29315995 +MTDH 92140 Neoplasm Metastasis MESH:D009362 therapeutic 19111877 +MTF1 4520 Autistic Disorder MESH:D001321 marker/mechanism 15446388 +MTFMT 123263 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15 OMIM:614947 marker/mechanism 614947.0 +MTH 38058 Organophosphate Poisoning MESH:D062025 marker/mechanism 25746179 +MTHFD1 4522 Abruptio Placentae MESH:D000037 marker/mechanism 15633187 +MTHFD1 4522 Neural tube defect, folate-sensitive MESH:C536409 marker/mechanism 601634.0 +MTHFD1 4522 Neural Tube Defects MESH:D009436 marker/mechanism 12384833|16552426 +MTHFD2 10797 Heart Failure MESH:D006333 marker/mechanism 36071497 +MTHFD2 10797 Hodgkin Disease MESH:D006689 marker/mechanism 24688052 +MTHFR 4524 Acute Kidney Injury MESH:D058186 marker/mechanism 17387702 +MTHFR 4524 Alopecia MESH:D000505 marker/mechanism 18381794 +MTHFR 4524 Alzheimer Disease MESH:D000544 marker/mechanism 17192785 +MTHFR 4524 Anemia MESH:D000740 marker/mechanism 19391036|25007187 +MTHFR 4524 Arsenic Poisoning MESH:D020261 marker/mechanism 24384392 +MTHFR 4524 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22104130 +MTHFR 4524 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +MTHFR 4524 Autistic Disorder MESH:D001321 marker/mechanism 19267885 +MTHFR 4524 Bipolar Disorder MESH:D001714 marker/mechanism 17074966 +MTHFR 4524 Blood Coagulation Disorders, Inherited MESH:D025861 marker/mechanism 17493413 +MTHFR 4524 Brain Ischemia MESH:D002545 marker/mechanism 15534175 +MTHFR 4524 Breast Neoplasms MESH:D001943 marker/mechanism 16777985|17595805|28114181 +MTHFR 4524 Cardiovascular Diseases MESH:D002318 marker/mechanism 16958597|25050994 +MTHFR 4524 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 18551038|19648163 +MTHFR 4524 Cleft Lip MESH:D002971 marker/mechanism 16470725 +MTHFR 4524 Clubfoot MESH:D003025 marker/mechanism 16936070 +MTHFR 4524 Colonic Neoplasms MESH:D003110 marker/mechanism 16284371 +MTHFR 4524 Colorectal Neoplasms MESH:D015179 marker/mechanism 15608557|16512993|16985020|17047490|17087956|17245555|17350979|18676755|26858257 +MTHFR 4524 Coronary Disease MESH:D003327 marker/mechanism 16792904 +MTHFR 4524 Coronary Restenosis MESH:D023903 marker/mechanism 16489563 +MTHFR 4524 Crohn Disease MESH:D003424 marker/mechanism 28002332 +MTHFR 4524 Depressive Disorder MESH:D003866 marker/mechanism 17074966 +MTHFR 4524 Diabetic Angiopathies MESH:D003925 marker/mechanism 16681562 +MTHFR 4524 Down Syndrome MESH:D004314 marker/mechanism 16353284|16489479|16845273|17431899 +MTHFR 4524 Drug Eruptions MESH:D003875 marker/mechanism 14723717 +MTHFR 4524 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15753437|16166815|17387702|17502830|18551038|19159907|19391036|19821069|21064136|25007187|26077125 +MTHFR 4524 Endometrial Neoplasms MESH:D016889 marker/mechanism 17301261 +MTHFR 4524 Gastrointestinal Diseases MESH:D005767 marker/mechanism 19648163 +MTHFR 4524 Graft vs Host Disease MESH:D006086 marker/mechanism 16518429 +MTHFR 4524 Hearing Loss, Sudden MESH:D003639 marker/mechanism 16275406 +MTHFR 4524 Heart Defects, Congenital MESH:D006330 marker/mechanism 16524890 +MTHFR 4524 Hematologic Diseases MESH:D006402 marker/mechanism 19159907 +MTHFR 4524 Hyperhomocysteinemia MESH:D020138 marker/mechanism|therapeutic 10459572|15226090|16317120|16397167|16411416|16575899|17387702|18234410|18551038|19204075|19646848 +MTHFR 4524 Hypersensitivity MESH:D006967 marker/mechanism 16766537 +MTHFR 4524 Infertility, Female MESH:D007247 marker/mechanism 16679164 +MTHFR 4524 Infertility, Male MESH:D007248 marker/mechanism 16861746 +MTHFR 4524 Kidney Diseases MESH:D007674 marker/mechanism 18551038 +MTHFR 4524 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 16706930 +MTHFR 4524 Leukoencephalopathies MESH:D056784 marker/mechanism 15753437 +MTHFR 4524 Leukopenia MESH:D007970 marker/mechanism 19648163 +MTHFR 4524 Liver Diseases MESH:D008107 marker/mechanism 16877991 +MTHFR 4524 Lung Neoplasms MESH:D008175 marker/mechanism 17389614 +MTHFR 4524 Lymphoma MESH:D008223 marker/mechanism 16799656 +MTHFR 4524 Lymphoma, Follicular MESH:D008224 marker/mechanism 16410450 +MTHFR 4524 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 17488658 +MTHFR 4524 Malnutrition MESH:D044342 marker/mechanism 16709328 +MTHFR 4524 Maxillofacial Abnormalities MESH:D019767 marker/mechanism 16832597 +MTHFR 4524 Meningomyelocele MESH:D008591 marker/mechanism 16602021 +MTHFR 4524 Methylenetetrahydrofolate reductase deficiency MESH:C537357 marker/mechanism 236250.0 +MTHFR 4524 Microsatellite Instability MESH:D053842 marker/mechanism 17350979 +MTHFR 4524 Microvascular Angina MESH:D017566 marker/mechanism 17491230 +MTHFR 4524 Mucositis MESH:D052016 marker/mechanism 17488658 +MTHFR 4524 Necrosis MESH:D009336 marker/mechanism 14723717 +MTHFR 4524 Neoplasm Metastasis MESH:D009362 marker/mechanism 17704422 +MTHFR 4524 Nervous System Diseases MESH:D009422 marker/mechanism 21064136 +MTHFR 4524 Neural tube defect, folate-sensitive MESH:C536409 marker/mechanism 601634.0 +MTHFR 4524 Neural Tube Defects MESH:D009436 marker/mechanism 23056169 +MTHFR 4524 Neutropenia MESH:D009503 marker/mechanism 19391036 +MTHFR 4524 Parkinson Disease MESH:D010300 marker/mechanism 30726997 +MTHFR 4524 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 16706930 +MTHFR 4524 Prostatic Neoplasms MESH:D011471 marker/mechanism 17967524 +MTHFR 4524 Pulmonary Embolism MESH:D011655 marker/mechanism 19123085 +MTHFR 4524 Schizophrenia MESH:D012559 marker/mechanism 181500.0 16641680|17074966|18583979 +MTHFR 4524 Sinus Thrombosis, Intracranial MESH:D012851 marker/mechanism 18941937 +MTHFR 4524 Skin Diseases MESH:D012871 marker/mechanism 17548696 +MTHFR 4524 Spinal Cord Diseases MESH:D013118 marker/mechanism 16361298 +MTHFR 4524 Spinal Dysraphism MESH:D016135 marker/mechanism 27713094 +MTHFR 4524 Stomach Neoplasms MESH:D013274 marker/mechanism 18505952|21347786 +MTHFR 4524 Stroke MESH:D020521 marker/mechanism 15534175|16681562|19646848 +MTHFR 4524 Thrombocytopenia MESH:D013921 marker/mechanism 19391036 +MTHFR 4524 Thrombophilia MESH:D019851 marker/mechanism 188050.0 17493413 +MTHFR 4524 Thyrotoxicosis MESH:D013971 marker/mechanism 18941937 +MTHFR 4524 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 22747749 +MTHFR 4524 Uterine Cervical Dysplasia MESH:D002578 marker/mechanism 17303386 +MTHFR 4524 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 17303386 +MTHFR 4524 Vascular Diseases MESH:D014652 marker/mechanism 19646848 +MTHFR 4524 Venous Thrombosis MESH:D020246 marker/mechanism 19123085 +MTHFS 10588 Cleft Lip MESH:D002971 marker/mechanism 21254359 +MTHFS 10588 Cleft Palate MESH:D002972 marker/mechanism 21254359 +MTM1 4534 Myopathies, Structural, Congenital MESH:D020914 marker/mechanism 310400.0 17376685 +MTMR14 64419 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 30365097 +MTMR14 64419 Myopathies, Structural, Congenital MESH:D020914 marker/mechanism 160150.0 +MTMR2 8898 Charcot-Marie-Tooth disease, Type 4B1 MESH:C535420 marker/mechanism 601382.0 +MTMR4 9110 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +MTMR7 9108 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MTNR1A 4543 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20657642 +MTNR1A 4543 Retinal Diseases MESH:D012164 marker/mechanism 21915336 +MTNR1B 4544 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20657642 +MTNR1B 4544 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 19060907|19060908|19060909|22286214|26551672 +MTNR1B 4544 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 20207350 +MTO1 25821 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10 OMIM:614702 marker/mechanism 614702.0 +MTOR 2475 Adenocarcinoma MESH:D000230 marker/mechanism 18058806|33129824 +MTOR 2475 Breast Neoplasms MESH:D001943 marker/mechanism 30705370 +MTOR 2475 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +MTOR 2475 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +MTOR 2475 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +MTOR 2475 Carcinoma, Small Cell MESH:D018288 marker/mechanism 20946520 +MTOR 2475 Clinical Deterioration MESH:D000075902 marker/mechanism 29384525 +MTOR 2475 Colonic Neoplasms MESH:D003110 marker/mechanism 30705370 +MTOR 2475 Endocrine System Diseases MESH:D004700 marker/mechanism 29384525 +MTOR 2475 Exocrine Pancreatic Insufficiency MESH:D010188 marker/mechanism 29384525 +MTOR 2475 Focal cortical dysplasia of Taylor MESH:C537067 marker/mechanism 607341.0 +MTOR 2475 Glioblastoma MESH:D005909 marker/mechanism 30705370 +MTOR 2475 Hepatomegaly MESH:D006529 therapeutic 30641053 +MTOR 2475 Hypertension MESH:D006973 marker/mechanism 19289642 +MTOR 2475 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 19289642 +MTOR 2475 Lymphatic Metastasis MESH:D008207 marker/mechanism 30705370 +MTOR 2475 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 17148679 +MTOR 2475 Malformations of Cortical Development MESH:D054220 marker/mechanism 22729223 +MTOR 2475 Mesothelioma MESH:D008654 marker/mechanism 21358348 +MTOR 2475 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 16955484 +MTOR 2475 Ovarian Neoplasms MESH:D010051 marker/mechanism 20138251|30705370 +MTOR 2475 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 19246562 +MTOR 2475 Prostatic Neoplasms MESH:D011471 marker/mechanism 33129824 +MTOR 2475 Pulmonary Fibrosis MESH:D011658 marker/mechanism 28936961 +MTOR 2475 Schizophrenia MESH:D012559 marker/mechanism 21822266 +MTOR 2475 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 36115647 +MTOR 2475 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 18058806 +MTPAP 55149 Melanoma MESH:D008545 marker/mechanism 22535842 +MTPAP 55149 SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE OMIM:613672 marker/mechanism 613672.0 +MTPN 136319 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +MTR 4548 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +MTR 4548 Breast Neoplasms MESH:D001943 marker/mechanism 17595805 +MTR 4548 Cleft Lip MESH:D002971 marker/mechanism 21254359 +MTR 4548 Cleft Palate MESH:D002972 marker/mechanism 21254359 +MTR 4548 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15753437|19159907 +MTR 4548 Gastrointestinal Diseases MESH:D005767 marker/mechanism 19159907 +MTR 4548 Hematologic Diseases MESH:D006402 marker/mechanism 19159907 +MTR 4548 Infertility, Male MESH:D007248 marker/mechanism 16861746 +MTR 4548 Leukoencephalopathies MESH:D056784 marker/mechanism 15753437 +MTR 4548 Lymphoma MESH:D008223 marker/mechanism 16799656 +MTR 4548 Lymphoma, Follicular MESH:D008224 marker/mechanism 16410450 +MTR 4548 Malnutrition MESH:D044342 marker/mechanism 16709328 +MTR 4548 Methylcobalamin Deficiency, CblG Type MESH:C565394 marker/mechanism 250940.0 +MTR 4548 Neural tube defect, folate-sensitive MESH:C536409 marker/mechanism 601634.0 +MTRFR 91574 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7 OMIM:613559 marker/mechanism 613559.0 +MTRFR 91574 Mitochondrial Encephalomyopathies MESH:D017237 marker/mechanism 20598281 +MTRR 4552 Adenoma MESH:D000236 marker/mechanism 17389618 +MTRR 4552 Colorectal Neoplasms MESH:D015179 marker/mechanism 16985020|17389618 +MTRR 4552 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 21064136 +MTRR 4552 Homocystinuria MESH:D006712 marker/mechanism 12555939|15714522 +MTRR 4552 Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type MESH:C565510 marker/mechanism 236270.0 +MTRR 4552 Hyperhomocysteinemia MESH:D020138 marker/mechanism 16575899|17369066 +MTRR 4552 Infertility, Male MESH:D007248 marker/mechanism 16861746 +MTRR 4552 Nervous System Diseases MESH:D009422 marker/mechanism 21064136 +MTRR 4552 Neural tube defect, folate-sensitive MESH:C536409 marker/mechanism 601634.0 +MTRR 4552 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 17136115 +MTSS1 9788 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +MTSS1 9788 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +MTTP 4547 Abetalipoproteinemia MESH:D000012 marker/mechanism 200100.0 +MTTP 4547 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +MTTP 4547 Fatty Liver MESH:D005234 marker/mechanism 17303181 +MTTP 4547 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +MUC1 4582 Cell Transformation, Neoplastic MESH:D002471 therapeutic 22457794 +MUC1 4582 COVID-19 MESH:D000086382 marker/mechanism 35255492 +MUC1 4582 Medullary cystic kidney disease 1 MESH:C536137 marker/mechanism 174000.0 23396133 +MUC1 4582 Mesothelioma MESH:D008654 marker/mechanism 18454162 +MUC1 4582 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 22784439 +MUC1 4582 Multiple Myeloma MESH:D009101 marker/mechanism 9949172 +MUC1 4582 Peritoneal Neoplasms MESH:D010534 marker/mechanism 22784439 +MUC1 4582 Precancerous Conditions MESH:D011230 marker/mechanism 28220687 +MUC1 4582 Stomach Neoplasms MESH:D013274 marker/mechanism 26098866 +MUC12 10071 Lung Neoplasms MESH:D008175 marker/mechanism 29054765 +MUC16 94025 Lung Neoplasms MESH:D008175 marker/mechanism 29552305 +MUC16 94025 Ovarian Neoplasms MESH:D010051 therapeutic 11706781 +MUC16 94025 Proteinuria MESH:D011507 marker/mechanism 12169874 +MUC19 283463 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 21983784 +MUC2 4583 Adenocarcinoma MESH:D000230 marker/mechanism 12468628 +MUC2 4583 Adenoma MESH:D000236 marker/mechanism 12468628 +MUC2 4583 Intestinal Neoplasms MESH:D007414 marker/mechanism 12468628 +MUC2 4583 Rectal Neoplasms MESH:D012004 marker/mechanism 12468628 +MUC4 4585 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +MUC4 4585 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +MUC4 4585 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +MUC5B 727897 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 178500.0 23583980 +MUC6 4588 Stomach Neoplasms MESH:D013274 marker/mechanism 24816253 +MUC7 4589 Asthma MESH:D001249 marker/mechanism 600807.0 +MUCL3 135656 Diffuse panbronchiolitis MESH:C536174 marker/mechanism 22152429 +MUG1 17836 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +MUG1 17836 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +MUSK 4593 Myasthenia Gravis MESH:D009157 marker/mechanism 22981737|27119269 +MUSK 4593 Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency MESH:C563829 marker/mechanism 616325.0 +MUSK 4593 Pena Shokeir syndrome, type 1 MESH:C536647 marker/mechanism 208150.0 +MUTYH 4595 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 15987719 +MUTYH 4595 Colonic Neoplasms MESH:D003110 marker/mechanism 25030372 +MUTYH 4595 Colorectal Adenomatous Polyposis, Autosomal Recessive MESH:C563924 marker/mechanism 608456.0 +MUTYH 4595 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 +MVD 4597 POROKERATOSIS 7, MULTIPLE TYPES OMIM:614714 marker/mechanism 614714 +MVK 4598 Arthralgia MESH:D018771 marker/mechanism 10369261 +MVK 4598 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +MVK 4598 Exanthema MESH:D005076 marker/mechanism 10369261 +MVK 4598 Fever MESH:D005334 marker/mechanism 10369261 +MVK 4598 Inflammation MESH:D007249 marker/mechanism 24073415 +MVK 4598 Mevalonate Kinase Deficiency MESH:D054078 marker/mechanism 260920|610377 10369261|12477733|17596604|18008182|24073415|27377765 +MVK 4598 Porokeratosis, disseminated superficial actinic 1 MESH:C536339 marker/mechanism 175900 22983302 +MVP 9961 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MVP 9961 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +MX1 4599 Disease Models, Animal MESH:D004195 marker/mechanism 36071497 +MX1 4599 Fanconi Anemia MESH:D005199 marker/mechanism 9389754 +MX1 4599 Heart Failure MESH:D006333 marker/mechanism 36071497 +MX1 4599 Influenza, Human MESH:D007251 marker/mechanism 23326326 +MX1 4599 Influenza in Birds MESH:D005585 therapeutic 178595 +MX1 4599 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +MX1 4599 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +MX1 4599 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +MX2 4600 Influenza, Human MESH:D007251 marker/mechanism 23326326 +MX2 4600 Melanoma MESH:D008545 marker/mechanism 21983787 +MXD1 4084 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +MXI1 4601 Kidney Diseases MESH:D007674 marker/mechanism 23316056 +MXI1 4601 Prostatic Neoplasms MESH:D011471 marker/mechanism 176807.0 +MXRA5 25878 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22696596 +MYADM 91663 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MYB 4602 Asthma MESH:D001249 marker/mechanism 19198610 +MYB 4602 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749|26829750 +MYB 4602 Disease Progression MESH:D018450 marker/mechanism 34626302 +MYB 4602 Glioma MESH:D005910 marker/mechanism 23583981|26829751 +MYB 4602 Neuroblastoma MESH:D009447 marker/mechanism 34626302 +MYB 4602 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 17435759|28671688 +MYBBP1A 10514 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +MYBL1 4603 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +MYBL1 4603 Glioma MESH:D005910 marker/mechanism 23583981 +MYBL1 4603 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +MYBL2 4605 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +MYBPC1 4604 ARTHROGRYPOSIS, DISTAL, TYPE 1B OMIM:614335 marker/mechanism 614335.0 +MYBPC1 4604 LETHAL CONGENITAL CONTRACTURE SYNDROME 4 OMIM:614915 marker/mechanism 614915.0 +MYBPC3 4607 Cardiomegaly MESH:D006332 marker/mechanism 22189562 +MYBPC3 4607 Cardiomyopathies MESH:D009202 marker/mechanism 19151713 +MYBPC3 4607 Cardiomyopathy, Familial Hypertrophic, 4 MESH:C566169 marker/mechanism 115197.0 +MYBPC3 4607 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 22076249|23816408|25566086|27994558 +MYBPC3 4607 Cardiomyopathy, Hypertrophic, Familial MESH:D024741 marker/mechanism 11815426|23896226|9241277 +MYBPC3 4607 Death, Sudden, Cardiac MESH:D016757 marker/mechanism 20435227 +MYBPC3 4607 Disease Models, Animal MESH:D004195 marker/mechanism 25566086 +MYBPC3 4607 LEFT VENTRICULAR NONCOMPACTION 10 OMIM:615396 marker/mechanism 615396.0 +MYC 4609 Adenocarcinoma MESH:D000230 marker/mechanism 26432044 +MYC 4609 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 26656844|27602772 +MYC 4609 Burkitt Lymphoma MESH:D002051 marker/mechanism 113970.0 +MYC 4609 Carcinoma MESH:D002277 marker/mechanism 2228319 +MYC 4609 Carcinoma, Ductal MESH:D044584 marker/mechanism 29295717 +MYC 4609 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12029619|15565109|29698666|9029167 +MYC 4609 Carcinoma, Merkel Cell MESH:D015266 marker/mechanism 25277525 +MYC 4609 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 24688052 +MYC 4609 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 26432044 +MYC 4609 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 22000973 +MYC 4609 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 12115494|2543982|29626521|31504995 +MYC 4609 Chromosome Breakage MESH:D019457 marker/mechanism 25933419 +MYC 4609 Cleft Lip MESH:D002971 marker/mechanism 24859337 +MYC 4609 Cleft Palate MESH:D002972 marker/mechanism 24859337 +MYC 4609 Colonic Neoplasms MESH:D003110 marker/mechanism 12189186|15059925|18283038|21081470 +MYC 4609 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +MYC 4609 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +MYC 4609 Disease Progression MESH:D018450 marker/mechanism 22321834|28191284|34510316|34626302 +MYC 4609 Endometrial Neoplasms MESH:D016889 marker/mechanism 26656844 +MYC 4609 Fatty Liver MESH:D005234 therapeutic 24210820 +MYC 4609 Glioblastoma MESH:D005909 marker/mechanism 21127729 +MYC 4609 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +MYC 4609 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 21472269 +MYC 4609 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 25956709 +MYC 4609 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MYC 4609 Liver Neoplasms MESH:D008113 marker/mechanism 11532874|8807143 +MYC 4609 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11280770|18560566|9079223 +MYC 4609 Lung Neoplasms MESH:D008175 marker/mechanism 16289808|28191284 +MYC 4609 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 27356265 +MYC 4609 Medulloblastoma MESH:D008527 marker/mechanism 19270706|31694585 +MYC 4609 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 10914558 +MYC 4609 Neoplasm Metastasis MESH:D009362 marker/mechanism 22321834 +MYC 4609 Neoplasms MESH:D009369 marker/mechanism 11559025 +MYC 4609 Neuroblastoma MESH:D009447 marker/mechanism 34626302|8761367 +MYC 4609 Neuroectodermal Tumors MESH:D017599 marker/mechanism 8761367 +MYC 4609 Osteosarcoma MESH:D012516 marker/mechanism 24646477|34508303 +MYC 4609 Ovarian Neoplasms MESH:D010051 marker/mechanism 20852632|34510316 +MYC 4609 Pancreatic Neoplasms MESH:D010190 marker/mechanism 25961927 +MYC 4609 Polycystic Kidney, Autosomal Dominant MESH:D016891 marker/mechanism 25877301 +MYC 4609 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048|23704919|29295717|32512071 +MYC 4609 Stomach Neoplasms MESH:D013274 marker/mechanism 17171786|21173787 +MYC 4609 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 2228319 +MYC 4609 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 26432044 +MYCBP 26292 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +MYCL 4610 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +MYCL 4610 Prostatic Neoplasms MESH:D011471 marker/mechanism 26005866 +MYCL 4610 Small Cell Lung Carcinoma MESH:D055752 therapeutic 22941189 +MYCN 4613 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +MYCN 4613 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +MYCN 4613 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22286764 +MYCN 4613 Chromosome Aberrations MESH:D002869 marker/mechanism 25174395 +MYCN 4613 Hyperplasia MESH:D006965 marker/mechanism 25174395 +MYCN 4613 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +MYCN 4613 Necrosis MESH:D009336 marker/mechanism 21214410 +MYCN 4613 Neuroblastoma MESH:D009447 marker/mechanism 16051641|16989911|17283129|18353067|22286764|22789543|23042116|23334666|23500671|25174395|26523776|26733615|29379199|30127528 +MYCN 4613 Oculodigitoesophagoduodenal syndrome MESH:C537734 marker/mechanism 164280.0 19852433|21532573 +MYCN 4613 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 28671688 +MYCN 4613 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +MYD88 4615 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24362818 +MYD88 4615 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +MYD88 4615 Eosinophilia MESH:D004802 marker/mechanism 26882889 +MYD88 4615 Hypertension MESH:D006973 marker/mechanism 27292124 +MYD88 4615 Inflammation MESH:D007249 marker/mechanism 22053092 +MYD88 4615 Lymphoma, Follicular MESH:D008224 marker/mechanism 24362818 +MYD88 4615 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 25049379 +MYD88 4615 MYD88 Deficiency MESH:C567379 marker/mechanism 612260.0 +MYD88 4615 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21473897 +MYD88 4615 Pneumonia MESH:D011014 marker/mechanism 26882889 +MYD88 4615 Pulmonary Eosinophilia MESH:D011657 marker/mechanism 29067999 +MYD88 4615 Reperfusion Injury MESH:D015427 marker/mechanism 25780291 +MYD88 4615 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 26861016 +MYD88 4615 Waldenstrom Macroglobulinemia MESH:D008258 marker/mechanism 153600.0 30126942 +MYDGF 56005 Keloid MESH:D007627 marker/mechanism 20128793 +MYH10 4628 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 9678433 +MYH11 4629 Aortic aneurysm, familial thoracic 4 MESH:C537784 marker/mechanism 132900.0 +MYH11 4629 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229|27798625 +MYH11 4629 Leukemia, Myelomonocytic, Acute MESH:D015479 marker/mechanism 10958941 +MYH13 8735 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +MYH14 79784 DEAFNESS, AUTOSOMAL DOMINANT 4A OMIM:600652 marker/mechanism 600652.0 +MYH14 79784 PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS OMIM:614369 marker/mechanism 614369.0 +MYH14 79784 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +MYH2 4620 Inclusion Body Myopathy 3, Autosomal Dominant MESH:C565311 marker/mechanism 605637.0 +MYH3 4621 Freeman-Sheldon syndrome MESH:C535483 marker/mechanism 193700.0 +MYH3 4621 Multiple Pterygium Syndrome, Autosomal Dominant MESH:C566739 marker/mechanism 178110.0 +MYH6 4624 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +MYH6 4624 Atrial Septal Defect 3 MESH:C563540 marker/mechanism 614089.0 +MYH6 4624 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 15998695 +MYH6 4624 Cardiomyopathy, Dilated, 1EE MESH:C567683 marker/mechanism 613252.0 +MYH6 4624 Cardiomyopathy, Familial Hypertrophic, 1 MESH:C566005 marker/mechanism 192600.0 +MYH6 4624 Cardiomyopathy, Familial Hypertrophic, 14 MESH:C567684 marker/mechanism 613251.0 +MYH6 4624 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 15998695|29741611 +MYH6 4624 Cardiomyopathy, Hypertrophic, Familial MESH:D024741 marker/mechanism 11815426 +MYH6 4624 Heart Defects, Congenital MESH:D006330 marker/mechanism 28991257 +MYH6 4624 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +MYH6 4624 Heart Septal Defects, Atrial MESH:D006344 marker/mechanism 15735645 +MYH6 4624 Sick Sinus Syndrome MESH:D012804 marker/mechanism 21378987 +MYH7 4625 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +MYH7 4625 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 11986409 +MYH7 4625 Cardiomyopathy, Dilated, 1s MESH:C563538 marker/mechanism 613426.0 +MYH7 4625 Cardiomyopathy, Familial Hypertrophic, 1 MESH:C566005 marker/mechanism 192600.0 +MYH7 4625 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 29686627|29741611 +MYH7 4625 Cardiomyopathy, Hypertrophic, Familial MESH:D024741 marker/mechanism 23896226 +MYH7 4625 CONGENITAL MYOPATHY 7A, MYOSIN STORAGE, AUTOSOMAL DOMINANT OMIM:608358 marker/mechanism 608358.0 +MYH7 4625 Coronary Stenosis MESH:D023921 marker/mechanism 12721106 +MYH7 4625 Distal Myopathies MESH:D049310 marker/mechanism 160500.0 +MYH7 4625 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +MYH7 4625 Hypertension MESH:D006973 marker/mechanism 32147540 +MYH7 4625 Myocardial Infarction MESH:D009203 marker/mechanism 11743230 +MYH7 4625 Myopathy, Hyaline Body, Autosomal Recessive MESH:C564970 marker/mechanism 255160.0 +MYH8 4626 Carney Complex Variant MESH:C563845 marker/mechanism 608837.0 +MYH8 4626 Hecht syndrome MESH:C535857 marker/mechanism 158300.0 +MYH9 4627 Breast Neoplasms MESH:D001943 marker/mechanism 28650484 +MYH9 4627 Carcinoma, Lobular MESH:D018275 marker/mechanism 28650484 +MYH9 4627 Deafness, autosomal dominant nonsyndromic sensorineural 17 MESH:C538050 marker/mechanism 603622.0 +MYH9 4627 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 18794856 +MYH9 4627 Hypertension, Renal MESH:D006977 marker/mechanism 18794856 +MYH9 4627 Kidney Failure, Chronic MESH:D007676 marker/mechanism 18794854|18794856 +MYH9 4627 Macrothrombocytopenia progressive deafness MESH:C537831 marker/mechanism 12621333 +MYH9 4627 MYH9-Related Disorders MESH:C535507 marker/mechanism 155100.0 10973259|11590545|12621333 +MYH9 4627 Neoplasm Invasiveness MESH:D009361 marker/mechanism 28650484 +MYH9 4627 Nephritis, Hereditary MESH:D009394 marker/mechanism 10973259 +MYL1 4632 Heart Injuries MESH:D006335 marker/mechanism 19854236 +MYL2 4633 Cardiomyopathy, Familial Hypertrophic, 10 MESH:C563865 marker/mechanism 608758.0 +MYL2 4633 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 9527842 +MYL2 4633 Cardiomyopathy, Hypertrophic, Familial MESH:D024741 marker/mechanism 9241277 +MYL3 4634 Cardiomyopathy, Familial Hypertrophic, 8 MESH:C563866 marker/mechanism 608751.0 +MYL4 4635 ATRIAL FIBRILLATION, FAMILIAL, 18 OMIM:617280 marker/mechanism 617280.0 +MYL4 4635 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 9527842 +MYL6B 140465 Keloid MESH:D007627 marker/mechanism 20128793 +MYL7 58498 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 9527842 +MYL9 10398 Brain Edema MESH:D001929 marker/mechanism 17419808 +MYL9 10398 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MYL9 10398 Vascular Diseases MESH:D014652 marker/mechanism 18511912 +MYLIP 29116 Endometriosis MESH:D004715 marker/mechanism 20864642 +MYLK 4638 Acute Lung Injury MESH:D055371 marker/mechanism 19374788 +MYLK 4638 AORTIC ANEURYSM, FAMILIAL THORACIC 7 OMIM:613780 marker/mechanism 613780.0 +MYLK 4638 Brain Edema MESH:D001929 marker/mechanism 19943851 +MYLK 4638 Gastrointestinal Diseases MESH:D005767 marker/mechanism 15621374 +MYLK 4638 Glaucoma MESH:D005901 marker/mechanism 20375339 +MYLK 4638 Glioma MESH:D005910 marker/mechanism 10232591 +MYLK 4638 Hypercholesterolemia MESH:D006937 marker/mechanism 21052790 +MYLK 4638 Hypersensitivity MESH:D006967 marker/mechanism 15621374 +MYLK 4638 Neoplasm Invasiveness MESH:D009361 marker/mechanism 10232591|12970723 +MYLK 4638 Neoplasm Metastasis MESH:D009362 marker/mechanism 12970723|18710790 +MYLK 4638 Pneumonia MESH:D011014 marker/mechanism 15863634 +MYLK 4638 Vascular Diseases MESH:D014652 marker/mechanism 18511912 +MYLK2 85366 Cardiomyopathy, Familial Hypertrophic, 1 MESH:C566005 marker/mechanism 192600.0 +MYO10 4651 Weight Gain MESH:D015430 marker/mechanism 19030233 +MYO15A 51168 Deafness, Autosomal Recessive 3 MESH:C563961 marker/mechanism 600316.0 33372036 +MYO18B 84700 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +MYO18B 84700 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29054765 +MYO18B 84700 KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM OMIM:616549 marker/mechanism 616549.0 +MYO18B 84700 Lung Neoplasms MESH:D008175 marker/mechanism 29054765 +MYO18B 84700 Mesothelioma MESH:D008654 therapeutic 17294804 +MYO1B 4430 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +MYO1B 4430 Weight Gain MESH:D015430 marker/mechanism 19030233 +MYO1C 4641 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +MYO1C 4641 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MYO1D 4642 Autistic Disorder MESH:D001321 marker/mechanism 17376794 +MYO1E 4643 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 614131.0 +MYO1F 4542 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MYO3A 53904 Deafness, Autosomal Recessive 30 MESH:C564624 marker/mechanism 607101.0 +MYO5A 4644 Griscelli syndrome type 1 MESH:C537301 marker/mechanism 214450.0 +MYO5A 4644 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MYO5A 4644 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +MYO5B 4645 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +MYO5B 4645 Diarrhea MESH:D003967 marker/mechanism 18724368 +MYO5B 4645 Intestinal Diseases MESH:D007410 marker/mechanism 18724368 +MYO5B 4645 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +MYO5B 4645 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 18724368 +MYO5B 4645 Microvillus inclusion disease MESH:C537470 marker/mechanism 251850.0 +MYO5C 55930 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +MYO6 4646 DEAFNESS, AUTOSOMAL DOMINANT 22;DFNA22 DEAFNESS, AUTOSOMAL DOMINANT 22, WITH HYPERTROPHIC CARDIOMYOPATHY, OMIM:606346 marker/mechanism 606346.0 +MYO6 4646 Deafness, Autosomal Recessive 37 MESH:C564331 marker/mechanism 607821.0 +MYO6 4646 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +MYO7A 4647 Deafness, Autosomal Dominant 11 MESH:C563353 marker/mechanism 601317.0 +MYO7A 4647 Deafness, Autosomal Recessive 2 MESH:C564007 marker/mechanism 600060.0 +MYO7A 4647 Melanoma MESH:D008545 marker/mechanism 22535842 +MYO7A 4647 Usher Syndromes MESH:D052245 marker/mechanism 15965244 +MYO7A 4647 Usher syndrome, type 1B MESH:C536485 marker/mechanism 276900.0 +MYO9B 4650 Celiac Disease MESH:D002446 marker/mechanism 609753.0 +MYO9B 4650 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +MYOC 4653 Glaucoma MESH:D005901 marker/mechanism 30389787|31959993 +MYOC 4653 Glaucoma 1, Open Angle, A MESH:C564234 marker/mechanism 137750.0 +MYOC 4653 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 21059646 +MYOC 4653 Heart Failure MESH:D006333 marker/mechanism 36071497 +MYOC 4653 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +MYOCD 93649 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +MYOCD 93649 Cardiomegaly MESH:D006332 marker/mechanism 16556869 +MYOD1 4654 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 21258934 +MYOD1 4654 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 21258934 +MYOD1 4654 Rhabdomyosarcoma, Embryonal MESH:D018233 marker/mechanism 24793135 +MYOT 9499 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +MYOT 9499 Cardiomyopathies MESH:D009202 marker/mechanism 15111675 +MYOT 9499 Muscle Weakness MESH:D018908 marker/mechanism 15111675 +MYOT 9499 Muscular Dystrophies, Limb-Girdle MESH:D049288 marker/mechanism 21336781 +MYOT 9499 MYOPATHY, MYOFIBRILLAR, 3 OMIM:609200 marker/mechanism 609200.0 +MYOT 9499 Myotilinopathy MESH:C563775 marker/mechanism 15111675 +MYOT 9499 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 15111675 +MYOZ1 58529 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +MYOZ2 51778 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16 OMIM:613838 marker/mechanism 613838.0 +MYPN 84665 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +MYPN 84665 CARDIOMYOPATHY, DILATED, 1KK OMIM:615248 marker/mechanism 615248.0 +MYPN 84665 CONGENITAL MYOPATHY 24 OMIM:617336 marker/mechanism 617336.0 +MYT1L 23040 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 39 OMIM:616521 marker/mechanism 616521.0 +MYT1L 23040 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +MYZAP 100820829 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +N4BP2L2 10443 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +N4BP2L2 10443 Skin Diseases MESH:D012871 marker/mechanism 16835338 +NAA10 8260 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +NAA10 8260 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +NAA10 8260 Microphthalmia, syndromic 1 MESH:C537464 marker/mechanism 309800.0 +NAA10 8260 OGDEN SYNDROME OMIM:300855 marker/mechanism 300855.0 +NAA15 80155 Intellectual Disability MESH:D008607 marker/mechanism 28191889 +NAB2 4665 Solitary Fibrous Tumors MESH:D054364 marker/mechanism 23313952|23313954 +NABP1 64859 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +NACA 4666 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +NACC1 112939 Neoplasms MESH:D009369 marker/mechanism 31101655 +NACC1 112939 NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION OMIM:617393 marker/mechanism 617393.0 +NADK2 133686 2,4-Dienoyl-CoA Reductase Deficiency MESH:C565624 marker/mechanism 616034.0 +NAGA 4668 Neuroaxonal Dystrophies MESH:D019150 marker/mechanism 2243144 +NAGA 4668 Schindler Disease, Type I MESH:C536631 marker/mechanism 609241|609242 19683538|2243144 +NAGK 55577 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NAGK 55577 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +NAGK 55577 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +NAGLU 4669 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V OMIM:616491 marker/mechanism 616491 +NAGLU 4669 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +NAGLU 4669 Mucopolysaccharidosis III MESH:D009084 marker/mechanism 252920 +NAGLU 4669 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +NAGS 162417 Hyperammonemia MESH:D022124 marker/mechanism 12594532|12754705|17703373 +NAGS 162417 N-acetyl glutamate synthetase deficiency MESH:C536109 marker/mechanism 237310 12594532|12754705 +NALCN 259232 CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY OMIM:616266 marker/mechanism 616266 +NALCN 259232 HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1 OMIM:615419 marker/mechanism 615419 +NALF1 728215 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +NALF1 728215 Diverticulitis MESH:D004238 marker/mechanism 28585551 +NAMPT 10135 Colitis MESH:D003092 marker/mechanism 23810507 +NAMPT 10135 Colorectal Neoplasms MESH:D015179 marker/mechanism 23922874|32005247 +NAMPT 10135 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +NAMPT 10135 Mouth Neoplasms MESH:D009062 marker/mechanism 28501332 +NAMPT 10135 Obesity MESH:D009765 marker/mechanism 23834033 +NAMPT 10135 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 28501332 +NANOG 79923 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 29626521 +NANOG 79923 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 16168501 +NANOS1 340719 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +NANOS1 340719 SPERMATOGENIC FAILURE 12 OMIM:615413 marker/mechanism 615413.0 +NANOS2 339345 Infertility, Male MESH:D007248 marker/mechanism 22190708 +NANS 54187 Bone Diseases, Developmental MESH:D001848 marker/mechanism 27213289 +NANS 54187 Developmental Disabilities MESH:D002658 marker/mechanism 27213289 +NANS 54187 Spondyloepimetaphyseal dysplasia, Genevieve type MESH:C535785 marker/mechanism 610442.0 +NANSA 322780 Bone Diseases, Developmental MESH:D001848 marker/mechanism 27213289 +NAP1L5 266812 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NARS2 79731 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24 OMIM:616239 marker/mechanism 616239.0 +NAT1 9 Chromosome Aberrations MESH:D002869 marker/mechanism 16537716 +NAT1 9 Dermatitis, Occupational MESH:D009783 marker/mechanism 19834256 +NAT1 9 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 11505221 +NAT1 9 Neoplasms MESH:D009369 marker/mechanism 11505221 +NAT1 9 Prostatic Neoplasms MESH:D011471 marker/mechanism 12618593 +NAT1 9 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 16003747 +NAT2 10 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NAT2 10 Breast Neoplasms MESH:D001943 marker/mechanism 19692670 +NAT2 10 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NAT2 10 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 11915035|16799928|17950035|25693865 +NAT2 10 Coronary Artery Disease MESH:D003324 marker/mechanism 21572414 +NAT2 10 Dermatitis, Occupational MESH:D009783 marker/mechanism 19834256 +NAT2 10 Drug Hypersensitivity MESH:D004342 marker/mechanism 20485159|20602614|21572414 +NAT2 10 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 17377643|17502830 +NAT2 10 Leukopenia MESH:D007970 marker/mechanism 12795783 +NAT2 10 Liver Neoplasms MESH:D008113 marker/mechanism 19666988 +NAT2 10 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 16697254 +NAT2 10 Neural Tube Defects MESH:D009436 marker/mechanism 20641098 +NAT2 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 22200898 +NAT2 10 Prostatic Neoplasms MESH:D011471 marker/mechanism 12618593|12622714|15717312|16083506 +NAT2 10 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 10022756|15717312|18505952|20972438|24221535 +NAT8 9027 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NAV2 89797 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +NAV3 89795 Autistic Disorder MESH:D001321 marker/mechanism 35982159 +NAV3 89795 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +NAV3 89795 Opioid-Related Disorders MESH:D009293 marker/mechanism 18438686 +NAXD 55739 Disease Progression MESH:D018450 marker/mechanism 21364753 +NAXD 55739 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +NAXE 128240 ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1 OMIM:617186 marker/mechanism 617186.0 +NBAS 51594 Disease Progression MESH:D018450 marker/mechanism 21364753 +NBAS 51594 INFANTILE LIVER FAILURE SYNDROME 2 OMIM:616483 marker/mechanism 616483.0 +NBAS 51594 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +NBEA 26960 Autistic Disorder MESH:D001321 marker/mechanism 12746398|20071347 +NBEA 26960 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NBEAL1 65065 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +NBEAL2 23218 Gray Platelet Syndrome MESH:D055652 marker/mechanism 139090.0 21765411|21765412|21765413 +NBN 4683 Anemia, Aplastic MESH:D000741 marker/mechanism 609135.0 +NBN 4683 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 25415046 +NBN 4683 Nijmegen Breakage Syndrome MESH:D049932 marker/mechanism 251260.0 16521404|17395558|18186968 +NBN 4683 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 613065.0 +NBN 4683 Prostatic Neoplasms MESH:D011471 marker/mechanism 14973119|25415046 +NBN 4683 Stomatitis MESH:D013280 marker/mechanism 24594932 +NCAM1 4684 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +NCAM1 4684 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19700239 +NCAN 1463 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +NCAN 1463 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +NCAPG 64151 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 34419073 +NCAPG 64151 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NCAPG 64151 Disease Progression MESH:D018450 marker/mechanism 34480403 +NCAPG 64151 Endometrial Neoplasms MESH:D016889 marker/mechanism 34480403 +NCAPG2 54892 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +NCAPH 23397 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NCEH1 57552 Neoplasms MESH:D009369 marker/mechanism 32171938 +NCF1 653361 Aortic Aneurysm, Abdominal MESH:D017544 marker/mechanism 16864727 +NCF1 653361 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524|28135245 +NCF1 653361 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21742780 +NCF1 653361 Diabetes Mellitus MESH:D003920 marker/mechanism 23723366 +NCF1 653361 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14871415|16380483 +NCF1 653361 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +NCF1 653361 Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I MESH:C565532 marker/mechanism 233700.0 +NCF1 653361 Hypercholesterolemia MESH:D006937 marker/mechanism 14871415 +NCF1 653361 Hypertension MESH:D006973 marker/mechanism 16331104|17324946|19018797|32165127 +NCF1 653361 Hypothermia MESH:D007035 therapeutic 30366073 +NCF1 653361 Intracranial Aneurysm MESH:D002532 marker/mechanism 19381132 +NCF1 653361 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +NCF1 653361 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 28135245 +NCF1 653361 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34453990 +NCF1 653361 Sjogren's Syndrome MESH:D012859 marker/mechanism 28135245 +NCF2 4688 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +NCF2 4688 Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type II MESH:C565531 marker/mechanism 233710.0 +NCF4 4689 Crohn Disease MESH:D003424 marker/mechanism 17435756 +NCF4 4689 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 3 OMIM:613960 marker/mechanism 613960.0 +NCF4 4689 Heart Diseases MESH:D006331 marker/mechanism 16330681 +NCK1 4690 Albuminuria MESH:D000419 marker/mechanism 19443634 +NCK1 4690 Nephrotic Syndrome MESH:D009404 marker/mechanism 19443634 +NCK1 4690 Proteinuria MESH:D011507 marker/mechanism 19443634 +NCK2 8440 Albuminuria MESH:D000419 marker/mechanism 19443634 +NCK2 8440 Alzheimer Disease MESH:D000544 marker/mechanism 33589840 +NCK2 8440 Nephrotic Syndrome MESH:D009404 marker/mechanism 19443634 +NCK2 8440 Proteinuria MESH:D011507 marker/mechanism 19443634 +NCKAP1 10787 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +NCKAP1L 3071 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NCL 4691 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +NCL 4691 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +NCL 4691 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +NCOA1 8648 Breast Neoplasms MESH:D001943 marker/mechanism 20332317 +NCOA1 8648 Endometriosis MESH:D004715 marker/mechanism 22138541 +NCOA1 8648 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 21080969 +NCOA1 8648 Neoplasm Metastasis MESH:D009362 marker/mechanism 21080969 +NCOA1 8648 Prostatic Neoplasms MESH:D011471 marker/mechanism 12237244 +NCOA2 10499 Breast Neoplasms MESH:D001943 marker/mechanism 20332317 +NCOA2 10499 Prostatic Neoplasms MESH:D011471 marker/mechanism 12237244 +NCOA3 8202 Adenocarcinoma MESH:D000230 marker/mechanism 20852035 +NCOA3 8202 Astrocytoma MESH:D001254 marker/mechanism 24680642 +NCOA3 8202 Bone Neoplasms MESH:D001859 marker/mechanism 24134957 +NCOA3 8202 Breast Neoplasms MESH:D001943 marker/mechanism 20332317 +NCOA3 8202 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 20852035 +NCOA3 8202 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 20852035 +NCOA3 8202 Leukemia MESH:D007938 marker/mechanism 19365708|19433130 +NCOA3 8202 Prostatic Neoplasms MESH:D011471 marker/mechanism 11927493|12237244 +NCOA4 8031 Thyroid Neoplasms MESH:D013964 marker/mechanism 23811263 +NCOA6 23054 Endometriosis MESH:D004715 marker/mechanism 22138541 +NCOA7 135112 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +NCOR1 9611 Breast Neoplasms MESH:D001943 marker/mechanism 19781322 +NCOR1 9611 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 21822268 +NCOR1 9611 Endometriosis MESH:D004715 marker/mechanism 22138541 +NCOR1 9611 Glioblastoma MESH:D005909 marker/mechanism 17312396 +NCOR1 9611 Hyperbilirubinemia, Neonatal MESH:D051556 marker/mechanism 28167773 +NCOR1 9611 Liver Neoplasms MESH:D008113 marker/mechanism 27064257 +NCOR1 9611 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +NCOR1 9611 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21822268 +NCOR2 9612 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NCR3 259197 Malaria MESH:D008288 marker/mechanism 609148.0 +NCSTN 23385 Alzheimer Disease MESH:D000544 marker/mechanism 17192785 +NCSTN 23385 Hidradenitis suppurativa, familial MESH:C538118 marker/mechanism 142690.0 20929727 +NCX-10 190821 Infertility MESH:D007246 marker/mechanism 25204677 +ND1 4535 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14563825 +ND1 4535 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +ND1 4535 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 535000.0 15342361|15505787|24569607|27449621|29991444 +ND2 4536 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 535000.0 +ND4 4538 Optic Atrophies, Hereditary MESH:D015418 marker/mechanism 11695835|8662757 +ND4 4538 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 535000.0 15342361|24569607 +ND4 4538 Schizophrenia MESH:D012559 marker/mechanism 14623372 +ND4L 4539 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 535000.0 +ND5 4540 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +ND5 4540 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 535000.0 31669237 +ND6 4541 Disease Susceptibility MESH:D004198 marker/mechanism 20130021 +ND6 4541 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +ND6 4541 Optic Atrophies, Hereditary MESH:D015418 marker/mechanism 10072046 +ND6 4541 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 535000.0 15342361|24569607|31669237 +NDC1 55706 Weight Gain MESH:D015430 marker/mechanism 19030233 +NDC80 10403 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NDE1 54820 Lissencephaly MESH:D054082 marker/mechanism 614019.0 +NDE1 54820 Microhydranencephaly MESH:C537555 marker/mechanism 605013.0 +NDEL1 81565 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +NDN 4692 Birth Weight MESH:D001724 marker/mechanism 31082282 +NDN 4692 Carcinoma MESH:D002277 marker/mechanism 21489049 +NDN 4692 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 21489049 +NDNF 79625 Endometriosis MESH:D004715 marker/mechanism 20864642 +NDP 4693 EXUDATIVE VITREORETINOPATHY 2, X-LINKED OMIM:305390 marker/mechanism 305390.0 +NDP 4693 Macular Edema MESH:D008269 marker/mechanism 29654250 +NDP 4693 Norrie disease MESH:C537849 marker/mechanism 310600.0 +NDP 4693 Retinal Neovascularization MESH:D015861 marker/mechanism 29654250 +NDP 4693 Retinitis MESH:D012173 marker/mechanism 29654250 +NDRG1 10397 Astrocytoma MESH:D001254 marker/mechanism 15341671 +NDRG1 10397 Breast Neoplasms MESH:D001943 marker/mechanism 15341671 +NDRG1 10397 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15341671 +NDRG1 10397 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 16778198 +NDRG1 10397 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +NDRG1 10397 Glioblastoma MESH:D005909 marker/mechanism 15341671 +NDRG1 10397 Hemangioblastoma MESH:D018325 marker/mechanism 15341671 +NDRG1 10397 Kidney Neoplasms MESH:D007680 marker/mechanism 15341671 +NDRG1 10397 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NDRG1 10397 Liver Neoplasms MESH:D008113 marker/mechanism 15341671 +NDRG1 10397 Melanoma MESH:D008545 marker/mechanism 15341671 +NDRG1 10397 Mouth Neoplasms MESH:D009062 marker/mechanism 22972152 +NDRG1 10397 Neoplasm Metastasis MESH:D009362 marker/mechanism|therapeutic 15867226|22972152 +NDRG1 10397 Neuropathy, hereditary motor and sensory, LOM type MESH:C535716 marker/mechanism 601455.0 +NDRG1 10397 Oropharyngeal Neoplasms MESH:D009959 marker/mechanism 22972152 +NDRG1 10397 Prostatic Neoplasms MESH:D011471 marker/mechanism 15341671 +NDRG1 10397 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 15341671 +NDRG1 10397 Smooth Muscle Tumor MESH:D018235 marker/mechanism 15341671 +NDRG1 10397 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 22972152 +NDRG2 57447 Cataract MESH:D002386 marker/mechanism 22043305 +NDRG2 57447 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +NDRG2 57447 Ischemic Attack, Transient MESH:D002546 marker/mechanism 23451161 +NDRG2 57447 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NDST1 3340 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16020517 +NDST1 3340 Eye Abnormalities MESH:D005124 marker/mechanism 16020517 +NDST1 3340 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +NDST1 3340 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 46 OMIM:616116 marker/mechanism 616116.0 +NDST1 3340 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +NDST1 3340 Malformations of Cortical Development MESH:D054220 marker/mechanism 16020517 +NDST2 8509 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +NDST4 64579 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +NDUFA13 51079 Thyroid cancer, Hurthle cell MESH:C536913 marker/mechanism 607464.0 +NDUFA2 4695 Disease Progression MESH:D018450 marker/mechanism 21364753 +NDUFA2 4695 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +NDUFA4L2 56901 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +NDUFAF2 91942 Brain Diseases, Metabolic, Inborn MESH:D020739 marker/mechanism 16200211 +NDUFB11 54539 LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3 OMIM:300952 marker/mechanism 300952.0 +NDUFB11 54539 Microphthalmia, syndromic 7 MESH:C537466 marker/mechanism 309801.0 +NDUFB7 4713 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +NDUFB8 4714 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +NDUFB8 4714 Skin Diseases MESH:D012871 marker/mechanism 16835338 +NDUFB9 4715 Weight Gain MESH:D015430 marker/mechanism 19030233 +NDUFS1 4719 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 9527842 +NDUFS1 4719 Disease Progression MESH:D018450 marker/mechanism 21364753 +NDUFS1 4719 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +NDUFS2 4720 Cardiomyopathies MESH:D009202 marker/mechanism 14729820 +NDUFS2 4720 Mitochondrial Encephalomyopathies MESH:D017237 marker/mechanism 14729820 +NDUFS3 4722 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +NDUFS3 4722 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +NDUFS3 4722 Leigh Disease MESH:D007888 marker/mechanism 14729820 +NDUFS3 4722 Optic Atrophy MESH:D009896 marker/mechanism 14729820 +NDUFS4 4724 Brain Diseases MESH:D001927 marker/mechanism 24935635 +NDUFS4 4724 Leigh Disease MESH:D007888 marker/mechanism 11181577 +NDUFS4 4724 Mitochondrial complex I deficiency MESH:C537475 marker/mechanism 252010.0 +NDUFS4 4724 Motor Skills Disorders MESH:D019957 marker/mechanism 24935635 +NDUFS8 4728 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +NDUFV1 4723 Disease Progression MESH:D018450 marker/mechanism 21364753 +NDUFV1 4723 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +NDUFV1 4723 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +NDUFV2 4729 Bipolar Disorder MESH:D001714 marker/mechanism 19135101 +NDUFV2 4729 Cardiomyopathies MESH:D009202 marker/mechanism 14729820 +NDUFV2 4729 Mitochondrial Encephalomyopathies MESH:D017237 marker/mechanism 14729820 +NDUFV2 4729 Schizophrenia MESH:D012559 marker/mechanism 19135101 +NEAT1 283131 Acute Lung Injury MESH:D055371 therapeutic 34687491 +NEAT1 283131 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +NEAT1 283131 Liver Neoplasms MESH:D008113 marker/mechanism 27064257 +NEAT1 283131 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +NEB 4703 Nemaline Myopathy 2 MESH:C538349 marker/mechanism 256030.0 +NEBL 10529 Atrial Fibrillation MESH:D001281 marker/mechanism 28416822 +NECAME_02783 25342821 Atrophy MESH:D001284 therapeutic 34051231 +NECAME_02783 25342821 Colitis, Ulcerative MESH:D003093 therapeutic 34051231 +NECAME_02783 25342821 Edema MESH:D004487 therapeutic 34051231 +NECAME_02783 25342821 Necrosis MESH:D009336 therapeutic 34051231 +NECAME_02783 25342821 Weight Loss MESH:D015431 therapeutic 34051231 +NECAP1 25977 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21 OMIM:615833 marker/mechanism 615833.0 +NECTIN1 5818 Herpes Simplex MESH:D006561 marker/mechanism 10729168 +NECTIN1 5818 Herpesviridae Infections MESH:D006566 marker/mechanism 10932188 +NECTIN1 5818 Zlotogora-Ogur syndrome MESH:C536726 marker/mechanism 225060.0 10932188 +NECTIN2 5819 Alzheimer Disease MESH:D000544 marker/mechanism 29107063|30319691|30320580 +NECTIN2 5819 Atherosclerosis MESH:D050197 marker/mechanism 28062492 +NECTIN2 5819 Breast Neoplasms MESH:D001943 therapeutic 23758976 +NECTIN2 5819 Cognitive Dysfunction MESH:D060825 marker/mechanism 30503753 +NECTIN2 5819 Dyslipidemias MESH:D050171 marker/mechanism 29670124 +NECTIN2 5819 Herpes Simplex MESH:D006561 marker/mechanism 10729168|11602758|30319691 +NECTIN2 5819 Leukemia, Myeloid, Acute MESH:D015470 therapeutic 29855615 +NECTIN2 5819 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NECTIN2 5819 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 27356265 +NECTIN2 5819 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 28659334 +NECTIN2 5819 Multiple Sclerosis MESH:D009103 marker/mechanism 16738668 +NECTIN2 5819 Neoplasm Metastasis MESH:D009362 marker/mechanism 29321541 +NECTIN2 5819 Orofacial Cleft 1 MESH:C566121 marker/mechanism 21637507 +NECTIN2 5819 Ovarian Neoplasms MESH:D010051 therapeutic 23758976 +NECTIN2 5819 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +NECTIN2 5819 Prostatic Neoplasms MESH:D011471 marker/mechanism 30614027 +NECTIN2 5819 Scleroderma, Systemic MESH:D012595 marker/mechanism 27482699 +NECTIN2 5819 Teratozoospermia MESH:D000072660 marker/mechanism 28689229 +NECTIN2 5819 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 29321541 +NECTIN3 25945 Teratozoospermia MESH:D000072660 marker/mechanism 28689229 +NECTIN4 81607 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1 OMIM:613573 marker/mechanism 613573.0 +NEDD4 4734 Keloid MESH:D007627 marker/mechanism 20711176 +NEDD4 4734 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +NEDD4 4734 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +NEDD4L 23327 Cleft Palate MESH:D002972 marker/mechanism 27694961 +NEDD4L 23327 Endometriosis MESH:D004715 marker/mechanism 20864642 +NEDD4L 23327 Hypertension MESH:D006973 marker/mechanism 18524855|23348737 +NEDD4L 23327 Periventricular Nodular Heterotopia MESH:D054091 marker/mechanism 617201.0 27694961 +NEDD4L 23327 Syndactyly MESH:D013576 marker/mechanism 27694961 +NEDD9 4739 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +NEFH 4744 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 105400.0 +NEFH 4744 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC OMIM:616924 marker/mechanism 616924.0 +NEFH 4744 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 10447555 +NEFL 4747 Charcot-Marie-Tooth disease, Type 1F MESH:C537987 marker/mechanism 607734.0 +NEFL 4747 Charcot-Marie-Tooth disease, Type 2E MESH:C537994 marker/mechanism 607684.0 +NEFM 4741 Endometriosis MESH:D004715 marker/mechanism 20864642 +NEGR1 257194 Obesity MESH:D009765 marker/mechanism 19079261 +NEIL1 79661 Dyslipidemias MESH:D050171 marker/mechanism 16446448 +NEIL1 79661 Fatty Liver MESH:D005234 marker/mechanism 16446448|21285402 +NEIL1 79661 Glucose Intolerance MESH:D018149 marker/mechanism 21285402 +NEIL1 79661 Hyperinsulinism MESH:D006946 marker/mechanism 16446448 +NEIL1 79661 Hyperlipidemias MESH:D006949 marker/mechanism 21285402 +NEIL1 79661 Insulin Resistance MESH:D007333 marker/mechanism 21285402 +NEIL1 79661 Metabolic Syndrome MESH:D024821 marker/mechanism 16446448|17389588 +NEIL1 79661 Obesity MESH:D009765 marker/mechanism 16446448|21285402 +NEIL3 55247 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NEK1 4750 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 26945885|27455347 +NEK1 4750 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 263520.0 21211617|22482978|22499340 +NEK2 4751 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NEK2 4751 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 28509438 +NEK2 4751 Neoplasm Invasiveness MESH:D009361 marker/mechanism 28509438 +NEK2 4751 RETINITIS PIGMENTOSA 67 OMIM:615565 marker/mechanism 615565.0 +NEK6 10783 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NEK7 140609 Weight Gain MESH:D015430 marker/mechanism 19030233 +NEK8 284086 Kidney Diseases MESH:D007674 marker/mechanism 18199800 +NEK8 284086 NEPHRONOPHTHISIS 9 OMIM:613824 marker/mechanism 613824.0 +NEK9 91754 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY OMIM:614262 marker/mechanism 614262.0 +NEK9 91754 LETHAL CONGENITAL CONTRACTURE SYNDROME 10 OMIM:617022 marker/mechanism 617022.0 +NEK9 91754 NEVUS COMEDONICUS OMIM:617025 marker/mechanism 617025.0 +NELL1 4745 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 17452981 +NELL1 4745 Craniosynostoses MESH:D003398 marker/mechanism 14672347 +NEMF 9147 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 28191889 +NES 10763 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 16137769 +NES 10763 Nephrosis MESH:D009401 marker/mechanism 16418842 +NETO2 81831 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +NETO2 81831 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +NEU1 4758 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 25401298 +NEU1 4758 Neuraminidase 1 deficiency MESH:C537366 marker/mechanism 256550.0 +NEURL1 9148 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +NEURL1 9148 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +NEUROD1 4760 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +NEUROD1 4760 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 16123366 +NEUROD1 4760 MODY, Type 6 MESH:C565231 marker/mechanism 606394.0 +NEUROD1 4760 Nervous System Diseases MESH:D009422 marker/mechanism 23203475 +NEUROG3 50674 Diarrhea 4, Malabsorptive, Congenital MESH:C563673 marker/mechanism 610370.0 +NEXMIF 340533 Epilepsy MESH:D004827 marker/mechanism 29942082 +NEXMIF 340533 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 98 OMIM:300912 marker/mechanism 300912.0 +NEXMIF 340533 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +NEXN 91624 Cardiomyopathy, Dilated, 1CC MESH:C567733 marker/mechanism 613122.0 +NEXN 91624 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20 OMIM:613876 marker/mechanism 613876.0 +NF1 4763 Adenoma MESH:D000236 marker/mechanism 25119042 +NF1 4763 Astrocytoma MESH:D001254 marker/mechanism 20176786|23817572 +NF1 4763 Autistic Disorder MESH:D001321 marker/mechanism 15389774 +NF1 4763 Fibrosarcoma MESH:D005354 marker/mechanism 20601955 +NF1 4763 Glioblastoma MESH:D005909 marker/mechanism 25119042 +NF1 4763 Glioma MESH:D005910 marker/mechanism 25119042 +NF1 4763 Intellectual Disability MESH:D008607 marker/mechanism 21236316 +NF1 4763 Learning Disabilities MESH:D007859 marker/mechanism 21949590 +NF1 4763 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 21441929|25822087 +NF1 4763 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 607785.0 22315502|26457647|26457648 +NF1 4763 Liposarcoma MESH:D008080 marker/mechanism 20601955 +NF1 4763 Melanoma MESH:D008545 marker/mechanism 25119042|26214590 +NF1 4763 Nerve Sheath Neoplasms MESH:D018317 marker/mechanism 20176786|25240281 +NF1 4763 Neurilemmoma MESH:D009442 marker/mechanism 25119042 +NF1 4763 Neurofibroma MESH:D009455 marker/mechanism 25119042 +NF1 4763 Neurofibromatoses MESH:D017253 marker/mechanism 21949590 +NF1 4763 Neurofibromatosis 1 MESH:D009456 marker/mechanism 162200.0 21501659 +NF1 4763 Neurofibromatosis, Familial Spinal MESH:C563523 marker/mechanism 162210.0 +NF1 4763 Neurofibromatosis-Noonan syndrome MESH:C537393 marker/mechanism 601321.0 +NF1 4763 Nevus, Pigmented MESH:D009508 marker/mechanism 25119042 +NF1 4763 Pheochromocytoma MESH:D010673 marker/mechanism 11151443 +NF1 4763 Retinal Neovascularization MESH:D015861 marker/mechanism 29847659 +NF1 4763 Sarcoma MESH:D012509 marker/mechanism 20601955 +NF1 4763 WATSON SYNDROME OMIM:193520 marker/mechanism 193520.0 +NF2 4771 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25401301 +NF2 4771 Meningioma MESH:D008579 marker/mechanism 23334667 +NF2 4771 Meningioma, familial MESH:C537443 marker/mechanism 607174.0 +NF2 4771 Mesothelioma MESH:D008654 marker/mechanism 12136076|12168054|12802287|16166281|16319530|18835652 +NF2 4771 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23435014|26463840|26678224|26928227|29112861 +NF2 4771 Neurofibromatosis 2 MESH:D016518 marker/mechanism 101000.0 12136076 +NF2 4771 Pleural Neoplasms MESH:D010997 marker/mechanism 23435014 +NFATC2 4773 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +NFATC2 4773 Hypertension, Pulmonary MESH:D006976 marker/mechanism 27522126 +NFATC2 4773 Nervous System Diseases MESH:D009422 marker/mechanism 21245421 +NFATC4 4776 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 34192554 +NFE2L2 4780 Acidosis MESH:D000138 marker/mechanism 29618784 +NFE2L2 4780 Acute Kidney Injury MESH:D058186 marker/mechanism 24958931 +NFE2L2 4780 Acute Lung Injury MESH:D055371 therapeutic 24812154 +NFE2L2 4780 Amyotrophic Lateral Sclerosis MESH:D000690 therapeutic 27012417 +NFE2L2 4780 Anemia, Sickle Cell MESH:D000755 marker/mechanism 29255069 +NFE2L2 4780 Breast Neoplasms MESH:D001943 marker/mechanism 32621833 +NFE2L2 4780 Carcinogenesis MESH:D063646 marker/mechanism 29228771 +NFE2L2 4780 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22561517 +NFE2L2 4780 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22684020|26482881|33148531 +NFE2L2 4780 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 21489257 +NFE2L2 4780 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18572023 +NFE2L2 4780 Cardiac Output, Low MESH:D002303 marker/mechanism 30096613 +NFE2L2 4780 Cell Transformation, Neoplastic MESH:D002471 therapeutic 35124418 +NFE2L2 4780 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 22491424|22627062|24813929|26958860|30215777 +NFE2L2 4780 Cholestasis MESH:D002779 therapeutic 20977460 +NFE2L2 4780 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 30026087 +NFE2L2 4780 Chromosome Breakage MESH:D019457 therapeutic 27774770 +NFE2L2 4780 Clinical Deterioration MESH:D000075902 marker/mechanism 29255069 +NFE2L2 4780 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 23564646 +NFE2L2 4780 Diabetic Nephropathies MESH:D003928 therapeutic 20103708 +NFE2L2 4780 Disease Models, Animal MESH:D004195 marker/mechanism|therapeutic 27012417|29255069 +NFE2L2 4780 Disease Progression MESH:D018450 marker/mechanism 32621833 +NFE2L2 4780 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 20605904 +NFE2L2 4780 Emphysema MESH:D004646 therapeutic 20133372 +NFE2L2 4780 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 19910389 +NFE2L2 4780 Endometrial Neoplasms MESH:D016889 marker/mechanism 20530669 +NFE2L2 4780 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +NFE2L2 4780 Fatty Liver MESH:D005234 marker/mechanism 28555106 +NFE2L2 4780 Fetal Death MESH:D005313 marker/mechanism 29255069 +NFE2L2 4780 Gastrointestinal Diseases MESH:D005767 marker/mechanism 20404090 +NFE2L2 4780 Heart Failure MESH:D006333 therapeutic 28373008 +NFE2L2 4780 Hepatic Insufficiency MESH:D048550 marker/mechanism 30026087 +NFE2L2 4780 Hepatomegaly MESH:D006529 marker/mechanism 30026087 +NFE2L2 4780 Hyperglycemia MESH:D006943 marker/mechanism 20086057 +NFE2L2 4780 Hyperplasia MESH:D006965 therapeutic 19234301 +NFE2L2 4780 Hypertension MESH:D006973 marker/mechanism 32165127 +NFE2L2 4780 Keratosis MESH:D007642 marker/mechanism 20404090 +NFE2L2 4780 Kidney Diseases MESH:D007674 therapeutic 20605904 +NFE2L2 4780 Liver Cirrhosis MESH:D008103 therapeutic 23793039 +NFE2L2 4780 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 30026087 +NFE2L2 4780 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 23341968 +NFE2L2 4780 Liver Neoplasms MESH:D008113 marker/mechanism 20722399 +NFE2L2 4780 Lung Neoplasms MESH:D008175 marker/mechanism 31227482 +NFE2L2 4780 Micronuclei, Chromosome-Defective MESH:D048629 therapeutic 27774770 +NFE2L2 4780 Necrosis MESH:D009336 therapeutic 24813929 +NFE2L2 4780 Neoplasm Invasiveness MESH:D009361 marker/mechanism 32682831 +NFE2L2 4780 Neoplasm Metastasis MESH:D009362 marker/mechanism 32682831 +NFE2L2 4780 Neurotoxicity Syndromes MESH:D020258 therapeutic 20211941 +NFE2L2 4780 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 25294219 +NFE2L2 4780 Primary Ovarian Insufficiency MESH:D016649 marker/mechanism 26247513 +NFE2L2 4780 Prostatic Neoplasms MESH:D011471 marker/mechanism 20124447|23441843 +NFE2L2 4780 Pulmonary Fibrosis MESH:D011658 marker/mechanism 23570914 +NFE2L2 4780 Skin Neoplasms MESH:D012878 marker/mechanism 18572023 +NFE2L2 4780 Splenomegaly MESH:D013163 marker/mechanism 29255069 +NFE2L2 4780 Vascular System Injuries MESH:D057772 therapeutic 19234301 +NFE2L2 4780 Ventricular Dysfunction, Left MESH:D018487 therapeutic 29353218 +NFE2L2 4780 Ventricular Remodeling MESH:D020257 therapeutic 29353218 +NFE2L2 4780 Vitiligo MESH:D014820 marker/mechanism 28836394 +NFIA 4774 BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS OMIM:613735 marker/mechanism 613735.0 +NFIB 4781 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +NFIC 4782 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +NFIL3 4783 Sleep Disorders, Circadian Rhythm MESH:D020178 marker/mechanism 25395965 +NFIX 4784 Marshall-Smith syndrome MESH:C536026 marker/mechanism 602535.0 +NFKB1 4790 Acute Kidney Injury MESH:D058186 marker/mechanism 29286200 +NFKB1 4790 Adenocarcinoma MESH:D000230 marker/mechanism 19028472 +NFKB1 4790 Brain Ischemia MESH:D002545 therapeutic 18628779 +NFKB1 4790 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism|therapeutic 20516118|28823542 +NFKB1 4790 Colonic Neoplasms MESH:D003110 marker/mechanism 19028472|20715105 +NFKB1 4790 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 616576.0 +NFKB1 4790 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 17107852 +NFKB1 4790 Heat Stroke MESH:D018883 marker/mechanism 24039931 +NFKB1 4790 Hyperoxaluria MESH:D006959 marker/mechanism 16284884 +NFKB1 4790 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +NFKB1 4790 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 21399635 +NFKB1 4790 Liver Diseases MESH:D008107 therapeutic 15743782 +NFKB1 4790 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +NFKB2 4791 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 615577.0 +NFKB2 4791 Heat Stroke MESH:D018883 marker/mechanism 24039931 +NFKB2 4791 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +NFKBIA 4792 Arteriosclerosis MESH:D001161 marker/mechanism 28569748 +NFKBIA 4792 Brain Ischemia MESH:D002545 marker/mechanism 18628779 +NFKBIA 4792 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +NFKBIA 4792 Carcinoma, Hepatocellular MESH:D006528 therapeutic 22022477 +NFKBIA 4792 Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant MESH:C567411 marker/mechanism 612132.0 +NFKBIA 4792 Hodgkin Disease MESH:D006689 marker/mechanism 19223558 +NFKBIA 4792 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 26806094 +NFKBIA 4792 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +NFKBIA 4792 Pancreatic Neoplasms MESH:D010190 therapeutic 15861417 +NFKBIA 4792 Psoriasis MESH:D011565 marker/mechanism 20953190 +NFKBIA 4792 Vasculitis MESH:D014657 marker/mechanism 28569748 +NFKBIE 4794 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22446963 +NFKBIE 4794 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NFKBIE 4794 Melanoma MESH:D008545 marker/mechanism 26343386 +NFKBIL1 4795 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 180300.0 +NFKBIZ 64332 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NFU1 27247 Multiple Mitochondrial Dysfunctions Syndrome MESH:C565304 marker/mechanism 605711.0 +NFXL1 152518 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +NFXL1 152518 Cholestasis MESH:D002779 marker/mechanism 26881866 +NFYA 4800 Lung Neoplasms MESH:D008175 marker/mechanism 16271038 +NGB 58157 Heredodegenerative Disorders, Nervous System MESH:D020271 marker/mechanism 16825958 +NGF 4803 Amnesia MESH:D000647 therapeutic 16405025|19694610 +NGF 4803 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 22871964 +NGF 4803 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17715210 +NGF 4803 Corneal Ulcer MESH:D003320 therapeutic 24244623 +NGF 4803 Cystitis MESH:D003556 marker/mechanism 16889433 +NGF 4803 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 16023256 +NGF 4803 Glomerulonephritis MESH:D005921 marker/mechanism 24244623 +NGF 4803 Hereditary Sensory and Autonomic Neuropathies MESH:D009477 marker/mechanism 608654.0 +NGF 4803 Heroin Dependence MESH:D006556 marker/mechanism 17715210 +NGF 4803 Hyperalgesia MESH:D006930 marker/mechanism 20457222 +NGF 4803 Hyperkinesis MESH:D006948 marker/mechanism 1661212 +NGF 4803 Infarction, Middle Cerebral Artery MESH:D020244 therapeutic 10408807 +NGF 4803 Inflammation MESH:D007249 marker/mechanism 10653021 +NGF 4803 Kidney Failure, Chronic MESH:D007676 marker/mechanism 24244623 +NGF 4803 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +NGF 4803 Lung Injury MESH:D055370 therapeutic 20075049 +NGF 4803 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25162674 +NGF 4803 Nephritis, Interstitial MESH:D009395 marker/mechanism 16889433 +NGF 4803 Nerve Degeneration MESH:D009410 therapeutic 22666365 +NGF 4803 Nervous System Diseases MESH:D009422 therapeutic 15093677 +NGF 4803 Neurobehavioral Manifestations MESH:D019954 therapeutic 22666365 +NGF 4803 Neurodegenerative Diseases MESH:D019636 therapeutic 24244623 +NGF 4803 Neurogenic Inflammation MESH:D020078 marker/mechanism 21570423 +NGF 4803 Parkinson Disease MESH:D010300 marker/mechanism 19276553 +NGF 4803 Parkinsonian Disorders MESH:D020734 therapeutic 19694610 +NGF 4803 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 15319252 +NGF 4803 Renal Insufficiency, Chronic MESH:D051436 marker/mechanism 24244623 +NGF 4803 Seizures MESH:D012640 marker/mechanism 18815271 +NGF 4803 Skin Ulcer MESH:D012883 therapeutic 24244623 +NGF 4803 Status Epilepticus MESH:D013226 marker/mechanism 8635431|8821376 +NGF 4803 Urinary Bladder, Overactive MESH:D053201 marker/mechanism 16600756 +NGFR 4804 Melanoma MESH:D008545 marker/mechanism 30339727 +NGFR 4804 Nerve Degeneration MESH:D009410 marker/mechanism 10436046 +NGFR 4804 Neurodegenerative Diseases MESH:D019636 marker/mechanism 12097334 +NGFR 4804 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 17409433|18056468 +NGFR 4804 Seizures MESH:D012640 marker/mechanism 10436046 +NGLY1 55768 CONGENITAL DISORDER OF DEGLYCOSYLATION 1 OMIM:615273 marker/mechanism 615273.0 +NHEJ1 79840 Severe Combined Immunodeficiency with Microcephaly, Growth Retardation, and Sensitivity to Ionizing Radiation MESH:C566970 marker/mechanism 611291.0 +NHERF1 9368 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 28235801 +NHERF1 9368 NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2 OMIM:612287 marker/mechanism 612287.0 +NHERF2 9351 Hypertension MESH:D006973 marker/mechanism 22228705 +NHLH2 4808 Obesity MESH:D009765 marker/mechanism 20808804 +NHLRC1 378884 Lafora Disease MESH:D020192 marker/mechanism 254780.0 +NHLRC1 378884 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 25401298 +NHP2 55651 Dyskeratosis Congenita, Autosomal Recessive MESH:C565611 marker/mechanism 224230.0 +NHP2 55651 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2 OMIM:613987 marker/mechanism 613987.0 +NHR-166 183605 Infertility MESH:D007246 marker/mechanism 25204677 +NHR-185 185907 Infertility MESH:D007246 marker/mechanism 25204677 +NHS 4810 Cataract, congenital, with microcornea or slight microphthalmia MESH:C535338 marker/mechanism 302200.0 +NHS 4810 Nance-Horan syndrome MESH:C538336 marker/mechanism 302350.0 +NIBAN1 116496 Cholestasis MESH:D002779 marker/mechanism 27989131 +NID1 4811 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NID1 4811 Weight Gain MESH:D015430 marker/mechanism 19030233 +NID2 22795 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NINJ1 4814 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +NIPA1 123606 Spastic paraplegia 6, autosomal dominant MESH:C536866 marker/mechanism 600363.0 +NIPAL2 79815 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NIPAL3 57185 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048 +NIPAL4 348938 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6 OMIM:612281 marker/mechanism 612281.0 +NIPBL 25836 Bone Diseases, Developmental MESH:D001848 marker/mechanism 19763162 +NIPBL 25836 Chromosome Breakage MESH:D019457 marker/mechanism 35435490 +NIPBL 25836 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19763162 +NIPBL 25836 De Lange Syndrome MESH:D003635 marker/mechanism 122470.0 19763162|19886366|29379197 +NIPBL 25836 Hearing Disorders MESH:D006311 marker/mechanism 19763162 +NIPBL 25836 Heart Defects, Congenital MESH:D006330 marker/mechanism 19763162 +NISCH 11188 Bradycardia MESH:D001919 marker/mechanism 11486246 +NISCH 11188 Breast Neoplasms MESH:D001943 marker/mechanism 29912916 +NISCH 11188 Hypotension MESH:D007022 marker/mechanism 11486246|22613216 +NKAPL 222698 Schizophrenia MESH:D012559 marker/mechanism 22037552 +NKILA 105416157 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 29481769 +NKX2-1 7080 Chorea MESH:D002819 marker/mechanism 118700.0 +NKX2-1 7080 Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress MESH:C567034 marker/mechanism 610978.0 +NKX2-1 7080 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10830305|16863852 +NKX2-1 7080 Lung Diseases MESH:D008171 marker/mechanism 16863852 +NKX2-1 7080 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 188550.0 +NKX2-3 159296 Colitis, Ulcerative MESH:D003093 marker/mechanism 18438405|18438406|20228799 +NKX2-3 159296 Crohn Disease MESH:D003424 marker/mechanism 17554261|18438405|18438406 +NKX2-5 1482 Atrial Fibrillation MESH:D001281 marker/mechanism 20062060|29892015|30061737 +NKX2-5 1482 ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS OMIM:108900 marker/mechanism 108900.0 +NKX2-5 1482 Cardiomegaly MESH:D006332 marker/mechanism 28973413 +NKX2-5 1482 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 28973413 +NKX2-5 1482 CONOTRUNCAL HEART MALFORMATIONS OMIM:217095 marker/mechanism 217095.0 +NKX2-5 1482 Heart Septal Defects, Ventricular MESH:D006345 marker/mechanism 614432.0 +NKX2-5 1482 Hypoplastic Left Heart Syndrome MESH:D018636 marker/mechanism 614435.0 +NKX2-5 1482 Hypothyroidism, Congenital, Nongoitrous, 5 MESH:C567123 marker/mechanism 225250.0 +NKX2-5 1482 Myotonic Dystrophy MESH:D009223 marker/mechanism 18084293 +NKX2-5 1482 Stroke MESH:D020521 marker/mechanism 29531354 +NKX2-5 1482 Tetralogy of Fallot MESH:D013771 marker/mechanism 187500.0 +NKX2-6 137814 CONOTRUNCAL HEART MALFORMATIONS OMIM:217095 marker/mechanism 217095.0 +NKX3-1 4824 Prostatic Neoplasms MESH:D011471 marker/mechanism 16817226|17173048|17202838|22610119|32690948 +NKX3-2 579 Spondylo-Megaepiphyseal-Metaphyseal Dysplasia MESH:C567639 marker/mechanism 613330.0 +NKX6-1 4825 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +NKX6-1 4825 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +NLG-1 181484 Sensation Disorders MESH:D012678 marker/mechanism 20083577 +NLGN1 22871 Autistic Disorder MESH:D001321 marker/mechanism 19404257 +NLGN3 54413 AUTISM, SUSCEPTIBILITY TO, X-LINKED 1;AUTSX1 ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1, FORMERLY, OMIM:300425 marker/mechanism 300425.0 +NLGN3 54413 Autistic Disorder MESH:D001321 marker/mechanism 12669065|18621663 +NLGN4X 57502 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 18252227 +NLGN4X 57502 AUTISM, SUSCEPTIBILITY TO, X-LINKED 2 OMIM:300495 marker/mechanism 300495.0 +NLGN4X 57502 Autistic Disorder MESH:D001321 marker/mechanism 12669065 +NLRC3 197358 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 30081150 +NLRC4 58484 AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS OMIM:616050 marker/mechanism 616050.0 +NLRC4 58484 Cryopyrin-Associated Periodic Syndromes MESH:D056587 marker/mechanism 616115.0 +NLRC4 58484 Enterocolitis MESH:D004760 marker/mechanism 25217960 +NLRC4 58484 Hereditary Autoinflammatory Diseases MESH:D056660 marker/mechanism 25217959|25217960 +NLRC4 58484 Macrophage Activation Syndrome MESH:D055501 marker/mechanism 25217959 +NLRC5 84166 Fatty Liver, Alcoholic MESH:D005235 marker/mechanism 36708882 +NLRC5 84166 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 26806094 +NLRP1 22861 AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS OMIM:617388 marker/mechanism 617388.0 +NLRP1 22861 PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING OMIM:615225 marker/mechanism 615225.0 +NLRP1 22861 VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 OMIM:606579 marker/mechanism 606579.0 +NLRP12 91662 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +NLRP12 91662 Familial Cold Autoinflammatory Syndrome 2 MESH:C567090 marker/mechanism 611762 +NLRP3 114548 Acne Vulgaris MESH:D000152 marker/mechanism 27106250 +NLRP3 114548 Acute Lung Injury MESH:D055371 marker/mechanism 33012731 +NLRP3 114548 Anaphylaxis MESH:D000707 marker/mechanism 19767079 +NLRP3 114548 Arsenic Poisoning MESH:D020261 marker/mechanism 35226250 +NLRP3 114548 Asbestosis MESH:D001195 marker/mechanism 24142982 +NLRP3 114548 Ataxia MESH:D001259 marker/mechanism 32014472 +NLRP3 114548 Crohn Disease MESH:D003424 marker/mechanism 19098911 +NLRP3 114548 Cryopyrin-Associated Periodic Syndromes MESH:D056587 marker/mechanism 120100|607115 11687797|12032915|12928894|25217959 +NLRP3 114548 Drug Hypersensitivity MESH:D004342 marker/mechanism 19767079 +NLRP3 114548 Food Hypersensitivity MESH:D005512 marker/mechanism 19767079 +NLRP3 114548 Hidradenitis Suppurativa MESH:D017497 marker/mechanism 27106250 +NLRP3 114548 Inflammation MESH:D007249 marker/mechanism 12032915|22325453 +NLRP3 114548 Insulin Resistance MESH:D007333 marker/mechanism 35226250 +NLRP3 114548 MUCKLE-WELLS SYNDROME OMIM:191900 marker/mechanism 191900 11687797 +NLRP3 114548 Multiple Sclerosis MESH:D009103 marker/mechanism 25458313 +NLRP3 114548 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 32014472 +NLRP3 114548 Pulmonary Edema MESH:D011654 marker/mechanism 33012731 +NLRP3 114548 Pyoderma Gangrenosum MESH:D017511 marker/mechanism 27106250 +NLRP7 199713 Hydatidiform Mole MESH:D006828 marker/mechanism 231090 +NMB 4828 Pruritus MESH:D011537 marker/mechanism 29669290 +NMBR 4829 Breast Neoplasms MESH:D001943 marker/mechanism 24349381 +NME1 4830 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +NME1 4830 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 9527842 +NME1 4830 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641 +NME1 4830 Hypoxia MESH:D000860 marker/mechanism 19579223 +NME1 4830 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +NME1 4830 Neoplasm Metastasis MESH:D009362 marker/mechanism 15928304 +NME2 4831 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +NME2 4831 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641 +NME2 4831 Mesothelioma MESH:D008654 marker/mechanism 15920167 +NME2 4831 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +NME2 4831 Ovarian Neoplasms MESH:D010051 therapeutic 15674352 +NME7 29922 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +NME7 29922 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +NME8 51314 Ciliary Dyskinesia, Primary, 6 MESH:C567057 marker/mechanism 610852.0 +NMI 9111 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NMNAT1 64802 Amaurosis congenita of Leber, type 9 MESH:C536603 marker/mechanism 608553.0 +NMNAT1 64802 Brain Injuries, Traumatic MESH:D000070642 therapeutic 27822499 +NMNAT1 64802 Hereditary macular coloboma MESH:C535968 marker/mechanism 22842230 +NMNAT1 64802 Leber Congenital Amaurosis MESH:D057130 marker/mechanism 22842227|22842229|22842230|22842231 +NMNAT1 64802 Macular Degeneration MESH:D008268 marker/mechanism 22842229 +NMNAT1 64802 Neurobehavioral Manifestations MESH:D019954 therapeutic 27822499 +NMNAT1 64802 Optic Atrophy MESH:D009896 marker/mechanism 22842229 +NMNAT1 64802 Retinal Degeneration MESH:D012162 marker/mechanism 22842230 +NMNAT1 64802 Wallerian Degeneration MESH:D014855 therapeutic 27822499 +NMNAT3 349565 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +NMT2 9397 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +NNAT 4826 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17043644 +NNAT 4826 Neuroblastoma MESH:D009447 marker/mechanism 17762496 +NNMT 4837 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NNT 23530 Familial Glucocorticoid Deficiency 1 MESH:C565974 marker/mechanism 22634753 +NNT 23530 GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY OMIM:614736 marker/mechanism 614736 +NOBOX 135935 Premature Ovarian Failure 5 MESH:C566921 marker/mechanism 611548 +NOCT 25819 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NOD1 10392 Nervous System Diseases MESH:D009422 marker/mechanism 11158245 +NOD2 64127 Acne Vulgaris MESH:D000152 marker/mechanism 27106250 +NOD2 64127 Blau syndrome MESH:C538157 marker/mechanism 186580 11528384|15086578|15459013|19467619 +NOD2 64127 Colitis, Ulcerative MESH:D003093 marker/mechanism 20452301 +NOD2 64127 Crohn Disease MESH:D003424 marker/mechanism 11385576|11385577|11528384|17435756|17568627|18371140|18438406|19467619|37156999 +NOD2 64127 Dermatitis MESH:D003872 marker/mechanism 19467619 +NOD2 64127 Hidradenitis Suppurativa MESH:D017497 marker/mechanism 27106250 +NOD2 64127 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 266600 21983784|26192919|28450277 +NOD2 64127 Pyoderma Gangrenosum MESH:D017511 marker/mechanism 27106250 +NOD2 64127 YAO SYNDROME OMIM:617321 marker/mechanism 617321 +NODAL 4838 HETEROTAXY, VISCERAL, 5, AUTOSOMAL OMIM:270100 marker/mechanism 270100 +NODAL 4838 Holoprosencephaly MESH:D016142 marker/mechanism 23264560 +NOG 9241 BRACHYDACTYLY, TYPE B2 OMIM:611377 marker/mechanism 611377 +NOG 9241 Cushing's symphalangism MESH:C536223 marker/mechanism 185800 +NOG 9241 MULTIPLE SYNOSTOSES SYNDROME 1 OMIM:186500 marker/mechanism 186500 +NOG 9241 NOG-Related-Symphalangism Spectrum Disorder MESH:C536943 marker/mechanism 184460|186570 +NOL3 8996 Mitochondrial Diseases MESH:D028361 therapeutic 19139834 +NOL3 8996 MYOCLONUS, FAMILIAL, 1 OMIM:614937 marker/mechanism 614937.0 +NOL8 55035 Prostatic Neoplasms MESH:D011471 marker/mechanism 30125550 +NOM1 64434 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 22474449 +NONO 4841 Glucose Intolerance MESH:D018149 marker/mechanism 29358041 +NONO 4841 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 34 OMIM:300967 marker/mechanism 300967.0 +NONO 4841 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +NOP10 55505 Dyskeratosis Congenita, Autosomal Recessive MESH:C565611 marker/mechanism 224230.0 +NOP16 51491 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +NOP16 51491 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +NOP53 29997 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +NOP56 10528 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +NOP56 10528 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +NOP56 10528 Disease Progression MESH:D018450 marker/mechanism 21364753 +NOP56 10528 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 614153.0 +NOP56 10528 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +NOP58 51602 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +NOP58 51602 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +NOP9 161424 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +NORAD 647979 Breast Neoplasms MESH:D001943 marker/mechanism 26942882 +NOS1 4842 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 15542708 +NOS1 4842 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NOS1 4842 Cerebellar Diseases MESH:D002526 marker/mechanism 25511929 +NOS1 4842 Depressive Disorder MESH:D003866 marker/mechanism 17854383 +NOS1 4842 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 21666113 +NOS1 4842 End Stage Liver Disease MESH:D058625 marker/mechanism 15025246 +NOS1 4842 Fetal Alcohol Spectrum Disorders MESH:D063647 marker/mechanism 25511929 +NOS1 4842 Fever MESH:D005334 marker/mechanism 9495865 +NOS1 4842 Hepatic Encephalopathy MESH:D006501 marker/mechanism 10206825|10564534 +NOS1 4842 Hyperalgesia MESH:D006930 marker/mechanism 19300402 +NOS1 4842 Hypoxia MESH:D000860 marker/mechanism 10956627 +NOS1 4842 Intestinal Perforation MESH:D007416 marker/mechanism 18030227 +NOS1 4842 Mental Disorders MESH:D001523 marker/mechanism 17426488 +NOS1 4842 Morphine Dependence MESH:D009021 marker/mechanism 17989510 +NOS1 4842 Nerve Degeneration MESH:D009410 marker/mechanism 10791088|9436549 +NOS1 4842 Nervous System Diseases MESH:D009422 marker/mechanism 9495865 +NOS1 4842 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 25511929 +NOS1 4842 Parkinson Disease MESH:D010300 marker/mechanism 26383258 +NOS1 4842 Radiation Injuries, Experimental MESH:D011833 marker/mechanism 20726721 +NOS1 4842 Schizophrenia MESH:D012559 marker/mechanism 18923069 +NOS1 4842 Seizures MESH:D012640 marker/mechanism 8749039 +NOS1 4842 Status Epilepticus MESH:D013226 marker/mechanism 20149694 +NOS1 4842 Trauma, Nervous System MESH:D020196 marker/mechanism 10531423 +NOS1 4842 Urination Disorders MESH:D014555 marker/mechanism 9142130 +NOS1 4842 Ventricular Remodeling MESH:D020257 marker/mechanism 16344403 +NOS2 4843 Acute Kidney Injury MESH:D058186 marker/mechanism 9810145 +NOS2 4843 Arthritis, Psoriatic MESH:D015535 marker/mechanism 20953189 +NOS2 4843 Asbestosis MESH:D001195 marker/mechanism 12160931 +NOS2 4843 Asthma MESH:D001249 marker/mechanism 19800904 +NOS2 4843 Atherosclerosis MESH:D050197 marker/mechanism 20720404 +NOS2 4843 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NOS2 4843 Autistic Disorder MESH:D001321 marker/mechanism 18563708 +NOS2 4843 Brain Edema MESH:D001929 marker/mechanism 19374494 +NOS2 4843 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 28642177 +NOS2 4843 Brain Ischemia MESH:D002545 marker/mechanism 17394460|9778187 +NOS2 4843 Breast Neoplasms MESH:D001943 marker/mechanism 15631943 +NOS2 4843 Bronchial Diseases MESH:D001982 marker/mechanism 15774269 +NOS2 4843 Burns MESH:D002056 marker/mechanism 15650120 +NOS2 4843 Cardiovascular Abnormalities MESH:D018376 marker/mechanism 19587355 +NOS2 4843 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 14700523 +NOS2 4843 Cholangiocarcinoma MESH:D018281 marker/mechanism 16818635 +NOS2 4843 Cholangitis, Sclerosing MESH:D015209 marker/mechanism 12612912 +NOS2 4843 Cholestasis MESH:D002779 marker/mechanism 12612912|20626112 +NOS2 4843 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 30026087 +NOS2 4843 Colitis MESH:D003092 marker/mechanism 17449036|8698225 +NOS2 4843 Colonic Neoplasms MESH:D003110 marker/mechanism 16105666|21081470 +NOS2 4843 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16380483|16959961 +NOS2 4843 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16959961 +NOS2 4843 Duodenal Ulcer MESH:D004381 marker/mechanism 12481160|17045617 +NOS2 4843 Emphysema MESH:D004646 marker/mechanism 24465666 +NOS2 4843 Endotoxemia MESH:D019446 marker/mechanism 12620498 +NOS2 4843 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 17923197 +NOS2 4843 Esophageal Neoplasms MESH:D004938 marker/mechanism 15264214 +NOS2 4843 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 16191423 +NOS2 4843 Heart Failure MESH:D006333 marker/mechanism 19168511 +NOS2 4843 Hepatic Insufficiency MESH:D048550 marker/mechanism 30026087 +NOS2 4843 Hepatomegaly MESH:D006529 marker/mechanism 30026087 +NOS2 4843 Hyperalgesia MESH:D006930 marker/mechanism 17989504|19300402 +NOS2 4843 Hyperemia MESH:D006940 marker/mechanism 12646421 +NOS2 4843 Hypertension MESH:D006973 marker/mechanism 18605955|25101153|27292124 +NOS2 4843 Hypothermia MESH:D007035 therapeutic 24675228 +NOS2 4843 Hypoxia-Ischemia, Brain MESH:D020925 marker/mechanism 23694759 +NOS2 4843 Inflammation MESH:D007249 marker/mechanism 11289658|24465666 +NOS2 4843 Intestinal Diseases MESH:D007410 marker/mechanism 11713966 +NOS2 4843 Kidney Diseases MESH:D007674 marker/mechanism 18441258 +NOS2 4843 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 30026087 +NOS2 4843 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 18380797 +NOS2 4843 Liver Diseases MESH:D008107 marker/mechanism 19784758 +NOS2 4843 Lung Neoplasms MESH:D008175 marker/mechanism 12460898|22369883 +NOS2 4843 Malaria MESH:D008288 marker/mechanism 611162.0 +NOS2 4843 Manganese Poisoning MESH:D020149 marker/mechanism 15010209|22174044 +NOS2 4843 Marfan Syndrome MESH:D008382 marker/mechanism 25101153 +NOS2 4843 Mitochondrial Diseases MESH:D028361 therapeutic 16157314 +NOS2 4843 Mycoplasma Infections MESH:D009175 marker/mechanism 20179380 +NOS2 4843 Myocardial Infarction MESH:D009203 marker/mechanism 10090345|11489778 +NOS2 4843 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism|therapeutic 12003803|12087064|14990356|19207477|20828608 +NOS2 4843 Myocardial Stunning MESH:D017682 marker/mechanism 11927517 +NOS2 4843 Necrosis MESH:D009336 marker/mechanism 10620138|10909967 +NOS2 4843 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 25634431 +NOS2 4843 Pneumonia, Aspiration MESH:D011015 marker/mechanism 15607125 +NOS2 4843 Psoriasis MESH:D011565 marker/mechanism 20953189 +NOS2 4843 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 21843929 +NOS2 4843 Reperfusion Injury MESH:D015427 marker/mechanism 10383581|19673871|23061969|23075401 +NOS2 4843 Retinal Diseases MESH:D012164 marker/mechanism 23075401 +NOS2 4843 Schistosomiasis mansoni MESH:D012555 therapeutic 9673227 +NOS2 4843 Seizures MESH:D012640 marker/mechanism 19559095 +NOS2 4843 Sepsis MESH:D018805 marker/mechanism 17138957|20035746 +NOS2 4843 Shock, Septic MESH:D012772 marker/mechanism 8745224 +NOS2 4843 Silicosis MESH:D012829 marker/mechanism 15292275 +NOS2 4843 Status Epilepticus MESH:D013226 marker/mechanism 20149694 +NOS2 4843 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 10620138 +NOS2 4843 Stomach Ulcer MESH:D013276 marker/mechanism 12481160|15138204|19066340 +NOS2 4843 Stroke MESH:D020521 marker/mechanism 20083630 +NOS2 4843 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 17053178 +NOS2 4843 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 19751225 +NOS2 4843 Takayasu Arteritis MESH:D013625 marker/mechanism 25101153 +NOS2 4843 Turner Syndrome MESH:D014424 marker/mechanism 25101153 +NOS2 4843 Ureteral Obstruction MESH:D014517 marker/mechanism 26207612 +NOS2 4843 Urinary Tract Infections MESH:D014552 marker/mechanism 9011564 +NOS3 4846 Abruptio Placentae MESH:D000037 marker/mechanism 11354626 +NOS3 4846 Acute Kidney Injury MESH:D058186 marker/mechanism 9788586 +NOS3 4846 Adenocarcinoma MESH:D000230 marker/mechanism 21472143 +NOS3 4846 Alzheimer Disease MESH:D000544 marker/mechanism 104300.0 10514107|16813604 +NOS3 4846 Arteriosclerosis MESH:D001161 therapeutic 14736551 +NOS3 4846 Atherosclerosis MESH:D050197 marker/mechanism|therapeutic 12677255|20720404 +NOS3 4846 Atrial Fibrillation MESH:D001281 therapeutic 11761419 +NOS3 4846 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NOS3 4846 Breast Neoplasms MESH:D001943 marker/mechanism 15375496|19671875 +NOS3 4846 Cardiomegaly MESH:D006332 marker/mechanism|therapeutic 11504159|12224825|16844920|17487232 +NOS3 4846 Cardiovascular Diseases MESH:D002318 marker/mechanism 12947532|20610621 +NOS3 4846 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 30026087 +NOS3 4846 Cleft Lip MESH:D002971 marker/mechanism 21254359 +NOS3 4846 Cleft Palate MESH:D002972 marker/mechanism 21254359 +NOS3 4846 Coronary Artery Disease MESH:D003324 marker/mechanism 10510054|14989558|17267746|19696404 +NOS3 4846 Coronary Vasospasm MESH:D003329 marker/mechanism 10359729|9737779 +NOS3 4846 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 11696579|14871415|15490108|16959961|18266981|19478208|22191573|22933112 +NOS3 4846 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 21666113 +NOS3 4846 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 12716763|16959961 +NOS3 4846 Diabetic Angiopathies MESH:D003925 marker/mechanism 12124201 +NOS3 4846 Diabetic Nephropathies MESH:D003928 marker/mechanism 20042665 +NOS3 4846 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 23650378 +NOS3 4846 Erectile Dysfunction MESH:D007172 marker/mechanism|therapeutic 12002441|17071732 +NOS3 4846 Esophageal Neoplasms MESH:D004938 marker/mechanism 21472143 +NOS3 4846 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +NOS3 4846 Fetal Growth Retardation MESH:D005317 marker/mechanism 22421449|23667712 +NOS3 4846 Heart Failure MESH:D006333 marker/mechanism 19168511|20304815 +NOS3 4846 Hepatic Insufficiency MESH:D048550 marker/mechanism 30026087 +NOS3 4846 Hepatomegaly MESH:D006529 marker/mechanism 30026087 +NOS3 4846 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 7576705|8863223 +NOS3 4846 Hyperglycemia MESH:D006943 marker/mechanism 11696579 +NOS3 4846 Hyperinsulinism MESH:D006946 therapeutic 19008412 +NOS3 4846 Hyperlipidemias MESH:D006949 marker/mechanism 11457755 +NOS3 4846 Hypertension MESH:D006973 marker/mechanism|therapeutic 11457755|12947532|16331104|19008412|19407804 +NOS3 4846 Hypertension, Portal MESH:D006975 therapeutic 18070013 +NOS3 4846 Hypertension, Pregnancy-Induced MESH:D046110 marker/mechanism 11745998 +NOS3 4846 Hypertension, Pulmonary MESH:D006976 marker/mechanism 21144100 +NOS3 4846 Hypertension, Renovascular MESH:D006978 therapeutic 18641695 +NOS3 4846 Hypoxia MESH:D000860 marker/mechanism 10956627 +NOS3 4846 Infertility, Male MESH:D007248 marker/mechanism 25517965 +NOS3 4846 Insulin Resistance MESH:D007333 marker/mechanism|therapeutic 11457755|12716763|12947532|19008412 +NOS3 4846 Intestinal Perforation MESH:D007416 marker/mechanism 18030227 +NOS3 4846 Ischemia MESH:D007511 therapeutic 15036356 +NOS3 4846 Ischemic Stroke MESH:D000083242 marker/mechanism 601367.0 +NOS3 4846 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 30026087 +NOS3 4846 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 18555214 +NOS3 4846 Metabolic Syndrome MESH:D024821 marker/mechanism 12947532|15269839|20876122 +NOS3 4846 Myocardial Infarction MESH:D009203 marker/mechanism 10510054|16337503 +NOS3 4846 Myocardial Ischemia MESH:D017202 therapeutic 12354446 +NOS3 4846 Myocardial Reperfusion Injury MESH:D015428 therapeutic 12354446 +NOS3 4846 Neoplasms MESH:D009369 marker/mechanism 18344980 +NOS3 4846 Oligospermia MESH:D009845 marker/mechanism 29983398 +NOS3 4846 Pre-Eclampsia MESH:D011225 marker/mechanism 189800.0 +NOS3 4846 Prostatic Neoplasms MESH:D011471 marker/mechanism 12429631|12445681|16458450 +NOS3 4846 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 21843929 +NOS3 4846 Pulmonary Edema MESH:D011654 therapeutic 16844920 +NOS3 4846 Reperfusion Injury MESH:D015427 marker/mechanism 21968084 +NOS3 4846 Sepsis MESH:D018805 marker/mechanism 20035746 +NOS3 4846 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +NOS3 4846 Stomach Ulcer MESH:D013276 marker/mechanism 19066340 +NOS3 4846 Tachycardia, Ventricular MESH:D017180 therapeutic 11761419 +NOS3 4846 Teratozoospermia MESH:D000072660 marker/mechanism 29983398 +NOS3 4846 Uremia MESH:D014511 marker/mechanism 19092814 +NOS3 4846 Ureteral Obstruction MESH:D014517 marker/mechanism 26207612 +NOS3 4846 Ventricular Premature Complexes MESH:D018879 therapeutic 11761419 +NOS3 4846 Vestibular Diseases MESH:D015837 marker/mechanism 18776599 +NOTCH1 4851 Adams Oliver syndrome MESH:C538225 marker/mechanism 616028.0 +NOTCH1 4851 Aortic Valve, Calcification of MESH:C562942 marker/mechanism 16025100 +NOTCH1 4851 AORTIC VALVE DISEASE 1 OMIM:109730 marker/mechanism 109730.0 +NOTCH1 4851 Astrocytoma MESH:D001254 marker/mechanism 21127729 +NOTCH1 4851 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NOTCH1 4851 Bicuspid Aortic Valve Disease MESH:D000082882 marker/mechanism 30455415 +NOTCH1 4851 Breast Neoplasms MESH:D001943 marker/mechanism 21036696|21679465 +NOTCH1 4851 Calcinosis MESH:D002114 marker/mechanism 22110751 +NOTCH1 4851 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +NOTCH1 4851 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +NOTCH1 4851 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27923803 +NOTCH1 4851 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22011395 +NOTCH1 4851 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 30394310 +NOTCH1 4851 Colonic Neoplasms MESH:D003110 marker/mechanism 19147571 +NOTCH1 4851 Congenital Abnormalities MESH:D000013 marker/mechanism 17849441 +NOTCH1 4851 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17849441 +NOTCH1 4851 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +NOTCH1 4851 Glioblastoma MESH:D005909 marker/mechanism 21127729 +NOTCH1 4851 Heart Valve Diseases MESH:D006349 marker/mechanism 22110751 +NOTCH1 4851 Leukemia, T-Cell MESH:D015458 marker/mechanism 25585350 +NOTCH1 4851 Lymphoma MESH:D008223 marker/mechanism 18798262 +NOTCH1 4851 Nervous System Diseases MESH:D009422 marker/mechanism 23203475 +NOTCH1 4851 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 19246562|19318552|21498710|24394663|28671688 +NOTCH1 4851 Scoliosis MESH:D012600 marker/mechanism 17849441 +NOTCH1 4851 Skin Neoplasms MESH:D012878 marker/mechanism 27923803 +NOTCH1 4851 Splenomegaly MESH:D013163 marker/mechanism 25585350 +NOTCH1 4851 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 25061499 +NOTCH2 4853 Alagille Syndrome MESH:D016738 marker/mechanism 610205.0 +NOTCH2 4853 Astrocytoma MESH:D001254 marker/mechanism 21127729 +NOTCH2 4853 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NOTCH2 4853 Breast Neoplasms MESH:D001943 marker/mechanism 21036696 +NOTCH2 4853 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27923803 +NOTCH2 4853 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 18372903 +NOTCH2 4853 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +NOTCH2 4853 Fibrosis MESH:D005355 marker/mechanism 32715474 +NOTCH2 4853 Follicular Cyst MESH:D005497 therapeutic 37277016 +NOTCH2 4853 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +NOTCH2 4853 Glioblastoma MESH:D005909 marker/mechanism 21127729 +NOTCH2 4853 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 32715474 +NOTCH2 4853 Hajdu-Cheney Syndrome MESH:D031845 marker/mechanism 102500.0 21378985|21378989 +NOTCH2 4853 Lung Neoplasms MESH:D008175 marker/mechanism 17804716 +NOTCH2 4853 Neoplasm Invasiveness MESH:D009361 marker/mechanism 30670679 +NOTCH2 4853 Neuroectodermal Tumors, Primitive MESH:D018242 marker/mechanism 21127729 +NOTCH2 4853 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 32715474 +NOTCH2 4853 Renal Insufficiency MESH:D051437 marker/mechanism 32715474 +NOTCH2 4853 Skin Neoplasms MESH:D012878 marker/mechanism 27923803 +NOTCH2 4853 Stomach Neoplasms MESH:D013274 marker/mechanism 30670679 +NOTCH2 4853 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 25061499 +NOTCH2NLC 100996717 Neuronal intranuclear inclusion disease MESH:C537395 marker/mechanism 31332380|31332381 +NOTCH3 4854 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NOTCH3 4854 Breast Neoplasms MESH:D001943 marker/mechanism 21036696 +NOTCH3 4854 CADASIL MESH:D046589 marker/mechanism 125310.0 +NOTCH3 4854 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NOTCH3 4854 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21994468 +NOTCH3 4854 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +NOTCH3 4854 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27923803 +NOTCH3 4854 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +NOTCH3 4854 Fibromatosis, Congenital Generalized MESH:C562978 marker/mechanism 615293.0 +NOTCH3 4854 Glioblastoma MESH:D005909 marker/mechanism 21127729 +NOTCH3 4854 Lateral meningocele syndrome MESH:C537878 marker/mechanism 130720.0 +NOTCH3 4854 Lung Neoplasms MESH:D008175 marker/mechanism 17804716 +NOTCH3 4854 Skin Neoplasms MESH:D012878 marker/mechanism 27923803 +NOTCH4 4855 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NOTCH4 4855 Breast Neoplasms MESH:D001943 marker/mechanism 21036696|21679465 +NOTCH4 4855 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 19208345 +NOTCH4 4855 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27923803 +NOTCH4 4855 Skin Neoplasms MESH:D012878 marker/mechanism 27923803 +NOTUM 147111 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NOX1 27035 Colonic Neoplasms MESH:D003110 marker/mechanism 20715105 +NOX1 27035 Heart Failure MESH:D006333 marker/mechanism 20304815 +NOX1 27035 Hypercholesterolemia MESH:D006937 marker/mechanism 20832062 +NOX3 50508 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +NOX4 50507 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +NOX4 50507 Colonic Neoplasms MESH:D003110 marker/mechanism 20715105 +NOX4 50507 Heart Failure MESH:D006333 marker/mechanism 20304815 +NOX4 50507 Hypertension MESH:D006973 marker/mechanism 27659729|27847271|32147540 +NOX4 50507 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +NOX4 50507 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NOX4 50507 Renal Insufficiency MESH:D051437 marker/mechanism 23325087 +NPAP1 23742 Melanoma MESH:D008545 marker/mechanism 22842228 +NPAP1 23742 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270.0 +NPAS2 4862 Autistic Disorder MESH:D001321 marker/mechanism 17264841 +NPAS2 4862 Chronobiology Disorders MESH:D021081 marker/mechanism 31284022 +NPAS2 4862 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NPB 256933 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +NPC1 4864 Ataxia MESH:D001259 marker/mechanism 21273508 +NPC1 4864 Atherosclerosis MESH:D050197 therapeutic 18483620 +NPC1 4864 Brucellosis MESH:D002006 marker/mechanism 12183525 +NPC1 4864 Dysarthria MESH:D004401 marker/mechanism 21273508 +NPC1 4864 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +NPC1 4864 Liver Cirrhosis MESH:D008103 marker/mechanism 22216111 +NPC1 4864 Liver Diseases MESH:D008107 marker/mechanism 24901380 +NPC1 4864 Niemann-Pick Disease, Type C MESH:D052556 marker/mechanism 257220.0 22216111|9802331 +NPC1 4864 Obesity MESH:D009765 marker/mechanism 19151714 +NPC1 4864 Ophthalmoplegia MESH:D009886 marker/mechanism 21273508 +NPC2 10577 Niemann-Pick disease, type C2 MESH:C536119 marker/mechanism 607625.0 +NPDC1 56654 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NPHP1 4867 Joubert syndrome 4 MESH:C536296 marker/mechanism 609583.0 +NPHP1 4867 Nephronophthisis, familial juvenile MESH:C537699 marker/mechanism 256100.0 +NPHP1 4867 Senior Loken Syndrome MESH:C537580 marker/mechanism 266900.0 +NPHP3 27031 Disease Models, Animal MESH:D004195 marker/mechanism 12089381 +NPHP3 27031 Nephronophthisis 3 MESH:C565780 marker/mechanism 604387.0 +NPHP3 27031 Polycystic Kidney, Autosomal Recessive MESH:D017044 marker/mechanism 12089381 +NPHP3 27031 RENAL-HEPATIC-PANCREATIC DYSPLASIA 1 OMIM:208540 marker/mechanism 208540.0 +NPHP3 27031 Renal hepatic pancreatic dysplasia Dandy Walker cyst MESH:C537756 marker/mechanism 267010.0 +NPHP4 261734 Nephronophthisis 4 MESH:C564640 marker/mechanism 606966.0 +NPHP4 261734 Senior-Loken syndrome 4 MESH:C537581 marker/mechanism 606996.0 +NPHS1 4868 Albuminuria MESH:D000419 marker/mechanism 15684566 +NPHS1 4868 Glomerulonephritis MESH:D005921 marker/mechanism 11337370|20962747 +NPHS1 4868 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 15942677 +NPHS1 4868 Hyperhomocysteinemia MESH:D020138 marker/mechanism 20116427 +NPHS1 4868 Kidney Diseases MESH:D007674 marker/mechanism 12012391|16382022 +NPHS1 4868 Nephrosis, congenital MESH:C535761 marker/mechanism 256300.0 10792613|11012881 +NPHS1 4868 Nephrosis, Lipoid MESH:D009402 marker/mechanism 18256598 +NPHS1 4868 Proteinuria MESH:D011507 marker/mechanism|therapeutic 12012391|16687628|20071462 +NPHS2 7827 Albuminuria MESH:D000419 marker/mechanism 15684566 +NPHS2 7827 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 15942677 +NPHS2 7827 Nephrosis MESH:D009401 marker/mechanism 15684566 +NPHS2 7827 Nephrotic Syndrome MESH:D009404 marker/mechanism 16898497 +NPHS2 7827 Nephrotic syndrome, idiopathic, steroid-resistant MESH:C536404 marker/mechanism 600995.0 21171529|24509478 +NPL 80896 Cholestasis MESH:D002779 marker/mechanism 27989131 +NPM 100195119 Lymphoma, Large-Cell, Anaplastic MESH:D017728 marker/mechanism 19503098 +NPM1 4869 Acute erythroleukemia MESH:C535673 marker/mechanism 30926971 +NPM1 4869 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +NPM1 4869 Clinical Deterioration MESH:D000075902 marker/mechanism 27602772 +NPM1 4869 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +NPM1 4869 Dyskeratosis Congenita MESH:D019871 marker/mechanism 31570891 +NPM1 4869 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 19822134|21441929|23877794|27992414|30420649 +NPM1 4869 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 14508522|26285909 +NPM1 4869 Silicosis MESH:D012829 therapeutic 37399107 +NPM1 4869 Stomach Neoplasms MESH:D013274 marker/mechanism 10619186 +NPM3 10360 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +NPM3 10360 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +NPPA 4878 Acute Kidney Injury MESH:D058186 marker/mechanism|therapeutic 1825077|19298916|2948068 +NPPA 4878 Adenocarcinoma MESH:D000230 therapeutic 18225537 +NPPA 4878 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +NPPA 4878 Atrial Fibrillation, Familial, 6 MESH:C567400 marker/mechanism 612201.0 +NPPA 4878 Atrial Standstill MESH:C563984 marker/mechanism 615745.0 +NPPA 4878 Carcinoma, Small Cell MESH:D018288 therapeutic 18717826 +NPPA 4878 Cardiomegaly MESH:D006332 marker/mechanism 12224825|18056528|20886221|21242511|21297083|22083722 +NPPA 4878 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 11986409|16762803 +NPPA 4878 Coronary Stenosis MESH:D023921 marker/mechanism 12721106 +NPPA 4878 Ductus Arteriosus, Patent MESH:D004374 marker/mechanism 1421905 +NPPA 4878 Heart Failure MESH:D006333 marker/mechanism 11136700|16101196|1647690|8112904 +NPPA 4878 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +NPPA 4878 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 11584395 +NPPA 4878 Hypercapnia MESH:D006935 marker/mechanism 11311734 +NPPA 4878 Hypertension MESH:D006973 marker/mechanism|therapeutic 12940879|19219041|24039778|2526952|32147540|7839143|8188982|9869009 +NPPA 4878 Hypertension, Renal MESH:D006977 marker/mechanism 8763405 +NPPA 4878 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 10755198|9455993 +NPPA 4878 Hypotension MESH:D007022 marker/mechanism 2951327|2961279 +NPPA 4878 Hypoxia MESH:D000860 marker/mechanism 11311734 +NPPA 4878 Liver Cirrhosis MESH:D008103 marker/mechanism 15613622 +NPPA 4878 Lung Neoplasms MESH:D008175 therapeutic 18717826 +NPPA 4878 Melanoma MESH:D008545 therapeutic 18004088 +NPPA 4878 Myocardial Infarction MESH:D009203 marker/mechanism|therapeutic 11743230|9527094 +NPPA 4878 Myocardial Ischemia MESH:D017202 marker/mechanism 1830552 +NPPA 4878 Neoplasm Metastasis MESH:D009362 therapeutic 18717826 +NPPA 4878 Pain MESH:D010146 therapeutic 13679232 +NPPA 4878 Prostatic Neoplasms MESH:D011471 therapeutic 18225537 +NPPA 4878 Skin Neoplasms MESH:D012878 therapeutic 18004088 +NPPA 4878 Ureteral Obstruction MESH:D014517 marker/mechanism 26207612 +NPPA 4878 Urination Disorders MESH:D014555 marker/mechanism 8318687 +NPPA 4878 Ventricular Remodeling MESH:D020257 marker/mechanism 20886221 +NPPB 4879 Anemia, Sickle Cell MESH:D000755 marker/mechanism 20408845 +NPPB 4879 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +NPPB 4879 Atrial Fibrillation MESH:D001281 marker/mechanism 15864246 +NPPB 4879 Brain Injuries MESH:D001930 therapeutic 19803787 +NPPB 4879 Cardiac Output, High MESH:D016534 marker/mechanism 20339970 +NPPB 4879 Cardiomegaly MESH:D006332 marker/mechanism 15942707|15969258|18056528|21565836 +NPPB 4879 Cardiomyopathies MESH:D009202 marker/mechanism 14745153|16127512 +NPPB 4879 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism|therapeutic 16762803|18628775 +NPPB 4879 Cardiotoxicity MESH:D066126 marker/mechanism 29959987 +NPPB 4879 Cardiovascular Diseases MESH:D002318 marker/mechanism 19220183 +NPPB 4879 Cerebral Hemorrhage MESH:D002543 therapeutic 19803787 +NPPB 4879 Coronary Artery Disease MESH:D003324 marker/mechanism 18022110 +NPPB 4879 Disease Models, Animal MESH:D004195 marker/mechanism 29394407 +NPPB 4879 Dyspnea MESH:D004417 therapeutic 20339970 +NPPB 4879 Heart Defects, Congenital MESH:D006330 marker/mechanism 16014188 +NPPB 4879 Heart Diseases MESH:D006331 marker/mechanism 18004637 +NPPB 4879 Heart Failure MESH:D006333 marker/mechanism|therapeutic 11136700|11279304|12628948|15732037|15860969|16101196|16333235|16360360|16762801|16777915|19650993|24535859|29959987 +NPPB 4879 Hypertension MESH:D006973 marker/mechanism|therapeutic 19219041|24039778|30310171|32147540|9194512 +NPPB 4879 Hypertension, Pulmonary MESH:D006976 marker/mechanism 20408845|21351102 +NPPB 4879 Hypokalemia MESH:D007008 marker/mechanism 20339970 +NPPB 4879 Hypotension MESH:D007022 marker/mechanism 20339970|9194512 +NPPB 4879 Inflammation MESH:D007249 therapeutic 19803787 +NPPB 4879 Pain MESH:D010146 therapeutic 27687165 +NPPB 4879 Postoperative Complications MESH:D011183 marker/mechanism 23019395 +NPPB 4879 Tachycardia, Ventricular MESH:D017180 marker/mechanism 20339970 +NPPB 4879 Ureteral Obstruction MESH:D014517 marker/mechanism 26207612 +NPPB 4879 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 16689991 +NPPB 4879 Ventricular Dysfunction, Right MESH:D018497 marker/mechanism 16014188|19650993 +NPPB 4879 Ventricular Remodeling MESH:D020257 marker/mechanism 29394407 +NPPC 4880 Bone Diseases, Developmental MESH:D001848 marker/mechanism 17676597 +NPPC 4880 Cartilage Diseases MESH:D002357 marker/mechanism 17676597 +NPPC 4880 Growth Disorders MESH:D006130 marker/mechanism 17676597 +NPPC 4880 Hyperkinesis MESH:D006948 therapeutic 11860464 +NPPC 4880 Ureteral Obstruction MESH:D014517 marker/mechanism 26207612 +NPR1 4881 Cardiomegaly MESH:D006332 marker/mechanism 20881240 +NPR1 4881 Fibrosis MESH:D005355 marker/mechanism 20881240 +NPR1 4881 Heart Failure MESH:D006333 marker/mechanism 20881240 +NPR1 4881 Hypertension MESH:D006973 marker/mechanism 20881240 +NPR1 4881 Kidney Diseases MESH:D007674 marker/mechanism 20881240 +NPR1 4881 Pain MESH:D010146 therapeutic 27687165 +NPR2 4882 Acromesomelic dysplasia, Maroteaux type MESH:C535661 marker/mechanism 602875.0 +NPR2 4882 EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE OMIM:615923 marker/mechanism 615923.0 +NPR3 4883 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +NPR3 4883 Weight Gain MESH:D015430 marker/mechanism 19030233 +NPRL2 10641 Epilepsy, Partial, with Variable Foci MESH:C565785 marker/mechanism 617116.0 +NPRL2 10641 Schizophrenia MESH:D012559 marker/mechanism 21822266 +NPRL3 8131 Epilepsy, Partial, with Variable Foci MESH:C565785 marker/mechanism 617118.0 +NPS 594857 Anxiety Disorders MESH:D001008 marker/mechanism|therapeutic 19339610|21466221 +NPS 594857 Cocaine-Related Disorders MESH:D019970 marker/mechanism 19339610|20974945|21466221 +NPS 594857 Hyperkinesis MESH:D006948 marker/mechanism 19339610 +NPSR1 387129 Asthma MESH:D001249 marker/mechanism 15710598|15764725|16926187 +NPSR1 387129 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2 OMIM:608584 marker/mechanism 608584.0 +NPTN 27020 Hypertension MESH:D006973 marker/mechanism 22228705 +NPTN 27020 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +NPTX2 4885 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 19084905 +NPY 4852 Alcoholism MESH:D000437 marker/mechanism 17572454 +NPY 4852 Alzheimer Disease MESH:D000544 marker/mechanism 11709213 +NPY 4852 Anorexia MESH:D000855 marker/mechanism 16084549|16101753|25825358 +NPY 4852 Anxiety Disorders MESH:D001008 therapeutic 11440811 +NPY 4852 Asthma MESH:D001249 marker/mechanism 9731035 +NPY 4852 Bronchitis, Chronic MESH:D029481 marker/mechanism 9731035 +NPY 4852 Cardiovascular Diseases MESH:D002318 marker/mechanism 9812770 +NPY 4852 Cerebral Infarction MESH:D002544 marker/mechanism 11821007 +NPY 4852 Cocaine-Related Disorders MESH:D019970 marker/mechanism 19063928 +NPY 4852 Depressive Disorder MESH:D003866 marker/mechanism|therapeutic 17572454|9729278 +NPY 4852 Epilepsy MESH:D004827 therapeutic 20064661|8868293 +NPY 4852 Epilepsy, Temporal Lobe MESH:D004833 therapeutic 15716408 +NPY 4852 Hyperkinesis MESH:D006948 marker/mechanism 19063928 +NPY 4852 Hypertrophy MESH:D006984 marker/mechanism 9812770 +NPY 4852 Memory Disorders MESH:D008569 marker/mechanism 2611661 +NPY 4852 Muscle Rigidity MESH:D009127 therapeutic 10675796 +NPY 4852 Nasal Obstruction MESH:D015508 therapeutic 9288221 +NPY 4852 Neurobehavioral Manifestations MESH:D019954 therapeutic 32956829 +NPY 4852 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 17686523 +NPY 4852 Rhinitis MESH:D012220 marker/mechanism 12746121 +NPY 4852 Seizures MESH:D012640 marker/mechanism|therapeutic 15451008|16194568|18005069 +NPY 4852 Substance-Related Disorders MESH:D019966 marker/mechanism 19063928 +NPY 4852 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 16952158 +NPY 4852 Weight Loss MESH:D015431 marker/mechanism 25825358 +NPY1R 4886 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 19566775 +NPY1R 4886 Anxiety Disorders MESH:D001008 therapeutic 11440811 +NPY1R 4886 Depressive Disorder MESH:D003866 marker/mechanism 9729278 +NPY1R 4886 Neural Tube Defects MESH:D009436 marker/mechanism 17400914 +NPY1R 4886 Obesity MESH:D009765 marker/mechanism 20975297 +NPY1R 4886 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 19566775 +NPY1R 4886 Toothache MESH:D014098 therapeutic 18809749 +NPY2R 4887 Alcoholism MESH:D000437 marker/mechanism 18828811 +NPY2R 4887 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18828811 +NPY2R 4887 Epilepsy MESH:D004827 therapeutic 8868293 +NPY2R 4887 Epilepsy, Temporal Lobe MESH:D004833 therapeutic 15716408 +NPY2R 4887 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 18828811 +NPY5R 4889 Obesity MESH:D009765 marker/mechanism 10849579 +NQO1 1728 Acute Kidney Injury MESH:D058186 marker/mechanism 26723870 +NQO1 1728 Asthma MESH:D001249 marker/mechanism 20049212 +NQO1 1728 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NQO1 1728 Breast Neoplasms MESH:D001943 marker/mechanism 18511948 +NQO1 1728 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21479364|9865924 +NQO1 1728 Cholestasis MESH:D002779 marker/mechanism 22461449 +NQO1 1728 Colorectal Neoplasms MESH:D015179 marker/mechanism 20593958 +NQO1 1728 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +NQO1 1728 Diabetes Mellitus, Experimental MESH:D003921 therapeutic 23458895 +NQO1 1728 Hemolytic-Uremic Syndrome MESH:D006463 marker/mechanism 12588957 +NQO1 1728 Hemorrhage MESH:D006470 marker/mechanism 27581200 +NQO1 1728 Hyperglycemia MESH:D006943 therapeutic 23458895 +NQO1 1728 Kidney Diseases MESH:D007674 therapeutic 21613233 +NQO1 1728 Leukemia, Myeloid MESH:D007951 marker/mechanism 11882782 +NQO1 1728 Liver Diseases MESH:D008107 marker/mechanism 16610002|17405841 +NQO1 1728 Multiple Myeloma MESH:D009101 marker/mechanism 16949155 +NQO1 1728 Neoplasms MESH:D009369 marker/mechanism 8375015 +NQO1 1728 Neoplasms, Experimental MESH:D009374 marker/mechanism|therapeutic 21034357|9496914 +NQO1 1728 Neurotoxicity Syndromes MESH:D020258 therapeutic 20849151 +NQO1 1728 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29289645 +NQO1 1728 Obesity MESH:D009765 marker/mechanism 17405841 +NQO1 1728 Occupational Diseases MESH:D009784 marker/mechanism 15576619|15727169|17178637|9230185 +NQO1 1728 Papilloma MESH:D010212 marker/mechanism 9496914 +NQO1 1728 Parkinson Disease MESH:D010300 marker/mechanism 17188257 +NQO1 1728 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 11774269|17332311 +NQO1 1728 Prostatic Neoplasms MESH:D011471 marker/mechanism 17507624 +NQO1 1728 Spinocerebellar Ataxia 17 MESH:C564616 marker/mechanism 24413982 +NQO1 1728 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 8631603 +NQO1 1728 Warfarin Sensitivity MESH:C567080 marker/mechanism 27581200 +NQO2 4835 Agranulocytosis MESH:D000380 marker/mechanism 14617031 +NQO2 4835 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +NQO2 4835 Bone Marrow Diseases MESH:D001855 marker/mechanism 12351651 +NQO2 4835 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +NQO2 4835 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +NQO2 4835 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NQO2 4835 Memory Disorders MESH:D008569 marker/mechanism 20861374 +NR0B1 190 Dosage-sensitive sex reversal MESH:C535601 marker/mechanism 300018.0 +NR0B1 190 Hypoadrenocorticism, Familial MESH:D000075262 marker/mechanism 300200.0 12519885|7990958 +NR0B1 190 Hypogonadism MESH:D007006 marker/mechanism 7990958 +NR0B1 190 Oligospermia MESH:D009845 marker/mechanism 23384712 +NR0B2 8431 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 23811326 +NR0B2 8431 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 29943110 +NR0B2 8431 Cognition Disorders MESH:D003072 marker/mechanism 29382564 +NR0B2 8431 Diabetes Complications MESH:D048909 marker/mechanism 29382564 +NR0B2 8431 Fatty Liver MESH:D005234 marker/mechanism 27664470 +NR0B2 8431 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414|17175557 +NR0B2 8431 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +NR0B2 8431 Obesity MESH:D009765 marker/mechanism 601665.0 +NR1D1 9572 Fatty Liver MESH:D005234 marker/mechanism 27664470 +NR1D2 9975 Endometriosis MESH:D004715 marker/mechanism 22138541 +NR1H2 7376 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +NR1H2 7376 Cholestasis MESH:D002779 therapeutic 17256725 +NR1H2 7376 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +NR1H3 10062 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 17256725 +NR1H3 10062 Cholestasis MESH:D002779 therapeutic 17256725 +NR1H3 10062 Fatty Liver MESH:D005234 marker/mechanism 23651738 +NR1H4 9971 Atherosclerosis MESH:D050197 therapeutic 30996006 +NR1H4 9971 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 23811326|25496033 +NR1H4 9971 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 12875239 +NR1H4 9971 Cholestasis MESH:D002779 marker/mechanism 22461449|23178280 +NR1H4 9971 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5 OMIM:617049 marker/mechanism 617049.0 +NR1H4 9971 Crohn Disease MESH:D003424 marker/mechanism 21829567 +NR1H4 9971 Disease Models, Animal MESH:D004195 marker/mechanism 29142166|32062620 +NR1H4 9971 Extravasation of Diagnostic and Therapeutic Materials MESH:D005119 marker/mechanism 22135065 +NR1H4 9971 Fatty Liver MESH:D005234 marker/mechanism 29142166 +NR1H4 9971 Hepatomegaly MESH:D006529 marker/mechanism 29142166 +NR1H4 9971 Infertility, Male MESH:D007248 marker/mechanism 30245210 +NR1H4 9971 Inflammation MESH:D007249 marker/mechanism 29142166 +NR1H4 9971 Intestinal Neoplasms MESH:D007414 marker/mechanism 23178280 +NR1H4 9971 Liver Diseases MESH:D008107 marker/mechanism 22130247 +NR1H4 9971 Liver Neoplasms MESH:D008113 marker/mechanism 23178280|24091600|24189133|29142166|30556042 +NR1H4 9971 Necrosis MESH:D009336 therapeutic 30996006 +NR1H4 9971 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29142166|32062620 +NR1H4 9971 Plaque, Atherosclerotic MESH:D058226 therapeutic 30996006 +NR1I2 8856 Adenocarcinoma MESH:D000230 marker/mechanism 21977915 +NR1I2 8856 Barrett Esophagus MESH:D001471 marker/mechanism 21977915 +NR1I2 8856 Calcinosis MESH:D002114 marker/mechanism 30963258 +NR1I2 8856 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism|therapeutic 19797606|28058446 +NR1I2 8856 Diabetes Mellitus MESH:D003920 marker/mechanism 20869355 +NR1I2 8856 Esophageal Neoplasms MESH:D004938 marker/mechanism 21977915 +NR1I2 8856 Fatty Liver MESH:D005234 marker/mechanism 25182422 +NR1I2 8856 Hepatomegaly MESH:D006529 marker/mechanism 23607986|32320717|36030841 +NR1I2 8856 Hypophosphatemia MESH:D017674 marker/mechanism 19898264 +NR1I2 8856 Infertility, Female MESH:D007247 marker/mechanism 23710174 +NR1I2 8856 Jaundice, Neonatal MESH:D007567 marker/mechanism 22371261 +NR1I2 8856 Metabolic Syndrome MESH:D024821 marker/mechanism 20869355 +NR1I2 8856 Obesity MESH:D009765 marker/mechanism 20869355 +NR1I2 8856 Osteosarcoma MESH:D012516 marker/mechanism 17279585 +NR1I2 8856 Plaque, Atherosclerotic MESH:D058226 marker/mechanism 29425287 +NR1I3 9970 Adenoma, Liver Cell MESH:D018248 marker/mechanism 25656644 +NR1I3 9970 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism|therapeutic 14742670|25656644|28058446 +NR1I3 9970 Diabetes Mellitus MESH:D003920 marker/mechanism 20869355 +NR1I3 9970 Hepatomegaly MESH:D006529 marker/mechanism|therapeutic 23607986|23721867|25656644|32320717|32435917 +NR1I3 9970 Liver Neoplasms MESH:D008113 marker/mechanism 19233941|19482888|22293087|24449422|28218408 +NR1I3 9970 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 17172636|24769335|25656644 +NR1I3 9970 Metabolic Syndrome MESH:D024821 marker/mechanism 20869355 +NR1I3 9970 Obesity MESH:D009765 marker/mechanism 20869355 +NR1I3 9970 Precancerous Conditions MESH:D011230 marker/mechanism 19233941|25656644 +NR2C1 7181 Endometriosis MESH:D004715 marker/mechanism 22138541 +NR2C2 7182 Endometriosis MESH:D004715 marker/mechanism 22138541 +NR2E3 10002 Enhanced S-Cone Syndrome MESH:C564835 marker/mechanism 268100.0 +NR2E3 10002 Retinitis Pigmentosa 37 MESH:C567005 marker/mechanism 611131.0 +NR2F1 7025 BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME OMIM:615722 marker/mechanism 615722.0 +NR2F1 7025 Breast Neoplasms MESH:D001943 marker/mechanism 11850205 +NR2F1 7025 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +NR2F2 7026 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +NR2F2 7026 CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4 OMIM:615779 marker/mechanism 615779.0 +NR2F2 7026 Endometriosis MESH:D004715 marker/mechanism 22138541 +NR2F2 7026 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 17436238 +NR2F2 7026 Infertility, Female MESH:D007247 marker/mechanism 17590085 +NR2F6 2063 Breast Neoplasms MESH:D001943 marker/mechanism 11850205 +NR2F6 2063 Endometriosis MESH:D004715 marker/mechanism 22138541 +NR3C1 2908 46, XX Disorders of Sex Development MESH:D058489 marker/mechanism 11932321 +NR3C1 2908 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +NR3C1 2908 Bipolar Disorder MESH:D001714 marker/mechanism 14708030 +NR3C1 2908 Cocaine-Related Disorders MESH:D019970 marker/mechanism 12805318|19234455 +NR3C1 2908 Depressive Disorder MESH:D003866 marker/mechanism 14708030 +NR3C1 2908 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 29802709 +NR3C1 2908 Endometriosis MESH:D004715 marker/mechanism 22138541 +NR3C1 2908 Glucocorticoid Receptor Deficiency MESH:C564221 marker/mechanism 615962.0 +NR3C1 2908 Glucose Metabolism Disorders MESH:D044882 marker/mechanism 29802709 +NR3C1 2908 Hypertension MESH:D006973 marker/mechanism 18434569|20659135 +NR3C1 2908 Hypokalemia MESH:D007008 marker/mechanism 11932321 +NR3C1 2908 Lung Diseases, Obstructive MESH:D008173 marker/mechanism 9926163 +NR3C1 2908 Mood Disorders MESH:D019964 marker/mechanism 29921868 +NR3C1 2908 Ocular Hypertension MESH:D009798 marker/mechanism 17563720 +NR3C1 2908 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +NR3C1 2908 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +NR3C1 2908 Schizophrenia MESH:D012559 marker/mechanism 14708030|21647420 +NR3C2 4306 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 21321305 +NR3C2 4306 Endometriosis MESH:D004715 marker/mechanism 22138541 +NR3C2 4306 Heart Failure MESH:D006333 marker/mechanism 15722665|21321305 +NR3C2 4306 Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy MESH:C565359 marker/mechanism 605115.0 +NR3C2 4306 Myocardial Infarction MESH:D009203 marker/mechanism 16413583|17587755 +NR3C2 4306 Pseudohypoaldosteronism MESH:D011546 marker/mechanism 177735.0 +NR3C2 4306 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 21321305 +NR4A1 3164 Depressive Disorder, Major MESH:D003865 marker/mechanism 29175309 +NR4A1 3164 Endometriosis MESH:D004715 marker/mechanism 22138541 +NR4A1 3164 Insulin Resistance MESH:D007333 marker/mechanism 17785466 +NR4A1 3164 Kidney Diseases MESH:D007674 marker/mechanism 24722447 +NR4A1 3164 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +NR4A1 3164 Pancreatic Neoplasms MESH:D010190 marker/mechanism 20660371 +NR4A1 3164 Proteinuria MESH:D011507 marker/mechanism 24722447 +NR4A2 4929 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +NR4A2 4929 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +NR4A2 4929 Arthritis, Psoriatic MESH:D015535 marker/mechanism 19732956 +NR4A2 4929 Colorectal Neoplasms MESH:D015179 marker/mechanism 16293616 +NR4A2 4929 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +NR4A2 4929 Skin Diseases MESH:D012871 marker/mechanism 16835338 +NR4A3 8013 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +NR4A3 8013 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +NR4A3 8013 Chondrosarcoma, Extraskeletal Myxoid MESH:C563195 marker/mechanism 612237.0 +NR4A3 8013 Hypercholesterolemia MESH:D006937 marker/mechanism 16005304 +NR4A3 8013 Insulin Resistance MESH:D007333 marker/mechanism 17785466 +NR5A1 2516 Adrenal Insufficiency MESH:D000309 marker/mechanism 10369247 +NR5A1 2516 Disorder of Sex Development, 46,XY MESH:D058490 marker/mechanism 612965.0 +NR5A1 2516 Endometriosis MESH:D004715 marker/mechanism 17519303 +NR5A1 2516 Gonadal Dysgenesis, 46,XX MESH:D023961 marker/mechanism 19246354 +NR5A1 2516 Gonadal Dysgenesis, 46,XY MESH:D006061 marker/mechanism 10369247|11932325|15070943 +NR5A1 2516 Infertility, Male MESH:D007248 marker/mechanism 20887963 +NR5A1 2516 Ovarian Neoplasms MESH:D010051 marker/mechanism 23291911 +NR5A1 2516 Premature Ovarian Failure 7 MESH:C567838 marker/mechanism 612964.0 +NR5A1 2516 Primary Ovarian Insufficiency MESH:D016649 marker/mechanism 19246354 +NR5A1 2516 SPERMATOGENIC FAILURE 8 OMIM:613957 marker/mechanism 613957.0 +NR5A2 2494 Anovulation MESH:D000858 marker/mechanism 18628394 +NR5A2 2494 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 29515023 +NR5A2 2494 Dyslipidemias MESH:D050171 marker/mechanism 29515023 +NR5A2 2494 Glucose Intolerance MESH:D018149 marker/mechanism 29515023 +NR5A2 2494 Hepatomegaly MESH:D006529 marker/mechanism 29515023 +NR5A2 2494 Infertility, Female MESH:D007247 marker/mechanism 17409375 +NR5A2 2494 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29515023 +NR5A2 2494 Pancreatic Neoplasms MESH:D010190 marker/mechanism 20101243|26098869 +NRARP 441478 Brain Neoplasms MESH:D001932 marker/mechanism 21127729 +NRAS 4893 Autoimmune Lymphoproliferative Syndrome MESH:D056735 marker/mechanism 17517660 +NRAS 4893 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +NRAS 4893 Epidermal Nevus MESH:C580062 marker/mechanism 162900.0 +NRAS 4893 Leukemia, Megakaryoblastic, of Down Syndrome MESH:C566025 marker/mechanism 24056718 +NRAS 4893 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 27992414 +NRAS 4893 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 19775298|26457647 +NRAS 4893 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 26285909 +NRAS 4893 Leukocytosis MESH:D007964 marker/mechanism 27725143 +NRAS 4893 Lymphoma MESH:D008223 marker/mechanism 9205081 +NRAS 4893 Lymphoma, B-Cell MESH:D016393 marker/mechanism 14633661 +NRAS 4893 Melanocytic nevus syndrome, congenital MESH:C536819 marker/mechanism 137550.0 +NRAS 4893 Melanoma MESH:D008545 marker/mechanism 22535842|22842228|23432625|25043973|26214590|29574239 +NRAS 4893 Neoplasms, Experimental MESH:D009374 marker/mechanism 9205081 +NRAS 4893 Neuroblastoma MESH:D009447 marker/mechanism 23334666 +NRAS 4893 Neurocutaneous melanosis MESH:C537387 marker/mechanism 249400.0 +NRAS 4893 Neurofibrosarcoma MESH:D018319 marker/mechanism 16239399 +NRAS 4893 Nevus, Sebaceous of Jadassohn MESH:D054000 marker/mechanism 163200.0 +NRAS 4893 Noonan Syndrome MESH:D009634 marker/mechanism 19966803 +NRAS 4893 Noonan Syndrome 6 MESH:C548084 marker/mechanism 613224.0 +NRAS 4893 Rectal Neoplasms MESH:D012004 marker/mechanism 3102434 +NRAS 4893 Splenomegaly MESH:D013163 marker/mechanism 27725143 +NRAS 4893 Thyroid cancer, follicular MESH:C572845 marker/mechanism 188470.0 12727991 +NRCAM 4897 Autistic Disorder MESH:D001321 marker/mechanism 17106428|18664314 +NRCAM 4897 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +NRCAM 4897 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +NRCAM 4897 Substance-Related Disorders MESH:D019966 marker/mechanism 16123759 +NREP 9315 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +NREP 9315 Fatty Liver MESH:D005234 marker/mechanism 25226513 +NREP 9315 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NRF1 4899 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22975021 +NRF1 4899 Bowen's Disease MESH:D001913 marker/mechanism 21514422 +NRG1 3084 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +NRG1 3084 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +NRG1 3084 Breast Neoplasms MESH:D001943 marker/mechanism 19617202 +NRG1 3084 Cardiotoxicity MESH:D066126 therapeutic 29305325 +NRG1 3084 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 19617202 +NRG1 3084 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +NRG1 3084 Heart Failure MESH:D006333 therapeutic 19801490 +NRG1 3084 Hirschsprung Disease MESH:D006627 marker/mechanism 22974608 +NRG1 3084 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NRG1 3084 Lung Neoplasms MESH:D008175 marker/mechanism 28604730 +NRG1 3084 Movement Disorders MESH:D009069 marker/mechanism 22226049 +NRG1 3084 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19617202 +NRG1 3084 Pain MESH:D010146 marker/mechanism 20561508 +NRG1 3084 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +NRG1 3084 Schizophrenia MESH:D012559 marker/mechanism 603013.0 12145742|17333138|17460065|17905522|20561508|20582876|20701826 +NRG1 3084 Stomach Ulcer MESH:D013276 marker/mechanism 16357062 +NRG3 10718 Schizophrenia MESH:D012559 marker/mechanism 20713722 +NRGN 4900 Schizophrenia MESH:D012559 marker/mechanism 17140601 +NRIP1 8204 Breast Neoplasms MESH:D001943 marker/mechanism 22267197 +NRIP1 8204 Endometrial Neoplasms MESH:D016889 marker/mechanism 27348297 +NRIP1 8204 Heart Failure MESH:D006333 marker/mechanism 22503866 +NRIP1 8204 Myocardial Infarction MESH:D009203 marker/mechanism 22503866 +NRIP1 8204 Schizophrenia MESH:D012559 marker/mechanism 21743468 +NRL 4901 Night Blindness MESH:D009755 marker/mechanism 12796249|15591106 +NRL 4901 Retinal Degeneration MESH:D012162 marker/mechanism 15591106 +NRL 4901 Retinitis Pigmentosa MESH:D012174 marker/mechanism 10192380|12796249 +NRL 4901 Retinitis Pigmentosa 27 MESH:C563526 marker/mechanism 613750.0 +NRP1 8829 Endometriosis MESH:D004715 marker/mechanism 21063030 +NRP1 8829 Liver Diseases MESH:D008107 marker/mechanism 19784758 +NRP1 8829 Pancreatic Neoplasms MESH:D010190 marker/mechanism 15956974 +NRP1 8829 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +NRP2 8828 Autistic Disorder MESH:D001321 marker/mechanism 17427189 +NRP2 8828 Seizures MESH:D012640 marker/mechanism 18657176 +NRROS 375387 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NRSN1 140767 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +NRXN1 9378 Abnormalities, Multiple MESH:D000015 marker/mechanism 18057082 +NRXN1 9378 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 18252227 +NRXN1 9378 Autistic Disorder MESH:D001321 marker/mechanism 17322880|18057082|18621663|20157312 +NRXN1 9378 CHROMOSOME 2p16.3 DELETION SYNDROME OMIM:614332 marker/mechanism 614332.0 +NRXN1 9378 Craniofacial Abnormalities MESH:D019465 marker/mechanism 18057082 +NRXN1 9378 Intellectual Disability MESH:D008607 marker/mechanism 18057082|28191889 +NRXN1 9378 Language Development Disorders MESH:D007805 marker/mechanism 20157312 +NRXN1 9378 PITT-HOPKINS-LIKE SYNDROME 2 OMIM:614325 marker/mechanism 614325.0 +NRXN1 9378 Pitt-Hopkins syndrome MESH:C537403 marker/mechanism 19896112 +NRXN1 9378 Schizophrenia MESH:D012559 marker/mechanism 20157312|21285140|21424692 +NRXN2 9379 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21424692 +NRXN3 9369 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +NSA2 10412 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 18422935 +NSD1 64324 Autistic Disorder MESH:D001321 marker/mechanism 18001468 +NSD1 64324 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +NSD1 64324 Intellectual Disability MESH:D008607 marker/mechanism 12807965 +NSD1 64324 Sotos Syndrome MESH:D058495 marker/mechanism 117550.0 12807965|14517949|14571271|15452385|15580547|15640245|16188863|16232326|17561922|18001468|18505455|20101679|21972110 +NSD1 64324 Weaver syndrome MESH:C536687 marker/mechanism 12807965 +NSD2 7468 Breast Neoplasms MESH:D001943 marker/mechanism 24874954 +NSD2 7468 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24076604 +NSD2 7468 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 therapeutic 24076604 +NSD2 7468 Wolf-Hirschhorn Syndrome MESH:D054877 marker/mechanism 194190.0 24874954 +NSDHL 50814 CK SYNDROME OMIM:300831 marker/mechanism 300831.0 +NSDHL 50814 Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects MESH:C562515 marker/mechanism 308050.0 25526675 +NSDHL 50814 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 23125191 +NSMCE3 56160 LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME OMIM:617241 marker/mechanism 617241.0 +NSMF 26012 Carcinoma MESH:D002277 marker/mechanism 12376462 +NSMF 26012 HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA OMIM:614838 marker/mechanism 614838.0 +NSMF 26012 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NSMF 26012 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +NSMF 26012 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +NSUN2 54888 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 31209396 +NSUN2 54888 Mental Retardation, Autosomal Recessive 5 MESH:C567018 marker/mechanism 611091.0 +NSUN6 221078 Breast Neoplasms MESH:D001943 marker/mechanism 28114269 +NSUN6 221078 Neoplasm Metastasis MESH:D009362 marker/mechanism 28114269 +NSUN7 79730 Infertility, Male MESH:D007248 marker/mechanism 17442852 +NT5C 30833 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641 +NT5C2 22978 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +NT5C2 22978 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 23377183 +NT5C2 22978 Recurrence MESH:D012008 marker/mechanism 23377183 +NT5C2 22978 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE OMIM:613162 marker/mechanism 613162.0 +NT5C3A 51251 Anemia, Hemolytic, Congenital Nonspherocytic MESH:D000746 marker/mechanism 16672222 +NT5C3A 51251 Chloracne MESH:D054506 marker/mechanism 17101203 +NT5C3A 51251 Uridine 5-Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia due to MESH:C564859 marker/mechanism 266120.0 +NT5DC1 221294 Melanoma MESH:D008545 marker/mechanism 22535842 +NT5E 4907 Calcification of Joints and Arteries MESH:C565891 marker/mechanism 211800.0 +NT5E 4907 Cell Transformation, Neoplastic MESH:D002471 therapeutic 34773529 +NT5E 4907 Disease Progression MESH:D018450 therapeutic 34773529 +NT5E 4907 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 18263696 +NT5E 4907 Neuroblastoma MESH:D009447 therapeutic 34773529 +NT5E 4907 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +NTF3 4908 Autistic Disorder MESH:D001321 marker/mechanism 16289943 +NTF3 4908 Diabetic Neuropathies MESH:D003929 therapeutic 11779407 +NTF3 4908 Down Syndrome MESH:D004314 marker/mechanism 16289943 +NTF3 4908 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 16023256 +NTF3 4908 Hearing Loss MESH:D034381 therapeutic 18024279 +NTF3 4908 Hyperalgesia MESH:D006930 therapeutic 15659614 +NTF3 4908 Nerve Degeneration MESH:D009410 therapeutic 8921280|8978711 +NTF3 4908 Schizophrenia MESH:D012559 marker/mechanism 18572319 +NTF3 4908 Status Epilepticus MESH:D013226 marker/mechanism 8635431 +NTF4 4909 Autistic Disorder MESH:D001321 marker/mechanism 11357950|16289943 +NTF4 4909 Glaucoma 1, Open Angle, O MESH:C567753 marker/mechanism 613100.0 +NTF4 4909 Intellectual Disability MESH:D008607 marker/mechanism 11357950 +NTF4 4909 Nerve Degeneration MESH:D009410 therapeutic 8921280 +NTF5 78405 Nerve Degeneration MESH:D009410 therapeutic 8921280 +NTHL1 4913 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 616415.0 25938944 +NTN1 9423 Brain Edema MESH:D001929 therapeutic 29162556 +NTN1 9423 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 35292334 +NTN1 9423 Neurobehavioral Manifestations MESH:D019954 therapeutic 29162556 +NTN1 9423 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 29162556 +NTNG1 22854 Bipolar Disorder MESH:D001714 marker/mechanism 17507910 +NTNG1 22854 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +NTNG1 22854 Schizophrenia MESH:D012559 marker/mechanism 17507910 +NTNG2 84628 Bipolar Disorder MESH:D001714 marker/mechanism 17507910 +NTNG2 84628 Schizophrenia MESH:D012559 marker/mechanism 17507910 +NTRK1 4914 Bipolar Disorder MESH:D001714 marker/mechanism 14708030 +NTRK1 4914 Glioma MESH:D005910 marker/mechanism 24705251 +NTRK1 4914 Hereditary Sensory and Autonomic Neuropathies MESH:D009477 marker/mechanism 256800.0 +NTRK1 4914 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +NTRK1 4914 Lung Injury MESH:D055370 therapeutic 20075049 +NTRK1 4914 Neuralgia MESH:D009437 marker/mechanism 18400411 +NTRK1 4914 Neuroblastoma MESH:D009447 marker/mechanism 16989911 +NTRK1 4914 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +NTRK1 4914 Schizophrenia MESH:D012559 marker/mechanism 14708030 +NTRK2 4915 Astrocytoma MESH:D001254 marker/mechanism 23817572 +NTRK2 4915 Autistic Disorder MESH:D001321 marker/mechanism 20662941 +NTRK2 4915 Bipolar Disorder MESH:D001714 marker/mechanism 19018715 +NTRK2 4915 Cocaine-Related Disorders MESH:D019970 marker/mechanism 20826313|20947769 +NTRK2 4915 Developmental Disabilities MESH:D002658 marker/mechanism 15494731 +NTRK2 4915 Glioma MESH:D005910 marker/mechanism 24705251 +NTRK2 4915 Hyperkinesis MESH:D006948 marker/mechanism 20826313|20947769 +NTRK2 4915 Hyperphagia MESH:D006963 marker/mechanism 15494731 +NTRK2 4915 Lewy Body Disease MESH:D020961 marker/mechanism 19276553 +NTRK2 4915 Neuroblastoma MESH:D009447 marker/mechanism 16051641 +NTRK2 4915 Obesity MESH:D009765 marker/mechanism 15494731 +NTRK2 4915 Obesity, Hyperphagia, and Developmental Delay MESH:C563938 marker/mechanism 613886.0 +NTRK2 4915 Status Epilepticus MESH:D013226 marker/mechanism 8635431|8821376 +NTRK3 4916 Endometriosis MESH:D004715 marker/mechanism 21063030 +NTRK3 4916 Glioma MESH:D005910 marker/mechanism 24705251 +NTRK3 4916 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 29119387 +NTRK3 4916 Status Epilepticus MESH:D013226 marker/mechanism 8635431 +NTS 4922 Bradycardia MESH:D001919 therapeutic 2326505 +NTS 4922 Catalepsy MESH:D002375 therapeutic 20882060 +NTS 4922 Hyperkinesis MESH:D006948 therapeutic 3748325|6682440 +NTS 4922 Muscle Rigidity MESH:D009127 therapeutic 8036282 +NTSR1 4923 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24781735 +NTSR1 4923 Pain MESH:D010146 therapeutic 20727387 +NTSR1 4923 Schizophrenia MESH:D012559 marker/mechanism 20659557 +N-TUTCA2 22069 Insulin Resistance MESH:D007333 marker/mechanism 28228267 +N-TUTCA2 22069 Myocarditis MESH:D009205 marker/mechanism 17142041 +NUAK1 9891 Multiple Myeloma MESH:D009101 marker/mechanism 26873845 +NUAK1 9891 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588|26873845 +NUBPL 80224 Mitochondrial Diseases MESH:D028361 marker/mechanism 20818383 +NUCB1 4924 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +NUCB2 4925 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +NUCKS1 64710 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +NUDCD3 23386 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +NUDT15 55270 THIOPURINES, POOR METABOLISM OF, 2 OMIM:616903 marker/mechanism 616903.0 +NUDT16 131870 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NUDT17 200035 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +NUDT2 318 Breast Neoplasms MESH:D001943 marker/mechanism 20533549 +NUDT21 11051 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +NUDT21 11051 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +NUDT7 283927 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +NUF2 83540 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NUMA1 4926 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +NUMA1 4926 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 612376.0 +NUP107 57122 NEPHROTIC SYNDROME, TYPE 11 OMIM:616730 marker/mechanism 616730.0 +NUP155 9631 ATRIAL FIBRILLATION, FAMILIAL, 15 OMIM:615770 marker/mechanism 615770.0 +NUP205 23165 Nephrotic syndrome, idiopathic, steroid-resistant MESH:C536404 marker/mechanism 26878725 +NUP205 23165 NEPHROTIC SYNDROME, TYPE 13 OMIM:616893 marker/mechanism 616893.0 +NUP205 23165 Osteitis Deformans MESH:D010001 marker/mechanism 21623375 +NUP214 8021 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +NUP214 8021 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 613065.0 +NUP35 129401 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +NUP62 23636 Striatonigral degeneration infantile MESH:C537500 marker/mechanism 271930.0 +NUP88 4927 HIV Infections MESH:D015658 marker/mechanism 15308739 +NUP93 9688 Nephrotic syndrome, idiopathic, steroid-resistant MESH:C536404 marker/mechanism 26878725 +NUP93 9688 NEPHROTIC SYNDROME, TYPE 12 OMIM:616892 marker/mechanism 616892.0 +NUP98 4928 Acute erythroleukemia MESH:C535673 marker/mechanism 30926971 +NUP98 4928 Anemia MESH:D000740 marker/mechanism 27725143 +NUP98 4928 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 21441929 +NUP98 4928 Lymphopenia MESH:D008231 marker/mechanism 27725143 +NUP98 4928 Neutropenia MESH:D009503 marker/mechanism 27725143 +NUPR1 26471 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +NUPR1 26471 Lipidoses MESH:D008064 marker/mechanism 17175557 +NUPR1 26471 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +NUPR1 26471 Pancreatitis MESH:D010195 marker/mechanism 16822955 +NUS1 116150 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 33812996 +NUS1 116150 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa OMIM:617082 marker/mechanism 617082.0 +NUS1 116150 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926|33812996 +NUS1 116150 Disease Models, Animal MESH:D004195 marker/mechanism 33812996 +NUS1 116150 Fatty Liver MESH:D005234 therapeutic 33812996 +NUS1 116150 Glucose Intolerance MESH:D018149 therapeutic 33812996 +NUS1 116150 Hyperglycemia MESH:D006943 therapeutic 33812996 +NUS1 116150 Insulin Resistance MESH:D007333 therapeutic 33812996 +NUS1 116150 Melanoma MESH:D008545 marker/mechanism 22535842 +NUS1 116150 Weight Gain MESH:D015430 marker/mechanism 33812996 +NUSAP1 51203 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +NUSAP1 51203 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +NUTF2 10204 HIV Infections MESH:D015658 marker/mechanism 15308739 +NUTM2B-AS1 101060691 Muscular Dystrophy, Oculopharyngeal MESH:D039141 marker/mechanism 31332380 +NXN 64359 Colorectal Neoplasms MESH:D015179 marker/mechanism 24836286 +NXPH2 11249 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +NYX 60506 Night blindness, congenital stationary MESH:C536122 marker/mechanism 310500.0 +OACYLP 390858 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +OAS1 4938 COVID-19 MESH:D000086382 marker/mechanism 35835913 +OAS1 4938 Influenza, Human MESH:D007251 marker/mechanism 23326326 +OAS1 4938 Virus Diseases MESH:D014777 marker/mechanism 15732009 +OAS1A 246730 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 17984051 +OAS2 4939 Influenza, Human MESH:D007251 marker/mechanism 23326326 +OAS3 4940 Influenza, Human MESH:D007251 marker/mechanism 23326326 +OASL 8638 Influenza, Human MESH:D007251 marker/mechanism 23326326 +OAT 4942 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +OAT 4942 Gyrate Atrophy MESH:D015799 marker/mechanism 258870.0 +OAT 4942 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +OAT 4942 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +OBP3 259247 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +OBP3 259247 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +OBP3 259247 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +OBP3 259247 Liver Diseases MESH:D008107 marker/mechanism 1715830 +OBP99B 43497 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +OBSL1 23363 Three M Syndrome 2 MESH:C567862 marker/mechanism 612921.0 +OC90 729330 Vestibular Diseases MESH:D015837 marker/mechanism 21269433 +OCA2 4948 Oculocutaneous albinism type 2 MESH:C537730 marker/mechanism 203200.0 +OCIAD1 54940 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +OCLN 100506658 Acute Kidney Injury MESH:D058186 marker/mechanism 19766176 +OCLN 100506658 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 25668593 +OCLN 100506658 Breast Neoplasms MESH:D001943 marker/mechanism 17459053|24014025 +OCLN 100506658 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24014025 +OCLN 100506658 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +OCLN 100506658 Hepatic Veno-Occlusive Disease MESH:D006504 marker/mechanism 17015055 +OCLN 100506658 Neoplasms MESH:D009369 marker/mechanism 16982755 +OCLN 100506658 PSEUDO-TORCH SYNDROME 1 OMIM:251290 marker/mechanism 251290.0 +OCLN 100506658 Retinal Diseases MESH:D012164 marker/mechanism 19324842 +OCLN 100506658 Rhinitis, Allergic MESH:D065631 marker/mechanism 33441633 +OCLN 100506658 Splenomegaly MESH:D013163 marker/mechanism 17015055 +OCRL 4952 Dent Disease 2 MESH:C564487 marker/mechanism 300555.0 +OCRL 4952 Oculocerebrorenal Syndrome MESH:D009800 marker/mechanism 309000.0 9430698 +ODAD1 93233 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ODAD1 93233 CILIARY DYSKINESIA, PRIMARY, 20 OMIM:615067 marker/mechanism 615067.0 +ODAD2 55130 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +ODAD2 55130 CILIARY DYSKINESIA, PRIMARY, 23 OMIM:615451 marker/mechanism 615451.0 +ODAD3 115948 CILIARY DYSKINESIA, PRIMARY, 30 OMIM:616037 marker/mechanism 616037.0 +ODAD4 83538 CILIARY DYSKINESIA, PRIMARY, 35 OMIM:617092 marker/mechanism 617092.0 +ODAPH 152816 AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4 OMIM:614832 marker/mechanism 614832.0 +ODC1 4953 Colonic Neoplasms MESH:D003110 marker/mechanism 12810952 +ODC1 4953 Colorectal Neoplasms MESH:D015179 marker/mechanism 21930798 +ODC1 4953 HIV Infections MESH:D015658 marker/mechanism 12878215 +ODC1 4953 Papilloma MESH:D010212 marker/mechanism 17928125 +ODC1 4953 Skin Neoplasms MESH:D012878 marker/mechanism 2591024|7653998 +ODR-4 175950 Infertility MESH:D007246 marker/mechanism 25204677 +OFD1 8481 Joubert Syndrome 10 MESH:C567582 marker/mechanism 300804.0 +OFD1 8481 Orofaciodigital syndrome type1 MESH:C537134 marker/mechanism 311200.0 +OFD1 8481 Oto-Palato-digital syndrome type 1 MESH:C536065 marker/mechanism 16783569 +OFD1 8481 RETINITIS PIGMENTOSA 23 OMIM:300424 marker/mechanism 300424.0 +OFD1 8481 Simpson-Golabi-Behmel Syndrome, Type 2 MESH:C564567 marker/mechanism 300209.0 +OGDH 4967 Alpha-ketoglutarate dehydrogenase deficiency MESH:C536582 marker/mechanism 203740.0 +OGDH 4967 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +OGDHL 55753 Heart Failure MESH:D006333 marker/mechanism 36071497 +OGG1 4968 Adenocarcinoma MESH:D000230 marker/mechanism 19336973 +OGG1 4968 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 23951099 +OGG1 4968 Brain Diseases MESH:D001927 marker/mechanism 24075420 +OGG1 4968 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 144700.0 +OGG1 4968 Chromosome Aberrations MESH:D002869 marker/mechanism 24036326 +OGG1 4968 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22652274 +OGG1 4968 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 24036326 +OGG1 4968 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 24599382 +OGG1 4968 Heart Diseases MESH:D006331 therapeutic 21873502 +OGG1 4968 HIV Infections MESH:D015658 marker/mechanism 29709520 +OGG1 4968 Huntington Disease MESH:D006816 marker/mechanism 19857538 +OGG1 4968 Hyperplasia MESH:D006965 marker/mechanism 19336973 +OGG1 4968 Infertility, Male MESH:D007248 marker/mechanism 23376476 +OGG1 4968 Lung Neoplasms MESH:D008175 marker/mechanism|therapeutic 17441966|19336973 +OGG1 4968 Lupus Erythematosus, Discoid MESH:D008179 marker/mechanism 33072095 +OGG1 4968 Lymphoma MESH:D008223 therapeutic 17441966 +OGG1 4968 Motor Skills Disorders MESH:D019957 marker/mechanism 18768699 +OGG1 4968 Nerve Degeneration MESH:D009410 marker/mechanism 26629949 +OGG1 4968 Obesity MESH:D009765 marker/mechanism 29709520 +OGG1 4968 Premature Birth MESH:D047928 marker/mechanism 29709520 +OGG1 4968 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 18768699 +OGG1 4968 Prenatal Injuries MESH:D049188 marker/mechanism 24075420 +OGG1 4968 Prostatic Neoplasms MESH:D011471 marker/mechanism 11956079|14634453 +OGG1 4968 Pulmonary Fibrosis MESH:D011658 marker/mechanism 35654123 +OGG1 4968 Skin Diseases MESH:D012871 marker/mechanism 16759981 +OGG1 4968 Urologic Neoplasms MESH:D014571 marker/mechanism 26359225 +OGN 4969 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +OIP5-AS1 729082 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 35044041 +OIT3 170392 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +OLFM1 10439 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +OLFM4 10562 Endometriosis MESH:D004715 marker/mechanism 21048224 +OLFML2A 169611 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +OLFML2B 25903 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +OLFML2B 25903 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +OLFML3 56944 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +OLR1 4973 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +OLR1 4973 Cardiomyopathies MESH:D009202 marker/mechanism 16055083 +OLR1 4973 Heart Failure MESH:D006333 marker/mechanism 22352330 +OLR1 4973 Hypertension MESH:D006973 marker/mechanism 22352330 +OLR1 4973 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 12646194|14684693 +OLR59 170816 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +OLR59 170816 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ONECUT2 9480 Prostatic Neoplasms MESH:D011471 marker/mechanism 29581250 +OPA1 4976 Behr syndrome MESH:C537669 marker/mechanism 210000.0 +OPA1 4976 GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO OMIM:606657 marker/mechanism 606657.0 +OPA1 4976 MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE) OMIM:616896 marker/mechanism 616896.0 +OPA1 4976 Optic atrophy 1 and deafness MESH:C537124 marker/mechanism 125250.0 +OPA1 4976 Optic Atrophy, Autosomal Dominant MESH:D029241 marker/mechanism 165500.0 19900585|23409176 +OPA1 4976 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +OPA1 4976 Ventricular Remodeling MESH:D020257 marker/mechanism 20886221 +OPA3 80207 Costeff optic atrophy syndrome MESH:C535311 marker/mechanism 258501.0 +OPA3 80207 Optic atrophy and cataract, autosomal dominant MESH:C537128 marker/mechanism 165300.0 +OPCML 4978 Ovarian Neoplasms MESH:D010051 marker/mechanism 167000.0 +OPHN1 4983 Craniofrontonasal dysplasia MESH:C536456 marker/mechanism 17941886 +OPHN1 4983 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 17941886 +OPHN1 4983 Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance MESH:C537456 marker/mechanism 300486.0 +OPLAH 26873 5-oxoprolinase deficiency MESH:C535322 marker/mechanism 260005.0 +OPN1LW 5956 Blue cone monochromatism MESH:C536238 marker/mechanism 303700.0 +OPN1LW 5956 COLORBLINDNESS, PARTIAL, PROTAN SERIES OMIM:303900 marker/mechanism 303900.0 +OPN1MW 2652 Blue cone monochromatism MESH:C536238 marker/mechanism 303700.0 +OPN1MW 2652 COLORBLINDNESS, PARTIAL, DEUTAN SERIES OMIM:303800 marker/mechanism 303800.0 +OPN1SW 611 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +OPN1SW 611 TRITANOPIA OMIM:190900 marker/mechanism 190900.0 +OPRD1 4985 Epilepsy MESH:D004827 marker/mechanism 2415332 +OPRD1 4985 Hypotension, Orthostatic MESH:D007024 marker/mechanism 2981652 +OPRD1 4985 Substance-Related Disorders MESH:D019966 marker/mechanism 17622222|20098672 +OPRD1 4985 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 2415332 +OPRK1 4986 Arrhythmias, Cardiac MESH:D001145 therapeutic 16995444 +OPRK1 4986 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18575850|20232055 +OPRK1 4986 Pain MESH:D010146 marker/mechanism 9463367 +OPRK1 4986 Seizures MESH:D012640 marker/mechanism|therapeutic 1675896|18042875 +OPRK1 4986 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 20232057|9463367 +OPRL1 4987 Arrhythmias, Cardiac MESH:D001145 therapeutic 16995444 +OPRL1 4987 Hypokinesia MESH:D018476 marker/mechanism 20950413 +OPRL1 4987 Morphine Dependence MESH:D009021 marker/mechanism 11027224 +OPRL1 4987 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 11027224 +OPRM1 4988 AIDS Dementia Complex MESH:D015526 marker/mechanism 27400929 +OPRM1 4988 Alcoholism MESH:D000437 marker/mechanism 12815747 +OPRM1 4988 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 16402083 +OPRM1 4988 Cocaine-Related Disorders MESH:D019970 marker/mechanism 12815747|16893609|18762918 +OPRM1 4988 Constipation MESH:D003248 marker/mechanism 27192616 +OPRM1 4988 Dyskinesias MESH:D020820 marker/mechanism 16435402 +OPRM1 4988 Encephalitis, Viral MESH:D018792 marker/mechanism 27400929 +OPRM1 4988 Epilepsy MESH:D004827 marker/mechanism 2415332 +OPRM1 4988 Hepatic Encephalopathy MESH:D006501 marker/mechanism 11991257 +OPRM1 4988 Hepatitis C MESH:D006526 marker/mechanism 12937158|17299060 +OPRM1 4988 Heroin Dependence MESH:D006556 marker/mechanism 20201854 +OPRM1 4988 Hyperalgesia MESH:D006930 marker/mechanism 17996026 +OPRM1 4988 Hypotension, Orthostatic MESH:D007024 marker/mechanism 2981652 +OPRM1 4988 Morphine Dependence MESH:D009021 marker/mechanism 3720824 +OPRM1 4988 Movement Disorders MESH:D009069 marker/mechanism 20298714 +OPRM1 4988 Nausea MESH:D009325 marker/mechanism 27192616 +OPRM1 4988 Neuralgia MESH:D009437 marker/mechanism 14718584|18400411 +OPRM1 4988 Pruritus MESH:D011537 marker/mechanism 27192616 +OPRM1 4988 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 16402083 +OPRM1 4988 Respiratory Insufficiency MESH:D012131 marker/mechanism 27192616 +OPRM1 4988 Seizures MESH:D012640 marker/mechanism 1675896|18042875 +OPRM1 4988 Substance-Related Disorders MESH:D019966 marker/mechanism 27192616 +OPTN 10133 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 21059646|25096716 +OPTN 10133 AMYOTROPHIC LATERAL SCLEROSIS 12 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA OMIM:613435 marker/mechanism 613435.0 +OPTN 10133 GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO OMIM:606657 marker/mechanism 606657.0 +OPTN 10133 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 137760.0 21059646|25096716 +OPTN 10133 Osteitis Deformans MESH:D010001 marker/mechanism 20436471|21059646 +OR2B3 442184 Dermatitis, Irritant MESH:D017453 marker/mechanism 27258892 +OR4C13 283092 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +OR4C46 119749 Schizophrenia MESH:D012559 marker/mechanism 21822266 +OR51E1 143503 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +OR5J2 282775 Skin Diseases MESH:D012871 marker/mechanism 28720099 +OR8S1 341568 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +ORAI1 84876 Hypertension MESH:D006973 marker/mechanism 19897708 +ORAI1 84876 Immune dysfunction with T-cell inactivation due to calcium entry defect 1 MESH:C557826 marker/mechanism 612782.0 +ORAI1 84876 Myopathies, Structural, Congenital MESH:D020914 marker/mechanism 615883.0 +ORC1 4998 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ORC1 4998 Dwarfism MESH:D004392 marker/mechanism 21358633 +ORC1 4998 Fetal Growth Retardation MESH:D005317 marker/mechanism 21358633 +ORC1 4998 Meier-Gorlin syndrome MESH:C538012 marker/mechanism 224690.0 21358632 +ORC1 4998 Microcephaly MESH:D008831 marker/mechanism 21358633 +ORC4 5000 Meier-Gorlin syndrome MESH:C538012 marker/mechanism 613800.0 21358631|21358632 +ORC6 23594 Meier-Gorlin syndrome MESH:C538012 marker/mechanism 613803.0 21358632 +ORM1 5004 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +ORM1 5004 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +ORM1 5004 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +ORM1 5004 Liver Failure MESH:D017093 therapeutic 18256743 +ORM1 5004 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +ORM2 5005 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +ORM2 5005 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +ORMDL3 94103 Asthma MESH:D001249 marker/mechanism 21150878|25256354 +ORMDL3 94103 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799 +OSBPL2 9885 DEAFNESS, AUTOSOMAL DOMINANT 67 OMIM:616340 marker/mechanism 616340.0 +OSBPL8 114882 Weight Gain MESH:D015430 marker/mechanism 19030233 +OSGEP 55644 Galloway Mowat syndrome MESH:C537548 marker/mechanism 28805828 +OSGIN1 29948 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +OSM 5008 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +OSM 5008 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 24979617 +OSM 5008 Chloracne MESH:D054506 marker/mechanism 17101203 +OSM 5008 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +OSM 5008 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 17640959 +OSM 5008 Neoplasm Metastasis MESH:D009362 marker/mechanism 21937440 +OSMR 9180 amyloidosis IX MESH:C562643 marker/mechanism 105250.0 +OSMR 9180 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427 +OSMR 9180 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +OSR2 116039 Endometriosis MESH:D004715 marker/mechanism 20864642 +OSTM1 28962 Osteopetrosis, Autosomal Recessive 5 MESH:C566883 marker/mechanism 259720.0 +OTC 5009 Brain Diseases MESH:D001927 marker/mechanism 8778603 +OTC 5009 Cognition Disorders MESH:D003072 marker/mechanism 8778603 +OTC 5009 Endotoxemia MESH:D019446 marker/mechanism 16741687 +OTC 5009 Hyperammonemia MESH:D022124 marker/mechanism 10227223|11286510|19669271|20406775|6825366|8424807|8562862|8581365|8778603|9598692 +OTC 5009 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +OTC 5009 Nerve Degeneration MESH:D009410 marker/mechanism 24161480 +OTC 5009 Ornithine Carbamoyltransferase Deficiency Disease MESH:D020163 marker/mechanism|therapeutic 16677864|19669271|8778603 +OTC 5009 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO OMIM:311250 marker/mechanism 311250.0 +OTOA 146183 Deafness, Autosomal Recessive 22 MESH:C564633 marker/mechanism 607039.0 +OTOF 9381 Deafness MESH:D003638 marker/mechanism 17967520 +OTOF 9381 Deafness, Autosomal Recessive 9 MESH:C563396 marker/mechanism 601071.0 +OTOG 340990 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +OTOG 340990 DEAFNESS, AUTOSOMAL RECESSIVE 18B OMIM:614945 marker/mechanism 614945.0 +OTOGL 283310 DEAFNESS, AUTOSOMAL RECESSIVE 84B OMIM:614944 marker/mechanism 614944.0 +OTUB2 78990 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +OTUD6B 51633 INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES OMIM:617452 marker/mechanism 617452.0 +OTUD7B 56957 Weight Loss MESH:D015431 therapeutic 36639017 +OTULIN 90268 AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME OMIM:617099 marker/mechanism 617099.0 +OTULINL 54491 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +OTX2 5015 Combined Pituitary Hormone Deficiency MESH:C580003 marker/mechanism 613986.0 +OTX2 5015 Jaw Abnormalities MESH:D007569 marker/mechanism 12183386 +OTX2 5015 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +OTX2 5015 Microphthalmia, Syndromic 5 MESH:C566441 marker/mechanism 610125.0 +OTX2 5015 Nerve Degeneration MESH:D009410 marker/mechanism 20573704 +OVA 34362 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 32284261 +OVAL 396058 Airway Obstruction MESH:D000402 marker/mechanism 29986831 +OVAL 396058 Airway Remodeling MESH:D056151 marker/mechanism 28935613 +OVAL 396058 Asthma MESH:D001249 marker/mechanism 22733167|24950052|25739523|26549244|28529457 +OVAL 396058 Disease Models, Animal MESH:D004195 marker/mechanism 22733167|24950052|26549244 +OVAL 396058 Hyperplasia MESH:D006965 marker/mechanism 28529457 +OVAL 396058 Hypersensitivity MESH:D006967 marker/mechanism 16979384|28529457 +OVAL 396058 Hypothermia MESH:D007035 marker/mechanism 27682001 +OVAL 396058 Inflammation MESH:D007249 marker/mechanism 29986831 +OVAL 396058 Pneumonia MESH:D011014 marker/mechanism 23642096 +OVAL 396058 Pulmonary Edema MESH:D011654 marker/mechanism 30713661 +OVAL 396058 Pulmonary Fibrosis MESH:D011658 marker/mechanism 29758289 +OVAL 396058 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 28935613|29758289 +OVAL 396058 Rhinitis, Allergic MESH:D065631 marker/mechanism 30148989 +OVAL 396058 Splenomegaly MESH:D013163 marker/mechanism 24051191 +OVGP1 5016 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +OVOL1 5017 Dermatitis, Atopic MESH:D003876 marker/mechanism 23042114 +OVOL1 5017 Pilomatrixoma MESH:D018296 marker/mechanism 26873447 +OVOL2 58495 Corneal Dystrophy, Posterior Polymorphous, 1 MESH:C562745 marker/mechanism 122000.0 26749309 +OVOL2 58495 Pilomatrixoma MESH:D018296 marker/mechanism 26873447 +OXCT1 5019 Osteoporosis MESH:D010024 marker/mechanism 18924182 +OXCT1 5019 Succinyl-CoA:3-oxoacid CoA transferase deficiency MESH:C537527 marker/mechanism 245050.0 +OXSR1 9943 Hypertension MESH:D006973 therapeutic 22949526 +OXT 5020 Anxiety Disorders MESH:D001008 therapeutic 19228979 +OXT 5020 Autistic Disorder MESH:D001321 marker/mechanism|therapeutic 15288368|18775368 +OXT 5020 Carcinoma MESH:D002277 therapeutic 8647655 +OXT 5020 Colonic Neoplasms MESH:D003110 therapeutic 8647655 +OXT 5020 Coma MESH:D003128 marker/mechanism 19397503|292422|5067144 +OXT 5020 Disseminated Intravascular Coagulation MESH:D004211 marker/mechanism 15547535 +OXT 5020 Dysmenorrhea MESH:D004412 marker/mechanism 10440088 +OXT 5020 Edema MESH:D004487 marker/mechanism 5067144|5538905 +OXT 5020 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 4988877|6407273 +OXT 5020 Fetal Death MESH:D005313 marker/mechanism 5067144 +OXT 5020 Fetal Distress MESH:D005316 marker/mechanism 2862618 +OXT 5020 Flushing MESH:D005483 marker/mechanism 7080326 +OXT 5020 Headache MESH:D006261 marker/mechanism 7080326 +OXT 5020 Hyperkinesis MESH:D006948 therapeutic 18092152 +OXT 5020 Hypertension MESH:D006973 therapeutic 18562099|9334988 +OXT 5020 Hyponatremia MESH:D007010 marker/mechanism 19397503|3923190|6407273 +OXT 5020 Hypotension MESH:D007022 marker/mechanism 11171655 +OXT 5020 Inflammation MESH:D007249 therapeutic 18940936 +OXT 5020 Ischemia MESH:D007511 marker/mechanism 10440088 +OXT 5020 Mammary Neoplasms, Experimental MESH:D008325 therapeutic 15089975|8647655 +OXT 5020 Muscle Hypertonia MESH:D009122 marker/mechanism 2862618 +OXT 5020 Pain MESH:D010146 therapeutic 17420069|6094376 +OXT 5020 Polyuria MESH:D011141 marker/mechanism 20649851 +OXT 5020 Prostatic Diseases MESH:D011469 marker/mechanism 17492653 +OXT 5020 Seizures MESH:D012640 marker/mechanism 19397503|292422|3923190|5067144|5493616|644406 +OXT 5020 Spasm MESH:D013035 marker/mechanism 2444298|3567346|5784655|8680739 +OXT 5020 Taste Disorders MESH:D013651 marker/mechanism 7080326 +OXT 5020 Water Intoxication MESH:D014869 marker/mechanism 292422|3923190|4988877|5067144|5493616|5528113|7360068|803783 +OXT 5020 Weight Gain MESH:D015430 marker/mechanism 18562099 +OXT 5020 Weight Loss MESH:D015431 marker/mechanism 18562099 +OXTR 5021 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20832055 +OXTR 5021 Autistic Disorder MESH:D001321 marker/mechanism 15288368|15992526|17383819|17893705|18207134|21082655 +OXTR 5021 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17043644 +OXTR 5021 Chromosome 3, monosomy 3p25 MESH:C536807 marker/mechanism 21082655 +OXTR 5021 Cognition Disorders MESH:D003072 marker/mechanism 20347913 +OXTR 5021 Schizophrenia MESH:D012559 marker/mechanism 20196918 +P2RX1 5023 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +P2RX2 22953 Deafness, Autosomal Dominant 41 MESH:C564272 marker/mechanism 608224.0 +P2RX2 22953 Epilepsy MESH:D004827 marker/mechanism 12941474 +P2RX2 22953 Hyperalgesia MESH:D006930 marker/mechanism 19383439 +P2RX3 5024 Hyperalgesia MESH:D006930 marker/mechanism 19383439 +P2RX3 5024 Trauma, Nervous System MESH:D020196 marker/mechanism 24136739 +P2RX4 5025 Epilepsy MESH:D004827 marker/mechanism 12941474 +P2RX4 5025 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 19084381 +P2RX7 5027 Disease Models, Animal MESH:D004195 marker/mechanism 27466191 +P2RX7 5027 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 12121326|19084381 +P2RX7 5027 Hypophosphatasia MESH:D007014 marker/mechanism 27466191 +P2RX7 5027 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 11003599 +P2RX7 5027 Liver Cirrhosis MESH:D008103 marker/mechanism 32721574 +P2RX7 5027 Multiple Sclerosis MESH:D009103 marker/mechanism 17728465 +P2RX7 5027 Spinal Cord Injuries MESH:D013119 therapeutic 15258577 +P2RY1 5028 Thrombosis MESH:D013927 marker/mechanism 17334511 +P2RY11 5032 Narcolepsy MESH:D009290 marker/mechanism 21170044 +P2RY12 64805 BLEEDING DISORDER, PLATELET-TYPE, 8 OMIM:609821 marker/mechanism 609821.0 +P2RY12 64805 Hemorrhage MESH:D006470 marker/mechanism 11196645 +P2RY12 64805 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 15304052 +P2RY12 64805 Myocardial Infarction MESH:D009203 marker/mechanism 19334620 +P2RY12 64805 Thrombosis MESH:D013927 marker/mechanism 17334511 +P2RY8 286530 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 19838194 +P3H1 64175 Osteogenesis Imperfecta MESH:D010013 marker/mechanism 18566967 +P3H1 64175 Osteogenesis imperfecta, type VIII MESH:C536049 marker/mechanism 610915.0 +P3H2 55214 MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION OMIM:614292 marker/mechanism 614292.0 +P3H3 10536 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +P4HA2 8974 MYOPIA 25, AUTOSOMAL DOMINANT OMIM:617238 marker/mechanism 617238.0 +P4HB 5034 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +P4HB 5034 Cole Carpenter syndrome MESH:C535963 marker/mechanism 112240.0 +P4HB 5034 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +P4HB 5034 Osteoporosis MESH:D010024 marker/mechanism 18924182 +P4HB 5034 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +P4HB 5034 Spinocerebellar Ataxia 17 MESH:C564616 marker/mechanism 24413982 +PA2G4 5036 Disease Progression MESH:D018450 marker/mechanism 21364753 +PA2G4 5036 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PABPC1 26986 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +PABPC1 26986 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 25783786 +PABPC1 26986 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 25783786 +PABPC4 8761 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +PABPC4 8761 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +PABPN1 8106 Muscular Dystrophy, Oculopharyngeal MESH:D039141 marker/mechanism 164300.0 12823221|16239242|25728001 +PACS1 55690 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +PACS1 55690 Obesity MESH:D009765 marker/mechanism 23563609 +PACS1 55690 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PACSIN2 11252 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +PADI3 51702 Uncombable hair syndrome MESH:C536939 marker/mechanism 191480.0 +PADI4 23569 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +PADI4 23569 Carcinoma MESH:D002277 marker/mechanism 12376462 +PADI4 23569 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +PADI4 23569 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +PADI4 23569 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 34322788|34363436 +PADI6 353238 OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 16 OMIM:617234 marker/mechanism 617234.0 +PAEP 5047 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +PAEP 5047 Breast Neoplasms MESH:D001943 marker/mechanism 22296396 +PAFAH1B1 5048 Carcinogenesis MESH:D063646 marker/mechanism 24487275 +PAFAH1B1 5048 Lissencephaly MESH:D054082 marker/mechanism 607432.0 +PAG1 55824 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 23334668 +PAG1 55824 Schizophrenia MESH:D012559 marker/mechanism 21822266 +PAGE4 9506 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +PAH 5053 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 31209396 +PAH 5053 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +PAH 5053 Phenylketonurias MESH:D010661 marker/mechanism 261600.0 +PAIP2 51247 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +PAK1 5058 Breast Neoplasms MESH:D001943 marker/mechanism 20179234 +PAK1 5058 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 17621631 +PAK1 5058 Neoplasm Invasiveness MESH:D009361 marker/mechanism 35066776 +PAK1 5058 Neoplasms, Experimental MESH:D009374 marker/mechanism 35066776 +PAK1 5058 Proteinuria MESH:D011507 marker/mechanism 20071462 +PAK1 5058 Thyroid Neoplasms MESH:D013964 marker/mechanism 35066776 +PAK2 5062 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +PAK2 5062 Proteinuria MESH:D011507 marker/mechanism 20071462 +PAK2 5062 Schizophrenia MESH:D012559 marker/mechanism 20691406 +PAK3 5063 Mental Retardation, X-Linked 30 MESH:C563146 marker/mechanism 300558.0 +PAK4 10298 Neuroblastoma MESH:D009447 marker/mechanism 29048629 +PAK6 56924 Prostatic Neoplasms MESH:D011471 marker/mechanism 18642328 +PAKAP 677884 Weight Gain MESH:D015430 marker/mechanism 19030233 +PALB2 79728 Breast Neoplasms MESH:D001943 marker/mechanism 28825726 +PALB2 79728 Fanconi Anemia, Complementation Group N MESH:C563657 marker/mechanism 610832.0 +PALB2 79728 Pancreatic Neoplasms MESH:D010190 marker/mechanism 613348.0 26098869 +PALB2 79728 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +PALLD 23022 Pancreatic Neoplasms MESH:D010190 marker/mechanism 606856.0 +PALLD 23022 Weight Gain MESH:D015430 marker/mechanism 19030233 +PALMD 54873 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PALS-27 175567 Infertility MESH:D007246 marker/mechanism 25204677 +PAM 5066 Anxiety Disorders MESH:D001008 marker/mechanism 19815072 +PAM 5066 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24464100|30054598 +PAM 5066 Seizures MESH:D012640 marker/mechanism 19815072 +PAMR1 25891 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PAMR1 25891 Heart Failure MESH:D006333 marker/mechanism 28751527 +PAMR1 25891 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 28751527 +PAMR1 25891 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PAN2 9924 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +PAN2 9924 Cholestasis MESH:D002779 marker/mechanism 26881866 +PANK1 53354 Nerve Degeneration MESH:D009410 therapeutic 35589691 +PANK2 80025 Hypoprebetalipoproteinemia, Acanthocytosis, Retinitis Pigmentosa, And Pallidal Degeneration MESH:C564603 marker/mechanism 607236.0 +PANK2 80025 Nerve Degeneration MESH:D009410 marker/mechanism 20493851 +PANK2 80025 Neurodegeneration with brain iron accumulation (NBIA) MESH:C538421 marker/mechanism 20629144 +PANK2 80025 Neurodegenerative Diseases MESH:D019636 marker/mechanism 16450344|17296847 +PANK2 80025 Pantothenate Kinase-Associated Neurodegeneration MESH:D006211 marker/mechanism 234200.0 14580665 +PANX1 24145 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 29246445 +PANX1 24145 Liver Failure, Acute MESH:D017114 marker/mechanism 29246445 +PANX1 24145 Massive Hepatic Necrosis MESH:D047508 marker/mechanism 29246445 +PAOX 196743 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PAOX 196743 Stroke MESH:D020521 marker/mechanism 16269634 +PAPPA 5069 Acute Coronary Syndrome MESH:D054058 marker/mechanism 11586954 +PAPPA 5069 Angina, Unstable MESH:D000789 marker/mechanism 11586954 +PAPPA 5069 Coronary Artery Disease MESH:D003324 marker/mechanism 11586954 +PAPPA 5069 Endometriosis MESH:D004715 marker/mechanism 21063030 +PAPPA 5069 Infertility, Female MESH:D007247 marker/mechanism 20130263 +PAPPA 5069 Myocardial Infarction MESH:D009203 marker/mechanism 11586954 +PAPPA2 60676 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PAPSS2 9060 Spondyloepimetaphyseal Dysplasia, Pakistani Type MESH:C567551 marker/mechanism 612847.0 +PAQR4 124222 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 27415467 +PAQR4 124222 Prostatic Neoplasms MESH:D011471 marker/mechanism 27415467 +PAQR9 344838 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PARA 32619 Paralysis MESH:D010243 marker/mechanism 14978727 +PARA 32619 Seizures MESH:D012640 marker/mechanism 14978727 +PARD3 56288 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PARD3 56288 Prostatic Neoplasms MESH:D011471 marker/mechanism 28319090 +PARD3B 117583 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +PARD6B 84612 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PARG 8505 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism|therapeutic 25628927|27003318 +PARG 8505 Embryo Loss MESH:D020964 marker/mechanism 15591342 +PARG 8505 Neoplasms, Experimental MESH:D009374 therapeutic 33044785 +PARK 40336 Movement Disorders MESH:D009069 marker/mechanism 31926197 +PARK 40336 Reperfusion Injury MESH:D015427 marker/mechanism 35312153 +PARK16 100359403 Parkinson Disease MESH:D010300 marker/mechanism 19915575|19915576 +PARK7 11315 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +PARK7 11315 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +PARK7 11315 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +PARK7 11315 Nerve Degeneration MESH:D009410 therapeutic 29649621 +PARK7 11315 Osteoporosis MESH:D010024 marker/mechanism 18924182 +PARK7 11315 Parkinson Disease MESH:D010300 marker/mechanism 15784737|17010972|20423725|20800516|22043175|22898350|23037695|23792957|25149416 +PARK7 11315 Parkinson Disease 7, Autosomal Recessive Early-Onset MESH:C565238 marker/mechanism 606324.0 28348719 +PARK7 11315 Parkinsonian Disorders MESH:D020734 marker/mechanism 23046578|26558463 +PARK7 11315 Reticulocytosis MESH:D045262 marker/mechanism 20800516 +PARN 5073 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6 OMIM:616353 marker/mechanism 616353.0 +PARN 5073 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 25848748 +PARN 5073 PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 4 OMIM:616371 marker/mechanism 616371.0 +PARP1 142 Alopecia MESH:D000505 marker/mechanism 20561897 +PARP1 142 Anemia MESH:D000740 marker/mechanism 20561897 +PARP1 142 Aortic Aneurysm, Abdominal MESH:D017544 marker/mechanism 30354818 +PARP1 142 Asthma MESH:D001249 marker/mechanism 18261157 +PARP1 142 Atherosclerosis MESH:D050197 marker/mechanism 18093987|19124646 +PARP1 142 Brain Injuries MESH:D001930 marker/mechanism 17640816 +PARP1 142 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 15829224|28642177 +PARP1 142 Brain Ischemia MESH:D002545 marker/mechanism 17640816 +PARP1 142 Breast Neoplasms MESH:D001943 marker/mechanism 20941507 +PARP1 142 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18695907 +PARP1 142 Cardiomyopathies MESH:D009202 marker/mechanism 20561897 +PARP1 142 Cell Transformation, Neoplastic MESH:D002471 therapeutic 33771647 +PARP1 142 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254 +PARP1 142 Colorectal Neoplasms MESH:D015179 marker/mechanism 27694308 +PARP1 142 Dermatitis MESH:D003872 marker/mechanism 20561897 +PARP1 142 Hepatitis MESH:D006505 marker/mechanism 20561897 +PARP1 142 Inflammation MESH:D007249 marker/mechanism 18261157 +PARP1 142 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +PARP1 142 Kidney Diseases MESH:D007674 marker/mechanism 20561897|21884784 +PARP1 142 Kyphosis MESH:D007738 marker/mechanism 20561897 +PARP1 142 Lung Injury MESH:D055370 marker/mechanism 16127429 +PARP1 142 Melanoma MESH:D008545 marker/mechanism 28759004 +PARP1 142 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 21543585 +PARP1 142 Multiple Myeloma MESH:D009101 marker/mechanism 21917757 +PARP1 142 Obesity MESH:D009765 marker/mechanism 20561897 +PARP1 142 Pancreatitis MESH:D010195 marker/mechanism 16127429 +PARP1 142 Paralysis MESH:D010243 marker/mechanism 15696051 +PARP1 142 Parkinsonian Disorders MESH:D020734 marker/mechanism 17640816 +PARP1 142 Plaque, Atherosclerotic MESH:D058226 marker/mechanism 18093987|19124646 +PARP1 142 Pneumonia MESH:D011014 marker/mechanism 20561897 +PARP1 142 Prostatic Neoplasms MESH:D011471 marker/mechanism 15342424 +PARP1 142 Pulmonary Edema MESH:D011654 therapeutic 11818323 +PARP1 142 Pulmonary Fibrosis MESH:D011658 marker/mechanism 27704718 +PARP1 142 Reperfusion Injury MESH:D015427 marker/mechanism 15696051|16798486 +PARP1 142 Spinal Cord Injuries MESH:D013119 marker/mechanism 15696051 +PARP1 142 Spinal Cord Ischemia MESH:D020760 marker/mechanism 15696051 +PARP1 142 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +PARP1 142 Vitamin A Deficiency MESH:D014802 marker/mechanism 18676402 +PARP12 64761 Influenza, Human MESH:D007251 marker/mechanism 23326326 +PARP12 64761 Macular Degeneration MESH:D008268 marker/mechanism 30742112 +PARP2 10038 Lipodystrophy MESH:D008060 marker/mechanism 21417348 +PARP4 143 Colonic Neoplasms MESH:D003110 marker/mechanism 16204055 +PARVA 55742 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PAS1 112278 Lung Neoplasms MESH:D008175 marker/mechanism 11992545|12807761 +PASK 23178 Autistic Disorder MESH:D001321 marker/mechanism 19365831 +PASK 23178 Chromosome 2q37 deletion syndrome MESH:C538317 marker/mechanism 19365831 +PATJ 10207 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PATJ 10207 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PAWR 5074 Adenocarcinoma MESH:D000230 marker/mechanism 15877079 +PAWR 5074 Endometrial Neoplasms MESH:D016889 marker/mechanism 15877079 +PAWR 5074 Prostatic Neoplasms MESH:D011471 marker/mechanism 15877079 +PAX1 5075 Otofaciocervical Syndrome MESH:C563481 marker/mechanism 615560 +PAX2 5076 Endometriosis MESH:D004715 marker/mechanism 22473392 +PAX2 5076 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +PAX2 5076 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 616002 +PAX2 5076 Kidney Failure, Chronic MESH:D007676 marker/mechanism 16631587 +PAX2 5076 Papillorenal syndrome MESH:C537168 marker/mechanism 120330 +PAX3 5077 Craniofacial Abnormalities MESH:D019465 marker/mechanism 14556253 +PAX3 5077 Craniofacial deafness hand syndrome MESH:C536453 marker/mechanism 122880 18553554 +PAX3 5077 Deafness MESH:D003638 marker/mechanism 14556253 +PAX3 5077 Hand Deformities, Congenital MESH:D006228 marker/mechanism 14556253 +PAX3 5077 Nervous System Malformations MESH:D009421 marker/mechanism 7556916 +PAX3 5077 Neural Tube Defects MESH:D009436 marker/mechanism|therapeutic 12739027|12854658|3293260 +PAX3 5077 Rhabdomyosarcoma, Alveolar MESH:D018232 marker/mechanism 268220 +PAX3 5077 Sarcoma MESH:D012509 marker/mechanism 24859338 +PAX3 5077 Sinonasal undifferentiated carcinoma MESH:C537344 marker/mechanism 24859338 +PAX3 5077 Spinal Dysraphism MESH:D016135 marker/mechanism 12854658|17149730|3902948|6385329 +PAX3 5077 Waardenburg Syndrome MESH:D014849 marker/mechanism 148820|193500 18553554 +PAX4 5078 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 612227 +PAX4 5078 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853 +PAX4 5078 Maturity-Onset Diabetes Of The Young, Type 9 MESH:C567393 marker/mechanism 612225 +PAX4 5078 Melanoma MESH:D008545 marker/mechanism 18949370 +PAX5 5079 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +PAX5 5079 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 24013638|30643249 +PAX5 5079 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 615545.0 26214592 +PAX6 5080 Aniridia MESH:D015783 marker/mechanism 106210.0 18322702|30221735 +PAX6 5080 Autistic Disorder MESH:D001321 marker/mechanism 18322702 +PAX6 5080 AXENFELD-RIEGER SYNDROME, TYPE 1 OMIM:180500 marker/mechanism 14630904 +PAX6 5080 Cataract MESH:D002386 marker/mechanism 30221735 +PAX6 5080 Coloboma MESH:D003103 marker/mechanism 120200.0 +PAX6 5080 Coloboma of optic nerve MESH:C535970 marker/mechanism 120430.0 +PAX6 5080 Craniofacial Abnormalities MESH:D019465 marker/mechanism 7559133|9079035|9363853 +PAX6 5080 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +PAX6 5080 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +PAX6 5080 Intellectual Disability MESH:D008607 marker/mechanism 18322702 +PAX6 5080 Keratitis, hereditary MESH:C537022 marker/mechanism 148190.0 +PAX6 5080 Melanoma MESH:D008545 marker/mechanism 16778180 +PAX6 5080 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +PAX6 5080 Nervous System Malformations MESH:D009421 marker/mechanism 19329571 +PAX6 5080 O'Donnell Pappas syndrome MESH:C537858 marker/mechanism 136520.0 +PAX6 5080 Optic Nerve Diseases MESH:D009901 marker/mechanism 12721955 +PAX6 5080 Optic Nerve Hypoplasia, Bilateral MESH:C563492 marker/mechanism 165550.0 +PAX6 5080 Peters anomaly MESH:C537884 marker/mechanism 604229.0 +PAX6 5080 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +PAX6 5080 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +PAX6 5080 Tooth Abnormalities MESH:D014071 marker/mechanism 7559133|9363853 +PAX6 5080 WAGR Syndrome MESH:D017624 marker/mechanism 194072.0 +PAX7 5081 Rhabdomyosarcoma, Alveolar MESH:D018232 marker/mechanism 268220.0 +PAX8 7849 Colorectal Neoplasms MESH:D015179 marker/mechanism 26075790 +PAX8 7849 Hypothyroidism, Congenital, Nongoitrous, 2 MESH:C566852 marker/mechanism 218700.0 +PAX8 7849 Thyroid cancer, follicular MESH:C572845 marker/mechanism 15785241 +PAX9 5083 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +PAX9 5083 Tooth Agenesis, Selective, 3 MESH:C567036 marker/mechanism 604625.0 +PBK 55872 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PBK 55872 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PBLD 64081 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +PBRM1 55193 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 144700.0 22138691|23797736 +PBRM1 55193 Cholangiocarcinoma MESH:D018281 marker/mechanism 24185509 +PBRM1 55193 Thymoma MESH:D013945 marker/mechanism 24974848 +PBSN 54192 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PBW1 112230 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 11529278 +PBX1 5087 Burkitt Lymphoma MESH:D002051 marker/mechanism 17244677|1967982 +PBX1 5087 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PBX4 80714 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +PC 5091 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +PC 5091 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143597 +PC 5091 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +PC 5091 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +PC 5091 Pyruvate Carboxylase Deficiency Disease MESH:D015324 marker/mechanism 266150.0 +PCARE 388939 RETINITIS PIGMENTOSA 54 OMIM:613428 marker/mechanism 613428.0 +PCAT1 100750225 Prostatic Neoplasms MESH:D011471 marker/mechanism 26752646 +PCAT14 101978785 Heart Failure MESH:D006333 marker/mechanism 36071497 +PCBD1 5092 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +PCBD1 5092 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +PCBD1 5092 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D OMIM:264070 marker/mechanism 264070.0 +PCBP1 5093 Breast Neoplasms MESH:D001943 marker/mechanism 35639300 +PCCA 5095 Propionic Acidemia MESH:D056693 marker/mechanism 606054.0 +PCCB 5096 Propionic Acidemia MESH:D056693 marker/mechanism 606054.0 +PCDH10 57575 Autistic Disorder MESH:D001321 marker/mechanism 18621663 +PCDH11X 27328 Alzheimer Disease MESH:D000544 marker/mechanism 19136949 +PCDH11Y 83259 Prostatic Neoplasms MESH:D011471 marker/mechanism 16637074 +PCDH15 65217 Cochlear Diseases MESH:D015834 marker/mechanism 10978835 +PCDH15 65217 Deafness MESH:D003638 marker/mechanism 10978835 +PCDH15 65217 Deafness, Autosomal Recessive 23 MESH:C563705 marker/mechanism 609533.0 +PCDH15 65217 Hearing Loss MESH:D034381 marker/mechanism 30029624 +PCDH15 65217 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PCDH15 65217 Usher Syndromes MESH:D052245 marker/mechanism 19309154 +PCDH15 65217 Usher syndrome, type 1D MESH:C536487 marker/mechanism 601067.0 +PCDH15 65217 Usher syndrome, type 1F MESH:C536489 marker/mechanism 602083.0 +PCDH19 57526 Epilepsy MESH:D004827 marker/mechanism 18469813 +PCDH19 57526 Epilepsy, Female-Restricted, with Mental Retardation MESH:C564715 marker/mechanism 300088.0 +PCDH19 57526 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 18469813 +PCDH8 5100 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +PCDH9 5101 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 18252227 +PCDHA13 56136 Hypoplastic Left Heart Syndrome MESH:D018636 marker/mechanism 28530678 +PCDHA3 56145 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +PCDHA9 9752 Heart Valve Diseases MESH:D006349 marker/mechanism 28530678 +PCDHA9 9752 Hypoplastic Left Heart Syndrome MESH:D018636 marker/mechanism 28530678 +PCDHB8 56128 Melanoma MESH:D008545 marker/mechanism 21499247 +PCDHGB6 56100 Breast Neoplasms MESH:D001943 marker/mechanism 15818620 +PCGEM1 64002 Heart Failure MESH:D006333 marker/mechanism 36071497 +PCK1 5105 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144|28284560 +PCK1 5105 Celiac Disease MESH:D002446 marker/mechanism 30097691 +PCK1 5105 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 20363216 +PCK1 5105 Heart Failure MESH:D006333 marker/mechanism 26670611 +PCK1 5105 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +PCK1 5105 Obesity MESH:D009765 marker/mechanism 20882379 +PCK1 5105 Phosphoenolpyruvate carboxykinase deficiency MESH:C536654 marker/mechanism 261680.0 +PCK2 5106 Hypoxia MESH:D000860 marker/mechanism 18258771 +PCK2 5106 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PCK2 5106 Phosphoenolpyruvate Carboxykinase Deficiency, Mitochondrial MESH:C564890 marker/mechanism 261650.0 +PCLAF 9768 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PCLO 27445 Pontocerebellar Hypoplasia Type 3 MESH:C548072 marker/mechanism 608027.0 +PCM1 5108 Schizophrenia MESH:D012559 marker/mechanism 19048012 +PCMT1 5110 Spinal Dysraphism MESH:D016135 marker/mechanism 16256389 +PCNA 5111 Adenocarcinoma MESH:D000230 marker/mechanism 19028472 +PCNA 5111 Ataxia Telangiectasia Like Disorder MESH:C565779 marker/mechanism 615919.0 +PCNA 5111 Brain Neoplasms MESH:D001932 marker/mechanism 20932960 +PCNA 5111 Colonic Neoplasms MESH:D003110 marker/mechanism 19028472|19723570 +PCNA 5111 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 17121042 +PCNA 5111 Hepatoblastoma MESH:D018197 marker/mechanism 11560253 +PCNA 5111 Ischemia MESH:D007511 marker/mechanism 19458120 +PCNA 5111 Lung Neoplasms MESH:D008175 marker/mechanism 11884234 +PCNA 5111 Neoplasms, Experimental MESH:D009374 marker/mechanism 20932960 +PCNA 5111 Psoriasis MESH:D011565 marker/mechanism 10384915 +PCNA 5111 Radiation Injuries, Experimental MESH:D011833 marker/mechanism 21931560 +PCNT 5116 Microcephalic Osteodysplastic Primordial Dwarfism, Type II MESH:C565898 marker/mechanism 210720.0 +PCNT 5116 Seckel syndrome 1 MESH:C537533 marker/mechanism 18157127 +PCNT 5116 Seckel syndrome 2 MESH:C537534 marker/mechanism 18174396 +PCNX3 399909 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 26808113 +PCOLCE 5118 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +PCOLCE 5118 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +PCOLCE2 26577 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +PCP4 5121 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +PCSK1 5122 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12 OMIM:612362 marker/mechanism 612362.0 +PCSK1 5122 Body Weight MESH:D001835 marker/mechanism 22344219 +PCSK1 5122 Obesity MESH:D009765 marker/mechanism 18604207 +PCSK1 5122 Proprotein Convertase 1 3 Deficiency MESH:C563423 marker/mechanism 600955.0 +PCSK1N 27344 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +PCSK1N 27344 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +PCSK2 5126 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +PCSK2 5126 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +PCSK5 5125 Anus, Imperforate MESH:D001006 marker/mechanism 18519639 +PCSK5 5125 Bone Diseases, Developmental MESH:D001848 marker/mechanism 18519639 +PCSK5 5125 Currarino triad MESH:C536221 marker/mechanism 18519639 +PCSK5 5125 Heart Septal Defects MESH:D006343 marker/mechanism 18519639 +PCSK5 5125 Heart Septal Defects, Ventricular MESH:D006345 marker/mechanism 18519639 +PCSK5 5125 Hernia, Umbilical MESH:D006554 marker/mechanism 18519639 +PCSK5 5125 Jaw Abnormalities MESH:D007569 marker/mechanism 18519639 +PCSK5 5125 Kidney Diseases MESH:D007674 marker/mechanism 18519639 +PCSK5 5125 Lower Extremity Deformities, Congenital MESH:D038061 marker/mechanism 18519639 +PCSK5 5125 Lung Diseases MESH:D008171 marker/mechanism 18519639 +PCSK5 5125 Mouth Abnormalities MESH:D009056 marker/mechanism 18519639 +PCSK5 5125 Sacral defect and anterior sacral meningocele MESH:C537221 marker/mechanism 18519639 +PCSK5 5125 Tracheoesophageal Fistula MESH:D014138 marker/mechanism 18519639 +PCSK5 5125 VATER association MESH:C536534 marker/mechanism 18519639 +PCSK9 255738 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990|27135400 +PCSK9 255738 Hypercholesterolemia MESH:D006937 marker/mechanism 12730697 +PCSK9 255738 Hypercholesterolemia, Autosomal Dominant, 3 MESH:C566337 marker/mechanism 603776.0 +PCX 18563 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +PCX 18563 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +PCYOX1 51449 Weight Gain MESH:D015430 marker/mechanism 19030233 +PCYT1A 5130 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +PCYT1A 5130 Spinal Dysraphism MESH:D016135 marker/mechanism 17184542 +PCYT1A 5130 Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy MESH:C563825 marker/mechanism 608940.0 +PCYT1B 9468 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +PDCD1 5133 Graves Disease MESH:D006111 marker/mechanism 33132244 +PDCD1 5133 Lung Neoplasms MESH:D008175 marker/mechanism 34166680 +PDCD1 5133 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 605218.0 +PDCD1 5133 Melanoma MESH:D008545 therapeutic 21802280 +PDCD1 5133 Multiple Sclerosis MESH:D009103 marker/mechanism 126200.0 +PDCD10 11235 Cerebral Cavernous Malformations 3 MESH:C566393 marker/mechanism 603285.0 +PDCD4 27250 Cell Transformation, Neoplastic MESH:D002471 therapeutic 27323401|27344173|28881718 +PDCD4 27250 Lung Neoplasms MESH:D008175 marker/mechanism 27323401 +PDCD4 27250 Neoplasm Invasiveness MESH:D009361 marker/mechanism 23272133 +PDCD6IP 10015 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +PDE10A 10846 DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET OMIM:616921 marker/mechanism 616921.0 +PDE10A 10846 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2 OMIM:616922 marker/mechanism 616922.0 +PDE11A 50940 Pigmented Nodular Adrenocortical Disease, Primary, 2 MESH:C566472 marker/mechanism 610475.0 +PDE12 201626 Cardiovirus Infections MESH:D018188 marker/mechanism 26055709 +PDE12 201626 Respiratory Syncytial Virus Infections MESH:D018357 marker/mechanism 26055709 +PDE1B 5153 Learning Disabilities MESH:D007859 marker/mechanism 12077213 +PDE1C 5137 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PDE2A 5138 Breast Neoplasms MESH:D001943 marker/mechanism 12972520 +PDE3A 5139 Brachydactyly with hypertension MESH:C537095 marker/mechanism 112410.0 25961942 +PDE3A 5139 Myocardial Infarction MESH:D009203 marker/mechanism 19027736 +PDE3A 5139 Stroke MESH:D020521 marker/mechanism 29531354 +PDE3A 5139 Thrombosis MESH:D013927 marker/mechanism 17482796 +PDE3B 5140 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PDE4A 5141 Autistic Disorder MESH:D001321 marker/mechanism 18090323 +PDE4B 5142 Alcoholism MESH:D000437 marker/mechanism 18438686 +PDE4B 5142 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +PDE4B 5142 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +PDE4B 5142 Asthma MESH:D001249 marker/mechanism 21912604 +PDE4B 5142 Autistic Disorder MESH:D001321 marker/mechanism 18090323 +PDE4B 5142 Bipolar Disorder MESH:D001714 marker/mechanism 18394866 +PDE4B 5142 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +PDE4B 5142 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PDE4B 5142 Schizophrenia MESH:D012559 marker/mechanism 16293762|18394866 +PDE4B 5142 Skin Diseases MESH:D012871 marker/mechanism 16835338 +PDE4D 5144 Acrodysostosis MESH:C538179 marker/mechanism 614613.0 +PDE4D 5144 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +PDE4D 5144 Asthma MESH:D001249 marker/mechanism 19426955|21611147 +PDE4D 5144 Prostatic Neoplasms MESH:D011471 marker/mechanism 16740699|29662167 +PDE5A 8654 Neoplasm Metastasis MESH:D009362 marker/mechanism 12972520 +PDE6A 5145 Retinitis Pigmentosa MESH:D012174 marker/mechanism 21039428|27551530|7493036 +PDE6A 5145 RETINITIS PIGMENTOSA 43 OMIM:613810 marker/mechanism 613810.0 +PDE6B 5158 Disease Models, Animal MESH:D004195 marker/mechanism 17213800 +PDE6B 5158 Night blindness, congenital stationary MESH:C536122 marker/mechanism 8075643 +PDE6B 5158 Night Blindness, Congenital Stationary, Autosomal Dominant 2 MESH:C566869 marker/mechanism 163500.0 +PDE6B 5158 Retinal Degeneration MESH:D012162 marker/mechanism 16123450|17213800|24586289|8692941 +PDE6B 5158 Retinitis Pigmentosa MESH:D012174 marker/mechanism 8394174 +PDE6B 5158 RETINITIS PIGMENTOSA 40 OMIM:613801 marker/mechanism 613801.0 +PDE6C 5146 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +PDE6C 5146 Cone Dystrophy 4 MESH:C567758 marker/mechanism 613093.0 +PDE6G 5148 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 +PDE6G 5148 RETINITIS PIGMENTOSA 57 OMIM:613582 marker/mechanism 613582.0 +PDE6H 5149 Color Vision Defects MESH:D003117 marker/mechanism 25739440 +PDE6H 5149 Retinal Cone Dystrophy 3A MESH:C566483 marker/mechanism 610024.0 +PDE8B 8622 Adrenal Hyperplasia, Congenital MESH:D000312 marker/mechanism 18272904 +PDE8B 8622 Basal Ganglia Diseases MESH:D001480 marker/mechanism 20085714 +PDE8B 8622 Dysarthria MESH:D004401 marker/mechanism 20085714 +PDE8B 8622 Muscle Rigidity MESH:D009127 marker/mechanism 20085714 +PDE8B 8622 Neurodegenerative Diseases MESH:D019636 marker/mechanism 20085714 +PDE8B 8622 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3 OMIM:614190 marker/mechanism 614190.0 +PDE8B 8622 Striatal Degeneration, Autosomal Dominant MESH:C563783 marker/mechanism 609161.0 +PDGFA 5154 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +PDGFA 5154 Bone Diseases, Endocrine MESH:D001849 marker/mechanism 18635661 +PDGFA 5154 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +PDGFA 5154 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +PDGFA 5154 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PDGFA 5154 Lung Diseases MESH:D008171 marker/mechanism 20920717 +PDGFA 5154 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942 +PDGFA 5154 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +PDGFA 5154 Mesothelioma MESH:D008654 marker/mechanism 11415934 +PDGFA 5154 Pulmonary Fibrosis MESH:D011658 marker/mechanism 16324872 +PDGFA 5154 Thrombocythemia, Essential MESH:D013920 marker/mechanism 15682418 +PDGFA 5154 Thyroid Neoplasms MESH:D013964 marker/mechanism 26037280 +PDGFB 5155 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5 OMIM:615483 marker/mechanism 615483.0 +PDGFB 5155 Basal Ganglia Diseases MESH:D001480 marker/mechanism 25938945 +PDGFB 5155 Calcinosis MESH:D002114 marker/mechanism 25938945 +PDGFB 5155 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 20506153 +PDGFB 5155 Dermatofibrosarcoma MESH:D018223 marker/mechanism 607907.0 +PDGFB 5155 Fahr's disease MESH:C536275 marker/mechanism 213600.0 23913003 +PDGFB 5155 Fibrosis MESH:D005355 marker/mechanism 22004089 +PDGFB 5155 Gingival Hyperplasia MESH:D005885 marker/mechanism 8708960 +PDGFB 5155 Meningioma, familial MESH:C537443 marker/mechanism 607174.0 +PDGFB 5155 Pulmonary Fibrosis MESH:D011658 marker/mechanism 15286697 +PDGFB 5155 Retinal Diseases MESH:D012164 therapeutic 11840346 +PDGFB 5155 Thrombocythemia, Essential MESH:D013920 marker/mechanism 15682418 +PDGFC 56034 Mesothelioma MESH:D008654 marker/mechanism 15920167 +PDGFD 80310 Coronary Artery Disease MESH:D003324 marker/mechanism 21378988|34961328 +PDGFD 80310 Fibrosis MESH:D005355 marker/mechanism 25280005 +PDGFD 80310 Lung Injury MESH:D055370 marker/mechanism 25280005 +PDGFRA 5156 Chondrosarcoma, Mesenchymal MESH:D018211 marker/mechanism 12817616 +PDGFRA 5156 Cleft Palate MESH:D002972 marker/mechanism 18264099 +PDGFRA 5156 Craniofacial Abnormalities MESH:D019465 marker/mechanism 11023856 +PDGFRA 5156 Fetal Death MESH:D005313 marker/mechanism 11023856 +PDGFRA 5156 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 20028860 +PDGFRA 5156 Heart Failure MESH:D006333 marker/mechanism 28347583 +PDGFRA 5156 Hypereosinophilic Syndrome MESH:D017681 marker/mechanism 607685.0 16778211|28347583|31036733 +PDGFRA 5156 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PDGFRA 5156 Lung Diseases MESH:D008171 marker/mechanism 20920717 +PDGFRA 5156 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +PDGFRA 5156 Respiratory System Abnormalities MESH:D015619 marker/mechanism 11023856 +PDGFRA 5156 Spinal Dysraphism MESH:D016135 marker/mechanism 11023856 +PDGFRB 5159 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4 OMIM:615007 marker/mechanism 615007.0 +PDGFRB 5159 Basal Ganglia Diseases MESH:D001480 marker/mechanism 25938945 +PDGFRB 5159 Calcinosis MESH:D002114 marker/mechanism 25938945 +PDGFRB 5159 Fahr's disease MESH:C536275 marker/mechanism 213600.0 +PDGFRB 5159 Fibromatosis, Congenital Generalized MESH:C562978 marker/mechanism 228550.0 +PDGFRB 5159 KOSAKI OVERGROWTH SYNDROME OMIM:616592 marker/mechanism 616592.0 +PDGFRB 5159 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15623374|18466260 +PDGFRB 5159 Myeloproliferative Disorder, Chronic, with Eosinophilia MESH:C565054 marker/mechanism 131440.0 +PDGFRB 5159 Penttinen-Aula syndrome MESH:C536653 marker/mechanism 601812.0 +PDGFRL 5157 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 114550.0 +PDGFRL 5157 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +PDHA1 5160 Acidosis, Lactic MESH:D000140 marker/mechanism 2537010 +PDHA1 5160 Disease Progression MESH:D018450 marker/mechanism 21364753 +PDHA1 5160 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PDHA1 5160 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +PDHA1 5160 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881|29335542 +PDHA1 5160 Pyruvate Dehydrogenase Complex Deficiency Disease MESH:D015325 marker/mechanism 312170.0 2378353 +PDHA1 5160 Pyruvate Metabolism, Inborn Errors MESH:D015323 marker/mechanism 2378353 +PDHA1 5160 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PDHB 5162 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25401301 +PDHB 5162 Pyruvate Dehydrogenase Complex Deficiency Disease MESH:D015325 marker/mechanism 15138885 +PDHB 5162 Pyruvate Dehydrogenase E1-Beta Deficiency MESH:C566729 marker/mechanism 614111.0 +PDHX 8050 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +PDHX 8050 Pyruvate Dehydrogenase E3-Binding Protein Deficiency MESH:C565447 marker/mechanism 245349.0 +PDIA3 2923 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +PDIA3 2923 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +PDIA3 2923 Neoplasms MESH:D009369 therapeutic 17353921 +PDIA3 2923 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973 +PDIA3 2923 Spinocerebellar Ataxia 17 MESH:C564616 marker/mechanism 24413982 +PDK2 5164 Cardiomyopathies MESH:D009202 marker/mechanism 21037199 +PDK4 5166 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28003426 +PDK4 5166 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism|therapeutic 21182459|31809757 +PDK4 5166 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14563825 +PDK4 5166 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PDK4 5166 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29289645 +PDLIM4 8572 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +PDLIM4 8572 Osteoporosis MESH:D010024 marker/mechanism 166710.0 +PDLIM4 8572 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PDLIM5 10611 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +PDLIM5 10611 Crohn Disease MESH:D003424 marker/mechanism 36038634 +PDLIM5 10611 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PDP1 54704 Prostatic Neoplasms MESH:D011471 marker/mechanism 29335542 +PDP1 54704 Pyruvate dehydrogenase phosphatase deficiency MESH:C536258 marker/mechanism 608782.0 +PDPK1 5170 Breast Neoplasms MESH:D001943 marker/mechanism 24739482 +PDPK1 5170 Heart Failure MESH:D006333 marker/mechanism 19429709 +PDPK1 5170 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21173233 +PDPN 10630 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 22784439 +PDPN 10630 Peritoneal Neoplasms MESH:D010534 marker/mechanism 22784439 +PDRG1 81572 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +PDS5A 23244 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +PDSS1 23590 COENZYME Q10 DEFICIENCY, PRIMARY, 2 OMIM:614651 marker/mechanism 614651.0 +PDSS2 57107 COENZYME Q10 DEFICIENCY, PRIMARY, 3 OMIM:614652 marker/mechanism 614652.0 +PDX1 3651 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +PDX1 3651 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 16123366|24464100 +PDX1 3651 Maturity-Onset Diabetes of the Young, Type 4 MESH:C563451 marker/mechanism 606392.0 21115832 +PDX1 3651 Pancreatic Agenesis, Congenital MESH:C564908 marker/mechanism 260370.0 22158542 +PDX1 3651 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19077462|25086665|26098869 +PDXDC1 23042 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25401301 +PDXK 8566 Status Epilepticus MESH:D013226 marker/mechanism 19356691 +PDYN 5173 Alcoholism MESH:D000437 marker/mechanism 17559549|18923396 +PDYN 5173 Amnesia MESH:D000647 therapeutic 7768285 +PDYN 5173 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 16529859 +PDYN 5173 Bradycardia MESH:D001919 marker/mechanism 1676337|6131355|6716269 +PDYN 5173 Cholestasis MESH:D002779 marker/mechanism 16919318 +PDYN 5173 Cocaine-Related Disorders MESH:D019970 marker/mechanism 16184603|17559549|18575850|18923396 +PDYN 5173 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism 21737418|9767399 +PDYN 5173 Dyskinesias MESH:D020820 marker/mechanism 21984936 +PDYN 5173 Hyperalgesia MESH:D006930 marker/mechanism 17670969 +PDYN 5173 Hypercapnia MESH:D006935 marker/mechanism 11311734 +PDYN 5173 Hypotension MESH:D007022 marker/mechanism 1676337|2536002|2566129|6131355 +PDYN 5173 Hypoxia MESH:D000860 marker/mechanism 11311734 +PDYN 5173 Movement Disorders MESH:D009069 marker/mechanism 20298714 +PDYN 5173 Pain MESH:D010146 marker/mechanism 17670969|20068450 +PDYN 5173 Parkinsonian Disorders MESH:D020734 marker/mechanism 9930741 +PDYN 5173 Pruritus MESH:D011537 marker/mechanism 29669290 +PDYN 5173 Respiration Disorders MESH:D012120 marker/mechanism 6131355 +PDYN 5173 Respiratory Insufficiency MESH:D012131 therapeutic 6662192 +PDYN 5173 Seizures MESH:D012640 therapeutic 1675896 +PDYN 5173 Sensation Disorders MESH:D012678 marker/mechanism 19200067 +PDYN 5173 Spinocerebellar ataxia 23 MESH:C537201 marker/mechanism 610245.0 +PDZD7 79955 Usher syndrome, type 2A MESH:C536490 marker/mechanism 276901.0 +PDZD7 79955 Usher syndrome, type 2C MESH:C536492 marker/mechanism 605472.0 +PDZK1 5174 Breast Neoplasms MESH:D001943 marker/mechanism 25751625 +PDZK1 5174 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +PDZK1 5174 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PDZK1 5174 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +PDZK1IP1 10158 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PDZRN3 23024 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PDZRN4 29951 Silicosis MESH:D012829 marker/mechanism 24986923 +PEA15A 18611 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PEBP1 5037 Carcinoma MESH:D002277 marker/mechanism 12376462 +PEBP1 5037 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25329396 +PEBP1 5037 Heart Failure MESH:D006333 marker/mechanism 26670611 +PEBP1 5037 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +PEBP1 5037 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +PEBP1 5037 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PEBP1 5037 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +PECAM1 5175 Autistic Disorder MESH:D001321 marker/mechanism 17509538 +PECAM1 5175 Autoimmune Diseases MESH:D001327 marker/mechanism 10848805 +PECAM1 5175 Coronary Artery Disease MESH:D003324 marker/mechanism 28530674 +PECAM1 5175 Thrombocytopenia MESH:D013921 marker/mechanism 10848805 +PECR 55825 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +PEG3 5178 Cholangiocarcinoma MESH:D018281 marker/mechanism 22561520 +PEG3 5178 Liver Diseases, Parasitic MESH:D008109 marker/mechanism 22561520 +PELI1 57162 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +PELI1 57162 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +PELI1 57162 Skin Diseases MESH:D012871 marker/mechanism 16835338 +PEMT 10400 Liver Cirrhosis MESH:D008103 marker/mechanism 29416063 +PEMT 10400 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29416063 +PENK 5179 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +PENK 5179 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism 9767399 +PENK 5179 Narcolepsy MESH:D009290 marker/mechanism 17521418 +PENK 5179 Nervous System Diseases MESH:D009422 therapeutic 12030189 +PENK 5179 Opioid-Related Disorders MESH:D009293 marker/mechanism 10321497 +PENK 5179 Pain MESH:D010146 therapeutic 15833551 +PENK 5179 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +PEPD 5184 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22158537 +PEPD 5184 Hepatomegaly MESH:D006529 marker/mechanism 16470701 +PEPD 5184 Infections MESH:D007239 marker/mechanism 16470701 +PEPD 5184 Organophosphate Poisoning MESH:D062025 therapeutic 22982776 +PEPD 5184 Prolidase Deficiency MESH:D056732 marker/mechanism 170100.0 16470701|1972707 +PEPD 5184 Respiratory Tract Diseases MESH:D012140 marker/mechanism 16470701 +PEPD 5184 Skin Ulcer MESH:D012883 marker/mechanism 16470701 +PEPD 5184 Splenomegaly MESH:D013163 marker/mechanism 16470701 +PER1 5187 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +PER1 5187 Autistic Disorder MESH:D001321 marker/mechanism 17264841 +PER1 5187 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 16999817 +PER1 5187 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 20738730 +PER2 8864 Advanced Sleep-Phase Syndrome, Familial MESH:C565789 marker/mechanism 604348.0 +PER2 8864 Alcoholic Intoxication MESH:D000435 marker/mechanism 15608650 +PER2 8864 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 16999817 +PER2 8864 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 20434889|20738730 +PER3 8863 Advanced Sleep-Phase Syndrome, Familial MESH:C565789 marker/mechanism 616882.0 +PER3 8863 Breast Neoplasms MESH:D001943 marker/mechanism 20625127 +PER3 8863 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 16999817 +PER3 8863 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 20738730 +PES1 23481 Cholangiocarcinoma MESH:D018281 marker/mechanism 34845814 +PEX1 5189 Deafness enamel hypoplasia nail defects MESH:C535994 marker/mechanism 234580.0 +PEX1 5189 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 9398847|9398848|9539740 +PEX1 5189 Refsum Disease, Infantile MESH:D052919 marker/mechanism 601539.0 +PEX1 5189 Zellweger Syndrome MESH:D015211 marker/mechanism 214100.0 10447258|26319495|9539740 +PEX10 5192 PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER) OMIM:614870 marker/mechanism 614870.0 +PEX10 5192 PEROXISOME BIOGENESIS DISORDER 6B OMIM:614871 marker/mechanism 614871.0 +PEX10 5192 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 10862081|9683594|9700193 +PEX10 5192 Zellweger Syndrome MESH:D015211 marker/mechanism 10862081|26319495|9683594|9700193 +PEX11A 8800 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +PEX11A 8800 Dyslipidemias MESH:D050171 marker/mechanism 30585412 +PEX11A 8800 Obesity MESH:D009765 marker/mechanism 30585412 +PEX11B 8799 PEROXISOME BIOGENESIS DISORDER 14B OMIM:614920 marker/mechanism 614920.0 +PEX12 5193 PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER) OMIM:614859 marker/mechanism 614859.0 +PEX12 5193 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 266510.0 9090384 +PEX12 5193 Zellweger Syndrome MESH:D015211 marker/mechanism 26319495|9090384 +PEX13 5194 Adrenoleukodystrophy MESH:D000326 marker/mechanism 10441568 +PEX13 5194 PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER) OMIM:614883 marker/mechanism 614883.0 +PEX13 5194 PEROXISOME BIOGENESIS DISORDER 11B OMIM:614885 marker/mechanism 614885.0 +PEX13 5194 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 10332040|10441568|19449432 +PEX13 5194 Zellweger Syndrome MESH:D015211 marker/mechanism 10332040|19449432 +PEX14 5195 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +PEX14 5195 PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER) OMIM:614887 marker/mechanism 614887.0 +PEX14 5195 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 15146459|18285423|20647552 +PEX14 5195 Zellweger Syndrome MESH:D015211 marker/mechanism 15146459|18285423 +PEX16 9409 PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER) OMIM:614876 marker/mechanism 614876.0 +PEX16 9409 PEROXISOME BIOGENESIS DISORDER 8B OMIM:614877 marker/mechanism 614877.0 +PEX16 9409 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 11890679|12223482 +PEX16 9409 Zellweger Syndrome MESH:D015211 marker/mechanism 11890679 +PEX19 5824 PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER) OMIM:614886 marker/mechanism 614886.0 +PEX19 5824 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 20683989 +PEX19 5824 Zellweger Syndrome MESH:D015211 marker/mechanism 10051604 +PEX2 5828 PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER) OMIM:614866 marker/mechanism 614866.0 +PEX2 5828 PEROXISOME BIOGENESIS DISORDER 5B OMIM:614867 marker/mechanism 614867.0 +PEX2 5828 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 10528859|1546315 +PEX2 5828 Refsum Disease, Infantile MESH:D052919 marker/mechanism 10528859 +PEX2 5828 Zellweger Syndrome MESH:D015211 marker/mechanism 1546315 +PEX26 55670 Adrenoleukodystrophy MESH:D000326 marker/mechanism 12851857 +PEX26 55670 PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER) OMIM:614872 marker/mechanism 614872.0 +PEX26 55670 PEROXISOME BIOGENESIS DISORDER 7B OMIM:614873 marker/mechanism 614873.0 +PEX26 55670 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 12851857 +PEX26 55670 Refsum Disease, Infantile MESH:D052919 marker/mechanism 12851857 +PEX26 55670 Zellweger Syndrome MESH:D015211 marker/mechanism 12851857|26319495 +PEX3 8504 PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER) OMIM:614882 marker/mechanism 614882.0 +PEX3 8504 PEROXISOME BIOGENESIS DISORDER 10B OMIM:617370 marker/mechanism 617370.0 +PEX3 8504 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 10942428 +PEX3 8504 Zellweger Syndrome MESH:D015211 marker/mechanism 10942428 +PEX5 5830 PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER) OMIM:214110 marker/mechanism 214110.0 +PEX5 5830 PEROXISOME BIOGENESIS DISORDER 2B OMIM:202370 marker/mechanism 202370.0 +PEX5 5830 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5 OMIM:616716 marker/mechanism 616716.0 +PEX6 5190 Deafness enamel hypoplasia nail defects MESH:C535994 marker/mechanism 616617.0 +PEX6 5190 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +PEX6 5190 PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER) OMIM:614862 marker/mechanism 614862.0 +PEX6 5190 PEROXISOME BIOGENESIS DISORDER 4B OMIM:614863 marker/mechanism 614863.0 +PEX6 5190 Peroxisome biogenesis disorders MESH:C536664 marker/mechanism 10408779|8940266 +PEX6 5190 Zellweger Syndrome MESH:D015211 marker/mechanism 10408779|8940266 +PEX7 5191 Chondrodysplasia Punctata, Rhizomelic MESH:D018902 marker/mechanism 9090381 +PEX7 5191 PEROXISOME BIOGENESIS DISORDER 9B OMIM:614879 marker/mechanism 614879.0 +PEX7 5191 Refsum Disease MESH:D012035 marker/mechanism 266500.0 12522768 +PEX7 5191 Rhizomelic chondrodysplasia punctata, type 1 MESH:C531651 marker/mechanism 215100.0 11781871|12522768 +PF4 5196 Autoimmune Diseases MESH:D001327 marker/mechanism 20162249 +PF4 5196 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +PF4 5196 Pneumonia MESH:D011014 marker/mechanism 21625544 +PF4 5196 Thrombocytopenia MESH:D013921 marker/mechanism 10381515|11588041|15795722|20162249|8282825|9158107|9446652 +PF4 5196 Thrombosis MESH:D013927 marker/mechanism 11588041|15795722|8282825|9446652 +PFKFB3 5209 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +PFKFB3 5209 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PFKFB3 5209 Obesity MESH:D009765 marker/mechanism 20882379 +PFKFB3 5209 Skin Diseases MESH:D012871 marker/mechanism 16835338 +PFKM 5213 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14563825 +PFKM 5213 Glycogen Storage Disease Type IV MESH:D006011 marker/mechanism 30792690 +PFKM 5213 Glycogen Storage Disease Type VII MESH:D006014 marker/mechanism 232800.0 2140573|8444874 +PFKM 5213 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PFKP 5214 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PFN1 5216 AMYOTROPHIC LATERAL SCLEROSIS 18 OMIM:614808 marker/mechanism 614808.0 +PFN1 5216 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +PFN1 5216 Keloid MESH:D007627 marker/mechanism 20128793 +PFN1 5216 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PGA5 5222 Esophagitis MESH:D004941 marker/mechanism 12928072 +PGAM1 5223 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +PGAM1 5223 Carcinoma MESH:D002277 marker/mechanism 16316942 +PGAM1 5223 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17094902 +PGAM1 5223 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +PGAM1 5223 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +PGAM1 5223 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +PGAM1 5223 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +PGAM1 5223 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +PGAM2 5224 Dimauro disease MESH:C536176 marker/mechanism 261670.0 +PGAM2 5224 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PGAP1 80055 NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FEATURES, SPASTICITY, AND BRAIN ABNORMALITIES OMIM:615802 marker/mechanism 615802.0 +PGAP2 27315 HYPERPHOSPHATASIA WITH IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 3 OMIM:614207 marker/mechanism 614207.0 +PGAP3 93210 Hyperphosphatasia with Mental Retardation MESH:C565495 marker/mechanism 615716.0 +PGBD1 84547 Schizophrenia MESH:D012559 marker/mechanism 22037552 +PGBD5 79605 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 28504702 +PGBD5 79605 Rhabdoid Tumor MESH:D018335 marker/mechanism 28504702 +PGD 5226 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +PGF 5228 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +PGGT1B 5229 Lung Neoplasms MESH:D008175 therapeutic 22028818 +PGK1 5230 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +PGK1 5230 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +PGK1 5230 Phosphoglycerate Kinase 1 Deficiency MESH:C567067 marker/mechanism 300653.0 +PGLS 25796 Osteoporosis MESH:D010024 marker/mechanism 18924182 +PGLYRP1 8993 Brain Injuries MESH:D001930 marker/mechanism 21549006 +PGM1 5236 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +PGM1 5236 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +PGM1 5236 Glycogen Storage Disease XIV MESH:C567859 marker/mechanism 614921.0 +PGM1 5236 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PGM3 5238 IMMUNODEFICIENCY 23 OMIM:615816 marker/mechanism 615816.0 +PGM5 5239 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +PGR 5241 Adenocarcinoma MESH:D000230 marker/mechanism 15639718 +PGR 5241 Breast Neoplasms MESH:D001943 marker/mechanism 19436038|21501481 +PGR 5241 Carcinoma MESH:D002277 marker/mechanism 15637090 +PGR 5241 Endometrial Neoplasms MESH:D016889 marker/mechanism 23200943 +PGR 5241 Endometriosis MESH:D004715 marker/mechanism 20864642|21232532 +PGR 5241 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 15637090 +PGR 5241 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 15637090 +PGR 5241 Meningioma MESH:D008579 marker/mechanism 19731987|19747051|8008172 +PGR 5241 Mesothelioma MESH:D008654 marker/mechanism 15639718 +PGR 5241 Progesterone Resistance MESH:C564871 marker/mechanism 264080.0 +PGR 5241 Recurrence MESH:D012008 marker/mechanism 19747051 +PGRMC1 10857 Alzheimer Disease MESH:D000544 marker/mechanism 25390692 +PGRMC1 10857 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +PHACTR1 221692 Cerebrovascular Trauma MESH:D020214 marker/mechanism 25420145 +PHACTR1 221692 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990|22751097|26098115|34961328 +PHACTR1 221692 Migraine without Aura MESH:D020326 marker/mechanism 22683712 +PHACTR1 221692 Myocardial Infarction MESH:D009203 marker/mechanism 19198609|26098115 +PHB1 5245 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +PHB1 5245 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +PHB1 5245 Carcinoma MESH:D002277 marker/mechanism 12376462 +PHB1 5245 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +PHB1 5245 Disease Progression MESH:D018450 marker/mechanism 21364753 +PHB1 5245 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +PHB1 5245 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +PHB1 5245 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +PHB1 5245 Precancerous Conditions MESH:D011230 marker/mechanism 15986332 +PHB1 5245 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 18504422 +PHB1 5245 Schizophrenia MESH:D012559 marker/mechanism 18504422 +PHB1 5245 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696|21364753 +PHC1 1911 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE OMIM:615414 marker/mechanism 615414.0 +PHC1 1911 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 16168501 +PHETA1 144717 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +PHEX 5251 Craniofacial Abnormalities MESH:D019465 marker/mechanism 1962291 +PHEX 5251 Familial Hypophosphatemic Rickets MESH:D053098 marker/mechanism 307800.0 11414762|18775977|3414685|9430241 +PHEX 5251 Nephrocalcinosis MESH:D009397 marker/mechanism 9430241 +PHF2 5253 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +PHF21A 51317 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +PHF6 84295 Borjeson-Forssman-Lehmann syndrome MESH:C536575 marker/mechanism 301900.0 +PHF6 84295 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 20228800 +PHF8 23133 Siderius X-linked mental retardation syndrome MESH:C537333 marker/mechanism 300263.0 +PHGDH 26227 Breast Neoplasms MESH:D001943 marker/mechanism 21804546 +PHGDH 26227 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 26482881 +PHGDH 26227 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21804546 +PHGDH 26227 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +PHGDH 26227 Melanoma MESH:D008545 marker/mechanism 21804546 +PHGDH 26227 Neu Laxova syndrome MESH:C536405 marker/mechanism 256520.0 +PHGDH 26227 Phosphoglycerate Dehydrogenase Deficiency MESH:C566618 marker/mechanism 601815.0 +PHGDH 26227 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PHIP 55023 Intellectual Disability MESH:D008607 marker/mechanism 28191889 +PHIP 55023 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097067 +PHKA1 5255 Glycogen Storage Disease, Type IXD MESH:C564485 marker/mechanism 300559.0 +PHKA2 5256 Glycogen Storage Disease MESH:D006008 marker/mechanism 7711737 +PHKA2 5256 GLYCOGEN STORAGE DISEASE IXa1 OMIM:306000 marker/mechanism 306000.0 +PHKB 5257 Glycogen Storage Disease IXB MESH:C563008 marker/mechanism 261750.0 +PHKG1P2 644032 Skin Diseases MESH:D012871 marker/mechanism 28720099 +PHKG2 5261 Glycogen Storage Disease IXC MESH:C567809 marker/mechanism 613027.0 +PHLDA1 22822 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +PHLDA1 22822 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PHLDA1 22822 Cognition Disorders MESH:D003072 marker/mechanism 36155068 +PHLDA1 22822 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +PHLDA2 7262 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427 +PHLDA2 7262 Osteosarcoma MESH:D012516 therapeutic 22021909 +PHLDA3 23612 Myocardial Infarction MESH:D009203 marker/mechanism 34351043 +PHLDA3 23612 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 34351043 +PHLDB1 23187 Glioma MESH:D005910 marker/mechanism 19578367 +PHLDB2 90102 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +PHLPP 35178 Tobacco Use Disorder MESH:D014029 marker/mechanism 18438686 +PHLPP1 23239 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21750348 +PHOSPHO1 162466 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 26773408 +PHOX2A 401 Fibrosis Of Extraocular Muscles, Congenital, 2 MESH:C566587 marker/mechanism 602078.0 +PHOX2B 8929 Congenital central hypoventilation syndrome MESH:C536209 marker/mechanism 209880.0 12640453|14608649 +PHOX2B 8929 Crohn Disease MESH:D003424 marker/mechanism 17435756 +PHOX2B 8929 Neuroblastoma MESH:D009447 marker/mechanism 613013.0 25174395|30127528 +PHRF1 57661 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 18204446 +PHYH 5264 Refsum Disease MESH:D012035 marker/mechanism 266500.0 12522768 +PI3 5266 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +PI4KB 5298 Coronavirus Infections MESH:D018352 marker/mechanism 22253445 +PI4KB 5298 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 22253445 +PIAS1 8554 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +PIAS1 8554 Skin Diseases MESH:D012871 marker/mechanism 16835338 +PIAS3 10401 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 25061499 +PIBF1 10464 Abortion, Threatened MESH:D000033 marker/mechanism 15760377 +PICALM 8301 Alzheimer Disease MESH:D000544 marker/mechanism 19734902|21460841 +PICALM 8301 Cognitive Dysfunction MESH:D060825 marker/mechanism 30503753 +PICALM 8301 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +PICK1 9463 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 17606663 +PICK1 9463 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 17606663 +PIDD1 55367 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 20208132 +PIEZO1 9780 Dehydrated Hereditary Stomatocytosis, Pseudohyperkalemia, and Perinatal Edema MESH:C566369 marker/mechanism 194380.0 +PIEZO1 9780 LYMPHATIC MALFORMATION 6 OMIM:616843 marker/mechanism 616843.0 +PIEZO2 63895 ARTHROGRYPOSIS, DISTAL, TYPE 3 OMIM:114300 marker/mechanism 114300.0 +PIEZO2 63895 ARTHROGRYPOSIS, DISTAL, TYPE 5 OMIM:108145 marker/mechanism 108145.0 +PIEZO2 63895 ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH OMIM:617146 marker/mechanism 617146.0 +PIEZO2 63895 Marden-Walker syndrome MESH:C535910 marker/mechanism 248700.0 +PIGA 5277 Hemoglobinuria, Paroxysmal MESH:D006457 marker/mechanism 300818.0 15720958|16767100 +PIGA 5277 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2 OMIM:300868 marker/mechanism 300868.0 +PIGA 5277 Occupational Diseases MESH:D009784 marker/mechanism 37271276 +PIGG 54872 NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPOTONIA, SEIZURES, AND CEREBELLAR ATROPHY OMIM:616917 marker/mechanism 616917.0 +PIGL 9487 Zunich neuroectodermal syndrome MESH:C536729 marker/mechanism 280000.0 +PIGM 93183 GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1 OMIM:610293 marker/mechanism 610293.0 +PIGM 93183 Seizures MESH:D012640 marker/mechanism 16767100 +PIGM 93183 Venous Thrombosis MESH:D020246 marker/mechanism 16767100 +PIGN 23556 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +PIGN 23556 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +PIGN 23556 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1 OMIM:614080 marker/mechanism 614080.0 +PIGO 84720 Hyperphosphatasia with Mental Retardation MESH:C565495 marker/mechanism 614749.0 +PIGP 51227 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +PIGR 5284 Stomach Neoplasms MESH:D013274 marker/mechanism 36914835 +PIGT 51604 Hemoglobinuria, Paroxysmal MESH:D006457 marker/mechanism 615399.0 25417052 +PIGT 51604 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3 OMIM:615398 marker/mechanism 615398.0 +PIGV 55650 Hyperphosphatasia with Mental Retardation MESH:C565495 marker/mechanism 239300.0 20802478 +PIGW 284098 Hyperphosphatasia with Mental Retardation MESH:C565495 marker/mechanism 616025.0 +PIGW-1 190940 Infertility MESH:D007246 marker/mechanism 25204677 +PIGY 84992 Hyperphosphatasia with Mental Retardation MESH:C565495 marker/mechanism 616809.0 +PIK3C2B 5287 Neoplasm Metastasis MESH:D009362 marker/mechanism 21986133 +PIK3CA 5290 Adenocarcinoma MESH:D000230 marker/mechanism 22484628 +PIK3CA 5290 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 23525077 +PIK3CA 5290 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 22135231 +PIK3CA 5290 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 19196980|19685490|20479250|21633166|22370636|25267515|25358515|26587011 +PIK3CA 5290 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +PIK3CA 5290 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +PIK3CA 5290 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 114550.0 +PIK3CA 5290 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +PIK3CA 5290 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 24224046 +PIK3CA 5290 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +PIK3CA 5290 Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi MESH:C567863 marker/mechanism 612918.0 +PIK3CA 5290 COWDEN SYNDROME 5 OMIM:615108 marker/mechanism 615108.0 +PIK3CA 5290 Disease Progression MESH:D018450 marker/mechanism 29106415 +PIK3CA 5290 Epidermal Nevus MESH:C580062 marker/mechanism 162900.0 +PIK3CA 5290 Growth Disorders MESH:D006130 marker/mechanism 22729222 +PIK3CA 5290 Hyperplasia MESH:D006965 marker/mechanism 22729222 +PIK3CA 5290 Keratosis, Seborrheic MESH:D017492 marker/mechanism 182000.0 +PIK3CA 5290 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 +PIK3CA 5290 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21173233 +PIK3CA 5290 Malformations of Cortical Development MESH:D054220 marker/mechanism 22729223 +PIK3CA 5290 Megalancephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome MESH:C566381 marker/mechanism 22729224 +PIK3CA 5290 Mouth Neoplasms MESH:D009062 marker/mechanism 24224046 +PIK3CA 5290 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +PIK3CA 5290 Neoplasm Metastasis MESH:D009362 marker/mechanism 29106415 +PIK3CA 5290 Ovarian Neoplasms MESH:D010051 marker/mechanism 167000.0 +PIK3CA 5290 Penile Neoplasms MESH:D010412 marker/mechanism 18355852 +PIK3CA 5290 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881|29610475 +PIK3CA 5290 Sarcoma MESH:D012509 marker/mechanism 20601955 +PIK3CA 5290 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 23873848 +PIK3CA 5290 Stomach Neoplasms MESH:D013274 marker/mechanism 613659.0 22484628 +PIK3CA 5290 Ventricular Dysfunction, Left MESH:D018487 therapeutic 31025080 +PIK3CA 5290 Weight Gain MESH:D015430 marker/mechanism 19030233 +PIK3CB 5291 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21173233 +PIK3CB 5291 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +PIK3CB 5291 Schizophrenia MESH:D012559 marker/mechanism 21743468 +PIK3CD 5293 IMMUNODEFICIENCY 14A WITH LYMPHOPROLIFERATION, AUTOSOMAL DOMINANT OMIM:615513 marker/mechanism 615513.0 +PIK3CD 5293 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21173233 +PIK3CD 5293 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 23676220 +PIK3CD 5293 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +PIK3CD 5293 Roifman-Chitayat Syndrome MESH:C567641 marker/mechanism 613328.0 +PIK3CG 5294 Autistic Disorder MESH:D001321 marker/mechanism 14627686 +PIK3CG 5294 Cardiomegaly MESH:D006332 marker/mechanism 12963636 +PIK3CG 5294 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 31626838 +PIK3CG 5294 Fibrosis MESH:D005355 marker/mechanism 12963636 +PIK3CG 5294 Heart Failure MESH:D006333 marker/mechanism 12963636 +PIK3CG 5294 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 21173233 +PIK3CG 5294 Medulloblastoma MESH:D008527 marker/mechanism 21652733 +PIK3IP1 113791 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +PIK3R1 5295 AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE OMIM:615214 marker/mechanism 615214.0 +PIK3R1 5295 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143597 +PIK3R1 5295 Carcinoma MESH:D002277 marker/mechanism 12606953 +PIK3R1 5295 Glucose Intolerance MESH:D018149 therapeutic 33567340 +PIK3R1 5295 IMMUNODEFICIENCY 36 WITH LYMPHOPROLIFERATION OMIM:616005 marker/mechanism 616005.0 +PIK3R1 5295 Insulin Resistance MESH:D007333 marker/mechanism 14714311 +PIK3R1 5295 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12606953 +PIK3R1 5295 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12606953 +PIK3R1 5295 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475|29662167|33129824 +PIK3R1 5295 SHORT syndrome MESH:C537327 marker/mechanism 269880.0 +PIK3R1 5295 Vitiligo MESH:D014820 marker/mechanism 28836394 +PIK3R2 5296 Megalancephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome MESH:C566381 marker/mechanism 603387.0 22729224 +PIK3R2 5296 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +PIK3R5 23533 ATAXIA-OCULOMOTOR APRAXIA 3 OMIM:615217 marker/mechanism 615217.0 +PIKFYVE 200576 Corneal Dystrophy, Fleck MESH:C563256 marker/mechanism 121850.0 +PILRA 29992 Alzheimer Disease MESH:D000544 marker/mechanism 33589840 +PIM1 5292 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +PIM1 5292 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23565217 +PIM1 5292 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +PIM1 5292 Disease Models, Animal MESH:D004195 marker/mechanism 25812446 +PIM1 5292 Glioblastoma MESH:D005909 marker/mechanism 23724780 +PIM1 5292 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 25812446 +PIM1 5292 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +PIM1 5292 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 23565217 +PIM1 5292 Pyelonephritis MESH:D011704 marker/mechanism 23565217 +PIM2 11040 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 19458359 +PIN1 5300 Breast Neoplasms MESH:D001943 marker/mechanism 19671742|19681904|32621833 +PIN1 5300 Disease Progression MESH:D018450 marker/mechanism 32621833 +PINK1 65018 Cognition Disorders MESH:D003072 marker/mechanism 36804394 +PINK1 65018 Nerve Degeneration MESH:D009410 marker/mechanism 24161480 +PINK1 65018 Neuroblastoma MESH:D009447 marker/mechanism 23334666 +PINK1 65018 Parkinson Disease MESH:D010300 marker/mechanism 17010972|21366594|22043175|24374061|25149416|30734931 +PINK1 65018 Parkinson Disease 6, Autosomal Recessive Early-Onset MESH:C565276 marker/mechanism 605909.0 19048950|21421046|24475098|27003823 +PINK1 65018 Parkinsonian Disorders MESH:D020734 marker/mechanism 11254447|15349871|23046578|24441527|24792327|26558463 +PINK1 65018 Reperfusion Injury MESH:D015427 marker/mechanism 35312153 +PIP 5304 Sinusitis MESH:D012852 marker/mechanism 18391768 +PIP4K2A 5305 Melanoma MESH:D008545 marker/mechanism 22535842 +PIP5K1A 8394 Lymphatic Metastasis MESH:D008207 marker/mechanism 34755307 +PIP5K1A 8394 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34755307 +PIP5K1A 8394 Neoplasms, Experimental MESH:D009374 marker/mechanism 34755307 +PIP5K1A 8394 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 34755307 +PIP5K1C 23396 Lethal Congenital Contractural Syndrome 3 MESH:C566961 marker/mechanism 611369.0 +PIPOX 51268 Peroxisomal Disorders MESH:D018901 marker/mechanism 10642506 +PIR 8544 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +PIRA2 18725 Lung Diseases MESH:D008171 marker/mechanism 21602193 +PITPNM1 9600 Schizophrenia MESH:D012559 marker/mechanism 21822266 +PITPNM3 83394 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PITPNM3 83394 Cone-Rod Dystrophy 5 MESH:C563415 marker/mechanism 600977.0 +PITRM1 10531 Tobacco Use Disorder MESH:D014029 marker/mechanism 29216386 +PITX1 5307 Autistic Disorder MESH:D001321 marker/mechanism 18053270 +PITX1 5307 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PITX1 5307 Clubfoot MESH:D003025 marker/mechanism 119800.0 +PITX1 5307 Synostosis, Carpal, with Dysplastic Elbow Joints and Brachydactyly MESH:C566090 marker/mechanism 186550.0 +PITX1 5307 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 23666240 +PITX2 5308 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +PITX2 5308 AXENFELD-RIEGER SYNDROME, TYPE 1 OMIM:180500 marker/mechanism 180500.0 10502778|10644443|14623826|14630904|15378534 +PITX2 5308 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10499585|14623826 +PITX2 5308 Heart Defects, Congenital MESH:D006330 marker/mechanism 10499585 +PITX2 5308 Iridogoniodysgenesis, dominant type MESH:C535536 marker/mechanism 137600.0 10502778 +PITX2 5308 Ring dermoid of cornea MESH:C535684 marker/mechanism 180550.0 +PITX2 5308 Stroke MESH:D020521 marker/mechanism 29531354 +PITX2 5308 Tooth Abnormalities MESH:D014071 marker/mechanism 10499585 +PITX3 5309 Anterior segment mesenchymal dysgenesis MESH:C537775 marker/mechanism 107250.0 18989383|9620774 +PITX3 5309 Cataract MESH:D002386 marker/mechanism 16565358|9620774 +PITX3 5309 Cataract, posterior polar, 4 MESH:C535344 marker/mechanism 610623.0 15286169 +PITX3 5309 Microphthalmos MESH:D008850 marker/mechanism 16565358 +PITX3 5309 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 27415467 +PITX3 5309 Neurologic Manifestations MESH:D009461 marker/mechanism 16565358 +PITX3 5309 Prostatic Neoplasms MESH:D011471 marker/mechanism 27415467 +PIWIL1 9271 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PIWIL2 55124 Celiac Disease MESH:D002446 marker/mechanism 30097691 +PIWIL3 440822 Oligospermia MESH:D009845 marker/mechanism 20940137 +PIWIL4 143689 Oligospermia MESH:D009845 marker/mechanism 20940137 +PJA1 64219 Craniofrontonasal dysplasia MESH:C536456 marker/mechanism 17941886 +PJVK 494513 Deafness MESH:D003638 marker/mechanism 17329413 +PJVK 494513 Deafness, Autosomal Recessive 59 MESH:C565698 marker/mechanism 610220.0 +PKD1 5310 Cysts MESH:D003560 marker/mechanism 21685914 +PKD1 5310 Disease Models, Animal MESH:D004195 marker/mechanism 25877301 +PKD1 5310 Polycystic Kidney, Autosomal Dominant MESH:D016891 marker/mechanism 12089381|19401297|25877301|28887310|7581371|8004675 +PKD1 5310 Polycystic Kidney Diseases MESH:D007690 marker/mechanism 173900.0 17932118|25877301|28887310 +PKD1L1 168507 HETEROTAXY, VISCERAL, 8, AUTOSOMAL OMIM:617205 marker/mechanism 617205.0 +PKD2 5311 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PKD2 5311 Neurodegenerative Diseases MESH:D019636 marker/mechanism 25013951 +PKD2 5311 Polycystic Kidney, Autosomal Dominant MESH:D016891 marker/mechanism 613095.0 12089381|15001556|24719335|25877301|28887310|30883612 +PKD2 5311 Retinal Diseases MESH:D012164 marker/mechanism 25013951 +PKD2 5311 Vascular Diseases MESH:D014652 marker/mechanism 25013951 +PKHD1 5314 Choledochal Cyst MESH:D015529 marker/mechanism 18988797 +PKHD1 5314 Polycystic Kidney, Autosomal Recessive MESH:D017044 marker/mechanism 263200.0 16133180|18988797|19524688|21685914 +PKLR 5313 Adenosine Triphosphate, Elevated, Of Erythrocytes MESH:C566310 marker/mechanism 102900.0 +PKLR 5313 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 20363216 +PKLR 5313 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PKLR 5313 Pyruvate Kinase Deficiency of Red Cells MESH:C564858 marker/mechanism 266200.0 +PKM 5315 Carcinoma MESH:D002277 marker/mechanism 16316942 +PKM 5315 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +PKM 5315 Lymphangioleiomyomatosis MESH:D018192 marker/mechanism 32078667 +PKM 5315 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +PKM 5315 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +PKM 5315 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980|15654357 +PKM 5315 Osteoporosis MESH:D010024 marker/mechanism 18924182 +PKMYT1 9088 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PKMYT1 9088 Melanoma MESH:D008545 marker/mechanism 22535842 +PKNOX2 63876 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +PKP1 5317 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +PKP1 5317 Ectodermal Dysplasia-Skin Fragility Syndrome MESH:C536183 marker/mechanism 604536.0 +PKP2 5318 Arrhythmogenic Right Ventricular Dysplasia, Familial, 9 MESH:C563808 marker/mechanism 609040.0 +PKP2 5318 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +PKP3 11187 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PLA2 406141 Cardiomyopathies MESH:D009202 marker/mechanism 10533957 +PLA2 406141 Necrosis MESH:D009336 marker/mechanism 10533957 +PLA2G12A 81579 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLA2G2A 5320 Atherosclerosis MESH:D050197 marker/mechanism 19237014 +PLA2G2A 5320 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +PLA2G2A 5320 Endometriosis MESH:D004715 marker/mechanism 25446850 +PLA2G2A 5320 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PLA2G2A 5320 Reperfusion Injury MESH:D015427 marker/mechanism 12967936 +PLA2G2D1 494318 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +PLA2G4A 5321 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 15816863 +PLA2G4A 5321 Asthma, Occupational MESH:D059366 marker/mechanism 27504716 +PLA2G4A 5321 Autistic Disorder MESH:D001321 marker/mechanism 15301788 +PLA2G4A 5321 Blood Platelet Disorders MESH:D001791 marker/mechanism 18451993 +PLA2G4A 5321 Breast Neoplasms MESH:D001943 marker/mechanism 21119660 +PLA2G4A 5321 Dermatitis MESH:D003872 marker/mechanism 18287786 +PLA2G4A 5321 Duodenal Ulcer MESH:D004381 marker/mechanism 18451993 +PLA2G4A 5321 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLA2G4A 5321 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 18451993 +PLA2G4A 5321 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 10881173 +PLA2G5 5322 Fleck Retina, Familial Benign MESH:C565564 marker/mechanism 228980.0 +PLA2G6 8398 NBIA2B MESH:C565699 marker/mechanism 610217.0 +PLA2G6 8398 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A OMIM:256600 marker/mechanism 256600.0 +PLA2G6 8398 Nevus MESH:D009506 marker/mechanism 19578365 +PLA2G6 8398 PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE OMIM:612953 marker/mechanism 612953.0 +PLA2G7 7941 Asthma MESH:D001249 marker/mechanism 10733466 +PLA2G7 7941 Coronary Disease MESH:D003327 marker/mechanism 21356620 +PLA2G7 7941 Hypersensitivity, Immediate MESH:D006969 marker/mechanism 10733466 +PLA2G7 7941 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 8675689 +PLA2G7 7941 Platelet-Activating Factor Acetylhydrolase Deficiency MESH:C566640 marker/mechanism 614278.0 +PLA2G7 7941 Stroke MESH:D020521 marker/mechanism 21356620 +PLA2R1 22925 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PLAA 9373 Inflammation MESH:D007249 marker/mechanism 11094054 +PLAC8 51316 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PLAC8 51316 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLAG1 5324 Lipoblastoma MESH:D062689 marker/mechanism 16308870 +PLAG1 5324 Salivary Gland Adenoma, Pleomorphic MESH:C563250 marker/mechanism 181030.0 +PLAGL1 5325 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +PLAT 5327 Acidosis, Lactic MESH:D000140 therapeutic 25331496 +PLAT 5327 Airway Obstruction MESH:D000402 therapeutic 25331496 +PLAT 5327 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 15659235 +PLAT 5327 Angioedema MESH:D000799 marker/mechanism 16184341|18453163|20547619 +PLAT 5327 Aphasia MESH:D001037 therapeutic 12690208 +PLAT 5327 Arterial Occlusive Diseases MESH:D001157 therapeutic 15557913 +PLAT 5327 Atherosclerosis MESH:D050197 therapeutic 12677255 +PLAT 5327 Back Pain MESH:D001416 marker/mechanism 12227717 +PLAT 5327 Bacteremia MESH:D016470 therapeutic 1430592 +PLAT 5327 Brain Edema MESH:D001929 therapeutic 29651748 +PLAT 5327 Brain Infarction MESH:D020520 therapeutic 16190367 +PLAT 5327 Brain Ischemia MESH:D002545 therapeutic 10572812|11108748|11940547|12221155|12511774|14986460|15017018|15087567|16126134|16763187|16809570|17086147|17525387|17903870|20123226|20212195|20488584|20536612|21037505|23876515|7477192|9259745|9400355|9479658|9566367|9633741 +PLAT 5327 Cardiac Tamponade MESH:D002305 marker/mechanism 9633741 +PLAT 5327 Cerebral Hemorrhage MESH:D002543 marker/mechanism 10501537|11113218|11940547|1430592|14630814|1579960|16126134|16190367|16908730|17690543|18346647|18369171|18753474|1899364|19095969|20212195|21088392|22436003|23876515|29651748|7477192|7723950|8969996|9836764 +PLAT 5327 Cerebral Infarction MESH:D002544 marker/mechanism|therapeutic 1579960|16148626|18195371|18544249|1899364|9183334 +PLAT 5327 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22507835 +PLAT 5327 Coronary Thrombosis MESH:D003328 therapeutic 1452937|15301905|8172379 +PLAT 5327 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +PLAT 5327 Embolism MESH:D004617 therapeutic 16148626 +PLAT 5327 Embolism and Thrombosis MESH:D016769 therapeutic 9684808 +PLAT 5327 Embolism, Cholesterol MESH:D017700 marker/mechanism 7939511 +PLAT 5327 Heart Failure MESH:D006333 marker/mechanism 22352330 +PLAT 5327 Hematoma, Epidural, Spinal MESH:D046748 marker/mechanism 10914357|12227717 +PLAT 5327 Hematoma, Subdural MESH:D006408 marker/mechanism 1899364 +PLAT 5327 Hemorrhage MESH:D006470 marker/mechanism 15016487|15502123|22507835|2514002|8082347|8427107|9199818|9266785 +PLAT 5327 Hypertension MESH:D006973 marker/mechanism 22352330 +PLAT 5327 Hypotension MESH:D007022 marker/mechanism 1492007 +PLAT 5327 Hypoxia MESH:D000860 therapeutic 25331496 +PLAT 5327 Infarction, Middle Cerebral Artery MESH:D020244 therapeutic 12297567|17690543|18453163|20547619|29651748 +PLAT 5327 Intracranial Embolism and Thrombosis MESH:D002542 therapeutic 7482654|8427107 +PLAT 5327 Intracranial Hemorrhages MESH:D020300 marker/mechanism 11320361|12230423|15017018|15215796|15557913|17612434|17687131|17903947|20123226|20536612|2104561|3168586|7902905|8961984 +PLAT 5327 Intracranial Thrombosis MESH:D020767 therapeutic 8678742 +PLAT 5327 Ischemic Stroke MESH:D000083242 therapeutic 12865603|15502123|19473668|19907167 +PLAT 5327 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLAT 5327 Low Back Pain MESH:D017116 therapeutic 7888893 +PLAT 5327 Meningoencephalitis MESH:D008590 therapeutic 1430592 +PLAT 5327 Myocardial Infarction MESH:D009203 therapeutic 10171637|10505926|10645301|10914357|11382373|11489769|12074692|12227717|12848087|1430592|1492007|15215796|15301905|18195371|1898952|1899364|1900011|19341228|20122609|2104561|2105625|2494454|2505604|2521976|3089627|3121335|7488445|7723950|7775709|7902905|8328192|8554022|8598594|9183334 +PLAT 5327 Nerve Degeneration MESH:D009410 marker/mechanism 19911010 +PLAT 5327 Neurologic Manifestations MESH:D009461 marker/mechanism|therapeutic 22436003|23876515|29651748 +PLAT 5327 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19442825 +PLAT 5327 Paresis MESH:D010291 therapeutic 12690208 +PLAT 5327 Pericardial Effusion MESH:D010490 marker/mechanism 9633741 +PLAT 5327 Pulmonary Embolism MESH:D011655 marker/mechanism|therapeutic 1899825|19415734|2123154|3105914|3122266|8082347|8451030|9199818|9266785 +PLAT 5327 Reperfusion Injury MESH:D015427 therapeutic 9472885 +PLAT 5327 Respiratory Insufficiency MESH:D012131 therapeutic 25331496 +PLAT 5327 Shock, Cardiogenic MESH:D012770 therapeutic 1430592 +PLAT 5327 Spinal Cord Compression MESH:D013117 marker/mechanism 12227717 +PLAT 5327 Stroke MESH:D020521 marker/mechanism|therapeutic 10171637|10346413|10436095|10572812|11061250|11108748|11113218|11239184|11739841|11940547|12221155|12230423|12384244|12511774|14581697|14657446|14986460|15016487|15017018|15087567|1598096|16126134|16184341|16763187|16809570|16908730|17086147|17525387|17612434|17903870|17903947|18346647|18369171|18560214|18753472|18753474|19286598|20123226|20212195|20488584|20536612|20705933|2124386|23876515|2514002|25245553|7477192|8427107|8598594|9056608|9259745|9400355|9472885|9479657|9479658|9566367|9633741|9707184|9836764|9933289 +PLAT 5327 Thromboembolism MESH:D013923 therapeutic 8451030 +PLAT 5327 Thrombosis MESH:D013927 marker/mechanism|therapeutic 12677255|19348381|2123154|22352330 +PLAT 5327 Vasospasm, Intracranial MESH:D020301 therapeutic 19057314|29651748 +PLAT 5327 Venous Thromboembolism MESH:D054556 marker/mechanism 16167916 +PLAT 5327 Venous Thrombosis MESH:D020246 therapeutic 11144008|15557913|19415734 +PLAT 5327 Ventricular Dysfunction, Left MESH:D018487 therapeutic 8763515 +PLAU 5328 Adenocarcinoma MESH:D000230 marker/mechanism 10467400 +PLAU 5328 Alzheimer Disease MESH:D000544 marker/mechanism 104300.0 +PLAU 5328 Angina Pectoris MESH:D000787 therapeutic 1730212 +PLAU 5328 Angina, Unstable MESH:D000789 therapeutic 2382605 +PLAU 5328 Anuria MESH:D001002 marker/mechanism 8225663 +PLAU 5328 Arterial Occlusive Diseases MESH:D001157 therapeutic 15557913|1713745|9181759|9731615 +PLAU 5328 Asthenozoospermia MESH:D053627 marker/mechanism 18998460 +PLAU 5328 Asthma MESH:D001249 marker/mechanism 21912604 +PLAU 5328 Bone Neoplasms MESH:D001859 marker/mechanism 16475674 +PLAU 5328 Brain Edema MESH:D001929 marker/mechanism 11677890 +PLAU 5328 Brain Ischemia MESH:D002545 therapeutic 10472989|10512912|17927297|9731615 +PLAU 5328 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 14644129 +PLAU 5328 Carotid Artery Diseases MESH:D002340 therapeutic 10512912 +PLAU 5328 Cerebral Hemorrhage MESH:D002543 marker/mechanism 1265806|15181847|17702958|8025938|9731615 +PLAU 5328 Cerebral Infarction MESH:D002544 therapeutic 12133459|16773802 +PLAU 5328 Cerebrovascular Disorders MESH:D002561 therapeutic 1265806|17308290 +PLAU 5328 Coronary Disease MESH:D003327 therapeutic 1730212|9181759 +PLAU 5328 Embolism, Cholesterol MESH:D017700 marker/mechanism 16773802 +PLAU 5328 Glomerulonephritis, IGA MESH:D005922 therapeutic 9002298 +PLAU 5328 Graft Occlusion, Vascular MESH:D006083 therapeutic 10392865|11041470|8025938|8416330 +PLAU 5328 Heart Rupture, Post-Infarction MESH:D006342 marker/mechanism 9403446 +PLAU 5328 Hematuria MESH:D006417 marker/mechanism 8225663 +PLAU 5328 Hemorrhage MESH:D006470 marker/mechanism 15502123|15557913|8225663|9266785 +PLAU 5328 Hypotension MESH:D007022 marker/mechanism 10392865 +PLAU 5328 Idiopathic Pulmonary Fibrosis MESH:D054990 therapeutic 18491991 +PLAU 5328 IgA Vasculitis MESH:D011695 therapeutic 12671112|9002298 +PLAU 5328 Infarction, Middle Cerebral Artery MESH:D020244 therapeutic 11677890|15181847|17702958 +PLAU 5328 Intracranial Embolism and Thrombosis MESH:D002542 therapeutic 9403446 +PLAU 5328 Intracranial Hemorrhages MESH:D020300 marker/mechanism 10392865|10472989|10512912|17308290 +PLAU 5328 Ischemia MESH:D007511 therapeutic 15557913|8662173 +PLAU 5328 Ischemic Stroke MESH:D000083242 therapeutic 15502123 +PLAU 5328 Liver Cirrhosis MESH:D008103 marker/mechanism|therapeutic 18481824|26396155 +PLAU 5328 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLAU 5328 Myocardial Infarction MESH:D009203 marker/mechanism|therapeutic 1908371|2174952|2382605|3068399|3984876|8416330 +PLAU 5328 Neoplasm Invasiveness MESH:D009361 marker/mechanism 14644129|26284488 +PLAU 5328 Neoplasm Metastasis MESH:D009362 marker/mechanism 16475674 +PLAU 5328 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 16430655 +PLAU 5328 Nephritis MESH:D009393 therapeutic 12671112 +PLAU 5328 Pancreatic Neoplasms MESH:D010190 marker/mechanism 10467400 +PLAU 5328 Prostatic Neoplasms MESH:D011471 marker/mechanism 11454671|16430655|17192053 +PLAU 5328 Pulmonary Embolism MESH:D011655 marker/mechanism|therapeutic 1098216|11041470|4430106|4884574|9038699|9266785 +PLAU 5328 Quebec platelet disorder MESH:C536260 marker/mechanism 601709.0 +PLAU 5328 Reperfusion Injury MESH:D015427 therapeutic 15181847 +PLAU 5328 Sagittal Sinus Thrombosis MESH:D020225 therapeutic 10668740 +PLAU 5328 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +PLAU 5328 Stroke MESH:D020521 marker/mechanism 12742636 +PLAU 5328 Thromboembolism MESH:D013923 therapeutic 3718210 +PLAU 5328 Thrombosis MESH:D013927 therapeutic 12830724|2106299|2133253|2795766|4884574|8657906 +PLAU 5328 Venous Thrombosis MESH:D020246 therapeutic 15557913|3161212|3488869|6359570 +PLAU 5328 Ventricular Fibrillation MESH:D014693 marker/mechanism 9083243 +PLAUR 5329 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +PLAUR 5329 Autistic Disorder MESH:D001321 marker/mechanism 19360663|21328570 +PLAUR 5329 Carcinoma MESH:D002277 marker/mechanism 15302576 +PLAUR 5329 Inflammation MESH:D007249 marker/mechanism 22261521 +PLAUR 5329 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22261521 +PLAUR 5329 Neoplasm Metastasis MESH:D009362 marker/mechanism 15659795 +PLAUR 5329 Neoplasms MESH:D009369 marker/mechanism 22261521 +PLAUR 5329 Prostatic Neoplasms MESH:D011471 marker/mechanism 15302576 +PLB1 151056 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 24520335 +PLBD1 79887 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427 +PLCB1 23236 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +PLCB1 23236 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12 OMIM:613722 marker/mechanism 613722.0 +PLCB1 23236 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 19805378 +PLCB1 23236 Pain MESH:D010146 marker/mechanism 16405873 +PLCB1 23236 Schizophrenia MESH:D012559 marker/mechanism 17667964 +PLCB4 5332 Auriculo-condylar syndrome MESH:C538270 marker/mechanism 614669.0 +PLCB4 5332 Melanoma MESH:D008545 marker/mechanism 21499247 +PLCB4 5332 Uveal melanoma MESH:C536494 marker/mechanism 27089179 +PLCD1 5333 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3 OMIM:151600 marker/mechanism 151600.0 +PLCD1 5333 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +PLCE1 51196 Adenocarcinoma MESH:D000230 marker/mechanism 20729852 +PLCE1 51196 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 20729852|20729853 +PLCE1 51196 NEPHROTIC SYNDROME, TYPE 3 OMIM:610725 marker/mechanism 610725.0 +PLCE1 51196 Severe Dengue MESH:D019595 marker/mechanism 22001756 +PLCE1 51196 Stomach Neoplasms MESH:D013274 marker/mechanism 20729852 +PLCG1 5335 Hemangiosarcoma MESH:D006394 marker/mechanism 24633157 +PLCG1 5335 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +PLCG1 5335 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +PLCG1 5335 Sezary Syndrome MESH:D012751 marker/mechanism 26551670 +PLCG2 5336 Alzheimer Disease MESH:D000544 marker/mechanism 28714976 +PLCG2 5336 AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION OMIM:614878 marker/mechanism 614878.0 +PLCG2 5336 Cryopyrin-Associated Periodic Syndromes MESH:D056587 marker/mechanism 614468.0 +PLCG2 5336 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 28067908 +PLCG2 5336 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 27542411 +PLCL2 23228 Schizophrenia MESH:D012559 marker/mechanism 21822266 +PLCZ1 89869 SPERMATOGENIC FAILURE 17 OMIM:617214 marker/mechanism 617214.0 +PLD1 5337 Cardiomegaly MESH:D006332 marker/mechanism 15988127 +PLD1 5337 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +PLD2 5338 Cardiomegaly MESH:D006332 marker/mechanism 15988127 +PLD2 5338 Orthomyxoviridae Infections MESH:D009976 marker/mechanism 25065577 +PLD4 122618 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22446963 +PLD4 122618 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLD5 200150 Autistic Disorder MESH:D001321 marker/mechanism 20663923 +PLEC 5339 Epidermolysa bullosa simplex and limb girdle muscular dystrophy MESH:C535955 marker/mechanism 226670.0 +PLEC 5339 EPIDERMOLYSIS BULLOSA SIMPLEX 5D, GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE OMIM:616487 marker/mechanism 616487.0 +PLEC 5339 Epidermolysis bullosa simplex, Ogna type MESH:C535962 marker/mechanism 131950.0 +PLEC 5339 Epidermolysis Bullosa Simplex With Pyloric Atresia MESH:C567408 marker/mechanism 612138.0 +PLEC 5339 Epidermolysis bullosa with pyloric atresia MESH:C535377 marker/mechanism 226730.0 +PLEC 5339 MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17 OMIM:613723 marker/mechanism 613723.0 +PLEK 5341 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +PLEK 5341 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLEK 5341 Osteoporosis MESH:D010024 marker/mechanism 18924182 +PLEK2 26499 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PLEKHA1 59338 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +PLEKHA7 144100 Glaucoma, Angle-Closure MESH:D015812 marker/mechanism 22922875|27064256 +PLEKHB1 58473 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLEKHD1 400224 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +PLEKHF1 79156 Ovarian Neoplasms MESH:D010051 marker/mechanism 21397856 +PLEKHG1 57480 Tobacco Use Disorder MESH:D014029 marker/mechanism 18438686 +PLEKHG2 64857 LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA OMIM:616763 marker/mechanism 616763.0 +PLEKHG5 57449 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C OMIM:615376 marker/mechanism 615376.0 +PLEKHG5 57449 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PLEKHG5 57449 Spinal Muscular Atrophy, Distal, Autosomal Recessive, 4 MESH:C567023 marker/mechanism 611067.0 +PLEKHH1 57475 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLEKHM1 9842 Osteopetrosis, Autosomal Recessive 6 MESH:C566931 marker/mechanism 611497.0 +PLEKHO1 51177 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +PLEKHS1 79949 Neoplasms MESH:D009369 marker/mechanism 25261935 +PLG 5340 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +PLG 5340 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22507835 +PLG 5340 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +PLG 5340 Hypertension MESH:D006973 marker/mechanism 6383834 +PLG 5340 Leukocyte Disorders MESH:D007960 marker/mechanism 30213540 +PLG 5340 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 14716496 +PLG 5340 Plasminogen Deficiency, Type I MESH:C566897 marker/mechanism 217090.0 +PLG 5340 Venous Thrombosis MESH:D020246 therapeutic 7215189 +PLIN1 5346 Lipodystrophy, Familial Partial MESH:D052496 marker/mechanism 613877.0 +PLIN1 5346 Obesity MESH:D009765 marker/mechanism 15001633 +PLIN2 123 Fatty Liver MESH:D005234 marker/mechanism 16439473 +PLIN2 123 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLIN2 123 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +PLIN3 10226 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLIN4 729359 Vacuolar Neuromyopathy MESH:C566617 marker/mechanism 601846.0 +PLK1 5347 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PLK1 5347 Glioma MESH:D005910 marker/mechanism 22000864 +PLK1 5347 Leukemia MESH:D007938 marker/mechanism 26008977 +PLK2 10769 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +PLK2 10769 Carcinoma MESH:D002277 marker/mechanism 12376462 +PLK2 10769 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 12897130 +PLK2 10769 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +PLK2 10769 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +PLK4 10733 Dwarfism MESH:D004392 marker/mechanism 25344692 +PLK4 10733 Eye Diseases, Hereditary MESH:D015785 marker/mechanism 25344692 +PLK4 10733 Microcephaly MESH:D008831 marker/mechanism 25344692 +PLK4 10733 Microcephaly with Chorioretinopathy, Autosomal Recessive MESH:C565379 marker/mechanism 616171.0 +PLLP 51090 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +PLN 5350 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +PLN 5350 Cardiomyopathy, Dilated, 1p MESH:C563690 marker/mechanism 609909.0 +PLN 5350 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18 OMIM:613874 marker/mechanism 613874.0 +PLN 5350 Myocardial Infarction MESH:D009203 marker/mechanism 16026515|16162791 +PLN 5350 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 10734148 +PLN 5350 Myocardial Stunning MESH:D017682 marker/mechanism 16317512 +PLN 5350 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 14991071 +PLOD1 5351 Ehlers-Danlos syndrome type 6 MESH:C536198 marker/mechanism 225400.0 15666309 +PLOD1 5351 Kyphosis MESH:D007738 marker/mechanism 15666309 +PLOD1 5351 Nevo syndrome MESH:C536113 marker/mechanism 15666309 +PLOD2 5352 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +PLOD2 5352 Bone Neoplasms MESH:D001859 marker/mechanism 15865105 +PLOD2 5352 Bruck syndrome 2 MESH:C537407 marker/mechanism 609220.0 +PLOD2 5352 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +PLOD2 5352 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLOD2 5352 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +PLOD3 8985 Bone Fragility with Contractures, Arterial Rupture, and Deafness MESH:C567320 marker/mechanism 612394.0 +PLP1 5354 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 21068375 +PLP1 5354 Pelizaeus-Merzbacher Disease MESH:D020371 marker/mechanism 312080.0 18571143 +PLP1 5354 Spastic paraplegia 2, X-linked MESH:C536857 marker/mechanism 312920.0 +PLPBP 11212 Pyridoxine-dependent epilepsy MESH:C536254 marker/mechanism 617290.0 +PLPP1 8611 Disease Progression MESH:D018450 marker/mechanism 21364753 +PLPP1 8611 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PLPP2 8612 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLPP3 8613 Cardiomegaly MESH:D006332 marker/mechanism 28982073 +PLPP3 8613 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990 +PLPP3 8613 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 28982073 +PLPPR1 54886 Seizures MESH:D012640 marker/mechanism 23266720 +PLS1 5357 Liver Neoplasms MESH:D008113 marker/mechanism 17114358 +PLS3 5358 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18 OMIM:300910 marker/mechanism 300910.0 +PLS3 5358 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +PLS3 5358 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +PLSCR1 5359 COVID-19 MESH:D000086382 marker/mechanism 35255492 +PLSCR1 5359 Influenza, Human MESH:D007251 marker/mechanism 23326326 +PLSCR1 5359 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLSCR2 57047 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLSCR4 57088 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +PLTP 5360 Dyslipidemias MESH:D050171 marker/mechanism 17952847 +PLTP 5360 Hypertriglyceridemia MESH:D015228 marker/mechanism 12754275 +PLTP 5360 Insulin Resistance MESH:D007333 marker/mechanism 12754275 +PLTP 5360 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PLVAP 83483 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PLXDC1 57125 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PLXNA2 5362 Schizophrenia MESH:D012559 marker/mechanism 18583979 +PLXNA3 55558 Endometrial Neoplasms MESH:D016889 marker/mechanism 21933904 +PLXNB1 5364 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +PLXNC1 10154 Endometriosis MESH:D004715 marker/mechanism 20864642 +PLXND1 23129 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +PMAIP1 5366 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 23770605 +PMAIP1 5366 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PMCH 5367 Obesity MESH:D009765 marker/mechanism 12355323 +PMEL 6490 Melanoma MESH:D008545 marker/mechanism 26640592 +PMEPA1 56937 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PMEPA1 56937 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 32215045 +PML 5371 Dyslipidemias MESH:D050171 marker/mechanism 32929351 +PML 5371 Glioblastoma MESH:D005909 marker/mechanism 23440206 +PML 5371 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 10742073|14706140|16788101|16835227|16891316|16935935|17294898|17649720|19029980|19035177|19884644|19887701|21345080|21613260|22213200|23208507|23734343|26285909|26728337|32882258|32929351|8616088 +PML 5371 Liver Neoplasms, Experimental MESH:D008114 therapeutic 20377131 +PML 5371 Neoplasm Metastasis MESH:D009362 marker/mechanism 29335545 +PML 5371 Neoplasms, Second Primary MESH:D016609 marker/mechanism 19884644 +PML 5371 Osteitis Deformans MESH:D010001 marker/mechanism 21623375 +PML 5371 Prostatic Neoplasms MESH:D011471 marker/mechanism 29335545 +PML 5371 Schizophrenia MESH:D012559 marker/mechanism 21822266 +PML 5371 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +PMM2 5373 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +PMM2 5373 Congenital disorder of glycosylation type 1A MESH:C535739 marker/mechanism 212065 21539312 +PMM2 5373 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +PMP22 5376 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 118220|180800 17275665|17303424|19427269 +PMP22 5376 Charcot-Marie-Tooth Disease, Demyelinating, Type 1e MESH:C566136 marker/mechanism 118300 +PMP22 5376 Demyelinating Diseases MESH:D003711 marker/mechanism 20739560 +PMP22 5376 Developmental Disabilities MESH:D002658 marker/mechanism 17275665 +PMP22 5376 Epilepsies, Myoclonic MESH:D004831 marker/mechanism 17275665 +PMP22 5376 Guillain-Barre Syndrome MESH:D020275 marker/mechanism 139393 +PMP22 5376 Hereditary Sensory and Motor Neuropathy MESH:D015417 marker/mechanism 145900 17701891 +PMP22 5376 Muscle Weakness MESH:D018908 marker/mechanism 12427913 +PMP22 5376 Paresthesia MESH:D010292 marker/mechanism 12427913 +PMP22 5376 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 12427913|20739560 +PMP22 5376 Quadriplegia MESH:D011782 marker/mechanism 12427913 +PMP22 5376 Reflex, Abnormal MESH:D012021 marker/mechanism 12427913 +PMP22 5376 Tomaculous neuropathy MESH:C536965 marker/mechanism 162500 +PMPCA 23203 Spinocerebellar Ataxia, Autosomal Recessive 2 MESH:C565865 marker/mechanism 213200 +PMS1 5378 Lynch syndrome I (site-specific colonic cancer) MESH:C537261 marker/mechanism 120435 +PMS1 5378 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +PMS2 5395 Cafe-au-Lait Spots MESH:D019080 marker/mechanism 15077197 +PMS2 5395 Colorectal Cancer, Hereditary Nonpolyposis, Type 4 MESH:C563971 marker/mechanism 614337.0 +PMS2 5395 Colorectal Neoplasms, Hereditary Nonpolyposis MESH:D003123 marker/mechanism 14756672|15887124|25701956 +PMS2 5395 Neoplasm Metastasis MESH:D009362 marker/mechanism 17717427 +PMS2 5395 Neuroectodermal Tumors, Primitive MESH:D018242 marker/mechanism 15077197 +PMS2 5395 Rhabdomyosarcoma MESH:D012208 marker/mechanism 19293170 +PMS2 5395 Supratentorial Neoplasms MESH:D015173 marker/mechanism 15077197 +PMS2 5395 Turcot syndrome MESH:C536928 marker/mechanism 10763829|15077197 +PMVK 10654 POROKERATOSIS 1, MULTIPLE TYPES OMIM:175800 marker/mechanism 175800.0 +PNKD 25953 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25401301 +PNKD 25953 Paroxysmal nonkinesigenic dyskinesia MESH:C537181 marker/mechanism 118800.0 21487022 +PNKP 11284 ATAXIA-OCULOMOTOR APRAXIA 4 OMIM:616267 marker/mechanism 616267.0 +PNKP 11284 Charcot-Marie-Tooth disease, Type 2B2 MESH:C537991 marker/mechanism 605589.0 +PNKP 11284 Developmental Disabilities MESH:D002658 marker/mechanism 20118933 +PNKP 11284 DNA Repair-Deficiency Disorders MESH:D049914 marker/mechanism 20118933 +PNKP 11284 Microcephaly MESH:D008831 marker/mechanism 20118933 +PNKP 11284 MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY OMIM:613402 marker/mechanism 613402.0 +PNKP 11284 Seizures MESH:D012640 marker/mechanism 20118933 +PNLIP 5406 PANCREATIC LIPASE DEFICIENCY OMIM:614338 marker/mechanism 614338.0 +PNOC 5368 Hyperalgesia MESH:D006930 marker/mechanism 12665541|19231294 +PNOC 5368 Hypotension MESH:D007022 marker/mechanism 10794074 +PNOC 5368 Learning Disabilities MESH:D007859 marker/mechanism 10401555 +PNOC 5368 Memory Disorders MESH:D008569 marker/mechanism 10401555 +PNOC 5368 Neurogenic Inflammation MESH:D020078 therapeutic 11973003 +PNOC 5368 Pain MESH:D010146 therapeutic 19231294 +PNOC 5368 Parkinsonian Disorders MESH:D020734 marker/mechanism 26687234 +PNOC 5368 Substance Withdrawal Syndrome MESH:D013375 therapeutic 10680585 +PNP 4860 Arsenic Poisoning MESH:D020261 marker/mechanism 18414634 +PNP 4860 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +PNP 4860 Osteoporosis MESH:D010024 marker/mechanism 18924182 +PNP 4860 Purine Nucleoside Phosphorylase Deficiency MESH:C562587 marker/mechanism 613179.0 9403342 +PNPLA1 285848 Ichthyosis MESH:D007057 marker/mechanism 22246504 +PNPLA1 285848 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10 OMIM:615024 marker/mechanism 615024.0 +PNPLA2 57104 Endomyocardial Fibrosis MESH:D004719 marker/mechanism 35218467 +PNPLA2 57104 Heart Diseases MESH:D006331 marker/mechanism 21585347|23867907 +PNPLA2 57104 Heart Failure MESH:D006333 marker/mechanism 35218467 +PNPLA2 57104 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 35218467 +PNPLA2 57104 Neutral Lipid Storage Disease with Myopathy MESH:C565192 marker/mechanism 610717.0 +PNPLA2 57104 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PNPLA2 57104 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 35218467 +PNPLA3 80339 Fatty Liver MESH:D005234 marker/mechanism 25678388 +PNPLA3 80339 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 19946271|26482880 +PNPLA3 80339 Liver Diseases, Alcoholic MESH:D008108 marker/mechanism 19946271 +PNPLA3 80339 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 18820647|24531328|27180240 +PNPLA6 10908 Chorioretinal Dystrophy, Spinocerebellar Ataxia, and Hypogonadotropic Hypogonadism MESH:C565850 marker/mechanism 215470.0 +PNPLA6 10908 Laurence-Moon Syndrome MESH:D007849 marker/mechanism 245800.0 +PNPLA6 10908 Motor Neuron Disease MESH:D016472 marker/mechanism 18313024|20603202 +PNPLA6 10908 Nervous System Diseases MESH:D009422 marker/mechanism 8211998 +PNPLA6 10908 Oliver-McFarlane syndrome MESH:C536554 marker/mechanism 275400.0 +PNPLA6 10908 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20188121 +PNPLA6 10908 Polyneuropathies MESH:D011115 marker/mechanism 22819951 +PNPLA6 10908 Sick Building Syndrome MESH:D018877 marker/mechanism 23418070 +PNPLA6 10908 Spastic Paraplegia 39, Autosomal Recessive MESH:C567433 marker/mechanism 612020.0 +PNPLA6 10908 Spastic Paraplegia, Hereditary MESH:D015419 marker/mechanism 20382209 +PNPLA8 50640 Mitochondrial myopathy with lactic acidosis MESH:C537476 marker/mechanism 251950.0 +PNPO 55163 Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency MESH:C566449 marker/mechanism 610090.0 +PNPO 55163 Status Epilepticus MESH:D013226 marker/mechanism 19356691 +PNPT1 87178 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +PNPT1 87178 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13 OMIM:614932 marker/mechanism 614932.0 +PNPT1 87178 DEAFNESS, AUTOSOMAL RECESSIVE 70, WITH OR WITHOUT ADULT-ONSET NEURODEGENERATION OMIM:614934 marker/mechanism 614934.0 +PNPT1 87178 Spinocerebellar ataxia 25 MESH:C537202 marker/mechanism 608703.0 +PNRC1 10957 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +POC1B 282809 CONE-ROD DYSTROPHY 20 OMIM:615973 marker/mechanism 615973.0 +PODXL 5420 Carotid Artery Diseases MESH:D002340 marker/mechanism 22016802 +PODXL 5420 Hemorrhage MESH:D006470 marker/mechanism 22016802 +PODXL 5420 Prostatic Neoplasms MESH:D011471 marker/mechanism 16434482 +PODXL 5420 Thrombosis MESH:D013927 marker/mechanism 22016802 +POF1B 79983 Premature Ovarian Failure 2b MESH:C564476 marker/mechanism 300604.0 +POFUT1 23509 Dowling-Degos Disease MESH:C562924 marker/mechanism 615327.0 +POGLUT1 56983 Dowling-Degos Disease MESH:C562924 marker/mechanism 615696.0 +POGLUT1 56983 MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21 OMIM:617232 marker/mechanism 617232.0 +POGZ 23126 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +POGZ 23126 WHITE-SUTTON SYNDROME OMIM:616364 marker/mechanism 616364.0 +POLA1 5422 Pigmentary Disorder, Reticulate, with Systemic Manifestations MESH:C564461 marker/mechanism 301220.0 +POLB 5423 Colonic Neoplasms MESH:D003110 marker/mechanism 25030372 +POLB 5423 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18006695 +POLB 5423 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 8631603 +POLD1 5424 Abnormalities, Multiple MESH:D000015 marker/mechanism 23770608 +POLD1 5424 Colorectal Neoplasms MESH:D015179 marker/mechanism 612591.0 23263490 +POLD1 5424 Deafness MESH:D003638 marker/mechanism 23770608 +POLD1 5424 Endometrial Neoplasms MESH:D016889 marker/mechanism 23263490 +POLD1 5424 Hypogonadism MESH:D007006 marker/mechanism 23770608 +POLD1 5424 Jaw Abnormalities MESH:D007569 marker/mechanism 23770608 +POLD1 5424 Lipodystrophy MESH:D008060 marker/mechanism 23770608 +POLD1 5424 MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME OMIM:615381 marker/mechanism 615381.0 +POLD3 10714 Colorectal Neoplasms MESH:D015179 marker/mechanism 22634755|30510241 +POLE 5426 Colorectal Neoplasms MESH:D015179 marker/mechanism 615083.0 23263490|26053496 +POLE 5426 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE OMIM:615139 marker/mechanism 615139.0 +POLG 5428 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 18208989|20138553 +POLG 5428 Diffuse Cerebral Sclerosis of Schilder MESH:D002549 marker/mechanism 17923349|18716558|20138553 +POLG 5428 Epilepsy MESH:D004827 marker/mechanism 18716558 +POLG 5428 Infertility, Male MESH:D007248 marker/mechanism 17923349 +POLG 5428 Mitochondrial Diseases MESH:D028361 marker/mechanism 18716558 +POLG 5428 MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE) OMIM:603041 marker/mechanism 603041.0 +POLG 5428 MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE) OMIM:203700 marker/mechanism 203700.0 +POLG 5428 MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE) OMIM:613662 marker/mechanism 613662.0 +POLG 5428 Ophthalmoplegia, Chronic Progressive External MESH:D017246 marker/mechanism 17923349 +POLG 5428 Parkinsonian Disorders MESH:D020734 marker/mechanism 17923349 +POLG 5428 Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1 MESH:C563575 marker/mechanism 157640.0 +POLG 5428 Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Recessive MESH:C564926 marker/mechanism 258450.0 +POLG 5428 Seizures MESH:D012640 marker/mechanism 20138553|20446108 +POLG 5428 Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis MESH:C537583 marker/mechanism 607459.0 17923349 +POLG2 11232 Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 4 MESH:C566437 marker/mechanism 610131.0 +POLH 5429 Xeroderma Pigmentosum MESH:D014983 marker/mechanism 22745795 +POLH 5429 Xeroderma pigmentosum, variant type MESH:C536766 marker/mechanism 278750.0 +POLK 51426 Glioblastoma MESH:D005909 marker/mechanism 26651356 +POLK 51426 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 26651356 +POLK 51426 Prostatic Neoplasms MESH:D011471 marker/mechanism 26046662 +POLR1A 25885 ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE OMIM:616462 marker/mechanism 616462.0 +POLR1C 9533 LEUKODYSTROPHY, HYPOMYELINATING, 11 OMIM:616494 marker/mechanism 616494.0 +POLR1C 9533 Mandibulofacial Dysostosis MESH:D008342 marker/mechanism 21131976 +POLR1C 9533 Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive MESH:C535707 marker/mechanism 248390.0 +POLR1D 51082 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +POLR1D 51082 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +POLR1D 51082 Mandibulofacial Dysostosis MESH:D008342 marker/mechanism 21131976 +POLR1D 51082 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +POLR1D 51082 TREACHER COLLINS SYNDROME 2 OMIM:613717 marker/mechanism 613717.0 +POLR1H 30834 Neoplasms, Experimental MESH:D009374 marker/mechanism 16609701 +POLR1H 30834 Stomach Neoplasms MESH:D013274 marker/mechanism 16609701 +POLR2G 5436 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +POLR3A 11128 Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism MESH:C567313 marker/mechanism 607694 +POLR3B 55703 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +POLR3B 55703 Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism MESH:C567313 marker/mechanism 607694|614381 +POLR3K 51728 Disease Progression MESH:D018450 marker/mechanism 21364753 +POLR3K 51728 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +POMC 5443 ACTH Syndrome, Ectopic MESH:D000182 marker/mechanism 1459535|2844640|4367732|8562174 +POMC 5443 Acute Kidney Injury MESH:D058186 therapeutic 17216604 +POMC 5443 Adrenal Cortex Diseases MESH:D000303 therapeutic 11370731 +POMC 5443 Amnesia MESH:D000647 marker/mechanism 2841920 +POMC 5443 Aortic Stenosis, Subvalvular MESH:D001020 marker/mechanism 1965992 +POMC 5443 Arthritis, Gouty MESH:D015210 therapeutic 8035395 +POMC 5443 Autistic Disorder MESH:D001321 marker/mechanism 8570775 +POMC 5443 Bipolar Disorder MESH:D001714 marker/mechanism 2843795|9664777 +POMC 5443 Body Weight MESH:D001835 marker/mechanism 1316127 +POMC 5443 Bradycardia MESH:D001919 marker/mechanism 1676337|19039989|2636709 +POMC 5443 Burns MESH:D002056 marker/mechanism 2968671 +POMC 5443 Calcinosis MESH:D002114 marker/mechanism 6143199 +POMC 5443 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 2844640 +POMC 5443 Cardiomegaly MESH:D006332 marker/mechanism 19039989|1965992|2821097|6088243|8279378|8381257 +POMC 5443 Cardiomyopathies MESH:D009202 marker/mechanism 6143199 +POMC 5443 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 2536513|2831920|2853496|8381257|8928979 +POMC 5443 Catalepsy MESH:D002375 marker/mechanism|therapeutic 2999739|6329457 +POMC 5443 Cerebral Hemorrhage MESH:D002543 marker/mechanism 6254450 +POMC 5443 Cerebral Palsy MESH:D002547 therapeutic 8980841 +POMC 5443 Cholestasis MESH:D002779 therapeutic 3421781 +POMC 5443 Chondrocalcinosis MESH:D002805 therapeutic 8035395 +POMC 5443 Cocaine-Related Disorders MESH:D019970 marker/mechanism 11750770|16520439|18201294|19279569 +POMC 5443 Constipation MESH:D003248 therapeutic 3421781 +POMC 5443 Cushing Syndrome MESH:D003480 marker/mechanism 19153526|6088243 +POMC 5443 Cystitis MESH:D003556 marker/mechanism 1267567 +POMC 5443 Depressive Disorder MESH:D003866 marker/mechanism 18201294 +POMC 5443 Diabetes Insipidus MESH:D003919 therapeutic 6258694 +POMC 5443 Diabetes Mellitus MESH:D003920 marker/mechanism 19153526 +POMC 5443 Edema MESH:D004487 marker/mechanism 1459535|4327920|8562174 +POMC 5443 Epilepsies, Myoclonic MESH:D004831 therapeutic 6088243 +POMC 5443 Epilepsy MESH:D004827 therapeutic 20708863 +POMC 5443 Epilepsy, Tonic-Clonic MESH:D004830 marker/mechanism 4371370 +POMC 5443 Eye Diseases MESH:D005128 marker/mechanism 4340068 +POMC 5443 Eye Pain MESH:D058447 marker/mechanism 4327920 +POMC 5443 Facial Paralysis MESH:D005158 therapeutic 4327920 +POMC 5443 Fatty Liver MESH:D005234 marker/mechanism 167377 +POMC 5443 Femur Head Necrosis MESH:D005271 marker/mechanism 4326745 +POMC 5443 Fever MESH:D005334 marker/mechanism 6350720 +POMC 5443 Gastrointestinal Diseases MESH:D005767 marker/mechanism 6254450 +POMC 5443 Glomerulonephritis MESH:D005921 marker/mechanism 4368615|6300362 +POMC 5443 Heart Failure MESH:D006333 marker/mechanism 3026683|8277081 +POMC 5443 Hematuria MESH:D006417 marker/mechanism 1267567|1324751 +POMC 5443 Hemorrhage MESH:D006470 marker/mechanism 1267567|3014908 +POMC 5443 Heroin Dependence MESH:D006556 marker/mechanism 18201294 +POMC 5443 Hirsutism MESH:D006628 marker/mechanism 1324751 +POMC 5443 Hypercalciuria MESH:D053565 marker/mechanism 1324751|3017235 +POMC 5443 Hypernatremia MESH:D006955 marker/mechanism 10100081|6279499 +POMC 5443 Hypertension MESH:D006973 marker/mechanism|therapeutic 10100081|10474778|10513829|10658937|11071300|11071304|11132610|11193135|11518849|11560123|11703388|12872045|12887135|1316127|1321011|1321309|1327015|1330390|1334993|15110907|15132301|15554453|16053986|16243970|1649024|16546835|16620303|1664305|17324744|17954371|17994356|18067589|18487447|187612|19153526|19458537|20186125|20659135|2157753|216942|2455169|2551692|2821097|2822310|2849322|2992854|3001556|3015460|323586|4367732|6088243|6089027|6097376|6100240|6135010|6143199|6254450|6274577|6279500|6283272|76749|8136112|8261660|8279378|8713685|8800598|9056691|9535146 +POMC 5443 Hypocalcemia MESH:D006996 marker/mechanism 3017235 +POMC 5443 Hypokalemia MESH:D007008 marker/mechanism 10100081|1327015|323586|4323972|6254450|6258369|6279499|8035395|8562174 +POMC 5443 Hypotension MESH:D007022 marker/mechanism 1676337|2536002|2566129|2636709 +POMC 5443 Hypoxia MESH:D000860 marker/mechanism 11311734|24412703 +POMC 5443 Immune System Diseases MESH:D007154 marker/mechanism 6107850 +POMC 5443 Infections MESH:D007239 marker/mechanism 6088243|6254450 +POMC 5443 Kidney Calculi MESH:D007669 marker/mechanism 1324751 +POMC 5443 Kidney Diseases MESH:D007674 marker/mechanism 6143199 +POMC 5443 Kidney Tubular Necrosis, Acute MESH:D007683 marker/mechanism 4358912|6254450 +POMC 5443 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 16508911|16511523 +POMC 5443 Liver Failure, Acute MESH:D017114 therapeutic 15313186 +POMC 5443 Long QT Syndrome MESH:D008133 marker/mechanism 19931775 +POMC 5443 Melanoma MESH:D008545 therapeutic 24412703 +POMC 5443 Mental Disorders MESH:D001523 marker/mechanism 18056188 +POMC 5443 Multiple Sclerosis MESH:D009103 therapeutic 2843795|9664777 +POMC 5443 Myasthenia Gravis MESH:D009157 therapeutic 4323972 +POMC 5443 Myocardial Ischemia MESH:D017202 marker/mechanism 10908253 +POMC 5443 Nausea MESH:D009325 marker/mechanism 11141589 +POMC 5443 Necrosis MESH:D009336 marker/mechanism 7608651 +POMC 5443 Nephrocalcinosis MESH:D009397 marker/mechanism 3017235 +POMC 5443 Neurogenic Inflammation MESH:D020078 therapeutic 19333140 +POMC 5443 Obesity MESH:D009765 marker/mechanism 601665 16289378|19153526 +POMC 5443 Oliguria MESH:D009846 marker/mechanism 6254450 +POMC 5443 Opsoclonus-Myoclonus Syndrome MESH:D053578 therapeutic 1318289 +POMC 5443 Osteoporosis MESH:D010024 marker/mechanism 19153526|3017235|4367732|6143199|6254450 +POMC 5443 Pain MESH:D010146 marker/mechanism|therapeutic 20084599|4345333|6094376 +POMC 5443 Pancreatic Diseases MESH:D010182 marker/mechanism 6143199 +POMC 5443 Penile Diseases MESH:D010409 marker/mechanism 1358647|2825910|3033702 +POMC 5443 Pituitary ACTH Hypersecretion MESH:D047748 marker/mechanism 16809932 +POMC 5443 Pneumonia MESH:D011014 marker/mechanism 6254450 +POMC 5443 Postoperative Complications MESH:D011183 marker/mechanism 4371370 +POMC 5443 Proopiomelanocortin Deficiency MESH:C565726 marker/mechanism 609734 +POMC 5443 Proteinuria MESH:D011507 marker/mechanism 4368615 +POMC 5443 Recurrence MESH:D012008 marker/mechanism 20078871 +POMC 5443 Restless Legs Syndrome MESH:D012148 marker/mechanism 18464280 +POMC 5443 Rhabdomyoma MESH:D012207 marker/mechanism 10908253 +POMC 5443 Sacroiliitis MESH:D058566 therapeutic 19533139 +POMC 5443 Seizures MESH:D012640 marker/mechanism|therapeutic 1656808|2169275|2554740|2821097|6324019|7127082 +POMC 5443 Sick Sinus Syndrome MESH:D012804 marker/mechanism 19039989 +POMC 5443 Sleep Wake Disorders MESH:D012893 marker/mechanism 18464280 +POMC 5443 Spasms, Infantile MESH:D013036 marker/mechanism|therapeutic 10908253|11341487|1324751|1327015|1656808|17287597|19039989|1965992|20078871|2551692|2554740|2853496|2983143|6107850|6143199|6254450|6259007|8381257|8928979|8980841 +POMC 5443 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism|therapeutic 15689546|15714323|20738730|225122 +POMC 5443 Synovitis MESH:D013585 therapeutic 8035395 +POMC 5443 Urinary Tract Infections MESH:D014552 marker/mechanism 6254450 +POMC 5443 Weight Gain MESH:D015430 marker/mechanism 4367732|6143199 +POMC 5443 Weight Loss MESH:D015431 marker/mechanism 11193135|1459535 +POMGNT1 55624 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 3 OMIM:613151 marker/mechanism 613151 +POMGNT1 55624 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3 OMIM:613157 marker/mechanism 613157 +POMGNT1 55624 RETINITIS PIGMENTOSA 76 OMIM:617123 marker/mechanism 617123 +POMGNT1 55624 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 253280 +POMGNT2 84892 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 614830 +POMK 84197 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12 OMIM:616094 marker/mechanism 616094 +POMK 84197 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 615249 +POMP 51371 Exfoliation Syndrome MESH:D017889 marker/mechanism 28553957 +POMP 51371 Keratosis Linearis with Ichthyosis Congenita and Sclerosing Keratoderma MESH:C566600 marker/mechanism 601952 +POMT1 10585 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +POMT1 10585 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1 OMIM:613155 marker/mechanism 613155 +POMT1 10585 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1 OMIM:609308 marker/mechanism 609308 +POMT1 10585 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 236670 +POMT2 29954 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +POMT2 29954 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2 OMIM:613156 marker/mechanism 613156 +POMT2 29954 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2 OMIM:613158 marker/mechanism 613158 +POMT2 29954 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 236670|613150 +PON1 5444 Acute Coronary Syndrome MESH:D054058 marker/mechanism 26241956 +PON1 5444 Agricultural Workers' Diseases MESH:D000382 marker/mechanism 15982977|18430447 +PON1 5444 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 28070599 +PON1 5444 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 17204329 +PON1 5444 Arteritis MESH:D001167 marker/mechanism 19022366 +PON1 5444 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 16055108 +PON1 5444 Atherosclerosis MESH:D050197 marker/mechanism|therapeutic 16216721|16229851|16331452|19371607|21629682|26241956 +PON1 5444 Autistic Disorder MESH:D001321 marker/mechanism 16027737|16297937|22490277 +PON1 5444 Birth Weight MESH:D001724 marker/mechanism 17237730 +PON1 5444 Brain Neoplasms MESH:D001932 marker/mechanism 16002382 +PON1 5444 Cardiovascular Diseases MESH:D002318 marker/mechanism|therapeutic 15169886|19152805 +PON1 5444 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +PON1 5444 Cholestasis MESH:D002779 marker/mechanism 27989131 +PON1 5444 Colorectal Neoplasms MESH:D015179 marker/mechanism 31004929 +PON1 5444 Constipation MESH:D003248 marker/mechanism 19022366 +PON1 5444 Coronary Artery Disease MESH:D003324 marker/mechanism|therapeutic 21629682|8675673|9215303 +PON1 5444 Coronary Disease MESH:D003327 marker/mechanism 16353344|16882531 +PON1 5444 Coronary Vasospasm MESH:D003329 marker/mechanism 11810302 +PON1 5444 Depressive Disorder MESH:D003866 marker/mechanism 19272368 +PON1 5444 Diabetes Complications MESH:D048909 marker/mechanism 19003935 +PON1 5444 Diabetes Mellitus MESH:D003920 marker/mechanism 16229851|19022366 +PON1 5444 Diabetic Nephropathies MESH:D003928 marker/mechanism 26884296 +PON1 5444 Diabetic Retinopathy MESH:D003930 marker/mechanism 20012460|9661650 +PON1 5444 Fatty Liver MESH:D005234 marker/mechanism 26945512 +PON1 5444 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 35764155 +PON1 5444 Glomerulonephritis, Membranoproliferative MESH:D015432 marker/mechanism 16175651 +PON1 5444 Heart Diseases MESH:D006331 marker/mechanism 28396702 +PON1 5444 Heart Failure MESH:D006333 marker/mechanism 26670611 +PON1 5444 Hematologic Neoplasms MESH:D019337 marker/mechanism 22800774 +PON1 5444 Hemorrhoids MESH:D006484 marker/mechanism 19022366 +PON1 5444 Hypercholesterolemia MESH:D006937 marker/mechanism 16229851 +PON1 5444 Hyperhomocysteinemia MESH:D020138 marker/mechanism 17292331|19028542 +PON1 5444 Hyperlipoproteinemias MESH:D006951 marker/mechanism 15324535 +PON1 5444 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 16030523|16238680 +PON1 5444 Hyperthyroidism MESH:D006980 marker/mechanism 14678291 +PON1 5444 Infertility, Male MESH:D007248 marker/mechanism 21561808|22206979 +PON1 5444 Lung Neoplasms MESH:D008175 marker/mechanism 16323636 +PON1 5444 Lymphoma MESH:D008223 marker/mechanism 22800774 +PON1 5444 Metabolic Diseases MESH:D008659 marker/mechanism 28396702 +PON1 5444 Metabolic Syndrome MESH:D024821 marker/mechanism 21573798 +PON1 5444 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 26839999 +PON1 5444 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5 OMIM:612633 marker/mechanism 612633.0 +PON1 5444 Neuroectodermal Tumors, Primitive MESH:D018242 marker/mechanism 16002382 +PON1 5444 Neurotoxicity Syndromes MESH:D020258 therapeutic 21329748 +PON1 5444 Occupational Diseases MESH:D009784 marker/mechanism 22800774 +PON1 5444 Organophosphate Poisoning MESH:D062025 marker/mechanism|therapeutic 11022865|20581384|20981111|23123254|24326413|26340881|28070599 +PON1 5444 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 26457621 +PON1 5444 Periodontal Diseases MESH:D010510 marker/mechanism 19003935 +PON1 5444 Persian Gulf Syndrome MESH:D018923 marker/mechanism 10373407 +PON1 5444 Prenatal Exposure Delayed Effects MESH:D011297 marker/mechanism 25463530|28396702 +PON1 5444 Prostatic Neoplasms MESH:D011471 marker/mechanism 12783936|15538743|21716162 +PON1 5444 Spinal Dysraphism MESH:D016135 marker/mechanism 21031563 +PON1 5444 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 35764155 +PON2 5445 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PON2 5445 Cardiovascular Diseases MESH:D002318 marker/mechanism 19152805 +PON2 5445 Hyperlipoproteinemia Type II MESH:D006938 marker/mechanism 16030523 +PON3 5446 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +POP1 10940 Anauxetic dysplasia MESH:C538256 marker/mechanism 617396.0 +POP4 10775 Ovarian Neoplasms MESH:D010051 marker/mechanism 21397856 +POR 5447 Adrenal Hyperplasia, Congenital MESH:D000312 marker/mechanism 18559916 +POR 5447 Amenorrhea MESH:D000568 marker/mechanism 14758361 +POR 5447 Antley-Bixler Syndrome Phenotype MESH:D054882 marker/mechanism 613571.0 14758361|15220035|16906539|27496950 +POR 5447 ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS OMIM:201750 marker/mechanism 201750.0 +POR 5447 ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS OMIM:207410 marker/mechanism 207410.0 +POR 5447 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 15089088 +POR 5447 Gliosarcoma MESH:D018316 therapeutic 9766669 +POR 5447 Heart Failure MESH:D006333 marker/mechanism 36071497 +POR 5447 Learning Disabilities MESH:D007859 marker/mechanism 21987461 +POR 5447 Lung Injury MESH:D055370 therapeutic 33033841 +POR 5447 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 8631603 +PORCN 64840 Focal Dermal Hypoplasia MESH:D005489 marker/mechanism 305600.0 17546030|17546031 +POSTN 10631 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 18391768 +POSTN 10631 Bronchopulmonary Dysplasia MESH:D001997 marker/mechanism 22363622 +POSTN 10631 Colorectal Neoplasms MESH:D015179 marker/mechanism 15731169 +POSTN 10631 Drug Hypersensitivity MESH:D004342 marker/mechanism 18391768 +POSTN 10631 Liver Cirrhosis MESH:D008103 marker/mechanism 32344006 +POSTN 10631 Muscular Dystrophy, Duchenne MESH:D020388 marker/mechanism 21641384 +POT1 25913 Chromosome Aberrations MESH:D002869 marker/mechanism 23502782 +POT1 25913 Chromosome Disorders MESH:D025063 marker/mechanism 23502782 +POT1 25913 Leukemia, Lymphoid MESH:D007945 marker/mechanism 23502782|24292274 +POT1 25913 Melanoma MESH:D008545 marker/mechanism 24686849 +POT1 25913 Skin Neoplasms MESH:D012878 marker/mechanism 24686849 +POT1 25913 TUMOR PREDISPOSITION SYNDROME 3 OMIM:615848 marker/mechanism 615848.0 +POU1F1 5449 Dwarfism, Pituitary MESH:D004393 marker/mechanism 9392392 +POU1F1 5449 Pituitary Hormone Deficiency, Combined, 1 MESH:C567803 marker/mechanism 613038.0 +POU2F2 5452 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +POU2F2 5452 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +POU3F1 5453 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +POU3F2 5454 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +POU3F3 5455 Osteoarthritis MESH:D010003 marker/mechanism 17568789 +POU3F4 5456 Progressive hearing loss stapes fixation MESH:C536424 marker/mechanism 304400.0 +POU4F1 5457 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +POU4F1 5457 Uterine Cervical Dysplasia MESH:D002578 marker/mechanism 20190800 +POU4F1 5457 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 21928122 +POU4F3 5459 Deafness, Autosomal Dominant 15 MESH:C566545 marker/mechanism 602459.0 +POU5F1 5460 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +POU5F1 5460 Carcinogenesis MESH:D063646 marker/mechanism 35506701 +POU5F1 5460 Gestational Trophoblastic Disease MESH:D031901 marker/mechanism 18440631 +POU5F1 5460 Glioma MESH:D005910 marker/mechanism 35506701 +POU5F1 5460 Heart Defects, Congenital MESH:D006330 marker/mechanism 26507003 +POU5F1 5460 Neoplasms, Experimental MESH:D009374 marker/mechanism 35506701 +POU5F1 5460 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 16168501 +POU6F2 11281 Autistic Disorder MESH:D001321 marker/mechanism 20663923 +POU6F2 11281 WILMS TUMOR 5 OMIM:601583 marker/mechanism 601583.0 +PPA2 27068 SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED OMIM:617223 marker/mechanism 617223.0 +PPA2 27068 SUDDEN CARDIAC FAILURE, INFANTILE OMIM:617222 marker/mechanism 617222.0 +PPAN 56342 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +PPAN 56342 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +PPAP2A 100164616 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PPAP2A 100164616 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +PPARA 5465 Abdominal obesity metabolic syndrome MESH:C535554 marker/mechanism 15309680 +PPARA 5465 Carcinoma MESH:D002277 marker/mechanism 11137312 +PPARA 5465 Cardiomegaly MESH:D006332 therapeutic 22198280 +PPARA 5465 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 24385052 +PPARA 5465 Crohn Disease MESH:D003424 marker/mechanism 21829567 +PPARA 5465 Dermatitis, Atopic MESH:D003876 marker/mechanism 18249437 +PPARA 5465 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 12967931|14563825|23090186 +PPARA 5465 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 17317762|31626838 +PPARA 5465 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 19683050 +PPARA 5465 Dyslipidemias MESH:D050171 therapeutic 16168052 +PPARA 5465 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 17261635 +PPARA 5465 Fatty Liver MESH:D005234 therapeutic 19124612 +PPARA 5465 Fatty Liver, Alcoholic MESH:D005235 marker/mechanism 18703563 +PPARA 5465 Hepatomegaly MESH:D006529 marker/mechanism 14982965 +PPARA 5465 Hyperlipidemias MESH:D006949 therapeutic 21640707 +PPARA 5465 Hyperlipoproteinemias MESH:D006951 marker/mechanism 10828087 +PPARA 5465 Hypertension MESH:D006973 marker/mechanism|therapeutic 16054168|19834340 +PPARA 5465 Hypertriglyceridemia MESH:D015228 marker/mechanism 15309680 +PPARA 5465 Hypoglycemia MESH:D007003 marker/mechanism 16777972 +PPARA 5465 Inflammation MESH:D007249 therapeutic 21300114 +PPARA 5465 Insulin Resistance MESH:D007333 therapeutic 16168052|21324916 +PPARA 5465 Kidney Diseases MESH:D007674 marker/mechanism 16316343 +PPARA 5465 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +PPARA 5465 Kidney Tubular Necrosis, Acute MESH:D007683 marker/mechanism 19834340 +PPARA 5465 Liver Neoplasms MESH:D008113 marker/mechanism 20143881|29134746 +PPARA 5465 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 11137312 +PPARA 5465 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 11137312 +PPARA 5465 Muscular Diseases MESH:D009135 marker/mechanism 19683050 +PPARA 5465 Myocardial Reperfusion Injury MESH:D015428 therapeutic 16411023 +PPARA 5465 Neoplasms MESH:D009369 marker/mechanism 17405874 +PPARA 5465 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 23603006 +PPARA 5465 Obesity MESH:D009765 marker/mechanism 11089532|30738174 +PPARA 5465 Prostatic Neoplasms MESH:D011471 marker/mechanism 22919386 +PPARA 5465 Proteinuria MESH:D011507 marker/mechanism 16054168 +PPARA 5465 Reperfusion Injury MESH:D015427 therapeutic 19151258 +PPARD 5467 Cardiomegaly MESH:D006332 marker/mechanism 20075336 +PPARD 5467 Cardiomyopathies MESH:D009202 marker/mechanism 20075336 +PPARD 5467 Fatty Liver MESH:D005234 marker/mechanism 23851158 +PPARD 5467 Liver Diseases, Alcoholic MESH:D008108 marker/mechanism 27765815 +PPARD 5467 Melanoma MESH:D008545 therapeutic 28962521 +PPARD 5467 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism|therapeutic 16574099|29289645 +PPARD 5467 Obesity MESH:D009765 therapeutic 16168052|20176998 +PPARD 5467 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405|21245421 +PPARD 5467 Skin Neoplasms MESH:D012878 marker/mechanism|therapeutic 19748995|21159610 +PPARD 5467 Weight Gain MESH:D015430 therapeutic 20176998 +PPARG 5468 Acute Kidney Injury MESH:D058186 marker/mechanism|therapeutic 20623750|24011919|24433871 +PPARG 5468 Acute Lung Injury MESH:D055371 therapeutic 21153920 +PPARG 5468 Adenocarcinoma MESH:D000230 marker/mechanism 11034103 +PPARG 5468 Alzheimer Disease MESH:D000544 marker/mechanism 15993441|16407166|30328325 +PPARG 5468 Antiphospholipid Syndrome MESH:D016736 marker/mechanism 28182703 +PPARG 5468 Atherosclerosis MESH:D050197 therapeutic 18269830 +PPARG 5468 Barrett Esophagus MESH:D001471 marker/mechanism 15387324 +PPARG 5468 Carcinoma, Hepatocellular MESH:D006528 therapeutic 16374840 +PPARG 5468 Carotid Intimal Medial Thickness 1 MESH:C563733 marker/mechanism 609338.0 +PPARG 5468 Chronobiology Disorders MESH:D021081 marker/mechanism 22899986 +PPARG 5468 Colonic Neoplasms MESH:D003110 therapeutic 20540935 +PPARG 5468 Colorectal Neoplasms MESH:D015179 marker/mechanism 16489531 +PPARG 5468 Crohn Disease MESH:D003424 marker/mechanism 21829567 +PPARG 5468 Diabetes Mellitus MESH:D003920 therapeutic 16168052 +PPARG 5468 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 12967931|16123366|21757225 +PPARG 5468 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism|therapeutic 125853.0 15592662|16123366|16249460|17317762|21484566|28182703|31626838 +PPARG 5468 Diabetic Nephropathies MESH:D003928 marker/mechanism 28182703 +PPARG 5468 Dyslipidemias MESH:D050171 therapeutic 16168052 +PPARG 5468 Glomerulonephritis MESH:D005921 therapeutic 11318962 +PPARG 5468 Heart Failure MESH:D006333 marker/mechanism 26670611 +PPARG 5468 Hypertension MESH:D006973 marker/mechanism|therapeutic 15199296|19666838|27292124 +PPARG 5468 Inflammation MESH:D007249 marker/mechanism|therapeutic 19926821|21354099 +PPARG 5468 Insulin Resistance MESH:D007333 therapeutic 16168052|21354099|21484566 +PPARG 5468 Ischemia MESH:D007511 therapeutic 12468449|24433871 +PPARG 5468 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +PPARG 5468 Leukostasis MESH:D018921 therapeutic 12468449 +PPARG 5468 Lipidoses MESH:D008064 marker/mechanism 21123845 +PPARG 5468 Lipodystrophy, Familial Partial MESH:D052496 marker/mechanism 604367.0 19793595 +PPARG 5468 Liver Neoplasms MESH:D008113 marker/mechanism 20143881 +PPARG 5468 Lymphoma, T-Cell MESH:D016399 marker/mechanism 17255338 +PPARG 5468 Melanoma MESH:D008545 marker/mechanism|therapeutic 14512786|28962521 +PPARG 5468 Metabolic Diseases MESH:D008659 marker/mechanism 19589179 +PPARG 5468 Nerve Degeneration MESH:D009410 therapeutic 18289512 +PPARG 5468 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +PPARG 5468 Obesity MESH:D009765 marker/mechanism 601665.0 11089532|28242765 +PPARG 5468 Osteoarthritis MESH:D010003 marker/mechanism 17568789 +PPARG 5468 Pancreatic Neoplasms MESH:D010190 marker/mechanism|therapeutic 11034103|11741176 +PPARG 5468 Pituitary ACTH Hypersecretion MESH:D047748 therapeutic 16809932 +PPARG 5468 Polycystic Kidney, Autosomal Dominant MESH:D016891 marker/mechanism 20210794 +PPARG 5468 Pre-Eclampsia MESH:D011225 marker/mechanism 34995009 +PPARG 5468 Psoriasis MESH:D011565 therapeutic 10815854 +PPARG 5468 Renal Insufficiency MESH:D051437 marker/mechanism 28182703 +PPARG 5468 Reperfusion Injury MESH:D015427 therapeutic 12468449|24011919|24433871 +PPARG 5468 Stomach Neoplasms MESH:D013274 marker/mechanism|therapeutic 15492468|19140230 +PPARG 5468 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 29162556 +PPARG 5468 Thyroid cancer, follicular MESH:C572845 marker/mechanism 15785241 +PPARG 5468 Thyroid Neoplasms MESH:D013964 therapeutic 15785241 +PPARGC1A 10891 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22975021 +PPARGC1A 10891 Bowen's Disease MESH:D001913 marker/mechanism 21514422 +PPARGC1A 10891 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254 +PPARGC1A 10891 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14563825 +PPARGC1A 10891 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 15592662|17317762 +PPARGC1A 10891 Heart Failure MESH:D006333 marker/mechanism 19808358|22503866 +PPARGC1A 10891 Lewy Body Disease MESH:D020961 marker/mechanism 30236862 +PPARGC1A 10891 Muscular Dystrophy, Animal MESH:D009137 therapeutic 22795790 +PPARGC1A 10891 Myocardial Infarction MESH:D009203 marker/mechanism 22503866 +PPARGC1A 10891 Parkinson Disease MESH:D010300 marker/mechanism 30236862 +PPARGC1B 133522 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22975021 +PPARGC1B 133522 Breast Neoplasms MESH:D001943 marker/mechanism 20961995 +PPARGC1B 133522 Hyperlipidemias MESH:D006949 marker/mechanism 17932310 +PPARGC1B 133522 Obesity MESH:D009765 marker/mechanism 30738174 +PPAT 5471 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 761203 +PPAT 5471 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PPBP 5473 Hypersensitivity MESH:D006967 marker/mechanism 23624239 +PPBP 5473 Hypertension MESH:D006973 marker/mechanism 15513305|6192689 +PPBP 5473 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +PPFIA4 8497 Atrial Fibrillation MESH:D001281 marker/mechanism 28416822|29892015|30061737 +PPFIBP1 8496 Plasma Cell Granuloma, Pulmonary MESH:D016726 marker/mechanism 21430068 +PPFIBP2 8495 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +PPFIBP2 8495 Prostatic Neoplasms MESH:D011471 marker/mechanism 26443449 +PPIA 5478 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17094902 +PPIA 5478 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +PPIA 5478 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +PPIA 5478 Neoplasm Metastasis MESH:D009362 marker/mechanism 21956400 +PPIA 5478 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +PPIB 5479 HIV Infections MESH:D015658 marker/mechanism 15308739 +PPIB 5479 Osteogenesis Imperfecta, Type IX MESH:C564921 marker/mechanism 259440.0 +PPIC 5480 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +PPIF 10105 Intestinal Diseases MESH:D007410 marker/mechanism 20668000 +PPIF 10105 Ulcer MESH:D014456 marker/mechanism 20668000 +PPL 5493 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +PPM1B 5495 Hypotonia-Cystinuria Syndrome MESH:C564710 marker/mechanism 26247364 +PPM1B 5495 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PPM1D 8493 Brain Stem Neoplasms MESH:D020295 marker/mechanism 24880341 +PPM1D 8493 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +PPM1D 8493 Glioma MESH:D005910 marker/mechanism 24880341 +PPM1D 8493 JANSEN-DE VRIES SYNDROME OMIM:617450 marker/mechanism 617450.0 +PPM1D 8493 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +PPM1E 22843 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +PPM1K 152926 Heart Failure MESH:D006333 marker/mechanism 36071497 +PPM1K 152926 Maple Syrup Urine Disease MESH:D008375 marker/mechanism 615135.0 +PPM1L 151742 Obesity MESH:D009765 marker/mechanism 18344982 +PPOX 5498 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +PPOX 5498 Porphyria, Variegate MESH:D046350 marker/mechanism 176200.0 +PPP1CC 5501 Ovarian Neoplasms MESH:D010051 marker/mechanism 21397856 +PPP1R12B 4660 Breast Neoplasms MESH:D001943 marker/mechanism 28650484 +PPP1R12B 4660 Carcinoma, Lobular MESH:D018275 marker/mechanism 28650484 +PPP1R12B 4660 Neoplasm Invasiveness MESH:D009361 marker/mechanism 28650484 +PPP1R13L 10848 Leukemia MESH:D007938 marker/mechanism 19299014 +PPP1R14A 94274 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +PPP1R14A 94274 Mesothelioma MESH:D008654 marker/mechanism 18835652 +PPP1R14B 26472 Melanoma MESH:D008545 marker/mechanism 22535842 +PPP1R15A 23645 Spinal Cord Injuries MESH:D013119 marker/mechanism 29793971 +PPP1R15B 84919 MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2 OMIM:616817 marker/mechanism 616817.0 +PPP1R17 10842 HYPERCHOLESTEROLEMIA, FAMILIAL, 1 OMIM:143890 marker/mechanism 143890.0 +PPP1R18 170954 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PPP1R1A 5502 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 20071777 +PPP1R1A 5502 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15010824 +PPP1R1A 5502 Cardiomyopathies MESH:D009202 marker/mechanism 20071777 +PPP1R1A 5502 Heart Failure MESH:D006333 therapeutic 20071777 +PPP1R1B 84152 Catalepsy MESH:D002375 therapeutic 20682746 +PPP1R1B 84152 Dyskinesias MESH:D020820 therapeutic 20682746 +PPP1R3A 5506 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 +PPP1R3B 79660 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PPP1R3C 5507 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PPP1R9B 84687 Sinusitis MESH:D012852 marker/mechanism 18391768 +PPP2CA 5515 Asthma MESH:D001249 marker/mechanism 22205926 +PPP2CA 5515 Heart Diseases MESH:D006331 marker/mechanism 15247211 +PPP2CA 5515 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PPP2R1A 5518 Disease Progression MESH:D018450 marker/mechanism 21364753 +PPP2R1A 5518 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 36 OMIM:616362 marker/mechanism 616362.0 +PPP2R1A 5518 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +PPP2R1A 5518 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PPP2R1B 5519 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 +PPP2R2A 5520 Chromosomal Instability MESH:D043171 therapeutic 25772433 +PPP2R2A 5520 Emphysema MESH:D004646 marker/mechanism 22223484 +PPP2R2A 5520 Micronuclei, Chromosome-Defective MESH:D048629 therapeutic 25772433 +PPP2R2A 5520 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +PPP2R2B 5521 Spinocerebellar Ataxia 12 MESH:C565790 marker/mechanism 604326.0 +PPP2R2B 5521 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 18940801 +PPP2R2C 5522 Emphysema MESH:D004646 marker/mechanism 22223484 +PPP2R3A 5523 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +PPP2R5A 5525 Emphysema MESH:D004646 marker/mechanism 22223484 +PPP2R5C 5527 Chromosomal Instability MESH:D043171 marker/mechanism 25772433 +PPP2R5C 5527 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 16038780 +PPP2R5C 5527 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 25772433 +PPP2R5C 5527 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +PPP2R5D 5528 HOUGE-JANSSENS SYNDROME 1 OMIM:616355 marker/mechanism 616355.0 +PPP2R5D 5528 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +PPP2R5E 5529 Chromosomal Instability MESH:D043171 therapeutic 25772433 +PPP2R5E 5529 Micronuclei, Chromosome-Defective MESH:D048629 therapeutic 25772433 +PPP3CA 5530 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +PPP3CA 5530 Brain Injuries MESH:D001930 marker/mechanism 14499481 +PPP3CA 5530 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 30365097 +PPP3CA 5530 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +PPP3CA 5530 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 18344631 +PPP3CA 5530 Pancreatitis MESH:D010195 marker/mechanism 22952646 +PPP3CA 5530 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +PPP3CA 5530 Testicular Diseases MESH:D013733 marker/mechanism 17785681 +PPP3CB 5532 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +PPP3CC 5533 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29275364 +PPP3CC 5533 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 29275364 +PPP3R1 5534 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 18344631 +PPP3R1 5534 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PPP4R3C 139420 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PPP6C 5537 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +PPP6C 5537 Melanoma MESH:D008545 marker/mechanism 22842228 +PPT1 5538 Ceroid Lipofuscinosis, Neuronal, 1 MESH:C564953 marker/mechanism 256730.0 9425237 +PPT1 5538 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254|27722792|7637805 +PPT1 5538 Neoplasms MESH:D009369 marker/mechanism 30442709 +PPTC7 160760 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +PQBP1 10084 Growth Disorders MESH:D006130 marker/mechanism 14634649|16740914 +PQBP1 10084 Heart Septal Defects, Atrial MESH:D006344 marker/mechanism 16740914 +PQBP1 10084 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 14634649|15024694 +PQBP1 10084 Microcephaly MESH:D008831 marker/mechanism 14634649|15024694|16740914 +PQBP1 10084 Renpenning syndrome 1 MESH:C537761 marker/mechanism 309500.0 15024694|15782410|16740914 +PQBP1 10084 Spastic Paraplegia, Hereditary MESH:D015419 marker/mechanism 14634649 +PRAF2 11230 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRAME 23532 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 16179254 +PRAME 23532 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 16179254 +PRAME 23532 Head and Neck Neoplasms MESH:D006258 marker/mechanism 16179254 +PRAME 23532 Leukemia MESH:D007938 marker/mechanism 16179254 +PRAME 23532 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 17157168 +PRAME 23532 Medulloblastoma MESH:D008527 marker/mechanism 16179254 +PRAME 23532 Melanoma MESH:D008545 marker/mechanism 16179254 +PRAME 23532 Multiple Myeloma MESH:D009101 marker/mechanism 16179254 +PRAME 23532 Sarcoma MESH:D012509 marker/mechanism 16179254 +PRC1 9055 Breast Neoplasms MESH:D001943 marker/mechanism 25038754 +PRC1 9055 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PRC1 9055 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +PRC1 9055 Ovarian Neoplasms MESH:D010051 marker/mechanism 31043753 +PRCC 5546 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 605074.0 +PRCD 768206 Retinitis Pigmentosa 36 MESH:C566431 marker/mechanism 610599.0 +PRDM1 639 Acute Lung Injury MESH:D055371 therapeutic 33109608 +PRDM1 639 Arthritis, Experimental MESH:D001169 therapeutic 36181686 +PRDM1 639 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19898481|20453842|23143596|36181686 +PRDM1 639 Colitis, Ulcerative MESH:D003093 marker/mechanism 21297633 +PRDM1 639 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838195 +PRDM1 639 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097067 +PRDM12 59335 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII OMIM:616488 marker/mechanism 616488.0 +PRDM12 59335 Pain Insensitivity, Congenital MESH:D000699 marker/mechanism 26005867 +PRDM14 63978 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 19043588 +PRDM14 63978 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 23666240 +PRDM16 63976 Coronary Artery Disease MESH:D003324 marker/mechanism 35590109 +PRDM16 63976 LEFT VENTRICULAR NONCOMPACTION 8 OMIM:615373 marker/mechanism 615373.0 +PRDM16 63976 Migraine Disorders MESH:D008881 marker/mechanism 21666692 +PRDM2 7799 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +PRDM2 7799 Thyroid Neoplasms MESH:D013964 marker/mechanism 17103461 +PRDM2 7799 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +PRDM5 11107 BRITTLE CORNEA SYNDROME 2 OMIM:614170 marker/mechanism 614170.0 +PRDM6 93166 Ductus Arteriosus, Patent MESH:D004374 marker/mechanism 617039.0 +PRDM8 56978 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 616640.0 +PRDX1 5052 Asbestosis MESH:D001195 marker/mechanism 22537621 +PRDX1 5052 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 27517622 +PRDX1 5052 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17094902 +PRDX1 5052 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +PRDX1 5052 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +PRDX1 5052 Keloid MESH:D007627 marker/mechanism 20128793 +PRDX1 5052 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 27517622 +PRDX1 5052 Lung Neoplasms MESH:D008175 marker/mechanism 22537621 +PRDX1 5052 Methylmalonic acidemia with homocystinuria MESH:C537359 marker/mechanism 277400.0 +PRDX1 5052 Precancerous Conditions MESH:D011230 marker/mechanism 15986332 +PRDX1 5052 Schistosomiasis MESH:D012552 therapeutic 19041905 +PRDX-2 266858 Death MESH:D003643 marker/mechanism 25204677 +PRDX-2 266858 Disease MESH:D004194 marker/mechanism 25204677 +PRDX-2 266858 Infertility MESH:D007246 marker/mechanism 25204677 +PRDX2 7001 Asbestosis MESH:D001195 marker/mechanism 22537621 +PRDX2 7001 Carcinoma MESH:D002277 marker/mechanism 16316942 +PRDX2 7001 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +PRDX2 7001 Down Syndrome MESH:D004314 marker/mechanism 11771762 +PRDX2 7001 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +PRDX2 7001 Keloid MESH:D007627 marker/mechanism 20128793 +PRDX2 7001 Leukemia, Myeloid MESH:D007951 therapeutic 16932348 +PRDX2 7001 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +PRDX2 7001 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +PRDX2 7001 Melanoma MESH:D008545 marker/mechanism 16778180 +PRDX2 7001 Neoplasm Invasiveness MESH:D009361 marker/mechanism 23911960 +PRDX2 7001 Osteosarcoma MESH:D012516 marker/mechanism 23911960 +PRDX2 7001 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973 +PRDX-3 175573 Death MESH:D003643 marker/mechanism 25204677 +PRDX-3 175573 Infertility MESH:D007246 marker/mechanism 25204677 +PRDX3 10935 Disease Progression MESH:D018450 marker/mechanism 16081686 +PRDX3 10935 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 16081686 +PRDX3 10935 Motor Neuron Disease MESH:D016472 marker/mechanism 16702190 +PRDX3 10935 Non-alcoholic Fatty Liver Disease MESH:D065626 therapeutic 34678374 +PRDX3 10935 Osteoporosis MESH:D010024 marker/mechanism 18924182 +PRDX4 10549 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +PRDX4 10549 Disease Progression MESH:D018450 marker/mechanism 16081686 +PRDX4 10549 Glucose Intolerance MESH:D018149 therapeutic 20446767 +PRDX4 10549 Hyperglycemia MESH:D006943 therapeutic 20446767 +PRDX4 10549 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 16081686 +PRDX5 25824 Alopecia Areata MESH:D000506 marker/mechanism 20596022 +PRDX5 25824 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +PRDX6 9588 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +PRDX6 9588 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +PRDX6 9588 Down Syndrome MESH:D004314 marker/mechanism 11771762 +PRDX6 9588 Lung Neoplasms MESH:D008175 marker/mechanism 23692979 +PRDX6 9588 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PRDX6 9588 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +PREP 5550 Amnesia MESH:D000647 marker/mechanism 8691432 +PREP 5550 Amnesia, Retrograde MESH:D000648 marker/mechanism 18318186 +PREP 5550 Disease Progression MESH:D018450 marker/mechanism 21364753 +PREP 5550 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PREPL 9581 Hypotonia-Cystinuria Syndrome MESH:C564710 marker/mechanism 26247364 +PREPL 9581 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 616224.0 +PRF1 5551 Anemia, Aplastic MESH:D000741 marker/mechanism 609135.0 +PRF1 5551 Autistic Disorder MESH:D001321 marker/mechanism 18762240 +PRF1 5551 Hemophagocytic lymphohistiocytosis, familial, 2 MESH:C537250 marker/mechanism 603553.0 +PRF1 5551 Influenza, Human MESH:D007251 marker/mechanism 26597256 +PRF1 5551 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 605027.0 +PRF1 5551 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 24211274 +PRG2 5553 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PRG4 10216 Contracture MESH:D003286 marker/mechanism 10545950 +PRG4 10216 Hyperplasia MESH:D006965 marker/mechanism 10545950 +PRG4 10216 Jacobs syndrome MESH:C537560 marker/mechanism 208250.0 10545950 +PRG4 10216 Pericarditis MESH:D010493 marker/mechanism 10545950 +PRICKLE1 144165 Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia MESH:C580388 marker/mechanism 612437.0 +PRICKLE2 166336 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +PRICKLE2 166336 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +PRICKLE3 4007 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 308905.0 +PRIMA1 145270 Muscular Dystrophies MESH:D009136 marker/mechanism 22906800 +PRIMPOL 201973 MYOPIA 22, AUTOSOMAL DOMINANT OMIM:615420 marker/mechanism 615420.0 +PRKAA1 5562 Glucose Intolerance MESH:D018149 marker/mechanism 19934007 +PRKAA1 5562 Helicobacter Infections MESH:D016481 marker/mechanism 28220687 +PRKAA1 5562 Insulin Resistance MESH:D007333 marker/mechanism 19934007 +PRKAA1 5562 Precancerous Conditions MESH:D011230 marker/mechanism 28220687 +PRKAA1 5562 Stomach Neoplasms MESH:D013274 marker/mechanism 26098866 +PRKAA2 5563 Cardiomegaly MESH:D006332 therapeutic 18812163 +PRKAA2 5563 Cardiomyopathies MESH:D009202 marker/mechanism 21037199 +PRKAA2 5563 Glucose Intolerance MESH:D018149 marker/mechanism 19934007 +PRKAA2 5563 Insulin Resistance MESH:D007333 marker/mechanism 19934007 +PRKAA2 5563 Stroke MESH:D020521 therapeutic 20847317 +PRKAA2 5563 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 29753072 +PRKAB1 5564 Disease Progression MESH:D018450 marker/mechanism 21364753 +PRKAB1 5564 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PRKACA 5566 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 24747643 +PRKACA 5566 Cholangiocarcinoma MESH:D018281 marker/mechanism 26258846 +PRKACA 5566 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29341352 +PRKACA 5566 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4 OMIM:615830 marker/mechanism 615830.0 +PRKACB 5567 Adrenocortical Adenoma MESH:D018246 marker/mechanism 29669941 +PRKACB 5567 Biliary Tract Neoplasms MESH:D001661 marker/mechanism 26258846 +PRKACB 5567 Cholangiocarcinoma MESH:D018281 marker/mechanism 26258846 +PRKACB 5567 Cushing Syndrome MESH:D003480 marker/mechanism 29669941 +PRKACB 5567 Prostatic Neoplasms MESH:D011471 marker/mechanism 16949795 +PRKACG 5568 BLEEDING DISORDER, PLATELET-TYPE, 19 OMIM:616176 marker/mechanism 616176.0 +PRKAG2 51422 Cardiomyopathy, Familial Hypertrophic, 6 MESH:C563436 marker/mechanism 600858.0 +PRKAG2 51422 Glycogen Storage Disease of Heart, Lethal Congenital MESH:C564888 marker/mechanism 261740.0 +PRKAG2 51422 Wolff-Parkinson-White Syndrome MESH:D014927 marker/mechanism 194200.0 +PRKAG3 53632 Carbohydrate Metabolism, Inborn Errors MESH:D002239 marker/mechanism 10818001|17878938 +PRKAG3 53632 Lipid Metabolism, Inborn Errors MESH:D008052 marker/mechanism 17878938 +PRKAR1A 5573 Acrodysostosis MESH:C538179 marker/mechanism 101800.0 27825928 +PRKAR1A 5573 Adrenal Hyperplasia, Congenital MESH:D000312 marker/mechanism 15521956 +PRKAR1A 5573 Alopecia MESH:D000505 marker/mechanism 29367455 +PRKAR1A 5573 Apparent mineralocorticoid excess MESH:C537422 marker/mechanism 15521956 +PRKAR1A 5573 Atrial myxoma, familial MESH:C538262 marker/mechanism 255960.0 +PRKAR1A 5573 Carney Complex MESH:D056733 marker/mechanism 160980.0 27825928 +PRKAR1A 5573 Cushing Syndrome MESH:D003480 marker/mechanism 15521956|29367455 +PRKAR1A 5573 Hyperglycemia MESH:D006943 marker/mechanism 29367455 +PRKAR1A 5573 Insulin Resistance MESH:D007333 marker/mechanism 29367455 +PRKAR1A 5573 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 17712046 +PRKAR1A 5573 Muscular Atrophy MESH:D009133 marker/mechanism 29367455 +PRKAR1A 5573 Obesity MESH:D009765 marker/mechanism 29367455 +PRKAR1A 5573 Pigmented Nodular Adrenocortical Disease, Primary, 1 MESH:C566469 marker/mechanism 610489.0 +PRKAR2B 5577 Heart Failure MESH:D006333 marker/mechanism 26670611 +PRKAR2B 5577 Obesity MESH:D009765 marker/mechanism 20975297 +PRKCA 5578 Asthma, Occupational MESH:D059366 marker/mechanism 27504716 +PRKCA 5578 Cardiomegaly MESH:D006332 marker/mechanism 21565836 +PRKCA 5578 Diabetes Insipidus, Nephrogenic MESH:D018500 marker/mechanism 25006961 +PRKCA 5578 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 12198386 +PRKCA 5578 Intestinal Neoplasms MESH:D007414 marker/mechanism 11983831 +PRKCA 5578 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29341352 +PRKCA 5578 Polyuria MESH:D011141 marker/mechanism 25006961 +PRKCB 5579 Autistic Disorder MESH:D001321 marker/mechanism 16027742 +PRKCB 5579 Cardiomegaly MESH:D006332 marker/mechanism 17121852 +PRKCB 5579 Colorectal Neoplasms MESH:D015179 marker/mechanism 7705931 +PRKCB 5579 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 15531508 +PRKCB 5579 Hyperglycemia MESH:D006943 marker/mechanism 17443133 +PRKCB 5579 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +PRKCB 5579 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRKCB 5579 Stomach Neoplasms MESH:D013274 marker/mechanism 17003101 +PRKCD 5580 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III OMIM:615559 marker/mechanism 615559.0 +PRKCD 5580 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 30393195 +PRKCD 5580 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 12198386 +PRKCD 5580 Fever MESH:D005334 therapeutic 31422080|32437895 +PRKCD 5580 Hypertension MESH:D006973 marker/mechanism 23973649 +PRKCD 5580 Hypothermia MESH:D007035 therapeutic 30366073 +PRKCD 5580 Intestinal Neoplasms MESH:D007414 marker/mechanism 11983831 +PRKCD 5580 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRKCD 5580 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 22512859 +PRKCD 5580 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29341352 +PRKCD 5580 Parkinsonian Disorders MESH:D020734 therapeutic 15681813 +PRKCD 5580 Seizures MESH:D012640 marker/mechanism 25895139 +PRKCE 5581 Cardiomyopathies MESH:D009202 marker/mechanism 15242976 +PRKCE 5581 Colorectal Neoplasms MESH:D015179 marker/mechanism 7705931 +PRKCE 5581 Coronary Stenosis MESH:D023921 marker/mechanism 16782078 +PRKCE 5581 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 12198386 +PRKCE 5581 Diabetic Nephropathies MESH:D003928 marker/mechanism 20665664 +PRKCE 5581 Hyperalgesia MESH:D006930 marker/mechanism 11738263|12582831|20457222 +PRKCE 5581 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +PRKCE 5581 Myocardial Infarction MESH:D009203 therapeutic 16782078 +PRKCE 5581 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PRKCE 5581 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29341352 +PRKCE 5581 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20726883 +PRKCE 5581 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PRKCG 5582 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +PRKCG 5582 Hyperalgesia MESH:D006930 marker/mechanism 19955894|27093858 +PRKCG 5582 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +PRKCG 5582 Spinocerebellar ataxia 14 MESH:C537196 marker/mechanism 605361.0 +PRKCG 5582 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 20398063 +PRKCG 5582 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +PRKCH 5583 Ischemic Stroke MESH:D000083242 marker/mechanism 601367.0 +PRKCH 5583 Obesity MESH:D009765 marker/mechanism 23563609 +PRKCH 5583 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PRKCI 5584 Autistic Disorder MESH:D001321 marker/mechanism 20957522 +PRKCQ 5588 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 18794853|20453842|23143596 +PRKCQ 5588 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 18978792 +PRKCQ 5588 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +PRKCQ 5588 Retinal Detachment MESH:D012163 marker/mechanism 26978024 +PRKCSH 5589 Polycystic Kidney Diseases MESH:D007690 marker/mechanism 21685914 +PRKCSH 5589 Polycystic liver disease MESH:C536330 marker/mechanism 174050.0 21685914|24719335 +PRKCZ 5590 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PRKCZ 5590 Cardiomegaly MESH:D006332 therapeutic 27094369 +PRKCZ 5590 Hyperalgesia MESH:D006930 marker/mechanism 27899695 +PRKCZ 5590 Leukemia MESH:D007938 marker/mechanism 12970779 +PRKCZ 5590 Prostatic Neoplasms MESH:D011471 marker/mechanism 16931574 +PRKD1 5587 Adenocarcinoma MESH:D000230 marker/mechanism 25240283 +PRKD1 5587 Asthma, Occupational MESH:D059366 marker/mechanism 27504716 +PRKD1 5587 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +PRKD1 5587 CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA OMIM:617364 marker/mechanism 617364.0 +PRKD1 5587 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 25240283 +PRKD2 25865 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18758461 +PRKD2 25865 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PRKD3 23683 Weight Gain MESH:D015430 marker/mechanism 19030233 +PRKDC 5591 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +PRKDC 5591 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 25125259 +PRKDC 5591 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 21224054 +PRKDC 5591 Hepatic Encephalopathy MESH:D006501 marker/mechanism 21224054 +PRKDC 5591 IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES OMIM:615966 marker/mechanism 615966.0 +PRKDC 5591 Lung Diseases MESH:D008171 marker/mechanism 17200189 +PRKDC 5591 Massive Hepatic Necrosis MESH:D047508 marker/mechanism 21224054 +PRKDC 5591 Poisoning MESH:D011041 marker/mechanism 20036648 +PRKDC 5591 Prostatic Neoplasms MESH:D011471 marker/mechanism 17196815|25415046 +PRKG1 5592 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +PRKG1 5592 AORTIC ANEURYSM, FAMILIAL THORACIC 8 OMIM:615436 marker/mechanism 615436.0 +PRKG1 5592 Hypertension, Pulmonary MESH:D006976 marker/mechanism 21351102 +PRKG1 5592 Neuralgia MESH:D009437 marker/mechanism 30152261 +PRKG1 5592 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +PRKG1 5592 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +PRKN 5071 Autistic Disorder MESH:D001321 marker/mechanism 19404257 +PRKN 5071 Colonic Neoplasms MESH:D003110 marker/mechanism 19946270 +PRKN 5071 Disease Models, Animal MESH:D004195 marker/mechanism 15882845 +PRKN 5071 Glioblastoma MESH:D005909 marker/mechanism 19946270 +PRKN 5071 Learning Disabilities MESH:D007859 marker/mechanism 12915482 +PRKN 5071 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 19946270|25640678 +PRKN 5071 Manganese Poisoning MESH:D020149 therapeutic 20089134 +PRKN 5071 Memory Disorders MESH:D008569 marker/mechanism 12915482 +PRKN 5071 Nerve Degeneration MESH:D009410 marker/mechanism 17687034 +PRKN 5071 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +PRKN 5071 Ovarian Neoplasms MESH:D010051 marker/mechanism 167000.0 +PRKN 5071 Parkinson Disease MESH:D010300 marker/mechanism 12588799|15198987|15882845|16573651|17010972|19946270|22043175|22841634|23628791|24582596|25149416|25631236|28284907 +PRKN 5071 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 15993444 +PRKN 5071 Parkinsonian Disorders MESH:D020734 marker/mechanism|therapeutic 600116.0 10072423|10894217|11254447|12764051|16914382|23046578|25640678|26558463 +PRKRA 8575 Congenital Microtia MESH:D065817 marker/mechanism 25554729 +PRKRA 8575 Craniofacial Abnormalities MESH:D019465 marker/mechanism 22194846 +PRKRA 8575 Dystonia MESH:D004421 marker/mechanism 612067.0 +PRKRA 8575 Dystonia 16 MESH:C567430 marker/mechanism 25554729 +PRKRA 8575 Dystonic Disorders MESH:D020821 marker/mechanism 18243799 +PRKRA 8575 Hearing Disorders MESH:D006311 marker/mechanism 25554729 +PRKRA 8575 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +PRKRA 8575 Parkinsonian Disorders MESH:D020734 marker/mechanism 18243799 +PRL 5617 Adenocarcinoma MESH:D000230 marker/mechanism 6280079 +PRL 5617 Adenoma MESH:D000236 marker/mechanism 12058109|2274009 +PRL 5617 Amenorrhea MESH:D000568 marker/mechanism 6777091 +PRL 5617 Anemia MESH:D000740 therapeutic 10340396 +PRL 5617 Autistic Disorder MESH:D001321 marker/mechanism 18207134 +PRL 5617 Basal Ganglia Diseases MESH:D001480 marker/mechanism 7214106 +PRL 5617 Bradycardia MESH:D001919 marker/mechanism 6350720 +PRL 5617 Catalepsy MESH:D002375 marker/mechanism 7197982 +PRL 5617 Cocaine-Related Disorders MESH:D019970 marker/mechanism 15064918 +PRL 5617 Endometriosis MESH:D004715 marker/mechanism 11925390 +PRL 5617 Erectile Dysfunction MESH:D007172 marker/mechanism 15829128|387166|4001434|7878608|8845563 +PRL 5617 Fetal Resorption MESH:D005327 therapeutic 3816235 +PRL 5617 Fever MESH:D005334 marker/mechanism 6350720 +PRL 5617 Galactorrhea MESH:D005687 marker/mechanism 20083845 +PRL 5617 Growth Hormone-Secreting Pituitary Adenoma MESH:D049912 marker/mechanism 2042694 +PRL 5617 Gynecomastia MESH:D006177 marker/mechanism 7878608|9334596 +PRL 5617 Heart Failure MESH:D006333 marker/mechanism 18926768 +PRL 5617 Hyperprolactinemia MESH:D006966 marker/mechanism 17303669|2880862|2948424|4001434 +PRL 5617 Hypogonadism MESH:D007006 marker/mechanism 15829128 +PRL 5617 Hypopituitarism MESH:D007018 marker/mechanism 1304515 +PRL 5617 Hypotension MESH:D007022 marker/mechanism 6350720|71628 +PRL 5617 Infarction MESH:D007238 marker/mechanism 718334 +PRL 5617 Infertility, Female MESH:D007247 marker/mechanism 19531635 +PRL 5617 Leydig Cell Tumor MESH:D007984 therapeutic 4092719 +PRL 5617 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 14870917 +PRL 5617 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942|6280079 +PRL 5617 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +PRL 5617 Memory Disorders MESH:D008569 therapeutic 36100143 +PRL 5617 Motor Disorders MESH:D000068079 therapeutic 36100143 +PRL 5617 Parkinsonian Disorders MESH:D020734 marker/mechanism 240179 +PRL 5617 Phobic Disorders MESH:D010698 marker/mechanism 2554359 +PRL 5617 Pituitary Neoplasms MESH:D010911 marker/mechanism|therapeutic 2274009|3498743|6156259 +PRL 5617 Pregnancy Complications, Cardiovascular MESH:D011249 marker/mechanism 18926768 +PRL 5617 Prolactinoma MESH:D015175 marker/mechanism 1407345|3776530|718334|9617019 +PRL 5617 Prostatic Hyperplasia MESH:D011470 marker/mechanism 2208075 +PRL 5617 Puerperal Disorders MESH:D011644 marker/mechanism 18926768 +PRL 5617 Sexual Dysfunction, Physiological MESH:D012735 marker/mechanism 10084644|15677431 +PRL 5617 Sexual Dysfunctions, Psychological MESH:D020018 marker/mechanism 15829128|9334596 +PRL 5617 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 9037573 +PRLR 5618 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +PRLR 5618 Autistic Disorder MESH:D001321 marker/mechanism 18207134 +PRLR 5618 Carcinoma MESH:D002277 marker/mechanism 16316942|17173897 +PRLR 5618 Endometriosis MESH:D004715 marker/mechanism 20864642 +PRLR 5618 Hyperprolactinemia MESH:D006966 marker/mechanism 615555.0 +PRLR 5618 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRLR 5618 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942|17173897 +PRLR 5618 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +PRLR 5618 MULTIPLE FIBROADENOMAS OF THE BREAST OMIM:615554 marker/mechanism 615554.0 +PRM 39002 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +PRMT5 10419 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 31123343 +PRMT5 10419 Medulloblastoma MESH:D008527 therapeutic 31694585 +PRMT5 10419 Multiple Myeloma MESH:D009101 marker/mechanism 29158558 +PRMT5 10419 Triple Negative Breast Neoplasms MESH:D064726 therapeutic 30957988 +PRMT6 55170 Cocaine-Related Disorders MESH:D019970 marker/mechanism 27506785 +PRNP 5621 Alzheimer Disease MESH:D000544 marker/mechanism 17192785 +PRNP 5621 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 123400.0 12572668|23349890 +PRNP 5621 Gerstmann-Straussler-Scheinker Disease MESH:D016098 marker/mechanism 137440.0 10203975 +PRNP 5621 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 16831968 +PRNP 5621 Huntington Disease-Like 1 MESH:C566398 marker/mechanism 603218.0 +PRNP 5621 Insomnia, Fatal Familial MESH:D034062 marker/mechanism 600072.0 +PRNP 5621 Kuru MESH:D007729 marker/mechanism 245300.0 +PRNP 5621 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRNP 5621 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +PRNP 5621 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 25401298 +PRNP 5621 Necrosis MESH:D009336 marker/mechanism 18547651 +PRNP 5621 Neoplasm Metastasis MESH:D009362 marker/mechanism 17387271 +PRNP 5621 Neoplasms, Experimental MESH:D009374 marker/mechanism 21265952 +PRNP 5621 Prion Diseases MESH:D017096 marker/mechanism 11701772|11994310|17257012|17274528 +PRNP 5621 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +PRNP 5621 Scrapie MESH:D012608 marker/mechanism 11701772|18717736|19486493|21533749 +PRNP 5621 Spongiform Encephalopathy with Neuropsychiatric Features MESH:C564678 marker/mechanism 606688.0 +PRNP 5621 Stomach Neoplasms MESH:D013274 marker/mechanism 17387271 +PROC 5624 Arteritis MESH:D001167 marker/mechanism 17139375 +PROC 5624 Cerebral Infarction MESH:D002544 marker/mechanism 33761690 +PROC 5624 Congenital thrombotic disease, due to Protein C deficiency MESH:C535424 marker/mechanism 176860.0 25748729 +PROC 5624 Disseminated Intravascular Coagulation MESH:D004211 marker/mechanism 18376272 +PROC 5624 Hypertension MESH:D006973 marker/mechanism 22352330 +PROC 5624 Protein C Deficiency MESH:D020151 marker/mechanism|therapeutic 14707701|18376272|21445774|33761690 +PROC 5624 Purpura Fulminans MESH:D055665 marker/mechanism 18376272 +PROC 5624 Sepsis MESH:D018805 therapeutic 11820775|17556722 +PROC 5624 Thromboembolism MESH:D013923 marker/mechanism 8052960 +PROC 5624 THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE OMIM:612304 marker/mechanism 612304.0 +PROC 5624 Thrombosis MESH:D013927 marker/mechanism 11132655|18376272|8967151|9164807 +PROC 5624 Venous Thromboembolism MESH:D054556 marker/mechanism|therapeutic 21445774|9149031 +PROC 5624 Venous Thrombosis MESH:D020246 marker/mechanism 12730085|25748729 +PROCR 10544 Coronary Artery Disease MESH:D003324 marker/mechanism 28530674 +PROCR 10544 Inflammation MESH:D007249 marker/mechanism 23774263 +PROCR 10544 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRODH 5625 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 17412540 +PRODH 5625 HYPERPROLINEMIA, TYPE I OMIM:239500 marker/mechanism 239500.0 +PRODH 5625 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRODH 5625 Nervous System Diseases MESH:D009422 marker/mechanism 17412540 +PRODH 5625 Schizophrenia MESH:D012559 marker/mechanism 600850.0 16234811 +PRODH2 58510 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PROK1 84432 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PROK2 60675 Hyperalgesia MESH:D006930 marker/mechanism 16793879 +PROK2 60675 Kallmann Syndrome MESH:D017436 marker/mechanism 610628.0 +PROKR1 10887 Hyperalgesia MESH:D006930 marker/mechanism 16793879 +PROKR1 10887 Pain MESH:D010146 marker/mechanism 16793879 +PROKR2 128674 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 20576534 +PROKR2 128674 Kallmann Syndrome MESH:D017436 marker/mechanism 244200.0 +PROM1 8842 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 32673656 +PROM1 8842 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 29626521 +PROM1 8842 Colonic Neoplasms MESH:D003110 marker/mechanism 21188121 +PROM1 8842 Colorectal Neoplasms MESH:D015179 marker/mechanism 18829568 +PROM1 8842 Cone-Rod Dystrophy 12 MESH:C567206 marker/mechanism 612657.0 +PROM1 8842 Glioblastoma MESH:D005909 marker/mechanism 18679414|18829568|19718438 +PROM1 8842 Macular Dystrophy, Retinal, 2 MESH:C562746 marker/mechanism 608051.0 +PROM1 8842 Mixed Tumor, Mullerian MESH:D018200 marker/mechanism 21919130 +PROM1 8842 Retinitis Pigmentosa 41 MESH:C567422 marker/mechanism 612095.0 +PROM1 8842 Stargardt disease 4 MESH:C535521 marker/mechanism 603786.0 +PROM1 8842 Uterine Neoplasms MESH:D014594 marker/mechanism 21919130 +PROP1 5626 Pituitary Hormone Deficiency, Combined, 2 MESH:C563172 marker/mechanism 262600.0 +PROS1 5627 Activated Protein C Resistance MESH:D020016 marker/mechanism 11703344 +PROS1 5627 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +PROS1 5627 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +PROS1 5627 Sagittal Sinus Thrombosis MESH:D020225 marker/mechanism 18382986 +PROS1 5627 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +PROS1 5627 Thromboembolism MESH:D013923 marker/mechanism 8052960 +PROS1 5627 Thrombophilia, Hereditary, Due To Protein S Deficiency, Autosomal Dominant MESH:C567347 marker/mechanism 612336.0 +PROS1 5627 Thrombophilia, Hereditary, Due To Protein S Deficiency, Autosomal Recessive MESH:C567348 marker/mechanism 614514.0 +PROS1 5627 Thrombosis MESH:D013927 marker/mechanism 10706858|11132655 +PROX1 5629 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 20081858 +PROX1 5629 Neoplasm Metastasis MESH:D009362 marker/mechanism 17415710 +PRPF19 27339 Disease Progression MESH:D018450 marker/mechanism 21364753 +PRPF19 27339 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PRPF3 9129 Retinitis Pigmentosa 18 MESH:C563320 marker/mechanism 601414.0 +PRPF31 26121 Retinitis Pigmentosa 11 MESH:C563991 marker/mechanism 600138.0 +PRPF4 9128 RETINITIS PIGMENTOSA 70 OMIM:615922 marker/mechanism 615922.0 +PRPF4 9128 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +PRPF6 24148 RETINITIS PIGMENTOSA 60 OMIM:613983 marker/mechanism 613983.0 +PRPF8 10594 HIV Infections MESH:D015658 marker/mechanism 15308739 +PRPF8 10594 Retinitis Pigmentosa 13 MESH:C564008 marker/mechanism 600059.0 +PRPF8 10594 Stroke MESH:D020521 marker/mechanism 29531354 +PRPH 5630 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 105400.0 +PRPH2 5961 Choroidal Dystrophy, Central Areolar 2 MESH:C567750 marker/mechanism 613105.0 +PRPH2 5961 Fundus Albipunctatus MESH:C562733 marker/mechanism 136880.0 +PRPH2 5961 Patterned dystrophy of retinal pigment epithelium MESH:C536309 marker/mechanism 169150.0 +PRPH2 5961 Retinal Dystrophies MESH:D058499 marker/mechanism 28723922 +PRPH2 5961 Retinitis Pigmentosa 7 MESH:C564284 marker/mechanism 608133.0 +PRPH2 5961 Vitelliform Macular Dystrophy MESH:D057826 marker/mechanism 608161.0 +PRPS1 5631 Arts syndrome MESH:C535388 marker/mechanism 301835.0 +PRPS1 5631 Deafness, X-Linked 1 MESH:C564433 marker/mechanism 304500.0 +PRPS1 5631 Optic atrophy polyneuropathy deafness MESH:C537129 marker/mechanism 311070.0 +PRPS1 5631 Phosphoribosylpyrophosphate Synthetase Superactivity MESH:C567064 marker/mechanism 300661.0 +PRPS1 5631 Weight Gain MESH:D015430 marker/mechanism 19030233 +PRR13 54458 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21157449 +PRR13 54458 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRR5-ARHGAP8 553158 Colonic Neoplasms MESH:D003110 marker/mechanism 25279216 +PRR5-ARHGAP8 553158 Stomach Neoplasms MESH:D013274 marker/mechanism 25279216 +PRRT2 112476 Familial paroxysmal dystonia MESH:C537180 marker/mechanism 128200.0 22101681 +PRRT2 112476 Infantile convulsions and paroxysmal choreoathetosis, familial MESH:C535522 marker/mechanism 602066.0 +PRRT2 112476 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +PRRT2 112476 SEIZURES, BENIGN FAMILIAL INFANTILE, 2 OMIM:605751 marker/mechanism 605751.0 +PRRX1 5396 Atrial Fibrillation MESH:D001281 marker/mechanism 22544366 +PRRX1 5396 Demyelinating Diseases MESH:D003711 marker/mechanism 30566868 +PRRX1 5396 Dysgnathia complex MESH:C537996 marker/mechanism 202650.0 23444262 +PRRX1 5396 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +PRRX1 5396 Retrognathia MESH:D063173 marker/mechanism 23444262 +PRSS1 5644 Hereditary pancreatitis MESH:C537262 marker/mechanism 167800.0 8841182 +PRSS1 5644 Pancreatitis MESH:D010195 marker/mechanism 23143602 +PRSS1 5644 Pancreatitis, Chronic MESH:D050500 marker/mechanism 18206817 +PRSS12 8492 Mental Retardation, Autosomal Recessive 1 MESH:C565406 marker/mechanism 249500.0 +PRSS2 5645 Hereditary pancreatitis MESH:C537262 marker/mechanism 167800.0 +PRSS2 5645 Pancreatitis, Chronic MESH:D050500 marker/mechanism 16699518|18206817 +PRSS23 11098 Melanoma MESH:D008545 marker/mechanism 22535842 +PRSS3 5646 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 15987713 +PRSS35 167681 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +PRSS46 74306 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +PRSS56 646960 Glaucoma, Angle-Closure MESH:D015812 marker/mechanism 21532570 +PRSS56 646960 MICROPHTHALMIA, ISOLATED 6 OMIM:613517 marker/mechanism 613517.0 +PRSS56 646960 Microphthalmos MESH:D008850 marker/mechanism 21532570 +PRSS56 646960 Myopia MESH:D009216 marker/mechanism 23396134 +PRSS8 5652 Fetal Diseases MESH:D005315 marker/mechanism 22705055 +PRSS8 5652 Neural Tube Defects MESH:D009436 therapeutic 24722141 +PRSS8 5652 Placenta Diseases MESH:D010922 therapeutic 24722141 +PRSS8 5652 Prenatal Injuries MESH:D049188 therapeutic 24722141 +PRSS8 5652 Prostatic Neoplasms MESH:D011471 marker/mechanism 16541421 +PRSS8 5652 Skin Diseases MESH:D012871 marker/mechanism 22705055 +PRTFDC1 56952 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17599052 +PRTFDC1 56952 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRTFDC1 56952 Mouth Neoplasms MESH:D009062 marker/mechanism 17599052 +PRTFDC1 56952 Ovarian Neoplasms MESH:D010051 marker/mechanism 17303177 +PRTG 283659 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRTN3 5657 Granulomatosis with Polyangiitis MESH:D014890 marker/mechanism 25288799 +PRTN3 5657 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 17157168 +PRUNE2 158471 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PRX 57716 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F OMIM:614895 marker/mechanism 614895.0 +PRX 57716 Hereditary Sensory and Motor Neuropathy MESH:D015417 marker/mechanism 145900.0 +PRXL2B 127281 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +PRY 9081 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +PRY2 442862 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +PSAP 5660 Combined Saposin Deficiency MESH:C567125 marker/mechanism 611721.0 +PSAP 5660 Gaucher Disease, Atypical, Due To Saposin C Deficiency MESH:C566435 marker/mechanism 610539.0 +PSAP 5660 Krabbe Disease, Atypical, due to Saposin A Deficiency MESH:C567097 marker/mechanism 611722.0 +PSAP 5660 Metachromatic Leukodystrophy due to Saposin B Deficiency MESH:C562609 marker/mechanism 249900.0 +PSAT1 29968 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +PSAT1 29968 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 26482881 +PSAT1 29968 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +PSAT1 29968 Neu Laxova syndrome MESH:C536405 marker/mechanism 616038.0 +PSAT1 29968 Phosphoserine Aminotransferase Deficiency MESH:C567032 marker/mechanism 610992.0 +PSCA 8000 Duodenal Ulcer MESH:D004381 marker/mechanism 22387998 +PSCA 8000 Helicobacter Infections MESH:D016481 marker/mechanism 28220687 +PSCA 8000 Linitis Plastica MESH:D008039 marker/mechanism 18488030 +PSCA 8000 Precancerous Conditions MESH:D011230 marker/mechanism 28220687 +PSCA 8000 Prostatic Neoplasms MESH:D011471 marker/mechanism 16015594 +PSCA 8000 Stomach Neoplasms MESH:D013274 marker/mechanism 18488030|26098866 +PSCA 8000 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 19648920|20083643 +PSD2 84249 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +PSD3 23362 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +PSD3 23362 Glioma MESH:D005910 marker/mechanism 16865689 +PSEN1 5663 Alzheimer Disease MESH:D000544 marker/mechanism 15622541|16449385|16651627|17192785|17573346|17962197|18227305|22507317|25352456|25714973|27117003|27567873|28448946|31467635|7596406 +PSEN1 5663 Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia MESH:C564330 marker/mechanism 607822.0 +PSEN1 5663 Amyloid Neuropathies MESH:D017772 marker/mechanism 27567873 +PSEN1 5663 Amyloidosis MESH:D000686 marker/mechanism 23541064 +PSEN1 5663 Asphyxia Neonatorum MESH:D001238 marker/mechanism 17963755 +PSEN1 5663 Cardiomyopathies MESH:D009202 marker/mechanism 29068127 +PSEN1 5663 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 17186461 +PSEN1 5663 Cardiomyopathy, Dilated, 1u MESH:C566296 marker/mechanism 613694.0 +PSEN1 5663 Cognition Disorders MESH:D003072 marker/mechanism 26945731 +PSEN1 5663 Disease Models, Animal MESH:D004195 marker/mechanism 16651627|27567873 +PSEN1 5663 Frontotemporal Dementia MESH:D057180 marker/mechanism 600274.0 11094121 +PSEN1 5663 Gliosis MESH:D005911 marker/mechanism 27567873 +PSEN1 5663 Hidradenitis suppurativa, familial MESH:C538118 marker/mechanism 613737.0 20929727 +PSEN1 5663 Learning Disabilities MESH:D007859 marker/mechanism 25213453 +PSEN1 5663 Memory Disorders MESH:D008569 marker/mechanism 25213453|27567873|28448946 +PSEN1 5663 Nerve Degeneration MESH:D009410 marker/mechanism 19522546|33971107 +PSEN1 5663 Neurodegenerative Diseases MESH:D019636 marker/mechanism 23541064 +PSEN1 5663 Pick Disease of the Brain MESH:D020774 marker/mechanism 172700.0 15122701|15622541 +PSEN1 5663 Plaque, Amyloid MESH:D058225 marker/mechanism 33096116 +PSEN1 5663 Splenomegaly MESH:D013163 marker/mechanism 27117003 +PSEN2 5664 Alzheimer Disease MESH:D000544 marker/mechanism 12925374|16651627|9050898 +PSEN2 5664 Alzheimer disease type 4 MESH:C536596 marker/mechanism 606889.0 +PSEN2 5664 Asphyxia Neonatorum MESH:D001238 marker/mechanism 17963755 +PSEN2 5664 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 17186461 +PSEN2 5664 Cardiomyopathy, Dilated, 1V MESH:C566856 marker/mechanism 613697.0 +PSENEN 55851 Hidradenitis suppurativa, familial MESH:C538118 marker/mechanism 613736.0 20929727 +PSG1 5669 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PSG3 5671 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PSG4 5672 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PSG5 5673 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860 +PSG6 5675 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PSG7 5676 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PSG9 5678 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PSIP1 11168 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +PSMA2 5683 Heart Diseases MESH:D006331 marker/mechanism 16844662 +PSMA2 5683 Osteoporosis MESH:D010024 marker/mechanism 18924182 +PSMA3-AS1 379025 Disease Progression MESH:D018450 marker/mechanism 34520102 +PSMA3-AS1 379025 Ovarian Neoplasms MESH:D010051 marker/mechanism 34520102 +PSMA4 5685 Carcinoma MESH:D002277 marker/mechanism 16316942 +PSMA4 5685 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMA4 5685 Liver Neoplasms MESH:D008113 marker/mechanism 20195826 +PSMA4 5685 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +PSMA4 5685 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +PSMA4 5685 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +PSMA5 5686 Fatty Liver MESH:D005234 marker/mechanism 25226513 +PSMA5 5686 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMA5 5686 Osteoporosis MESH:D010024 marker/mechanism 18924182 +PSMA6 5687 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMA6 5687 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 16845397 +PSMB1 5689 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +PSMB1 5689 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +PSMB1 5689 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 21228734 +PSMB10 5699 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMB10 5699 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PSMB2 5690 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +PSMB4 5692 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMB5 5693 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PSMB7 5695 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +PSMB8 5696 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PSMB8 5696 PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1 OMIM:256040 marker/mechanism 256040.0 +PSMB9 5698 Acrodermatitis MESH:D000169 marker/mechanism 27258892 +PSMB9 5698 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PSMB9 5698 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +PSMC3 5702 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMC3IP 29893 OVARIAN DYSGENESIS 3 OMIM:614324 marker/mechanism 614324.0 +PSMC3IP 29893 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PSMC5 5705 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMC5 5705 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +PSMD11 5717 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +PSMD12 5718 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +PSMD13 5719 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMD14 10213 Disease Progression MESH:D018450 marker/mechanism 30871063 +PSMD14 10213 Neuroblastoma MESH:D009447 marker/mechanism 30871063 +PSMD3 5709 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMD6 9861 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22158537 +PSMD6 9861 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMD8 5714 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSME1 5720 Carcinoma MESH:D002277 marker/mechanism 16316942 +PSME1 5720 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +PSME1 5720 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSME1 5720 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +PSME1 5720 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +PSME2 5721 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +PSME2 5721 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSME2 5721 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PSME3 10197 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSME4 23198 HIV Infections MESH:D015658 marker/mechanism 15308739 +PSMG1 8624 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799 +PSORS1C1 170679 Behcet Syndrome MESH:D001528 marker/mechanism 23396137 +PSORS1C1 170679 Scleroderma, Systemic MESH:D012595 marker/mechanism 21750679 +PSORS1C2 170680 Multiple Myeloma MESH:D009101 marker/mechanism 23955597 +PSPH 5723 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 14673469 +PSPH 5723 PHOSPHOSERINE PHOSPHATASE DEFICIENCY OMIM:614023 marker/mechanism 614023.0 +PSRC1 84722 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +PSTPIP1 9051 Acne Vulgaris MESH:D000152 marker/mechanism 27106250 +PSTPIP1 9051 Hidradenitis Suppurativa MESH:D017497 marker/mechanism 27106250 +PSTPIP1 9051 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PSTPIP1 9051 Pyoderma Gangrenosum MESH:D017511 marker/mechanism 27106250 +PSTPIP1 9051 Pyogenic arthritis, pyoderma gangrenosum, and acne MESH:C536253 marker/mechanism 604416.0 27106250 +PSTPIP2 9050 Acquired Hyperostosis Syndrome MESH:D020083 marker/mechanism 27106250 +PTAFR 5724 Crohn Disease MESH:D003424 marker/mechanism 36038634 +PTAFR 5724 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTAFR 5724 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PTBP1 5725 Carcinoma MESH:D002277 marker/mechanism 12376462 +PTBP1 5725 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +PTBP1 5725 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +PTBP1 5725 Osteosarcoma MESH:D012516 marker/mechanism 34508303 +PTCH1 5727 Basal Cell Nevus Syndrome MESH:D001478 marker/mechanism 109400.0 16405370|16936257|18539553|19287498|25559776|25876211 +PTCH1 5727 Brain Neoplasms MESH:D001932 marker/mechanism 9581815 +PTCH1 5727 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 605462.0 18854826|26950094|9581815 +PTCH1 5727 Cleft Lip MESH:D002971 marker/mechanism 16405370 +PTCH1 5727 Cleft Palate MESH:D002972 marker/mechanism 16405370 +PTCH1 5727 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16405370|18539553 +PTCH1 5727 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +PTCH1 5727 HIV Infections MESH:D015658 marker/mechanism 12878215 +PTCH1 5727 Holoprosencephaly 7 MESH:C563660 marker/mechanism 610828.0 +PTCH1 5727 Medulloblastoma MESH:D008527 marker/mechanism 18347096|19155313|19213072 +PTCH1 5727 Neuroectodermal Tumors, Primitive MESH:D018242 marker/mechanism 9581815 +PTCH1 5727 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19077462 +PTCH1 5727 Rhabdomyosarcoma MESH:D012208 marker/mechanism 19155313 +PTCH1 5727 Skin Neoplasms MESH:D012878 marker/mechanism 9581815 +PTCH2 8643 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 605462 +PTCH2 8643 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +PTCH2 8643 Medulloblastoma MESH:D008527 marker/mechanism 155255 +PTCHD1 139411 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 18252227|20844286 +PTCHD1 139411 Autistic Disorder MESH:D001321 marker/mechanism 300830 21091464 +PTCHD1 139411 Intellectual Disability MESH:D008607 marker/mechanism 20844286 +PTCHD1 139411 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 21091464 +PTCRA 171558 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PTDSS1 9791 Lenz Majewski hyperostotic dwarfism MESH:C537115 marker/mechanism 151050 24241535 +PTEN 5728 Abnormalities, Multiple MESH:D000015 marker/mechanism 18759867 +PTEN 5728 Adenocarcinoma MESH:D000230 marker/mechanism 17909629 +PTEN 5728 Adenoma, Liver Cell MESH:D018248 marker/mechanism 27022031 +PTEN 5728 Anisometropia MESH:D015858 marker/mechanism 9286463 +PTEN 5728 Asthma MESH:D001249 therapeutic 17982072 +PTEN 5728 Autistic Disorder MESH:D001321 marker/mechanism 11496368|18759867|19211884|19265751 +PTEN 5728 Breast Neoplasms MESH:D001943 marker/mechanism 18066063|19685490|19968660|20400965 +PTEN 5728 Carcinoma MESH:D002277 marker/mechanism 9326929 +PTEN 5728 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +PTEN 5728 Carcinoma, Ductal MESH:D044584 marker/mechanism 29295717 +PTEN 5728 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 27022031 +PTEN 5728 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25401301 +PTEN 5728 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 28823542 +PTEN 5728 Cholangiocarcinoma MESH:D018281 marker/mechanism 27022031 +PTEN 5728 Craniofacial Abnormalities MESH:D019465 marker/mechanism 14574156|17427195|18759867|19265751|19321504|9286463 +PTEN 5728 Developmental Disabilities MESH:D002658 marker/mechanism 18759867|19265751|19321504 +PTEN 5728 Disease Progression MESH:D018450 marker/mechanism 20729295 +PTEN 5728 Endometrial Hyperplasia MESH:D004714 marker/mechanism 16402032 +PTEN 5728 Endometrial Neoplasms MESH:D016889 marker/mechanism 12888921|16402032|16804899|9326929 +PTEN 5728 Fatty Liver MESH:D005234 marker/mechanism 27022031 +PTEN 5728 Glioma MESH:D005910 marker/mechanism 613028 12085208 +PTEN 5728 Hamartoma Syndrome, Multiple MESH:D006223 marker/mechanism 158350|601728 10353779|10400993|11496368|11685670|11748304|14574156|17427195|17526800|19321504|19968660|9140396|9241266|9259288|9286463 +PTEN 5728 Hemangioma MESH:D006391 marker/mechanism 9286463 +PTEN 5728 Hypertension MESH:D006973 marker/mechanism 15646324 +PTEN 5728 Hypertrophy MESH:D006984 marker/mechanism 19211884 +PTEN 5728 Insulin Resistance MESH:D007333 marker/mechanism 18303120 +PTEN 5728 Intellectual Disability MESH:D008607 marker/mechanism 11496368|14574156|17427195|18759867|19265751 +PTEN 5728 Language Development Disorders MESH:D007805 marker/mechanism 9286463 +PTEN 5728 LEOPARD Syndrome MESH:D044542 marker/mechanism 11685670 +PTEN 5728 Leukemia MESH:D007938 marker/mechanism 12970779 +PTEN 5728 Lipoma MESH:D008067 marker/mechanism 9286463 +PTEN 5728 Lipomatosis MESH:D008068 marker/mechanism 11748304 +PTEN 5728 Liver Cirrhosis MESH:D008103 marker/mechanism 26023714 +PTEN 5728 Long QT Syndrome MESH:D008133 marker/mechanism 21097842 +PTEN 5728 Lung Neoplasms MESH:D008175 marker/mechanism 17909629|27980214 +PTEN 5728 Lymphoma MESH:D008223 marker/mechanism 22287727 +PTEN 5728 Macrocephaly Autism Syndrome MESH:C565342 marker/mechanism 605309 15805158|17286265|17427195 +PTEN 5728 Melanoma MESH:D008545 marker/mechanism 10978354|19282848|22535842 +PTEN 5728 Melanoma, Experimental MESH:D008546 marker/mechanism 29179997 +PTEN 5728 Meningioma MESH:D008579 marker/mechanism 12085208 +PTEN 5728 Meningioma, familial MESH:C537443 marker/mechanism 607174 +PTEN 5728 Motor Skills Disorders MESH:D019957 marker/mechanism 9286463 +PTEN 5728 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 19038262 +PTEN 5728 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +PTEN 5728 Neoplasm Invasiveness MESH:D009361 therapeutic 21994956 +PTEN 5728 Neoplasm Metastasis MESH:D009362 marker/mechanism 10978354 +PTEN 5728 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +PTEN 5728 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 26023714 +PTEN 5728 Ovarian Neoplasms MESH:D010051 marker/mechanism 21372221 +PTEN 5728 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19917848 +PTEN 5728 Polydactyly MESH:D017689 marker/mechanism 17427195 +PTEN 5728 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 19081794|22581815 +PTEN 5728 Prostatic Neoplasms MESH:D011471 marker/mechanism 176807 16421604|17173048|19081794|19396168|20729295|21456062|21714127|22581815|22610119|23248098|28319090|29295717|29335545|29610475|32525019|33129824|9371490 +PTEN 5728 Proteus Syndrome MESH:D016715 marker/mechanism 11748304|12471211|17427195 +PTEN 5728 Reperfusion Injury MESH:D015427 marker/mechanism 19038262 +PTEN 5728 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +PTEN 5728 Silicosis MESH:D012829 marker/mechanism 27621875 +PTEN 5728 Skin Diseases MESH:D012871 marker/mechanism 19321504 +PTEN 5728 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941188 +PTEN 5728 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 11801303|23873848 +PTEN 5728 VACTERL Association With Hydrocephalus MESH:C564751 marker/mechanism 11748304 +PTER 9317 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTER 9317 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +PTER 9317 Melanoma MESH:D008545 marker/mechanism 22535842 +PTF1A 256297 Cerebellar Diseases MESH:D002526 marker/mechanism 15543146|19650412 +PTF1A 256297 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 21182459 +PTF1A 256297 Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis MESH:C563796 marker/mechanism 609069 15543146|19650412 +PTF1A 256297 Pancreatic Agenesis, Congenital MESH:C564908 marker/mechanism 615935 15543146|22158542|24212882 +PTGDR 5729 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1 OMIM:607277 marker/mechanism 607277 +PTGDR2 11251 Asthma MESH:D001249 therapeutic 27103662 +PTGDR2 11251 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 20485159 +PTGER1 5731 Adenocarcinoma MESH:D000230 marker/mechanism 11751431 +PTGER1 5731 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 11751431 +PTGER1 5731 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21739481 +PTGER1 5731 Hydronephrosis MESH:D006869 marker/mechanism 30641090 +PTGER1 5731 Hyperalgesia MESH:D006930 marker/mechanism 11375261 +PTGER1 5731 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 11751431 +PTGER1 5731 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 11751431 +PTGER1 5731 Sexual Dysfunction, Physiological MESH:D012735 therapeutic 18726914 +PTGER2 5732 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 16502481 +PTGER2 5732 Asthma, Nasal Polyps, And Aspirin Intolerance MESH:C565935 marker/mechanism 208550.0 +PTGER2 5732 Endometriosis MESH:D004715 marker/mechanism 19407222 +PTGER2 5732 Infertility MESH:D007246 marker/mechanism 10359563 +PTGER2 5732 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTGER2 5732 Sexual Dysfunction, Physiological MESH:D012735 therapeutic 18726914 +PTGER3 5733 Drug Hypersensitivity MESH:D004342 marker/mechanism 20587336 +PTGER3 5733 Pemphigoid, Benign Mucous Membrane MESH:D010390 marker/mechanism 21966456 +PTGER3 5733 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PTGER3 5733 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 21966456 +PTGER3 5733 Thrombosis MESH:D013927 marker/mechanism 17242161 +PTGER4 5734 Arthritis, Experimental MESH:D001169 marker/mechanism 18287210 +PTGER4 5734 Chloracne MESH:D054506 marker/mechanism 17101203 +PTGER4 5734 Endometriosis MESH:D004715 marker/mechanism 19407222 +PTGER4 5734 Inflammation MESH:D007249 marker/mechanism 18287210 +PTGER4 5734 Lymphoma MESH:D008223 therapeutic 19075289 +PTGER4 5734 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +PTGER4 5734 Sexual Dysfunction, Physiological MESH:D012735 therapeutic 18726914 +PTGER4 5734 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 21743469 +PTGES 9536 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PTGES 9536 Fever MESH:D005334 marker/mechanism 25164664 +PTGES 9536 Hydronephrosis MESH:D006869 marker/mechanism 22430074|25015655 +PTGES 9536 Inflammation MESH:D007249 marker/mechanism 25314295 +PTGES 9536 Polyuria MESH:D011141 marker/mechanism 19692487 +PTGES2 80142 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PTGES2 80142 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 31444509 +PTGES2 80142 Thyroid Neoplasms MESH:D013964 marker/mechanism 22387750 +PTGES3 10728 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PTGES3 10728 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 29471019 +PTGFR 5737 Airway Obstruction MESH:D000402 marker/mechanism 1219628 +PTGFR 5737 Endometriosis MESH:D004715 marker/mechanism 25446850 +PTGIR 5739 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 20485159 +PTGIR 5739 Heart Diseases MESH:D006331 marker/mechanism 16154102 +PTGIS 5740 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +PTGIS 5740 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PTGIS 5740 Ductus Arteriosus, Patent MESH:D004374 marker/mechanism 19336370 +PTGIS 5740 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +PTGIS 5740 Lung Neoplasms MESH:D008175 therapeutic 11830527 +PTGIS 5740 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +PTGR1 22949 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PTGS1 5742 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 15167967 +PTGS1 5742 Asthma, Occupational MESH:D059366 marker/mechanism 25721048 +PTGS1 5742 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +PTGS1 5742 Breast Neoplasms MESH:D001943 marker/mechanism 18488158 +PTGS1 5742 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 17508966 +PTGS1 5742 Carcinoma MESH:D002277 marker/mechanism 12189197 +PTGS1 5742 Drug Hypersensitivity MESH:D004342 marker/mechanism 17508966 +PTGS1 5742 Esophageal Neoplasms MESH:D004938 marker/mechanism 12189197 +PTGS1 5742 Flushing MESH:D005483 marker/mechanism 16322797 +PTGS1 5742 Heart Failure MESH:D006333 marker/mechanism 20304815 +PTGS1 5742 Hyperalgesia MESH:D006930 marker/mechanism 17989504 +PTGS1 5742 Intestinal Polyps MESH:D007417 marker/mechanism 10753194|12189188 +PTGS1 5742 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +PTGS1 5742 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTGS1 5742 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +PTGS1 5742 Reperfusion Injury MESH:D015427 marker/mechanism 10594344 +PTGS1 5742 Sleep Deprivation MESH:D012892 marker/mechanism 16343605 +PTGS1 5742 Stomach Ulcer MESH:D013276 marker/mechanism 10594344|19066340 +PTGS2 5743 Adenocarcinoma MESH:D000230 marker/mechanism 10485483|16820089 +PTGS2 5743 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 12507933 +PTGS2 5743 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 17942926 +PTGS2 5743 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 15492235 +PTGS2 5743 Albuminuria MESH:D000419 marker/mechanism 17890881 +PTGS2 5743 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 11220737|15816863 +PTGS2 5743 Aortic Aneurysm, Abdominal MESH:D017544 marker/mechanism 16514081 +PTGS2 5743 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 19376970 +PTGS2 5743 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 11978490|19192274 +PTGS2 5743 Asphyxia Neonatorum MESH:D001238 marker/mechanism 17963755 +PTGS2 5743 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 16502481|20485159 +PTGS2 5743 Asthma, Occupational MESH:D059366 marker/mechanism 25721048 +PTGS2 5743 Atherosclerosis MESH:D050197 marker/mechanism 20720404 +PTGS2 5743 Autistic Disorder MESH:D001321 marker/mechanism 18579107 +PTGS2 5743 Barrett Esophagus MESH:D001471 marker/mechanism 11059772|15387324|17244951 +PTGS2 5743 Bone Neoplasms MESH:D001859 marker/mechanism 16489006 +PTGS2 5743 Brain Injuries MESH:D001930 marker/mechanism 12410334|20810888|21549006 +PTGS2 5743 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 28642177 +PTGS2 5743 Brain Ischemia MESH:D002545 marker/mechanism 15737438|17394460|17564305|19417757 +PTGS2 5743 Breast Neoplasms MESH:D001943 marker/mechanism 16127422|16870006|17285134|18498876|18509974 +PTGS2 5743 Burns MESH:D002056 marker/mechanism 15650120 +PTGS2 5743 Cachexia MESH:D002100 marker/mechanism 17878525 +PTGS2 5743 Carcinoma MESH:D002277 marker/mechanism 10485483 +PTGS2 5743 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 21153458 +PTGS2 5743 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 11872629|12024111|14563831|16374840|17510421 +PTGS2 5743 Carcinoma in Situ MESH:D002278 marker/mechanism 10582676|10873095 +PTGS2 5743 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 12664575 +PTGS2 5743 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 16543248|18202791 +PTGS2 5743 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 10582676|10873095|12151359|12664575 +PTGS2 5743 Cardiomyopathies MESH:D009202 marker/mechanism 11978490 +PTGS2 5743 Cardiovascular Diseases MESH:D002318 therapeutic 17518513 +PTGS2 5743 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 11743745 +PTGS2 5743 Cholangiocarcinoma MESH:D018281 marker/mechanism 16818635 +PTGS2 5743 Cognition Disorders MESH:D003072 marker/mechanism 12410334 +PTGS2 5743 Colitis MESH:D003092 marker/mechanism 11820457 +PTGS2 5743 Colonic Neoplasms MESH:D003110 marker/mechanism 12189188|17667525|21081470 +PTGS2 5743 Colorectal Neoplasms MESH:D015179 marker/mechanism 10485483|11375891|12837940|15753380|19671906|20427397 +PTGS2 5743 Coronary Artery Disease MESH:D003324 marker/mechanism 14642682 +PTGS2 5743 Depressive Disorder MESH:D003866 marker/mechanism 19356723 +PTGS2 5743 Diabetes Mellitus MESH:D003920 marker/mechanism 15885672 +PTGS2 5743 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14514642|21414306 +PTGS2 5743 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 10698006 +PTGS2 5743 Duodenal Ulcer MESH:D004381 marker/mechanism 12481160 +PTGS2 5743 Edema MESH:D004487 marker/mechanism 11820457 +PTGS2 5743 Endometriosis MESH:D004715 marker/mechanism 25446850 +PTGS2 5743 Esophageal Neoplasms MESH:D004938 marker/mechanism 11059772|16322294|17707579 +PTGS2 5743 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 15756444|16543248|18197933 +PTGS2 5743 Fever MESH:D005334 marker/mechanism 25164664 +PTGS2 5743 Fibrosis MESH:D005355 marker/mechanism 11872629 +PTGS2 5743 Gastroesophageal Reflux MESH:D005764 marker/mechanism 21451212 +PTGS2 5743 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 16330497 +PTGS2 5743 Glioma MESH:D005910 marker/mechanism 15561105 +PTGS2 5743 Graves Ophthalmopathy MESH:D049970 marker/mechanism 17614770 +PTGS2 5743 Heart Failure MESH:D006333 marker/mechanism 20304815 +PTGS2 5743 Hydronephrosis MESH:D006869 marker/mechanism 22430074 +PTGS2 5743 Hyperalgesia MESH:D006930 marker/mechanism 17112505|17989504 +PTGS2 5743 Hyperemia MESH:D006940 marker/mechanism 11820457 +PTGS2 5743 Hyperglycemia MESH:D006943 marker/mechanism 14514642 +PTGS2 5743 Hyperplasia MESH:D006965 marker/mechanism 12151359|17093206|22561872 +PTGS2 5743 Hypertension MESH:D006973 marker/mechanism|therapeutic 14757778|15834289|20667508|22349312 +PTGS2 5743 Inflammation MESH:D007249 marker/mechanism 11094054|11321505|19084589 +PTGS2 5743 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 11820457 +PTGS2 5743 Intestinal Polyps MESH:D007417 marker/mechanism 10753194|11245490|11507063 +PTGS2 5743 Kidney Diseases MESH:D007674 marker/mechanism 19643929 +PTGS2 5743 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +PTGS2 5743 Kidney Neoplasms MESH:D007680 marker/mechanism 12664575 +PTGS2 5743 Leiomyosarcoma MESH:D007890 marker/mechanism 18645019 +PTGS2 5743 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 16314473 +PTGS2 5743 Leukoplakia, Oral MESH:D007972 marker/mechanism 18202791 +PTGS2 5743 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17565644|18555214 +PTGS2 5743 Lung Diseases MESH:D008171 marker/mechanism 19084589 +PTGS2 5743 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 17761345 +PTGS2 5743 Lymphoma, B-Cell MESH:D016393 marker/mechanism 14654083 +PTGS2 5743 Melanoma MESH:D008545 marker/mechanism 17145863|17499752|18454317 +PTGS2 5743 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +PTGS2 5743 Mouth Neoplasms MESH:D009062 marker/mechanism 12969226 +PTGS2 5743 Neoplasm Metastasis MESH:D009362 marker/mechanism 16489006|18509974 +PTGS2 5743 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 14566678 +PTGS2 5743 Neoplasms MESH:D009369 marker/mechanism 20155627 +PTGS2 5743 Nervous System Diseases MESH:D009422 marker/mechanism 10698006 +PTGS2 5743 Neurogenic Inflammation MESH:D020078 marker/mechanism 17539917 +PTGS2 5743 Obesity MESH:D009765 marker/mechanism 21156398 +PTGS2 5743 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +PTGS2 5743 Osteoarthritis MESH:D010003 marker/mechanism 32004530 +PTGS2 5743 Pancreatic Neoplasms MESH:D010190 marker/mechanism 10485483|10657949|15705899|16820089 +PTGS2 5743 Pancreatitis MESH:D010195 marker/mechanism 19820421 +PTGS2 5743 Papilloma MESH:D010212 marker/mechanism 12151359|16144915 +PTGS2 5743 Pericardial Effusion MESH:D010490 marker/mechanism 20801906 +PTGS2 5743 Precancerous Conditions MESH:D011230 marker/mechanism 12151359|19522023 +PTGS2 5743 Premature Birth MESH:D047928 marker/mechanism 26055944|27748297 +PTGS2 5743 Prostatic Neoplasms MESH:D011471 marker/mechanism 10753955|14754878|15126378|16506214|17609663 +PTGS2 5743 Proteinuria MESH:D011507 marker/mechanism 19643929 +PTGS2 5743 Puberty, Precocious MESH:D011629 marker/mechanism 21402727 +PTGS2 5743 Reperfusion Injury MESH:D015427 marker/mechanism 10588920|10594344|11567657|16386242|18258783|19673871 +PTGS2 5743 Rhinitis, Allergic MESH:D065631 marker/mechanism 16979129 +PTGS2 5743 Seizures MESH:D012640 marker/mechanism 14518562 +PTGS2 5743 Skin Diseases MESH:D012871 marker/mechanism 15451306 +PTGS2 5743 Skin Neoplasms MESH:D012878 marker/mechanism 17499752|19748995|21159610 +PTGS2 5743 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 12969226 +PTGS2 5743 Status Epilepticus MESH:D013226 marker/mechanism 18988310 +PTGS2 5743 Stomach Neoplasms MESH:D013274 marker/mechanism 10404093|17003101|17224647|22385256 +PTGS2 5743 Stomach Ulcer MESH:D013276 marker/mechanism 10594344|11376495|12481160|19066340|9024292 +PTGS2 5743 Stroke MESH:D020521 marker/mechanism 20083630 +PTGS2 5743 Thrombosis MESH:D013927 marker/mechanism 20350286 +PTGS2 5743 Thyroid Neoplasms MESH:D013964 marker/mechanism 22387750 +PTGS2 5743 Tongue Neoplasms MESH:D014062 marker/mechanism 16543248|22561872 +PTGS2 5743 Urinary Bladder Neck Obstruction MESH:D001748 marker/mechanism 15311063 +PTGS2 5743 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 10582676|10873095|12442003|12664575|16098373|17093206|29396848|36115647 +PTH 5741 Anemia MESH:D000740 marker/mechanism 15354979|19578808 +PTH 5741 Basal Cell Nevus Syndrome MESH:D001478 marker/mechanism 24803734 +PTH 5741 Bone Diseases, Endocrine MESH:D001849 marker/mechanism 18635661 +PTH 5741 Bone Resorption MESH:D001862 marker/mechanism 9881647 +PTH 5741 Disease Models, Animal MESH:D004195 therapeutic 30639440 +PTH 5741 Fractures, Bone MESH:D050723 therapeutic 16094769 +PTH 5741 Heart Failure MESH:D006333 marker/mechanism 17162251 +PTH 5741 Hypercalcemia MESH:D006934 marker/mechanism 10638776|12399635|17164314|4004906|7891547|9382671 +PTH 5741 Hypercalciuria MESH:D053565 marker/mechanism 17164314 +PTH 5741 Hyperostosis MESH:D015576 marker/mechanism 25289773 +PTH 5741 Hyperparathyroidism, Secondary MESH:D006962 marker/mechanism 21350317|22118402|22373954 +PTH 5741 Hyperphosphatemia MESH:D054559 marker/mechanism 12399635 +PTH 5741 Hypertension MESH:D006973 marker/mechanism 1930854 +PTH 5741 Hypocalcemia MESH:D006996 marker/mechanism 11701698|11770836 +PTH 5741 Hypoparathyroidism familial isolated MESH:C537156 marker/mechanism 146200.0 +PTH 5741 Osteoporosis MESH:D010024 therapeutic 15710971|17317460|17882678|19578808|21306167|30639440 +PTH 5741 Osteoporosis, Postmenopausal MESH:D015663 therapeutic 20567999 +PTH 5741 Rickets MESH:D012279 marker/mechanism 10375030 +PTH 5741 Uremia MESH:D014511 marker/mechanism 2051637 +PTH1R 5745 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PTH1R 5745 Chondrodysplasia, blomstrand type MESH:C537914 marker/mechanism 215045.0 +PTH1R 5745 Eiken Skeletal Dysplasia MESH:C564010 marker/mechanism 600002.0 +PTH1R 5745 Failure of Tooth Eruption, Primary MESH:C565114 marker/mechanism 125350.0 +PTH1R 5745 Hyperparathyroidism MESH:D006961 marker/mechanism 11014383 +PTH1R 5745 Jansen type metaphyseal chondrodysplasia MESH:C537564 marker/mechanism 156400.0 +PTH1R 5745 Lung Diseases MESH:D008171 marker/mechanism 20857298 +PTH1R 5745 Rickets MESH:D012279 marker/mechanism 10375030 +PTHLH 5744 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +PTHLH 5744 Bone Resorption MESH:D001862 marker/mechanism 16769263 +PTHLH 5744 BRACHYDACTYLY, TYPE E2 OMIM:613382 marker/mechanism 613382.0 +PTHLH 5744 Breast Neoplasms MESH:D001943 marker/mechanism 22267197 +PTHLH 5744 Cachexia MESH:D002100 marker/mechanism 17878525 +PTHLH 5744 Carcinoma, Non-Small-Cell Lung MESH:D002289 therapeutic 17676588 +PTHLH 5744 Edema MESH:D004487 marker/mechanism 25035110 +PTHLH 5744 Foot Deformities, Congenital MESH:D005532 marker/mechanism 20170896 +PTHLH 5744 Growth Disorders MESH:D006130 marker/mechanism 20170896 +PTHLH 5744 Hand Deformities, Congenital MESH:D006228 marker/mechanism 20170896 +PTHLH 5744 Hyperalgesia MESH:D006930 marker/mechanism 16769263 +PTHLH 5744 Hypercalcemia MESH:D006934 marker/mechanism 10638776|11054717|12358896|3616618 +PTHLH 5744 Lung Diseases MESH:D008171 marker/mechanism 20857298 +PTHLH 5744 Multiple Myeloma MESH:D009101 marker/mechanism 11054717 +PTHLH 5744 Neuroendocrine Tumors MESH:D018358 marker/mechanism 17625444 +PTHLH 5744 Osteolysis MESH:D010014 marker/mechanism 11054717 +PTHLH 5744 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17625444 +PTHLH 5744 Pancreatitis, Acute Necrotizing MESH:D019283 marker/mechanism 25035110 +PTHLH 5744 Pancreatitis, Alcoholic MESH:D019512 marker/mechanism 22280800 +PTHLH 5744 Pancreatitis, Chronic MESH:D050500 marker/mechanism 25035110 +PTHLH 5744 Prostatic Neoplasms MESH:D011471 marker/mechanism 16243370 +PTHLH 5744 Superior Vena Cava Syndrome MESH:D013479 marker/mechanism 12358896 +PTI 404172 Blood Loss, Surgical MESH:D016063 therapeutic 9806378 +PTI 404172 Graft Occlusion, Vascular MESH:D006083 marker/mechanism 9806378 +PTI 404172 Shock MESH:D012769 therapeutic 18263716 +PTK2 5747 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +PTK2 5747 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +PTK2 5747 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 14578863 +PTK2 5747 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism|therapeutic 21401805|25199511 +PTK2 5747 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23804419 +PTK2 5747 Glioblastoma MESH:D005909 marker/mechanism 12811834 +PTK2 5747 Mammary Neoplasms, Experimental MESH:D008325 therapeutic 24809783 +PTK2 5747 Mouth Neoplasms MESH:D009062 therapeutic 25199511 +PTK2 5747 Neoplasm Invasiveness MESH:D009361 marker/mechanism|therapeutic 12811834|25199511 +PTK2B 2185 Alzheimer Disease MESH:D000544 marker/mechanism 33589840 +PTK2B 2185 Bone Diseases MESH:D001847 marker/mechanism 29428397 +PTK2B 2185 Melanoma MESH:D008545 marker/mechanism 19718025 +PTK2B 2185 Skin Neoplasms MESH:D012878 marker/mechanism 19718025 +PTK2B 2185 Status Epilepticus MESH:D013226 marker/mechanism 16600505 +PTK7 5754 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +PTMA 5757 Adenoma MESH:D000236 therapeutic 10822126 +PTMA 5757 Fatty Liver MESH:D005234 therapeutic 15885234 +PTMA 5757 Lung Neoplasms MESH:D008175 therapeutic 10822126 +PTMA 5757 Rhabdomyosarcoma MESH:D012208 marker/mechanism 16669873 +PTN 5764 Body Weight MESH:D001835 marker/mechanism 36566969 +PTN 5764 Carcinoma MESH:D002277 marker/mechanism 16316942 +PTN 5764 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTN 5764 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +PTN 5764 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +PTOV1 53635 Disease Progression MESH:D018450 marker/mechanism 21364753 +PTOV1 53635 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PTP4A2 8073 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +PTP4A3 11156 Colonic Neoplasms MESH:D003110 therapeutic 23555575 +PTPA 5524 Disease Progression MESH:D018450 marker/mechanism 21364753 +PTPA 5524 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PTPN1 5770 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 +PTPN1 5770 Hodgkin Disease MESH:D006689 marker/mechanism 24531327 +PTPN1 5770 Hyperinsulinism MESH:D006946 therapeutic 28899902 +PTPN1 5770 Hypertension MESH:D006973 therapeutic 28899902 +PTPN1 5770 Inflammation MESH:D007249 therapeutic 28899902 +PTPN1 5770 Insulin Resistance MESH:D007333 marker/mechanism 10744717 +PTPN1 5770 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 26739621 +PTPN1 5770 Lymphoma, B-Cell MESH:D016393 marker/mechanism 24531327 +PTPN1 5770 Mediastinal Neoplasms MESH:D008479 marker/mechanism 24531327 +PTPN1 5770 Obesity MESH:D009765 marker/mechanism 10744717|20075852 +PTPN1 5770 Rett Syndrome MESH:D015518 marker/mechanism 26214522 +PTPN11 5781 Adenocarcinoma MESH:D000230 marker/mechanism 26432044 +PTPN11 5781 Astrocytoma MESH:D001254 marker/mechanism 23817572 +PTPN11 5781 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 26432044 +PTPN11 5781 Cardiofaciocutaneous syndrome MESH:C535579 marker/mechanism 17703371 +PTPN11 5781 Costello Syndrome MESH:D056685 marker/mechanism 17703371 +PTPN11 5781 Enchondromatosis MESH:D004687 marker/mechanism 20577567|21533187 +PTPN11 5781 Exostoses, Multiple Hereditary MESH:D005097 marker/mechanism 21533187 +PTPN11 5781 LEOPARD Syndrome MESH:D044542 marker/mechanism 151100.0 17603483 +PTPN11 5781 Leukemia MESH:D007938 marker/mechanism 15273746 +PTPN11 5781 Leukemia, Experimental MESH:D007942 marker/mechanism 32417439 +PTPN11 5781 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 27992414 +PTPN11 5781 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 607785.0 22315502|26457647 +PTPN11 5781 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32417439 +PTPN11 5781 Metachondromatosis MESH:C562938 marker/mechanism 156250.0 +PTPN11 5781 Neuroblastoma MESH:D009447 marker/mechanism 23334666 +PTPN11 5781 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +PTPN11 5781 Noonan Syndrome MESH:D009634 marker/mechanism 163950.0 15273746|17603482|17603483|17703371 +PTPN11 5781 Osteochondroma MESH:D015831 marker/mechanism 20577567 +PTPN12 5782 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +PTPN14 5784 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +PTPN14 5784 CHOANAL ATRESIA AND LYMPHEDEMA OMIM:613611 marker/mechanism 613611.0 +PTPN14 5784 Neuroblastoma MESH:D009447 marker/mechanism 26121086 +PTPN14 5784 Recurrence MESH:D012008 marker/mechanism 26121086 +PTPN18 26469 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTPN2 5771 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 22446963 +PTPN2 5771 Colitis, Ulcerative MESH:D003093 marker/mechanism 18438405 +PTPN2 5771 Crohn Disease MESH:D003424 marker/mechanism 17554261 +PTPN2 5771 Leukemia, T-Cell MESH:D015458 marker/mechanism 20473312 +PTPN2 5771 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 20473312 +PTPN22 26191 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 180300.0 19898480|20453842|21190368|23143596|30224649 +PTPN22 26191 Autoimmune Diseases MESH:D001327 marker/mechanism 21341673 +PTPN22 26191 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 222100.0 21190368|30224649 +PTPN22 26191 Graves Disease MESH:D006111 marker/mechanism 21190368 +PTPN22 26191 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 21983784 +PTPN22 26191 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 152700.0 18204446|21190368 +PTPN3 5774 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +PTPN5 84867 Nerve Degeneration MESH:D009410 marker/mechanism 17360923 +PTPN6 5777 Calcinosis MESH:D002114 marker/mechanism 21335463 +PTPN6 5777 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +PTPN6 5777 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 18441283 +PTPRA 5786 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PTPRB 5787 Hemangiosarcoma MESH:D006394 marker/mechanism 24633157 +PTPRC 5788 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +PTPRC 5788 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +PTPRC 5788 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTPRC 5788 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +PTPRC 5788 Retinal Diseases MESH:D012164 marker/mechanism 19324842 +PTPRD 5789 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 19546859 +PTPRD 5789 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +PTPRD 5789 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +PTPRD 5789 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTPRD 5789 Restless Legs Syndrome MESH:D012148 marker/mechanism 18660810 +PTPRF 5792 BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2 OMIM:616001 marker/mechanism 616001.0 +PTPRF 5792 Disease Progression MESH:D018450 marker/mechanism 21364753 +PTPRF 5792 Heart Failure MESH:D006333 marker/mechanism 28751527 +PTPRF 5792 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 28751527 +PTPRF 5792 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +PTPRF 5792 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PTPRG 5793 Stomach Neoplasms MESH:D013274 marker/mechanism 17963294 +PTPRJ 5795 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +PTPRK 5796 Melanoma MESH:D008545 marker/mechanism 22535842|22842228 +PTPRK 5796 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +PTPRO 5800 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTPRO 5800 Liver Neoplasms MESH:D008113 marker/mechanism 19233941|20163174 +PTPRO 5800 Melanoma MESH:D008545 marker/mechanism 21499247 +PTPRO 5800 NEPHROTIC SYNDROME, TYPE 6 OMIM:614196 marker/mechanism 614196.0 +PTPRQ 374462 DEAFNESS, AUTOSOMAL RECESSIVE 84A OMIM:613391 marker/mechanism 613391.0 +PTPRZ1 5803 Helicobacter Infections MESH:D016481 marker/mechanism 17030583 +PTPRZ1 5803 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +PTRH1 138428 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTRH2 51651 NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 1 OMIM:616263 marker/mechanism 616263.0 +PTRH2 51651 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +PTRHD1 391356 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PTS 5805 6-pyruvoyl-tetrahydropterin synthase deficiency MESH:C535325 marker/mechanism 261640.0 +PTTG1 9232 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PTTG1 9232 Psoriasis MESH:D011565 marker/mechanism 20953187 +PTTG1 9232 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097067 +PTX3 5806 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +PTX3 5806 Pulmonary Fibrosis MESH:D011658 marker/mechanism 22210019 +PTX3 5806 Skin Diseases MESH:D012871 marker/mechanism 16835338 +PUF60 22827 Mesothelioma MESH:D008654 therapeutic 21435101 +PUF60 22827 Necrosis MESH:D009336 marker/mechanism 21435101 +PUF60 22827 Neoplasms, Experimental MESH:D009374 therapeutic 21435101 +PUF60 22827 VERHEIJ SYNDROME OMIM:615583 marker/mechanism 615583.0 +PUM1 9698 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +PURA 5813 Epilepsy MESH:D004827 marker/mechanism 29942082 +PURA 5813 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +PURA 5813 NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES OMIM:616158 marker/mechanism 616158.0 +PUS1 80324 Disease Progression MESH:D018450 marker/mechanism 21364753 +PUS1 80324 Myopathy with lactic acidosis and sideroblastic anemia MESH:C536101 marker/mechanism 600462.0 +PUS1 80324 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +PUS3 83480 NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND GRAY SCLERAE OMIM:617051 marker/mechanism 617051.0 +PVALB 5816 Adenoma, Oxyphilic MESH:D018249 marker/mechanism 16927643 +PVALB 5816 Bipolar Disorder MESH:D001714 marker/mechanism 14708030 +PVALB 5816 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 16927643 +PVALB 5816 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +PVALB 5816 Schizophrenia MESH:D012559 marker/mechanism 14708030 +PVALB 5816 Seizures MESH:D012640 marker/mechanism 18495095 +PVR 5817 Leukemia, Myeloid, Acute MESH:D015470 therapeutic 29855615 +PVR 5817 Orofacial Cleft 1 MESH:C566121 marker/mechanism 21637507 +PVR 5817 Poliomyelitis MESH:D011051 marker/mechanism 28446605|3020560 +PVR 5817 Prostatic Neoplasms MESH:D011471 marker/mechanism 30614027 +PVT1 5820 Hodgkin Disease MESH:D006689 marker/mechanism 21037568 +PVT1 5820 IgA Deficiency MESH:D017098 marker/mechanism 27723758 +PVT1 5820 Neoplasm Invasiveness MESH:D009361 marker/mechanism 35213076 +PWAR1 145624 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270.0 +PWAR6 100506965 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +PWRN1 791114 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270.0 +PWWP2B 170394 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +PXDN 7837 Anterior segment mesenchymal dysgenesis MESH:C537775 marker/mechanism 269400.0 +PXDN 7837 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +PXDN 7837 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PXK 54899 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842 +PXK 54899 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 18204446 +PXN 5829 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21159652 +PXN 5829 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 28100775 +PXN 5829 Melanoma, Experimental MESH:D008546 marker/mechanism 18492274 +PXN 5829 Neoplasm Metastasis MESH:D009362 marker/mechanism 18492274 +PYCARD 29108 Adenocarcinoma MESH:D000230 marker/mechanism 16778195 +PYCARD 29108 Albuminuria MESH:D000419 marker/mechanism 22647887 +PYCARD 29108 Calcinosis MESH:D002114 marker/mechanism 21335463 +PYCARD 29108 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17471463 +PYCARD 29108 Carcinoma, Large Cell MESH:D018287 marker/mechanism 16778195 +PYCARD 29108 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 16778195 +PYCARD 29108 Carcinoma, Small Cell MESH:D018288 marker/mechanism 16778195 +PYCARD 29108 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 16778195 +PYCARD 29108 Colorectal Neoplasms MESH:D015179 marker/mechanism 17986858 +PYCARD 29108 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +PYCARD 29108 Hyperhomocysteinemia MESH:D020138 marker/mechanism 22647887 +PYCARD 29108 Kidney Diseases MESH:D007674 marker/mechanism|therapeutic 22647887|24508291 +PYCARD 29108 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PYCARD 29108 Lung Neoplasms MESH:D008175 marker/mechanism 16778195 +PYCARD 29108 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26935421 +PYCARD 29108 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +PYCARD 29108 Weight Gain MESH:D015430 therapeutic 24508291 +PYCR1 5831 Cutis Laxa MESH:D003483 marker/mechanism 19648921 +PYCR1 5831 Cutis Laxa, Autosomal Recessive, Type IIB MESH:C567855 marker/mechanism 612940.0 +PYCR1 5831 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB OMIM:614438 marker/mechanism 614438.0 +PYCR1 5831 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +PYCR1 5831 Progeria MESH:D011371 marker/mechanism 19648921 +PYCR2 29920 LEUKODYSTROPHY, HYPOMYELINATING, 10 OMIM:616420 marker/mechanism 616420.0 +PYD3 40916 Purine-Pyrimidine Metabolism, Inborn Errors MESH:D011686 marker/mechanism 16361227 +PYGB 5834 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +PYGB 5834 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +PYGB 5834 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +PYGL 5836 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 2885971 +PYGL 5836 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +PYGL 5836 Glycogen Storage Disease Type VI MESH:D006013 marker/mechanism 232700.0 9529348|9536091 +PYGM 5837 Glycogen Storage Disease Type V MESH:D006012 marker/mechanism 232600.0 12666117|18380285 +PYGM 5837 Muscular Diseases MESH:D009135 marker/mechanism 18380285 +PYHIN1 149628 Asthma MESH:D001249 marker/mechanism 21804549 +PYHIN1 149628 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +PYROXD1 79912 Myofibrillar Myopathy MESH:C580316 marker/mechanism 617258.0 +PYY 5697 Alzheimer Disease MESH:D000544 marker/mechanism 11709213 +PYY 5697 Anorexia MESH:D000855 marker/mechanism 22903826|29689362 +PYY 5697 Diarrhea MESH:D003967 therapeutic 19925840 +PYY 5697 Neural Tube Defects MESH:D009436 marker/mechanism 17400914 +PYY 5697 Obesity MESH:D009765 marker/mechanism 16368708 +PYY 5697 Vomiting MESH:D014839 marker/mechanism 33581213|37286030 +PZP 5858 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +PZP 5858 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +QARS1 5859 MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY OMIM:615760 marker/mechanism 615760.0 +QARS1 5859 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +QDPR 5860 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C OMIM:261630 marker/mechanism 261630.0 +QDPR 5860 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +QDPR 5860 Phenylketonurias MESH:D010661 marker/mechanism 25526675 +QKI 9444 Demyelinating Diseases MESH:D003711 marker/mechanism 16245024 +QKI 9444 Glioma MESH:D005910 marker/mechanism 26829751 +QPCT 25797 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +QPCT 25797 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 23770605 +QPCT 25797 Melanoma MESH:D008545 marker/mechanism 17145863 +QSOX1 5768 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +R06C7.6 187641 Infertility MESH:D007246 marker/mechanism 25204677 +R3HDM2 22864 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +R3HDM2 22864 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RAB11A 8766 Chloracne MESH:D054506 marker/mechanism 17101203 +RAB11B 9230 HIV Infections MESH:D015658 marker/mechanism 15308739 +RAB11FIP5 26056 Autistic Disorder MESH:D001321 marker/mechanism 18384058 +RAB12 201475 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RAB18 22931 Warburg Sjo Fledelius syndrome MESH:C536681 marker/mechanism 614222.0 +RAB1B 81876 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RAB21 23011 Obesity MESH:D009765 marker/mechanism 29273807 +RAB23 51715 Acrocephalopolysyndactyly Type II MESH:C563187 marker/mechanism 201000.0 +RAB23 51715 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +RAB27A 5873 Disease Progression MESH:D018450 marker/mechanism 34291859 +RAB27A 5873 Griscelli syndrome type 2 MESH:C537302 marker/mechanism 607624.0 +RAB27A 5873 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34291859 +RAB27A 5873 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 34291859 +RAB27B 5874 Disease Progression MESH:D018450 marker/mechanism 34291859 +RAB27B 5874 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34291859 +RAB27B 5874 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 34291859 +RAB28 9364 CONE-ROD DYSTROPHY 18 OMIM:615374 marker/mechanism 615374.0 +RAB2A 5862 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +RAB30 27314 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RAB31 11031 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RAB32 10981 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +RAB32 10981 HIV Infections MESH:D015658 marker/mechanism 15308739 +RAB32 10981 Leprosy MESH:D007918 marker/mechanism 22019778 +RAB32 10981 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RAB39B 116442 Autistic Disorder MESH:D001321 marker/mechanism 20159109 +RAB39B 116442 Craniofacial Abnormalities MESH:D019465 marker/mechanism 20159109 +RAB39B 116442 Epilepsy MESH:D004827 marker/mechanism 20159109 +RAB39B 116442 Intellectual Disability MESH:D008607 marker/mechanism 21076407 +RAB39B 116442 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 20159109 +RAB39B 116442 Mental Retardation, X-Linked 72 MESH:C564547 marker/mechanism 300271.0 +RAB39B 116442 Parkinsonism, early onset with mental retardation MESH:C537179 marker/mechanism 311510.0 +RAB3A 5864 Ependymoma MESH:D004806 marker/mechanism 26075792 +RAB3GAP1 22930 Warburg Sjo Fledelius syndrome MESH:C536681 marker/mechanism 600118.0 +RAB3GAP2 25782 Martsolf syndrome MESH:C536028 marker/mechanism 212720.0 +RAB3GAP2 25782 Warburg Sjo Fledelius syndrome MESH:C536681 marker/mechanism 614225.0 +RAB40AL 282808 Cognition Disorders MESH:D003072 marker/mechanism 22581972 +RAB40AL 282808 Craniofacial Abnormalities MESH:D019465 marker/mechanism 22581972 +RAB40AL 282808 Facies MESH:D019066 marker/mechanism 22581972 +RAB40AL 282808 Growth Disorders MESH:D006130 marker/mechanism 22581972 +RAB40AL 282808 Martin-Probst Deafness-Mental Retardation Syndrome MESH:C564495 marker/mechanism 22581972 +RAB40AL 282808 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 22581972 +RAB40B 10966 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RAB4B 53916 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RAB5A 5868 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RAB7A 7879 Charcot-Marie-Tooth disease, Type 2B MESH:C537989 marker/mechanism 600882.0 +RAB7A 7879 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RAB7B 338382 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +RAB7B 338382 Osteoporosis MESH:D010024 marker/mechanism 18924182 +RAB8A 4218 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +RAB8B 51762 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RABGAP1L 9910 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RABL3 285282 Pancreatic Neoplasms MESH:D010190 marker/mechanism 31406347 +RABL6 55684 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +RAC1 5879 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18506888 +RAC1 5879 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 16155095 +RAC1 5879 Cardiotoxicity MESH:D066126 marker/mechanism 28710503 +RAC1 5879 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22011395 +RAC1 5879 Diabetes Mellitus MESH:D003920 marker/mechanism 23723366 +RAC1 5879 Heart Failure MESH:D006333 marker/mechanism 16155095 +RAC1 5879 Liver Diseases MESH:D008107 marker/mechanism 17058265 +RAC1 5879 Melanoma MESH:D008545 marker/mechanism 22842228 +RAC1 5879 Neoplasm Metastasis MESH:D009362 marker/mechanism 18506888 +RAC1 5879 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 28710503 +RAC2 5880 Disease Progression MESH:D018450 marker/mechanism 35331739 +RAC2 5880 Heart Diseases MESH:D006331 marker/mechanism 16330681 +RAC2 5880 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 35331739 +RAC2 5880 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457648 +RAC2 5880 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RAC2 5880 Lymphoma MESH:D008223 marker/mechanism 19783987 +RAC2 5880 Melanoma MESH:D008545 marker/mechanism 17145863 +RAC2 5880 Neutrophil Immunodeficiency Syndrome MESH:C564275 marker/mechanism 608203.0 +RAC3 5881 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 35331739 +RACGAP1 29127 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +RACGAP1 29127 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +RACK1 10399 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +RACK1 10399 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +RAD21 5885 De Lange Syndrome MESH:D003635 marker/mechanism 614701.0 +RAD21 5885 Leukemia, Megakaryoblastic, of Down Syndrome MESH:C566025 marker/mechanism 24056718 +RAD21 5885 Leukemia, Myeloid MESH:D007951 marker/mechanism 23955599 +RAD21 5885 Mungan Syndrome MESH:C548078 marker/mechanism 611376.0 +RAD23A 5886 Disease Progression MESH:D018450 marker/mechanism 21364753 +RAD23A 5886 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RAD23B 5887 Craniofacial Abnormalities MESH:D019465 marker/mechanism 11809813 +RAD23B 5887 Infertility, Male MESH:D007248 marker/mechanism 11809813 +RAD23B 5887 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +RAD50 10111 Asthma MESH:D001249 marker/mechanism 24241537 +RAD50 10111 Nijmegen Breakage Syndrome-Like Disorder MESH:C567767 marker/mechanism 613078.0 +RAD51 5888 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +RAD51 5888 FANCONI ANEMIA, COMPLEMENTATION GROUP R OMIM:617244 marker/mechanism 617244.0 +RAD51 5888 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 22613844 +RAD51 5888 Head and Neck Neoplasms MESH:D006258 marker/mechanism 22613844 +RAD51 5888 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 9885240 +RAD51 5888 MIRROR MOVEMENTS 2 OMIM:614508 marker/mechanism 614508.0 +RAD51 5888 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 34998818 +RAD51B 5890 Breast Neoplasms MESH:D001943 marker/mechanism 19330030 +RAD51B 5890 Breast Neoplasms, Male MESH:D018567 marker/mechanism 23001122 +RAD51B 5890 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +RAD51C 5889 Breast Neoplasms MESH:D001943 marker/mechanism 20400964|28825726 +RAD51C 5889 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3 OMIM:613399 marker/mechanism 613399.0 +RAD51C 5889 Fanconi Anemia MESH:D005199 marker/mechanism 20400963 +RAD51C 5889 FANCONI ANEMIA, COMPLEMENTATION GROUP O OMIM:613390 marker/mechanism 613390.0 +RAD51C 5889 Ovarian Neoplasms MESH:D010051 marker/mechanism 20400964 +RAD51D 5892 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4 OMIM:614291 marker/mechanism 614291.0 +RAD51D 5892 Chromosome Deletion MESH:D002872 marker/mechanism 27924006 +RAD51D 5892 Ovarian Neoplasms MESH:D010051 marker/mechanism 21822267 +RAD52 5893 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 26013599 +RAD52 5893 Lung Neoplasms MESH:D008175 marker/mechanism 26013599 +RAD54B 25788 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +RAD54B 25788 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 605027.0 +RAD54L 8438 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +RAD54L 8438 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +RAD54L 8438 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 605027.0 +RAD9A 5883 Neoplasms, Second Primary MESH:D016609 marker/mechanism 21991345 +RAET1L 154064 Alopecia Areata MESH:D000506 marker/mechanism 20596022 +RAF 31221 Coronavirus Infections MESH:D018352 marker/mechanism 20484496 +RAF 31221 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 20484496 +RAF1 5894 Breast Neoplasms MESH:D001943 therapeutic 12432273 +RAF1 5894 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 16862215 +RAF1 5894 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +RAF1 5894 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 24777450 +RAF1 5894 CARDIOMYOPATHY, DILATED, 1NN OMIM:615916 marker/mechanism 615916.0 +RAF1 5894 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 17603482|17603483 +RAF1 5894 Glioma MESH:D005910 marker/mechanism 23583981 +RAF1 5894 Hyperalgesia MESH:D006930 marker/mechanism 18976650 +RAF1 5894 Kidney Neoplasms MESH:D007680 marker/mechanism 21813464 +RAF1 5894 LEOPARD Syndrome MESH:D044542 marker/mechanism 17603483 +RAF1 5894 LEOPARD syndrome, 2 MESH:C537117 marker/mechanism 611554.0 +RAF1 5894 Liver Neoplasms MESH:D008113 marker/mechanism 19499222 +RAF1 5894 Lung Neoplasms MESH:D008175 marker/mechanism 11884234 +RAF1 5894 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +RAF1 5894 Noonan Syndrome MESH:D009634 marker/mechanism 17603482|17603483 +RAF1 5894 Noonan Syndrome 5 MESH:C548083 marker/mechanism 611553.0 +RAF1 5894 Prostatic Neoplasms MESH:D011471 marker/mechanism 32512071 +RAG1 5896 Alpha-Beta T-Cell Lymphopenia with Gamma-Delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity MESH:C563691 marker/mechanism 609889.0 +RAG1 5896 Combined Cellular And Humoral Immune Defects With Granulomas MESH:C567115 marker/mechanism 233650.0 +RAG1 5896 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +RAG1 5896 Reticuloendotheliosis, familial, with eosinophilia MESH:C538564 marker/mechanism 603554.0 +RAG1 5896 Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive MESH:C563311 marker/mechanism 601457.0 +RAG2 5897 Arthritis, Experimental MESH:D001169 therapeutic 20974942 +RAG2 5897 Combined Cellular And Humoral Immune Defects With Granulomas MESH:C567115 marker/mechanism 233650.0 +RAG2 5897 Eosinophilia MESH:D004802 therapeutic 27315767 +RAG2 5897 Metaplasia MESH:D008679 therapeutic 27315767 +RAG2 5897 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 24211274 +RAG2 5897 Reticuloendotheliosis, familial, with eosinophilia MESH:C538564 marker/mechanism 603554.0 +RAG2 5897 Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive MESH:C563311 marker/mechanism 601457.0 +RAI1 10743 Anxiety Disorders MESH:D001008 marker/mechanism 18285828 +RAI1 10743 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20981775 +RAI1 10743 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19116176 +RAI1 10743 Dyssomnias MESH:D020920 marker/mechanism 19752160 +RAI1 10743 Growth Disorders MESH:D006130 marker/mechanism 18285828 +RAI1 10743 Intellectual Disability MESH:D008607 marker/mechanism 19752160 +RAI1 10743 Melanoma MESH:D008545 marker/mechanism 22535842 +RAI1 10743 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 19116176 +RAI1 10743 Obesity MESH:D009765 marker/mechanism 15459175|19116176 +RAI1 10743 Potocki-Lupski syndrome MESH:C538355 marker/mechanism 17517686 +RAI1 10743 Psychomotor Agitation MESH:D011595 marker/mechanism 18285828 +RAI1 10743 Smith-Magenis Syndrome MESH:D058496 marker/mechanism 182290.0 15459175|15746153|15788730|16845274|17273973|17517686|18285828|19116176|19236431|19752160|20691407|20981775 +RALBP1 10928 Hypertension MESH:D006973 marker/mechanism 23821548 +RALBP1 10928 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RALBP1 10928 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RALGDS 5900 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +RALGPS1 9649 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +RALY 22913 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +RALYL 138046 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +RAMP1 10267 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RAMP2 10266 Adenocarcinoma MESH:D000230 marker/mechanism 17671114 +RAMP2 10266 Lung Neoplasms MESH:D008175 marker/mechanism 17671114 +RAMP2 10266 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +RAMP2 10266 Weight Gain MESH:D015430 marker/mechanism 19030233 +RAN 5901 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +RAN 5901 HIV Infections MESH:D015658 marker/mechanism 15308739 +RAN 5901 Keloid MESH:D007627 marker/mechanism 20128793 +RAN 5901 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942 +RAN 5901 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +RAN 5901 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +RANBP1 5902 HIV Infections MESH:D015658 marker/mechanism 15308739 +RANBP1 5902 Kidney Neoplasms MESH:D007680 marker/mechanism 28321044 +RANBP10 57610 Disease Progression MESH:D018450 marker/mechanism 21364753 +RANBP10 57610 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RANBP2 5903 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3 OMIM:608033 marker/mechanism 608033.0 +RANBP2 5903 Granuloma, Plasma Cell MESH:D006104 marker/mechanism 21030459 +RANGAP1 5905 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 27150054 +RANGRF 29098 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RANGRF 29098 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RAP1GAP 5909 Disease Progression MESH:D018450 marker/mechanism 22614916 +RAP1GAP 5909 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 22614916 +RAP1GAP 5909 Melanoma MESH:D008545 marker/mechanism 19147557|22614916 +RAP1GAP 5909 Pancreatic Neoplasms MESH:D010190 marker/mechanism 22614916 +RAP1GAP 5909 Thyroid Neoplasms MESH:D013964 marker/mechanism 22614916 +RAP2A 5911 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +RAPGEF2 9693 Epilepsies, Myoclonic MESH:D004831 marker/mechanism 29507423 +RAPGEF3 10411 Acute Kidney Injury MESH:D058186 marker/mechanism 21745194 +RAPGEF3 10411 Glucose Intolerance MESH:D018149 marker/mechanism 27381457 +RAPGEF3 10411 Obesity MESH:D009765 marker/mechanism 29273807 +RAPGEF3 10411 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 22363678 +RAPGEF3 10411 Rickettsia Infections MESH:D012282 marker/mechanism 24218580 +RAPGEF3 10411 Tick-Borne Diseases MESH:D017282 marker/mechanism 24218580 +RAPGEF5 9771 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +RAPSN 5913 Autoimmune Diseases MESH:D001327 marker/mechanism 9668287 +RAPSN 5913 Muscular Diseases MESH:D009135 marker/mechanism 9668287 +RAPSN 5913 Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency MESH:C563829 marker/mechanism 616326.0 +RARA 5914 Breast Neoplasms MESH:D001943 marker/mechanism 26437033 +RARA 5914 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18026104 +RARA 5914 Dyslipidemias MESH:D050171 marker/mechanism 32929351 +RARA 5914 Fibroadenoma MESH:D018226 marker/mechanism 26437033 +RARA 5914 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 612376.0 10742073|14508522|14706140|16239915|16788101|16835227|16891316|16935935|17294898|17649720|17712046|19029980|19035177|19884644|19887701|21613260|22213200|23208507|25583766|26285909|26728337|28314734|32882258|32929351|8616088 +RARA 5914 Neoplasms, Second Primary MESH:D016609 marker/mechanism 19884644 +RARA 5914 Phyllodes Tumor MESH:D003557 marker/mechanism 26437033 +RARA 5914 Sciatic Neuropathy MESH:D020426 marker/mechanism 16782282 +RARB 5915 Adenocarcinoma MESH:D000230 marker/mechanism 14656941 +RARB 5915 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 31209396 +RARB 5915 Breast Neoplasms MESH:D001943 therapeutic 16255778 +RARB 5915 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17549354 +RARB 5915 Endometriosis MESH:D004715 marker/mechanism 22138541 +RARB 5915 Head and Neck Neoplasms MESH:D006258 marker/mechanism 17549354 +RARB 5915 Lung Neoplasms MESH:D008175 marker/mechanism 14656941 +RARB 5915 MICROPHTHALMIA, SYNDROMIC 12 OMIM:615524 marker/mechanism 615524.0 +RARB 5915 Sciatic Neuropathy MESH:D020426 marker/mechanism 16782282 +RARB 5915 Stomach Neoplasms MESH:D013274 marker/mechanism 16134180 +RARB 5915 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 17961338 +RARG 5916 Cardiotoxicity MESH:D066126 marker/mechanism 26237429 +RARG 5916 Cleft Palate MESH:D002972 marker/mechanism 21807577 +RARG 5916 Heart Diseases MESH:D006331 marker/mechanism 26237429 +RARG 5916 Musculoskeletal Abnormalities MESH:D009139 marker/mechanism 9142499 +RARRES1 5918 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RARRES1 5918 Stomach Neoplasms MESH:D013274 marker/mechanism 16134180 +RARRES2 5919 Glucose Intolerance MESH:D018149 marker/mechanism 22355640 +RARRES2 5919 Granulosa Cell Tumor MESH:D006106 marker/mechanism 29653259 +RARRES2 5919 Pre-Eclampsia MESH:D011225 marker/mechanism 34398343 +RARS1 5917 LEUKODYSTROPHY, HYPOMYELINATING, 9 OMIM:616140 marker/mechanism 616140.0 +RARS2 57038 Pontocerebellar Hypoplasia Type 6 MESH:C548074 marker/mechanism 611523.0 +RAS 19412 Coronavirus Infections MESH:D018352 marker/mechanism 20484496 +RAS 19412 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 20484496 +RASA1 5921 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +RASA1 5921 Arteriovenous Malformations MESH:D001165 marker/mechanism 14639529 +RASA1 5921 Capillary Malformation-Arteriovenous Malformation MESH:C564254 marker/mechanism 608354.0 +RASA1 5921 Carcinoma MESH:D002277 marker/mechanism 12606953 +RASA1 5921 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 605462.0 +RASA1 5921 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27158780 +RASA1 5921 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +RASA1 5921 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12606953 +RASA1 5921 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12606953 +RASA1 5921 Port-Wine Stain MESH:D019339 marker/mechanism 14639529 +RASA2 5922 Melanoma MESH:D008545 marker/mechanism 26214590|26502337 +RASAL1 8437 Kidney Diseases MESH:D007674 marker/mechanism 23665422 +RASAL2 9462 Disease Progression MESH:D018450 marker/mechanism 34826200 +RASAL2 9462 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34826200 +RASAL2 9462 Neoplasms, Experimental MESH:D009374 marker/mechanism 34826200 +RASAL2 9462 Stomach Neoplasms MESH:D013274 marker/mechanism 34826200 +RASD1 51655 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RASGEF1B 153020 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +RASGRF1 5923 Dyskinesia, Drug-Induced MESH:D004409 therapeutic 21115823 +RASGRF1 5923 Myopia MESH:D009216 marker/mechanism 23396134 +RASGRF1 5923 Refractive Errors MESH:D012030 marker/mechanism 20835236 +RASGRF2 5924 Carcinoma MESH:D002277 marker/mechanism 12606953 +RASGRF2 5924 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12606953 +RASGRF2 5924 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12606953 +RASGRP1 10125 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +RASGRP1 10125 Endometriosis MESH:D004715 marker/mechanism 20864642 +RASGRP1 10125 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 21441929 +RASGRP1 10125 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 26808113 +RASGRP2 10235 BLEEDING DISORDER, PLATELET-TYPE, 18 OMIM:615888 marker/mechanism 615888.0 +RASGRP3 25780 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838193 +RASL10B 91608 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +RASL11A 387496 Colorectal Neoplasms MESH:D015179 marker/mechanism 30224643 +RASL11A 387496 Endometriosis MESH:D004715 marker/mechanism 20864642 +RASSF1 11186 Adenocarcinoma MESH:D000230 marker/mechanism 15639718 +RASSF1 11186 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 18337602 +RASSF1 11186 Cardiomyopathy, Hypertrophic MESH:D002312 therapeutic 19652091 +RASSF1 11186 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 24146755 +RASSF1 11186 Lung Neoplasms MESH:D008175 marker/mechanism 18337602 +RASSF1 11186 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 20008439 +RASSF1 11186 Medulloblastoma MESH:D008527 marker/mechanism 21880625 +RASSF1 11186 Mesothelioma MESH:D008654 marker/mechanism 12082623|15639718 +RASSF1 11186 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 26410583 +RASSF1 11186 Schistosomiasis MESH:D012552 marker/mechanism 23527093 +RASSF1 11186 Urinary Bladder Diseases MESH:D001745 marker/mechanism 23527093 +RASSF1 11186 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 15987713 +RASSF2 9770 Lymphatic Metastasis MESH:D008207 marker/mechanism 17013896 +RASSF2 9770 Nasopharyngeal Neoplasms MESH:D009303 marker/mechanism 17013896 +RASSF3 283349 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +RASSF4 83937 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RASSF5 83593 Kidney Neoplasms MESH:D007680 marker/mechanism 25217643 +RASSF5 83593 Neuroblastoma MESH:D009447 marker/mechanism 18452173 +RASSF8 11228 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +RATNP-3B 498659 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +RAX 30062 Anophthalmos MESH:D000853 marker/mechanism 15789424 +RAX 30062 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15789424 +RAX 30062 Melanoma MESH:D008545 marker/mechanism 16778180 +RAX 30062 Microphthalmia, Isolated 3 MESH:C567025 marker/mechanism 611038.0 +RAX2 84839 Cone-Rod Dystrophy 11 MESH:C563671 marker/mechanism 610381.0 +RAX2 84839 Macular Degeneration, Age-Related, 6 MESH:C563674 marker/mechanism 613757.0 +RAX2 84839 Retinal Degeneration MESH:D012162 marker/mechanism 15028672 +RB1 5925 Acute erythroleukemia MESH:C535673 marker/mechanism 30926971 +RB1 5925 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 24747643 +RB1 5925 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 24747642 +RB1 5925 Brain Ischemia MESH:D002545 marker/mechanism 17901229 +RB1 5925 Breast Neoplasms MESH:D001943 marker/mechanism 14672398|19234134|20948315 +RB1 5925 Carcinoma MESH:D002277 marker/mechanism 14522882 +RB1 5925 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +RB1 5925 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12029619|14961299 +RB1 5925 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 16862215 +RB1 5925 Carcinoma, Small Cell MESH:D018288 marker/mechanism 182280.0 +RB1 5925 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +RB1 5925 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +RB1 5925 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 17854601 +RB1 5925 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 14522882 +RB1 5925 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 14522882 +RB1 5925 Neoplasm Metastasis MESH:D009362 marker/mechanism 27137931 +RB1 5925 Neoplasms, Experimental MESH:D009374 marker/mechanism 27137931 +RB1 5925 Osteosarcoma MESH:D012516 marker/mechanism 259500.0 27137931 +RB1 5925 Pancreatic Neoplasms MESH:D010190 marker/mechanism 21699781 +RB1 5925 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 23334668 +RB1 5925 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +RB1 5925 Retinoblastoma MESH:D012175 marker/mechanism 180200.0 +RB1 5925 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +RB1 5925 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941188|22941189 +RB1 5925 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +RB1 5925 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 109800.0 +RB1CC1 9821 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 21466612 +RB1CC1 9821 Schizophrenia MESH:D012559 marker/mechanism 21822266 +RBBP8 5932 Microcephaly with Mental Retardation and Digital Anomalies MESH:C567101 marker/mechanism 251255.0 +RBBP8 5932 Seckel syndrome 2 MESH:C537534 marker/mechanism 606744.0 +RBCK1 10616 Cardiomegaly MESH:D006332 marker/mechanism 17121852 +RBFOX1 54715 Autistic Disorder MESH:D001321 marker/mechanism 17503474|18621663 +RBFOX1 54715 Seizures MESH:D012640 marker/mechanism 21623373 +RBFOX2 23543 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +RBFOX2 23543 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +RBL2 5934 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 16038780 +RBL2 5934 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RBL2 5934 Ovarian Neoplasms MESH:D010051 therapeutic 16936753 +RBM10 8241 TARP syndrome MESH:C536942 marker/mechanism 311900.0 +RBM12 10137 Psychotic Disorders MESH:D011618 marker/mechanism 28628109 +RBM17 84991 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 18337722 +RBM20 282996 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +RBM20 282996 Cardiomyopathy, Dilated, 1DD MESH:C567725 marker/mechanism 613172.0 +RBM26 64062 Anthracosis MESH:D055008 marker/mechanism 29394417 +RBM28 55131 Alopecia, Neurologic Defects, and Endocrinopathy Syndrome MESH:C567425 marker/mechanism 612079.0 +RBM3 5935 Breast Neoplasms MESH:D001943 marker/mechanism 19734850 +RBM3 5935 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RBM38 55544 Colorectal Neoplasms MESH:D015179 therapeutic 34453780 +RBM38 55544 Neoplasm Invasiveness MESH:D009361 therapeutic 34453780 +RBM47 54502 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +RBM7 10179 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15496427 +RBM8A 9939 Absent radii and thrombocytopenia MESH:C536940 marker/mechanism 274000.0 22366785 +RBMS3 27303 Exfoliation Syndrome MESH:D017889 marker/mechanism 28553957 +RBMX 27316 Orofaciodigital syndrome, Shashi type MESH:C537135 marker/mechanism 300238.0 +RBMY 19657 Adenoma MESH:D000236 marker/mechanism 22073224 +RBMY 19657 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22073224 +RBMY 19657 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 22073224 +RBMY1A1 5940 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +RBP1 5947 Carcinoma MESH:D002277 marker/mechanism 12376462 +RBP1 5947 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +RBP1 5947 Fetal Growth Retardation MESH:D005317 marker/mechanism 28157488 +RBP1 5947 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +RBP1 5947 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +RBP1 5947 Stomach Neoplasms MESH:D013274 marker/mechanism 16134180|16367923 +RBP3 5949 Autoimmune Diseases MESH:D001327 marker/mechanism 20007828|21850155 +RBP3 5949 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 23486466 +RBP3 5949 RETINITIS PIGMENTOSA 66 OMIM:615233 marker/mechanism 615233.0 +RBP3 5949 Uveitis MESH:D014605 marker/mechanism 21850155 +RBP4 5950 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +RBP4 5950 Breast Neoplasms MESH:D001943 marker/mechanism 35191604 +RBP4 5950 Carcinoma MESH:D002277 marker/mechanism 16316942 +RBP4 5950 Heart Failure MESH:D006333 marker/mechanism 26670611 +RBP4 5950 Keratomalacia MESH:C536156 marker/mechanism 9888420 +RBP4 5950 Kidney Diseases MESH:D007674 marker/mechanism 22061828 +RBP4 5950 Liver Diseases, Alcoholic MESH:D008108 marker/mechanism 16762690 +RBP4 5950 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +RBP4 5950 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +RBP4 5950 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10 OMIM:616428 marker/mechanism 616428.0 +RBP4 5950 Necrosis MESH:D009336 marker/mechanism 22061828 +RBP4 5950 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 17456573 +RBP4 5950 RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME OMIM:615147 marker/mechanism 615147.0 +RBP4 5950 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +RBP4 5950 Vitamin A Deficiency MESH:D014802 marker/mechanism 16157297 +RBPJ 3516 Adams Oliver syndrome MESH:C538225 marker/mechanism 614814.0 +RBPJ 3516 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +RBPJ 3516 Endometriosis MESH:D004715 marker/mechanism 22138541 +RBPJ 3516 Multiple Sclerosis MESH:D009103 marker/mechanism 25853421 +RBX1 9978 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +RCAN1 1827 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +RCAN1 1827 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +RCAN1 1827 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15906378 +RCAN1 1827 Down Syndrome MESH:D004314 marker/mechanism 15906378 +RCAN1 1827 Heart Defects, Congenital MESH:D006330 marker/mechanism 15906378 +RCAN1 1827 Huntington Disease MESH:D006816 marker/mechanism 19270310 +RCBTB1 55213 RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES OMIM:617175 marker/mechanism 617175.0 +RCCD1 91433 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +RCHY1 25898 Disease Progression MESH:D018450 marker/mechanism 28191284 +RCHY1 25898 Lung Neoplasms MESH:D008175 marker/mechanism 28191284 +RCL1 10171 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RCL1 10171 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RCN1 5954 Carcinoma MESH:D002277 marker/mechanism 16316942 +RCN1 5954 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RCN1 5954 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +RCN1 5954 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +RCN2 5955 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RCN3 57333 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +RCOR1 23186 Colonic Neoplasms MESH:D003110 marker/mechanism 25043185 +RCSD1 92241 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RD3 343035 Leber Congenital Amaurosis 12 MESH:C565697 marker/mechanism 610612.0 +RDGA 31826 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +RDH10 157506 Craniofacial Abnormalities MESH:D019465 marker/mechanism 27793605 +RDH10 157506 Fetal Death MESH:D005313 marker/mechanism 27793605 +RDH10 157506 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RDH11 51109 RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME OMIM:616108 marker/mechanism 616108.0 +RDH12 145226 Leber Congenital Amaurosis 13 MESH:C567197 marker/mechanism 612712.0 25526675 +RDH12 145226 Retinal Degeneration MESH:D012162 marker/mechanism 16269441 +RDH12 145226 Retinal Dystrophies MESH:D058499 marker/mechanism 18048336 +RDH12 145226 Retinitis Pigmentosa MESH:D012174 marker/mechanism 16968212 +RDH13 112724 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 27865848 +RDH13 112724 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 27865848 +RDH13 112724 Necrosis MESH:D009336 marker/mechanism 27865848 +RDH2 107460 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +RDH3 100305177 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +RDH5 5959 Fundus Albipunctatus MESH:C562733 marker/mechanism 136880.0 18048336|25526675 +RDH5 5959 Myopia MESH:D009216 marker/mechanism 23396134 +RDL 39054 Seizures MESH:D012640 marker/mechanism 17074045 +RDX 5962 Cholestasis MESH:D002779 marker/mechanism 17681005 +RDX 5962 Deafness, Autosomal Recessive, 24 MESH:C567027 marker/mechanism 611022.0 +RDX 5962 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29341352 +REC8 9985 Melanoma MESH:D008545 marker/mechanism 16778180 +REC8 9985 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RECK 8434 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17233834 +RECK 8434 Colonic Neoplasms MESH:D003110 marker/mechanism 17443689 +RECK 8434 Glioblastoma MESH:D005909 therapeutic 20127710 +RECK 8434 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RECK 8434 Neoplasm Invasiveness MESH:D009361 therapeutic 20127710 +RECK 8434 Neoplasm Metastasis MESH:D009362 marker/mechanism 17233834 +RECQL 5965 Breast Neoplasms MESH:D001943 marker/mechanism 25915596 +RECQL4 9401 Craniosynostosis radial aplasia syndrome MESH:C536788 marker/mechanism 218600.0 +RECQL4 9401 Rapadilino syndrome MESH:C535288 marker/mechanism 266280.0 +RECQL4 9401 Rothmund-Thomson Syndrome MESH:D011038 marker/mechanism 268400.0 18616953 +REEP1 65055 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +REEP1 65055 Neuronopathy, Distal Hereditary Motor, Type V MESH:C563443 marker/mechanism 614751.0 +REEP1 65055 Spastic Paraplegia 31, Autosomal Dominant MESH:C565210 marker/mechanism 610250.0 +REEP2 51308 SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE OMIM:615625 marker/mechanism 615625.0 +REEP3 221035 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +REEP3 221035 Autistic Disorder MESH:D001321 marker/mechanism 17290275 +REEP5 7905 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +REEP5 7905 Cholestasis MESH:D002779 marker/mechanism 26881866 +REEP5 7905 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +REEP6 92840 RETINITIS PIGMENTOSA 77 OMIM:617304 marker/mechanism 617304.0 +REG1 19692 Stomach Neoplasms MESH:D013274 therapeutic 15940630 +REG3G 130120 Hypertension MESH:D006973 marker/mechanism 27798352 +REG4 83998 Stomach Neoplasms MESH:D013274 marker/mechanism 17237819 +REL 5966 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19503088|20453842|23143596 +REL 5966 Heat Stroke MESH:D018883 marker/mechanism 24039931 +REL 5966 Hodgkin Disease MESH:D006689 marker/mechanism 21037568 +REL 5966 Hypokinesia MESH:D018476 therapeutic 31481676 +REL 5966 Memory Disorders MESH:D008569 marker/mechanism 20477932 +REL 5966 Psoriasis MESH:D011565 marker/mechanism 20953190 +REL 5966 Tremor MESH:D014202 therapeutic 31481676 +RELA 5970 Adenocarcinoma MESH:D000230 marker/mechanism 34973135 +RELA 5970 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 19689456 +RELA 5970 Barrett Esophagus MESH:D001471 marker/mechanism 15387324 +RELA 5970 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 25668593|28642177 +RELA 5970 Brain Ischemia MESH:D002545 therapeutic 18628779 +RELA 5970 Brain Neoplasms MESH:D001932 marker/mechanism 20932960 +RELA 5970 Breast Neoplasms MESH:D001943 marker/mechanism 20154269 +RELA 5970 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 18089796 +RELA 5970 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 23069812|29501572 +RELA 5970 Cholestasis MESH:D002779 marker/mechanism 20626112 +RELA 5970 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951|30026087 +RELA 5970 Colitis MESH:D003092 marker/mechanism 23810507 +RELA 5970 Colitis, Ulcerative MESH:D003093 marker/mechanism 15955209 +RELA 5970 Colonic Neoplasms MESH:D003110 marker/mechanism 20715105 +RELA 5970 Crohn Disease MESH:D003424 marker/mechanism 36038634 +RELA 5970 Cystitis MESH:D003556 marker/mechanism 22099998 +RELA 5970 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22138235 +RELA 5970 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23500658 +RELA 5970 Diabetic Angiopathies MESH:D003925 marker/mechanism 25381014 +RELA 5970 Diabetic Nephropathies MESH:D003928 marker/mechanism 17900838 +RELA 5970 Disease Progression MESH:D018450 marker/mechanism 34626302|34973135 +RELA 5970 Drug Eruptions MESH:D003875 marker/mechanism 31150805 +RELA 5970 Heat Stroke MESH:D018883 marker/mechanism 24039931 +RELA 5970 Hepatic Insufficiency MESH:D048550 marker/mechanism 30026087 +RELA 5970 Hepatomegaly MESH:D006529 marker/mechanism 30026087 +RELA 5970 Hypertension MESH:D006973 marker/mechanism 19018797|27659729|32147540 +RELA 5970 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +RELA 5970 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +RELA 5970 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 30026087 +RELA 5970 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 26806094 +RELA 5970 Lymphoma, Large-Cell, Anaplastic MESH:D017728 marker/mechanism 17261581 +RELA 5970 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19896475|29501572 +RELA 5970 Neoplasms, Experimental MESH:D009374 marker/mechanism 20932960 +RELA 5970 Neuroblastoma MESH:D009447 marker/mechanism 34626302 +RELA 5970 Pancreatic Carcinoma MESH:C562463 marker/mechanism 34686948 +RELA 5970 Reperfusion Injury MESH:D015427 marker/mechanism 20302854|23743330 +RELA 5970 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 26861016 +RELA 5970 Skin Neoplasms MESH:D012878 marker/mechanism 23069812 +RELA 5970 Stomach Neoplasms MESH:D013274 marker/mechanism 34973135 +RELA 5970 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 27157545 +RELA 5970 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +RELB 5971 Heat Stroke MESH:D018883 marker/mechanism 24039931 +RELL1 768211 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RELN 5649 Alzheimer Disease MESH:D000544 marker/mechanism 20610758 +RELN 5649 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24781735|28191889 +RELN 5649 Autistic Disorder MESH:D001321 marker/mechanism 11317216|11814262|20442744 +RELN 5649 Bipolar Disorder MESH:D001714 marker/mechanism 11126396|14708030|15560956 +RELN 5649 Depressive Disorder MESH:D003866 marker/mechanism 14708030 +RELN 5649 Depressive Disorder, Major MESH:D003865 marker/mechanism 11126396 +RELN 5649 EPILEPSY, FAMILIAL TEMPORAL LOBE, 1 OMIM:600512 marker/mechanism 600512.0 +RELN 5649 EPILEPSY, FAMILIAL TEMPORAL LOBE, 7 OMIM:616436 marker/mechanism 616436.0 +RELN 5649 Norman Roberts lissencephaly syndrome MESH:C537848 marker/mechanism 257320.0 +RELN 5649 Schizophrenia MESH:D012559 marker/mechanism 11126396|14708030|15560956|19110320 +REN 5972 Albuminuria MESH:D000419 marker/mechanism 12414515|18679781 +REN 5972 Allanson Pantzar McLeod syndrome MESH:C537048 marker/mechanism 16116425 +REN 5972 Anemia MESH:D000740 marker/mechanism 3524928 +REN 5972 Azotemia MESH:D053099 marker/mechanism 6338847 +REN 5972 Bartter Syndrome MESH:D001477 marker/mechanism 15976003|3519017|929154 +REN 5972 Cardiomegaly MESH:D006332 marker/mechanism 20429690|20811386 +REN 5972 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 18829990 +REN 5972 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 8723173 +REN 5972 Fetal Growth Retardation MESH:D005317 marker/mechanism 17537837 +REN 5972 Fibrosis MESH:D005355 marker/mechanism 12414515 +REN 5972 Heart Failure MESH:D006333 marker/mechanism 1647690|20811386|7034517 +REN 5972 Hemorrhage MESH:D006470 marker/mechanism 6991409 +REN 5972 Hypertension MESH:D006973 marker/mechanism 1071603|1149188|11501062|12414515|12600921|17537837|18679781|18847324|19770776|19934029|20429690|20811386|21393355|45830|62162|6381767|7721401|998518 +REN 5972 Hypertension, Malignant MESH:D006974 marker/mechanism 2493837 +REN 5972 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 18679781|8349331 +REN 5972 Hyperuricemic Nephropathy, Familial Juvenile 2 MESH:C567760 marker/mechanism 613092.0 +REN 5972 Hypotension MESH:D007022 marker/mechanism|therapeutic 11171655|3536153|6251761 +REN 5972 Ischemia MESH:D007511 marker/mechanism 3915608 +REN 5972 Kidney Diseases MESH:D007674 marker/mechanism 12414515|6156352|8723173 +REN 5972 Liddle Syndrome MESH:D056929 marker/mechanism 12185466 +REN 5972 Liver Cirrhosis MESH:D008103 marker/mechanism 15613622 +REN 5972 Myocardial Infarction MESH:D009203 marker/mechanism 1668233 +REN 5972 Nephrosis MESH:D009401 marker/mechanism 2046802|6358456 +REN 5972 Osteoporosis MESH:D010024 marker/mechanism 18847324 +REN 5972 Proteinuria MESH:D011507 marker/mechanism 2046802|464098 +REN 5972 Psoriasis MESH:D011565 marker/mechanism 3540694 +REN 5972 RENAL TUBULAR DYSGENESIS OMIM:267430 marker/mechanism 267430.0 +REN 5972 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 28415 +REN2 19702 Albuminuria MESH:D000419 marker/mechanism 12586211|27428043 +REN2 19702 Cardiomegaly MESH:D006332 marker/mechanism 12586211|9869009 +REN2 19702 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 27428043 +REN2 19702 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 27428043 +REN2 19702 Hypertension MESH:D006973 marker/mechanism 12512695|12586211|9595497|9869009 +REN2 19702 Hypertension, Malignant MESH:D006974 marker/mechanism 27428043 +REN2 19702 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 9595497 +REN2 19702 Inflammation MESH:D007249 marker/mechanism 12586211 +REN2 19702 Nephritis, Interstitial MESH:D009395 marker/mechanism 27428043 +REN2 19702 Weight Loss MESH:D015431 marker/mechanism 27428043 +RENBP 5973 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 12612874 +REPS2 9185 Breast Neoplasms MESH:D001943 marker/mechanism 19776672 +RERE 473 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +RERE 473 NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART OMIM:616975 marker/mechanism 616975.0 +REST 5978 DEAFNESS, AUTOSOMAL DOMINANT 27 OMIM:612431 marker/mechanism 612431.0 +REST 5978 Seizures MESH:D012640 therapeutic 21905079 +REST 5978 Wilms Tumor MESH:D009396 marker/mechanism 26551668 +REST 5978 WILMS TUMOR 6 OMIM:616806 marker/mechanism 616806.0 +RET 5979 Amyloidosis, Familial MESH:D028226 marker/mechanism 12864791 +RET 5979 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143597 +RET 5979 Carcinoma, Medullary MESH:D018276 marker/mechanism 7915165 +RET 5979 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +RET 5979 Congenital central hypoventilation syndrome MESH:C536209 marker/mechanism 12086152|9497256 +RET 5979 Familial medullary thyroid carcinoma MESH:C536911 marker/mechanism 155240.0 12864791|7915165 +RET 5979 Hereditary renal agenesis MESH:C536482 marker/mechanism 18252215 +RET 5979 Hirschsprung Disease MESH:D006627 marker/mechanism 142623.0 8114938|8896568 +RET 5979 Multiple Endocrine Neoplasia MESH:D009377 marker/mechanism 17664273 +RET 5979 Multiple Endocrine Neoplasia Type 2a MESH:D018813 marker/mechanism 171400.0 12864791|7915165|8099202 +RET 5979 Multiple Endocrine Neoplasia Type 2b MESH:D018814 marker/mechanism 162300.0 +RET 5979 Pheochromocytoma MESH:D010673 marker/mechanism 171300.0 12000816 +RET 5979 Status Epilepticus MESH:D013226 marker/mechanism 12914250 +RET 5979 Thyroid cancer, medullary MESH:C536914 marker/mechanism 7915165 +RET 5979 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +RET 5979 Thyroid Neoplasms MESH:D013964 marker/mechanism 16940797 +RETININ 53564 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +RETN 56729 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 +RETN 56729 Heart Failure MESH:D006333 marker/mechanism 26670611 +RETN 56729 Heroin Dependence MESH:D006556 marker/mechanism 15717844 +RETN 56729 Insulin Resistance MESH:D007333 marker/mechanism 16493877 +RETN 56729 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19539174 +RETN 56729 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +RETN 56729 Metabolic Syndrome MESH:D024821 marker/mechanism 18328350 +RETN 56729 Renal Insufficiency, Chronic MESH:D051436 marker/mechanism 22421264 +RETNLA 57262 Asbestosis MESH:D001195 marker/mechanism 26699812 +RETNLA 57262 Hypertension, Pulmonary MESH:D006976 marker/mechanism 20582166 +RETNLA 57262 Silicosis MESH:D012829 marker/mechanism 15292275 +RETNLG 245195 Chemically-Induced Disorders MESH:D064419 marker/mechanism 35999755 +RETNLG 245195 Colitis, Ulcerative MESH:D003093 marker/mechanism 35999755 +RETREG1 54463 Hereditary Sensory and Autonomic Neuropathies MESH:D009477 marker/mechanism 19838196 +RETREG1 54463 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA OMIM:201300 marker/mechanism 201300.0 +RETREG1 54463 Neuropathy, Hereditary Sensory And Autonomic, Type IIB MESH:C567738 marker/mechanism 613115.0 +RETSAT 54884 Simpson-Golabi-Behmel syndrome MESH:C537340 marker/mechanism 19139408 +REXO1 57455 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +RFC1 5981 Bilateral Vestibulopathy MESH:D000071699 marker/mechanism 30926972 +RFC1 5981 Cerebellar Ataxia MESH:D002524 marker/mechanism 30926972 +RFC1 5981 Colonic Neoplasms MESH:D003110 marker/mechanism 18926688 +RFC1 5981 Hereditary Sensory and Motor Neuropathy MESH:D015417 marker/mechanism 30926972 +RFC1 5981 Osteosarcoma MESH:D012516 marker/mechanism 19159907 +RFC4 5984 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RFC4 5984 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RFK 55312 Prostatic Neoplasms MESH:D011471 marker/mechanism 21308351 +RFLNB 359845 Cholestasis MESH:D002779 marker/mechanism 27989131 +RFNG 5986 Weight Gain MESH:D015430 marker/mechanism 19030233 +RFT1 91869 Congenital Disorder Of Glycosylation, Type In MESH:C567437 marker/mechanism 612015.0 +RFWD3 55159 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 23666239 +RFX3 5991 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +RFX3 5991 Skin Diseases MESH:D012871 marker/mechanism 16835338 +RFX5 5993 Bare lymphocyte syndrome 2 MESH:C537079 marker/mechanism 209920.0 +RFX6 222546 Melanoma MESH:D008545 marker/mechanism 22535842 +RFX6 222546 Mitchell-Riley Syndrome MESH:C567570 marker/mechanism 615710.0 +RFX6 222546 Prostatic Neoplasms MESH:D011471 marker/mechanism 24390282 +RFX7 64864 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +RFXANK 8625 Bare lymphocyte syndrome 2 MESH:C537079 marker/mechanism 209920.0 +RFXAP 5994 Bare lymphocyte syndrome 2 MESH:C537079 marker/mechanism 209920.0 +RGCC 28984 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RGD1561149 500552 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RGD1565959 301230 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +RGMB 285704 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17568789 +RGMB 285704 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +RGN 9104 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +RGN 9104 Kidney Diseases MESH:D007674 marker/mechanism 18805471 +RGN 9104 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +RGN 9104 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +RGN 9104 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +RGR 5995 Retinitis Pigmentosa MESH:D012174 marker/mechanism 10581022|16968212 +RGR 5995 RETINITIS PIGMENTOSA 44 OMIM:613769 marker/mechanism 613769.0 +RGS1 5996 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +RGS1 5996 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +RGS1 5996 Osteosarcoma MESH:D012516 marker/mechanism 14767549 +RGS1 5996 Skin Diseases MESH:D012871 marker/mechanism 16835338 +RGS10 6001 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RGS12 6002 Schizophrenia MESH:D012559 marker/mechanism 21822266 +RGS17 26575 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +RGS2 5997 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +RGS2 5997 Hypertension MESH:D006973 therapeutic 1798635 +RGS2 5997 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +RGS2 5997 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RGS2 5997 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 18347610 +RGS2 5997 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +RGS3 5998 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RGS4 5999 Endometriosis MESH:D004715 marker/mechanism 20864642 +RGS5 8490 Essential Hypertension MESH:D000075222 marker/mechanism 145500.0 +RGS5 8490 Hypertension MESH:D006973 therapeutic 1798635 +RGS5 8490 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RGS7 6000 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +RGS7 6000 Stroke MESH:D020521 marker/mechanism 29531354 +RGS9 8787 Dyskinesia, Drug-Induced MESH:D004409 marker/mechanism|therapeutic 18160641|24663062 +RGS9 8787 Prolonged Electroretinal Response Suppression MESH:C564243 marker/mechanism 608415.0 +RGS9 8787 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 17318883 +RGS9 8787 Schizophrenia MESH:D012559 marker/mechanism 17318883 +RHAG 6005 Rh-Null, Regulator Type MESH:C564833 marker/mechanism 268150.0 +RHAG 6005 Stomatocytosis I MESH:C566111 marker/mechanism 185000.0 +RHBDD1 84236 Pancreatic Neoplasms MESH:D010190 therapeutic 35442567 +RHBDD3 25807 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +RHBDF2 79651 Keratosis palmoplantaris with esophageal cancer MESH:C536164 marker/mechanism 148500.0 +RHCE 6006 Anemia, Hemolytic, Congenital MESH:D000745 marker/mechanism 9657769 +RHD 6007 Anemia, Hemolytic, Congenital MESH:D000745 marker/mechanism 9657769 +RHEB 6009 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 20554106 +RHO 6010 Fundus Albipunctatus MESH:C562733 marker/mechanism 136880.0 8554077 +RHO 6010 Night blindness, congenital stationary MESH:C536122 marker/mechanism 8358437 +RHO 6010 Night Blindness, Congenital Stationary, Autosomal Dominant 1 MESH:C566474 marker/mechanism 610445.0 +RHO 6010 Retinal Degeneration MESH:D012162 marker/mechanism 27233447|8692941 +RHO 6010 Retinitis Pigmentosa MESH:D012174 marker/mechanism 16737970|18273801|19206210|2137202|2215617|28715844|9020854|9391065 +RHO 6010 Retinitis Pigmentosa 4 MESH:C566706 marker/mechanism 613731.0 +RHOA 387 Abnormalities, Drug-Induced MESH:D000014 marker/mechanism 25783350 +RHOA 387 Alopecia MESH:D000505 marker/mechanism 31570889 +RHOA 387 Carcinoma MESH:D002277 marker/mechanism 24816255 +RHOA 387 Cocaine-Related Disorders MESH:D019970 marker/mechanism 30158054 +RHOA 387 Craniofacial Abnormalities MESH:D019465 marker/mechanism 31570889 +RHOA 387 Disease Models, Animal MESH:D004195 marker/mechanism 25783350 +RHOA 387 Ectodermal Dysplasia MESH:D004476 marker/mechanism 31570889 +RHOA 387 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 25783350 +RHOA 387 Hypopigmentation MESH:D017496 marker/mechanism 31570889 +RHOA 387 Immunoblastic Lymphadenopathy MESH:D007119 marker/mechanism 24413737|24584070 +RHOA 387 Leukoencephalopathies MESH:D056784 marker/mechanism 31570889 +RHOA 387 Lymphoma, T-Cell MESH:D016399 marker/mechanism 24584070 +RHOA 387 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +RHOA 387 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 24413734|24413737 +RHOA 387 Neoplasm Invasiveness MESH:D009361 marker/mechanism 19896475 +RHOA 387 Neurocutaneous Syndromes MESH:D020752 marker/mechanism 31570889 +RHOA 387 Proteinuria MESH:D011507 marker/mechanism 19955829 +RHOA 387 Stomach Neoplasms MESH:D013274 marker/mechanism 15448013|24816253|24816255|36914835 +RHOA 387 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 30158054 +RHOA 387 Tooth Diseases MESH:D014076 marker/mechanism 31570889 +RHOA 387 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 19896475 +RHOB 388 Scleroderma, Systemic MESH:D012595 marker/mechanism 21750679 +RHOBTB1 9886 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +RHOBTB2 23221 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +RHOC 389 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RHOC 389 Neoplasm Metastasis MESH:D009362 marker/mechanism 18230616 +RHOJ 57381 Cardiomyopathies MESH:D009202 marker/mechanism 21037199 +RHOJ 57381 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +RHOQ 23433 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RHOX3H 434758 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25926378 +RHPN1 114822 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +RHPN1-AS1 78998 Disease Progression MESH:D018450 marker/mechanism 36125241 +RHPN1-AS1 78998 Prostatic Neoplasms MESH:D011471 marker/mechanism 36125241 +RHPN2 85415 Colorectal Neoplasms MESH:D015179 marker/mechanism 19011631 +RIBC2 26150 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +RIC8A 60626 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +RIDA 10247 Liver Failure, Acute MESH:D017114 marker/mechanism 35172013 +RIGI 23586 Disease Progression MESH:D018450 marker/mechanism 20170495 +RIGI 23586 Hepatitis C MESH:D006526 marker/mechanism 20170495 +RIGI 23586 Influenza, Human MESH:D007251 marker/mechanism 23326326 +RIGI 23586 Orthomyxoviridae Infections MESH:D009976 marker/mechanism 25780039 +RIGI 23586 Psoriasis MESH:D011565 marker/mechanism 23143594 +RIMS1 22999 Autistic Disorder MESH:D001321 marker/mechanism 25961944 +RIMS1 22999 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +RIMS1 22999 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +RIMS2 9699 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +RIN1 9610 Melanoma MESH:D008545 marker/mechanism 22535842 +RIN2 54453 Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis MESH:C567770 marker/mechanism 613075.0 +RIN3 79890 Osteitis Deformans MESH:D010001 marker/mechanism 21623375 +RIOX2 84864 Lung Neoplasms MESH:D008175 marker/mechanism 15897898 +RIPK2 8767 Colitis, Ulcerative MESH:D003093 marker/mechanism 20452301 +RIPK3 11035 Calcinosis MESH:D002114 marker/mechanism 21335463 +RIPK3 11035 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 26769846 +RIPK3 11035 Fatty Liver MESH:D005234 therapeutic 26769846 +RIPK3 11035 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +RIPK4 54101 Popliteal Pterygium Syndrome, Lethal Type MESH:C564874 marker/mechanism 263650.0 +RIPOR2 9750 Deafness, Autosomal Dominant 21 MESH:C564634 marker/mechanism 607017.0 +RIPOR2 9750 DEAFNESS, AUTOSOMAL RECESSIVE 104 OMIM:616515 marker/mechanism 616515.0 +RIPPLY2 134701 Spondylocostal dysostosis, autosomal recessive MESH:C535781 marker/mechanism 616566.0 +RIT1 6016 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RIT1 6016 NOONAN SYNDROME 8 OMIM:615355 marker/mechanism 615355.0 +RLBP1 6017 Bothnia Retinal Dystrophy MESH:C564392 marker/mechanism 607475.0 +RLBP1 6017 Eye Diseases, Hereditary MESH:D015785 marker/mechanism 16968212 +RLBP1 6017 Fundus Albipunctatus MESH:C562733 marker/mechanism 136880.0 +RLBP1 6017 Macular Degeneration MESH:D008268 marker/mechanism 30742112 +RLBP1 6017 Newfoundland Rod-Cone Dystrophy MESH:C564391 marker/mechanism 607476.0 +RLIM 51132 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +RLIM 51132 TONNE-KALSCHEUER SYNDROME OMIM:300978 marker/mechanism 300978.0 +RLN1 6013 Hypertrophy MESH:D006984 marker/mechanism 22028442 +RLN2 6019 Prostatic Neoplasms MESH:D011471 marker/mechanism 16434975 +RLN3 117579 Hyperplasia MESH:D006965 therapeutic 16112403 +RLN3 117579 Myocardial Ischemia MESH:D017202 therapeutic 16112403 +RMDN2 151393 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RMND1 55005 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +RMND1 55005 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11 OMIM:614922 marker/mechanism 614922.0 +RMND5B 64777 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RMRP 6023 Anauxetic dysplasia MESH:C538256 marker/mechanism 607095.0 +RMRP 6023 Cartilage-hair hypoplasia MESH:C535916 marker/mechanism 250250.0 +RMRP 6023 Metaphyseal Dysplasia without Hypotrichosis MESH:C563574 marker/mechanism 250460.0 +RMST 196475 Heart Failure MESH:D006333 marker/mechanism 36071497 +RMST 196475 Obesity MESH:D009765 marker/mechanism 23563609 +RN7SKP114 106480868 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +RNASE3 6037 Asthma MESH:D001249 marker/mechanism 12153692|12587966|8874658 +RNASE3 6037 Gram-Negative Bacterial Infections MESH:D016905 therapeutic 21696142 +RNASE3 6037 Gram-Positive Bacterial Infections MESH:D016908 therapeutic 21696142 +RNASE4 6038 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +RNASE4 6038 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RNASE6 6039 Liver Diseases MESH:D008107 marker/mechanism 19784758 +RNASE6 6039 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +RNASEH1 246243 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2 OMIM:616479 marker/mechanism 616479.0 +RNASEH2A 10535 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 34254728 +RNASEH2A 10535 Aicardi-Goutieres Syndrome 4 MESH:C563681 marker/mechanism 610333.0 +RNASEH2B 79621 Aicardi-Goutieres syndrome MESH:C535607 marker/mechanism 610181.0 +RNASEH2C 84153 Aicardi-Goutieres Syndrome 3 MESH:C563683 marker/mechanism 610329.0 +RNASEL 6041 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RNASEL 6041 Prostate cancer, familial MESH:C537243 marker/mechanism 601518.0 +RNASEL 6041 Prostatic Neoplasms MESH:D011471 marker/mechanism 16114055|17020975|27318894 +RNASET2 8635 Brain Diseases MESH:D001927 marker/mechanism 19525954 +RNASET2 8635 Graves Disease MESH:D006111 marker/mechanism 21841780 +RNASET2 8635 Leukoencephalopathy, Cystic, Without Megalencephaly MESH:C567845 marker/mechanism 612951.0 +RNASET2 8635 Lung Neoplasms MESH:D008175 marker/mechanism 28604730 +RND3 390 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +RNF10 9921 Cardiotoxicity MESH:D066126 therapeutic 36740146 +RNF103 7844 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +RNF113A 7737 TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE OMIM:300953 marker/mechanism 300953.0 +RNF114 55905 Psoriasis MESH:D011565 marker/mechanism 20953190 +RNF115 27246 Breast Neoplasms MESH:D001943 marker/mechanism 25751625 +RNF125 54941 TENORIO SYNDROME OMIM:616260 marker/mechanism 616260.0 +RNF130 55819 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RNF135 84282 Growth Disorders MESH:D006130 marker/mechanism 17632510 +RNF135 84282 NF1 Microdeletion Syndrome MESH:C563524 marker/mechanism 17632510 +RNF139 11236 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 144700.0 +RNF144B 255488 Endometrial Neoplasms MESH:D016889 marker/mechanism 29724995 +RNF157 114804 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +RNF168 165918 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 34873829 +RNF168 165918 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 34873829 +RNF168 165918 Disease Progression MESH:D018450 marker/mechanism 34873829 +RNF168 165918 Riddle Syndrome MESH:C567453 marker/mechanism 611943.0 +RNF170 81790 ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT OMIM:608984 marker/mechanism 608984.0 +RNF180 285671 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 34998818 +RNF182 221687 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +RNF182 221687 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500 +RNF19A 25897 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +RNF207 388591 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +RNF213 57674 Moyamoya disease 2 MESH:C536992 marker/mechanism 607151.0 +RNF216 54476 Cerebellar Ataxia and Hypogonadotropic Hypogonadism MESH:C565870 marker/mechanism 212840.0 +RNF31 55072 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +RNF34 80196 Colonic Neoplasms MESH:D003110 therapeutic 16270526 +RNF39 80352 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RNF43 54894 Cholangiocarcinoma MESH:D018281 marker/mechanism 22561520 +RNF43 54894 Colorectal Neoplasms MESH:D015179 marker/mechanism 25344691 +RNF43 54894 Endometrial Neoplasms MESH:D016889 marker/mechanism 25344691 +RNF43 54894 Liver Diseases, Parasitic MESH:D008109 marker/mechanism 22561520 +RNF43 54894 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +RNF43 54894 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +RNF43 54894 Stomach Neoplasms MESH:D013274 marker/mechanism 24816253 +RNF6 6049 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +RNF6 6049 Esophageal Neoplasms MESH:D004938 marker/mechanism 133239.0 +RNF8 9025 Autistic Disorder MESH:D001321 marker/mechanism 18621663 +RNLS 55328 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +RNPEP 6051 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16619500 +RNR1 4549 Deafness MESH:D003638 marker/mechanism 12031626|12037390|15722487|9391883 +RNR1 4549 Deafness, Sensorineural, Autosomal-Mitochondrial Type MESH:C565637 marker/mechanism 500008.0 +RNR1 4549 Muscular Diseases MESH:D009135 marker/mechanism 12031626 +RNR1 4549 Tinnitus MESH:D014012 marker/mechanism 15141753 +RNU12 267010 Craniosynostosis, anal anomalies, and porokeratosis MESH:C536789 marker/mechanism 603116.0 +RNU4ATAC 100151683 Microcephalic osteodysplastic primordial dwarfism, type 1 MESH:C537577 marker/mechanism 210710.0 26522830 +RNU4ATAC 100151683 Roifman syndrome MESH:C535866 marker/mechanism 616651.0 26522830 +RNU6-148P 106479631 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +RNU6-456P 106481323 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +RNU6-491P 106479784 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +ROBO1 6091 Adenocarcinoma MESH:D000230 marker/mechanism 17671114 +ROBO1 6091 Autistic Disorder MESH:D001321 marker/mechanism 18270976 +ROBO1 6091 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ROBO1 6091 Lung Neoplasms MESH:D008175 marker/mechanism 17671114 +ROBO1 6091 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +ROBO2 6092 Autistic Disorder MESH:D001321 marker/mechanism 18270976 +ROBO2 6092 Cholangiocarcinoma MESH:D018281 marker/mechanism 22561520 +ROBO2 6092 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ROBO2 6092 Liver Diseases, Parasitic MESH:D008109 marker/mechanism 22561520 +ROBO2 6092 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +ROBO2 6092 Vesicoureteral Reflux 2 MESH:C567053 marker/mechanism 610878.0 +ROBO3 64221 Autistic Disorder MESH:D001321 marker/mechanism 18270976 +ROBO3 64221 gaze palsy, familial horizontal, with progressive scoliosis MESH:C564593 marker/mechanism 607313.0 +ROBO4 54538 Aortic Aneurysm, Thoracic MESH:D017545 marker/mechanism 30455415 +ROBO4 54538 Autistic Disorder MESH:D001321 marker/mechanism 18270976 +ROBO4 54538 Bicuspid Aortic Valve Disease MESH:D000082882 marker/mechanism 30455415 +ROCK1 6093 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32417439 +ROCK1 6093 Prenatal Injuries MESH:D049188 marker/mechanism 18956198 +ROCK2 9475 Cardiomegaly MESH:D006332 marker/mechanism 29394407 +ROCK2 9475 Disease Models, Animal MESH:D004195 marker/mechanism 29394407 +ROCK2 9475 Heart Failure MESH:D006333 marker/mechanism 29394407 +ROCK2 9475 Prenatal Injuries MESH:D049188 marker/mechanism 18956198 +ROCK2 9475 Ventricular Remodeling MESH:D020257 marker/mechanism 29394407 +ROGDI 79641 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 31209396 +ROGDI 79641 Kohlschutter Tonz syndrome MESH:C537213 marker/mechanism 226750.0 +ROM1 6094 Retinitis Pigmentosa MESH:D012174 marker/mechanism 268000.0 +ROM1 6094 Retinitis Pigmentosa 7 MESH:C564284 marker/mechanism 608133.0 +ROR1 4919 Breast Neoplasms MESH:D001943 marker/mechanism 28114269 +ROR1 4919 Neoplasm Metastasis MESH:D009362 marker/mechanism 28114269 +ROR2 4920 Brachydactyly, Type B1 MESH:C566196 marker/mechanism 113000.0 12815588 +ROR2 4920 Robinow syndrome, autosomal recessive MESH:C535863 marker/mechanism 268310.0 12815588|15952209 +RORA 6095 Autistic Disorder MESH:D001321 marker/mechanism 20375269|21359227 +RORA 6095 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +RORB 6096 Endometriosis MESH:D004715 marker/mechanism 20864642 +RORC 6097 IMMUNODEFICIENCY 42 OMIM:616622 marker/mechanism 616622.0 +RORC 6097 Inflammation MESH:D007249 marker/mechanism 22325453 +RORC 6097 Sleep Disorders, Circadian Rhythm MESH:D020178 marker/mechanism 25395965 +ROS1 6098 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 22215748 +ROS1 6098 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22215748|22585869|22617245|22919003 +ROS1 6098 Glioma MESH:D005910 marker/mechanism 19276365 +ROS1 6098 Melanoma MESH:D008545 marker/mechanism 22535842 +RP1 6101 Retinitis pigmentosa 1 MESH:C538365 marker/mechanism 180100.0 +RP1L1 94137 OCCULT MACULAR DYSTROPHY OMIM:613587 marker/mechanism 613587.0 +RP2 6102 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +RP2 6102 Retinitis Pigmentosa 2 MESH:C567523 marker/mechanism 312600.0 +RP9 6100 Retinitis Pigmentosa 9 MESH:C566716 marker/mechanism 180104.0 +RPA1 6117 Chloracne MESH:D054506 marker/mechanism 17101203 +RPE65 6121 Amaurosis congenita of Leber, type 2 MESH:C536601 marker/mechanism 204100.0 +RPE65 6121 Blindness MESH:D001766 marker/mechanism|therapeutic 16150724|16226919 +RPE65 6121 Eye Diseases, Hereditary MESH:D015785 therapeutic 16968212 +RPE65 6121 Leber Congenital Amaurosis MESH:D057130 marker/mechanism 19339306|9326927|9501220 +RPE65 6121 Nystagmus, Congenital MESH:D020417 marker/mechanism 32971638 +RPE65 6121 Optic Atrophy, Hereditary, Leber MESH:D029242 marker/mechanism 16828753|17011878 +RPE65 6121 Retinal Degeneration MESH:D012162 marker/mechanism 24849605|32971638 +RPE65 6121 Retinal Dystrophies MESH:D058499 marker/mechanism 9326941 +RPE65 6121 Retinitis Pigmentosa MESH:D012174 marker/mechanism 16272259|16968212|9501220 +RPE65 6121 Retinitis Pigmentosa 20 MESH:C566718 marker/mechanism 613794.0 +RPGR 6103 CONE-ROD DYSTROPHY, X-LINKED, 1 OMIM:304020 marker/mechanism 304020.0 +RPGR 6103 Hearing Loss MESH:D034381 marker/mechanism 12920075 +RPGR 6103 Macular Degeneration MESH:D008268 marker/mechanism 12160730 +RPGR 6103 MACULAR DEGENERATION, ATROPHIC, X-LINKED OMIM:300834 marker/mechanism 300834.0 +RPGR 6103 Respiratory Tract Infections MESH:D012141 marker/mechanism 12920075 +RPGR 6103 Retinal Degeneration MESH:D012162 marker/mechanism 19430481 +RPGR 6103 Retinal Dystrophies MESH:D058499 marker/mechanism 11857109 +RPGR 6103 Retinitis Pigmentosa MESH:D012174 marker/mechanism 10094550|12920075|17480003 +RPGR 6103 Retinitis Pigmentosa 3 MESH:C564520 marker/mechanism 300029.0 +RPGR 6103 Retinitis Pigmentosa, X-Linked, And Sinorespiratory Infections, With Or Without Deafness MESH:C567595 marker/mechanism 300455.0 +RPGRIP1 57096 Cone-Rod Dystrophy 13 MESH:C567698 marker/mechanism 608194.0 +RPGRIP1 57096 Leber Congenital Amaurosis MESH:D057130 marker/mechanism 11283794|11528500 +RPGRIP1 57096 Leber Congenital Amaurosis 6 MESH:C565327 marker/mechanism 613826.0 +RPGRIP1 57096 Nystagmus, Pathologic MESH:D009759 marker/mechanism 11283794 +RPGRIP1 57096 Retinal Dystrophies MESH:D058499 marker/mechanism 12920076 +RPGRIP1 57096 Retinitis Pigmentosa MESH:D012174 marker/mechanism 16272259 +RPGRIP1L 23322 Cerebellar Diseases MESH:D002526 marker/mechanism 17558407|17558409 +RPGRIP1L 23322 Ciliary Motility Disorders MESH:D002925 marker/mechanism 17558407|17558409 +RPGRIP1L 23322 Eye Diseases MESH:D005128 marker/mechanism 17558407|17558409 +RPGRIP1L 23322 Joubert Syndrome 7 MESH:C566916 marker/mechanism 611560.0 +RPGRIP1L 23322 Kidney Diseases MESH:D007674 marker/mechanism 17558407|17558409 +RPGRIP1L 23322 Meckel Syndrome, Type 5 MESH:C566915 marker/mechanism 611561.0 +RPGRIP1L 23322 Retinal Degeneration MESH:D012162 marker/mechanism 19430481 +RPH3AL 9501 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +RPIA 22934 Ribose 5-Phosphate Isomerase Deficiency MESH:C563212 marker/mechanism 608611.0 +RPL10 6134 Autistic Disorder MESH:D001321 marker/mechanism 300847.0 16940977 +RPL10 6134 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 23263491 +RPL10 6134 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RPL10A 4736 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RPL10A 4736 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RPL11 6135 Diamond-Blackfan Anemia 7 MESH:C567254 marker/mechanism 612562.0 +RPL11 6135 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +RPL12 6136 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RPL13 6137 Disease Progression MESH:D018450 marker/mechanism 21364753 +RPL13 6137 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RPL13A 23521 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RPL13A 23521 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RPL14 9045 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +RPL14 9045 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +RPL15 6138 DIAMOND-BLACKFAN ANEMIA 12 OMIM:615550 marker/mechanism 615550.0 +RPL15 6138 Disease Progression MESH:D018450 marker/mechanism 21364753 +RPL15 6138 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RPL17 6139 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RPL18 6141 Disease Progression MESH:D018450 marker/mechanism 21364753 +RPL18 6141 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RPL21 6144 Hypotrichosis MESH:D007039 marker/mechanism 615885.0 +RPL23A 6147 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +RPL23A 6147 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +RPL24 6152 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +RPL26 6154 DIAMOND-BLACKFAN ANEMIA 11 OMIM:614900 marker/mechanism 614900.0 +RPL27 6155 DIAMOND-BLACKFAN ANEMIA 16 OMIM:617408 marker/mechanism 617408.0 +RPL27A 6157 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RPL27A 6157 Cerebellar Ataxia MESH:D002524 marker/mechanism 21674502 +RPL27A 6157 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RPL27A 6157 Hyperpigmentation MESH:D017495 marker/mechanism 21674502 +RPL27A 6157 Pancytopenia MESH:D010198 marker/mechanism 21674502 +RPL28 6158 Weight Gain MESH:D015430 marker/mechanism 19030233 +RPL3 6122 Carcinoma MESH:D002277 marker/mechanism 16316942 +RPL3 6122 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +RPL3 6122 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +RPL31 6160 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +RPL35A 6165 Diamond-Blackfan Anemia 5 MESH:C567280 marker/mechanism 612528.0 +RPL36A 6173 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RPL36A 6173 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RPL37A 6168 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +RPL3L 6123 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +RPL3L 6123 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +RPL4 6124 Sepsis MESH:D018805 marker/mechanism 27978524 +RPL5 6125 DIAMOND-BLACKFAN ANEMIA 6 OMIM:612561 marker/mechanism 612561.0 +RPL5 6125 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +RPL5 6125 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 23263491 +RPL6 6128 Carcinoma MESH:D002277 marker/mechanism 12376462 +RPL6 6128 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +RPL6 6128 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +RPL6 6128 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +RPL9 6133 Sepsis MESH:D018805 marker/mechanism 27978524 +RPLP2 6181 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +RPN2 6185 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RPP38 10557 Melanoma MESH:D008545 marker/mechanism 22535842 +RPRD2 23248 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +RPRM 56475 Barrett Esophagus MESH:D001471 marker/mechanism 17121882 +RPRM 56475 Esophageal Neoplasms MESH:D004938 marker/mechanism 17121882 +RPS10 6204 Diamond-Blackfan Anemia 9 MESH:C567650 marker/mechanism 613308.0 +RPS14 6208 Carcinoma MESH:D002277 marker/mechanism 16316942 +RPS14 6208 Chromosome 5q Deletion Syndrome MESH:C535323 marker/mechanism 153550.0 +RPS14 6208 Hypoxia MESH:D000860 marker/mechanism 18258771 +RPS14 6208 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +RPS14 6208 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +RPS14 6208 Neutropenia MESH:D009503 marker/mechanism 27725143 +RPS15 6209 Disease Progression MESH:D018450 marker/mechanism 21364753 +RPS15 6209 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RPS17 6218 Anemia, Diamond-Blackfan MESH:D029503 marker/mechanism 17647292 +RPS17 6218 Diamond-Blackfan Anemia 4 MESH:C567281 marker/mechanism 612527.0 +RPS19 6223 Anemia, Diamond-Blackfan MESH:D029503 marker/mechanism 105650.0 +RPS19 6223 Disease Progression MESH:D018450 marker/mechanism 21364753 +RPS19 6223 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +RPS19 6223 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RPS2 6187 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +RPS2 6187 Hypoxia MESH:D000860 marker/mechanism 18258771 +RPS21 6227 Disease Progression MESH:D018450 marker/mechanism 21364753 +RPS21 6227 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RPS23 6228 BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY OMIM:617412 marker/mechanism 617412.0 +RPS24 6229 Anemia, Diamond-Blackfan, 3 MESH:C536355 marker/mechanism 610629.0 +RPS26 6231 Diamond-Blackfan Anemia 10 MESH:C567649 marker/mechanism 613309.0 +RPS26 6231 Disease Progression MESH:D018450 marker/mechanism 21364753 +RPS26 6231 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RPS27 6232 DIAMOND-BLACKFAN ANEMIA 17 OMIM:617409 marker/mechanism 617409.0 +RPS28 6234 DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS OMIM:606164 marker/mechanism 606164.0 +RPS28 6234 Weight Gain MESH:D015430 marker/mechanism 19030233 +RPS29 6235 DIAMOND-BLACKFAN ANEMIA 13 OMIM:615909 marker/mechanism 615909.0 +RPS3 6188 Chromosomal Instability MESH:D043171 marker/mechanism 25341047 +RPS3 6188 Melanoma MESH:D008545 marker/mechanism 22535842 +RPS4X 6191 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +RPS4Y2 140032 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +RPS6 6194 Breast Neoplasms MESH:D001943 marker/mechanism 20197467 +RPS6 6194 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +RPS6 6194 Disease Progression MESH:D018450 marker/mechanism 21364753 +RPS6 6194 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RPS6KA1 6195 Fetal Alcohol Spectrum Disorders MESH:D063647 marker/mechanism 29109170 +RPS6KA1 6195 Sezary Syndrome MESH:D012751 marker/mechanism 26551670 +RPS6KA2 6196 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +RPS6KA3 6197 Bone Diseases, Developmental MESH:D001848 marker/mechanism 8955270 +RPS6KA3 6197 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22561517 +RPS6KA3 6197 Coffin-Lowry Syndrome MESH:D038921 marker/mechanism 303600.0 21488662|8955270 +RPS6KA3 6197 Mental Retardation, X-Linked 19 MESH:C563141 marker/mechanism 300844.0 +RPS6KA3 6197 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21488662 +RPS6KA3 6197 Neoplasm Metastasis MESH:D009362 marker/mechanism 21488662 +RPS6KA3 6197 Psychomotor Disorders MESH:D011596 marker/mechanism 8955270 +RPS6KA5 9252 Cocaine-Related Disorders MESH:D019970 marker/mechanism 16339038 +RPS6KB1 6198 Atrophy MESH:D001284 marker/mechanism 16391472 +RPS6KB1 6198 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254 +RPS6KB1 6198 Hypertension MESH:D006973 marker/mechanism 19289642 +RPS6KB1 6198 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 19289642 +RPS6KB1 6198 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 19223503 +RPS6KB2 6199 Breast Neoplasms MESH:D001943 marker/mechanism 20953835 +RPS7 6201 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +RPS7 6201 Diamond-Blackfan Anemia 8 MESH:C567253 marker/mechanism 612563.0 +RPS8 6202 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +RPS8 6202 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +RPS8 6202 Weight Gain MESH:D015430 marker/mechanism 19030233 +RPSA 3921 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RPSA 3921 ASPLENIA, ISOLATED CONGENITAL OMIM:271400 marker/mechanism 271400.0 +RPSA 3921 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RPSA 3921 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +RPTOR 57521 Motor Skills Disorders MESH:D019957 therapeutic 32773031 +RPTOR 57521 Tobacco Use Disorder MESH:D014029 marker/mechanism 18438686 +RRAD 6236 Breast Neoplasms MESH:D001943 marker/mechanism 17195088 +RRAD 6236 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17195088 +RRAD 6236 Cardiomegaly MESH:D006332 marker/mechanism 18056528 +RRAGC 64121 Lymphoma, Follicular MESH:D008224 marker/mechanism 26691987 +RRAS 6237 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +RRAS 6237 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +RRAS2 22800 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +RRAS2 22800 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21147764 +RRM1 6240 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RRM1 6240 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 22547773 +RRM1 6240 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18230555 +RRM1 6240 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21496433 +RRM1 6240 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RRM1 6240 Disease Progression MESH:D018450 marker/mechanism 21496433 +RRM1 6240 Neural Tube Defects MESH:D009436 marker/mechanism 10716750 +RRM2 6241 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RRM2 6241 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18230555|28284560 +RRM2 6241 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641 +RRM2 6241 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RRM2 6241 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +RRM2B 50484 Acidosis, Lactic MESH:D000140 marker/mechanism 19138848 +RRM2B 50484 Kidney Diseases MESH:D007674 marker/mechanism 19138848 +RRM2B 50484 MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY) OMIM:612075 marker/mechanism 612075.0 +RRM2B 50484 Mitochondrial Myopathies MESH:D017240 marker/mechanism 17486094|19138848 +RRM2B 50484 Muscle Hypotonia MESH:D009123 marker/mechanism 19138848 +RRM2B 50484 Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5 MESH:C567768 marker/mechanism 613077.0 +RRM2B 50484 Visceral myopathy familial external ophthalmoplegia MESH:C536350 marker/mechanism 19667227 +RRP9 9136 Disease Progression MESH:D018450 marker/mechanism 21364753 +RRP9 9136 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RRS1 23212 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +RRS1 23212 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +RS1 6247 Retinoschisis MESH:D041441 marker/mechanism 312700.0 16088326|21738583 +RSAD2 91543 Disease Models, Animal MESH:D004195 marker/mechanism 36071497 +RSAD2 91543 Heart Failure MESH:D006333 marker/mechanism 36071497 +RSAD2 91543 Influenza, Human MESH:D007251 marker/mechanism 23326326 +RSAD2 91543 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RSPH1 89765 CILIARY DYSKINESIA, PRIMARY, 24 OMIM:615481 marker/mechanism 615481.0 +RSPH3 83861 CILIARY DYSKINESIA, PRIMARY, 32 OMIM:616481 marker/mechanism 616481.0 +RSPH4A 345895 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +RSPH4A 345895 Ciliary Dyskinesia, Primary, 11 MESH:C567212 marker/mechanism 612649.0 +RSPH9 221421 Ciliary Dyskinesia, Primary, 12 MESH:C567211 marker/mechanism 612650.0 +RSPO1 284654 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 25581431 +RSPO1 284654 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and Sex Reversal MESH:C565693 marker/mechanism 610644.0 +RSPO3 84870 Breast Neoplasms MESH:D001943 marker/mechanism 17468756 +RSPO3 84870 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +RSPO4 343637 Anonychia congenita MESH:C536377 marker/mechanism 206800.0 +RSRP1 57035 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RSU1 6251 Chloracne MESH:D054506 marker/mechanism 17101203 +RSU1 6251 Osteoporosis MESH:D010024 marker/mechanism 18924182 +RT1-BA 309621 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RT1-CE5 309607 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RT1-DA 294269 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RT1-DB1 294270 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RT1-DMA 294274 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RT1-DMB 294273 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RT1-DOA 24984 Liver Diseases MESH:D008107 marker/mechanism 19784758 +RT1-M3-1 24747 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RT1-N3 24750 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RTBDN 83546 Ependymoma MESH:D004806 marker/mechanism 26075792 +RTEL1 51750 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5 OMIM:615190 marker/mechanism 615190.0 +RTEL1 51750 Glioma MESH:D005910 marker/mechanism 19578366|19578367 +RTEL1 51750 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 25848748 +RTEL1 51750 Lung Neoplasms MESH:D008175 marker/mechanism 28604730 +RTEL1 51750 PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 3 OMIM:616373 marker/mechanism 616373.0 +RTL6 84247 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +RTN1 6252 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RTN2 6253 Spastic paraplegia 12, autosomal dominant MESH:C537484 marker/mechanism 604805.0 +RTN4 57142 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RTN4 57142 Schizophrenia MESH:D012559 marker/mechanism 20071518 +RTN4IP1 84816 OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES OMIM:616732 marker/mechanism 616732.0 +RTN4R 65078 Schizophrenia MESH:D012559 marker/mechanism 181500.0 +RTNL1 33721 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +RTP3 83597 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17693185 +RTP3 83597 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +RTP3 83597 Liver Neoplasms MESH:D008113 marker/mechanism 17693185 +RTP4 64108 Influenza, Human MESH:D007251 marker/mechanism 23326326 +RTTN 25914 MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES OMIM:614833 marker/mechanism 614833.0 +RUBCN 9711 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 615705.0 +RUFY3 22902 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +RUFY3 22902 Skin Diseases MESH:D012871 marker/mechanism 16835338 +RUNX1 861 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +RUNX1 861 Glioblastoma MESH:D005909 marker/mechanism 23582323 +RUNX1 861 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 18206229|27798625|30420649 +RUNX1 861 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +RUNX1 861 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 27992414 +RUNX1 861 Platelet Disorder, Familial, with Associated Myeloid Malignancy MESH:C563324 marker/mechanism 601399.0 +RUNX1 861 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 15217836|24413735 +RUNX1 861 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 17255265 +RUNX1 861 Prostatic Neoplasms MESH:D011471 marker/mechanism 17909013 +RUNX1T1 862 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229|27798625 +RUNX1T1 862 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +RUNX2 860 Arthritis, Psoriatic MESH:D015535 marker/mechanism 20008919 +RUNX2 860 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20008919 +RUNX2 860 Breast Neoplasms MESH:D001943 marker/mechanism 32198086 +RUNX2 860 Cleidocranial Dysplasia MESH:D002973 marker/mechanism 119600.0 14688224|17022082|20357738 +RUNX2 860 Cocaine-Related Disorders MESH:D019970 marker/mechanism 30158054 +RUNX2 860 Craniofacial Abnormalities MESH:D019465 marker/mechanism 14688224 +RUNX2 860 Metaphyseal Dysplasia with Maxillary Hypoplasia and Brachydactyly MESH:C563586 marker/mechanism 156510.0 +RUNX2 860 Osteoarthritis MESH:D010003 marker/mechanism 20008919 +RUNX2 860 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +RUNX2 860 Osteosarcoma MESH:D012516 marker/mechanism 24646477|25307878 +RUNX2 860 Spondylarthritis MESH:D025241 marker/mechanism 20008919 +RUNX2 860 Stomatognathic System Abnormalities MESH:D018640 marker/mechanism 20357738 +RUNX2 860 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 30158054 +RUNX2 860 Tooth Abnormalities MESH:D014071 marker/mechanism 14688224 +RUNX2 860 Uremia MESH:D014511 marker/mechanism 19092814 +RUNX3 864 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +RUNX3 864 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28458013 +RUNX3 864 Celiac Disease MESH:D002446 marker/mechanism 20190752 +RUNX3 864 Esophageal Neoplasms MESH:D004938 marker/mechanism 18058463 +RUNX3 864 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +RUNX3 864 Glioblastoma MESH:D005909 marker/mechanism 16909125 +RUNX3 864 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +RUNX3 864 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +RUNX3 864 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +RUNX3 864 Psoriasis MESH:D011565 marker/mechanism 23143594 +RUNX3 864 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 21743469 +RUNX3 864 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +RUP2 619560 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +RUP2 619560 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +RX3 30474 Adrenal Insufficiency MESH:D000309 marker/mechanism 27941970 +RX3 30474 Disease Models, Animal MESH:D004195 marker/mechanism 27941970 +RX3 30474 Eye Abnormalities MESH:D005124 marker/mechanism 27941970 +RXFP1 59350 Endometriosis MESH:D004715 marker/mechanism 21063030 +RXRA 6256 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +RXRA 6256 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +RXRA 6256 Prostatic Neoplasms MESH:D011471 marker/mechanism 15318950 +RXRA 6256 Sciatic Neuropathy MESH:D020426 marker/mechanism 16782282 +RXRA 6256 Thyroid Neoplasms MESH:D013964 marker/mechanism 23811263 +RXRB 6257 Breast Neoplasms MESH:D001943 marker/mechanism 22322885 +RXRB 6257 Disease Progression MESH:D018450 marker/mechanism 21364753 +RXRB 6257 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +RXRG 6258 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RXYLT1 10329 Walker-Warburg Syndrome MESH:D058494 marker/mechanism 615041.0 +RYK 6259 Cleft Palate MESH:D002972 marker/mechanism 10932185 +RYK 6259 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10932185 +RYK 6259 Weight Gain MESH:D015430 marker/mechanism 19030233 +RYR1 6261 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +RYR1 6261 Malignant Hyperthermia MESH:D008305 marker/mechanism 11695996|14570802|14708096|16917943|17707769|19191329|19191333|21485675|30329129 +RYR1 6261 Malignant hyperthermia susceptibility type 1 MESH:C535694 marker/mechanism 145600.0 +RYR1 6261 Minicore Myopathy with External Ophthalmoplegia MESH:C564969 marker/mechanism 255320.0 +RYR1 6261 Myopathies, Structural, Congenital MESH:D020914 marker/mechanism 17376685 +RYR1 6261 Myopathy, Central Core MESH:D020512 marker/mechanism 117000.0 14570802|14708096|16917943 +RYR2 6262 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 115000.0 +RYR2 6262 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21151189 +RYR2 6262 Death, Sudden, Cardiac MESH:D016757 marker/mechanism 31913406 +RYR2 6262 Diabetic Cardiomyopathies MESH:D058065 marker/mechanism 16685413 +RYR2 6262 Familial Sudden Death MESH:C566172 marker/mechanism 31913406 +RYR2 6262 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +RYR2 6262 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +RYR2 6262 Polymorphic catecholergic ventricular tachycardia MESH:C536334 marker/mechanism 20080988|20513597 +RYR2 6262 Tachycardia MESH:D013610 marker/mechanism 15749201 +RYR2 6262 Tachycardia, Ventricular MESH:D017180 marker/mechanism 18052993|20944434 +RYR2 6262 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY OMIM:604772 marker/mechanism 604772.0 +S100A1 6271 Vasospasm, Intracranial MESH:D020301 marker/mechanism 12186470 +S100A10 6281 Depressive Disorder MESH:D003866 marker/mechanism 21682946 +S100A10 6281 Disease Models, Animal MESH:D004195 marker/mechanism 21682946 +S100A10 6281 Keloid MESH:D007627 marker/mechanism 20128793 +S100A10 6281 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +S100A10 6281 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +S100A10 6281 Medulloblastoma MESH:D008527 marker/mechanism 17579622 +S100A11 6282 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +S100A11 6282 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +S100A11 6282 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20388789 +S100A12 6283 Mouth Diseases MESH:D009059 marker/mechanism 17682004 +S100A4 6275 Colonic Neoplasms MESH:D003110 marker/mechanism 21685359 +S100A4 6275 Ischemia MESH:D007511 marker/mechanism 19458120 +S100A4 6275 Keloid MESH:D007627 marker/mechanism 20128793 +S100A4 6275 Medulloblastoma MESH:D008527 marker/mechanism 17579622 +S100A4 6275 Melanoma MESH:D008545 marker/mechanism 29179997 +S100A4 6275 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +S100A4 6275 Neoplasm Metastasis MESH:D009362 marker/mechanism 21636539|21685359|36008464 +S100A4 6275 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +S100A4 6275 Osteoarthritis MESH:D010003 marker/mechanism 16948116 +S100A4 6275 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +S100A4 6275 Vasospasm, Intracranial MESH:D020301 marker/mechanism 12186470 +S100A5 6276 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 25257527 +S100A6 6277 Carcinoma MESH:D002277 marker/mechanism 16316942 +S100A6 6277 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +S100A6 6277 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +S100A6 6277 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +S100A6 6277 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +S100A6 6277 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +S100A6 6277 Medulloblastoma MESH:D008527 marker/mechanism 17579622 +S100A6 6277 Vasospasm, Intracranial MESH:D020301 marker/mechanism 12186470 +S100A7 6278 Psoriasis MESH:D011565 marker/mechanism 18194266 +S100A7A 338324 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +S100A8 6279 Dermatitis, Atopic MESH:D003876 marker/mechanism 18336422 +S100A8 6279 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +S100A8 6279 Keloid MESH:D007627 marker/mechanism 20128793 +S100A8 6279 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 21971985 +S100A8 6279 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 22248470 +S100A9 6280 Celiac Disease MESH:D002446 marker/mechanism 30097691 +S100A9 6280 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +S100A9 6280 Keloid MESH:D007627 marker/mechanism 20128793 +S100A9 6280 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +S100A9 6280 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +S100B 6285 Attention Deficit and Disruptive Behavior Disorders MESH:D019958 marker/mechanism 25451971 +S100B 6285 Bipolar Disorder MESH:D001714 marker/mechanism 15581912|16476148 +S100B 6285 Brain Edema MESH:D001929 marker/mechanism 19027832 +S100B 6285 Brain Injuries MESH:D001930 marker/mechanism|therapeutic 11520488|21783483 +S100B 6285 Brain Injuries, Diffuse MESH:D000070625 marker/mechanism 30076900 +S100B 6285 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +S100B 6285 Cerebral Hemorrhage MESH:D002543 marker/mechanism 19027832 +S100B 6285 Disease Models, Animal MESH:D004195 marker/mechanism 12888777|34792689 +S100B 6285 Down Syndrome MESH:D004314 marker/mechanism 12888777 +S100B 6285 Hematoma MESH:D006406 marker/mechanism 19027832 +S100B 6285 Hepatic Encephalopathy MESH:D006501 marker/mechanism 34792689 +S100B 6285 Mercury Poisoning, Nervous System MESH:D020262 marker/mechanism 30076900 +S100B 6285 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 28377727 +S100B 6285 Myocardial Infarction MESH:D009203 marker/mechanism 9788975 +S100B 6285 Vasospasm, Intracranial MESH:D020301 marker/mechanism 12186470 +S100P 6286 Mouth Neoplasms MESH:D009062 marker/mechanism 31066245 +S100P 6286 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +S1PR1 1901 Carcinoma MESH:D002277 marker/mechanism 12376462 +S1PR1 1901 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +S1PR1 1901 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +S1PR1 1901 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +S1PR1 1901 Neointima MESH:D058426 marker/mechanism 29609002 +S1PR1 1901 Vascular System Injuries MESH:D057772 marker/mechanism 29609002 +S1PR2 9294 Deafness, Autosomal Recessive 68 MESH:C563669 marker/mechanism 610419.0 +S1PR2 9294 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22406263 +S1PR2 9294 Fibrosis MESH:D005355 therapeutic 37169277 +S1PR2 9294 Heart Diseases MESH:D006331 marker/mechanism 16844662 +S1PR2 9294 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26518876 +S1PR4 8698 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22406263 +S1PR5 53637 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22406263 +S1PR5 53637 Scleroderma, Systemic MESH:D012595 marker/mechanism 29033951 +SAA1 6288 Arthritis, Experimental MESH:D001169 marker/mechanism 15944321 +SAA1 6288 Dermatitis, Contact MESH:D003877 marker/mechanism 15944321 +SAC3D1 29901 Melanoma MESH:D008545 marker/mechanism 22535842 +SACS 26278 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 25401298 +SACS 26278 Spastic ataxia Charlevoix-Saguenay type MESH:C536787 marker/mechanism 270550.0 +SAG 6295 Night blindness, congenital stationary MESH:C536122 marker/mechanism 7670478 +SAG 6295 Oguchi disease MESH:C537743 marker/mechanism 258100.0 7670478|9565049 +SAG 6295 Retinitis Pigmentosa MESH:D012174 marker/mechanism 9565049 +SAG 6295 RETINITIS PIGMENTOSA 47 OMIM:613758 marker/mechanism 613758.0 +SAG 6295 Uveitis MESH:D014605 marker/mechanism 8407215 +SAGG 103917 Cutis Laxa MESH:D003483 marker/mechanism 16424879 +SAGG 103917 Ehlers-Danlos Syndrome MESH:D004535 marker/mechanism 16424879 +SALL1 6299 Congenital Abnormalities MESH:D000013 marker/mechanism 20127799 +SALL1 6299 Limb Deformities, Congenital MESH:D017880 marker/mechanism 16088922|9425907 +SALL1 6299 Townes-Brocks syndrome MESH:C536974 marker/mechanism 107480.0 16088922|9425907 +SALL2 6297 Coloboma MESH:D003103 marker/mechanism 216820.0 +SALL3 27164 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143597 +SALL3 27164 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15282310 +SALL3 27164 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +SALL4 57167 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16402211 +SALL4 57167 Duane Retraction Syndrome MESH:D004370 marker/mechanism 607323.0 16402211|30067223 +SALL4 57167 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 30431698 +SALL4 57167 Heart Septal Defects, Ventricular MESH:D006345 marker/mechanism 30067223 +SALL4 57167 Holt-Oram syndrome MESH:C535326 marker/mechanism 30067223 +SALL4 57167 Limb Deformities, Congenital MESH:D017880 marker/mechanism 30067223 +SALL4 57167 Oculootoradial syndrome MESH:C535544 marker/mechanism 147750.0 +SAMD11 148398 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SAMD12 401474 Epilepsies, Myoclonic MESH:D004831 marker/mechanism 29507423 +SAMD12 401474 Epilepsy, Myoclonic, Benign Adult Familial, Type 1 MESH:C563399 marker/mechanism 601068.0 +SAMD4A 23034 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +SAMD9 54809 Fetal Growth Retardation MESH:D005317 marker/mechanism 27182967 +SAMD9 54809 Hypoadrenocorticism, Familial MESH:D000075262 marker/mechanism 27182967 +SAMD9 54809 Infections MESH:D007239 marker/mechanism 27182967 +SAMD9 54809 Influenza, Human MESH:D007251 marker/mechanism 23326326 +SAMD9 54809 Intestinal Diseases MESH:D007410 marker/mechanism 27182967 +SAMD9 54809 MIRAGE SYNDROME OMIM:617053 marker/mechanism 617053.0 +SAMD9 54809 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 27182967 +SAMD9 54809 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +SAMD9 54809 Tumoral Calcinosis, Normophosphatemic, Familial MESH:C566473 marker/mechanism 610455.0 +SAMD9 54809 Urogenital Abnormalities MESH:D014564 marker/mechanism 27182967 +SAMD9L 219285 Myelocerebellar Disorder MESH:C563233 marker/mechanism 159550.0 +SAMHD1 25939 Aicardi-Goutieres syndrome MESH:C535607 marker/mechanism 23364794 +SAMHD1 25939 Aicardi-Goutieres syndrome 5 MESH:C535608 marker/mechanism 612952.0 19525956 +SAMHD1 25939 Chilblain lupus 1 MESH:C535924 marker/mechanism 27566796 +SAMHD1 25939 CHILBLAIN LUPUS 2 OMIM:614415 marker/mechanism 614415.0 +SAMHD1 25939 Deoxyguanosine Kinase Deficiency MESH:C580039 marker/mechanism 26342080 +SAO 789307 Necrosis MESH:D009336 marker/mechanism 10942576 +SAP130 79595 Hypoplastic Left Heart Syndrome MESH:D018636 marker/mechanism 28530678 +SAP130A 100073341 Heart Defects, Congenital MESH:D006330 marker/mechanism 28530678 +SAP30BP 29115 Schizophrenia MESH:D012559 marker/mechanism 21822266 +SAP30L 79685 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +SAR1B 51128 Chylomicron retention disease MESH:C535460 marker/mechanism 246700.0 +SARDH 1757 Hypoxia MESH:D000860 marker/mechanism 19579223 +SARDH 1757 Sarcosinemia MESH:C537236 marker/mechanism 268900.0 +SARM1 23098 Respiratory Syncytial Virus Infections MESH:D018357 marker/mechanism 24478430 +SARM1 23098 Vision Disorders MESH:D014786 therapeutic 35163535 +SARS1 6301 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +SARS2 54938 HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME OMIM:613845 marker/mechanism 613845.0 +SASH1 23328 Dyschromatosis Universalis Hereditaria 1 MESH:C567273 marker/mechanism 127500.0 +SASH3 54440 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SASS6 163786 MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE OMIM:616402 marker/mechanism 616402.0 +SAT1 6303 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +SAT1 6303 Obesity MESH:D009765 marker/mechanism 20882379 +SATB1 6304 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SATB1 6304 Clinical Deterioration MESH:D000075902 marker/mechanism 27602772 +SATB1 6304 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SATB2 23314 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 26780400 +SATB2 23314 Chromosome 2q32-Q33 Deletion Syndrome MESH:C567350 marker/mechanism 612313.0 +SATB2 23314 Cleft Palate MESH:D002972 marker/mechanism 16960803|19170718 +SATB2 23314 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +SATB2 23314 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16960803 +SATB2 23314 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +SBDS 51119 Anemia, Aplastic MESH:D000741 marker/mechanism 609135.0 +SBDS 51119 Shwachman-Diamond Syndrome MESH:D000081003 marker/mechanism 260400.0 +SBF1 6305 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3 OMIM:615284 marker/mechanism 615284.0 +SBF2 81846 Charcot-Marie-Tooth disease, Type 4B2 MESH:C535421 marker/mechanism 604563.0 +SBNO1 55206 Osteoarthritis, Knee MESH:D020370 marker/mechanism 30374069 +SBNO1 55206 Schizophrenia MESH:D012559 marker/mechanism 21743468 +SBP 20234 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SBSPON 157869 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +SC5D 6309 Intellectual Disability MESH:D008607 marker/mechanism 12189593 +SC5D 6309 Lathosterolosis MESH:C537880 marker/mechanism 607330.0 12189593 +SC5D 6309 Liver Diseases MESH:D008107 marker/mechanism 12189593 +SCAF1 58506 Autistic Disorder MESH:D001321 marker/mechanism 35982159 +SCAMP5 192683 Autistic Disorder MESH:D001321 marker/mechanism 20071347 +SCAP 22937 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 14563831 +SCAPER 49855 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +SCARB1 949 Carcinoma MESH:D002277 marker/mechanism 12376462 +SCARB1 949 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 21131975 +SCARB1 949 Cocaine-Related Disorders MESH:D019970 marker/mechanism 17205118 +SCARB1 949 Follicular Cyst MESH:D005497 marker/mechanism 20404351 +SCARB1 949 Hepatitis C MESH:D006526 marker/mechanism 17517063 +SCARB1 949 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6 OMIM:610762 marker/mechanism 610762.0 +SCARB1 949 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +SCARB1 949 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +SCARB1 949 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +SCARB1 949 Marijuana Abuse MESH:D002189 marker/mechanism 17205118 +SCARB1 949 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 23127599 +SCARB1 949 Phencyclidine Abuse MESH:D010623 marker/mechanism 17205118 +SCARB2 950 EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE OMIM:254900 marker/mechanism 254900.0 +SCARF2 91179 Marden Walker like syndrome MESH:C535909 marker/mechanism 600920.0 +SCD 6319 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +SCD 6319 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +SCD 6319 Graves Ophthalmopathy MESH:D049970 marker/mechanism 17614770 +SCD 6319 Lipidoses MESH:D008064 marker/mechanism 21123845 +SCD 6319 Liver Neoplasms MESH:D008113 marker/mechanism 12419843 +SCD 6319 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942 +SCD 6319 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +SCD1 20249 Eye Diseases MESH:D005128 marker/mechanism 21661758 +SCD1 20249 Fatty Liver MESH:D005234 therapeutic 21661758 +SCD1 20249 Glucose Intolerance MESH:D018149 marker/mechanism 21661758 +SCD1 20249 Heart Failure MESH:D006333 marker/mechanism 26670611 +SCD1 20249 Insulin Resistance MESH:D007333 therapeutic 21661758 +SCD1 20249 Obesity MESH:D009765 marker/mechanism 20882379 +SCD1 20249 Skin Diseases MESH:D012871 marker/mechanism 21661758 +SCD1 20249 Weight Gain MESH:D015430 therapeutic 21661758 +SCD2 20250 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SCD2 20250 Weight Gain MESH:D015430 marker/mechanism 19030233 +SCD5 79966 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +SCFD1 23256 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 27455348 +SCG5 6447 Colorectal Neoplasms MESH:D015179 marker/mechanism 18084292 +SCG5 6447 Medulloblastoma MESH:D008527 marker/mechanism 17334394 +SCGB1A1 7356 Inflammation MESH:D007249 marker/mechanism 16052892 +SCGB1A1 7356 Lung Diseases MESH:D008171 marker/mechanism 16052892 +SCGB1A1 7356 Respiration Disorders MESH:D012120 marker/mechanism 18288317 +SCGB3A1 92304 Endometriosis MESH:D004715 marker/mechanism 21063030 +SCGB3A2 117156 Asthma MESH:D001249 marker/mechanism 600807.0 +SCHLAP1 101669767 Neoplasm Metastasis MESH:D009362 marker/mechanism 24076601 +SCHLAP1 101669767 Prostatic Neoplasms MESH:D011471 marker/mechanism 24076601 +SCMH1 22955 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +SCML2 10389 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +SCN10A 6336 Atrial Fibrillation MESH:D001281 marker/mechanism 20062060|29892015|30061737 +SCN10A 6336 Brugada Syndrome MESH:D053840 marker/mechanism 23872634 +SCN10A 6336 EPISODIC PAIN SYNDROME, FAMILIAL, 2 OMIM:615551 marker/mechanism 615551.0 +SCN10A 6336 Heart Block MESH:D006327 marker/mechanism 20062061 +SCN10A 6336 Hyperalgesia MESH:D006930 marker/mechanism 16545521 +SCN10A 6336 Neuralgia MESH:D009437 marker/mechanism 18400411 +SCN10A 6336 Ventricular Fibrillation MESH:D014693 marker/mechanism 20062061 +SCN11A 11280 EPISODIC PAIN SYNDROME, FAMILIAL, 3 OMIM:615552 marker/mechanism 615552.0 +SCN11A 11280 Hyperalgesia MESH:D006930 marker/mechanism 23264124 +SCN11A 11280 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII OMIM:615548 marker/mechanism 615548.0 +SCN11A 11280 Pain Insensitivity, Congenital MESH:D000699 marker/mechanism 24036948 +SCN1A 6323 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21572417 +SCN1A 6323 Epilepsies, Myoclonic MESH:D004831 marker/mechanism 607208.0 12907273|19099883|21480876|29929108|30123852 +SCN1A 6323 Epilepsy MESH:D004827 marker/mechanism 15805193|19694741|23708187|29942082 +SCN1A 6323 Epilepsy, Generalized MESH:D004829 marker/mechanism 21480876 +SCN1A 6323 Generalized Epilepsy With Febrile Seizures Plus, Type 2 MESH:C565810 marker/mechanism 604403.0 +SCN1A 6323 Intellectual Disability MESH:D008607 marker/mechanism 28191889 +SCN1A 6323 Migraine, Familial Hemiplegic, 3 MESH:C566500 marker/mechanism 609634.0 +SCN1A 6323 Movement Disorders MESH:D009069 marker/mechanism 12907273 +SCN1A 6323 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +SCN1A 6323 Seizures, Febrile MESH:D003294 marker/mechanism 21480876|25344690|25362483 +SCN1B 6324 ATRIAL FIBRILLATION, FAMILIAL, 13 OMIM:615377 marker/mechanism 615377.0 +SCN1B 6324 Brugada Syndrome MESH:D053840 marker/mechanism 22155597 +SCN1B 6324 Brugada Syndrome 5 MESH:C567556 marker/mechanism 612838.0 +SCN1B 6324 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52 OMIM:617350 marker/mechanism 617350.0 +SCN1B 6324 Generalized Epilepsy With Febrile Seizures Plus, Type 1 MESH:C565809 marker/mechanism 604233.0 +SCN1B 6324 Seizures, Febrile MESH:D003294 marker/mechanism 25362483 +SCN1B 6324 Sudden Infant Death MESH:D013398 marker/mechanism 22155597 +SCN2A 6326 Autistic Disorder MESH:D001321 marker/mechanism 35982159 +SCN2A 6326 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +SCN2A 6326 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11 OMIM:613721 marker/mechanism 613721.0 +SCN2A 6326 Epilepsy MESH:D004827 marker/mechanism 16464983|23708187|29942082 +SCN2A 6326 Epilepsy, Benign Neonatal, 3 MESH:C564274 marker/mechanism 607745.0 +SCN2A 6326 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +SCN2A 6326 Seizures, Febrile MESH:D003294 marker/mechanism 25344690 +SCN2B 6327 ATRIAL FIBRILLATION, FAMILIAL, 14 OMIM:615378 marker/mechanism 615378.0 +SCN3A 6328 Epilepsy, Complex Partial MESH:D017029 marker/mechanism 18242854 +SCN3B 55800 Brugada Syndrome 7 MESH:C567734 marker/mechanism 613120.0 +SCN4A 6329 Hypokalemic Periodic Paralysis MESH:D020514 marker/mechanism 11912116 +SCN4A 6329 HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 OMIM:170400 marker/mechanism 170400.0 +SCN4A 6329 Hypokalemic Periodic Paralysis, Type 2 MESH:C567635 marker/mechanism 613345.0 +SCN4A 6329 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 614198.0 12766226 +SCN4A 6329 Myotonia MESH:D009222 marker/mechanism 8308722 +SCN4A 6329 Myotonia Congenita MESH:D009224 marker/mechanism 1316765 +SCN4A 6329 Myotonic Disorders MESH:D020967 marker/mechanism 168300.0 +SCN4A 6329 Paralysis, Hyperkalemic Periodic MESH:D020513 marker/mechanism 170500.0 1659948 +SCN4A 6329 Potassium aggravated myotonia MESH:C538353 marker/mechanism 608390.0 16832098 +SCN4B 6330 Long Qt Syndrome 10 MESH:C567514 marker/mechanism 611819.0 +SCN5A 6331 Atrial Fibrillation MESH:D001281 marker/mechanism 20062060|30061737 +SCN5A 6331 ATRIAL FIBRILLATION, FAMILIAL, 10 OMIM:614022 marker/mechanism 614022.0 +SCN5A 6331 Brugada Syndrome MESH:D053840 marker/mechanism 601144.0 10662748|12687841|15520322|16144991|16239976|16945804|17728436|17805561|18507554|18599870|19140927|19875396|20174578|20513597|23872634|30232268 +SCN5A 6331 Cardiomyopathy, Dilated, 1E MESH:C563384 marker/mechanism 601154.0 +SCN5A 6331 Long QT Syndrome MESH:D008133 marker/mechanism 10627139|12208804|12796143|14510655|16301357|17110414|19140927|20513597 +SCN5A 6331 Long Qt Syndrome 3 MESH:C565840 marker/mechanism 603830.0 +SCN5A 6331 Long QT syndrome type 3 MESH:C537034 marker/mechanism 17805561 +SCN5A 6331 Paroxysmal ventricular fibrillation MESH:C537182 marker/mechanism 603829.0 +SCN5A 6331 PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA OMIM:113900 marker/mechanism 113900.0 +SCN5A 6331 Sick Sinus Syndrome 1, Autosomal Recessive MESH:C563907 marker/mechanism 608567.0 +SCN5A 6331 Sudden Infant Death MESH:D013398 marker/mechanism 272120.0 +SCN5A 6331 Tachycardia, Ventricular MESH:D017180 marker/mechanism 18848812 +SCN5A 6331 Torsades de Pointes MESH:D016171 marker/mechanism 12208804|16301357 +SCN7A 6332 Autistic Disorder MESH:D001321 marker/mechanism 18621663 +SCN8A 6334 Ataxia MESH:D001259 marker/mechanism 19261867 +SCN8A 6334 Cerebellar Ataxia MESH:D002524 marker/mechanism 16236810 +SCN8A 6334 COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA OMIM:614306 marker/mechanism 614306.0 +SCN8A 6334 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13 OMIM:614558 marker/mechanism 614558.0 +SCN8A 6334 Epilepsy MESH:D004827 marker/mechanism 23708187|29942082 +SCN8A 6334 Herpesviridae Infections MESH:D006566 marker/mechanism 23382806 +SCN8A 6334 Intellectual Disability MESH:D008607 marker/mechanism 16236810 +SCN8A 6334 Nervous System Diseases MESH:D009422 marker/mechanism 15170223 +SCN8A 6334 Neuralgia, Postherpetic MESH:D051474 marker/mechanism 23382806 +SCN8A 6334 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +SCN8A 6334 SEIZURES, BENIGN FAMILIAL INFANTILE, 5 OMIM:617080 marker/mechanism 617080.0 +SCN8A 6334 Status Epilepticus MESH:D013226 marker/mechanism 19306853 +SCN8A 6334 Tremor MESH:D014202 marker/mechanism 19261867 +SCN9A 6335 Chronic Pain MESH:D059350 marker/mechanism 21634377 +SCN9A 6335 Erythromelalgia MESH:D004916 marker/mechanism 133020.0 17145499|19549232|19557861 +SCN9A 6335 Herpesviridae Infections MESH:D006566 marker/mechanism 23382806 +SCN9A 6335 Indifference to Pain, Congenital, Autosomal Recessive MESH:C565467 marker/mechanism 243000.0 +SCN9A 6335 Neuralgia MESH:D009437 marker/mechanism 19557861 +SCN9A 6335 Neuralgia, Postherpetic MESH:D051474 marker/mechanism 23382806 +SCN9A 6335 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA OMIM:201300 marker/mechanism 201300.0 +SCN9A 6335 Paroxysmal Extreme Pain Disorder MESH:C563475 marker/mechanism 167400.0 17145499|17679678 +SCN9A 6335 Pruritus MESH:D011537 marker/mechanism 24820863 +SCNN1A 6337 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SCNN1A 6337 Bronchiectasis With Or Without Elevated Sweat Chloride 2 MESH:C567813 marker/mechanism 613021.0 +SCNN1A 6337 Cystic Fibrosis MESH:D003550 marker/mechanism 15077107|19462466 +SCNN1A 6337 Hypertension MESH:D006973 marker/mechanism 11752024|23348737 +SCNN1A 6337 Liddle Syndrome MESH:D056929 marker/mechanism 23348737 +SCNN1A 6337 Lung Diseases MESH:D008171 marker/mechanism 15077107|19462466 +SCNN1A 6337 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 16168501 +SCNN1A 6337 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +SCNN1A 6337 Pre-Eclampsia MESH:D011225 marker/mechanism 16555725 +SCNN1A 6337 Proteinuria MESH:D011507 marker/mechanism 11752024 +SCNN1A 6337 Pseudohypoaldosteronism MESH:D011546 marker/mechanism 264350.0 11752024 +SCNN1B 6338 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SCNN1B 6338 Bronchiectasis With Or Without Elevated Sweat Chloride 1 MESH:C567618 marker/mechanism 211400.0 +SCNN1B 6338 Cystic Fibrosis MESH:D003550 marker/mechanism 16207733|16463024 +SCNN1B 6338 Hypertension MESH:D006973 marker/mechanism 15174897|15198480|19344079 +SCNN1B 6338 Liddle Syndrome MESH:D056929 marker/mechanism 177200.0 18398334|19344079 +SCNN1B 6338 Lung Diseases MESH:D008171 marker/mechanism 16207733 +SCNN1B 6338 Lung Diseases, Obstructive MESH:D008173 marker/mechanism 27982104 +SCNN1B 6338 Pulmonary Emphysema MESH:D011656 marker/mechanism 27982104 +SCNN1G 6340 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SCNN1G 6340 Bronchiectasis With Or Without Elevated Sweat Chloride 3 MESH:C567772 marker/mechanism 613071.0 +SCNN1G 6340 Cystic Fibrosis MESH:D003550 marker/mechanism 16463024 +SCNN1G 6340 Hypertension MESH:D006973 marker/mechanism 15198480 +SCNN1G 6340 Hypotension MESH:D007022 marker/mechanism 11463765 +SCNN1G 6340 Pseudohypoaldosteronism MESH:D011546 marker/mechanism 8640238 +SCO1 6341 Brain Diseases MESH:D001927 marker/mechanism 23345593 +SCO1 6341 Heart Diseases MESH:D006331 marker/mechanism 23345593 +SCO1 6341 Liver Diseases MESH:D008107 marker/mechanism 23345593 +SCO1 6341 Liver Failure, Acute MESH:D017114 marker/mechanism 20864674 +SCO1 6341 Mitochondrial Diseases MESH:D028361 marker/mechanism 17182746 +SCO2 9997 Brain Diseases, Metabolic, Inborn MESH:D020739 marker/mechanism 23345593 +SCO2 9997 Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency MESH:C565784 marker/mechanism 604377.0 20864674|22515166 +SCO2 9997 Cardiomyopathies MESH:D009202 marker/mechanism 16326995 +SCO2 9997 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 11027508|14970747 +SCO2 9997 Cytochrome-c Oxidase Deficiency MESH:D030401 marker/mechanism 11027508|16326995 +SCO2 9997 Influenza, Human MESH:D007251 marker/mechanism 23326326 +SCO2 9997 Mitochondrial Encephalomyopathies MESH:D017237 marker/mechanism 16326995|23345593 +SCO2 9997 Myopia 6 MESH:C536105 marker/mechanism 608908.0 +SCP2 6342 Dystonia MESH:D004421 marker/mechanism 16685654 +SCP2 6342 Leukoencephalopathies MESH:D056784 marker/mechanism 16685654 +SCP2 6342 LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY OMIM:613724 marker/mechanism 613724.0 +SCP2 6342 Polyneuropathies MESH:D011115 marker/mechanism 16685654 +SCRN1 9805 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +SCRN1 9805 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +SCT 6343 Autistic Disorder MESH:D001321 therapeutic 12732234|15206007|15272612|16168596 +SCT 6343 Choledochal Cyst MESH:D015529 marker/mechanism 18988797 +SCT 6343 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +SCT 6343 Tachycardia MESH:D013610 marker/mechanism 2103752 +SCTR 6344 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +SCYL1 57410 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 616719.0 +SDC1 6382 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 27032653 +SDC3 9672 Obesity MESH:D009765 marker/mechanism 601665.0 +SDC4 6385 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22919003 +SDCBP 6386 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +SDCCAG8 10806 BARDET-BIEDL SYNDROME 16 OMIM:615993 marker/mechanism 615993.0 +SDCCAG8 10806 Kidney Diseases, Cystic MESH:D052177 marker/mechanism 20835237 +SDCCAG8 10806 Retinal Diseases MESH:D012164 marker/mechanism 20835237 +SDF2L1 23753 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +SDF2L1 23753 Crohn Disease MESH:D003424 marker/mechanism 36038634 +SDF2L1 23753 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SDF4 51150 Schizophrenia MESH:D012559 marker/mechanism 21743468 +SDHA 6389 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 613642.0 +SDHA 6389 Mitochondrial Complex II Deficiency MESH:C565375 marker/mechanism 252011.0 +SDHA 6389 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +SDHA 6389 PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5 OMIM:614165 marker/mechanism 614165.0 +SDHAF1 644096 Dementia, Vascular MESH:D015140 marker/mechanism 19465911 +SDHAF2 54949 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +SDHAF2 54949 Paragangliomas 2 MESH:C566646 marker/mechanism 601650.0 +SDHB 6390 Carney-Stratakis Syndrome MESH:C564650 marker/mechanism 606864.0 +SDHB 6390 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 606764.0 +SDHB 6390 Paraganglioma MESH:D010235 marker/mechanism 19927285|30013182 +SDHB 6390 PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 4 OMIM:115310 marker/mechanism 115310.0 +SDHB-1 174482 Embryo Loss MESH:D020964 marker/mechanism 19233206 +SDHC 6391 Carney-Stratakis Syndrome MESH:C564650 marker/mechanism 606864.0 +SDHC 6391 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 606764.0 +SDHC 6391 Paragangliomas 3 MESH:C565335 marker/mechanism 605373.0 +SDHD 6392 Carney-Stratakis Syndrome MESH:C564650 marker/mechanism 606864.0 +SDHD 6392 Melanoma MESH:D008545 marker/mechanism 25261935 +SDHD 6392 Paraganglioma MESH:D010235 marker/mechanism 168000.0 21318381 +SDR42E1 93517 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SDS 10993 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SEC16B 89866 Body Weight MESH:D001835 marker/mechanism 22344219|22344221 +SEC23A 10484 Craniolenticulosutural Dysplasia MESH:C564332 marker/mechanism 607812.0 17981132 +SEC23A 10484 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +SEC23B 10483 Anemia, Dyserythropoietic, Congenital MESH:D000742 marker/mechanism 224100.0 19561605 +SEC23B 10483 COWDEN SYNDROME 7 OMIM:616858 marker/mechanism 616858.0 +SEC24D 9871 Cole Carpenter syndrome MESH:C535963 marker/mechanism 616294.0 +SEC31A 22872 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 22474449 +SEC61A1 29927 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +SEC61A1 29927 TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 5 OMIM:617056 marker/mechanism 617056.0 +SEC63 11231 Polycystic Kidney Diseases MESH:D007690 marker/mechanism 21685914 +SEC63 11231 Polycystic liver disease MESH:C536330 marker/mechanism 617004.0 21685914 +SECISBP2 79048 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 16228000 +SECISBP2 79048 Growth Disorders MESH:D006130 marker/mechanism 19602558 +SECISBP2 79048 Thyroid Hormone Metabolism, Abnormal MESH:C566454 marker/mechanism 609698.0 19602558 +SECISBP2L 9728 Lung Neoplasms MESH:D008175 marker/mechanism 28604730 +SECTM1B 58210 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SELE 6401 Atrial Fibrillation MESH:D001281 marker/mechanism 17890461 +SELE 6401 Brain Ischemia MESH:D002545 marker/mechanism 17394460 +SELE 6401 Cardiovascular Diseases MESH:D002318 marker/mechanism 16332659|16544732 +SELE 6401 COVID-19 MESH:D000086382 marker/mechanism 35255492 +SELE 6401 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17597826 +SELE 6401 Dermatitis, Atopic MESH:D003876 marker/mechanism 12410700 +SELE 6401 Hypercholesterolemia MESH:D006937 marker/mechanism 14602771 +SELE 6401 Multiple Sclerosis MESH:D009103 marker/mechanism 20175758 +SELE 6401 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +SELE 6401 Reperfusion Injury MESH:D015427 marker/mechanism 17112405|23743330 +SELE 6401 Urticaria MESH:D014581 marker/mechanism 12121561 +SELENBP1 8991 Adenocarcinoma MESH:D000230 marker/mechanism 14991897|15378696 +SELENBP1 8991 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +SELENBP1 8991 Colorectal Neoplasms MESH:D015179 marker/mechanism 18435490 +SELENBP1 8991 Halitosis MESH:D006209 marker/mechanism 29255262 +SELENBP1 8991 Lung Neoplasms MESH:D008175 marker/mechanism 14991897 +SELENBP1 8991 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 29255262 +SELENBP1 8991 Ovarian Neoplasms MESH:D010051 marker/mechanism 16380993|18272210 +SELENBP1 8991 Psychotic Disorders MESH:D011618 marker/mechanism 18163446 +SELENBP1 8991 Schizophrenia MESH:D012559 marker/mechanism 16223876|18163446 +SELENBP1 8991 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696|19424620 +SELENBP2 20342 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15650968 +SELENOM 140606 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SELENON 57190 Muscular Dystrophies MESH:D009136 marker/mechanism 17123513 +SELENON 57190 Rigid spine syndrome MESH:C535683 marker/mechanism 602771.0 +SELENOP 6414 Adenoma MESH:D000236 marker/mechanism 18483336 +SELENOP 6414 Cadmium Poisoning MESH:D002105 marker/mechanism 20643113 +SELENOP 6414 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +SELENOP 6414 Colorectal Neoplasms MESH:D015179 marker/mechanism 18483336 +SELENOP 6414 Endometriosis MESH:D004715 marker/mechanism 20864642 +SELENOP 6414 Infertility, Male MESH:D007248 marker/mechanism 17961124 +SELENOP 6414 Insulin Resistance MESH:D007333 marker/mechanism 14714311 +SELENOP 6414 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SELENOP 6414 Lung Neoplasms MESH:D008175 marker/mechanism 19058871 +SELENOP 6414 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942 +SELENOP 6414 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +SELENOP 6414 Nerve Degeneration MESH:D009410 marker/mechanism 18172410 +SELENOP 6414 Nervous System Diseases MESH:D009422 marker/mechanism 14704310|17961124 +SELENOP 6414 Neurodegenerative Diseases MESH:D019636 marker/mechanism 15964507 +SELENOP 6414 Prostatic Neoplasms MESH:D011471 marker/mechanism 12235003 +SELENOS 55829 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 20471133 +SELENOS 55829 Inflammation MESH:D007249 marker/mechanism 16227999 +SELENOS 55829 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SELENOW 6415 Epilepsy MESH:D004827 marker/mechanism 19499324 +SELENOW 6415 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SELL 6402 Myocardial Infarction MESH:D009203 marker/mechanism 10070497 +SELP 6403 Depressive Disorder MESH:D003866 marker/mechanism 25451969 +SELP 6403 Hypersensitivity MESH:D006967 marker/mechanism 12929084 +SELP 6403 Hypertension MESH:D006973 marker/mechanism 15513305 +SELP 6403 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +SELP 6403 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 12087064 +SELP 6403 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 25451969 +SELP 6403 Pleurisy MESH:D010998 marker/mechanism 11181422 +SELP 6403 Primary Graft Dysfunction MESH:D055031 marker/mechanism 28569748 +SELP 6403 Thrombosis MESH:D013927 marker/mechanism 10544909 +SELPLG 6404 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +SELS 100186840 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +SEM1 7979 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18922899 +SEM1 7979 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +SEMA3A 10371 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 33290778 +SEMA3A 10371 HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA OMIM:614897 marker/mechanism 614897.0 +SEMA3B 7869 Endometrial Neoplasms MESH:D016889 marker/mechanism 21933904 +SEMA3B 7869 Neuroblastoma MESH:D009447 marker/mechanism 17452250 +SEMA3C 10512 Truncus Arteriosus, Persistent MESH:D014339 marker/mechanism 15548583 +SEMA3E 9723 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 +SEMA3F 6405 Endometrial Neoplasms MESH:D016889 marker/mechanism 21933904 +SEMA4A 64218 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 33290778 +SEMA4A 64218 Cone-Rod Dystrophy 10 MESH:C564597 marker/mechanism 610283.0 +SEMA4A 64218 Retinitis Pigmentosa 35 MESH:C565206 marker/mechanism 610282.0 +SEMA4F 10505 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +SEMA5A 9037 Autistic Disorder MESH:D001321 marker/mechanism 17028446 +SEMA6D 80031 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SEMA6D 80031 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +SENP1 29843 Arteriosclerosis MESH:D001161 marker/mechanism 28569748 +SENP1 29843 Neointima MESH:D058426 marker/mechanism 28569748 +SENP1 29843 Primary Graft Dysfunction MESH:D055031 marker/mechanism 28569748 +SENP1 29843 Vascular Remodeling MESH:D066253 marker/mechanism 28569748 +SENP1 29843 Vasculitis MESH:D014657 marker/mechanism 28569748 +SENP2 59343 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 29535048 +SENP2 59343 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 29535048 +SENP2 59343 Seizures MESH:D012640 marker/mechanism 34509475 +SENP6 26054 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +SEPSECS 51091 PONTOCEREBELLAR HYPOPLASIA, TYPE 2D OMIM:613811 marker/mechanism 613811.0 +SEPSECS 51091 Weight Gain MESH:D015430 marker/mechanism 19030233 +SEPTIN11 55752 Methylmalonic acidemia MESH:C537358 marker/mechanism 16823967 +SEPTIN12 124404 SPERMATOGENIC FAILURE 10 OMIM:614822 marker/mechanism 614822.0 +SEPTIN14 346288 Glioblastoma MESH:D005909 marker/mechanism 23917401 +SEPTIN2 4735 Methylmalonic acidemia MESH:C537358 marker/mechanism 16823967 +SEPTIN5 5413 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +SEPTIN9 10801 Brachial Plexus Neuritis MESH:D020968 marker/mechanism 162100.0 17546647 +SEPTIN9 10801 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 10339604 +SEPTIN9 10801 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20388789 +SERAC1 84947 3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME OMIM:614739 marker/mechanism 614739.0 +SERAC1 84947 Deafness MESH:D003638 marker/mechanism 22683713 +SERAC1 84947 Dystonia MESH:D004421 marker/mechanism 22683713 +SERAC1 84947 Lipid Metabolism, Inborn Errors MESH:D008052 marker/mechanism 22683713 +SERBP1 26135 Disease Progression MESH:D018450 marker/mechanism 21364753 +SERBP1 26135 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +SERINC3 10955 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SERPINA1 5265 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +SERPINA1 5265 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +SERPINA1 5265 alpha 1-Antitrypsin Deficiency MESH:D019896 marker/mechanism 613490.0 17559149|3485249 +SERPINA1 5265 Anxiety Disorders MESH:D001008 marker/mechanism 17659342 +SERPINA1 5265 Arteriosclerosis MESH:D001161 marker/mechanism 12692006 +SERPINA1 5265 Asbestosis MESH:D001195 marker/mechanism 12368052 +SERPINA1 5265 Bipolar Disorder MESH:D001714 marker/mechanism 17659342 +SERPINA1 5265 Bronchiectasis MESH:D001987 marker/mechanism 7785020 +SERPINA1 5265 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284|6258829 +SERPINA1 5265 Cholestasis MESH:D002779 marker/mechanism 4117022 +SERPINA1 5265 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +SERPINA1 5265 Emphysema MESH:D004646 marker/mechanism 25579632 +SERPINA1 5265 Gastro-enteropancreatic neuroendocrine tumor MESH:C535650 marker/mechanism 29915428 +SERPINA1 5265 Hemorrhage MESH:D006470 marker/mechanism 412531 +SERPINA1 5265 HIV Infections MESH:D015658 therapeutic 17448989 +SERPINA1 5265 Hypoglycemia MESH:D007003 marker/mechanism 17659342 +SERPINA1 5265 Liver Cirrhosis MESH:D008103 marker/mechanism 20511674|25579632|3485248 +SERPINA1 5265 Liver Diseases MESH:D008107 marker/mechanism 17006946|17659342|3485248|4117996|5095241|6600583 +SERPINA1 5265 Lung Diseases MESH:D008171 marker/mechanism 17659342 +SERPINA1 5265 Lung Neoplasms MESH:D008175 marker/mechanism 17902193 +SERPINA1 5265 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +SERPINA1 5265 Neurodegenerative Diseases MESH:D019636 marker/mechanism 17659342 +SERPINA1 5265 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +SERPINA1 5265 Panniculitis, Nodular Nonsuppurative MESH:D010201 marker/mechanism 3259592|6982619 +SERPINA1 5265 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 16278826|25579632 +SERPINA1 5265 Pulmonary Emphysema MESH:D011656 marker/mechanism 3485249 +SERPINA1 5265 Pulmonary Fibrosis MESH:D011658 marker/mechanism 72955 +SERPINA1 5265 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +SERPINA1 5265 Thiamine Deficiency MESH:D013832 marker/mechanism 17659342 +SERPINA1 5265 Vasculitis MESH:D014657 marker/mechanism 1684994 +SERPINA10 51156 Thrombophilia MESH:D019851 marker/mechanism 15461625 +SERPINA10 51156 Venous Thrombosis MESH:D020246 marker/mechanism 15461625 +SERPINA3 12 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414|17175557 +SERPINA3 12 Prostatic Neoplasms MESH:D011471 marker/mechanism 18383875 +SERPINA3 12 Renal Insufficiency, Chronic MESH:D051436 marker/mechanism 35635602 +SERPINA3K 20714 Diabetic Retinopathy MESH:D003930 marker/mechanism 19324842 +SERPINA3K 20714 Inflammation MESH:D007249 therapeutic 19324842 +SERPINA3K 20714 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15650968 +SERPINA3K 20714 Retinal Diseases MESH:D012164 therapeutic 19324842 +SERPINA3M 20717 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +SERPINA3M 20717 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SERPINA3N 20716 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +SERPINA4 5267 Carcinoma, Hepatocellular MESH:D006528 therapeutic 19709125 +SERPINA4 5267 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SERPINA4 5267 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +SERPINA5 5104 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +SERPINA5 5104 Cholestasis MESH:D002779 marker/mechanism 27989131 +SERPINA6 866 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +SERPINA6 866 Corticosteroid-Binding Globulin Deficiency MESH:C565152 marker/mechanism 611489.0 +SERPINA6 866 Fatty Liver MESH:D005234 marker/mechanism 25226513 +SERPINA6 866 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +SERPINA6 866 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SERPINA7 6906 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SERPINA7 6906 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 2155256 +SERPINB10 5273 Prostatic Neoplasms MESH:D011471 marker/mechanism 16172807 +SERPINB2 5055 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +SERPINB2 5055 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615 +SERPINB2 5055 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 21245421 +SERPINB2 5055 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +SERPINB3 6317 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +SERPINB3 6317 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +SERPINB3 6317 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +SERPINB3 6317 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +SERPINB3 6317 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +SERPINB3 6317 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +SERPINB3 6317 Precancerous Conditions MESH:D011230 marker/mechanism 15986332 +SERPINB4 6318 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +SERPINB4 6318 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +SERPINB5 5268 Breast Neoplasms MESH:D001943 marker/mechanism 16799634 +SERPINB5 5268 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 19944674 +SERPINB5 5268 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +SERPINB5 5268 Colorectal Neoplasms MESH:D015179 marker/mechanism 16331619 +SERPINB5 5268 Keloid MESH:D007627 marker/mechanism 20128793 +SERPINB5 5268 Neoplasm Metastasis MESH:D009362 marker/mechanism 19514085 +SERPINB6 5269 DEAFNESS, AUTOSOMAL RECESSIVE 91 OMIM:613453 marker/mechanism 613453.0 +SERPINB6A 20719 Weight Gain MESH:D015430 marker/mechanism 19030233 +SERPINB7 8710 PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE OMIM:615598 marker/mechanism 615598.0 +SERPINB8 5271 Peeling Skin Syndrome MESH:C564818 marker/mechanism 617115.0 +SERPINB8 5271 Psoriasis MESH:D011565 marker/mechanism 20953187 +SERPINB9 5272 Chloracne MESH:D054506 marker/mechanism 17101203 +SERPINB9 5272 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SERPINC1 462 Acute Coronary Syndrome MESH:D054058 therapeutic 7923645 +SERPINC1 462 Antithrombin III Deficiency MESH:D020152 marker/mechanism 613118.0 6435583 +SERPINC1 462 Blood Coagulation Disorders MESH:D001778 marker/mechanism 62897 +SERPINC1 462 Brain Injuries MESH:D001930 therapeutic 21534203 +SERPINC1 462 Cerebral Hemorrhage MESH:D002543 marker/mechanism 6636041 +SERPINC1 462 Craniocerebral Trauma MESH:D006259 marker/mechanism 8810955 +SERPINC1 462 Disseminated Intravascular Coagulation MESH:D004211 marker/mechanism|therapeutic 6233579|8810955|9637888 +SERPINC1 462 Intracranial Thrombosis MESH:D020767 marker/mechanism 6636041 +SERPINC1 462 Liver Failure, Acute MESH:D017114 marker/mechanism 4089794 +SERPINC1 462 Nephrotic Syndrome MESH:D009404 marker/mechanism 11304663 +SERPINC1 462 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 8810955 +SERPINC1 462 Thrombosis MESH:D013927 marker/mechanism|therapeutic 11132655|2133253|6889048|8967151 +SERPINC1 462 Venous Thromboembolism MESH:D054556 marker/mechanism 453287 +SERPINC1 462 Venous Thrombosis MESH:D020246 marker/mechanism 55783|6435583|8810955 +SERPIND1 3053 Carotid Artery Thrombosis MESH:D002341 therapeutic 11805133 +SERPIND1 3053 Heparin Cofactor II Deficiency MESH:C562865 marker/mechanism 612356.0 +SERPIND1 3053 Mesenteric Vascular Occlusion MESH:D008641 marker/mechanism 1831893 +SERPIND1 3053 Thrombophilia MESH:D019851 marker/mechanism 2214444 +SERPIND1 3053 Venous Thromboembolism MESH:D054556 marker/mechanism 1831893 +SERPINE1 5054 Atherosclerosis MESH:D050197 marker/mechanism 12677255 +SERPINE1 5054 Autistic Disorder MESH:D001321 marker/mechanism 19360663 +SERPINE1 5054 Behcet Syndrome MESH:D001528 marker/mechanism 12074830 +SERPINE1 5054 Cholestasis MESH:D002779 marker/mechanism 21224055 +SERPINE1 5054 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 21757225 +SERPINE1 5054 Diabetic Nephropathies MESH:D003928 marker/mechanism 18682491 +SERPINE1 5054 Disease Models, Animal MESH:D004195 marker/mechanism 21051829 +SERPINE1 5054 Fatty Liver MESH:D005234 marker/mechanism 18641190|29684222 +SERPINE1 5054 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 18682491 +SERPINE1 5054 Heart Failure MESH:D006333 marker/mechanism 22352330 +SERPINE1 5054 Hypertension MESH:D006973 marker/mechanism 21051829|22352330 +SERPINE1 5054 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +SERPINE1 5054 Liver Diseases MESH:D008107 marker/mechanism 29684222 +SERPINE1 5054 Liver Neoplasms MESH:D008113 marker/mechanism 21159647 +SERPINE1 5054 Nephrotic Syndrome MESH:D009404 marker/mechanism 17513194 +SERPINE1 5054 Nervous System Diseases MESH:D009422 marker/mechanism 21245421 +SERPINE1 5054 Obesity MESH:D009765 marker/mechanism 23819014 +SERPINE1 5054 Plasminogen Activator Inhibitor-1 Deficiency MESH:C567640 marker/mechanism 613329.0 +SERPINE1 5054 Pre-Eclampsia MESH:D011225 marker/mechanism 18679377 +SERPINE1 5054 Prostatic Neoplasms MESH:D011471 marker/mechanism 16172807 +SERPINE1 5054 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 24211530 +SERPINE1 5054 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +SERPINE1 5054 Thrombosis MESH:D013927 marker/mechanism 12677255|22352330 +SERPINE1 5054 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +SERPINF1 5176 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +SERPINF1 5176 Corneal Ulcer MESH:D003320 therapeutic 19553628 +SERPINF1 5176 Diabetic Angiopathies MESH:D003925 marker/mechanism 25381014 +SERPINF1 5176 Keloid MESH:D007627 marker/mechanism 20128793 +SERPINF1 5176 Osteogenesis imperfecta, type 6 MESH:C536047 marker/mechanism 613982.0 +SERPINF1 5176 Prostatic Neoplasms MESH:D011471 therapeutic 21671747 +SERPINF1 5176 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +SERPINF1 5176 Uveitis MESH:D014605 therapeutic 19553628 +SERPINF2 5345 Anti-plasmin deficiency, congenital MESH:C537777 marker/mechanism 262850.0 +SERPING1 710 Acquired angioedema MESH:C538173 marker/mechanism|therapeutic 23406939|9734886 +SERPING1 710 Angioedemas, Hereditary MESH:D054179 marker/mechanism|therapeutic 106100.0 19477491|23406939|23634741|23844784|23866957|9734886 +SERPING1 710 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +SERPING1 710 Complement Component 4, Partial Deficiency Of MESH:C565168 marker/mechanism 120790.0 +SERPING1 710 Hereditary Angioedema Types I and II MESH:D056829 marker/mechanism 15806011|1644161|18387221 +SERPING1 710 Influenza, Human MESH:D007251 marker/mechanism 23326326 +SERPING1 710 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +SERPING1 710 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +SERPING1 710 Lupus Nephritis MESH:D008181 marker/mechanism 4014294 +SERPINH1 871 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +SERPINH1 871 Ischemia MESH:D007511 marker/mechanism 19458120 +SERPINH1 871 Liver Cirrhosis MESH:D008103 marker/mechanism 24321339 +SERPINH1 871 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 18376398|25380136 +SERPINH1 871 OSTEOGENESIS IMPERFECTA, TYPE X OMIM:613848 marker/mechanism 613848.0 +SERPINH1 871 Preterm Premature Rupture of the Membranes MESH:C563032 marker/mechanism 610504.0 +SERPINH1 871 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +SERPINI1 5274 Familial encephalopathy with neuroserpin inclusion bodies MESH:C536841 marker/mechanism 604218.0 +SERPINI1 5274 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 25401298 +SERTAD1 29950 Colonic Neoplasms MESH:D003110 marker/mechanism 18097604 +SESN2 83667 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 28209544 +SESN2 83667 Colorectal Neoplasms MESH:D015179 marker/mechanism 31054940 +SESN2 83667 Hepatomegaly MESH:D006529 therapeutic 28209544 +SESN3 143686 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +SESTD1 91404 Weight Gain MESH:D015430 marker/mechanism 19030233 +SET 6418 Necrosis MESH:D009336 marker/mechanism 24555657 +SET 6418 Neoplasm Invasiveness MESH:D009361 marker/mechanism 24555657 +SETBP1 26040 Abnormalities, Multiple MESH:D000015 marker/mechanism 20436468 +SETBP1 26040 Breast Neoplasms MESH:D001943 marker/mechanism 25751625 +SETBP1 26040 Craniofacial Abnormalities MESH:D019465 marker/mechanism 20436468 +SETBP1 26040 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29 OMIM:616078 marker/mechanism 616078.0 +SETBP1 26040 Intellectual Disability MESH:D008607 marker/mechanism 20436468|25217958 +SETBP1 26040 Language Development Disorders MESH:D007805 marker/mechanism 25217958 +SETBP1 26040 Leukemia, Myeloid MESH:D007951 marker/mechanism 23832012 +SETBP1 26040 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative MESH:D054438 marker/mechanism 23222956 +SETBP1 26040 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 23832011|26457647 +SETBP1 26040 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +SETBP1 26040 Schinzel-Giedion syndrome MESH:C536632 marker/mechanism 269150.0 23222956|23832012 +SETBP1 26040 Weight Gain MESH:D015430 marker/mechanism 19030233 +SETD2 29072 Breast Neoplasms MESH:D001943 marker/mechanism 26437033 +SETD2 29072 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +SETD2 29072 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691|23797736 +SETD2 29072 Leukemia MESH:D007938 marker/mechanism 24509477 +SETD2 29072 LUSCAN-LUMISH SYNDROME OMIM:616831 marker/mechanism 616831.0 +SETD2 29072 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +SETD2 29072 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +SETD2 29072 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +SETD2 29072 Phyllodes Tumor MESH:D003557 marker/mechanism 26437033 +SETD2 29072 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +SETD2 29072 Rhabdomyosarcoma, Embryonal MESH:D018233 marker/mechanism 29376028 +SETD5 55209 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 23 OMIM:615761 marker/mechanism 615761.0 +SETD5 55209 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +SETD7 80854 Cognition Disorders MESH:D003072 therapeutic 35187972 +SETDB1 9869 Melanoma MESH:D008545 marker/mechanism 21983785 +SETDB1 9869 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +SETDB1 9869 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +SETX 23064 Amyotrophic Lateral Sclerosis 4, Juvenile MESH:C566550 marker/mechanism 602433.0 +SETX 23064 Spinocerebellar ataxia, autosomal recessive 1 MESH:C537308 marker/mechanism 606002.0 +SEZ6 124925 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SEZ6L2 26470 Autistic Disorder MESH:D001321 marker/mechanism 19242545 +SF1 7536 Melanoma MESH:D008545 marker/mechanism 22535842 +SF3A3 10946 HIV Infections MESH:D015658 marker/mechanism 15308739 +SF3B1 23451 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 22158541 +SF3B1 23451 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +SF3B1 23451 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 614286.0 +SF3B1 23451 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +SF3B1 23451 Uveal melanoma MESH:C536494 marker/mechanism 23313955|23793026 +SF3B2 10992 Goldenhar Syndrome MESH:D006053 marker/mechanism 164210.0 +SF3B4 10262 Acrofacial dysostosis, Nager type MESH:C538184 marker/mechanism 154400.0 +SFN 2810 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +SFN 2810 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +SFN 2810 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +SFN 2810 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +SFN 2810 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +SFN 2810 Keloid MESH:D007627 marker/mechanism 20128793 +SFN 2810 Lymphatic Metastasis MESH:D008207 marker/mechanism 19381893 +SFN 2810 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +SFPQ 6421 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +SFPQ 6421 HIV Infections MESH:D015658 marker/mechanism 15308739 +SFPQ 6421 Skin Diseases MESH:D012871 marker/mechanism 16835338 +SFRP1 6422 Breast Neoplasms MESH:D001943 marker/mechanism 18283316 +SFRP1 6422 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SFRP1 6422 Colorectal Neoplasms MESH:D015179 marker/mechanism 17923031|18716850 +SFRP1 6422 Fibrosis MESH:D005355 marker/mechanism 30377735 +SFRP1 6422 Heart Diseases MESH:D006331 marker/mechanism 30377735 +SFRP1 6422 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +SFRP1 6422 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 18716850 +SFRP1 6422 Leiomyoma MESH:D007889 marker/mechanism 15972578 +SFRP2 6423 Breast Neoplasms MESH:D001943 marker/mechanism 18283316 +SFRP2 6423 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 18404682 +SFRP2 6423 Colorectal Neoplasms MESH:D015179 marker/mechanism 17923031|18716850 +SFRP2 6423 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 18716850 +SFRP4 6424 Arthritis, Experimental MESH:D001169 marker/mechanism 25194984 +SFRP4 6424 Colorectal Neoplasms MESH:D015179 marker/mechanism 17923031 +SFRP4 6424 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23140642 +SFRP4 6424 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +SFRP4 6424 Pyle disease MESH:C536252 marker/mechanism 265900.0 +SFRP5 6425 Breast Neoplasms MESH:D001943 marker/mechanism 18283316 +SFRP5 6425 Colorectal Neoplasms MESH:D015179 marker/mechanism 17923031 +SFSWAP 6433 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24781735 +SFTPA2 729238 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 178500.0 +SFTPB 6439 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10830305|16863852 +SFTPB 6439 Lung Diseases MESH:D008171 marker/mechanism 16863852 +SFTPB 6439 Lung Neoplasms MESH:D008175 marker/mechanism 16570259 +SFTPB 6439 Surfactant Metabolism Dysfunction, Pulmonary, 1 MESH:C566882 marker/mechanism 265120.0 +SFTPC 6440 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 25851810 +SFTPC 6440 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10751355 +SFTPC 6440 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 178500.0 +SFTPC 6440 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +SFTPC 6440 Surfactant Metabolism Dysfunction, Pulmonary, 2 MESH:C567048 marker/mechanism 610913.0 +SFTPD 6441 Acute Lung Injury MESH:D055371 therapeutic 30060251 +SFTPD 6441 Lung Neoplasms MESH:D008175 marker/mechanism 14522914|15136449 +SFTPD 6441 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 28166215 +SFXN1 94081 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SFXN1 94081 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +SFXN1 94081 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SFXN4 119559 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18 OMIM:615578 marker/mechanism 615578.0 +SGCA 6442 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +SGCA 6442 Sarcoglycanopathies MESH:D058088 marker/mechanism 608099.0 +SGCB 6443 Cardiomyopathies MESH:D009202 marker/mechanism 21037199 +SGCB 6443 Limb-girdle muscular dystrophy, type 2E MESH:C535902 marker/mechanism 604286.0 +SGCB 6443 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SGCD 6444 Cardiomyopathies MESH:D009202 marker/mechanism 20675662|25281567 +SGCD 6444 Cardiomyopathy, Dilated, 1l MESH:C564679 marker/mechanism 606685.0 +SGCD 6444 Limb-girdle muscular dystrophy type 2F MESH:C535896 marker/mechanism 601287.0 20675662 +SGCE 8910 Myoclonic dystonia MESH:C536096 marker/mechanism 159900.0 +SGCG 6445 Limb-girdle muscular dystrophy, type 2C MESH:C535900 marker/mechanism 253700.0 +SGCG 6445 Osteoarthritis MESH:D010003 marker/mechanism 17568789 +SGCZ 137868 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +SGCZ 137868 Skin Diseases MESH:D012871 marker/mechanism 28720099 +SGF29 112869 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SGF29 112869 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +SGK1 6446 Carcinoma MESH:D002277 marker/mechanism 16316942 +SGK1 6446 Diabetic Neuropathies MESH:D003929 marker/mechanism 16696316 +SGK1 6446 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +SGK1 6446 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +SGK1 6446 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +SGK1 6446 Uremia MESH:D014511 marker/mechanism 18768591 +SGK2 10110 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SGO1 151648 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 25282101 +SGO1 151648 CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA OMIM:616201 marker/mechanism 616201.0 +SGO1 151648 Chronobiology Disorders MESH:D021081 marker/mechanism 25282101 +SGO1 151648 Intestinal Diseases MESH:D007410 marker/mechanism 25282101 +SGSH 6448 Mucopolysaccharidosis III MESH:D009084 marker/mechanism 252900.0 +SH2B1 25970 Obesity MESH:D009765 marker/mechanism 19079261 +SH2B3 10019 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990 +SH2B3 10019 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 30224649 +SH2B3 10019 Inflammation MESH:D007249 therapeutic 21496118 +SH2B3 10019 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +SH2B3 10019 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838195 +SH2B3 10019 Myocardial Infarction MESH:D009203 marker/mechanism 19198610 +SH2B3 10019 Polycythemia, primary familial and congenital MESH:C536842 marker/mechanism 133100.0 +SH2B3 10019 Primary Myelofibrosis MESH:D055728 marker/mechanism 254450.0 +SH2B3 10019 Stroke MESH:D020521 marker/mechanism 29531354 +SH2B3 10019 Thrombocytosis MESH:D013922 marker/mechanism 187950.0 +SH2B3 10019 Vitiligo MESH:D014820 marker/mechanism 22561518 +SH2D1A 4068 Lymphoproliferative Disorders MESH:D008232 marker/mechanism 308240.0 10229804 +SH3BGRL2 83699 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +SH3BGRL3 83442 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SH3BP2 6452 Cherubism MESH:D002636 marker/mechanism 118400.0 +SH3GL1 6455 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 33838155 +SH3GL1 6455 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +SH3KBP1 30011 Agammaglobulinemia, X-linked, type 2 MESH:C538057 marker/mechanism 300310.0 +SH3KBP1 30011 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +SH3PXD2A 9644 Atrial Fibrillation MESH:D001281 marker/mechanism 28416822 +SH3PXD2A 9644 Stroke MESH:D020521 marker/mechanism 29531354 +SH3PXD2B 285590 Bone Diseases, Developmental MESH:D001848 marker/mechanism 19669234 +SH3PXD2B 285590 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19669234 +SH3PXD2B 285590 Disease Models, Animal MESH:D004195 marker/mechanism 28719234 +SH3PXD2B 285590 Eye Abnormalities MESH:D005124 marker/mechanism 19669234 +SH3PXD2B 285590 Glaucoma, Angle-Closure MESH:D015812 marker/mechanism 28719234 +SH3PXD2B 285590 Growth Disorders MESH:D006130 marker/mechanism 19669234 +SH3PXD2B 285590 Hearing Loss MESH:D034381 marker/mechanism 19669234 +SH3PXD2B 285590 Ocular Hypertension MESH:D009798 marker/mechanism 28719234 +SH3PXD2B 285590 Ter Haar syndrome MESH:C537274 marker/mechanism 249420.0 +SH3RF3 344558 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +SH3TC1 54436 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +SH3TC2 79628 Charcot-Marie-Tooth disease, Type 4C MESH:C535423 marker/mechanism 601596.0 +SH3TC2 79628 MONONEUROPATHY OF THE MEDIAN NERVE, MILD OMIM:613353 marker/mechanism 613353.0 +SHANK1 50944 Anxiety Disorders MESH:D001008 marker/mechanism 18272690 +SHANK1 50944 Autistic Disorder MESH:D001321 marker/mechanism 18272690 +SHANK1 50944 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +SHANK1 50944 Motor Skills Disorders MESH:D019957 marker/mechanism 20868654 +SHANK2 22941 Autistic Disorder MESH:D001321 marker/mechanism 613436.0 20473310|20531469 +SHANK2 22941 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +SHANK2 22941 Intellectual Disability MESH:D008607 marker/mechanism 20473310 +SHANK3 85358 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 17173049|18252227 +SHANK3 85358 Autistic Disorder MESH:D001321 marker/mechanism 18621663|26027926|35982159 +SHANK3 85358 Developmental Disabilities MESH:D002658 marker/mechanism 16284256 +SHANK3 85358 Intellectual Disability MESH:D008607 marker/mechanism 16284256 +SHANK3 85358 Language Development Disorders MESH:D007805 marker/mechanism 16284256|17173049 +SHANK3 85358 Schizophrenia MESH:D012559 marker/mechanism 613950.0 +SHANK3 85358 Telomeric 22q13 Monosomy Syndrome MESH:C536801 marker/mechanism 606232.0 16284256 +SHARPIN 81858 Dermatitis MESH:D003872 marker/mechanism 19650867 +SHARPIN 81858 Eosinophilia MESH:D004802 marker/mechanism 19650867 +SHBG 6462 Alcoholism MESH:D000437 marker/mechanism 8590623 +SHBG 6462 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 25996886 +SHBG 6462 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 21982312 +SHBG 6462 Erectile Dysfunction MESH:D007172 marker/mechanism 17961146 +SHBG 6462 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 28377727 +SHBG 6462 Metabolic Syndrome MESH:D024821 marker/mechanism 16968811|17992261 +SHBG 6462 Prostatic Neoplasms MESH:D011471 marker/mechanism 17220347 +SHC1 6464 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +SHC1 6464 Cardiomegaly MESH:D006332 marker/mechanism 19168439 +SHC1 6464 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249|32659284 +SHC1 6464 Liver Cirrhosis MESH:D008103 marker/mechanism 32659284 +SHCBP1 79801 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SHCBP1 79801 Sarcoma, Synovial MESH:D013584 marker/mechanism 27572315 +SHFM1 772237 Disease Progression MESH:D018450 marker/mechanism 30871063 +SHFM1 772237 Neuroblastoma MESH:D009447 marker/mechanism 30871063 +SHH 6469 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 26189965 +SHH 6469 Eye Abnormalities MESH:D005124 marker/mechanism 24973920 +SHH 6469 Facial Dysmorphism with Multiple Malformations MESH:C565579 marker/mechanism 27585885 +SHH 6469 Familial schizencephaly MESH:C538514 marker/mechanism 269160.0 +SHH 6469 Holoprosencephaly MESH:D016142 marker/mechanism 15107988|17525797|23264560|27585885|31642701 +SHH 6469 Holoprosencephaly 3 MESH:C564181 marker/mechanism 142945.0 +SHH 6469 Microphthalmia, Isolated, with Coloboma 5 MESH:C566899 marker/mechanism 611638.0 +SHH 6469 Microphthalmos MESH:D008850 marker/mechanism|therapeutic 31690747|32472575 +SHH 6469 Parkinson Disease, Secondary MESH:D010302 therapeutic 11771942 +SHH 6469 Single upper central incisor MESH:C537342 marker/mechanism 147250.0 +SHHA 30269 Jaw Abnormalities MESH:D007569 marker/mechanism 16580747 +SHISA3 152573 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SHMT1 6470 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SHMT1 6470 Breast Neoplasms MESH:D001943 marker/mechanism 17595805 +SHMT1 6470 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SHMT1 6470 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 21064136 +SHMT1 6470 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 17119116 +SHMT1 6470 Nervous System Diseases MESH:D009422 marker/mechanism 21064136 +SHMT2 6472 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 26482881 +SHOC2 8036 Hair Diseases MESH:D006201 marker/mechanism 19684605 +SHOC2 8036 Noonan Syndrome MESH:D009634 marker/mechanism 19684605 +SHOC2 8036 NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1 OMIM:607721 marker/mechanism 607721.0 +SHOX 6473 Langer mesomelic dysplasia MESH:C537267 marker/mechanism 249700.0 +SHOX 6473 Leri-Weil syndrome MESH:C537119 marker/mechanism 127300.0 +SHOX 6473 Short Stature, Idiopathic, X-Linked MESH:C564479 marker/mechanism 300582.0 +SI 6476 Sucrase-isomaltase deficiency, congenital MESH:C538139 marker/mechanism 222900.0 +SIAE 54414 Autoimmune Diseases MESH:D001327 marker/mechanism 613551.0 +SIAH2 6478 Lens Diseases MESH:D007905 marker/mechanism 24282676 +SIDT2 51092 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +SIGLEC1 6614 Influenza, Human MESH:D007251 marker/mechanism 23326326 +SIGLEC5 8778 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SIGLEC6 946 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 26808113 +SIGMAR1 10280 Amnesia MESH:D000647 therapeutic 12028363 +SIGMAR1 10280 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 24885036 +SIGMAR1 10280 AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE OMIM:614373 marker/mechanism 614373.0 +SIGMAR1 10280 Cocaine-Related Disorders MESH:D019970 marker/mechanism 12736327|16132061 +SIGMAR1 10280 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 30661753 +SIGMAR1 10280 Frontotemporal Lobar Degeneration MESH:D057174 marker/mechanism 24885036 +SIGMAR1 10280 HIV Infections MESH:D015658 marker/mechanism 16204638 +SIGMAR1 10280 Learning Disabilities MESH:D007859 therapeutic 15451042 +SIGMAR1 10280 Memory Disorders MESH:D008569 therapeutic 15451042 +SIGMAR1 10280 Prenatal Exposure Delayed Effects MESH:D011297 therapeutic 15451042 +SIGMAR1 10280 Seizures MESH:D012640 marker/mechanism 11684152 +SIGMAR1 10280 Spinal muscular atrophy, Jerash type MESH:C535715 marker/mechanism 605726.0 +SIK1 150094 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +SIK1 150094 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 16243910 +SIK1 150094 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30 OMIM:616341 marker/mechanism 616341.0 +SIK2 23235 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 34491613 +SIK2 23235 Disease Progression MESH:D018450 marker/mechanism 34491613 +SIL1 64374 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SIL1 64374 Spinocerebellar Degenerations MESH:D013132 marker/mechanism 248800.0 +SIM1 6492 Breast Neoplasms MESH:D001943 marker/mechanism 15818620 +SIM1 6492 Hyperglycemia MESH:D006943 marker/mechanism 18056790 +SIM2 6493 Cleft Palate MESH:D002972 marker/mechanism 12203729 +SIM2 6493 Craniofacial Abnormalities MESH:D019465 marker/mechanism 12203729 +SIN3A 25942 Agenesis of Corpus Callosum MESH:D061085 marker/mechanism 27399968 +SIN3A 25942 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 27399968 +SIN3A 25942 Craniofacial Abnormalities MESH:D019465 marker/mechanism 27399968 +SIN3A 25942 Dwarfism MESH:D004392 marker/mechanism 27399968 +SIN3A 25942 Hydrocephalus MESH:D006849 marker/mechanism 27399968 +SIN3A 25942 Intellectual Disability MESH:D008607 marker/mechanism 27399968 +SIN3A 25942 Microcephaly MESH:D008831 marker/mechanism 27399968 +SIN3A 25942 WITTEVEEN-KOLK SYNDROME OMIM:613406 marker/mechanism 613406.0 +SINHCAF 58516 Pancreatic Carcinoma MESH:C562463 marker/mechanism 35213078 +SIPA1 6494 Melanoma MESH:D008545 marker/mechanism 22535842 +SIPA1L1 26037 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +SIPA1L1 26037 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +SIPA1L1 26037 Weight Gain MESH:D015430 marker/mechanism 19030233 +SIPA1L3 23094 CATARACT 45 OMIM:616851 marker/mechanism 616851.0 +SIRPA 140885 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +SIRT1 23411 Acute Kidney Injury MESH:D058186 marker/mechanism 21416250 +SIRT1 23411 Atherosclerosis MESH:D050197 marker/mechanism 20068143 +SIRT1 23411 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +SIRT1 23411 Autoimmune Diseases MESH:D001327 marker/mechanism 23993977 +SIRT1 23411 Brain Infarction MESH:D020520 marker/mechanism 22878646 +SIRT1 23411 Brain Neoplasms MESH:D001932 marker/mechanism 22523472 +SIRT1 23411 Breast Neoplasms MESH:D001943 marker/mechanism 19839049 +SIRT1 23411 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254 +SIRT1 23411 Colitis MESH:D003092 marker/mechanism 19940103|24548422|24782617 +SIRT1 23411 Demyelinating Diseases MESH:D003711 therapeutic 23547115 +SIRT1 23411 Diabetes Mellitus MESH:D003920 marker/mechanism 24894401 +SIRT1 23411 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 23090186|23792339 +SIRT1 23411 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23834033 +SIRT1 23411 Diabetic Retinopathy MESH:D003930 marker/mechanism 24894401 +SIRT1 23411 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 therapeutic 23547115 +SIRT1 23411 Fatty Liver MESH:D005234 marker/mechanism|therapeutic 21321189|23834033|24184811|24210820|24442997 +SIRT1 23411 Fibrosis MESH:D005355 marker/mechanism 20651248 +SIRT1 23411 Genomic Instability MESH:D042822 marker/mechanism 23217256 +SIRT1 23411 Glucose Intolerance MESH:D018149 therapeutic 21321189 +SIRT1 23411 Heart Diseases MESH:D006331 marker/mechanism 23217256 +SIRT1 23411 Heart Failure MESH:D006333 therapeutic 24535859 +SIRT1 23411 HIV Infections MESH:D015658 marker/mechanism 19720090 +SIRT1 23411 Hypertrophy MESH:D006984 therapeutic 23297412 +SIRT1 23411 Insulin Resistance MESH:D007333 marker/mechanism|therapeutic 20068143|21321189|24442997|25849131|26026874 +SIRT1 23411 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 26435214 +SIRT1 23411 Lung Injury MESH:D055370 therapeutic 24633890 +SIRT1 23411 Metabolic Syndrome MESH:D024821 marker/mechanism 20068143 +SIRT1 23411 Myocardial Reperfusion Injury MESH:D015428 therapeutic 21060073 +SIRT1 23411 Neoplasm Metastasis MESH:D009362 marker/mechanism 27793039 +SIRT1 23411 Nerve Degeneration MESH:D009410 therapeutic 17581637 +SIRT1 23411 Neurodegenerative Diseases MESH:D019636 therapeutic 17581637|17652729 +SIRT1 23411 Non-alcoholic Fatty Liver Disease MESH:D065626 therapeutic 26026874 +SIRT1 23411 Obesity MESH:D009765 therapeutic 24184811 +SIRT1 23411 Osteosarcoma MESH:D012516 marker/mechanism 27793039 +SIRT1 23411 Paralysis MESH:D010243 therapeutic 23547115 +SIRT1 23411 Pneumonia MESH:D011014 therapeutic 24633890 +SIRT1 23411 Pneumonia, Pneumococcal MESH:D011018 marker/mechanism 24894820 +SIRT1 23411 Prostatic Neoplasms MESH:D011471 marker/mechanism 21062352 +SIRT1 23411 Retinal Diseases MESH:D012164 marker/mechanism 23217256 +SIRT1 23411 Scleroderma, Systemic MESH:D012595 therapeutic 25707573 +SIRT1 23411 Thrombosis MESH:D013927 therapeutic 25339356 +SIRT1 23411 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 37030624 +SIRT1 23411 Wallerian Degeneration MESH:D014855 marker/mechanism 24252177 +SIRT2 22933 Acute Lung Injury MESH:D055371 marker/mechanism 32063085 +SIRT3 23410 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21472714 +SIRT3 23410 Diabetes, Gestational MESH:D016640 marker/mechanism 23956348 +SIRT3 23410 Mouth Neoplasms MESH:D009062 marker/mechanism 21472714 +SIRT3 23410 Obesity MESH:D009765 marker/mechanism 23956348 +SIRT3 23410 Ototoxicity MESH:D000081015 therapeutic 36800006 +SIRT4 23409 Cardiomegaly MESH:D006332 marker/mechanism 27099261 +SIRT4 23409 Endomyocardial Fibrosis MESH:D004719 marker/mechanism 27099261 +SIRT4 23409 Weight Loss MESH:D015431 therapeutic 35134463 +SIRT6 51548 Cardiomegaly MESH:D006332 marker/mechanism|therapeutic 22335191|35798905 +SIRT6 51548 Cardiotoxicity MESH:D066126 therapeutic 34713381 +SIRT6 51548 Endomyocardial Fibrosis MESH:D004719 therapeutic 34713381 +SIRT6 51548 Fatty Liver MESH:D005234 therapeutic 28536482 +SIRT6 51548 Fibrosis MESH:D005355 marker/mechanism 35798905 +SIRT6 51548 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 35798905 +SIRT6 51548 Ventricular Dysfunction, Left MESH:D018487 therapeutic 34713381 +SIRT6 51548 Ventricular Remodeling MESH:D020257 therapeutic 34713381 +SIRT7 51547 Fatty Liver MESH:D005234 marker/mechanism 24210820 +SIRT7 51547 Reperfusion Injury MESH:D015427 therapeutic 28675767 +SIRT7 51547 Scleroderma, Systemic MESH:D012595 marker/mechanism 25707573 +SIVA1 10572 Coxsackievirus Infections MESH:D003384 marker/mechanism 16683188 +SIX1 6495 Branchiootic Syndrome 3 MESH:C564248 marker/mechanism 608389.0 +SIX1 6495 Branchio-Oto-Renal Syndrome MESH:D019280 marker/mechanism 113650.0 +SIX1 6495 Congenital Abnormalities MESH:D000013 marker/mechanism 12834866 +SIX1 6495 Craniofacial Abnormalities MESH:D019465 marker/mechanism 12834866 +SIX1 6495 Deafness, Autosomal Dominant 23 MESH:C565357 marker/mechanism 605192.0 +SIX1 6495 Endometrial Neoplasms MESH:D016889 marker/mechanism 27259717 +SIX1 6495 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +SIX2 10736 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +SIX2 10736 Frontonasal dysplasia MESH:C538065 marker/mechanism 18570229 +SIX2 10736 Kidney Diseases MESH:D007674 marker/mechanism 18570229 +SIX2 10736 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +SIX3 6496 Familial schizencephaly MESH:C538514 marker/mechanism 269160.0 +SIX3 6496 Holoprosencephaly MESH:D016142 marker/mechanism 10369266 +SIX3 6496 Holoprosencephaly 2 MESH:C563579 marker/mechanism 157170.0 +SIX3 6496 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +SIX3 6496 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +SIX5 147912 Branchio-Oto-Renal Syndrome MESH:D019280 marker/mechanism 610896.0 +SIX6 4990 Microphthalmia, Isolated, with Cataract 2 MESH:C565876 marker/mechanism 212550.0 +SIX6 4990 Microphthalmia, Syndromic 3 MESH:C565948 marker/mechanism 206900.0 +SIX6 4990 Myopia MESH:D009216 marker/mechanism 23396134 +SKA1 220134 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SKA3 221150 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SKAP1 8631 Ovarian Neoplasms MESH:D010051 marker/mechanism 20852632 +SKAP2 8935 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SKI 6497 Aortic Aneurysm MESH:D001014 marker/mechanism 23023332 +SKI 6497 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9284043 +SKI 6497 Musculoskeletal Abnormalities MESH:D009139 marker/mechanism 9284043 +SKI 6497 Neural Tube Defects MESH:D009436 marker/mechanism 9284043 +SKI 6497 Shprintzen Golberg craniosynostosis MESH:C537328 marker/mechanism 182212.0 23023332 +SKIC2 6499 Trichohepatoenteric Syndrome MESH:C565627 marker/mechanism 614602.0 +SKIC3 9652 Trichohepatoenteric Syndrome MESH:C565627 marker/mechanism 222470.0 +SKIL 6498 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +SKIL 6498 Paraquat lung MESH:C537171 therapeutic 23590892 +SKIL 6498 Pulmonary Fibrosis MESH:D011658 therapeutic 23590892 +SKIL 6498 Skin Diseases MESH:D012871 marker/mechanism 16835338 +SKN-1 177343 Gait Disorders, Neurologic MESH:D020233 marker/mechanism 23555279 +SKN-1 177343 Manganese Poisoning MESH:D020149 therapeutic 20865164 +SKN-1 177343 Nerve Degeneration MESH:D009410 therapeutic 20865164|23106139 +SKN-1 177343 Neuromuscular Manifestations MESH:D020879 marker/mechanism 23555279 +SKP2 6502 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 12717389 +SKP2 6502 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 18850583 +SKP2 6502 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +SKP2 6502 Neoplasms MESH:D009369 marker/mechanism 18451165 +SKP2 6502 Osteoarthritis, Spine MESH:D055013 marker/mechanism 34697729 +SKP2 6502 Ovarian Neoplasms MESH:D010051 marker/mechanism 19636294 +SLA 6503 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLA 6503 Vitiligo MESH:D014820 marker/mechanism 22561518 +SLAMF8 56833 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 28067908 +SLAMF9 89886 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLBP 7884 Coloboma MESH:D003103 marker/mechanism 30695021 +SLBP 7884 Optic Atrophy MESH:D009896 marker/mechanism 30695021 +SLBP 7884 Retinal Dysplasia MESH:D015792 marker/mechanism 30695021 +SLC10A1 6554 Hepatitis B MESH:D006509 marker/mechanism 25550158 +SLC10A1 6554 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +SLC10A2 6555 Bile Acid Malabsorption, Primary MESH:C567652 marker/mechanism 613291.0 +SLC10A2 6555 Cognition Disorders MESH:D003072 marker/mechanism 29382564 +SLC10A2 6555 Diabetes Complications MESH:D048909 marker/mechanism 29382564 +SLC10A2 6555 Nervous System Diseases MESH:D009422 marker/mechanism 21245421 +SLC10A2 6555 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +SLC10A6 345274 Breast Neoplasms MESH:D001943 marker/mechanism 30186172 +SLC10A7 84068 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +SLC10A7 84068 Cholestasis MESH:D002779 marker/mechanism 26881866 +SLC11A1 6556 Acute Kidney Injury MESH:D058186 marker/mechanism 20623750 +SLC11A1 6556 Arthritis, Juvenile MESH:D001171 marker/mechanism 16597321 +SLC11A1 6556 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 16597321 +SLC11A1 6556 Buruli Ulcer MESH:D054312 marker/mechanism 610446.0 +SLC11A1 6556 Colitis, Ulcerative MESH:D003093 marker/mechanism 16059695 +SLC11A1 6556 Crohn Disease MESH:D003424 marker/mechanism 16059695 +SLC11A1 6556 Dermatitis, Atopic MESH:D003876 marker/mechanism 16597321 +SLC11A1 6556 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 16597321 +SLC11A1 6556 Food Hypersensitivity MESH:D005512 marker/mechanism 16597321 +SLC11A1 6556 HIV Infections MESH:D015658 marker/mechanism 16597321 +SLC11A1 6556 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 16597321 +SLC11A1 6556 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 16597321 +SLC11A1 6556 Leprosy MESH:D007918 marker/mechanism 16597321 +SLC11A1 6556 Meningitis, Meningococcal MESH:D008585 marker/mechanism 16597321 +SLC11A1 6556 Multiple Sclerosis MESH:D009103 marker/mechanism 16597321 +SLC11A1 6556 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948.0 +SLC11A1 6556 Sarcoidosis MESH:D012507 marker/mechanism 16597321 +SLC11A1 6556 Tuberculosis MESH:D014376 marker/mechanism 16597321 +SLC11A2 4891 Anemia, Hypochromic Microcytic, With Iron Overload MESH:C567144 marker/mechanism 206100.0 +SLC11A2 4891 Anemia, Iron-Deficiency MESH:D018798 marker/mechanism 17116712 +SLC11A2 4891 Hemochromatosis MESH:D006432 marker/mechanism 11439223 +SLC11A2 4891 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +SLC12A1 6557 Bartter Syndrome MESH:D001477 marker/mechanism 10561751 +SLC12A1 6557 Bartter syndrome, antenatal type 1 MESH:C537652 marker/mechanism 601678.0 +SLC12A2 6558 Carcinoma MESH:D002277 marker/mechanism 12376462 +SLC12A2 6558 Cardiovascular Diseases MESH:D002318 marker/mechanism 15135928 +SLC12A2 6558 Epilepsy MESH:D004827 marker/mechanism 18550034 +SLC12A2 6558 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 19674083 +SLC12A2 6558 Glucose Intolerance MESH:D018149 marker/mechanism 22872759 +SLC12A2 6558 Hypertension MESH:D006973 marker/mechanism 17259435 +SLC12A2 6558 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +SLC12A2 6558 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +SLC12A2 6558 Movement Disorders MESH:D009069 marker/mechanism 15135928 +SLC12A2 6558 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SLC12A3 6559 Gitelman Syndrome MESH:D053579 marker/mechanism 263800.0 10561751 +SLC12A3 6559 Hypertension MESH:D006973 marker/mechanism 18480177 +SLC12A3 6559 Kidney Diseases MESH:D007674 marker/mechanism 21865292 +SLC12A3 6559 Vascular Diseases MESH:D014652 marker/mechanism 23348737 +SLC12A5 57468 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34 OMIM:616645 marker/mechanism 616645.0 +SLC12A5 57468 Epilepsy MESH:D004827 marker/mechanism 12000122|18550034 +SLC12A5 57468 Epilepsy, Idiopathic Generalized MESH:C562694 marker/mechanism 616685.0 +SLC12A5 57468 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 19674083 +SLC12A5 57468 Hyperalgesia MESH:D006930 marker/mechanism 20086212 +SLC12A5 57468 Seizures MESH:D012640 marker/mechanism 20086212 +SLC12A5 57468 Status Epilepticus MESH:D013226 marker/mechanism 20600929 +SLC12A6 9990 Corpus callosum agenesis neuronopathy MESH:C536446 marker/mechanism 218000.0 +SLC12A6 9990 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 21245421 +SLC12A7 10723 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC12A7 10723 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +SLC13A4 26266 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC13A4 26266 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +SLC13A4 26266 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +SLC13A5 284111 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA OMIM:615905 marker/mechanism 615905.0 +SLC13A5 284111 Fatty Liver MESH:D005234 marker/mechanism 26303333 +SLC14A1 6563 Anemia, Hemolytic, Autoimmune MESH:D000744 marker/mechanism 6427987 +SLC15A2 6565 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SLC15A2 6565 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SLC15A2 6565 Melanoma MESH:D008545 marker/mechanism 22842228 +SLC15A3 51296 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC15A4 121260 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838193 +SLC16A1 6566 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC16A1 6566 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 11953883 +SLC16A1 6566 Colonic Neoplasms MESH:D003110 marker/mechanism 11953883 +SLC16A1 6566 Erythrocyte Lactate Transporter Defect MESH:C565449 marker/mechanism 245340.0 +SLC16A1 6566 Hyperinsulinemic hypoglycemia, familial, 7 MESH:C538376 marker/mechanism 610021.0 +SLC16A1 6566 MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY OMIM:616095 marker/mechanism 616095.0 +SLC16A12 387700 Cataract, Juvenile, With Microcornea And Glucosuria MESH:C567434 marker/mechanism 612018.0 +SLC16A2 6567 Allan-Herndon-Dudley syndrome MESH:C537047 marker/mechanism 300523.0 +SLC16A2 6567 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 24781735 +SLC16A2 6567 Cholestasis MESH:D002779 marker/mechanism 27989131 +SLC16A2 6567 Hypothyroidism MESH:D007037 marker/mechanism 31121238 +SLC16A3 9123 Breast Neoplasms MESH:D001943 marker/mechanism 22313602 +SLC16A3 9123 Stomach Neoplasms MESH:D013274 marker/mechanism 27224918 +SLC16A6 9120 Endometriosis MESH:D004715 marker/mechanism 20864642 +SLC16A7 9194 Obesity MESH:D009765 marker/mechanism 20882379 +SLC16A8 23539 Macular Degeneration MESH:D008268 marker/mechanism 26691988 +SLC17A1 6568 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980|25380136 +SLC17A2 10246 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +SLC17A2 10246 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC17A3 10786 URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4 OMIM:612671 marker/mechanism 612671 +SLC17A5 26503 Melanoma MESH:D008545 marker/mechanism 21499247 +SLC17A5 26503 Sialic Acid Storage Disease MESH:D029461 marker/mechanism 269920|604369 +SLC17A6 57084 Learning Disabilities MESH:D007859 marker/mechanism 21295146 +SLC17A6 57084 Memory Disorders MESH:D008569 marker/mechanism 21295146 +SLC17A7 57030 Learning Disabilities MESH:D007859 marker/mechanism 21295146 +SLC17A7 57030 Memory Disorders MESH:D008569 marker/mechanism 21295146 +SLC17A7 57030 Seizures MESH:D012640 marker/mechanism 18495095 +SLC17A8 246213 Deafness, Autosomal Dominant 25 MESH:C565319 marker/mechanism 605583.0 +SLC17A9 63910 POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE OMIM:616063 marker/mechanism 616063.0 +SLC18A2 6571 Nerve Degeneration MESH:D009410 marker/mechanism 18643795 +SLC18A2 6571 Nervous System Diseases MESH:D009422 marker/mechanism 12890883 +SLC18A2 6571 Parkinson Disease MESH:D010300 marker/mechanism 16112329|34774656 +SLC18A2 6571 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 34774656 +SLC18A2 6571 Parkinsonian Disorders MESH:D020734 therapeutic 16269145 +SLC18A3 6572 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 617239.0 +SLC19A1 6573 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SLC19A1 6573 Adenoma MESH:D000236 marker/mechanism 16963246 +SLC19A1 6573 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC19A1 6573 Autistic Disorder MESH:D001321 marker/mechanism 16917939|20468076 +SLC19A1 6573 Cleft Lip MESH:D002971 marker/mechanism 21254359 +SLC19A1 6573 Cleft Palate MESH:D002972 marker/mechanism 21254359 +SLC19A1 6573 Clinical Deterioration MESH:D000075902 marker/mechanism 27602772 +SLC19A1 6573 Colonic Neoplasms MESH:D003110 marker/mechanism 15705887 +SLC19A1 6573 Colorectal Neoplasms MESH:D015179 marker/mechanism 16963246 +SLC19A1 6573 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SLC19A1 6573 Down Syndrome MESH:D004314 marker/mechanism 16845273|17431899 +SLC19A1 6573 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 21064136 +SLC19A1 6573 Nervous System Diseases MESH:D009422 marker/mechanism 21064136 +SLC19A1 6573 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 17255265 +SLC19A1 6573 Recurrence MESH:D012008 marker/mechanism 17255265 +SLC19A1 6573 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 21760912 +SLC19A2 10560 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC19A2 10560 Thiamine responsive megaloblastic anemia syndrome MESH:C536510 marker/mechanism 249270.0 +SLC19A3 80704 Basal ganglia disease, biotin-responsive MESH:C537658 marker/mechanism 607483.0 15871139 +SLC19A3 80704 Basal Ganglia Diseases MESH:D001480 marker/mechanism 19387023 +SLC1A1 6505 Atrophy MESH:D001284 marker/mechanism 22575539 +SLC1A1 6505 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 31209396|35663546 +SLC1A1 6505 Brain Diseases MESH:D001927 marker/mechanism 22575539 +SLC1A1 6505 Cognition Disorders MESH:D003072 marker/mechanism 22575539 +SLC1A1 6505 Dicarboxylicaminoaciduria MESH:C536171 marker/mechanism 222730.0 +SLC1A1 6505 Endometriosis MESH:D004715 marker/mechanism 21063030 +SLC1A1 6505 Epilepsy MESH:D004827 marker/mechanism 12151515 +SLC1A1 6505 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 11906504 +SLC1A1 6505 Low Tension Glaucoma MESH:D057066 marker/mechanism 28703795 +SLC1A1 6505 Malformations of Cortical Development MESH:D054220 marker/mechanism 11906504 +SLC1A1 6505 Nerve Degeneration MESH:D009410 marker/mechanism 28703795 +SLC1A1 6505 Retinal Degeneration MESH:D012162 marker/mechanism 28703795 +SLC1A1 6505 Schizophrenia MESH:D012559 marker/mechanism 615232.0 +SLC1A1 6505 Seizures MESH:D012640 marker/mechanism 23262392 +SLC1A2 6506 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 11723166 +SLC1A2 6506 Cocaine-Related Disorders MESH:D019970 therapeutic 19625514 +SLC1A2 6506 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41 OMIM:617105 marker/mechanism 617105.0 +SLC1A2 6506 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +SLC1A2 6506 Epilepsy MESH:D004827 marker/mechanism 19853022 +SLC1A2 6506 Nerve Degeneration MESH:D009410 therapeutic 22645130 +SLC1A2 6506 Stomach Neoplasms MESH:D013274 marker/mechanism 21471434 +SLC1A3 6507 Autistic Disorder MESH:D001321 marker/mechanism 11706102 +SLC1A3 6507 Epilepsy MESH:D004827 marker/mechanism 19853022 +SLC1A3 6507 Episodic Ataxia, Type 6 MESH:C567207 marker/mechanism 612656.0 +SLC1A4 6509 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC1A5 6510 Pancreatic Neoplasms MESH:D010190 marker/mechanism 35929395 +SLC20A1 6574 Aortic Valve, Calcification of MESH:C562942 marker/mechanism 23308213 +SLC20A1 6574 Bone Diseases, Metabolic MESH:D001851 marker/mechanism 26773408 +SLC20A1 6574 Endometriosis MESH:D004715 marker/mechanism 20864642 +SLC20A1 6574 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC20A2 6575 Basal Ganglia Diseases MESH:D001480 marker/mechanism 25938945 +SLC20A2 6575 Calcinosis MESH:D002114 marker/mechanism 25938945 +SLC20A2 6575 Fahr's disease MESH:C536275 marker/mechanism 213600.0 22327515 +SLC22A1 6580 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SLC22A1 6580 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +SLC22A1 6580 Obesity MESH:D009765 marker/mechanism 20956498 +SLC22A10 387775 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560|30705370 +SLC22A10 387775 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +SLC22A10 387775 Glioblastoma MESH:D005909 marker/mechanism 30705370 +SLC22A10 387775 Lymphatic Metastasis MESH:D008207 marker/mechanism 30705370 +SLC22A10 387775 Ovarian Neoplasms MESH:D010051 marker/mechanism 30705370 +SLC22A12 116085 Acute Kidney Injury MESH:D058186 marker/mechanism 14655203 +SLC22A12 116085 Renal hypouricemia MESH:C537757 marker/mechanism 220150.0 14655203|14694169|22132990 +SLC22A15 55356 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +SLC22A16 85413 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +SLC22A18 5002 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 +SLC22A18 5002 Lung Neoplasms MESH:D008175 marker/mechanism 211980.0 +SLC22A18 5002 Rhabdomyosarcoma 1 MESH:C537883 marker/mechanism 268210.0 +SLC22A2 6582 Kidney Diseases MESH:D007674 therapeutic 22525860 +SLC22A2 6582 Obesity MESH:D009765 marker/mechanism 27401566 +SLC22A2 6582 Poisoning MESH:D011041 therapeutic 22525860 +SLC22A23 63027 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC22A24 283238 Acute Kidney Injury MESH:D058186 marker/mechanism 23649842|26230185 +SLC22A3 6581 Coxsackievirus Infections MESH:D003384 marker/mechanism 21641380 +SLC22A3 6581 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +SLC22A3 6581 Myocarditis MESH:D009205 marker/mechanism 21641380 +SLC22A3 6581 Obesity MESH:D009765 marker/mechanism 27401566 +SLC22A3 6581 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048 +SLC22A3 6581 Substance-Related Disorders MESH:D019966 marker/mechanism 17010131 +SLC22A4 6583 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 180300.0 +SLC22A4 6583 Coxsackievirus Infections MESH:D003384 marker/mechanism 21641380 +SLC22A4 6583 Enterovirus Infections MESH:D004769 marker/mechanism 21641380 +SLC22A4 6583 Myocarditis MESH:D009205 marker/mechanism 21641380 +SLC22A5 6584 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC22A5 6584 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 21641380 +SLC22A5 6584 Coxsackievirus Infections MESH:D003384 marker/mechanism 21641380 +SLC22A5 6584 Inflammation MESH:D007249 marker/mechanism 21641380 +SLC22A5 6584 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +SLC22A5 6584 Myocarditis MESH:D009205 marker/mechanism 21641380 +SLC22A5 6584 Systemic carnitine deficiency MESH:C536778 marker/mechanism 212140.0 17703373 +SLC22A6 9356 Calcinosis MESH:D002114 marker/mechanism 12803500 +SLC22A8 9376 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +SLC22A8 9376 Fatty Liver MESH:D005234 marker/mechanism 25226513 +SLC22A8 9376 Influenza, Human MESH:D007251 marker/mechanism 23129053 +SLC22A8 9376 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +SLC22A8 9376 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC23A1 9963 Cholestasis MESH:D002779 marker/mechanism 18706437 +SLC23A1 9963 Intracranial Hemorrhages MESH:D020300 marker/mechanism 11984597 +SLC23A1 9963 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC23A1 9963 Respiratory Insufficiency MESH:D012131 marker/mechanism 11984597 +SLC23A2 9962 Cholestasis MESH:D002779 marker/mechanism 18706437 +SLC24A1 9187 Night blindness, congenital stationary MESH:C536122 marker/mechanism 613830.0 +SLC24A3 57419 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +SLC24A3 57419 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +SLC24A4 123041 AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5 OMIM:615887 marker/mechanism 615887.0 +SLC24A5 283652 Skin-Hair-Eye Pigmentation, Variation In, 4 MESH:C567300 marker/mechanism 113750.0 +SLC25A1 6576 2-Hydroxyglutaricaciduria MESH:C535306 marker/mechanism 615182.0 +SLC25A10 1468 Carcinoma MESH:D002277 marker/mechanism 12376462 +SLC25A10 1468 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +SLC25A10 1468 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +SLC25A11 8402 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +SLC25A12 8604 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +SLC25A12 8604 Autistic Disorder MESH:D001321 marker/mechanism 15056512|18348195 +SLC25A12 8604 Hypomyelination, Global Cerebral MESH:C567847 marker/mechanism 612949.0 +SLC25A13 10165 Adult-onset citrullinemia type 2 MESH:C538053 marker/mechanism 603471.0 16449956 +SLC25A13 10165 Fractures, Bone MESH:D050723 marker/mechanism 22504420 +SLC25A13 10165 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC25A13 10165 Neonatal-onset citrullinemia type 2 MESH:C536398 marker/mechanism 605814.0 +SLC25A15 10166 HHH syndrome MESH:C538380 marker/mechanism 238970.0 +SLC25A19 60386 Amish lethal microcephaly MESH:C538247 marker/mechanism 607196.0 +SLC25A19 60386 THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE) OMIM:613710 marker/mechanism 613710.0 +SLC25A20 788 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC25A20 788 Carnitine-Acylcarnitine Translocase Deficiency MESH:C562812 marker/mechanism 212138.0 +SLC25A22 79751 Epileptic Encephalopathy, Early Infantile, 3 MESH:C562695 marker/mechanism 609304.0 +SLC25A24 29957 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC25A25 114789 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC25A26 115286 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28 OMIM:616794 marker/mechanism 616794.0 +SLC25A29 123096 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +SLC25A3 5250 Mitochondrial Phosphate Carrier Deficiency MESH:C563665 marker/mechanism 610773.0 +SLC25A30 253512 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC25A37 51312 Anemia MESH:D000740 marker/mechanism 22253756 +SLC25A38 54977 Anemia, Sideroblastic MESH:D000756 marker/mechanism 19412178 +SLC25A38 54977 Anemia, Sideroblastic, Pyridoxine-Refractory, Autosomal Recessive MESH:C567145 marker/mechanism 205950.0 +SLC25A4 291 Diabetic Cardiomyopathies MESH:D058065 therapeutic 18945756 +SLC25A4 291 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC25A4 291 MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT OMIM:617184 marker/mechanism 617184.0 +SLC25A4 291 MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE OMIM:615418 marker/mechanism 615418.0 +SLC25A4 291 Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 2 MESH:C563750 marker/mechanism 609283.0 +SLC25A45 283130 Melanoma MESH:D008545 marker/mechanism 22535842 +SLC25A46 91137 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 26168012 +SLC25A46 91137 NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY OMIM:616505 marker/mechanism 616505.0 +SLC25A46 91137 Optic Atrophy MESH:D009896 marker/mechanism 26168012 +SLC25A47 283600 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SLC26A1 10861 Hyperoxaluria MESH:D006959 marker/mechanism 20160351 +SLC26A1 10861 Nephrocalcinosis MESH:D009397 marker/mechanism 20160351 +SLC26A1 10861 Nephrolithiasis, Calcium Oxalate MESH:C563477 marker/mechanism 167030.0 +SLC26A1 10861 Urolithiasis MESH:D052878 marker/mechanism 19002488|20160351 +SLC26A2 1836 Achondrogenesis type 1B MESH:C536016 marker/mechanism 600972.0 +SLC26A2 1836 Atelosteogenesis type 2 MESH:C535395 marker/mechanism 256050.0 +SLC26A2 1836 Bone Diseases, Developmental MESH:D001848 marker/mechanism 18925670 +SLC26A2 1836 Craniofacial Abnormalities MESH:D019465 marker/mechanism 18925670 +SLC26A2 1836 Diastrophic dysplasia MESH:C536170 marker/mechanism 222600.0 +SLC26A2 1836 Ear Diseases MESH:D004427 marker/mechanism 18925670 +SLC26A2 1836 Epiphyseal dysplasia, multiple, 4 MESH:C535504 marker/mechanism 226900.0 +SLC26A2 1836 Kyphosis MESH:D007738 marker/mechanism 18925670 +SLC26A3 1811 Colitis, Ulcerative MESH:D003093 marker/mechanism 19915573 +SLC26A3 1811 Congenital chloride diarrhea MESH:C536210 marker/mechanism 214700.0 +SLC26A4 5172 DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT OMIM:600791 marker/mechanism 600791.0 +SLC26A4 5172 Goiter MESH:D006042 marker/mechanism 15279074|16053392|17322586 +SLC26A4 5172 Hearing Loss MESH:D034381 marker/mechanism 22116360|29320412 +SLC26A4 5172 Hearing Loss, Sensorineural MESH:D006319 marker/mechanism 15279074|16053392|17322586 +SLC26A4 5172 Pendred syndrome MESH:C536648 marker/mechanism 274600.0 10644529|17697873 +SLC26A4 5172 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SLC26A5 375611 Deafness MESH:D003638 marker/mechanism 12719379 +SLC26A5 375611 DEAFNESS, AUTOSOMAL RECESSIVE 61 OMIM:613865 marker/mechanism 613865.0 +SLC26A5 375611 Hearing Loss MESH:D034381 marker/mechanism 34273409 +SLC26A6 65010 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SLC26A7 115111 Schizophrenia MESH:D012559 marker/mechanism 21822266 +SLC26A8 116369 Azoospermia, Nonobstructive MESH:C564665 marker/mechanism 606766.0 +SLC26A8 116369 Schizophrenia MESH:D012559 marker/mechanism 21822266 +SLC26A9 115019 CYSTIC FIBROSIS, MODIFIER OF, 1 OMIM:603855 marker/mechanism 22466613 +SLC26A9 115019 Intestinal Obstruction MESH:D007415 marker/mechanism 22466613 +SLC27A2 11001 Fibrosis MESH:D005355 marker/mechanism 28871336 +SLC27A4 10999 Ichthyosis prematurity syndrome MESH:C536271 marker/mechanism 608649.0 +SLC27A6 28965 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +SLC28A1 9154 Breast Neoplasms MESH:D001943 marker/mechanism 16837820 +SLC29A1 2030 Alcohol Withdrawal Seizures MESH:D020270 marker/mechanism 21283641 +SLC29A1 2030 Disease Models, Animal MESH:D004195 marker/mechanism 27567601 +SLC29A1 2030 Huntington Disease MESH:D006816 marker/mechanism 27567601 +SLC29A1 2030 Pancreatic Neoplasms MESH:D010190 marker/mechanism 18728667 +SLC29A3 55315 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 19336477|20140240 +SLC29A3 55315 Hearing Loss MESH:D034381 marker/mechanism 20140240 +SLC29A3 55315 Heart Defects, Congenital MESH:D006330 marker/mechanism 20140240 +SLC29A3 55315 Hepatomegaly MESH:D006529 marker/mechanism 20140240 +SLC29A3 55315 Histiocytosis MESH:D015614 marker/mechanism 22238637 +SLC29A3 55315 Histiocytosis, Sinus MESH:D015618 marker/mechanism 20140240 +SLC29A3 55315 Histiocytosis with joint contractures and sensorineural deafness MESH:C538322 marker/mechanism 602782.0 20140240 +SLC29A3 55315 Hyperpigmentation MESH:D017495 marker/mechanism 19336477|20140240 +SLC29A3 55315 Hypertrichosis MESH:D006983 marker/mechanism 19336477|20140240 +SLC29A3 55315 Hypogonadism MESH:D007006 marker/mechanism 20140240 +SLC2A1 6513 Ataxia MESH:D001259 marker/mechanism 11603379 +SLC2A1 6513 Breast Neoplasms MESH:D001943 marker/mechanism 20197467 +SLC2A1 6513 Carcinoma, Ductal MESH:D044584 marker/mechanism 20526721 +SLC2A1 6513 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 8364915 +SLC2A1 6513 Carcinoma, Intraductal, Noninfiltrating MESH:D002285 marker/mechanism 20526721 +SLC2A1 6513 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 7921415 +SLC2A1 6513 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 11953883 +SLC2A1 6513 Choreoathetosis-Spasticity, Episodic MESH:C563401 marker/mechanism 601042.0 +SLC2A1 6513 Colonic Neoplasms MESH:D003110 marker/mechanism 11953883 +SLC2A1 6513 Cryohydrocytosis, Stomatin-Deficient, with Mental Retardation, Seizures, Cataracts, and Massive Hepatosplenomegaly MESH:C563840 marker/mechanism 608885.0 +SLC2A1 6513 Developmental Disabilities MESH:D002658 marker/mechanism 10980529|11603379|9462754 +SLC2A1 6513 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 9589670 +SLC2A1 6513 Glut1 Deficiency Syndrome MESH:C536830 marker/mechanism 606777.0 10980529|11603379|17489814|9462754 +SLC2A1 6513 GLUT1 DEFICIENCY SYNDROME 2 OMIM:612126 marker/mechanism 612126.0 +SLC2A1 6513 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +SLC2A1 6513 Liver Neoplasms MESH:D008113 marker/mechanism 26943884 +SLC2A1 6513 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 22784439 +SLC2A1 6513 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 23452774 +SLC2A1 6513 Microcephaly MESH:D008831 marker/mechanism 10980529|9462754 +SLC2A1 6513 Nervous System Diseases MESH:D009422 marker/mechanism 23452774 +SLC2A1 6513 Osteoarthritis MESH:D010003 marker/mechanism 18973239 +SLC2A1 6513 Ovarian Neoplasms MESH:D010051 marker/mechanism 20138251 +SLC2A1 6513 Peritoneal Neoplasms MESH:D010534 marker/mechanism 22784439 +SLC2A1 6513 Seizures MESH:D012640 marker/mechanism 10980529|11603379|9462754 +SLC2A10 81031 Arterial Tortuosity Syndrome MESH:C565942 marker/mechanism 208050.0 +SLC2A10 81031 Breast Neoplasms MESH:D001943 marker/mechanism 25151356 +SLC2A13 114134 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +SLC2A14 144195 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC2A14 144195 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +SLC2A2 6514 Breast Neoplasms MESH:D001943 marker/mechanism 19579870 +SLC2A2 6514 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 8364915 +SLC2A2 6514 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +SLC2A2 6514 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 16123366 +SLC2A2 6514 Fanconi Syndrome MESH:D005198 marker/mechanism 227810.0 11810292 +SLC2A2 6514 Fatty Liver MESH:D005234 marker/mechanism 12048068 +SLC2A3 6515 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +SLC2A3 6515 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC2A3 6515 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +SLC2A3 6515 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414 +SLC2A3 6515 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 16168501 +SLC2A4 6517 Alzheimer Disease MESH:D000544 marker/mechanism 24055495 +SLC2A4 6517 Cardiomegaly MESH:D006332 marker/mechanism 22221582 +SLC2A4 6517 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 11947963|14563825|18266981|22138235 +SLC2A4 6517 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 11947963|17107852|22384078|31626838 +SLC2A4 6517 Insulin Resistance MESH:D007333 therapeutic 11947963 +SLC2A5 6518 Breast Neoplasms MESH:D001943 therapeutic 15449313 +SLC2A9 56606 Gout MESH:D006073 marker/mechanism 18327256|18327257 +SLC2A9 56606 Hyperuricemia MESH:D033461 marker/mechanism 18989453 +SLC2A9 56606 Hypouricemia, Renal, 2 MESH:C567426 marker/mechanism 612076.0 +SLC2A9 56606 Renal hypouricemia MESH:C537757 marker/mechanism 18989453|22132990 +SLC30A1 7779 Seizures MESH:D012640 marker/mechanism 23266720 +SLC30A10 55532 Cholestasis MESH:D002779 marker/mechanism 27989131 +SLC30A10 55532 Dystonia MESH:D004421 marker/mechanism 22926781 +SLC30A10 55532 HYPERMANGANESEMIA WITH DYSTONIA 1 OMIM:613280 marker/mechanism 613280.0 +SLC30A10 55532 Hypermanganesemia with Dystonia Polycythemia and Cirrhosis MESH:C548016 marker/mechanism 22341971|22926781 +SLC30A10 55532 Hypothyroidism MESH:D007037 marker/mechanism 28860195 +SLC30A10 55532 Liver Cirrhosis MESH:D008103 marker/mechanism 22926781 +SLC30A10 55532 Manganese Poisoning MESH:D020149 marker/mechanism 28860195|29429640 +SLC30A10 55532 Parkinson Disease MESH:D010300 marker/mechanism 25149416 +SLC30A10 55532 Parkinsonian Disorders MESH:D020734 marker/mechanism 26220508 +SLC30A10 55532 Polycythemia MESH:D011086 marker/mechanism 22926781 +SLC30A2 7780 Zinc Deficiency, Neonatal, due to Low Breast Milk Zinc MESH:C564286 marker/mechanism 608118.0 17065149 +SLC30A4 7782 Alzheimer Disease MESH:D000544 marker/mechanism 16580781 +SLC30A4 7782 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +SLC30A6 55676 Alzheimer Disease MESH:D000544 marker/mechanism 16580781 +SLC30A7 148867 Esophageal Neoplasms MESH:D004938 marker/mechanism 17068819 +SLC30A8 169026 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism|therapeutic 125853.0 19479076|19542200|20424817|21461562|21779873|24584071 +SLC31A1 1317 Congenital Abnormalities MESH:D000013 marker/mechanism 11391004 +SLC31A1 1317 Embryo Loss MESH:D020964 marker/mechanism 11391004 +SLC31A1 1317 Hypertension, Pulmonary MESH:D006976 marker/mechanism 24614111 +SLC31A1 1317 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +SLC31A1 1317 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 23792645 +SLC31A1 1317 Manganese Poisoning MESH:D020149 marker/mechanism 22465424 +SLC31A1 1317 Necrosis MESH:D009336 marker/mechanism 19144690 +SLC31A1 1317 Prostatic Neoplasms MESH:D011471 marker/mechanism 25320179 +SLC33A1 9197 Cataract MESH:D002386 marker/mechanism 22243965 +SLC33A1 9197 CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION OMIM:614482 marker/mechanism 614482.0 +SLC33A1 9197 Developmental Disabilities MESH:D002658 marker/mechanism 22243965 +SLC33A1 9197 Hearing Loss MESH:D034381 marker/mechanism 22243965 +SLC33A1 9197 Spastic Paraplegia 42, Autosomal Dominant MESH:C567262 marker/mechanism 612539.0 +SLC34A1 6569 Bone Diseases, Developmental MESH:D001848 marker/mechanism 9560283 +SLC34A1 6569 Fanconi Syndrome MESH:D005198 marker/mechanism 613388.0 +SLC34A1 6569 Hypercalcemia MESH:D006934 marker/mechanism 9560283 +SLC34A1 6569 Hypercalcemia, Infantile MESH:C562999 marker/mechanism 616963.0 +SLC34A1 6569 Hypercalciuria MESH:D053565 marker/mechanism 9560283 +SLC34A1 6569 Hypophosphatemia MESH:D017674 marker/mechanism 9560283 +SLC34A1 6569 NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1 OMIM:612286 marker/mechanism 612286.0 +SLC34A2 10568 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 22617245|22919003 +SLC34A2 10568 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15805072 +SLC34A2 10568 Pulmonary Alveolar Microlithiasis MESH:C562405 marker/mechanism 265100.0 +SLC34A3 142680 Hypophosphatemic Rickets with Hypercalciuria, Hereditary MESH:C562793 marker/mechanism 241530.0 +SLC35A1 10559 Congenital Disorder Of Glycosylation, Type IIF MESH:C567040 marker/mechanism 603585.0 +SLC35A2 7355 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm OMIM:300896 marker/mechanism 300896.0 +SLC35A3 23443 ARTHROGRYPOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES OMIM:615553 marker/mechanism 615553.0 +SLC35C1 55343 Congenital disorder of glycosylation, type 2C MESH:C535755 marker/mechanism 266265.0 +SLC35D1 23169 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +SLC35D1 23169 Schneckenbecken dysplasia MESH:C536637 marker/mechanism 269250.0 +SLC35F1 222553 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +SLC35F3 148641 Diverticular Diseases MESH:D000076385 marker/mechanism 30177863 +SLC35G2 80723 Melanoma MESH:D008545 marker/mechanism 16778180 +SLC36A2 153201 HYPERGLYCINURIA OMIM:138500 marker/mechanism 138500.0 +SLC36A2 153201 Iminoglycinuria MESH:C536285 marker/mechanism 242600.0 +SLC37A4 2542 Glycogen Storage Disease IB MESH:C562594 marker/mechanism 232220.0 +SLC37A4 2542 Glycogen Storage Disease IC MESH:C562805 marker/mechanism 232240.0 +SLC37A4 2542 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +SLC38A2 54407 Parkinson Disease MESH:D010300 therapeutic 35728354 +SLC38A8 146167 Foveal Hypoplasia and Anterior Segment Dysgenesis MESH:C563774 marker/mechanism 609218.0 +SLC38A9 153129 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +SLC39A1 27173 Prostatic Neoplasms MESH:D011471 marker/mechanism 16700911|19208208 +SLC39A1 27173 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +SLC39A10 57181 Neoplasm Invasiveness MESH:D009361 marker/mechanism 17359283 +SLC39A12 221074 Melanoma MESH:D008545 marker/mechanism 22535842 +SLC39A13 91252 Bone Diseases MESH:D001847 marker/mechanism 22228435 +SLC39A13 91252 Connective Tissue Diseases MESH:D003240 marker/mechanism 18985159|22228435 +SLC39A13 91252 Ehlers-Danlos Syndrome MESH:D004535 marker/mechanism 18985159 +SLC39A13 91252 Kyphosis MESH:D007738 marker/mechanism 18985159 +SLC39A13 91252 Spondylocheirodysplasia, Ehlers-Danlos Syndrome-Like MESH:C567340 marker/mechanism 612350.0 +SLC39A13 91252 Tooth Abnormalities MESH:D014071 marker/mechanism 18985159|22228435 +SLC39A14 23516 Dystonia-Parkinsonism, Adult-Onset MESH:C567844 marker/mechanism 36152728 +SLC39A14 23516 HYPERMANGANESEMIA WITH DYSTONIA 2 OMIM:617013 marker/mechanism 617013.0 +SLC39A14 23516 Hypokinesia MESH:D018476 marker/mechanism 36152728 +SLC39A14 23516 Manganese Poisoning MESH:D020149 marker/mechanism 28860195 +SLC39A14 23516 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +SLC39A4 55630 Acrodermatitis MESH:D000169 marker/mechanism 16714095|16819703|16889938|17190629|17202136 +SLC39A4 55630 Acrodermatitis enteropathica MESH:C538178 marker/mechanism 201100.0 12068297|14709598|15358787|17483098 +SLC39A4 55630 Neoplasm Metastasis MESH:D009362 marker/mechanism 20957146 +SLC39A4 55630 Prenatal Injuries MESH:D049188 marker/mechanism 17483098 +SLC39A4 55630 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 17085522 +SLC39A5 283375 MYOPIA 24, AUTOSOMAL DOMINANT OMIM:615946 marker/mechanism 615946.0 +SLC39A6 25800 Breast Neoplasms MESH:D001943 marker/mechanism 12839489 +SLC39A6 25800 Esophageal Squamous Cell Carcinoma MESH:D000077277 therapeutic 23644492 +SLC39A6 25800 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC39A6 25800 Neoplasm Metastasis MESH:D009362 marker/mechanism 12839489 +SLC39A8 64116 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn OMIM:616721 marker/mechanism 616721.0 +SLC39A8 64116 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC39A8 64116 Manganese Poisoning MESH:D020149 marker/mechanism 29429640 +SLC3A1 6519 Cystinuria MESH:D003555 marker/mechanism 220100.0 +SLC3A1 6519 Hypotonia-Cystinuria Syndrome MESH:C564710 marker/mechanism 26247364 +SLC3A2 6520 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC3A2 6520 Lung Neoplasms MESH:D008175 marker/mechanism 26621329 +SLC40A1 30061 Anemia MESH:D000740 marker/mechanism 16434484 +SLC40A1 30061 Autistic Disorder MESH:D001321 marker/mechanism 15446388 +SLC40A1 30061 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21785164 +SLC40A1 30061 Endometriosis MESH:D004715 marker/mechanism 20864642 +SLC40A1 30061 Familial apoceruloplasmin deficiency MESH:C536004 marker/mechanism 20655381 +SLC40A1 30061 Hemochromatosis MESH:D006432 marker/mechanism 16457665|21411349 +SLC40A1 30061 Hemochromatosis, type 4 MESH:C537249 marker/mechanism 606069.0 +SLC40A1 30061 Hemolysis MESH:D006461 marker/mechanism 25247420 +SLC40A1 30061 Iron Overload MESH:D019190 marker/mechanism 17052926 +SLC40A1 30061 Liver Neoplasms MESH:D008113 marker/mechanism 21785164 +SLC43A2 124935 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC43A3 29015 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +SLC44A2 57153 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC45A2 51151 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 19578363 +SLC45A2 51151 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 19578363 +SLC45A2 51151 Melanoma MESH:D008545 marker/mechanism 18563784|21559390 +SLC45A2 51151 Oculocutaneous Albinism, Type IV MESH:C564696 marker/mechanism 606574.0 +SLC45A2 51151 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +SLC46A1 113235 Anemia MESH:D000740 marker/mechanism 21346251 +SLC46A1 113235 Folate Malabsorption, Hereditary MESH:C562799 marker/mechanism 229050.0 21346251 +SLC46A1 113235 Hyperhomocysteinemia MESH:D020138 marker/mechanism 19204075 +SLC46A1 113235 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC46A1 113235 Malabsorption Syndromes MESH:D008286 marker/mechanism 17129779|17446347 +SLC46A1 113235 Pancytopenia MESH:D010198 marker/mechanism 21346251 +SLC47A1 55244 Kidney Diseases MESH:D007674 marker/mechanism 24001450|35710981 +SLC4A1 6521 Acidosis, Renal Tubular MESH:D000141 marker/mechanism 179800.0 23460825|9312167 +SLC4A1 6521 Anemia, Hemolytic MESH:D000743 marker/mechanism 16227998 +SLC4A1 6521 Elliptocytosis 4 MESH:C566231 marker/mechanism 166900.0 +SLC4A1 6521 Elliptocytosis, Hereditary MESH:D004612 marker/mechanism 1737855 +SLC4A1 6521 Hematologic Diseases MESH:D006402 marker/mechanism 8343110 +SLC4A1 6521 Malaria MESH:D008288 marker/mechanism 611162.0 +SLC4A1 6521 Pseudohyperkalemia Cardiff MESH:C535827 marker/mechanism 185020.0 +SLC4A1 6521 Renal Tubular Acidosis, Distal, With Hemolytic Anemia MESH:C566910 marker/mechanism 611590.0 +SLC4A1 6521 Spherocytosis, Hereditary MESH:D013103 marker/mechanism 1378323 +SLC4A1 6521 Spherocytosis, Type 4 MESH:C567208 marker/mechanism 612653.0 +SLC4A10 57282 Cognition Disorders MESH:D003072 marker/mechanism 18413482 +SLC4A10 57282 Epilepsy MESH:D004827 therapeutic 18165320 +SLC4A10 57282 Epilepsy, Frontal Lobe MESH:D017034 marker/mechanism 18413482 +SLC4A10 57282 Intellectual Disability MESH:D008607 marker/mechanism 18413482 +SLC4A10 57282 Intracranial Hypertension MESH:D019586 therapeutic 18165320 +SLC4A11 83959 Corneal dystrophy and perceptive deafness MESH:C535473 marker/mechanism 217400.0 +SLC4A11 83959 Corneal Dystrophy, Fuchs Endothelial, 4 MESH:C567677 marker/mechanism 613268.0 +SLC4A11 83959 Corneal endothelial dystrophy type 2 MESH:C536439 marker/mechanism 217700.0 +SLC4A2 6522 Choledochal Cyst MESH:D015529 marker/mechanism 18988797 +SLC4A2 6522 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 18188457 +SLC4A2 6522 Polycystic Kidney, Autosomal Recessive MESH:D017044 marker/mechanism 18988797 +SLC4A2 6522 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +SLC4A3 6508 Heart Diseases MESH:D006331 marker/mechanism 16844662 +SLC4A4 8671 Acidosis, Renal Tubular MESH:D000141 marker/mechanism 18614622 +SLC4A4 8671 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SLC4A4 8671 Cataract MESH:D002386 marker/mechanism 18614622 +SLC4A4 8671 Corneal Opacity MESH:D003318 marker/mechanism 18614622 +SLC4A4 8671 Developmental Disabilities MESH:D002658 marker/mechanism 18614622 +SLC4A4 8671 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SLC4A4 8671 Glaucoma MESH:D005901 marker/mechanism 18614622 +SLC4A4 8671 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC4A4 8671 Renal Tubular Acidosis, Proximal, With Ocular Abnormalities And Mental Retardation MESH:C567038 marker/mechanism 604278.0 +SLC4A7 9497 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SLC4A7 9497 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SLC51A 200931 Cholestasis MESH:D002779 marker/mechanism 16423920|22461449 +SLC51A 200931 Cognition Disorders MESH:D003072 marker/mechanism 29382564 +SLC51A 200931 Diabetes Complications MESH:D048909 marker/mechanism 29382564 +SLC51A 200931 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 16423920 +SLC51B 123264 Cholestasis MESH:D002779 marker/mechanism 16423920|22461449 +SLC51B 123264 Cognition Disorders MESH:D003072 marker/mechanism 29382564 +SLC51B 123264 Diabetes Complications MESH:D048909 marker/mechanism 29382564 +SLC51B 123264 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 16423920 +SLC52A1 55065 Riboflavin Deficiency MESH:D012257 marker/mechanism 615026.0 +SLC52A2 79581 Brown-Vialetto-Van Laere syndrome MESH:C537111 marker/mechanism 614707.0 +SLC52A3 113278 Brown-Vialetto-Van Laere syndrome MESH:C537111 marker/mechanism 211530.0 +SLC52A3 113278 Bulbar Palsy, Progressive MESH:D010244 marker/mechanism 211500.0 +SLC52A3 113278 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 20729853 +SLC52A3 113278 Precancerous Conditions MESH:D011230 marker/mechanism 28220687 +SLC5A1 6523 Glucose-Galactose Malabsorption MESH:C562602 marker/mechanism 606824.0 +SLC5A2 6524 Glycosuria, Renal MESH:D006030 marker/mechanism 233100.0 14614622 +SLC5A3 6526 Bipolar Disorder MESH:D001714 marker/mechanism 16420717 +SLC5A3 6526 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25401301 +SLC5A3 6526 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +SLC5A5 6528 Breast Neoplasms MESH:D001943 therapeutic 12489024 +SLC5A5 6528 Carcinoma, Hepatocellular MESH:D006528 therapeutic 15347726|15520214 +SLC5A5 6528 Cholangiocarcinoma MESH:D018281 marker/mechanism 17408651 +SLC5A5 6528 Glioma MESH:D005910 therapeutic 12489024 +SLC5A5 6528 Kidney Neoplasms MESH:D007680 therapeutic 12489024 +SLC5A5 6528 Melanoma MESH:D008545 therapeutic 12489024 +SLC5A5 6528 Neoplasms MESH:D009369 therapeutic 15522214 +SLC5A5 6528 Ovarian Neoplasms MESH:D010051 therapeutic 12489024 +SLC5A5 6528 Prostatic Neoplasms MESH:D011471 therapeutic 12489024|14633711 +SLC5A5 6528 Thyroid Dyshormonogenesis 1 MESH:C564766 marker/mechanism 274400.0 +SLC5A5 6528 Thyroid Neoplasms MESH:D013964 marker/mechanism|therapeutic 16954431|17045167 +SLC5A7 60482 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 617143.0 +SLC5A7 60482 Neuropathy, Distal Hereditary Motor, Type VIIA MESH:C563562 marker/mechanism 158580.0 +SLC5A8 160728 Colonic Neoplasms MESH:D003110 marker/mechanism 15090606|16670197 +SLC5A8 160728 Hyperuricemia MESH:D033461 marker/mechanism 20589576 +SLC66A3 130814 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC66A3 130814 Liver Neoplasms MESH:D008113 marker/mechanism 25058030 +SLC6A1 6529 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 20132478 +SLC6A1 6529 Epilepsy MESH:D004827 marker/mechanism 29942082 +SLC6A1 6529 MYOCLONIC-ATONIC EPILEPSY OMIM:616421 marker/mechanism 616421.0 +SLC6A1 6529 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +SLC6A1 6529 Schizophrenia MESH:D012559 marker/mechanism 18923069 +SLC6A1 6529 Seizures MESH:D012640 marker/mechanism 11074187 +SLC6A1 6529 Substance Withdrawal Syndrome MESH:D013375 therapeutic 14598306 +SLC6A11 6538 Melanoma MESH:D008545 marker/mechanism 21499247 +SLC6A12 6539 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +SLC6A14 11254 Celiac Disease MESH:D002446 marker/mechanism 30097691 +SLC6A14 11254 CYSTIC FIBROSIS, MODIFIER OF, 1 OMIM:603855 marker/mechanism 22466613 +SLC6A14 11254 Intestinal Obstruction MESH:D007415 marker/mechanism 22466613 +SLC6A17 388662 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48 OMIM:616269 marker/mechanism 616269.0 +SLC6A18 348932 Hypertension MESH:D006973 marker/mechanism 15121838 +SLC6A19 340024 Hartnup Disease MESH:D006250 marker/mechanism 234500.0 +SLC6A2 6530 Hypertension MESH:D006973 marker/mechanism 22533655 +SLC6A2 6530 Orthostatic Intolerance MESH:D054971 marker/mechanism 604715.0 11458707 +SLC6A2 6530 Seizures MESH:D012640 marker/mechanism 15911120 +SLC6A20 54716 Iminoglycinuria MESH:C536285 marker/mechanism 21572414 +SLC6A20 54716 Mesothelioma MESH:D008654 marker/mechanism 17659810 +SLC6A20B 22599 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SLC6A3 6531 Alcoholism MESH:D000437 marker/mechanism 27219321 +SLC6A3 6531 Alcohol Withdrawal Delirium MESH:D000430 marker/mechanism 27219321 +SLC6A3 6531 Alcohol Withdrawal Seizures MESH:D020270 marker/mechanism 27219321 +SLC6A3 6531 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 12931138 +SLC6A3 6531 Anxiety Disorders MESH:D001008 marker/mechanism 19120712 +SLC6A3 6531 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 12699766|15059031|19120712|22034972 +SLC6A3 6531 Cocaine-Related Disorders MESH:D019970 marker/mechanism|therapeutic 11320258|11746736|16537431|19602552 +SLC6A3 6531 Dementia MESH:D003704 marker/mechanism 18579413 +SLC6A3 6531 Dyslexia MESH:D004410 marker/mechanism 35940320 +SLC6A3 6531 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 27219321 +SLC6A3 6531 Hyperkinesis MESH:D006948 marker/mechanism 18347339|18588534 +SLC6A3 6531 Memory Disorders MESH:D008569 marker/mechanism 17992686 +SLC6A3 6531 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 20875051 +SLC6A3 6531 Nerve Degeneration MESH:D009410 marker/mechanism 12871582|18206288 +SLC6A3 6531 Nervous System Diseases MESH:D009422 marker/mechanism 12890883 +SLC6A3 6531 Paranoid Disorders MESH:D010259 marker/mechanism 8825631 +SLC6A3 6531 Parkinson Disease MESH:D010300 marker/mechanism 16112329|16963468|19590691|9763484 +SLC6A3 6531 Parkinsonism-Dystonia, Infantile MESH:C567730 marker/mechanism 613135.0 27555326 +SLC6A3 6531 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 12931138 +SLC6A3 6531 Schizophrenia MESH:D012559 marker/mechanism 16762269 +SLC6A3 6531 Sleep Wake Disorders MESH:D012893 marker/mechanism 24403155 +SLC6A3 6531 Tic Disorders MESH:D013981 marker/mechanism 19120712 +SLC6A3 6531 TOBACCO ADDICTION, SUSCEPTIBILITY TO OMIM:188890 marker/mechanism 188890.0 +SLC6A4 6532 Alcoholism MESH:D000437 marker/mechanism 15520362|17000009 +SLC6A4 6532 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 19689456 +SLC6A4 6532 Anxiety Disorders MESH:D001008 marker/mechanism 607834.0 18686203 +SLC6A4 6532 Asperger Syndrome MESH:D020817 marker/mechanism 18197083 +SLC6A4 6532 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLC6A4 6532 Autistic Disorder MESH:D001321 marker/mechanism 16721604|17203304|17280648|20649385|9152989 +SLC6A4 6532 Bipolar Disorder MESH:D001714 marker/mechanism 11772685|16395126 +SLC6A4 6532 Cocaine-Related Disorders MESH:D019970 marker/mechanism 11320258 +SLC6A4 6532 Cognition Disorders MESH:D003072 marker/mechanism 23209555 +SLC6A4 6532 Depressive Disorder MESH:D003866 marker/mechanism 12898347|18458677|18686203|21843009 +SLC6A4 6532 Depressive Disorder, Major MESH:D003865 marker/mechanism 16055263 +SLC6A4 6532 Hypertension, Pulmonary MESH:D006976 marker/mechanism 18506000 +SLC6A4 6532 Memory Disorders MESH:D008569 marker/mechanism 18661256|18686203 +SLC6A4 6532 Mood Disorders MESH:D019964 marker/mechanism 19878141 +SLC6A4 6532 Obsessive-Compulsive Disorder MESH:D009771 marker/mechanism 164230.0 18197083 +SLC6A4 6532 Personality Disorders MESH:D010554 marker/mechanism 17000009 +SLC6A4 6532 Schizophrenia MESH:D012559 marker/mechanism 18583979 +SLC6A4 6532 Substance-Related Disorders MESH:D019966 marker/mechanism 19272758 +SLC6A4 6532 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 17000009 +SLC6A4 6532 Sudden Infant Death MESH:D013398 marker/mechanism 12599191 +SLC6A5 9152 Apnea MESH:D001049 marker/mechanism 25480793 +SLC6A5 9152 Brain Diseases MESH:D001927 marker/mechanism 25480793 +SLC6A5 9152 Hyperexplexia hereditary MESH:C538136 marker/mechanism 614618.0 25480793 +SLC6A6 6533 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +SLC6A8 6535 Autistic Disorder MESH:D001321 marker/mechanism 18461508 +SLC6A8 6535 Creatine deficiency, X-linked MESH:C535598 marker/mechanism 300352.0 11326334|12210795|17465020 +SLC6A8 6535 Developmental Disabilities MESH:D002658 marker/mechanism 11326334 +SLC6A8 6535 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 18350323 +SLC6A9 6536 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 17582620 +SLC6A9 6536 GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE OMIM:617301 marker/mechanism 617301.0 +SLC7A1 6541 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLC7A1 6541 Prostatic Neoplasms MESH:D011471 marker/mechanism 11401523 +SLC7A11 23657 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +SLC7A11 23657 Neoplasm Metastasis MESH:D009362 marker/mechanism 19015640 +SLC7A14 57709 RETINITIS PIGMENTOSA 68 OMIM:615725 marker/mechanism 615725.0 +SLC7A5 8140 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17374397 +SLC7A5 8140 Lung Neoplasms MESH:D008175 marker/mechanism 26621329 +SLC7A7 9056 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 11544277 +SLC7A7 9056 Lysinuric Protein Intolerance MESH:C562687 marker/mechanism 222700.0 +SLC7A8 23428 Endometriosis MESH:D004715 marker/mechanism 20864642 +SLC7A9 11136 Cystinuria MESH:D003555 marker/mechanism 220100.0 +SLC7A9 11136 Kidney Diseases MESH:D007674 marker/mechanism 21572414 +SLC8A1 6546 Megacolon MESH:D008531 marker/mechanism 15185227|17560225 +SLC8A1 6546 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +SLC8A1 6546 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 15215644 +SLC8A1 6546 Seizures MESH:D012640 marker/mechanism 20888801 +SLC8A1 6546 Status Epilepticus MESH:D013226 marker/mechanism 20888801 +SLC8A3 6547 Seizures MESH:D012640 marker/mechanism 20888801 +SLC8A3 6547 Status Epilepticus MESH:D013226 marker/mechanism 20888801 +SLC9A1 6548 Barrett Esophagus MESH:D001471 marker/mechanism 21127259 +SLC9A1 6548 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 19111554 +SLC9A1 6548 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 20003708 +SLC9A1 6548 Edema MESH:D004487 marker/mechanism 20553904 +SLC9A1 6548 Heart Failure MESH:D006333 marker/mechanism 19027022 +SLC9A1 6548 LICHTENSTEIN-KNORR SYNDROME OMIM:616291 marker/mechanism 616291.0 +SLC9A1 6548 Pain MESH:D010146 marker/mechanism 19248819 +SLC9A1 6548 Reperfusion Injury MESH:D015427 therapeutic 19027022 +SLC9A1 6548 Shock, Hemorrhagic MESH:D012771 marker/mechanism 17724433 +SLC9A1 6548 Ventricular Remodeling MESH:D020257 marker/mechanism 20886221 +SLC9A2 6549 Edema MESH:D004487 marker/mechanism 20553904 +SLC9A3 6550 CYSTIC FIBROSIS, MODIFIER OF, 1 OMIM:603855 marker/mechanism 22466613 +SLC9A3 6550 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 20003708 +SLC9A3 6550 Diarrhea MESH:D003967 marker/mechanism 26564064 +SLC9A3 6550 DIARRHEA 8, SECRETORY SODIUM, CONGENITAL OMIM:616868 marker/mechanism 616868.0 +SLC9A3 6550 Edema MESH:D004487 marker/mechanism 20553904 +SLC9A3 6550 Hypotension MESH:D007022 marker/mechanism 26564064 +SLC9A3 6550 Intestinal Obstruction MESH:D007415 marker/mechanism 22466613 +SLC9A4 389015 Acidosis MESH:D000138 marker/mechanism 20484819 +SLC9A6 10479 Mental Retardation, X-Linked, Syndromic, Christianson Type MESH:C567484 marker/mechanism 300243.0 +SLC9A8 23315 Dementia MESH:D003704 marker/mechanism 19234771 +SLC9A9 285195 Autistic Disorder MESH:D001321 marker/mechanism 613410.0 18621663 +SLC9B1 150159 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +SLCO1A1 28248 Cholestasis MESH:D002779 marker/mechanism 22461449 +SLCO1A1 28248 Liver Diseases MESH:D008107 marker/mechanism 22461449 +SLCO1A4 28250 Cholestasis MESH:D002779 marker/mechanism 22461449 +SLCO1A5 108096 Epilepsy MESH:D004827 marker/mechanism 19570321 +SLCO1B1 10599 Breast Neoplasms MESH:D001943 marker/mechanism 21457551 +SLCO1B1 10599 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 32259555 +SLCO1B1 10599 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 21387541 +SLCO1B1 10599 HYPERBILIRUBINEMIA, ROTOR TYPE OMIM:237450 marker/mechanism 237450.0 +SLCO1B1 10599 Muscular Diseases MESH:D009135 marker/mechanism 15681900|18650507|19238167|19833260|21243006 +SLCO1B2 28253 Hyperbilirubinemia MESH:D006932 marker/mechanism 18296417 +SLCO1B3 28234 Colonic Neoplasms MESH:D003110 marker/mechanism 22326869|25625007 +SLCO1B3 28234 Colorectal Neoplasms MESH:D015179 marker/mechanism 29491222 +SLCO1B3 28234 HYPERBILIRUBINEMIA, ROTOR TYPE OMIM:237450 marker/mechanism 237450.0 +SLCO1B3 28234 Lung Neoplasms MESH:D008175 marker/mechanism 22326869|25625007 +SLCO1C1 53919 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLCO2A1 6578 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SLCO2A1 6578 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +SLCO2A1 6578 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15805072 +SLCO2A1 6578 Osteoarthropathy, Primary Hypertrophic MESH:D010004 marker/mechanism 614441.0 +SLFN14 342618 BLEEDING DISORDER, PLATELET-TYPE, 20 OMIM:616913 marker/mechanism 616913.0 +SLFN2 20556 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SLIT2 9353 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19100240 +SLIT2 9353 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 20153733 +SLIT2 9353 Leukemia, Promyelocytic, Acute MESH:D015473 therapeutic 33120864 +SLIT2 9353 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941188 +SLIT3 6586 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +SLIT3 6586 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 17436238 +SLITRK1 114798 Tourette Syndrome MESH:D005879 marker/mechanism 137580.0 +SLITRK1 114798 Trichotillomania MESH:D014256 marker/mechanism 613229.0 +SLITRK5 26050 Obsessive-Compulsive Disorder MESH:D009771 marker/mechanism 20418887 +SLITRK6 84189 DEAFNESS AND MYOPIA OMIM:221200 marker/mechanism 221200.0 +SLK 9748 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +SLPI 6590 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 17984051 +SLPI 6590 Reperfusion Injury MESH:D015427 therapeutic 8215636 +SLU7 10569 Weight Gain MESH:D015430 marker/mechanism 19030233 +SLURP1 57152 Keratoderma, Palmoplantar MESH:D007645 marker/mechanism 248300.0 25168896 +SLX4 84464 Fanconi Anemia MESH:D005199 marker/mechanism 21240275|21240276|21240277 +SLX4 84464 FANCONI ANEMIA, COMPLEMENTATION GROUP P OMIM:613951 marker/mechanism 613951.0 +SMAD1 4086 Cocaine-Related Disorders MESH:D019970 marker/mechanism 30158054 +SMAD1 4086 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 30158054 +SMAD2 4087 Acromicric dysplasia MESH:C535662 marker/mechanism 18677313 +SMAD2 4087 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +SMAD2 4087 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15183723|9655392 +SMAD2 4087 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +SMAD2 4087 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16570350 +SMAD2 4087 Ventricular Remodeling MESH:D020257 marker/mechanism 16635409 +SMAD3 4088 Aortic Aneurysm MESH:D001014 marker/mechanism 21217753 +SMAD3 4088 Aortic Dissection MESH:D000784 marker/mechanism 21217753 +SMAD3 4088 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +SMAD3 4088 Cocaine-Related Disorders MESH:D019970 marker/mechanism 27422367 +SMAD3 4088 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +SMAD3 4088 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15183723|21217753 +SMAD3 4088 Crohn Disease MESH:D003424 marker/mechanism 21102463 +SMAD3 4088 Leiomyoma MESH:D007889 marker/mechanism 22228119 +SMAD3 4088 Liver Cirrhosis MESH:D008103 marker/mechanism 21605584 +SMAD3 4088 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +SMAD3 4088 Loeys-Dietz Syndrome MESH:D055947 marker/mechanism 613795.0 22772368 +SMAD3 4088 Osteoarthritis MESH:D010003 marker/mechanism 21217753|22772368 +SMAD3 4088 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +SMAD3 4088 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +SMAD3 4088 Uterine Neoplasms MESH:D014594 marker/mechanism 22228119 +SMAD3 4088 Ventricular Remodeling MESH:D020257 marker/mechanism 16635409 +SMAD4 4089 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 23525077|24952744 +SMAD4 4089 Brachydactyly MESH:D059327 marker/mechanism 22158539 +SMAD4 4089 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 20565773 +SMAD4 4089 Cholangiocarcinoma MESH:D018281 marker/mechanism 22561520 +SMAD4 4089 Cognition Disorders MESH:D003072 marker/mechanism 22158539 +SMAD4 4089 Colorectal Neoplasms MESH:D015179 marker/mechanism 16144935|20565773|25944804 +SMAD4 4089 Craniofacial Abnormalities MESH:D019465 marker/mechanism 22158539 +SMAD4 4089 Deafness MESH:D003638 marker/mechanism 22158539 +SMAD4 4089 Growth mental deficiency syndrome of Myhre MESH:C537620 marker/mechanism 139210.0 22158539 +SMAD4 4089 Juvenile polyposis syndrome MESH:C537702 marker/mechanism 174900.0 +SMAD4 4089 Juvenile Polyposis with Hereditary Hemorrhagic Telangiectasia MESH:C563412 marker/mechanism 175050.0 +SMAD4 4089 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16570350 +SMAD4 4089 Liver Diseases, Parasitic MESH:D008109 marker/mechanism 22561520 +SMAD4 4089 Muscular Diseases MESH:D009135 marker/mechanism 22158539 +SMAD4 4089 Pancreatic Neoplasms MESH:D010190 marker/mechanism 260350.0 +SMAD4 4089 Stomach Neoplasms MESH:D013274 marker/mechanism 21105199 +SMAD5 4090 Cocaine-Related Disorders MESH:D019970 marker/mechanism 30158054 +SMAD5 4090 Diabetes Mellitus, Type 2 MESH:D003924 therapeutic 20079400 +SMAD5 4090 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 30158054 +SMAD6 4091 AORTIC VALVE DISEASE 2 OMIM:614823 marker/mechanism 614823.0 +SMAD6 4091 Bicuspid Aortic Valve Disease MESH:D000082882 marker/mechanism 30455415 +SMAD6 4091 Craniosynostoses MESH:D003398 marker/mechanism 617439.0 +SMAD7 4092 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +SMAD7 4092 Colorectal Neoplasms MESH:D015179 marker/mechanism 612229.0 17934461 +SMAD7 4092 Paraquat lung MESH:C537171 therapeutic 23590892 +SMAD7 4092 Pulmonary Fibrosis MESH:D011658 therapeutic 23590892 +SMAD9 4093 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +SMAD9 4093 Familial Primary Pulmonary Hypertension MESH:D065627 marker/mechanism 615342.0 +SMARCA1 6594 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +SMARCA2 6595 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +SMARCA2 6595 Coffin-Siris syndrome MESH:C536436 marker/mechanism 22426308 +SMARCA2 6595 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +SMARCA2 6595 Nicolaides Baraitser syndrome MESH:C536116 marker/mechanism 601358.0 22366787 +SMARCA4 6597 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 28973294 +SMARCA4 6597 Burkitt Lymphoma MESH:D002051 marker/mechanism 23143597 +SMARCA4 6597 Carcinoma, Small Cell MESH:D018288 marker/mechanism 24658001|24658002|24658004|26343384 +SMARCA4 6597 Cocaine-Related Disorders MESH:D019970 marker/mechanism 27422367 +SMARCA4 6597 Coffin-Siris syndrome MESH:C536436 marker/mechanism 614609.0 22426308 +SMARCA4 6597 Ovarian Neoplasms MESH:D010051 marker/mechanism 24658001|24658002|24658004|26343384 +SMARCA4 6597 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 28671688 +SMARCA4 6597 Rhabdoid Tumor Predisposition Syndrome 2 MESH:C567643 marker/mechanism 613325.0 +SMARCA4 6597 Sarcoma MESH:D012509 marker/mechanism 26343384 +SMARCA4 6597 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +SMARCA4 6597 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 26343384 +SMARCA4 6597 Thoracic Neoplasms MESH:D013899 marker/mechanism 26343384 +SMARCAD1 56916 Basan syndrome MESH:C537659 marker/mechanism 129200.0 +SMARCAD1 56916 Fingerprints, Absence of MESH:C565010 marker/mechanism 136000.0 +SMARCAD1 56916 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +SMARCAD1 56916 Sclerotylosis MESH:C537526 marker/mechanism 181600.0 +SMARCAL1 50485 Schimke immunoosseous dysplasia MESH:C536629 marker/mechanism 242900.0 16237566 +SMARCB1 6598 Coffin-Siris syndrome MESH:C536436 marker/mechanism 614608.0 22426308 +SMARCB1 6598 Rhabdoid Tumor MESH:D018335 marker/mechanism 25009291|26343384 +SMARCB1 6598 Rhabdoid Tumor Predisposition Syndrome 1 MESH:C563738 marker/mechanism 609322.0 +SMARCB1 6598 Schwannomatosis MESH:C536641 marker/mechanism 162091.0 24362817 +SMARCC1 6599 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +SMARCC1 6599 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SMARCC1 6599 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SMARCC1 6599 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SMARCC1 6599 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +SMARCD2 6603 Leukemia, Myeloid MESH:D007951 marker/mechanism 28369036 +SMARCD2 6603 Neutropenia MESH:D009503 marker/mechanism 28369036 +SMARCD2 6603 Specific Granule Deficiency MESH:C562873 marker/mechanism 28369034|28369036 +SMARCE1 6605 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +SMARCE1 6605 Coffin-Siris syndrome MESH:C536436 marker/mechanism 616938.0 22426308 +SMARCE1 6605 Meningioma MESH:D008579 marker/mechanism 35681054 +SMARCE1 6605 Meningioma, familial MESH:C537443 marker/mechanism 607174.0 23377182 +SMC1A 8243 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +SMC1A 8243 De Lange Syndrome MESH:D003635 marker/mechanism 300590.0 +SMC1A 8243 Epilepsy MESH:D004827 marker/mechanism 29942082 +SMC1A 8243 Leukemia, Myeloid MESH:D007951 marker/mechanism 23955599 +SMC1A 8243 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +SMC1A 8243 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121791 +SMC1B 27127 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121791 +SMC2 10592 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SMC2 10592 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +SMC3 9126 De Lange Syndrome MESH:D003635 marker/mechanism 610759.0 +SMC3 9126 Leukemia, Myeloid MESH:D007951 marker/mechanism 23955599 +SMC3 9126 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +SMC5 23137 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SMCHD1 23347 Arhinia, choanal atresia, and microphthalmia MESH:C537429 marker/mechanism 603457.0 28067909|28067911 +SMCHD1 23347 Facioscapulohumeral Muscular Dystrophy 1B MESH:C563557 marker/mechanism 158901.0 23143600|28067909|28067911 +SMD-1 173269 Infertility MESH:D007246 marker/mechanism 25204677 +SMF-3 177044 Nerve Degeneration MESH:D009410 marker/mechanism 23106139 +SMG9 56006 HEART AND BRAIN MALFORMATION SYNDROME OMIM:616920 marker/mechanism 616920.0 +SMIM43 132332 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +SMN1 6606 Infant Death MESH:D066088 marker/mechanism 27111068 +SMN1 6606 Muscular Atrophy, Spinal MESH:D009134 marker/mechanism 15862279|19150990|21350916|21819082|27111068 +SMN1 6606 Spinal Muscular Atrophies of Childhood MESH:D014897 marker/mechanism 253300|253400|253550 17924536 +SMN1 6606 Spinal muscular atrophy 4 MESH:C538417 marker/mechanism 271150 +SMN2 6607 Muscular Atrophy, Spinal MESH:D009134 therapeutic 21350916 +SMN2 6607 Spinal Muscular Atrophies of Childhood MESH:D014897 marker/mechanism 253400 +SMO 6608 Ameloblastoma MESH:D000564 marker/mechanism 24859340 +SMO 6608 Brain Neoplasms MESH:D001932 marker/mechanism 9581815 +SMO 6608 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 605462 26950094|9581815 +SMO 6608 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +SMO 6608 Hypothalamic hamartomas MESH:C537158 marker/mechanism 241800 +SMO 6608 Infertility, Female MESH:D007247 marker/mechanism 28560483 +SMO 6608 Jaw Abnormalities MESH:D007569 marker/mechanism 16580747 +SMO 6608 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 23867347 +SMO 6608 Maxillary Neoplasms MESH:D008441 marker/mechanism 24859340 +SMO 6608 Meningioma MESH:D008579 marker/mechanism 23334667 +SMO 6608 Neuroectodermal Tumors, Primitive MESH:D018242 marker/mechanism 9581815 +SMO 6608 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +SMO 6608 Skin Neoplasms MESH:D012878 marker/mechanism 9581815 +SMO 6608 Winter Shortland Temple syndrome MESH:C536735 marker/mechanism 601707 +SMOC1 64093 Anophthalmos with limb anomalies MESH:C537769 marker/mechanism 206920 +SMOC1 64093 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SMOC2 64094 Dentin dysplasia, type 1 MESH:C538215 marker/mechanism 125400 +SMOC2 64094 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SMOX 54498 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 30576531 +SMOX 54498 Stroke MESH:D020521 marker/mechanism 16269634 +SMPD1 6609 Kidney Diseases MESH:D007674 therapeutic 26980705 +SMPD1 6609 Neoplasm Invasiveness MESH:D009361 marker/mechanism 24951586 +SMPD1 6609 Niemann-Pick Diseases MESH:D009542 marker/mechanism 12631268 +SMPD1 6609 Niemann-Pick Disease, Type A MESH:D052536 marker/mechanism 257200.0 +SMPD1 6609 Niemann-Pick Disease, Type B MESH:D052537 marker/mechanism 607616.0 +SMPD3 55512 Leukemia MESH:D007938 marker/mechanism 18283525 +SMPD3 55512 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 18283525 +SMPDL3A 10924 Endometriosis MESH:D004715 marker/mechanism 20864642 +SMPX 23676 Deafness, X-Linked 4 MESH:C564723 marker/mechanism 300066.0 +SMS 6611 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +SMS 6611 Snyder Robinson syndrome MESH:C536678 marker/mechanism 309583.0 +SMURF1 57154 Cocaine-Related Disorders MESH:D019970 marker/mechanism 30158054 +SMURF1 57154 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 30158054 +SMYD2 56950 Esophageal Neoplasms MESH:D004938 marker/mechanism 25825497 +SMYD3 64754 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +SMYD4 114826 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +SNAI1 6615 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +SNAI1 6615 Breast Neoplasms MESH:D001943 marker/mechanism 11850205|24014025 +SNAI1 6615 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 35841383 +SNAI1 6615 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24014025 +SNAI1 6615 Cholestasis MESH:D002779 marker/mechanism 21224055 +SNAI1 6615 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22580338|24014025 +SNAI1 6615 Neoplasm Metastasis MESH:D009362 marker/mechanism 22580338|23219715 +SNAI1 6615 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +SNAI1 6615 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +SNAI1 6615 Ureteral Obstruction MESH:D014517 marker/mechanism 28318631 +SNAI2 6591 Breast Neoplasms MESH:D001943 marker/mechanism 11850205 +SNAI2 6591 Calcinosis MESH:D002114 marker/mechanism 29358327 +SNAI2 6591 Esophageal Neoplasms MESH:D004938 marker/mechanism 17068819 +SNAI2 6591 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22580338 +SNAI2 6591 Neoplasm Metastasis MESH:D009362 marker/mechanism 22580338 +SNAI2 6591 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +SNAI3 333929 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +SNAP23 8773 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SNAP23 8773 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +SNAP25 6616 Bipolar Disorder MESH:D001714 marker/mechanism 14708030 +SNAP25 6616 Depressive Disorder MESH:D003866 marker/mechanism 14708030 +SNAP25 6616 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 16123366 +SNAP25 6616 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16123366 +SNAP25 6616 Epilepsy MESH:D004827 marker/mechanism 29942082 +SNAP25 6616 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 616330.0 +SNAP25 6616 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 29942082 +SNAP25 6616 Neuromuscular Manifestations MESH:D020879 marker/mechanism 17023870 +SNAP25 6616 Psychotic Disorders MESH:D011618 marker/mechanism 14708030 +SNAP25 6616 Tics MESH:D020323 marker/mechanism 17023870 +SNAP29 9342 Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome MESH:C537943 marker/mechanism 609528.0 +SNAP29 9342 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SNAP47 116841 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 34664776 +SNAR-I 100170222 Alzheimer Disease MESH:D000544 marker/mechanism 30320580 +SNCA 6622 Alcoholism MESH:D000437 marker/mechanism 18055133 +SNCA 6622 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 15542733|32278788 +SNCA 6622 Ataxia MESH:D001259 therapeutic 31783120 +SNCA 6622 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18055133 +SNCA 6622 Disease Models, Animal MESH:D004195 marker/mechanism 21892157|26075822 +SNCA 6622 Gaucher Disease MESH:D005776 marker/mechanism 19576930 +SNCA 6622 Heart Failure MESH:D006333 marker/mechanism 36071497 +SNCA 6622 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 23519153 +SNCA 6622 Lameness, Animal MESH:D007794 marker/mechanism 23219665 +SNCA 6622 Lewy Body Disease MESH:D020961 marker/mechanism 127750.0 16141792|19628769 +SNCA 6622 Manganese Poisoning MESH:D020149 marker/mechanism 23934647 +SNCA 6622 Nerve Degeneration MESH:D009410 marker/mechanism|therapeutic 21039522|23106139|27585560|34562559 +SNCA 6622 Neurobehavioral Manifestations MESH:D019954 marker/mechanism 32278788 +SNCA 6622 Neurodegenerative Diseases MESH:D019636 marker/mechanism 17296847|18514411|26075822 +SNCA 6622 Parkinson Disease MESH:D010300 marker/mechanism 11535288|12151787|12732244|12885775|14535945|15099020|17131421|17690948|18322262|18353766|18841091|19915575|19915576|20664293|20711177|21245015|21892157|22043175|22110584|22166454|22185909|22355530|24509835|24833599|25064009|25106480|25149416|25475535|25631236 +SNCA 6622 PARKINSON DISEASE 1, AUTOSOMAL DOMINANT OMIM:168601 marker/mechanism 168601.0 +SNCA 6622 Parkinson Disease 4, Autosomal Dominant Lewy Body MESH:C565324 marker/mechanism 605543.0 +SNCA 6622 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 34332006 +SNCA 6622 Parkinsonian Disorders MESH:D020734 marker/mechanism 20464527|22319455|23046578|23295396|26075822|26558463|26687234|27026137|27324791 +SNCA 6622 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 15542733 +SNCA 6622 Synucleinopathies MESH:D000080874 marker/mechanism 34332006 +SNCA 6622 Weight Loss MESH:D015431 marker/mechanism 32278788 +SNCAIP 9627 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +SNCB 6620 Lewy Body Disease MESH:D020961 marker/mechanism 127750.0 +SNCG 6623 Breast Neoplasms MESH:D001943 marker/mechanism 20595634 +SNCG 6623 Carcinoma MESH:D002277 marker/mechanism 16316942 +SNCG 6623 Hyperkinesis MESH:D006948 marker/mechanism 18588534 +SNCG 6623 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +SNCG 6623 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +SND1 27044 Autistic Disorder MESH:D001321 marker/mechanism 20442744 +SND1 27044 Lung Neoplasms MESH:D008175 marker/mechanism 25940438 +SNF4AGAMMA 42515 Neurodegenerative Diseases MESH:D019636 marker/mechanism 22266106 +SNHG11 128439 Liver Neoplasms MESH:D008113 marker/mechanism 17114358 +SNHG12 85028 Neurotoxicity Syndromes MESH:D020258 therapeutic 35410500 +SNHG14 104472715 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 34529319 +SNHG6 641638 Pulmonary Fibrosis MESH:D011658 marker/mechanism 35785413 +SNORA16B 692157 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +SNORD115-1 338433 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270.0 +SNORD116-1 100033413 Prader-Willi Syndrome MESH:D011218 marker/mechanism 176270.0 +SNORD118 727676 Leukoencephalopathy Brain Calcifications and Cysts MESH:C000598644 marker/mechanism 614561.0 +SNORD22 9304 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SNORD22 9304 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SNORD3A 780851 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +SNORD50A 26799 Carcinogenesis MESH:D063646 marker/mechanism 26595770 +SNORD50A 26799 Neoplasms MESH:D009369 marker/mechanism 26595770 +SNORD50B 692088 Carcinogenesis MESH:D063646 marker/mechanism 26595770 +SNORD50B 692088 Neoplasms MESH:D009369 marker/mechanism 26595770 +SNRNP200 23020 Retinitis Pigmentosa 33 MESH:C563676 marker/mechanism 610359.0 +SNRNP27 11017 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +SNRPB 6628 Cerebrocostomandibular Syndrome MESH:C562538 marker/mechanism 117650.0 +SNRPB 6628 Disease Progression MESH:D018450 marker/mechanism 21364753 +SNRPB 6628 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +SNRPD3 6634 Carcinoma MESH:D002277 marker/mechanism 16316942 +SNRPD3 6634 HIV Infections MESH:D015658 marker/mechanism 15308739 +SNRPD3 6634 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +SNRPD3 6634 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +SNRPE 6635 Hypotrichosis MESH:D007039 marker/mechanism 615059.0 +SNRPG 6637 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SNRPG 6637 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SNRPN 6638 Angelman Syndrome MESH:D017204 marker/mechanism 105830.0 +SNRPN 6638 Autistic Disorder MESH:D001321 marker/mechanism 209850.0 +SNTA1 6640 Long Qt Syndrome 12 MESH:C567842 marker/mechanism 612955.0 +SNTA1 6640 Status Epilepticus MESH:D013226 marker/mechanism 20886625 +SNTG2 54221 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20808228 +SNTG2 54221 Autistic Disorder MESH:D001321 marker/mechanism 17292328 +SNX10 29887 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +SNX10 29887 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8 OMIM:615085 marker/mechanism 615085.0 +SNX14 57231 Cerebellar Ataxia MESH:D002524 marker/mechanism 25848753 +SNX14 57231 Intellectual Disability MESH:D008607 marker/mechanism 25848753 +SNX14 57231 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 616354.0 +SNX18 112574 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 17984051 +SNX27 81609 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 36029209 +SNX27 81609 Disease Progression MESH:D018450 marker/mechanism 36029209 +SNX27 81609 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 36029209 +SNX32 254122 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +SNX5 27131 Disease Progression MESH:D018450 marker/mechanism 21364753 +SNX5 27131 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +SNX7 51375 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SOAT1 6646 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SOAT2 8435 Celiac Disease MESH:D002446 marker/mechanism 30097691 +SOBP 55084 IMPAIRED INTELLECTUAL DEVELOPMENT, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS OMIM:613671 marker/mechanism 613671.0 +SOCS1 8651 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +SOCS1 8651 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15197228 +SOCS1 8651 Liver Diseases MESH:D008107 marker/mechanism 15197228 +SOCS1 8651 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 15197228 +SOCS1 8651 Reperfusion Injury MESH:D015427 therapeutic 25780291 +SOCS1A 445073 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +SOCS2 8835 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SOCS2 8835 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 35305058 +SOCS2 8835 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +SOCS2 8835 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SOCS2 8835 Narcolepsy MESH:D009290 marker/mechanism 17521418 +SOCS3 9021 Atherosclerosis MESH:D050197 marker/mechanism 19330073 +SOCS3 9021 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16831601 +SOCS3 9021 Endometrial Neoplasms MESH:D016889 marker/mechanism 16804899 +SOCS3 9021 Liver Diseases MESH:D008107 marker/mechanism 19784758 +SOCS3 9021 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +SOCS3A 335409 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +SOCS4 122809 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +SOCS7 30837 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 30365097 +SOD1 6647 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +SOD1 6647 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 10025816|10930589|11220737|11590119|11723166|12586733|12626432|12684256|16495328|17097207|17319283|17496168|18233996|19635794|19929749|20132483|20177826|20348957|20515040|21867702|22537108|23027932|23280792|23583883|24885036|25164820|26630559|28038988|28478440|29374221|29419416|29434186|29649360|30503815|33269387|7887412|9065559 +SOD1 6647 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 105400.0 10764647|11181815|11346368|11675877|11796754|11951178|12127151|15096637|15264227|15522870|16105836|19227972|20485746|21140194|23612299|24163136|24256636|26694608|8967745 +SOD1 6647 Anemia, Iron-Deficiency MESH:D018798 marker/mechanism 17057260 +SOD1 6647 Aortic Diseases MESH:D001018 marker/mechanism 25101153 +SOD1 6647 Asphyxia Neonatorum MESH:D001238 marker/mechanism 17963755 +SOD1 6647 Asthma MESH:D001249 marker/mechanism 22867017 +SOD1 6647 Atherosclerosis MESH:D050197 marker/mechanism 20720404 +SOD1 6647 Brain Ischemia MESH:D002545 therapeutic 11756504 +SOD1 6647 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 33010264 +SOD1 6647 Cell Transformation, Neoplastic MESH:D002471 therapeutic 21742780|2982513 +SOD1 6647 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750|27349771 +SOD1 6647 Deficiency Diseases MESH:D003677 marker/mechanism 12514262 +SOD1 6647 Depressive Disorder MESH:D003866 marker/mechanism 19605942 +SOD1 6647 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +SOD1 6647 Diabetes Mellitus MESH:D003920 marker/mechanism 23786522 +SOD1 6647 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 23090186 +SOD1 6647 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 15531508 +SOD1 6647 Diabetic Retinopathy MESH:D003930 therapeutic 19074809 +SOD1 6647 Disease Models, Animal MESH:D004195 marker/mechanism 12586733|12684256|19227972|20177826|21867702|23583883|24885036|28038988|28123103|29374221|29434186 +SOD1 6647 Disease Progression MESH:D018450 marker/mechanism 29434186 +SOD1 6647 Down Syndrome MESH:D004314 marker/mechanism 11181815 +SOD1 6647 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +SOD1 6647 Fatigue MESH:D005221 marker/mechanism 28123103 +SOD1 6647 Fatty Liver MESH:D005234 marker/mechanism 27349771 +SOD1 6647 Fatty Liver, Alcoholic MESH:D005235 marker/mechanism 19951287 +SOD1 6647 Fetal Growth Retardation MESH:D005317 marker/mechanism 21893188 +SOD1 6647 Gait Disorders, Neurologic MESH:D020233 marker/mechanism 21867702 +SOD1 6647 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 35764155 +SOD1 6647 Glioma MESH:D005910 therapeutic 11861405 +SOD1 6647 Gliosis MESH:D005911 marker/mechanism 24918341|29434186 +SOD1 6647 Hearing Loss MESH:D034381 therapeutic 11474137 +SOD1 6647 Heart Failure MESH:D006333 marker/mechanism 20304815 +SOD1 6647 Hemolysis MESH:D006461 marker/mechanism 25247420 +SOD1 6647 Hepatitis, Chronic MESH:D006521 marker/mechanism 25053573 +SOD1 6647 Hypertension MESH:D006973 marker/mechanism|therapeutic 25101153|32165127|9024144 +SOD1 6647 Hyperthyroidism MESH:D006980 marker/mechanism 19914224 +SOD1 6647 Hypotension MESH:D007022 marker/mechanism 9024144 +SOD1 6647 Hypothermia MESH:D007035 marker/mechanism 11731100 +SOD1 6647 Inflammation MESH:D007249 marker/mechanism 22867017 +SOD1 6647 Ischemia MESH:D007511 therapeutic 10698074 +SOD1 6647 Ischemic Attack, Transient MESH:D002546 therapeutic 12629175|15829915|16538228|16868554 +SOD1 6647 Kidney Calculi MESH:D007669 marker/mechanism 24360074 +SOD1 6647 Liver Diseases MESH:D008107 marker/mechanism 17877538 +SOD1 6647 Marfan Syndrome MESH:D008382 marker/mechanism 25101153 +SOD1 6647 MELAS Syndrome MESH:D017241 marker/mechanism 11907800 +SOD1 6647 Meningomyelocele MESH:D008591 marker/mechanism 22972774 +SOD1 6647 Motor Neuron Disease MESH:D016472 marker/mechanism 16702190 +SOD1 6647 Motor Skills Disorders MESH:D019957 marker/mechanism 29434186 +SOD1 6647 Muscle Weakness MESH:D018908 marker/mechanism 29434186|33269387 +SOD1 6647 Muscular Atrophy MESH:D009133 marker/mechanism 24163136|29374221 +SOD1 6647 Myocardial Infarction MESH:D009203 therapeutic 21600015 +SOD1 6647 Necrosis MESH:D009336 therapeutic 9548797 +SOD1 6647 Nephrosis MESH:D009401 therapeutic 2273594 +SOD1 6647 Nerve Degeneration MESH:D009410 marker/mechanism 17581637|19243126|24885036|24918341 +SOD1 6647 Nervous System Diseases MESH:D009422 marker/mechanism 11158245 +SOD1 6647 Obesity MESH:D009765 marker/mechanism 24042701 +SOD1 6647 Ophthalmoplegia, Chronic Progressive External MESH:D017246 marker/mechanism 11907800 +SOD1 6647 Ovarian Neoplasms MESH:D010051 marker/mechanism 16179351 +SOD1 6647 Paralysis MESH:D010243 marker/mechanism 29434186 +SOD1 6647 Parkinson Disease MESH:D010300 marker/mechanism|therapeutic 15824117|16353238|21318773 +SOD1 6647 Protein Aggregation, Pathological MESH:D066263 marker/mechanism 29649360 +SOD1 6647 Protein Deficiency MESH:D011488 therapeutic 16214328 +SOD1 6647 Proteinuria MESH:D011507 therapeutic 2273594 +SOD1 6647 Pulmonary Fibrosis MESH:D011658 marker/mechanism 26699812 +SOD1 6647 Radiation Injuries, Experimental MESH:D011833 therapeutic 22247605 +SOD1 6647 Reperfusion Injury MESH:D015427 marker/mechanism|therapeutic 15364863|16397181|23061969|23743330 +SOD1 6647 Retinal Degeneration MESH:D012162 marker/mechanism|therapeutic 16741961|19074809 +SOD1 6647 Schistosomiasis mansoni MESH:D012555 marker/mechanism 16564582 +SOD1 6647 Scrapie MESH:D012608 marker/mechanism 11701772 +SOD1 6647 Spinal Cord Injuries MESH:D013119 therapeutic 17457363 +SOD1 6647 Stroke MESH:D020521 marker/mechanism 10698074 +SOD1 6647 Turner Syndrome MESH:D014424 marker/mechanism 25101153 +SOD1 6647 Ureteral Calculi MESH:D014514 marker/mechanism 24360074 +SOD1 6647 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 35764155 +SOD1 6647 Weight Loss MESH:D015431 marker/mechanism 24163136|29434186 +SOD2 6648 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +SOD2 6648 Adenocarcinoma MESH:D000230 marker/mechanism 12907644 +SOD2 6648 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +SOD2 6648 Adenomatous Polyposis Coli MESH:D011125 marker/mechanism 12907644 +SOD2 6648 Adrenoleukodystrophy MESH:D000326 marker/mechanism 16319717 +SOD2 6648 Albuminuria MESH:D000419 marker/mechanism 17942768 +SOD2 6648 Alveolitis, Extrinsic Allergic MESH:D000542 marker/mechanism 10673208 +SOD2 6648 Alzheimer Disease MESH:D000544 marker/mechanism 19374891 +SOD2 6648 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 8866423 +SOD2 6648 Anemia MESH:D000740 marker/mechanism 20800516 +SOD2 6648 Anemia, Sideroblastic MESH:D000756 marker/mechanism 16910769|21326867 +SOD2 6648 Aortic Aneurysm, Abdominal MESH:D017544 marker/mechanism 17196988 +SOD2 6648 Aortic Diseases MESH:D001018 marker/mechanism 25101153 +SOD2 6648 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +SOD2 6648 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524|15292528|24313545 +SOD2 6648 Asphyxia Neonatorum MESH:D001238 marker/mechanism 17963755 +SOD2 6648 Atherosclerosis MESH:D050197 marker/mechanism|therapeutic 12677255|20720404 +SOD2 6648 Autoimmune Diseases MESH:D001327 marker/mechanism 21850155 +SOD2 6648 Brain Injuries MESH:D001930 therapeutic 24462953 +SOD2 6648 Brain Ischemia MESH:D002545 marker/mechanism 15060315|17901229|19429140 +SOD2 6648 Brain Neoplasms MESH:D001932 marker/mechanism 21749277 +SOD2 6648 Breast Neoplasms MESH:D001943 marker/mechanism 17965603|19385967|19756960|20562527 +SOD2 6648 Carcinoma MESH:D002277 marker/mechanism 10853026|11053990 +SOD2 6648 Carcinoma, Ductal, Breast MESH:D018270 marker/mechanism 23964924 +SOD2 6648 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16767786|18760346|19731237|21472284|33010264 +SOD2 6648 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 11731445|17094902 +SOD2 6648 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +SOD2 6648 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism|therapeutic 12543247|15274141 +SOD2 6648 Cardiomegaly MESH:D006332 marker/mechanism 19293248 +SOD2 6648 Cardiomyopathies MESH:D009202 therapeutic 23536361 +SOD2 6648 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 16155095|21195081 +SOD2 6648 Cataract and cardiomyopathy MESH:C538280 marker/mechanism 23266196 +SOD2 6648 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism|therapeutic 20516118|21742780|23964924|25448439|9067545 +SOD2 6648 Central Nervous System Diseases MESH:D002493 marker/mechanism 10942521 +SOD2 6648 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +SOD2 6648 Colonic Neoplasms MESH:D003110 marker/mechanism 25279216 +SOD2 6648 Colorectal Neoplasms MESH:D015179 marker/mechanism 10853026|12907644 +SOD2 6648 Depressive Disorder, Major MESH:D003865 marker/mechanism 20471444 +SOD2 6648 Diabetes, Gestational MESH:D016640 marker/mechanism 23956348|30738174|34175429 +SOD2 6648 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism|therapeutic 15855331|23090186 +SOD2 6648 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 15531508 +SOD2 6648 Diabetic Nephropathies MESH:D003928 marker/mechanism 24819633 +SOD2 6648 Disease Progression MESH:D018450 marker/mechanism|therapeutic 10673208|11283936|16081686|18930813|20618948|21749277|22547077 +SOD2 6648 Endotoxemia MESH:D019446 marker/mechanism 16741687 +SOD2 6648 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +SOD2 6648 Esophageal Neoplasms MESH:D004938 marker/mechanism 11053990|15986332 +SOD2 6648 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 18167182|21517111 +SOD2 6648 Esophageal Stenosis MESH:D004940 therapeutic 11121210 +SOD2 6648 Esophagitis MESH:D004941 therapeutic 11121210 +SOD2 6648 Farber Lipogranulomatosis MESH:D055577 marker/mechanism 10428046 +SOD2 6648 Fatty Liver MESH:D005234 marker/mechanism 10860543 +SOD2 6648 Fever MESH:D005334 therapeutic 11165872 +SOD2 6648 Fibrosis MESH:D005355 marker/mechanism 19293248 +SOD2 6648 Granuloma, Respiratory Tract MESH:D015769 marker/mechanism 10673208 +SOD2 6648 Heart Failure MESH:D006333 marker/mechanism 16105639|16155095|20304815|21195081|21284947 +SOD2 6648 Hypertension MESH:D006973 marker/mechanism 11834524|21593737|25101153 +SOD2 6648 Hypertension, Pulmonary MESH:D006976 marker/mechanism 20110409 +SOD2 6648 Hyperthyroidism MESH:D006980 marker/mechanism 19914224 +SOD2 6648 Hypoglycemia MESH:D007003 marker/mechanism 20620209 +SOD2 6648 Hypoxia MESH:D000860 marker/mechanism 18258771|19579223 +SOD2 6648 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 21940958 +SOD2 6648 Infertility, Male MESH:D007248 marker/mechanism 22206979 +SOD2 6648 Insulin Resistance MESH:D007333 therapeutic 22829583 +SOD2 6648 Ischemia MESH:D007511 therapeutic 11328670|18227068 +SOD2 6648 Ischemic Attack, Transient MESH:D002546 marker/mechanism 11333366 +SOD2 6648 Kidney Diseases MESH:D007674 marker/mechanism 19917352|21571061 +SOD2 6648 Kidney Neoplasms MESH:D007680 marker/mechanism 25279216 +SOD2 6648 Kidney Tubular Necrosis, Acute MESH:D007683 therapeutic 19917352 +SOD2 6648 Lewy Body Disease MESH:D020961 marker/mechanism 16141792 +SOD2 6648 Liver Cirrhosis MESH:D008103 marker/mechanism 32659284 +SOD2 6648 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 19731237 +SOD2 6648 Lung Diseases MESH:D008171 marker/mechanism 8063194 +SOD2 6648 Lung Diseases, Interstitial MESH:D017563 marker/mechanism 10673208 +SOD2 6648 Lymphatic Metastasis MESH:D008207 marker/mechanism 10853026|19381893|20618948 +SOD2 6648 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 16081686 +SOD2 6648 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 23964924 +SOD2 6648 Marfan Syndrome MESH:D008382 marker/mechanism 25101153 +SOD2 6648 MELAS Syndrome MESH:D017241 marker/mechanism 11907800 +SOD2 6648 Meningomyelocele MESH:D008591 marker/mechanism 22972774 +SOD2 6648 Mesothelioma MESH:D008654 marker/mechanism 11283936|15039138|17290392|9533946 +SOD2 6648 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 20617513 +SOD2 6648 Methylmalonic acidemia MESH:C537358 marker/mechanism 16823967 +SOD2 6648 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6 OMIM:612634 marker/mechanism 612634.0 +SOD2 6648 Mitochondrial Diseases MESH:D028361 marker/mechanism 9917329 +SOD2 6648 Mouth Neoplasms MESH:D009062 marker/mechanism|therapeutic 12543247|15274141 +SOD2 6648 Multiple Chemical Sensitivity MESH:D018777 marker/mechanism 23967348 +SOD2 6648 Multiple Myeloma MESH:D009101 marker/mechanism 15908783 +SOD2 6648 Myocardial Infarction MESH:D009203 therapeutic 12160945 +SOD2 6648 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +SOD2 6648 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 20461718 +SOD2 6648 Necrosis MESH:D009336 marker/mechanism|therapeutic 19293248|9548797 +SOD2 6648 Neoplasm Invasiveness MESH:D009361 marker/mechanism 10853026|11053990|15048980|15654357|21749277|22580338 +SOD2 6648 Neoplasm Metastasis MESH:D009362 marker/mechanism 12538496|18930813|19487542|22580338 +SOD2 6648 Neoplasms MESH:D009369 marker/mechanism|therapeutic 11165872|11278550|11853549|12032862|17632733|19676086 +SOD2 6648 Nephrotic Syndrome MESH:D009404 marker/mechanism 9152291 +SOD2 6648 Nerve Degeneration MESH:D009410 therapeutic 11146106 +SOD2 6648 Neurodegenerative Diseases MESH:D019636 marker/mechanism 10942521|12709579|15964507 +SOD2 6648 Obesity MESH:D009765 marker/mechanism 16317704|23956348|30738174 +SOD2 6648 Ophthalmoplegia, Chronic Progressive External MESH:D017246 marker/mechanism 11907800|14680979 +SOD2 6648 Osteoarthritis MESH:D010003 marker/mechanism 15292528|18784066|22108257 +SOD2 6648 Osteoporosis MESH:D010024 marker/mechanism 18924182 +SOD2 6648 Ovarian Neoplasms MESH:D010051 marker/mechanism 16179351|18594523 +SOD2 6648 Pancreatic Carcinoma MESH:C562463 marker/mechanism 11328670 +SOD2 6648 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17895890 +SOD2 6648 Papilloma MESH:D010212 marker/mechanism 11507057 +SOD2 6648 Parkinson Disease MESH:D010300 marker/mechanism 17188257|18353766|25279756 +SOD2 6648 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +SOD2 6648 Precancerous Conditions MESH:D011230 marker/mechanism 15986332|21472284 +SOD2 6648 Premature Birth MESH:D047928 marker/mechanism 26055944 +SOD2 6648 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 12592389|17465268|17646272|18829485|19074884|22564066|23315858|26468117 +SOD2 6648 Psoriasis MESH:D011565 marker/mechanism 7744320 +SOD2 6648 Psychoses, Substance-Induced MESH:D011605 marker/mechanism 16807759 +SOD2 6648 Radiation Injuries MESH:D011832 therapeutic 16540396|21945096 +SOD2 6648 Radiation Injuries, Experimental MESH:D011833 therapeutic 11121210|20726721 +SOD2 6648 Reperfusion Injury MESH:D015427 marker/mechanism|therapeutic 16682413|19193722|19917352|21940958|23743330|8215636 +SOD2 6648 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +SOD2 6648 Reticulocytosis MESH:D045262 marker/mechanism 20800516 +SOD2 6648 Sarcoidosis MESH:D012507 marker/mechanism 10673208 +SOD2 6648 Seizures MESH:D012640 marker/mechanism 20446108 +SOD2 6648 Shock, Cardiogenic MESH:D012770 marker/mechanism 21062213 +SOD2 6648 Skin Abnormalities MESH:D012868 marker/mechanism 24494196 +SOD2 6648 Skin Diseases MESH:D012871 marker/mechanism 16835338 +SOD2 6648 Skin Neoplasms MESH:D012878 marker/mechanism|therapeutic 11507057|20454814|22009531|25362851 +SOD2 6648 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 20618948 +SOD2 6648 Stomach Neoplasms MESH:D013274 marker/mechanism 10853026|14503839|19424620|25279216 +SOD2 6648 Thyroid Carcinoma, Anaplastic MESH:D065646 marker/mechanism 15887859 +SOD2 6648 Tongue Neoplasms MESH:D014062 marker/mechanism 20618948 +SOD2 6648 Turner Syndrome MESH:D014424 marker/mechanism 25101153 +SOD2 6648 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 14729580|18930813 +SOD2 6648 Uveitis MESH:D014605 marker/mechanism 19578012|21850155 +SOD2 6648 Vascular Diseases MESH:D014652 marker/mechanism 18596060 +SOD2 6648 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 19293248 +SOD3 6649 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 11529661 +SOD3 6649 Dermatitis, Contact MESH:D003877 therapeutic 17392825 +SOD3 6649 Disease Progression MESH:D018450 marker/mechanism 16081686 +SOD3 6649 Heart Failure MESH:D006333 marker/mechanism 20304815 +SOD3 6649 Hypertension MESH:D006973 marker/mechanism|therapeutic 16864745|17023265 +SOD3 6649 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 16081686 +SOD3 6649 Necrosis MESH:D009336 therapeutic 11529661 +SOD3 6649 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 16399992|16467073 +SOD3 6649 Pulmonary Fibrosis MESH:D011658 therapeutic 15298984 +SON 6651 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +SON 6651 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +SON 6651 ZTTK SYNDROME OMIM:617140 marker/mechanism 617140.0 +SORBS2 8470 Weight Gain MESH:D015430 marker/mechanism 19030233 +SORD 6652 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 32367058 +SORD 6652 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 12763371 +SORD 6652 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +SORD 6652 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 18549825 +SORL1 6653 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +SORL1 6653 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +SORL1 6653 Cholestasis MESH:D002779 marker/mechanism 26881866 +SORL1 6653 Cognitive Dysfunction MESH:D060825 marker/mechanism 30503753 +SORL1 6653 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +SORT1 6272 Cardiovascular Diseases MESH:D002318 marker/mechanism 25805502 +SORT1 6272 Cholestasis MESH:D002779 marker/mechanism 28453831 +SORT1 6272 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990|34961328 +SORT1 6272 Liver Diseases MESH:D008107 marker/mechanism 28453831 +SOS1 6654 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +SOS1 6654 FIBROMATOSIS, GINGIVAL, 1 OMIM:135300 marker/mechanism 135300.0 +SOS1 6654 Noonan Syndrome MESH:D009634 marker/mechanism 17603482|17603483 +SOS1 6654 Noonan Syndrome 4 MESH:C548082 marker/mechanism 610733.0 +SOS2 6655 NOONAN SYNDROME 9 OMIM:616559 marker/mechanism 616559.0 +SOST 50964 Craniodiaphyseal Dysplasia, Autosomal Dominant MESH:C567275 marker/mechanism 122860.0 +SOST 50964 Sclerosteosis MESH:C537525 marker/mechanism 269500.0 +SOX10 6663 Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease MESH:C563789 marker/mechanism 609136.0 +SOX10 6663 Waardenburg syndrome type 2 MESH:C536463 marker/mechanism 611584.0 +SOX10 6663 Waardenburg Syndrome, Type 4c MESH:C567679 marker/mechanism 613266.0 +SOX11 6664 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +SOX11 6664 Coffin-Siris syndrome MESH:C536436 marker/mechanism 615866.0 +SOX11 6664 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +SOX11 6664 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +SOX15 6665 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +SOX15 6665 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +SOX17 64321 Colorectal Neoplasms MESH:D015179 marker/mechanism 18413743 +SOX17 64321 Teratogenesis MESH:D064793 marker/mechanism 24154490 +SOX17 64321 Vesico-Ureteral Reflux MESH:D014718 marker/mechanism 613674.0 +SOX18 54345 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +SOX18 54345 HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME OMIM:137940 marker/mechanism 137940.0 +SOX18 54345 Hypotrichosis-Lymphedema-Telangiectasia Syndrome MESH:C564327 marker/mechanism 607823.0 +SOX18 54345 Skin Diseases MESH:D012871 marker/mechanism 16835338 +SOX2 6657 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 25184679 +SOX2 6657 Anophthalmos MESH:D000853 marker/mechanism 21532573 +SOX2 6657 Ataxia MESH:D001259 marker/mechanism 29732603 +SOX2 6657 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +SOX2 6657 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 19801978 +SOX2 6657 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 19801978 +SOX2 6657 Lung Neoplasms MESH:D008175 marker/mechanism 19801978 +SOX2 6657 Microphthalmia, Syndromic 3 MESH:C565948 marker/mechanism 206900.0 +SOX2 6657 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 27415467 +SOX2 6657 Osteosarcoma MESH:D012516 marker/mechanism 34508303 +SOX2 6657 Prostatic Neoplasms MESH:D011471 marker/mechanism 27415467 +SOX2 6657 Sarcoma MESH:D012509 marker/mechanism 26343384 +SOX2 6657 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +SOX2 6657 Thoracic Neoplasms MESH:D013899 marker/mechanism 26343384 +SOX2 6657 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 29396848 +SOX2-OT 347689 Heart Failure MESH:D006333 marker/mechanism 36071497 +SOX3 6658 Mental Retardation, X-Linked, With Panhypopituitarism MESH:C567485 marker/mechanism 300123.0 +SOX3 6658 Panhypopituitarism X-linked MESH:C538613 marker/mechanism 312000.0 +SOX30 11063 Lung Neoplasms MESH:D008175 therapeutic 25435374 +SOX4 6659 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +SOX4 6659 Cardiomegaly MESH:D006332 marker/mechanism 29394407 +SOX4 6659 Heart Failure MESH:D006333 marker/mechanism 29394407 +SOX4 6659 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SOX4 6659 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 21147764 +SOX4 6659 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +SOX5 6660 Atrial Fibrillation MESH:D001281 marker/mechanism 20062060 +SOX5 6660 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20808228 +SOX5 6660 LAMB-SHAFFER SYNDROME OMIM:616803 marker/mechanism 616803.0 +SOX8 30812 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 20864405 +SOX9 6662 Anonychia congenita MESH:C536377 marker/mechanism 19639023 +SOX9 6662 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 20868653 +SOX9 6662 Campomelic Dysplasia MESH:D055036 marker/mechanism 114290.0 +SOX9 6662 Carcinoma MESH:D002277 marker/mechanism 16316942 +SOX9 6662 Craniofacial Abnormalities MESH:D019465 marker/mechanism 11807034 +SOX9 6662 Hand Deformities, Congenital MESH:D006228 marker/mechanism 19639023 +SOX9 6662 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +SOX9 6662 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +SOX9 6662 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +SOX9 6662 Neoplasm Invasiveness MESH:D009361 marker/mechanism 32682831 +SOX9 6662 Neoplasm Metastasis MESH:D009362 marker/mechanism 32682831 +SOX9 6662 Pierre Robin Syndrome MESH:D010855 marker/mechanism 19234473 +SOX9 6662 Stomach Neoplasms MESH:D013274 marker/mechanism 36914835 +SOX9A 60641 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +SOX9A 60641 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +SOX9B 60642 Craniofacial Abnormalities MESH:D019465 marker/mechanism 30398377 +SP1 6667 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22009531 +SP1 6667 Colorectal Neoplasms MESH:D015179 marker/mechanism 35072892 +SP1 6667 Disease Progression MESH:D018450 marker/mechanism 35072892 +SP1 6667 Hyperglycemia MESH:D006943 marker/mechanism 11696579 +SP1 6667 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26317792|35072892 +SP1 6667 Neoplasm Metastasis MESH:D009362 marker/mechanism 12538496|35072892 +SP1 6667 Skin Neoplasms MESH:D012878 marker/mechanism 22009531 +SP110 3431 Hepatic venoocclusive disease with immunodeficiency MESH:C537257 marker/mechanism 235550.0 +SP110 3431 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948.0 +SP140 11262 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18758461 +SP140 11262 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SP4 6671 Bipolar Disorder MESH:D001714 marker/mechanism 19401786 +SP4 6671 Schizophrenia MESH:D012559 marker/mechanism 19401786 +SP5 389058 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SP7 121340 OSTEOGENESIS IMPERFECTA, TYPE XII OMIM:613849 marker/mechanism 613849.0 +SPAG1 6674 CILIARY DYSKINESIA, PRIMARY, 28 OMIM:615505 marker/mechanism 615505.0 +SPAG5 10615 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +SPARC 6678 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 22156929 +SPARC 6678 Carcinogenesis MESH:D063646 marker/mechanism 26783756 +SPARC 6678 Colonic Neoplasms MESH:D003110 marker/mechanism 17397030 +SPARC 6678 Colorectal Neoplasms MESH:D015179 marker/mechanism 18458674 +SPARC 6678 Hepatitis MESH:D006505 marker/mechanism 23408952 +SPARC 6678 Hyperalgesia MESH:D006930 marker/mechanism 20714283 +SPARC 6678 Intervertebral Disc Degeneration MESH:D055959 marker/mechanism 20714283 +SPARC 6678 Kidney Diseases MESH:D007674 marker/mechanism 12660331 +SPARC 6678 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +SPARC 6678 Liver Cirrhosis MESH:D008103 marker/mechanism 23408952 +SPARC 6678 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism|therapeutic 18615449|25380136 +SPARC 6678 Low Back Pain MESH:D017116 marker/mechanism 20714283 +SPARC 6678 Multiple Myeloma MESH:D009101 marker/mechanism 18172295 +SPARC 6678 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +SPARC 6678 Necrosis MESH:D009336 marker/mechanism 23408952 +SPARC 6678 Neoplasms, Experimental MESH:D009374 therapeutic 20164124 +SPARC 6678 Osteogenesis Imperfecta MESH:D010013 marker/mechanism 1793673 +SPARC 6678 OSTEOGENESIS IMPERFECTA, TYPE XVII OMIM:616507 marker/mechanism 616507.0 +SPARC 6678 Ovarian Neoplasms MESH:D010051 marker/mechanism 19177197 +SPARC 6678 Thrombocytopenia MESH:D013921 marker/mechanism 27725143 +SPARC 6678 Uremia MESH:D014511 marker/mechanism 19092814 +SPARC 6678 Weight Gain MESH:D015430 marker/mechanism 19030233 +SPARCL1 8404 Endometriosis MESH:D004715 marker/mechanism 20864642 +SPARCL1 8404 Epilepsy MESH:D004827 marker/mechanism 18488994 +SPART 23111 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 23525077 +SPART 23111 Spastic paraplegia 20, autosomal recessive MESH:C536858 marker/mechanism 275900.0 +SPAST 6683 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +SPAST 6683 Spastic paraplegia 4, autosomal dominant MESH:C536865 marker/mechanism 182601.0 +SPATA16 83893 SPERMATOGENIC FAILURE 6 OMIM:102530 marker/mechanism 102530.0 +SPATA18 132671 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +SPATA18 132671 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +SPATA21 374955 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +SPATA21 374955 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +SPATA7 55812 Leber Congenital Amaurosis MESH:D057130 marker/mechanism 19268277 +SPATA7 55812 Leber Congenital Amaurosis 3 MESH:C565814 marker/mechanism 604232.0 +SPATA7 55812 Retinitis Pigmentosa MESH:D012174 marker/mechanism 19268277 +SPATS2L 26010 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +SPC25 57405 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SPDEF 25803 Ovarian Neoplasms MESH:D010051 marker/mechanism 18567002 +SPE-49 187315 Death MESH:D003643 marker/mechanism 25204677 +SPECC1L 23384 Hypertelorism with esophageal abnormality and hypospadias MESH:C538387 marker/mechanism 145420.0 +SPECC1L 23384 Oculomaxillofacial dysostosis MESH:C537736 marker/mechanism 600251.0 +SPEG 10290 Myopathy, Centronuclear, Autosomal Recessive MESH:C562934 marker/mechanism 615959.0 +SPEN 23013 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +SPG11 80208 Amyotrophic Lateral Sclerosis 5 MESH:C566576 marker/mechanism 602099.0 +SPG11 80208 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X OMIM:616668 marker/mechanism 616668.0 +SPG11 80208 Spastic paraplegia 11, autosomal recessive MESH:C537483 marker/mechanism 604360.0 +SPG21 51324 MAST Syndrome MESH:C565409 marker/mechanism 248900.0 +SPG7 6687 Paraplegia MESH:D010264 marker/mechanism 11549317 +SPG7 6687 Spastic Paraplegia 7, Autosomal Recessive MESH:C564599 marker/mechanism 607259.0 +SPHK1 8877 Colitis, Ulcerative MESH:D003093 marker/mechanism 24055189 +SPHK1 8877 Fibrosis MESH:D005355 therapeutic 19657322 +SPHK1 8877 Leukemia MESH:D007938 marker/mechanism 18283525 +SPHK1 8877 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 18283525 +SPHK2 56848 Infarction, Middle Cerebral Artery MESH:D020244 therapeutic 23043544 +SPHK2 56848 Memory Disorders MESH:D008569 marker/mechanism 24859201 +SPHKAP 80309 Heart Failure MESH:D006333 marker/mechanism 36071497 +SPI1 6688 Leukemia, Myeloid MESH:D007951 therapeutic 17361223 +SPI1 6688 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 26237430 +SPI1 6688 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 28671687 +SPIB 6689 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 20639880 +SPIN2A 54466 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +SPIN2A 54466 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +SPINK1 6690 Hereditary pancreatitis MESH:C537262 marker/mechanism 167800.0 +SPINK1 6690 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19896093 +SPINK1 6690 Pancreatitis MESH:D010195 marker/mechanism 23143602 +SPINK1 6690 Pancreatitis, Chronic MESH:D050500 marker/mechanism 18206817 +SPINK1 6690 Prostatic Neoplasms MESH:D011471 marker/mechanism 25735316 +SPINK1 6690 Tropical Calcific Pancreatitis MESH:C564276 marker/mechanism 608189.0 +SPINK5 11005 Netherton Syndrome MESH:D056770 marker/mechanism 256500.0 20657595 +SPINK5 11005 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SPINT2 10653 Carcinoma MESH:D002277 marker/mechanism 16316942 +SPINT2 10653 Diarrhea 3, Secretory Sodium, Congenital MESH:C562576 marker/mechanism 270420.0 +SPINT2 10653 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +SPINT2 10653 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +SPINT2 10653 Neural Tube Defects MESH:D009436 marker/mechanism 24722141 +SPINT2 10653 Placenta Diseases MESH:D010922 marker/mechanism 24722141 +SPINT2 10653 Prenatal Injuries MESH:D049188 marker/mechanism 24722141 +SPMD1 100035378 Alcohol-Related Disorders MESH:D019973 marker/mechanism 28000031 +SPMD1 100035378 Depressive Disorder MESH:D003866 marker/mechanism 28000031 +SPMD1 100035378 Neurodegenerative Diseases MESH:D019636 marker/mechanism 28000031 +SPMD1 100035378 Niemann-Pick Diseases MESH:D009542 marker/mechanism 28000031 +SPMIP5 143379 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +SPN 6693 Calcinosis MESH:D002114 marker/mechanism 21335463 +SPN 6693 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +SPNS1 83985 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +SPOCK1 6695 Prostatic Neoplasms MESH:D011471 marker/mechanism 17929269 +SPON2 10417 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +SPOP 8405 Carcinoma, Ductal MESH:D044584 marker/mechanism 29295717 +SPOP 8405 Endometrial Neoplasms MESH:D016889 marker/mechanism 23104009 +SPOP 8405 Prostatic Neoplasms MESH:D011471 marker/mechanism 22610119|29295717|29610475 +SPP1 6696 Acute Kidney Injury MESH:D058186 marker/mechanism 11274264|20623750 +SPP1 6696 Adenocarcinoma MESH:D000230 marker/mechanism 20495387|21552421 +SPP1 6696 Asbestosis MESH:D001195 marker/mechanism 16221779|21514415 +SPP1 6696 Brain Neoplasms MESH:D001932 marker/mechanism 16651633 +SPP1 6696 Breast Neoplasms MESH:D001943 marker/mechanism 18949741|22531848 +SPP1 6696 Calcinosis MESH:D002114 marker/mechanism 21193197|21335463 +SPP1 6696 Carotid Stenosis MESH:D016893 marker/mechanism 26564003 +SPP1 6696 Cerebral Hemorrhage MESH:D002543 therapeutic 20440599 +SPP1 6696 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +SPP1 6696 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 14555839 +SPP1 6696 Diabetic Cardiomyopathies MESH:D058065 marker/mechanism 16980342 +SPP1 6696 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15805072 +SPP1 6696 Glioma MESH:D005910 marker/mechanism 16651633 +SPP1 6696 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 9294829 +SPP1 6696 Heart Diseases MESH:D006331 marker/mechanism 23558518 +SPP1 6696 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +SPP1 6696 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +SPP1 6696 Kidney Calculi MESH:D007669 marker/mechanism 10890885|8325891 +SPP1 6696 Kidney Diseases MESH:D007674 marker/mechanism 27026710 +SPP1 6696 Leukoencephalopathies MESH:D056784 marker/mechanism 11868353 +SPP1 6696 Liver Cirrhosis MESH:D008103 marker/mechanism 16221502 +SPP1 6696 Liver Diseases, Alcoholic MESH:D008108 marker/mechanism 18703563 +SPP1 6696 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +SPP1 6696 Lung Neoplasms MESH:D008175 marker/mechanism 21552421|22481206 +SPP1 6696 Mammary Neoplasms, Experimental MESH:D008325 therapeutic 15318939 +SPP1 6696 Mesothelioma MESH:D008654 marker/mechanism 16221779|18550471 +SPP1 6696 Neoplasm Metastasis MESH:D009362 marker/mechanism 22407340 +SPP1 6696 Neoplasms, Experimental MESH:D009374 therapeutic 21852811 +SPP1 6696 Osteolysis MESH:D010014 marker/mechanism 22407340 +SPP1 6696 Pancreatic Diseases MESH:D010182 marker/mechanism 20495387 +SPP1 6696 Pleural Neoplasms MESH:D010997 marker/mechanism 16221779 +SPP1 6696 Pneumonia MESH:D011014 marker/mechanism 21625544 +SPP1 6696 Proteinuria MESH:D011507 marker/mechanism 11972865 +SPP1 6696 Pulmonary Fibrosis MESH:D011658 marker/mechanism 25216247 +SPP1 6696 Uremia MESH:D014511 marker/mechanism 19092814 +SPP1 6696 Vascular System Injuries MESH:D057772 marker/mechanism 11868353 +SPP1 6696 Wounds and Injuries MESH:D014947 therapeutic 9525990 +SPP-20 34700636 Death MESH:D003643 marker/mechanism 25204677 +SPP-20 34700636 Infertility MESH:D007246 marker/mechanism 25204677 +SPR 6697 Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency MESH:C562657 marker/mechanism 612716.0 25526675 +SPRED1 161742 Cafe-au-Lait Spots MESH:D019080 marker/mechanism 17704776 +SPRED1 161742 Legius syndrome MESH:C548032 marker/mechanism 611431.0 +SPRED1 161742 Nervous System Malformations MESH:D009421 marker/mechanism 17704776 +SPRED1 161742 Neurofibromatosis 1 MESH:D009456 marker/mechanism 17704776 +SPRED2 200734 Alzheimer Disease MESH:D000544 marker/mechanism 33589840 +SPRED2 200734 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +SPRR1A 6698 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 8617999 +SPRR1A 6698 Papilloma MESH:D010212 marker/mechanism 8617999 +SPRR2A 6700 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +SPRR2B 6701 Asthma MESH:D001249 marker/mechanism 21912604 +SPRTN 83932 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 25261934 +SPRTN 83932 Genomic Instability MESH:D042822 marker/mechanism 25261934 +SPRTN 83932 Progeria MESH:D011371 marker/mechanism 25261934 +SPRTN 83932 RUIJS-AALFS SYNDROME OMIM:616200 marker/mechanism 616200.0 +SPRY2 10253 Cleft Lip MESH:D002971 marker/mechanism 17576140 +SPRY2 10253 Cleft Palate MESH:D002972 marker/mechanism 17576140 +SPRY2 10253 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17576140 +SPRY2 10253 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 616818.0 +SPRY2 10253 Lung Diseases MESH:D008171 marker/mechanism 24210189 +SPRY2 10253 Lung Neoplasms MESH:D008175 marker/mechanism 15136453 +SPRY4 81848 HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA OMIM:615266 marker/mechanism 615266.0 +SPRY4 81848 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 +SPRY4 81848 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 25822087 +SPSB4 92369 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SPTA1 6708 Elliptocytosis 2 MESH:C565058 marker/mechanism 130600.0 +SPTA1 6708 Pyropoikilocytosis, Hereditary MESH:C563004 marker/mechanism 266140.0 +SPTA1 6708 Spherocytosis, Type 3 MESH:C567489 marker/mechanism 270970.0 +SPTAN1 6709 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5 OMIM:613477 marker/mechanism 613477.0 +SPTAN1 6709 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SPTAN1 6709 Neurodegenerative Diseases MESH:D019636 marker/mechanism 25015659 +SPTB 6710 Anemia, Hemolytic MESH:D000743 marker/mechanism 9005995 +SPTB 6710 Anemia, Neonatal MESH:D000751 marker/mechanism 9005995 +SPTB 6710 Elliptocytosis, Hereditary MESH:D004612 marker/mechanism 1975598 +SPTB 6710 Spherocytosis, Hereditary MESH:D013103 marker/mechanism 19538529|8102379 +SPTB 6710 SPHEROCYTOSIS, TYPE 2 OMIM:616649 marker/mechanism 616649 +SPTBN1 6711 Fractures, Bone MESH:D050723 marker/mechanism 22504420 +SPTBN1 6711 Weight Gain MESH:D015430 marker/mechanism 19030233 +SPTBN2 6712 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 600224|615386 +SPTBN4 57731 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +SPTBN4 57731 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +SPTLC1 10558 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA OMIM:162400 marker/mechanism 162400 +SPTLC2 9517 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC OMIM:613640 marker/mechanism 613640 +SPZ1 84654 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +SQLE 6713 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +SQSTM1 8878 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 19765191 +SQSTM1 8878 Distal myopathy, Nonaka type MESH:C536816 marker/mechanism 617158.0 +SQSTM1 8878 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3 OMIM:616437 marker/mechanism 616437.0 +SQSTM1 8878 Macular Degeneration MESH:D008268 marker/mechanism 23922739 +SQSTM1 8878 Motor Skills Disorders MESH:D019957 marker/mechanism 32773031 +SQSTM1 8878 NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET OMIM:617145 marker/mechanism 617145.0 +SQSTM1 8878 Osteitis Deformans MESH:D010001 marker/mechanism 167250.0 +SQSTM1 8878 Spinal Cord Injuries MESH:D013119 marker/mechanism 29793971 +SQSTM1 8878 Starvation MESH:D013217 marker/mechanism 26483381 +SRA1 10011 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 +SRAB-21 188653 Hypoxia MESH:D000860 therapeutic 19936206 +SRC 6714 Breast Neoplasms MESH:D001943 marker/mechanism 21357651 +SRC 6714 Cardiomegaly MESH:D006332 marker/mechanism 18194989 +SRC 6714 Colitis MESH:D003092 marker/mechanism 17551092 +SRC 6714 Colonic Neoplasms MESH:D003110 marker/mechanism 14569062 +SRC 6714 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 +SRC 6714 Neoplasm Invasiveness MESH:D009361 marker/mechanism 18844224|21291860 +SRC 6714 Polycystic Kidney, Autosomal Recessive MESH:D017044 marker/mechanism 18385429 +SRC 6714 Status Epilepticus MESH:D013226 marker/mechanism 16600505 +SRC 6714 THROMBOCYTOPENIA 6 OMIM:616937 marker/mechanism 616937.0 +SRC 6714 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 11723127|17093206 +SRCAP 10847 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +SRCAP 10847 Floating-harbor syndrome MESH:C537062 marker/mechanism 136140.0 +SRCAP 10847 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +SRCIN1 80725 Cocaine-Related Disorders MESH:D019970 therapeutic 27506785 +SRD5A1 6715 Endometriosis MESH:D004715 marker/mechanism 21232532|23183084 +SRD5A1 6715 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SRD5A1 6715 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543|22381227 +SRD5A1 6715 Prostatic Neoplasms MESH:D011471 marker/mechanism 18500220|20564326 +SRD5A2 6716 Alopecia MESH:D000505 marker/mechanism 17136762 +SRD5A2 6716 Endometrial Neoplasms MESH:D016889 marker/mechanism 23200943 +SRD5A2 6716 Endometriosis MESH:D004715 marker/mechanism 21232532 +SRD5A2 6716 Prostatic Hyperplasia MESH:D011470 marker/mechanism 20823678 +SRD5A2 6716 Prostatic Neoplasms MESH:D011471 marker/mechanism 16998812|17136762|17823934|18306354|18500220 +SRD5A2 6716 Pseudovaginal Perineoscrotal Hypospadias MESH:C535830 marker/mechanism 264600.0 7554313 +SRD5A3 79644 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq OMIM:612379 marker/mechanism 612379.0 +SRD5A3 79644 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +SRD5A3 79644 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +SRD5A3 79644 Kahrizi Syndrome MESH:C567196 marker/mechanism 612713.0 +SRE-25 13187443 Infertility MESH:D007246 marker/mechanism 25204677 +SRE-30 186476 Embryo Loss MESH:D020964 marker/mechanism 25204677 +SREBF1 6720 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 14563831|21147110 +SREBF1 6720 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 10900012|23090186 +SREBF1 6720 Fatty Liver MESH:D005234 marker/mechanism 24469900 +SREBF1 6720 Insulin Resistance MESH:D007333 marker/mechanism 22658938 +SREBF1 6720 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +SREBF1 6720 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SREBF1 6720 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 23603006|24633463 +SREBF1 6720 Obesity MESH:D009765 marker/mechanism 10900012 +SREBF2 6721 Breast Neoplasms MESH:D001943 marker/mechanism 30394316 +SREBF2 6721 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +SREBF2 6721 Disease Progression MESH:D018450 marker/mechanism 21364753 +SREBF2 6721 Insulin Resistance MESH:D007333 marker/mechanism 20699619 +SREBF2 6721 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19878707 +SREBF2 6721 Neoplasm Metastasis MESH:D009362 marker/mechanism 30394316 +SREBF2 6721 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +SRF 6722 HIV Infections MESH:D015658 marker/mechanism 15308739 +SRF 6722 Neoplasms MESH:D009369 therapeutic 17116645 +SRGAP1 57522 Thyroid cancer, follicular MESH:C572845 marker/mechanism 188470.0 +SRGAP3 9901 Chromosome 3, monosomy 3p25 MESH:C536807 marker/mechanism 21082655 +SRGAP3 9901 Intellectual Disability MESH:D008607 marker/mechanism 21082655 +SRGAP3 9901 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +SRGN 5552 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SRH-250 183606 Infertility MESH:D007246 marker/mechanism 25204677 +SRI 6717 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SRI 6717 Weight Gain MESH:D015430 therapeutic 33930463 +SRM 6723 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SRM 6723 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SRMS 6725 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +SRP54 6729 Shwachman-Diamond Syndrome MESH:D000081003 marker/mechanism 260400.0 +SRP68 6730 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +SRP68 6730 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +SRP68 6730 Skin Diseases MESH:D012871 marker/mechanism 16835338 +SRP72 6731 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +SRP72 6731 Cholestasis MESH:D002779 marker/mechanism 26881866 +SRP72 6731 Congenital Bone Marrow Failure Syndromes MESH:D000080984 marker/mechanism 614675.0 +SRPK2 6733 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +SRPX 8406 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SRPX2 27286 Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia, X-Linked MESH:C564467 marker/mechanism 300643.0 +SRR 63826 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SRR 63826 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SRR 63826 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SRRM4 84530 Hearing Disorders MESH:D006311 marker/mechanism 17613114 +SRRM4 84530 Vestibular Diseases MESH:D015837 marker/mechanism 17613114 +SRRT 51593 Glioblastoma MESH:D005909 marker/mechanism 30542699 +SRSF1 6426 HIV Infections MESH:D015658 marker/mechanism 15308739 +SRSF1 6426 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +SRSF1 6426 Schizophrenia MESH:D012559 marker/mechanism 16223876 +SRSF10 10772 Endometrial Neoplasms MESH:D016889 marker/mechanism 21072693 +SRSF10 10772 Ovarian Neoplasms MESH:D010051 marker/mechanism 21072693 +SRSF10 10772 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +SRSF2 6427 Carcinoma MESH:D002277 marker/mechanism 16316942 +SRSF2 6427 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +SRSF2 6427 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +SRSF2 6427 Supranuclear Palsy, Progressive MESH:D013494 marker/mechanism 25402454 +SRSF5 6430 Liver Diseases MESH:D008107 marker/mechanism 19784758 +SRSF5 6430 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +SRSF9 8683 HIV Infections MESH:D015658 marker/mechanism 15308739 +SRY 6736 46,XX SEX REVERSAL 1 OMIM:400045 marker/mechanism 400045.0 +SRY 6736 46,XY SEX REVERSAL 1 OMIM:400044 marker/mechanism 400044.0 +SRY 6736 Gonadal Dysgenesis, 46,XY MESH:D006061 marker/mechanism 27576690 +SS18 6760 Sarcoma, Synovial MESH:D013584 marker/mechanism 27572315|9428816 +SS18L1 26039 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 28973294 +SSBP1 6742 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +SSBP1 6742 Skin Diseases MESH:D012871 marker/mechanism 16835338 +SSBP2 23635 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +SSBP2 23635 Prostatic Neoplasms MESH:D011471 marker/mechanism 18559593 +SSPN 8082 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +SSR2 6746 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SSR4 6748 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy OMIM:300934 marker/mechanism 300934.0 +SST 6750 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +SST 6750 Barrett Esophagus MESH:D001471 marker/mechanism 17999418 +SST 6750 Endometriosis MESH:D004715 marker/mechanism 21063030 +SST 6750 Esophageal and Gastric Varices MESH:D004932 therapeutic 1385068 +SST 6750 Esophageal Neoplasms MESH:D004938 marker/mechanism 17999418 +SST 6750 Hypokalemia MESH:D007008 therapeutic 2563217 +SST 6750 Ischemia MESH:D007511 therapeutic 18624922 +SST 6750 Mood Disorders MESH:D019964 marker/mechanism 25600109 +SST 6750 Multiple Organ Failure MESH:D009102 therapeutic 15834315 +SST 6750 Neoplasms MESH:D009369 therapeutic 21692635 +SST 6750 Pancreatic Neoplasms MESH:D010190 therapeutic 2868874 +SST 6750 Pancreatitis MESH:D010195 therapeutic 7911442 +SST 6750 Seizures MESH:D012640 marker/mechanism|therapeutic 16771832|20134357|7913897 +SST 6750 Vipoma MESH:D003969 therapeutic 2868874 +SSTR1 6751 Neuroendocrine Tumors MESH:D018358 marker/mechanism 17625444 +SSTR1 6751 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17625444 +SSTR1 6751 Status Epilepticus MESH:D013226 marker/mechanism 18951627 +SSTR2 6752 Neuroendocrine Tumors MESH:D018358 marker/mechanism 17625444 +SSTR2 6752 Pancreatic Neoplasms MESH:D010190 marker/mechanism|therapeutic 15259086|17625444|19917848 +SSTR2 6752 Paraganglioma MESH:D010235 marker/mechanism 29163802 +SSTR2 6752 Seizures MESH:D012640 therapeutic 16771832 +SSTR2 6752 Status Epilepticus MESH:D013226 marker/mechanism 18951627 +SSTR3 6753 Neuroendocrine Tumors MESH:D018358 marker/mechanism 17625444 +SSTR3 6753 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17625444 +SSTR3 6753 Status Epilepticus MESH:D013226 marker/mechanism 18951627 +SSTR4 6754 Status Epilepticus MESH:D013226 marker/mechanism 18951627 +SSTR5 6755 Status Epilepticus MESH:D013226 marker/mechanism 18951627 +SSX1 6756 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +SSX1 6756 Sarcoma, Synovial MESH:D013584 marker/mechanism 27572315|9428816 +SSX2 6757 Prostatic Neoplasms MESH:D011471 marker/mechanism 17929270 +SSX2 6757 Sarcoma, Synovial MESH:D013584 marker/mechanism 300813.0 9428816 +ST14 6768 Ichthyosis with hypotrichosis, autosomal recessive MESH:C536273 marker/mechanism 602400.0 17273967|18445049 +ST14 6768 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 26599507 +ST14 6768 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ST14 6768 Netherton Syndrome MESH:D056770 marker/mechanism 20657595 +ST14 6768 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +ST3GAL1 6482 Enterovirus Infections MESH:D004769 marker/mechanism 28446605 +ST3GAL3 6487 Mental Retardation, Autosomal Recessive 12 MESH:C567019 marker/mechanism 611090.0 +ST3GAL4 6484 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +ST3GAL4 6484 Enterovirus Infections MESH:D004769 marker/mechanism 28446605 +ST3GAL4 6484 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +ST3GAL5 8869 Amish Infantile Epilepsy Syndrome MESH:C563799 marker/mechanism 609056.0 +ST6GAL1 6480 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +ST6GAL1 6480 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 21874001 +ST6GALNAC2 10610 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 17480010 +ST6GALNAC5 81849 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 17379860|17568789 +ST8SIA1 6489 Liver Diseases MESH:D008107 marker/mechanism 19784758 +ST8SIA1 6489 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +ST8SIA2 8128 Autistic Disorder MESH:D001321 marker/mechanism 20663923 +ST8SIA6-AS1 100128098 Triple Negative Breast Neoplasms MESH:D064726 therapeutic 35730485 +STAB1 23166 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +STAB2 55576 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +STAB2 55576 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +STAC 6769 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +STAC3 246329 Hepatomegaly MESH:D006529 marker/mechanism 28108177 +STAC3 246329 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +STAC3 246329 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +STAC3 246329 Native American myopathy MESH:C538343 marker/mechanism 255995.0 +STAG1 10274 Intellectual Disability MESH:D008607 marker/mechanism 28191889 +STAG2 10735 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 24121792 +STAG2 10735 Leukemia, Megakaryoblastic, of Down Syndrome MESH:C566025 marker/mechanism 24056718 +STAG2 10735 Leukemia, Myeloid MESH:D007951 marker/mechanism 23955599 +STAG2 10735 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 27992414 +STAG2 10735 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121789|24121791|24121792 +STAG3 10734 PREMATURE OVARIAN FAILURE 8 OMIM:615723 marker/mechanism 615723.0 +STAG3L1 54441 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +STAG3L1 54441 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +STAMBP 10617 Brain Diseases MESH:D001927 marker/mechanism 23542699 +STAMBP 10617 Capillary Malformation-Arteriovenous Malformation MESH:C564254 marker/mechanism 23542699 +STAMBP 10617 Developmental Disabilities MESH:D002658 marker/mechanism 23542699 +STAMBP 10617 Epilepsy MESH:D004827 marker/mechanism 23542699 +STAMBP 10617 Microcephaly MESH:D008831 marker/mechanism 23542699 +STAMBP 10617 MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME OMIM:614261 marker/mechanism 614261.0 +STAR 6770 Endometrial Neoplasms MESH:D016889 marker/mechanism 23200943 +STAR 6770 Lipoid congenital adrenal hyperplasia MESH:C537027 marker/mechanism 201710.0 11502818|22028173 +STAR 6770 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21262361 +STARD10 10809 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +STARD13 90627 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +STARD3 10948 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881|17592021 +STARD7 56910 Epilepsy, Myoclonic, Benign Adult Familial, Type 2 MESH:C564313 marker/mechanism 607876.0 +STARD8 9754 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +STARD8 9754 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +STARD9 57519 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +STAT1 6772 Arthritis, Experimental MESH:D001169 marker/mechanism 15188379 +STAT1 6772 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +STAT1 6772 Candidiasis, Chronic Mucocutaneous MESH:D002178 marker/mechanism 21714643 +STAT1 6772 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22488367 +STAT1 6772 Cytomegalovirus Infections MESH:D003586 marker/mechanism 16688530 +STAT1 6772 Disease Progression MESH:D018450 marker/mechanism 22488367 +STAT1 6772 Hearing Loss MESH:D034381 marker/mechanism 20712533 +STAT1 6772 IMMUNODEFICIENCY 31A OMIM:614892 marker/mechanism 614892.0 +STAT1 6772 IMMUNODEFICIENCY 31B OMIM:613796 marker/mechanism 613796.0 +STAT1 6772 IMMUNODEFICIENCY 31C OMIM:614162 marker/mechanism 614162.0 +STAT1 6772 Influenza, Human MESH:D007251 marker/mechanism 23326326 +STAT1 6772 Liver Cirrhosis MESH:D008103 therapeutic 17133483 +STAT1 6772 Lupus Nephritis MESH:D008181 marker/mechanism 31182691 +STAT1 6772 Mycobacterium Infections MESH:D009164 marker/mechanism 11452125 +STAT1 6772 Neoplasm Metastasis MESH:D009362 marker/mechanism 29147627 +STAT1 6772 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 23471820 +STAT2 6773 IMMUNODEFICIENCY 44 OMIM:616636 marker/mechanism 616636.0 +STAT3 6774 Adenocarcinoma MESH:D000230 marker/mechanism 19028472|26432044 +STAT3 6774 Arthritis, Experimental MESH:D001169 marker/mechanism 15188379|21937456 +STAT3 6774 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +STAT3 6774 Atherosclerosis MESH:D050197 marker/mechanism 19330073 +STAT3 6774 Atrophy MESH:D001284 marker/mechanism 16391472 +STAT3 6774 AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1 OMIM:615952 marker/mechanism 615952.0 +STAT3 6774 Autoimmune Diseases MESH:D001327 marker/mechanism 25038750 +STAT3 6774 Brain Ischemia MESH:D002545 marker/mechanism 17901229 +STAT3 6774 Breast Neoplasms MESH:D001943 marker/mechanism 14975756 +STAT3 6774 Carcinoma MESH:D002277 marker/mechanism 16316942 +STAT3 6774 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21549414 +STAT3 6774 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17566705|26432044 +STAT3 6774 Cardiomegaly MESH:D006332 marker/mechanism 10618415|19299911|24448315 +STAT3 6774 Cardiomyopathies MESH:D009202 marker/mechanism|therapeutic 10618415|24448315 +STAT3 6774 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 25970160|26101800|34953898 +STAT3 6774 Colitis, Ulcerative MESH:D003093 marker/mechanism 18438405|20228799 +STAT3 6774 Colonic Neoplasms MESH:D003110 marker/mechanism 19028472 +STAT3 6774 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +STAT3 6774 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 25038750 +STAT3 6774 Disease Models, Animal MESH:D004195 marker/mechanism 25812446 +STAT3 6774 Fever MESH:D005334 marker/mechanism 25429137 +STAT3 6774 Fibrosis MESH:D005355 marker/mechanism 24448315 +STAT3 6774 Heart Failure MESH:D006333 marker/mechanism 36071497 +STAT3 6774 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +STAT3 6774 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 25812446 +STAT3 6774 Hyper-Ige Recurrent Infection Syndrome, Autosomal Dominant MESH:C567925 marker/mechanism 147060.0 +STAT3 6774 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 30481203 +STAT3 6774 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 21940958 +STAT3 6774 Inflammation MESH:D007249 marker/mechanism|therapeutic 20943775|21937456|24448315 +STAT3 6774 Job Syndrome MESH:D007589 marker/mechanism 25038750 +STAT3 6774 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 24090995 +STAT3 6774 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 19796711 +STAT3 6774 Leukemia, T-Cell MESH:D015458 marker/mechanism 19796711 +STAT3 6774 Liver Neoplasms MESH:D008113 marker/mechanism 12957465 +STAT3 6774 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 26297436|28100771 +STAT3 6774 Lymphatic Metastasis MESH:D008207 marker/mechanism 21549414 +STAT3 6774 Lymphoma, Large-Cell, Anaplastic MESH:D017728 marker/mechanism 22155737 +STAT3 6774 Lymphoma, T-Cell MESH:D016399 marker/mechanism 26192917 +STAT3 6774 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +STAT3 6774 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +STAT3 6774 Medulloblastoma MESH:D008527 marker/mechanism 19001435 +STAT3 6774 Memory Disorders MESH:D008569 therapeutic 17928813 +STAT3 6774 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26101800 +STAT3 6774 Neoplasm Metastasis MESH:D009362 marker/mechanism 21937440|23382965|26101800 +STAT3 6774 Neoplasms, Experimental MESH:D009374 marker/mechanism 29507229 +STAT3 6774 Ovarian Neoplasms MESH:D010051 marker/mechanism 21909139 +STAT3 6774 Pancreatic Neoplasms MESH:D010190 marker/mechanism 22348037|23845849 +STAT3 6774 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +STAT3 6774 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 19796711 +STAT3 6774 Prostatic Neoplasms MESH:D011471 marker/mechanism 14975756|16427044|25970160 +STAT3 6774 Psoriasis MESH:D011565 marker/mechanism 23143594 +STAT3 6774 Pulmonary Fibrosis MESH:D011658 marker/mechanism 30658076 +STAT3 6774 Reperfusion Injury MESH:D015427 marker/mechanism 21940958 +STAT3 6774 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 27064016 +STAT3 6774 Stomach Neoplasms MESH:D013274 marker/mechanism 23382965 +STAT3 6774 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 36115647 +STAT3 6774 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 25061499 +STAT4 6775 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +STAT4 6775 Asthma MESH:D001249 marker/mechanism 28807506 +STAT4 6775 Behcet Syndrome MESH:D001528 marker/mechanism 23291587 +STAT4 6775 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 23242368 +STAT4 6775 Disease Susceptibility MESH:D004198 marker/mechanism 27444301 +STAT4 6775 Hepatitis B MESH:D006509 marker/mechanism 27444301 +STAT4 6775 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 21399635 +STAT4 6775 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 612253.0 18204446|19838193 +STAT4 6775 Multiple Sclerosis MESH:D009103 marker/mechanism 24076602 +STAT4 6775 Scleroderma, Systemic MESH:D012595 marker/mechanism 20383147 +STAT4 6775 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097066|24097067 +STAT5A 6776 Adenocarcinoma MESH:D000230 marker/mechanism 20235097|21552421 +STAT5A 6776 Breast Neoplasms MESH:D001943 marker/mechanism 15609129 +STAT5A 6776 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942|17173897 +STAT5A 6776 Carcinoma, Ductal MESH:D044584 marker/mechanism 15609129 +STAT5A 6776 Carcinoma, Intraductal, Noninfiltrating MESH:D002285 marker/mechanism 15609129 +STAT5A 6776 Carcinoma, Lobular MESH:D018275 marker/mechanism 15609129 +STAT5A 6776 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +STAT5A 6776 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|15609129|16316942|17173897|20235097 +STAT5A 6776 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|15609129|16316942 +STAT5A 6776 Myocardial Ischemia MESH:D017202 marker/mechanism 15746188 +STAT5A 6776 Precancerous Conditions MESH:D011230 marker/mechanism 15609129 +STAT5B 6777 Enteropathy-Associated T-Cell Lymphoma MESH:D058527 marker/mechanism 29200404 +STAT5B 6777 Laron syndrome type 2 MESH:C537871 marker/mechanism 245590.0 17030597 +STAT5B 6777 Leukemia, Large Granular Lymphocytic MESH:D054066 marker/mechanism 26192916|29200404 +STAT5B 6777 Leukemia, Prolymphocytic, T-Cell MESH:D015461 marker/mechanism 29200404 +STAT5B 6777 Lymphoma, Extranodal NK-T-Cell MESH:D054391 marker/mechanism 29200404 +STAT5B 6777 Lymphoma, T-Cell MESH:D016399 marker/mechanism 26192917 +STAT5B 6777 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +STAT5B 6777 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 29200404 +STAT5B 6777 Splenomegaly MESH:D013163 marker/mechanism 29200404 +STAT5B 6777 T-Lymphocytopenia MESH:C536783 marker/mechanism 17030597 +STAT6 6778 Dermatitis, Atopic MESH:D003876 therapeutic 15306842 +STAT6 6778 Edema MESH:D004487 therapeutic 15306842 +STAT6 6778 Head and Neck Neoplasms MESH:D006258 marker/mechanism 21765211 +STAT6 6778 Pulmonary Fibrosis MESH:D011658 therapeutic 26699812 +STAT6 6778 Solitary Fibrous Tumors MESH:D054364 marker/mechanism 23313952|23313954 +STATH 6779 Autistic Disorder MESH:D001321 marker/mechanism 19367726 +STAU1 6780 Myotonic Dystrophy MESH:D009223 marker/mechanism 27030674 +STAU2 27067 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +STC2 8614 Breast Neoplasms MESH:D001943 marker/mechanism 18492817 +STC2 8614 Endometriosis MESH:D004715 marker/mechanism 20864642 +STC2 8614 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 24097666 +STEAP3 55240 Anemia, Hypochromic Microcytic, With Iron Overload MESH:C567144 marker/mechanism 615234.0 +STEAP4 79689 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +STEAP4 79689 Prostatic Neoplasms MESH:D011471 marker/mechanism 25320179 +STG 43466 Eye Abnormalities MESH:D005124 therapeutic 17517339 +STIL 6491 Microcephaly, Primary Autosomal Recessive, 7 MESH:C567198 marker/mechanism 612703.0 +STIM1 6786 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +STIM1 6786 Hypertension MESH:D006973 marker/mechanism 19897708 +STIM1 6786 Immune dysfunction with T-cell inactivation due to calcium entry defect 2 MESH:C557827 marker/mechanism 612783.0 +STIM1 6786 Lung Neoplasms MESH:D008175 marker/mechanism 27863410 +STIM1 6786 Myopathies, Structural, Congenital MESH:D020914 marker/mechanism 160565.0 +STIM1 6786 Neoplasms, Experimental MESH:D009374 marker/mechanism 27863410 +STIM2 57620 Weight Gain MESH:D015430 marker/mechanism 19030233 +STING1 340061 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 36520315 +STING1 340061 Chilblain lupus 1 MESH:C535924 marker/mechanism 27566796 +STING1 340061 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25129146 +STING1 340061 STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET OMIM:615934 marker/mechanism 615934.0 +STIP1 10963 Colorectal Neoplasms MESH:D015179 marker/mechanism 33766539 +STIP1 10963 Melanoma MESH:D008545 marker/mechanism 22535842 +STK10 6793 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +STK11 6794 Adenocarcinoma MESH:D000230 marker/mechanism 17676035 +STK11 6794 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 24793789 +STK11 6794 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 26887594 +STK11 6794 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17676035 +STK11 6794 Hypertension MESH:D006973 marker/mechanism 19289642 +STK11 6794 Hypertrophy, Left Ventricular MESH:D017379 marker/mechanism 19289642 +STK11 6794 Intestinal Polyposis MESH:D044483 marker/mechanism 18311138 +STK11 6794 Lung Neoplasms MESH:D008175 marker/mechanism 17676035 +STK11 6794 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1 OMIM:155600 marker/mechanism 155600.0 +STK11 6794 Pancreatic Neoplasms MESH:D010190 marker/mechanism 260350.0 26098869 +STK11 6794 Peutz-Jeghers Syndrome MESH:D010580 marker/mechanism 175200.0 26887594 +STK11 6794 Testicular Germ Cell Tumor MESH:C563236 marker/mechanism 273300.0 +STK19 8859 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +STK36 27148 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +STK39 27347 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +STK39 27347 Autistic Disorder MESH:D001321 marker/mechanism 18348195 +STK39 27347 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +STK39 27347 Hypertension MESH:D006973 therapeutic 22949526 +STK4 6789 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +STK4 6789 IMMUNODEFICIENCY 110 WITH LYMPHOPROLIFERATION OMIM:614868 marker/mechanism 614868.0 +STMN1 3925 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +STMN1 3925 Carcinoma MESH:D002277 marker/mechanism 12376462 +STMN1 3925 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +STMN1 3925 Glioma MESH:D005910 marker/mechanism 17440165 +STMN1 3925 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +STMN1 3925 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +STMN1 3925 Prostatic Neoplasms MESH:D011471 marker/mechanism 17455228 +STN1 79991 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28346442 +STN1 79991 Cerebroretinal Microangiopathy with Calcifications and Cysts MESH:C567401 marker/mechanism 617341.0 +STN1 79991 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 23583980 +STN1 79991 Lung Neoplasms MESH:D008175 marker/mechanism 28604730 +STOML2 30968 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +STOX1 219736 Preeclampsia Eclampsia 4 MESH:C563724 marker/mechanism 609404.0 +STRA6 64220 Alveolar capillary dysplasia MESH:C536590 marker/mechanism 17273977 +STRA6 64220 Anophthalmia with pulmonary hypoplasia MESH:C537768 marker/mechanism 601186.0 17503335|18316031 +STRA6 64220 Anophthalmos MESH:D000853 marker/mechanism 17273977 +STRA6 64220 Cardiovascular Abnormalities MESH:D018376 marker/mechanism 18316031 +STRA6 64220 Craniofacial Abnormalities MESH:D019465 marker/mechanism 18316031 +STRA6 64220 Heart Defects, Congenital MESH:D006330 marker/mechanism 17273977 +STRA6 64220 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 17273977 +STRA6 64220 Intellectual Disability MESH:D008607 marker/mechanism 17273977 +STRA6 64220 Lung Diseases MESH:D008171 marker/mechanism 17273977 +STRA6 64220 Microphthalmos MESH:D008850 marker/mechanism 18316031 +STRADA 92335 Medulloblastoma MESH:D008527 marker/mechanism 21652733 +STRADA 92335 Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy MESH:C567020 marker/mechanism 611087.0 +STRAP 11171 Colorectal Neoplasms MESH:D015179 marker/mechanism 15720808 +STRBP 55342 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +STRBP 55342 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +STRC 161497 Deafness, Autosomal Recessive 16 MESH:C566339 marker/mechanism 603720.0 +STRC 161497 Deafness, Sensorineural, And Male Infertility MESH:C567010 marker/mechanism 611102.0 +STRC 161497 Spermatogenic Failure 7 MESH:C567832 marker/mechanism 612997.0 +STS 412 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +STS 412 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 18413370 +STS 412 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +STS 412 Diabetes Mellitus, Experimental MESH:D003921 therapeutic 24497646 +STS 412 Fatty Liver MESH:D005234 therapeutic 24497646 +STS 412 Hepatitis, Alcoholic MESH:D006519 marker/mechanism 26220752 +STS 412 Ichthyosis, X-Linked MESH:D016114 marker/mechanism 308100.0 10679952|14641695|9623797 +STS 412 Inflammation MESH:D007249 therapeutic 24497646 +STS 412 Insulin Resistance MESH:D007333 therapeutic 24497646 +STS 412 Obesity MESH:D009765 therapeutic 24497646 +STS 412 Weight Gain MESH:D015430 therapeutic 24497646 +STT3A 3703 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL RECESSIVE OMIM:615596 marker/mechanism 615596.0 +STT3B 201595 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix OMIM:615597 marker/mechanism 615597.0 +STUB1 10273 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 615768.0 +STX11 8676 Hemophagocytic lymphohistiocytosis, familial, 4 MESH:C537252 marker/mechanism 603552.0 +STX16 8675 Pseudohypoaldosteronism MESH:D011546 marker/mechanism 603233.0 +STX17 55014 Alopecia Areata MESH:D000506 marker/mechanism 20596022 +STX17 55014 Melanoma MESH:D008545 marker/mechanism 18641652 +STX1A 6804 Autistic Disorder MESH:D001321 marker/mechanism 18593506 +STX1B 112755 Epilepsy MESH:D004827 marker/mechanism 25362483 +STX1B 112755 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9 OMIM:616172 marker/mechanism 616172.0 +STX1B 112755 Seizures, Febrile MESH:D003294 marker/mechanism 25362483 +STX2 2054 Infertility, Male MESH:D007248 marker/mechanism 18277055 +STX4A 20909 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +STX6 10228 Ceroid Lipofuscinosis, Neuronal, 6 MESH:C566627 marker/mechanism 23516525 +STX6 10228 Supranuclear Palsy, Progressive MESH:D013494 marker/mechanism 21685912 +STXBP1 6812 Epilepsies, Myoclonic MESH:D004831 marker/mechanism 18469812|29929108 +STXBP1 6812 Epilepsy MESH:D004827 marker/mechanism 29942082 +STXBP1 6812 Epileptic Encephalopathy, Early Infantile, 4 MESH:C567404 marker/mechanism 612164.0 +STXBP1 6812 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +STXBP2 6813 Blood Platelet Disorders MESH:D001791 marker/mechanism 30696774 +STXBP2 6813 Carotid Artery Thrombosis MESH:D002341 therapeutic 30696774 +STXBP2 6813 Hemophagocytic Lymphohistiocytosis, Familial, 5 MESH:C567752 marker/mechanism 613101.0 +STXBP2 6813 Hemorrhage MESH:D006470 marker/mechanism 30696774 +STXBP4 252983 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +STXBP6 29091 Autistic Disorder MESH:D001321 marker/mechanism 20071347 +SUCLA2 8803 MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA) OMIM:612073 marker/mechanism 612073.0 +SUCLA2 8803 Obesity MESH:D009765 marker/mechanism 20882379 +SUCLG1 8802 Disease Progression MESH:D018450 marker/mechanism 21364753 +SUCLG1 8802 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA) OMIM:245400 marker/mechanism 245400.0 +SUCLG1 8802 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +SUCLG2 8801 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +SUCLG2 8801 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +SUCLG2 8801 Endometriosis MESH:D004715 marker/mechanism 23284138 +SUCLG2 8801 Methylmalonic acidemia MESH:C537358 marker/mechanism 16823967 +SUCLG2 8801 Obesity MESH:D009765 marker/mechanism 20882379 +SUFU 51684 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 26950094 +SUFU 51684 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +SUFU 51684 Medulloblastoma MESH:D008527 marker/mechanism 155255.0 +SUFU 51684 Meningioma, familial MESH:C537443 marker/mechanism 607174.0 +SUGCT 79783 Glutaric Aciduria III MESH:C562818 marker/mechanism 231690.0 +SUGCT 79783 Migraine Disorders MESH:D008881 marker/mechanism 23793025 +SUGCT 79783 Pancreatic Neoplasms MESH:D010190 marker/mechanism 26098869 +SUGCT 79783 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +SUL-3 183778 Infertility MESH:D007246 marker/mechanism 25204677 +SULF1 23213 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SULF1 23213 Ovarian Neoplasms MESH:D010051 marker/mechanism 17310998 +SULF1 23213 Precancerous Conditions MESH:D011230 marker/mechanism 30127996 +SULF2 55959 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SULF2 55959 Endometriosis MESH:D004715 marker/mechanism 20864642|21063030 +SULT1A1 6817 Breast Neoplasms MESH:D001943 marker/mechanism 30120701 +SULT1A1 6817 Chromosome Aberrations MESH:D002869 marker/mechanism 16537716 +SULT1A1 6817 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +SULT1A1 6817 Genomic Instability MESH:D042822 marker/mechanism 28326452 +SULT1A1 6817 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +SULT1A1 6817 Neural Tube Defects MESH:D009436 marker/mechanism 24307569 +SULT1A1 6817 Prostatic Neoplasms MESH:D011471 marker/mechanism 14973106 +SULT1A1 6817 Recurrence MESH:D012008 marker/mechanism 30120701 +SULT1A1 6817 Urologic Neoplasms MESH:D014571 marker/mechanism 18006944 +SULT1A2 6799 Chromosome Aberrations MESH:D002869 marker/mechanism 16537716 +SULT1B1 27284 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SULT1C2 6819 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SULT1C3 442038 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SULT1C3 442038 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +SULT1E1 6783 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +SULT1E1 6783 Hepatitis, Alcoholic MESH:D006519 marker/mechanism 26220752 +SULT1E1 6783 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +SULT1E1 6783 Liver Diseases MESH:D008107 marker/mechanism 25922074 +SULT1E1 6783 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SULT1E1 6783 Reperfusion Injury MESH:D015427 marker/mechanism 25922074 +SULT2A1 6822 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17072980 +SULT2A1 6822 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +SULT2B1 6820 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SULT2B1 6820 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 27052460 +SULT2B1 6820 Cholestasis MESH:D002779 marker/mechanism 27052460 +SULT2B1 6820 Colorectal Neoplasms MESH:D015179 marker/mechanism 29766219 +SULT2B1 6820 Endometrial Neoplasms MESH:D016889 marker/mechanism 25437045 +SULT2B1 6820 Inflammation MESH:D007249 marker/mechanism 27052460 +SULT2B1 6820 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +SULT3A1 57430 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 25376053 +SUMF1 285362 Multiple Sulfatase Deficiency Disease MESH:D052517 marker/mechanism 272200.0 17657823 +SUMO1 7341 Cleft Lip MESH:D002971 marker/mechanism 16990542 +SUMO1 7341 Cleft Palate MESH:D002972 marker/mechanism 16990542 +SUMO1 7341 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +SUMO1 7341 Orofacial Cleft 10 MESH:C566605 marker/mechanism 613705.0 +SUMO4 387082 Diabetes Mellitus, Insulin-Dependent, 5 MESH:C563958 marker/mechanism 600320.0 +SUN1 23353 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +SUN5 140732 SPERMATOGENIC FAILURE 16 OMIM:617187 marker/mechanism 617187.0 +SUOX 6821 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SUOX 6821 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +SUOX 6821 Sulfite oxidase deficiency MESH:C538141 marker/mechanism 272300.0 +SUPV3L1 6832 Alopecia MESH:D000505 marker/mechanism 19145458 +SUPV3L1 6832 Ichthyosis MESH:D007057 marker/mechanism 19145458 +SUPV3L1 6832 Sarcopenia MESH:D055948 marker/mechanism 19145458 +SUPV3L1 6832 Skin Abnormalities MESH:D012868 marker/mechanism 19145458 +SU(R) 31858 Purine-Pyrimidine Metabolism, Inborn Errors MESH:D011686 marker/mechanism 16361227 +SURF1 6834 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K OMIM:616684 marker/mechanism 616684.0 +SURF1 6834 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16765830 +SURF1 6834 Cytochrome-c Oxidase Deficiency MESH:D030401 marker/mechanism 220110.0 +SURF1 6834 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +SURF1 6834 Leigh Disease MESH:D007888 marker/mechanism 16765830 +SURF1 6834 Leigh syndrome , French Canadian type MESH:C537004 marker/mechanism 16326995 +SURF4 6836 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +SUV39H1 6839 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 29391238 +SUV39H1 6839 Chromosome Breakage MESH:D019457 marker/mechanism 29391238 +SUZ12 23512 Adenoma MESH:D000236 marker/mechanism 25119042 +SUZ12 23512 Endometrial Neoplasms MESH:D016889 marker/mechanism 18264096 +SUZ12 23512 Glioblastoma MESH:D005909 marker/mechanism 25119042 +SUZ12 23512 Glioma MESH:D005910 marker/mechanism 25119042 +SUZ12 23512 Melanoma MESH:D008545 marker/mechanism 25119042 +SUZ12 23512 Nerve Sheath Neoplasms MESH:D018317 marker/mechanism 25240281|25305755 +SUZ12 23512 Neurilemmoma MESH:D009442 marker/mechanism 25119042 +SUZ12 23512 Neurofibroma MESH:D009455 marker/mechanism 25119042 +SUZ12 23512 Nevus, Pigmented MESH:D009508 marker/mechanism 25119042 +SV2B 9899 Kidney Diseases MESH:D007674 marker/mechanism 16943307 +SVIL 6840 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +SYCE1 93426 PREMATURE OVARIAN FAILURE 12 OMIM:616947 marker/mechanism 616947.0 +SYCE1 93426 SPERMATOGENIC FAILURE 15 OMIM:616950 marker/mechanism 616950.0 +SYCP1 6847 Adenocarcinoma MESH:D000230 marker/mechanism 14991579 +SYCP1 6847 Pancreatic Neoplasms MESH:D010190 marker/mechanism 14991579 +SYCP3 50511 Abortion, Habitual MESH:D000026 marker/mechanism 19110213 +SYCP3 50511 Azoospermia MESH:D053713 marker/mechanism 14643120 +SYCP3 50511 SPERMATOGENIC FAILURE 4 OMIM:270960 marker/mechanism 270960.0 +SYK 6850 Arthritis MESH:D001168 marker/mechanism 33782605 +SYK 6850 Colitis MESH:D003092 marker/mechanism 33782605 +SYK 6850 Dermatitis MESH:D003872 marker/mechanism 33782605 +SYK 6850 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 33782605 +SYK 6850 Melanoma MESH:D008545 marker/mechanism 17145863 +SYK 6850 Mesothelioma MESH:D008654 marker/mechanism 17659810 +SYMPK 8189 Disease Progression MESH:D018450 marker/mechanism 21364753 +SYMPK 8189 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +SYN1 6853 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +SYN1 6853 Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders MESH:C564505 marker/mechanism 300491.0 +SYN1 6853 Mental Retardation, X-Linked 50 MESH:C564713 marker/mechanism 300115.0 +SYN2 6854 Hyperalgesia MESH:D006930 marker/mechanism 18701217 +SYN2 6854 Schizophrenia MESH:D012559 marker/mechanism 181500.0 +SYN2 6854 Seizures MESH:D012640 marker/mechanism 18701217 +SYNCRIP 10492 Leukemia MESH:D007938 therapeutic 28436985 +SYNE1 23345 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +SYNE1 23345 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500|21278247 +SYNE1 23345 Muscular Dystrophy, Emery-Dreifuss MESH:D020389 marker/mechanism 612998.0 +SYNE1 23345 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 24952746 +SYNE1 23345 Spinocerebellar Ataxia, Autosomal Recessive 8 MESH:C565188 marker/mechanism 610743.0 +SYNE1 23345 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +SYNE2 23224 Atrial Fibrillation MESH:D001281 marker/mechanism 22544366|29892015 +SYNE2 23224 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +SYNE2 23224 Muscular Dystrophy, Emery-Dreifuss MESH:D020389 marker/mechanism 612999.0 +SYNE4 163183 DEAFNESS, AUTOSOMAL RECESSIVE 76 OMIM:615540 marker/mechanism 615540.0 +SYNGAP1 8831 Autistic Disorder MESH:D001321 marker/mechanism 20531469 +SYNGAP1 8831 Epilepsy MESH:D004827 marker/mechanism 23708187|29942082 +SYNGAP1 8831 Intellectual Disability MESH:D008607 marker/mechanism 21076407 +SYNGAP1 8831 Mental Retardation, Autosomal Dominant 5 MESH:C567234 marker/mechanism 612621.0 +SYNGAP1 8831 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +SYNGR1 9145 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +SYNGR1 9145 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 26808113 +SYNJ1 8867 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53 OMIM:617389 marker/mechanism 617389.0 +SYNJ1 8867 PARKINSON DISEASE 20, EARLY-ONSET OMIM:615530 marker/mechanism 615530.0 +SYNJ2 8871 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +SYNPO2 171024 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 25581431 +SYNPO2L 79933 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +SYNRG 11276 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +SYP 6855 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21595568 +SYP 6855 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254 +SYP 6855 Ceroid Lipofuscinosis, Neuronal, 6 MESH:C566627 marker/mechanism 23516525 +SYP 6855 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 96 OMIM:300802 marker/mechanism 300802.0 +SYP 6855 Learning Disabilities MESH:D007859 marker/mechanism 21295146 +SYP 6855 Memory Disorders MESH:D008569 marker/mechanism 21295146 +SYP 6855 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 19377476 +SYP 6855 Schizophrenia MESH:D012559 marker/mechanism 11483314 +SYS1 90196 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +SYT13 57586 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +SYT14 255928 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 614229.0 +SYT2 127833 Myasthenic Syndromes, Congenital MESH:D020294 marker/mechanism 616040.0 +SYT4 6860 Melanoma MESH:D008545 marker/mechanism 21499247 +SZT2 23334 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18 OMIM:615476 marker/mechanism 615476.0 +T07E3.4 175961 Death MESH:D003643 marker/mechanism 25204677 +T07E3.4 175961 Infertility MESH:D007246 marker/mechanism 25204677 +T20F7.3 188657 Infertility MESH:D007246 marker/mechanism 25204677 +T22E5.1 188743 Infertility MESH:D007246 marker/mechanism 25204677 +TAB1 10454 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TAB2 23118 CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2 OMIM:614980 marker/mechanism 614980.0 +TAC1 6863 Amnesia MESH:D000647 therapeutic 20600432|7562510|9521815 +TAC1 6863 Anorexia MESH:D000855 marker/mechanism 30336258 +TAC1 6863 Arthritis, Experimental MESH:D001169 marker/mechanism 9259450 +TAC1 6863 Bipolar Disorder MESH:D001714 marker/mechanism 15845098 +TAC1 6863 Bradycardia MESH:D001919 marker/mechanism 2445440|8960879 +TAC1 6863 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 16777450 +TAC1 6863 Corneal Diseases MESH:D003316 therapeutic 12824234 +TAC1 6863 Depressive Disorder, Major MESH:D003865 marker/mechanism 15845098 +TAC1 6863 Drug Eruptions MESH:D003875 marker/mechanism 1371395 +TAC1 6863 Drug Hypersensitivity MESH:D004342 marker/mechanism 21233199 +TAC1 6863 Edema MESH:D004487 marker/mechanism 7508328 +TAC1 6863 Extravasation of Diagnostic and Therapeutic Materials MESH:D005119 marker/mechanism 8938667|9622145 +TAC1 6863 Fibrosis MESH:D005355 marker/mechanism 28647476 +TAC1 6863 Gastroesophageal Reflux MESH:D005764 marker/mechanism 20616304 +TAC1 6863 Hyperalgesia MESH:D006930 marker/mechanism 10499367|12351280|12787826|15626726|16259764|18234883|19231294|8864563|9714424 +TAC1 6863 Hyperemia MESH:D006940 therapeutic 10564113|7507874 +TAC1 6863 Hypersensitivity MESH:D006967 marker/mechanism 11160071 +TAC1 6863 Hypotension MESH:D007022 marker/mechanism 20138590|2445440 +TAC1 6863 Inflammation MESH:D007249 marker/mechanism 14499429|21294877|30116771|8880065 +TAC1 6863 Migraine without Aura MESH:D020326 marker/mechanism 11304026 +TAC1 6863 Narcolepsy MESH:D009290 marker/mechanism 17521418 +TAC1 6863 Neuralgia MESH:D009437 marker/mechanism 18400411 +TAC1 6863 Neurogenic Inflammation MESH:D020078 marker/mechanism 17257769|17961222|20138590|21570423|9291295 +TAC1 6863 Pain MESH:D010146 marker/mechanism 10445233|7694222 +TAC1 6863 Pruritus MESH:D011537 marker/mechanism 19652466 +TAC1 6863 Schizophrenia MESH:D012559 marker/mechanism 15845098 +TAC1 6863 Sialorrhea MESH:D012798 marker/mechanism 8938667 +TAC1 6863 Vomiting MESH:D014839 marker/mechanism 31738934 +TAC3 6866 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TAC3 6866 Hypogonadism MESH:D007006 marker/mechanism 19079066 +TAC3 6866 HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA OMIM:614839 marker/mechanism 614839.0 +TACC3 10460 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TACC3 10460 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 24121792 +TACC3 10460 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 24121792 +TACO1 51204 Cytochrome-c Oxidase Deficiency MESH:D030401 marker/mechanism 19503089 +TACO1 51204 Leigh Disease MESH:D007888 marker/mechanism 19503089 +TACR1 6869 Alcoholism MESH:D000437 marker/mechanism 19204064 +TACR1 6869 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 19204064 +TACR1 6869 Bipolar Disorder MESH:D001714 marker/mechanism 19204064 +TACR1 6869 Bradycardia MESH:D001919 therapeutic 9696263 +TACR1 6869 Bronchial Diseases MESH:D001982 marker/mechanism 15774269 +TACR1 6869 Hyperalgesia MESH:D006930 marker/mechanism 15964684|17123731 +TACR1 6869 Hypertension MESH:D006973 marker/mechanism 21294877 +TACR1 6869 Neurogenic Inflammation MESH:D020078 marker/mechanism 17257769|21570423 +TACR1 6869 Substance Withdrawal Syndrome MESH:D013375 marker/mechanism 7692360 +TACR1 6869 Vomiting MESH:D014839 marker/mechanism 15680276 +TACR2 6865 Bronchial Diseases MESH:D001982 marker/mechanism 15774269 +TACR3 6870 Alcoholism MESH:D000437 marker/mechanism 18422838 +TACR3 6870 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18422838 +TACR3 6870 Hypogonadism MESH:D007006 marker/mechanism 19079066 +TACR3 6870 HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA OMIM:614840 marker/mechanism 614840.0 +TACSTD2 4070 Corneal dystrophy, gelatinous drop-like MESH:C535480 marker/mechanism 204870.0 +TACSTD2 4070 Endometriosis MESH:D004715 marker/mechanism 20864642 +TAF1 6872 Dystonia 3, Torsion, X-Linked MESH:C564048 marker/mechanism 314250.0 +TAF1 6872 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 33 OMIM:300966 marker/mechanism 300966.0 +TAF13 6884 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 60 OMIM:617432 marker/mechanism 617432.0 +TAF15 8148 Chondrosarcoma, Extraskeletal Myxoid MESH:C563195 marker/mechanism 612237.0 +TAF15 8148 Disease Progression MESH:D018450 marker/mechanism 21364753 +TAF15 8148 Osteosarcoma MESH:D012516 marker/mechanism 14767549 +TAF15 8148 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +TAF1C 9013 Autistic Disorder MESH:D001321 marker/mechanism 20663923 +TAF1D 79101 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +TAF1D 79101 Skin Diseases MESH:D012871 marker/mechanism 16835338 +TAF1L 138474 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +TAF2 6873 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +TAF2 6873 NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES, THIN CORPUS CALLOSUM, AND FOOT DEFORMITY OMIM:615599 marker/mechanism 615599.0 +TAF4B 6875 SPERMATOGENIC FAILURE 13 OMIM:615841 marker/mechanism 615841.0 +TAF6 6878 ALAZAMI-YUAN SYNDROME OMIM:617126 marker/mechanism 617126.0 +TAF9 6880 HIV Infections MESH:D015658 marker/mechanism 15308739 +TAFA2 338811 Anxiety Disorders MESH:D001008 marker/mechanism 29339520 +TAFA2 338811 Cognitive Dysfunction MESH:D060825 marker/mechanism 29339520 +TAFA4 151647 Breast Neoplasms MESH:D001943 marker/mechanism 15818620 +TAFAZZIN 6901 Barth Syndrome MESH:D056889 marker/mechanism 302060.0 18430085|25185984 +TAGAP 117289 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +TAGAP 117289 Crohn Disease MESH:D003424 marker/mechanism 21102463|36038634 +TAGAP 117289 Psoriasis MESH:D011565 marker/mechanism 23143594 +TAGLN 6876 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +TAGLN 6876 Endometriosis MESH:D004715 marker/mechanism 21063030 +TAGLN 6876 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +TAGLN 6876 Keloid MESH:D007627 marker/mechanism 20128793 +TAGLN 6876 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414|17175557 +TAGLN2 8407 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +TAGLN2 8407 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +TAGLN2 8407 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +TAGLN2 8407 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +TAGLN2 8407 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TAL1 6886 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 613065.0 +TAL1 6886 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 19246562|24394663 +TAL2 6887 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 613065.0 +TALDO1 6888 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19436114 +TALDO1 6888 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 19436114 +TALDO1 6888 Parkinson Disease MESH:D010300 marker/mechanism 23233872 +TALDO1 6888 Transaldolase Deficiency MESH:C563207 marker/mechanism 606003.0 +TANC2 26115 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +TANK 10010 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +TAOK1 57551 Hearing Loss, Noise-Induced MESH:D006317 marker/mechanism 23472202 +TAP1 6890 Bare Lymphocyte Syndrome, Type I MESH:C565759 marker/mechanism 604571.0 +TAP1 6890 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +TAP1 6890 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +TAP1 6890 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +TAP2 6891 Bare Lymphocyte Syndrome, Type I MESH:C565759 marker/mechanism 604571.0 +TAP2 6891 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TAP2 6891 Pneumoconiosis MESH:D011009 marker/mechanism 35506645 +TAPBP 6892 Bare Lymphocyte Syndrome, Type I MESH:C565759 marker/mechanism 604571.0 +TAPT1 202018 OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE OMIM:616897 marker/mechanism 616897.0 +TARBP2 6895 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +TARDBP 23435 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 18372902|21167262|22879928|23104007|23891805|24019256|24252504|26980269|28122516|28478440|29419416|30157956 +TARDBP 23435 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 24477737 +TARDBP 23435 Amyotrophic Lateral Sclerosis 10 MESH:C567429 marker/mechanism 612069.0 +TARDBP 23435 Frontotemporal Lobar Degeneration MESH:D057174 marker/mechanism 24019256|24252504|24477737|26980269 +TARDBP 23435 Neurodegenerative Diseases MESH:D019636 marker/mechanism 33479441 +TARS1 6897 Myositis MESH:D009220 marker/mechanism 23425968 +TARS2 80222 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21 OMIM:615918 marker/mechanism 615918.0 +TAS1R3 83756 Infertility, Male MESH:D007248 marker/mechanism 23818598 +TAS2R16 50833 Alcoholism MESH:D000437 marker/mechanism 103780.0 16385453|17250611 +TAS2R38 5726 Alcoholism MESH:D000437 marker/mechanism 17250611 +TAS2R38 5726 THIOUREA TASTING OMIM:171200 marker/mechanism 171200.0 +TAS2R60 338398 Melanoma MESH:D008545 marker/mechanism 21499247 +TAT 6898 Tyrosinemias MESH:D020176 marker/mechanism 276600.0 +TATDN1 83940 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +TAX1BP3 30851 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TBC-18 181091 Infertility MESH:D007246 marker/mechanism 25204677 +TBC1D1 23216 Obesity MESH:D009765 marker/mechanism 16893906|18325908|18931681 +TBC1D2 55357 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +TBC1D20 128637 Warburg Sjo Fledelius syndrome MESH:C536681 marker/mechanism 615663.0 +TBC1D24 57465 DEAFNESS, AUTOSOMAL DOMINANT 65 OMIM:616044 marker/mechanism 616044.0 +TBC1D24 57465 DEAFNESS, AUTOSOMAL RECESSIVE 86 OMIM:614617 marker/mechanism 614617.0 +TBC1D24 57465 Epilepsy, rolandic with paroxysmal exercise-induced dystonia and writer's cramp MESH:C535499 marker/mechanism 608105.0 +TBC1D24 57465 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 25401298 +TBC1D24 57465 MYOCLONIC EPILEPSY, FAMILIAL INFANTILE OMIM:605021 marker/mechanism 605021.0 +TBC1D4 9882 TYPE 2 DIABETES 5 OMIM:616087 marker/mechanism 616087.0 +TBC1D7 51256 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +TBC1D9 23158 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TBCA 6902 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 9527842 +TBCB 1155 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +TBCD 6904 Developmental Disabilities MESH:D002658 marker/mechanism 27666370 +TBCD 6904 ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM OMIM:617193 marker/mechanism 617193.0 27666370|27666374 +TBCD 6904 Intellectual Disability MESH:D008607 marker/mechanism 27666370 +TBCD 6904 Malformations of Cortical Development MESH:D054220 marker/mechanism 27666370 +TBCD 6904 Microcephaly MESH:D008831 marker/mechanism 27666370|27666374 +TBCD 6904 Muscle Weakness MESH:D018908 marker/mechanism 27666374 +TBCD 6904 Neurodegenerative Diseases MESH:D019636 marker/mechanism 27666370 +TBCD 6904 Optic Atrophy MESH:D009896 marker/mechanism 27666370 +TBCD 6904 Quadriplegia MESH:D011782 marker/mechanism 27666370 +TBCD 6904 Respiratory Insufficiency MESH:D012131 marker/mechanism 27666374 +TBCD 6904 Seizures MESH:D012640 marker/mechanism 27666370 +TBCE 6905 Bacterial Infections MESH:D001424 marker/mechanism 12389028 +TBCE 6905 Craniofacial Abnormalities MESH:D019465 marker/mechanism 12389028 +TBCE 6905 ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY OMIM:617207 marker/mechanism 617207.0 +TBCE 6905 Facies MESH:D019066 marker/mechanism 12389028 +TBCE 6905 Hypoparathyroidism-retardation-dysmorphism syndrome MESH:C537157 marker/mechanism 241410.0 12389028 +TBCE 6905 Kenny-Caffey syndrome, Type 1 MESH:C537021 marker/mechanism 244460.0 +TBCE 6905 Kenny-Caffey syndrome, type 2 MESH:C537020 marker/mechanism 12389028 +TBCE 6905 Osteosclerosis MESH:D010026 marker/mechanism 12389028 +TBCK 93627 HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3 OMIM:616900 marker/mechanism 616900.0 +TBK1 29110 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4 OMIM:616439 marker/mechanism 616439.0 +TBK1 29110 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 26861016 +TBKBP1 9755 Spondylitis, Ankylosing MESH:D013167 marker/mechanism 21743469 +TBL1X 6907 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 22050706 +TBL1XR1 79718 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 41 OMIM:616944 marker/mechanism 616944.0 +TBL1XR1 79718 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +TBL1XR1 79718 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +TBL1XR1 79718 Plantar Lipomatosis, Unusual Facies, and Developmental Delay MESH:C566559 marker/mechanism 602342.0 +TBL1XR1 79718 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +TBP 6908 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +TBP 6908 Spinocerebellar Ataxia 17 MESH:C564616 marker/mechanism 607136.0 +TBR1 10716 Autistic Disorder MESH:D001321 marker/mechanism 606053.0 +TBR1 10716 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +TBX1 6899 CONOTRUNCAL HEART MALFORMATIONS OMIM:217095 marker/mechanism 217095 +TBX1 6899 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15190012|17000704 +TBX1 6899 DiGeorge Syndrome MESH:D004062 marker/mechanism 188400|192430 15190012|16399080|17000704 +TBX1 6899 Heart Defects, Congenital MESH:D006330 marker/mechanism 17000704 +TBX1 6899 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TBX1 6899 Tetralogy of Fallot MESH:D013771 marker/mechanism 187500 25093829 +TBX15 6913 COUSIN SYNDROME OMIM:260660 marker/mechanism 260660 +TBX15 6913 Craniofacial Abnormalities MESH:D019465 marker/mechanism 19068278 +TBX15 6913 Growth Disorders MESH:D006130 marker/mechanism 19068278 +TBX15 6913 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +TBX15 6913 Pelviscapular dysplasia MESH:C535550 marker/mechanism 19068278 +TBX18 9096 Multicystic renal dysplasia, bilateral MESH:C537373 marker/mechanism 143400 +TBX19 9095 ACTH Deficiency, Isolated MESH:C562707 marker/mechanism 201400 16390921 +TBX19 9095 Alcoholism MESH:D000437 marker/mechanism 18438686 +TBX2 6909 Coronary Artery Disease MESH:D003324 marker/mechanism 35590109 +TBX2 6909 Neuroblastoma MESH:D009447 marker/mechanism 30127528 +TBX20 57057 Atrial Septal Defect 4 MESH:C566963 marker/mechanism 611363 +TBX20 57057 Cardiomegaly MESH:D006332 marker/mechanism 29394407 +TBX20 57057 Disease Models, Animal MESH:D004195 marker/mechanism 29394407 +TBX20 57057 Heart Failure MESH:D006333 marker/mechanism 29394407 +TBX20 57057 Ventricular Remodeling MESH:D020257 marker/mechanism 29394407 +TBX21 30009 Asthma MESH:D001249 marker/mechanism 15806396 +TBX21 30009 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 16502481 +TBX21 30009 Asthma, Nasal Polyps, And Aspirin Intolerance MESH:C565935 marker/mechanism 208550 +TBX21 30009 Inflammation MESH:D007249 marker/mechanism 22325453 +TBX21 30009 Kidney Failure, Chronic MESH:D007676 marker/mechanism 26970513 +TBX22 50945 Abruzzo Erickson syndrome MESH:C535559 marker/mechanism 302905 +TBX22 50945 Cleft palate X-linked MESH:C536426 marker/mechanism 303400 +TBX3 6926 Breast Neoplasms MESH:D001943 marker/mechanism 21098263 +TBX3 6926 Limb Deformities, Congenital MESH:D017880 marker/mechanism 9207801 +TBX3 6926 Prostatic Neoplasms MESH:D011471 marker/mechanism 29662167 +TBX3 6926 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +TBX3 6926 Stroke MESH:D020521 marker/mechanism 29531354 +TBX3 6926 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +TBX3 6926 Tooth Abnormalities MESH:D014071 marker/mechanism 9207801 +TBX3 6926 Ulnar-mammary syndrome MESH:C536937 marker/mechanism 181450 9207801 +TBX4 9496 Ischiopatellar dysplasia MESH:C535540 marker/mechanism 147891 +TBX5 6910 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +TBX5 6910 Holt-Oram syndrome MESH:C535326 marker/mechanism 142900 15735645 +TBX6 6911 Cakut MESH:C566906 marker/mechanism 30578417 +TBX6 6911 SPONDYLOCOSTAL DYSOSTOSIS 5 OMIM:122600 marker/mechanism 122600.0 +TBXA2R 6915 Asthma, Aspirin-Induced MESH:D055963 marker/mechanism 16502481|20485159 +TBXA2R 6915 Bleeding Disorder due to Defective Thromboxane A2 Receptor MESH:C566055 marker/mechanism 614009.0 +TBXA2R 6915 Blood Platelet Disorders MESH:D001791 marker/mechanism 19828703|7929844 +TBXA2R 6915 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 22206755 +TBXA2R 6915 Hemorrhagic Disorders MESH:D006474 marker/mechanism 19828703 +TBXA2R 6915 Necrosis MESH:D009336 marker/mechanism 22206755 +TBXA2R 6915 Pulmonary Embolism MESH:D011655 marker/mechanism 7740511 +TBXA2R 6915 Rhinitis MESH:D012220 marker/mechanism 12167471 +TBXAS1 6916 Drug Hypersensitivity MESH:D004342 marker/mechanism 21449675 +TBXAS1 6916 Ghosal Hematodiaphyseal Dysplasia MESH:C565551 marker/mechanism 231095.0 18264100 +TBXAS1 6916 Prostatic Neoplasms MESH:D011471 marker/mechanism 22919386 +TBXT 6862 Chordoma MESH:D002817 marker/mechanism 19801981|23064415 +TBXT 6862 Neural Tube Defects MESH:D009436 marker/mechanism 182940.0 +TCAP 8557 Cardiomyopathy, Dilated, 1N MESH:C564388 marker/mechanism 607487.0 +TCAP 8557 Muscular Dystrophy, Limb-Girdle, Type 2G MESH:C566599 marker/mechanism 601954.0 +TCEA2 6919 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +TCEAL7 56849 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +TCERG1L 256536 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +TCF12 6938 Craniosynostoses MESH:D003398 marker/mechanism 615314.0 23354436 +TCF15 6939 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TCF19 6941 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TCF19 6941 Colonic Neoplasms MESH:D003110 marker/mechanism 15059925 +TCF20 6942 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TCF21 6943 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990|22751097 +TCF3 6929 Agammaglobulinemia MESH:D000361 marker/mechanism 616941.0 +TCF3 6929 Burkitt Lymphoma MESH:D002051 marker/mechanism 17244677|1967982 +TCF3 6929 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 19246562 +TCF3 6929 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 26214592 +TCF4 6925 Corneal Dystrophy, Fuchs Endothelial, 3 MESH:C567678 marker/mechanism 613267.0 +TCF4 6925 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17436254 +TCF4 6925 Heart Diseases MESH:D006331 marker/mechanism 16844662 +TCF4 6925 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TCF4 6925 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +TCF4 6925 Microcephaly MESH:D008831 marker/mechanism 18728071 +TCF4 6925 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +TCF4 6925 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 21228734 +TCF4 6925 Pitt-Hopkins syndrome MESH:C537403 marker/mechanism 610954.0 17436254|18728071 +TCF4 6925 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +TCF4 6925 Seizures MESH:D012640 marker/mechanism 18728071 +TCF7 6932 Crohn Disease MESH:D003424 marker/mechanism 24994854 +TCF7 6932 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 26808113 +TCF7L1 83439 Thyroid Neoplasms MESH:D013964 marker/mechanism 23811263 +TCF7L2 6934 Adenocarcinoma MESH:D000230 marker/mechanism 21892161 +TCF7L2 6934 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TCF7L2 6934 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 29394407 +TCF7L2 6934 Colonic Neoplasms MESH:D003110 marker/mechanism 21383188 +TCF7L2 6934 Colorectal Neoplasms MESH:D015179 marker/mechanism 21892161|24836286 +TCF7L2 6934 Coronary Disease MESH:D003327 marker/mechanism 28869590 +TCF7L2 6934 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 17460697|23104008|28869590 +TCF7L2 6934 Disease Models, Animal MESH:D004195 marker/mechanism 29394407 +TCF7L2 6934 Hyperalgesia MESH:D006930 marker/mechanism 33607128 +TCF7L2 6934 Hyperplasia MESH:D006965 marker/mechanism 21383188 +TCF7L2 6934 Myocardial Ischemia MESH:D017202 marker/mechanism 29394407 +TCF7L2 6934 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +TCF7L2 6934 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +TCF7L2 6934 Ventricular Remodeling MESH:D020257 marker/mechanism 29394407 +TCHH 7062 Uncombable hair syndrome MESH:C536939 marker/mechanism 617252.0 +TCIM 56892 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TCIRG1 10312 Osteopetrosis, Autosomal Recessive 1 MESH:C564915 marker/mechanism 259700.0 +TCL1B 9623 Breast Neoplasms MESH:D001943 marker/mechanism 20228224 +TCL1B 9623 Neoplasm Metastasis MESH:D009362 marker/mechanism 20228224 +TCL1B 9623 Parkinson Disease MESH:D010300 marker/mechanism 25475535 +TCN1 6947 Anemia, Megaloblastic MESH:D000749 marker/mechanism 4627864 +TCN2 6948 Adenoma MESH:D000236 marker/mechanism 17389618 +TCN2 6948 Anemia, Megaloblastic MESH:D000749 marker/mechanism 4627864 +TCN2 6948 Autistic Disorder MESH:D001321 marker/mechanism 16917939 +TCN2 6948 Cleft Lip MESH:D002971 marker/mechanism 16470748 +TCN2 6948 Colorectal Neoplasms MESH:D015179 marker/mechanism 17389618 +TCN2 6948 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 15753437 +TCN2 6948 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 29379198 +TCN2 6948 Leukoencephalopathies MESH:D056784 marker/mechanism 15753437 +TCN2 6948 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TCN2 6948 TRANSCOBALAMIN II DEFICIENCY OMIM:275350 marker/mechanism 275350.0 +TCOF1 6949 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16938878 +TCOF1 6949 Mandibulofacial Dysostosis MESH:D008342 marker/mechanism 154500.0 16938878 +TCP1 6950 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973 +TCRA 21473 Lupus Erythematosus, Cutaneous MESH:D008178 marker/mechanism 15086387 +TCTN1 79600 Agenesis of Cerebellar Vermis MESH:C536293 marker/mechanism 21725307 +TCTN1 79600 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 17984051 +TCTN3 26123 Orofaciodigital syndrome 4 MESH:C537133 marker/mechanism 258860.0 +TCTP 41341 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +TDO2 6999 Autistic Disorder MESH:D001321 marker/mechanism 14755447 +TDO2 6999 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 35687267 +TDO2 6999 Starvation MESH:D013217 marker/mechanism 7306070 +TDP1 55775 Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy MESH:C537313 marker/mechanism 607250.0 +TDP2 51567 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 616949.0 +TDRD7 23424 Cataract MESH:D002386 marker/mechanism 21436445 +TDRD7 23424 CATARACT 36 OMIM:613887 marker/mechanism 613887.0 +TDRD7 23424 Glaucoma MESH:D005901 marker/mechanism 21436445 +TDRD7 23424 Infertility, Male MESH:D007248 marker/mechanism 21436445 +TDRD7 23424 Influenza, Human MESH:D007251 marker/mechanism 23326326 +TDRG1 732253 Colorectal Neoplasms MESH:D015179 marker/mechanism 35730470 +TEAD1 7003 Sveinsson Chorioretinal Atrophy MESH:C566236 marker/mechanism 108985.0 +TEAD1B 100006454 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +TEAD2 8463 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TECPR2 9895 Neuroaxonal Dystrophies MESH:D019150 marker/mechanism 26555167 +TECPR2 9895 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY OMIM:615031 marker/mechanism 615031.0 +TECPR2 9895 Paraparesis, Spastic MESH:D020336 marker/mechanism 23176824 +TECPR2 9895 Spastic Paraplegia, Hereditary MESH:D015419 marker/mechanism 23176824 +TECR 9524 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 14 OMIM:614020 marker/mechanism 614020.0 +TECRL 253017 Polymorphic catecholergic ventricular tachycardia MESH:C536334 marker/mechanism 614021.0 +TECTA 7007 Deafness, Autosomal Dominant 12 MESH:C563295 marker/mechanism 601543.0 +TECTA 7007 Deafness, Autosomal Recessive 21 MESH:C566353 marker/mechanism 603629.0 +TEDC2 80178 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TEK 7010 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 17533168 +TEK 7010 GLAUCOMA 3, PRIMARY CONGENITAL, E OMIM:617272 marker/mechanism 617272.0 +TEK 7010 Glaucoma 3, primary infantile, B MESH:C536824 marker/mechanism 600975.0 +TEK 7010 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +TEK 7010 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11956651 +TEK 7010 Neovascularization, Pathologic MESH:D009389 marker/mechanism 17533168 +TEK 7010 Venous Malformations, Multiple Cutaneous and Mucosal MESH:C563977 marker/mechanism 600195.0 19079259 +TEKT5 146279 Schizophrenia MESH:D012559 marker/mechanism 21822266 +TELO2 9894 YOU-HOOVER-FONG SYNDROME OMIM:616954 marker/mechanism 616954.0 +TENM2 57451 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +TENM3 55714 Asthma, Occupational MESH:D059366 marker/mechanism 25918132 +TENM3 55714 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +TENM3 55714 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9 OMIM:615145 marker/mechanism 615145.0 +TENM4 26011 Bipolar Disorder MESH:D001714 marker/mechanism 21926972 +TENM4 26011 TREMOR, HEREDITARY ESSENTIAL, 5 OMIM:616736 marker/mechanism 616736.0 +TEP1 7011 Lung Neoplasms MESH:D008175 marker/mechanism 11323394 +TERC 7012 Carcinoma, Squamous Cell MESH:D002294 therapeutic 16051514 +TERC 7012 Dyskeratosis Congenita MESH:D019871 marker/mechanism 17785587 +TERC 7012 Dyskeratosis Congenita, Autosomal Dominant MESH:C565079 marker/mechanism 127550.0 +TERC 7012 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 17392301|17460043|23535734 +TERC 7012 Prostatic Neoplasms MESH:D011471 therapeutic 16520278 +TERC 7012 PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 2 OMIM:614743 marker/mechanism 614743.0 +TERC 7012 Tongue Neoplasms MESH:D014062 therapeutic 16051514 +TERF2 7014 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 17643074 +TERT 7015 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 24747642 +TERT 7015 Anemia, Aplastic MESH:D000741 marker/mechanism 609135.0 15814878 +TERT 7015 Breast Neoplasms MESH:D001943 marker/mechanism 23535731 +TERT 7015 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 19151717 +TERT 7015 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16651430|22634754|25362482|25822088 +TERT 7015 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 21252717 +TERT 7015 Coronary Artery Disease MESH:D003324 marker/mechanism 16890917 +TERT 7015 Cri-du-Chat Syndrome MESH:D003410 marker/mechanism 12629597 +TERT 7015 Disease Progression MESH:D018450 marker/mechanism 21252717 +TERT 7015 Dyskeratosis Congenita MESH:D019871 marker/mechanism 16247010|17785587|18042801 +TERT 7015 Dyskeratosis Congenita, Autosomal Dominant MESH:C565079 marker/mechanism 127550.0 +TERT 7015 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2 OMIM:613989 marker/mechanism 613989.0 +TERT 7015 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29047144 +TERT 7015 Glioma MESH:D005910 marker/mechanism 18021753|19578367 +TERT 7015 Hoyeraal Hreidarsson syndrome MESH:C536068 marker/mechanism 17785587 +TERT 7015 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 178500.0 17392301|17460043|23535734|23583980|30203795 +TERT 7015 Kidney Diseases MESH:D007674 marker/mechanism 16968891 +TERT 7015 Leukemia, Lymphoid MESH:D007945 marker/mechanism 24292274 +TERT 7015 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 17157168 +TERT 7015 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 601626.0 +TERT 7015 Liver Neoplasms MESH:D008113 marker/mechanism 27064257 +TERT 7015 Lung Neoplasms MESH:D008175 marker/mechanism 11323394|19151717|23433592 +TERT 7015 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 26808113 +TERT 7015 Melanoma MESH:D008545 therapeutic 20856939 +TERT 7015 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9 OMIM:615134 marker/mechanism 615134.0 +TERT 7015 Myeloproliferative Disorders MESH:D009196 marker/mechanism 29047144 +TERT 7015 Neoplasms MESH:D009369 marker/mechanism 25261935 +TERT 7015 Neuroblastoma MESH:D009447 marker/mechanism 26523776 +TERT 7015 Ovarian Neoplasms MESH:D010051 marker/mechanism 23535731 +TERT 7015 Pancreatic Neoplasms MESH:D010190 marker/mechanism 25086665|26098869 +TERT 7015 Prostatic Neoplasms MESH:D011471 marker/mechanism 19151717|21743467 +TERT 7015 PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 1 OMIM:614742 marker/mechanism 614742.0 +TERT 7015 Reperfusion Injury MESH:D015427 marker/mechanism 16968891 +TERT 7015 Thyroid Neoplasms MESH:D013964 marker/mechanism 25383969 +TERT 7015 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 19151717 +TERT 7015 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 19151717 +TES 26136 Glioblastoma MESH:D005909 marker/mechanism 16909125 +TES 26136 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TET1 80312 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 25290267 +TET2 54790 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +TET2 54790 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +TET2 54790 Immunoblastic Lymphadenopathy MESH:D007119 marker/mechanism 24413737 +TET2 54790 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 26285909 +TET2 54790 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 24413734|24413737 +TET2 54790 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 614286.0 19483684|27992414 +TET2 54790 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 26285909 +TET2 54790 Prostatic Neoplasms MESH:D011471 marker/mechanism 23593118 +TET2 54790 Sezary Syndrome MESH:D012751 marker/mechanism 26551667 +TET3 200424 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 25290267 +TEX11 56159 SPERMATOGENIC FAILURE, X-LINKED, 2 OMIM:309120 marker/mechanism 309120.0 +TEX41 401014 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +TF 7018 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +TF 7018 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 19381893 +TF 7018 Alcoholism MESH:D000437 marker/mechanism 11000917|21792595 +TF 7018 Alzheimer Disease MESH:D000544 marker/mechanism 15060098|17192785 +TF 7018 Anemia, hypochromic microcytic MESH:C536357 marker/mechanism 11110675 +TF 7018 Autistic Disorder MESH:D001321 marker/mechanism 15363659 +TF 7018 Carcinoma MESH:D002277 marker/mechanism 16316942|9879772 +TF 7018 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +TF 7018 Congenital atransferrinemia MESH:C538259 marker/mechanism 209300.0 11110675|12111369 +TF 7018 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +TF 7018 Echinococcosis MESH:D004443 marker/mechanism 24270252 +TF 7018 Fatty Liver MESH:D005234 marker/mechanism 20008134|21907177 +TF 7018 Hepatitis MESH:D006505 marker/mechanism 21907177 +TF 7018 Inflammation MESH:D007249 marker/mechanism 20008134 +TF 7018 Iron Overload MESH:D019190 marker/mechanism 11110675 +TF 7018 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942|9879772 +TF 7018 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942|9879772 +TF 7018 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26818092 +TF 7018 Neoplasm Invasiveness MESH:D009361 marker/mechanism 20390345 +TF 7018 Nephrotic Syndrome MESH:D009404 marker/mechanism 17178036 +TF 7018 Obesity MESH:D009765 marker/mechanism 20882379 +TF 7018 Paratuberculosis MESH:D010283 marker/mechanism 22633222 +TF 7018 Restless Legs Syndrome MESH:D012148 marker/mechanism 16930377 +TFAM 7019 Alzheimer Disease MESH:D000544 marker/mechanism 17192785 +TFAM 7019 Bowen's Disease MESH:D001913 marker/mechanism 21514422 +TFAM 7019 Ceroid lipofuscinosis, neuronal 1, infantile MESH:C537948 marker/mechanism 21224254 +TFAM 7019 Disease Models, Animal MESH:D004195 marker/mechanism 28595911 +TFAM 7019 MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE) OMIM:617156 marker/mechanism 617156.0 +TFAM 7019 Parkinson Disease, Secondary MESH:D010302 marker/mechanism 28595911 +TFAP2A 7020 Branchio-Oto-Renal Syndrome MESH:D019280 marker/mechanism 113620.0 19685247 +TFAP2A 7020 Breast Neoplasms MESH:D001943 therapeutic 16204029 +TFAP2A 7020 Craniofacial Abnormalities MESH:D019465 marker/mechanism 14534133|19685247 +TFAP2A 7020 Eye Abnormalities MESH:D005124 marker/mechanism 19685247 +TFAP2A 7020 Kidney Diseases MESH:D007674 marker/mechanism 19685247 +TFAP2B 7021 Body Weight MESH:D001835 marker/mechanism 22344219 +TFAP2B 7021 Char syndrome MESH:C566815 marker/mechanism 169100.0 +TFAP2B 7021 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10802654 +TFAP2B 7021 Ductus Arteriosus, Patent MESH:D004374 marker/mechanism 617035.0 10802654|19336370 +TFAP2B 7021 Hand Deformities, Congenital MESH:D006228 marker/mechanism 10802654 +TFAP2C 7022 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +TFDP1 7027 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TFDP2 7029 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +TFE3 7030 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 300854.0 +TFEB 7942 Nerve Degeneration MESH:D009410 therapeutic 34562559 +TFEC 22797 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TFF1 7031 Acute Lung Injury MESH:D055371 marker/mechanism 19880587 +TFF1 7031 Celiac Disease MESH:D002446 marker/mechanism 30097691 +TFF1 7031 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 21283680 +TFF2 7032 Acute Lung Injury MESH:D055371 marker/mechanism 19880587 +TFF3 7033 Acute Kidney Injury MESH:D058186 marker/mechanism 23052191 +TFF3 7033 Hepatitis, Animal MESH:D006520 marker/mechanism 18559427 +TFF3 7033 Kidney Diseases MESH:D007674 marker/mechanism 24863737 +TFF3 7033 Mucositis MESH:D052016 therapeutic 19636011 +TFG 10342 Neuropathy, hereditary motor and sensory, Okinawa type MESH:C535717 marker/mechanism 604484.0 +TFG 10342 SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE OMIM:615658 marker/mechanism 615658.0 +TFPI 7035 Activated Protein C Resistance MESH:D020016 marker/mechanism 11703344 +TFPI 7035 Airway Obstruction MESH:D000402 therapeutic 23727623 +TFPI 7035 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TFPI 7035 Hypoxia MESH:D000860 therapeutic 23727623 +TFPI 7035 Purpura, Thrombotic Thrombocytopenic MESH:D011697 marker/mechanism 7740478 +TFPI 7035 Venous Thrombosis MESH:D020246 therapeutic 18480984 +TFPI2 7980 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 15292528|17379860 +TFPI2 7980 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +TFPI2 7980 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 17464989|28284560 +TFPI2 7980 Colorectal Neoplasms MESH:D015179 marker/mechanism 19435926 +TFPI2 7980 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TFPI2 7980 Melanoma MESH:D008545 marker/mechanism 17372906 +TFPI2 7980 Neoplasm Metastasis MESH:D009362 marker/mechanism 17372906 +TFPI2 7980 Osteoarthritis MESH:D010003 marker/mechanism 15292528 +TFPI2 7980 Pancreatic Neoplasms MESH:D010190 marker/mechanism 16965396 +TFR2 7036 beta-Thalassemia MESH:D017086 marker/mechanism 16755567 +TFR2 7036 Hemochromatosis MESH:D006432 marker/mechanism 16935854|17241880|21411349|22383097 +TFR2 7036 Hemochromatosis, type 3 MESH:C537248 marker/mechanism 604250.0 +TFRC 7037 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TFRC 7037 Anemia, Iron-Deficiency MESH:D018798 marker/mechanism 16733738|17162259|17163184 +TFRC 7037 Arenaviridae Infections MESH:D001117 therapeutic 17287727 +TFRC 7037 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TFRC 7037 beta-Thalassemia MESH:D017086 marker/mechanism 16755567 +TFRC 7037 Breast Neoplasms MESH:D001943 marker/mechanism 16904380|19238537 +TFRC 7037 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21785164 +TFRC 7037 Colorectal Neoplasms MESH:D015179 marker/mechanism 16111806 +TFRC 7037 Glioma MESH:D005910 marker/mechanism 16904380 +TFRC 7037 Helicobacter Infections MESH:D016481 marker/mechanism 16733738|17163184 +TFRC 7037 IMMUNODEFICIENCY 46 OMIM:616740 marker/mechanism 616740.0 +TFRC 7037 Inflammation MESH:D007249 marker/mechanism 16603144 +TFRC 7037 Iron Metabolism Disorders MESH:D019189 marker/mechanism 17163184|17254562 +TFRC 7037 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 16904380 +TFRC 7037 Lung Neoplasms MESH:D008175 marker/mechanism 16904380 +TFRC 7037 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 16904380 +TFRC 7037 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +TFRC 7037 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 18549825 +TFRC 7037 Obesity MESH:D009765 marker/mechanism 17062801|20882379 +TFRC 7037 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TFRC 7037 Severe Combined Immunodeficiency MESH:D016511 marker/mechanism 26642240 +TFRC 7037 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 16904380 +TG 7038 Anxiety Disorders MESH:D001008 marker/mechanism 30373627 +TG 7038 Autoimmune Diseases MESH:D001327 marker/mechanism 27869686 +TG 7038 Depressive Disorder MESH:D003866 marker/mechanism 30373627 +TG 7038 Disease Models, Animal MESH:D004195 marker/mechanism 30373627 +TG 7038 Dwarfism MESH:D004392 marker/mechanism 24582622 +TG 7038 Goiter MESH:D006042 marker/mechanism 24582622|8094490 +TG 7038 Graves Disease MESH:D006111 marker/mechanism 33132244 +TG 7038 Hashimoto Disease MESH:D050031 marker/mechanism 30373627 +TG 7038 Thyroid Dyshormonogenesis 3 MESH:C562769 marker/mechanism 274700.0 +TG 7038 Thyroiditis, Autoimmune MESH:D013967 marker/mechanism 608175.0 29385629 +TGDS 23483 CATEL-MANZKE SYNDROME OMIM:616145 marker/mechanism 616145.0 +TGFA 7039 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 15565109|9029167 +TGFA 7039 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 16230376 +TGFA 7039 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 14514962 +TGFA 7039 Head and Neck Neoplasms MESH:D006258 marker/mechanism 15342401 +TGFA 7039 Hepatoblastoma MESH:D018197 marker/mechanism 11560253 +TGFA 7039 Hypertension, Pulmonary MESH:D006976 marker/mechanism 18424623 +TGFA 7039 Hypertrophy, Right Ventricular MESH:D017380 marker/mechanism 18424623 +TGFA 7039 Inflammation MESH:D007249 therapeutic 11919079 +TGFA 7039 Liver Neoplasms MESH:D008113 marker/mechanism 8807143 +TGFA 7039 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 9079223 +TGFA 7039 Lung Injury MESH:D055370 therapeutic 11919079 +TGFA 7039 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 8603490 +TGFA 7039 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 8603490 +TGFA 7039 Mucositis MESH:D052016 therapeutic 18803016 +TGFA 7039 Nerve Degeneration MESH:D009410 therapeutic 9263032 +TGFA 7039 Nonsyndromic Deafness MESH:C580334 marker/mechanism 27356075 +TGFA 7039 Papilloma MESH:D010212 marker/mechanism 8603490 +TGFA 7039 Prostatic Neoplasms MESH:D011471 therapeutic 17136230 +TGFA 7039 Psoriasis MESH:D011565 marker/mechanism 7519033 +TGFA 7039 Pulmonary Edema MESH:D011654 therapeutic 11919079 +TGFA 7039 Pulmonary Fibrosis MESH:D011658 marker/mechanism 18424623 +TGFA 7039 Stomach Neoplasms MESH:D013274 therapeutic 15723263 +TGFB1 7040 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TGFB1 7040 Acromicric dysplasia MESH:C535662 marker/mechanism 18677313 +TGFB1 7040 Acute Kidney Injury MESH:D058186 marker/mechanism 10469268 +TGFB1 7040 Acute Lung Injury MESH:D055371 marker/mechanism 16100012 +TGFB1 7040 Adenocarcinoma MESH:D000230 therapeutic 17418594 +TGFB1 7040 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +TGFB1 7040 Asthma MESH:D001249 marker/mechanism 16365456|19138248 +TGFB1 7040 Asthma, Occupational MESH:D059366 marker/mechanism 25721048 +TGFB1 7040 Berylliosis MESH:D001607 marker/mechanism 15750822|17785866 +TGFB1 7040 Brain Diseases MESH:D001927 marker/mechanism 29483653 +TGFB1 7040 Calcinosis MESH:D002114 marker/mechanism 24142982 +TGFB1 7040 Camurati-Engelmann Syndrome MESH:D003966 marker/mechanism 131300.0 +TGFB1 7040 Carcinoma MESH:D002277 therapeutic 12417722 +TGFB1 7040 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 9029167 +TGFB1 7040 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 20852150 +TGFB1 7040 Carcinosarcoma MESH:D002296 marker/mechanism 15132766 +TGFB1 7040 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 20172950 +TGFB1 7040 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951|30026087|31932644 +TGFB1 7040 Cleft Palate MESH:D002972 marker/mechanism 25450421 +TGFB1 7040 Colorectal Neoplasms MESH:D015179 marker/mechanism 24836286 +TGFB1 7040 Copper-Overload Cirrhosis MESH:C566858 marker/mechanism 22879914 +TGFB1 7040 Cystic Fibrosis MESH:D003550 marker/mechanism 219700.0 +TGFB1 7040 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 17177138|23090186 +TGFB1 7040 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 23500658 +TGFB1 7040 Diabetic Nephropathies MESH:D003928 marker/mechanism 18682491|19960420 +TGFB1 7040 Diabetic Neuropathies MESH:D003929 marker/mechanism 16696316 +TGFB1 7040 Dry Eye Syndromes MESH:D015352 marker/mechanism 22194977 +TGFB1 7040 Duodenal Ulcer MESH:D004381 therapeutic 12868675 +TGFB1 7040 Endomyocardial Fibrosis MESH:D004719 marker/mechanism 25450231 +TGFB1 7040 Epilepsy MESH:D004827 marker/mechanism 29483653 +TGFB1 7040 Fibrosis MESH:D005355 marker/mechanism 10469268|16306446|17947678|18705752|24142982|26054450|27870162|30809271 +TGFB1 7040 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 11728950 +TGFB1 7040 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 16191423|18682491|20493835 +TGFB1 7040 Gout MESH:D006073 marker/mechanism 36850003 +TGFB1 7040 Graves Disease MESH:D006111 marker/mechanism 33132244 +TGFB1 7040 Hepatic Insufficiency MESH:D048550 marker/mechanism 30026087 +TGFB1 7040 Hepatitis, Autoimmune MESH:D019693 marker/mechanism 21227906 +TGFB1 7040 Hepatitis, Chronic MESH:D006521 marker/mechanism 22879914 +TGFB1 7040 Hepatomegaly MESH:D006529 marker/mechanism 30026087 +TGFB1 7040 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10646786 +TGFB1 7040 Hyperplasia MESH:D006965 marker/mechanism 20172950 +TGFB1 7040 Hypersensitivity MESH:D006967 marker/mechanism 19138248|21625544 +TGFB1 7040 Hypertension MESH:D006973 marker/mechanism 11682445|19018797 +TGFB1 7040 Hyperuricemia MESH:D033461 marker/mechanism 36850003 +TGFB1 7040 Infant, Newborn, Diseases MESH:D007232 marker/mechanism 29483653 +TGFB1 7040 Inflammation MESH:D007249 marker/mechanism|therapeutic 19138248|20172950 +TGFB1 7040 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 29483653 +TGFB1 7040 Intervertebral Disc Degeneration MESH:D055959 therapeutic 21351055 +TGFB1 7040 Kidney Diseases MESH:D007674 marker/mechanism|therapeutic 11682445|14675041|18390891 +TGFB1 7040 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19420110 +TGFB1 7040 Liver Cirrhosis MESH:D008103 marker/mechanism 21037076|35101388|36368619 +TGFB1 7040 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +TGFB1 7040 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 30026087 +TGFB1 7040 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism|therapeutic 12586293|15772939|16579972|26806094|27605418 +TGFB1 7040 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 28100771 +TGFB1 7040 Lung Diseases MESH:D008171 marker/mechanism 11472967 +TGFB1 7040 Lung Neoplasms MESH:D008175 marker/mechanism|therapeutic 11074608|11641043|17418594 +TGFB1 7040 Lymphomatoid Papulosis MESH:D017731 therapeutic 11594583 +TGFB1 7040 Muscular Diseases MESH:D009135 marker/mechanism 21152098 +TGFB1 7040 Muscular Dystrophy, Duchenne MESH:D020388 marker/mechanism 21641384 +TGFB1 7040 Myocardial Infarction MESH:D009203 marker/mechanism 16310260 +TGFB1 7040 Neoplasm Invasiveness MESH:D009361 marker/mechanism 23992306|24727557|24793912|25884904|26896736|32745479 +TGFB1 7040 Neoplasm Metastasis MESH:D009362 marker/mechanism 23146760|23992306|26896736|31381904 +TGFB1 7040 Neoplasm Regression, Spontaneous MESH:D009365 marker/mechanism 11594583 +TGFB1 7040 Nephrosclerosis MESH:D009400 marker/mechanism 30818366 +TGFB1 7040 Nephrotic Syndrome MESH:D009404 marker/mechanism 10515446|1281619|8023968 +TGFB1 7040 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 21664615|32613381 +TGFB1 7040 Occupational Diseases MESH:D009784 marker/mechanism 24142982 +TGFB1 7040 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +TGFB1 7040 Osteoarthritis MESH:D010003 marker/mechanism 30664745 +TGFB1 7040 Osteoporosis MESH:D010024 marker/mechanism 12706579 +TGFB1 7040 Osteoporosis, Postmenopausal MESH:D015663 marker/mechanism 10750555 +TGFB1 7040 Pancreatic Neoplasms MESH:D010190 marker/mechanism 23992306 +TGFB1 7040 Papilloma MESH:D010212 marker/mechanism 20172950 +TGFB1 7040 Penile Induration MESH:D010411 marker/mechanism 14996430 +TGFB1 7040 Peritoneal Fibrosis MESH:D056627 marker/mechanism 17199790 +TGFB1 7040 Pleural Diseases MESH:D010995 marker/mechanism 24142982 +TGFB1 7040 Pneumonia MESH:D011014 marker/mechanism 21625544 +TGFB1 7040 Posterior Leukoencephalopathy Syndrome MESH:D054038 marker/mechanism 29483653 +TGFB1 7040 Prostatic Neoplasms MESH:D011471 marker/mechanism 15159307|18082198 +TGFB1 7040 Proteinuria MESH:D011507 marker/mechanism 12937228 +TGFB1 7040 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 16365456|31349846 +TGFB1 7040 Pulmonary Emphysema MESH:D011656 therapeutic 12634787 +TGFB1 7040 Pulmonary Fibrosis MESH:D011658 marker/mechanism 15286001|16324872|16365456|17266442|19817698|24762191|26817844 +TGFB1 7040 Sarcoidosis MESH:D012507 marker/mechanism 17785866 +TGFB1 7040 Sepsis MESH:D018805 marker/mechanism 16003065 +TGFB1 7040 Skin Neoplasms MESH:D012878 marker/mechanism 8148055 +TGFB1 7040 Stroke MESH:D020521 marker/mechanism 12374626 +TGFB1 7040 Thrombocythemia, Essential MESH:D013920 marker/mechanism 15682418 +TGFB1 7040 Uremia MESH:D014511 marker/mechanism 19092814 +TGFB1 7040 Ureteral Obstruction MESH:D014517 marker/mechanism 17164399 +TGFB1 7040 Urticaria MESH:D014581 marker/mechanism 19138248 +TGFB1 7040 Ventricular Remodeling MESH:D020257 marker/mechanism 16635409 +TGFB1A 359834 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +TGFB2 7042 Aortic Aneurysm, Thoracic MESH:D017545 marker/mechanism 22772368|22772371 +TGFB2 7042 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +TGFB2 7042 Autoimmune Diseases MESH:D001327 marker/mechanism 25055964 +TGFB2 7042 Bone Diseases, Developmental MESH:D001848 marker/mechanism 9217007 +TGFB2 7042 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 33010264 +TGFB2 7042 Cholangitis MESH:D002761 marker/mechanism 25055964 +TGFB2 7042 Cleft Palate MESH:D002972 marker/mechanism 25450421 +TGFB2 7042 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9217007 +TGFB2 7042 Cyanosis MESH:D003490 marker/mechanism 9217007 +TGFB2 7042 Endometriosis MESH:D004715 marker/mechanism 20864642 +TGFB2 7042 Eye Abnormalities MESH:D005124 marker/mechanism 9217007 +TGFB2 7042 Glaucoma MESH:D005901 marker/mechanism 20375339 +TGFB2 7042 Heart Defects, Congenital MESH:D006330 marker/mechanism 9217007 +TGFB2 7042 Limb Deformities, Congenital MESH:D017880 marker/mechanism 9217007 +TGFB2 7042 Loeys-Dietz Syndrome MESH:D055947 marker/mechanism 614816.0 22772368 +TGFB2 7042 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +TGFB2 7042 Musculoskeletal Abnormalities MESH:D009139 marker/mechanism 9217007 +TGFB2 7042 Respiratory System Abnormalities MESH:D015619 marker/mechanism 9217007 +TGFB2 7042 Ureteral Obstruction MESH:D014517 marker/mechanism 17164399 +TGFB2 7042 Urogenital Abnormalities MESH:D014564 marker/mechanism 9217007 +TGFB3 7043 Arrhythmogenic Right Ventricular Dysplasia, Familial, 1 MESH:C566254 marker/mechanism 107970.0 +TGFB3 7043 Cleft Palate MESH:D002972 marker/mechanism 26971374|7493022 +TGFB3 7043 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TGFB3 7043 Loeys-Dietz Syndrome MESH:D055947 marker/mechanism 615582.0 +TGFB3 7043 Nonsyndromic Deafness MESH:C580334 marker/mechanism 27356075 +TGFB3 7043 Respiratory System Abnormalities MESH:D015619 marker/mechanism 7493022 +TGFBI 7045 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TGFBI 7045 Corneal dystrophy Avellino type MESH:C535474 marker/mechanism 607541.0 +TGFBI 7045 Corneal dystrophy, epithelial basement membrane MESH:C535477 marker/mechanism 121820.0 +TGFBI 7045 Corneal Dystrophy, Lattice Type IIIA MESH:C563923 marker/mechanism 608471.0 +TGFBI 7045 Corneal dystrophy of Bowman layer, type 1 MESH:C535476 marker/mechanism 608470.0 +TGFBI 7045 Corneal dystrophy, Thiel-Behnke type MESH:C535942 marker/mechanism 602082.0 +TGFBI 7045 Diabetic Nephropathies MESH:D003928 marker/mechanism 18682491 +TGFBI 7045 Groenouw type I corneal dystrophy MESH:C537304 marker/mechanism 121900.0 +TGFBI 7045 Lattice corneal dystrophy type 1 MESH:C537881 marker/mechanism 122200.0 +TGFBI 7045 Sepsis MESH:D018805 marker/mechanism 27887929 +TGFBR1 7046 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TGFBR1 7046 Acute Kidney Injury MESH:D058186 marker/mechanism 34677723 +TGFBR1 7046 Aortic Dissection MESH:D000784 marker/mechanism 22772368 +TGFBR1 7046 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28560358 +TGFBR1 7046 Colorectal Neoplasms MESH:D015179 marker/mechanism 18703712 +TGFBR1 7046 Disease Models, Animal MESH:D004195 marker/mechanism 27228633 +TGFBR1 7046 Keratoacanthoma familial MESH:C536150 marker/mechanism 132800.0 21358634 +TGFBR1 7046 Liver Cirrhosis MESH:D008103 marker/mechanism 28560358 +TGFBR1 7046 Loeys-Dietz Syndrome MESH:D055947 marker/mechanism 609192.0 20358619|22772368 +TGFBR1 7046 Scleroderma, Diffuse MESH:D045743 marker/mechanism 27228633 +TGFBR1 7046 Skin Neoplasms MESH:D012878 marker/mechanism 21358634 +TGFBR1 7046 Uremia MESH:D014511 marker/mechanism 19092814 +TGFBR2 7048 Aortic Aneurysm MESH:D001014 marker/mechanism 16885183 +TGFBR2 7048 Aortic Aneurysm, Thoracic MESH:D017545 marker/mechanism 16027248 +TGFBR2 7048 Aortic Dissection MESH:D000784 marker/mechanism 16027248|16885183 +TGFBR2 7048 Bone Diseases MESH:D001847 marker/mechanism 20358619 +TGFBR2 7048 Bone Neoplasms MESH:D001859 therapeutic 16489006 +TGFBR2 7048 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +TGFBR2 7048 Carcinoma MESH:D002277 marker/mechanism 10789724 +TGFBR2 7048 Colonic Neoplasms MESH:D003110 marker/mechanism 7761852 +TGFBR2 7048 Colorectal Cancer, Hereditary Nonpolyposis, Type 6 MESH:C566039 marker/mechanism 614331.0 +TGFBR2 7048 Colorectal Neoplasms, Hereditary Nonpolyposis MESH:D003123 marker/mechanism 9590282 +TGFBR2 7048 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16368934|16885183 +TGFBR2 7048 Diabetic Nephropathies MESH:D003928 marker/mechanism 15496156 +TGFBR2 7048 Esophageal Neoplasms MESH:D004938 marker/mechanism 133239.0 10789724 +TGFBR2 7048 Eye Abnormalities MESH:D005124 marker/mechanism 16885183 +TGFBR2 7048 Fatigue MESH:D005221 marker/mechanism 16885183 +TGFBR2 7048 Fractures, Bone MESH:D050723 marker/mechanism 20358619 +TGFBR2 7048 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +TGFBR2 7048 Hernia, Inguinal MESH:D006552 marker/mechanism 16885183 +TGFBR2 7048 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 15942678|16627068 +TGFBR2 7048 Loeys-Dietz Syndrome MESH:D055947 marker/mechanism 15235604|18084123|19006214|20358619|22772368 +TGFBR2 7048 LOEYS-DIETZ SYNDROME 2 OMIM:610168 marker/mechanism 610168.0 +TGFBR2 7048 Lung Neoplasms MESH:D008175 marker/mechanism 11074608 +TGFBR2 7048 Marfan Syndrome MESH:D008382 marker/mechanism 15235604 +TGFBR2 7048 Microsatellite Instability MESH:D053842 marker/mechanism 25701956|7761852 +TGFBR2 7048 Migraine Disorders MESH:D008881 marker/mechanism 16885183 +TGFBR2 7048 Neoplasm Metastasis MESH:D009362 therapeutic 16489006 +TGFBR2 7048 Prostatic Neoplasms MESH:D011471 marker/mechanism 18381416 +TGIF1 7050 Holoprosencephaly MESH:D016142 marker/mechanism 16705179 +TGIF1 7050 Holoprosencephaly 4 MESH:C564180 marker/mechanism 142946.0 +TGIF1 7050 Neoplasm Invasiveness MESH:D009361 marker/mechanism 25791921 +TGIF1 7050 Neoplasm Metastasis MESH:D009362 therapeutic 29746904 +TGM1 7051 Chloracne MESH:D054506 marker/mechanism 21237254 +TGM1 7051 Dry Eye Syndromes MESH:D015352 marker/mechanism 16146918 +TGM1 7051 Ichthyosis, Lamellar MESH:D017490 marker/mechanism 242300.0 +TGM1 7051 Liver Diseases MESH:D008107 marker/mechanism 19784758 +TGM1 7051 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +TGM1 7051 Vitamin A Deficiency MESH:D014802 marker/mechanism 16146918 +TGM2 7052 Brain Neoplasms MESH:D001932 therapeutic 16170020 +TGM2 7052 Breast Neoplasms MESH:D001943 marker/mechanism 19579870 +TGM2 7052 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 15108329 +TGM2 7052 Celiac Disease MESH:D002446 marker/mechanism 17190764 +TGM2 7052 Esophageal Neoplasms MESH:D004938 marker/mechanism 17068819 +TGM2 7052 Glioblastoma MESH:D005909 marker/mechanism|therapeutic 16170020|17099729 +TGM2 7052 Hypertension MESH:D006973 marker/mechanism 17898543 +TGM2 7052 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +TGM2 7052 Pancreatic Neoplasms MESH:D010190 marker/mechanism 30108682 +TGM3 7053 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TGM3 7053 Uncombable hair syndrome MESH:C536939 marker/mechanism 617251.0 +TGM5 9333 Peeling skin syndrome, acral type MESH:C536316 marker/mechanism 609796.0 +TGM6 343641 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 613908.0 +TGOLN1 22134 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +TGOLN2 10618 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +TH 7054 Brain Diseases MESH:D001927 therapeutic 7842013 +TH 7054 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +TH 7054 Catalepsy MESH:D002375 marker/mechanism 10984662|9822156 +TH 7054 Dyskinesia, Drug-Induced MESH:D004409 therapeutic 15659429 +TH 7054 Dystonia MESH:D004421 marker/mechanism 15505183 +TH 7054 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +TH 7054 Heart Diseases MESH:D006331 marker/mechanism 9822156 +TH 7054 Hyperkinesis MESH:D006948 marker/mechanism 9822156 +TH 7054 Hypertension MESH:D006973 marker/mechanism 27659729|32147540|32165127 +TH 7054 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +TH 7054 Learning Disabilities MESH:D007859 marker/mechanism 10984662|9822156 +TH 7054 Lewy Body Disease MESH:D020961 marker/mechanism 30236862 +TH 7054 Nerve Degeneration MESH:D009410 marker/mechanism 12871582 +TH 7054 Neuroblastoma MESH:D009447 marker/mechanism 25174395 +TH 7054 Parkinson Disease MESH:D010300 marker/mechanism 30236862 +TH 7054 Parkinsonian Disorders MESH:D020734 marker/mechanism 11246459|8817341 +TH 7054 Pheochromocytoma MESH:D010673 marker/mechanism 22569243 +TH 7054 Segawa syndrome, autosomal recessive MESH:C537537 marker/mechanism 605407.0 8528210|8817341 +THADA 63892 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 18372903 +THAP1 55145 Dystonia MESH:D004421 marker/mechanism 23222958 +THAP1 55145 Dystonia 6, torsion MESH:C538003 marker/mechanism 602629.0 19182804 +THAP1 55145 Dystonic Disorders MESH:D020821 marker/mechanism 23222958 +THAP3 90326 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +THAS 7055 Anencephaly MESH:D000757 marker/mechanism 4039891 +THAS 7055 Cleft Lip MESH:D002971 marker/mechanism 4039891 +THAS 7055 Heart Defects, Congenital MESH:D006330 marker/mechanism 2139758|4039891 +THAS 7055 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 2139758 +THAS 7055 Hernia, Ventral MESH:D006555 marker/mechanism 2139758 +THAS 7055 Hydrocephalus MESH:D006849 marker/mechanism 4039891 +THAS 7055 Kidney Diseases MESH:D007674 marker/mechanism 4039891 +THAS 7055 Lung Diseases MESH:D008171 marker/mechanism 2139758 +THAS 7055 Pentalogy of Cantrell MESH:D058502 marker/mechanism 2139758 +THAS 7055 Thoracic Diseases MESH:D013896 marker/mechanism 2139758 +THBD 7056 Atypical Hemolytic Uremic Syndrome MESH:D065766 marker/mechanism 612926.0 19625716 +THBD 7056 Disseminated Intravascular Coagulation MESH:D004211 therapeutic 9134660 +THBD 7056 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 27474498 +THBD 7056 Hyperalgesia MESH:D006930 therapeutic 27474498 +THBD 7056 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 16206674 +THBD 7056 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +THBD 7056 Myocardial Infarction MESH:D009203 marker/mechanism 10627464|9843165 +THBD 7056 Neuropathy, Painful MESH:C564945 therapeutic 27474498 +THBD 7056 Pulmonary Embolism MESH:D011655 marker/mechanism 7811989 +THBD 7056 Purpura, Thrombotic Thrombocytopenic MESH:D011697 marker/mechanism 7740478 +THBD 7056 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 12707536 +THBD 7056 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +THBD 7056 Thrombophilia MESH:D019851 marker/mechanism 12139752 +THBD 7056 Thrombophilia due to Thrombomodulin Defect MESH:C566057 marker/mechanism 614486.0 +THBD 7056 Thrombosis MESH:D013927 marker/mechanism 11132655|11518727 +THBS1 7057 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +THBS1 7057 Breast Neoplasms MESH:D001943 therapeutic 9309585 +THBS1 7057 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 35357534 +THBS1 7057 Diabetic Angiopathies MESH:D003925 marker/mechanism 25381014 +THBS1 7057 Diabetic Retinopathy MESH:D003930 marker/mechanism 17117553 +THBS1 7057 Fibrosis MESH:D005355 marker/mechanism 16005714 +THBS1 7057 Hepatic Veno-Occlusive Disease MESH:D006504 marker/mechanism 35357534 +THBS1 7057 Liver Cirrhosis MESH:D008103 marker/mechanism 18407596 +THBS1 7057 Nephritis, Interstitial MESH:D009395 marker/mechanism 16005714 +THBS1 7057 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +THBS1 7057 Schizophrenia MESH:D012559 marker/mechanism 21822266 +THBS2 7058 Diabetes Mellitus MESH:D003920 marker/mechanism 23723366 +THBS2 7058 Diabetic Angiopathies MESH:D003925 marker/mechanism 25381014 +THBS2 7058 Intervertebral disc disease MESH:C535531 marker/mechanism 603932.0 +THEM4 117145 Carcinoma, Hepatocellular MESH:D006528 therapeutic 23392203 +THEMIS 387357 Celiac Disease MESH:D002446 marker/mechanism 20190752 +THEMIS2 9473 Breast Neoplasms MESH:D001943 therapeutic 19942713 +THG1L 54974 Fibrosis MESH:D005355 marker/mechanism 21784897 +THG1L 54974 Kidney Diseases MESH:D007674 marker/mechanism 21784897 +THOC2 57187 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 12 OMIM:300957 marker/mechanism 300957.0 +THOC6 79228 BEAULIEU-BOYCOTT-INNES SYNDROME OMIM:613680 marker/mechanism 613680.0 +THPO 7066 Cardiomyopathies MESH:D009202 therapeutic 16651473 +THPO 7066 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 33122006 +THPO 7066 Thrombocytosis MESH:D013922 marker/mechanism 187950.0 15813844|33122006 +THRA 7067 Endometriosis MESH:D004715 marker/mechanism 22138541 +THRA 7067 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 11685700 +THRA 7067 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6 OMIM:614450 marker/mechanism 614450.0 +THRB 7068 Adenocarcinoma, Follicular MESH:D018263 marker/mechanism 27440272 +THRB 7068 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +THRB 7068 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10660344 +THRB 7068 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 11685700 +THRB 7068 Thyroid Hormone Resistance, Generalized, Autosomal Dominant MESH:C567934 marker/mechanism 188570.0 +THRB 7068 Thyroid Hormone Resistance, Generalized, Autosomal Recessive MESH:C567936 marker/mechanism 274300.0 +THRB 7068 Thyroid Hormone Resistance, Selective Pituitary MESH:C564154 marker/mechanism 145650.0 +THRB 7068 Thyroid Hormone Resistance Syndrome MESH:D018382 marker/mechanism 10660344|9349583 +THRSP 7069 Carcinoma MESH:D002277 marker/mechanism 16316942 +THRSP 7069 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +THRSP 7069 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +THSD4 79875 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +THSD7A 221981 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +THY1 7070 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +THY1 7070 Reperfusion Injury MESH:D015427 marker/mechanism 23075401 +THY1 7070 Retinal Diseases MESH:D012164 marker/mechanism 23075401 +THYN1 29087 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +THYN1 29087 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +TIA1 7072 Welander distal myopathy, Swedish type MESH:C536690 marker/mechanism 604454.0 +TIAL1 7073 Astrocytoma MESH:D001254 marker/mechanism 27106762 +TIAL1 7073 Disease Progression MESH:D018450 marker/mechanism 27106762 +TIAL1 7073 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TIAM1 7074 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +TIAM1 7074 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27862620 +TIAM1 7074 Mouth Neoplasms MESH:D009062 marker/mechanism 27862620 +TIAM2 26230 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +TICAM1 148022 Encephalitis, Herpes Simplex MESH:D020803 marker/mechanism 614850.0 +TICAM1 148022 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +TICAM1 148022 Reperfusion Injury MESH:D015427 marker/mechanism 25780291 +TICAM1 148022 Respiratory Syncytial Virus Infections MESH:D018357 marker/mechanism 24478430 +TICAM2 353376 Brain Injuries MESH:D001930 marker/mechanism 21549006 +TICAM2 353376 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 26861016 +TICRR 90381 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TIGAR 57103 Nerve Degeneration MESH:D009410 therapeutic 33359019 +TIMD4 91937 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TIMD4 91937 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +TIMM10 26519 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +TIMM10 26519 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +TIMM10 26519 Rhabdomyosarcoma MESH:D012208 marker/mechanism 16669873 +TIMM8A 1678 Jensen syndrome MESH:C537568 marker/mechanism 11803487 +TIMM8A 1678 Mohr-Tranebjaerg syndrome MESH:C535808 marker/mechanism 304700.0 11803487 +TIMM8A1 30058 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +TIMM8A1 30058 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +TIMP1 7076 Aortic Valve Insufficiency MESH:D001022 marker/mechanism 21216836 +TIMP1 7076 Autoimmune Diseases MESH:D001327 marker/mechanism 25055964 +TIMP1 7076 Calcinosis MESH:D002114 marker/mechanism 21335463 +TIMP1 7076 Cholangitis MESH:D002761 marker/mechanism 25055964 +TIMP1 7076 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +TIMP1 7076 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 21963884 +TIMP1 7076 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 16023759 +TIMP1 7076 Disease Models, Animal MESH:D004195 marker/mechanism 21051829 +TIMP1 7076 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +TIMP1 7076 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +TIMP1 7076 Heart Diseases MESH:D006331 marker/mechanism 23558518 +TIMP1 7076 Heart Valve Diseases MESH:D006349 marker/mechanism 21335463 +TIMP1 7076 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 26241054 +TIMP1 7076 Hypertension MESH:D006973 marker/mechanism 21051829 +TIMP1 7076 Inflammation MESH:D007249 marker/mechanism 17569694 +TIMP1 7076 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +TIMP1 7076 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16507762|16718785|16762003|21163135|25380136 +TIMP1 7076 Neoplasm Invasiveness MESH:D009361 therapeutic 1318976 +TIMP1 7076 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +TIMP1 7076 Pulmonary Fibrosis MESH:D011658 marker/mechanism 21468558 +TIMP1 7076 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +TIMP1 7076 Varicose Veins MESH:D014648 marker/mechanism 17643059 +TIMP1 7076 Vascular Diseases MESH:D014652 marker/mechanism 17569694 +TIMP2 7077 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TIMP2 7077 Calcinosis MESH:D002114 marker/mechanism 24142982 +TIMP2 7077 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +TIMP2 7077 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 21963884 +TIMP2 7077 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TIMP2 7077 Myocardial Infarction MESH:D009203 marker/mechanism 24358288 +TIMP2 7077 Occupational Diseases MESH:D009784 marker/mechanism 24142982 +TIMP2 7077 Pleural Diseases MESH:D010995 marker/mechanism 24142982 +TIMP2 7077 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 30548095 +TIMP3 7078 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TIMP3 7078 Asthma MESH:D001249 marker/mechanism 16926187 +TIMP3 7078 Colitis MESH:D003092 marker/mechanism 24548422 +TIMP3 7078 Fundus Dystrophy, Pseudoinflammatory, Of Sorsby MESH:C564992 marker/mechanism 136900.0 +TIMP3 7078 Liver Diseases MESH:D008107 marker/mechanism 19784758 +TIMP3 7078 Macular Degeneration MESH:D008268 marker/mechanism 26691988 +TIMP3 7078 Neoplasm Invasiveness MESH:D009361 therapeutic 23109338 +TIMP3 7078 Neurotoxicity Syndromes MESH:D020258 marker/mechanism 19784758 +TIMP3 7078 Schistosomiasis MESH:D012552 marker/mechanism 23527093 +TIMP3 7078 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +TIMP3 7078 Urinary Bladder Diseases MESH:D001745 marker/mechanism 23527093 +TIMP4 7079 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TINAG 27283 Diabetic Nephropathies MESH:D003928 marker/mechanism 19634143 +TINF2 26277 Bone Marrow Diseases MESH:D001855 marker/mechanism 18252230 +TINF2 26277 Cerebellar Diseases MESH:D002526 marker/mechanism 18252230 +TINF2 26277 Dyskeratosis Congenita MESH:D019871 marker/mechanism 18252230 +TINF2 26277 Dyskeratosis Congenita, Autosomal Dominant MESH:C565079 marker/mechanism 127550.0 +TINF2 26277 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3 OMIM:613990 marker/mechanism 613990.0 +TINF2 26277 Growth Disorders MESH:D006130 marker/mechanism 18252230 +TINF2 26277 Nail Diseases MESH:D009260 marker/mechanism 18252230 +TINF2 26277 Revesz Debuse syndrome MESH:C538371 marker/mechanism 268130.0 18252230 +TIPARP 25976 Ovarian Neoplasms MESH:D010051 marker/mechanism 20852632 +TIRAP 114609 Bacteremia MESH:D016470 marker/mechanism 614382.0 17322885 +TIRAP 114609 Malaria MESH:D008288 marker/mechanism 611162.0 17322885 +TIRAP 114609 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948.0 +TIRAP 114609 Pneumococcal Infections MESH:D011008 marker/mechanism 17322885 +TIRAP 114609 Prostatic Neoplasms MESH:D011471 marker/mechanism 16284379 +TIRAP 114609 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 26861016 +TIRAP 114609 Tuberculosis MESH:D014376 marker/mechanism 17322885 +TJP1 7082 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TJP1 7082 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +TJP2 9414 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TJP2 9414 Cholestasis, Intrahepatic MESH:D002780 marker/mechanism 24614073 +TJP2 9414 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4 OMIM:615878 marker/mechanism 615878.0 +TJP2 9414 Hearing Loss MESH:D034381 marker/mechanism 21782914 +TJP2 9414 Hypercholanemia, Familial MESH:C564336 marker/mechanism 607748.0 +TJP3 27134 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TJP3 27134 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TK1 7083 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +TK1 7083 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TK1 7083 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641 +TK1 7083 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +TK1 7083 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 11420682 +TK2 7084 MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE) OMIM:609560 marker/mechanism 609560.0 +TK2 7084 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3 OMIM:617069 marker/mechanism 617069.0 +TKFC 26007 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TKT 7086 Carcinoma MESH:D002277 marker/mechanism 12376462 +TKT 7086 Hypoxia MESH:D000860 marker/mechanism 19579223 +TKT 7086 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +TKT 7086 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +TKT 7086 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15654357 +TKT 7086 Wernicke Encephalopathy MESH:D014899 marker/mechanism 3762968 +TLCD5 219902 Exfoliation Syndrome MESH:D017889 marker/mechanism 28553957 +TLE3 7090 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +TLE3 7090 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596 +TLE3 7090 Breast Neoplasms MESH:D001943 marker/mechanism 19075277 +TLE4 7091 Carcinoma MESH:D002277 marker/mechanism 12376462 +TLE4 7091 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +TLE4 7091 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +TLE4 7091 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +TLE5 166 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +TLE6 79816 OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 15 OMIM:616814 marker/mechanism 616814.0 +TLK1 9874 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +TLK1 9874 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 17481512 +TLL1 7092 Atrial Septal Defect 6 MESH:C567764 marker/mechanism 613087.0 +TLN1 7094 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21291860 +TLN1 7094 Osteoporosis MESH:D010024 marker/mechanism 18924182 +TLR1 7096 Brain Injuries MESH:D001930 marker/mechanism 21549006 +TLR1 7096 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 18466103 +TLR1 7096 Leprosy MESH:D007918 marker/mechanism 613223.0 +TLR2 7097 Acute Kidney Injury MESH:D058186 marker/mechanism 29286200 +TLR2 7097 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +TLR2 7097 Brain Injuries MESH:D001930 marker/mechanism 21549006 +TLR2 7097 Cardiomyopathies MESH:D009202 marker/mechanism 15505089 +TLR2 7097 Cardiotoxicity MESH:D066126 marker/mechanism 29959987 +TLR2 7097 Cholestasis MESH:D002779 marker/mechanism 27989131 +TLR2 7097 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 16879199|17892325 +TLR2 7097 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 18466103|31557154 +TLR2 7097 Eosinophilia MESH:D004802 marker/mechanism 26882889 +TLR2 7097 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +TLR2 7097 Eye Infections, Bacterial MESH:D015818 marker/mechanism 23661603 +TLR2 7097 Heart Failure MESH:D006333 marker/mechanism 29959987 +TLR2 7097 Inflammation MESH:D007249 marker/mechanism 22178603 +TLR2 7097 Keratitis MESH:D007634 marker/mechanism 23661603 +TLR2 7097 Leprosy MESH:D007918 marker/mechanism 246300.0 +TLR2 7097 Mite Infestations MESH:D008924 marker/mechanism 29253318 +TLR2 7097 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO OMIM:607948 marker/mechanism 607948.0 +TLR2 7097 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 28963909 +TLR2 7097 Reperfusion Injury MESH:D015427 marker/mechanism 25780291 +TLR2 7097 Staphylococcal Infections MESH:D013203 marker/mechanism 23661603 +TLR3 7098 Encephalitis, Herpes Simplex MESH:D020803 marker/mechanism 613002.0 +TLR3 7098 Fever MESH:D005334 marker/mechanism 28726298 +TLR3 7098 HIV Infections MESH:D015658 marker/mechanism 609423.0 +TLR3 7098 Weight Loss MESH:D015431 marker/mechanism 28726298 +TLR4 7099 Acute Coronary Syndrome MESH:D054058 marker/mechanism 20981132 +TLR4 7099 Acute Kidney Injury MESH:D058186 marker/mechanism 29286200 +TLR4 7099 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 23525077 +TLR4 7099 Angina, Stable MESH:D060050 marker/mechanism 20981132 +TLR4 7099 Atherosclerosis MESH:D050197 marker/mechanism 12124407 +TLR4 7099 Brain Injuries MESH:D001930 marker/mechanism 21549006 +TLR4 7099 Carcinoma MESH:D002277 marker/mechanism 22180778 +TLR4 7099 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 27022031 +TLR4 7099 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +TLR4 7099 Colorectal Neoplasms MESH:D015179 marker/mechanism 16879199|22180778 +TLR4 7099 Coronary Artery Disease MESH:D003324 marker/mechanism 20524934 +TLR4 7099 Crohn Disease MESH:D003424 marker/mechanism 17914947 +TLR4 7099 Dermatitis, Contact MESH:D003877 marker/mechanism 18725520 +TLR4 7099 Diabetic Neuropathies MESH:D003929 marker/mechanism 14693986 +TLR4 7099 Dysbiosis MESH:D064806 marker/mechanism 35390362 +TLR4 7099 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 23650378 +TLR4 7099 Eosinophilia MESH:D004802 marker/mechanism 26882889 +TLR4 7099 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +TLR4 7099 Fatty Liver MESH:D005234 marker/mechanism 18641190|27022031 +TLR4 7099 Fibrosis MESH:D005355 marker/mechanism 27585667 +TLR4 7099 Hearing Loss MESH:D034381 marker/mechanism 21148032 +TLR4 7099 Hypertension MESH:D006973 marker/mechanism 27292124|32147540 +TLR4 7099 Inflammation MESH:D007249 marker/mechanism 16651628|22053092|22178603|22300504 +TLR4 7099 Learning Disabilities MESH:D007859 marker/mechanism 29107071 +TLR4 7099 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TLR4 7099 Lung Injury MESH:D055370 marker/mechanism 22300504 +TLR4 7099 Lung Neoplasms MESH:D008175 marker/mechanism 19925653 +TLR4 7099 Macular Degeneration MESH:D008268 marker/mechanism 15829498 +TLR4 7099 Melanoma MESH:D008545 marker/mechanism 22842228 +TLR4 7099 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21473897 +TLR4 7099 Neoplasm Metastasis MESH:D009362 marker/mechanism 22180778 +TLR4 7099 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34808223 +TLR4 7099 Ovarian Neoplasms MESH:D010051 marker/mechanism 21616060 +TLR4 7099 Pneumonia MESH:D011014 marker/mechanism 26882889 +TLR4 7099 Prostatic Neoplasms MESH:D011471 marker/mechanism 17301271 +TLR4 7099 Renal Insufficiency MESH:D051437 marker/mechanism 27585667 +TLR4 7099 Reperfusion Injury MESH:D015427 marker/mechanism 25780291|27064547 +TLR4 7099 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 10835634 +TLR4 7099 Sepsis MESH:D018805 marker/mechanism 20624996 +TLR4 7099 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 27442881 +TLR4 7099 Weight Loss MESH:D015431 marker/mechanism 31442584 +TLR5 7100 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 30508503 +TLR5 7100 Hyperammonemia MESH:D022124 marker/mechanism 30508503 +TLR5 7100 Legionnaires' Disease MESH:D007877 marker/mechanism 608556.0 +TLR5 7100 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 601744.0 +TLR5 7100 Melioidosis MESH:D008554 marker/mechanism 615557.0 +TLR5 7100 Prostatic Neoplasms MESH:D011471 marker/mechanism 16284379 +TLR6 10333 Prostatic Neoplasms MESH:D011471 marker/mechanism 16537705 +TLR7 51284 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 24990399 +TLR7 51284 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +TLR7 51284 Hepatitis C MESH:D006526 marker/mechanism 27385120 +TLR7 51284 Orthomyxoviridae Infections MESH:D009976 marker/mechanism 22916010 +TLR8 51311 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +TLR8 51311 Hepatitis C MESH:D006526 marker/mechanism 27385120 +TLR9 54106 Brain Injuries MESH:D001930 marker/mechanism 21549006 +TLR9 54106 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 24990399 +TLR9 54106 Crohn Disease MESH:D003424 marker/mechanism 15236225|17914947 +TLR9 54106 Granuloma, Foreign-Body MESH:D015745 marker/mechanism 19797157 +TLR9 54106 Granuloma, Respiratory Tract MESH:D015769 marker/mechanism 19797157 +TLR9 54106 Inflammation MESH:D007249 marker/mechanism 19797157 +TLR9 54106 Schistosomiasis mansoni MESH:D012555 marker/mechanism 19797157 +TLR9 54106 Triple Negative Breast Neoplasms MESH:D064726 therapeutic 24273604 +TLX1 3195 Aneuploidy MESH:D000782 marker/mechanism 20972433 +TLX1 3195 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 20972433 +TLX1 3195 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 1717256 +TLX1 3195 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 20972433 +TLX1 3195 Splenic Diseases MESH:D013158 marker/mechanism 7908720 +TM4SF20 79853 SPECIFIC LANGUAGE IMPAIRMENT 5 OMIM:615432 marker/mechanism 615432.0 +TM4SF4 7104 Liver Diseases MESH:D008107 marker/mechanism 17069928 +TM6SF1 53346 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TM6SF2 53345 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 26482880 +TM6SF2 53345 Myocardial Infarction MESH:D009203 marker/mechanism 24633158 +TM6SF2 53345 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 24531328 +TMBIM1 64114 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TMBIM4 51643 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +TMC1 117531 Deafness, Autosomal Dominant 36 MESH:C564675 marker/mechanism 606705.0 +TMC1 117531 Deafness, Autosomal Recessive 7 MESH:C563417 marker/mechanism 600974.0 +TMC6 11322 Epidermodysplasia Verruciformis MESH:D004819 marker/mechanism 226400.0 +TMCO1 54499 Bone Diseases, Developmental MESH:D001848 marker/mechanism 20018682 +TMCO1 54499 Craniofacial Abnormalities MESH:D019465 marker/mechanism 20018682 +TMCO1 54499 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 21532571 +TMCO1 54499 Intellectual Disability MESH:D008607 marker/mechanism 20018682 +TMCO1 54499 Musculoskeletal Abnormalities MESH:D009139 marker/mechanism 20018682 +TMCO1 54499 Tooth Abnormalities MESH:D014071 marker/mechanism 20018682 +TMED2 10959 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +TMED7 51014 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +TMED7 51014 Cholestasis MESH:D002779 marker/mechanism 26881866 +TMEFF2 23671 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TMEFF2 23671 Prostatic Neoplasms MESH:D011471 marker/mechanism 23405127 +TMEM106A 113277 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TMEM106B 54664 COVID-19 MESH:D000086382 marker/mechanism 33686287 +TMEM106B 54664 Frontotemporal Lobar Degeneration MESH:D057174 marker/mechanism 20154673 +TMEM117 84216 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +TMEM117 84216 Cholestasis MESH:D002779 marker/mechanism 26881866 +TMEM126A 84233 Optic Atrophy 7 MESH:C567833 marker/mechanism 612989.0 +TMEM127 55654 Pheochromocytoma MESH:D010673 marker/mechanism 171300.0 20154675 +TMEM132B 114795 Melanoma MESH:D008545 marker/mechanism 21499247 +TMEM132D 121256 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +TMEM132D 121256 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +TMEM132D 121256 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +TMEM135 65084 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +TMEM135 65084 Glioblastoma MESH:D005909 marker/mechanism 30705370 +TMEM135 65084 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +TMEM139 135932 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +TMEM151A 256472 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TMEM151B 441151 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TMEM164 84187 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +TMEM165 55858 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk OMIM:614727 marker/mechanism 614727.0 +TMEM165 55858 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TMEM17 200728 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +TMEM178 68027 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TMEM18 129787 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +TMEM18 129787 Obesity MESH:D009765 marker/mechanism 19079261 +TMEM184B 25829 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TMEM199 147007 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp OMIM:616829 marker/mechanism 616829.0 +TMEM216 51259 Joubert syndrome 2 MESH:C536294 marker/mechanism 608091.0 +TMEM216 51259 Meckel syndrome type 2 MESH:C536131 marker/mechanism 603194.0 +TMEM230 29058 Parkinson Disease MESH:D010300 marker/mechanism 27270108 +TMEM231 79583 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +TMEM238L 100289255 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +TMEM240 339453 Spinocerebellar ataxia 21 MESH:C537200 marker/mechanism 607454.0 +TMEM25 84866 Breast Neoplasms MESH:D001943 marker/mechanism 19776672 +TMEM30B 161291 Melanoma MESH:D008545 marker/mechanism 16778180 +TMEM37 140738 Carcinoma MESH:D002277 marker/mechanism 21489049 +TMEM37 140738 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 21489049 +TMEM38B 55151 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +TMEM38B 55151 OSTEOGENESIS IMPERFECTA, TYPE XIV OMIM:615066 marker/mechanism 615066.0 +TMEM43 79188 Arrhythmogenic Right Ventricular Dysplasia, Familial, 5 MESH:C565776 marker/mechanism 604400.0 +TMEM43 79188 Death, Sudden, Cardiac MESH:D016757 marker/mechanism 20435227 +TMEM43 79188 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TMEM43 79188 Muscular Dystrophy, Emery-Dreifuss MESH:D020389 marker/mechanism 614302.0 +TMEM45A 55076 Lung Neoplasms MESH:D008175 marker/mechanism 27935865 +TMEM59L 25789 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +TMEM63A 9725 Disease Progression MESH:D018450 marker/mechanism 21364753 +TMEM63A 9725 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +TMEM65 157378 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TMEM67 91147 Bardet-Biedl Syndrome MESH:D020788 marker/mechanism 18327255 +TMEM67 91147 Bardet-Biedl Syndrome 14 MESH:C567141 marker/mechanism 615991.0 +TMEM67 91147 COACH syndrome MESH:C536430 marker/mechanism 216360.0 +TMEM67 91147 Joubert syndrome 6 MESH:C537689 marker/mechanism 610688.0 +TMEM67 91147 Kidney Diseases, Cystic MESH:D052177 marker/mechanism 19508969 +TMEM67 91147 Liver Cirrhosis MESH:D008103 marker/mechanism 19508969 +TMEM67 91147 Meckel syndrome type 3 MESH:C536132 marker/mechanism 607361.0 +TMEM67 91147 NEPHRONOPHTHISIS 11 OMIM:613550 marker/mechanism 613550.0 +TMEM70 54968 Adenoma, Liver Cell MESH:D018248 marker/mechanism 27914986 +TMEM70 54968 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 27914986 +TMEM70 54968 Cardiomyopathies MESH:D009202 marker/mechanism 18953340 +TMEM70 54968 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2 OMIM:614052 marker/mechanism 614052.0 +TMEM70 54968 Mitochondrial Encephalomyopathies MESH:D017237 marker/mechanism 18953340 +TMEM71 137835 Heart Failure MESH:D006333 marker/mechanism 36071497 +TMEM98 26022 NANOPHTHALMOS 4 OMIM:615972 marker/mechanism 615972.0 +TMF1 7110 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TMF1 7110 Prostatic Neoplasms MESH:D011471 marker/mechanism 19208208 +TMIE 259236 Deafness, Autosomal Recessive 6 MESH:C563418 marker/mechanism 600971.0 +TMLHE 55217 Autistic Disorder MESH:D001321 marker/mechanism 300872.0 +TMOD1 7111 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +TMOD1 7111 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +TMPO 7112 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 12833524 +TMPO 7112 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 16247757 +TMPO 7112 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +TMPRSS11D 9407 Coronavirus Infections MESH:D018352 marker/mechanism 24227843 +TMPRSS11D 9407 Influenza, Human MESH:D007251 marker/mechanism 20237084|23072892 +TMPRSS11D 9407 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 24227843 +TMPRSS15 5651 Enterokinase Deficiency MESH:C562649 marker/mechanism 226200.0 +TMPRSS2 7113 Cancer Pain MESH:D000072716 marker/mechanism 25734995 +TMPRSS2 7113 Coronavirus Infections MESH:D018352 marker/mechanism 24027332|24227843|27550352|27733646|28778717 +TMPRSS2 7113 COVID-19 MESH:D000086382 marker/mechanism 32142651|32165541|32404436 +TMPRSS2 7113 Influenza, Human MESH:D007251 marker/mechanism|therapeutic 20237084|21123387|23072892|26889029|28778717|31391268 +TMPRSS2 7113 Prostatic Neoplasms MESH:D011471 marker/mechanism 18798265|25735316|28783165|29610475 +TMPRSS2 7113 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 22496216|24227843|30626688 +TMPRSS3 64699 DEAFNESS, AUTOSOMAL RECESSIVE 8 OMIM:601072 marker/mechanism 601072.0 +TMPRSS3 64699 Pneumoconiosis MESH:D011009 marker/mechanism 25445010 +TMPRSS4 56649 COVID-19 MESH:D000086382 marker/mechanism 32404436 +TMPRSS4 56649 Influenza, Human MESH:D007251 marker/mechanism 26889029 +TMPRSS6 164656 Anemia, Iron-Deficiency MESH:D018798 marker/mechanism 18408718|22169218 +TMPRSS6 164656 Iron-Refractory Iron Deficiency Anemia MESH:C562385 marker/mechanism 206200.0 +TMPRSS7 344805 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +TMSB10 9168 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 17597826 +TMSB10 9168 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TMSB4X 7114 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +TMSB4X 7114 Prostatic Neoplasms MESH:D011471 marker/mechanism 17916567 +TMT1A 25840 Endometriosis MESH:D004715 marker/mechanism 20864642 +TMT1B 196410 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +TMTC2 160335 Deafness MESH:D003638 marker/mechanism 27311106 +TMTC3 160418 Lissencephaly MESH:D054082 marker/mechanism 617255.0 +TNC 3371 Asthma MESH:D001249 marker/mechanism 16115819 +TNC 3371 DEAFNESS, AUTOSOMAL DOMINANT 56 OMIM:615629 marker/mechanism 615629.0 +TNC 3371 Endometriosis MESH:D004715 marker/mechanism 20864642 +TNC 3371 Lung Injury MESH:D055370 marker/mechanism 18978301 +TNC 3371 Melanoma MESH:D008545 marker/mechanism 22842228 +TNC 3371 Osteoarthritis, Hip MESH:D015207 marker/mechanism 30374069 +TNC 3371 Pleural Diseases MESH:D010995 marker/mechanism 10950882 +TNC 3371 Varicose Veins MESH:D014648 marker/mechanism 17643059 +TNF 7124 Acquired Hyperostosis Syndrome MESH:D020083 therapeutic 27108452 +TNF 7124 Acute Coronary Syndrome MESH:D054058 marker/mechanism 20981132 +TNF 7124 Acute Kidney Injury MESH:D058186 marker/mechanism 16595132|18460982|20623750 +TNF 7124 Acute Lung Injury MESH:D055371 marker/mechanism 34390737 +TNF 7124 Adenocarcinoma MESH:D000230 marker/mechanism|therapeutic 1733439|19028472 +TNF 7124 Albuminuria MESH:D000419 marker/mechanism 17167242 +TNF 7124 Alzheimer Disease MESH:D000544 marker/mechanism 17192785 +TNF 7124 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +TNF 7124 Anemia MESH:D000740 marker/mechanism 16566752 +TNF 7124 Anemia, Refractory MESH:D000753 marker/mechanism 10870480 +TNF 7124 Anemia, Sickle Cell MESH:D000755 marker/mechanism 14965870 +TNF 7124 Angina, Stable MESH:D060050 marker/mechanism 20981132 +TNF 7124 Anorexia MESH:D000855 marker/mechanism 25392278 +TNF 7124 Anthracosis MESH:D055008 marker/mechanism 20005085 +TNF 7124 Anxiety Disorders MESH:D001008 marker/mechanism 20194079 +TNF 7124 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +TNF 7124 Arthritis, Experimental MESH:D001169 marker/mechanism 19203382|19330884|19765281|20131233|20974942|21452922|22450443|7589090|9598899 +TNF 7124 Arthritis, Infectious MESH:D001170 marker/mechanism 19203382 +TNF 7124 Arthritis, Psoriatic MESH:D015535 marker/mechanism 12746914|19732956 +TNF 7124 Arthritis, Rheumatoid MESH:D001172 marker/mechanism|therapeutic 12566094|2001072|22450443|34459104|8391952 +TNF 7124 Asbestosis MESH:D001195 marker/mechanism 20486865|8473757 +TNF 7124 Asthma MESH:D001249 marker/mechanism 600807.0 12356572|14681301|16456144|17450233|20049212 +TNF 7124 Asthma, Occupational MESH:D059366 marker/mechanism 25721048 +TNF 7124 Atherosclerosis MESH:D050197 marker/mechanism 20720404 +TNF 7124 Berylliosis MESH:D001607 marker/mechanism 12449171|15127972|16980557|8428540 +TNF 7124 Brain Edema MESH:D001929 marker/mechanism 21276434 +TNF 7124 Brain Injuries MESH:D001930 marker/mechanism 19800810|21549006 +TNF 7124 Brain Injuries, Traumatic MESH:D000070642 marker/mechanism 28642177 +TNF 7124 Brain Ischemia MESH:D002545 marker/mechanism 15756928 +TNF 7124 Breast Neoplasms MESH:D001943 marker/mechanism 16298037|17516992|19446661 +TNF 7124 Bronchiectasis MESH:D001987 marker/mechanism 17931847 +TNF 7124 Burns MESH:D002056 marker/mechanism 18277951 +TNF 7124 Cachexia MESH:D002100 marker/mechanism 17878525 +TNF 7124 Calcinosis MESH:D002114 marker/mechanism 30963258 +TNF 7124 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 27022031 +TNF 7124 Carcinoma, Transitional Cell MESH:D002295 therapeutic 3361654 +TNF 7124 Cardiomegaly MESH:D006332 marker/mechanism 15302781|17337591|18034274 +TNF 7124 Cardiomyopathies MESH:D009202 marker/mechanism 10716473 +TNF 7124 Cardiotoxicity MESH:D066126 marker/mechanism 29959987|32068018 +TNF 7124 Cardiovirus Infections MESH:D018188 marker/mechanism 10609881 +TNF 7124 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism|therapeutic 17709330|19638433|20623750|21984482|7532385|9696492 +TNF 7124 Chemically-Induced Disorders MESH:D064419 marker/mechanism 36108500 +TNF 7124 Chlamydia Infections MESH:D002690 marker/mechanism 19203382 +TNF 7124 Cholestasis MESH:D002779 marker/mechanism 20626112 +TNF 7124 Cholestasis, Extrahepatic MESH:D001651 marker/mechanism 28789951 +TNF 7124 Colitis MESH:D003092 marker/mechanism 23810507|24548422 +TNF 7124 Colitis, Ulcerative MESH:D003093 marker/mechanism 19617644|20452301|22119283 +TNF 7124 Colonic Neoplasms MESH:D003110 marker/mechanism|therapeutic 12842827|19028472 +TNF 7124 Colorectal Neoplasms MESH:D015179 marker/mechanism 23431386 +TNF 7124 Coronary Restenosis MESH:D023903 marker/mechanism 16319143 +TNF 7124 COVID-19 MESH:D000086382 marker/mechanism 31986264 +TNF 7124 Coxsackievirus Infections MESH:D003384 marker/mechanism 25396421 +TNF 7124 Crohn Disease MESH:D003424 marker/mechanism 10700533|21829567 +TNF 7124 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 15849067 +TNF 7124 Dermatomyositis MESH:D003882 marker/mechanism 19035492 +TNF 7124 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 12123627|12193562|19478208|20388520|22138235|24513509 +TNF 7124 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 23640034 +TNF 7124 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 24513509 +TNF 7124 Diabetic Cardiomyopathies MESH:D058065 marker/mechanism 17909696 +TNF 7124 Disease Models, Animal MESH:D004195 marker/mechanism 27093858 +TNF 7124 Disease Progression MESH:D018450 marker/mechanism 34626302 +TNF 7124 Drug Eruptions MESH:D003875 marker/mechanism 31150805 +TNF 7124 Drug Hypersensitivity MESH:D004342 marker/mechanism 11294926|20485159 +TNF 7124 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +TNF 7124 Edema MESH:D004487 marker/mechanism 19874808 +TNF 7124 Essential Hypertension MESH:D000075222 marker/mechanism 34453990 +TNF 7124 Fanconi Anemia MESH:D005199 marker/mechanism 22628295 +TNF 7124 Fatty Liver MESH:D005234 marker/mechanism 23348005 +TNF 7124 Fever MESH:D005334 marker/mechanism 10379864|11852909|15384034 +TNF 7124 Fibromatosis, Aggressive MESH:D018222 therapeutic 19944662 +TNF 7124 Fibrosis MESH:D005355 marker/mechanism 18034274 +TNF 7124 Glioma MESH:D005910 marker/mechanism 22199285 +TNF 7124 Glomerulonephritis MESH:D005921 marker/mechanism 10910440|9403216 +TNF 7124 Heart Arrest MESH:D006323 marker/mechanism 9806674 +TNF 7124 Heart Failure MESH:D006333 marker/mechanism 15135663|15231041|17337591|18034274|29959987 +TNF 7124 Heat Stroke MESH:D018883 marker/mechanism 16878031|24039931 +TNF 7124 Hemochromatosis MESH:D006432 marker/mechanism 16793930 +TNF 7124 Hemolytic-Uremic Syndrome MESH:D006463 marker/mechanism 15384034 +TNF 7124 Hepatic Encephalopathy MESH:D006501 marker/mechanism 16338762|9696492 +TNF 7124 Hepatitis, Alcoholic MESH:D006519 marker/mechanism 12586603 +TNF 7124 Hepatolenticular Degeneration MESH:D006527 marker/mechanism 25002079 +TNF 7124 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 10541330 +TNF 7124 HIV Wasting Syndrome MESH:D019247 marker/mechanism 7979221 +TNF 7124 Hyperalgesia MESH:D006930 marker/mechanism 10401557|12727271|16472913|17320857|18463260|18582539|20383154|26141506|27093858|7582491|7881729 +TNF 7124 Hyperbilirubinemia MESH:D006932 marker/mechanism 10379864 +TNF 7124 Hypercalcemia MESH:D006934 marker/mechanism 10638776 +TNF 7124 Hyperhomocysteinemia MESH:D020138 marker/mechanism 12615666 +TNF 7124 Hyperinsulinism MESH:D006946 marker/mechanism 29035695 +TNF 7124 Hypersensitivity MESH:D006967 marker/mechanism 16095146|21625544 +TNF 7124 Hypertension MESH:D006973 marker/mechanism 18605955|27292124|27659729|27847271|32147540 +TNF 7124 Hypertension, Pulmonary MESH:D006976 therapeutic 2518282 +TNF 7124 Hypoglycemia MESH:D007003 marker/mechanism 8774068 +TNF 7124 Hypotension MESH:D007022 marker/mechanism 10379864|15384034 +TNF 7124 Hypothermia MESH:D007035 marker/mechanism 16369138|34942311 +TNF 7124 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 8473757 +TNF 7124 Infections MESH:D007239 marker/mechanism 16513158 +TNF 7124 Inflammation MESH:D007249 marker/mechanism 11181422|12843254|14970111|16001271|16227999|19324842|19803787|20167660|20943792|21146893|21467745|22452660|23348408|23371441|23795810|34942311 +TNF 7124 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 15086448|27793764 +TNF 7124 Insulin Resistance MESH:D007333 marker/mechanism 16493877|20943792 +TNF 7124 Intervertebral Disc Degeneration MESH:D055959 marker/mechanism 34600870 +TNF 7124 Intrahepatic Cholestasis of Pregnancy MESH:C535932 marker/mechanism 23627780 +TNF 7124 Kidney Failure, Chronic MESH:D007676 marker/mechanism 19539174 +TNF 7124 Leishmaniasis MESH:D007896 marker/mechanism 16540374 +TNF 7124 Leishmaniasis, Cutaneous MESH:D016773 marker/mechanism 20102417 +TNF 7124 Leishmaniasis, Visceral MESH:D007898 marker/mechanism 1901333|22461696 +TNF 7124 Listeriosis MESH:D008088 marker/mechanism 16751399 +TNF 7124 Liver Cirrhosis, Alcoholic MESH:D008104 marker/mechanism 23274713 +TNF 7124 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 16085334 +TNF 7124 Liver Diseases MESH:D008107 marker/mechanism 15946935 +TNF 7124 Liver Failure, Acute MESH:D017114 marker/mechanism 19505222 +TNF 7124 Liver Neoplasms MESH:D008113 marker/mechanism 24183702 +TNF 7124 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 28100771 +TNF 7124 Lung Diseases MESH:D008171 marker/mechanism 11472967 +TNF 7124 Lung Injury MESH:D055370 marker/mechanism|therapeutic 2518282|26243812|34255241 +TNF 7124 Lung Neoplasms MESH:D008175 marker/mechanism 14587096|22369883 +TNF 7124 Malaria MESH:D008288 marker/mechanism 611162.0 +TNF 7124 Manganese Poisoning MESH:D020149 marker/mechanism 18041089 +TNF 7124 Melanoma MESH:D008545 therapeutic 10379864|18388930|9794839|9843018 +TNF 7124 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 33961948 +TNF 7124 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1 OMIM:157300 marker/mechanism 157300.0 +TNF 7124 Mitochondrial Myopathies MESH:D017240 marker/mechanism 7979221 +TNF 7124 Multiple Organ Failure MESH:D009102 marker/mechanism 10890648|9696492 +TNF 7124 Muscular Atrophy MESH:D009133 marker/mechanism 24534773 +TNF 7124 Myocardial Infarction MESH:D009203 marker/mechanism 15883752|16310260 +TNF 7124 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533|16775501 +TNF 7124 Myocardial Stunning MESH:D017682 marker/mechanism 11927517 +TNF 7124 Myocarditis MESH:D009205 marker/mechanism 18627770|25396421 +TNF 7124 Nausea MESH:D009325 marker/mechanism 10379864 +TNF 7124 Necrosis MESH:D009336 marker/mechanism 10631206|10909967|22345571|24548419 +TNF 7124 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22199285|23431386|23899529|24613819 +TNF 7124 Neoplasm Metastasis MESH:D009362 marker/mechanism 23431386|8032535 +TNF 7124 Neoplasms, Experimental MESH:D009374 therapeutic 12627504|1674182|3361654 +TNF 7124 Nerve Degeneration MESH:D009410 marker/mechanism|therapeutic 15153526|22921461|9710261 +TNF 7124 Nervous System Diseases MESH:D009422 therapeutic 14999072 +TNF 7124 Neuralgia MESH:D009437 marker/mechanism 20846523 +TNF 7124 Neuroblastoma MESH:D009447 marker/mechanism 34626302 +TNF 7124 Neurogenic Inflammation MESH:D020078 marker/mechanism 21570423 +TNF 7124 Neuroinflammatory Diseases MESH:D000090862 marker/mechanism 34453990 +TNF 7124 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 32613381 +TNF 7124 Obesity MESH:D009765 marker/mechanism 11328671|20141834|29035695|9502777 +TNF 7124 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 16311067 +TNF 7124 Osteoarthritis, Spine MESH:D055013 marker/mechanism 34697729 +TNF 7124 Osteolysis MESH:D010014 marker/mechanism 15878362 +TNF 7124 Osteoporosis, Postmenopausal MESH:D015663 marker/mechanism 9032749 +TNF 7124 Pain MESH:D010146 marker/mechanism 18582539|20383154 +TNF 7124 Pancreatic Neoplasms MESH:D010190 therapeutic 16211219 +TNF 7124 Parkinson Disease MESH:D010300 marker/mechanism 21318773 +TNF 7124 Placenta Diseases MESH:D010922 marker/mechanism 16007645 +TNF 7124 Pleural Effusion MESH:D010996 therapeutic 2518282 +TNF 7124 Pleurisy MESH:D010998 marker/mechanism 11181422|15380531 +TNF 7124 Pneumonia MESH:D011014 marker/mechanism|therapeutic 21625544|28917655|34390737 +TNF 7124 Polymyositis MESH:D017285 marker/mechanism 7979221 +TNF 7124 Pregnancy Complications, Cardiovascular MESH:D011249 marker/mechanism 10716473 +TNF 7124 Premature Birth MESH:D047928 marker/mechanism 27748297 +TNF 7124 Psoriasis MESH:D011565 marker/mechanism 16844318|7744320 +TNF 7124 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 15337792|29497291|34652871 +TNF 7124 Pulmonary Edema MESH:D011654 marker/mechanism|therapeutic 21188088|34390737 +TNF 7124 Pulmonary Emphysema MESH:D011656 marker/mechanism 25106431 +TNF 7124 Pulmonary Fibrosis MESH:D011658 marker/mechanism 11394717|16324872|17266442|25216247|26368622 +TNF 7124 Radiation Injuries, Experimental MESH:D011833 marker/mechanism 11121210 +TNF 7124 Reperfusion Injury MESH:D015427 marker/mechanism 10706834|12024109|15829914|16971220|17112405|18460982|19058328|23743330|23875703|24898700 +TNF 7124 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 18394133 +TNF 7124 Respiratory Tract Diseases MESH:D012140 marker/mechanism 22414385 +TNF 7124 Retinal Diseases MESH:D012164 marker/mechanism 19324842 +TNF 7124 Sarcoma MESH:D012509 therapeutic 15675481|16767912|17203757|9794839 +TNF 7124 Schizophrenia MESH:D012559 marker/mechanism 16478754 +TNF 7124 Scleroderma, Localized MESH:D012594 marker/mechanism 9843018 +TNF 7124 Sepsis MESH:D018805 marker/mechanism 15489642|8741040|9806674 +TNF 7124 Shock, Hemorrhagic MESH:D012771 marker/mechanism 21192278 +TNF 7124 Shock, Septic MESH:D012772 marker/mechanism 20054000 +TNF 7124 Skin Diseases MESH:D012871 marker/mechanism 16835338 +TNF 7124 Soft Tissue Neoplasms MESH:D012983 therapeutic 16767912|17203757 +TNF 7124 Spinal Cord Compression MESH:D013117 marker/mechanism 15135227 +TNF 7124 Status Epilepticus MESH:D013226 marker/mechanism 18455351 +TNF 7124 Stomach Neoplasms MESH:D013274 marker/mechanism|therapeutic 15201584|1733439 +TNF 7124 Stomach Ulcer MESH:D013276 marker/mechanism 15138204 +TNF 7124 Stroke MESH:D020521 marker/mechanism 10950380 +TNF 7124 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 27157545 +TNF 7124 Tachycardia MESH:D013610 marker/mechanism 10379864 +TNF 7124 Thrombosis MESH:D013927 marker/mechanism 19691487 +TNF 7124 Thyroid Neoplasms MESH:D013964 marker/mechanism 26037280 +TNF 7124 Trigeminal Neuralgia MESH:D014277 marker/mechanism 27093858 +TNF 7124 Urinary Bladder Neoplasms MESH:D001749 therapeutic 1674182 +TNF 7124 Urticaria MESH:D014581 marker/mechanism 12121561|19250144|20485159 +TNF 7124 Vascular Diseases MESH:D014652 marker/mechanism 14965870 +TNF 7124 Vascular System Injuries MESH:D057772 marker/mechanism 19234301 +TNF 7124 Venous Thromboembolism MESH:D054556 marker/mechanism 22473048 +TNF 7124 Ventricular Dysfunction MESH:D018754 marker/mechanism 20626112 +TNF 7124 Vitiligo MESH:D014820 marker/mechanism 28836394 +TNF 7124 Weight Gain MESH:D015430 marker/mechanism 20521320 +TNF 7124 Wounds and Injuries MESH:D014947 marker/mechanism 21192278 +TNFAIP1 7126 Diabetic Nephropathies MESH:D003928 marker/mechanism 20665664 +TNFAIP2 7127 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +TNFAIP3 7128 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 18794853|20453842|21841782|23143596|30224649 +TNFAIP3 7128 Autoimmune Diseases MESH:D001327 marker/mechanism 24453940 +TNFAIP3 7128 AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE 1 OMIM:616744 marker/mechanism 616744.0 +TNFAIP3 7128 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24362818 +TNFAIP3 7128 Hereditary Autoinflammatory Diseases MESH:D056660 marker/mechanism 26642243 +TNFAIP3 7128 Inflammation MESH:D007249 marker/mechanism 24453940 +TNFAIP3 7128 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19165918|19165919|19838193|21336280 +TNFAIP3 7128 Lymphoma, Follicular MESH:D008224 marker/mechanism 24362818 +TNFAIP3 7128 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +TNFAIP3 7128 Multiple Sclerosis MESH:D009103 marker/mechanism 24076602 +TNFAIP3 7128 Psoriasis MESH:D011565 marker/mechanism 19169254|20953190 +TNFAIP3 7128 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097066|24097067 +TNFAIP6 7130 Acute Lung Injury MESH:D055371 therapeutic 26313688 +TNFAIP6 7130 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +TNFAIP6 7130 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TNFAIP6 7130 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404|17374397 +TNFAIP6 7130 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +TNFAIP6 7130 Influenza, Human MESH:D007251 marker/mechanism 23326326 +TNFAIP6 7130 Skin Diseases MESH:D012871 marker/mechanism 16835338 +TNFAIP8 25816 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TNFAIP8 25816 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21969086 +TNFAIP8 25816 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TNFAIP8 25816 Neoplasm Metastasis MESH:D009362 marker/mechanism 21969086 +TNFRSF10A 8797 Adenocarcinoma MESH:D000230 marker/mechanism 21472143 +TNFRSF10A 8797 Alopecia MESH:D000505 marker/mechanism 19652058 +TNFRSF10A 8797 Anemia MESH:D000740 marker/mechanism 19652058 +TNFRSF10A 8797 Anorexia MESH:D000855 marker/mechanism 19652058 +TNFRSF10A 8797 Colonic Neoplasms MESH:D003110 marker/mechanism 17075118 +TNFRSF10A 8797 Drug Hypersensitivity MESH:D004342 marker/mechanism 19652058 +TNFRSF10A 8797 Esophageal Neoplasms MESH:D004938 marker/mechanism 21472143 +TNFRSF10A 8797 Fatigue MESH:D005221 marker/mechanism 19652058 +TNFRSF10A 8797 Macular Degeneration MESH:D008268 marker/mechanism 21909106 +TNFRSF10A 8797 Nausea MESH:D009325 marker/mechanism 19652058 +TNFRSF10A 8797 Neoplasms MESH:D009369 therapeutic 19652058 +TNFRSF10A 8797 Neutropenia MESH:D009503 marker/mechanism 19652058 +TNFRSF10A 8797 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 19652058 +TNFRSF10A 8797 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +TNFRSF10A 8797 Thrombocytopenia MESH:D013921 marker/mechanism 19652058 +TNFRSF10B 8795 Liver Neoplasms, Experimental MESH:D008114 therapeutic 18079962 +TNFRSF10B 8795 Pancreatic Neoplasms MESH:D010190 therapeutic 18089714 +TNFRSF10B 8795 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 275355.0 +TNFRSF10C 8794 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TNFRSF11A 8792 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 16270354 +TNFRSF11A 8792 Osteitis Deformans MESH:D010001 marker/mechanism 602080.0 20436471 +TNFRSF11A 8792 Osteopetrosis, Autosomal Recessive 7 MESH:C567354 marker/mechanism 612301.0 +TNFRSF11A 8792 Polyostotic osteolytic dysplasia, hereditary expansile MESH:C536335 marker/mechanism 174810.0 +TNFRSF11B 4982 Arthritis, Experimental MESH:D001169 therapeutic 23333834 +TNFRSF11B 4982 Arthritis, Rheumatoid MESH:D001172 therapeutic 23333834 +TNFRSF11B 4982 Bone Resorption MESH:D001862 marker/mechanism|therapeutic 15845617|18496637|23333834 +TNFRSF11B 4982 Carotid Stenosis MESH:D016893 marker/mechanism 26564003 +TNFRSF11B 4982 Hyperalgesia MESH:D006930 therapeutic 16769263 +TNFRSF11B 4982 Hypercalcemia MESH:D006934 therapeutic 15845617 +TNFRSF11B 4982 Inflammation MESH:D007249 therapeutic 23333834 +TNFRSF11B 4982 Osteolysis MESH:D010014 therapeutic 12548581 +TNFRSF11B 4982 Osteoporosis MESH:D010024 marker/mechanism 17667143 +TNFRSF11B 4982 PAGET DISEASE OF BONE 5, JUVENILE-ONSET OMIM:239000 marker/mechanism 239000.0 +TNFRSF11B 4982 Uremia MESH:D014511 marker/mechanism 19092814 +TNFRSF12A 51330 Acute Kidney Injury MESH:D058186 marker/mechanism 23052191 +TNFRSF12A 51330 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TNFRSF12A 51330 Myocardial Infarction MESH:D009203 marker/mechanism 20082609 +TNFRSF13B 23495 Brain Injuries MESH:D001930 marker/mechanism 23159883 +TNFRSF13B 23495 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 240500 +TNFRSF13B 23495 Immunoglobulin a deficiency 2 MESH:C536291 marker/mechanism 609529 +TNFRSF13B 23495 Multiple Myeloma MESH:D009101 marker/mechanism 23955597 +TNFRSF13C 115650 Brain Injuries MESH:D001930 marker/mechanism 23159883 +TNFRSF13C 115650 Common Variable Immunodeficiency MESH:D017074 marker/mechanism 240500|613494 +TNFRSF14 8764 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842 +TNFRSF14 8764 Brain Injuries MESH:D001930 marker/mechanism 23159883 +TNFRSF14 8764 Celiac Disease MESH:D002446 marker/mechanism 20190752 +TNFRSF18 8784 Leishmaniasis MESH:D007896 marker/mechanism 20139272 +TNFRSF19 55504 Melanoma MESH:D008545 marker/mechanism 17187358 +TNFRSF19 55504 Nasopharyngeal Neoplasms MESH:D009303 marker/mechanism 20512145 +TNFRSF1A 7132 Anorexia MESH:D000855 therapeutic 18801959 +TNFRSF1A 7132 Autoimmune Diseases MESH:D001327 marker/mechanism 21074606 +TNFRSF1A 7132 Brain Injuries MESH:D001930 marker/mechanism 21549006 +TNFRSF1A 7132 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +TNFRSF1A 7132 Cachexia MESH:D002100 therapeutic 18801959 +TNFRSF1A 7132 Cystic Fibrosis MESH:D003550 marker/mechanism 16463024 +TNFRSF1A 7132 Diabetes Mellitus, Experimental MESH:D003921 therapeutic 12193562 +TNFRSF1A 7132 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 11882518 +TNFRSF1A 7132 Fever MESH:D005334 marker/mechanism 11175303 +TNFRSF1A 7132 Heart Failure MESH:D006333 marker/mechanism 16360360 +TNFRSF1A 7132 Hyperoxia MESH:D018496 marker/mechanism 10781441 +TNFRSF1A 7132 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +TNFRSF1A 7132 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 21399635 +TNFRSF1A 7132 Lung Injury MESH:D055370 marker/mechanism 10781441 +TNFRSF1A 7132 Multiple Sclerosis MESH:D009103 marker/mechanism 614810 19525953|24076602 +TNFRSF1A 7132 Periodic fever, familial, autosomal dominant MESH:C536657 marker/mechanism 142680 +TNFRSF1A 7132 Pneumonia MESH:D011014 marker/mechanism 21625544 +TNFRSF1B 7133 Autistic Disorder MESH:D001321 marker/mechanism 16139734 +TNFRSF1B 7133 Brain Ischemia MESH:D002545 marker/mechanism 15829914 +TNFRSF1B 7133 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 11882518 +TNFRSF1B 7133 Fractures, Bone MESH:D050723 marker/mechanism 15071724 +TNFRSF1B 7133 Hypersensitivity MESH:D006967 marker/mechanism 21625544 +TNFRSF1B 7133 Hypoalbuminemia MESH:D034141 marker/mechanism 15044820 +TNFRSF1B 7133 Liver Cirrhosis MESH:D008103 marker/mechanism 20353583 +TNFRSF1B 7133 Mycosis Fungoides MESH:D009182 marker/mechanism 26258847 +TNFRSF1B 7133 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 20353583 +TNFRSF1B 7133 Obesity MESH:D009765 marker/mechanism 11782876 +TNFRSF1B 7133 Pneumonia MESH:D011014 marker/mechanism 21625544 +TNFRSF1B 7133 Sezary Syndrome MESH:D012751 marker/mechanism 26258847 +TNFRSF21 27242 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 24113175 +TNFRSF21 27242 Gliosis MESH:D005911 marker/mechanism 24113175 +TNFRSF21 27242 Prostatic Neoplasms MESH:D011471 marker/mechanism 11753679 +TNFRSF26 244237 Brain Injuries MESH:D001930 marker/mechanism 23159883 +TNFRSF4 7293 Autoimmune Diseases MESH:D001327 marker/mechanism 9766631 +TNFRSF4 7293 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 12031769 +TNFRSF4 7293 IMMUNODEFICIENCY 16 OMIM:615593 marker/mechanism 615593.0 +TNFRSF4 7293 Myocarditis MESH:D009205 marker/mechanism 12031769 +TNFRSF4 7293 Virus Diseases MESH:D014777 marker/mechanism 12031769 +TNFRSF8 943 AIDS-Related Opportunistic Infections MESH:D017088 marker/mechanism 9379333 +TNFRSF8 943 Carcinoma, Embryonal MESH:D018236 marker/mechanism 9111512 +TNFRSF8 943 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 12031769 +TNFRSF8 943 Ectromelia, Infectious MESH:D004482 therapeutic 12235215 +TNFRSF8 943 Emphysema MESH:D004646 therapeutic 29984229 +TNFRSF8 943 Gingivitis MESH:D005891 marker/mechanism 9379333 +TNFRSF8 943 Graft vs Host Disease MESH:D006086 marker/mechanism 15322151 +TNFRSF8 943 Graves Disease MESH:D006111 marker/mechanism 16372246 +TNFRSF8 943 Hashimoto Disease MESH:D050031 marker/mechanism 16372246 +TNFRSF8 943 Hemorrhage MESH:D006470 therapeutic 29984229 +TNFRSF8 943 HIV Infections MESH:D015658 marker/mechanism 8811349 +TNFRSF8 943 Hodgkin Disease MESH:D006689 marker/mechanism 10908157|12358914|12453859|16879607|17261581|7621881|8701986 +TNFRSF8 943 Lymphoma, Large-Cell, Anaplastic MESH:D017728 marker/mechanism 10908157|17261581 +TNFRSF8 943 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 23056237 +TNFRSF8 943 Mycobacterium Infections MESH:D009164 therapeutic 15316035 +TNFRSF8 943 Myocarditis MESH:D009205 marker/mechanism 12031769 +TNFRSF8 943 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 27543511 +TNFRSF8 943 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 29984229 +TNFRSF8 943 Virus Diseases MESH:D014777 marker/mechanism 12031769|9826579 +TNFRSF9 3604 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 12031769 +TNFRSF9 3604 Celiac Disease MESH:D002446 marker/mechanism 30097691 +TNFRSF9 3604 Colonic Neoplasms MESH:D003110 marker/mechanism 25279216 +TNFRSF9 3604 Kidney Neoplasms MESH:D007680 marker/mechanism 25279216 +TNFRSF9 3604 Myocarditis MESH:D009205 marker/mechanism 12031769 +TNFRSF9 3604 Stomach Neoplasms MESH:D013274 marker/mechanism 25279216 +TNFRSF9 3604 Virus Diseases MESH:D014777 marker/mechanism 12031769 +TNFSF10 8743 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TNFSF10 8743 Adenocarcinoma of Lung MESH:D000077192 therapeutic 24345465 +TNFSF10 8743 Brain Injuries MESH:D001930 marker/mechanism 23159883 +TNFSF10 8743 Breast Neoplasms MESH:D001943 therapeutic 18483385 +TNFSF10 8743 Carcinoma, Hepatocellular MESH:D006528 therapeutic 17326159 +TNFSF10 8743 Carcinoma, Renal Cell MESH:D002292 therapeutic 20403343 +TNFSF10 8743 Colonic Neoplasms MESH:D003110 therapeutic 15993848 +TNFSF10 8743 Colorectal Neoplasms MESH:D015179 therapeutic 17273769 +TNFSF10 8743 Endometrial Neoplasms MESH:D016889 therapeutic 20071162 +TNFSF10 8743 Glioblastoma MESH:D005909 therapeutic 21877938 +TNFSF10 8743 Glioma MESH:D005910 therapeutic 16820965|19229339 +TNFSF10 8743 Influenza, Human MESH:D007251 marker/mechanism 23326326 +TNFSF10 8743 Kidney Neoplasms MESH:D007680 therapeutic 16985049 +TNFSF10 8743 Leukemia MESH:D007938 therapeutic 17204177 +TNFSF10 8743 Leukemia, Myeloid, Acute MESH:D015470 therapeutic 12780785 +TNFSF10 8743 Liver Neoplasms MESH:D008113 therapeutic 18980244 +TNFSF10 8743 Mammary Neoplasms, Experimental MESH:D008325 therapeutic 21252285 +TNFSF10 8743 Neoplasm Metastasis MESH:D009362 therapeutic 21209944 +TNFSF10 8743 Neoplasms, Experimental MESH:D009374 therapeutic 17767197|24345465 +TNFSF10 8743 Neovascularization, Pathologic MESH:D009389 therapeutic 19509267|21209944 +TNFSF10 8743 Neuroblastoma MESH:D009447 therapeutic 16820965 +TNFSF10 8743 Ovarian Neoplasms MESH:D010051 therapeutic 21616060 +TNFSF10 8743 Pancreatic Neoplasms MESH:D010190 therapeutic 11234897 +TNFSF10 8743 Prostatic Neoplasms MESH:D011471 therapeutic 16368536|17636462|17718901|21209944 +TNFSF11 8600 Alveolar Bone Loss MESH:D016301 marker/mechanism 19249596 +TNFSF11 8600 Bone Resorption MESH:D001862 marker/mechanism 26319416 +TNFSF11 8600 Chronic Periodontitis MESH:D055113 marker/mechanism 20731768 +TNFSF11 8600 Hypercalcemia MESH:D006934 marker/mechanism 15845617 +TNFSF11 8600 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 16270354 +TNFSF11 8600 Osteolysis MESH:D010014 marker/mechanism 18606716 +TNFSF11 8600 Osteopetrosis MESH:D010022 marker/mechanism 17632511 +TNFSF11 8600 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2 OMIM:259710 marker/mechanism 259710.0 +TNFSF11 8600 Osteoporosis MESH:D010024 therapeutic 17882678 +TNFSF12 8742 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +TNFSF12 8742 Brain Injuries MESH:D001930 marker/mechanism 23159883 +TNFSF13 8741 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TNFSF13 8741 Colorectal Neoplasms MESH:D015179 marker/mechanism 18423122 +TNFSF13 8741 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 22197929 +TNFSF14 8740 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20008919 +TNFSF14 8740 Multiple Sclerosis MESH:D009103 marker/mechanism 24076602 +TNFSF15 9966 Colitis, Ulcerative MESH:D003093 marker/mechanism 20228799 +TNFSF15 9966 Crohn Disease MESH:D003424 marker/mechanism 37156999 +TNFSF15 9966 Enteritis MESH:D004751 marker/mechanism 20980995 +TNFSF15 9966 Inflammation MESH:D007249 marker/mechanism 20980995 +TNFSF15 9966 Inflammatory Bowel Diseases MESH:D015212 marker/mechanism 26192919 +TNFSF15 9966 Osteoarthritis MESH:D010003 marker/mechanism 30664745 +TNFSF4 7292 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 12031769 +TNFSF4 7292 Leishmaniasis MESH:D007896 marker/mechanism 10637281 +TNFSF4 7292 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 18059267|19838193 +TNFSF4 7292 Myocardial Infarction MESH:D009203 marker/mechanism 608446.0 +TNFSF4 7292 Myocarditis MESH:D009205 marker/mechanism 12031769 +TNFSF4 7292 Virus Diseases MESH:D014777 marker/mechanism 12031769 +TNFSF8 944 Carcinogenesis MESH:D063646 marker/mechanism 11552987 +TNFSF8 944 Carcinoma, Embryonal MESH:D018236 marker/mechanism 9111512 +TNFSF8 944 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 12031769 +TNFSF8 944 Coxsackievirus Infections MESH:D003384 marker/mechanism 11745696 +TNFSF8 944 Diabetes Mellitus, Congenital Autoimmune MESH:C565730 marker/mechanism 12930356 +TNFSF8 944 Disease Progression MESH:D018450 marker/mechanism 11552987 +TNFSF8 944 Ectromelia, Infectious MESH:D004482 therapeutic 12235215 +TNFSF8 944 Endodermal Sinus Tumor MESH:D018240 marker/mechanism 9111512 +TNFSF8 944 Graft vs Host Disease MESH:D006086 marker/mechanism 15322151 +TNFSF8 944 Graves Disease MESH:D006111 marker/mechanism 16372246 +TNFSF8 944 Hashimoto Disease MESH:D050031 marker/mechanism 16372246 +TNFSF8 944 Hodgkin Disease MESH:D006689 marker/mechanism 10908157|11552987|12358914|7621881|8656679|8701986|8896393|9058727 +TNFSF8 944 Hypereosinophilic Syndrome MESH:D017681 marker/mechanism 8896393 +TNFSF8 944 Leprosy MESH:D007918 marker/mechanism 25320285 +TNFSF8 944 Leukemia, Hairy Cell MESH:D007943 marker/mechanism 9058727 +TNFSF8 944 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 9058727 +TNFSF8 944 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 9058727 +TNFSF8 944 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 10512160|11918534|9058727 +TNFSF8 944 Leukemia, Prolymphocytic, T-Cell MESH:D015461 marker/mechanism 9058727 +TNFSF8 944 Listeriosis MESH:D008088 marker/mechanism|therapeutic 16177108|21699557 +TNFSF8 944 Lymphoma, B-Cell MESH:D016393 marker/mechanism 9058727 +TNFSF8 944 Lymphoma, T-Cell, Peripheral MESH:D016411 marker/mechanism 9058727 +TNFSF8 944 Lymphomatoid Papulosis MESH:D017731 therapeutic 11594583 +TNFSF8 944 Multiple Myeloma MESH:D009101 marker/mechanism 9058727 +TNFSF8 944 Mycobacterium Infections MESH:D009164 marker/mechanism|therapeutic 15316035|18941223 +TNFSF8 944 Mycobacterium tuberculosis, susceptibility to infection by MESH:C536092 marker/mechanism 30202016 +TNFSF8 944 Myocarditis MESH:D009205 marker/mechanism 11745696|12031769 +TNFSF8 944 Neoplasm Regression, Spontaneous MESH:D009365 marker/mechanism 11594583 +TNFSF8 944 Neuralgia MESH:D009437 marker/mechanism 31432094 +TNFSF8 944 Pleurisy MESH:D010998 marker/mechanism 15380531 +TNFSF8 944 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma MESH:D015452 marker/mechanism 9058727 +TNFSF8 944 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 29984229 +TNFSF8 944 Virus Diseases MESH:D014777 marker/mechanism 12031769 +TNFSF9 8744 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 12031769 +TNFSF9 8744 Coxsackievirus Infections MESH:D003384 marker/mechanism 11745696 +TNFSF9 8744 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +TNFSF9 8744 Myocarditis MESH:D009205 marker/mechanism 11745696|12031769 +TNFSF9 8744 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +TNFSF9 8744 Virus Diseases MESH:D014777 marker/mechanism 12031769 +TNIK 23043 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +TNIK 23043 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TNIK 23043 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 54 OMIM:617028 marker/mechanism 617028.0 +TNIK 23043 Skin Diseases MESH:D012871 marker/mechanism 16835338 +TNIP1 10318 Asthma MESH:D001249 marker/mechanism 24453940 +TNIP1 10318 Breast Neoplasms MESH:D001943 marker/mechanism 16298037 +TNIP1 10318 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 19838193|19838195 +TNIP1 10318 Psoriasis MESH:D011565 marker/mechanism 19169254|20953190 +TNIP1 10318 Scleroderma, Systemic MESH:D012595 marker/mechanism 21750679 +TNIP1 10318 Sjogren's Syndrome MESH:D012859 marker/mechanism 24097067 +TNK2 10188 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +TNK2 10188 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +TNNC1 7134 Cardiomyopathy, Dilated, 1z MESH:C567506 marker/mechanism 611879.0 +TNNC1 7134 Cardiomyopathy, Familial Hypertrophic, 13 MESH:C567686 marker/mechanism 613243.0 +TNNI2 7136 Distal arthrogryposis type 2B MESH:C538400 marker/mechanism 601680.0 +TNNI2 7136 Muscular Diseases MESH:D009135 marker/mechanism 19628585 +TNNI3 7137 Acute Coronary Syndrome MESH:D054058 marker/mechanism 15966572 +TNNI3 7137 Cardiomyopathies MESH:D009202 marker/mechanism 17587482 +TNNI3 7137 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 15070570 +TNNI3 7137 Cardiomyopathy, Dilated, 1FF MESH:C567654 marker/mechanism 613286.0 +TNNI3 7137 Cardiomyopathy, Dilated, 2a MESH:C567505 marker/mechanism 611880.0 +TNNI3 7137 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7 OMIM:613690 marker/mechanism 613690.0 +TNNI3 7137 Cardiomyopathy, Familial Restrictive, 1 MESH:C566168 marker/mechanism 115210.0 +TNNI3 7137 Cardiomyopathy, Hypertrophic, Familial MESH:D024741 marker/mechanism 11801593|11815426|9241277 +TNNI3 7137 Cardiomyopathy, Restrictive MESH:D002313 marker/mechanism 12531876 +TNNI3 7137 Heart Diseases MESH:D006331 marker/mechanism 19549929 +TNNI3 7137 Myocardial Infarction MESH:D009203 marker/mechanism 12359538 +TNNI3K 51086 CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY OMIM:616117 marker/mechanism 616117.0 +TNNI3K 51086 Cardiac Conduction System Disease MESH:D000075224 marker/mechanism 32529721 +TNNT1 7138 Nemaline myopathy 5 MESH:C538397 marker/mechanism 605355.0 +TNNT2 7139 Acute Coronary Syndrome MESH:D054058 marker/mechanism 15966572 +TNNT2 7139 Cardiomegaly MESH:D006332 marker/mechanism 17556660 +TNNT2 7139 Cardiomyopathies MESH:D009202 marker/mechanism 14745153|17587482 +TNNT2 7139 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 17556660|19477965 +TNNT2 7139 Cardiomyopathy, Dilated, 1D MESH:C563306 marker/mechanism 601494.0 +TNNT2 7139 Cardiomyopathy, Familial Hypertrophic, 2 MESH:C566171 marker/mechanism 115195.0 +TNNT2 7139 Cardiomyopathy, Familial Restrictive, 3 MESH:C567316 marker/mechanism 612422.0 +TNNT2 7139 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 19087273 +TNNT2 7139 Cardiomyopathy, Hypertrophic, Familial MESH:D024741 marker/mechanism 12600890|9241277 +TNNT2 7139 Cardiovascular Diseases MESH:D002318 marker/mechanism 14761428 +TNNT2 7139 Death, Sudden, Cardiac MESH:D016757 marker/mechanism 17556660 +TNNT2 7139 Glycogen Storage Disease Type II MESH:D006009 marker/mechanism 26787432 +TNNT2 7139 Heart Diseases MESH:D006331 marker/mechanism 17848144 +TNNT2 7139 Heart Failure MESH:D006333 marker/mechanism 12322705|17698733 +TNNT2 7139 Heart Injuries MESH:D006335 marker/mechanism 19854236 +TNNT2 7139 Myocardial Ischemia MESH:D017202 marker/mechanism 10789933 +TNNT2 7139 Necrosis MESH:D009336 marker/mechanism 17848144 +TNNT2 7139 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 18068611 +TNNT2 7139 Respiratory Distress Syndrome, Newborn MESH:D012127 marker/mechanism 10789933 +TNNT2 7139 Tachycardia, Ventricular MESH:D017180 marker/mechanism 12600890 +TNNT2 7139 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 14618274 +TNPO2 30000 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TNPO3 23534 Muscular Dystrophy, Limb-Girdle, Type 1F MESH:C564242 marker/mechanism 608423.0 +TNR 7143 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TNR 7143 Gliosis MESH:D005911 marker/mechanism 15120744 +TNRC6A 27327 Epilepsies, Myoclonic MESH:D004831 marker/mechanism 29507423 +TNRC6B 23112 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +TNRC6B 23112 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TNS1A 565181 Mitral Valve Insufficiency MESH:D008944 marker/mechanism 26301497 +TNXB 7148 Ehlers-Danlos syndrome caused by tenascin-X deficiency MESH:C536193 marker/mechanism 606408.0 +TNXB 7148 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 29379198 +TNXB 7148 Vesico-Ureteral Reflux MESH:D014718 marker/mechanism 615963.0 +TOB1 10140 Chloracne MESH:D054506 marker/mechanism 17101203 +TOB1 10140 Endometriosis MESH:D004715 marker/mechanism 21063030 +TOB1 10140 Neoplasms, Experimental MESH:D009374 marker/mechanism 12756225 +TOB2 10766 Vitiligo MESH:D014820 marker/mechanism 22561518 +TOE1 114034 Pontocerebellar Hypoplasia MESH:C580383 marker/mechanism 28092684 +TOE1 114034 PONTOCEREBELLAR HYPOPLASIA, TYPE 7 OMIM:614969 marker/mechanism 614969.0 +TOM1L1 10040 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TOMM40 10452 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +TOMM40 10452 Alzheimer Disease MESH:D000544 marker/mechanism 27023435|29107063|30319691|30320580 +TOMM40 10452 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +TOMM40 10452 Dyslipidemias MESH:D050171 marker/mechanism 29670124 +TONSL 4796 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TONSL 4796 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TOP1 7150 Disease Progression MESH:D018450 marker/mechanism 30132517 +TOP1 7150 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 19931604 +TOP1 7150 Liver Neoplasms MESH:D008113 marker/mechanism 30132517 +TOP1 7150 Neoplasms MESH:D009369 marker/mechanism 11598410 +TOP1 7150 Recurrence MESH:D012008 marker/mechanism 30132517 +TOP2A 7153 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +TOP2A 7153 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 23533247 +TOP2A 7153 Breast Neoplasms MESH:D001943 marker/mechanism 11583189|12006526|16234514|22204715 +TOP2A 7153 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +TOP2A 7153 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TOP2A 7153 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +TOP2A 7153 Disease Progression MESH:D018450 marker/mechanism 22204715|30132517 +TOP2A 7153 Glioma MESH:D005910 marker/mechanism 18402387 +TOP2A 7153 Leukemia MESH:D007938 marker/mechanism 15833037 +TOP2A 7153 Liver Neoplasms MESH:D008113 marker/mechanism 30132517 +TOP2A 7153 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TOP2A 7153 Prostatic Neoplasms MESH:D011471 marker/mechanism 17363613 +TOP2A 7153 Recurrence MESH:D012008 marker/mechanism 20079691|22204715|30132517 +TOP2A 7153 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +TOP2A 7153 Sepsis MESH:D018805 marker/mechanism 27978524 +TOP2B 7155 Leukemia, Myeloid MESH:D007951 therapeutic 16932348 +TOP2B 7155 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 20601956 +TOPBP1 11073 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 18006695 +TOPORS 10210 Osteosarcoma MESH:D012516 marker/mechanism 14767549 +TOPORS 10210 Retinitis Pigmentosa 31 MESH:C563685 marker/mechanism 609923.0 +TOR1A 1861 Dystonia MESH:D004421 marker/mechanism 20227500|21078339|23222958 +TOR1A 1861 Dystonia musculorum deformans type 1 MESH:C538005 marker/mechanism 128100.0 +TOR1A 1861 Dystonic Disorders MESH:D020821 marker/mechanism 23222958 +TOR1A 1861 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +TOR1AIP1 26092 MYOPATHY, AUTOSOMAL RECESSIVE, WITH RIGID SPINE AND DISTAL JOINT CONTRACTURES OMIM:617072 marker/mechanism 617072.0 +TOR1B 27348 Influenza, Human MESH:D007251 marker/mechanism 23326326 +TOR4A 54863 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TOX3 27324 Breast Neoplasms MESH:D001943 marker/mechanism 17529967 +TOX3 27324 Breast Neoplasms, Male MESH:D018567 marker/mechanism 23001122 +TOX3 27324 Liver Neoplasms MESH:D008113 marker/mechanism 28108177 +TP53 7157 Acquired Hyperostosis Syndrome MESH:D020083 marker/mechanism 19779722 +TP53 7157 Acute erythroleukemia MESH:C535673 marker/mechanism 30926971 +TP53 7157 Acute Kidney Injury MESH:D058186 marker/mechanism 20603111 +TP53 7157 Adenocarcinoma MESH:D000230 marker/mechanism|therapeutic 10797276|11798837|22484628 +TP53 7157 Adenocarcinoma, Clear Cell MESH:D018262 marker/mechanism 9754764 +TP53 7157 Adenocarcinoma Of Esophagus MESH:C562730 marker/mechanism 23525077 +TP53 7157 Adenoma MESH:D000236 marker/mechanism 21946351 +TP53 7157 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 24747643 +TP53 7157 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 23585556|24747642|9815696 +TP53 7157 Adrenocortical Carcinoma, Hereditary MESH:C565972 marker/mechanism 202300.0 +TP53 7157 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 17434459 +TP53 7157 Aortic Valve, Calcification of MESH:C562942 marker/mechanism 29358327 +TP53 7157 Arsenic Poisoning MESH:D020261 marker/mechanism 18621066|19203779 +TP53 7157 Balkan Nephropathy MESH:D001449 marker/mechanism 22071594 +TP53 7157 Brain Ischemia MESH:D002545 marker/mechanism 19095966 +TP53 7157 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 15802278|16968874|17388661|26192916|26229107|30381462 +TP53 7157 Calcinosis MESH:D002114 marker/mechanism 29358327 +TP53 7157 Carcinoma MESH:D002277 marker/mechanism 17450239|9626339 +TP53 7157 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +TP53 7157 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 614740.0 11511317|21946351|26950094 +TP53 7157 Carcinoma, Ductal MESH:D044584 marker/mechanism 29295717 +TP53 7157 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism|therapeutic 114550.0 17191126|18477611|22675488|25822088|8033108|9029167 +TP53 7157 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17290066|23435014|24688052|30381462 +TP53 7157 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 25535366 +TP53 7157 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 17275163|22138691|23797736|25401301 +TP53 7157 Carcinoma, Small Cell MESH:D018288 marker/mechanism 17290066 +TP53 7157 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17979968|24224046 +TP53 7157 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 22929185 +TP53 7157 Cardiomyopathies MESH:D009202 therapeutic 31618665 +TP53 7157 Cardiomyopathy, Hypertrophic MESH:D002312 marker/mechanism 22000973 +TP53 7157 Cardiotoxicity MESH:D066126 marker/mechanism 30009776|34713381 +TP53 7157 Carotid Artery Diseases MESH:D002340 marker/mechanism 16973168 +TP53 7157 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 15550242 +TP53 7157 Central Nervous System Neoplasms MESH:D016543 marker/mechanism 26192916 +TP53 7157 Cholangiocarcinoma MESH:D018281 marker/mechanism 22561520 +TP53 7157 Chromosome 17 deletion MESH:C538045 marker/mechanism 14961032 +TP53 7157 Colonic Neoplasms MESH:D003110 marker/mechanism 17075118|17192441|26192916 +TP53 7157 Colorectal Neoplasms MESH:D015179 marker/mechanism 114500.0 12645814|15172127|15814641|16110022|16524972|17949449|18676755|21946351 +TP53 7157 Demyelinating Diseases MESH:D003711 marker/mechanism 18550754 +TP53 7157 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 23792339 +TP53 7157 Disease Progression MESH:D018450 marker/mechanism 30381462 +TP53 7157 Emphysema MESH:D004646 marker/mechanism 22276220 +TP53 7157 Esophageal Neoplasms MESH:D004938 marker/mechanism 17634542|26192916 +TP53 7157 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25151357 +TP53 7157 Gallbladder Neoplasms MESH:D005706 marker/mechanism 24185509|24997986 +TP53 7157 Glioma MESH:D005910 marker/mechanism 137800.0 16899598|21946351|24705251 +TP53 7157 Hemangiosarcoma MESH:D006394 marker/mechanism 10626228 +TP53 7157 Hypertension MESH:D006973 marker/mechanism 22228705 +TP53 7157 Infertility, Female MESH:D007247 marker/mechanism 22532853 +TP53 7157 Infertility, Male MESH:D007248 marker/mechanism 22773013 +TP53 7157 Ischemia MESH:D007511 marker/mechanism 15172883 +TP53 7157 Keratosis MESH:D007642 marker/mechanism 16930632|28785074 +TP53 7157 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 16439677 +TP53 7157 Leukemia, Megakaryoblastic, of Down Syndrome MESH:C566025 marker/mechanism 24056718 +TP53 7157 Li-Fraumeni Syndrome MESH:D016864 marker/mechanism 151623.0 25860607 +TP53 7157 Liver Diseases, Parasitic MESH:D008109 marker/mechanism 22561520 +TP53 7157 Liver Neoplasms MESH:D008113 marker/mechanism 12378512|16410370 +TP53 7157 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 10626228 +TP53 7157 Lung Neoplasms MESH:D008175 marker/mechanism|therapeutic 11798837|16410370|17325666|20727180|26192916|8049841 +TP53 7157 Lymphoma, T-Cell MESH:D016399 marker/mechanism 26192917 +TP53 7157 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +TP53 7157 Melanoma MESH:D008545 marker/mechanism 17210701|21691232|22842228|29574239 +TP53 7157 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +TP53 7157 Mitochondrial Diseases MESH:D028361 marker/mechanism 30673822 +TP53 7157 Mouth Neoplasms MESH:D009062 marker/mechanism 24224046 +TP53 7157 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 27992414 +TP53 7157 Myeloproliferative Disorders MESH:D009196 marker/mechanism 29370077 +TP53 7157 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 607107.0 24952746 +TP53 7157 Neoplasm Metastasis MESH:D009362 marker/mechanism 17949449 +TP53 7157 Osteosarcoma MESH:D012516 marker/mechanism|therapeutic 259500.0 16211088 +TP53 7157 Ovarian Neoplasms MESH:D010051 marker/mechanism 30258081 +TP53 7157 Pancreatic Neoplasms MESH:D010190 marker/mechanism 260350.0 +TP53 7157 Papilloma, Choroid Plexus MESH:D020288 marker/mechanism 260500.0 +TP53 7157 Penile Neoplasms MESH:D010412 marker/mechanism 9626339 +TP53 7157 Polyploidy MESH:D011123 marker/mechanism 25125259 +TP53 7157 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 23334668 +TP53 7157 Prostatic Neoplasms MESH:D011471 marker/mechanism 16434975|17202838|20875869|21946351|25735316|26005866|29295717|29610475 +TP53 7157 Psoriasis MESH:D011565 marker/mechanism 10384915 +TP53 7157 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 17274270 +TP53 7157 Sarcoma MESH:D012509 marker/mechanism 20601955 +TP53 7157 Schizophrenia MESH:D012559 marker/mechanism 18583979 +TP53 7157 Sezary Syndrome MESH:D012751 marker/mechanism 26551667|26551670 +TP53 7157 Skin Neoplasms MESH:D012878 marker/mechanism 12635827 +TP53 7157 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941188|22941189 +TP53 7157 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 25086664|30594912 +TP53 7157 Stomach Neoplasms MESH:D013274 marker/mechanism 22484628|24816253 +TP53 7157 Thymoma MESH:D013945 marker/mechanism 24974848 +TP53 7157 Thyroid Neoplasms MESH:D013964 marker/mechanism 16940797 +TP53 7157 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 12376482|15906354|22929185|29644616|9610789 +TP53 7157 Urogenital Neoplasms MESH:D014565 marker/mechanism 17300232 +TP53 7157 Urologic Neoplasms MESH:D014571 marker/mechanism 22071594 +TP53 7157 Vulvar Lichen Sclerosus MESH:D007724 marker/mechanism 17300232 +TP53 7157 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +TP53BP1 7158 Breast Neoplasms MESH:D001943 marker/mechanism 30705370 +TP53BP1 7158 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +TP53BP1 7158 Colonic Neoplasms MESH:D003110 marker/mechanism 30705370 +TP53BP1 7158 Glioblastoma MESH:D005909 marker/mechanism 30705370 +TP53BP1 7158 Lymphatic Metastasis MESH:D008207 marker/mechanism 30705370 +TP53BP1 7158 Ovarian Neoplasms MESH:D010051 marker/mechanism 30705370 +TP53BP2 7159 Breast Neoplasms MESH:D001943 marker/mechanism 28650484 +TP53BP2 7159 Carcinoma, Lobular MESH:D018275 marker/mechanism 28650484 +TP53BP2 7159 Neoplasm Invasiveness MESH:D009361 marker/mechanism 28650484 +TP53I3 9540 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TP53I3 9540 Carcinoma MESH:D002277 marker/mechanism 21489049 +TP53I3 9540 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 21489049 +TP53RK 112858 Galloway Mowat syndrome MESH:C537548 marker/mechanism 28805828 +TP53TG1 11257 Colorectal Neoplasms MESH:D015179 marker/mechanism 17892325 +TP63 8626 Abnormalities, Multiple MESH:D000015 marker/mechanism 21466819 +TP63 8626 Adenocarcinoma MESH:D000230 marker/mechanism 20871597 +TP63 8626 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 24880342 +TP63 8626 Breast Diseases MESH:D001941 marker/mechanism 11462173 +TP63 8626 Carcinoma MESH:D002277 marker/mechanism 23271742 +TP63 8626 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 21527555 +TP63 8626 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22011395 +TP63 8626 Cleft Lip MESH:D002971 marker/mechanism 16688749 +TP63 8626 Cleft Palate MESH:D002972 marker/mechanism 11462173 +TP63 8626 Colorectal Neoplasms MESH:D015179 marker/mechanism 15875781 +TP63 8626 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10227294 +TP63 8626 Ectrodactyly-cleft lip-palate syndrome MESH:C536189 marker/mechanism 11462173 +TP63 8626 Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3 MESH:C565799 marker/mechanism 604292.0 12161593 +TP63 8626 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +TP63 8626 Foot Deformities, Congenital MESH:D005532 marker/mechanism 11462173 +TP63 8626 Hand Deformities, Congenital MESH:D006228 marker/mechanism 11462173 +TP63 8626 Hay-Wells syndrome MESH:C535847 marker/mechanism 106260.0 19239083|19676059 +TP63 8626 Limb Deformities, Congenital MESH:D017880 marker/mechanism 10227294 +TP63 8626 Limb-mammary syndrome MESH:C535903 marker/mechanism 603543.0 11462173 +TP63 8626 Lung Neoplasms MESH:D008175 marker/mechanism 20871597|21725308 +TP63 8626 Nasopharyngeal Carcinoma MESH:D000077274 marker/mechanism 27543511 +TP63 8626 Neoplasm Metastasis MESH:D009362 marker/mechanism 15875781 +TP63 8626 Neoplasms, Squamous Cell MESH:D018307 marker/mechanism 23271742 +TP63 8626 Ovarian Neoplasms MESH:D010051 marker/mechanism 21266360 +TP63 8626 Pancreatic Neoplasms MESH:D010190 marker/mechanism 26098869 +TP63 8626 Propping Zerres syndrome MESH:C538052 marker/mechanism 103285.0 +TP63 8626 Rapp-Hodgkin syndrome MESH:C535289 marker/mechanism 129400.0 15748593|19239083|19676059 +TP63 8626 Skin Abnormalities MESH:D012868 marker/mechanism 10227294 +TP63 8626 Split-Hand-Foot Malformation 4 MESH:C565344 marker/mechanism 605289.0 16688749 +TP63 8626 Sweat Gland Neoplasms MESH:D013544 marker/mechanism 20740144 +TP73 7161 Breast Neoplasms MESH:D001943 marker/mechanism 28212736 +TP73 7161 Inflammation MESH:D007249 marker/mechanism 28212736 +TP73 7161 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +TP73 7161 Lung Neoplasms MESH:D008175 marker/mechanism 28212736 +TP73 7161 Rhabdomyosarcoma, Alveolar MESH:D018232 marker/mechanism 21245298 +TPBG 7162 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TPCN1 53373 Oligospermia MESH:D009845 marker/mechanism 24451262 +TPD52 7163 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 27415467 +TPD52 7163 Prostatic Neoplasms MESH:D011471 marker/mechanism|therapeutic 17875733|27415467 +TPD52L1 7164 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TPH1 7166 Hypertension, Pulmonary MESH:D006976 marker/mechanism 18506000 +TPH1 7166 Kidney Neoplasms MESH:D007680 marker/mechanism 28321044 +TPH1 7166 Schizophrenia MESH:D012559 marker/mechanism 18583979 +TPH2 121278 Attention Deficit Disorder with Hyperactivity MESH:D001289 marker/mechanism 613003.0 +TPH2 121278 Autistic Disorder MESH:D001321 marker/mechanism 15768392 +TPH2 121278 Depressive Disorder MESH:D003866 marker/mechanism 17950541 +TPH2 121278 Depressive Disorder, Major MESH:D003865 marker/mechanism 608516.0 +TPH2 121278 Fever MESH:D005334 marker/mechanism 20722968 +TPI 43582 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +TPI 43582 Clinical Deterioration MESH:D000075902 marker/mechanism 27602772 +TPI1 7167 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +TPI1 7167 Alzheimer Disease MESH:D000544 marker/mechanism 19374891 +TPI1 7167 Anemia, Hemolytic MESH:D000743 marker/mechanism 2876430 +TPI1 7167 Anemia, Hemolytic, Congenital Nonspherocytic MESH:D000746 marker/mechanism 8503454 +TPI1 7167 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +TPI1 7167 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +TPI1 7167 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +TPI1 7167 Metabolism, Inborn Errors MESH:D008661 marker/mechanism 2876430|8503454 +TPI1 7167 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +TPI1 7167 Neuromuscular Diseases MESH:D009468 marker/mechanism 8503454 +TPI1 7167 Neuromuscular Manifestations MESH:D020879 marker/mechanism 2876430|8503454 +TPI1 7167 Osteoporosis MESH:D010024 marker/mechanism 18924182 +TPI1 7167 Triosephosphate Isomerase Deficiency MESH:C566029 marker/mechanism 615512.0 +TPK1 27010 THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE) OMIM:614458 marker/mechanism 614458.0 +TPM1 7168 Cardiomyopathy, Dilated, 1y MESH:C567507 marker/mechanism 611878.0 +TPM1 7168 Cardiomyopathy, Familial Hypertrophic, 3 MESH:C566170 marker/mechanism 115196.0 +TPM1 7168 Cardiomyopathy, Hypertrophic, Familial MESH:D024741 marker/mechanism 9241277 +TPM1 7168 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +TPM1 7168 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +TPM1 7168 Hypertension MESH:D006973 marker/mechanism 22228705 +TPM1 7168 Keloid MESH:D007627 marker/mechanism 20128793 +TPM1 7168 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TPM2 7169 ARTHROGRYPOSIS, DISTAL, TYPE 1A OMIM:108120 marker/mechanism 108120.0 +TPM2 7169 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +TPM2 7169 Nemaline myopathy 4 MESH:C538351 marker/mechanism 609285.0 +TPM3 7170 Adenocarcinoma MESH:D000230 marker/mechanism 15378696 +TPM3 7170 Carcinoma MESH:D002277 marker/mechanism 12376462|16316942 +TPM3 7170 Colonic Neoplasms MESH:D003110 marker/mechanism 19369484 +TPM3 7170 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TPM3 7170 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462|16316942 +TPM3 7170 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462|16316942 +TPM3 7170 Myopathies, Structural, Congenital MESH:D020914 marker/mechanism 255310.0 +TPM3 7170 Nemaline myopathy 1 MESH:C538348 marker/mechanism 609284.0 +TPM3 7170 Stomach Neoplasms MESH:D013274 marker/mechanism 15378696 +TPM3 7170 Thyroid Neoplasms MESH:D013964 marker/mechanism 23811263 +TPM4 7171 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +TPM4 7171 Asbestosis MESH:D001195 marker/mechanism 22537621 +TPM4 7171 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +TPM4 7171 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TPM4 7171 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +TPM4 7171 Osteoporosis MESH:D010024 marker/mechanism 18924182 +TPM4 7171 Precancerous Conditions MESH:D011230 marker/mechanism 15986332 +TPM4 7171 Weight Gain MESH:D015430 marker/mechanism 19030233 +TPMT 7172 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TPMT 7172 HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO OMIM:613290 marker/mechanism 19898482 +TPMT 7172 Leukopenia MESH:D007970 marker/mechanism 18662289|22535280|25108385 +TPMT 7172 Neutropenia MESH:D009503 marker/mechanism 18662289 +TPMT 7172 Thiopurine S methyltranferase deficiency MESH:C536512 marker/mechanism 610460.0 +TPO 7173 Autoimmune Diseases MESH:D001327 marker/mechanism 27869686 +TPO 7173 Congenital Hypothyroidism MESH:D003409 marker/mechanism 12564727|14751036|16187919|17381485 +TPO 7173 Goiter MESH:D006042 marker/mechanism 12564727|14751036|17547680 +TPO 7173 Graves Disease MESH:D006111 marker/mechanism 33132244 +TPO 7173 Thyroid Dyshormonogenesis 2A MESH:C563206 marker/mechanism 274500.0 +TPP1 1200 Alzheimer Disease MESH:D000544 marker/mechanism 10320038 +TPP1 1200 Ceroid Lipofuscinosis, Neuronal, 2 MESH:C566857 marker/mechanism 204500.0 +TPP1 1200 Neuronal Ceroid-Lipofuscinoses MESH:D009472 marker/mechanism 10320038|11589009 +TPP1 1200 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TPP1 1200 Spinocerebellar Ataxia, Autosomal Recessive 7 MESH:C563753 marker/mechanism 609270.0 +TPR 7175 Thyroid Neoplasms MESH:D013964 marker/mechanism 23811263 +TPRKB 51002 Galloway Mowat syndrome MESH:C537548 marker/mechanism 28805828 +TPRN 286262 Deafness, Autosomal Recessive 79 MESH:C567651 marker/mechanism 613307.0 +TPSAB1 7177 Connective Tissue Diseases MESH:D003240 marker/mechanism 27749843 +TPSAB1 7177 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +TPSAB1 7177 Flushing MESH:D005483 marker/mechanism 27749843 +TPSAB1 7177 Irritable Bowel Syndrome MESH:D043183 marker/mechanism 27749843 +TPSAB1 7177 Primary Dysautonomias MESH:D054969 marker/mechanism 27749843 +TPSAB1 7177 Pruritus MESH:D011537 marker/mechanism 27749843 +TPSB2 64499 Keloid MESH:D007627 marker/mechanism 20128793 +TPST1 8460 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TPST2 8459 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TPT1 7178 Kidney Neoplasms MESH:D007680 marker/mechanism 28321044 +TPT1 7178 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +TPX2 22974 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TRA 6955 Narcolepsy MESH:D009290 marker/mechanism 19412176 +TRA2A 29896 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +TRA2A 29896 Skin Diseases MESH:D012871 marker/mechanism 16835338 +TRA2B 6434 Supranuclear Palsy, Progressive MESH:D013494 marker/mechanism 25402454 +TRAC 28755 IMMUNODEFICIENCY 7 OMIM:615387 marker/mechanism 615387.0 +TRAF1 7185 Abortion, Spontaneous MESH:D000022 marker/mechanism 18539642 +TRAF1 7185 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 18794853|23143596 +TRAF1 7185 Ductus Arteriosus, Patent MESH:D004374 marker/mechanism 19336370 +TRAF1 7185 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +TRAF1 7185 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TRAF3 7187 Encephalitis, Herpes Simplex MESH:D020803 marker/mechanism 614849.0 +TRAF3IP2 10758 Arthritis, Psoriatic MESH:D015535 marker/mechanism 20953186|20953188 +TRAF3IP2 10758 CANDIDIASIS, FAMILIAL, 8 OMIM:615527 marker/mechanism 615527.0 +TRAF3IP2 10758 Psoriasis MESH:D011565 marker/mechanism 614070.0 20953186|20953188|20953190 +TRAF4 9618 Brain Injuries MESH:D001930 marker/mechanism 23159883 +TRAF6 7189 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 20453842|23143596 +TRAF6 7189 Coronary Artery Disease MESH:D003324 marker/mechanism 20524934 +TRAF7 84231 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +TRAFD1 10906 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TRAIP 10293 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TRAIP 10293 Dwarfism MESH:D004392 marker/mechanism 26595769 +TRAIP 10293 Microcephaly MESH:D008831 marker/mechanism 26595769 +TRAJ18 28737 Chemical and Drug Induced Liver Injury MESH:D056486 therapeutic 36520315 +TRAJ18 28737 Cholestasis MESH:D002779 therapeutic 32987112 +TRAK1 22906 Schizophrenia MESH:D012559 marker/mechanism 21822266 +TRAK2 66008 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TRANK1 9881 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +TRAP1 10131 Disease Progression MESH:D018450 marker/mechanism 21364753 +TRAP1 10131 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +TRAP1 10131 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +TRAPPC10 7109 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +TRAPPC10 7109 Skin Diseases MESH:D012871 marker/mechanism 16835338 +TRAPPC11 60684 MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18 OMIM:615356 marker/mechanism 615356.0 +TRAPPC2 6399 Osteochondrodysplasias MESH:D010009 marker/mechanism 313400.0 +TRAPPC9 83696 Mental Retardation, Autosomal Recessive 13 MESH:C567714 marker/mechanism 613192.0 +TRDN 10345 CARDIAC ARRHYTHMIA SYNDROME, WITH OR WITHOUT SKELETAL MUSCLE WEAKNESS OMIM:615441 marker/mechanism 615441.0 +TRDN 10345 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +TRDN 10345 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY OMIM:604772 marker/mechanism 604772.0 +TREH 11181 Trehalase Deficiency MESH:C562603 marker/mechanism 612119.0 +TREM 42392 Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy MESH:C536329 marker/mechanism 17430113 +TREM1 54210 Liver Diseases MESH:D008107 marker/mechanism 12651611 +TREM2 54209 Alzheimer Disease MESH:D000544 marker/mechanism 24663666|28714976 +TREM2 54209 Dementia MESH:D003704 marker/mechanism 18546367 +TREML1 340205 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TRERF1 55809 Breast Neoplasms MESH:D001943 marker/mechanism 19075277 +TREX1 11277 Aicardi-Goutieres syndrome MESH:C535607 marker/mechanism 225750.0 16845398 +TREX1 11277 Brain Diseases MESH:D001927 marker/mechanism 16845398 +TREX1 11277 Chilblain lupus 1 MESH:C535924 marker/mechanism 610448.0 27566796 +TREX1 11277 Inflammation MESH:D007249 marker/mechanism 16845398 +TREX1 11277 Influenza, Human MESH:D007251 marker/mechanism 23326326 +TREX1 11277 Lupus Erythematosus, Systemic MESH:D008180 marker/mechanism 152700.0 17660818 +TREX1 11277 Vasculopathy, Retinal, With Cerebral Leukodystrophy MESH:C566007 marker/mechanism 192315.0 17660820 +TRF 22041 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 15650968 +TRH 7200 Amnesia MESH:D000647 therapeutic 7562510|7617693|8405091 +TRH 7200 Arrhythmias, Cardiac MESH:D001145 marker/mechanism 6813757 +TRH 7200 Bradycardia MESH:D001919 therapeutic 6350720|6813757 +TRH 7200 Catalepsy MESH:D002375 therapeutic 2547386 +TRH 7200 Coma, Post-Head Injury MESH:D020207 therapeutic 8690305 +TRH 7200 Endometriosis MESH:D004715 marker/mechanism 21063030 +TRH 7200 Hypertension MESH:D006973 marker/mechanism 6350720 +TRH 7200 Hypothermia MESH:D007035 marker/mechanism 6350720 +TRH 7200 Learning Disabilities MESH:D007859 therapeutic 8405091 +TRH 7200 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +TRH 7200 Narcolepsy MESH:D009290 marker/mechanism 2845442 +TRH 7200 Pain MESH:D010146 therapeutic 6409194 +TRH 7200 Respiratory Insufficiency MESH:D012131 therapeutic 1305443|1833029 +TRH 7200 Seizures MESH:D012640 marker/mechanism 10443546|15781040 +TRH 7200 Stereotypic Movement Disorder MESH:D019956 marker/mechanism 8736133 +TRH 7200 Stupor MESH:D053608 therapeutic 416961|8690305 +TRH 7200 Tachycardia MESH:D013610 marker/mechanism 6350720 +TRH 7200 THYROTROPIN-RELEASING HORMONE DEFICIENCY OMIM:275120 marker/mechanism 275120.0 +TRH 7200 Tremor MESH:D014202 marker/mechanism|therapeutic 103733|416961 +TRH 7200 Unconsciousness MESH:D014474 therapeutic 6281507 +TRHR 7201 Hypothyroidism MESH:D007037 marker/mechanism 9141550 +TRHR 7201 Thyroid Hormone Resistance Syndrome MESH:D018382 marker/mechanism 9141550 +TRIB1 10221 Coronary Artery Disease MESH:D003324 marker/mechanism 24097064 +TRIB1 10221 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 35654975 +TRIB3 57761 Insulin Resistance MESH:D007333 marker/mechanism 20461355 +TRIB3 57761 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 32929351 +TRIB3 57761 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TRIB3 57761 Metabolic Syndrome MESH:D024821 marker/mechanism 18497449 +TRIB3 57761 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29289645 +TRIM10 10107 Dermatitis, Irritant MESH:D017453 marker/mechanism 27258892 +TRIM12A 76681 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +TRIM16 10626 Ovarian Neoplasms MESH:D010051 marker/mechanism 35442568 +TRIM2 23321 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R OMIM:615490 marker/mechanism 615490.0 +TRIM2 23321 Osteoarthritis MESH:D010003 marker/mechanism 17568789 +TRIM22 10346 Influenza, Human MESH:D007251 marker/mechanism 23326326 +TRIM24 8805 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18026104 +TRIM24 8805 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TRIM24 8805 Prostatic Neoplasms, Castration-Resistant MESH:D064129 marker/mechanism 27238081 +TRIM28 10155 Atherosclerosis MESH:D050197 marker/mechanism 31351049 +TRIM28 10155 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241 +TRIM29 23650 Glioma MESH:D005910 marker/mechanism 30929997 +TRIM31 11074 Dermatitis, Irritant MESH:D017453 marker/mechanism 27258892 +TRIM32 22954 Bardet-Biedl Syndrome 11 MESH:C565920 marker/mechanism 615988.0 +TRIM32 22954 Limb-girdle muscular dystrophy type 2H MESH:C535897 marker/mechanism 254110.0 +TRIM36 55521 Anencephaly MESH:D000757 marker/mechanism 206500.0 +TRIM37 4591 Craniofacial Abnormalities MESH:D019465 marker/mechanism 14757854 +TRIM37 4591 Fibrous Dysplasia of Bone MESH:D005357 marker/mechanism 14757854 +TRIM37 4591 Hepatomegaly MESH:D006529 marker/mechanism 14757854 +TRIM37 4591 Mulibrey Nanism MESH:D050336 marker/mechanism 253250.0 14757854 +TRIM40 135644 Dermatitis, Irritant MESH:D017453 marker/mechanism 27258892 +TRIM44 54765 Aniridia MESH:D015783 marker/mechanism 617142.0 +TRIM47 91107 Breast Neoplasms MESH:D001943 marker/mechanism 31981573 +TRIM47 91107 Neoplasm Invasiveness MESH:D009361 marker/mechanism 31981573 +TRIM47 91107 Neoplasms, Experimental MESH:D009374 marker/mechanism 31981573 +TRIM49C 642612 Stomach Neoplasms MESH:D013274 marker/mechanism 36914835 +TRIM5 85363 HIV Infections MESH:D015658 therapeutic 15249687 +TRIM59 286827 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TRIM63 84676 Atrophy MESH:D001284 marker/mechanism 19168726 +TRIM63 84676 Cardiomegaly MESH:D006332 therapeutic 19168726 +TRIM63 84676 Cardiomyopathies MESH:D009202 therapeutic 19168726 +TRIM63 84676 Muscular Atrophy MESH:D009133 marker/mechanism 21139329 +TRIM64B 642446 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TRIO 7204 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY OMIM:617061 marker/mechanism 617061.0 +TRIO 7204 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +TRIO 7204 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +TRIO 7204 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +TRIO 7204 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +TRIOBP 11078 Deafness, Autosomal Recessive 28 MESH:C565218 marker/mechanism 609823.0 +TRIP11 9321 Achondrogenesis type 1A MESH:C536015 marker/mechanism 200600.0 +TRIP12 9320 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +TRIP13 9319 Aneuploidy MESH:D000782 marker/mechanism 28553959 +TRIP13 9319 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TRIP13 9319 Mosaic variegated aneuploidy syndrome MESH:C536987 marker/mechanism 28553959 +TRIP13 9319 Neoplasms, Germ Cell and Embryonal MESH:D009373 marker/mechanism 28553959 +TRIP13 9319 Wilms Tumor MESH:D009396 marker/mechanism 28553959 +TRIP4 9325 MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE OMIM:617066 marker/mechanism 617066.0 +TRIP4 9325 SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1 OMIM:616866 marker/mechanism 616866.0 +TRIT1 54802 Precancerous Conditions MESH:D011230 marker/mechanism 21472284 +TRMT1 55621 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +TRMT10A 93587 MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1 OMIM:616033 marker/mechanism 616033.0 +TRMT10C 54931 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30 OMIM:616974 marker/mechanism 616974.0 +TRMT11 60487 Breast Neoplasms MESH:D001943 marker/mechanism 30705370 +TRMT11 60487 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 30705370 +TRMT11 60487 Colonic Neoplasms MESH:D003110 marker/mechanism 30705370 +TRMT11 60487 Esophageal Neoplasms MESH:D004938 marker/mechanism 30705370 +TRMT11 60487 Glioblastoma MESH:D005909 marker/mechanism 30705370 +TRMT11 60487 Liver Neoplasms MESH:D008113 marker/mechanism 30705370 +TRMT11 60487 Lymphatic Metastasis MESH:D008207 marker/mechanism 30705370 +TRMT11 60487 Ovarian Neoplasms MESH:D010051 marker/mechanism 30705370 +TRMT5 57570 PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY OMIM:616539 marker/mechanism 616539.0 +TRMU 55687 Deafness, Aminoglycoside-Induced MESH:C564013 marker/mechanism 580000.0 +TRMU 55687 LIVER FAILURE, INFANTILE, TRANSIENT OMIM:613070 marker/mechanism 613070.0 +TRNC 4511 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +TRNF 4558 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +TRNF 4558 MERRF Syndrome MESH:D017243 marker/mechanism 545000.0 +TRNI 4565 MERRF Syndrome MESH:D017243 marker/mechanism 545000.0 +TRNK 4566 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +TRNK 4566 MERRF Syndrome MESH:D017243 marker/mechanism 545000.0 +TRNL1 4567 Acidosis, Lactic MESH:D000140 marker/mechanism 17018649 +TRNL1 4567 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 17018649|19027590 +TRNL1 4567 MERRF Syndrome MESH:D017243 marker/mechanism 545000.0 +TRNL1 4567 Mitochondrial Encephalomyopathies MESH:D017237 marker/mechanism 17018649 +TRNL1 4567 Noninsulin-dependent diabetes mellitus with deafness MESH:C536246 marker/mechanism 17018649 +TRNN 4570 Cytochrome-c Oxidase Deficiency MESH:D030401 marker/mechanism 220110.0 +TRNP 4571 MERRF Syndrome MESH:D017243 marker/mechanism 545000.0 +TRNQ 4572 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +TRNS1 4574 Cytochrome-c Oxidase Deficiency MESH:D030401 marker/mechanism 220110.0 +TRNS1 4574 Deafness, Aminoglycoside-Induced MESH:C564013 marker/mechanism 580000.0 +TRNS1 4574 Deafness, Sensorineural, Autosomal-Mitochondrial Type MESH:C565637 marker/mechanism 500008.0 +TRNS1 4574 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 17894844 +TRNS2 4575 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +TRNT 4576 Myopathy, Mitochondrial, Lethal Infantile MESH:C564017 marker/mechanism 551000.0 +TRNT 4576 PARKINSON DISEASE, LATE-ONSET OMIM:168600 marker/mechanism 168600.0 +TRNT 4576 Parkinson Disease, Mitochondrial MESH:C564015 marker/mechanism 556500.0 +TRNT1 51095 RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS OMIM:616959 marker/mechanism 616959.0 +TRNV 4577 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +TRNW 4578 MELAS Syndrome MESH:D017241 marker/mechanism 540000.0 +TROAP 10024 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TRP53 22059 Adenocarcinoma MESH:D000230 marker/mechanism 16247444|7955072 +TRP53 22059 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 26206333 +TRP53 22059 Aortic Valve, Calcification of MESH:C562942 marker/mechanism 29358327 +TRP53 22059 Astrocytoma MESH:D001254 marker/mechanism 20176786 +TRP53 22059 Bone Diseases, Developmental MESH:D001848 marker/mechanism 9493073 +TRP53 22059 Brain Neoplasms MESH:D001932 marker/mechanism 16860786 +TRP53 22059 Breast Neoplasms MESH:D001943 marker/mechanism 12165863 +TRP53 22059 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 16651430|19919837 +TRP53 22059 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 29844410 +TRP53 22059 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 16543248|19435901|25125259|27923803 +TRP53 22059 Cardiomyopathies MESH:D009202 marker/mechanism 16013437 +TRP53 22059 Cardiotoxicity MESH:D066126 marker/mechanism 30009776|34713381 +TRP53 22059 Cecal Neoplasms MESH:D002430 marker/mechanism 14688030 +TRP53 22059 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 22009531 +TRP53 22059 Cholangiocarcinoma MESH:D018281 marker/mechanism 16818635 +TRP53 22059 Craniofacial Abnormalities MESH:D019465 marker/mechanism 9493073 +TRP53 22059 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 21078376 +TRP53 22059 Disease Models, Animal MESH:D004195 marker/mechanism 23873029 +TRP53 22059 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 9369336 +TRP53 22059 Endometrial Neoplasms MESH:D016889 marker/mechanism 7955072 +TRP53 22059 Esophageal Neoplasms MESH:D004938 marker/mechanism 12706858 +TRP53 22059 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 16543248 +TRP53 22059 Glioma MESH:D005910 marker/mechanism 25119042 +TRP53 22059 Heart Failure MESH:D006333 marker/mechanism 21284947 +TRP53 22059 Hemangiosarcoma MESH:D006394 marker/mechanism 10930038|13678655|20737008 +TRP53 22059 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 25822087 +TRP53 22059 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 28100771 +TRP53 22059 Lung Neoplasms MESH:D008175 marker/mechanism 16247444|26390243 +TRP53 22059 Lymphoma MESH:D008223 marker/mechanism 19258306 +TRP53 22059 Lymphoma, T-Cell MESH:D016399 marker/mechanism 29438700 +TRP53 22059 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 24809783 +TRP53 22059 Mesothelioma MESH:D008654 marker/mechanism 12151629 +TRP53 22059 Mouth Neoplasms MESH:D009062 marker/mechanism 19435901 +TRP53 22059 Myocardial Infarction MESH:D009203 marker/mechanism 24358288 +TRP53 22059 Neoplasm Metastasis MESH:D009362 marker/mechanism 22009531|23873029|27137931 +TRP53 22059 Neoplasms, Experimental MESH:D009374 marker/mechanism 12756225|27137931 +TRP53 22059 Nerve Sheath Neoplasms MESH:D018317 marker/mechanism 20176786 +TRP53 22059 Nervous System Diseases MESH:D009422 marker/mechanism 9369336 +TRP53 22059 Neuroblastoma MESH:D009447 marker/mechanism 15814359 +TRP53 22059 Osteosarcoma MESH:D012516 marker/mechanism 27137931 +TRP53 22059 Pancreatic Neoplasms MESH:D010190 marker/mechanism 23873029|26390243 +TRP53 22059 Precancerous Conditions MESH:D011230 marker/mechanism 21317887 +TRP53 22059 Sarcoma MESH:D012509 marker/mechanism 19258306 +TRP53 22059 Skin Neoplasms MESH:D012878 marker/mechanism 22009531|27923803 +TRP53 22059 Thymus Neoplasms MESH:D013953 marker/mechanism 10850423 +TRP53 22059 Tongue Neoplasms MESH:D014062 marker/mechanism 16543248 +TRP53 22059 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 11376694|12706858 +TRP63 22061 Breast Neoplasms MESH:D001943 marker/mechanism 25739959 +TRP63 22061 Neoplasms, Experimental MESH:D009374 marker/mechanism 25739959 +TRP63 22061 Prostatic Intraepithelial Neoplasia MESH:D019048 marker/mechanism 22581815 +TRP63 22061 Prostatic Neoplasms MESH:D011471 marker/mechanism 22581815 +TRP73 22062 Nervous System Malformations MESH:D009421 marker/mechanism 24190996 +TRP73 22062 Neurologic Manifestations MESH:D009461 marker/mechanism 24190996 +TRPA1 8989 Asthma MESH:D001249 marker/mechanism 19458046 +TRPA1 8989 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 19458046 +TRPA1 8989 Cough MESH:D003371 marker/mechanism 27545873 +TRPA1 8989 EPISODIC PAIN SYNDROME, FAMILIAL, 1 OMIM:615040 marker/mechanism 615040.0 +TRPA1 8989 Hyperalgesia MESH:D006930 marker/mechanism 18234885|21481532|23523557 +TRPA1 8989 Inflammation MESH:D007249 marker/mechanism 20601631 +TRPA1 8989 Pain MESH:D010146 marker/mechanism 20601631 +TRPA1 8989 Sneezing MESH:D012912 marker/mechanism 27545873 +TRPA1 8989 Urinary Bladder, Overactive MESH:D053201 marker/mechanism|therapeutic 21367919|23523557 +TRPC1 7220 Cardiomegaly MESH:D006332 marker/mechanism 17174323 +TRPC1 7220 Inflammation MESH:D007249 marker/mechanism 25736131 +TRPC3 7222 Bipolar Disorder MESH:D001714 marker/mechanism 23602965 +TRPC3 7222 Hypertension MESH:D006973 marker/mechanism 17351372 +TRPC3 7222 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 616410.0 +TRPC5 7224 Hypertension MESH:D006973 marker/mechanism 17351372 +TRPC6 7225 Disease Susceptibility MESH:D004198 marker/mechanism 20130021 +TRPC6 7225 Focal Segmental Glomerulosclerosis 2 MESH:C565831 marker/mechanism 603965.0 +TRPC6 7225 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 26892346 +TRPC6 7225 Hypertrophy MESH:D006984 marker/mechanism 20177073 +TRPC6 7225 Mental Disorders MESH:D001523 marker/mechanism 21059368 +TRPM1 4308 Night blindness, congenital stationary MESH:C536122 marker/mechanism 613216.0 +TRPM2 7226 Bipolar Disorder MESH:D001714 marker/mechanism 23602965 +TRPM2 7226 Parkinson Disease MESH:D010300 marker/mechanism 27957685 +TRPM3 80036 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +TRPM4 54795 Atrioventricular Block MESH:D054537 marker/mechanism 32681584|33959666 +TRPM4 54795 Death, Sudden MESH:D003645 marker/mechanism 30391667 +TRPM4 54795 Heart Failure MESH:D006333 marker/mechanism 33594499 +TRPM4 54795 Progressive Familial Heart Block, Type Ib MESH:C567037 marker/mechanism 604559.0 +TRPM4 54795 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +TRPM4 54795 Respiration Disorders MESH:D012120 marker/mechanism 30789900 +TRPM6 140803 Hypomagnesemia 1, Intestinal MESH:C566593 marker/mechanism 602014.0 +TRPM7 54822 Adenoma MESH:D000236 marker/mechanism 17823441 +TRPM7 54822 AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1 OMIM:105500 marker/mechanism 105500.0 +TRPM7 54822 Colonic Polyps MESH:D003111 marker/mechanism 17823441 +TRPM7 54822 Colorectal Neoplasms MESH:D015179 marker/mechanism 17823441 +TRPM7 54822 Immune System Diseases MESH:D007154 marker/mechanism 30770447 +TRPM7 54822 Infant Death MESH:D066088 marker/mechanism 30770447 +TRPM7 54822 Kidney Calculi MESH:D007669 marker/mechanism 24291744 +TRPM7 54822 Liver Cirrhosis MESH:D008103 marker/mechanism 25150141 +TRPM7 54822 Neoplasm Invasiveness MESH:D009361 marker/mechanism 30710498 +TRPM7 54822 Paralysis MESH:D010243 marker/mechanism 24291744 +TRPM8 79054 Migraine Disorders MESH:D008881 marker/mechanism 21666692 +TRPM8 79054 Migraine without Aura MESH:D020326 marker/mechanism 22683712 +TRPS1 7227 Bone Diseases, Developmental MESH:D001848 marker/mechanism 19759027 +TRPS1 7227 Carcinoma MESH:D002277 marker/mechanism 16316942 +TRPS1 7227 Craniofacial Abnormalities MESH:D019465 marker/mechanism 11708946|19759027 +TRPS1 7227 Langer-Giedion Syndrome MESH:D015826 marker/mechanism 11708946 +TRPS1 7227 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +TRPS1 7227 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +TRPS1 7227 Trichorhinophalangeal Syndrome, Type I MESH:C536820 marker/mechanism 190350.0 +TRPS1 7227 Trichorhinophalangeal Syndrome, Type III MESH:C566033 marker/mechanism 190351.0 +TRPV1 7442 Atherosclerosis MESH:D050197 marker/mechanism 21908651 +TRPV1 7442 Cough MESH:D003371 marker/mechanism 27545873 +TRPV1 7442 Endometrial Neoplasms MESH:D016889 marker/mechanism 32751388 +TRPV1 7442 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 20144892 +TRPV1 7442 Esophageal Diseases MESH:D004935 marker/mechanism 19566590 +TRPV1 7442 Esophagitis MESH:D004941 marker/mechanism 16091555 +TRPV1 7442 Heartburn MESH:D006356 marker/mechanism 19566590 +TRPV1 7442 Hyperalgesia MESH:D006930 marker/mechanism 12151517|18234885|18774343|23006841 +TRPV1 7442 Inflammation MESH:D007249 marker/mechanism 17575321|20712533 +TRPV1 7442 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 17043671 +TRPV1 7442 Neoplasms MESH:D009369 marker/mechanism 21349818 +TRPV1 7442 Obesity MESH:D009765 marker/mechanism 17347480 +TRPV1 7442 Pain MESH:D010146 marker/mechanism|therapeutic 16996476|17575321|20422007|23006841 +TRPV1 7442 Pancreatitis MESH:D010195 marker/mechanism 17698068 +TRPV1 7442 Sneezing MESH:D012912 marker/mechanism 27545873 +TRPV1 7442 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 19502594 +TRPV2 51393 Endometrial Neoplasms MESH:D016889 marker/mechanism 32751388 +TRPV3 162514 Hyperplasia MESH:D006965 therapeutic 32535744 +TRPV3 162514 OLMSTED SYNDROME 1 OMIM:614594 marker/mechanism 614594.0 +TRPV3 162514 PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2 OMIM:616400 marker/mechanism 616400.0 +TRPV4 59341 Bone Diseases MESH:D001847 marker/mechanism 21964574|22187434 +TRPV4 59341 Brachyolmia Type 3 MESH:C562963 marker/mechanism 113500.0 +TRPV4 59341 Charcot-Marie-Tooth Disease MESH:D002607 marker/mechanism 22187434 +TRPV4 59341 Digital Arthropathy-Brachydactyly, Familial MESH:C564656 marker/mechanism 606835.0 +TRPV4 59341 Femur Head Necrosis MESH:D005271 marker/mechanism 617383.0 +TRPV4 59341 Glioma MESH:D005910 marker/mechanism 33629929 +TRPV4 59341 Hereditary Motor And Sensory Neuropathy, Type IIC MESH:C565261 marker/mechanism 606071.0 20037586|20037587|20037588 +TRPV4 59341 Hyperalgesia MESH:D006930 marker/mechanism 18234883 +TRPV4 59341 Hyponatremia MESH:D007010 marker/mechanism 19666518 +TRPV4 59341 Metatropic dwarfism MESH:C537356 marker/mechanism 156530.0 20425821 +TRPV4 59341 Muscular Atrophy, Spinal MESH:D009134 marker/mechanism 22187434 +TRPV4 59341 Osteoarthritis MESH:D010003 marker/mechanism 21964574 +TRPV4 59341 Osteochondrodysplasias MESH:D010009 marker/mechanism 18587396 +TRPV4 59341 Parastremmatic dwarfism MESH:C537172 marker/mechanism 168400.0 +TRPV4 59341 Pulmonary Disease, Chronic Obstructive MESH:D029424 marker/mechanism 21245013 +TRPV4 59341 SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY OMIM:181405 marker/mechanism 181405.0 20037587|20037588 +TRPV4 59341 SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1 OMIM:613508 marker/mechanism 613508.0 +TRPV4 59341 Spinal Muscular Atrophy, Distal, Congenital Nonprogressive MESH:C563981 marker/mechanism 600175.0 20037588 +TRPV4 59341 SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE OMIM:184095 marker/mechanism 184095.0 +TRPV4 59341 Spondylometaphyseal dysplasia, Kozlowski type MESH:C535797 marker/mechanism 184252.0 +TRPV4 59341 Urination Disorders MESH:D014555 marker/mechanism 20956320 +TRPV6 55503 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TRRAP 8295 Melanoma MESH:D008545 marker/mechanism 21499247 +TRRAP 8295 Schizophrenia MESH:D012559 marker/mechanism 21822266|23042115 +TSC1 7248 Autistic Disorder MESH:D001321 marker/mechanism 18067135 +TSC1 7248 Brain Diseases MESH:D001927 marker/mechanism 21062901 +TSC1 7248 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21499249 +TSC1 7248 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +TSC1 7248 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18538015 +TSC1 7248 Cognition Disorders MESH:D003072 marker/mechanism 18067135 +TSC1 7248 Epilepsy MESH:D004827 marker/mechanism 12112044|21062901 +TSC1 7248 Focal cortical dysplasia of Taylor MESH:C537067 marker/mechanism 607341.0 12112044|28215400 +TSC1 7248 Lymphangioleiomyomatosis MESH:D018192 marker/mechanism 606690.0 32078667 +TSC1 7248 Mouth Neoplasms MESH:D009062 marker/mechanism 18538015 +TSC1 7248 Myoclonic Epilepsies, Progressive MESH:D020191 marker/mechanism 17484760 +TSC1 7248 Seizures MESH:D012640 marker/mechanism 28215400 +TSC1 7248 Spasms, Infantile MESH:D013036 marker/mechanism 18345974 +TSC1 7248 Tuberous Sclerosis MESH:D014402 marker/mechanism 18345974|21062901|21345208 +TSC1 7248 Tuberous Sclerosis 1 MESH:C565346 marker/mechanism 191100.0 +TSC2 7249 Autistic Disorder MESH:D001321 marker/mechanism 14627686 +TSC2 7249 Brain Diseases MESH:D001927 marker/mechanism 21062901 +TSC2 7249 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 18538015 +TSC2 7249 Epilepsy MESH:D004827 marker/mechanism 21062901 +TSC2 7249 Focal cortical dysplasia of Taylor MESH:C537067 marker/mechanism 607341.0 28215400 +TSC2 7249 Inflammation MESH:D007249 marker/mechanism 26297436 +TSC2 7249 Kidney Neoplasms MESH:D007680 marker/mechanism 11170505|12110509|21693435 +TSC2 7249 Leiomyoma MESH:D007889 marker/mechanism 15937110 +TSC2 7249 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 19250671 +TSC2 7249 Lung Neoplasms MESH:D008175 marker/mechanism 30008631 +TSC2 7249 Lymphangioleiomyomatosis MESH:D018192 marker/mechanism 606690.0 32078667 +TSC2 7249 Mouth Neoplasms MESH:D009062 marker/mechanism 18538015 +TSC2 7249 Nerve Degeneration MESH:D009410 marker/mechanism 21419848 +TSC2 7249 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19917848 +TSC2 7249 Precancerous Conditions MESH:D011230 marker/mechanism 26297436 +TSC2 7249 Seizures MESH:D012640 marker/mechanism 21062901|28215400 +TSC2 7249 Spasms, Infantile MESH:D013036 marker/mechanism 18345974 +TSC2 7249 Tuberous Sclerosis MESH:D014402 marker/mechanism 10732801|18345974|21062901|21345208 +TSC2 7249 Tuberous Sclerosis 2 MESH:C566021 marker/mechanism 613254.0 10732801 +TSC22D1 8848 Carcinoma MESH:D002277 marker/mechanism 16316942 +TSC22D1 8848 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 15089088 +TSC22D1 8848 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TSC22D1 8848 Liver Neoplasms, Experimental MESH:D008114 marker/mechanism 15833021|17533171 +TSC22D1 8848 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +TSC22D1 8848 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +TSC22D3 1831 Hyperinsulinism MESH:D006946 marker/mechanism 22556341 +TSC22D3 1831 Infertility, Male MESH:D007248 marker/mechanism 22556341 +TSC22D3 1831 Testicular Diseases MESH:D013733 marker/mechanism 22556341 +TSC22D3 1831 Weight Loss MESH:D015431 marker/mechanism 22556341 +TSEN15 116461 PONTOCEREBELLAR HYPOPLASIA, TYPE 2F OMIM:617026 marker/mechanism 617026.0 +TSEN2 80746 Deglutition Disorders MESH:D003680 marker/mechanism 18711368 +TSEN2 80746 Intellectual Disability MESH:D008607 marker/mechanism 18711368 +TSEN2 80746 Microcephaly MESH:D008831 marker/mechanism 18711368 +TSEN2 80746 Movement Disorders MESH:D009069 marker/mechanism 18711368 +TSEN2 80746 Pontocerebellar Hypoplasia Type 2B MESH:C567325 marker/mechanism 612389.0 +TSEN2 80746 Vision Disorders MESH:D014786 marker/mechanism 18711368 +TSEN2 80746 Weight Gain MESH:D015430 marker/mechanism 19030233 +TSEN34 79042 Deglutition Disorders MESH:D003680 marker/mechanism 18711368 +TSEN34 79042 Intellectual Disability MESH:D008607 marker/mechanism 18711368 +TSEN34 79042 Microcephaly MESH:D008831 marker/mechanism 18711368 +TSEN34 79042 Movement Disorders MESH:D009069 marker/mechanism 18711368 +TSEN34 79042 Pontocerebellar Hypoplasia Type 2C MESH:C567324 marker/mechanism 612390.0 +TSEN34 79042 Vision Disorders MESH:D014786 marker/mechanism 18711368 +TSEN54 283989 Deglutition Disorders MESH:D003680 marker/mechanism 18711368 +TSEN54 283989 Intellectual Disability MESH:D008607 marker/mechanism 18711368 +TSEN54 283989 Microcephaly MESH:D008831 marker/mechanism 18711368 +TSEN54 283989 Movement Disorders MESH:D009069 marker/mechanism 18711368 +TSEN54 283989 Pontocerebellar Hypoplasia Type 2A MESH:C564738 marker/mechanism 277470.0 +TSEN54 283989 PONTOCEREBELLAR HYPOPLASIA, TYPE 4 OMIM:225753 marker/mechanism 225753.0 +TSEN54 283989 Vision Disorders MESH:D014786 marker/mechanism 18711368 +TSFM 10102 Combined Oxidative Phosphorylation Deficiency 3 MESH:C566467 marker/mechanism 610505.0 +TSFM 10102 Dyskinesias MESH:D020820 marker/mechanism 30297209 +TSHB 7252 Bipolar Disorder MESH:D001714 marker/mechanism 6455462 +TSHB 7252 Coma MESH:D003128 marker/mechanism 24729111 +TSHB 7252 Graves Disease MESH:D006111 marker/mechanism 33132244 +TSHB 7252 Hypothermia MESH:D007035 marker/mechanism 6350720 +TSHB 7252 Hypothyroidism MESH:D007037 marker/mechanism 18031379|24729111 +TSHB 7252 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4 OMIM:275100 marker/mechanism 275100.0 +TSHR 7253 Adenoma MESH:D000236 marker/mechanism 8413627 +TSHR 7253 Adrenal Gland Neoplasms MESH:D000310 marker/mechanism 19131502 +TSHR 7253 Carcinoma MESH:D002277 marker/mechanism 9062474 +TSHR 7253 Congenital Hypothyroidism MESH:D003409 marker/mechanism 12629076 +TSHR 7253 Graves Disease MESH:D006111 marker/mechanism 1955520|21841780 +TSHR 7253 Graves Ophthalmopathy MESH:D049970 marker/mechanism 31705858 +TSHR 7253 Hyperthyroidism MESH:D006980 marker/mechanism 7800007|8413627|8964822 +TSHR 7253 Hyperthyroidism, Familial Gestational MESH:C566384 marker/mechanism 603373.0 +TSHR 7253 Hyperthyroidism, Nonautoimmune MESH:C563786 marker/mechanism 609152.0 +TSHR 7253 Hypothyroidism, Congenital, Nongoitrous, 1 MESH:C576976 marker/mechanism 275200.0 +TSHR 7253 Lung Neoplasms MESH:D008175 marker/mechanism 9062474 +TSHR 7253 Lymphatic Metastasis MESH:D008207 marker/mechanism 9062474 +TSHR 7253 Thyroiditis, Autoimmune MESH:D013967 marker/mechanism 17952073 +TSHR 7253 Thyroid Neoplasms MESH:D013964 marker/mechanism 8413627|9062474 +TSHR 7253 Thyrotoxicosis MESH:D013971 marker/mechanism 9062474 +TSHZ1 10194 Aural Atresia, Congenital MESH:C564321 marker/mechanism 607842.0 +TSHZ1 10194 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +TSHZ3 57616 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 27668656 +TSLP 85480 Albuminuria MESH:D000419 marker/mechanism 17686814 +TSLP 85480 Asthma MESH:D001249 marker/mechanism 21804549 +TSLP 85480 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TSLP 85480 Dermatitis, Atopic MESH:D003876 marker/mechanism 16880407|22355542|23688403|27869817 +TSLP 85480 Eosinophilic Esophagitis MESH:D057765 marker/mechanism 20208534 +TSLP 85480 Glomerulonephritis, Membranoproliferative MESH:D015432 marker/mechanism 17686814 +TSLP 85480 Inflammation MESH:D007249 therapeutic 28329851 +TSLP 85480 Respiratory Hypersensitivity MESH:D012130 therapeutic 28329851 +TSPAN12 23554 Disease Susceptibility MESH:D004198 marker/mechanism 20130021 +TSPAN12 23554 Exudative Vitreoretinopathy 5 MESH:C567648 marker/mechanism 613310.0 +TSPAN14 81619 Alzheimer Disease MESH:D000544 marker/mechanism 33589840 +TSPAN18 90139 Schizophrenia MESH:D012559 marker/mechanism 22037552 +TSPAN2 10100 Stroke MESH:D020521 marker/mechanism 29531354 +TSPAN7 7102 Mental Retardation, X-Linked 58 MESH:C564566 marker/mechanism 300210.0 +TSPAN8 7103 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TSPAN8 7103 Respiratory Distress Syndrome MESH:D012128 marker/mechanism 25070658 +TSPEAR 54084 DEAFNESS, AUTOSOMAL RECESSIVE 98 OMIM:614861 marker/mechanism 614861.0 +TSPO 706 End Stage Liver Disease MESH:D058625 marker/mechanism 15025246 +TSPO 706 Hepatic Encephalopathy MESH:D006501 marker/mechanism 10206825|10564534 +TSPO 706 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TSPYL1 7259 Sudden Infant Death with Dysgenesis of the Testes Syndrome MESH:C563856 marker/mechanism 608800.0 +TSPYL2 64061 Endometrial Neoplasms MESH:D016889 marker/mechanism 23104009 +TSPYL4 23270 Melanoma MESH:D008545 marker/mechanism 22535842 +TSR2 90121 DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS OMIM:300946 marker/mechanism 300946.0 +TSSK1 22114 Autoimmune Diseases MESH:D001327 marker/mechanism 15140057 +TST 7263 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21472284 +TST 7263 Colitis MESH:D003092 marker/mechanism 19647029 +TST 7263 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TSTD3 100130890 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TTBK2 146057 Spinocerebellar Ataxia 11 MESH:C565772 marker/mechanism 604432.0 +TTBK2 146057 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 18037885 +TTC19 54902 Gait Disorders, Neurologic MESH:D020233 marker/mechanism 21278747 +TTC19 54902 Infertility MESH:D007246 marker/mechanism 21278747 +TTC19 54902 Mitochondrial Complex III Deficiency MESH:C565128 marker/mechanism 615157.0 21278747 +TTC19 54902 Nervous System Diseases MESH:D009422 marker/mechanism 21278747 +TTC19 54902 Neurodegenerative Diseases MESH:D019636 marker/mechanism 21278747 +TTC21B 79809 Jeune syndrome MESH:C537571 marker/mechanism 21258341 +TTC21B 79809 Kidney Diseases MESH:D007674 marker/mechanism 21258341 +TTC21B 79809 NEPHRONOPHTHISIS 12 OMIM:613820 marker/mechanism 613820.0 +TTC21B 79809 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 613819.0 +TTC21B 79809 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +TTC28 23331 Prostate cancer, familial MESH:C537243 marker/mechanism 29892016 +TTC36 143941 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TTC36 143941 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TTC39A 22996 Liver Neoplasms MESH:D008113 marker/mechanism 17114358 +TTC7A 57217 Intestinal Atresia, Multiple MESH:C562441 marker/mechanism 243150.0 +TTC8 123016 Bardet-Biedl Syndrome 8 MESH:C565917 marker/mechanism 615985.0 +TTC8 123016 RETINITIS PIGMENTOSA 51 OMIM:613464 marker/mechanism 613464.0 +TTC9 23508 Opioid-Related Disorders MESH:D009293 marker/mechanism 18438686 +TTC9C 283237 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +TTF1 7270 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 25851810 +TTI2 80185 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 39 OMIM:615541 marker/mechanism 615541.0 +TTI2 80185 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +TTK 7272 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +TTK 7272 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TTLL5 23093 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TTLL5 23093 CONE-ROD DYSTROPHY 19 OMIM:615860 marker/mechanism 615860.0 +TTLL9 164395 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +TTLL9 164395 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +TTLL9 164395 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +TTN 7273 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +TTN 7273 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 11846417|17444505|27869827 +TTN 7273 Cardiomyopathy, Dilated, 1g MESH:C565824 marker/mechanism 604145.0 +TTN 7273 Cardiomyopathy, Familial Hypertrophic, 9 MESH:C566044 marker/mechanism 613765.0 10462489|22335739 +TTN 7273 Distal Myopathies MESH:D049310 marker/mechanism 600334.0 12145747 +TTN 7273 familial dilated cardiomyopathy MESH:C536231 marker/mechanism 11788824 +TTN 7273 Hereditary Myopathy with Early Respiratory Failure MESH:C566343 marker/mechanism 603689.0 +TTN 7273 Muscle Weakness MESH:D018908 marker/mechanism 17444505 +TTN 7273 Muscular Diseases MESH:D009135 marker/mechanism 15802564 +TTN 7273 Muscular Dystrophy, Limb-Girdle, Type 2J MESH:C563854 marker/mechanism 608807.0 +TTN 7273 Myopathy, Early-Onset, with Fatal Cardiomyopathy MESH:C567129 marker/mechanism 611705.0 +TTN-AS1 100506866 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +TTPA 7274 Ataxia with vitamin E deficiency MESH:C535393 marker/mechanism 277460.0 10896705|11752462|12470185|15300460|18458655|19566498 +TTPA 7274 Atherosclerosis MESH:D050197 marker/mechanism 11095717 +TTPA 7274 Disease Models, Animal MESH:D004195 marker/mechanism 11095717|11752462 +TTPA 7274 Hearing Disorders MESH:D006311 marker/mechanism 10896705 +TTPA 7274 Muscular Atrophy MESH:D009133 marker/mechanism 10896705 +TTPA 7274 Nervous System Diseases MESH:D009422 marker/mechanism 11752462 +TTPA 7274 Reflex, Abnormal MESH:D012021 marker/mechanism 10896705 +TTPA 7274 Retinal Diseases MESH:D012164 marker/mechanism 11752462 +TTPA 7274 Retinitis Pigmentosa MESH:D012174 marker/mechanism 10896705 +TTPA 7274 Somatosensory Disorders MESH:D020886 marker/mechanism 10896705 +TTPA 7274 Speech Disorders MESH:D013064 marker/mechanism 10896705 +TTPA 7274 Urination Disorders MESH:D014555 marker/mechanism 10896705 +TTPA 7274 Vision Disorders MESH:D014786 marker/mechanism 10896705 +TTPA 7274 Vitamin E Deficiency MESH:D014811 marker/mechanism 11095717 +TTR 7276 Acute Kidney Injury MESH:D058186 marker/mechanism 28885000 +TTR 7276 Amyloid Neuropathies, Familial MESH:D028227 marker/mechanism 10529370|12707074|15469931|20030258 +TTR 7276 Amyloidosis MESH:D000686 marker/mechanism 25595224 +TTR 7276 Amyloidosis, Familial MESH:D028226 marker/mechanism 17701470|18326041 +TTR 7276 Amyloidosis, Hereditary, Transthyretin-Related MESH:C567782 marker/mechanism 105210.0 9717013 +TTR 7276 Carpal Tunnel Syndrome MESH:D002349 marker/mechanism 115430.0 +TTR 7276 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 16099942 +TTR 7276 Drug Eruptions MESH:D003875 marker/mechanism 21055120 +TTR 7276 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 28885000 +TTR 7276 Dystransthyretinemic Euthyroidal Hyperthyroxinemia MESH:C567719 marker/mechanism 145680.0 +TTR 7276 Lung Neoplasms MESH:D008175 marker/mechanism 17902193|19180532 +TUB 7275 RETINAL DYSTROPHY AND OBESITY OMIM:616188 marker/mechanism 616188.0 +TUBA1A 7846 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +TUBA1A 7846 Lissencephaly 3 MESH:C566908 marker/mechanism 611603.0 +TUBA1A 7846 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +TUBA1B 10376 Osteoporosis MESH:D010024 marker/mechanism 18924182 +TUBA1C 84790 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +TUBA1C 84790 Osteoporosis MESH:D010024 marker/mechanism 18924182 +TUBA1C 84790 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +TUBA4A 7277 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 28478440 +TUBA4A 7277 AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA OMIM:616208 marker/mechanism 616208.0 +TUBA8 51807 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +TUBB 203068 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6 OMIM:615771 marker/mechanism 615771.0 +TUBB1 81027 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +TUBB1 81027 Macrothrombocytopenia, Autosomal Dominant, Tubb1-Related MESH:C567747 marker/mechanism 613112.0 +TUBB2A 7280 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +TUBB2A 7280 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5 OMIM:615763 marker/mechanism 615763.0 +TUBB2A 7280 Creutzfeldt-Jakob Syndrome MESH:D007562 marker/mechanism 23349890 +TUBB2A 7280 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 17330099 +TUBB2B 347733 Carcinoma MESH:D002277 marker/mechanism 12376462 +TUBB2B 347733 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7 OMIM:610031 marker/mechanism 610031.0 +TUBB2B 347733 Malformations of Cortical Development MESH:D054220 marker/mechanism 19465910 +TUBB2B 347733 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +TUBB2B 347733 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +TUBB3 10381 Breast Neoplasms MESH:D001943 marker/mechanism 21781528 +TUBB3 10381 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1 OMIM:614039 marker/mechanism 614039.0 +TUBB3 10381 Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement MESH:C567572 marker/mechanism 600638.0 +TUBB3 10381 Ovarian Neoplasms MESH:D010051 marker/mechanism 18497984 +TUBB4A 10382 Whispering dysphonia, hereditary MESH:C536698 marker/mechanism 128101.0 +TUBB4B 10383 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +TUBB5 22154 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 16155095 +TUBB5 22154 Enterocolitis, Necrotizing MESH:D020345 marker/mechanism 18806098 +TUBB5 22154 Heart Failure MESH:D006333 marker/mechanism 16155095 +TUBB6 84617 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TUBB8 347688 OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 2 OMIM:616780 marker/mechanism 616780.0 +TUBG1 7283 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4 OMIM:615412 marker/mechanism 615412.0 +TUBG1 7283 Malformations of Cortical Development MESH:D054220 marker/mechanism 23603762 +TUBG1 7283 Microcephaly MESH:D008831 marker/mechanism 23603762 +TUBGCP4 27229 Microcephaly with Chorioretinopathy, Autosomal Recessive MESH:C565379 marker/mechanism 616335.0 +TUBGCP6 85378 Microcephaly with Chorioretinopathy, Autosomal Recessive MESH:C565379 marker/mechanism 251270.0 +TUFM 7284 Combined Oxidative Phosphorylation Deficiency 4 MESH:C565690 marker/mechanism 610678.0 +TUFM 7284 Esophageal Neoplasms MESH:D004938 marker/mechanism 15986332 +TULP1 7287 LEBER CONGENITAL AMAUROSIS 15 OMIM:613843 marker/mechanism 613843.0 +TULP1 7287 Retinitis Pigmentosa 14 MESH:C563992 marker/mechanism 600132.0 +TULP3 7289 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +TUSC3 7991 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TUSC3 7991 Mental Retardation, Autosomal Recessive 7 MESH:C567016 marker/mechanism 611093.0 +TWF1 5756 Lymphoma MESH:D008223 marker/mechanism 19783987 +TWIST1 7291 Acrocephalosyndactylia MESH:D000168 marker/mechanism 101400.0 15923834|23354436 +TWIST1 7291 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +TWIST1 7291 Craniosynostoses MESH:D003398 marker/mechanism 123100.0 12221714 +TWIST1 7291 Lymphoma, Large-Cell, Anaplastic MESH:D017728 marker/mechanism 22155737 +TWIST1 7291 Neoplasm Invasiveness MESH:D009361 marker/mechanism 22155737 +TWIST1 7291 Neoplasm Metastasis MESH:D009362 marker/mechanism 19806464 +TWIST1 7291 Robinow Sorauf syndrome MESH:C537183 marker/mechanism 180750.0 +TWIST1 7291 Saethre-Chotzen Syndrome with Eyelid Anomalies MESH:C566325 marker/mechanism 11474656 +TWIST1 7291 Stomach Neoplasms MESH:D013274 marker/mechanism 19806464 +TWIST2 117581 Ablepharon macrostomia syndrome MESH:C535557 marker/mechanism 200110.0 +TWIST2 117581 Barber Say syndrome MESH:C537908 marker/mechanism 209885.0 +TWIST2 117581 Focal Facial Dermal Dysplasias MESH:D000090303 marker/mechanism 227260.0 +TWNK 56652 MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE) OMIM:271245 marker/mechanism 271245.0 +TWNK 56652 Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 3 MESH:C563747 marker/mechanism 609286.0 +TWNK 56652 Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis MESH:C537583 marker/mechanism 607459.0 +TWSG1 57045 Holoprosencephaly MESH:D016142 marker/mechanism 15013800 +TWSG1 57045 Jaw Abnormalities MESH:D007569 marker/mechanism 15013800 +TXN 7295 Acute Lung Injury MESH:D055371 therapeutic 16298680 +TXN 7295 Breast Neoplasms MESH:D001943 marker/mechanism 30396169 +TXN 7295 Bronchopulmonary Dysplasia MESH:D001997 therapeutic 20812253 +TXN 7295 Congenital Abnormalities MESH:D000013 therapeutic 31310794 +TXN 7295 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +TXN 7295 Hydrocephalus MESH:D006849 marker/mechanism 31310794 +TXN 7295 Liver Diseases MESH:D008107 therapeutic 16996028 +TXN 7295 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 27032653 +TXN 7295 Neoplasm Invasiveness MESH:D009361 marker/mechanism 15048980 +TXN 7295 Neoplasm Metastasis MESH:D009362 marker/mechanism 30396169 +TXN 7295 Neoplasms, Experimental MESH:D009374 marker/mechanism 28574600 +TXN1 22166 Cardiomyopathies MESH:D009202 therapeutic 12221060 +TXN1 22166 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 11462148 +TXN2 25828 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29 OMIM:616811 marker/mechanism 616811.0 +TXN2 25828 Spinal Dysraphism MESH:D016135 marker/mechanism 19165900 +TXNDC17 84817 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 21517111 +TXNDC5 81567 Arthritis, Experimental MESH:D001169 marker/mechanism 23326410 +TXNDC5 81567 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23326410 +TXNDC5 81567 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +TXNDC5 81567 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +TXNIP 10628 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 19192274 +TXNIP 10628 Diabetic Nephropathies MESH:D003928 marker/mechanism 17582205 +TXNIP 10628 Disease Progression MESH:D018450 marker/mechanism 16081686 +TXNIP 10628 Endometriosis MESH:D004715 marker/mechanism 21063030 +TXNIP 10628 Lymphoma, Large B-Cell, Diffuse MESH:D016403 marker/mechanism 16081686 +TXNIP 10628 Stomach Neoplasms MESH:D013274 marker/mechanism 35246762 +TXNL4A 10907 Burn-Mckeown syndrome MESH:C537411 marker/mechanism 608572.0 +TXNRD1 7296 Adenoma MESH:D000236 marker/mechanism 18483336 +TXNRD1 7296 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TXNRD1 7296 Carcinoma, Lewis Lung MESH:D018827 marker/mechanism 16565519 +TXNRD1 7296 Colorectal Neoplasms MESH:D015179 marker/mechanism 18483336 +TXNRD1 7296 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +TXNRD1 7296 Epilepsy MESH:D004827 marker/mechanism 19499324 +TXNRD1 7296 Heart Failure MESH:D006333 marker/mechanism 36071497 +TXNRD1 7296 Mesothelioma MESH:D008654 marker/mechanism 17316382 +TXNRD1 7296 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +TXNRD1 7296 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +TXNRD2 10587 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +TXNRD2 10587 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 26752265 +TXNRD2 10587 Prostatic Neoplasms MESH:D011471 marker/mechanism 21716162 +TXNRD3 114112 Cardiomyopathies MESH:D009202 marker/mechanism 36421005 +TYK2 7297 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 23143596|30224649 +TYK2 7297 Autistic Disorder MESH:D001321 marker/mechanism 20957522 +TYK2 7297 Cocaine-Related Disorders MESH:D019970 marker/mechanism 18438686 +TYK2 7297 COVID-19 MESH:D000086382 marker/mechanism 33307546 +TYK2 7297 Crohn Disease MESH:D003424 marker/mechanism 21102463 +TYK2 7297 Diabetes Mellitus, Type 1 MESH:D003922 marker/mechanism 30224649 +TYK2 7297 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 22961000 +TYK2 7297 Multiple Sclerosis MESH:D009103 marker/mechanism 19525955 +TYK2 7297 Paranoid Disorders MESH:D010259 marker/mechanism 18438686 +TYK2 7297 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 23471820 +TYK2 7297 Psoriasis MESH:D011565 marker/mechanism 20953190 +TYK2 7297 Tyrosine Kinase 2 Deficiency MESH:C566928 marker/mechanism 611521.0 +TYMP 1890 Carcinoma MESH:D002277 marker/mechanism 11103787|12565868 +TYMP 1890 Colonic Neoplasms MESH:D003110 marker/mechanism 18652704 +TYMP 1890 Colorectal Neoplasms MESH:D015179 marker/mechanism 15706408|17047489 +TYMP 1890 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 11641616 +TYMP 1890 MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE) OMIM:603041 marker/mechanism 603041.0 +TYMP 1890 Neoplasm Metastasis MESH:D009362 marker/mechanism 11103787 +TYMP 1890 Pancreatic Neoplasms MESH:D010190 marker/mechanism 17443278 +TYMP 1890 Stomach Neoplasms MESH:D013274 marker/mechanism 18652704 +TYMP 1890 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 11103787|15841086 +TYMP 1890 Visceral myopathy familial external ophthalmoplegia MESH:C536350 marker/mechanism 16972839|22977166 +TYMS 7298 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +TYMS 7298 Anemia MESH:D000740 marker/mechanism 19648163 +TYMS 7298 Brain Diseases MESH:D001927 marker/mechanism 20714149 +TYMS 7298 Breast Neoplasms MESH:D001943 marker/mechanism 16723031|19020767|21501481 +TYMS 7298 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18019677|18230555 +TYMS 7298 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 16280240 +TYMS 7298 Cleft Lip MESH:D002971 marker/mechanism 21254359 +TYMS 7298 Cleft Palate MESH:D002972 marker/mechanism 21254359 +TYMS 7298 Colonic Neoplasms MESH:D003110 marker/mechanism 15355913|16284371|16609021|18192902|18652704|19105824 +TYMS 7298 Colorectal Neoplasms MESH:D015179 marker/mechanism 15222106|15386371|15500737|16141798|16943523|17047489|17943475|18607850|18676755|19020767|25944804 +TYMS 7298 Digestive System Neoplasms MESH:D004067 marker/mechanism 18281538 +TYMS 7298 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +TYMS 7298 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 19648163|21064136|25007187|26077125 +TYMS 7298 Head and Neck Neoplasms MESH:D006258 marker/mechanism 19020767 +TYMS 7298 Hyperammonemia MESH:D022124 marker/mechanism 20714149 +TYMS 7298 Lung Neoplasms MESH:D008175 marker/mechanism 18281538|19020767 +TYMS 7298 Lymphoma, Follicular MESH:D008224 marker/mechanism 16410450 +TYMS 7298 Lymphoma, Non-Hodgkin MESH:D008228 marker/mechanism 16365025 +TYMS 7298 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 18192902 +TYMS 7298 Nervous System Diseases MESH:D009422 marker/mechanism 21064136 +TYMS 7298 Neuroendocrine Tumors MESH:D018358 marker/mechanism 18281538 +TYMS 7298 Ovarian Neoplasms MESH:D010051 marker/mechanism 21795601 +TYMS 7298 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19020767 +TYMS 7298 Prostatic Neoplasms MESH:D011471 marker/mechanism 15999119 +TYMS 7298 Rectal Neoplasms MESH:D012004 marker/mechanism 16931962 +TYMS 7298 Stomach Neoplasms MESH:D013274 marker/mechanism 15837757|18505590|18652704|19020767 +TYMS 7298 Tongue Neoplasms MESH:D014062 marker/mechanism 16280240 +TYR 7299 Albinism, Oculocutaneous MESH:D016115 marker/mechanism 2511845|9158138 +TYR 7299 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 18488027 +TYR 7299 Melanoma MESH:D008545 marker/mechanism 18488027|19578364|21559390|26640592 +TYR 7299 Oculocutaneous albinism type 1 MESH:C537728 marker/mechanism 203100.0 11781109 +TYR 7299 Oculocutaneous albinism type 1B MESH:C537729 marker/mechanism 606952.0 +TYR 7299 Skin Neoplasms MESH:D012878 marker/mechanism 18488027 +TYRO3 7301 Thrombosis MESH:D013927 marker/mechanism 15733062 +TYROBP 7305 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +TYROBP 7305 Liver Diseases MESH:D008107 marker/mechanism 12651611 +TYROBP 7305 Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy MESH:C536329 marker/mechanism 221770.0 17430113 +TYRP1 7306 Adenocarcinoma MESH:D000230 marker/mechanism 21552421 +TYRP1 7306 Lung Neoplasms MESH:D008175 marker/mechanism 21552421 +TYRP1 7306 Melanoma MESH:D008545 marker/mechanism 26640592 +TYRP1 7306 Rufous oculocutaneous albinism MESH:C537189 marker/mechanism 203290.0 +U2AF1 7307 HIV Infections MESH:D015658 marker/mechanism 15308739 +U2AF1 7307 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 22158538 +U2AF1 7307 Osteoporosis MESH:D010024 marker/mechanism 18924182 +U2AF1 7307 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +U2SURP 23350 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +U2SURP-PS1 500042 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +UBA1 7317 Arthrogryposis multiplex congenita, distal, X-linked MESH:C535380 marker/mechanism 301830.0 +UBA1 7317 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 19014429 +UBA5 79876 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 26881866 +UBA5 79876 Cholestasis MESH:D002779 marker/mechanism 26881866 +UBA5 79876 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44 OMIM:617132 marker/mechanism 617132.0 +UBA5 79876 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 617133.0 +UBA7 7318 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 19014429 +UBASH3A 53347 Cholangitis, Sclerosing MESH:D015209 marker/mechanism 27992413 +UBB 7314 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 22994484 +UBD 10537 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +UBD 10537 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 19363144 +UBD 10537 Celiac Disease MESH:D002446 marker/mechanism 30097691 +UBD 10537 Hepatitis, Animal MESH:D006520 marker/mechanism 18559427 +UBD 10537 Liver Cirrhosis, Biliary MESH:D008105 marker/mechanism 18422935 +UBD 10537 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +UBE2A 7319 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, NASCIMENTO TYPE OMIM:300860 marker/mechanism 300860.0 +UBE2C 11065 Breast Neoplasms MESH:D001943 marker/mechanism 17659439 +UBE2C 11065 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +UBE2C 11065 Chromosome Aberrations MESH:D002869 therapeutic 27129209 +UBE2E1 7324 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +UBE2E1 7324 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +UBE2E1 7324 Skin Diseases MESH:D012871 marker/mechanism 16835338 +UBE2E2 7325 Adenoma, Liver Cell MESH:D018248 marker/mechanism 27914986 +UBE2E2 7325 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 27914986 +UBE2E2 7325 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 20818381 +UBE2H 7328 Autistic Disorder MESH:D001321 marker/mechanism 14639049 +UBE2H 7328 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +UBE2I 7329 Carcinoma MESH:D002277 marker/mechanism 16316942 +UBE2I 7329 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +UBE2I 7329 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +UBE2L3 7332 Hepatitis B, Chronic MESH:D019694 marker/mechanism 24162738 +UBE2L6 9246 Influenza, Human MESH:D007251 marker/mechanism 23326326 +UBE2N 7334 Embryo Loss MESH:D020964 marker/mechanism 16738225 +UBE2T 29089 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +UBE2T 29089 FANCONI ANEMIA, COMPLEMENTATION GROUP T OMIM:616435 marker/mechanism 616435.0 +UBE2T 29089 Kidney Neoplasms MESH:D007680 marker/mechanism 28321044 +UBE3A 7337 Angelman Syndrome MESH:D017204 marker/mechanism 105830.0 15878204 +UBE3A 7337 Autistic Disorder MESH:D001321 marker/mechanism 11543639|19404257|20609483 +UBE3A 7337 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15878204 +UBE3A 7337 Epilepsy MESH:D004827 marker/mechanism 15878204 +UBE3B 89910 Kaufman oculocerebrofacial syndrome MESH:C537013 marker/mechanism 244450.0 28003368 +UBE3C 9690 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +UBE4B 10277 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +UBE4B 10277 Brain Injuries, Traumatic MESH:D000070642 therapeutic 27822499 +UBE4B 10277 Neurobehavioral Manifestations MESH:D019954 therapeutic 27822499 +UBE4B 10277 Wallerian Degeneration MESH:D014855 therapeutic 27822499 +UBIAD1 29914 Corneal Dystrophy, Crystalline, of Schnyder MESH:C535475 marker/mechanism 121800.0 +UBIAD1 29914 Edema, Cardiac MESH:D004489 marker/mechanism 23533172 +UBIAD1 29914 Intracranial Hemorrhages MESH:D020300 marker/mechanism 23533172 +UBLCP1 134510 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +UBQLN1 29979 Neoplasm Invasiveness MESH:D009361 marker/mechanism 24747970 +UBQLN2 29978 AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA OMIM:300857 marker/mechanism 300857.0 +UBR1 197131 Johanson Blizzard syndrome MESH:C535880 marker/mechanism 243800.0 +UBR7 55148 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +UBXN1 51035 Disease Progression MESH:D018450 marker/mechanism 21364753 +UBXN1 51035 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +UCHL1 7345 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18666234 +UCHL1 7345 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 17094902 +UCHL1 7345 Esophageal Neoplasms MESH:D004938 marker/mechanism 15930319 +UCHL1 7345 Gallbladder Neoplasms MESH:D005706 marker/mechanism 16965602 +UCHL1 7345 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 18958481 +UCHL1 7345 PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO OMIM:613643 marker/mechanism 613643.0 +UCHL1 7345 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 16797537 +UCHL1 7345 SPASTIC PARAPLEGIA 79B, AUTOSOMAL RECESSIVE OMIM:615491 marker/mechanism 615491.0 +UCHL3 7347 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +UCK2 7371 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +UCK2 7371 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +UCK2 7371 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +UCMAA 100037325 Bone Diseases, Developmental MESH:D001848 marker/mechanism 21839171 +UCMAA 100037325 Prenatal Injuries MESH:D049188 marker/mechanism 21839171 +UCN 7349 Anxiety Disorders MESH:D001008 marker/mechanism 16488545 +UCN 7349 Hypertension MESH:D006973 therapeutic 20237592 +UCN 7349 Hypotension MESH:D007022 marker/mechanism 10213916 +UCN 7349 Inflammation MESH:D007249 therapeutic 10213916 +UCN2 90226 Anorexia MESH:D000855 marker/mechanism 17627984 +UCN2 90226 Heart Failure MESH:D006333 therapeutic 16330704 +UCN3 114131 Inflammation MESH:D007249 therapeutic 16855006 +UCN3 114131 Lung Diseases MESH:D008171 therapeutic 16855006 +UCP1 7350 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 26670611 +UCP1 7350 Heart Failure MESH:D006333 marker/mechanism 26670611 +UCP1 7350 Obesity MESH:D009765 therapeutic 15592485 +UCP2 7351 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4 OMIM:607447 marker/mechanism 607447.0 +UCP2 7351 Brain Injuries MESH:D001930 therapeutic 12858170 +UCP2 7351 Brain Ischemia MESH:D002545 marker/mechanism 17052689 +UCP2 7351 Carcinoma MESH:D002277 marker/mechanism 16316942 +UCP2 7351 Cardiomegaly MESH:D006332 therapeutic 25703824 +UCP2 7351 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 14563825|16123366 +UCP2 7351 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 15562023|16123366 +UCP2 7351 Fatty Liver MESH:D005234 marker/mechanism 10860543 +UCP2 7351 Hypertension MESH:D006973 marker/mechanism 16685210 +UCP2 7351 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +UCP2 7351 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +UCP2 7351 Obesity MESH:D009765 marker/mechanism 11381268 +UCP2 7351 Stroke MESH:D020521 therapeutic 12858170 +UCP3 7352 Obesity MESH:D009765 marker/mechanism 601665.0 +UCP3 7352 Prostatic Neoplasms MESH:D011471 marker/mechanism 22919386 +UEV-2 186377 Infertility MESH:D007246 marker/mechanism 25204677 +UFD1 7353 Craniofacial Abnormalities MESH:D019465 marker/mechanism 10024240 +UFD1 7353 Heart Defects, Congenital MESH:D006330 marker/mechanism 10024240 +UFSP2 55325 Hip Dysplasia, Beukes Type MESH:C564185 marker/mechanism 142669.0 +UGCG 7357 COVID-19 MESH:D000086382 marker/mechanism 33639165 +UGCG 7357 Influenza, Human MESH:D007251 marker/mechanism 33639165 +UGCG 7357 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +UGCG 7357 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +UGDH 7358 Liver Neoplasms MESH:D008113 marker/mechanism 17114358 +UGT1A 7361 Gilbert Disease MESH:D005878 marker/mechanism 22213127 +UGT1A1 54658 Acute Kidney Injury MESH:D058186 marker/mechanism 3864191 +UGT1A1 54658 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT1A1 54658 Carcinoma, Small Cell MESH:D018288 marker/mechanism 20946520 +UGT1A1 54658 Crigler-Najjar Syndrome MESH:D003414 marker/mechanism 218800.0 25370011 +UGT1A1 54658 Crigler Najjar syndrome, type 2 MESH:C536213 marker/mechanism 606785.0 +UGT1A1 54658 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +UGT1A1 54658 Drug-Related Side Effects and Adverse Reactions MESH:D064420 therapeutic 19931604 +UGT1A1 54658 Gilbert Disease MESH:D005878 marker/mechanism 143500.0 10421657|15180166|15297419 +UGT1A1 54658 Hodgkin Disease MESH:D006689 marker/mechanism 18768784 +UGT1A1 54658 Hyperbilirubinemia MESH:D006932 marker/mechanism 20194756|21983082|23950218|25370011|27060662 +UGT1A1 54658 Hyperbilirubinemia, Neonatal MESH:D051556 marker/mechanism 28167773 +UGT1A1 54658 Hyperbilirubinemia, Transient Familial Neonatal MESH:C562692 marker/mechanism 237900.0 +UGT1A1 54658 Kernicterus MESH:D007647 marker/mechanism 20194756|28167773 +UGT1A1 54658 Neutropenia MESH:D009503 marker/mechanism 17549067 +UGT1A10 54575 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT1A3 54659 Schizophrenia MESH:D012559 marker/mechanism 21822266 +UGT1A4 54657 Celiac Disease MESH:D002446 marker/mechanism 30097691 +UGT1A6 54578 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT1A6 54578 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +UGT1A8 54576 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT1A9 54600 Acute Kidney Injury MESH:D058186 marker/mechanism 20623750 +UGT1A9 54600 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 20623750 +UGT2A1 10941 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT2A3 79799 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT2B 24862 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +UGT2B10 7365 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT2B10 7365 Melanoma MESH:D008545 marker/mechanism 21499247 +UGT2B11 10720 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT2B15 7366 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT2B15 7366 Prostatic Neoplasms MESH:D011471 marker/mechanism 16859836 +UGT2B17 7367 Adenocarcinoma MESH:D000230 marker/mechanism 17416778 +UGT2B17 7367 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12 OMIM:612560 marker/mechanism 612560.0 +UGT2B17 7367 Graft vs Host Disease MESH:D006086 marker/mechanism 19935662 +UGT2B17 7367 Lung Neoplasms MESH:D008175 marker/mechanism 17416778 +UGT2B17 7367 Prostatic Neoplasms MESH:D011471 marker/mechanism 17826523 +UGT2B4 7363 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT2B7 7364 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +UGT2B7 7364 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 15615884 +UHRF1 29128 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 23685749 +UHRF1 29128 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ULBP2 80328 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +ULBP3 79465 Alopecia Areata MESH:D000506 marker/mechanism 20596022 +ULK2 9706 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 26928227 +ULK4 54986 Multiple Myeloma MESH:D009101 marker/mechanism 22120009 +UMOD 7369 Hypertension MESH:D006973 marker/mechanism 22228705 +UMOD 7369 Kidney Diseases MESH:D007674 marker/mechanism 19430482|8486146 +UMOD 7369 TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 1 OMIM:162000 marker/mechanism 162000.0 +UMPS 7372 Anemia, Hypoplastic, Congenital MESH:D029502 marker/mechanism 38827 +UMPS 7372 Anemia, Sickle Cell MESH:D000755 marker/mechanism 38827 +UMPS 7372 beta-Thalassemia MESH:D017086 marker/mechanism 38827 +UMPS 7372 Breast Neoplasms MESH:D001943 marker/mechanism 19020767|19151563 +UMPS 7372 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 18230555 +UMPS 7372 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 16757204 +UMPS 7372 Colonic Neoplasms MESH:D003110 marker/mechanism 18652704 +UMPS 7372 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641|19020767 +UMPS 7372 Leukemia, Erythroblastic, Acute MESH:D004915 marker/mechanism 38827 +UMPS 7372 Mouth Neoplasms MESH:D009062 marker/mechanism 16757204 +UMPS 7372 Oroticaciduria 1 MESH:C537136 marker/mechanism 258900.0 +UMPS 7372 Prostatic Neoplasms MESH:D011471 marker/mechanism 15999119|19082440 +UMPS 7372 Spherocytosis, Hereditary MESH:D013103 marker/mechanism 38827 +UMPS 7372 Stomach Neoplasms MESH:D013274 marker/mechanism 16912530|17089033|18652704 +UNC119 9094 Retinitis Pigmentosa MESH:D012174 marker/mechanism 11006213 +UNC119 9094 T-Lymphocytopenia, Idiopathic CD4-Positive MESH:D018344 marker/mechanism 615518.0 +UNC13A 23025 Amyotrophic Lateral Sclerosis MESH:D000690 marker/mechanism 19734901 +UNC13D 201294 Hemophagocytic lymphohistiocytosis, familial, 3 MESH:C537251 marker/mechanism 608898.0 +UNC13D 201294 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +UNC45B 146862 CATARACT 43 OMIM:616279 marker/mechanism 616279.0 +UNC45B 146862 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17189627 +UNC45B 146862 Heart Diseases MESH:D006331 marker/mechanism 17189627 +UNC45B 146862 Paralysis MESH:D010243 marker/mechanism 17189627 +UNC5B 219699 Subarachnoid Hemorrhage MESH:D013345 marker/mechanism 29162556 +UNC5C 8633 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 21600761 +UNC5CL 222643 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +UNC80 285175 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 28191889 +UNC80 285175 HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2 OMIM:616801 marker/mechanism 616801.0 +UNC93B1 81622 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +UNC93B1 81622 Encephalitis, Herpes Simplex MESH:D020803 marker/mechanism 610551.0 +UNC93B1 81622 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +UNC93B1 81622 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +UNG 7374 Bloom Syndrome MESH:D001816 marker/mechanism 2106500 +UNG 7374 Colorectal Neoplasms MESH:D015179 marker/mechanism 15814641 +UNG 7374 Hyper-IgM Immunodeficiency Syndrome MESH:D053306 marker/mechanism 608106.0 +UOX 391051 Acute Kidney Injury MESH:D058186 therapeutic 16313266 +UOX 391051 Oliguria MESH:D009846 therapeutic 16313266 +UOX 391051 Ovarian Cysts MESH:D010048 marker/mechanism 21239663 +UOX 391051 Tumor Lysis Syndrome MESH:D015275 therapeutic 16313266 +UP 104073 Parkinson Disease MESH:D010300 marker/mechanism 18353766 +UPB1 51733 Autistic Disorder MESH:D001321 marker/mechanism 18853477 +UPB1 51733 Beta-Ureidopropionase Deficiency MESH:C563210 marker/mechanism 613161.0 +UPB1 51733 Celiac Disease MESH:D002446 marker/mechanism 30097691 +UPB1 51733 Metabolic Diseases MESH:D008659 marker/mechanism 18853477 +UPB1 51733 Spasms, Infantile MESH:D013036 marker/mechanism 18853477 +UPF3B 65109 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 17704778 +UPF3B 65109 Mental Retardation, X-Linked, Syndromic 14 MESH:C567063 marker/mechanism 300676.0 +UPK1B 7348 Breast Neoplasms MESH:D001943 marker/mechanism 25330770 +UPP1 7378 Dermatitis, Allergic Contact MESH:D017449 marker/mechanism 16033404 +UPP1 7378 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 24211530 +UPP2 151531 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 21151189 +UQCC2 84300 Mitochondrial Complex III Deficiency MESH:C565128 marker/mechanism 615824.0 +UQCC3 790955 Mitochondrial Complex III Deficiency MESH:C565128 marker/mechanism 616111.0 +UQCR11 10975 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +UQCRB 7381 Mitochondrial Complex III Deficiency MESH:C565128 marker/mechanism 615158.0 +UQCRC2 7385 Mitochondrial Complex III Deficiency MESH:C565128 marker/mechanism 615160.0 +UQCRC2 7385 Obesity MESH:D009765 marker/mechanism 20882379 +UQCRFS1 7386 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +UQCRQ 27089 Mitochondrial Complex III Deficiency MESH:C565128 marker/mechanism 615159.0 +URI1 8725 Carcinoma MESH:D002277 marker/mechanism 21397856 +URI1 8725 Neoplasms, Experimental MESH:D009374 marker/mechanism 21397856 +URI1 8725 Ovarian Neoplasms MESH:D010051 marker/mechanism 21397856 +URM1 81605 Disease Progression MESH:D018450 marker/mechanism 21364753 +URM1 81605 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +UROC1 131669 Ataxia MESH:D001259 marker/mechanism 19304569 +UROC1 131669 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +UROC1 131669 Intellectual Disability MESH:D008607 marker/mechanism 19304569 +UROC1 131669 Urocanase deficiency MESH:C536479 marker/mechanism 276880.0 19304569 +UROD 7389 Head and Neck Neoplasms MESH:D006258 marker/mechanism 21270338 +UROD 7389 Porphyria Cutanea Tarda MESH:D017119 marker/mechanism 176100.0 12030801|17360334 +UROS 7390 Porphyria, Erythropoietic MESH:D017092 marker/mechanism 263700.0 +USB1 79650 Poikiloderma with Neutropenia MESH:C565820 marker/mechanism 604173.0 +USF1 7391 Hyperlipidemia, Familial Combined MESH:D006950 marker/mechanism 602491.0 +USH1C 10083 DEAFNESS, AUTOSOMAL RECESSIVE 18A OMIM:602092 marker/mechanism 602092.0 +USH1C 10083 Usher syndrome, type 1B MESH:C536485 marker/mechanism 276900.0 +USH1C 10083 Usher syndrome, type 1C MESH:C536486 marker/mechanism 276904.0 12136232 +USH1G 124590 Hearing Loss MESH:D034381 marker/mechanism 30029624 +USH1G 124590 Usher Syndrome, Type IG MESH:C564643 marker/mechanism 606943.0 +USH2A 7399 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 31209396 +USH2A 7399 Retinitis Pigmentosa MESH:D012174 marker/mechanism 10775529|15025721|9624053 +USH2A 7399 RETINITIS PIGMENTOSA 39 OMIM:613809 marker/mechanism 613809.0 +USH2A 7399 Usher syndrome, type 2A MESH:C536490 marker/mechanism 276901.0 15025721|9624053 +USO1 8615 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +USO1 8615 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +USO1 8615 Skin Diseases MESH:D012871 marker/mechanism 16835338 +USP13 8975 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +USP13 8975 Skin Diseases MESH:D012871 marker/mechanism 16835338 +USP15 9958 Diabetic Neuropathies MESH:D003929 marker/mechanism 35478295 +USP18 11274 Acute Lung Injury MESH:D055371 therapeutic 33930521 +USP18 11274 Aicardi-Goutieres syndrome MESH:C535607 marker/mechanism 617397.0 +USP18 11274 Leiomyosarcoma MESH:D007890 marker/mechanism 26555296 +USP18 11274 Lung Neoplasms MESH:D008175 marker/mechanism 27980214 +USP2 9099 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21147110 +USP27X 389856 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 105 OMIM:300984 marker/mechanism 300984.0 +USP28 57646 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475|29662167 +USP3 9960 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +USP32 84669 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 28811376 +USP34 9736 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +USP39 10713 Colonic Neoplasms MESH:D003110 marker/mechanism 34822033 +USP39 10713 Neoplasms, Experimental MESH:D009374 marker/mechanism 34822033 +USP4 7375 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 35841383 +USP48 84196 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +USP48 84196 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +USP5 8078 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +USP6NL 9712 Melanoma MESH:D008545 marker/mechanism 22535842 +USP7 7874 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +USP7 7874 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +USP8 9101 ACTH-Secreting Pituitary Adenoma MESH:D049913 marker/mechanism 219090.0 25485838 +USP8 9101 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 35022897 +USP8 9101 Pituitary ACTH Hypersecretion MESH:D047748 marker/mechanism 25485838 +USP9X 8239 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99 OMIM:300919 marker/mechanism 300919.0 +USP9X 8239 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED OMIM:300968 marker/mechanism 300968.0 +USP9Y 8287 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +UST 10090 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +UST 10090 Endometriosis MESH:D004715 marker/mechanism 20864642 +UST5R 171398 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +UST5R 171398 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513 +UST5R 171398 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +UTP25 27042 Hirschsprung Disease MESH:D006627 marker/mechanism 25007945 +UTS2 10911 Bradycardia MESH:D001919 marker/mechanism 16160878 +UTS2 10911 Feeding and Eating Disorders MESH:D001068 marker/mechanism 16160878 +UTS2 10911 Hypertension MESH:D006973 marker/mechanism 16160878 +UTS2 10911 Movement Disorders MESH:D009069 marker/mechanism 16160878 +UTS2 10911 Water Intoxication MESH:D014869 marker/mechanism 16160878 +UVSSA 57654 UV-Sensitive Syndrome MESH:C563466 marker/mechanism 614640.0 22466610|22466612 +UXS1 80146 Craniofacial Abnormalities MESH:D019465 marker/mechanism 16759393 +UXT 8409 Prostatic Neoplasms MESH:D011471 marker/mechanism 19318562 +VAC14 55697 STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET OMIM:617054 marker/mechanism 617054.0 +VAMP1 6843 Ataxia, Spastic, 1, Autosomal Dominant MESH:C566993 marker/mechanism 108600.0 +VAMP5 10791 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +VAMP7 6845 Papillomavirus Infections MESH:D030361 marker/mechanism 23358896 +VAMP7 6845 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 23358896 +VAMP8 8673 Carcinoma MESH:D002277 marker/mechanism 16316942 +VAMP8 8673 Coronary Artery Disease MESH:D003324 marker/mechanism 34961328 +VAMP8 8673 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +VAMP8 8673 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +VANGL1 81839 Neural Tube Defects MESH:D009436 marker/mechanism 182940.0 17409324|19319979 +VANGL1 81839 Sacral defect and anterior sacral meningocele MESH:C537221 marker/mechanism 600145.0 +VANGL2 57216 Neural Tube Defects MESH:D009436 marker/mechanism 182940.0 2373757 +VANGL2 57216 Spinal Dysraphism MESH:D016135 marker/mechanism 21404367 +VAPB 9217 Amyotrophic Lateral Sclerosis 8 MESH:C563895 marker/mechanism 608627.0 +VAPB 9217 Spinal Muscular Atrophy, Late-Onset, Finkel Type MESH:C566673 marker/mechanism 182980.0 +VARS2 57176 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20 OMIM:615917 marker/mechanism 615917.0 +VASN 114990 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 25826090 +VASP 7408 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +VAV1 7409 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27158780 +VAV1 7409 Leukemia-Lymphoma, Adult T-Cell MESH:D015459 marker/mechanism 26437031 +VAV1 7409 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +VAV1 7409 Medulloblastoma MESH:D008527 marker/mechanism 19270706 +VAV3 10451 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25305756 +VAV3 10451 Hypertension MESH:D006973 marker/mechanism 21115475 +VAV3 10451 Hyperventilation MESH:D006985 marker/mechanism 21115475 +VAV3 10451 Prostatic Neoplasms MESH:D011471 marker/mechanism 17909013 +VAV3 10451 Tachycardia MESH:D013610 marker/mechanism 21115475 +VAX1 11023 MICROPHTHALMIA, SYNDROMIC 11 OMIM:614402 marker/mechanism 614402.0 +VCAM1 7412 Anemia, Sickle Cell MESH:D000755 marker/mechanism 16916123 +VCAM1 7412 Arteriosclerosis MESH:D001161 marker/mechanism 28569748 +VCAM1 7412 Atherosclerosis MESH:D050197 marker/mechanism 12677255 +VCAM1 7412 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 22922871 +VCAM1 7412 Cardiovascular Diseases MESH:D002318 marker/mechanism 16332659|25575156 +VCAM1 7412 Cholestasis MESH:D002779 marker/mechanism 21224055 +VCAM1 7412 Colitis, Ulcerative MESH:D003093 marker/mechanism 15553846 +VCAM1 7412 Dermatitis MESH:D003872 marker/mechanism 27206134 +VCAM1 7412 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 12759764 +VCAM1 7412 Hypercholesterolemia MESH:D006937 marker/mechanism 14602771 +VCAM1 7412 Hypertension MESH:D006973 marker/mechanism 11834524|19018797 +VCAM1 7412 Intrahepatic Cholestasis of Pregnancy MESH:C535932 marker/mechanism 28851649 +VCAM1 7412 Multiple Sclerosis MESH:D009103 marker/mechanism 20175758 +VCAM1 7412 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +VCAM1 7412 Primary Graft Dysfunction MESH:D055031 marker/mechanism 28569748 +VCAM1 7412 Uremia MESH:D014511 marker/mechanism 17347482 +VCAM1 7412 Urticaria MESH:D014581 marker/mechanism 12121561 +VCAN 1462 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +VCAN 1462 Endometriosis MESH:D004715 marker/mechanism 21063030 +VCAN 1462 Hyaloideoretinal degeneration of Wagner MESH:C536075 marker/mechanism 143200.0 +VCAN 1462 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +VCL 7414 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +VCL 7414 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +VCL 7414 Cardiomyopathy, Dilated, 1w MESH:C566954 marker/mechanism 611407.0 +VCL 7414 Cardiomyopathy, Familial Hypertrophic, 15 MESH:C567681 marker/mechanism 613255.0 +VCL 7414 Osteoporosis MESH:D010024 marker/mechanism 18924182 +VCP 7415 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y OMIM:616687 marker/mechanism 616687.0 +VCP 7415 Cytomegalovirus Infections MESH:D003586 marker/mechanism 28494016 +VCP 7415 Disease Models, Animal MESH:D004195 marker/mechanism 25884947 +VCP 7415 Disease Progression MESH:D018450 marker/mechanism 29693262 +VCP 7415 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 6 OMIM:613954 marker/mechanism 613954.0 +VCP 7415 Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia MESH:C563476 marker/mechanism 167320.0 25884947 +VCP 7415 Muscle Weakness MESH:D018908 marker/mechanism 25884947 +VCP 7415 Prostatic Neoplasms MESH:D011471 marker/mechanism 29693262 +VCP 7415 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 25811541 +VCY 9084 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +VDAC1 7416 Diabetic Nephropathies MESH:D003928 marker/mechanism 19634143 +VDAC1 7416 Epilepsy MESH:D004827 marker/mechanism 17893921 +VDAC1 7416 Mitochondrial Myopathies MESH:D017240 marker/mechanism 8726225 +VDAC1 7416 Myocardial Infarction MESH:D009203 marker/mechanism 25488258 +VDAC1 7416 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 25488258 +VDAC1 7416 Psychomotor Disorders MESH:D011596 marker/mechanism 8726225 +VDAC1 7416 Ventricular Dysfunction, Left MESH:D018487 marker/mechanism 25488258 +VDAC2 7417 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15274141 +VDAC2 7417 Diabetic Nephropathies MESH:D003928 marker/mechanism 19634143 +VDAC2 7417 Epilepsy MESH:D004827 marker/mechanism 17893921 +VDAC2 7417 Mouth Neoplasms MESH:D009062 marker/mechanism 15274141 +VDAC2 7417 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +VDR 7421 Alopecia MESH:D000505 marker/mechanism 1338926|22466564 +VDR 7421 Breast Neoplasms MESH:D001943 marker/mechanism 16280049|22892281 +VDR 7421 Carcinoma, Transitional Cell MESH:D002295 marker/mechanism 16080513 +VDR 7421 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 18534255 +VDR 7421 Genetic Diseases, Inborn MESH:D030342 marker/mechanism 17451081 +VDR 7421 Hypertension MESH:D006973 marker/mechanism 11335187 +VDR 7421 Ischemic Stroke MESH:D000083242 marker/mechanism 25498546 +VDR 7421 Lead Poisoning MESH:D007855 marker/mechanism 20692022|23433214 +VDR 7421 Leukemia, Lymphocytic, Chronic, B-Cell MESH:D015451 marker/mechanism 12446453 +VDR 7421 Multiple Sclerosis MESH:D009103 marker/mechanism 25853421 +VDR 7421 Neoplasms MESH:D009369 marker/mechanism 10389917 +VDR 7421 Prostatic Neoplasms MESH:D011471 marker/mechanism 20347977 +VDR 7421 Rickets MESH:D012279 marker/mechanism 1338926|17451081|22466564 +VDR 7421 Uremia MESH:D014511 marker/mechanism 19092814 +VDR 7421 Vitamin D Deficiency MESH:D014808 marker/mechanism 9525346 +VDR 7421 Vitamin D-Dependent Rickets, Type 2A MESH:C562794 marker/mechanism 277440.0 +VEGF 100136118 Myocardial Ischemia MESH:D017202 marker/mechanism 11289497 +VEGFA 7422 Acute Kidney Injury MESH:D058186 marker/mechanism|therapeutic 20943766|22808199 +VEGFA 7422 Adenocarcinoma MESH:D000230 marker/mechanism 26432044 +VEGFA 7422 Alzheimer Disease MESH:D000544 marker/mechanism 15732116 +VEGFA 7422 Arthritis, Experimental MESH:D001169 marker/mechanism 26221077|9598899 +VEGFA 7422 Arthritis, Rheumatoid MESH:D001172 marker/mechanism 16368150 +VEGFA 7422 Asthma MESH:D001249 marker/mechanism 11907124|15201500|19263519 +VEGFA 7422 Atherosclerosis MESH:D050197 marker/mechanism 15937083 +VEGFA 7422 Brain Injuries MESH:D001930 therapeutic 18065154 +VEGFA 7422 Brain Neoplasms MESH:D001932 marker/mechanism 20932960 +VEGFA 7422 Bronchitis, Chronic MESH:D029481 marker/mechanism 19263519 +VEGFA 7422 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 15956251 +VEGFA 7422 Carcinoma, Pancreatic Ductal MESH:D021441 marker/mechanism 17481528 +VEGFA 7422 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 15956251|26432044 +VEGFA 7422 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 30090327 +VEGFA 7422 Cerebral Hemorrhage MESH:D002543 marker/mechanism 17888890 +VEGFA 7422 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +VEGFA 7422 Choroidal Neovascularization MESH:D020256 marker/mechanism 16680105 +VEGFA 7422 Clear-cell metastatic renal cell carcinoma MESH:C538445 marker/mechanism 25239121 +VEGFA 7422 Colonic Neoplasms MESH:D003110 marker/mechanism 18987561 +VEGFA 7422 Corneal Neovascularization MESH:D016510 marker/mechanism 9301478 +VEGFA 7422 Coronary Artery Disease MESH:D003324 marker/mechanism|therapeutic 14668888|15937083 +VEGFA 7422 Dermatitis, Contact MESH:D003877 marker/mechanism 25724174 +VEGFA 7422 Diabetes Complications MESH:D048909 marker/mechanism 26073000 +VEGFA 7422 Diabetes Mellitus, Experimental MESH:D003921 marker/mechanism 22191573 +VEGFA 7422 Diabetic Nephropathies MESH:D003928 marker/mechanism 18630688 +VEGFA 7422 Diabetic Retinopathy MESH:D003930 marker/mechanism 11978667|15788408|20577866 +VEGFA 7422 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31068094 +VEGFA 7422 Endometrial Neoplasms MESH:D016889 marker/mechanism 17380299 +VEGFA 7422 Epilepsy, Temporal Lobe MESH:D004833 marker/mechanism 17533168 +VEGFA 7422 Erectile Dysfunction MESH:D007172 marker/mechanism 12002441 +VEGFA 7422 Glioblastoma MESH:D005909 marker/mechanism 16356833 +VEGFA 7422 Gliosarcoma MESH:D018316 marker/mechanism 16533777 +VEGFA 7422 Head and Neck Neoplasms MESH:D006258 marker/mechanism 16499871 +VEGFA 7422 Heart Defects, Congenital MESH:D006330 marker/mechanism 26073000 +VEGFA 7422 Heart Diseases MESH:D006331 marker/mechanism 16844662 +VEGFA 7422 Heart Failure MESH:D006333 marker/mechanism 15732037|15880336 +VEGFA 7422 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +VEGFA 7422 Hemorrhage MESH:D006470 marker/mechanism 31068094 +VEGFA 7422 Hypertension, Portal MESH:D006975 therapeutic 18416461 +VEGFA 7422 Hypoxia-Ischemia, Brain MESH:D020925 marker/mechanism 23694759 +VEGFA 7422 Inflammation MESH:D007249 marker/mechanism 19324842 +VEGFA 7422 Learning Disabilities MESH:D007859 therapeutic 20801723 +VEGFA 7422 Leukemia, Myeloid MESH:D007951 marker/mechanism 21535412 +VEGFA 7422 Liver Cirrhosis MESH:D008103 marker/mechanism 11981751 +VEGFA 7422 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism|therapeutic 18416461|18458672 +VEGFA 7422 Liver Failure MESH:D017093 therapeutic 16757304 +VEGFA 7422 Lung Diseases MESH:D008171 marker/mechanism 23618901 +VEGFA 7422 Macular Degeneration MESH:D008268 marker/mechanism 15788408 +VEGFA 7422 Macular Edema MESH:D008269 marker/mechanism 20577866 +VEGFA 7422 Memory Disorders MESH:D008569 therapeutic 20801723 +VEGFA 7422 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1 OMIM:603933 marker/mechanism 603933.0 +VEGFA 7422 Myocardial Ischemia MESH:D017202 marker/mechanism|therapeutic 14503966|14583313|15347709|16214533|9860779 +VEGFA 7422 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 22050707 +VEGFA 7422 Neoplasm Metastasis MESH:D009362 marker/mechanism 15659795|18930813|20158913 +VEGFA 7422 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 20158913 +VEGFA 7422 Neoplasms MESH:D009369 marker/mechanism 18494554 +VEGFA 7422 Neoplasms, Experimental MESH:D009374 marker/mechanism|therapeutic 20376344|20932960|28574600 +VEGFA 7422 Neovascularization, Pathologic MESH:D009389 marker/mechanism 12399228|17533168 +VEGFA 7422 Osteochondrodysplasias MESH:D010009 therapeutic 24235232 +VEGFA 7422 Osteosarcoma MESH:D012516 marker/mechanism 20158913 +VEGFA 7422 Precancerous Conditions MESH:D011230 marker/mechanism 12399228 +VEGFA 7422 Prostatic Neoplasms MESH:D011471 marker/mechanism 12893367|16606632|16908180|20052738 +VEGFA 7422 Proteinuria MESH:D011507 marker/mechanism 22808199 +VEGFA 7422 Psoriasis MESH:D011565 marker/mechanism 16385345 +VEGFA 7422 Respiratory Hypersensitivity MESH:D012130 marker/mechanism 30608172 +VEGFA 7422 Retinal Diseases MESH:D012164 marker/mechanism 19324842 +VEGFA 7422 Retinal Vein Occlusion MESH:D012170 marker/mechanism 16680105 +VEGFA 7422 Rhabdomyosarcoma MESH:D012208 marker/mechanism 16116481 +VEGFA 7422 Spinal Cord Injuries MESH:D013119 marker/mechanism 21092735 +VEGFA 7422 Status Epilepticus MESH:D013226 marker/mechanism 17533168 +VEGFA 7422 Stomach Ulcer MESH:D013276 marker/mechanism 11353854 +VEGFA 7422 Thrombotic Microangiopathies MESH:D057049 marker/mechanism 22808199 +VEGFA 7422 Urologic Neoplasms MESH:D014571 marker/mechanism 23009795 +VEGFA 7422 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 26432044 +VEGFAA 30682 Cerebrovascular Disorders MESH:D002561 therapeutic 24128854 +VEGFB 7423 Breast Neoplasms MESH:D001943 marker/mechanism 23146280 +VEGFB 7423 Disease Progression MESH:D018450 marker/mechanism 23146280 +VEGFB 7423 Pancreatic Neoplasms MESH:D010190 marker/mechanism 24604347 +VEGFC 7424 Breast Neoplasms MESH:D001943 marker/mechanism 18509974|26124351 +VEGFC 7424 Hemangiosarcoma MESH:D006394 marker/mechanism 17569031 +VEGFC 7424 LYMPHATIC MALFORMATION 4 OMIM:615907 marker/mechanism 615907.0 +VEGFC 7424 Melanoma MESH:D008545 marker/mechanism 17562445 +VEGFC 7424 Recurrence MESH:D012008 marker/mechanism 26124351 +VEGFD 2277 Lymphangioleiomyomatosis MESH:D018192 marker/mechanism 20038814 +VEGFD 2277 Reperfusion Injury MESH:D015427 marker/mechanism 16526316 +VENTX 27287 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 30431698 +VGF 7425 Hyperphagia MESH:D006963 therapeutic 12177191 +VGF 7425 Obesity MESH:D009765 therapeutic 12177191 +VGF 7425 Stomach Ulcer MESH:D013276 therapeutic 20805684 +VGLL2 245806 Melanoma MESH:D008545 marker/mechanism 22535842 +VHL 7428 Adenoma MESH:D000236 marker/mechanism 16061637 +VHL 7428 Carcinoma MESH:D002277 marker/mechanism 16061637 +VHL 7428 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 144700.0 10340905|11171960|15177666|19473641|21097529|22138691|23797736|24755467|9137812 +VHL 7428 Erythrocytosis, Familial, 2 MESH:C563918 marker/mechanism 263400.0 +VHL 7428 Kidney Neoplasms MESH:D007680 marker/mechanism 11880179 +VHL 7428 Lung Neoplasms MESH:D008175 marker/mechanism 16061637 +VHL 7428 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +VHL 7428 Pheochromocytoma MESH:D010673 marker/mechanism 171300.0 9215674 +VHL 7428 von Hippel-Lindau Disease MESH:D006623 marker/mechanism 193300.0 11171960 +VHL 7428 Wilms Tumor MESH:D009396 marker/mechanism 11880179 +VIL1 7429 Cholestasis MESH:D002779 marker/mechanism 27989131 +VIM 7431 Acute Coronary Syndrome MESH:D054058 marker/mechanism 21751358 +VIM 7431 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +VIM 7431 Breast Neoplasms MESH:D001943 marker/mechanism 21501481|24014025|25330770|27811057 +VIM 7431 Carcinosarcoma MESH:D002296 marker/mechanism 15132766 +VIM 7431 Cataract MESH:D002386 marker/mechanism 19126778 +VIM 7431 Cataract, Nuclear Diffuse Nonprogressive MESH:C566157 marker/mechanism 116300.0 +VIM 7431 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 24014025 +VIM 7431 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +VIM 7431 Disease Models, Animal MESH:D004195 marker/mechanism 16831193 +VIM 7431 Fibrosis MESH:D005355 marker/mechanism 31697999 +VIM 7431 Kidney Diseases MESH:D007674 marker/mechanism 31697999 +VIM 7431 Liver Cirrhosis MESH:D008103 marker/mechanism 25226513|26396155|32659284 +VIM 7431 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +VIM 7431 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 22784439 +VIM 7431 Motor Neuron Disease MESH:D016472 marker/mechanism 16831193 +VIM 7431 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27811057 +VIM 7431 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +VIM 7431 Nephrosis MESH:D009401 marker/mechanism 16418842 +VIM 7431 Neurodegenerative Diseases MESH:D019636 marker/mechanism 16831193 +VIM 7431 Osteoarthritis MESH:D010003 marker/mechanism 16876394|18784066 +VIM 7431 Peritoneal Neoplasms MESH:D010534 marker/mechanism 22784439 +VIM 7431 Prostatic Neoplasms MESH:D011471 marker/mechanism 17566973|24763052 +VIM 7431 Reperfusion Injury MESH:D015427 marker/mechanism 23075401 +VIM 7431 Retinal Diseases MESH:D012164 marker/mechanism 23075401 +VIM 7431 Sarcoma, Synovial MESH:D013584 marker/mechanism 15043115 +VIM 7431 Severe Acute Respiratory Syndrome MESH:D045169 marker/mechanism 26801988 +VIM 7431 Weight Gain MESH:D015430 marker/mechanism 19030233 +VIP 7432 Acute Lung Injury MESH:D055371 therapeutic 8643465 +VIP 7432 Autistic Disorder MESH:D001321 marker/mechanism 17521630 +VIP 7432 Bronchial Hyperreactivity MESH:D016535 marker/mechanism 15127121|15144609 +VIP 7432 Cognition Disorders MESH:D003072 therapeutic 8208360 +VIP 7432 Down Syndrome MESH:D004314 marker/mechanism 16289943 +VIP 7432 Edema MESH:D004487 marker/mechanism 7508328 +VIP 7432 Erectile Dysfunction MESH:D007172 therapeutic 10233493 +VIP 7432 Flushing MESH:D005483 marker/mechanism 10233493 +VIP 7432 Hyperalgesia MESH:D006930 marker/mechanism 12787826 +VIP 7432 Hypotension MESH:D007022 marker/mechanism 9881641 +VIP 7432 Intellectual Disability MESH:D008607 marker/mechanism 11357950 +VIP 7432 Neoplasm Metastasis MESH:D009362 marker/mechanism 19189304 +VIP 7432 Pain MESH:D010146 therapeutic 9920454 +VIP 7432 Prostatic Neoplasms MESH:D011471 marker/mechanism 19189304 +VIP 7432 Rhinitis MESH:D012220 marker/mechanism 12746121|14680090 +VIP 7432 Tachycardia MESH:D013610 marker/mechanism 3261545 +VIP 7432 Urinary Bladder Diseases MESH:D001745 marker/mechanism 18299998 +VIPAS39 63894 Arthrogryposis renal dysfunction cholestasis syndrome MESH:C535382 marker/mechanism 613404.0 20190753 +VIPR1 7433 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +VIPR1 7433 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +VIPR2 7434 Schizophrenia MESH:D012559 marker/mechanism 21285140 +VKORC1 79001 Aortic Rupture MESH:D001019 marker/mechanism 16549638 +VKORC1 79001 Blood Coagulation Disorders MESH:D001778 marker/mechanism 19141161 +VKORC1 79001 Coronary Disease MESH:D003327 marker/mechanism 16549638 +VKORC1 79001 Coumarin Resistance MESH:C563039 marker/mechanism 122700.0 14765194|20210733|20386359|20497562|20579077 +VKORC1 79001 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 26445138 +VKORC1 79001 Hemorrhage MESH:D006470 marker/mechanism 20597268|26445138 +VKORC1 79001 Stroke MESH:D020521 marker/mechanism 16549638 +VKORC1 79001 Thrombosis MESH:D013927 marker/mechanism 29581108 +VKORC1 79001 Vascular Diseases MESH:D014652 marker/mechanism 16549638 +VKORC1 79001 VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2 OMIM:607473 marker/mechanism 607473.0 14765194 +VLDLR 7436 Autistic Disorder MESH:D001321 marker/mechanism 15820235 +VLDLR 7436 Dysequilibrium syndrome MESH:C535731 marker/mechanism 224050.0 +VLDLR 7436 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 29289645 +VLDLR 7436 Obesity MESH:D009765 marker/mechanism 20975297 +VMA21 203547 Myopathy, X-Linked, with Excessive Autophagy MESH:C564093 marker/mechanism 310440.0 +VMAT 3346192 Infertility MESH:D007246 marker/mechanism 16189511 +VMO1 284013 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +VN1R31P 100312787 Skin Diseases MESH:D012871 marker/mechanism 28720099 +VNN1 8876 Celiac Disease MESH:D002446 marker/mechanism 30097691 +VNN1 8876 Dermatitis, Atopic MESH:D003876 marker/mechanism 19322213 +VNN1 8876 Dyslipidemias MESH:D050171 marker/mechanism 17873875 +VNN1 8876 Inflammatory Bowel Diseases MESH:D015212 therapeutic 17145956 +VNN1 8876 Psoriasis MESH:D011565 marker/mechanism 19322213 +VNN2 8875 Dermatitis, Atopic MESH:D003876 marker/mechanism 19322213 +VNN2 8875 Psoriasis MESH:D011565 marker/mechanism 19322213 +VNN3P 55350 Psoriasis MESH:D011565 marker/mechanism 19322213 +VOPP1 81552 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +VOPP1 81552 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +VPREB1 7441 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 26214592 +VPS11 55823 LEUKODYSTROPHY, HYPOMYELINATING, 12 OMIM:616683 marker/mechanism 616683.0 +VPS13A 23230 Neuroacanthocytosis MESH:D054546 marker/mechanism 200150.0 +VPS13B 157680 Cohen syndrome MESH:C536438 marker/mechanism 216550.0 12730828|15154116|17990063 +VPS13C 54832 PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET OMIM:616840 marker/mechanism 616840.0 +VPS13D 55187 Spinocerebellar ataxia, autosomal recessive 4 MESH:C537310 marker/mechanism 607317.0 +VPS13D 55187 Weight Gain MESH:D015430 marker/mechanism 19030233 +VPS26A 9559 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 21874001 +VPS33A 65082 MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME OMIM:617303 marker/mechanism 617303.0 +VPS33B 26276 Arthrogryposis renal dysfunction cholestasis syndrome MESH:C535382 marker/mechanism 208085.0 +VPS35 55737 Parkinson Disease MESH:D010300 marker/mechanism 25149416 +VPS35 55737 PARKINSON DISEASE 17 OMIM:614203 marker/mechanism 614203.0 +VPS35 55737 Schizophrenia MESH:D012559 marker/mechanism 21822266 +VPS37A 137492 SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE OMIM:614898 marker/mechanism 614898.0 +VPS39 23339 Breast Neoplasms MESH:D001943 marker/mechanism 21466612 +VPS39 23339 Schizophrenia MESH:D012559 marker/mechanism 23042115 +VPS45 11311 Familial myelofibrosis MESH:C536848 marker/mechanism 23599270 +VPS45 11311 NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE OMIM:615285 marker/mechanism 615285.0 +VPS45 11311 Neutropenia, Severe Congenital, Autosomal Recessive 3 MESH:C537592 marker/mechanism 23599270 +VPS52 6293 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +VPS53 55275 PONTOCEREBELLAR HYPOPLASIA, TYPE 2E OMIM:615851 marker/mechanism 615851.0 +VPS54 51542 Nerve Degeneration MESH:D009410 marker/mechanism 19693665 +VRK1 7443 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +VRK1 7443 Pontocerebellar Hypoplasia Type 1 MESH:C548069 marker/mechanism 607596.0 +VSIG4 11326 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +VSIG4 11326 Glomerulonephritis, IGA MESH:D005922 marker/mechanism 25133636 +VSIG4 11326 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 18206229 +VSIR 64115 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +VSNL1 7447 Alzheimer Disease MESH:D000544 marker/mechanism 25806004 +VSX1 30813 Auditory Perceptual Disorders MESH:D001308 marker/mechanism 15051220 +VSX1 30813 Corneal Dystrophies, Hereditary MESH:D003317 marker/mechanism 11978762 +VSX1 30813 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15051220 +VSX1 30813 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME OMIM:614195 marker/mechanism 614195.0 +VSX1 30813 Empty Sella Syndrome MESH:D004652 marker/mechanism 15051220 +VSX1 30813 Eye Abnormalities MESH:D005124 marker/mechanism 15051220 +VSX1 30813 Keratoconus MESH:D007640 marker/mechanism 11978762|15623752 +VSX1 30813 Keratoconus 1 MESH:C563649 marker/mechanism 148300.0 +VSX1 30813 Retinal Diseases MESH:D012164 marker/mechanism 15051220 +VSX2 338917 Microphthalmia, Isolated 2 MESH:C566446 marker/mechanism 610093.0 +VSX2 338917 Microphthalmia, Isolated, with Coloboma 3 MESH:C566447 marker/mechanism 610092.0 +VTI1A 143187 Adenocarcinoma MESH:D000230 marker/mechanism 21892161 +VTI1A 143187 Colorectal Neoplasms MESH:D015179 marker/mechanism 21892161 +VTN 7448 Crohn Disease MESH:D003424 marker/mechanism 19751734 +VTN 7448 Liver Cirrhosis MESH:D008103 marker/mechanism 26396155 +VWA3A 146177 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +VWA3B 200403 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 616948.0 +VWA8 23078 Autistic Disorder MESH:D001321 marker/mechanism 20663923 +VWF 7450 Atrial Fibrillation MESH:D001281 marker/mechanism 17890461 +VWF 7450 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +VWF 7450 Cardiovascular Diseases MESH:D002318 marker/mechanism 16332659 +VWF 7450 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 28527913 +VWF 7450 Drug Hypersensitivity Syndrome MESH:D063926 marker/mechanism 34142820 +VWF 7450 Exanthema MESH:D005076 marker/mechanism 34142820 +VWF 7450 Heart Failure MESH:D006333 marker/mechanism 22352330 +VWF 7450 Hypertension MESH:D006973 marker/mechanism 12149661|12425201|22352330 +VWF 7450 Intracranial Thrombosis MESH:D020767 marker/mechanism 3111251 +VWF 7450 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 28527913 +VWF 7450 Stevens-Johnson Syndrome MESH:D013262 marker/mechanism 34142820 +VWF 7450 Thrombosis MESH:D013927 marker/mechanism 22352330|3875694 +VWF 7450 von Willebrand Disease, Type 1 MESH:D056725 marker/mechanism 193400.0 +VWF 7450 von Willebrand Disease, Type 2 MESH:D056728 marker/mechanism 613554.0 +VWF 7450 von Willebrand Disease, Type 3 MESH:D056729 marker/mechanism 277480.0 +W04G3.5 181299 Infertility MESH:D007246 marker/mechanism 25204677 +WAC 51322 DESANTO-SHINAWI SYNDROME OMIM:616708 marker/mechanism 616708.0 +WAC 51322 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +WAC 51322 Prostatic Neoplasms MESH:D011471 marker/mechanism 28319090 +WAP 22373 Carcinoma MESH:D002277 marker/mechanism 16316942 +WAP 22373 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 16316942 +WAP 22373 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 16316942 +WARS1 7453 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +WAS 7454 Neutropenia, Severe Congenital, X-Linked MESH:C564539 marker/mechanism 300299.0 17724125 +WAS 7454 Thrombocytopenia 1 MESH:C564052 marker/mechanism 313900.0 +WAS 7454 Wiskott-Aldrich Syndrome MESH:D014923 marker/mechanism 301000.0 11598004 +WASF3 10810 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +WASF3 10810 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +WASHC4 23325 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 43 OMIM:615817 marker/mechanism 615817.0 +WASHC5 9897 3C syndrome MESH:C535313 marker/mechanism 220210.0 +WASHC5 9897 Spastic Paraplegia Type 8 MESH:C580458 marker/mechanism 603563.0 +WASL 8976 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +WDFY3 23001 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +WDFY4 57705 Autistic Disorder MESH:D001321 marker/mechanism 30559488 +WDFY4 57705 Developmental Disabilities MESH:D002658 marker/mechanism 30559488 +WDPCP 51057 BARDET-BIEDL SYNDROME 15 OMIM:615992 marker/mechanism 615992.0 +WDPCP 51057 Orstavik Lindemann Solberg syndrome MESH:C537137 marker/mechanism 217085.0 +WDR1 9948 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +WDR1 9948 Inflammation MESH:D007249 marker/mechanism 17515402 +WDR1 9948 Osteoporosis MESH:D010024 marker/mechanism 18924182 +WDR1 9948 Thrombocytopenia MESH:D013921 marker/mechanism 17515402 +WDR11 55717 HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA OMIM:614858 marker/mechanism 614858.0 +WDR11 55717 Idiopathic Hypogonadotropic Hypogonadism MESH:C562785 marker/mechanism 146110.0 +WDR11 55717 Schizophrenia MESH:D012559 marker/mechanism 21822266 +WDR11 55717 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +WDR12 55759 Cardiomyopathy, Dilated MESH:D002311 marker/mechanism 25915632 +WDR12 55759 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990 +WDR12 55759 Myocardial Infarction MESH:D009203 marker/mechanism 19198609|25915632 +WDR17 116966 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +WDR19 57728 Cranioectodermal Dysplasia MESH:C562966 marker/mechanism 614378.0 +WDR20 91833 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +WDR-23 172518 Gait Disorders, Neurologic MESH:D020233 marker/mechanism 23555279 +WDR35 57539 Cranioectodermal Dysplasia MESH:C562966 marker/mechanism 613610.0 +WDR35 57539 Craniosynostoses MESH:D003398 marker/mechanism 20817137 +WDR35 57539 Short Rib-Polydactyly Syndrome MESH:D012779 marker/mechanism 614091.0 +WDR36 134430 Asthma MESH:D001249 marker/mechanism 19198610 +WDR36 134430 Glaucoma 1, Open Angle, G MESH:C563692 marker/mechanism 609887.0 +WDR36 134430 Glaucoma, Open-Angle MESH:D005902 marker/mechanism 21059646 +WDR45 11152 ALBINISM, OCULOCUTANEOUS, TYPE VII OMIM:615179 marker/mechanism 615179.0 +WDR45 11152 Epilepsy MESH:D004827 marker/mechanism 29942082 +WDR45 11152 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +WDR45 11152 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5 OMIM:300894 marker/mechanism 300894.0 +WDR45 11152 Neurodegeneration with brain iron accumulation (NBIA) MESH:C538421 marker/mechanism 23435086 +WDR45 11152 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889|29942082 +WDR45B 56270 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +WDR46 9277 Disease Progression MESH:D018450 marker/mechanism 21364753 +WDR46 9277 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +WDR48 57599 Cognition Disorders MESH:D003072 therapeutic 36047109 +WDR62 284403 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +WDR62 284403 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +WDR62 284403 Malformations of Cortical Development MESH:D054220 marker/mechanism 23341463 +WDR62 284403 Microcephaly MESH:D008831 marker/mechanism 20890278|20890279 +WDR62 284403 Microcephaly, Primary Autosomal Recessive, 2 MESH:C565794 marker/mechanism 604317.0 +WDR72 256764 Amelogenesis Imperfecta, Hypomaturation Type, Iia3 MESH:C567706 marker/mechanism 613211.0 +WDR73 84942 Galloway Mowat syndrome MESH:C537548 marker/mechanism 251300.0 25466283 +WDR74 54663 Melanoma MESH:D008545 marker/mechanism 22535842 +WDR74 54663 Neoplasms MESH:D009369 marker/mechanism 25261935 +WDR76 79968 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +WDR77 79084 Ovarian Neoplasms MESH:D010051 marker/mechanism 22022581 +WDR81 124997 Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 2 MESH:C567656 marker/mechanism 610185.0 +WEE1 7465 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 34664776 +WEE1 7465 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 25125259 +WFDC1 58189 Melanoma MESH:D008545 marker/mechanism 17145863 +WFDC2 10406 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +WFDC21 66107 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +WFDC21P 645638 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 34953898 +WFS1 7466 CATARACT 41 OMIM:116400 marker/mechanism 116400.0 +WFS1 7466 Deafness, Autosomal Dominant 6 MESH:C563421 marker/mechanism 600965.0 +WFS1 7466 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 125853.0 17603484 +WFS1 7466 Wolfram-Like Syndrome, Autosomal Dominant MESH:C565631 marker/mechanism 614296.0 +WFS1 7466 Wolfram Syndrome MESH:D014929 marker/mechanism 222300.0 24705017 +WHCR 7467 Wolf-Hirschhorn Syndrome MESH:D054877 marker/mechanism 194190.0 +WHRN 25861 Deafness, Autosomal Recessive 31 MESH:C564629 marker/mechanism 607084.0 +WHRN 25861 USHER SYNDROME, TYPE IID OMIM:611383 marker/mechanism 611383.0 +WHT-6 188911 Embryo Loss MESH:D020964 marker/mechanism 25204677 +WIF1 11197 Colorectal Neoplasms MESH:D015179 marker/mechanism 17923031 +WIF1 11197 Esophageal Neoplasms MESH:D004938 marker/mechanism 17384664 +WIF1 11197 Nasopharyngeal Neoplasms MESH:D009303 marker/mechanism 17384664 +WIF1 11197 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +WIPF1 7456 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +WIPF1 7456 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +WIPF1 7456 Wiskott-Aldrich Syndrome MESH:D014923 marker/mechanism 614493.0 +WIPI1 55062 Cholestasis MESH:D002779 marker/mechanism 27989131 +WIPI1 55062 Lipidoses MESH:D008064 marker/mechanism 15342952|16919414|17175557 +WLS 79971 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +WNK1 65125 Hypertension MESH:D006973 marker/mechanism 22949526 +WNK1 65125 Kidney Diseases MESH:D007674 marker/mechanism 21865292 +WNK1 65125 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA OMIM:201300 marker/mechanism 201300.0 +WNK1 65125 Pseudohypoaldosteronism MESH:D011546 marker/mechanism 22949526 +WNK1 65125 Pseudohypoaldosteronism, Type IIc MESH:C564162 marker/mechanism 614492.0 +WNK4 65266 Hypertension MESH:D006973 marker/mechanism 22949526 +WNK4 65266 Pseudohypoaldosteronism MESH:D011546 marker/mechanism 22949526 +WNK4 65266 Pseudohypoaldosteronism, Type IIb MESH:C564161 marker/mechanism 614491.0 +WNT1 7471 OSTEOGENESIS IMPERFECTA, TYPE XV OMIM:615220 marker/mechanism 615220.0 +WNT1 7471 Osteoporosis MESH:D010024 marker/mechanism 615221.0 +WNT10A 80326 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 18787224 +WNT10A 80326 Odontoonychodermal dysplasia MESH:C537742 marker/mechanism 257980.0 +WNT10A 80326 Schopf-Schulz-Passarge Syndrome MESH:C565607 marker/mechanism 224750.0 +WNT10A 80326 Tooth Agenesis, Selective, 4 MESH:C563634 marker/mechanism 150400.0 +WNT10B 7480 Breast Neoplasms MESH:D001943 marker/mechanism 12437293 +WNT10B 7480 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 27415467 +WNT10B 7480 Prostatic Neoplasms MESH:D011471 marker/mechanism 27415467 +WNT10B 7480 Split-Hand-Foot Malformation 6 MESH:C567616 marker/mechanism 225300.0 +WNT10B 7480 TOOTH AGENESIS, SELECTIVE, 8 OMIM:617073 marker/mechanism 617073.0 +WNT11 7481 Abnormalities, Drug-Induced MESH:D000014 marker/mechanism 25783350 +WNT11 7481 Disease Models, Animal MESH:D004195 marker/mechanism 25783350 +WNT11 7481 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 25783350 +WNT2 7472 Autistic Disorder MESH:D001321 marker/mechanism 11449391|19895723 +WNT2 7472 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 25061499 +WNT2B 7482 Stroke MESH:D020521 marker/mechanism 29531354 +WNT3 7473 Atrial Fibrillation MESH:D001281 marker/mechanism 30061737 +WNT3 7473 Lymphoma, Mantle-Cell MESH:D020522 marker/mechanism 18787224 +WNT3 7473 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +WNT3 7473 Tetra-amelia autosomal recessive MESH:C536498 marker/mechanism 273395.0 +WNT3A 89780 Obesity MESH:D009765 marker/mechanism 28242765 +WNT3A 89780 Reperfusion Injury MESH:D015427 therapeutic 23875703 +WNT4 54361 46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS OMIM:611812 marker/mechanism 611812.0 +WNT4 54361 Carcinoma, Ovarian Epithelial MESH:D000077216 marker/mechanism 25581431 +WNT4 54361 Dwarfism MESH:D004392 marker/mechanism 17505543 +WNT4 54361 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +WNT4 54361 Kidney Diseases MESH:D007674 marker/mechanism 11832423 +WNT4 54361 Mullerian Aplasia and Hyperandrogenism MESH:C567186 marker/mechanism 158330.0 +WNT4 54361 Prostatic Neoplasms MESH:D011471 marker/mechanism 17013881 +WNT5A 7474 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 19061910 +WNT5A 7474 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +WNT5A 7474 Idiopathic Pulmonary Fibrosis MESH:D054990 marker/mechanism 28726637 +WNT5A 7474 Lung Neoplasms MESH:D008175 marker/mechanism 23349696 +WNT5A 7474 Robinow Syndrome MESH:C562492 marker/mechanism 180700.0 +WNT5A 7474 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 25061499 +WNT5B 81029 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +WNT5B 81029 Leiomyoma MESH:D007889 marker/mechanism 15972578 +WNT5B 81029 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +WNT7A 7476 Al Awadi syndrome MESH:C535612 marker/mechanism 276820.0 +WNT7A 7476 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +WNT7A 7476 Female Urogenital Diseases MESH:D052776 marker/mechanism 16002989 +WNT7A 7476 Fuhrmann syndrome MESH:C538189 marker/mechanism 228930.0 +WNT7A 7476 Ovarian Neoplasms MESH:D010051 marker/mechanism 25174399 +WNT7A 7476 Urogenital Neoplasms MESH:D014565 marker/mechanism 15751030 +WNT8A 7478 Atrial Fibrillation MESH:D001281 marker/mechanism 22544366 +WRAP53 55135 Body Weight MESH:D001835 marker/mechanism 31243981 +WRAP53 55135 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3 OMIM:613988 marker/mechanism 613988.0 +WRN 7486 Aging, Premature MESH:D019588 marker/mechanism 21267443 +WRN 7486 DNA Repair-Deficiency Disorders MESH:D049914 marker/mechanism 29616805 +WRN 7486 Werner Syndrome MESH:D014898 marker/mechanism 277700.0 21267443|22766507 +WSCD1 23302 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +WSCD1 23302 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +WT1 7490 Aniridia MESH:D015783 marker/mechanism 106210.0 +WT1 7490 Breast Neoplasms MESH:D001943 marker/mechanism 14961577 +WT1 7490 Colonic Neoplasms MESH:D003110 marker/mechanism 14961577 +WT1 7490 Denys-Drash Syndrome MESH:D030321 marker/mechanism 194080.0 +WT1 7490 Frasier Syndrome MESH:D052159 marker/mechanism 136680.0 +WT1 7490 Glioblastoma MESH:D005909 marker/mechanism 20820871 +WT1 7490 Glomerulonephritis MESH:D005921 marker/mechanism 20962747 +WT1 7490 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 17436238 +WT1 7490 Hernias, Diaphragmatic, Congenital MESH:D065630 marker/mechanism 21072664 +WT1 7490 Leukemia MESH:D007938 marker/mechanism 14961577 +WT1 7490 Leukemia, Myelogenous, Chronic, BCR-ABL Positive MESH:D015464 marker/mechanism 17157168 +WT1 7490 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 19822134|27992414 +WT1 7490 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 26285909 +WT1 7490 Lung Neoplasms MESH:D008175 marker/mechanism 14961577 +WT1 7490 Meacham Winn Culler syndrome MESH:C538162 marker/mechanism 608978.0 +WT1 7490 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 156240.0 22784439 +WT1 7490 NEPHROTIC SYNDROME, TYPE 4 OMIM:256370 marker/mechanism 256370.0 +WT1 7490 Neurilemmoma MESH:D009442 therapeutic 25474318 +WT1 7490 Osteosarcoma MESH:D012516 marker/mechanism 28107196 +WT1 7490 Pancreatic Neoplasms MESH:D010190 marker/mechanism 19196508 +WT1 7490 Peritoneal Neoplasms MESH:D010534 marker/mechanism 22784439 +WT1 7490 Primary Ovarian Insufficiency MESH:D016649 marker/mechanism 26358501 +WT1 7490 WAGR Syndrome MESH:D017624 marker/mechanism 194072.0 +WT1 7490 Wilms Tumor MESH:D009396 marker/mechanism 194070.0 15591903|28825729 +WTRS 619509 Wittwer syndrome MESH:C536737 marker/mechanism 25251057 +WTRS 619509 Wolf-Hirschhorn Syndrome MESH:D054877 marker/mechanism 25251057 +WWC1 23286 Mesothelioma, Malignant MESH:D000086002 marker/mechanism 25756049 +WWOX 51741 Alzheimer Disease MESH:D000544 marker/mechanism 30820047 +WWOX 51741 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +WWOX 51741 Breast Neoplasms MESH:D001943 marker/mechanism 17200365 +WWOX 51741 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 17575124 +WWOX 51741 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28 OMIM:616211 marker/mechanism 616211.0 +WWOX 51741 Esophageal Neoplasms MESH:D004938 marker/mechanism 133239.0 +WWOX 51741 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 25526675 +WWOX 51741 Spinocerebellar Ataxias MESH:D020754 marker/mechanism 614322.0 +WWOX 51741 Stomach Neoplasms MESH:D013274 marker/mechanism 17575124 +WWOX 51741 Urologic Neoplasms MESH:D014571 marker/mechanism 23618899 +WWP2 11060 Osteoarthritis, Knee MESH:D020370 marker/mechanism 30374069 +WWTR1 25937 Muscular Atrophy MESH:D009133 therapeutic 24550007 +WWTR1 25937 Rhabdomyosarcoma, Alveolar MESH:D018232 marker/mechanism 31494105 +XAF1 54739 Colonic Neoplasms MESH:D003110 marker/mechanism 15843754|17087954 +XAF1 54739 Colorectal Neoplasms MESH:D015179 marker/mechanism 17570219 +XAF1 54739 Disease Models, Animal MESH:D004195 marker/mechanism 36071497 +XAF1 54739 Glioma MESH:D005910 marker/mechanism 28122345 +XAF1 54739 Heart Failure MESH:D006333 marker/mechanism 36071497 +XAF1 54739 Influenza, Human MESH:D007251 marker/mechanism 23326326 +XAF1 54739 Stomach Neoplasms MESH:D013274 marker/mechanism 17087954 +XAGE1A 653220 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 24648988 +XAGE1B 653067 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +XAGE3 170626 Autism Spectrum Disorder MESH:D000067877 marker/mechanism 35663546 +XBP1 7494 Encephalomyelitis, Autoimmune, Experimental MESH:D004681 marker/mechanism 30661753 +XBP1 7494 Fatty Liver MESH:D005234 marker/mechanism 24097666 +XBP1 7494 Glioma MESH:D005910 marker/mechanism 21138464 +XBP1 7494 Glucose Intolerance MESH:D018149 therapeutic 27325692 +XBP1 7494 Insulin Resistance MESH:D007333 therapeutic 27325692 +XBP1 7494 Major Affective Disorder 7 MESH:C567529 marker/mechanism 612371.0 +XBP1 7494 Multiple Sclerosis MESH:D009103 marker/mechanism 30661753 +XBP1 7494 Non-alcoholic Fatty Liver Disease MESH:D065626 marker/mechanism 24097666 +XBP1 7494 Spinal Cord Injuries MESH:D013119 marker/mechanism 29793971 +XDH 7498 Autistic Disorder MESH:D001321 marker/mechanism 15205966 +XDH 7498 Carcinoma MESH:D002277 marker/mechanism 12376462 +XDH 7498 Depressive Disorder, Major MESH:D003865 marker/mechanism 20471444 +XDH 7498 Gout MESH:D006073 marker/mechanism 29071757 +XDH 7498 Heart Diseases MESH:D006331 marker/mechanism 17217956 +XDH 7498 Heart Failure MESH:D006333 marker/mechanism 19933411 +XDH 7498 Hyperuricemia MESH:D033461 marker/mechanism 29071757 +XDH 7498 Infarction, Middle Cerebral Artery MESH:D020244 marker/mechanism 12374626 +XDH 7498 Ischemia MESH:D007511 marker/mechanism 22688000 +XDH 7498 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +XDH 7498 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +XDH 7498 Multiple Organ Failure MESH:D009102 marker/mechanism 26968635 +XDH 7498 Nerve Degeneration MESH:D009410 marker/mechanism 9147382 +XDH 7498 Pulmonary Embolism MESH:D011655 marker/mechanism 2510358 +XDH 7498 Reperfusion Injury MESH:D015427 marker/mechanism 12910483 +XDH 7498 Thrombocytopenia MESH:D013921 marker/mechanism 2510358 +XDH 7498 Xanthinuria, Type I MESH:C562584 marker/mechanism 278300.0 +XIAP 331 Amyotrophic lateral sclerosis 1 MESH:C531617 marker/mechanism 11796754 +XIAP 331 Esophageal Neoplasms MESH:D004938 marker/mechanism 17611394 +XIAP 331 Lymphoproliferative Disorders MESH:D008232 marker/mechanism 308240.0 +XIAP 331 Lymphoproliferative Syndrome, X-Linked, 2 MESH:C564469 marker/mechanism 300635.0 +XIAP 331 Mammary Neoplasms, Experimental MESH:D008325 therapeutic 12766084 +XIAP 331 Myocardial Reperfusion Injury MESH:D015428 marker/mechanism 14998631 +XIAP 331 Ovarian Neoplasms MESH:D010051 marker/mechanism 21442130 +XIRP1 165904 Poisoning MESH:D011041 marker/mechanism 21964422 +XIST 7503 Influenza, Human MESH:D007251 marker/mechanism 23326326 +XIST 7503 X Inactivation, Familial Skewed, 1 MESH:C564716 marker/mechanism 300087.0 +XK 7504 Hematologic Diseases MESH:D006402 marker/mechanism 8004674|8619554 +XK 7504 Mental Disorders MESH:D001523 marker/mechanism 11261514 +XK 7504 Movement Disorders MESH:D009069 marker/mechanism 11261514 +XK 7504 Neuroacanthocytosis MESH:D054546 marker/mechanism 11761473|8619554 +XK 7504 Neuroacanthocytosis, Mcleod Type MESH:C564038 marker/mechanism 300842.0 +XK 7504 Neuromuscular Diseases MESH:D009468 marker/mechanism 8004674|8619554 +XK 7504 Peripheral Nervous System Diseases MESH:D010523 marker/mechanism 11761473 +XKR4 114786 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +XKRY 9082 Spermatogenic Failure, Nonobstructive, Y-Linked MESH:C564030 marker/mechanism 415000.0 +XPA 7507 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 17687452 +XPA 7507 Intestinal Neoplasms MESH:D007414 marker/mechanism 16962818 +XPA 7507 Liver Neoplasms MESH:D008113 marker/mechanism 24084170 +XPA 7507 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 21216194|9885240 +XPA 7507 Skin Neoplasms MESH:D012878 marker/mechanism 10755388|16962818 +XPA 7507 Xeroderma Pigmentosum MESH:D014983 marker/mechanism 278700.0 24084170 +XPC 7508 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 21327329|27777383 +XPC 7508 Amino Acid Metabolism, Inborn Errors MESH:D000592 marker/mechanism 9804340 +XPC 7508 Autistic Disorder MESH:D001321 marker/mechanism 9804340 +XPC 7508 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 27777383 +XPC 7508 Carcinoma, Squamous Cell MESH:D002294 marker/mechanism 27777383 +XPC 7508 Chromosome Aberrations MESH:D002869 marker/mechanism 20106949 +XPC 7508 Disease Progression MESH:D018450 marker/mechanism 27777383 +XPC 7508 Liver Neoplasms MESH:D008113 marker/mechanism 24084170 +XPC 7508 Lung Neoplasms MESH:D008175 marker/mechanism 17325666|24084170 +XPC 7508 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 21216194 +XPC 7508 Neoplasm Invasiveness MESH:D009361 marker/mechanism 27777383 +XPC 7508 Neoplasm Metastasis MESH:D009362 marker/mechanism 27777383 +XPC 7508 Xeroderma Pigmentosum MESH:D014983 marker/mechanism 24084170 +XPC 7508 Xeroderma Pigmentosum, Complementation Group C MESH:C567886 marker/mechanism 278720.0 +XPD 37414 Skin Neoplasms MESH:D012878 marker/mechanism 26295053 +XPNPEP2 7512 Angioedema MESH:D000799 marker/mechanism 16175507 +XPNPEP2 7512 ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO OMIM:300909 marker/mechanism 300909.0 +XPNPEP2 7512 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +XPNPEP2 7512 Primary Ovarian Insufficiency MESH:D016649 marker/mechanism 25568306 +XPNPEP3 63929 NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1 OMIM:613159 marker/mechanism 613159.0 +XPO1 7514 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +XPO1 7514 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475 +XPO5 57510 Lead Poisoning MESH:D007855 marker/mechanism 28042866 +XPO5 57510 Microsatellite Instability MESH:D053842 marker/mechanism 25701956 +XPO5 57510 Nephrotic syndrome, idiopathic, steroid-resistant MESH:C536404 marker/mechanism 26878725 +XPO5 57510 Wilms Tumor MESH:D009396 marker/mechanism 28825729 +XPO6 23214 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +XPO7 23039 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +XPR1 9213 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6 OMIM:616413 marker/mechanism 616413.0 +XPR1 9213 Basal Ganglia Diseases MESH:D001480 marker/mechanism 25938945 +XPR1 9213 Calcinosis MESH:D002114 marker/mechanism 25938945 +XRCC1 7515 Birth Weight MESH:D001724 marker/mechanism 27592400 +XRCC1 7515 Erythema MESH:D004890 marker/mechanism 24594932 +XRCC1 7515 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 16639733 +XRCC1 7515 Glioma MESH:D005910 marker/mechanism 25227852 +XRCC1 7515 Infertility, Male MESH:D007248 marker/mechanism 30998386 +XRCC1 7515 Mesothelioma MESH:D008654 marker/mechanism 16564556|20705543 +XRCC1 7515 Micronuclei, Chromosome-Defective MESH:D048629 marker/mechanism 20223788|21351625 +XRCC1 7515 Occupational Diseases MESH:D009784 marker/mechanism 15612468 +XRCC1 7515 Precursor Cell Lymphoblastic Leukemia-Lymphoma MESH:D054198 marker/mechanism 21983886 +XRCC1 7515 Prostatic Neoplasms MESH:D011471 marker/mechanism 16406883|17196815|17486273 +XRCC1 7515 Stomach Neoplasms MESH:D013274 marker/mechanism 22452940 +XRCC1 7515 Stomatitis MESH:D013280 marker/mechanism 24594932 +XRCC2 7516 Breast Neoplasms MESH:D001943 marker/mechanism 12023982 +XRCC2 7516 FANCONI ANEMIA, COMPLEMENTATION GROUP U OMIM:617247 marker/mechanism 617247.0 +XRCC3 7517 Breast Neoplasms MESH:D001943 marker/mechanism 114480.0 12023982 +XRCC3 7517 Carcinoma, Basal Cell MESH:D002280 marker/mechanism 16501254 +XRCC3 7517 Esophageal Neoplasms MESH:D004938 marker/mechanism 21347786 +XRCC3 7517 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 22613844 +XRCC3 7517 Head and Neck Neoplasms MESH:D006258 marker/mechanism 22613844 +XRCC3 7517 Lead Poisoning MESH:D007855 marker/mechanism 23803535 +XRCC3 7517 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 21283680 +XRCC3 7517 Melanoma MESH:D008545 marker/mechanism 11059748 +XRCC3 7517 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6 OMIM:613972 marker/mechanism 613972.0 +XRCC3 7517 Mesothelioma MESH:D008654 marker/mechanism 16564556 +XRCC3 7517 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21283680 +XRCC3 7517 Skin Neoplasms MESH:D012878 marker/mechanism 11059748|16501254 +XRCC3 7517 Stomach Neoplasms MESH:D013274 marker/mechanism 21347786 +XRCC4 7518 Chromosome Aberrations MESH:D002869 marker/mechanism 20726224 +XRCC5 7520 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +XRCC5 7520 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +XRCC6 2547 Adenocarcinoma of Lung MESH:D000077192 marker/mechanism 27602772 +XRCC6 2547 Disease Models, Animal MESH:D004195 marker/mechanism 27602772 +XXYLT1 152002 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015|30061737 +XYLB 9942 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25231249 +XYLT1 64131 Desbuquois syndrome MESH:C535943 marker/mechanism 615777.0 +XYLT1 64131 Pseudoxanthoma Elasticum MESH:D011561 marker/mechanism 264800.0 +XYLT1 64131 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +XYLT2 64132 Pseudoxanthoma Elasticum MESH:D011561 marker/mechanism 264800.0 16571645 +Y110A2AL.9 173632 Embryo Loss MESH:D020964 marker/mechanism 25204677 +Y17G7B.19 189458 Infertility MESH:D007246 marker/mechanism 25204677 +Y57G11A.2 178389 Infertility MESH:D007246 marker/mechanism 25204677 +Y60A9.1 190439 Death MESH:D003643 marker/mechanism 25204677 +Y62H9A.3 181363 Infertility MESH:D007246 marker/mechanism 25204677 +YAP1 10413 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +YAP1 10413 Breast Neoplasms MESH:D001943 marker/mechanism 28114269|28524356 +YAP1 10413 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 29698666 +YAP1 10413 COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR IMPAIRED INTELLECTUAL DEVELOPMENT OMIM:120433 marker/mechanism 120433.0 +YAP1 10413 Colorectal Neoplasms MESH:D015179 marker/mechanism 30510241|34351699 +YAP1 10413 Disease Progression MESH:D018450 marker/mechanism 30703373 +YAP1 10413 Hemangioma MESH:D006391 marker/mechanism 31351048 +YAP1 10413 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34351699 +YAP1 10413 Neoplasm Metastasis MESH:D009362 marker/mechanism 28114269 +YAP1 10413 Neuroblastoma MESH:D009447 marker/mechanism 26121086 +YAP1 10413 Ovarian Neoplasms MESH:D010051 marker/mechanism 20947521 +YAP1 10413 Recurrence MESH:D012008 marker/mechanism 26121086 +YAP1 10413 Rhabdomyosarcoma, Embryonal MESH:D018233 marker/mechanism 31494105 +YAP1 10413 Squamous Cell Carcinoma of Head and Neck MESH:D000077195 marker/mechanism 20729916 +YAP1 10413 Triple Negative Breast Neoplasms MESH:D064726 marker/mechanism 30703373 +YARS1 8565 Charcot-Marie-Tooth Disease, Dominant Intermediate C MESH:C564257 marker/mechanism 608323.0 +YARS2 51067 Myopathy with lactic acidosis and sideroblastic anemia MESH:C536101 marker/mechanism 613561.0 +YBX1 4904 Breast Neoplasms MESH:D001943 marker/mechanism 15703814 +YBX1 4904 Colonic Neoplasms MESH:D003110 marker/mechanism 28077578 +YBX1 4904 Liver Cirrhosis, Experimental MESH:D008106 therapeutic 16012952 +YBX1 4904 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 15703814 +YEATS2 55689 Disease Progression MESH:D018450 marker/mechanism 34686948 +YEATS2 55689 Pancreatic Carcinoma MESH:C562463 marker/mechanism 34686948 +YEATS4 8089 Liposarcoma MESH:D008080 therapeutic 20601955 +YES1 7525 Double Outlet Right Ventricle MESH:D004310 marker/mechanism 24478334 +YES1 7525 Heart Septal Defects, Ventricular MESH:D006345 marker/mechanism 24478334 +YES1 7525 Prenatal Injuries MESH:D049188 marker/mechanism 24478334 +YES1 7525 Vascular Malformations MESH:D054079 marker/mechanism 24478334 +YIF1A 10897 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +YIF1A 10897 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +YIPF3 25844 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +YJEFN3 374887 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 26039340 +YME1L1 10730 OPTIC ATROPHY 11 OMIM:617302 marker/mechanism 617302.0 +YPEL3 83719 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +YTHDC2 64848 Oligospermia MESH:D009845 therapeutic 34822792 +YTHDC2 64848 Teratozoospermia MESH:D000072660 therapeutic 34822792 +YTHDF1 54915 Multiple Myeloma MESH:D009101 marker/mechanism 35038059 +YTHDF2 51441 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28104805 +YWHAE 7531 Neoplasm Metastasis MESH:D009362 marker/mechanism 17085005 +YWHAG 7532 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +YWHAH 7533 Cardiomyopathies MESH:D009202 therapeutic 18342293 +YWHAH 7533 Diabetes Mellitus, Experimental MESH:D003921 therapeutic 18342293 +YWHAQ 10971 Osteoarthritis MESH:D010003 marker/mechanism 18784066 +YWHAZ 7534 Carcinoma MESH:D002277 marker/mechanism 12376462 +YWHAZ 7534 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +YWHAZ 7534 Mammary Neoplasms, Animal MESH:D015674 marker/mechanism 12376462 +YWHAZ 7534 Mammary Neoplasms, Experimental MESH:D008325 marker/mechanism 12376462 +YWHAZ 7534 Neoplasm Recurrence, Local MESH:D009364 marker/mechanism 16849584 +YY1 7528 Diabetic Nephropathies MESH:D003928 marker/mechanism 35445903 +YY1 7528 Disease Progression MESH:D018450 marker/mechanism 21792014 +YY1 7528 HIV Infections MESH:D015658 marker/mechanism 15308739 +YY1 7528 Intellectual Disability MESH:D008607 marker/mechanism 21076407 +YY1 7528 Multiple Myeloma MESH:D009101 marker/mechanism 35038059 +YY1 7528 Neoplasms MESH:D009369 marker/mechanism 22467534 +YY1 7528 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 21792014 +YY1AP1 55249 Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly MESH:C566529 marker/mechanism 602531.0 +ZAP70 7535 AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2 OMIM:617006 marker/mechanism 617006.0 +ZAP70 7535 IMMUNODEFICIENCY 48 OMIM:269840 marker/mechanism 269840.0 +ZAP70 7535 Immunologic Deficiency Syndromes MESH:D007153 marker/mechanism 17767948 +ZAP70 7535 Severe Combined Immunodeficiency MESH:D016511 marker/mechanism 8202713 +ZAP70 7535 T cell immunodeficiency primary MESH:C536780 marker/mechanism 8124727 +ZBED1 9189 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +ZBTB11 27107 Gastrointestinal Stromal Tumors MESH:D046152 marker/mechanism 27793025 +ZBTB16 7704 Leukemia, Promyelocytic, Acute MESH:D015473 marker/mechanism 23208507 +ZBTB16 7704 Neoplasm Invasiveness MESH:D009361 marker/mechanism 26213588 +ZBTB16 7704 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052 +ZBTB18 10472 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 22 OMIM:612337 marker/mechanism 612337.0 +ZBTB20 26137 Precancerous Conditions MESH:D011230 marker/mechanism 28220687 +ZBTB20 26137 Primrose syndrome MESH:C536420 marker/mechanism 259050.0 25017102 +ZBTB20 26137 Prostatic Neoplasms MESH:D011471 marker/mechanism 28319090 +ZBTB20 26137 Stomach Neoplasms MESH:D013274 marker/mechanism 22037551 +ZBTB24 9841 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2 OMIM:614069 marker/mechanism 614069.0 +ZBTB4 57659 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ZBTB40 9923 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ZBTB42 100128927 LETHAL CONGENITAL CONTRACTURE SYNDROME 6 OMIM:616248 marker/mechanism 616248.0 +ZBTB7A 51341 Glioblastoma MESH:D005909 marker/mechanism 25875864 +ZBTB7A 51341 Leukemia, Myeloid, Acute MESH:D015470 marker/mechanism 27798625 +ZBTB7A 51341 Prostatic Neoplasms MESH:D011471 therapeutic 23727861 +ZBTB7B 51043 Obesity MESH:D009765 marker/mechanism 29273807 +ZBTB8OS 339487 Precancerous Conditions MESH:D011230 marker/mechanism 19233941 +ZC3H10 84872 Hyperglycemia MESH:D006943 therapeutic 31775033 +ZC3H10 84872 Insulin Resistance MESH:D007333 therapeutic 31775033 +ZC3H10 84872 Obesity MESH:D009765 therapeutic 31775033 +ZC3H11A 9877 Breast Neoplasms MESH:D001943 marker/mechanism 25038754 +ZC3H12A 80149 Arterial Occlusive Diseases MESH:D001157 marker/mechanism 22196138 +ZC3H12C 85463 Psoriasis MESH:D011565 marker/mechanism 23143594 +ZC3H12D 340152 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 34545456 +ZC3H14 79882 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 56 OMIM:617125 marker/mechanism 617125.0 +ZC3H4 23211 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +ZC3HC1 51530 Coronary Artery Disease MESH:D003324 marker/mechanism 21378990 +ZC3HC1 51530 Coronary Disease MESH:D003327 marker/mechanism 28869590 +ZC3HC1 51530 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 28869590 +ZC4H2 55906 Arthrogryposis multiplex congenita, distal, X-linked MESH:C535380 marker/mechanism 23623388 +ZC4H2 55906 Microcephaly MESH:D008831 marker/mechanism 26056227 +ZC4H2 55906 Wieacker syndrome MESH:C536703 marker/mechanism 314580.0 26056227 +ZCCHC12 170261 Esophageal Squamous Cell Carcinoma MESH:D000077277 marker/mechanism 30431698 +ZCCHC14 23174 Stroke MESH:D020521 marker/mechanism 29531354 +ZCCHC2 54877 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +ZCCHC2 54877 Influenza, Human MESH:D007251 marker/mechanism 23326326 +ZCCHC6 100857368 Drug-Related Side Effects and Adverse Reactions MESH:D064420 marker/mechanism 31557154 +ZCCHC8 55596 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ZDBF2 57683 Small Cell Lung Carcinoma MESH:D055752 marker/mechanism 22941189 +ZDHHC13 54503 Alopecia MESH:D000505 marker/mechanism 20548961 +ZDHHC13 54503 Amyloidosis MESH:D000686 marker/mechanism 20548961 +ZDHHC13 54503 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ZDHHC13 54503 Osteoporosis MESH:D010024 marker/mechanism 20548961 +ZDHHC2 51201 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ZDHHC2 51201 Liver Neoplasms MESH:D008113 marker/mechanism 25058030|28108177 +ZDHHC2 51201 Weight Gain MESH:D015430 marker/mechanism 19030233 +ZDHHC23 254887 Chemical and Drug Induced Liver Injury MESH:D056486 marker/mechanism 25226513 +ZDHHC9 51114 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE OMIM:300799 marker/mechanism 300799.0 +ZEB1 6935 Breast Neoplasms MESH:D001943 marker/mechanism 19839049|21501481 +ZEB1 6935 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21954225 +ZEB1 6935 Corneal Dystrophy, Fuchs Endothelial, 6 MESH:C567675 marker/mechanism 613270.0 +ZEB1 6935 Corneal Dystrophy, Posterior Polymorphous, 3 MESH:C563788 marker/mechanism 609141.0 +ZEB1 6935 Disease Progression MESH:D018450 marker/mechanism 19839049 +ZEB1 6935 Endometrial Neoplasms MESH:D016889 marker/mechanism 18622689 +ZEB1 6935 Lymphoma, T-Cell, Cutaneous MESH:D016410 marker/mechanism 26192916 +ZEB1 6935 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ZEB1 6935 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21954225 +ZEB1 6935 Oral Submucous Fibrosis MESH:D009914 marker/mechanism 26934322 +ZEB1 6935 Ovarian Neoplasms MESH:D010051 marker/mechanism 18622689 +ZEB1 6935 Sezary Syndrome MESH:D012751 marker/mechanism 26551670 +ZEB1 6935 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +ZEB1B 114425 Brain Neoplasms MESH:D001932 marker/mechanism 27935819 +ZEB2 9839 Breast Neoplasms MESH:D001943 marker/mechanism 19839049 +ZEB2 9839 Cell Transformation, Neoplastic MESH:D002471 marker/mechanism 21954225 +ZEB2 9839 Cerebellar Diseases MESH:D002526 marker/mechanism 29326173 +ZEB2 9839 Disease Progression MESH:D018450 marker/mechanism 19839049 +ZEB2 9839 Heart Defects, Congenital MESH:D006330 marker/mechanism 17478475 +ZEB2 9839 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ZEB2 9839 Motor Disorders MESH:D000068079 marker/mechanism 29326173 +ZEB2 9839 Mowat-Wilson syndrome MESH:C536990 marker/mechanism 235730.0 15006694|17103451|17478475 +ZEB2 9839 Neoplasm Invasiveness MESH:D009361 marker/mechanism 21954225 +ZEB2 9839 Thyroid Cancer, Papillary MESH:D000077273 marker/mechanism 28030816 +ZEB2-AS1 100303491 Heart Failure MESH:D006333 marker/mechanism 36071497 +ZFAND3 60685 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ZFAND3 60685 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 22158537 +ZFAND5 7763 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +ZFAND6 54469 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +ZFAND6 54469 Delayed Emergence from Anesthesia MESH:D055191 marker/mechanism 16115977 +ZFAND6 54469 Skin Diseases MESH:D012871 marker/mechanism 16835338 +ZFAS1 441951 Colorectal Neoplasms MESH:D015179 marker/mechanism 35072892 +ZFAS1 441951 Neoplasm Invasiveness MESH:D009361 marker/mechanism 35072892 +ZFAT 57623 Thyroiditis, Autoimmune MESH:D013967 marker/mechanism 608175.0 +ZFC3H1 196441 Arthritis, Juvenile MESH:D001171 marker/mechanism 19565504 +ZFHX3 463 Atrial Fibrillation MESH:D001281 marker/mechanism 19597491|19597492|22544366|29892015|30061737 +ZFHX3 463 Ischemic Stroke MESH:D000083242 marker/mechanism 19597491 +ZFHX3 463 Obesity MESH:D009765 marker/mechanism 29273807 +ZFHX3 463 Prostatic Neoplasms MESH:D011471 marker/mechanism 176807.0 16637072|17013881|29610475 +ZFHX3 463 Stroke MESH:D020521 marker/mechanism 29531354 +ZFHX4 79776 Ptosis, Hereditary Congenital 1 MESH:C566737 marker/mechanism 178300.0 +ZFP110 65020 Nerve Degeneration MESH:D009410 marker/mechanism 18815271 +ZFP36 7538 Alopecia MESH:D000505 marker/mechanism 15944294 +ZFP36 7538 Arthritis MESH:D001168 marker/mechanism 15944294 +ZFP36 7538 Cachexia MESH:D002100 marker/mechanism 12756304|15944294 +ZFP36 7538 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ZFP36 7538 Dermatitis MESH:D003872 marker/mechanism 15944294 +ZFP36 7538 Hyperplasia MESH:D006965 marker/mechanism 15944294 +ZFP36 7538 Inflammation MESH:D007249 marker/mechanism 12756304 +ZFP36 7538 Myocardial Ischemia MESH:D017202 marker/mechanism 16214533 +ZFP36 7538 Neoplasm Invasiveness MESH:D009361 therapeutic 25556371 +ZFP366 238803 Breast Neoplasms MESH:D001943 marker/mechanism 21122099 +ZFP36L2 678 Colorectal Neoplasms MESH:D015179 marker/mechanism 25944804 +ZFP36L2 678 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma MESH:D054218 marker/mechanism 28671688 +ZFP36L2 678 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +ZFP37 7539 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ZFP532 328977 Heart Failure, Diastolic MESH:D054144 marker/mechanism 29556499 +ZFP57 346171 Diabetes Mellitus MESH:D003920 marker/mechanism 18622393 +ZFP57 346171 Diabetes Mellitus, Transient Neonatal, 1 MESH:C563322 marker/mechanism 601410.0 +ZFP91 80829 Hypothermia MESH:D007035 therapeutic 34942311 +ZFPM2 23414 46,XY SEX REVERSAL 9 OMIM:616067 marker/mechanism 616067.0 +ZFPM2 23414 Diaphragmatic Hernia 3 MESH:C565710 marker/mechanism 610187.0 +ZFPM2 23414 Hernia, Diaphragmatic MESH:D006548 marker/mechanism 17436238 +ZFPM2 23414 Tetralogy of Fallot MESH:D013771 marker/mechanism 187500.0 +ZFR 51663 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34323000 +ZFR 51663 Thyroid Neoplasms MESH:D013964 marker/mechanism 34323000 +ZFR2 23217 Obesity MESH:D009765 marker/mechanism 29273807 +ZFYVE16 9765 Liver Cirrhosis, Experimental MESH:D008106 marker/mechanism 25380136 +ZFYVE26 23503 Spastic paraplegia 15, autosomal recessive MESH:C536642 marker/mechanism 270700.0 +ZFYVE27 118813 Spastic Paraplegia 33, Autosomal Dominant MESH:C565214 marker/mechanism 610244.0 +ZIC1 7545 Craniosynostoses MESH:D003398 marker/mechanism 616602.0 +ZIC2 7546 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ZIC2 7546 Holoprosencephaly 5 MESH:C566464 marker/mechanism 609637.0 +ZIC2 7546 Neural Tube Defects MESH:D009436 marker/mechanism 15136147 +ZIC2 7546 Prostatic Neoplasms MESH:D011471 marker/mechanism 17173048 +ZIC3 7547 Bone Diseases, Developmental MESH:D001848 marker/mechanism 17127413 +ZIC3 7547 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17127413 +ZIC3 7547 Dextrocardia MESH:D003914 marker/mechanism 17127413 +ZIC3 7547 Facial Asymmetry MESH:D005146 marker/mechanism 17127413 +ZIC3 7547 Heterotaxy, visceral, X-linked MESH:C538116 marker/mechanism 306955.0 +ZIC3 7547 VACTERL Association With Hydrocephalus MESH:C564751 marker/mechanism 314390.0 +ZIC4 84107 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ZIC5 85416 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ZIC5 85416 Craniofacial Abnormalities MESH:D019465 marker/mechanism 15136147 +ZIC5 85416 Neural Tube Defects MESH:D009436 marker/mechanism 15136147 +ZIM2 23619 Carcinoma, Adenoid Cystic MESH:D003528 marker/mechanism 16762588 +ZIM2 23619 Salivary Gland Neoplasms MESH:D012468 marker/mechanism 16762588 +ZK262.8 191270 Hypoxia MESH:D000860 therapeutic 19936206 +ZKSCAN3 80317 Colorectal Neoplasms MESH:D015179 marker/mechanism 18519692 +ZKSCAN4 387032 Schizophrenia MESH:D012559 marker/mechanism 22037552 +ZMAT3 64393 Nerve Degeneration MESH:D009410 marker/mechanism 17234339 +ZMIZ1 57178 Celiac Disease MESH:D002446 marker/mechanism 20190752 +ZMIZ1 57178 Colorectal Neoplasms MESH:D015179 marker/mechanism 24836286 +ZMIZ1 57178 Osteosarcoma MESH:D012516 marker/mechanism 34508303 +ZMIZ1-AS1 283050 Disease Progression MESH:D018450 marker/mechanism 34508303 +ZMIZ1-AS1 283050 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34508303 +ZMIZ1-AS1 283050 Osteosarcoma MESH:D012516 marker/mechanism 34508303 +ZMPSTE24 10269 Acro-Osteolysis MESH:D030981 marker/mechanism 12913070|17152860 +ZMPSTE24 10269 Craniofacial Abnormalities MESH:D019465 marker/mechanism 17152860 +ZMPSTE24 10269 Glomerulosclerosis, Focal Segmental MESH:D005923 marker/mechanism 17152860 +ZMPSTE24 10269 HIV-Associated Lipodystrophy Syndrome MESH:D039682 marker/mechanism 18230615 +ZMPSTE24 10269 Lipodystrophy MESH:D008060 marker/mechanism 12913070 +ZMPSTE24 10269 Mandibular Diseases MESH:D008336 marker/mechanism 12913070 +ZMPSTE24 10269 Mandibuloacral dysplasia with type B lipodystrophy MESH:C535706 marker/mechanism 608612.0 +ZMPSTE24 10269 Progeria MESH:D011371 marker/mechanism 23217256 +ZMPSTE24 10269 Tight skin contracture syndrome, lethal MESH:C536920 marker/mechanism 275210.0 +ZMYM2 7750 Intellectual Disability MESH:D008607 marker/mechanism 28191889 +ZMYM2 7750 Myeloproliferative Disorders MESH:D009196 marker/mechanism 22875613 +ZMYM3 9203 Prostatic Neoplasms MESH:D011471 marker/mechanism 24763052|29610475|29662167 +ZMYM5 9205 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ZMYND10 51364 CILIARY DYSKINESIA, PRIMARY, 22 OMIM:615444 marker/mechanism 615444.0 +ZMYND11 10771 Autistic Disorder MESH:D001321 marker/mechanism 25217958 +ZMYND11 10771 INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 30, WITH SPEECH DELAY AND BEHAVIORAL ABNORMALITIES OMIM:616083 marker/mechanism 616083.0 +ZMYND15 84225 SPERMATOGENIC FAILURE 14 OMIM:615842 marker/mechanism 615842.0 +ZNF148 7707 GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES OMIM:617260 marker/mechanism 617260.0 +ZNF160 90338 Prostatic Neoplasms MESH:D011471 marker/mechanism 17199135 +ZNF160 90338 Stomach Neoplasms MESH:D013274 marker/mechanism 19424620 +ZNF169 169841 Obesity MESH:D009765 marker/mechanism 29273807 +ZNF177 7730 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +ZNF205 7755 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ZNF217 7764 Prostatic Neoplasms, Castration-Resistant MESH:D064129 marker/mechanism 29581250 +ZNF23 7571 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 21965783 +ZNF257 113835 Diabetes Mellitus, Type 2 MESH:D003924 marker/mechanism 30718926 +ZNF267 10308 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +ZNF267 10308 Multiple Sclerosis MESH:D009103 marker/mechanism 31068361 +ZNF267 10308 Skin Diseases MESH:D012871 marker/mechanism 16835338 +ZNF292 23036 Colorectal Neoplasms MESH:D015179 marker/mechanism 25559195 +ZNF292 23036 Neurodevelopmental Disorders MESH:D065886 marker/mechanism 28191889 +ZNF292 23036 Prostatic Neoplasms MESH:D011471 marker/mechanism 29610475|29662167 +ZNF331 55422 Arsenic Poisoning MESH:D020261 marker/mechanism 16835338 +ZNF331 55422 Skin Diseases MESH:D012871 marker/mechanism 16835338 +ZNF335 63925 MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE OMIM:615095 marker/mechanism 615095.0 +ZNF365 22891 Breast Neoplasms MESH:D001943 marker/mechanism 21278746 +ZNF365 22891 Dermatitis, Atopic MESH:D003876 marker/mechanism 23042114 +ZNF365 22891 NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO OMIM:605990 marker/mechanism 605990.0 +ZNF366 167465 Breast Neoplasms MESH:D001943 marker/mechanism 20008677 +ZNF366 167465 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ZNF367 195828 Colorectal Neoplasms MESH:D015179 marker/mechanism 34351699 +ZNF367 195828 Neoplasm Invasiveness MESH:D009361 marker/mechanism 34351699 +ZNF367 195828 Prostatic Neoplasms, Castration-Resistant MESH:D064129 marker/mechanism 29581250 +ZNF385D 79750 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +ZNF385D 79750 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ZNF404 342908 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +ZNF408 79797 EXUDATIVE VITREORETINOPATHY 6 OMIM:616468 marker/mechanism 616468.0 +ZNF408 79797 RETINITIS PIGMENTOSA 72 OMIM:616469 marker/mechanism 616469.0 +ZNF41 7592 Cognition Disorders MESH:D003072 marker/mechanism 14628291 +ZNF41 7592 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 14628291 +ZNF423 23090 Amphetamine-Related Disorders MESH:D019969 marker/mechanism 18316681 +ZNF423 23090 NEPHRONOPHTHISIS 14 OMIM:614844 marker/mechanism 614844.0 +ZNF430 80264 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ZNF432 9668 Breast Neoplasms MESH:D001943 marker/mechanism 18507500 +ZNF432 9668 Colorectal Neoplasms MESH:D015179 marker/mechanism 18507500 +ZNF438 220929 Melanoma MESH:D008545 marker/mechanism 22535842 +ZNF462 58499 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +ZNF462 58499 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 29059373 +ZNF469 84627 Brittle cornea syndrome 1 MESH:C536192 marker/mechanism 229200.0 18452888 +ZNF469 84627 Corneal Diseases MESH:D003316 marker/mechanism 18452888 +ZNF469 84627 Joint Instability MESH:D007593 marker/mechanism 18452888 +ZNF469 84627 Skin Abnormalities MESH:D012868 marker/mechanism 18452888 +ZNF480 147657 Schizophrenia MESH:D012559 marker/mechanism 21743468 +ZNF513 130557 RETINITIS PIGMENTOSA 58 OMIM:613617 marker/mechanism 613617.0 +ZNF526 116115 Intellectual Disability MESH:D008607 marker/mechanism 21937992 +ZNF530 348327 Schizophrenia MESH:D012559 marker/mechanism 21822266 +ZNF536 9745 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 23797736 +ZNF559 84527 Stomach Neoplasms MESH:D013274 marker/mechanism 16367923 +ZNF565 147929 Schizophrenia MESH:D012559 marker/mechanism 21743468 +ZNF569 148266 Colorectal Neoplasms MESH:D015179 marker/mechanism 21278247 +ZNF592 9640 Bipolar Disorder MESH:D001714 marker/mechanism 31043756 +ZNF592 9640 Spinocerebellar ataxia, autosomal recessive 5 MESH:C537311 marker/mechanism 20531441 +ZNF593 51042 Disease Progression MESH:D018450 marker/mechanism 21364753 +ZNF593 51042 Stomach Neoplasms MESH:D013274 marker/mechanism 21364753 +ZNF595 152687 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29054765 +ZNF595 152687 Lung Neoplasms MESH:D008175 marker/mechanism 29054765 +ZNF606 80095 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ZNF609 23060 Urinary Bladder Neoplasms MESH:D001749 marker/mechanism 35567596 +ZNF644 84146 Acute Kidney Injury MESH:D058186 marker/mechanism 36052886 +ZNF644 84146 MYOPIA 21, AUTOSOMAL DOMINANT OMIM:614167 marker/mechanism 614167.0 +ZNF658 26149 Skin Diseases MESH:D012871 marker/mechanism 28720099 +ZNF667-AS1 100128252 Bile Duct Neoplasms MESH:D001650 marker/mechanism 29707199 +ZNF667-AS1 100128252 Breast Neoplasms MESH:D001943 marker/mechanism 28690657 +ZNF667-AS1 100128252 Carcinosarcoma MESH:D002296 marker/mechanism 29707199 +ZNF667-AS1 100128252 Esophageal Neoplasms MESH:D004938 marker/mechanism 29707199 +ZNF667-AS1 100128252 Mesothelioma MESH:D008654 marker/mechanism 29707199 +ZNF667-AS1 100128252 Sarcoma MESH:D012509 marker/mechanism 29707199 +ZNF667-AS1 100128252 Stomach Neoplasms MESH:D013274 marker/mechanism 29707199 +ZNF667-AS1 100128252 Uterine Cervical Neoplasms MESH:D002583 marker/mechanism 29707199 +ZNF667-AS1 100128252 Uveal melanoma MESH:C536494 therapeutic 33512044 +ZNF668 79759 Ependymoma MESH:D004806 marker/mechanism 26075792 +ZNF674 641339 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 16385466 +ZNF676 163223 Thyroid Diseases MESH:D013959 marker/mechanism 23397585 +ZNF683 257101 Chloracne MESH:D054506 marker/mechanism 17101203 +ZNF687 57592 Osteitis Deformans MESH:D010001 marker/mechanism 616833.0 +ZNF711 7552 Mental Retardation, X-Linked MESH:D038901 marker/mechanism 19377476 +ZNF750 79755 Seborrhea-Like Dermatitis with Psoriasiform Elements MESH:C565217 marker/mechanism 610227.0 +ZNF765 91661 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 25401301 +ZNF804A 91752 Carcinoma, Renal Cell MESH:D002292 marker/mechanism 22138691 +ZNF804A 91752 Schizophrenia MESH:D012559 marker/mechanism 18677311 +ZNF804A 91752 Substance-Related Disorders MESH:D019966 marker/mechanism 20098672 +ZNF812P 729648 Genetic Predisposition to Disease MESH:D020022 marker/mechanism 29054765 +ZNF812P 729648 Lung Neoplasms MESH:D008175 marker/mechanism 29054765 +ZNF816 125893 Psoriasis MESH:D011565 marker/mechanism 20953187|24212883 +ZNF831 128611 Melanoma MESH:D008545 marker/mechanism 21499247 +ZNHIT3 9326 PEHO syndrome MESH:C536317 marker/mechanism 260565.0 +ZNRF3 84133 Adrenocortical Carcinoma MESH:D018268 marker/mechanism 24747642 +ZNRF3 84133 Pancreatic Neoplasms MESH:D010190 marker/mechanism 25086665|26098869 +ZP1 22917 OOCYTE/ZYGOTE/EMBRYO MATURATION ARREST 1 OMIM:615774 marker/mechanism 615774.0 +ZPBP2 124626 Atrial Fibrillation MESH:D001281 marker/mechanism 29892015 +ZRSR2 8233 Leukemia, Myelomonocytic, Juvenile MESH:D054429 marker/mechanism 26457647 +ZRSR2 8233 Myelodysplastic Syndromes MESH:D009190 marker/mechanism 27992414 +ZSCAN22 342945 Liver Neoplasms MESH:D008113 marker/mechanism 19233941 +ZSCAN31 64288 Carcinoma, Non-Small-Cell Lung MESH:D002289 marker/mechanism 28722770 +ZSWIM5 57643 Breast Neoplasms MESH:D001943 marker/mechanism 29915430 +ZSWIM6 57688 Acromelic Frontonasal Dysostosis MESH:C566345 marker/mechanism 603671.0 +ZSWIM9 374920 Polycystic Ovary Syndrome MESH:D011085 marker/mechanism 21411543 +ZW10 9183 Osteosarcoma MESH:D012516 marker/mechanism 14767549 +ZWILCH 55055 Weight Gain MESH:D015430 marker/mechanism 19030233 +ZWINT 11130 Carcinoma, Hepatocellular MESH:D006528 marker/mechanism 28284560 +ZYX 7791 Colorectal Neoplasms MESH:D015179 marker/mechanism 30697742 +ZZZ3 26009 Pancreatic Carcinoma MESH:C562463 marker/mechanism 34686948